{
  "nbformat": 4,
  "nbformat_minor": 0,
  "metadata": {
    "colab": {
      "name": "finetune.ipynb",
      "version": "0.3.2",
      "provenance": [],
      "collapsed_sections": [],
      "include_colab_link": true
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    },
    "accelerator": "GPU"
  },
  "cells": [
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "view-in-github",
        "colab_type": "text"
      },
      "source": [
        "<a href=\"https://colab.research.google.com/github/L-ENA/LSTM-PICO-Detection/blob/master/finetune.ipynb\" target=\"_parent\"><img src=\"https://colab.research.google.com/assets/colab-badge.svg\" alt=\"Open In Colab\"/></a>"
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "sHC2E5NBAkUG",
        "colab_type": "code",
        "outputId": "d235777a-0082-4d7f-e6df-5b3b556b8dfd",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 389
        }
      },
      "source": [
        "from google.colab import drive\n",
        "drive.mount('/content/drive')\n",
        "!pip install bert\n",
        "!rm -rf bert\n",
        "!pip install bert-tensorflow\n",
        "import tensorflow as tf\n",
        "import os\n",
        "import collections\n",
        "import pandas as pd\n",
        "\n",
        "import tensorflow_hub as hub\n",
        "from datetime import datetime\n",
        "\n",
        "import bert\n",
        "from bert import run_classifier\n",
        "from bert import optimization\n",
        "from bert import tokenization\n",
        "from bert import modeling\n",
        "\n",
        "\n",
        "from google.colab import drive\n",
        "drive.mount('/content/drive')\n",
        "\n",
        "!git clone https://github.com/google-research/bert\n",
        "import sys\n",
        "sys.path.append('bert/')\n",
        "from __future__ import absolute_import\n",
        "from __future__ import division\n",
        "from __future__ import print_function\n",
        "import codecs\n",
        "\n",
        "import json\n",
        "import re\n",
        "\n",
        "import pprint\n",
        "import numpy as np\n",
        "TPU_ADDRESS=''\n",
        "####################set tpu adress\n",
        "assert 'COLAB_TPU_ADDR' in os.environ, 'ERROR: Not connected to a TPU runtime; please see the first cell in this notebook for instructions!'\n",
        "TPU_ADDRESS = 'grpc://' + os.environ['COLAB_TPU_ADDR']\n",
        "print('TPU address is', TPU_ADDRESS)\n",
        "\n",
        "from google.colab import auth\n",
        "auth.authenticate_user()\n",
        "with tf.Session(TPU_ADDRESS) as session:\n",
        "  print('TPU devices:')\n",
        "  pprint.pprint(session.list_devices())\n",
        "\n",
        "  # Upload credentials to TPU.\n",
        "  with open('/content/adc.json', 'r') as f:\n",
        "    auth_info = json.load(f)\n",
        "  tf.contrib.cloud.configure_gcs(session, credentials=auth_info)\n",
        "  # Now credentials are set for all future sessions on this TPU.\n",
        "  \n"
      ],
      "execution_count": 48,
      "outputs": [
        {
          "output_type": "stream",
          "text": [
            "Requirement already satisfied: bert-tensorflow in /usr/local/lib/python3.6/dist-packages (1.0.1)\n",
            "Requirement already satisfied: six in /usr/local/lib/python3.6/dist-packages (from bert-tensorflow) (1.12.0)\n",
            "Drive already mounted at /content/drive; to attempt to forcibly remount, call drive.mount(\"/content/drive\", force_remount=True).\n",
            "Cloning into 'bert'...\n",
            "remote: Enumerating objects: 333, done.\u001b[K\n",
            "remote: Total 333 (delta 0), reused 0 (delta 0), pack-reused 333\u001b[K\n",
            "Receiving objects: 100% (333/333), 279.30 KiB | 7.98 MiB/s, done.\n",
            "Resolving deltas: 100% (183/183), done.\n"
          ],
          "name": "stdout"
        },
        {
          "output_type": "error",
          "ename": "AssertionError",
          "evalue": "ignored",
          "traceback": [
            "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
            "\u001b[0;31mAssertionError\u001b[0m                            Traceback (most recent call last)",
            "\u001b[0;32m<ipython-input-48-59f6e4f4017c>\u001b[0m in \u001b[0;36m<module>\u001b[0;34m()\u001b[0m\n\u001b[1;32m     37\u001b[0m \u001b[0mTPU_ADDRESS\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0;34m''\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     38\u001b[0m \u001b[0;31m####################set tpu adress\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m---> 39\u001b[0;31m \u001b[0;32massert\u001b[0m \u001b[0;34m'COLAB_TPU_ADDR'\u001b[0m \u001b[0;32min\u001b[0m \u001b[0mos\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0menviron\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m'ERROR: Not connected to a TPU runtime; please see the first cell in this notebook for instructions!'\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m     40\u001b[0m \u001b[0mTPU_ADDRESS\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0;34m'grpc://'\u001b[0m \u001b[0;34m+\u001b[0m \u001b[0mos\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0menviron\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;34m'COLAB_TPU_ADDR'\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     41\u001b[0m \u001b[0mprint\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m'TPU address is'\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mTPU_ADDRESS\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;31mAssertionError\u001b[0m: ERROR: Not connected to a TPU runtime; please see the first cell in this notebook for instructions!"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "jmi79d-Tgmd5",
        "colab_type": "code",
        "colab": {}
      },
      "source": [
        ""
      ],
      "execution_count": 0,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "2Wd0IYoRcof9",
        "colab_type": "code",
        "colab": {}
      },
      "source": [
        "######Bert models from git\n",
        "#BERT_MODEL = 'uncased_L-12_H-768_A-12'\n",
        "#BERT_PRETRAINED_DIR = 'gs://cloud-tpu-checkpoints/bert/' + BERT_MODEL\n",
        "#print('***** BERT pretrained directory: {} *****'.format(BERT_PRETRAINED_DIR))\n",
        "#!gsutil ls $BERT_PRETRAINED_DIR\n",
        "\n",
        "###############################################scibert further pretrained model\n",
        "#Bert from drive\n",
        "#BERT_MODEL = 'uncased_L-12_H-768_A-12'\n",
        "BERT_PRETRAINED_DIR = '/content/drive/My Drive/scibert_scivocab_uncased'\n",
        "#print('***** BERT pretrained directory: {} *****'.format(BERT_PRETRAINED_DIR))\n",
        "#!gsutil ls $BERT_PRETRAINED_DIR\n",
        "\n",
        "###############################################Finetuned on basis of normal bert\n",
        "#Bert from drive\n",
        "##BERT_MODEL = 'uncased_L-12_H-768_A-12'\n",
        "#BERT_PRETRAINED_DIR = '/content/drive/My Drive/finetunedJinBase/output'\n",
        "#print('***** BERT pretrained directory: {} *****'.format(BERT_PRETRAINED_DIR))\n",
        "\n",
        "#BERT_MODEL = 'uncased_L-12_H-768_A-12'###when uing finetuned from base\n",
        "#BERT_BASE = 'gs://cloud-tpu-checkpoints/bert/' + BERT_MODEL\n",
        "\n",
        "#BERT_BASE='/content/drive/My Drive/scibert_scivocab_uncased'#use this when using scibert as base\n",
        "\n",
        "#!gsutil ls $BERT_BASE"
      ],
      "execution_count": 0,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "wS0tWtYMc22j",
        "colab_type": "code",
        "outputId": "a971a0e7-6f00-4c4e-93ef-ff3fd41a8aa4",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 72
        }
      },
      "source": [
        "\n",
        "import os\n",
        "import collections\n",
        "import pandas as pd\n",
        "import tensorflow as tf\n",
        "import tensorflow_hub as hub\n",
        "from datetime import datetime\n",
        "import numpy as np\n",
        "\n",
        "import sklearn.utils\n",
        "import logging\n",
        "from imp import reload\n",
        "\n",
        "\n",
        "\n",
        "\n",
        "####################################################################PARAMS####SETUP\n",
        "MAX_SEQ_LENGTH = 64#128 orig\n",
        "\n",
        "\n",
        "# Compute train and warmup steps from batch size\n",
        "# These hyperparameters are copied from this colab notebook (https://colab.sandbox.google.com/github/tensorflow/tpu/blob/master/tools/colab/bert_finetuning_with_cloud_tpus.ipynb)\n",
        "BATCH_SIZE = 32#32\n",
        "LEARNING_RATE = 2e-5#2-5\n",
        "NUM_TRAIN_EPOCHS = 1.0\n",
        "\n",
        "# Warmup is a period of time where hte learning rate \n",
        "# is small and gradually increases--usually helps training.\n",
        "WARMUP_PROPORTION = 0.1\n",
        "# Model configs\n",
        "SAVE_CHECKPOINTS_STEPS = 1000\n",
        "SAVE_SUMMARY_STEPS = 500\n",
        "\n",
        "NUM_TPU_CORES = 8\n",
        "\n",
        "MODE='n'\n",
        "#MODE = 'EVAL'\n",
        "#MODE='FINETUNE'\n",
        "\n",
        "if MODE=='GIT':#use original vocab and config file from github when using the finetuned models\n",
        "  BERT_VOCAB= BERT_BASE + '/vocab.txt'#Contains model vocabulary [ words to indexes mapping]\n",
        "  BERT_CONFIG = BERT_BASE + '/bert_config.json'\n",
        "  BERT_INIT_CHKPNT = BERT_PRETRAINED_DIR + '/model.ckpt-3585'\n",
        "elif MODE=='EVAL':\n",
        "  BERT_CONFIG = BERT_PRETRAINED_DIR + '/bert_config.json'\n",
        "  BERT_VOCAB= BERT_PRETRAINED_DIR + '/vocab.txt'#Contains model vocabulary [ words to indexes mapping]\n",
        "  BERT_INIT_CHKPNT = BERT_PRETRAINED_DIR + '/bert_model.ckpt'\n",
        "  \n",
        "else:\n",
        "  BERT_CONFIG = BERT_PRETRAINED_DIR + '/bert_config.json'\n",
        "  BERT_VOCAB= BERT_PRETRAINED_DIR + '/vocab.txt'#Contains model vocabulary [ words to indexes mapping]\n",
        "  #BERT_INIT_CHKPNT = BERT_PRETRAINED_DIR + '/bert_model.ckpt'\n",
        "  BERT_INIT_CHKPNT ='/content/drive/My Drive/scibert_scivocab_uncased/bert_model.ckpt'\n",
        "\n",
        "MODE = 'FINETUNE' \n",
        "print(BERT_INIT_CHKPNT)\n",
        "print(BERT_VOCAB)\n",
        "print(BERT_CONFIG)\n",
        "\n",
        "trainDat = '/content/drive/My Drive/dataframes/dfTRAINjin.df'##original csv files from toxic comment example\n",
        "devDat = '/content/drive/My Drive/dataframes/dfDEVjin.df'\n",
        "testDat = '/content/drive/My Drive/dataframes/dfTESTcszg.df'\n",
        "\n",
        "OUTPUT_DIR = \"/content/drive/My Drive/finetuned/output\"\n",
        "\n",
        "TRAIN_MINI=False#use unly subaset od data while developing model\n",
        "NR_TRAIN=250\n",
        "NR_TEST=100\n",
        "\n",
        "#################Logger setup\n",
        "reload(logging)\n",
        "\n",
        "LOG_FILENAME = os.path.join(OUTPUT_DIR, 'BERTlog.txt')\n",
        "\n",
        "\n",
        "logging.basicConfig(level=logging.DEBUG,\n",
        "                    format='%(asctime)s %(levelname)s %(message)s',\n",
        "                    filename=LOG_FILENAME,\n",
        "                    filemode='a')\n",
        "logging.info('------------------------------------------------------------------------------------------------------NEW Finetune')\n",
        "logging.info('Finetuning bert')\n",
        "\n",
        "logging.info('MAX_SEQ_LENGTH {}, BATCH_SIZE {}, LEARNING_RATE {}, NUM_TRAIN_EPOCHS {}, OUTPUT_DIR {}'.format(MAX_SEQ_LENGTH, BATCH_SIZE, LEARNING_RATE, NUM_TRAIN_EPOCHS, OUTPUT_DIR))\n",
        "######################################################################################################get the data\n",
        "\n"
      ],
      "execution_count": 102,
      "outputs": [
        {
          "output_type": "stream",
          "text": [
            "/content/drive/My Drive/scibert_scivocab_uncased/bert_model.ckpt\n",
            "/content/drive/My Drive/scibert_scivocab_uncased/vocab.txt\n",
            "/content/drive/My Drive/scibert_scivocab_uncased/bert_config.json\n"
          ],
          "name": "stdout"
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "TDT58POWuxHp",
        "colab_type": "code",
        "colab": {}
      },
      "source": [
        ""
      ],
      "execution_count": 0,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "Q23yMcxdCDu5",
        "colab_type": "code",
        "colab": {}
      },
      "source": [
        "\n",
        "  \n",
        "class InputExample(object):\n",
        "    \"\"\"A single training/test example for simple sequence classification.\"\"\"\n",
        "\n",
        "    def __init__(self, guid, text_a, text_b=None, labels=None):\n",
        "        \"\"\"Constructs a InputExample.\n",
        "\n",
        "        Args:\n",
        "            guid: Unique id for the example.\n",
        "            text_a: string. The untokenized text of the first sequence. For single\n",
        "            sequence tasks, only this sequence must be specified.\n",
        "            text_b: (Optional) string. The untokenized text of the second sequence.\n",
        "            Only must be specified for sequence pair tasks.\n",
        "            labels: (Optional) [string]. The label of the example. This should be\n",
        "            specified for train and dev examples, but not for test examples.\n",
        "        \"\"\"\n",
        "        self.guid = guid\n",
        "        self.text_a = text_a\n",
        "        self.text_b = text_b\n",
        "        self.labels = labels\n",
        "\n",
        "\n",
        "class InputFeatures(object):\n",
        "    \"\"\"A single set of features of data.\"\"\"\n",
        "\n",
        "    def __init__(self, input_ids, input_mask, segment_ids, label_ids, is_real_example=True):\n",
        "        self.input_ids = input_ids\n",
        "        self.input_mask = input_mask\n",
        "        self.segment_ids = segment_ids\n",
        "        self.label_ids = label_ids,\n",
        "        self.is_real_example=is_real_example\n",
        "        \n",
        "def create_examples(df, labels_available=True, nr_labels=7):\n",
        "    \"\"\" Reads input df and gives examples in the right formant\n",
        "    Creates examples for the training and dev sets.\"\"\"\n",
        "    examples = []\n",
        "    for (i, row) in enumerate(df.values):\n",
        "        guid = row[0]\n",
        "        text_a = row[1]\n",
        "        if labels_available:\n",
        "            labels = row[2:]\n",
        "        else:\n",
        "            labels = [0,0,0,0,0,0, 0]\n",
        "        examples.append(\n",
        "            InputExample(guid=guid, text_a=text_a, labels=labels))\n",
        "    return examples\n",
        "\n",
        "###########################################\n",
        "def convert_examples_to_features(examples,  max_seq_length, tokenizer):\n",
        "    \"\"\"Loads a data file into a list of `InputBatch`s.\"\"\"\n",
        "\n",
        "    features = []\n",
        "    for (ex_index, example) in enumerate(examples):\n",
        "        print(example.text_a)\n",
        "        tokens_a = tokenizer.tokenize(example.text_a)\n",
        "\n",
        "        tokens_b = None\n",
        "        if example.text_b:\n",
        "            tokens_b = tokenizer.tokenize(example.text_b)\n",
        "            # Modifies `tokens_a` and `tokens_b` in place so that the total\n",
        "            # length is less than the specified length.\n",
        "            # Account for [CLS], [SEP], [SEP] with \"- 3\"\n",
        "            _truncate_seq_pair(tokens_a, tokens_b, max_seq_length - 3)\n",
        "        else:\n",
        "            # Account for [CLS] and [SEP] with \"- 2\"\n",
        "            if len(tokens_a) > max_seq_length - 2:\n",
        "                tokens_a = tokens_a[:(max_seq_length - 2)]\n",
        "\n",
        "        # The convention in BERT is:\n",
        "        # (a) For sequence pairs:\n",
        "        #  tokens:   [CLS] is this jack ##son ##ville ? [SEP] no it is not . [SEP]\n",
        "        #  type_ids: 0   0  0    0    0     0       0 0    1  1  1  1   1 1\n",
        "        # (b) For single sequences:\n",
        "        #  tokens:   [CLS] the dog is hairy . [SEP]\n",
        "        #  type_ids: 0   0   0   0  0     0 0\n",
        "        #\n",
        "        # Where \"type_ids\" are used to indicate whether this is the first\n",
        "        # sequence or the second sequence. The embedding vectors for `type=0` and\n",
        "        # `type=1` were learned during pre-training and are added to the wordpiece\n",
        "        # embedding vector (and position vector). This is not *strictly* necessary\n",
        "        # since the [SEP] token unambigiously separates the sequences, but it makes\n",
        "        # it easier for the model to learn the concept of sequences.\n",
        "        #\n",
        "        # For classification tasks, the first vector (corresponding to [CLS]) is\n",
        "        # used as as the \"sentence vector\". Note that this only makes sense because\n",
        "        # the entire model is fine-tuned.\n",
        "        tokens = [\"[CLS]\"] + tokens_a + [\"[SEP]\"]\n",
        "        segment_ids = [0] * len(tokens)\n",
        "\n",
        "        if tokens_b:\n",
        "            tokens += tokens_b + [\"[SEP]\"]\n",
        "            segment_ids += [1] * (len(tokens_b) + 1)\n",
        "\n",
        "        input_ids = tokenizer.convert_tokens_to_ids(tokens)\n",
        "\n",
        "        # The mask has 1 for real tokens and 0 for padding tokens. Only real\n",
        "        # tokens are attended to.\n",
        "        input_mask = [1] * len(input_ids)\n",
        "\n",
        "        # Zero-pad up to the sequence length.\n",
        "        padding = [0] * (max_seq_length - len(input_ids))\n",
        "        input_ids += padding\n",
        "        input_mask += padding\n",
        "        segment_ids += padding\n",
        "\n",
        "        assert len(input_ids) == max_seq_length\n",
        "        assert len(input_mask) == max_seq_length\n",
        "        assert len(segment_ids) == max_seq_length\n",
        "        \n",
        "        labels_ids = []\n",
        "        for label in example.labels:\n",
        "            labels_ids.append(int(label))\n",
        "\n",
        "        if ex_index < 0:\n",
        "            print(\"*** Example ***\")\n",
        "            print(\"guid: %s\" % (example.guid))\n",
        "            print(\"tokens: %s\" % \" \".join(\n",
        "                    [str(x) for x in tokens]))\n",
        "            print(\"input_ids: %s\" % \" \".join([str(x) for x in input_ids]))\n",
        "            print(\"input_mask: %s\" % \" \".join([str(x) for x in input_mask]))\n",
        "            print(\n",
        "                    \"segment_ids: %s\" % \" \".join([str(x) for x in segment_ids]))\n",
        "            print(\"label: %s (id = %s)\" % (example.labels, labels_ids))\n",
        "\n",
        "        features.append(\n",
        "                InputFeatures(input_ids=input_ids,\n",
        "                              input_mask=input_mask,\n",
        "                              segment_ids=segment_ids,\n",
        "                              label_ids=labels_ids))\n",
        "    return features\n",
        "\n",
        "def create_model(bert_config, is_training, input_ids, input_mask, segment_ids,\n",
        "                 labels, num_labels, use_one_hot_embeddings):\n",
        "    \"\"\"Creates a classification model.\"\"\"\n",
        "    model = modeling.BertModel(\n",
        "        config=bert_config,\n",
        "        is_training=is_training,\n",
        "        input_ids=input_ids,\n",
        "        input_mask=input_mask,\n",
        "        token_type_ids=segment_ids,\n",
        "        use_one_hot_embeddings=use_one_hot_embeddings)\n",
        "\n",
        "    # In the demo, we are doing a simple classification task on the entire\n",
        "    # segment.\n",
        "    #\n",
        "    # If you want to use the token-level output, use model.get_sequence_output()\n",
        "    # instead.\n",
        "    output_layer = model.get_pooled_output()\n",
        "\n",
        "    hidden_size = output_layer.shape[-1].value\n",
        "\n",
        "    output_weights = tf.get_variable(\n",
        "        \"output_weights\", [num_labels, hidden_size],\n",
        "        initializer=tf.truncated_normal_initializer(stddev=0.02))\n",
        "\n",
        "    output_bias = tf.get_variable(\n",
        "        \"output_bias\", [num_labels], initializer=tf.zeros_initializer())\n",
        "\n",
        "    with tf.variable_scope(\"loss\"):\n",
        "        if is_training:\n",
        "            # I.e., 0.1 dropout\n",
        "            output_layer = tf.nn.dropout(output_layer, keep_prob=0.9)\n",
        "\n",
        "        logits = tf.matmul(output_layer, output_weights, transpose_b=True)\n",
        "        logits = tf.nn.bias_add(logits, output_bias)\n",
        "        ######################################################################################\n",
        "        modePred ='x'\n",
        "        if modePred =='threshold':\n",
        "            # probabilities = tf.nn.softmax(logits, axis=-1) ### multiclass case\n",
        "            probabilities = tf.nn.sigmoid(logits)#### multi-label case\n",
        "\n",
        "            ####make predictions wrt threshold\n",
        "            def multi_label_hot(prediction, threshold=0.2):\n",
        "                print('Making predictions now ----------------------------------------------')\n",
        "                #prediction = tf.cast(prediction, tf.float32)\n",
        "                threshold = float(threshold)\n",
        "                return tf.cast(tf.greater(prediction, threshold), tf.int64)\n",
        "            probabilities= multi_label_hot(probabilities)#not actually probability anymore\n",
        "            \n",
        "        elif modePred =='max':\n",
        "            #probabilities = tf.nn.softmax(logits, axis=-1) ### multiclass case\n",
        "            probabilities = tf.nn.sigmoid(logits)#### multi-label case\n",
        "\n",
        "            ####make predictions wrt threshold\n",
        "            def single_label_hot(a):\n",
        "                print(a)\n",
        "                a = tf.cast(a, tf.float32)\n",
        "                one_hot = tf.one_hot(\n",
        "                    tf.argmax(a), \n",
        "                    7, \n",
        "                    on_value=1.0,\n",
        "                    off_value=0.0)# num classes\n",
        "                \n",
        "                return one_hot\n",
        "            probabilities= single_label_hot(probabilities)#not actually probability anymore    \n",
        "            \n",
        "        else:##original\n",
        "            probabilities = tf.nn.sigmoid(logits)\n",
        "            \n",
        "        #######################################################################################\n",
        "        labels = tf.cast(labels, tf.float32)\n",
        "        tf.logging.info(\"num_labels:{};logits:{};labels:{}\".format(num_labels, logits, labels))\n",
        "        per_example_loss = tf.nn.sigmoid_cross_entropy_with_logits(labels=labels, logits=logits)\n",
        "        loss = tf.reduce_mean(per_example_loss)\n",
        "\n",
        "        # probabilities = tf.nn.softmax(logits, axis=-1)\n",
        "        # log_probs = tf.nn.log_softmax(logits, axis=-1)\n",
        "        #\n",
        "        # one_hot_labels = tf.one_hot(labels, depth=num_labels, dtype=tf.float32)\n",
        "        #\n",
        "        # per_example_loss = -tf.reduce_sum(one_hot_labels * log_probs, axis=-1)\n",
        "        # loss = tf.reduce_mean(per_example_loss)\n",
        "\n",
        "        return (loss, per_example_loss, logits, probabilities)\n",
        "\n",
        "\n",
        "\n",
        "def input_fn_builder(features, seq_length, is_training, drop_remainder):\n",
        "  \"\"\"Creates an `input_fn` closure to be passed to TPUEstimator.\"\"\"\n",
        "\n",
        "  all_input_ids = []\n",
        "  all_input_mask = []\n",
        "  all_segment_ids = []\n",
        "  all_label_ids = []\n",
        "\n",
        "  for feature in features:\n",
        "    all_input_ids.append(feature.input_ids)\n",
        "    all_input_mask.append(feature.input_mask)\n",
        "    all_segment_ids.append(feature.segment_ids)\n",
        "    all_label_ids.append(feature.label_ids)\n",
        "\n",
        "  def input_fn(params):\n",
        "    \"\"\"The actual input function.\"\"\"\n",
        "    batch_size = params[\"batch_size\"]\n",
        "\n",
        "    num_examples = len(features)\n",
        "\n",
        "    # This is for demo purposes and does NOT scale to large data sets. We do\n",
        "    # not use Dataset.from_generator() because that uses tf.py_func which is\n",
        "    # not TPU compatible. The right way to load data is with TFRecordReader.\n",
        "    d = tf.data.Dataset.from_tensor_slices({\n",
        "        \"input_ids\":\n",
        "            tf.constant(\n",
        "                all_input_ids, shape=[num_examples, seq_length],\n",
        "                dtype=tf.int32),\n",
        "        \"input_mask\":\n",
        "            tf.constant(\n",
        "                all_input_mask,\n",
        "                shape=[num_examples, seq_length],\n",
        "                dtype=tf.int32),\n",
        "        \"segment_ids\":\n",
        "            tf.constant(\n",
        "                all_segment_ids,\n",
        "                shape=[num_examples, seq_length],\n",
        "                dtype=tf.int32),\n",
        "        \"label_ids\":\n",
        "            tf.constant(all_label_ids, shape=[num_examples, 7], dtype=tf.int32),################manually set to 6, change later!!\n",
        "    })\n",
        "\n",
        "    if is_training:\n",
        "      d = d.repeat()\n",
        "      d = d.shuffle(buffer_size=100)\n",
        "\n",
        "    d = d.batch(batch_size=batch_size, drop_remainder=drop_remainder)\n",
        "    return d\n",
        "\n",
        "  return input_fn\n",
        "\n",
        "class PaddingInputExample(object):\n",
        "    \"\"\"Fake example so the num input examples is a multiple of the batch size.\n",
        "    When running eval/predict on the TPU, we need to pad the number of examples\n",
        "    to be a multiple of the batch size, because the TPU requires a fixed batch\n",
        "    size. The alternative is to drop the last batch, which is bad because it means\n",
        "    the entire output data won't be generated.\n",
        "    We use this class instead of `None` because treating `None` as padding\n",
        "    battches could cause silent errors.\n",
        "    \"\"\"\n",
        "    \n",
        "def convert_single_example(ex_index, example, max_seq_length,\n",
        "                           tokenizer):\n",
        "    \"\"\"Converts a single `InputExample` into a single `InputFeatures`.\"\"\"\n",
        "\n",
        "    if isinstance(example, PaddingInputExample):\n",
        "        return InputFeatures(\n",
        "            input_ids=[0] * max_seq_length,\n",
        "            input_mask=[0] * max_seq_length,\n",
        "            segment_ids=[0] * max_seq_length,\n",
        "            label_ids=0,\n",
        "            is_real_example=False)\n",
        "\n",
        "    tokens_a = tokenizer.tokenize(str(example.text_a))\n",
        "    tokens_b = None\n",
        "    if example.text_b:\n",
        "        tokens_b = tokenizer.tokenize(example.text_b)\n",
        "\n",
        "    if tokens_b:\n",
        "        # Modifies `tokens_a` and `tokens_b` in place so that the total\n",
        "        # length is less than the specified length.\n",
        "        # Account for [CLS], [SEP], [SEP] with \"- 3\"\n",
        "        _truncate_seq_pair(tokens_a, tokens_b, max_seq_length - 3)\n",
        "    else:\n",
        "        # Account for [CLS] and [SEP] with \"- 2\"\n",
        "        if len(tokens_a) > max_seq_length - 2:\n",
        "            tokens_a = tokens_a[0:(max_seq_length - 2)]\n",
        "\n",
        "    # The convention in BERT is:\n",
        "    # (a) For sequence pairs:\n",
        "    #  tokens:   [CLS] is this jack ##son ##ville ? [SEP] no it is not . [SEP]\n",
        "    #  type_ids: 0     0  0    0    0     0       0 0     1  1  1  1   1 1\n",
        "    # (b) For single sequences:\n",
        "    #  tokens:   [CLS] the dog is hairy . [SEP]\n",
        "    #  type_ids: 0     0   0   0  0     0 0\n",
        "    #\n",
        "    # Where \"type_ids\" are used to indicate whether this is the first\n",
        "    # sequence or the second sequence. The embedding vectors for `type=0` and\n",
        "    # `type=1` were learned during pre-training and are added to the wordpiece\n",
        "    # embedding vector (and position vector). This is not *strictly* necessary\n",
        "    # since the [SEP] token unambiguously separates the sequences, but it makes\n",
        "    # it easier for the model to learn the concept of sequences.\n",
        "    #\n",
        "    # For classification tasks, the first vector (corresponding to [CLS]) is\n",
        "    # used as the \"sentence vector\". Note that this only makes sense because\n",
        "    # the entire model is fine-tuned.\n",
        "    tokens = []\n",
        "    segment_ids = []\n",
        "    tokens.append(\"[CLS]\")\n",
        "    segment_ids.append(0)\n",
        "    for token in tokens_a:\n",
        "        tokens.append(token)\n",
        "        segment_ids.append(0)\n",
        "    tokens.append(\"[SEP]\")\n",
        "    segment_ids.append(0)\n",
        "\n",
        "    if tokens_b:\n",
        "        for token in tokens_b:\n",
        "            tokens.append(token)\n",
        "            segment_ids.append(1)\n",
        "        tokens.append(\"[SEP]\")\n",
        "        segment_ids.append(1)\n",
        "\n",
        "    input_ids = tokenizer.convert_tokens_to_ids(tokens)\n",
        "\n",
        "    # The mask has 1 for real tokens and 0 for padding tokens. Only real\n",
        "    # tokens are attended to.\n",
        "    input_mask = [1] * len(input_ids)\n",
        "\n",
        "    # Zero-pad up to the sequence length.\n",
        "    while len(input_ids) < max_seq_length:\n",
        "        input_ids.append(0)\n",
        "        input_mask.append(0)\n",
        "        segment_ids.append(0)\n",
        "\n",
        "    assert len(input_ids) == max_seq_length\n",
        "    assert len(input_mask) == max_seq_length\n",
        "    assert len(segment_ids) == max_seq_length\n",
        "\n",
        "    labels_ids = []\n",
        "    for label in example.labels:\n",
        "        try:\n",
        "            labels_ids.append(int(label))\n",
        "        except:\n",
        "            print('Caught broken label: ' + str(label))\n",
        "            labels_ids.append(0)\n",
        "\n",
        "\n",
        "    feature = InputFeatures(\n",
        "        input_ids=input_ids,\n",
        "        input_mask=input_mask,\n",
        "        segment_ids=segment_ids,\n",
        "        label_ids=labels_ids,\n",
        "        is_real_example=True)\n",
        "    return feature\n",
        "\n",
        "\n",
        "def file_based_convert_examples_to_features(\n",
        "        examples, max_seq_length, tokenizer, output_file):\n",
        "    \"\"\"Convert a set of `InputExample`s to a TFRecord file.\"\"\"\n",
        "\n",
        "    writer = tf.python_io.TFRecordWriter(output_file)\n",
        "\n",
        "    for (ex_index, example) in enumerate(examples):\n",
        "        if ex_index % 10000 == 0:\n",
        "            tf.logging.info(\"Writing example %d of %d\" % (ex_index, len(examples)))\n",
        "            print(\"Writing example %d of %d\" % (ex_index, len(examples)))\n",
        "\n",
        "        feature = convert_single_example(ex_index, example,max_seq_length, tokenizer)\n",
        "\n",
        "        def create_int_feature(values):\n",
        "            f = tf.train.Feature(int64_list=tf.train.Int64List(value=list(values)))\n",
        "            return f\n",
        "\n",
        "        features = collections.OrderedDict()\n",
        "        features[\"input_ids\"] = create_int_feature(feature.input_ids)\n",
        "        features[\"input_mask\"] = create_int_feature(feature.input_mask)\n",
        "        features[\"segment_ids\"] = create_int_feature(feature.segment_ids)\n",
        "        features[\"is_real_example\"] = create_int_feature(\n",
        "            [int(feature.is_real_example)])\n",
        "        ##############################################multiple ids or single label? \n",
        "        if isinstance(feature.label_ids, list):\n",
        "            label_ids = feature.label_ids\n",
        "        else:\n",
        "            label_ids = feature.label_ids[0]\n",
        "            \n",
        "        features[\"label_ids\"] = create_int_feature(label_ids)\n",
        "\n",
        "        tf_example = tf.train.Example(features=tf.train.Features(feature=features))\n",
        "        writer.write(tf_example.SerializeToString())\n",
        "    writer.close()\n",
        "\n",
        "\n",
        "def file_based_input_fn_builder(input_file, seq_length, is_training,\n",
        "                                drop_remainder,numLabs=7):\n",
        "    \"\"\"Creates an `input_fn` closure to be passed to TPUEstimator.\"\"\"\n",
        "\n",
        "    name_to_features = {\n",
        "        \"input_ids\": tf.FixedLenFeature([seq_length], tf.int64),\n",
        "        \"input_mask\": tf.FixedLenFeature([seq_length], tf.int64),\n",
        "        \"segment_ids\": tf.FixedLenFeature([seq_length], tf.int64),\n",
        "        \"label_ids\": tf.FixedLenFeature([numLabs], tf.int64),\n",
        "        \"is_real_example\": tf.FixedLenFeature([], tf.int64),\n",
        "    }\n",
        "\n",
        "    def _decode_record(record, name_to_features):\n",
        "        \"\"\"Decodes a record to a TensorFlow example.\"\"\"\n",
        "        example = tf.parse_single_example(record, name_to_features)\n",
        "\n",
        "        # tf.Example only supports tf.int64, but the TPU only supports tf.int32.\n",
        "        # So cast all int64 to int32.\n",
        "        for name in list(example.keys()):\n",
        "            t = example[name]\n",
        "            if t.dtype == tf.int64:\n",
        "                t = tf.to_int32(t)\n",
        "            example[name] = t\n",
        "\n",
        "        return example\n",
        "\n",
        "    def input_fn(params):\n",
        "        \"\"\"The actual input function.\"\"\"\n",
        "        batch_size = params[\"batch_size\"]\n",
        "\n",
        "        # For training, we want a lot of parallel reading and shuffling.\n",
        "        # For eval, we want no shuffling and parallel reading doesn't matter.\n",
        "        d = tf.data.TFRecordDataset(input_file)\n",
        "        if is_training:\n",
        "            d = d.repeat()\n",
        "            d = d.shuffle(buffer_size=100)\n",
        "\n",
        "        d = d.apply(\n",
        "            tf.contrib.data.map_and_batch(\n",
        "                lambda record: _decode_record(record, name_to_features),\n",
        "                batch_size=batch_size,\n",
        "                drop_remainder=drop_remainder))\n",
        "\n",
        "        return d\n",
        "\n",
        "    return input_fn\n",
        "\n",
        "\n",
        "def _truncate_seq_pair(tokens_a, tokens_b, max_length):\n",
        "    \"\"\"Truncates a sequence pair in place to the maximum length.\"\"\"\n",
        "\n",
        "    # This is a simple heuristic which will always truncate the longer sequence\n",
        "    # one token at a time. This makes more sense than truncating an equal percent\n",
        "    # of tokens from each, since if one sequence is very short then each token\n",
        "    # that's truncated likely contains more information than a longer sequence.\n",
        "    while True:\n",
        "        total_length = len(tokens_a) + len(tokens_b)\n",
        "        if total_length <= max_length:\n",
        "            break\n",
        "        if len(tokens_a) > len(tokens_b):\n",
        "            tokens_a.pop()\n",
        "        else:\n",
        "            tokens_b.pop()    \n",
        "   \n",
        "\n",
        "\n",
        "def model_fn_builder(bert_config, num_labels, init_checkpoint, learning_rate,\n",
        "                     num_train_steps, num_warmup_steps, use_tpu,\n",
        "                     use_one_hot_embeddings):\n",
        "    \"\"\"Returns `model_fn` closure for TPUEstimator.\"\"\"\n",
        "    print('building model...')\n",
        "    \n",
        "    def model_fn(features, labels, mode, params):  # pylint: disable=unused-argument\n",
        "        \"\"\"The `model_fn` for TPUEstimator.\"\"\"\n",
        "\n",
        "        #tf.logging.info(\"*** Features ***\")\n",
        "        #for name in sorted(features.keys()):\n",
        "        #    tf.logging.info(\"  name = %s, shape = %s\" % (name, features[name].shape))\n",
        "        print('in model fn')\n",
        "        input_ids = features[\"input_ids\"]\n",
        "        input_mask = features[\"input_mask\"]\n",
        "        segment_ids = features[\"segment_ids\"]\n",
        "        label_ids = features[\"label_ids\"]\n",
        "        is_real_example = None\n",
        "        if \"is_real_example\" in features:\n",
        "             is_real_example = tf.cast(features[\"is_real_example\"], dtype=tf.float32)\n",
        "        else:\n",
        "             is_real_example = tf.ones(tf.shape(label_ids), dtype=tf.float32)\n",
        "\n",
        "        is_training = (mode == tf.estimator.ModeKeys.TRAIN)\n",
        "\n",
        "        (total_loss, per_example_loss, logits, probabilities) = create_model(\n",
        "            bert_config, is_training, input_ids, input_mask, segment_ids, label_ids,\n",
        "            num_labels, use_one_hot_embeddings)\n",
        "\n",
        "        tvars = tf.trainable_variables()\n",
        "        initialized_variable_names = {}\n",
        "        scaffold_fn = None#tf.train.Scaffold()\n",
        "        print(type(scaffold_fn))\n",
        "        print(init_checkpoint)\n",
        "        if init_checkpoint:\n",
        "            (assignment_map, initialized_variable_names\n",
        "             ) = modeling.get_assignment_map_from_checkpoint(tvars, init_checkpoint)\n",
        "            if use_tpu:\n",
        "\n",
        "                def tpu_scaffold():\n",
        "                    print('using tpu')\n",
        "                    tf.train.init_from_checkpoint(init_checkpoint, assignment_map)\n",
        "                    return tf.train.Scaffold()\n",
        "\n",
        "                scaffold_fn = tpu_scaffold\n",
        "            else:\n",
        "                tf.train.init_from_checkpoint(init_checkpoint, assignment_map)\n",
        "\n",
        "        tf.logging.info(\"**** Trainable Variables ****\")\n",
        "        for var in tvars:\n",
        "            init_string = \"\"\n",
        "            if var.name in initialized_variable_names:\n",
        "                init_string = \", *INIT_FROM_CKPT*\"\n",
        "            #tf.logging.info(\"  name = %s, shape = %s%s\", var.name, var.shape,init_string)\n",
        "\n",
        "        output_spec = None\n",
        "        if mode == tf.estimator.ModeKeys.TRAIN:\n",
        "\n",
        "            train_op = optimization.create_optimizer(\n",
        "                total_loss, learning_rate, num_train_steps, num_warmup_steps, use_tpu)\n",
        "\n",
        "            output_spec = tf.estimator.EstimatorSpec(\n",
        "                mode=mode,\n",
        "                loss=total_loss,\n",
        "                train_op=train_op,\n",
        "                scaffold=scaffold_fn)\n",
        "        elif mode == tf.estimator.ModeKeys.EVAL:\n",
        "\n",
        "            def metric_fn(per_example_loss, label_ids, probabilities, is_real_example):\n",
        "                ######\n",
        "                eval_dict = {}\n",
        "                #predictions = tf.argmax(logits, axis=-1, output_type=tf.int32)\n",
        "                accuracy = tf.metrics.accuracy(\n",
        "                     labels=label_ids, predictions=probabilities, weights=is_real_example)\n",
        "                \n",
        "                label_ids = tf.cast(label_ids, dtype=tf.int64)\n",
        "                probabilities= tf.cast(probabilities, dtype=tf.int64)\n",
        "                print(label_ids)\n",
        "                print(probabilities)\n",
        "               # metric1 = tf.metrics.precision_at_k(label_ids, probabilities, 1, class_id=0)\n",
        "                #metric2 = tf.metrics.precision_at_k(label_ids, probabilities, 1, class_id=1)\n",
        "                #metric3 = tf.metrics.precision_at_k(label_ids, probabilities, 1, class_id=2)\n",
        "                \n",
        "                loss = tf.metrics.mean(values=per_example_loss, weights=is_real_example)\n",
        "                \n",
        "\n",
        "                return {\n",
        "                    \"eval_accuracy\": accuracy,\n",
        "                    #\"prec1\": metric1,\n",
        "                    #\"prec2\": metric2,\n",
        "                    #\"prec3\": metric3,\n",
        "                    \"eval_loss\": loss,\n",
        "                }  \n",
        "                #####ORIGINAL\n",
        "                #logits_split = tf.split(probabilities, num_labels, axis=-1)\n",
        "                #label_ids_split = tf.split(label_ids, num_labels, axis=-1)\n",
        "                # metrics change to auc of every class\n",
        "                #eval_dict = {}\n",
        "                #for j, logits in enumerate(logits_split):\n",
        "                    #label_id_ = tf.cast(label_ids_split[j], dtype=tf.int32)\n",
        "                    #current_auc, update_op_auc = tf.metrics.auc(label_id_, logits)\n",
        "                    #eval_dict[str(j)] = (current_auc, update_op_auc)\n",
        "                #eval_dict['eval_loss'] = tf.metrics.mean(values=per_example_loss)\n",
        "                return eval_dict\n",
        "\n",
        "                ## original eval metrics\n",
        "                # predictions = tf.argmax(logits, axis=-1, output_type=tf.int32)\n",
        "                # accuracy = tf.metrics.accuracy(\n",
        "                #     labels=label_ids, predictions=predictions, weights=is_real_example)\n",
        "                # loss = tf.metrics.mean(values=per_example_loss, weights=is_real_example)\n",
        "                # return {\n",
        "                #     \"eval_accuracy\": accuracy,\n",
        "                #     \"eval_loss\": loss,\n",
        "                # }\n",
        "\n",
        "            eval_metrics = metric_fn(per_example_loss, label_ids, probabilities, is_real_example)\n",
        "            output_spec = tf.estimator.EstimatorSpec(\n",
        "                mode=mode,\n",
        "                loss=total_loss,\n",
        "                eval_metric_ops=eval_metrics,\n",
        "                scaffold=scaffold_fn)\n",
        "        else:\n",
        "            print(\"mode:\", mode,\"probabilities:\", probabilities)\n",
        "            output_spec = tf.estimator.EstimatorSpec(\n",
        "                mode=mode,\n",
        "                predictions={\"probabilities\": probabilities},\n",
        "                scaffold=scaffold_fn)\n",
        "        return output_spec\n",
        "\n",
        "    return model_fn        \n",
        "\n",
        "def create_output(predictions, columns):\n",
        "    probabilities = []\n",
        "    \n",
        "    for (i, prediction) in enumerate(predictions):\n",
        "        preds = prediction[\"probabilities\"]\n",
        "        probabilities.append(preds)\n",
        "        \n",
        "    dff = pd.DataFrame(probabilities)\n",
        "    dff.columns = columns\n",
        "    \n",
        "    return dff "
      ],
      "execution_count": 0,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "YnPFWqWLE_ek",
        "colab_type": "code",
        "colab": {}
      },
      "source": [
        ""
      ],
      "execution_count": 0,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "Wp3gYsj3BTLA",
        "colab_type": "code",
        "colab": {}
      },
      "source": [
        ""
      ],
      "execution_count": 0,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "oXkSsiIkFpCq",
        "colab_type": "code",
        "outputId": "6defeabd-d048-46f7-b81e-f5f0a2f67f78",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 35
        }
      },
      "source": [
        "train = pd.read_pickle(trainDat).dropna()#yhis was necessary when getting data from csvs, but probably not needed when importing from the dataframes\n",
        "\n",
        "##print(train.head())\n",
        "dev = pd.read_pickle(devDat).dropna()\n",
        "train = pd.concat([train,dev])#for convenience, and to make sure that different runs have different examples\n",
        "#train = sklearn.utils.shuffle(train)#optional shuffle\n",
        "\n",
        "\n",
        "\n",
        "test = pd.read_pickle(testDat).dropna()\n",
        "\n",
        "if TRAIN_MINI:####use this to test training with small samples (only during development)\n",
        "    test = test.sample(n=NR_TEST)\n",
        "    train = train.sample(n=NR_TRAIN)#optional reduction of df for testing/development\n",
        "##print(train.head())\n",
        "\n",
        "\n",
        "\n",
        "ID = 'id'##the id\n",
        "DATA_COLUMN = 'comment_text'#the sent\n",
        "#LABEL_COLUMNS = ['toxic','severe_toxic','obscene','threat','insult','identity_hate']#label prose\n",
        "LABEL_COLUMNS = ['P','I','O', 'A','M','R','C']\n",
        "\n",
        "\n",
        "TRAIN_VAL_RATIO = 0.8#for creating train and dev sets\n",
        "LEN = train.shape[0]#get nr of rows/ shape is rows*columns\n",
        "\n",
        "SIZE_TRAIN = int(TRAIN_VAL_RATIO*LEN)\n",
        "\n",
        "x_train = train[:SIZE_TRAIN]\n",
        "x_val = train[SIZE_TRAIN:]\n",
        "\n",
        "# Use the InputExample class from BERT's run_classifier code to create examples from the data\n",
        "train_examples = create_examples(x_train)\n",
        "\n",
        "\n",
        "\n",
        "print('all: {} -- train: {} -- val: {}'.format(train.shape, x_train.shape, x_val.shape))\n",
        "logging.info('all: {} -- train: {} -- val: {}'.format(train.shape, x_train.shape, x_val.shape))\n"
      ],
      "execution_count": 104,
      "outputs": [
        {
          "output_type": "stream",
          "text": [
            "all: (143439, 9) -- train: (114751, 9) -- val: (28688, 9)\n"
          ],
          "name": "stdout"
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "MWkyfbPiJOJc",
        "colab_type": "code",
        "outputId": "e94c3c46-b9b6-4073-9ae3-1ecbcb3b6260",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 271
        }
      },
      "source": [
        "###########################################################Create the tokeniser obj and other objs\n",
        "bert_config = modeling.BertConfig.from_json_file(BERT_CONFIG)#load config file\n",
        "\n",
        "tokenization.validate_case_matches_checkpoint(True,BERT_INIT_CHKPNT)\n",
        "tokenizer = tokenization.FullTokenizer(\n",
        "      vocab_file=BERT_VOCAB, do_lower_case=True)\n",
        "\n",
        "run_config = tf.estimator.RunConfig(#assign some config values like directory or amount of saved checkpoints\n",
        "    model_dir=OUTPUT_DIR,\n",
        "    save_summary_steps=SAVE_SUMMARY_STEPS,\n",
        "    keep_checkpoint_max=1,\n",
        "    save_checkpoints_steps=SAVE_CHECKPOINTS_STEPS)\n",
        "\n",
        "# Compute # train and warmup steps from batch size\n",
        "num_train_steps = int(len(train_examples) / BATCH_SIZE * NUM_TRAIN_EPOCHS)\n",
        "num_warmup_steps = int(num_train_steps * WARMUP_PROPORTION)\n",
        "\n",
        "\n",
        "\n",
        "train_file = os.path.join(OUTPUT_DIR, \"train.tf_record\")\n",
        "#filename = Path(train_file)\n",
        "if not os.path.exists(train_file):\n",
        "    open(train_file, 'w').close()\n",
        "\n",
        "\n",
        "###########################################################\n",
        "logging.info('Converting train examples to features')   \n",
        "if MODE=='FINETUNE':\n",
        "  file_based_convert_examples_to_features(train_examples, MAX_SEQ_LENGTH, tokenizer, train_file)#store examples in file. here multiple/single label has to be changed\n",
        "logging.info(\"***** Training phase *****\")\n",
        "logging.info(\"  Num examples = {}\".format(len(train_examples)))\n",
        "logging.info(\"  Batch size =  {}\".format(BATCH_SIZE))\n",
        "logging.info(\"  Num steps = {}\".format(num_train_steps))\n",
        "\n",
        "\n",
        "\n",
        "train_input_fn = file_based_input_fn_builder(\n",
        "    input_file=train_file,\n",
        "    seq_length=MAX_SEQ_LENGTH,\n",
        "    is_training=True,\n",
        "    drop_remainder=True)\n",
        "\n",
        "\n",
        "RESULTS_DIR = os.path.join(OUTPUT_DIR, 'output')\n",
        "## Specify outpit directory and number of checkpoint steps to save\n",
        "##run_config = tf.estimator.tpu.RunConfig(\n",
        "##    model_dir=RESULTS_DIR,\n",
        "##    save_summary_steps=SAVE_SUMMARY_STEPS,\n",
        "##    keep_checkpoint_max=1,\n",
        "##    save_checkpoints_steps=SAVE_CHECKPOINTS_STEPS)\n",
        "\n",
        "is_per_host = tf.contrib.tpu.InputPipelineConfig.PER_HOST_V2\n",
        "tpu_cluster_resolver = tf.contrib.cluster_resolver.TPUClusterResolver(TPU_ADDRESS)\n",
        "run_config = tf.contrib.tpu.RunConfig(\n",
        "    model_dir=RESULTS_DIR,\n",
        "    save_summary_steps=SAVE_SUMMARY_STEPS,\n",
        "    keep_checkpoint_max=1,\n",
        "    save_checkpoints_steps=SAVE_CHECKPOINTS_STEPS,\n",
        "    cluster=tpu_cluster_resolver,\n",
        "    tpu_config=tf.contrib.tpu.TPUConfig(\n",
        "          \n",
        "          num_shards=NUM_TPU_CORES,\n",
        "          per_host_input_for_training=is_per_host))\n",
        "print(BERT_INIT_CHKPNT)\n",
        "model_fn = model_fn_builder(\n",
        "  bert_config=bert_config,\n",
        "  num_labels= len(LABEL_COLUMNS),\n",
        "  init_checkpoint=BERT_INIT_CHKPNT,\n",
        "  learning_rate=LEARNING_RATE,\n",
        "  num_train_steps=num_train_steps,\n",
        "  num_warmup_steps=num_warmup_steps,\n",
        "  use_tpu=False,\n",
        "  use_one_hot_embeddings=False)\n",
        "\n",
        "estimator = tf.estimator.Estimator(\n",
        "  model_fn=model_fn,\n",
        "  config=run_config,\n",
        "  params={\"batch_size\": BATCH_SIZE})\n"
      ],
      "execution_count": 105,
      "outputs": [
        {
          "output_type": "stream",
          "text": [
            "Writing example 0 of 114751\n",
            "Writing example 10000 of 114751\n",
            "Writing example 20000 of 114751\n",
            "Writing example 30000 of 114751\n",
            "Writing example 40000 of 114751\n",
            "Writing example 50000 of 114751\n",
            "Writing example 60000 of 114751\n",
            "Writing example 70000 of 114751\n",
            "Writing example 80000 of 114751\n",
            "Writing example 90000 of 114751\n",
            "Writing example 100000 of 114751\n",
            "Writing example 110000 of 114751\n",
            "/content/drive/My Drive/scibert_scivocab_uncased/bert_model.ckpt\n",
            "building model...\n"
          ],
          "name": "stdout"
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "SdNOrRIJKjPw",
        "colab_type": "code",
        "outputId": "d2dbfebb-9260-485d-c2f5-f9fb9fe760d8",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        }
      },
      "source": [
        "##########################Train\n",
        "\n",
        "if MODE=='FINETUNE':\n",
        "    print(f'Beginning Training!')\n",
        "    logging.info('Running training')\n",
        "    current_time = datetime.now()\n",
        "    estimator.train(input_fn=train_input_fn, max_steps=num_train_steps)\n",
        "    print(\"Training took time \", datetime.now() - current_time)\n",
        "    logging.info(\"Training took time \", datetime.now() - current_time)\n",
        "\n",
        "eval_file = os.path.join(OUTPUT_DIR, \"eval.tf_record\")\n",
        "#filename = Path(train_file)\n",
        "if not os.path.exists(eval_file):\n",
        "    open(eval_file, 'w').close()\n",
        "\n",
        "eval_examples = create_examples(x_val)\n",
        "file_based_convert_examples_to_features(eval_examples, MAX_SEQ_LENGTH, tokenizer, eval_file)\n",
        "\n",
        "eval_steps = None\n",
        "\n",
        "eval_drop_remainder = False\n",
        "eval_input_fn = file_based_input_fn_builder(\n",
        "    input_file=eval_file,\n",
        "    seq_length=MAX_SEQ_LENGTH,\n",
        "    is_training=False,\n",
        "    drop_remainder=False)\n",
        "\n",
        "result = estimator.evaluate(input_fn=eval_input_fn, steps=eval_steps)\n",
        "print(result.keys())\n",
        "output_eval_file = os.path.join(OUTPUT_DIR, \"eval_results.txt\")\n",
        "with tf.gfile.GFile(output_eval_file, \"w\") as writer:\n",
        "    tf.logging.info(\"***** Eval results *****\")###tf.logging.info(\"***** Eval results *****\")\n",
        "    logging.info(\"***** Eval results *****\")\n",
        "    for key in sorted(result.keys()):\n",
        "        tf.logging.info(\"  %s = %s\", key, str(result[key]))\n",
        "        logging.info(\"  %s = %s\", key, str(result[key]))\n",
        "        writer.write(\"%s = %s\\n\" % (key, str(result[key])))\n",
        "        \n",
        "\n",
        "\n",
        "x_test = test #testing a small sample\n",
        "x_test = x_test.reset_index(drop=True)\n",
        "predict_examples = create_examples(x_test,False)#first step: get data that is to be tested\n",
        "\n",
        "\n",
        "\n",
        "test_features = convert_examples_to_features(predict_examples, MAX_SEQ_LENGTH, tokenizer)#create bert friendlly input\n",
        "\n",
        "print('Beginning Predictions!')\n",
        "logging.info('Beginning Predictions!')\n",
        "current_time = datetime.now()\n",
        "\n",
        "predict_input_fn = input_fn_builder(features=test_features, seq_length=MAX_SEQ_LENGTH, is_training=False, drop_remainder=False)\n",
        "predictions = estimator.predict(predict_input_fn)\n",
        "print(\"Prediction took time \", datetime.now() - current_time)\n",
        "#logging.info(\"Prediction took time \", datetime.now() - current_time)\n",
        "\n",
        "output_df = create_output(predictions, LABEL_COLUMNS)\n",
        "output_df.to_pickle(os.path.join(OUTPUT_DIR, 'predictionsCSZG.df'))#save predictions\n",
        "\n",
        "merged_df =  pd.concat([x_test, output_df], axis=1)\n",
        "#print(merged_df[['comment_text']])\n",
        "#submission = merged_df.drop(['comment_text'], axis=1)#drop orig sent data\n",
        "merged_df.to_csv(os.path.join(OUTPUT_DIR, \"resultsCSZG.csv\"), index=False)\n",
        "logging.info('merged df:')\n",
        "for i in range(6):\n",
        "    logging.info(str(merged_df.loc[i].to_csv(header=None, index=False).strip('\\n').split('\\n')))\n",
        "merged_df.head()        "
      ],
      "execution_count": 106,
      "outputs": [
        {
          "output_type": "stream",
          "text": [
            "W0806 10:23:14.830646 140163326392192 deprecation.py:323] From /usr/local/lib/python3.6/dist-packages/tensorflow/python/training/training_util.py:236: Variable.initialized_value (from tensorflow.python.ops.variables) is deprecated and will be removed in a future version.\n",
            "Instructions for updating:\n",
            "Use Variable.read_value. Variables in 2.X are initialized automatically both in eager and graph (inside tf.defun) contexts.\n"
          ],
          "name": "stderr"
        },
        {
          "output_type": "stream",
          "text": [
            "Beginning Training!\n",
            "in model fn\n"
          ],
          "name": "stdout"
        },
        {
          "output_type": "stream",
          "text": [
            "W0806 10:23:14.968724 140163326392192 deprecation.py:506] From /usr/local/lib/python3.6/dist-packages/bert/modeling.py:358: calling dropout (from tensorflow.python.ops.nn_ops) with keep_prob is deprecated and will be removed in a future version.\n",
            "Instructions for updating:\n",
            "Please use `rate` instead of `keep_prob`. Rate should be set to `rate = 1 - keep_prob`.\n"
          ],
          "name": "stderr"
        },
        {
          "output_type": "stream",
          "text": [
            "<class 'NoneType'>\n",
            "/content/drive/My Drive/scibert_scivocab_uncased/bert_model.ckpt\n"
          ],
          "name": "stdout"
        },
        {
          "output_type": "stream",
          "text": [
            "W0806 10:23:18.602239 140163326392192 deprecation_wrapper.py:119] From /usr/local/lib/python3.6/dist-packages/bert/optimization.py:27: The name tf.train.get_or_create_global_step is deprecated. Please use tf.compat.v1.train.get_or_create_global_step instead.\n",
            "\n",
            "W0806 10:23:18.604883 140163326392192 deprecation_wrapper.py:119] From /usr/local/lib/python3.6/dist-packages/bert/optimization.py:32: The name tf.train.polynomial_decay is deprecated. Please use tf.compat.v1.train.polynomial_decay instead.\n",
            "\n",
            "W0806 10:23:18.625349 140163326392192 deprecation.py:323] From /usr/local/lib/python3.6/dist-packages/tensorflow/python/keras/optimizer_v2/learning_rate_schedule.py:409: div (from tensorflow.python.ops.math_ops) is deprecated and will be removed in a future version.\n",
            "Instructions for updating:\n",
            "Deprecated in favor of operator or tf.math.divide.\n",
            "W0806 10:23:18.648388 140163326392192 deprecation_wrapper.py:119] From /usr/local/lib/python3.6/dist-packages/bert/optimization.py:70: The name tf.trainable_variables is deprecated. Please use tf.compat.v1.trainable_variables instead.\n",
            "\n",
            "W0806 10:39:19.758485 140163326392192 deprecation.py:323] From /usr/local/lib/python3.6/dist-packages/tensorflow/python/training/saver.py:960: remove_checkpoint (from tensorflow.python.training.checkpoint_management) is deprecated and will be removed in a future version.\n",
            "Instructions for updating:\n",
            "Use standard file APIs to delete files with this prefix.\n"
          ],
          "name": "stderr"
        },
        {
          "output_type": "stream",
          "text": [
            "Training took time  0:53:50.841374\n",
            "Writing example 0 of 28688\n"
          ],
          "name": "stdout"
        },
        {
          "output_type": "stream",
          "text": [
            "--- Logging error ---\n",
            "Traceback (most recent call last):\n",
            "  File \"/usr/lib/python3.6/logging/__init__.py\", line 994, in emit\n",
            "    msg = self.format(record)\n",
            "  File \"/usr/lib/python3.6/logging/__init__.py\", line 840, in format\n",
            "    return fmt.format(record)\n",
            "  File \"/usr/lib/python3.6/logging/__init__.py\", line 577, in format\n",
            "    record.message = record.getMessage()\n",
            "  File \"/usr/lib/python3.6/logging/__init__.py\", line 338, in getMessage\n",
            "    msg = msg % self.args\n",
            "TypeError: not all arguments converted during string formatting\n",
            "Call stack:\n",
            "  File \"/usr/lib/python3.6/runpy.py\", line 193, in _run_module_as_main\n",
            "    \"__main__\", mod_spec)\n",
            "  File \"/usr/lib/python3.6/runpy.py\", line 85, in _run_code\n",
            "    exec(code, run_globals)\n",
            "  File \"/usr/local/lib/python3.6/dist-packages/ipykernel_launcher.py\", line 16, in <module>\n",
            "    app.launch_new_instance()\n",
            "  File \"/usr/local/lib/python3.6/dist-packages/traitlets/config/application.py\", line 658, in launch_instance\n",
            "    app.start()\n",
            "  File \"/usr/local/lib/python3.6/dist-packages/ipykernel/kernelapp.py\", line 477, in start\n",
            "    ioloop.IOLoop.instance().start()\n",
            "  File \"/usr/local/lib/python3.6/dist-packages/tornado/ioloop.py\", line 832, in start\n",
            "    self._run_callback(self._callbacks.popleft())\n",
            "  File \"/usr/local/lib/python3.6/dist-packages/tornado/ioloop.py\", line 605, in _run_callback\n",
            "    ret = callback()\n",
            "  File \"/usr/local/lib/python3.6/dist-packages/tornado/stack_context.py\", line 277, in null_wrapper\n",
            "    return fn(*args, **kwargs)\n",
            "  File \"/usr/local/lib/python3.6/dist-packages/zmq/eventloop/zmqstream.py\", line 536, in <lambda>\n",
            "    self.io_loop.add_callback(lambda : self._handle_events(self.socket, 0))\n",
            "  File \"/usr/local/lib/python3.6/dist-packages/zmq/eventloop/zmqstream.py\", line 450, in _handle_events\n",
            "    self._handle_recv()\n",
            "  File \"/usr/local/lib/python3.6/dist-packages/zmq/eventloop/zmqstream.py\", line 480, in _handle_recv\n",
            "    self._run_callback(callback, msg)\n",
            "  File \"/usr/local/lib/python3.6/dist-packages/zmq/eventloop/zmqstream.py\", line 432, in _run_callback\n",
            "    callback(*args, **kwargs)\n",
            "  File \"/usr/local/lib/python3.6/dist-packages/tornado/stack_context.py\", line 277, in null_wrapper\n",
            "    return fn(*args, **kwargs)\n",
            "  File \"/usr/local/lib/python3.6/dist-packages/ipykernel/kernelbase.py\", line 283, in dispatcher\n",
            "    return self.dispatch_shell(stream, msg)\n",
            "  File \"/usr/local/lib/python3.6/dist-packages/ipykernel/kernelbase.py\", line 235, in dispatch_shell\n",
            "    handler(stream, idents, msg)\n",
            "  File \"/usr/local/lib/python3.6/dist-packages/ipykernel/kernelbase.py\", line 399, in execute_request\n",
            "    user_expressions, allow_stdin)\n",
            "  File \"/usr/local/lib/python3.6/dist-packages/ipykernel/ipkernel.py\", line 196, in do_execute\n",
            "    res = shell.run_cell(code, store_history=store_history, silent=silent)\n",
            "  File \"/usr/local/lib/python3.6/dist-packages/ipykernel/zmqshell.py\", line 533, in run_cell\n",
            "    return super(ZMQInteractiveShell, self).run_cell(*args, **kwargs)\n",
            "  File \"/usr/local/lib/python3.6/dist-packages/IPython/core/interactiveshell.py\", line 2718, in run_cell\n",
            "    interactivity=interactivity, compiler=compiler, result=result)\n",
            "  File \"/usr/local/lib/python3.6/dist-packages/IPython/core/interactiveshell.py\", line 2822, in run_ast_nodes\n",
            "    if self.run_code(code, result):\n",
            "  File \"/usr/local/lib/python3.6/dist-packages/IPython/core/interactiveshell.py\", line 2882, in run_code\n",
            "    exec(code_obj, self.user_global_ns, self.user_ns)\n",
            "  File \"<ipython-input-106-28552bc58a93>\", line 8, in <module>\n",
            "    logging.info(\"Training took time \", datetime.now() - current_time)\n",
            "Message: 'Training took time '\n",
            "Arguments: (datetime.timedelta(0, 3230, 842570),)\n"
          ],
          "name": "stderr"
        },
        {
          "output_type": "stream",
          "text": [
            "Writing example 10000 of 28688\n",
            "Writing example 20000 of 28688\n",
            "in model fn\n",
            "<class 'NoneType'>\n",
            "/content/drive/My Drive/scibert_scivocab_uncased/bert_model.ckpt\n",
            "Tensor(\"Cast_3:0\", shape=(?, 7), dtype=int64)\n",
            "Tensor(\"Cast_4:0\", shape=(?, 7), dtype=int64)\n",
            "dict_keys(['eval_accuracy', 'eval_loss', 'loss', 'global_step'])\n",
            "Subjects were @ schizophrenic patients .\n",
            "Matched in pairs , one of each pair was randomly assigned to ethe experimental rehabilitation group and other to control group .\n",
            "@ experimental months .\n",
            "Rehabilitation patients kept occupied usefully while control group had custodial treatment .\n",
            "Although a strong trend for the rehabilitation patients to stay out of hospital longer than controls , the difference between rehabilitation and control patients with respect to mean number of weeks out of hospital does not reach a satisfactory level of statistical significance .\n",
            "AB : All antipsychotic drugs in clinical use are known to block dopamine receptors .\n",
            "The classical neuroleptic effect in animal models and the antipsychotic response in patients have been attributed to antagonism at the dopamine D@ receptor ( Seeman @ ) .\n",
            "There is evidence , however , that the atypical antipsychotic clozapine which appears to be unsurpasssed with respect to its antipsychotic efficacy , typically occupies about @ % of dopamine D@ receptors in patients - less than typical neuroleptics ( Farde et al. , @ ) .\n",
            "Therefore , other effects must contribute to clozapine 's unique properties .\n",
            "Clozapine has a higher affinity for D@ , @-HT@ , histamine H@ and ?\n",
            "@ - adrenergic receptors than for D@ receptors .\n",
            "Antagonism at the latter two receptors seems to mediate sedation and orthostatic hypotension , respectively , whereas D@ and @-HT@ receptors - alone or in combination - might be responsible for its unique antipsychotic properties .\n",
            "LU @ [ ( + ) - ( @S ,@ R ,@ S ) - exo-@ - [ @ - [ @ - ( @-fluorophenyl ) -@ - azabicyclo [ @.@ ] heptane-@yl ] - ethyl ] -@ H,@H-quinazoline-@ ,@-dione fumarate ] is chemically distinct from clozapine but has a similar mixed receptor profile in radioligand binding studies .\n",
            "It displayed the highest affinities for human ( h ) D@ ( Ki @ nM ) , h@-HT@A ( @ nM ) , histamine H@ ( @ nM ) and ?\n",
            "@-adrenergic ( @ nM ) receptors .\n",
            "Like clozapine , LU @ had a higher affinity for D@ and @-HT@A receptors than D@ receptors ( D@/D@ , @ - and @-fold and @-HT@A / D@ , @-and @-fold , for LU @ and clozapine , respectively ) but did not bind to muscarinic receptors in concentrations below @ nM .\n",
            "In a human embryonic kidney cell line ( HEK @ ) transfected with the hD@ .@ receptor and a DNA construct encoding luciferase as a reporter driven by a cAMP-dependent promoter , LU @ proved to be a pure antagonist .\n",
            "It induced c-fos translocation in different areas of the rat forebrain with an intensity and an anatomical pattern , which were similar to clozapine and clearly differed from those of haloperidol .\n",
            "Compared with clozapine , LU @ was twice as potent in antagonising the quinpirole-induced inhibition of the firing rate of dopaminergic midbrain neurones .\n",
            "As expected due to its relatively low affinity for the dopamine D@ receptor , LU @ had a lower potency than clozapine in inhibiting both , apomorphine-induced climbing in mice and the conditioned avoidance response in rats .\n",
            "It was virtually equipotent with clozapine in inhibiting methamphetamine-induced hypermotility .\n",
            "The high antagonist potency in mescaline-induced scratching in mice ( EC@ : @ mg/kg orally ) can be attributed to its high affinity for @-HT@ receptors .\n",
            "Isolation rearing-induced deficits in prepulse inhibition ( PPI ) seem to be sensitive to clinically efficacious typical as well as atypical antipsychotic drugs ( Geyer et al. , @ ) .\n",
            "The PPI deficit induced by isolation rearing in rats was partially restored by LU @ , @ mg/kg i.p .\n",
            "The receptor mediating this effect remains to be elucidated .\n",
            "Even doses of LU @ as high as @ mg/kg orally did not induce catalepsy , increase plasma prolactin , or increase dopamine release in the brain of rats , all features that suggest low D@ receptor occupancy .\n",
            "In clinical phase I studies with more than @ volunteers , LU @ in single doses of up to @ mg/day and @ mg/day for ten days was well tolerated .\n",
            "Sedation appeared to be less severe than with other antipsychotics and the drug was not perceived as being aversive .\n",
            "Orthostatic hypotension was observed at higher dose levels as predicted by the moderate ?\n",
            "- adrenolytic properties of the drug .\n",
            "In a first double blind , placebo-controlled , rising dose study of tolerability and efficacy in twelve hospitalized schizophrenic patients with a minimum total score of @ on the Positive and Negative Symptom Scale ( PANSS ) , LU @ was dosed twice daily .\n",
            "Dose titration completely avoided orthostatic hypotension and doses up to @ mg were generally well tolerated .\n",
            "LU @ provoked neither extrapyramidal symptoms nor hyperprolactinaemia .\n",
            "Six patients on LU @ showed a reduction of the PANSS score , @ were unchanged or worse .\n",
            "Two patients on placebo improved and two did not .\n",
            "Median reduction in PANSS total score compared to baseline was @ % in patients on LU @ and @ % in patients on placebo .\n",
            "These data are clearly encouraging , but it remains unknown whether this effect is mediated by antagonism at dopamine D@ receptors , at serotonin @-HT@A receptors or a combination of both .\n",
            "A predominant D@ receptor blockade , however , is unlikely .\n",
            "The pharmacology and first clinical experience with LU @ suggest that it may have clozapine-like activity with an improved side-effect profile .\n",
            "Reference : Farde , L. , Nordstrm , A.-L. , Wiesel , F.A. , Pauli , S. , Halldin , C. , Sedvall , G. ( @ ) Positron emission tomographic analysis of central D@ and D@ dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine : relation to extrapyramidal side effects .\n",
            "Arch .\n",
            "Gen. Psychiatry @ : @-@ Geyer MA , Wilkinson , LS , Humby T , Robbins ( @ ) Isolation rearing of rats produces a deficit in prepulse inhibition of acoustic startle similar to that in schizophrenia .\n",
            "Biol .\n",
            "Psychiatry @ : @-@ Seeman , P. ( @ ) Dopamine receptor sequences : therapeutic levels of neuroleptics occupy D@ receptors ; clozapine occupies D@ .\n",
            "Neuropsychopharmacology @ : @-@\n",
            "BACKGROUND : Bipolar disorder ( BD ) and unipolar disorder ( UD ) are associated with cognitive deficits and abnormal neural activity in a \" cognitive control network . \"\n",
            "There is an increased prevalence of cognitive dysfunction in psychiatric patients ' first-degree relatives , which constitutes a risk factor for psychiatric illness onset .\n",
            "However , there is no treatment with enduring pro-cognitive efficacy .\n",
            "We found preliminary evidence for beneficial effects of eight weekly doses of recombinant human erythropoietin ( EPO ) on cognition in BD in a recent randomized controlled trial ( RCT ) .\n",
            "The present RCT consists of two sub-studies that extend our previous work by investigating important novel aspects : ( @ ) the effects of @ weekly doses of EPO on cognition in first-degree relatives of patients with BD , UD , or schizophrenia ; and ( @ ) the effects of extending the treatment schedule from @ to @ weeks in remitted patients with BD or UD ; and ( @ ) assessment of early treatment-associated neural activity changes that may predict cognitive improvement .\n",
            "METHODS : The trial comprises two parallel sub-studies with randomized , controlled , double-blinded , parallel group designs .\n",
            "First-degree relatives ( sub-study @ ; n = @ ) and partially or fully remitted patients with BD or UD ( sub-study @ ; n = @ ) with objectively verified cognitive dysfunction are randomized to receive weekly high-dose EPO ( @ IU/mL ) or placebo ( saline ) infusions for @ weeks .\n",
            "Assessments of cognition and mood are conducted at baseline , after two weeks of treatment , after treatment completion , and at six-month follow-up .\n",
            "Functional magnetic resonance imaging ( fMRI ) is conducted at baseline and after two weeks of treatment .\n",
            "Psychosocial function is assessed at baseline , after treatment completion and six-month follow-up .\n",
            "The primary outcome is change in a cognitive composite score of attention , verbal memory , and executive functions .\n",
            "Statistical power of > / = @ % is reached to detect a clinically relevant between-group difference by including @ first-degree relatives and @ patients with BD or UD , respectively .\n",
            "Behavioral data are analyzed with an intention-to-treat approach using mixed models .\n",
            "fMRI data are analyzed with the FMRIB Software Library .\n",
            "DISCUSSION : If this trial reveals pro-cognitive effects of EPO , this may influence future treatment of mood disorders and/or preventive strategies in at-risk populations .\n",
            "The fMRI analyses may unravel key neurobiological targets for pro-cognitive treatment .\n",
            "TRIAL REGISTRATION : ClinicalTrials.gov , NCT@ .\n",
            "Registered on @ October @ .\n",
            "OBJECTIVE : Interventions improving adherence to antipsychotic medication are needed .\n",
            "The present study examined the effects on medication adherence of @ years of integrated treatment for patients with schizophrenia .\n",
            "METHOD : Adherence to medication was examined in a randomized controlled trial of @ years of integrated treatment versus standard treatment .\n",
            "The @ included patients were consecutively referred to a specialized psychiatric team for treatment of psychosis and were diagnosed with DSM-IV schizophrenia or schizoaffective or schizophreniform disorder .\n",
            "The patients were clinically stable and had less than @ years ' duration of illness .\n",
            "Integrated treatment consisted of assertive outreach community treatment , family psychoeducation and involvement , and social skills training .\n",
            "Good adherence was defined as less than @ month without medication .\n",
            "Outcomes were compared over @-month and @-month follow-up periods .\n",
            "The study was conducted from February @ to October @ .\n",
            "RESULTS : No difference in adherence between the integrated treatment group and the standard treatment group ( chi ( @ ) = @ , NS ) was found .\n",
            "Men were more nonadherent than women ( OR @ [ CI @ to @ ] , p = .@ ) .\n",
            "Patients living in families with low expressed emotion were less adherent than patients living in families with high expressed emotion ( OR @ [ CI @ to @ ] , p = .@ ) .\n",
            "CONCLUSION : No effects of integrated treatment on medication adherence were found .\n",
            "CLINICAL TRIALS REGISTRATION : ClinicalTrials.gov identifier NCT@ .\n",
            "RN @ ( Antipsychotic Agents ) .\n",
            "An eight-week study with baseline , @-month , @-month , and @ month follow-up assessments , in which dually diagnosed patients who meet inclusion criteria and sign informed consent will be randomly assigned to one of two groups : one group will receive treatment as usual in Acute Psychiatry and at the Day Treatment Center in addition to participating in four group and one individual health education sessions ( i.e. , the attention control group ) , or to a group that receives treatment as usual on Acute Psychiatry and at the Day Treatment Center along with an enhanced Time Limited Case Management community linkage intervention ( TLC ) .\n",
            "The length of the health education sessions ( four group session and one individual session ) will match the amount of attention provided to the treatment group .\n",
            "The health education sessions will cover topics such as nutrition , disease prevention , injury prevention , and healthy aging .\n",
            "Patients assigned to TLC will be offered enhanced services that begin on Acute Psychiatry and continue for a total of eight weeks through the community and Day Treatment Center transition .\n",
            "Comparison between the TLC ( treatment group ) and health education group ( control group ) will be examined via the following hypotheses :\n",
            "AIM : Understanding factors that contribute to treatment delay would inform early detection and intervention strategies in psychotic disorders .\n",
            "However , existing data were mixed and primarily conducted among early-onset young patients .\n",
            "We examined duration of untreated psychosis ( DUP ) and its clinical and sociodemographic correlates in a large cohort of adult-onset patients with psychosis .\n",
            "METHODS : A total of @ patients with first-onset psychosis aged @-@ years were recruited consecutively as part of a controlled study of an early psychosis intervention service in Hong Kong Chinese .\n",
            "Demographic , sociodemographic and clinical characteristics relating to DUP were assessed within @ months of onset .\n",
            "RESULTS : The population had a mean onset age of @ years ( SD   =    @ ) .\n",
            "The mean and median DUP were @ days ( SD   =    @ ) and @ days ( inter-quartile range from @ to @ ) , respectively .\n",
            "Multivariate regression analysis suggested that insidious mode of onset , hospitalization , a diagnosis of schizophrenia , poorer insight and younger age at onset significantly prolonged DUP .\n",
            "DUP was not related to premorbid functioning , family involvement during help seeking and living alone .\n",
            "CONCLUSIONS : The initial period of untreated psychosis is determined by multiple factors .\n",
            "Whether family involvement is considered a kind of social support in shortening or prolonging DUP needs further examination .\n",
            "Local early intervention program for psychosis should take reference from these findings when formulating personalized plans to reduce delay .\n",
            "Weight gain induced by antipsychotics is the second most frequently given reason for noncompliance with pharmacologic therapy ; excessive sedative effects rank first , with extrapyramidal side effects ranking third .\n",
            "Frequently , weight gain leads to inconsistent pharmacologic treatment ; this exposes patients to the risk of recurrent symptoms .\n",
            "In fact , one of the key contributors to good clinical outcomes in schizophrenic patients is compliance with pharmacologic treatment .\n",
            "The goals of this study were to evaluate weight gain in a group of patients treated with olanzapine , diet modifications , and moderate physical activity and to compare the findings with those from a second group of patients who were given only olanzapine treatment .\n",
            "For @ wk , investigators followed @ groups of patients suffering from schizophrenia and hypomania in bipolar disorder , according to the nosographic criteria of The Diagnostic and Statistical Manual of Mental Disorders , Fourth Edition ( DSM-IV ) .\n",
            "The first group ( A ) of @ patients ( @ female , @ male ) affected by manic episodes in bipolar disorder received olanzapine ( @-@ mg/d ) , jogged lightly for @ min @ times a week , and complied with a diet that consisted of @ kcal/d less than usual .\n",
            "The second group ( B ) of @ patients ( @ female , @ male ) with schizophrenia received only olanzapine ( @-@ mg/d ) .\n",
            "All patients from both groups were weighed at the beginning of the observation period and weekly thereafter for @ mo .\n",
            "After @ mo of observation , group A showed a mean weight gain of @ kg , whereas group B exhibited a mean weight gain of @ kg ; the difference between the @ groups was almost @ kg ( P < .@ ) .\n",
            "Group A showed a statistically significant reduction in weight gain compared with group B , clearly demonstrating the effectiveness of moderate physical activity and diet therapy in reducing weight gain in atypical antipsychotic treatment .\n",
            "Therefore , patient weight and body mass index must be monitored during the first weeks of antipsychotic treatment , with the goals of avoiding significant weight gain and treatment interruption .\n",
            "RN @ ( Antipsychotic Agents ) .\n",
            "@ ( Benzodiazepines ) .\n",
            "@-@-@ ( olanzapine ) .\n",
            "Objective To investigate the rational emotive therapy on self-esteem and quality of life in schizophrenia .\n",
            "Methods @ patients with schizophrenia were randomly divided into study group and the control group , treatment and general individual health education based on the use of antipsychotics in both groups , the study group only rational emotive therapy intervention .\n",
            "Before the intervention , after using the Self-Esteem Scale ( SES ) , Feelings of Inadequacy Scale ( FIS ) , the World Health Organization Quality of Life BREF ( WHOQOL-BREF ) effect evaluation .\n",
            "Result intervention patients SES , FIS and WHOQOL-BREF score difference was no significant .\n",
            "The study group after the intervention of SES rated significantly higher FIS scores were significantly lower , the difference was significant ( t = @,@ ; P < @ ) .\n",
            "The total score of quality of life and physical domain , psychological field , the field of social relations , and the environmental field scores were higher , the difference was significant ( t = @ , P < @ ) .\n",
            "Objective : First-month data of a @-week acute schizophrenia study were used to compare paliperidone palmitate to oral risperidone during initiation of long-acting injectable risperidone .\n",
            "Design : Double-blind , randomized study .\n",
            "Setting : Outpatient or inpatient .\n",
            "Participants : Adults with established ( > = @ year ) schizophrenia .\n",
            "Those assigned to risperidone longacting injectable ( n = @ ) received @ mg on Days @ and @ with oral risperidone ( @-@mg ) supplementation for the first @ days .\n",
            "The paliperidone palmitate group ( n = @ ) received @ mg eq .\n",
            "on Day @ , @ mg eq .\n",
            "on Day @ , and oral placebo supplementation for the first @ days .\n",
            "Measurements : Positive and Negative Syndrome Scale , Personal and Social Performance Scale , Clinical Global Impression-Severity score , and responder rate ( percentage of patients with <sup> @ </sup> @ % reduction in PANSS total score ) .\n",
            "An analysis of covariance model estimated least-square mean differences between treatment groups .\n",
            "A post-hoc analysis of efficacy data for the period of interest , i.e. , at the time points before and after the first @ days , was conducted .\n",
            "Results : Positive and Negative Syndrome Scale , Personal and Social Performance Scale , Clinical Global Impression-Severity scores showed similar efficacy between the treatment groups during the first weeks of treatment , corresponding to the risperidone long-acting injection initiation period .\n",
            "Mean Positive and Negative Syndrome Scale total score at baseline was @ for paliperidone palmitate and @ for oral risperidone , on Day @ was @ and @ , respectively , and on Day @ was @ and @ , respectively .\n",
            "Overall incidence of adverse events in the first @ days was generally similar ( @ % for paliperidone palmitate vs. @ % for oral risperidone ) , except for injection site pain ( @ % vs. @ % ) .\n",
            "Similar active moiety plasma concentrations were obtained during this period .\n",
            "Conclusion : During the first month , paliperidone palmitate without oral supplementation has similar efficacy and safety to oral risperidone ( during initiation of risperidone long-acting injectable ) in acutely exacerbated schizophrenia .\n",
            "BACKGROUND : Cognitive behavior therapy for psychosis ( CBTp ) is an effective intervention for people who hear distressing voices ( auditory hallucinations ) .\n",
            "However , there continues to be a problem of poor access to CBTp .\n",
            "Constraints on health care funding require this problem to be addressed without a substantial increase in funding .\n",
            "One solution is to develop guided self-help forms of CBTp to improve access , and a symptom-specific focus on , for example , distressing voices ( auditory verbal hallucinations ) has the potential to enhance effectiveness .\n",
            "We term this cognitive behavior therapy for distressing voices ( CBTv ) .\n",
            "METHODS/DESIGN : This trial is an external pilot randomized controlled trial comparing the effects of @-week guided self-help CBTv ( with eight therapist support sessions ) with a wait list control condition .\n",
            "Informed consent will be obtained from each participant .\n",
            "Half of the @ participants will be randomized to receive guided self-help CBTv immediately ; the remaining half will receive the intervention after a @-week delay .\n",
            "All participants will continue with their usual treatment throughout the study .\n",
            "Outcomes will be assessed using questionnaires completed at baseline and @ weeks postrandomization .\n",
            "Interviews will be offered to all those who receive therapy immediately to explore their experiences with the intervention .\n",
            "DISCUSSION : The outcomes of this trial , both quantitative and qualitative , will inform the design of a definitive randomized controlled trial of guided self-help CBTv .\n",
            "If this intervention is effective , it could help to increase access to CBT for those who hear distressing voices .\n",
            "TRIAL REGISTRATION : ISRCTN registration number ISRCTN@ .\n",
            "Registered on @ July @ .\n",
            "Study Type : Interventional ; Disease ( s ) : Schizophrenia ; Psychosis ; Current Status : Open ; Closure Date : @/@/@ ; Sample Size : @ ; Inclusion Criteria : Liaison phase : Inclusion criteria : @ .\n",
            "PCPs and HEIs in Cambridgeshire and Peterborough areas .\n",
            "@ .\n",
            "Signed agreement form from PCPs Partners and HEIs .\n",
            "Follow  up phase ( at  risk  mental  states ' data collection ) : Inclusion criteria : @ .\n",
            "Patients confirmed as at  risk  mental  states for psychosis after being previously identified by PCPs and/or HEIs .\n",
            "@ .\n",
            "Informed consent signed for data collection .\n",
            "Exclusion Criteria : @ .\n",
            "Lack of mental capacity to provide informed consent\n",
            "Background : Group psychotherapeutic treatments can improve negative symptoms and social functioning deficits in the treatment of schizophrenia .\n",
            "These treatments may include different modalities including group cognitive behavioral therapy , psychoeducation and metacognitive training ( MCT ) .\n",
            "MCT is effective for preventing delusions by modifying the cognitive biases most related to psychosis .\n",
            "Our primary goal was to address whether cognitive biases improve more specifically with MCT when compared to psychoeducation in a sample of patients with recent onset psychosis .\n",
            "Methods : Design : a multicenter randomized , pilot clinical trial was performed , in which one group received psychoeducation and the other MCT .\n",
            "Sample : @ patients aged between @-@ years and with a diagnosis of psychotic disorder according to DSM-IV-TR criteria and less than @ years of duration of illness .\n",
            "All patients were recruited at two Early Psychosis Programmes in Spain ( ParcTauli Hospital Universitari , Sabadell ; Hospital UniversitariInstitut Pere Mata , Reus ) .\n",
            "Ethical approval was obtained from the local Ethics Committees of both institutions .\n",
            "Outcomes : Patients were evaluated at baseline and at the end of each intervention .\n",
            "The primary outcome was cognitive biases , assessed with Cognitive Biases Questionnaire for Psychosis ( CBQ ) .\n",
            "Secondary outcomes included cognitive insight , psychopathological symptoms ( positive , negative , depressive ) and psychosocial functioning .\n",
            "Interventions : The interventions consisted of @ weekly group sessions of MCT ( developed at the University of Hamburg-Eppendorf by Steffen Moritz ) or psychoeducation .\n",
            "MCT program included sessions dealing with attributional style , jumping to conclusions , changing beliefs , empathy , memory , and depression and self-esteem .\n",
            "The psychoeducational program included sessions addressing aspects related to psychotic illness ( psychotic symptoms , risk factors of relapse , stress management , psychopharmacological treatment , substance use , physical health and social skills ) .\n",
            "Statistical analysis : A general linear model for repeated measures was performed in order to compare the longitudinal effect of the intervention and to test whether changes in outcome variables differed by treatment group .\n",
            "All analyses were adjusted for gender .\n",
            "A p value < @ ( two-tailed ) was considered to be significant .\n",
            "Results : Of all @ patients , @ ( @ % ) completed at least @ % of the sessions , and were included in the final analyses .\n",
            "@ received psychoeducation and @ MCT .\n",
            "Cognitive biases improved significantly in both psychoeducation ( @ + / - @ vs @ + / - @ ) and MCT groups ( @ + / - @ vs @ + / - @ ) .\n",
            "The time effect was significant ( F = @ , p < @ ) without a different pattern in the change of CBQ scores between groups ( interaction time x group , F = @ , p = @ ) .\n",
            "An improvement in negative symptoms was also observed after receiving both treatments , without significant differences between groups .\n",
            "No significant changes over time were observed in positive symptoms , depressive symptoms or psychosocial functioning .\n",
            "Discussion : Both group psychoeducation and MCT improve cognitive biases in recent onset psychosis .\n",
            "Our study does not support a superiority of one intervention over the other in terms of improving cognitive biases .\n",
            "Background : A post hoc analysis from a multiphase trial with open-label transition and maintenance phases , a double-blind relapse prevention phase , and an optional open-label extension examined the long-term tolerability with continuous once-monthly injectable paliperidone palmitate @ , @ , @ , or @ mg ( @ , @ , @ , or @ mg equivalents [ mg eq ] of paliperidone ) in subjects with recently diagnosed ( < = @ years ; n = @ ) versus chronic illness ( > @ years ; n = @ ) schizophrenia .\n",
            "Methods : Adverse events reported at a > = @ % margin between subgroups were identified .\n",
            "Relative risks ( in the recently diagnosed compared with the chronically ill ) and @ % confidence intervals ( CI ) were determined , and CI not including @ were considered potentially significant .\n",
            "Results : In both subgroups , the mean monthly dose was @ mg ( @ mg eq ) .\n",
            "Continuous mean exposures were @ + / - @ and @ + / - @ days in the recently diagnosed and chronic illness subgroups , respectively .\n",
            "Using the criteria outlined in the methods , nasopharyngitis was a potentially significant event reported in more chronically ill than recently diagnosed subjects at months @ , @ , @ , and endpoint ( @ % versus @ % ; relative risk @ ; @ % CI @-@ ) .\n",
            "Influenza ( @ % versus @ % ; relative risk @ ; @ % CI @-@ ) and amenorrhea ( @ % versus @ % ; relative risk @ ; @ % CI @-@ ) at endpoint were potentially significant events in more recently diagnosed than chronically ill subjects .\n",
            "Mean weight changes , sedation/somnolence , any extrapyramidal symptom-related or glucose-related events were generally similar between the groups .\n",
            "The mean prolactin level increased in both sexes in both subgroups ( changes from baseline of +@ ng/mL and +@ ng/mL in recently diagnosed and chronic illness females and +@ ng/mL and +@ ng/mL in recently diagnosed and chronic illness males , respectively ) , and were higher in females with recently diagnosed illness than in females who were chronically ill ( P = @ at endpoint ) .\n",
            "Prolactin-related events were reported by @ % of recently diagnosed subjects with schizophrenia and @ % of those who were chronically ill .\n",
            "Conclusion : The long-term tolerability of paliperidone palmitate was generally similar in recently diagnosed schizophrenia subjects and those with more chronic illness , with the exception of some prolactin-related measures .\n",
            "( PsycINFO Database Record ( c ) @ APA , all rights reserved ) ( journal abstract )\n",
            "Objective : To investigate the Booz Clear and simple schizophrenia clozapine treatment efficacy and safety .\n",
            "Methods : A randomized , double-blind , will be diagnosed with simple schizophrenia patients were divided into treatment group and control group .\n",
            "Application panss Scale scores after one week drug washout period were given Booz cleared clozapine treatment , depending on the condition changes to adjust the dose .\n",
            "Sufficient quantities of @ , @ , @ and @ months of treatment and are again panss scale score .\n",
            "Results : @ months @ months panss points deduction Booz clear , clozapine was no significant difference ( p > @ ) , @ months , @ months Booz cleared clozapine panss minus point there is a significant difference ( p < @ ) , at Booz clear panss less points than clozapine significantly .\n",
            "Hospital patients with serious mental illness ( SMI ) have high rates of smoking .\n",
            "There are few post-discharge treatment models available for this population and limited research on their treatment uptake following discharge .\n",
            "This study is a secondary analysis of an RCT that compared multi-session intensive telephone counseling versus referral to state quitline counseling at two safety net hospitals in New York City .\n",
            "For this analysis , we selected all trial participants with a history of schizophrenia , schizoaffective disorder or bipolar disorder ( N = @ ) and used multivariable logistic regression to compare groups on self-reported @-day abstinence at @ months and to identify patient factors associated with use of tobacco treatment .\n",
            "Analyses found no significant group differences in abstinence @ months ( @ % quitline vs. @ % intervention , p > @ ) , use of cessation medications ( @ % quitline vs. @ % intervention , p > @ ) or receipt of at least one counseling call ( @ % quitline vs. @ % intervention , p > @ ) .\n",
            "Patients with hazardous drinking ( p = @ ) or perceived good health ( p = @ ) were less likely to use cessation medications .\n",
            "Homeless patients were less likely to use counseling ( p = @ ) .\n",
            "Most patients did not use cessation treatment after discharge , and the intensive intervention did not improve abstinence rates over quitline referral .\n",
            "Interventions are needed to improve use of cessation treatment and long-term abstinence in patients with SMI .\n",
            "BACKGROUND : Aripiprazole lauroxil ( AL ) is a long-acting injectable medication approved for the treatment of schizophrenia .\n",
            "Current AL regimens are @ mg , @ mg , and @ mg administered monthly ( every @ weeks [ q@wk ] ) , or @ mg administered every @ weeks ( q@wk ) .\n",
            "OBJECTIVE : We examined the feasibility of a @-month ( every @ weeks [ q@wk ] ) dosing interval of AL in a phase I open-label pharmacokinetic study investigating AL @ mg administered q@wk for @ weeks , followed by @ weeks of safety and pharmacokinetic measurements ( ClinicalTrials.gov ID : NCT@ ) .\n",
            "Second , a population pharmacokinetic model ( referred to as the @MPopPK model ) was generated using data collected from the present trial , as well as data obtained from earlier studies .\n",
            "METHODS : The phase I study included patients with schizophrenia or schizoaffective disorder maintained on an oral antipsychotic ( n = @ ) who were assigned to one of three groups : AL @ mg q@wk , AL @ mg q@wk , or AL @ mg q@wk , with a total of seven , five , or four injections administered , respectively .\n",
            "No oral aripiprazole lead-in supplementation was administered and patients continued on maintenance oral antipsychotics .\n",
            "Pharmacokinetic samples were collected at various time points during the @-week study period and the @-week follow-up period .\n",
            "Plasma concentrations obtained from the phase I study were analyzed using non-compartmental methods .\n",
            "Additionally , the data were combined with data collected from prior studies to develop the @MPopPK model .\n",
            "RESULTS : Following the final injection of AL in the phase I study , maximum aripiprazole concentrations were achieved @-@ days after the last dose and persisted for the duration of the study .\n",
            "The mean C avg , ss values were @ ng/ml , @ ng/ml , and @ ng/ml for the @ mg q@wk , @ mg q@wk , and @ mg q@wk doses , respectively .\n",
            "The mean elimination half-life of aripiprazole following the last dose was @ days for the @ mg dose , @ days for the @ mg dose , and @ days for the @ mg dose .\n",
            "The @MPopPK dataset included @ aripiprazole concentrations from @ patients with schizophrenia .\n",
            "The duration of absorption of aripiprazole was estimated as @ days ( @ % confidence interval [ CI ] @-@ days ) , which was preceded by a @-day lag time ( @ % CI @-@ days ) for a total duration of input into the systemic circulation of @ days following intramuscular administration of AL .\n",
            "Multiple-dose simulations showed that the @ mg q@wk regimen provides aripiprazole concentrations within the concentration range associated with @ mg and @ mg q@wk doses previously demonstrated to be efficacious in a phase III study .\n",
            "CONCLUSION : These data from the phase I study and the @MPopPK model support the suitability of using the AL @ mg dose as a @-month ( q@wk ) dose interval option for the treatment of schizophrenia .\n",
            "Background : We developed a smartphone-based personalised technology to monitor symptoms in real time and showed good acceptability , reliability and validity for active remote monitoring of symptoms in previous published studies ( www.clintouch.com ) .\n",
            "We report a randomised trial testing its efficacy in improving psychotic symptom control , and its potential as an early warning system for relapse when embedded into the ICT systems of mental health provider organisations , and as a tool for identifying new phenotypes for precision medicine .\n",
            "Methods : Participants with SMI receive a semi-random beep @-@ times per day on their smartphone app and answer @ key symptom rating items using a touchscreen slider .\n",
            "Responses are uploaded wirelessly in real time to a central server and build into a graphical readout on the handset , allowing active symptom monitoring and attempts at self-management .\n",
            "We built this into an end-to-end system in two NHS Hospital Trusts ( Manchester and South London ) to stream data into electronic care records and enable detection by the clinical team of early signs of relapse in people with SMI when key symptoms exceeded a personalised severity threshold .\n",
            "We conducted an open randomised controlled trial of this active symptom monitoring ( ASM ) using the smartphone app compared to usual management with the aim of assessing : ( i ) acceptability of continuous monitoring over @ months ; ( ii ) impact of active self-monitoring on PANSS positive symptoms and Empowerment Rating Scale score assessed at @ and @ weeks ; ( iii ) efficiency of detecting early warning signs of relapse .\n",
            "Eligible participants with a DSM@ diagnosis of schizophrenia and related disorders and a history of relapse within the previous two years were included from an early intervention team ( early psychosis group ) and a community team ( chronic psychosis group ) .\n",
            "Results : Of @ eligible , @ were randomised to either active symptom monitoring or management as usual .\n",
            "@ % stayed in the trial for @ weeks .\n",
            "Of the @ in the ASM arm who completed @-week follow up , adherence defined as responding to > @ % of alerts was @ % , > @ % of alerts was @ % .\n",
            "At @ weeks , ASM compared to usual management was associated with no difference on empowerment scale .\n",
            "PANSS positive subscale score showed a significant mean reduction in the ASM group over @ weeks in the early psychosis group ( n = @ , planned ANCOVA p < @ ) , but no effect in the chronic psychosis group ( n = @ ) .\n",
            "Early warning sign alerts generated by the system occurred in @ % of cases and blind comparison with electronic case record data suggested good sensitivity and lower specificity , but with clear indications of how to adjust the gain of the system to improve future eventdetection efficiency .\n",
            "Multivariate analyses pointed to the ability of the system to identify clinical subtypes .\n",
            "Discussion : The active smartphone monitoring system is feasible and acceptable over three months in people with schizophrenia and related disorders .\n",
            "It was associated with psychotic symptom improvement in recent onset participants , supporting the notion of improved self-management .\n",
            "When built into clinical management workflows to enable personalised alerts of symptom deterioration , it was shown to have potential use in promoting earlier intervention for relapse .\n",
            "The relationship between enlargement of the lateral ventricles in the brains of schizophrenic patients and clinical response to neuroleptic treatment , as assessed by the ventricle-brain ratio ( VBR ) and psychopathology scores , was studied in a sample of @ patients with schizophrenia or schizoaffective psychosis during a drug-free washout and after @ @/@ weeks of treatment with either haloperidol or thioridazine .\n",
            "There was a weak , but statistically significant positive relationship between VBR and improvement on BPRS Psychosis factor scores after @ @/@ weeks of treatment , and a negative correlation between VBR and baseline ( washout ) scores on the BPRS Anergia factor .\n",
            "Patients with enlarged VBRs , as defined by two criteria , also tended to show a better response to neuroleptics than patients below these criterion values .\n",
            "One hundred and four patients with schizophrenia ( CCMD-@-R ) were selected to study the curative effect of UBIO in the treatment of schizophrenia .\n",
            "The score of BPRS was  @ at enrolment into the study .\n",
            "They were randomly divided into @ groups .\n",
            "Studied group consisted of @ patients who taken UBIO combining with small dosage of antipsychitics ; the control of @ ones who did the single antipsychotics .\n",
            "At the end of @rd week of treament ( @ UBIOs were made in studeid gruop ) , BPRS , CQI-SI , GAS\n",
            "CAJ Objective : To determine the efficacy and safety of sultopride hydrochloride injection in treating patients with psychiatric disorders .\n",
            "Methods : A Random , double-blinded control study was carried out .\n",
            "@ patients who met the CCMD - ?\n",
            "criteria of schizophrenia , mood disorders , mental retardation and alcoholic disorders were recruited for the study .\n",
            "@ patients were treated wit sultopride hydrochloride injection and the others with sulpiride hydrochloride injection ( @-@ mg  d -@ ) for one week .\n",
            "Background : Cognitive remediation ( CR ) therapy in its various disguises can be helpful for people with schizophrenia but it is not clear if patient characteristics are likely to interfere with its effectiveness .\n",
            "Methodology : This paper describes the assessment of one putative moderating variable , age , on the outcome of CRT in a rigorous randomised control trial with memory , cognitive flexibility and planning as primary outcomes and social behaviour , symptoms and self-esteem as secondary outcomes .\n",
            "Calendar age was divided into younger ( < @ ; N@ ) and older ( @ or more years ; N@ ) .\n",
            "There were no differences between the groups at baseline in their cognitive , social or demographic data except on predicted variables .\n",
            "Results : Younger people benefited more from cognitive remediation in two of the three cognitive domains tested .\n",
            "In the memory domain both groups benefited .\n",
            "Only negative symptoms showed a moderating effect of age on CRT , where again the younger group showed improvements in the context of CRT but the older group did not .\n",
            "When older people did show a cognitive advantage in memory following therapy this cognitive improvement benefited social behaviour .\n",
            "Conclusion : CRT needs some modification to increase the benefits to older participants .\n",
            "However , any cognitive improvements do still seem to have a beneficial effect .\n",
            "Background : The effectiveness of long-term prescription of Atypical Neuroleptics is not yet fully established .\n",
            "Study : This @ year , prospective multicenter , open-label , parallel group study was designed as a \" naturalistic \" study of schizophrenic patients randomized either to RIS or to CNLP if their total PANSS was within @ to @ ; previous exposure to Clozapine and Lithium co-medication were excluded .\n",
            "Depot NLP was shifted to equivalent oral form and RIS was introduced with a NLP overlap strategy .\n",
            "Anticholinergics were decreased or kept as needed in both groups .\n",
            "Neurological tolerance was assessed with the ESRS ( Chouinard @ ) .\n",
            "@ patients were included ( RIS = @ , CNLP = @ ) of whom @ ( @ % ) were outpatients .\n",
            "Results : @ - By @ months , @ RIS patients ( @ % ) and @ CNLP ( @ % ) have dropped out , mainly for non response .\n",
            "Average dose of RIS and CNLP was @ mg and @ mg Eq.CPZ at @ months .\n",
            "@ - At @ months , RIS patients demonstrate a significant greater improvement in total PANSS ( p = @ ) in PANSS negative ( p = @ ) in PANSS positive ( p = @ ) and general psychopathology sub-scale ( p = @ ) scores .\n",
            "RIS advantage on negative symptoms is manifest at @ months ( p = @ ) and appears significant for positive symptoms between @ and @ months .\n",
            "Twice as many patients decrease their PANSS by @ % on RIS ( @ % ) vs CNLP ( @ % ) at @ months .\n",
            "CGI comparisons reflect the same effect ( RIS CNLP ; p = @ ) .\n",
            "@ - At @ months , subjective tolerance of NLP , assessed by ESRS part I , is better for RIS ( p = @ ) .\n",
            "The parkinsonian total score ( ESRS part II - item akathisia ) and the akathisia score are also significantly lower ( p = @ and p = @ , respectively ) .\n",
            "@ - Analysis of the dose - psychopathological changes relationship with the partial correlation method reveals an absolute unidirectionnal negative correlation between doses of NLP and improvement of negative and positive symptoms in both RIS and CNLP groups .\n",
            "Research findings are particularly important for medication choice for first-episode patients as individual prior medication response to guide treatment decisions is unavailable .\n",
            "We describe the first large-scale double-masked randomized comparison with first-episode patients of aripiprazole and risperidone , @ commonly used first-episode treatment agents .\n",
            "One hundred ninety-eight participants aged @-@ years with schizophrenia , schizophreniform disorder , schizoaffective disorder or psychotic disorder Not Otherwise Specified , and who had been treated in their lifetime with antipsychotics for @ weeks or less were randomly assigned to double-masked aripiprazole ( @-@mg / d ) or risperidone ( @-@mg / d ) and followed for @ weeks .\n",
            "Positive symptom response rates did not differ ( @ % vs @ % ) nor did time to response .\n",
            "Aripiprazole-treated participants had better negative symptom outcomes but experienced more akathisia .\n",
            "Body mass index change did not differ between treatments but advantages were found for aripiprazole treatment for total and low-density lipoprotein cholesterol , fasting glucose , and prolactin levels .\n",
            "Post hoc analyses suggested advantages for aripiprazole on depressed mood .\n",
            "Overall , if the potential for akathisia is a concern , low-dose risperidone as used in this trial maybe a preferred choice over aripiprazole .\n",
            "Otherwise , aripiprazole would be the preferred choice over risperidone in most situations based upon metabolic outcome advantages and some symptom advantages within the context of similar positive symptom response between medications .\n",
            "A double-blind comparison of orally administered haloperidol and trifluoperazine was conducted with @ acutely psychotic patients , mainly paranoid schizophrenics .\n",
            "In six of @ patients receiving haloperidol and five of eight receiving trifluoperazine , symptomatology was reduced enough that the patients could be discharged from the hospital .\n",
            "In patients in whom the drugs were effective , haloperidol 's average time of onset of action was @ days , trifluoperazine 's was @ days .\n",
            "Maximum effect was achieved , on the average , in @ days with haloperidol and in @ days with trifluoperazine .\n",
            "The results indicate not only that haloperidol is as effective as trifluoperazine but that its effect are obtained more quickly .\n",
            "Background : The CATIE trial is one of the most influential studies of the comparative efficacy of antipsychotic medications to date .\n",
            "It compared several antipsychotic medications and concluded that all antipsychotics compared in Phase @ are equal in their efficacy and tolerability .\n",
            "It remains unclear however if there are separable patterns of antipsychotic response that may suggest a drug-by-patient effect .\n",
            "Latent variable modeling allows researchers to test for individual differences in developmental trajectories that may underlie psychiatric data .\n",
            "Latent growth curve ( LGC ) modeling and growth mixture models ( GMM ) are particularly informative for investigating rate of change in longitudinal data and repeated measures data with several time points .\n",
            "The goal of the presentation is to illustrate the use of latent variable modeling to investigate differential patterns of antipsychotic response in the CATIE trial .\n",
            "Methods : Participants were @ respondents with schizophrenia drawn from the CATIE trial that completed measures of psychosis , cognition , and psychosocial functioning .\n",
            "Participants were administered the Positive and Negative Syndrome Scale ( PANSS ) , neurocognitive measures , and the Quality of Life Interview at baseline and several follow-up periods .\n",
            "First , we submitted participant scores to Latent Growth Curve Analysis ( LGCA ) to examine changes in psychotic symptoms , neurocognition , and functioning during the study from baseline to each followup period .\n",
            "Next , we used Latent Class Growth Modeling ( LCGM ) and Growth Mixture Modeling ( GMM ) to investigate the presence of sub-populations within the data that may differ in their trajectory of symptom improvement .\n",
            "We tested models with predictors including age , sex , marital status , ethnicity , education , illness duration , CGI severity , and medication type .\n",
            "We evaluated the fit of latent variable models using appropriate fit indices-Comparative Curve Fit Index ( CFI ) , Tucker Lewis Fit Index ( TLI ) , Akaike Information Criteria ( AIC ) , Bayesian Information Criteria ( BIC ) , Sample Size Adjusted BIC ( SSA-BIC ) , Lo-Mendell Rubin Test ( LMR ) and the Bootstrap Likelihood Ratio Test ( BLRT ) .\n",
            "Results : A linear function proved to be the best model of change for both the PANSS , psychosocial function , and the neurocognition scores when fit indices such as the comparative fit index ( CFI ) and information criteria are examined .\n",
            "Age , race , years of education , and years of present ill/treatment were significant predictors of change in positive and negative symptoms , whereas education level and ethnicity were significant predictors of change in neurocognition and functional status during antipsychotic treatment .\n",
            "Next we addressed the question of whether latent subgroups are apparent in change trajectory of outcome measures .\n",
            "In both the LCGM and the GMM , the AIC , BIC , and SSA-BIC best supported the three-class model .\n",
            "Similarly , the LMR and the BLRT also supported the three class model with very low probability that a @ or @-class model would have produced the data ( p < @ ) .\n",
            "The information criteria indices were however lower for the @-class GMM than the @-class LCGM , suggesting that a three-subgroup pattern of change in which there exists variability within subgroups best explain the pattern of antipsychotic response in PANSS scores .\n",
            "For the neurocogniton data , the LCGM tended to favor the @-class model when the information criteria and the BLRT are examined .\n",
            "In contrast , the GMM favored a @-class model when the information criteria , LMR , and the BLRT are examined .\n",
            "The two-class GMM was a better fit to the neurocognition data compared to the four-class LCGM .\n",
            "Mixture modeling of functioning data is pending .\n",
            "Conclusions : Latent trajectories are apparent in the pattern of response to antipsychotic medications in Phase @ of the CATIE trial when PANSS and neurocognition scores are considered .\n",
            "Age , race , education , and illness duration but not antipsychotic type predicted treatment response within unveiled subgroups .\n",
            "This is partly consistent with the conclusion drawn by the original CATIE investi ators .\n",
            "Latent variable models are adaptable to studying repeated measures data when collected longitudinally at known time points .\n",
            "The treatment of schizophrenic patients who fail to respond to adequate trials of neuroleptics is a major challenge .\n",
            "Clozapine , an atypical antipsychotic drug , has long been of scientific interest , but its clinical development has been delayed because of an associated risk of agranulocytosis .\n",
            "This report describes a multicenter clinical trial to assess clozapine 's efficacy in the treatment of patients who are refractory to neuroleptics .\n",
            "DSM-III schizophrenics who had failed to respond to at least three different neuroleptics underwent a prospective , single-blind trial of haloperidol ( mean dosage , @ + / - @ mg/d ) for six weeks .\n",
            "Patients whose condition remained unimproved were then randomly assigned , in a double-blind manner , to clozapine ( up to @ mg/d ) or chlorpromazine ( up to @ mg/d ) for six weeks .\n",
            "Two hundred sixty-eight patients were entered in the double-blind comparison .\n",
            "When a priori criteria were used , @ % of the clozapine-treated patients were categorized as responders compared with @ % of chlorpromazine-treated patients .\n",
            "Clozapine produced significantly greater improvement on the Brief Psychiatric Rating Scale , Clinical Global Impression Scale , and Nurses ' Observation Scale for Inpatient Evaluation ; this improvement included \" negative \" as well as positive symptom areas .\n",
            "Although no cases of agranulocytosis occurred during this relatively brief study , in our view , the apparently increased comparative risk requires that the use of clozapine be limited to selected treatment-resistant patients .\n",
            "Introduction : Calcium channel-blockers are used primarily to treat hypertension , cardiac arrhythmias and angina pectoris .\n",
            "Since @ , some reports have appeared in literature about using this group of drugs in the treatment postneuroleptic tardive dyskinesia .\n",
            "The various studies have yielded conflicting results as to efficacy in the treatment of tardive dyskinesia ( @ , @ , @ ) .\n",
            "Methods : Place of study : out-patients and in-patients of the Institute Psgchiatry and Neurology Study design : double-blind , duration @ weeks Investigated groups : treatment with diltiazem @ mg/@ h , and for comprising group treatment with diazepam @ mg/@ h. Evaluation : The Brief Psychiatric Rating Scale ( BPRS Overall and Graham @ ) , Clinical Global Impression ( CGI ) , The Tardive Dyskinesia Rating Scale ( TDRS Simpson and all @ ) , side effects ( ARI ) , physical examination , a routine blood tests , ECG .\n",
            "Assessment time : @ , @ , @ and @ days .\n",
            "Including criteria : schizophrenic patients ( ICD @ diagnostic criteria ) with postneuroleptic tardive dyskinesia .\n",
            "Exclusing criteria : concurent somatic illness , alcohol or drugs abuse any psychiatric disorder , other than the target discorder .\n",
            "Results : Characteristic of patients and results are summarized in Tables @ and @ .\n",
            "Table @ .\n",
            "Characteristic of study subject Drug Diltiazem Diazepam Number of patients @ @ Out patient @ @ In patient @ @ Mean age ( years ) @ @ male @ @ Gender female @ @ Maintenance neuroleptic therapy @  @ @  @ ( years ) Duration of TD @  @ @  @ ( years ) range @ range @ Symptoms of TD entire body @ facial and oral @ ( before treatment ) facial and lower extr .\n",
            "@ and number oral @ entire body @ of patients lower extr .\n",
            "@ upper extr .\n",
            "@ trunk @ Concomitant In consequence of chronic psychosis medication all the patients received antipsychotic medication Table @ .\n",
            "Results after treatment Drug and daily dose Diltiazem Diazepam ( @ mg ) ( @ mg ) Reduction @ @ on BPRS score ( % ) Significant depressive mood quilt feeling improvement in BPRS quilt feeling excitement symptoms anxiety motor retardation excitement Reduction @ @ on TDRS score ( % ) Significant abnormal movements of lower extremities improvement in TDRS ( restless leg , stamping and crossing symptoms movements ) akathisia , facial movements Drop out two patients because of worsening psychotic symptoms ( increasing of anxiety , tension , suspiciousness , delusions ) Side effects one patient had a headache , hypertension , diarrhoea , disturbances of accommodation two patients from both group had a transient increase of a liver tests in a second week of therapy .\n",
            "Conclusion : Diltiazem was well tolerated also by elderly patients as there were no significant changes in blood pressure or ECG parameters .\n",
            "No statistically significant differences were found between the two treatment groups regarding efficacy or safety during or at the end of the study period .\n",
            "Patients with severe tardive dyskinesia responded more favourably to treatment diltiazem than patients with less severe sings and symptoms .\n",
            "The responders had a shorter period of time tardive dyskinesia .\n",
            "Our study have shown that diltiazem may be useful calcium - channel blocker for treating tardive dyskinesia especially facial movements and akathisia .\n",
            "Diltiazem and diazepam added to antipsychotic drugs has caused the significant improvement of the psychopatology , too .\n",
            "Reference : @ .\n",
            "Adler L. , Duncan E. , et al .\n",
            "Effects of calcium-channel antagonists on tardive dyskinesia and psychosis .\n",
            "Psychopharmacol Bull @ ; @:@ .\n",
            "@ .\n",
            "Leys D. , Vermersch P. , et al .\n",
            "Diltiazem for tardive dyskinesia , Lancet @ ; @:@ .\n",
            "@ .\n",
            "Loonen AJM , Verwey HA. , et al .\n",
            "Is diltiazem effective treating the symptoms of ( tardive ) dyskinesia in chronic psychiatric inpatients ?\n",
            "A negative , double-blind , placebo-controlled trial .\n",
            "J Clin Psychopharmacol @ ; @:@ .\n",
            "We adapted an evidence-based transitional care model for older adults being released from acute care hospitals for patients with serious mental illness and medical co-morbidities being discharged from two psychiatric units of an acute care hospital ( TCare ) and evaluated implementation issues .\n",
            "An advisory group ( AG ) of community stakeholders assessed barriers and facilitators of a @-day T-Care intervention delivered by a psychiatric nurse practitioner ( NP ) in the context of conducting a pilot randomized controlled trial .\n",
            "Minutes of AG and case narratives by NP of @ intervention participants were content analyzed .\n",
            "Patients with immediate and pressing physical health problems were most receptive and actively utilized the service .\n",
            "Provider barriers consisted of communication and privacy issues making it difficult to contact patients in mental health facilities .\n",
            "In contrast , the NP was accepted and valued in the physical health arena .\n",
            "Psychosocial needs and relationship issues were demanding , and we recommend a team approach for TCare with the addition of a social worker , peer provider , and consulting psychiatrist for severely mentally ill patients being released from an acute physical health hospitalization .\n",
            "This randomized , double-blind , multicentre study compared the effects of long-term treatment with aripiprazole and olanzapine on body weight in patients with schizophrenia .\n",
            "A total of @ patients were randomised to receive treatment with aripiprazole ( @-@ mg/day ) or olanzapine ( @-@ mg/day ) for @ weeks .\n",
            "The primary outcome measure was the proportion of patients experiencing significant weight gain ( = @ % increase ) from baseline to endpoint .\n",
            "Throughout the study period , significantly more patients receiving olanzapine experienced significant weight gain ( = @ % increase ) than those receiving aripiprazole .\n",
            "Mean changes in body weight differed significantly between the groups at weeks @ and @ .\n",
            "At week @ , there was a mean weight gain of @ kg with olanzapine treatment compared with a mean weight loss of @ kg with aripiprazole treatment ( p < @ ) .\n",
            "Differences favouring aripiprazole were also seen for total cholesterol , high density lipoprotein ( HDL ) cholesterol , and triglyceride levels .\n",
            "The rate of response of clinical symptoms did not differ between the two treatment groups .\n",
            "In summary , the incidence of weight gain and dyslipidaemias was significantly lower with aripiprazole than with olanzapine , suggesting a more advantageous long-term metabolic profile for patients treated with aripiprazole , compared with those receiving olanzapine .\n",
            "BACKGROUND : Treatment of psychotic disorders consists primarily of second generation antipsychotics , which are associated with metabolic side effects such as overweight/obesity , diabetes , and dyslipidemia .\n",
            "Evidence-based clinical practice guidelines recommend timely assessment and management of these conditions ; however , research studies show deficits and delays in metabolic monitoring and management for these patients .\n",
            "This protocol article describes the project ' Monitoring and Management for Metabolic Side Effects of Antipsychotics , ' which is testing an approach to implement recommendations for these practices .\n",
            "METHODS/DESIGN : This project employs a cluster randomized clinical trial design to test effectiveness of an evidence-based quality improvement plus facilitation intervention .\n",
            "Eligible study sites were VA Medical Centers with > / = @ patients started on a new antipsychotic prescription in a six-month period .\n",
            "A total of @ sites , matched in pairs based on scores on an organizational practice survey , were then randomized within pairs to intervention or control conditions.Study participants include VA employees involved in metabolic monitoring and management of patients treated with antipsychotics at participating sites .\n",
            "The intervention involves researchers partnering with clinical stakeholders to facilitate tailoring of local implementation strategies to address barriers to metabolic side-effect monitoring and management .\n",
            "The intervention includes a Design Phase ( initial site visit and subsequent development of a local implementation plan ) ; Implementation Phase ( guided by an experienced external facilitator ) ; and a Sustainability Phase .\n",
            "Evaluation includes developmental , implementation-focused , progress-focused and interpretative formative evaluation components , as well as summative evaluation .\n",
            "Evaluation methods include surveys , qualitative data collection from provider participants , and quantitative data analysis of data for all patients prescribed a new antipsychotic medication at a study site who are due for monitoring or management of metabolic side effects during the study phases .\n",
            "Changes in rates of recommended monitoring and management actions at intervention and control sites will be compared using time series analyses .\n",
            "DISCUSSION : Improving monitoring for metabolic side effects of antipsychotics , as well as promoting timely evidence-based management when these effects emerge , will lead to improved patient safety and long-term outcomes .\n",
            "This article discusses key strengths and challenges of the study .\n",
            "TRIAL REGISTRATION : NCT@ .\n",
            "Introduction : The present study examined whether social support served as a mediator ( i.e. , an apparent causal mechanism ) for the relationship between mental illness ( MI ) and drug and/or alcohol abuse ( SA ) .\n",
            "Objective : This study   s objective was to determine the role of social support as a potential mediator in the relationship between mental illness and drug and/or alcohol abuse .\n",
            "Methods : We utilized data from a randomized controlled trial ( RCT ) , conducted on individuals at risk for HIV in Philadelphia jails by following @ study participants coming out of jails .\n",
            "Out of these @ individuals , data was selected for individuals with mental illness and drug and/or alcohol abuse .\n",
            "In the parent study , these individuals were identified by asking questions about their mental illness , and drug and/or alcohol abuse problems .\n",
            "They also answered Norbeck Social Support Questionnaire about social support .\n",
            "They provided demographic data on their age , race , gender , religion , marital status and education level , which was collected as part of a face-to-face demographic interview conducted during the baseline assessment .\n",
            "Results : Data was analyzed using negative binomial regression method to test for mediation effect .\n",
            "Results indicated that social support mediated the relationship between mental illness and drug abuse .\n",
            "We ran two generalized linear and one general linear regression models .\n",
            "In the first model , we looked at the total effect of mental illness on drug abuse ( c ) ; we found that the incidence rate for drug abuse ( SA ) would be expected to increase by a factor of @ , ( IRR ,@ ; CI,@-@ ; P = @ ) for every one-unit increase in mental illness ( M@ ) , while holding all other variables in the model constant .\n",
            "In the second model we adjusted our mediator , social support ( SS ) and looked at the direct effect of mental illness on drug abuse ( c   ) .\n",
            "We interpreted that for every one-unit increase in mental illness , the incidence rate for drug abuse would be expected to increase by a factor of @ , ( IRR ,@ ; @ % CI ,@ - @ ; P = .@ ) .\n",
            "For every one-unit increase in social support , the incidence rate for drug abuse is expected to decrease by a factor of .@ , ( IRR , .@ ; @ % CI , .@ - .@ ; P = .@ ) .\n",
            "In the third model we found , for every one-unit increase in mental illness , there is an associated increase by @ units in social support , P = .@ .\n",
            "There was an inconsistent mediation in our model .\n",
            "Effect size for mediation by Percent mediation ( Pm ) method was found to be @ , it is the proportion of the effect that is mediated by our mediator social support .\n",
            "Sobel test showed the significance of mediation with a test statistic of @ at a significance level of @ .\n",
            "Conclusion : Our data supported an alternative theory of inconsistent mediation .\n",
            "We found that social support mediates the relationship between mental illness and drug abuse , where positive social support has a stimulator effect on mental illness and a suppressor effect on drug abuse .\n",
            "Mental illness may have direct unfavorable effects on the drug abuse ( outcome ) and positive social network has beneficial effects on this outcome .\n",
            "We conclude that positive support allows betterment of mental health of patients and prevents involvement in drug abuse .\n",
            "Further , there is a need to consider both the positive and negative effects of social support while keeping in mind these associations may differ among sociodemographic groups .\n",
            "Objective To verify the efficacy and side effects of quetiap ine on first@ep isode schizophrenia .\n",
            "Methods Patientswho metDSM@ criteria for schizophrenia were randomized into two group s : quetiap ine group ( n = @ ) and sulp iride group ( n = @ ) in control study .\n",
            "The treatment duration was @ weeks .\n",
            "The PANSS , BPRS , CGI , TESS and related lab tests were emp loyed for assessing the treatment effectiveness and side effects .\n",
            "Results At the end of treatments , the scores of PANSS and BPRS in both treatment group s decreased significantly compared with baseline .\n",
            "In quetiap ine group , the total scores of PANSS and BPRS are ( @ .\n",
            "@  @ .\n",
            "@ ) and ( @ .\n",
            "@  @ .\n",
            "@ ) , t values are @ .\n",
            "@ and @ .\n",
            "@ .\n",
            "In sulp iride group , the total scores of PANSS and BPRS are ( @ .\n",
            "@  @ .\n",
            "@ ) and ( @  @ .\n",
            "@ ) , t values are @ .\n",
            "@ and @ .\n",
            "@ ( P < @ .\n",
            "@ ) .\n",
            "At the @ th , @ th , @ th week of treatments , the scores of PANSS total , negative and general p sychopathology were significant differences between two group s ( P < @ .\n",
            "@ ) and it was lower in quetiap ine group than in sulp iride group .\n",
            "Total clinical effective rateswere @ .\n",
            "@ % in quetiap ine group and @ .\n",
            "@ % in Sulp iride group , which was significant difference between two group s ( @ = @ .\n",
            "@ , P < @ .\n",
            "@ ) .\n",
            "Less and lighter side effectswere in both group s and significant difference between them .\n",
            "Conclusion Quetiap ine has better efficacy than sulp iride and less side effects , especially in imp roving negative symp tom .\n",
            "Schizophrenia is a serious mental health problems that affects how a person thinks , feels and behaves .\n",
            "Schizoaffective disorder is a serious mental illness that has features of both schizophrenia , and an affective ( mood ) disorder , such as depression ( low mood ) .\n",
            "Traditionally , deciding upon the most appropriate treatment for patients is done by doctors .\n",
            "This study is looking at a shared decision making ( SDM ) approach , in which patients work with nurse to present a summary of the patient 's preferences regarding treatment .\n",
            "The aim of this study is to find out whether this participative way of making decisions of which treatment to take at discharge from acute ( sudden ) hospitalization is better than a more doctor-driven decision making in treatment compliance and readmissions at @ months .\n",
            "Objective Biqilaxi ketone and Aripiprazole in the treatment of predominantly negative symptoms of schizophrenia efficacy and adverse effects .\n",
            "Methods @ patients with predominantly negative symptoms of schizophrenia were randomly divided into two groups , respectively Ziprasidone and Aripiprazole treatment for eight weeks , and efficacy by the Positive and Negative Syndrome Scale ( panss ) , Assessment of Negative Symptoms Scale ( sans ) and clinical Global Impression ( cgi-gi ) assessed side effects assessed by the the side reactions scale ( tess ) .\n",
            "Results of ziprasidone Abilify gung azole efficacy considerable impact on cognitive function was no significant difference ( p > @ ) , significantly lower than the severity of the side effects of ziprasidone Aripiprazole .\n",
            "BACKGROUND : Recent advances in the neurobiology of cannabinoids have renewed interest in the association between cannabis and psychotic disorders .\n",
            "METHODS : In a @-day , double-blind , randomized , placebo-controlled study , the behavioral , cognitive , motor , and endocrine effects of @ mg , @ mg , and @ mg intravenous Delta-@-tetrahydrocannabinol ( Delta-@-THC ) were characterized in @ stable , antipsychotic-treated schizophrenia patients .\n",
            "These data were compared with effects in healthy subjects reported elsewhere .\n",
            "RESULTS : Delta-@-tetrahydrocannabinol transiently increased @ ) learning and recall deficits ; @ ) positive , negative , and general schizophrenia symptoms ; @ ) perceptual alterations ; @ ) akathisia , rigidity , and dyskinesia ; @ ) deficits in vigilance ; and @ ) plasma prolactin and cortisol .\n",
            "Schizophrenia patients were more vulnerable to Delta-@-THC effects on recall relative to control subjects .\n",
            "There were no serious short - or long-term adverse events associated with study participation .\n",
            "CONCLUSIONS : Delta-@-tetrahydrocannabinol is associated with transient exacerbation in core psychotic and cognitive deficits in schizophrenia .\n",
            "These data do not provide a reason to explain why schizophrenia patients use or misuse cannabis .\n",
            "Furthermore , Delta-@-THC might differentially affect schizophrenia patients relative to control subjects .\n",
            "Finally , the enhanced sensitivity to the cognitive effects of Delta-@-THC warrants further study into whether brain cannabinoid receptor dysfunction contributes to the pathophysiology of the cognitive deficits associated with schizophrenia\n",
            "Introduction : Schizophrenia is a clinical syndrome , a devastating psychiatric disorder .\n",
            "The clinical outcome of patients suffering from schizophrenic psychoses has been considerably improved by atypical antipsychotics .\n",
            "The evolution of various pharmacological therapies for schizophrenia has given rise to several pharmacological models for the neuroreceptor targets of antipsychotics and the influence of various neuroreceptors on specific symptoms and side effects .\n",
            "Clozapine is the prototypic atypical antipsychotic medication and has long been the gold standard for treatment of patients with treatment-resistant schizophrenia .\n",
            "It binds to many neurotransmitter receptors , but it also binds less than typical agents to dopamine D@ receptors , many patients remain symptomatic despite adequate treatment with this medication [ @ ] .\n",
            "While clozapine interacts with a variety of neurotransmitter receptors , amisulpride predominantly binds with high affinity to D@/D@-dopamine receptors .\n",
            "Amisulpride could have beneficial effects in ameliorating positive and negative symptoms in those with clozapine resistance [ @ ] .\n",
            "Combination can be considered if a supplementary dopamine-receptor blockade is desired [ @ ] .\n",
            "Aim ( s ) : The aim was to compare the effectiveness and tolerability of the combination of amisulpride and clozapine with the clozapine monotherapy in patients with treatment-resistant schizophrenia .\n",
            "Method ( s ) : In a randomized , double-blind , placebo-controlled @-week trial , @ patients unresponsive or partially responsive to @ mg/day of clozapine monotherapy ( N = @ ) received a steady dose of @ mg/day clozapine combined with or up to @ mg/day of amisulpiride ( N = @ ) .\n",
            "Efficacy measures at @-week intervals consisted of the Brief Psychiatric Rating Scale ( BPRS ) , the Scale for the Assessment of Negative Symptoms ( SANS ) , the Scale for the Assessment of Positive Symptoms ( SAPS ) , and the Clinical Global Impression ( CGI ) scale .\n",
            "Result ( s ) : From baseline to week @ and week @ , mean BPRS total and positive symptom subscale scores were reduced significantly in both groups , but the reductions were significantly greater with clozapine/amisulpride treatment .\n",
            "This difference was noted as early as the third week of follow-up in terms of CGI scores , and by the sixth week with regard to BPRS , SANS , and SAPS scores and both drugs were well tolerated .\n",
            "Improvement favoring clozapine/amisulpride could be attributed to the selective D@/D@ binding property of amisulpride , which had an additional effect in improving symptoms of schizophrenia .\n",
            "Reductions in SANS scores were also significantly greater with clozapine/amisulpride treatment than with clozapine monotherapy group .\n",
            "A substantial improvement occurred in both groups by the end of the eighth week ; however , the improvement associated with amisulpride was significantly greater than that seen with clozapine .\n",
            "Conclusion ( s ) : The addition of amisulpride improved overall symptoms and positive and negative symptoms of schizophrenia .\n",
            "Clozapine augmentation with amisulpride appears to be well tolerated and safe , but clinicians should approach this augmentation strategy with caution because polypharmacy is associated with potential risks .\n",
            "Augmentation of clozapine with amisulpride may provide additional clinical benefit for patients who are nonresponsive or only partially responsive to clozapine alone .\n",
            "Copyright   @\n",
            "Oral methylphenidate ( @ mg/kg ) and intravenous methylphenidate ( @ mg/kg ) were compared as to their ability to increase behavioral activation , pulse , blood pressure , and serum growth hormone .\n",
            "Intravenous methylphenidate was considerably more effective than oral methylphenidate in activating behavior and in increasing pulse and blood pressure .\n",
            "Although oral methylphenidate appeared to increase behavioral activation , this effect was not statistically significant .\n",
            "Objectives : This study was designed to examine the effect of a @-week weight management program on the quality of life , self-esteem and psychotic symptoms of schizophrenia .\n",
            "Methods : The subjects of the experiment consisted of psychiatric patients taking antipsychotics who were diagnosed with DSM-IV schizophrenia .\n",
            "The experimental group were patients with body mass index of @ kg/m@ or above who participated in a @-week weight management program , while the control group did not join the program .\n",
            "All the patients were admitted in closed psychiatry ward of a mental hospital .\n",
            "The program consisted of diet therapy , exercise , behavior modification and education .\n",
            "All the patients were checked on Brief Psychiatric Rating Scale ( BPRS ) , Rosenberg Self-esteem Scale ( RSES ) , Korean version of the SmithKlein Beecham Quality of Life ( KvSBQOL ) , Korean version of @th revision of Schizophrenia Quality of Life Scale ( SQLS-R@K ) and the weight .\n",
            "Results : After the @-week weight management program , RSES , KvSBQOL and SQLS-R@K were increased significantly in the experimental group ( p < @ ) , as opposed to the control group .\n",
            "While the experimental group showed a notable increase in body weight and body mass index ( BMI ) , the change in the control group was insignificant .\n",
            "BPRS was decreased significantly ( p < @ ) .\n",
            "Conclusion : @-week weight management program had a positive effect to decrease the weight and to increase the self-esteem and quality of life .\n",
            "This study provides evidence for the potential and beneficial effect of weight management program for schizophrenic patients .\n",
            "The combination of pharmacotherapy and cognitive retraining ( CRT ) for the cognitive deficits of schizophrenia may be more efficacious than either approach alone , but this has not yet been tested .\n",
            "This study evaluated the feasibility , safety , tolerability , and efficacy of @ weeks of D-serine , combined with CRT in the treatment of cognitive deficits in schizophrenia at two academic sites in parallel , in India and the United States .\n",
            "In a randomized , partial double-blind , placebo-controlled , parallel-group design , @ schizophrenia subjects ( US site = @ , Indian site = @ ) were randomized to : ( @ ) D-serine ( @ mg/kg ) + CRT ( @ h/week ) , ( @ ) D-serine + control CRT , ( @ ) CRT + placebo D-serine , and ( @ ) placebo + control CRT .\n",
            "Completion rates were @ and @ % in the Indian and US samples , respectively .\n",
            "On various outcome measures of safety and tolerability , the interventions were well tolerated .\n",
            "D-Serine and CRT did not show any significant effect on the Global Cognitive Index , although both interventions showed differential site effects on individual test performance .\n",
            "CRT resulted in a significant improvement in Verbal Working Memory , and a trend toward improvement in Attention/Vigilance .\n",
            "This is the first study to demonstrating the feasibility , safety , and tolerability of combination pharmacotherapy and CRT in a multicenter international clinical trial .\n",
            "These preliminary findings provide support for future studies using higher doses of D-serine that have been shown to be efficacious or other pharmacotherapies , along with the newer cognitive remediation strategies that are individualized and that target basic information processing .\n",
            "Objective To investigate the role of health education in convalescent rehabilitation of patients with schizophrenia .\n",
            "Methods @ patients were randomly divided into observation group of @ patients , @ patients in both groups were enrolled in stable condition after drug treatment .\n",
            "The observation group to the health education care control group to the general hygiene education , a total of @ weeks .\n",
            "Brief Psychiatric Rating Scale ( bprs ) , Inpatient Nurses Observation Scale ( nosie ) , the @,@ weekend enrolled into the group after all the assessment .\n",
            "Results the observation group into the group of @ weeks and @ weekend bprs rated were ( @  @ ) ( @  @ ) min ] , and the control group ( @  @ ) compared to ( @  @ ) min ] statistics significance ; nosie the rating observation group @ weekend social interest , personal hygiene , points of psychosis factor with the control group was statistically significant from @ weeks remaining factors divided into two groups were statistically significant .\n",
            "Objective : To investigate the clinical efficacy of fluphenazine decanoate Point Injection Treatment of schizophrenia auditory hallucinations .\n",
            "Methods : @ the Kuei patients with schizophrenia to listen to patients were divided into @ groups of @ cases of hallucinations .\n",
            "The control group was treated with antipsychotics .\n",
            "Treatment group with fluphenazine decanoate antipsychotics on the basis of listening to the palace , hearing into the express injection every two weeks , each @ mg .\n",
            "The use of antipsychotic dose was no difference .\n",
            "Results : The treatment group was significantly better than the control group , auditory hallucinations disappeared time shorter than the control group , in particular , is a chronic disease course of more than five years , the remarkable efficiency of the treatment group than the control group .\n",
            "Objective : To investigate the clinical efficacy of fluphenazine decanoate Point Injection Treatment of schizophrenia auditory hallucinations .\n",
            "Methods : @ the Kuei patients with schizophrenia to listen to patients were divided into @ groups of @ cases of hallucinations .\n",
            "The control group was treated with antipsychotics .\n",
            "Treatment group with fluphenazine decanoate antipsychotics on the basis of listening to the palace , hearing into the express injection every two weeks , each @ mg .\n",
            "The use of antipsychotic dose was no difference .\n",
            "Results : The treatment group was significantly better than the control group , auditory hallucinations disappeared time shorter than the control group , in particular , is a chronic disease course of more than five years , the remarkable efficiency of the treatment group than the control group .\n",
            "Conclusion : fluphenazine decanoate Point Injection Treatment of auditory hallucinations of schizophrenia is one of the more desirable method of treatment .\n",
            "At the conclusion of this session ( the participant should better understand the effects of metabolic parameters during long-term treatment with aripiprazole.Objective : To examine the effects on metabolic parameters during long - term treatment with aripiprazole , an antipsychotic associated with minimal weight gain.Methods : Levels of glucose , plasma lipids , and glycosylated hemoglobin ( A@C ) were determined from fasted blood samples collected in a @-week trial comparing aripiprazole with placebo for prevention of relapse in patients with chronic stable schizophrenia.Results : Changes from baseline to endpoint in mean fasting plasma glucose were minimal with both aripiprazole ( @ mg/dL ) and placebo ( @ mg / dL ) .\n",
            "A@C decreased by @ % and @ % in the placebo and aripiprazole groups , respectively .\n",
            "Small decreases in levels of fasting total and LDL cholesterol were observed with aripiprazole and placebo , while plasma HDL cholesterol levels increased slightly in both arms of the study .\n",
            "Median fasting plasma triglycerides levels were reduced by @ mg/dL and @ mg / dL in the aripiprazole and placebo groups , respectively .\n",
            "Conclusion : Aripiprazole was not associated with adverse metabolic changes during long-term therapy .\n",
            "Effects on glycemic control and plasma lipid profile were similar to those of placebo )\n",
            "Primary Drug / Intervention : Secretin Dosage : @ vials Secondary Drug / Intervention : Other Drug / Intervention : Illness : Schizophrenia Sample Size : @ Trial Design : Double-blind , placebo-controlled , adjunctive , randomized Duration of Study Period for Each Subject : @ weeks Outcome Measurements : NOSIE , PANSS , CGI , CPT , RBS .\n",
            "RBANS .\n",
            "WAIS III , ABC , SDS Results : In a preliminary trial of @ patients with severe schizophrenia , this pancreatic hormone produced transient improvements in some patients .\n",
            "A follow-up study is desirable but difficult to do as the compound has limited availability .\n",
            "Purpose - We investigate whether the add-on specific antitoxoplasmatic medication has positive effects in individuals with schizophrenia or major depression seropositive for Toxoplasma gondii ( TG ) infection .\n",
            "As TG modulates neurotransmitter metabolism affecting serotonin and dopamine we hypothesize that this chronic persistent infection might play a role for depressive and psychotic symptomatology .\n",
            "Therefore , on the basis of an ex juvantibus approach , specific anti TG medication might further improve psychiatric symptomatology in affected patients .\n",
            "This is investigated in a double-blind , placebo-controlled , randomized treatment trial .\n",
            "Condition Intervention Phase Schizophrenia Major Depression Drug - daraprim Drug - pyrimethamine Drug - folinic acid Phase III Primary Outcome Measures - Psychopathology ratings Secondary Outcome Measures - TG infection parameters Total Enrollment - @ Study start - January @ ; Study completion - September @ Eligibility - Ages Eligible for Study - @ Years and above , Genders Eligible for Study - Both Criteria Inclusion Criteria - Schizophrenia or Major Depression Both genders Adult Patients are able to give informed consent Exclusion Criteria - Additional diagnosis of substance abuse/dependency Continuous treatment with medication not compatible with study medication Medical status not compatible with study medication Any condition that increases study risk considerably Pregnancy , nursing\n",
            "There is current disagreement over whether men and women respond differently to typical or atypical antipsychotic medications .\n",
            "This study reanalyzed a large international clinical trial of olanzapine ( Olz ) compared with haloperidol ( Hal ) to test for sex differences in treatment response , controlling for illness chronicity and menopausal status .\n",
            "We hypothesized that women would show a greater response to either medication than men , particularly among first admission , premenopausal women .\n",
            "DSM-III-R schizophrenia inpatients ( @ women and @ men ) were randomly assigned to a @-week trial of Olz vs. Hal .\n",
            "Longitudinal random effect models were used to test for interactions of sex with medication , chronicity and menopausal status on treatment response .\n",
            "Findings showed that women on olanzapine had a greater drop in overall symptomatology by week @ than any other group , and their level of symptomatology remained lower throughout the @-week trial .\n",
            "The sex differences in treatment response in olanzapine compared with haloperidol were , in part , dependent on chronicity and , in women , menopausal status .\n",
            "That is , first episode women on haloperidol exhibited an increase in symptomatology over the @-week trial compared to their male counterparts , while multiply hospitalized women had a better treatment response on haloperidol than their male counterparts .\n",
            "Women on olanzapine had a significantly better treatment response than men , regardless of chronicity .\n",
            "Finally , premenopausal women had a significantly better treatment response than postmenopausal women , regardless of treatment and chronicity .\n",
            "OBJECTIVE : To investigate the effects of Ginkgo biloba extract ( EGb ) administration on T lymphocyte subsets and superoxide dismutase ( SOD ) levels in schizophrenia .\n",
            "METHODS : One hundred and nine schizophrenic inpatients were randomly assigned to @ weeks of treatment with @ mg/day of EGb plus a stable dose of @ mg kg ( -@ ) day ( -@ ) of haloperidol and placebo plus the same dose of haloperidol using a double-blind design .\n",
            "Clinical efficacy was determined using the Brief Psychiatric Rating Scale ( BPRS ) , Scale for Assessment of Positive Symptoms , and Scale for Assessment of Negative Symptoms .\n",
            "T lymphocytes ( CD@ + ) , T helper cells ( CD@ + ) , T suppressor cells ( CD@ + ) , and IL-@-secreting cells were measured using the alkaline phosphatase/antialkaline phosphatase technique ; and SOD levels were measured by radioimmunometric assay at baseline and at posttreatment , as compared to @ sex - and age-matched normal subjects .\n",
            "RESULTS : Patients demonstrated significantly lower CD@ + , CD@ + , and IL-@-secreting cells , together with CD@/CD@ ratio , and significantly higher blood SOD levels than did healthy controls at baseline .\n",
            "There was a significantly negative relationship between SOD and CD@ + cells in the schizophrenic group at baseline .\n",
            "After a @-week treatment , CD@ + , CD@ + , and IL-@-secreting cells , together with CD@/CD@ ratio , showed a significant increase , but a significant decrease in SOD levels in the EGb group .\n",
            "There was only a significant increase in CD@ + cells but no change in SOD levels in the placebo group .\n",
            "There was a significant correlation between the change in CD@ + cells at posttreatment vs pretreatment and a reduction of BPRS total score in the whole patient group .\n",
            "CONCLUSIONS : EGb may improve the decreased peripheral immune functions in schizophrenia .\n",
            "The beneficial effects of EGb on the immune systems and the improvement of schizophrenic symptoms may be medicated through its antioxidant activity .\n",
            "RN @ ( Antigens , CD@ ) .\n",
            "@ ( Antioxidants ) .\n",
            "@ ( Antipsychotic Agents ) .\n",
            "@ ( Drugs , Chinese Herbal ) .\n",
            "@ ( IL@ protein , human ) .\n",
            "@ ( Interleukin-@ ) .\n",
            "@-@-@ ( Haloperidol ) .\n",
            "EC @-@-@-@ ( Superoxide Dismutase ) .\n",
            "Does a community-based , integrated treatment plan improve one year clinical and social outcome in people with first episode psychosis ?\n",
            ", METHODS , Design : Randomised controlled trial .\n",
            "Allocation : Concealed. , Blinding : Unblinded. , Follow up period : One year. , Setting : Mental health services and the community in Copenhagen and Aarhus , Denmark ; recruitment January @ to January @ .\n",
            ", Patients : @ adults ( @-@ years old ) with first episode psychosis ( ICD-@ diagnosis of schizophrenia , schizotypal disorder , acute psychosis , schizoaffective psychosis , delusional disorder , or unspecified non-organic psychosis ) .\n",
            "Exclusion criteria : psychosis due to intoxication or withdrawal ; > @ weeks use of antipsychotics ; mental retardation ; or organic mental disorder. , Intervention : Integrated care : based on the \" Assertive Community Treatment \" model , and was delivered by a multidisciplinary team .\n",
            "Each person was assigned a treatment coordinator ( @:@ caseload ) , and received social skill training or general psychoeducation as required .\n",
            "Standard care : the usual mental health services , with a caseload of @:@ to @:@ .\n",
            "Both integrated and standard care could include standard antipsychotic medication. , Outcomes : Poor outcome ( Scale for Assessment of Positive Symptoms or Scale for Assessment of Negative Symptoms scores > @ ; substance misuse or dependence present ; Global Assessment of Functioning - Symptom and Global Assessment of Functioning - Disability ( GAF-D ) scores < @ ; being homeless , or in sheltered or supervised accommodation ; unemployed/not undertaking education/training , or death ) .\n",
            ", Patient follow up : @ % in the integrated care group , @ % in the standard care group. , MAIN RESULTS , At one year follow up , integrated care reduced poor outcome on all outcome measures outlined above , except for GAF-D and death .\n",
            "Standard care increased the likelihood of having at least one poor outcome at one year follow up ( @ % with integrated care v @ % with standard care ; OR @ ; @ % CI @ to @ ) .\n",
            ", CONCLUSIONS , Integrated treatment reduces poor clinical and social outcomes in first episode psychosis at one year follow up , NOTES , Differential dropout between the groups , and an association between lower education levels and loss to follow up may have skewed results .\n",
            "The nature of the antipsychotic use in both groups was not reported .\n",
            "This randomized , double-blind , placebo-controlled , parallel-group study was to determine the pharmacokinetic characteristics , safety , and tolerability of multiple doses of inhaled loxapine aerosol in subjects on a stable , oral , chronic antipsychotic regimen .\n",
            "Loxapine was delivered by means of a unique thermally generated aerosol comprising drug particles of a size designed for deep lung delivery and absorption .\n",
            "Thirty-two subjects were randomized @:@:@:@ to receive inhaled loxapine ( total doses of @ , @ , or @ mg ) or inhaled placebo administered in @ divided doses , given @ hours apart .\n",
            "Following inhalation , the median Tmax was @ minutes , and concentrations declined to about half Cmax approximately @ minutes later across the @ dose levels .\n",
            "The dose proportionality across data from this study combined with data from the single-dose study showed a slope ( @ % CI ) of log AUCinf versus log dose of @ ( @-@ ) across the @ doses ( n = @ subjects ) studied , indicating reasonable dose proportionality .\n",
            "The most common adverse events were cough ( @ of @ , @ % ) , sedation ( @ of @ , @ % ) , and dysgeusia ( @ of @ , @ % ) .\n",
            "The inhalation of multiple doses of inhaled loxapine were well tolerated in study subjects and provided a safe , well-tolerated means for rapidly and reliably achieving therapeutic plasma concentrations of loxapine .\n",
            "ClinicalTrials.gov identifier : NCT@ .\n",
            "Objective : To evaluate the cross-sectional and prospective effects of olanzapine , risperidone and haloperidol on development of hypertension , diabetes and metabolic changes in drug-naive patients with first-episode schizophrenia and compared them with a healthy matched control group .\n",
            "Methods : In the first part of the study , a cross-sectional sample of @ patients on steady doses of antipsychotics was evaluated for the presence of hypertension , diabetes and metabolic changes .\n",
            "In the second part , newly diagnosed patients with first-episode schizophrenia , randomized in a double blind trial to be treated with antipsychotic medication-olanzapine , risperidone , or haloperidol-and matched healthy controls were followed for @ weeks .\n",
            "Body mass index ( BMI ) , blood sugar , blood pressure changes and lipid profile changes were monitored and repeated after @ weeks .\n",
            "Results : The cross-sectional data revealed a prevalence of obesity in @ % , hypertension in @ % and metabolic syndrome in @ % .\n",
            "In the prospective part , ninety-nine patients with first-episode schizophrenia and @ healthy controls were examined .\n",
            "Significant changes , between baseline and endpoint , in BMI , serum triglycerides , serum HDL , serum glucose and blood pressure was noted in the patient group .\n",
            "Conclusion : The results confirm clinically significant and substantial changes induced by antipsychotic treatment in drug-naive patients with first-episode schizophrenia and underscore the need to carry out early monitoring of patients on atypical antipsychotics .\n",
            "Objective : To analyze the clinical treatment of schizophrenia drugs , clinical choose a safe , effective , economical treatment program to provide a reasonable basis .\n",
            "Method : select our hospital from January @ to January @ , @ patients were treated schizophrenia patients were randomly divided into four groups , a group for taking risperidone group b group taking ziprasidone group , c group taking quetiapine fumarate group , d taking olanzapine level group .\n",
            "Results : In group @ , ziprasidone program the lowest incidence of adverse reactions , significant efficiency was slightly higher .\n",
            "\" Objective : Because oxytocin ( OT ) has prosocial and antipsychoticlike effects in animals and recent human studies , we hypothesized that a trial of OT treatment would reduce social cognition deficits as well as psychotic symptoms in schizophrenia .\n",
            "Methods : A double blind study compared twice daily intranasal OT ( @ IU/dose , N = @ ) vs. placebo ( N = @ ) for @ days on social cognition tests , PANSS scores and Paranoia Scale self-ratings .\n",
            "Subjects ' symptoms ( PANSS > @ ) and psychotropic medications were stable for > @ month prior to starting the treatment trial and medications were unchanged during the trial .\n",
            "Results : From baseline to treatment day @ , the OT group : @ ) significantly increased accuracy in recognition of @nd and @rd order false belief on the Brune Theory of Mind Task ; @ ) trended toward greater accuracy in recognizing deception on the Brune Task and more trustworthy ratings of faces on the Trustworthiness Task .\n",
            "Also , mean scores on PANSS social items ( suspiciousness , hostility , social withdrawal [ passive/apathetic , active ] , uncooperativeness ) declined dramatically .\n",
            "There were significant reductions in PANSS total , positive , negative and general subscale scores , the individual suspiciousness and anxiety item scores as well as Paranoia Scale scores .\n",
            "In the placebo group , only PANSS suspiciousness and anxiety item scores declined significantly .\n",
            "ANCOVAs controlling for baseline revealed that the OT group vs. placebo group had significantly greater declines in PANSS total scores and trends toward greater declines in PANSS mean social item and positive subscale scores .\n",
            "Conclusion : Enhancement of social cognition suggests that OT treatment may improve social dysfunction , which responds poorly to antipsychotic medications and is the major cause of disability in schizophrenia .\n",
            "OT may augment antipsychotic efficacy and should be tested as a monotherapy for schizophrenia .\n",
            "Our results indicate that OT may play an important role in the pathophysiology of psychotic symptoms in schizophrenia and associated social cognition and social function deficits . \"\n",
            "Objective : To investigate the influence of Orem mode medication compliance and overall well-being of patients with schizophrenia .\n",
            "Methods : The @ cases of hospitalized elderly patients with schizophrenia were randomly divided into observation group and control group @ cases each group .\n",
            "Both groups were to be routine psychiatric treatment and care , on the basis of the observation group in Orem theory as a framework , to take appropriate self-care training for @ weeks .\n",
            "Before and after training with the use of medication compliance assessment criteria assessed medication compliance , overall happiness rating scale overall happiness .\n",
            "Results : Before training groups medication compliance , overall happiness scores was no significant difference ( P > @ ) ; observation group after training medication compliance and overall well-being were significantly higher ( P < @ ) .\n",
            "Conclusion : The use of Orem model can significantly improve medication compliance and overall well-being in elderly patients with schizophrenia .\n",
            "AIM This study compares the efficacy and safety of olanzapine compared with risperidone , and measures the ability of the gen - eral population to value the outcomes of treatment by trading off time versus health to derive utilities .\n",
            "METHOD Efficacy was measured by defining a responder as those with a @ % improve - ment in total PANSS score from baseline .\n",
            "Safety was measured in terms of patients with and without extra-pyramidal side - effects ( EPS ) .\n",
            "The results of the Tran @ trial were analysed using a quadrant approach method , which involved the trial population for olanzapine and risperidone being separated into a combined outcome measure that captured both efficacy and safety benefits as in the following scenarios ; Non-responder with EPS Responder with EPS Non-responder without EPS Responder without EPS The time trade off ( TTO ) methodology was then used to illicit utilities for each of these scenarios .\n",
            "RESULTS The results of the study show that olanzapine offers superior out - comes in rates of responder without EPS and non-responder with EPS , when compared with risperidone .\n",
            "The difference in out - comes was statistically significant ( p = @ ) for the two treat - ment groups .\n",
            "The TTO survey was completed by @ people .\n",
            "The utility scores derived from the TTO survey were as follows : non - responder with EPS @ ( @ years traded ) , non-responder without EPS @ +@ ( @ years traded ) , responder with EPS @ ( @ years traded ) and responder with no EPS @ ( @ years traded ) .\n",
            "Participants traded significantly more years for the responder than non-responder state and irrespective or respon - der categorisation + traded significantly more years for the \" with - out EPS \" state .\n",
            "CONCLUSIONS This is a useful way to analyse results as both the EPS and the symptoms of the disease con - tribute to the enormous burden of schizophrenia .\n",
            "The results of this study show the ability of a community sample to value , ymptoms and side-effects ( EPS ) of schizophrenia using a time trade-off methodology .\n",
            "They support the value of antipsychotic medication that is both effective in reducing schizophrenia symptoms as well as having a favourable EPS side effect profile .\n",
            "I. Tran PV .\n",
            "Hamilton SH , Kuntz AJ , et al .\n",
            "Double-blind com - parison of Olanzapine versus Risperidone in the Treatment of Schizophrenia and Other Psychotic Disorders .\n",
            "J Clin Psy - chopharmacol @:@:@-@ .\n",
            "Background : In @ % -@ % of cases , psychosis disrupts vocational or academic engagement [ @ ] .\n",
            "JobPrescription aims for employment/studies through Individual Placement and Support ( IPS ) .\n",
            "Sixty-one participants ( @-@ ) with psychotic disorders entered the project , about half on the initiative of treating clinician .\n",
            "@ % attained regular paid employment , @ % were in internships .\n",
            "The mean time from project inclusion to employment was @ months ( SD @ ) .\n",
            "However , these figures have not been compared to a control group , and the group was a mix of chronic and first-episode patients .\n",
            "Objective : To evaluate the effect of this intervention using a randomised controlled trial .\n",
            "Methods : First-episode psychosis ( FEP ) patients aged @-@ are referred by TIPS early detection and randomised to treatment as usual or Job - Prescription .\n",
            "Single blind assessments are carried out at baseline , @ and @ months .\n",
            "Primary outcome measures are employment/study status .\n",
            "Secondary outcomes are quality of life and psychological well-being .\n",
            "Symptom levels and neuropsychological function are analysed as covariates .\n",
            "Results : By April @ , @ patients were included .\n",
            "Four of @ in the control and @ of @ in the experimental arm are engaged in employment or studies .\n",
            "Preliminary results on symptoms , quality of life , and ( neuro ) psychological factors will be presented .\n",
            "Study inclusion continues until @ participants .\n",
            "Discussion : Experiences from JobPrescription seem to indicate favourable results .\n",
            "However , threats to the RCT include a @ % refusal rate , possibly due to the risk of randomisation to the wait-list condition ; and treatment as usual increasingly making use of IPS methods and thus contaminating the control arm .\n",
            "BACKGROUND : Childhood-onset schizophrenia is a rare but severe form of the disorder that is frequently treatment resistant .\n",
            "The psychiatrist has a limited evidence base to guide treatment , particularly as there are no trials in children comparing atypical antipsychotics , the mainstay of current treatment .\n",
            "OBJECTIVE : To compare the efficacy and safety of olanzapine and clozapine , hypothesizing that clozapine would be more efficacious .\n",
            "DESIGN : Double-blind randomized @-week controlled trial , with a @-year open-label follow-up .\n",
            "SETTING : National Institute of Mental Health study , January @ to June @ .\n",
            "Patients underwent reassessment @ years after discharge .\n",
            "PATIENTS : Children and adolescents recruited nationally , aged @ to @ years , meeting unmodified DSM-IV criteria for schizophrenia , and resistant to treatment with at least @ antipsychotics .\n",
            "INTERVENTIONS : After drug washout and a @ - to @-week antipsychotic-free period , patients were randomized to treatment with clozapine ( n = @ ) or olanzapine ( n = @ ) .\n",
            "MAIN OUTCOME MEASURES : The Clinical Global Impression Severity of Symptoms Scale and Schedule for the Assessment of Negative/Positive Symptoms .\n",
            "RESULTS : Clozapine was associated with a significant reduction in all outcome measures , whereas olanzapine showed a less consistent profile of clinical improvement .\n",
            "While there were moderate to large differential treatment effects in favor of clozapine , these reached significance only in the alleviation of negative symptoms from an antipsychotic-free baseline ( P = .@ ; effect size , @ ) .\n",
            "Clozapine was associated with more overall adverse events .\n",
            "At @-year follow-up , @ patients were receiving clozapine with evidence of sustained clinical improvement , but additional adverse events emerged , including lipid anomalies ( n = @ ) and seizures ( n = @ ) .\n",
            "CONCLUSIONS : While not demonstrating definitively the superiority of clozapine compared with olanzapine in treatment-refractory childhood-onset schizophrenia , the study suggests that clozapine has a more favorable profile of clinical response , which is balanced against more associated adverse events .\n",
            "RN @ ( Antipsychotic Agents ) .\n",
            "@ ( Benzodiazepines ) .\n",
            "@-@-@ ( olanzapine ) .\n",
            "@-@-@ ( Clozapine ) .\n",
            "Severe mental illness comes along with cyclic hospital re-admission , heavy losses in quality of life and stigmatization .\n",
            "Therefore a refinement of intervention is still required , for patients themselves and their relatives .\n",
            "In mental health services there is an international trend toward recovery-orientated interventions , like peer support .\n",
            "In Germany this is the first trial to implement peer-support area-wide in a metropolis .\n",
            "This article describes the implementation of the network , the methodology of the research setting and the baseline data of the randomized controlled trial .\n",
            "OBJECTIVES : In @ , Medicare Part D transitioned prescription drug coverage for dual-eligible nursing home residents from Medicaid to Medicare and randomly assigned them to Part D prescription drug plans ( PDPs ) .\n",
            "Because PDPs may differ in coverage , plans may be more or less generous for drugs that an individual is taking .\n",
            "Taking advantage of the fact that randomization mitigates potential selection bias common in observational studies , this study sought to assess the effect of PDP coverage on resident outcomes for three medication classes - antidepressants , antipsychotics , and cholinesterase inhibitors .\n",
            "DESIGN : Retrospective cohort study to examine the effect of coverage restrictions - including noncoverage and coverage with restrictions - on depression , hallucinations and delusions , aggressive behaviors , cognitive performance , and activities of daily living for dual-eligible nursing home residents randomized to PDPs in @ to @ .\n",
            "The analyses further adjusted for baseline health status to address any residual imbalances in the comparison groups .\n",
            "SETTING : Linked data from Medicare claims , Minimum Data Set assessments , pharmacy claims , and PDP formulary information .\n",
            "PARTICIPANTS : Dual-eligible nursing home residents aged @ and older living in facilities that contracted with a single pharmacy provider .\n",
            "RESULTS : PDP coverage restrictions in three medication classes of interest were not significantly associated with the resident outcomes examined .\n",
            "Although cholinesterase inhibitor users facing coverage restrictions had a @-point lower depression rating score than residents facing no restrictions , this difference was not statistically significant after adjusting for multiple comparisons .\n",
            "CONCLUSION : The findings suggest that exogenous changes in coverage for three commonly used medication classes had no detectable effect on nursing home resident outcomes in @ to @ .\n",
            "There are several possible explanations for this lack of association , including the role of policy protections for dual-eligible nursing home residents and the possibility that suitable clinical alternatives were identified or that previously used medications offered little clinical benefit .\n",
            "Kurz et al. conducted the first study of the intra-individual variability of clozapine plasma concentrations but did not take into account the effect of smoking and co-medication .\n",
            "As patients were receiving varying doses , Kurz et al. standardized plasma levels by using a plasma level/dose/kg ratio .\n",
            "In @ patients , the mean coefficient of variation ( CV ) was @ % ( S.D. = @ ) .\n",
            "In this new study , plasma clozapine and norclozapine concentrations were measured every @ weeks in @ patients randomized to @ , @ , or @ mg/day for @-week double-blind clozapine trials under controlled conditions ( stable smoking , limited co-medication and absence of caffeinated beverages ) .\n",
            "For @ , @ and @ mg/day , the respective mean CVs for plasma clozapine concentrations were @ % ( S.D. = @ ) , @ % ( S.D. = @ ) and @ % ( S.D. = @ ) .\n",
            "For the combined concentrations of clozapine and norclozapine , the respective mean CVs were @ % ( S.D. = @ ) , @ % ( S.D. = @ ) and @ % ( S.D. = @ ) .\n",
            "Under @ mg/day , the mean CV for clozapine concentrations was significantly higher for heavy smokers than non-heavy smokers ( @ % , S.D. = @ vs. @ % , S.D. = @ ) ( p = @ ) .\n",
            "Studies of CVs in other environments are needed .\n",
            "Clozapine CVs may be important in order to understand the importance of variations around the therapeutic range and to interpret drug interactions above the usual noise of measuring plasma concentrations\n",
            "Objectives : To evaluate the efficacy of fixed-dose lurasidone , compared with placebo in acutely exacerbated schizophrenia patients .\n",
            "Methods : A @-week , double-blind , randomized , parallel-group study ( Study @ ) was conducted to evaluate the efficacy of once-daily @ mg lurasidone versus placebo in the treatment of patients with schizophrenia experiencing an acute exacerbation of symptoms ( diagnosed by DSM-IV criteria ) as measured by reductions from baseline in the scores of the BPRS derived from PANSS , PANSS total and subscale , CGI-S and MADRS .\n",
            "This was a study with a total of @ patients at @ centers in the US .\n",
            "Enrolled patients entered a @ to @-day single-blind placebo washout , followed by up to @ weeks of double-blind treatment with placebo or @ mg lurasidone .\n",
            "Patients were hospitalized during the single-blind placebo washout period and the first @ weeks of the double-blind treatment period .\n",
            "At the discretion of the investigator , the hospitalization would be extended an additional @ weeks during double-blind treatment .\n",
            "Results : @ ) Acute efficacy Lurasidone , at once daily doses of @ mg after a placebo washout period , was significantly superior to placebo on PANSS total score and CGI-S score , with significant effects first appearing three days after the initiation of treatment ( p = @ and p = @ , respectively ) , and this effect was maintained throughout the study .\n",
            "@ ) Endpoint analysis Statistically significant differences ( p < @ ) favoring lurasidone were also demonstrated for mean change from baseline in the scores of PANSS Total , PANSS Positive , PANSS Negative , PANSS Cognitive Component , PANSS Depression , BPRS Total , MADRS and CGI-S , using an LOCF ITT analysis .\n",
            "Conclusion : The results suggest that lurasidone , at once daily doses of @ mg , is an effective treatment for the rapid improvement of acute psychosis and across a broad range of symptomatology in chronic schizophrenic patients experiencing an acute exacerbation .\n",
            "Objective To compare the to Risperidone one with clozapine in the treatment of negative symptoms of schizophrenia efficacy and side effects , @ cases of hospitalized patients with schizophrenia with predominantly negative symptoms , were randomly divided into two groups , respectively , risperidone and chlorine mirtazapine treatment for eight weeks , and negative Syndrome Scale ( SANS ) and Brief Psychiatric Rating scale ( BPRS ) assessed the efficacy and side effects scale ( TESS ) assessment of adverse drug reaction .\n",
            "the results of the spirit of risperidone on negative symptoms schizophrenia slightly better than the efficacy of clozapine , and a low incidence of side effects of risperidone .\n",
            "Objective : To observe the aripiprazole and risperidone in the treatment of schizophrenia and adverse reactions .\n",
            "Method : to comply with the standard version @ diagnostic criteria of classification and diagnosis of mental disorders in China @ schizophrenic patients , were randomly divided into aripiprazole group and the risperidone group .\n",
            "Cleaning @W , A Leekpai azole group , the initial dose of @ mg / d to @ mg / d , @ W to @ W was added to @ mg / d ~ @ mg / d .\n",
            "The risperidone group initial dose of @ mg / d to @ mg / d , @ W to @ W was added to @ mg / d to @ mg / d during the observation period substandard with other antipsychotic drugs , treatment @ W. Positive and Negative Syndrome Scale ( PANSS ) and the side effects scale ( TESS ) to evaluate the efficacy and adverse reactions .\n",
            "Results : aripiprazole significant efficiency and the effective rate was @ % and @ % , respectively .\n",
            "Risperidone group was @ % and @ % , similar to the two groups ( P > @ ) , aripiprazole group in the treatment of @ W negative symptom factor score decreased aripiprazole group extrapyramidal reactions ( EPS ) incidence of @ cases was significantly lower than the risperidone group ( P < @ ) in the @ cases .\n",
            "Few and mild side effects of the keto group of the side effects of aripiprazole group Bili Pei .\n",
            "The outcome of group therapy for psychotic patients was used as the dependent variable in assessing the comparative efficacy of trained and untrained therapists .\n",
            "The latter were undergraduate students with no training or experience in psychotherapy .\n",
            "For this reason , their role in psychotherapy was viewed as analogous to that of a placebo in studies assessing drug effects .\n",
            "Changes in psychological test performance of @ patients before and after @ mo. of group therapy served as the criterion of therapeutic behavior change .\n",
            "By comparison to an untreated control group the lay therapists achieved slightly better results than psychiatrists and psychiatric social workers doing group therapy with similar patients .\n",
            "Caution is urged in extending the implications of these results beyond group therapy with schizophrenic patients .\n",
            "Educational Objectives : At the end of the presentation , the participant will learn about the potential benefits and barriers to inflating an atypical antipsychotic by long-acting route in patients who have recently been treated for a first episode of schizophrenia .\n",
            "Summary : Overview : A long-acting atypical antipsychotic has theoretical advantages for first-episode schizophrenia patients , given the very high rates of nonadherence , and have the most to lose from an otherwise preventable relapse .\n",
            "One important question is the acceptability of a recommendation for long-acting antipsychotic , compared to remaining on an oral route , for patients who have had a first-episode of schizophrenia .\n",
            "Methods : First-episode patients were invited into a maintenance study comparing long-acting and oral atypical antipsychotic treatment after an acute first-episode is treated .\n",
            "Consenting patients meeting criteria for maintenance antipsychotic were randomized to receive either a recommendation of long-acting atypical ( risperidone ) or a recommendation of oral atypical antipsychotic in a @:@ ratio .\n",
            "Of the randomized patients to date ( N = @ ) , nine ( @ % ) were randomized to continuing on their oral antipsychotic and @ to the long-acting route ( @ % ) .\n",
            "Results : Most patients randomized to a long-acting route were initially reluctant ( @ % ) or opposed ( @ % ) to trying a long-acting medication route when it was initially presented to them .\n",
            "Despite these obstacles , @ of the @ ( @ % ) randomized to the longacting route accepted at least one long-acting injection .\n",
            "Since the possibility of a long-acting injection may have been a reason for refusing Phase II , adding these nine patients to the patient base sets a lower boundary acceptance rate of @ out of @ ( @ % ) .\n",
            "Conclusion : Our preliminary results show that the majority of first-episode schizophrenia patients who agree to maintenance antipsychotic therapy are likely to accept a long-acting injection version of the medication when presented in an integrated treatment fashion .\n",
            "When indicated , a long-acting route can usually be initiated in first-episode patients who transition to an outpatient service already stabilized on oral atypical antipsychotic regimen .\n",
            "( a ) To examine the metabolic effects of bifeprunox in patients with acute and stable schizophrenia .\n",
            "( b ) Metabolic data was compiled from one @-month and four @-week studies of bifeprunox in patients with stable and acute schizophrenia , respectively .\n",
            "In the @-month study , patients received bifeprunox ( n = @ ) or placebo ( PBO ) ( n = @ ) .\n",
            "In the @-week studies , the pooled treatment groups were : bifeprunox ( n = @ ) , PBO ( n = @ ) , haloperidol ( n = @ ) , risperidone ( n = @ ) and olanzapine ( n = @ ) .\n",
            "All studies were randomized , double-blinded and PBO-controlled ; an active reference was included in all @-week studies .\n",
            "Metabolic evaluations included body weight , body mass index ( BMI ) , plasma glucose and lipid profiles .\n",
            "Fasting glucose and lipid values were assessed in one @ - week study and in the @-month study .\n",
            "Triglyceride : HDL ratio ( TG : HDL ) was calculated as a marker of insulin resistance .\n",
            "( c ) In the @-month study , mean weight decreases occurred with bifeprunox ( -@ kg ) and PBO ( -@ kg ) treatment .\n",
            "Similar reductions were noted in @-week studies ( bifeprunox , -@ kg ; PBO , - @ kg ) .\n",
            "Olanzapine ( +@ kg ) and risperidone ( +@ kg ) groups experienced weight increases .\n",
            "Mean weight loss occurred in patients receiving bifeprunox in all but the lowest BMI group ( < @ kg/m@ ) , with the greatest weight loss experienced by obese patients ( > @kg/m@ ) in @-week studies.A minor reduction in mean fasting glucose versus PBO was noted in one @-week study ; minimal glucose changes from baseline in PBO and bifeprunox groups were observed in @ week and @ month tests .\n",
            "Total cholesterol ( TC ) was decreased in the @-month ( bifeprunox , @ % ; -@ mmol/L vs. PBO , @ % ; -@ mmol/L ) and @-week studies ( bifeprunox , @ % ; - @ mmol/L vs. PBO , @ % ; -@ mmol/L ) .\n",
            "Over @-months , TG values decreased in the bifeprunox ( @ % ; -@ mmol/L ) and PBO groups ( @ % ; -@ mmol/L ) .\n",
            "Additionally , a @ % decrease in TG : HDL was noted in patients receiving bifeprunox in the @-month study , compared to a @ % decrease in the PBO group .\n",
            "Similar decreases in TG ( @ % , -@ mmol/L ) and TG : HDL were observed in @ week studies ; the PBO group had comparable reductions in TG ( @ % ; -@ mmol/L ) and TG : HDL ( @ % ) .\n",
            "( d ) Decreases in body weight and improvement in lipid profiles were observed in bifeprunox-treated patients .\n",
            "Reductions in weight , TG , TC and TG : HDL were sustained over @ months .\n",
            "The metabolic profile of bifeprunox suggests that it may be a safe agent for use in the treatment of schizophrenia .\n",
            "Objective : To study the efficacy and safty of mirtazapine on negative symptoms of schizophrenia .\n",
            "Methods : @ cases of schizophrenia with promient negative symptoms were randomly enrolled into study group ( n = @ ) and control group ( n = @ ) .\n",
            "@ cases of risper\n",
            "Schizophrenia requires integrative treatment .\n",
            "Monotherapies have low treatment adherents ; effects hardly tend to generalize resulting in disabling residual symptoms and handicapped social functioning .\n",
            "HIT , Hallucination focussed Integrative Treatment , aims at enhancing control and social functioning reducing symptoms and subjective burden .\n",
            "It integrates motivational interviewing , cognitive behaviour treatment , coping training , single family treatment with CAU .\n",
            "RCT compared CAU with HIT .\n",
            "Seventy-six chronic drug-refractory schizophrenics mean age @ years ; sds@ .@ with auditory hallucinations mean @ years ; sds@ .@ were RANDOMISED over treatment groups .\n",
            "Independent assessment Auditory Hallucination Rating Scale , Positive And Negative Symptoms Scale , Groningen Social Disabilities Schedule occurred pre - and post treatment .\n",
            "Groups differed not significantly on relevant socio-demographic , diagnostic psychopathology and coping-behaviour , medication or medical history at baseline .\n",
            "Statistical analysis : intention to treat of all patients included , irrespective of actual treatment .\n",
            "Results : Post-treatment group mean scores of medication were not statistically different haldol equivalents : ts@ .@ , dfs@ , .\n",
            "ps@ .@ .\n",
            "Results of HIT are significantly p-@ better on : Symptoms : PANSS-dimensions positive ; disorganization ; total ; depression : p-@ , Burden : AHRS-dimensions interference ; duration-control .\n",
            "Significantly more experimentals improved on distress ; interference and control .\n",
            "Effect sizes vary from @ depression to @ positive dimension ; with @ on social functioning abstract Wiersma et al. .\n",
            "Numbers-Needed-to-Treat vary from @ positive dimension to @-@ disorganization .\n",
            "Low non-adherence @ % .\n",
            "Conclusion : Significant improvements subjective burden , Objective symptoms , social functioning , and effect sizes recommend implementation of integrative treatment for chronic psychotic patients with auditory hallucinations as preferred form of treatment .\n",
            "Standard smoking cessation treatments achieve mediocre results in the general population , and are less successful among smokers with schizophrenia .\n",
            "Nonpsychiatrically ill groups of heavy smokers , given exogenous nicotine concurrent with smoking , smoke fewer cigarettes , have less carbon monoxide in expired air , and maintain stable nicotine blood levels .\n",
            "If sustained , such smoking reduction may have salutary long-term health effects for those unable to quit .\n",
            "The feasibility and tolerability of such an intervention as a treatment for smokers with schizophrenia is unknown .\n",
            "We used a double-blind , placebo-controlled , cross-over design to measure smoking behavior , psychiatric symptoms , and medication side effects in @ heavy smokers with schizophrenia during @ hours of ad libitum smoking while wearing @mg/day or placebo transdermal nicotine patches .\n",
            "Among all @ subjects , smoking on active patch compared to placebo over @ days did not result in a change in the number of cigarettes smoked , level of carbon monoxide in expired air , or scores on positive and negative symptom scales .\n",
            "There was a significant increase in AIMS score , and a trend toward a decrease in EPS during smoking on active patch .\n",
            "All subjects tolerated the experiment without difficulty .\n",
            "Smoking while wearing the transdermal nicotine patch appears feasible and well tolerated for short periods of time in smokers with schizophrenia .\n",
            "Robust decreases in smoking behavior were not seen over the brief time of exposure .\n",
            "The purpose of this study was to evaluate the effect of two intensive community mental health programs on the suicidality of clients with serious mental illness .\n",
            "Eighty individuals with severe and persistent mental illness were enrolled in this randomized controlled study comparing two models of intensive community support : Assertive Community Treatment ( ACT ) and Intensive Case Management ( ICM ) .\n",
            "Suicidal ideation and behaviours were measured using the Modified Scale for Suicide Ideation .\n",
            "Study clients underwent comprehensive interviews at baseline and were reinterviewed @ and @ months later .\n",
            "The Dartmouth Assertive Community Treatment Scale ( DACTS ) instrument was used to gain more insight into the specific ACT and ICM program structures and characteristics that provide crisis support and suicide intervention .\n",
            "A chart review of @ randomly chosen months of service looked at the on-call after-hours pager use of ACT program clients .\n",
            "The ACT intervention was effective in reducing suicidal ideation over @ months .\n",
            "In addition , the prevalence of suicidal ideation was significantly lower at @ months in ACT clients versus ICM clients .\n",
            "This is the first study to suggest that ACT may confer some additional benefit in terms of reduced suicidality in clients with severe and persistent mental illness .\n",
            "Objective : To evaluate the efficacy and safety of ziprasidone treatment of older schizophrenia .\n",
            "Methods : @ patients were randomly divided into two groups , @ cases ziprasidone group , perphenazine group of @ cases .\n",
            "Negative and positive symptoms scale ( panss ) and side effects scale ( tess ) , each assessed before treatment and after @ , @ , @ , @ , weekend time to evaluate the efficacy and adverse reactions .\n",
            "RESULTS : Ziprasidone elderly schizophrenia ( p < @ ) , adverse reactions was significantly less than the perphenazine group , and especially extrapyramidal side effects was significantly less than the perphenazine group ( p < @ ) .\n",
            "Objective : Electroconvulsive therapy ( ECT ) is an effective treatment of severe psychiatric disorders and has a favorable side effect profile .\n",
            "The efficacy of ECT is related to seizure duration and to the relative stimulus dosage above seizure threshold .\n",
            "Seizure duration of @ seconds is considered to be the norm in modern ECT , although a definite correlation between seizure duration and clinical outcome remains to be demonstrated .\n",
            "Short seizures are considered negative predictors of outcome .\n",
            "The ideal hypnotic agent for ECT anesthesia should have a short half-life , not interfere with seizure duration and quality , and guarantee the patient 's hemodynamic stability .\n",
            "We aimed to investigate the effects of propofol and propofol remifentanil combination to seizure duration and hemodynamic outcomes in ECT treatment .\n",
            "Material and method : Twenty patients diagnosed with treatment resistant major depressive disorder and schizophrenia were included in this study .\n",
            "Heart rate ( HR ) , systolic arterial pressure ( SAP ) , diastolic arterial pressure ( DAP ) , mean arterial pressure ( MAP ) , peripheral oxygen saturation ( SpO@ ) , and bispectral index ( BIS ) were measured and electroencephalograph was monitored in all patients .\n",
            "Patients were randomized into two groups as propofol remifentanil group ( PR , n = @ ) and propofol group ( P , n = @ ) in a double-blind design .\n",
            "Fifty ECT for each group and a total of @ ECT were evaluated .\n",
            "@ mcg/kg remifentanil infused in @-@ second in group PR and same dose isotonic solution infused to group P. Propofol infusion applied to all patients subsequently up to BIS rate becoming @ .\n",
            "Succinylcholine ( @ mg/kg ) infusion used for muscular relaxation .\n",
            "All referred values ( HR , SAP , DAP , MAP and SpO@ ) were recorded before anaesthesia and during @ , @ , @ , @ , @th .\n",
            "Minutes of anesthesia .\n",
            "Seizure duration was measured by contraction time ( i.e. , duration of motor seizure ) at isolated arm and seizure activity was recorded by EEG ( i.e. , duration of EEG seizure ) .\n",
            "Anaesthesia duration was defined as the time between BIS rate becoming @ and reaction to verbal stimulation .\n",
            "Results : There was no significant difference between two groups in age , height , and weight ( p > @ ) .\n",
            "The differences in SAP , DAP , MAP , HR , and SpO@ measures before anaesthesia , before ECT , and after ECT were not significant between two groups ( p > @ ) .\n",
            "Seizure durations in isolated arms and EEG records were longer in PR group ( p < @ for both ) .\n",
            "Mean anaesthesia period was longer in group PR ( p < @ ) than grup P. Propofol doses were remarkably lower in all @ ECT sessions in group PR ( p < @ ) .\n",
            "Conclusion : Lower doses of propofol usage during anaesthesia in ECT applications may moderate the shortening effect of propofol of seizure duration .\n",
            "Remifentanil did not cause a clear hemodynamic change even with lower doses of propofol .\n",
            "Thus remifentanil may be an augmentation choice in ECT for patients with short seizure duration .\n",
            "Patients with schizophrenia who refuse antipsychotic therapy or are acutely agitated are frequently treated with short acting intramuscular ( SAIM ) formulations of typical antipsychotic medication .\n",
            "Atypical medications have been demonstrated in the literature to be safer than typical antipsychotics .\n",
            "A SAIM formulation of the atypical antipsychotic medication olanzapine has been developed in order to facilitate the treatment of patients with schizophrenia who refuse antipsychotic therapy or are acutely agitated .\n",
            "A total of @ acutely agitated patients with schizophrenia were randomised ( @:@:@ ratio ) to receive up to a maximum of @ injections within @ hours of SAIM olanzapine ( @ mg/inj ) , SAIM haloperidol ( @ mg/inj ) or IM placebo .\n",
            "The primary endpoint was the reduction in agitation , as measured by the @ item PANSS Excited Component ( PEC ) ( uncooperativeness , hostility , tension , poor impulse control , excitement ) at @ hours post first IM injection .\n",
            "Within this window it was collected at @ , @ , @ , @ , @ , and @ minutes post first IM injection .\n",
            "SAIM olanzapine and SAIM haloperidol showed statistically significantly greater improvement compared to IM placebo for the change from baseline in PEC at @ hours ( LS Means : SAIM olz ?\n",
            "@ ; SAIM hal ?\n",
            "@ ; IM pla ?\n",
            "@ ) .\n",
            "SAIM was shown to be non-inferior to SAIM haloperidol at @ hours ( difference in LS Means = @ , one-sided lower @ % CI = ?\n",
            "@ ) .\n",
            "SAIM olanzapine showed statistically significantly greater improvement at all post-baseline timepoints compared to IM placebo ( p < .@ ) , but SAIM haloperidol did not show a statistically significant difference to IM placebo until @ minutes .\n",
            "SAIM olanzapine showed statistically significant improvement to SAIM haloperidol at @ , @ and @ minutes ( p ?\n",
            ".@ ) indicating a faster onset of action .\n",
            "The sustained alleviation of acute agitation in SAIM olanzapine and SAIM haloperidol versus IM placebo was also demonstrated at @ hours ( p < .@ in both cases ) .\n",
            "Significantly fewer SAIM olanzapine and IM placebo treated patients required concomitant anticholinergic therapy during the @ hour IM period compared to SAIM haloperidol ( @ % vs. @ % vs. @ % ; p < .@ and p = .@ , respectively ) .\n",
            "Significantly fewer SAIM olanzapine and SAIM haloperidol treated patients required concomitant benzodiazepine therapy when compared with placebo treated patients ( @ % vs. @ % vs. @ % , respectively ; p = .@ and p = .@ , respectively ) .\n",
            "A statistically significantly greater incidence of treatment-emergent adverse events was shown for SAIM haloperidol treated patients compared to SAIM olanzapine for extrapyramidal syndrome ( @ % vs. @ % , p = .@ ) and dystonia ( @ % vs. @ % , p = .@ ) .\n",
            "SAIM olanzapine and IM placebo treated patients experienced improvement in symptoms of parkinsonism as measured by the Simpson-Angus Scale while SAIM haloperidol treated patients worsened ( p < .@ in both cases ) .\n",
            "SAIM olanzapine treated patients experienced improvement in akathisia symptoms as measured by the Barnes Akathisia Global score while SAIM haloperidol treated patients worsened ( p = .@ ) .\n",
            "The study provides evidence that SAIM olanzapine rapidly and effectively provides a sustained and safe alleviation of acute agitation in patients with schizophrenia .\n",
            "Olanzapine Haloperidol Schizophrenia : drug therapy Intramuscular drug administration Agitation Akathisia\n",
            "The purpose of this study is to compare the effects of D-cycloserine and glycine for treating negative symptoms ( such as loss of interest , loss of energy , loss of warmth , and loss of humor ) which occur between phases of positive symptoms ( marked by hallucinations , delusions , and thought confusions ) in schizophrenics .\n",
            "Clozapine is currently the most effective treatment for negative symptoms of schizophrenia .\n",
            "Two other drugs , D-cycloserine and glycine , are being investigated as new treatments .\n",
            "D-cycloserine improves negative symptoms when added to some drugs , but may worsen these symptoms when given with clozapine .\n",
            "Glycine also improves negative symptoms and may still be able to improve these symptoms when given with clozapine .\n",
            "This study gives either D-cycloserine or glycine ( or an inactive placebo ) with clozapine to determine which is the best combination .\n",
            "Patients will be assigned to @ of @ groups .\n",
            "Group @ will receive D - cycloserine plus clozapine .\n",
            "Group @ will receive glycine plus clozapine .\n",
            "Group @ will receive an inactive placebo plus clozapine .\n",
            "Patients will receive these medications for @ weeks .\n",
            "Negative symptoms of schizophrenia will be monitored , and tests will be done on blood and cerebrospinal fluid ( CSF ) to measure the body 's response to the medications .\n",
            "An individual may be eligible for this study if he/she : Is @ to @ years old and has been diagnosed with schizophrenia .\n",
            "To determine if glycine produces improvement in negative symptoms and D-cycloserine produces worsening in symptoms compared to placebo .\n",
            "To determine whether cerebrospinal fluid concentrations of glycine and other relevant amino acids predict response and measure effects of D-cycloserine and glycine on serum amino acid concentrations .\n",
            "Clozapine is more effective for negative symptoms of schizophrenia than conventional neuroleptics , but the neurochemical actions contributing to this superior clinical efficacy remain unclear .\n",
            "Recent evidence points to a role for glutamatergic dysregulation in schizophrenia , as well as important differences between conventional agents and clozapine in effects upon glutamatergic systems .\n",
            "D-cycloserine , a partial agonist at the glycine modulatory site of the NMDA receptor , improves negative symptoms when added to conventional agents and worsens negative symptoms when added to clozapine .\n",
            "High-dose glycine also improves negative symptoms and has provided preliminary evidence suggesting that glycine improves negative symptoms when added to clozapine .\n",
            "Serum concentrations of glycine predicted response to both high-dose glycine and D-cycloserine .\n",
            "Both clozapine and D-cycloserine may improve negative symptoms by activation of the glycine modulatory site of the NMDA receptor complex .\n",
            "Because D-cycloserine is a partial agonist , it may act as an antagonist at the glycine site in the presence of clozapine , whereas the full agonist , glycine , would not be expected to worsen negative symptoms in the presence of clozapine .\n",
            "A fixed-dose of D - cycloserine , glycine , or placebo is added to clozapine in @ patients with schizophrenia .\n",
            "Because assessments are standardized between studies , results from this study can be compared with results from a previous study of D-cycloserine added to conventional neuroleptic .\n",
            "Participants : Schizophrenia .\n",
            "Ages Eligible for Study : @ Years - @ Years , Genders Eligible for Study : Both Inclusion Criteria Patients must have : Schizophrenia .\n",
            "Interventions : / D-cycloserine / Glycine / Clozapine\n",
            "Twenty-four chronic schizophrenic patients were treated successfully with the addition of acetazolamide and thiamine ( A + T ) to their unchanged existing therapies in a double-blind , placebo-controlled crossover study .\n",
            "Therapeutic effects were measured by the Scale for the Assessment of Positive Symptoms and the Scale for the Assessment of Negative Symptoms .\n",
            "Overall , @ % of the patients showed improvement on all assessment scales .\n",
            "No untoward effects occurred in these patients or in patients in previous studies who have been treated continuously with A + T therapy for as long as @ years\n",
            "Introduction : Cariprazine , a dopamine D@/D@ receptor partial agonist with preferential binding to D@ receptors , is being developed for the treatment of schizophrenia Objective : To explore the effect of cariprazine on negative symptoms of schizophrenia .\n",
            "Methods : Subjects aged @-@ years with acute schizophrenia , current acute episode < @ weeks , and a PANSS total score > @ and < @ were randomly allocated in a @-Week study NCT@ to cariprazine @ mg/d , cariprazine @ mg/d , aripiprazole @ mg/d ( active control ) , or placebo [ @ ] .\n",
            "Post-hoc analyses were performed on subjects with severe negative symptoms and low-to-moderate positive symptoms , defined according to Marder .\n",
            "Results of the Post-Hoc Analyses : Data of @ subjects were included in the cariprazine @ mg/d ( @ % of the total sample ) , @ in the cariprazine @ mg/d ( @ % ) , @ in the aripiprazole ( @ % ) and @ in the placebo ( @ % ) groups , respectively .\n",
            "Change from baseline to Week @ in the PANSS Factor Score for Negative Symptoms ( PFSNS ) was statistically significant for cariprazine @ mg/d versus placebo ( least squares mean difference : cariprazine @ mg/d = -@ , p = @ ; cariprazine @ mg/d = -@ , p = .@ ) .\n",
            "Cariprazine @ mg/d was superior to placebo at each weekly assessment from Week @ .\n",
            "The changes in PFSNS for aripiprazole were not statistically significant at any weekly assessment .\n",
            "Conclusion : Post-hoc analyses performed on subjects with acute schizophrenia , high level of negative symptoms and low-to-moderate positive symptoms , showed that the patients in the cariprazine @ mg/d group had a significantly greater improvement relative to placebo on the PFSNS .\n",
            "Objectives : During a schizophrenia treatment episode , persistence with the initial antipsychotic may indicate optimal pharmacotherapy and be a precursor to longer-term effectiveness and other positive outcomes .\n",
            "The objective of this study was to examine the ability of selected variables to predict antipsychotic persistence among patients receiving olanzapine or risperidone as initial treatment .\n",
            "Research design and methods : Data for this analysis , which was not defined in the original study protocol , came from a naturalistic , randomized , open-label trial comparing costs and effectiveness of first-line antipsychotic treatment options in schizophrenia .\n",
            "Predictor variables were as follows : ( @ ) patients ' initial antipsychotic ( olanzapine [ n = @ ] or risperidone [ n = @ ] ) ; ( @ ) current ( within @ days ) comorbid diagnosis of substance abuse ; and ( @ ) nine self-report items from the Rating of Medication Influence ( ROMI ) scale , including an item assessing patients ' perceptions of the role of their therapeutic alliance in their adherence .\n",
            "Main outcome measures : For the primary analysis , a stepwise logistic regression was used in predicting antipsychotic persistence of at least @ days .\n",
            "Variables found to be significantly predictive were included in a second analysis that assessed persistence at additional thresholds ( > @ days , > @ days , and completion of the @-year study ) .\n",
            "Results : Four variables predicted longer antipsychotic persistence ; olanzapine as initial antipsychotic ( p = @ ) , absence of comorbid substance abuse ( p = @ ) , and two of the ROMI items representing patients ' subjective response to treatment - positive relationship with clinical staff ( p = @ ) and fulfillment of life goals ( p = @ ) .\n",
            "Conclusions : Within a randomized trial design , this study corroborated the influence of several factors on antipsychotic persistence in schizophrenia .\n",
            "Results support the importance of the initial antipsychotic treatment option , presence of a comorbid substance abuse diagnosis , and the role of patients ' subjective responses .\n",
            "Additional research is needed to further explore these and other factors as predictors of antipsychotic persistence , and of subsequent treatment outcomes .\n",
            "RN @ ( Antipsychotic Agents ) .\n",
            "@ ( Benzodiazepines ) .\n",
            "@-@-@ ( Risperidone ) .\n",
            "@-@-@ ( olanzapine ) .\n",
            "Significance : About @ % of young adults with schizophrenia , bipolar disorder , and other severe mental illnesses smoke tobacco , but few studies have evaluated interventions for this group .\n",
            "Methods : We conducted a randomized pilot study among @ young adult smokers with severe mental illnesses comparing a brief interactive web-based motivational tool , Let 's Talk About Smoking , to computerized standard education from the National Cancer Institute .\n",
            "An additional @ subjects received minimal tobacco assessment at baseline and no intervention , providing a comparison condition for naturalistic cessation behavior .\n",
            "All participants ( total n = @ ) were assessed for smoking and breath carbon monoxide at baseline and @ weeks and had access to standard cessation treatments .\n",
            "Results : The @ participants were stable outpatients ages @-@ ( mean @ years ) : @ % were diagnosed with schizophrenia-spectrum disorders , the remainder with severe mood and anxiety disorders .\n",
            "They smoked @ + / - @ cigarettes per day .\n",
            "All participants completed their assigned intervention ; @ % of Let 's Talk About Smoking users and @ % of standard education users rated their intervention \" good \" or \" very good . \"\n",
            "At @ weeks , less than @ % of participants in all conditions had used additional cessation treatment .\n",
            "Let 's Talk About Smoking users were more likely to have biologically verified abstinence at @ weeks than standard education users ( @ % vs. @ % ; X@ = @ , p = .@ ) .\n",
            "None of the participants in the naturalistic comparison condition were abstinent at @ weeks .\n",
            "Conclusions : Interactive , web-based motivational interventions are feasible and promising for smoking cessation among young smokers with severe mental illnesses .\n",
            "Such interventions warrant further study among this group of smokers .\n",
            "Implications : Young adult smokers with severe mental illnesses are a vulnerable population that , without intervention , goes on to experience disparate morbidity and mortality .\n",
            "Brief , easily disseminable interventions are needed to facilitate cessation in this group .\n",
            "This pilot research indicates that brief , technology-delivered , motivational interventions that are tailored for this group may be able to activate a significant number to quit without additional cessation intervention .\n",
            "The posthospital treatment of @ schizophrenics was controlled and evaluated for two years .\n",
            "Relapse rates for the first year were recorded .\n",
            "At clinic intake , patients were randomly assigned to major role therapy ( MRT ; social casework and vocational rehabilitation counseling ) and stabilized through the administration of chlorpromazine .\n",
            "After two months , further assignment to drug or placebo was made .\n",
            "Four groups were studied in each of three aftercare clinics : placebo alone ; placebo and MRT ; drug alone ; drug and MRT .\n",
            "Relapse in the placebo group is twice that of the drug group , but one half of all relapsers ( drug and placebo ) cease medication prior to relapse .\n",
            "The prophylactic action of the drug is established for many remitted schizophrenics .\n",
            "The MRT also lowers relapse rate significantly , but only after six months .\n",
            "Drug and sociotherapy effects are additive rather interactive by @ months .\n",
            "Results replicate across all clinics .\n",
            "Acute psychotic states ( APS ) usually are diagnosed as schizophrenia spectrum and affective disorders and make up about @ % of cases .\n",
            "The goal of the study was to elucidate the effect of benzodiazepines ( BDZ ) and valproic acid augmentation in the APS pharmacotherapy .\n",
            "The study was carried out on @ inpatients diagnosed up to ICD-@ as schizophrenia ( n = @ ) , acute and transient psychotic disorders ( n = @ ) , other mental disorders due to brain damage and dysfunction and to physical disease ( n = @ ) , schizoaffective disorder ( n = @ ) , bipolar affective disorder ( n = @ ) .\n",
            "Patients were randomized into four therapeutic groups : - benzodiazepines ( BDZ ) ; - one neuroleptic or combination of one neuroleptic and one BDZ ( NBDZ ) ; - combination of valproic acid with BDZ or neuroleptic ( VBDZN ) ; - polypragmasy ( PP ) : from two drugs of one group up to four and more drugs at the same time .\n",
            "The mental state of the patients was evaluated daily and estimated before , weekly and after APS termination by BPRS and CGI scale .\n",
            "The APS in all groups lasted from @ to @ days ( mean @ ) .\n",
            "The shortest duration of APS was In BDZ group - @ days ; in VBDZN and NBDZ , the duration was @ and @ days ( P < @ ) ; in PP group , the treatment lasted @ days ( P < @ ) .\n",
            "Before therapy , average BPRS rate was @ + / -@ , CGI - @ + / -@ ; after APS , BPRS was @ + / -@ , CGI - @ + / -@ .\n",
            "All rates did not differ among subgroups .\n",
            "APS therapy by BDZ and its combination with neuroleptics and valproic acid was effective compared to the polypragmasy .\n",
            "Purpose : To study the effects of metformin ( Glucophage @ ) on body mass index ( BMI = kg/m @ ; ) , weight and waist circumference in children and adolescents who have gained excessive weight taking olanzapine ( Zyprexa @ ) , risperidone ( Risperdal @ ) , or quetiapine ( Seroquel @ ) .\n",
            "Background : Atypical antipsychotic effectively treat psychiatric illness in children and adolescents but weight gain and metabolic issues , including diabetes complicate their use .\n",
            "A previous open label study in @ children and adolescents showed significant mean weight loss after the addition of metformin ( Glucophage @ ) while continuing atypical antipsychotics .\n",
            "Methods : Thirty nine subjects , ages @-@ years who had gained @ ; @ % of their pre medication body weight after up to one year @ ; s therapy with one of three atypicals were enrolled in a @ week , randomized double-blind trial with either placebo or metformin ( Glucophage @ ) in addition to dietary and activity counseling with a registered dietician .\n",
            "Metformin was dosed @ mg PO QPM and increased stepwise weekly to @ mg BID .\n",
            "Anthropometric measures , fasting insulin glucose liver function tests and electrolytes were taken at regular intervals .\n",
            "Results : Mean changes in metformin vs. placebo respectively were statistically significant for weight @ .\n",
            "@ + @ .\n",
            "@ vs. +@ .\n",
            "@ + @ .\n",
            "@ kg BMI @ .\n",
            "@ + @ .\n",
            "@ vs. + @ .\n",
            "@ + @ .\n",
            "@ kg m @ ; ) and waist circumference ( - @ + / - @ vs. @ + / - @ cm ) ( all p @ ; .@ ) .\n",
            "Two subjects were diabetic at baseline and two placebo-treated subjects became diabetic either during the study or shortly thereafter .\n",
            "placebo treatment was associated with the need for oral glucose tolerance tests based on insulin and glucose Results : , p @ ; .@ ) .\n",
            "No serious adverse events or abnormalities in @ ; safety @ ; laboratories resulted from metformin ( Glucophage @ ; ) treatment.Conclusion : Metformin ( Glucophage @ ) arrests weight gain , reduces BMI and waist circumference and is protective against hyperglycemia in children and adolescents on atypicals .\n",
            "Key words atypical antipsychotics obesity diabetes metformin ( Glucophage @ ) Running title : metformin ( Glucophage @ , and ) and atypical induced weight gain\n",
            "Objective : To investigate the compound Danshen dripping pills clozapine induced elevated liver enzymes , efficacy and possible mechanism .\n",
            "Method : Select admission urinalysis , normal liver and kidney function , after admission weekend review of liver enzymes ALT and AST < @U / L schizophrenia @ cases were randomly divided into the CSDP treatment sister ( treatment sister ) @ cases of @ cases and blank control group .\n",
            "SPSS@ .@ statistical package data separately  ^ @ , test @ group sex distribution , age had no significant difference ( P > @ ) .\n",
            "Results : The daily dose of clozapine in the @ groups of patients before and after treatment , clozapine blood concentration and norepinephrine clozapine blood concentration had no significant difference ( P > @ ) , treatment sister ALT , AST than those before treatment decreased significantly .\n",
            "Very significant difference ( P < @ ) ; according to sister ALT , AST has decreased , but not statistically significant ( P > @ ) .\n",
            "Conclusion : CSDP treatment to clozapine induced liver enzyme abnormalities efficacy .\n",
            "Study design Two arm single centre randomised controlled trial ; Countries of recruitment Germany ; Disease/condition/study domain @ .\n",
            "Mental Health Disorders according to ICD-@-F ; @ .\n",
            "Inpatient psychotherapy ; Participants - inclusion criteria @ .\n",
            "Treated for a mental disorder according to ICD-@-F ; within the study-centre ; @ .\n",
            "Internet-access ; @ .\n",
            "German-speaking ; @ .\n",
            "Ages @ - @ ; Participants - exclusion criteria @ .\n",
            "Psychotic symptoms ; @ .\n",
            "Alcohol/substance-addiction ; @ .\n",
            "High risk of suicide ; @ .\n",
            "Problems with reading/writing ; Anticipated start date @/@/@ ; Anticipated end date @/@/@ ; Status of trial Completed ; Patient information material Not available in web format , please use the contact details ; below to request a patient information sheet ; Target number of participants @ ; Interventions @ .\n",
            "TIMT : transdiagnostic internet based maintenance treatment involves a ; motivation-plan , a weekly web-diary , self-management module , asynchronous patienttherapist ; communication , a patient support group and an online-based progress ; monitoring .\n",
            "Duration : @ month. ; @ .\n",
            "TAU : Treatment as usual involves unstructured access to outpatient psychotherapy , ; and/or standardised outpatient face-to-face continuation treatment , and/or psychotropic ; management .\n",
            "Follow Ups : @ and @ month after inpatient treatment ; Primary outcome measure ( s ) @ .\n",
            "Psychopathological symptom severity measured by : ; PSS - HEALTH-@ ; Rabung et .\n",
            "al @ ; @ .\n",
            "Inpatient admission ( t@ ) ; @ .\n",
            "Inpatient discharge ( t@ ) ; @ .\n",
            "@-month-follow-up ( t@ ) ; @ .\n",
            "@-month-follow-up ( t@ ) ; Secondary outcome measure ( s ) @ .\n",
            "Psychological wellbeing ( WB - HEALTH-@ ; Rabung ; et .\n",
            "al @ ) ; @ .\n",
            "Positive and negative-affect ( PA/NA - PANAS ; Watson , Clark , & Tellegen , @ ) ; @ .\n",
            "Self-efficacy ( SE - HEALTH-@ ; Rabung et .\n",
            "al @ ) ; @ .\n",
            "Interpersonal-problems ( IPP - HEALTH-@ ; Rabung et .\n",
            "al @ ) ; @ .\n",
            "Emotion-regulation-skills ( Total - ERSQ ; Mediator ; Berking & Orth , @ ) ; @ .\n",
            "Self-management-skills ( VCI ; Mediator ; Kuhl & Fuhrmann , @ ) ; @ .\n",
            "Therapist-alliance ( HAQ ; Process-Quality ; Bassler , Potratz , & Krauthauser , @ ) ; Sources of funding @ .\n",
            "Philipps-University of Marburg and Leuphana University of ; L  neburg ( Germany ) ; @ .\n",
            "Vogelsbergklinik - Dr. Ebel clinics for psychotherapy and psychosomatics ( Germany ) ; ;\n",
            "Background : Speed of onset of therapeutic effect is an important dimension of drugs employed to treat psychosis and schizophrenia .\n",
            "Objectives - This report consists of a post-hoc sub-analysis of data from a large double blind RANDOMized pivotal trial in which we compared onset of therapeutic effect between risperidone and haloperidol .\n",
            "Methods - During an eight week period @ patients with chronic schizophrenia received @ mg risperidone and @ patients received @ mg haloperidol .\n",
            "Changes in symptoms were assessed with the Positive and Negative Syndrome Scale for schizophrenia ( PANSS ) and Clinical Global Impression ( CGI ) .\n",
            "Results - Patients receiving risperidone improved more rapidly than those receiving haloperidol as measured by the total PANSS and CGI .\n",
            "Differences were most pronounced during the first week of treatment .\n",
            "Conclusions - Results suggest that risperidone offers a more rapid response than haloperidol particularly during the active phase of illness when time can be crucial .\n",
            "Background : Schizophrenia is a complex neuropsychiatric syndrome characterized by positive symptoms ( e.g. , delusions , hallucinations ) , negative symptoms ( e.g. , anhedonia ) , and several domains of cognitive impairment .\n",
            "Antipsychotics have efficacy on positive symptoms , but the treatment of negative symptoms remains a clinical challenge .\n",
            "Cariprazine is an orally active and potent dopamine D@ and D@ receptor partial agonist antipsychotic with preferential binding to D@ receptors ; it is currently in development for the treatment of schizophrenia , bipolar mania , bipolar depression , and as an adjunctive treatment for major depressive disorder .\n",
            "A pooled post hoc analysis of @ randomized controlled Phase II/III cariprazine trials ( NCT@ , NCT@ ) was conducted to investigate the effects of cariprazine on the negative symptoms of schizophrenia in a subset of patients with acute exacerbation of schizophrenia and predominant negative symptoms .\n",
            "Methods : The constituent studies were @-week , international , randomized , fixed-dose , double-blind , placebo - and active controlled studies in adults with acute exacerbation of schizophrenia .\n",
            "In RGH-MD-@ ( n = @ ) , cariprazine @ , @ , and @ mg/d and risperidone @ mg/d were investigated ; in RGH-MD-@ ( n = @ ) , cariprazine @ and @ mg/d and aripiprazole @ mg/d were investigated .\n",
            "The primary efficacy measure in both studies was change from baseline to Week @ on the Positive and Negative Syndrome Scale ( PANSS ) total score .\n",
            "Cariprazine doses of @-@ and @-@ mg/d were pooled for post hoc analyses .\n",
            "Patients with predominant negative symptoms were identified based on a model defining @ states of schizophrenia ( Lenert et al , Schizophr Res .\n",
            "@ ; @:@-@ ) ; the selected schizophrenia health status for the patient subset being investigated ( n = @/@ ) was State @ at baseline ( ie , PANSS factor score for negative symptoms    @ , PANSS factor score for positive symptoms    @ , and PANSS factor score for cognitive impairment    @ ) .\n",
            "Patients in State @ are clinically considered as having severe negative symptoms , mild to moderate positive symptoms , and severe cognitive dysfunction .\n",
            "Mean change from baseline in PANSS factor scores for negative symptoms ( items N@-N@ , N@ , G@ , G@ ) was analyzed using a mixed-effects model for repeated measures (   = @ , @-sided , without adjustments for multiple comparisons ) in the patient subset with predominant negative symptoms ; effects sizes were calculated by dividing the mean difference versus placebo by the pooled standard deviation .\n",
            "Results : In the pooled subset of patients with predominant negative symptoms ( n = @ ) , mean ( SD ) baseline PANSS factor scores for negative symptoms were @ ( @ ) for placebo ( n = @ ) , @ ( @ ) for cariprazine @-@ mg/d ( n = @ ) , @ ( @ ) for cariprazine @-@ mg/day ( n = @ ) , @ ( @ ) for risperidone @ mg/d ( n = @ ) , and @ ( @ ) for aripiprazole @ mg/d ( n = @ ) .\n",
            "The least squares mean difference ( LSMD [ @ % CI ] ) in change from baseline to Week @ on the PANSS factor score for negative symptoms was statistically significant versus placebo for cariprazine @-@ mg/d ( -@ [ -@ , -@ ] , P = .@ ; effect size = @ ) , cariprazine @-@ mg/d ( -@ [ -@ , -@ ] , P < .@ ; effect size = @ ) , and risperidone ( -@ [ -@ , -@ ] , P = .@ ; effect size = @ ) ; however , the LSMD for aripiprazole versus placebo was not statistically significant ( -@ [ -@ , @ ] , P = .@ ; effect size = @ ) .\n",
            "Significant effect versus placebo was observed by Week @ for cariprazine @-@ and @-@ mg/d and by Week @ for risperidone .\n",
            "Conclusions : After @ weeks of treatment , significantly greater statistical improvement versus placebo on the PANSS factor score for negative symptoms was observed for cariprazine and for risperidone , but not for aripiprazole .\n",
            "This pooled post hoc analysis suggests that cariprazine may have an effect on negative symptoms in patients with schizophrenia and predominantly negative symptoms .\n",
            "Since patients in the constituent studies and subsequent post hoc analysis had acute exacerbation of schizophrenia , cariprazine trials in which patients are prospectively selected for primary negative symptoms are merited .\n",
            "Keywords : schizophrenia , Negative Symptoms , cariprazine Disclosures : Supported by funding from Forest Laboratories , LLC , an affiliate of Actavis , Inc. , and Gedeon Richter Plc .\n",
            "I , Willie R Earley , am an employee and shock shareholder of Forest Research Institute , an affiliate of Actavis , Inc .\n",
            "Background : Evidence is accumulating that cognitive behaviour therapy has a beneficial effect on negative symptoms .\n",
            "Objective : To describe this evidence and techniques being used .\n",
            "Method : Review of evidence including Tarrier and colleagues @ who have shown differential effects as compared with routine care ; Rector who has shown similar effects @ ; our own group Sensky et al. , @ who have found such effects compared with a befriending ' control present time months after the end of the intervention with affective flattening appearing to , unexpectedly , predict good outcome ; finally , in a study of a brief six session intervention of a CBT psychoeducation package , negative symptoms are improved at a year compared to treatment as usual .\n",
            "The specific techniques being used will be described in the presentation based around the premise that you ca n't push patients out of negative symptoms ' .\n",
            "Conclusion : There is good evidence for the effectiveness of CBT with medication for negative symptoms .\n",
            "Implications for future research will be discussed .\n",
            "Olanzapine treatment has been associated with clinically meaningful weight increases , hypertriglyceridemia , insulin resistance , and diabetes mellitus .\n",
            "There are few options for olanzapine responders who fail other antipsychotic agents .\n",
            "Aripiprazole is a potent ( high-affinity ) partial agonist at D@ and @-HT@A receptors and a potent antagonist at @-HT@A receptor and is associated with less weight gain than olanzapine .\n",
            "We report the results of a @-week placebo-controlled , double-blind crossover study that examined @ mg/d aripiprazole 's effects on weight , lipids , glucose metabolism , and psychopathology in overweight and obese schizophrenia and schizoaffective disorder subjects treated with a stable dose of olanzapine .\n",
            "During the @ weeks of aripiprazole treatment , there were significant decreases in weight ( P = @ ) and body mass index ( P = @ ) compared with placebo .\n",
            "Total serum cholesterol ( P = @ ) , high-density lipoprotein cholesterol ( HDL-C ; P = @ ) , HDL-@ ( P = @ ) , HDL-@ ( P = @ ) , and low-density lipoprotein cholesterol ( P = @ ) did not change significantly comparing aripiprazole treatment to placebo treatment .\n",
            "However , total serum triglycerides ( P = @ ) , total very low-density lipoprotein cholesterol ( VLDL-C ; P = @ ) , and VLDL-@C and VLDL-@C ( P = @ ) decreased significantly during the aripiprazole treatment phase .\n",
            "The VLDL-@C tended lower during aripiprazole , but the decrease was not significant ( P = @ ) .\n",
            "There was a decrease in C-reactive protein comparing aripiprazole treatment to placebo , although it did not reach significance ( P = @ ) .\n",
            "The addition of aripiprazole to a stable dose of olanzapine was well tolerated and resulted in significant improvements on several outcome measures that predict risk for medical morbidity .\n",
            "Allocation : randomised .\n",
            "Participants : schizophrenia , schizophreniform disorder and schizoaffective disorder .\n",
            "N = @ .\n",
            "Interventions : Olanzapine and haloperidol .\n",
            "Outcomes : BPRS , PANSS , CGI , MADRS .\n",
            "OBJECTIVE : Disease management systems that incorporate medication algorithms have been proposed as cost-effective means to offer optimal treatment for patients with severe and chronic mental illnesses .\n",
            "The Texas Medication Algorithm Project was designed to compare health care costs and clinical outcomes between patients who received algorithm-guided medication management or usual care in @ public mental health clinics .\n",
            "METHODS : This longitudinal cohort study for patients with major depression ( N = @ ) , bipolar disorder ( N = @ ) , and schizophrenia ( N = @ ) applied a multi-part declining-effects cost model .\n",
            "Outcomes were assessed by the Inventory of Depressive Symptomatology and the Brief Psychiatric Rating Scale .\n",
            "RESULTS : Compared with patients in usual care , patients in algorithm-based care incurred higher medication costs and had more frequent physician visits , although these differences often became smaller with time .\n",
            "For major depression , algorithm-based care achieved better outcomes sustainable with time but at higher agency and non-agency costs ( mixed cost-effective ) .\n",
            "For bipolar disorder , patients in algorithm-based management achieved better outcomes at lower agency costs ( cost-effective ) .\n",
            "For schizophrenia , patients in algorithm-based care achieved better outcomes that diminished with time , with no detectable difference in health care costs ( cost-effective ) .\n",
            "CONCLUSIONS : Cost outcomes of algorithm-based care and usual care varied by disorder and over time .\n",
            "For bipolar disorder and schizophrenia , algorithm-based care improved outcomes without higher costs for health care services .\n",
            "For major depression , substantively better and sustained outcomes were obtained but at greater costs .\n",
            "RN @ ( Antipsychotic Agents ) .\n",
            "Objective : by classic antipsychotics replacement of SDA drug comparison risperidone , clozapine of two SDA drugs on the efficacy of schizophrenia with anxiety .\n",
            "Methods : are using some kind of classic antipsychotics in schizophrenic patients , were randomly divided into two groups , respectively switching to risperidone ( I group ) , of clozapine ( II group ) .\n",
            "Before treatment , the treatment of the first @ , @ , @ , @ weekend blinded assessment BPRS , HAMA .\n",
            "Results : @ cases into groups to complete the @ cases , @ cases in two groups .\n",
            "The two groups of patients before and after treatment BPRS total score decreased appear significant difference .\n",
            "A greater understanding of the links between cognitive and social functioning changes is needed to refine cognitive treatments for schizophrenia .\n",
            "To date , studies have been cross-sectional , and few have investigated the impact of cognitive change .\n",
            "This single-blind randomized controlled trial explored the links between changes in executive/memory functions and social behavior , as well as the moderating effect of cognitive remediation therapy ( CRT ) .\n",
            "A total of @ participants with schizophrenia received @ sessions of CRT ( an individual psychological therapy aiming to improve attention , memory , and problem solving ) or treatment-as-usual .\n",
            "At baseline , social functioning was significantly associated with \" verbal working memory , \" \" response inhibition , \" \" verbal long-term memory , \" and \" visuo-spatial long-term memory , \" but not \" schema generation , \" factors .\n",
            "However , only improvement in \" schema generation \" predicted improved social functioning .\n",
            "This was true whether or not participants had received CRT .\n",
            "These results suggest that cross-sectional associations between cognitive functions and social functioning may not offer the best means for identifying good targets for intervention .\n",
            "Improvement in the ability to generate new schemas has a beneficial impact on social functioning .\n",
            "Introduction : The objective of this study was to assess whether olanzapine 's favourable risk-benefit profile contributes to improved treatment satisfactory versus fluphenazine .\n",
            "Methods : This study was a multicentre , randomised , double blind study conducted in Croatia .\n",
            "Patients were treated either with olanzapine ( @ -@ mg/day ) or fluphenazine ( @ - @ mg/day ) for a period of @ weeks .\n",
            "Patient satisfaction was measured using the Drug Attitude Inventory ( DAI ) and the Van Putten Scale ( VPS ) .\n",
            "Results : Sixty patients were enrolled .\n",
            "The mean age was @ years and @ % were male .\n",
            "The VPS total score improved from baseline to endpoint in the olanzapine treatment group ; the mean change from baseline to endpoint worsened in the fluphenazine group ( p = @ ) .\n",
            "Olanzapine was also significantly superior ( p = @ ) to fluphenazine with regards to the mean on the DAI total score .\n",
            "Conclusions : Olanzapine demonstrated a statistically significant greater drug acceptance during acute treatment and can probably help to overcome drug-related non-compliance .\n",
            "Schizophrenia and other Psychotic Disorders\n",
            "Variations in responsivity to primary , secondary asocial and interpersonal rewards and punishments between major schizophrenic subgroups were investigated in a probability learning study .\n",
            "The subgroups compared were process and reactive , paranoid and nonparanoid , long - and short-hospitalization , and long - and short-length of illness schizophrenics .\n",
            "No evidence of differential responsivity to these reward - punishment/modality combinations appeared between high and low scorers on any of the four schizophrenic subgrouping dimensions .\n",
            "The groups then were matched closely so that the effects of each individual difference measure could be evaluated independently of the other three .\n",
            "Again , no significant differences in responsiveness to the reinforcement/modality combinations appeared .\n",
            "The results do not support the view that any of the four dimensions relate to differential responsiveness to primary , secondary asocial or verbal reward or punishment -- at least on relatively simple tasks .\n",
            "These analyses explore the effect of olanzapine versus haloperidol in the treatment of first episode psychosis in an international , multicenter , double-blind , parallel trial .\n",
            "This trial compared the efficacy and safety of a single dose range of olanzapine , @-@ mg/day , to a single dose range of haloperidol , @-@ mg/day , in the treatment of @ in - and out-patients with a DSM-III-R diagnosis of schizophrenia , schizophreniform disorder , or schizoaffective disorder .\n",
            "Patients were assigned by random allocation to double-blind therapy in the ratio of @ olanzapine to @ haloperidol assignment .\n",
            "The acute phase of the trial was @ weeks in length which was followed by a double-blind responder extension and a open-label non - responder extension .\n",
            "Of the @ patients enrolled in the trial , @ ( @ olanzapine , @ haloperidol ) were in their first episode of psychosis with an episode duration of ?\n",
            "@ years and age at onset of ?\n",
            "@ years .\n",
            "In this subgroup of first episode patients , olanzapine was statistically significantly superior to haloperidol in the reduction of BPRS total score , BPRS negative score , PANSS total score , and PANSS positive score from baseline to endpoint of the acute phase ( last-observation-carried-forward ) .\n",
            "Also , haloperidol first episode patients suffered statistically significantly more EPS and akathisia than olanzapine first episode patients as measured by changes in Simpson-Angus total and Barnes global item from baseline to endpoint of the acute therapy .\n",
            "Background : Decision-making , as measured by the Iowa Gambling Test ( IGT ) , depends on the cumulative effect of reward and punishment on behavioral selection ( Bechara et al. , @ ) .\n",
            "It has been raised that second-generation antipsychotics have a detrimental effect on IGT performances , whereas first-generation drugs do not show such effects ( Beninger et al. , @ ) .\n",
            "The aim of this study was to replicate and extend these findings in carefully matched groups of patients with schizophrenia .\n",
            "Methods : Seventy-five patients with DSM-IV schizophrenia ( gender : @ male , @ female ; subtype : @ paranoid , @ residual , @ undifferentiated , and @ disorganized ; mean age : @ years ( SD = @ ) ; mean illness duration : @ years ( SD = @ ) ) participated in the study .\n",
            "Forty-three of them received first-generation drugs ( haloperidol , zuclopenthixol , chlorprothixene , fluphenazine , and flupentixol ) , whereas @ patients received second-generation drugs ( risperidone , olanzapine , clozapine , aripiprazole , amisulpride , and quetiapine ) .\n",
            "The symptoms were assessed using the Positive and Negative Syndrome Scale ( positive : @ ( SD = @ ) , negative : @ ( SD = @ ) , general : @ ( SD = @ ) ) .\n",
            "The Wechsler Adult Intelligence Scale ( revised version ) was used to assess general intellectual functions ( mean IQ : @ ( SD = @ ) ) .\n",
            "In the IGT , participants select from four decks of cards .\n",
            "Advantageous decks are characterized by immediate small reward but even smaller future punishment .\n",
            "In contrast , disadvantageous decks are characterized by immediate large reward but even larger future punishment .\n",
            "Selecting from the advantageous decks leads to higher overall gain .\n",
            "The test included @ trials .\n",
            "Results : Patients receiving first - and second-generation drugs did not differ in age , gender-distribution , years of education , duration of illness , number of hospitalization , scores on the Positive and Negative Syndrome Scale , and IQ .\n",
            "By the end of the test ( last @ trials ) , the patients receiving first-generation drugs achieved a performance of @ % ( SD = @ ) , whereas this value was @.@ % ( SD = @ ) in the group of patients receiving second-generation drugs .\n",
            "An analysis of linear trend revealed significant learning in both groups ( p < @ ) , and there was not significant difference between them ( p > @ ) .\n",
            "Concerning the subtypes , disorganized patients were impaired on the IGT compared with paranoid and undifferentiated patients .\n",
            "By the end of the test , the mean performance in the disorganized group was @ % ( SD = @ ) .\n",
            "An analysis of linear trend revealed no significant learning in the disorganized group ( p > @ ) , whereas the main effect of group was significant ( p < @ ) even when the confounding effects of age , gender , education , and IQ were taken into consideration as covariates in the analysis of variance .\n",
            "Conclusions : Disorganized symptoms , but not the type of antipsychotic medication , significantly affected decision-making in schizophrenia .\n",
            "In general , the patients with schizophrenia were able to use reward and punishment contingencies to develop an optimal decision-making strategy , which may indicate sufficient functioning of the ventromedial prefrontal cortex ( Bechara et al. , @ ) .\n",
            "However , in disorganized schizophrenia these functions were disrupted , which may be responsible for the inadequate social adaptation of these patients .\n",
            "@ .\n",
            "Bechara A , Tranel D , Damasio H , @ , Characterization of the decision-making deficit of patients with ventromedial prefrontal cortex lesions , Brain , @ , @-@ .\n",
            "Obesity and diabetes have caused problems for individuals with schizophrenia long before atypical antipsychotic agents .\n",
            "The prevalence of obesity , insulin resistance , impaired glucose tolerance , type @ diabetes mellitus , dyslipidemia , and the Metabolic Syndrome has increased in people with schizophrenia as compared to the general population .\n",
            "Risk reduction studies for persons with obesity , diabetes , and cardiovascular disease indicate that cognitive/behavioral interventions that promote motivation and provide strategies to overcome the barriers in adherence to diet and activity modification are effective interventions for weight management and risk reduction .\n",
            "In the landmark multi-center randomized-controlled trial study , the Diabetes Prevention Project ( DPP ) , a cognitive/behavioral intervention , was more successful in producing weight loss and preventing diabetes than the drugs metformin , troglitazone or placebo .\n",
            "This pilot study examined the effectiveness of a cognitive/behavioral group intervention , modified after the DPP program , in individuals with schizophrenia or schizoaffective disorder taking atypical antipsychotics in a large urban public mental health system .\n",
            "Outcome measures included body weight , body mass index , waist-hip ratios , and fasting glucose levels .\n",
            "Both groups demonstrated elevated fasting glucose levels and were obese with a mean BMI of @ .\n",
            "The group that received the cognitive/behavioral group intervention lost more weight than the treatment as usual group .\n",
            "The CB group participants lost an average of @ lb or @ % of body weight , and those in the control group lost @ lb or @ % body weight .\n",
            "The range of weight loss for the treatment group was from @ to @ lb .\n",
            "This pilot study has demonstrated that weight loss is possible with cognitive/behavioral interventions in a population with a psychotic disorder .\n",
            "RN @ ( Antipsychotic Agents ) .\n",
            "A double-blind trial using the cross-over design was carried out on @ patients with functional psychosis and persistent dyskinesia associated with prolonged phenothiazine therapy .\n",
            "Each patient whose dyskinesia had persisted unchanged for at least one month after phenothiazine withdrawal received thiopropazate ( Dartalan ) @ mg t.i.d. orally for a @-week period and placebo for a similar period .\n",
            "Patients were evaluated before the trial , at @ weeks and at @ weeks .\n",
            "Dyskinesia was assessed according to @ rating scales , the coefficient of correlation of inter - observer ratings of which were @ , @ and @ respectively .\n",
            "All patients completed the trial Thiopropazate was found to be significantly more effective than placebo in relieving dyskinesia .\n",
            "It also improved psychotic behaviour .\n",
            "None of the selected clinical variables influenced response to thiopropazate or to placebo - age , sex , severity of dyskinesia , total duration of dyskinesia , duration of dyskinesia after phenothiazine withdrawal , lateness of onset of dyskinesia , duration of phenothiazine therapy , distribution of dyskinesia and length of psychotic illness .\n",
            "Side effects were noted in @ patients receiving thiopropazate , @ having parkinsonism and @ drowsiness .\n",
            "None had side effects whilst on placebo .\n",
            "The findings indicate that thiopropazate is of value in the treatment of persistent dyskinesia associated with prolonged phenothiazine intake but further research is required to determine the long-term effectiveness of the drug .\n",
            "@ chronic schizophrenic out-patients were given either fluphenazine decanoate or enanthate for a @-year double-blind trial .\n",
            "Doses of @ mg were given for the first @ months and @ mg for the last @ months .\n",
            "For both agents the intervals between treatments lengthened significantly over the course of the trial .\n",
            "Fluphenazine decanoate showed a non-significant trend for a longer duration of action coupled with a significantly lower incidence of extrapyramidal side effects .\n",
            "AIMS : To study the impact of risperidone ( RISP ) on clozapine ( CLZ ) biotransformation in vitro in microsomal fractions containing varying expression of CYP oxidases and in vivo in patients .\n",
            "METHODS : Human liver microsomes ( n = @ ) were assessed for expression of CYPs @A@ , @D@ and @A@ , because these enzymes mediate RISP and CLZ oxidation .\n",
            "Inhibition of CLZ oxidation by RISP was assessed .\n",
            "Plasma CLZ elimination was estimated in patients with schizophrenia who received either CLZ alone or the CLZ-RISP combination ( n = @ per group ) .\n",
            "RESULTS : ( i ) The CYP@A@ and CYP@A@ inhibitors ketoconazole and fluvoxamine inhibited CLZ oxidation to varying extents in individual microsomal fractions .\n",
            "( ii ) RISP did not inhibit CLZ oxidation , regardless of variations in CYP expression .\n",
            "( iii ) RISP co-administration did not impair CLZ clearance .\n",
            "CONCLUSIONS : No evidence was found for CYP-mediated inhibitory or pharmacokinetic interactions between RISP and CLZ .\n",
            "Occasional literature reports of such interactions may involve other pathways that participate in CLZ disposition .\n",
            "Objective : In four double-blind clinical trials , the safety of intramuscular ( IM ) olanzapine @-@ mg/injection in acutely agitated patients with schizophrenia ( fixed-dose , N = @ ; dose-range , N = @ ) , bipolar mania ( N = @ ) , or dementia ( N = @ ) was compared with IM haloperidol @ mg/injection , lorazepam @ or @ mg/injection , and placebo .\n",
            "Methods : Patients were treated with @-@ IM injections/@ hours .\n",
            "Safety assessments included baseline to endpoint changes in extrapyramidal symptoms ( EPS ) , electrocardiograms ( ECGs ) ( including QTc intervals ) , and vital signs .\n",
            "Excessive levels of sedation and treatment-emergent adverse events were also compared .\n",
            "Results : The incidence of EPS with IM olanzapine was similar to IM placebo , with no reports of acute dystonia .\n",
            "There were no clinically significant changes in ECGs , including QTc intervals , during treatment with IM olanzapine .\n",
            "Small and infrequent decrements in blood pressure and heart rate were observed during treatment with IM olanzapine ; however , there were no substantial differences among treatment groups in relevant clinical adverse events ( e.g. , syncope , dizziness ) .\n",
            "IM olanzapine-treated patients did not experience excessive or undesirable sedation .\n",
            "In general , IM olanzapine had a favorable adverse event profile , including few reports of injection site pain .\n",
            "Conclusions : In four large , double-blind , placebo - and comparator-controlled studies , IM olanzapine was safe and well-tolerated in patients with schizophrenia , bipolar mania , and dementia .\n",
            "Background : There is urgent need for the identification of new pharmacological targets for the treatment of schizophrenia .\n",
            "We recently discovered that increase of anandamide levels by blocking its degradation by administration of cannabidiol , a purified phytocannabinoid , is accompanied by significant improvement of symptoms in acute schizophrenic patients .\n",
            "Methods : We performed a randomized , double-blind , placebocontrolled , cross-over clinical trial in acute , antipsychotic-naive , first-break paranoid schizophrenia patients , fulfilling diagnostic criteria of DSM-IV .\n",
            "@ patients were treated after written informed consent with either cannabidiol ( @ mg per day ) or placebo for @ days and than switched to the corresponding cross-over condition .\n",
            "Additional patients to gain a total of @ patients treated per protocol replaced dropouts .\n",
            "Results : Cannabidiol significantly improved psychotic symptoms in the cannabidiol-placebo condition during the first @ days of treatment when compared to baseline .\n",
            "A MMRM analysis of all randomized patients ( n  @ ) yielded an mean improvement of @ points ( standard error @ ) on PANSS total in favor of cannabidiol ( vs. placebo ) , albeit not statistically significant .\n",
            "Only one patient on sequence cannabidiolplacebo terminated treatment early ( last seen at visit @ ) whereas @ patients terminated early on sequence placebo-cannabidiol .\n",
            "The most frequent reason given was worsening of symptoms ( @/@ patients ) .\n",
            "Discussion : Although limited by design issues ( cross-over ) , duration of treatment ( @ days ) , and relevant placebo-response rates , this is the second study to provide evidence for antipsychotic properties of cannabidiol accompanied by a superior side-effect profile .\n",
            "Future placebo-controlled parallel-group trials studying the antipsychotic properties of cannabidiol in acute schizophrenia are necessary to S@ ACNP @th Annual Conference provide further evidence for its efficacy in the treatment of this devastating disease\n",
            "INTRODUCTION : Although the pathogenesis of symptoms of schizophrenia is largely unknown , a variety of neurotransmitters are implicated , including serotonin and norepinephrine .\n",
            "Here we investigate the effectiveness of duloxetine as a serotonin-norepinephrine inhibitor in the treatment of negative symptoms .\n",
            "METHODS : We performed a double-blind clinical trial on @ patients with stable schizophrenia and no prominent symptoms of depression .\n",
            "Patients received risperidone ( up to @ mg/day ) plus either duloxetine ( @ mg/day ) or placebo .\n",
            "Psychotic symptoms were assessed by the Positive and Negative Syndrome Scale ( PANSS ) at the onset of the trial , and at @ , @ , @ and @ weeks of therapy .\n",
            "RESULTS : Compared to the placebo group , the duloxetine group showed significantly higher improvement in negative symptoms ( p < @ ) , PANSS total ( p < @ ) , and the general psychopathology subscale scores ( p = @ ) , but no significant difference in positive symptoms ( p = @ ) .\n",
            "The side effect profiles of the @ treatment regimens were not significantly different .\n",
            "DISCUSSION : Duloxetine adjuvant to risperidone seems to be a tolerable and efficacious treatment for primary negative symptoms of schizophrenia .\n",
            "Objective : To compare changes in neuropsychological functioning over time among adults with schizophrenia treated with atypical and conventional antipsychotics , controlling for phenomenological changes , medication dosage , concomitant use of anticholinergic medications , and practice effects .\n",
            "Methods : In a larger clinical trial , @ patients diagnosed with schizophrenia or schizoaffective disorder were randomly assigned to medication groups ( risperidone , olanzapine , or conventional medications ) , treated in an open-label design , and monitored prospectively for @ months using standard neuropsychological and symptomatology instruments .\n",
            "Results : Significant differential effects were evident on the ability to maintain and rapidly shift mental set within a psychomotor task , with patients in the conventional medication group consistently making more errors over time until the @-month follow-up , when the olanzapine group made significantly more errors .\n",
            "Significant differential effects were also evident on delayed memory , with patients receiving olanzapine improving more steadily over time until the @-month followup , when patients in the conventional group were able to recall significantly more .\n",
            "Positive and negative symptomatology was a significant , inversely related covariate on most of the cognitive measures examined .\n",
            "Conclusions : The atypical and conventional medications examined were not consistently differential enhancers of cognitive functioning on disparate cognitive functioning measures over time .\n",
            "Olanzapine is a putative ' atypical ' antipsychotic agent that belongs to the class of thienobenzodiazepine , which is structurally related to clozapine .\n",
            "In vitro studies indicate that olanzapine has high affinity for dopamine D@/D@/D@ , serotonin @HT@A/@C , @HT@ , @HT@ , histamine H@ , and @andronergic as well as muscarinic ( especially M@ ) receptors .\n",
            "Olanzapine shows a greater affinity for serotonin ( @HT@A/@C ) than dopamine ( D@/D@ ) receptors .\n",
            "Anticholinergic activity and serotonin receptor antagonism , along with a relatively weaker dopamine D@ antagonism , as shown by the atypical antipsychotic clozapine , are thought to reduce the incidence and severity of drug-induced extrapyramidal symptoms ( EPS ) and possibly reduce the risk of tardive dyskinesia .\n",
            "In vivo behavioural studies further suggest that olanzapine possesses antipsychotic activity with low propensity to produce EPS .\n",
            "Study FID-MC-HGAD was a double-blind , randomized , parallel , placebo and haloperidol-controlled study of @ patients who met criteria for schizophrenia according to DSM-III-R .\n",
            "The study was conducted in @ study centres throughout the United States and Canada .\n",
            "Patients with a minimum baseline psychotic psychopathology ( BPRS @ and CGI Severity @ ) were randomized to one of the @ treatment groups - placebo , olanzapine low-dose range ( Olz-L , @ @ mg/day ) , olanzapine medium-dose range ( Olz-M , @ @ mg/day ) , olanzapine high-dose range ( Olz-H , @ @ mg/day ) , or ( Hal , @ @ mg/day ) .\n",
            "The acute phase FO the study lasted for @ weeks with evaluations performed weekly .\n",
            "Responders could continue double-blind therapy , with the same initial study drug at the same dose-range , in the extension phase at least @ months .\n",
            "Objective : The objective in this post-hoc analysis was to assess the effects of aripiprazole once-monthly - the first extended release dopamine D@ partial agonist - compared to a sub-threshold therapeutic dose and to oral aripiprazole on the five Marder PANSS dimensions of schizophrenia .\n",
            "Methods : A @-week , double-blind , active-controlled , noninferiority study ( NCT@ ) ; randomisation ( @:@:@ ) to aripiprazole once-monthly @ mg , oral aripiprazole ( @-@ mg/day ) , or aripiprazole once-monthly @ mg assessing the efficacy and safety of aripiprazole once-monthly in patients requiring chronic antipsychotic treatment .\n",
            "Secondary efficacy assessments included mean change from baseline to endpoint during Phase @ in Positive and Negative Syndrome Scale ( PANSS ) .\n",
            "Here , we present results on a post-hoc analysis on the change from the baseline to Week @ ( end of study ) of Phase @ on the five Marder PANSS factors of schizophrenia symptoms , based on mixed-effect repeated measure model ( MMRM ) with fixed effects of treatment , visit , and interaction of treatment by visit , and with baseline measurement as a covariate .\n",
            "Results : A total of @ patients were randomized to : aripiprazole once-monthly @ mg ( n = @ ) ; oral aripiprazole ( n = @ ) ; or aripiprazole once-monthly @ mg ( n = @ ) .\n",
            "Improvement from baseline to Week @ in the PANSS Marder Factor - Positive and - Hostility symptom scores were statistically significantly greater following treatment with aripiprazole oncemonthly @ mg than with aripiprazole once-monthly @ mg ( Table @ ) .\n",
            "Aripiprazole once-monthly @ mg was associated with significant improvements from baseline to Week @ in PANSS Marder Factor - Positive symptoms score versus oral aripiprazole ( Table @ ) .\n",
            "( Table Presented ) Conclusions : In the current study , aripiprazole once-monthly @ mg was shown to be statistically significantly better than the subtherapeutic dose and the oral dose in PANSS Marder Factor score for positive symptoms , and significantly better than the subtherapeutic dose on Marder Factor hostility symptoms .\n",
            "Preventing emergence of overt psychotic symptoms is an important potential benefit of aripiprazole once-monthly and should be factored into treatment decisions for patients with schizophrenia .\n",
            "Background : Psychoeducational programs are among the most widely studied psychosocial interventions for psychotic disorders .\n",
            "These programs are systematic and didactic , and consist of psychotherapeutic interventions aimed at providing information about the disease in question to patients and their relatives to foster coping skills and understanding .\n",
            "Studies in adult populations with schizophrenia have shown that psychoeducational interventions can reduce the probability of relapse , number of hospitalizations , and symptom severity .\n",
            "They can also improve social and occupational functioning and increase adherence to treatment .\n",
            "Additional benefits include reduced family burden , improved coping skills , and recognition and understanding of psychosis as a disease .\n",
            "In accordance with the stressvulnerability model , environmental factors such as family interactions can play an important role in the continuity of the disorder .\n",
            "Hence , family psychoeducational programs are aimed at influencing the environment in which the patient lives by reducing anxiety and increasing family members ' self-confidence and ability to react constructively to behavioral disturbances and the patient 's symptoms .\n",
            "This result has been confirmed in recent studies that show that the relapse rate can be reduced by approximately @ % if the parents of patients with schizophrenia are included in the treatment .\n",
            "Strenuous efforts to engage families in the prevention of relapses are justified , because @ % to @ % of patients are living with their parents when they are referred for treatment .\n",
            "To our knowledge , only @ study has assessed the efficacy of a psychoeducational treatment program in adolescents with psychosis , although it was not a randomized controlled trial .\n",
            "Furthermore , despite the fact that some programs offer psychoeducational approaches for young adults with a first episode of psychosis that include parents as an important complement in the program , none of them includes a specific age range for adolescents .\n",
            "Other studies evaluate the efficacy of a family-focused psychoeducational approach for adolescents with mood disorders who frequently have accompanying psychotic features .\n",
            "Our study aimed to examine the efficacy of a parallel , structured , and specific psychoeducational group intervention ( PE ) for adolescent patients and their families by comparing it with a nonstructured group intervention ( NS ) .\n",
            "To the best of our knowledge , this is the first randomized controlled trial to compare a PE intervention with an NS intervention in adolescents with early-onset psychosis .\n",
            "We hypothesized that patients in the PE group would have fewer hospitalizations , days in hospital , and visits to the emergency department .\n",
            "We also hypothesized that these patients would have better clinical outcomes and more favorably perceived family environments .\n",
            "At the end of the group intervention , @ % of patients in the psychoeducational group and @ % patients in the nonstructured group had visited the emergency department ( w@ = @ , df = @ , p = .@ ) .\n",
            "The improvement in negative symptoms was more pronounced in the psychoeducational group ( @ [ @ ] ) than in the nonstructured group ( @ [ @ ] ) ( p = .@ ) .\n",
            "We present now a study to determine whether the beneficial effects observed immediately after a structured , psychoeducational , parallel-group program for adolescents with early-onset psychosis and their families were maintained @ years later .\n",
            "The long-term results of this trial have not yet been published .\n",
            "Methods : The current study examines the two-year longitudinal efficacy of a randomized controlled trial ( @ ) based on a structured , psychoeducational , problem-solving , group intervention for adolescents with early-onset psychosis and their families ( PE group ) compared with a non-structured group intervention ( NS group ) .\n",
            "All patients and their parents or legal guardians signed an informed consent before enrolling in the study .\n",
            "The study was approved by the hospital IRB .\n",
            "We analyzed whether the differences between the PE and NS groups found after the intervention persisted\n",
            "In a double-blind study of @ chronic schizophrenic in-patients , haloperidol decanoate was compared with fluphenazine decanoate as maintenance therapy over @ weeks .\n",
            "Both drugs were given by injection at @-week intervals .\n",
            "Haloperidol and fluphenazine were assumed to be equipotent ; the mean starting dose of the former was @ mg and of the latter @ mg .\n",
            "The number of withdrawals over @ weeks was similar in both groups but relapses , strictly defined , were significantly more frequent in the haloperidol group .\n",
            "When patients were switched to haloperidol , Parkinsonism diminished more quickly than in the fluphenazine group , but after @ weeks there was no difference in severity in the two drug groups .\n",
            "The higher relapse rate and the quicker reduction in Parkinsonism in the haloperidol group might be due to a misjudgement in equivalent doses of the two drugs .\n",
            "Plasma haloperidol steady state levels were reached in most patients by @-@ weeks .\n",
            "Plasma neuroleptic and prolactin levels , week-by-week systemic drug availability and Parkinsonism showed less variation between injections with haloperidol than with fluphenazine .\n",
            "Eleven patients with tardive dyskinesia were treated in a double-blind study of vitamin E or placebo for @ weeks .\n",
            "Abnormal Involuntary Movement Scale ( AIMS ) ratings were performed before and after treatment .\n",
            "Patients receiving vitamin E showed a significant reduction in their AIMS scale score , but patients receiving placebo showed no significant change .\n",
            "Vitamin E had a helpful effect even for patients whose tardive dyskinesia was mild and long-term .\n",
            "Background : The focus of current consensus guidelines for clinical trials of neurocognitive drugs for schizophrenia is on adjunctive therapies .\n",
            "The guidelines anticipate but do not fully explicate clinical trial design issues regarding     broad spectrum      agents , which have both antipsychotic and pro-cognitive effects .\n",
            "CYP-@ is a new chemical entity that combines dopamine antagonism with GABAergic activity , thus possessing the potential for broad spectrum efficacy .\n",
            "Data from @-weeks of acute treatment and a @-week extension of a Phase @b trial of CYP-@ in patients with schizophrenia was used to approximate a hybrid clinical trial design , enabling both an acute analysis of antipsychotic efficacy and neurotoxicity of CYP-@ , placebo and risperidone at @-weeks , and an analysis of pseudospecificity through comparable antipsychotic efficacy but differential cognitive activity of CYP-@ versus risperidone at @-weeks .\n",
            "Methods : The EAGLE ( Effective Antipsychosis via GABA Level Enhancement ) @-week study was conducted under a U.S. FDA , IND application at @ sites in US , Europe , and India .\n",
            "A total of @ patients with schizophrenia were randomized equally to treatment with low - ( @ mg/d ; LD ) or high - ( @-@ mg/d ; HD ) dose CYP-@ , a positive control using risperidone ( @-@ mg/d ) , or placebo .\n",
            "A subset of patients from the @-week trial ( N  @ ) were dosed an additional @-weeks .\n",
            "The study was designed to demonstrate the superiority of high-dose CYP - @ versus placebo on the total score of the PANSS at @-weeks .\n",
            "Cognitive impact , as measured by the Brief Assessment of Cognition in Schizophrenia ( BACS ) , was an exploratory endpoint .\n",
            "Safety endpoints included assessment of adverse events , laboratory parameters , and extrapyramidal side effects .\n",
            "Post hoc analyses included an examination of changes in PANSS and BACS over @-weeks .\n",
            "Results : The ITT LOCF data for the acute ( @-week ) phase of the trial revealed significant antipsychotic efficacy as measured by change on the PANSS total score for both HD CYP-@ ( LSM  -@ , SE  @ ) and risperidone ( LSM  -@ , SE  @ ) versus placebo ( LSM  -@ , SE  @ ; pso .@ , for both active treatments ) .\n",
            "There were no statistically significant efficacy differences between HD CYP [ [ Unsupported Character - Codename & shy ;] ] @ and risperidone ( p  .@ ) .\n",
            "LD CYP-@ did not separate .\n",
            "Age - and gender-corrected BACS total score changes from baseline were similar among placebo ( LSM  @ , S@ ACNP @th Annual Conference SE  @ ) risperidone ( LSM  @ , SE  @ ) , and LD CYP-@ patients ( LSM  @ , SE  @ ; all ps@ .@ ) , suggesting no cognitive adverse effects .\n",
            "However , HD CYP-@ produced an acute cognitive improvement ( LSM  @ , SE  @ , estimated effect size of @ compared to either placebo or risperidone ) versus placebo and risperidone ( pso .@ ) .\n",
            "An examination of the @ subjects with @-week extension data revealed that while HD CYP-@ produced antipsychotic efficacy similar to that of risperidone at @-weeks , its procognitive effect was further enhanced over the subsequent @-weeks , as compared both to the results observed among patients on HD CYP - @ at @-weeks ( M  @ , SD  @ ) as well as patients on risperidone at @-weeks ( M  @ , SD  @ ) .\n",
            " within the CYP-@ and risperidone groups for both the acute and chronic phases of the study .\n",
            "There were no clinically relevant changes in the measurements of the ECG , laboratory or vital signs ( BP , HR , temp ) .\n",
            "There were also no clinically relevant changes or AEs of body weight gain , glucose increases , or lipid changes in the CYP-@ arms .\n",
            "Discussion : The results of this initial acute/chronic hybrid trial suggest that antipsychotic and pro-cognitive effects can be determined within a single study design .\n",
            "The @-@ mg/d dose of CYP-@ in this study was safe and well-tolerated , and appears to have an antipsychotic effect similar to risperidone versus placebo at @-weeks and a superior pro-cognitive effect versus risperidone at both @ - and @ - weeks .\n",
            "Moving forward , prospectively conducted , appropriately powered acute/chronic hybrid clinical trials may be able to assess antipsychotic efficacy and cognitive functioning in the same study while adequately examining pseudospecificity and neurotoxicity .\n",
            "Such trials could assess patients using both placebo and active controls during the acute treatment phase in schizophrenia , and then follow patients on active therapy over @-months to fully understand both the antipsychotic and cognitive profiles of broad spectrum agents .\n",
            "Objectives : Study objectives were to compare mental health outcomes of a peer-led recovery group , a clinician-led recovery group , and usual treatment and to examine the effect of group attendance on outcomes .\n",
            "Methods : The study used a randomized design with three groups : a recovery-oriented peer-led group ( Vet-to-Vet ) , a clinician-led recovery group , and usual treatment .\n",
            "The sample included @ veterans .\n",
            "Recovery and mental health assessments were obtained at enrollment and three months later .\n",
            "Intention-to-treat analysis using mixed-model regression was performed to examine the effect of the intervention .\n",
            "\" As treated \" analysis was performed to examine the effect of group attendance .\n",
            "Results : There were no statistically significant differences in improvement among the groups .\n",
            "Across groups , depression and functioning , psychotic symptoms , and overall mental health improved significantly .\n",
            "Better group attendance was associated with more improvement .\n",
            "Conclusions : This study adds to the evidence suggesting no shortterm incremental benefit ( or harm ) from peer services beyond usual care .\n",
            "BACKGROUND : Clozapine ( clozaril , Mylan Products Ltd ) is a first-choice treatment for people with schizophrenia who have a poor response to standard antipsychotic medication .\n",
            "However , a significant number of patients who trial clozapine have an inadequate response and experience persistent symptoms , called clozapine-resistant schizophrenia ( CRS ) .\n",
            "There is little evidence regarding the clinical effectiveness of pharmacological or psychological interventions for this population .\n",
            "OBJECTIVES : To evaluate the clinical effectiveness and cost-effectiveness of cognitive-behavioural therapy ( CBT ) for people with CRS and to identify factors predicting outcome .\n",
            "DESIGN : The Focusing on Clozapine Unresponsive Symptoms ( FOCUS ) trial was a parallel-group , randomised , outcome-blinded evaluation trial .\n",
            "Randomisation was undertaken using permuted blocks of random size via a web-based platform .\n",
            "Data were analysed on an intention-to-treat ( ITT ) basis , using random-effects regression adjusted for site , age , sex and baseline symptoms .\n",
            "Cost-effectiveness analyses were carried out to determine whether or not CBT was associated with a greater number of quality-adjusted life-years ( QALYs ) and higher costs than treatment as usual ( TAU ) .\n",
            "SETTING : Secondary care mental health services in five cities in the UK .\n",
            "PARTICIPANTS : People with CRS aged > / = @ years , with an International Classification of Diseases , Tenth Revision ( ICD-@ ) schizophrenia spectrum diagnoses and who are experiencing psychotic symptoms .\n",
            "INTERVENTIONS : Individual CBT included up to @ hours of therapy delivered over @ months .\n",
            "The comparator was TAU , which included care co-ordination from secondary care mental health services .\n",
            "MAIN OUTCOME MEASURES : The primary outcome was the Positive and Negative Syndrome Scale ( PANSS ) total score at @ months and the primary secondary outcome was PANSS total score at the end of treatment ( @ months post randomisation ) .\n",
            "The health benefit measure for the economic evaluation was the QALY , estimated from the EuroQol-@ Dimensions , five-level version ( EQ-@D-@L ) , health status measure .\n",
            "Service use was measured to estimate costs .\n",
            "RESULTS : Participants were allocated to CBT ( n = @ ) or TAU ( n = @ ) .\n",
            "There was no significant difference between groups on the prespecified primary outcome [ PANSS total score at @ months was @ points lower in the CBT arm than in the TAU arm , @ % confidence interval ( CI ) -@ to @ points ; p = @ ] , although PANSS total score at the end of treatment ( @ months ) was significantly lower in the CBT arm ( -@ points , @ % CI -@ to -@ points ; p = @ ) .\n",
            "CBT was associated with a net cost of pound@ ( @ % CI - pound@ ,@ to pound@ ,@ ) and a net QALY gain of @ ( @ % CI @ to @ QALYs ) compared with TAU .\n",
            "The cost-effectiveness acceptability analysis indicated a low likelihood that CBT was cost-effective , in the primary and sensitivity analyses ( probability < @ % ) .\n",
            "In the CBT arm , @ participants reported at least one adverse event ( AE ) , whereas @ participants in the TAU arm reported at least one AE ( odds ratio @ , @ % CI @ to @ ; p = @ ) .\n",
            "CONCLUSIONS : Cognitive-behavioural therapy for CRS was not superior to TAU on the primary outcome of total PANSS symptoms at @ months , but was superior on total PANSS symptoms at @ months ( end of treatment ) .\n",
            "CBT was not found to be cost-effective in comparison with TAU .\n",
            "There was no suggestion that the addition of CBT to TAU caused adverse effects .\n",
            "Future work could investigate whether or not specific therapeutic techniques of CBT have value for some CRS individuals , how to identify those who may benefit and how to ensure that effects on symptoms can be sustained .\n",
            "TRIAL REGISTRATION : Current Controlled Trials ISRCTN@ .\n",
            "FUNDING : This project was funded by the National Institute for Health Research ( NIHR ) Health Technology Assessment programme and will be published in full in Health Technology Assessment ; Vol .\n",
            "@ , No. @ .\n",
            "See the NIHR Journals Library website for further project information .\n",
            "Objective : To investigate the efficacy of MIN-@ , a compound with affinities for sigma@ and @-HT@A receptors in treating negative symptoms in stabilized patients with schizophrenia .\n",
            "Methods : The trial enrolled @ patients who were symptom-atically stable for > @ months and had scores > @ on the negative subscale of the PANSS .\n",
            "Patients were randomized to MIN-@ @ mg/day , MIN-@ @ mg/day , or placebo for @ weeks .\n",
            "The primary endpoint was the PANSS negative factor score ( pentagonal structure model ) .\n",
            "Secondary outcomes were the PANSS total , CGI , BASS , BACS and the Calgary Depression Scale for Schizophrenia ( CDSS ) .\n",
            "Study registration : EudraCT # : @-@-@ .\n",
            "Results : A total of @ patients were randomized ( safety population ) and received at least one dose of study medication .\n",
            "There was a statistically significant reduction in the primary end-point score , the PANSS negative symptoms pentagonal structure factor model for MIN-@ @ mg and @ mg compared to placebo ( p < = @ , ES = @ , and p < = @ , ES = @ respectively .\n",
            "Consistent with these results was the statistically significant or trend level superiority of MIN-@ over placebo on total and activation factor score CGI-S , BNSS , and CDSS .\n",
            "We also examined the Pearson correlation between change from baseline to endpoint on depression , measured by the CDSS total score and change from baseline to endpoint on negative symptoms pentagonal structure factor model which yielded r = @ .\n",
            "Since the correlation between change in depression and negative symptoms were low this supported the notion that improvement in negative symptoms in this study was not synonymous with improvement on mood .\n",
            "Second , we performed an ANCOVA analysis to examine treatment effects ( change from baseline to endpoint ) before and after controlling for changes from baseline to endpoint on the CDSS scores .\n",
            "We found that the superiority of both doses of MIN@ versus placebo for the PANSS negative pentagonal factor model was maintained .\n",
            "After controlling for change in depression the effect size on the PANSS negative pentagonal factor for @ mg declined only by d = @ and for @ mg by d = @ .\n",
            "There were no statistically significant differences between the @ treatment groups in PANSS positive symptoms scores .\n",
            "There was no n weight gain or clinically significant changes in vital signs , routine laboratory values , and extrapyramidal symptom ratings .\n",
            "There were @ patients with serious adverse events , @ in the placebo group and @ in the MIN-@ groups of whom @ were hospitalized for worsening of schizophrenia symptoms ( @ in the placebo group , @ in the @ mg MIN-@ group and none in MIN-@ @ mg group ) .\n",
            "The @ remaining SAEs occurred with MIN-@ ( @ mg ) : vomiting and abdominal pain in one patient and syncope and bradycardia in another patient .\n",
            "Discussion : This study is unique in reporting on a drug which is not a D@ blocking drug with specific therapeutic effects on negative symptoms of schizophrenia .\n",
            "The validity of the results is supported by the primary outcome , the secondary outcomes , and by the lack of potential confounders such as improvements in EPS or positive symptoms or unbinding by adverse effects .\n",
            "Objective : Post-traumatic stress disorder is highly prevalent in patients with psychotic disorders and negatively influences prognosis and wellbeing .\n",
            "Psychosis has been an exclusion criterion in PTSD treatment trials and clinical practice .\n",
            "Aim of this study was to examine the efficacy and safety of prolonged exposure ( PE ) and eye movement desensitization and reprocessing ( EMDR ) compared to waiting list ( WL ) in individuals with psychotic disorder .\n",
            "Methods : In the ' Treating Trauma in Psychosis trial ( T-TIP ) @ patients with a psychotic disorder and comorbid PTSD were randomly assigned to PE , EMDR or Waiting List ( WL ) .\n",
            "In the treatment conditions participants received eight @-min sessions of therapy .\n",
            "Standard protocols were used .\n",
            "Treatment was not preceded by stabilizing psychotherapeutic interventions .\n",
            "Baseline , post-treatment and @-month follow-up assessments were made .\n",
            "Results : Participants in both PE and EMDR showed greater reduction of PTSD symptoms than those in WL .\n",
            "Between group effect sizes were large .\n",
            "About @ % of the participants in the treatment groups achieved loss of diagnosis .\n",
            "Treatment effects were maintained at sixmonth follow-up for both PE and EMDR .\n",
            "Treatments did not result in serious adversities .\n",
            "Conclusion : Standard PE and EMDR protocols appear to be effective , safe and feasible in patients with psychosis .\n",
            "At the conclusion of this presentation ( the participant should be able to have a better understanding and compare the long term risk of tardive dyskinesia induced by olanzapine and typical antipsychotics.Objectives : To assess the risk of tardive dyskinesia among patients with schizophrenia and related disorders undergoing treatment with olanzapine or conventional antipsychotics.Method : This was an open-label , pragmatic , controlled randomized trial that was conducted in three psychiatric hospitals in Brazil .\n",
            "Patients were admitted with a DSM-IV diagnosis of schizophrenia or related disorders with a BPRS score &gt; @ , and were randomly assigned to either olanzapine or conventional antipsychotic treatment .\n",
            "After hospital discharge , patients were evaluated using the Positive and Negative Syndrome Scale ( PANSS ) , Clinical Global Impressions Scale ( CGI ) , and Abnormal Involuntary Movement Scale ( AIMS ) , and were then observed for nine months in a naturalistic setting.Results : The sample comprised @ patients , with a completion rate of @ % for olanzapine-treated patients and @ % for patients treated with conventional antipsychotics ( p = .@ ) .\n",
            "The mean differences on the PANSS were in favor of olanzapine .\n",
            "The risk of presenting tardive dyskinesia among patients treated with conventional antipsychotics was @ times higher than that among olanzapine-treated patients ( RR = @ ; @ % CI : @-@ , p &lt; .@ ) .\n",
            "Conclusions : The results of this open-label , pragmatic , controlled randomized trial showed that olanzapine had a favorable impact on negative symptoms , decreased general psychopathology , and reduced the risk of tardive dyskinesia )\n",
            "The importance of therapeutic alliance in predicting treatment outcomes is well established , but less is known about client characteristics that predict alliance .\n",
            "Clients with co-occurring psychosis and substance misuse ( n = @ ) who received integrated motivational interviewing and cognitive behavior therapy in the context of a large randomized controlled trial completed the Working Alliance Inventory .\n",
            "Their trial therapists also completed Working Alliance Inventories .\n",
            "Rating perspectives were compared , and in a cross-sectional study , client predictors of therapeutic alliance were examined .\n",
            "As hypothesized , clients ' negative attitudes to treatment , including lack of insight , were predictive of poorer alliance .\n",
            "Therapist-rated alliance was also predicted by the client 's attitude to medication , self-reported depression , and living situation .\n",
            "Symptom severity and substance use measures were unrelated to alliance .\n",
            "Consistent with previous studies , rating perspectives differed , with clients rating alliance more positive than therapists .\n",
            "copyright @ Lippincott Williams & Wilkins , Inc .\n",
            "Background : Cognitive deficits are commonly noted in patients with schizophrenia .\n",
            "Patients receiving atypical antipsychotics including risperidone have shown improved cognition and independent role functioning .\n",
            "This report examines correlations between cognition and functioning in patients treated with long-acting risperidone .\n",
            "Methods : Data are from a prospective randomized double-blind international @-week study of stable patients with schizophrenia or schizoaffective disorder receiving long-acting injectable risperidone @ or @ mg every @ weeks Patients completed a computer-administered cognitive battery at multiple time points .\n",
            "Correlation analyses were performed to assess relationships between the neurocognitive composite score NCS and @ cognitive domains processing speed attention and impulsivity working memory declarative memory visual memory executive function and social cognition with Positive and Negative Syndrome Scale PANSS total PANSS factors Personal and Social Performance scale PSP and Strauss-Carpenter Level of Functioning LOF scores .\n",
            "Results : Improvements from baseline were seen in the NCS and @ cognitive domains processing speed attention and impulsivity declarative memory visual memory executive function and social cognition at endpoint .\n",
            "Significant but weak correlations were observed at endpoint between improvements in @ cognitive domains processing speed attention working memory declarative memory and social cognition and PSP LOF and PANSS total scores each P @ ; @ ) .\n",
            "Significant , but weak correlations were also observed between the same @ cognitive domains and the disorganized-thoughts factor and PANSS negative-symptom factor each P @ , and @ ) , although not for other PANSS subscales anxiety depression PANSS positive and uncontrolled hostility factors .\n",
            "Discussion : Cognitive functioning improved significantly in multiple domains in clinically stable patients receiving maintenance treatment with long-acting risperidone .\n",
            "These improvements correlate weakly with improvements in patient functioning and symptoms .\n",
            "Data suggest that changes in cognitive function may not be strongly correlated with clinical improvement in stable patients or that a temporal relationship undetected here exists between these variables .\n",
            "Source of Funding Janssen LP .\n",
            "Purpose : Psychotic agitation characterized by psychotic symptoms , anxiety , hostility , and uncontrolled or violent behavior is often manifested by patients with psychiatric diseases .\n",
            "It is needed to relieve psychotic agitation rapidly for the patients in emergency room or inpatient ward .\n",
            "Haloperidol is frequently used for psychotic agitation due to a potency of rapid tranquilization and relatively low risk of side effects .\n",
            "However , parenteral or intramuscular administration of haloperidol has a risk of accidental needle stick injury associated with infection .\n",
            "As risperidone orodispersible tablet is quickly absorbed in an oral cavity of a patient within a few seconds , it could be used for the patients with psychotic agitation .\n",
            "In this study , comparison of the efficacy and safety of oral risperidone and intramuscular haloperidol was performed in emergency treatment of psychotic agitation by prospective , randomized , and rater-blinded way .\n",
            "Methods : One hundred and forty four patients with psychotic agitation were recruited at emergency room or inpatient ward at Catholic University of Korea , Kangnam St. Mary 's hospital , Seoul , South Korea .\n",
            "They were diagnosed as schizophrenia or schizoaffective disorder , bipolar I disorder with or without psychotic features , delusional disorders , or psychotic disorder , NOS by DSM-IV .\n",
            "All the patients enrolled in this study were provided written informed consent before taking medication and randomly assigned to either group of risperidone orodispersible tablet or intramuscular haloperidol .\n",
            "Efficacy of both treatments were measured and compared by the scores of @ - item acute-agitation cluster and total scores from the Positive and Negative Syndrome Scale ( PANSS ) and Clinical Global Impressions-Severity of Illness scale ( CGI-S ) .\n",
            "Extrapyramidal side effect was assessed by Abnormal Involuntary Movement Scale ( AIMS ) and Simpson-Angus Scale ( SAS ) .\n",
            "Any adverse effects occurred after medication was recorded .\n",
            "Sedation was assessed by means of a @-point scale .\n",
            "All scales were performed before taking medication and after @ minutes and @ , @ , @ , and @ hours after receiving the initial dose of study medication .\n",
            "The data was analyzed on an intent-to-treat ( ITT ) basis with the lastobservationcarried - forward ( LOCF ) for the endpoint .\n",
            "The PANSS , YMRS and CGI-S scores were analyzed by repeated measures of analysis of variance ( ANOVA ) in terms of the within-subject factors and the between-subject factors over the study periods .\n",
            "An interaction effect was also considered between time and the treatment group .\n",
            "SAS and AIMS scores were analyzed using the same ANOVA model in PANSS .\n",
            "Descriptive statistics and chi-square test were performed for the group difference in the frequencies of side effects .\n",
            "Odds ratio ( OD ) and @ % confidence interval ( CI ) were presented where appropriate .\n",
            "P < @ ( two-tailed ) was considered statistically significant .\n",
            "Statistical analyses were performed using the SPSS @ for Windows program .\n",
            "Results : There were no differences in gender , age , diagnoses , severity of symptoms before taking medication between two groups .\n",
            "The @-item acute-agitation cluster from PANSS and CGI-S scores were significantly decreased over time in both treatment groups without any significant group difference and time by the group interaction effect ( F = @ , P < @ ) .\n",
            "Tolerability and safety by SAS and AIMS were not different between two groups .\n",
            "There were no serious adverse events in both groups .\n",
            "Conclusion : For the emergency treatment of psychotic agitation , risperidone orodispersible tablet was as effective and tolerable as intramuscular administration of haloperidol .\n",
            "Therefore , it is considerable to choose oral medication instead of intramuscular injection for treatment of patients with acute psychotic agitation .\n",
            "Smooth pursuit eye movement ( SPEM ) gain , total saccades , and subtypes of saccades were quantified from the visual pursuit tracking of @ fluphenazine-treated patients with schizophrenia and @ normal controls .\n",
            "Tracking was repeated in @ patients who underwent a placebo - controlled , double-blind crossover comparison of fluphenazine and clozapine .\n",
            "Fluphenazine-treated patients showed significant reduction in SPEM gain and significant increases in both total , intrusive , and anticipatory saccades and in saccadic amplitude , when compared to controls .\n",
            "Clozapine significantly reduced SPEM gain and significantly increased total and catch-up saccades , when compared to placebo or fluphenazine .\n",
            "High amplitude of intrusive saccades in drug-free patients predicted poor response to clozapine , suggesting that intact frontal cortical function may enable optimal clozapine response .\n",
            "INTRODUCTION : Growing evidence suggests that pallidal deep brain stimulation represents a potential new therapeutic avenue in tardive dystonia/dyskinesia , but controlled and blinded randomized studies ( RCT ) are missing .\n",
            "The present RCT compares dystonia/dyskinesia severity of pallidal neurostimulation in patients with tardive dystonia using a delayed-start design paradigm .\n",
            "METHODS : Dystonia/dyskinesia severity was assessed via blinded videos following pallidal neurostimulation at @ ( blinded phase ) and @ months ( open extension phase ) .\n",
            "Primary endpoint was the percentage change of dystonia severity ( Burke-Fahn-Marsden-Dystonia-Rating-Scale , BFMDRS ) at @ months between active vs. sham neurostimulation using blinded-video assessment .\n",
            "Secondary endpoints comprised clinical rating scores for movement disorders .\n",
            "Clinicaltrials.gov NCT@ .\n",
            "RESULTS : Twenty-five patients were randomized ( @:@ ) to active ( n = @ ) or sham neurostimulation ( n = @ ) .\n",
            "In the intention-to-treat analyses the between group difference of dystonia severity ( BFMDRS ) between active vs. sham stimulation was not significant at @ months .\n",
            "Three months post-randomisation dystonia severity improved significantly within the neurostimulation by @ % and non-significantly within the sham group ( @ % ) compared to their respective baseline severity .\n",
            "During the open-label extension with both groups being actively treated , significant and pronounced improvements of @ % were observed via blinded evaluation .\n",
            "Adverse events ( n = @ ) occurred in @/@ of patients during the @ months , mostly related to surgical implantation of the device ; all resolved without sequelae .\n",
            "CONCLUSION : The primary endpoint of this randomized trial was not significant , most likely due to incomplete recruitment .\n",
            "However , pronounced improvements of most secondary endpoints at @ and @ months provide evidence for efficacy and safety of pallidal neurostimulation in tardive dystonia .\n",
            "For the purpose of on-set time analysis of administering Haloperidol and Sultopride to mania and schizophrenia , I used clinical data of double blind test in many hospitals .\n",
            "Statistical analysis was chiefly applied by chi-squares test per week during @ weeks , Mantel-Haenszel test on @ stratification , cumulative life table analysis , Kaplan-Meier type , adaptation to distribution of exponential and Weibull equations , linear and non - linear regression analysis ( proportional hazard model ) .\n",
            "According to results of analyses , the combination group between mania and Sultopride was specially suitable to each another , so patients belonged to it healed faster than other groups that were included SCHIZO.-Halop , SCHIZO .\n",
            "- Sulto , and mania-Halop .\n",
            "groups .\n",
            "These were statistically significant less than @ % in @ stratification of chi-squares , Mantel-Haenszel test , Z-test in cumulative life table and Kaplan-Meier 's .\n",
            "By the way of proportional hazard model , the relationship among final global improvement rate ( FGIR ) , on-set time , D & A ( continuation of drug administration or stop ) , were proved importantly .\n",
            "Monitored changes in regional cerebral blood flow ( CBF ) and behavioral and physiological indices after administration of d - amphetamine sulfate or placebo in @ patients with schizophrenia and @ normal controls .\n",
            "Measures included the Brief Psychiatric Rating Scale and the Profile of Mood States .\n",
            "Amphetamine administration was associated with decreased anxiety , emotional withdrawal , depressed mood , blunted affect , and increased excitement in patients .\n",
            "Ss who received amphetamine showed significant increases in systolic and diastolic blood pressure and reduction in end-tidal carbon dioxide .\n",
            "Post-amphetamine CBF was decreased equally in both patients and controls ; however , the CBF change did not show any regional variations .\n",
            "Background : ECT , though not favoured in the West for treating schizophrenia , is regularly practiced in India for this indication , particularly in poorly responding/treatment resistant cases .\n",
            "Therefore , its role in treatment-resistant schizophrenia is a subject of systematic investigation .\n",
            "Aim : To compare the effectiveness and safety of Electroconvulsive therapy ( ECT ) in a group of treatment-resistant schizophrenia patients with a control group .\n",
            "Method : Eligible and consenting patients were randomly allocated to the ECT or Sham ECT groups .\n",
            "Both received antipsychotic drugs .\n",
            "Twenty-five patients completed the study ( ECT , n = @ ; Sham ECT , n = @ ) .\n",
            "The study was conducted in a double-blind manner .\n",
            "Clinical change was assessed weekly with BPRS , CGI and adverse event measures .\n",
            "ANOVA for repeated measures and other post-hoc comparisons were used for data analysis .\n",
            "Results : ECT treated patients improved significantly over successive weeks ( p < @ ) after @ ECTs , whereas the group receiving sham-ECT did not .\n",
            "In both the groups , however , CGI scores did not change significantly , suggesting a dissociated response pattern .\n",
            "ECT was associated with greater relief among carers and lower re-hospitalization .\n",
            "Conclusion : ECT augmentation may well have a significant impact on the clinical course of patients with treatment resistance schizophrenia .\n",
            "It is unclear , but possible , that these changes may be reinforced and maintained by maintenance ECTs .\n",
            "Replication of the present investigation and further studies on maintenance ECT would be rewarding .\n",
            "Sixty-three chronic schizophrenic in-patients were included in the double-blind , double-dummy clinical trial comparing antipsychotic activity and side effects of cis ( Z ) - clopenthixol and haloperidol .\n",
            "Test treatment was administered at least @ and in most cases @ weeks with clinical evaluations including BPRS , NOSIE-@ , CGI and single side effects done at weeks @ , @ , @ , @ , and @ .\n",
            "The average end-of-trial doses were @ mg cis ( Z ) - clopenthixol and @ mg haloperidol .\n",
            "Statistically significant improvements of total BPRS-score and Thinking disturbance were registered with both drugs from week @ onwards .\n",
            "At week @ when @ patients were receiving test treatment total BPRS-score was reduced by @ % in the cis ( Z ) - clopenthixol group and by @ % in the haloperidol group .\n",
            "At week @ Thinking disturbance was reduced by @ % in the cis ( Z ) - clopenthixol group and by @ % in the haloperidol group -- these findings constituted the only significant difference between test drugs .\n",
            "Compared to the BPRS-results less improvements and no differences between test drugs were registered with NOSIE-@ and CGI .\n",
            "Any trends towards different frequency and severity of side effects were in the favour of cis ( Z ) - clopenthixol .\n",
            "Health Condition ( s ) or Problem ( s ) studied Schizophrenia Schizophrenia Intervention ( s ) Intervention @ : Both of group get antipsychotic Risperidone@-@ mg/day ( Dr Abidi pharma ) and placebo group received a similar placebo tablet daily .\n",
            ".\n",
            ".\n",
            "Intervention @ : Both of group get antipsychotic Risperidone@-@ mg/day and intervention group were received bupropion @-@mg / day ( Dr Abidi pharma ) .\n",
            ".\n",
            "Primary Outcome ( s ) Executive functions .\n",
            "Timepoint : in begging of study , @nd , @th , @th , @th of study .\n",
            "Method of measurement : ( WCST ) Wisconsin Card Sorting Test Memory .\n",
            "Timepoint : in begging of study , @nd , @th , @th , @th of study .\n",
            "Method of measurement : ( WMS ) Wechsler Memory Scale Memory .\n",
            "Timepoint : in begging of study , @nd , @th , @th , @th of study .\n",
            "Method of measurement : Digit Span Positive and Negative Symptoms Scale .\n",
            "Timepoint : beginning of study , @th and @th day of study .\n",
            "Method of measurement : Positive and Negative Symptoms Scale ( PANSS ) Psychotic and anti-psychotic symptoms assessment .\n",
            "Timepoint : beginning of study , @th and @th day of study .\n",
            "Method of measurement : Brief psychiatric rating scale ( BPRS ) Selective attention and cognitive flexibility .\n",
            "Timepoint : in begging of study , @nd , @th , @th , @th of study .\n",
            "Method of measurement : Stroop test\n",
            "OBJECTIVE : Given the high prevalence of obesity and diabetes in patients with serious mental illness ( SMI ) and the lack of evidence on the effects of weight loss programs in SMI patients with diabetes , we evaluated the effectiveness of a behavioral weight loss intervention among SMI participants with and without diabetes .\n",
            "RESEARCH DESIGN AND METHODS : Using data from ACHIEVE , a randomized controlled trial to evaluate the effects of a behavioral weight loss intervention among overweight/obese people with SMI , we assessed and compared weight change from baseline to @ months in participants with and without diabetes using a longitudinal mixed-effects model .\n",
            "RESULTS : Of the @ trial participants , @ ( @ % ) participants had diabetes ( @ and @ in intervention and control groups , respectively ) at baseline .\n",
            "Participants with diabetes were more likely to be taking antipsychotics ( @ % vs. @ % , P = @ ) .\n",
            "At @ months , participants in the control group with diabetes lost @ lb ( @ % ) of body weight compared with @ lb ( @ % ) among those without diabetes .\n",
            "In the intervention group , participants with diabetes lost @ lb ( @ % ) of their initial body weight compared with @ lb ( @ % ) for those without diabetes .\n",
            "Corresponding net effects ( intervention minus control ) were @ lb ( @ % ) and @ lb ( @ % ) net weight reduction over @ months in the no diabetes and the diabetes subgroups , respectively .\n",
            "However , the between-group difference in intervention effects was statistically nonsignificant ( absolute weight change : P-interaction = @ ; % weight change : P-interaction = @ ) .\n",
            "CONCLUSIONS : A behavioral weight loss intervention is effective among overweight and obese individuals with SMI regardless of their diabetes status .\n",
            "Objective : To evaluate the efficacy and safety of ziprasidone in the treatment of schizophrenia : @ patients with schizophrenia were randomly divided ziprasidone group and risperidone group , n = @ cases .\n",
            "Were given ziprasidone and risperidone for @ weeks .\n",
            "The positive and negative syndrome scale ( panss ) , the Clinical Global Impression ( cgi ) and treatment emergent symptom scale ( tess ) assessed the efficacy and adverse reactions .\n",
            "Results : the end of the treatment , the two groups panss total score and factor divided than before treatment to significantly reduce ( p < @ ) ; no significant difference between the two groups ( p > @ ) ; ziprasidone group clinical total efficiency of @ % , @ % risperidone group ; two groups the incidence of adverse reactions similar ( p > @ ) .\n",
            "BACKGROUND : Recently , long-acting injection ( LAI ) of second-generation antipsychotics has become a valuable strategy for the treatment of schizophrenia .\n",
            "However , few studies have compared the effects of different LAI antipsychotics on cognitive functions so far .\n",
            "The present study aimed to compare the influence of risperidone LAIs ( RLAI ) and paliperidone palmitate LAIs ( PP ) on cognitive function in outpatients with schizophrenia .\n",
            "METHODS : In this @-month , open-label , randomized , and controlled study , @ patients with schizophrenia who were treated with RLAIs were randomly allocated to the RLAI-continued group or the PP group .\n",
            "At baseline and @ months , the patients were evaluated using the Brief Assessment of Cognition in Schizophrenia ( BACS ) that was the primary outcome of the study .\n",
            "The Subjective Well-being under Neuroleptic drug treatment-Short form ( SWNS ) , the Positive and Negative Syndrome Scale ( PANSS ) , and the Drug-Induced Extrapyramidal Symptoms Scale ( DIEPSS ) scores were secondary outcome variables and they were tested at the same time points .\n",
            "RESULTS : The two groups did not differ in terms of PANSS , DIEPSS , or SWNS total score changes .\n",
            "However , the BACS score for the attention and processing speed item showed higher improvement in the PP group than the RLAI group ( p = @ ) .\n",
            "CONCLUSIONS : The results of this preliminary study suggest that PPs may improve attention and processing speed more than RLAIs .\n",
            "Anyway , a replication in a larger and double-blind study is needed .\n",
            "TRIAL REGISTRATION : UMIN@ .\n",
            "Registered @ July @ .\n",
            "Background : Cognitive Adaptation Training ( CAT ) has been shown to im prove functional outcome in schizophrenia outpatients living in the United States .\n",
            "The effectiveness of CAT for patients living outside the US as well as for long-term hospitalized patients remains to be determined .\n",
            "In addition , it has not yet been studied whether CAT can be successful if patients receive the treatment from psychiatric nurses .\n",
            "The aim of this pilot study was to investigate the effectiveness and feasibility of CAT as a nursing intervention for schizophrenia patients living in the Netherlands .\n",
            "Methods : Thirty schizophrenia patients ( long-term hospitalized patients : @ % ) participated in this study .\n",
            "Sixteen patients received treatment as usual ( TAU ) plus CAT , fourteen patients only received TAU .\n",
            "Patients in CAT participated in the treatment for eight months , consisting of weekly home-visits by a psychiatric nurse , supervised by a psychologist .\n",
            "After eight months , CAT interventions were integrated in the usual treatment .\n",
            "Outcome measures were the Multnomah Community Ability Scale ( MCAS ) the Social and Occupational Functioning Scale ( SOFAS ) , and the Negative Symptom Assessment-Motivation subscale ( NSA-M ) .\n",
            "For the inpatients participation in work-related activities was also tracked , for a duration of @ months .\n",
            "Results : Patients receiving CAT had better scores on the MCAS ( trend ) as compared to TAU patients .\n",
            "Moreover , inpatients ' work-related activities increased in CAT , relative to TAU inpatients , reaching significance after ten months .\n",
            "Improvements on the SOFAS and NSA-M were not significant .\n",
            "Discussion : These results indicate that CAT as a nursing intervention may improve outcomes in patients with schizophrenia living in the Netherlands including long-term hospitalized patients .\n",
            "Larger , randomized controlled studies are needed to investigate the long-term effects of CAT as a nursing intervention systematically .\n",
            "OBJECTIVE : This paper evaluates the effects of an educational intervention about tardive dyskinesia on knowledge and clinical stability at long-term follow up .\n",
            "METHOD : Fifty-six patients receiving antipsychotic maintenance completed a questionnaire assessing their knowledge about tardive dyskinesia .\n",
            "After RANDOM allocation to either educational intervention or control group , their knowledge , clinical stability and rates of tardive dyskinesia were reassessed after four years .\n",
            "RESULTS : Seventy per cent of patients completed the study .\n",
            "The patients in the educational group retained significantly more knowledge at follow up than at baseline but this knowledge was not significantly greater than that of the control group .\n",
            "There were no significant differences in the clinical outcomes between the groups .\n",
            "CONCLUSION : Patients can retain a small but significant amount of information with a low risk of noncompliance .\n",
            "Discussion about tardive dyskinesia is necessary in the process of obtaining informed consent to treatment .\n",
            "CAS Registry/EC Number @ ( Antipsychotic Agents )\n",
            "Educational objective - At the conclusion of this session , the participant should be able to recognize acute agitation in a schizophrenic population and understand a potential new treatment method for that condition .\n",
            "SUMMARY : This Phase @ randomized , double-blind , placebo-controlled clinical study assessed the efficacy and safety of inhaled loxapine in treating acute agitation in schizophrenic patients.Loxapine was administered via inhalation using the Staccato  system , which delivers thermally-generated drug aerosol to the deep lung for rapid systemic absorption with IV-like kinetics .\n",
            "Consenting male and female adults , @ to @ years of age , who met DSMIV criteria for schizophrenia , schizophreniform disorder , or schizoaffective disorder , presenting with a relevant degree of agitation at baseline , were enrolled in the study and randomly assigned to treatment .\n",
            "A total of @ patients received a single inhalation of either @ mg , @ mg , or @ mg of loxapine in an in-patient treatment facility.The primary efficacy endpoint was the absolute change in Positive and Negative Syndrome Scale Excited Component ( PEC ) score from baseline to @ hours following treatment .\n",
            "The primary endpoint following @ mg Staccato Loxapine vs. placebo was statistically significant beginning at @ min and continuing for the entire @ hour assessment period .\n",
            "Clinical Global Impression-Improvement ( CGI-I ) at @ hours post-dose and responder analysis for CGI I were statistically significant for both the @ mg and @ mg doses vs. placebo .\n",
            "Differences in change from baseline BARS score , as well as the time to first rescue medication , for the @ mg dose vs placebo were statistically significant .\n",
            "In conclusion , inhaled loxapine produced rapid and significant improvement in agitated schizophrenic patients in clinical settings .\n",
            "Statistically significant effects were observed as early as @ minutes and continued through @ hours post treatment with the higher dose .\n",
            "Superiority of the @ mg dose on some but not all measures is consistent with a dose response effect .\n",
            "Staccato loxapine may provide a rapid , simple , less intrusive alternative for agitated patients.This research was funded by Alexza Pharmaceuticals .\n",
            "BACKGROUND : People with serious mental illness have high rates of obesity and related medical problems , and die years prematurely , most commonly from cardiovascular disease .\n",
            "Specialized , in-person weight management interventions result in weight loss in efficacy trials with highly motivated patients .\n",
            "In usual care , patient enrollment and retention are low with these interventions , and effectiveness has been inconsistent .\n",
            "OBJECTIVE : To determine whether computerized provision of weight management with peer coaching is feasible to deliver , is acceptable to patients , and is more effective than in-person delivery or usual care .\n",
            "DESIGN : Mixed-methods randomized controlled trial .\n",
            "PARTICIPANTS : Two hundred seventy-six overweight patients with serious mental illness receiving care at a Veterans Administration medical center .\n",
            "INTERVENTIONS : Patients were randomized to @ ) computerized weight management with peer coaching ( WebMOVE ) , @ ) in-person clinician-led weight services , or @ ) usual care .\n",
            "Both active interventions offered the same educational content .\n",
            "MAIN MEASURES : Body mass index ; and feasibility and acceptability of the intervention .\n",
            "KEY RESULTS : At @ months , in obese patients ( n = @ ) , there was a significant condition by visit effect ( F = @ , p = @ ) .\n",
            "The WebMOVE group had an average estimated BMI change from baseline to @ months of @ + / - @ to @ + / - @ .\n",
            "This corresponds to @ kg ( @ lbs ) weight loss ( t = @ , p = @ ) .\n",
            "No significant change in BMI was seen with either in-person services ( t = @ , p = @ ) , or usual care ( t = -@ , p = @ ) .\n",
            "The average percentage of modules completed in the WebMOVE group was @ % and in the in-person group was @ % ( t = @ , p = @ ) .\n",
            "When non-obese patients were included in the analyses , there was a trend towards a condition by visit effect ( F = @ , p = @ ) .\n",
            "WebMOVE was well received , while the acceptability of in-person services was mixed .\n",
            "CONCLUSIONS : Computerized weight management with peer support results in lower weight , and can have greater effectiveness than clinician-led in-person services .\n",
            "This intervention is well received , and could be feasible to disseminate .\n",
            "Obesity , a major problem worldwide , is more prevalent among people with schizophrenia .\n",
            "This study examined the effect of behavior intervention , nutritional information and physical exercise on the body mass index ( BMI ) and weight of people who were hospitalized with persistent DSM-IV schizophrenia and schizoaffective disorders .\n",
            "Fifty nine inpatients with a BMI greater than @ participated , ( @ intervention group ; @ control group ) .\n",
            "Significant reductions in BMI and weight were observed in the intervention group after @ months and were maintained @-year post study [ F ( @ ) = @ , p = .@ ) and F ( @ ) = @ , P = .@ , respectively ] .\n",
            "If provided with adequate information and an appropriate framework , people with persistent schizophrenia can significantly reduce BMI and weight and maintain the loss .\n",
            "Background : A signifcant proportion of people with schizophrenia are characterized by impaired ability to socially engage with others , which may refect social aversion secondary to defeatist beliefs ; decreased motivation for social interactions ; and/or impairment in the normal reinforcement value of social interactions .\n",
            "Unfortunately , pharmacological interventions have limited benefts for impaired social function , whereas psychosocial interventions provide only partial beneft for this critical aspect of the ill-ness .\n",
            "The development of an effective intervention for functional outcomes remains a central therapeutic challenge .\n",
            "The current study assessed whether the addition of intranasal oxytocin to Cognitive Behavioral Social Skills Training ( CBSST ) improved social function .\n",
            "Methods : Participants with DSM-IV-TR schizophrenia or schizoaffective disorder entered a @-week , double-blind , placebo-controlled , randomized clinical trial with a @-month follow-up evaluation .\n",
            "The study was conducted at two sites : Maryland and California .\n",
            "Participants were randomized to either : intranasal oxytocin @ I.U. ( @ sprays ) BID ( n = @ ) or intranasal placebo-oxytocin @ sprays BID ( n = @ ) .\n",
            "All participants received CBSST , which was delivered in four @-session modules ( cognitive , social , and prob-lem-solving CBSST modules plus a module adapted from Social Cognition and Interaction Training ) .\n",
            "The modules were delivered twice in biweekly @-hour sessions , for a total of @ sessions over @ weeks .\n",
            "Birchwood Social Functioning Scale ( SFS ) was used to assess social function ; the Defeatist Performance Attitude Scale ( DPAS ) was used to assess defeatist beliefs ; the Asocial Beliefs Scale ( ABS ) was used to assess social disinterest and aversion ; and the Scale for the Assessment of Negative Symptoms ( SANS ) total score was used to assess negative symptoms .\n",
            "Results : In the intent-to-treat analyses , there were no signifcant group dif-ferences in the SFS total score ( Treatment x Week interaction : F = @ ; df = @ , @ ; P = .@ ) or ABS total score ( Treatment x Week interaction : F = .@ ; df = @ , @ ; P = .@ ) .\n",
            "There was a trend for a signifcant reduction in defeatist beliefs among the participants randomized to oxytocin ( Treatment x Week interaction : F = @ ; df = @ , @ ; P = .@ ) .\n",
            "There were no signifcant group differences in SANS total score ( Treatment x Week interaction : F = @ ; df = @ , @ ; P = @ ) , though the interpretation of the effect of oxytocin on SANS total score was complicated by the presence of a signifcant site effect : there was a signifcant placebo effect at the California site , which was markedly greater in magnitude than the observed oxytocin effect for these symptoms .\n",
            "Conclusion : The results of the intent-to-treat analyses provide minimal support for the utility of add-on intranasal oxytocin to CBSST for improvement in social function .\n",
            "Oxytocin was associated with trend improvement in defeatist attitudes and greater reduction in negative symptoms at one of the two study sites .\n",
            "( clinicaltrials.gov , trial number : NCT@ ) .\n",
            "Ninety seven outpatients with schizophrenia spectrum disorders ( SSDs ) were randomly assigned to the Walk , Address Sensations , Learn About Exercise , Cue Exercise Behavior for SSDs ( WALC-S ) , a motivational intervention designed to increase exercise in SSDs ( n = @ ) , or a time and attention control group ( TAC , n = @ ) .\n",
            "WALC-S and TAC groups met weekly for @ weeks before a @ week walking program was offered to all subjects .\n",
            "We compared the exercise attendance , persistence and compliance of the groups during the walking program .\n",
            "WALC-S recipients attended more walking groups , for more weeks and walked more minutes than those receiving TAC .\n",
            "Percent of WALC-S or TAC groups attended was significantly correlated with overall attendance ( r = @ , P = @ ) and persistence ( r =   .@ , P = @ ) , as well as number of minutes walked .\n",
            "This study is among the first to examine interventions designed to enhance exercise motivation in SSDs .\n",
            "Understanding the biological processes that underlie why patients relapse is an issue of fundamental importance to the detection and prevention of relapse in schizophrenia .\n",
            "Brain Derived Neurotrophic Factor ( BDNF ) , a facilitator of brain plasticity , is reduced in patients with schizophrenia .\n",
            "In the present study , we examined whether decreases in plasma BDNF levels could be used as a biological predictor of relapse in schizophrenia .\n",
            "A total of @ patients were prospectively evaluated for relapse over @ months in the Preventing Relapse in Schizophrenia : Oral Antipsychotics Compared to Injectables : eValuating Efficacy ( PROACTIVE ) study .\n",
            "Serial blood samples were collected at a maximum of @ time points during the @-month trial and BDNF levels were measured in plasma samples by ELISA .\n",
            "Receiver Operating Characteristic ( ROC ) curve analysis indicated that BDNF was not a significant predictor of relapse , hospitalization or exacerbation .\n",
            "Regardless of treatment group ( oral second generation antipsychotic vs. long-acting injectable risperidone microspheres ) , baseline BDNF value did not differ significantly between those who experienced any of the adverse outcomes and those who did not .\n",
            "While contrary to the study hypothesis , these robust results offer little support for the use of plasma BDNF alone as a biomarker to predict relapse in schizophrenia .\n",
            "Background : TREC-SAVE is the third of the TREC studies in Brazil .\n",
            "The first two evaluated commonly used drug treatments for management of people with psychosis who have become acutely aggressive .\n",
            "TREC-SAVE address issues of seclusion or restraint of this same group .\n",
            "It is the first randomised trial addressing this question .\n",
            "Methods : This pragmatic trial was designed after close consultation with all involved .\n",
            "Participants were anyone aggressive or violent in the emergency wards of a large psychiatric hospital in Rio de Janeiro ( Psychiatric Institute Philippe Pinel ) for whom some kind of restriction was indicated by nursing and medical staff , and for whom staff were unsure whether seclusion or restraint would be best .\n",
            "People were randomised to use of four-point restraint ( strong cotton banding to edge of bed ) or use of a minimally furnished seclusion room with open but barred windows onto the nursing station .\n",
            "All participants used medication as prescribed .\n",
            "Protocol and analysis plan was published and main outcomes chosen by clinicians and managers , the local ethics committee approved the study .\n",
            "Data were analysed by intention-to-treat .\n",
            "Trial registration : ISRCTN@ Results : Recruitment started in July @ and ended Jan @ .\n",
            "@ participants were included ( restraints = @ ; seclusion = @ ) with similar demographic and clinical data across groups .\n",
            "People allocated to the least restrictive option ( seclusion room ) were at greater risk of needing an early change of their treatment to restraints compared with those allocated to restraints ( RR @ @ % CI @-@ ) .\n",
            "However , even taking into account the move out of seclusion into restraints , this study provides evidence that this care pathway does not increase overall time in restriction of some sort ( RR Not restricted - by @ hours @ CI @-@ ) .\n",
            "Participants tended to be less satisfied with their care in the restraints group ( @ % vs @ % ) but this did not reach conventional levels of statistical significance .\n",
            "Discussion : This study suggests that opting for the least restrictive option in circumstances where there is clinical doubt does not harm or prolong coercion .\n",
            "This is one small trial of short duration but its outcomes and circumstances of conduct apply to very great numbers of people who are at risk of maltreatment .\n",
            "These most coercive parts of heath care have been under-researched and researchers have not employed randomized trials .\n",
            "For the first time , a randomised pragmatic clinical trial was undertaken to illustrate how objective evaluation of these techniques can , humanely and ethically , be applicable worldwide .\n",
            "Two pharmacolkinetic parameters viz. the minimum serum concentration in the dosage interval and the sera under the serum concentration curve have been correlated to @ parameters for clinical outcome , viz. total points and factor points from the three rating scales , BPRS , CPRS , and side effects scale , in a double blind clinical trial of clopenthixol and flupenthixol depot preparations in outpatient schizophrenics .\n",
            "No statistically significant correlations were observed .\n",
            "It is of some interest , however , that the results suggest that the treatment of individual patients with neuroleptics may be adjusted by means of repeated ratings , residual percentage , changes in psychopathology , and determinations of serum concentrations .\n",
            "Our results do not indicate any optimal concentration range for these depot neuroleptics in the maintenance phase of schizophrenia .\n",
            "The so-called therapeutic window as to neuroleptics obviously varies with regard to the phase of the disease as well as the patients ' social situation .\n",
            "Introduction : This is a post hoc analysis of data from a previously performed RCT which administered add-on aspirin or placebo to patients with schizophrenia receiving anti-psychotics .\n",
            "We hypothesized that patients with high levels of CRP , perhaps reflecting high levels of inflammation , would have a better response to aspirin compared to patients with lower levels of CRP .\n",
            "Methods : The original study was a multi-center , N = @ trial was designed with one placebo arm to be employed as a comparator for @ active arms .\n",
            "Inclusion criteria were @ ( moderate ) or above on CGI-S and @ ( moderate ) score on two of the following four PANSS items : delusions , hallucinatory behaviors , conceptual disorganization or suspiciousness/persecution , and/or a total PANSS negative symptoms score above @ .\n",
            "Before entering the trial and throughout the trial all subjects received anti-psychotics at doses within PORT recommendations .\n",
            "Upon entering the trial they were randomized to aspirin @ mg/d + pantoprazole @ mg/d , minocycline @ mg/d , pramipexole @ mg , or placebo .\n",
            "Duration of the study was @ weeks .\n",
            "Primary outcome measure was changes in total PANSS scores , secondary outcome measures included PANSS subscales .\n",
            "Results : Mean age of patients was @ , @ % were females , mean duration of illness was @ years , mean PANSS total score at baseline was @ .\n",
            "The ANOVA for overall change for all comparison of @ drugs and placebo for the primary outcome of the total PANSS scores was significant , p = @ .\n",
            "Individual comparisons between each drug and placebo showed trends for significance ( Effect size , ES = @ , p = @ ) for aspirin , and were nonsignificant for minocycline ( ES = @ , p = @ ) and for pramipexole ( ES = @ , p = @ ) .\n",
            "For positive symptoms the overall ANOVA was not significant , p = @ .\n",
            "Individual comparisons between each drug and placebo showed a trend for significance for aspirin ( ES = @ , p = @ ) , and were non-significant for minocycline ( ES = @ , p = @ ) and pramipexole ( ES = @ , p = @ ) .\n",
            "The sample was then divided into thirds according to CRP level at baseline .\n",
            "Patients with high ( CRP > @ ng/ml ) were significantly more likely to have improvements in their mean PANSS positive scores ( ES = @ , p = @ ) , whereas patients with intermediate CRP scores @ < CRP < @ ng/ml , ES = @ , p = @ ) or low CRP scores ( CRP < @ ng/ml , ES = -@ , p = @ ) did not .\n",
            "These results were not observed on the effects of aspirin on negative symptoms , general psychopathology or total PANSS , nor were they observed in the patients receiving minocycline or pramipexole .\n",
            "Discussion : The results of this post-hoc analysis might cautiously be interpreted as indicating that a subgroup of patients with relatively high levels of CRP , a non-specific marker of inflammation , have significant improvements in positive symptoms upon inhibition of COX-@ or COX-@ , or other biological effects , both inflammatory and non-inflammatory of aspirin .\n",
            "The effect of aspirin on this small subgroup of responders might be the reason that previous studies found a small , consistently replicated over-all effect of aspirin in schizophrenia which was too small to be of clinical significance .\n",
            "This issue should be further tested by @ ) performing similar post-hoc analyses on previous RCTs which administered aspirin or other anti-inflammatory agents in schizophrenia .\n",
            "Future studies might screen patients for CRP and randomize those with high CRP levels to add-on treatment with aspirin or placebo .\n",
            "Schizophrenia is associated with extensive neurocognitive and behavioral impairments .\n",
            "Studies indicate that N-acetylaspartate ( NAA ) , a marker of neuronal integrity , and choline , a marker of cell membrane turnover and white matter integrity , may be altered in schizophrenia .\n",
            "Davunetide is a neurotrophic peptide that can enhance cognitive function in animal models of neurodegeneration .\n",
            "Davunetide has recently demonstrated modest functional improvement in a study of people with schizophrenia .\n",
            "In a subset of these subjects , proton magnetic resonance spectroscopy ( ( @ ) H-MRS ) was conducted to explore the effects of davunetide on change in NAA/creatine ( NAA/Cr ) and choline/creatine ( choline/Cr ) over @ weeks of treatment .\n",
            "Of @ outpatients with schizophrenia who received randomized davunetide ( @ and @ mg/day ) or placebo in the parent clinical trial , @ successfully completed ( @ ) H-MRS in dorsolateral prefrontal cortex ( DLPFC ) at baseline and at @ weeks .\n",
            "Cognition was assessed using the MATRICS Consensus Cognitive Battery ( MCCB ) .\n",
            "NAA/Cr was unchanged for combined high - and low-dose davunetide groups ( N = @ ) .\n",
            "NAA/Cr in the high-dose davunetide group ( N = @ ) suggested a trend increase of @ % ( P = @ ) over placebo ( N = @ ) .\n",
            "Choline/Cr for combined high - and low-dose davunetide groups suggested a @ % increase ( P = @ ) , while the high-dose group showed a @ % increase ( P = @ ) over placebo .\n",
            "Baseline NAA/Cr correlated with the composite MCCB score ( R = @ , P = @ ) , as did individual cognitive domains of attention/vigilance , verbal learning , and social cognition ; however , neither metabolite correlated with functional capacity .\n",
            "In this exploratory study , @ weeks of adjunctive davunetide appeared to produce modest increases in NAA/Cr and choline/Cr in DLPFC in people with schizophrenia .\n",
            "This is consistent with a potential neuroprotective mechanism for davunetide .\n",
            "The data also support use of MRS as a useful biomarker of baseline cognitive function in schizophrenia .\n",
            "Future clinical and preclinical studies are needed to fully define the mechanism of action and cognitive effects of davunetide in schizophrenia .\n",
            "Siblings of individuals with first episode psychosis ( FEP ) are both a vulnerable group to develop mental ill health due to the negative impact caused by the psychosis within the family , as well as being the most effective and natural agents to promote service users   recovery .\n",
            "This study aims to develop and evaluate an online multi-component psychoeducational intervention for this commonly overlooked group of resources and family members .\n",
            "The intervention aims to enhance siblings   knowledge about psychosis and their coping capacity , thus reducing their vulnerability to mental ill health as well as improving their contribution to the service users   recovery .\n",
            "The intervention content and delivery formats will be designed as informed by evidence in the literature as well as the siblings   inputs through consultations and an expert advisory group .\n",
            "Mixed methods incorporated within the MRC phased research design for complex interventions will be used to develop and undertake a preliminary evaluation of the intervention .\n",
            "Qualitative data collection methods such as focus groups and semi-structured individual interviews with siblings will be employed in conjunction with a factorial design randomised trial with several outcome measures to test the effectiveness , feasibility and acceptability of the newly developed intervention with the target population .\n",
            "Cognitive therapy has shown to be an effective adjunctive treatment in symptoms of established psychosis .\n",
            "The aim of the study was to evaluate its effectiveness in the absence of drug treatment in help seeking individuals operationally defined as being of ultra high risk of developing psychosis .\n",
            "In a multicentre randomised control trial , @ individuals seeking help for apparently prodromal symptoms were assessed .\n",
            "Sixty three were found to meet criteria ofYung et al. ( @ ) of attenuated symptoms ; brief limited symptoms ; or genetic high risk plus functional decline .\n",
            "Sixty eligible subjects agreed to randomisa - tion to one of two conditions .\n",
            "Both conditions included standardised monitoring of mental state at monthly follow-up intervals .\n",
            "In addi .\n",
            "tion , the experimental group received a course of standardised , man .\n",
            "ualised cognitive therapy aimed at alleviating current symptoms and reducing risk of transition to psychosis .\n",
            "Two subjects were exclud .\n",
            "ed because they proved to be already psychotic at baseline , leaving @ subjects .\n",
            "Interim data analysis showed that by @ month follow-up @ individuals had made an operationally defined transition to a schiz - ophrenia spectrum psychosis according to PANSS and DSM@ .\n",
            "Of these , @ were in the monitoring control group and @ in the cognitive therapy group .\n",
            "Overall transition rate at @ month in this sample proved to be @ % .\n",
            "These preliminary data suggest that cognitive ther - apy may be an effective intervention for preventing or postponing onset of psychosis in ultra high risk , help seeking individuals .\n",
            "EFFECTIVENESS OF THE INTEGRATED\n",
            "We challenged five patients suffering from tardive akathisia ( TA ) with intravenous benztropine ( @ mg ) , propranolol ( @ mg ) and placebo ( saline ) using a random , double-blind cross-over design to examine the effects of the drugs on the subjective , objective and global manifestations of neuroleptic-induced akathisia .\n",
            "Benztropine produced a marginally significant , and propranolol a significant improvement in the overall manifestations of the disorder .\n",
            "The patients demonstrated a considerable placebo effect and marked variation in their responses to the drugs .\n",
            "The implications of these findings for the pathophysiology of TA in relation to acute akathisia and tardive dyskinesia are discussed .\n",
            "Background : Relative benefits of long-acting injectable atypical antipsychotic compared with oral antipsychotics ( OA s ) remain a subject of debate .\n",
            "This exploratory analysis of the Paliperidone palmitate Research In Demonstrating Effectiveness ( PRIDE ; NCT@ ) study compared treatment outcomes following once-monthly paliperidone palmitate ( PP ) or @ of @ atypical OA s ( of @ OA s allowed ) .\n",
            "Methods : PRIDE was a @-month prospective , randomized , open-label , event-monitoring board-blinded study .\n",
            "@ subjects with schizophrenia were randomly assigned to PP or to @ of @ commonly prescribed OA s. Primary endpoint was time to first treatment failure ( TF ) , defined as arrest/incarceration , psychiatric hospitalization , suicide , discontinuation due to inadequate efficacy or safety/tolerability , treatment supplementation due to inadequate efficacy , or increase in psychiatric services to prevent psychiatric hospitalization .\n",
            "Kaplan-Meier analysis estimated event-free probabilities .\n",
            "This exploratory analysis reported randomization-based individual comparisons of PP vs olanzapine ( n = @ , n = @ ) , aripiprazole ( n = @ , n = @ ) , and quetiapine ( n = @ , n = @ ) as well as PP vs oral risperidone ( n = @ , n = @ ) , and paliperidone ( n = @ , n = @ ) ( different delivery of same or similar molecule ) .\n",
            "Results : Incidences of extrapyramidal symptom-related adverse events ( AEs ) were @ % , @ % , @ % , @ % , @ % , and @ % for olanzapine , aripiprazole , quetiapine , risperidone , paliperidone , and PP , respectively .\n",
            "Incidences of prolactin-related AEs were @ % , @ % , @ % , @ % , @ % , and @ % , respectively .\n",
            "Incidences of > @ % weight increase were @ % , @ % , @ % , @ % , @ % , and @ % , respectively .\n",
            "Compared with PP , risk for first TF was @ % higher with atypical OA s ( HR : @ ; @ % CI : @-@ ) .\n",
            "Compared with PP , risk for first TF was @ % , @ % , and @ % higher with olanzapine , aripiprazole , and quetiapine , respectively , and @ % and @ % higher with risperidone and paliperidone ( Table ) .\n",
            "Mean ( SD ) daily dose of prescribed atypical OA s and monthly PP dose are shown in the Table .\n",
            "Conclusion : These exploratory analyses suggest a lower risk of TF following treatment with PP compared to treatment with atypical OA s. Additional studies are needed to confirm the findings .\n",
            "BACKGROUND : We hypothesised that a combined regimen of clozapine , a relatively weak D@-dopaminergic antagonist , and sulpiride , a selective D@ blocker , would demonstrate a greater antipsychotic efficacy by enhancing the D@ blockade of clozapine .\n",
            "METHOD : Twenty-eight people with schizophrenia , previously unresponsive to typical antipsychotics and only partially responsive to current treatment with clozapine , received , double-blind , @ mg/day sulpiride or placebo , in addition to an ongoing clozapine treatment .\n",
            "The clinical status was evaluated before , during , and at the end of @ weeks of sulpiride addition using the Brief Psychiatric Rating Scale ( BPRS ) , Scale for the Assessment of Positive Symptoms ( SAPS ) , Scale for the Assessment of Negative Symptoms , and Hamilton Rating Scale for Depression .\n",
            "RESULTS : The clozapine - sulpiride group exhibited substantially greater and significant improvements in positive and negative psychotic symptoms .\n",
            "About half of them , characterised by a younger age and lower baseline SAPS scores , had a mean reduction of @ and @ % in their BPRS and SAPS scores , respectively .\n",
            "CONCLUSIONS : A subgroup of patients with chronic schizophrenia may substantially benefit from sulpiride addition to clozapine .\n",
            "Background : Various problems are associated with schizophrenia which may theoretically lead to impaired educability about treatment .\n",
            "Method : The Understanding of Medication Questionnaire , designed to measure knowledge about treatment in schizophrenia , is described and presented .\n",
            "An educational programme based on a specially designed information booklet was developed .\n",
            "Sixty-four patients with DSM-III-R diagnosis schizophrenia were randomly allocated to groups receiving none ( control ) , one session or three sessions of education .\n",
            "Results : Pre - intervention low levels of knowledge about illness and treatment increased significantly immediately after a standard education session .\n",
            "Three education sessions led to significantly greater knowledge gain than one session .\n",
            "There was no significant change in the control group .\n",
            "Only the PANSS negative syndrome score independently and consistently explained a significant proportion of the education effect .\n",
            "The influence on educability of attitudes to education , impaired insight , cognitive impairment and other variables were considered .\n",
            "Three sessions of education led to significantly increased insight , but no change in compliance .\n",
            "Conclusions : Techniques appropriate for educating schizophrenic patients were discussed , and the value of involving patients in education emphasized .\n",
            "A series of patient education sessions is needed to consolidate learning , rather than a single informing process .\n",
            "The strong association between impaired learning and more severe negative schizophrenic syndrome emphasizes the need for responsible prescribing of antipsychotic treatment in schizophrenia .\n",
            "Background : The @-item Positive and Negative Syndrome Scale ( PANSS-@ ) is frequently used in research , but considered too time consuming for clinical use .\n",
            "We recently demonstrated that a six-item version of PANSS ( PANSS-@ : P@ = Delusions , P@ = Conceptual disorganization , P@ = Hallucinations , N@ = Blunted Affect , N@ = Social withdrawal , N@ = Lack of spontaneity/flow of conversation ) may be a more practical alternative to PANSS-@ .\n",
            "The aim of the present study was to test the validity and sensitivity of PANSS-@ further via a reanalysis of data from the Clinical Antipsychotic Trials of Intervention Effectiveness ( CATIE ) study .\n",
            "Methods : First , we tested the scalability of PANSS-@ and PANSS-@ .\n",
            "Scalability is present when each symptom item in a rating scale provides unique information regarding syndrome severity .\n",
            "Subsequently , we tested the level of correlation between the total scores of PANSS-@ and PANSS-@ in order to determine whether PANSS-@ conveys similar information as PANSS-@ .\n",
            "Finally , to test whether PANSS-@ was equally sensitive as PANSS-@ in detecting differences in antipsychotic efficacy , we compared the effect of the five antipsychotics studied in CATIE , using the total scores of PANSS-@ and PANSS-@ as outcomes .\n",
            "Results : For the @ subjects contributing data to the scalability analyses ( those with complete PANSS ratings at baseline , month @ , month @ , and month @ ) , PANSS-@ was scalable , whereas this was not the case for PANSS-@ .\n",
            "In the @ subjects in the intention to treat ( ITT ) sample , the total scores on PANSS-@ and PANSS-@ were highly correlated ( Spearman coefficient = @ based on @ ratings ) .\n",
            "In the ITT sample , PANSS-@ and PANSS-@ identified the same statistically significant differences in antipsychotic efficacy , namely that olanzapine was superior to risperidone ( PANSS-@ P-value = @ & PANSS-@ P-value = @ ) and ziprasidone ( PANSS-@ p-value = @ & PANSS-@ P-value = @ ) .\n",
            "Conclusions : PANSS-@ is a brief and scalable , clinicianbased rating scale for schizophrenia that adequately measures symptom severity and antipsychotic efficacy .\n",
            "Research should test acceptability of PANSS-@ for routine , measurement-based care .\n",
            "Objective : To compare the clinical and economic outcomes associated with olanzapine and risperidone treatment for schizophrenia .\n",
            "Design and setting : An international , multicentre , double-blind , prospective study .\n",
            "To facilitate economic comparisons , our sample was restricted to patients enrolled in US sites .\n",
            "@ patients with a Diagnostic and Statistical Manual of mental disorders , @th edition ( DSM-IV ) diagnosis of schizophrenia , schizoaffective disorder or schizophreniform disorder were randomised to therapy with either olanzapine @ to @ mg/day ( n = @ ) or risperidone @ to @ mg/day ( n = @ ) for a maximum of @ weeks .\n",
            "In addition to tolerability and efficacy assessments , use of health services was assessed at baseline and prospectively , at @-week intervals and at study completion .\n",
            "Clinically important response , defined as a @ % improvement in the Positive and Negative Syndrome Scale total score , maintenance of response and rates of treatment-emergent extrapyramidal symptoms were compared between groups .\n",
            "Direct medical costs were estimated by assigning standardised prices to resource units .\n",
            "Median total , inpatient/outpatient service and medication acquisition costs were compared between treatment groups .\n",
            "Main outcome measures and results : The mean modal dosages for the olanzapine and risperidone treatment groups were @  @ mg/day and @  @ mg/day , respectively .\n",
            "Olanzapine-treated patients were more likely to maintain response compared with risperidone-treated patients ( p = @ ) .\n",
            "In addition , a smaller proportion of olanzapine-treated patients required anticholinergic therapy compared with risperidone-treated patients ( @ vs @ % ; p = @ ) .\n",
            "Total per patient medical costs over the study interval were $ US@ ( @ values ) [ @ % ] lower in the olanzapine treatment group than in the risperidone treatment group ( p = @ ) .\n",
            "Medication costs were significantly higher for olanzapine-treated patients ( $ US@ vs $ US@ ; p < @ ) , but this difference was offset by a reduction of $ US@ ( @ % ) in inpatient/outpatient service costs for olanzapine-treated patients in comparison with risperidone-treated patients ( $ US@ vs $ US@ , p = @ ) .\n",
            "Median cost findings were consistent with results observed using other robust measures of central tendency and provide conservative estimates of potential savings that may be obtained from olanzapine therapy .\n",
            "Conclusions : In this study , olanzapine-treated patients experienced clinical improvements that translated into savings in costs of care for both inpatient and outpatient services .\n",
            "These savings offset the difference in medication acquisition cost between olanzapine and risperidone .\n",
            "We studied @ patients with paranoid schizophrenia with resistance to neuroleptics .\n",
            "All patients were divided into two groups - basic ( @ patients ) and comparison ( @ patients ) .\n",
            "Both groups received traditional treatment .\n",
            "Patients of the basic group were treated with the combination of reamberin and cycloferon .\n",
            "Before treatment , significant alterations in the interferon status ( IFS ) , which were characterized by the decrease of serum interferon ( SIFN ) activity and blood alpha - and gamma-interferons ( IFN ) levels , were identified in both group .\n",
            "The positive effect of the drug combination on clinical symptoms and interferon status ( the normalization of SIFN activity , increase in blood alpha - and gamma-IFN levels ) was found .\n",
            "BACKGROUND : Neurocognitive impairments experienced by individuals at ultra-high risk ( UHR ) for psychosis are potential predictors of outcome within this population , however there is inconsistency regarding the specific neurocognitive domains implicated .\n",
            "This study aimed to examine whether baseline neurocognition predicted transition to psychosis , or functional outcomes , at medium-term ( mean = @ years ) follow-up , while controlling for other clinical/treatment variables associated with transition to psychosis .\n",
            "METHOD : Analysis of data collected as part of a multi-centre RCT of omega-@ fatty acids and cognitive-behavioural case management ( NEURAPRO ) for UHR individuals was conducted on the @ participants ( @ males , @ females ) who completed neurocognitive assessment ( Brief Assessment of Cognition for Schizophrenia ) at baseline .\n",
            "Transition to psychosis was determined using the Comprehensive Assessment of At-Risk Mental States ( CAARMS ) , and functioning was measured with the Global Functioning : Social and Role Scales .\n",
            "RESULTS : Mean baseline z-scores indicated that UHR participants performed a quarter to half a standard deviation below normative means in all domains ( range mean z = -@ to -@ ) , except for executive functioning ( mean z = @ ) .\n",
            "After adjusting for covariates , poorer Executive ( p = .@ ) and Motor ( p = .@ ) functions were predictive of transition to psychosis .\n",
            "Processing Speed and Verbal Fluency were significant predictors of role functioning at @ months ( p = .@ ) , and social functioning at medium-term follow-up ( p = .@ ) , respectively .\n",
            "CONCLUSIONS : Neurocognitive abilities are independent predictors of both transition to psychosis and functional outcomes within the UHR population .\n",
            "Further research is needed to determine the best combination of risk variables in UHR individuals for prediction of psychosis transition , functioning and other psychopathology outcomes .\n",
            "OBJECTIVE : To test effectiveness of the Early Detection , Intervention , and Prevention of Psychosis Program in preventing the onset of severe psychosis and improving functioning in a national sample of at-risk youth .\n",
            "METHODS : In a risk-based allocation study design , @ youth ( age @-@ ) at risk of psychosis were assigned to treatment groups based on severity of positive symptoms .\n",
            "Those at clinically higher risk ( CHR ) or having an early first episode of psychosis ( EFEP ) were assigned to receive Family-aided Assertive Community Treatment ( FACT ) ; those at clinically lower risk ( CLR ) were assigned to receive community care .\n",
            "Between-groups differences on outcome variables were adjusted statistically according to regression-discontinuity procedures and evaluated using the Global Test Procedure that combined all symptom and functional measures .\n",
            "RESULTS : A total of @ young people ( mean age : @ ) were assigned to the treatment group ( CHR + EFEP , n = @ ) or comparison group ( CLR , n = @ ) .\n",
            "On the primary variable , positive symptoms , after @ years FACT , were superior to community care ( @ df , p < .@ ) for both CHR ( p = .@ ) and EFEP ( p < .@ ) subgroups .\n",
            "Rates of conversion ( @ % CHR vs @ % CLR ) and first negative event ( @ % CHR vs @ % CLR ) were low but did not differ .\n",
            "FACT was superior in the Global Test ( p = .@ ; p = .@ for CHR and p = .@ for EFEP , vs CLR ) and in improvement in participation in work and school ( p = .@ ) .\n",
            "CONCLUSION : FACT is effective in improving positive , negative , disorganized and general symptoms , Global Assessment of Functioning , work and school participation and global outcome in youth at risk for , or experiencing very early , psychosis .\n",
            "Many patients with obsessive compulsive disorder ( OCD ) , depression , as well as patients with schizophrenia go untreated .\n",
            "This is due to a lack of accessible treatment options and the reluctance of patients to engage in face-to-face treatment .\n",
            "Even though cognitive behavioral therapy with stimulus exposure and response prevention is the most effective psychotherapeutic treatment for OCD only a small number of patients actually receive psychotherapy and many therapists trained in cognitive behavioral therapy do not practice evidence-based techniques .\n",
            "A quarter of individuals with OCD fail to initiate cognitive behavioral therapy and another @ % who initiate treatment drop out prematurely , stating fear of engaging in cognitive behavioral therapy as one of the main reasons .\n",
            "The situation is similar for patients with schizophrenia or depression .\n",
            "Even though cognitive behavioral therapy serves as a standard treatment for schizophrenia it is rarely applied , and patients with depression often experience a relapse .\n",
            "Thus alternative and accessible interventions are needed for patients with obsessive compulsive disorder , schizophrenia and depression .\n",
            "This study investigated the effectiveness of mindfulness-based training in comparison to progressive muscle relaxation , delivered as a bibliotherapeutic self-help approach .\n",
            "Background .\n",
            "The ACE project involved @ participants with a first episode of psychosis randomly assigned to either a cognitive behaviour therapy ( CBT ) intervention known as Active Cognitive Therapy for Early Psychosis ( ACE ) or a control condition known as Befriending .\n",
            "The study hypotheses were that : ( @ ) treating participants with ACE in the acute phase would lead to faster reductions in positive and negative symptoms and more rapid improvement in functioning than Befriending ; ( @ ) these improvements in symptoms and functioning would be sustained at a @-year follow-up ; and ( @ ) ACE would lead to fewer hospitalizations than Befriending as assessed at the @-year follow-up .\n",
            "Method .\n",
            "Two therapists treated the participants across both conditions .\n",
            "Participants could not receive any more than @ sessions within @ weeks .\n",
            "Participants were assessed by independent raters on four primary outcome measures of symptoms and functioning : at pretreatment , the middle of treatment , the end of treatment and at @-year follow-up .\n",
            "An independent pair of raters assessed treatment integrity .\n",
            "Results .\n",
            "Both groups improved significantly over time .\n",
            "ACE significantly outperformed Befriending by improving functioning at mid-treatment , but it did not improve positive or negative symptoms .\n",
            "Past the mid-treatment assessment , Befriending caught up with the ACE group and there were no significant differences in any outcome measure and in hospital admissions at follow-up .\n",
            "Conclusions .\n",
            "There is some preliminary evidence that ACE promotes better early recovery in functioning and this finding needs to be replicated in other independent research centres with larger samples .\n",
            "The manpower and operating cost of home-based treatment was compared with the manpower and operating cost of hospital-based treatment during the second year and at the end of two years of treatment .\n",
            "Of the @ patients destined to receive inpatient treatment , @ were randomly assigned to home treatment , @ to hospital treatment .\n",
            "The two groups were similar as to important social , demographic , and clinical characteristics , including psychiatric diagnosis .\n",
            "The manpower and operating cost of treatment , measured in two ways , was similar in the two groups during the second year .\n",
            "However , over the @-year period hospital-based treatment of patients in each of the three diagnostic groups was more expensive than home-based treatment .\n",
            "Also , regardless of which treatment was given , the cost of treating schizophrenics was higher than the cost of treating manic-depressives which , in turn , was higher than the cost of treating individuals with depressive neurosis .\n",
            "Treatment failures were discussed .\n",
            "Over the @ - year period , failures in home-based treatment accounted for @ % of the total manpower and operating cost of home-based treatment , calculated according to Cost Model @ , and for @ % of the cost calculated according to Cost Model @ .\n",
            "The concept of failure in hospital-based treatment is also discussed .\n",
            "@ neuroleptic-treated outpatients ( aged @-@ yrs ) , @ with schizophrenia ( SCZ ) and @ with schizoaffective disorder in clinical remission , received @ infusions , one with methylphenidate and the other with normal saline , under double-blind conditions .\n",
            "@ Ss were withdrawn from neuroleptics and given a @nd set of infusions .\n",
            "Ss were rated as being psychotic symptom activators to the infusion or as showing no change in psychotic symptoms .\n",
            "Overall response by mood category was as follows : @ % euphoric , @ % neutral , @ % mixed and @ % dysphoric .\n",
            "Mood responses were not correlated with sex , methylphenidate plasma levels , or diagnostic distinctions between SCZ and schizoaffective disorder .\n",
            "Dysphoric and mixed mood responses were associated with high rates of psychotic activation .\n",
            "Ss on neuroleptics had more euphoric responses than did the same Ss off neuroleptics .\n",
            "Objectives : Comparisons of diabetic potential , glucose related metabolic levels , and insulin resistance between olanzapine and risperidone have produced variable results in cross-sectional and epidemiological studies .\n",
            "Randomized prospective studies of metabolic effects during treatment with these drugs may provide results that are more informative .\n",
            "We present a randomized controlled study of glucose and insulin dynamics of schizophrenics treated with olanzapine or risperidone .\n",
            "Methods : Hospitalized patients with chronic schizophrenia , most of whom had been treated with multiple antipsychotics in the past , were randomly assigned to treatment with a single antipsychotic , olanzapine or risperidone , for a period of @ months .\n",
            "Glucose , insulin , weight and related metabolic parameters were assessed monthly over a @ month periods and a glucose toelrance test was perfomed on @ occassions during this study .\n",
            "Results : There were no overall drug treatment differences in fasting glucose or glycohemoglobin or @ hr glucose levels in OGTT , and no differences between the two drug groups at the @ month time point There were no consistent drug treatment differences in the number of patients who developed borderline or diabetic glucose levels .\n",
            "Olanzapine treated patients showed a significantly greater increase than risperidone treated patients in a fasting measure of insulin resistance ( P = .@ ) , and olanzapine patients showed greater decreases in insulin sensitivity during OGTT ( P = .@ ) compared to risperidone treated patients .\n",
            "Olanzapine treated patients had a significantly greater increase in @ hour glucose and insulin levels during OGTT in subsequent months compared to baseline , and greater increase in glucose and insulin area under the curve over time than the risperidone treated patients .\n",
            "Conclusions : The increase in insulin levels during olanzapine treatment may compensate for the increase in insulin resistance , and serve to reduce fasting and postprandial glucose levels .\n",
            "This may contribute to the lack of differences between olanzapine and risperidone in indices of diabetic or pre-diabetic glucose levels or glycohemoglobin .\n",
            "How many years this compensatory mechanism will persist needs further investigation .\n",
            "Objective : To explore and risperidone oral treatment of schizophrenia patient compliance .\n",
            "Methods : @ cases of CCMD-@ diagnostic criteria for schizophrenia patients were randomly divided into two groups , were given risperidone oral solution ( B group ) and aripiprazole ( A group ) for @ weeks , Condensed psychiatric symptoms scale ( BPRS ) to assess the clinical assessment of side effects , side effects scale ( TESS ) .\n",
            "The two groups were compared medication compliance .\n",
            "Results : After @ weeks of treatment , the differences in the two groups is not significant , the B group of drugs is fully compliant @ % , significantly higher than @ % of the group A. Non-compliance from @ % , significantly lower than @ % of the group A. Risperidone adverse extrapyramidal mainly aripiprazole by lethargy , but it is easy to ease .\n",
            "[ Objective ] To explore the positive role of home health services in the prevention of recurrence of schizophrenia .\n",
            "[ Methods ] @ patients with schizophrenia were randomly divided into two home visits and control groups of the @ cases , home visits to patients discharged after a period of one year home health services , the control group received conventional maintenance therapy , does not accept other interventions .\n",
            "Discharge and after discharge end of the year , with positive and negative syndrome scale ( panss ) and Social Disability Screening Scale ( sdss ) to assess the patient 's condition and changes in social function to determine whether recurrence , side effects scale ( tess ) assessment of adverse reactions .\n",
            "[ Results ] The home visits to patients after discharge the year @ panss and sdss rated lower than the control group , the recurrence rate and readmission rate is also lower than that of the control group , the difference was statistically significant , tess assessed no significant differences between the @ groups .\n",
            "[ Conclusion ] home health services conducive to stable condition and social function of schizophrenia recovery and reduce recurrence .\n",
            "The study aims to answer two principle questions : Can DUP ( Duration of untreated psychosis ) be reduced by a primary care training programme in early recognition of psychosis and adherence to guidelines ?\n",
            "Does a reduction in DUP lead to a reduction in time to recovery ?\n",
            "Patient questionnaires ; interviews with families and carers ; observation @ new patients , between @ and @ years old will be recruited into the study over a @ year period .\n",
            "The delay in recognition of psychosis and referral to early intervention services can be improved by training GPs to better recognise and act on early symptoms .\n",
            "BACKGROUND : Many studies have indicated that excess free radical formation may be involved in the pathogenesis of patients with SCHIZOphrenia .\n",
            "Some investigators suggested that the use of free radical scavengers might provide improvement in SCHIZOphrenia .\n",
            "The aim of this study was to determine the effectiveness and to evaluate the side effects of extract of Ginkgo biloba ( EGb ) plus haloperidol in chronic , treatment-resistant inpatients with SCHIZOphrenia .\n",
            "METHOD : One hundred nine patients meeting DSM-III-R criteria for SCHIZOphrenia completed a double-BLIND , placebo-controlled , parallel-group study of EGb plus haloperidol .\n",
            "Fifty-six of the patients were RANDOMly assigned to receive a fixed dose of @ mg/day of EGb plus a stable dose of haloperidol , @ mg/kg/day , and @ were assigned to receive placebo plus the same dose of haloperidol for @ weeks .\n",
            "Patients were assessed using the Brief Psychiatric Rating Scale ( BPRS ) , the Scale for the Assessment of Negative Symptoms ( SANS ) , and the Scale for the Assessment of Positive Symptoms ( SAPS ) at baseline , week @ , and week @ and the Treatment Emergent Symptom Scale ( TESS ) for side effects at week @ .\n",
            "RESULTS : There was a significant reduction in both groups in BPRS total score after @ weeks of treatment ( p < .@ ) .\n",
            "However , a significant reduction in total SAPS and SANS scores was noted in the EGb group ( p < .@ ) , but not in the placebo group .\n",
            "There was a lower SAPS total score in the EGb group than in the placebo group at the end of @ weeks of treatment ( p < .@ ) .\n",
            "Of those treated with EGb plus haloperidol , @ % were rated as responders as compared with only @ % of those receiving placebo plus haloperidol when assessed by the SAPS ( chi@ = @ .\n",
            "@ , p = .@ ) .\n",
            "After @ weeks of treatment , TESS subscore @ ( behavioral toxicity ) and subscore @ ( symptoms of nerve system ) were significantly decreased in the EGb group compared with the placebo group ( p < .@ ) .\n",
            "CONCLUSION : EGb treatment may enhance the effectiveness of antipsychotic drugs and reduce their extrapyramidal side effects\n",
            "Objective To explore the impact of the Ginkgo biloba extract on the immune function of schizophrenia .\n",
            "Methods A double-blind , control method , application of Ginkgo biloba extract @ mg / day ( trade name Shu Xue Ning ) combined with fixed doses of haloperidol in the treatment of @ patients with chronic schizophrenia @ weeks before and after treatment to detect T cells subsets and leukocyte interleukin @ ( IL-@ ) secreting cells .\n",
            "Results Before treatment , patients with immune function is low , a significant reduction of CD@ + , CD@ + cells and CD@/CD@ and IL-@ secreting cells .\n",
            "After treatment , the haloperidol group of CD@ + cells was significantly increased , ginkgo biloba extract combined haloperidol treatment group CD@ + cells of CD@ + cells , CD@/CD@ and IL-@ secreting cells were significantly increased .\n",
            "Objectives : Psychotic agitation of psychiatric patients is a common manifestation that needs emergent management .\n",
            "Traditionally , parenteral or intramuscular injection of anti-psychotics was conducted for treatment of psychotic agitation .\n",
            "Considering that the rapidly absorbed form of risperidone ( risperidone orodispersible tablet ) could be used for the agitated patient , comparison of oral risperidone and intramuscular haloperidol was performed in emergency treatment of psychotic agitation in this study .\n",
            "Methods : @ patients with psychotic agitation were recruited at the emergency room or inpatient ward .\n",
            "They were randomly assigned to either the group of oral risperidone or intramuscular haloperidol .\n",
            "Efficacy of both treatments was measured and compared using the @-item acute agitation cluster from the Positive and Negative Syndrome Scale-Excited Component ( PANSS-EC ) and the Clinical Global Impression-Severity of Illness Scale ( CGI-S ) .\n",
            "Tolerability and safety were also compared between the two groups .\n",
            "Results : The PANSS-EC and CGI-S scores were significantly decreased over time in both treatment groups without any significant group difference and time by group interaction effect ( F = @ , p < @ ) .\n",
            "There were no serious adverse events in both groups .\n",
            "Conclusion : For the emergency treatment of psychotic agitation , risperidone orodispersible tablet was as effective and tolerable as intramuscular administration of haloperidol .\n",
            "Therefore , we might choose oral medication instead of intramuscular injection for treatment of patients with acute psychotic agitation .\n",
            "Copyright ( C ) @ S. Karger AG , Basel\n",
            "Background : To determine if IV droperidol or olanzapine , as adjuncts to midazolam administration , improve sedation quality for the acutely agitated ED patient Methods : We undertook a randomised , double-blind , placebo-controlled , double-dummy , clinical trial in three EDs ( August @ to March @ ) .\n",
            "Adult patients requiring IV drug sedation for acute agitation were enrolled .\n",
            "Each was randomized to receive an IV bolus of either saline ( control ) , droperidol ( @ mg ) or olanzapine ( @ mg ) .\n",
            "This bolus was immediately followed by an IV midazolam bolus ( @-@mg ) then additional boluses until sedation to a pre-determined endpoint was achieved .\n",
            "The primary outcome was time to sedation .\n",
            "Secondary outcomes were the need for \" rescue \" sedation and adverse events .\n",
            "Results : @ patients were enrolled .\n",
            "The baseline characteristics of the groups did not differ ( p > @ ) .\n",
            "However , the median ( IQR ) times to sedation ( min ) differed significantly ( p < @ ) : control group @ ( @-@ ) , droperidol @ ( @-@ ) , olanzapine @ ( @-@ ) .\n",
            "At any time point , patients in the droperidol and olanzapine groups were @ times more likely to be sedated compared to controls : droperidol and olanzapine group hazard ratios ( @ % CI ) were @ ( @-@ ) and @ ( @-@ ) , respectively , ( p = @ ) .\n",
            "The droperidol and olanzapine groups required less rescue sedation and alternative drug use at any time after initial sedation had been achieved ( p < @ ) .\n",
            "The group adverse event profiles and lengths of stay did not differ ( p = @ and @ , respectively ) .\n",
            "Discussion : Droperidol or olanzapine administration , as adjuncts to midazolam , is safe and significantly improves sedation quality .\n",
            "These findings will inform best-practice for sedation of the acutely agitated ED patient .\n",
            "Support and educational packages to relatives have been shown to have benefits in terms of patient compliance and fewer admissions .\n",
            "They may however have failed to maximise these and other benefits by neglecting factors concerning ethnicity .\n",
            "In inner city areas with a diverse mix of people from ethnic minority backgrounds and cultures it is important that support to relatives takes into account the specific needs of these families .\n",
            "Results from our own research show that those patients without family support are at greater risk of poor outcomes .\n",
            "We aim to provide a support package to relatives at the earliest point after first presentation to psychiatric services and thereby to minimise the erosion of family support that generally follows severe mental illness .\n",
            "This intervention is substantially different from other interventions in that it targets all patients with a first episode of psychotic illness and not just patients with schizophrenia or only those admitted to hospital .\n",
            "Cost-benefit-analysis , Interviews , Questionnaires , Randomized-controlled-trial\n",
            "Background : RP@ is a novel dopamine-serotonin system stabilizer with an optimum balance of potent partial agonist activity at the dopamine D@ , D@ , D@ , serotonin @-HT@A and @-HT@A receptors , and antagonist activity at the serotonin @-HT@ and @-HT@ receptors .\n",
            "Positive initial PK , safety and efficacy in stable outpatient schizophrenia patients has already been presented .\n",
            "Methods : REFRESH , the Phase @ study was a global randomized placebocontrolled inpatient trial .\n",
            "RP@ ( @ mg , @ mg and @ mg ) was administered to subjects with an acute exacerbation of schizophrenia or schizoaffective disorder and efficacy was measured by change from baseline to week @ on the Positive and Negative Syndrome Scale ( PANSS ) .\n",
            "A total of @ patients randomized to one of the three doses of RP@ ( @ mg/day or @ mg/day or @ mg/day ) , placebo , or aripiprazole ( @ mg/day ) in a ratio of @:@:@:@ : @ .\n",
            "Safety was assessed by blood labs , centralized ECG , EPS scales and standard AE reporting throughout the study .\n",
            "Results : RP@ showed remission level superior efficacy across all three doses ( @ , @ , and @ mg ) tested when compared to aripiprazole ( @ mg ) , an assay sensitivity comparator or placebo .\n",
            "RP@ was well tolerated at all three dose levels and no clinically relevant adverse effects , tolerability or safety issues were reported .\n",
            "RP@ showed highly predictable and linear pharmacokinetic profile , with a PK-PD profile showing no demographic or ethnic contributing factors .\n",
            "Furthermore , depression and cognition also showed trends toward improvement despite being a small and short study .\n",
            "All the three dose groups of RP@ were safe and well tolerated by the study subjects .\n",
            "Body weight , cardiac assessments , metabolic factors and EPS measurements were not different from placebo .\n",
            "Serum prolactin levels significantly decreased in RP@ groups and returned higher levels upon restarting patients former antipsychotics .\n",
            "Discussion : RP@ showed robust efficacy and safety in the Phase @ trial , Phase @ trials are now under development at various global clinical trial sites including India .\n",
            "With a unique receptor balanced profile and efficacy across psychotic , anxiety-depressive and cognitive domains of schizophrenia/schizoaffective disorder , this novel agent may offer significant therapeutic improvement over current treatments .\n",
            "\" The primary aim of the present study was to assess the possible associations between dopaminergic , serotonergic , and glutamatergic system-related genes and adverse events after antipsychotic treatment in paranoid schizophrenia patients .\n",
            "The second aim of the study was to compare the intensity of these symptoms between atypical ( ziprasidone and olanzapine ) and typical ( perazine ) antipsychotic drugs .\n",
            "One-hundred and ninety-one Polish patients suffering from paranoid schizophrenia were genotyped for polymorphisms of DRD@ , DAT@ , COMT , MAOA , SERT , @HT@A , and GRIK@ .\n",
            "The patients were randomized to treatment with perazine , olanzapine or ziprasidone monotherapy for @ months .\n",
            "The intensity of side effects ( changes in body weights and extrapyramidal symptoms ( EPS ) ) was measured at baseline and after @ weeks of antipsychotic treatment .\n",
            "After @ months of therapy , the weight increase was the greatest in the group treated with olanzapine and the least in the group treated with ziprasidone .\n",
            "None of the examined gene polymorphisms was associated with the body weight changes .\n",
            "Perazine treatment was associated with the significantly highest intensity of EPS .\n",
            "None of the examined polymorphisms was associated with the changes in extrapyramidal adverse events after antipsychotic treatment .\n",
            "The selected polymorphisms are not primarily involved in changes in body weights and EPS related to antipsychotic treatment in paranoid schizophrenia patients . \"\n",
            "This randomized , open-label study in patients with psychotic disorder compared the tolerability and safety of three fixed doses of IM ziprasidone with flexible-dose , IM haloperidol .\n",
            "Patients received either IM ziprasidone @ mg/day ( n = @ ) , @ mg/day ( n = @ ) or @ mg/day ( n = @ ) , all given qid , or IM haloperidol @-@ mg/day ( n = @ ) , given bid-qid ( mostly bid ) , for @ days .\n",
            "After IM treatment , patients received @ days ' oral treatment with randomized therapy ( ziprasidone @-@ mg/day , haloperidol initial dose equal to last IM dose ) .\n",
            "Discontinuation due to adverse events was rare .\n",
            "Almost all adverse events were of mild or moderate severity .\n",
            "Tachycardia and postural hypotension were very infrequently associated with ziprasidone .\n",
            "Notable was the lower incidence of EPS , dystonia and akathisia associated with IM ziprasidone compared with IM haloperidol .\n",
            "The proportion of patients taking benztropine during the study was lower than baseline in the ziprasidone groups but higher in the haloperidol group .\n",
            "Benztropine use was at least two-fold greater with haloperidol than with any ziprasidone dose , both during the IM period and at any time during the study .\n",
            "Ziprasidone IM was most frequently associated with headache , nausea and insomnia .\n",
            "Patients had modest levels of overall psychopathology , as shown by the mean baseline BPRS total and core items scores and the CGI-severity score .\n",
            "In all treatment groups there was a moderate reduction in mean BPRS total score in the IM treatment period which was maintained during the oral treatment period .\n",
            "In the three ziprasidone treatment groups , there was a reduction in mean scores on the Behavioral Activity Rating Scale ( BARS ) , a novel measure of agitated behaviour .\n",
            "This reduction was more rapid than that observed with haloperidol , and was maintained in most patients for at least @ h post-dose with ziprasidone @ and @ mg , and at least @ h post-dose with ziprasidone @ mg .\n",
            "Ziprasidone shows promise as a novel IM treatment for acutely agitated patients and may have tolerability advantages over conventional rapid-acting , IM antipsychotics , particlularly with regard to movement disorders .\n",
            "Objective : The study investigated the provision of client-focused services to community-based clients with schizophrenia and bipolar disorder .\n",
            "It hypothesised that the delivery of more client-focused services would improve client outcome in terms of functioning ( disability and satisfaction with services .\n",
            "Client-focused services were developed using an empowerment model of case management and by the addition of consumer advocates .\n",
            "Method : Clients referred for case management were randomly allocated to one of three groups : standard case management ( n = @ ) , client-focused case management ( n = @ ) , or client-focused case management plus consumer advocacy ( n = @ ) .\n",
            "Measures of functioning , disability , quality of life , burden of care and service satisfaction were measured at baseline and @ months .\n",
            "Outcome data were collected concerning number and duration of hospital readmission , crisis intervention and compliance with treatment and services .\n",
            "Results : While there were no differences between the groups on quantitative measures of functioning , disability , quality of life , service satisfaction and burden of care , there were significant between-group differences on qualitative measures of satisfaction with services .\n",
            "Conclusions : Several methodological difficulties hampered interpretation of the findings .\n",
            "Although clients did not differ on outcome measures of functioning and disability , the group receiving client-focused case management reported greater satisfaction with service delivery . )\n",
            "EDUCATIONAL OBJECTIVES : At the conclusion of this session , the participant should be able to know more on the frequency of death by suicide and on the assessment of various forms of suicidal behavior in patients with schizophrenia , and obtain information on the differential impact of first - and second-generation antipsychotic drugs on suicidal behavior in schizophrenia .\n",
            "SUMMARY : The occurrence of death by suicide and suicide attempts was analyzed in a prospective cohort of patients with schizophrenia who were randomly assigned to treatment with sertindole ( @ pts . )\n",
            "or risperidone ( @ pts . )\n",
            "in a parallel-group open-label study with blinded classification of outcomes ( SCoP study ) .\n",
            "The total exposure was @ and @ patient-years ( mean number of days : @ and @ ) in the sertindole and risperidone groups , respectively .\n",
            "Suicide mortality in the study was fairly low ( @ and @ per @ patients per year with sertindole and risperidone , respectively ) .\n",
            "There was a tendency for sertindole-treated patients to have a lower risk of death by suicide than risperidone-treated patients , but this was not statistically significant ( hazard ratio [ @ % CI ] : @ [ @    @ ] , p = @ ) .\n",
            "Suicide attempts , defined by the association of suicidal act and intent to die , were reported by the treating psychiatrists .\n",
            "Cox   s proportional hazards model analysis of the time to the first suicide attempt showed a significantly lower risk of suicide attempt for sertindole-treated patients than for risperidone-treated patients ( HR [ @ % CI ] : @ [ @    @ ] , p = @ ) .\n",
            "When suicide attempts were classified by an independent safety committee using a broader definition including suicidal behavior , suicidal ideation , suicidal tendency , and self-injuries and overdoses for which there was no clear suicidal intent , the results were still in favor of sertindole , although not statistically significant ( HR [ @ % CI ] : @ [ @    @ ] , p = @ ) .\n",
            "A history of previous suicide attempts was significantly associated with completed and attempted suicides in both treatment groups .\n",
            "Patients who had attempted suicide within the @ years prior to study entry had a significantly higher risk of death by suicide than patients who had never attempted suicide ( p < @ ) .\n",
            "Sertindole with its specific pharmacological profile might confer protection from suicide .\n",
            "Quality of life was measured as a function of weight change in schizophrenic patients who received treatment with olanzapine ( OLZ ) .\n",
            "This analysis examined @ patients receiving OLZ treatment .\n",
            "Data were collected from a controlled , multi-center , double-blind , parallel clinical trial with patients ( N = @ ) diagnosed with schizophrenia or related disorders .\n",
            "The objective Heinrichs-Carpenter Quality of Life Scale ( QLS ) and the subjective Medical Outcomes Study Short Form Health Survey ( SF-@ ) were used to evaluate quality of life .\n",
            "The QLS evaluated patients ' functioning , richness of personal experience , quality of interpersonal relationships and productivity in occupational roles .\n",
            "The SF-@ scale evaluated physical and mental health .\n",
            "Change in quality of life as a function of change in weight was measured up to @ weeks ( LOCF ) .\n",
            "A significant positive association ( p = @ ) was found between improvement in the QLS Total score and weight change during OLZ therapy .\n",
            "Similar associations were demonstrated between improvement in SF-@ rated subjective perceptions of functioning and OLZ-related weight change .\n",
            "These findings suggest that weight change ( gain ) during long-term OLZ treatment generally does not detract from treatment-related improvements in key aspects of patients ' quality of life .\n",
            "Background : In search of new mechanisms for antipsychotic drugs translational approaches are of increasing relevance .\n",
            "We recently discovered that increasing of anandamide levels is accompanied by significantly less pronounced psychopathology in acute schizophrenic patients .\n",
            "We therefore tested the hypothesis that cannabidiol ( CBD ) modulated ananamide levels in humans and may thereby counterbalance psychotic symptoms in acute schizophrenia .\n",
            "Methods : We performed @ randomized , double-blind , controlled , clinical trials in acute , paranoid schizophrenia patients , fulfilling diagnostic criteria of DSM-IV .\n",
            "First , we performed a @-week double-blind , @-armed , randomized , active-controlled clinical trial of CBD vs. the dopamine D@/D@-receptor antagonist amisulpride in @ schizophrenic patients .\n",
            "In a second clinical trial , @ antipsychotic-nave , first-break schizophrenic patients were treated with either CBD or placebo for @ days and than switched to the corresponding cross-over condition .\n",
            "Drop-out patients were replaced per protocol to gain a total of @ patients treated .\n",
            "Endocannabinoids were measured by HPLC/MS in cerebrospinal fluid and serum from patients at certain timepoints during the trials .\n",
            "Results : Well comparable to amisulpride , treatment with CBD was safe and significantly improved psychotic symptoms compared with baseline .\n",
            "CBD displayed , however , a side-effect profile that was markedly superior to amisulpride 's .\n",
            "It did not induce prolactin elevation , extrapyramidal symptoms or weight gain .\n",
            "CBD induced a significant increase in serum anandamide concentration .\n",
            "A linear regression slope analysis of psychotic symptom progression vs. anandamide changes in serum revealed a significant association between both .\n",
            "In our second , placebo-controlled trial , CBD again significantly improved psychotic symptoms during the first @ days of treatment when compared with baseline .\n",
            "A MMRM analysis of all randomized patients yielded a favorable albeit not significant improvement on PANSS total for CBD vs. placebo .\n",
            "Ten patients terminated on placebo while only @ patient did so early on CBD .\n",
            "Conclusion : Based on our findings , we suggest that the endocannabinoid system plays a significant pathophysiolgical role in schizophrenia and that modulation its functioning may yield antipsychotic effects in this devasting disease .\n",
            "Thus , modulation of anandamide levels by CBD represents a promising new approach to the treatment of acute schizophrenia .\n",
            "Question : Is haloperidol alone more effective than haloperidol plus promethazine for rapid tranquillisation of mentally ill patients ?\n",
            "Patients : @ adults presenting to the psychiatric emergency room with agitation or dangerous behaviour requiring intramuscular sedation , for whom an attending doctor was available to record the diagnosis and severity of the episode .\n",
            "Setting : One psychiatric emergency room , Rio de Janeiro , Brazil ; January @ to July @ .\n",
            "Intervention : Single intramuscular injection of haloperidol ( @ or @ mg ) or haloperidol ( @ or @ mg ) plus promethazine ( up to @ mg ) .\n",
            "In the haloperidol alone group , @ % received @ mg and @ % received @ mg .\n",
            "In the haloperidol plus promethazine group @ % received @ mg haloperidol and @ % received @ mg .\n",
            "Outcomes : Primary outcome : proportion of patients tranquil ( calm and non-agitated with no threatening behaviour ) or asleep at @ min .\n",
            "Secondary outcomes included : tranquil or asleep at @ , @ and @ min ; need for further medical attention within @ h ; adverse events .\n",
            "Patient follow-up : Data available for @ % for the primary outcome ; @ % analysed in conservative intention to treat analysis .\n",
            "METHODS Design : Pragmatic randomised controlled trial .\n",
            "Allocation : Concealed .\n",
            "Blinding : Unblinded .\n",
            "Follow-up period : @ min following antipsychotic injection ( primary outcome ) ; @ , @ , and @ min , @ h and @ weeks following ( secondary outcomes ) .\n",
            "MAIN RESULTS Haloperidol plus promethazine increased the proportion of patients tranquil or asleep at @ min compared with haloperidol alone ( proportion tranquil or asleep : @ % with combined treatment vs @ % with haloperidol alone ; RR @ , @ % CI @ to @ ) .\n",
            "The combined treatment increased the proportion of patients asleep at @ min ( @ % with combined treatment vs @ % with haloperidol alone ; RR @ , @ % CI @ to @ ) .\n",
            "There was no difference between interventions in the proportion of patients tranquil or asleep after @ min ( @ min : RR @ , @ % CI @ to @ ; @ min : RR @ , @ % CI @ to @ ; @ min : RR @ , @ % CI @ to @ ) .\n",
            "Haloperidol plus promethazine increased the proportion of patients who did not need to have a doctor recalled ( @ % with combined treatment vs @ % with haloperidol alone ; RR @ , @ % CI @ to @ ) .\n",
            "Haloperidol alone increased the risk of serious adverse events compared with haloperidol plus promethazine ( @ % with combined treatment vs @ % with haloperidol alone ; RR @ , @ % CI @ to @ ) .\n",
            "Most of the serious adverse events in the haloperidol alone group were acute dystonia ( @ cases vs none with haloperidol plus promethazine ) .\n",
            "CONCLUSIONS There is no benefit of giving haloperidol alone compared to haloperidol plus promethazine for agitated or aggressive patients with mental illness presenting to the psychiatric emergency room .\n",
            "The combination is faster acting and has reduced risk of serious adverse events .\n",
            "ABSTRACTED FROM Huf G , Coutinho ESF , Adams CE , et al .\n",
            "Rapid tranquillisation in psychiatric emergency settings in Brazil : pragmatic randomised controlled trial of intramuscular haloperidol versus intramuscular haloperidol plus promethazine .\n",
            "BMJ @ ; @:@-@ .\n",
            "CONTEXT : The administration of nicotine transiently improves many neurobiological and cognitive functions in schizophrenia and schizoaffective disorder .\n",
            "It is not yet clear which nicotinic acetylcholine receptor ( nAChR ) subtype or subtypes are responsible for these seemingly pervasive nicotinic effects in schizophrenia and schizoaffective disorder .\n",
            "OBJECTIVE : Because alpha@beta@ is a key nAChR subtype for nicotinic actions , we investigated the effect of varenicline tartrate , a relatively specific alpha@beta@ partial agonist and antagonist , on key biomarkers that are associated with schizophrenia and are previously shown to be responsive to nicotinic challenge in humans .\n",
            "DESIGN : A double-blind , parallel , randomized , placebo-controlled trial of patients with schizophrenia or schizoaffective disorder to examine the effects of varenicline on biomarkers at @ weeks ( short-term treatment ) and @ weeks ( long-term treatment ) , using a slow titration and moderate dosing strategy for retaining alpha@beta@-specific effects while minimizing adverse effects .\n",
            "SETTING : Outpatient clinics .\n",
            "PARTICIPANTS : A total of @ smoking and nonsmoking patients ; @ patients completed week @ , and @ patients completed week @ .\n",
            "Intervention Varenicline .\n",
            "MAIN OUTCOME MEASURES : Prepulse inhibition , sensory gating , antisaccade , spatial working memory , eye tracking , processing speed , and sustained attention .\n",
            "RESULTS : A moderate dose of varenicline ( @ ) significantly reduced the P@ sensory gating deficit in nonsmokers after long-term treatment ( P = .@ ) , ( @ ) reduced startle reactivity ( P = .@ ) regardless of baseline smoking status , and ( @ ) improved executive function by reducing the antisaccadic error rate ( P = .@ ) regardless of smoking status .\n",
            "A moderate dose of varenicline had no significant effect on spatial working memory , predictive and maintenance pursuit measures , processing speed , or sustained attention by Conners ' Continuous Performance Test .\n",
            "Clinically , there was no evidence of exacerbation of psychiatric symptoms , psychosis , depression , or suicidality using a gradual titration ( @-mg daily dose ) .\n",
            "CONCLUSIONS : Moderate-dose treatment with varenicline has a unique treatment profile on core schizophrenia-related biomarkers .\n",
            "Further development is warranted for specific nAChR compounds and dosing and duration strategies to target subgroups of schizophrenic patients with specific biological deficits .\n",
            "Trial Registration clinicaltrials.gov Identifier : NCT@ .\n",
            "Background : New pharmacological targets for the treatment of schizophrenia are urgently required .\n",
            "We initially identified one of the two major endocannabinoids , anandamide , as a counterbalancing if not protective factor in paranoid schizophrenia .\n",
            "Most recently , we reported that increasing levels of anandamide by blocking its metabolization by cannabidiol , a purified phytocannabinoid , significantly ameliorates psychotic symptoms in acute schizophrenia .\n",
            "Methods : We performed a randomized , double-blind , placebo-controlled , cross-over clinical trial in acute , antipsychotic-naive , first-break paranoid schizophrenia patients , fulfilling diagnostic criteria of DSM-IV .\n",
            "@ patients were treated after written informed consent with either cannabidiol ( @ mg per day ) or placebo for @ days and than switched to the corresponding cross-over condition .\n",
            "Additional patients to gain a total of @ patients treated per protocol replaced dropouts .\n",
            "Results : Cannabidiol significantly improved psychotic symptoms in the cannabidiol-placebo condition during the first @ days of treatment when compared to baseline .\n",
            "A MMRM analysis of all randomized patients ( n = @ ) yielded a mean improvement of @ points ( standard error @ ) on PANSS total in favor of cannabidiol ( vs. placebo ) , albeit not statistically significant .\n",
            "Only one patient on sequence cannabidiol-placebo terminated treatment early ( last seen at visit @ ) whereas @ patients terminated early on sequence placebo - cannabidiol .\n",
            "The most frequent reason given was worsening of symptoms ( @/@ patients ) .\n",
            "In addition , cannabidiol was detectable in serum of almost all patients in the cannabidiol-placebo group .\n",
            "Side-effects of cannabidiol were on the level of placebo .\n",
            "Conclusions : Although limited by design issues ( cross-over ) , duration of treatment ( @ days ) , carry-over effects ( serum levels of cannabidiol ) , and relevant placebo-response rates , this is the second study to provide evidence for antipsychotic properties of cannabidiol accompanied by a superior side-effect profile .\n",
            "Future placebo-controlled parallel-group trials studying the antipsychotic properties of cannabidiol in acute schizophrenia are necessary to provide further evidence for its efficacy in the treatment of this devastating disease .\n",
            "The reduced metabolic activity in the prefrontal brain lobes , so-called hypofrontality , is associated with increased electrophysiological delta-band activity .\n",
            "Schizophrenia inpatients ( N = @ ) received sham-controlled @Hz rTMS over the left dorsolateral prefrontal cortex in a randomised design .\n",
            "After treatment , the resting electroencephalography revealed a significant decrease in the delta-band activity , which originated in the right prefrontal cortex and correlated with improvements in facial affect recognition .\n",
            "Objective : Patients with schizophrenia are at increased risk of developing diabetes mellitus and cardiovascular disease .\n",
            "Furthermore , some atypical antipsychotics are associated with metabolic disturbances , which augment the risk for these comorbid conditions .\n",
            "In clinical trials , effects on metabolic parameters with aripiprazole are similar to those with placebo and superior to those with olanzapine , and the Schizophrenia Trial of Aripiprazole ( STAR ) demonstrated comparable efficacy of aripiprazole versus standard of care ( SoC ; physicians ' selection of quetiapine , olanzapine , or risperidone ) .\n",
            "Method : In this post hoc analysis , data from STAR were used to assess the risks of diabetes and coronary heart disease ( CHD ) in patients with schizophrenia .\n",
            "The Stern ( San Antonio Heart Disease Study ) and Framingham models , with modifications , were used to predict the risk of diabetes at @ years and CHD at @ years , respectively .\n",
            "Results : Aripiprazole-treated patients had more favorable changes in lipids , glucose , and body weight versus SoC .\n",
            "In a subsample of patients who had fasting lipid and glucose test results , the Stern model predicted @ fewer incidences of new-onset diabetes with aripiprazole versus SoC in a hypothetical @-patient cohort .\n",
            "The number needed to treat with aripiprazole to avoid @ adverse outcome expected with SoC was @ .\n",
            "In the same population , the Framingham model predicted @ fewer CHD events , with a number needed to treat with aripiprazole of @ .\n",
            "Conclusion : Aripiprazole-treated patients had more favorable changes in metabolic parameters compared with SoC , leading to a reduced risk of diabetes and CHD , based on validated models .\n",
            "Trial Registration : clinicaltrials.gov Identifier : NCT@ ( Schizophrenia Trial of Aripiprazole ) .\n",
            "The abnormal involuntary movements in tardive dyskinesia can be reduced by the dopamine antagonist drugs , phenothiazines and butyrophenones , but most cause an increase in Parkinsonian signs .\n",
            "Sulpiride , a benzamide derivative , and selective antagonist of D@ receptors had a significantly beneficial effect on most of @ patients ( p less than @ ) .\n",
            "In @ patients the improvement was marked .\n",
            "The reduction of abnormal movements was observed even with low doses , and it was not necessary to increase the dose of sulpiride above @ mg daily .\n",
            "There were no significant side effects during the trial nor during an additional three months of treatment .\n",
            "Introduction : Tardive dyskinesia TD , a persistent abnormal involuntary movement disorder usually considered neuroleptic-induced , currently has no specific treatment .\n",
            "We report preliminary findings of the effects of olanzapine OLZ treatment upon TD .\n",
            "Methods : Eligible schizophrenic subjects met restricted Research Diagnosis Tardive Dyskinesia criteria restricted RD-TD that specified for abnormal involuntary movements to be of at least moderate severity .\n",
            "Subjects received OLZ , @-@ mgrday for @ months within a DOUBLE-BLIND design that included up to @ medication reduction @ % periods of @ weeks ' duration .\n",
            "TD was assessed with the Abnormal Involuntary Movement Scale AIMS and psychopathology with the Positive and Negative Syndrome Scale PANSS .\n",
            "Results : A significant reduction in mean AIMS Total score was demonstrated Ns@ ; BLs@ .@ ; EPs@ .@ ; p-@ ; LOCF .\n",
            "Nearly @ % of subjects no longer met the restricted RD-TD criteria after up to @ months of treatment , with greater than @ % improvingas early as @ weeks .\n",
            "No statistically significant rebound worsening of TD was found during the blinded drug reduction periods .\n",
            "A significant improvement in the PANSS occurred BLs@ .@ ; EPs@ .@ ; p-@ , LOCF .\n",
            "Conclusions : These data , suggesting an ameliorative , rather than masking effect , and the concurrent further improvement in clinical status suggests that OLZ may offer a potential treatment alternative for managing the schizophrenic patient with pre-existingTD .\n",
            "The first double-blind placebo-controlled clinical trial of an atypical neuroleptic medication is being conducted in symptomatic treatment-seeking patients meeting new diagnostic criteria for a putative prodromal syndrome .\n",
            "This identifies them as being at high risk for developing psychosis in the near future .\n",
            "The study aims include prevention of psychosis onset and disability , as well as palliation of ongoing symptomatology.The purpose of this report is to describe the study 's \" prodromally symptomatic \" sample at baseline , i.e. , at intake immediately prior to randomization and prior to receiving study medication .\n",
            "Sixty treatment-seeking patients meeting prodromal inclusion criteria were recruited across four sites : New Haven , CT ( n = @ ) , Toronto , Ontario ( n = @ ) , Calgary , Alberta ( n = @ ) , and Chapel Hill , NC ( n = @ ) .\n",
            "The sample was young ( median age @ ) , largely male ( @ % ) , and came from families with high titers of serious mental illness ( @ % ) .\n",
            "Most patients ( @ % ) met criteria for the Attenuated Positive Symptom ( APS ) prodromal syndrome and presented with significant but nonpsychotic suspiciousness , perceptual aberrations , unusual thought content , and conceptual disorganization .\n",
            "They presented with minimal to mild affective symptoms and substance use/abuse , but they were quite functionally compromised ( mean Global Assessment of Functioning ( GAF ) score = @ ) .\n",
            "The prodromal sample was compared with other clinical-trial samples of adolescent depression , adolescent mania , and first episode schizophrenia .\n",
            "Prodromal patients proved not to be depressed or manic .\n",
            "They were less severely ill than untreated first episode schizophrenia but more severely ill than treated first episode schizophrenia .\n",
            "While not psychotically disabled , these patients nevertheless present with a clinical syndrome .\n",
            "Subsequent reports will detail the effects of drug versus placebo on prodromal symptoms , neuropsychological profile , and the rate of conversion to psychosis\n",
            "The authors assessed the effects on Wisconsin Card Sort ( WCST ) performance and psychiatric symptoms of @ mg d-amphetamine , a dopamine and norepinephrine agonist , vs placebo in nine patients with schizotypal personality disorder ( SPD ) .\n",
            "Patients , particularly those who made more perseverative errors , demonstrated amphetamine-associated improvement on WCST performance .\n",
            "The data in this preliminary study suggest that some of the cognitive dysfunction present in SPD may improve with amphetamine challenge .\n",
            "Objective : To evaluate the efficacy and safety of olanzapine ( Olz ) compared with Risperidone ( Ris ) after @ year of treatment .\n",
            "Methods : This was a multi-center , randomized , open-label , parallel , dose-flexible , @ year study of outpatients with schizophrenia with prominent negative symptoms ( SANS Global score z@ ) .\n",
            "Patients were assigned to treatment with an initial dose of at least @ mg/day OlzN = @ ) or at least @ mg/day Ris ( N = @ ) .\n",
            "The primary efficacy measure was the SANS Global score .\n",
            "Secondary efficacy measures included the SAPS and CGI-S .\n",
            "The response rate was defined as a @ % of improvement in the SANS Global score .\n",
            "Safety was evaluated by recording treatment-emergent adverse events ( TEAEs ) and measuring vital signs and weight .\n",
            "Extrapyramidal symptoms were evaluated by using a questionnaire based on the UKU scale .\n",
            "Results : The mean dose was @ ( F@ .@ ) mg/day for Olz and @ ( F@ ) mg/day for Ris .\n",
            "At one year , Olz patients showed significantly higher improvement than Ris patients on the SANS Global ( p = @ ) , the SAPS Global ( p = @ ) , and CGI-S ( p = @ ) scores .\n",
            "The response rate was greater ( p = @ ) in the Olz group ( @ % ) than the Ris group ( @ % ) .\n",
            "Significantly more ( p = @ ) Ris patients ( @ % ) experienced sexual dysfunction than Olz patients ( @ % ) .\n",
            "Incidence of treatment emergent EPS , or worsening of the previous one , were statistically significant higher ( p < @ ) in the Ris group ( @ % ) than the Olz group ( @ % ) .\n",
            "Conclusion : Long-term treatment with Olz was associated with significantly better improvement in psychopathology as compared to Ris in outpatients with schizophrenia and prominent negative symptoms .\n",
            "OBJECTIVE : Treatment efficacy in schizophrenia is typically defined in terms of symptom reduction .\n",
            "However , new antipsychotic medications could potentially have an impact on aspects of disability , such as neurocognitive deficits .\n",
            "The authors evaluated the effects of risperidone on verbal working memory , a memory component of theoretical interest because of its link to prefrontal activity and of practical interest because of its link to psychosocial rehabilitation .\n",
            "METHOD : Verbal working memory of @ treatment-resistant schizophrenic patients was assessed as part of a randomized , double-blind comparison of treatment with risperidone and haloperidol .\n",
            "Verbal working memory was measured under both distracting and nondistracting conditions at baseline and after @ weeks of both fixed - and flexible-dose pharmacotherapy .\n",
            "RESULTS : Risperidone treatment had a greater beneficial effect on verbal working memory than haloperidol treatment across testing conditions ( with and without distraction ) and study phases ( fixed and flexible dose ) .\n",
            "The treatment effect remained significant after the effects of benztropine cotreatment , change in psychotic symptoms , and change in negative symptoms were controlled .\n",
            "Neither benztropine status nor symptom changes were significantly related to memory performance .\n",
            "CONCLUSIONS : Treatment with risperidone appears to exert a more favorable effect on verbal working memory than treatment with a conventional neuroleptic .\n",
            "The beneficial effect appears to be due , at least partially , to a direct effect of the drug , possibly through antagonism of the @-HT@A receptor .\n",
            "Results from this study suggest that pharmacotherapeutic efficacy in schizophrenia treatment could be broadened to include impact on neurocognitive abilities .\n",
            "Objective To compare the clinical efficacy and safety in the treatment of schizophrenia with clozapine ziprasidone .\n",
            "@ cases of patients with schizophrenia were randomly divided into ziprasidone and clozapine group , @ weeks , with the positive and negative syndrome scale ( panss ) and treatment emergent symptom scale ( tess ) to evaluate the efficacy and adverse reaction .\n",
            "Results After treatment panss score significantly decreased , and no significant difference between the two groups ( p > @ ) .\n",
            "Neurocognitive impairment is prominent in schizophrenia and a significant predictor of poor occupational outcomes .\n",
            "Vocational rehabilitation ( VR ) is frequently implemented to counteract high unemployment rates .\n",
            "Individuals with schizophrenia however face numerous challenges such as neurocognitive impairments and psychotic symptoms .\n",
            "Hence , augmenting VR to address illness-related factors may optimize occupational outcomes .\n",
            "The aim of this study was to examine the effects of Cognitive Remediation ( CR ) combined with VR ( CR+VR ) compared to techniques from Cognitive Behavioral Therapy ( CBT ) combined with VR ( CBT+VR ) on neurocognition and occupational functioning over a @ year period .\n",
            "A total of @participants underwent assessment with the MATRICS Consensus Cognitive Battery ( MCCB ) at baseline , post treatment ( after @ months ) and follow-up ( @ years after randomization ) .\n",
            "Occupational status and number of hours worked were recorded at all assessment points .\n",
            "Both groups improved on several neurocognitive domains .\n",
            "All improvements were however in favor of the CR group .\n",
            "There was a significant increase in number of participants working and hours worked in both groups throughout the project period , with no between-group differences .\n",
            "Number of hours worked at follow-up was predicted by change in Working Memory and the Composite Score in the CR group .\n",
            "CR-augmented VR improved several domains , particularly Verbal Learning and Working Memory , which were central in the CR program .\n",
            "The combination of VR and CR or CBT thus enabled a significant proportion of participants to attain and maintain work .\n",
            "Elevated creatine phosphokinase ( CPK ) activity seen in psychotic patients has been attributed to intense motor activity resulting form psychotic agitation or conventional neuroleptic medication .\n",
            "In this study , we examined CPK levels in patients treated with Risperidone ( @-@ mg ) , Haloperidol ( @-@ mg ) , MAR @ ( @-@ mg ) and placebo .\n",
            "The Positive and Negative Symptom Scale ( PANSS ) and Extrapyramidal Symptom Rating Scale ( ESRS ) were used as clinical instruments to evaluate efficacy and side effects .\n",
            "Forty-five male patients ( ages @-@ ) who met the DSM IIIR criteria for schizophrenia signed informed consents .\n",
            "Following a @-@ day washout period , @ patients received Risperidone , @ received Haloperidol , @ received MAR @ , and @ received placebo in a DOUBLE-blind , randomized fashion .\n",
            "CPK measurements , PANSS and ESRS ratings were completed at the end of washout and throughout treatment .\n",
            "Analysis using two factor repeated measures of ANOVA did not show any relationship between CPK activity and drug treatment .\n",
            "Furthermore , we failed to establish any correlation between CPK activity , positive and negative symptoms or extrapyramidal symptoms .\n",
            "Alternatively , CPK activity appears to be a nonspecific and independent variable seen in psychiatric patients .\n",
            "A @-week , inhospital holistic health program for male schizophrenic patients was compared with an equally intense social skills training program .\n",
            "The holistic program included training in the stress reduction techniques of exercise and meditation as well as education in stress management .\n",
            "Patients were also encouraged to explore the growth potential of their psychotic experiences and to develop positive beliefs about the outcome of their illness .\n",
            "Both groups showed similar significant decreases in psychopathology from admission to discharge , but the use of medication and a token economy milieu by all patients confounds the interpretability of this finding .\n",
            "After the holistic patients were discharged into the community , there was no maintenance of any of the holistic techniques .\n",
            "The @-year relapse rate did not differ significantly between the two treatments .\n",
            "Findings from various studies associating schizophrenic relapse with stressful life events and familial tension make further experimentation with stress reduction techniques for the treatment of schizophrenia worthwhile .\n",
            "Hyperprolactinemia is a common adverse effect that occurs as a result of antipsychotic therapies , which often results in discontinuation .\n",
            "Empirical evidence has shown that some herbal medicines have suppressive effects on prolactin ( PRL ) hyperactivities .\n",
            "This study was designed to compare the herbal preparation called Peony-Glycyrrhiza Decoction ( PGD ) with bromocriptine ( BMT ) , a dopamine agonist widely used for PRL-secreting disorders , in the treatment of risperidone-induced hyperprolactinemia .\n",
            "Twenty schizophrenic women who were under risperidone maintenance treatment , diagnosed with hyperprolactinemia ( serum PRL levels > @ mug/L ) , and currently experiencing oligomenorrhea or amenorrhea were selected for the study .\n",
            "Subjects were randomized to additional treatment with PGD ( @ g/d ) followed by BMT ( @ mg/d ) or BMT followed by PGD at the same doses for @ weeks each , with an interval of @-week washout period between @ treatment sessions .\n",
            "The severity of psychotic symptoms , adverse events , serum PRL , estradiol , testosterone , and progesterone levels were examined at baseline and end point .\n",
            "Peony-Glycyrrhiza Decoction treatment produced a significant baseline-end point decrease in serum PRL levels , without exacerbating psychosis and changing other hormones , and the decreased amplitudes were similar to those of BMT ( @ % vs @ % -@ % ) .\n",
            "Moreover , there was a significantly greater proportion of patients during PGD treatment than BMT treatment showing improvements on adverse effects associated with hyperprolactinemia ( @ % vs @ % , P = @ ) .\n",
            "These results suggest that the herbal therapy can yield additional benefits while having comparable efficacy in treating antipsychotic-induced hyperprolactinemia in individuals with schizophrenia .\n",
            "RN @ ( Antipsychotic Agents ) .\n",
            "@ ( Drugs , Chinese Herbal ) .\n",
            "@ ( Plant Extracts ) .\n",
            "@-@-@ ( Risperidone ) .\n",
            "@-@-@ ( Bromocriptine ) .\n",
            "@-@-@ ( Estradiol ) .\n",
            "@-@-@ ( Progesterone ) .\n",
            "@-@-@ ( Testosterone ) .\n",
            "@-@-@ ( Prolactin ) .\n",
            "Parent trainings constitute an effective method to target aspects of parenting in child and adolescent psychiatric and psychotherapeutic care .\n",
            "Past research has mainly been conducted in outpatient contexts , with parents of children with externalizing disorders and often included only small sample sizes .\n",
            "The aim of the current study was first to assess the effectiveness of a novel parent training which is characterized by a universal approach , an open group concept , and short duration , and second to identify variables that have an influence on the effectiveness .\n",
            "A sample of n = @ parent-child dyads treated in an inpatient clinic was included in the study and randomly assigned to a treatment group and a waiting-list control group .\n",
            "As dependent measures served child behavior problems , dysfunctional parenting , parental mental health , and parental self-efficacy measured with parent-rated questionnaires prior to the training , post training and @ months after discharge of the clinic .\n",
            "Additionally , a parent-child-interaction observation was conducted and rated by blind raters .\n",
            "Results indicated a general inpatient treatment effect on all dependent measures assessed with questionnaires .\n",
            "An additional effect of the parent training was only shown for parenting and parental mental health with the treatment group revealing better outcomes post training and at follow-up .\n",
            "No effects were found for the measures assessed by interaction observation .\n",
            "Out of a number of variables , only a low monthly income was associated with a higher reduction of dysfunctional parenting .\n",
            "Results indicate that parent training does not contribute additionally to standard inpatient care with respect to child behavior , but does have an influence on parental well-being , which might have a positive effect on the long run .\n",
            "Background .\n",
            "Brain @-hydroxytryptamine ( @-HT ) function is implicated in the pathophysiology of schizophrenia and the action of new generation antipsychotic drugs .\n",
            "By the method of acute tryptophan depletion ( ATD ) @-HT can be selectively manipulated .\n",
            "The aim of this study was to examine the effects of ATD on symptoms , mood and cognition in schizophrenic patients .\n",
            "Methods .\n",
            "Twenty-eight schizophrenic patients participated in a within subject , double-blind , placebo-controlled counterbalanced cross-over study .\n",
            "Patients with a concurrent DSM-IV axis I diagnosis were excluded .\n",
            "Symptoms , mood and cognitive function were evaluated following ATD or ingestion of a control drink .\n",
            "Results .\n",
            "The depleting drink significantly reduced plasma total and free tryptophan .\n",
            "Tryptophan / LNAA ratios did not alter with the administration of the control drink , but differed significantly with ATD ; however there was no significant change in tyrosine/LNAA ratio .\n",
            "ATD led to impairment in executive function that was dependent upon the order of administration .\n",
            "Tests of sustained attention , speed of processing , and everyday memory were not affected .\n",
            "No effects were observed on subjective mood ratings , movement disorders or PANSS scores .\n",
            "Conclusions .\n",
            "Acute tryptophan depletion selectively alters cognition in schizophrenia , but has no effect on symptoms , mood ratings or movement disorders .\n",
            "Obj : Longitudinal neuroimaging studies of first episode schizophrenia have demonstrated morphological changes in brain volumes ( VOLS ) that have been suggested to reflect pathological processes .\n",
            "While treatment may either contribute to or prevent brain morphological changes , no study has examined the comparative effects of atypical and conventional antipsychotic drugs in a controlled long-term trial .\n",
            "Methods : This randomized controlled trial examined the effects of haloperidol ( HAL ) and olanzapine ( OLZ ) on psychopathology , cognition and brain morphology in patients with schizophrenia and schizoaffective disorder under double blind conditions for @ wks .\n",
            "High-RES sMRI was performed at baseline and after @,@ wks of treatment .\n",
            "Computerized morphometric analysis was used to determine VOLS of specified ROIs .\n",
            "@ ( of @ ) patients ( mean age @ yrs @ % male ) had baseline and gtoreq@ follow-up sMRI .\n",
            "Baseline volume ( VOL ) was used as a covariate , with adjustments for investigator , age , gender.Results : Total cerebral gray matter @-wk change to least squares mean + - SE for HAL was -@ + -@ , while OLZ was -@ + -@ ( P < @ ) .\n",
            "Lateral ventricular VOL change to least squares mean for HAL was @ + -@ , while OLZ was -@ + -@ ( P = @ ) .\n",
            "LOCF and OC analyses yielded similar results .\n",
            "The differences in VOL changes were significant at all time points for gray matter and all except @ wks for ventricular VOL .\n",
            "Concl : Results replicate prior studies that reported progressive changes in brain morphology consistent with the hypothesized effect of illness progression that can be selectively attenuated by treatment with OLZ , and possibly other atypical antipsychotic meds .\n",
            "CAJ Objectives : To study the efficacy and safety of risperidone added with intramuscular clonazepam in the treatment of excitement of schizophrenia .\n",
            "Method : Subjects were inpatients aged @ ?\n",
            "@ who met the ICD @ criteria for schizophrenia or schizophrenia form disorder with a sore of @ or higher on the Positive and Negative Synptoms Scale ( PANSS ) and were randomly divided info three groups .\n",
            "Efficacy and side effects were evaluated with CGI , PANSS and TESS , respectively .\n",
            "Objective To explore the effect of social skill training on the social function in patients with chronic schizophrenia .\n",
            "Methods @ patients with chronic schizophrenia were randomly divided into training group ( @ cases ) and control group ( @ cases ) .\n",
            "The control group received treatment by anti-psychotic drugs , and training group received treatment with anti-psychotic drugs and social living skill training .\n",
            "All patients were evaluated with NOISE ( nurses  observation scale for inpatient evaluation ) , SANS ( scale for assessment of negative symptoms ) and SDSS ( social disability screening schedule ) before and after the treatment .\n",
            "Results The total scores on NOSIE , the scores on SANS and on SDSS before training were significantly different from those after training ( P < @ ) .\n",
            "Conclusions Social skill training is very effective in improving the social function of patients with chronic schizophrenia and enhancing their quality of life .\n",
            "Objective To investigate the the antipsychotic joint meridian oxygen therapy for the long-term efficacy and safety of hospitalized patients with schizophrenia negative symptoms .\n",
            "Methods @ cases of hospitalization > @a patients with predominantly negative symptoms of schizophrenia were randomly divided into two groups of @ cases , the two groups continue to use the original antipsychotic drug treatment , the joint study group meridian oxygen therapy treatment .\n",
            "Observed @w .\n",
            "Before treatment and treatment @w , @w , @w end of the Brief Psychiatric Rating Scale , Negative Syndrome Scale to evaluate the efficacy , side effects rating scale adverse reactions .\n",
            "Results of the treatment of the @w end total efficiency of @ % and @ % in the control group , the difference was statistically significant (  @ = @ , P < @ ) ; Brief Psychiatric Rating Scale score treatment @w @w end of the study group compared with the control group decreased significantly ( P < @ ) differences @w end no statistically significant ( P > @ ) .\n",
            "Negative Syndrome Scale score treatment the @w end of the study group compared with the control group decreased significantly ( P < @ ) ; research group incidence of adverse reactions was significantly lower than the control group ( P < @ ) .\n",
            "The the joint conclusion antipsychotics meridian oxygen therapy treatment of long-term hospitalized negative symptoms of schizophrenia than single antipsychotics significant effect of adverse reactions of antipsychotics can be improved to a certain extent .\n",
            "Objective : Neurocognitive impairments are widespread in the early phases of psychosis and interfere with social and role functioning .\n",
            "Cognitive enhancement with remediation has been moderately successful , but thus far , pharmacological interventions have been largely negative .\n",
            "We explored the impact of addition of N-Acetyl-Cysteine ( NAC ) to standard anti-psychotic treatment in early psychosis ( EP ) patients on neurocognition .\n",
            "Method ( s ) : Double-blind , randomized , placebo-controlled trial of addition of NAC , @ mg daily , to antipsychotic treatment over @ months .\n",
            "Neurocognition was assessed at baseline and at the end of @ months of treatment with the MATRICS Consensus Cognitive Battery ( MCCB ) excluding the MSCEIT .\n",
            "The sample was comprised of @ patients with psychotic illnesses ( @ NAC , @ placebo ) , largely schizophrenia spectrum disorders , with less than @ years of illness .\n",
            "Result ( s ) : There was no significant difference in an overall cognition score .\n",
            "All @ factors showed absolute improvement in the NAC group while only @/@ improved in absolute terms in Placebo .\n",
            "There was a significant interaction showing improvement in Processing Speed/PS ( NAC > Placebo ; F ( @ , @ ) = @ , p = .@ ) , with the interaction favouring NAC on @ of @ PS tasks ( Trail Making A , F ( @ , @ ) = @ , p = .@ and Verbal Fluency , F ( @ , @ ) = @ , p = .@ ) .\n",
            "Moreover , NAC improved PS in a sub-group of patients having a low basal peroxidase activity ( GPx ) .\n",
            "Conclusion ( s ) : While addition of NAC did not produce an overall improvement in cognition , it did significantly improve Processing Speed and this was related to low GPX .\n",
            "Future , larger studies on antioxidant interventions in EP are needed to replicate these findings .\n",
            "BACKGROUND : A relapse prevention program called the Information Technology Aided Relapse Prevention Programme in Schizophrenia ( ITAREPS ) has been developed and is reported to be highly effective .\n",
            "However the effectiveness was influenced by user adherence to the protocol of the program , the exact effectiveness and the role of the ITAREPS have been partially uncertain .\n",
            "OBJECTIVE : The purpose of this study is to evaluate the effectiveness of the ITAREPS excluding the effect of user adherence to the protocol of the program .\n",
            "METHOD : We attempted to perform a randomized controlled trial by the devised method with visiting nurse service .\n",
            "Outpatients with schizophrenia were randomized to the ITAREPS ( n = @ ) or control group ( n = @ ) and were observed for @ months .\n",
            "RESULTS : The risk of rehospitalization was reduced in the ITAREPS group ( @ [ @ % ] ) compared with the control group ( @ [ @ % ] ) ( hazard ratio = @ , @ % CI @-@ , p = @ ; number needed to treat ( NNT ) = @ , @ % CI @-@ ) .\n",
            "The mean number of inpatient days was significantly lower in the ITAREPS group ( @ days ) compared with the control group ( @ days ) ( p = @ ) .\n",
            "The ratio of the number of rehospitalizations to that of relapses was significantly lower ( p = @ ) and the mean change in total BPRS scores at relapse from baseline was significantly less in the ITAREPS group ( p = @ ) .\n",
            "CONCLUSIONS : The relapse prevention effectiveness of the ITAREPS was high , and we confirmed that the ITAREPS , i.e. , detecting signs of relapse and increasing medication during the warning state , is an effective intervention during the early stages of relapse .\n",
            "Objective To investigate the atypical antipsychotics risperidone , quetiapine , aripiprazole , ziprasidone schizophrenia glucose and lipid metabolism .\n",
            "Random block design of the @ cases of schizophrenia patients were divided into @ groups , were given risperidone @ ~ @ mg / d , quetiapine level @ ~ @ mg / d , aripiprazole @ of @ mg / d and ziprasidone @ to @ mg / d , @ weeks of treatment , before treatment , after measurement of body weight , waist circumference , fasting blood sugar ( FBS ) , serum insulin ( NS ) , @h postprandial blood glucose ( @hBS ) , @h postprandial serum insulin ( @hNS ) and fasting lipid .\n",
            "Results change between the two groups of the body weight and fasting blood sugar of the four groups of patients ( @ ) after eight weeks of treatment , the difference was statistically significant ( P < @ ) , quetiapine on weight the greatest impact , while aripiprazole minimum impact on body weight , aripiprazole azole increased fasting insulin level is the most obvious , and quetiapine lower fasting insulin levels ; atypical antipsychotics had no significant effect on waist circumference , blood lipids , blood glucose and insulin levels ; metabolic syndrome was no significant correlation between the abnormal indicators .\n",
            "The effectiveness of ritanserin , a selective @-HT@ and @-HT@c antagonist , in reducing negative symptoms in schizophrenia was investigated in a double-blind , placebo-controlled trial .\n",
            "Trial treatment was added to a stable neuroleptic treatment in @ schizophrenic patients with predominantly negative symptoms .\n",
            "Ritanserin reduced the negative symptoms , as measured with the SANS .\n",
            "The main reduction was for the items facial expression , global affective flattening , and relationships with friends and peers .\n",
            "Also a reduction in total BPRS score was found , which approached statistical significance .\n",
            "Significant reductions were observed for the BPRS items emotional withdrawal and depressive mood .\n",
            "Ritanserin or other drugs blocking @-HT@ and/or @-HT@c receptors could be important in reducing specific symptoms in schizophrenic patients .\n",
            "Objective : To explore the change of EKG caused by Aripiprazole .\n",
            "Methods : @ inpatients with schizophrenia were randomly assigned to two groups ; the experimental group ( @ cases ) and the control group ( @cases ) .\n",
            "The patient in the two groups were treated by Aripiprazole or Clozapine respectively , and were checked EKG before and after the treatment @ th and @ th week .\n",
            "Results : Both of Aripiprazole and Clozapine had effected to EKG of the patients .\n",
            "In the experimental group the abnormal rate of EKG was lower than that in the control group ( P < @ .\n",
            "@ l ) , and the Severity of electrocardiography abnormality was slight .\n",
            "The most of them was sinus tachycardia .\n",
            "Conclusions : Aripiprazole can cause electrocardiography abnormality , but the abnormal rate is lower and the Severity is slight .\n",
            "It has a favorable safety\n",
            "Neurexins are presynaptic neuronal adhesion molecules that interact with postsynaptic neuroligins to form an inter-synaptic complex required for synaptic specification and efficient neurotransmission .\n",
            "Deletions and point mutations in the neurexin @ ( NRXN@ ) gene are associated with a broad spectrum of neuropsychiatric and neurodevelopmental disorders , including autism , intellectual disability , epilepsy , developmental delay , and schizophrenia .\n",
            "Recently , small nucleotide polymorphisms in NRXN@ have been associated with antipsychotic drug response in patients with schizophrenia .\n",
            "Based on previous suggestive evidence of an impact on clozapine response in patients with schizophrenia , we conducted an association study of NRXN@ polymorphisms ( rs@ and rs@ ) with antipsychotic treatment response in @ patients with schizophrenia in a double blind , placebo-controlled NIMH inpatient crossover trial and examined for association with risk for schizophrenia in independent case-control and family-based clinical cohorts .\n",
            "Pharmacogenetic analysis in the placebo controlled trial revealed significant association of rs@and rs@ with drug response , whereby individuals homozygous for the A allele , at either SNP , showed significant improvement in positive symptoms , general psychopathology , thought disturbance , and negative symptoms , whereas patients carrying the G allele showed no overall response .\n",
            "Although we did not find evidence of the same NRXN@ SNPs being associated with results of the NIMH sponsored CATIE trial , other SNPs showed weakly positive signals .\n",
            "The family and case-control analyses for schizophrenia risk were negative .\n",
            "Our results provide confirmatory evidence of genetically determined differences in drug response in patients with schizophrenia related to NRXN@ variation .\n",
            "Furthermore , these findings potentially implicate NRXN@ in the therapeutic actions of antipsychotic drugs .\n",
            "Background : Deficits in social cognition ( e.g. , emotion processing , social perception , and mental state attribution ) are common in individuals with schizophrenia and predict poor community functioning .\n",
            "Given the current limitations of psychosocial treatments and the lack of pharmacological treatments for social cognitive deficits , the development of novel therapeutic agents could enhance the treatment of schizophrenia .\n",
            "The oxytocin system , given its importance in the social brain , has garnered much recent attention in research on disorders associated with social cognitive deficits .\n",
            "In this pilot study , we test the hypothesis that a single dose of intranasal oxytocin will improve social cognitive functioning in individuals with schizophrenia .\n",
            "Methods : Twenty-four male veterans between the ages of @ and @ who met the DSM-IV-TR criteria for schizophrenia were enrolled in this study .\n",
            "Baseline assessments of \" low level \" ( @ .\n",
            "facial affect perception , @ .\n",
            "social perception ) and \" high level \" ( @ .\n",
            "detection of sarcasm and deception , @ .\n",
            "empathy ) social cognition were performed , as were assessments of schizophrenia symptom severity .\n",
            "One week later , patients received a single dose of @ IU intranasal oxytocin or placebo , assigned by double-blind randomization , and the social cognition assessment battery and symptom assessments were repeated .\n",
            "The pre-specified primary endpoint was the change on a composite score based on the four social cognitive tests between baseline and treatment visits .\n",
            "Results : Twenty-three individuals completed the study .\n",
            "The treatment and assessments were well-tolerated , and subjects were unable to guess which treatment they had received .\n",
            "There were no significant differences between groups on the social cognition composite score ( +@ versus +@ for the mean change in z-score in the placebo and oxytocin groups , respectively ) or on any of the component social cognitive measures .\n",
            "Post-hoc responder analysis showed @ % of subjects who received oxytocin had > = @ standard deviations improvement from baseline on the composite score versus @ % of subjects receiving placebo .\n",
            "Conclusion : This study demonstrates the feasibility and tolerability of intranasal oxytocin and assessments of multiple domains of social cognition in patients with schizophrenia .\n",
            "Results from this pilot study found that a single dose of intranasal oxytocin did not improve social cognition in schizophrenia .\n",
            "Repeated doses of intranasal oxytocin may be necessary to exert a significant effect .\n",
            "A review of the literature revealed the absence of research on social skills training with married psychiatric patients and their spouses .\n",
            "The present study evaluated such a training program for this population .\n",
            "A social skills training group was compared to an attention double-blind control group .\n",
            "The patients were drawn from the Day Treatment Center at the Veterans Administration Medical Center in Wood , Wisconsin .\n",
            "Patients and their spouses were volunteers and were randomly assigned to the experimental group or the control group .\n",
            "The social skills training focused on self-awareness , awareness of spouse , communication skills , and problem solving .\n",
            "The attention double-blind group focused on a general discussion of marital concerns , and no skills training occurred in this condition .\n",
            "Compared to the control group , it was expected that the experimental group would increase the social skills of both partners in the relationship , and would increase the perceived marital satisfaction of both partners .\n",
            "However , treatment yielded significant changes only on the behavioral measure of couples ' communication skills .\n",
            "It had no impact on the self-report measures of marital satisfaction .\n",
            "No significant follow-up changes were found .\n",
            "Possible reasons for these findings , including demographic variables and type of treatment intervention , are discussed .\n",
            "Future research implications are presented at the end .\n",
            "Background : Cognitive impairment associated with the onset of schizophrenia is severe , nearly ubiquitous , and associated with functional outcomes .\n",
            "The development of interventions to address this aspect of the illness has been ambitiously pursued .\n",
            "Cognitive training approaches that aim to restore abilities have shown some promise .\n",
            "However , gains have been modest , and the inconsistency with which learning generalizes to untrained cognitive tasks significantly limits the viability of cognitive training as a clinical intervention .\n",
            "Transcranial direct current stimulation ( tDCS ) is a neuromodulation technique that modulates neuroexcitablity and can be used in conjunction with cognitive training .\n",
            "To explore the efficacy of this combination , the neural system supporting working memory processes was targeted with repeated , concurrent administration of these interventions .\n",
            "Data from two studies will be presented to demonstrate evidence of target engagement and to quantify the magnitude of training gains and generalization when working memory training is combined with tDCS versus sham .\n",
            "Methods : In study @ , @ patients with schizophrenia were randomized to receive @ hours of working memory training or a time-matched , active placebo condition .\n",
            "Working memory training consisted of adaptive training tasks selected from commercial software as well as N-back tasks developed for this protocol .\n",
            "Outcomes were assessed with a training task ( word N-back ) , a novel version of this training task ( picture N-back ) , and untrained tasks of working memory and related cognitive abilities from the MATRICS Consensus Cognitive Battery ( MCCB ) .\n",
            "A portion of the sample ( n = @ ) underwent fMRI pre - and post-intervention to examine change in brain connectivity attributable to working memory training .\n",
            "In study @ , @ patients with schizophrenia completed the working memory training protocol from study @ with concurrent tDCS ( n = @ ) or sham ( n = @ ) stimulation .\n",
            "Beginning in the third week of training , twice a week , @ mA of anodal tDCS or sham stimulation was applied to the dorsal lateral prefrontal cortex ( F@ ) concurrent with the first @ min of training .\n",
            "Cognitive and symptom outcomes were assessed as well as tolerability of this combination of interventions .\n",
            "Results : Training gains in study @ demonstrated that change on the N-back training task ( learning ) was positively associated with generalization to an untrained task , r = .\n",
            "@ , p = .@ ( unpublished data ) .\n",
            "In study @ , patients who received working memory training with tDCS made significantly greater gains than patients in the sham condition on word , d = .@ , and picture , d = .@ , N-back training tasks and demonstrated greater generalization to untrained tasks .\n",
            "In a subset of the study @ sample , performance gains on the N-back task were associated with increases in thalamo-corticial connectivity following working memory training .\n",
            "Conclusions : Learning on training tasks is predictive of generalization to untrained tasks .\n",
            "Results indicate that tDCS is a safe and efficacious means of promoting learning and generalization of working memory training and suggests that cognitive training methods can be enhanced with tDCS .\n",
            "Intervention-induced change in working memory performance was associated with change in thalamo-cortical connectivity , suggesting that this network might be a fruitful target of intervention with behavioral and neuromodulatory techniques .\n",
            "A RANDOMized clinical trial was carried out including@ schizophrenic patients with residual auditory hallucinations AH .\n",
            "The target symptoms were mainly the AH , but some generalization to social functioningoccurred as well .\n",
            "Mainly the control over voices and interference with functioningcaused by AH improved in the experimental group .\n",
            "The @ frequency and duration of the voices did not change significantly .\n",
            "Many role areas in social functioningimproved significantly as well in the CBT group .\n",
            "But not all subjects in the CBT condition attained clinically significant improvement .\n",
            "Which characteristicsrfactors predict better outcome on measures like : psychopathology , social functioning and quality of life ?\n",
            "Literature is virtually absent in this regard .\n",
            "Most CBT outcome prediction research has been done in non-psychotic disorders .\n",
            "The only relevant study has been done by Garety et al. @ , whose target symptom was delusions .\n",
            "They found that number of admissions in recent years and flexibility of beliefs were associated with outcome .\n",
            "Data collection has just been completed and results of the prediction analysis were not available at the time of abstract submission .\n",
            "The results will include the factors predicting outcome on psychopathology , social functioning and quality of life .\n",
            "Predictors will include : patient history , duration of symptoms , socio demographic variables and first assessment variables .\n",
            "Instruments used are : PANSS , AHRS Auditory Hallucinations Rating Scale , GSDS Groningen Social Disabilities Schedule , WHO Quality of life BREF , Euroqol-@d .\n",
            "Structured daily activity , and paid work in particular , have been shown to have significant impact on the outcome of ensuring psychotic disorders .\n",
            "This study will examine the impact of a dedicated ` work placement co-ordinator ' on the access to work opportunites of @ patients currently in the care of secondary mental health services in two inner London Boroughs .\n",
            "The intervention will be compared to standard care using random allocation between @ sector teams .\n",
            "The intervention consists of a taining package on work placement for the team members and on-going team access to a vocational counsellor for advice .\n",
            "Outcome will be measured by improvements in individual patient activity at one year .\n",
            "Patient predictors of response to the intervention will be sought .\n",
            "Improvement in work activity is of direct benefit to individual patients in terms of self esteen and in stemming clinical and social deterioration .\n",
            "It has also been shown to reduce carer burden , thereby addressing the NHS 's commitment to the needs of families and carers .\n",
            "Work activity may also reduce relapse rate in the longer term and may save on inpatient bed pressure .\n",
            "The establishment of even asmall number of patients in paid employment represents enormous savings in social security transfer payments .\n",
            "A simple generalisable model for work placement in the NHS will be developed .\n",
            "This is a randomised controlled study of the impact of vocational training plus standard CMHT practice .\n",
            "The unit of randomisation will be CMHTs and the unit of outcome will be individual patient employment status .\n",
            "Randomisation will take place withiin Boroughs and will be conducted in a statistician independent to , and remote from , the study .\n",
            "The purpose of comparing aripiprazole and perphenazine treatment efficacy and safety of elderly schizophrenia .\n",
            "Methods @ elderly patients with schizophrenia were randomly divided into two groups , were given aripiprazole and perphenazine @ weeks of treatment , and Brief Psychiatric Rating weekend before treatment and after @ , @ , @ , @ table ( bprs ) , the side reactions scale ( tess ) evaluate the efficacy and adverse reactions .\n",
            "Results of aripiprazole , perphenazine in the treatment of senile schizophrenia was no significant difference ( p > @ ) , but aripiprazole perphenazine adverse reactions were few and mild .\n",
            "We examined whether the interaction of baseline stimulant use , assessed by urine drug tests , and type of serious mental illness ( SMI ) diagnosis predicted stimulant use in a trial of contingency management ( CM ) .\n",
            "The interaction between baseline stimulant use and SMI diagnoses was significant in the overall sample ( p = @ ) when controlling for the main effects of treatment condition , baseline stimulant use , and SMI diagnosis .\n",
            "Similar results were also found within the CM sample .\n",
            "Individuals with bipolar disorder were more or less likely , depending on their baseline stimulant-drug test results , to use stimulants during treatment compared to those with other SMI diagnoses .\n",
            "In this double-blind six-week study , @ chronic schizophrenic patients receiving long-term neuroleptic treatment and trihexyphenidyl were switched to either placebo or study trihexyphenidyl .\n",
            "Fifty-one ( @ % ) of the @ patients given placebo versus @ of the @ patients who continued on active trihexyphenidyl developed severe worsening of extrapyramidal signs , necessitating early termination from the study .\n",
            "Twenty-one ( @ % ) of the placebo patients versus @ ( @ % ) of the trihexyphenidyl patients developed less severe worsening .\n",
            "Furthermore , @ ( @ % ) of the placebo patients but only @ ( @ % ) of the trihexyphenidyl patients had psychotic or other severe physical symptoms related to withdrawal of prestudy antiparkinsonian medication .\n",
            "The authors conclude that these data support the need for continuous use of antiparkinsonian medication in the long - term neuroleptic therapy of chronic schizophrenic patients .\n",
            "Purpose - The primary features of schizophrenia and schizoaffective disorder are characterized by positive ( inability to think clearly and distinguish reality from fantasy ) and negative symptoms ( reduction or absence of normal behavior or emotions ) .\n",
            "Other symptoms include reduced ability to recall and learn information , difficulty in problem solving or maintaining productive employment .\n",
            "Asenapine is an investigational drug that may help to correct the above characteristics of schizophrenia by altering the inbalance of brain hormones such as dopamine and serotonin .\n",
            "This is a @-month trial that will test the efficacy and safety of asenapine using an active comparator ( olanzapine ) in the treatment of patients with schizophrenia .\n",
            "Patients who complete the @-month trial will have the option of continuing on drug until the treatment code for the @-month trial is unblinded .\n",
            "Primary Outcome Measures - Change in total PANSS score at endpoint ( @-week double-blind or last assessment after baseline ) from baseline Secondary Outcome Measures - Changes in PANSS subscale scores and Marder factor scores at Weeks @ , @ , @ , @ , @ , @ , @ , @ , @ , and endpoint Changes in CGI-S at each assessment time point from baseline Patient functionality and subjective well-being ( as measured by LOF , SF-@ and SWN ) at Weeks @ , @ , @ , @ , @ , and endpoint Severity of depressed mood ( as measured by the Calgary Depression Scale for Schizophrenia ) at Weeks @ , @ , and endpoint Resource utilization ( as measured by frequency and length of hospital stay ) during the study period Satisfaction with treatment in comparison with previous treatment as assessed by the investigator and patient ) at endpoint Population kinetics ( plasma samples at weeks @ and @ in comparison with baseline ) Pharmacogenetics ( as part of a global effort to investigate possible associations between genetic polymorphisms in relation to response to asenapine and related drugs and in relation to characteristics of schizophrenia and related conditions ) Safety and tolerability - EPS ( AIMS , BARS , SARS ) at Weeks @ , @ , @ , @ , @ , @ , @ , and endpoint AEs continuously and up to @ days after endpoint pregnancy test at endpoint blood tests at Weeks @ , @ , @ , @ , @ , @ , @ , and endpoint weight and vital signs at all assessment time points from baseline ECGs Weeks @ , @ , @ , and endpoint Total Enrollment - @ Study start - September @ ; Study completion - February @ Eligibility - Ages Eligible for Study - @ Years and above , Genders Eligible for Study - Both Criteria Inclusion Criteria - Subject with schizophrenia or schizoaffective disorder .\n",
            "Subject must sign a written informed consent .\n",
            "Exclusion Criteria - Have an uncontrolled , unstable , clinically significant medical condition .\n",
            "Have any other psychiatric disorder other than schizophrenia as a primary diagnosis including depression .\n",
            "BACKGROUND : Negative symptoms of schizophrenia represent deficiencies in emotional responsiveness , motivation , socialisation , speech and movement .\n",
            "When persistent , they are held to account for much of the poor functional outcomes associated with schizophrenia .\n",
            "There are currently no approved pharmacological treatments .\n",
            "While the available evidence suggests that a combination of antipsychotic and antidepressant medication may be effective in treating negative symptoms , it is too limited to allow any firm conclusions .\n",
            "OBJECTIVE : To establish the clinical effectiveness and cost-effectiveness of augmentation of antipsychotic medication with the antidepressant citalopram for the management of negative symptoms in schizophrenia .\n",
            "DESIGN : A multicentre , double-blind , individually randomised , placebo-controlled trial with @-month follow-up .\n",
            "SETTING : Adult psychiatric services , treating people with schizophrenia .\n",
            "PARTICIPANTS : Inpatients or outpatients with schizophrenia , on continuing , stable antipsychotic medication , with persistent negative symptoms at a criterion level of severity .\n",
            "INTERVENTIONS : Eligible participants were randomised @ : @ to treatment with either placebo ( one capsule ) or @ mg of citalopram per day for @ weeks , with the clinical option at @ weeks to increase the daily dosage to @ mg of citalopram or two placebo capsules for the remainder of the study .\n",
            "MAIN OUTCOME MEASURES : The primary outcomes were quality of life measured at @ and @ weeks assessed using the Heinrich 's Quality of Life Scale , and negative symptoms at @ weeks measured on the negative symptom subscale of the Positive and Negative Syndrome Scale .\n",
            "RESULTS : No therapeutic benefit in terms of improvement in quality of life or negative symptoms was detected for citalopram over @ weeks or at @ weeks , but secondary analysis suggested modest improvement in the negative symptom domain , avolition/amotivation , at @ weeks ( mean difference -@ , @ % confidence interval -@ to -@ ) .\n",
            "There were no statistically significant differences between the two treatment arms over @-week follow-up in either the health economics outcomes or costs , and no differences in the frequency or severity of adverse effects , including corrected QT interval prolongation .\n",
            "LIMITATIONS : The trial under-recruited , partly because cardiac safety concerns about citalopram were raised , with the @ participants recruited falling well short of the target recruitment of @ .\n",
            "Although this was the largest sample randomised to citalopram in a randomised controlled trial of antidepressant augmentation for negative symptoms of schizophrenia and had the longest follow-up , the power of statistical analysis to detect significant differences between the active and placebo groups was limited .\n",
            "CONCLUSION : Although adjunctive citalopram did not improve negative symptoms overall , there was evidence of some positive effect on avolition/amotivation , recognised as a critical barrier to psychosocial rehabilitation and achieving better social and community functional outcomes .\n",
            "Comprehensive assessment of side-effect burden did not identify any serious safety or tolerability issues .\n",
            "The addition of citalopram as a long-term prescribing strategy for the treatment of negative symptoms may merit further investigation in larger studies .\n",
            "FUTURE WORK : Further studies of the viability of adjunctive antidepressant treatment for negative symptoms in schizophrenia should include appropriate safety monitoring and use rating scales that allow for evaluation of avolition/amotivation as a discrete negative symptom domain .\n",
            "Overcoming the barriers to recruiting an adequate sample size will remain a challenge .\n",
            "TRIAL REGISTRATION : European Union Drug Regulating Authorities Clinical Trials ( EudraCT ) number @-@-@ and Current Controlled Trials ISRCTN@ .\n",
            "FUNDING : This project was funded by the NIHR Health Technology Assessment programme and will be published in full in Health Technology Assessment ; Vol .\n",
            "@ , No. @ .\n",
            "See the NIHR Journals Library website for further project information .\n",
            "Objective : Huperzine efficacy of memory dysfunction in schizophrenia .\n",
            "Methods : @ patients with schizophrenia patients Wechsler Memory Scale ( WMS ) A rating their memory function , and then randomly divided into study group ( Huperzine A therapeutic dose of @  @ g / d ) and control group ( maintaining clozapine treatment ) of the @ cases , @ weeks WMS b-type assess changes in memory function , treatment of the memory function of the difference between before and after the group observed two groups were compared within the group .\n",
            "Results : The study group after @ weeks of treatment @  @ accumulation , picture recognition , renewable , tactile , understanding , MQ significantly better than before treatment ( P < @-@ ) , MQ average increase in value of @ .\n",
            "Objective To compare the clinical efficacy and safety of ziprasidone and risperidone in the treatment of schizophrenia .\n",
            "Method in line @ of the @rd edition of the Chinese classification of mental disorders and diagnostic criteria diagnostic criteria for schizophrenia patients were randomly divided into two groups , were given ziprasidone and risperidone for @ weeks , with Scale panss assessment of efficacy , side effects scale the tess assessment of adverse reactions .\n",
            "Results of the two groups showed no significant difference ( p > @ ) , treatment in the two groups before and after panss score relatively positive symptom score , negative symptom score and general psychopathology scores were statistically significant ( p < @ ) after treatment .\n",
            "Background and study aims Persecutory delusions are strong unfounded fears that others intend harm .\n",
            "They are very common , affecting over @ % of patients with schizophrenia ( a mental health problem that affects how a person thinks , feels and behaves ) .\n",
            "These fears can be very upsetting and may cause people to become so anxious that they find it hard to cope with day-to-day life .\n",
            "Many patients do not show enough improvement with current treatments being offered .\n",
            "Therefore a new , more effective treatment is needed .\n",
            "One theory is that persecutory delusions stem from a belief about being   unsafe  .\n",
            "This belief of being   unsafe  is maintained by , for example , worrying , low self-confidence , poor sleep , biases in thinking ( tendencies to think in certain ways ) and avoiding other people .\n",
            "The fear can be reduced by targeting these factors and enabling the patient to relearn that they are safe .\n",
            "This study will compare two treatments which both aim to help people feel safe .\n",
            "The first is a new treatment which has been developed by the study team called   The Feeling Safe Programme  .\n",
            "The second is an existing treatment called   Befriending  .\n",
            "Both treatments are talking therapies which aim to help people feel safe .\n",
            "The Feeling Safe Programme is a targeted and personalised cognitive treatment which focuses on overcoming the key factors which maintain persecutory beliefs , allowing the patient to relearn that they are safe .\n",
            "The Befriending treatment is a social support treatment that simulates how a good friend would respond .\n",
            "Through a supportive , safe relationship it aims to help reduce isolation , provide warmth and empathy , and distract from concerns .\n",
            "The aim of this study is to find out if the Feeling Safe Programme will be more effective in helping people to feel safer ( reduced persecutory delusions ) , feel happier ( improved psychological wellbeing ) and do more of what they want in their life ( increased activity levels ) compared to Befriending .\n",
            "Who can participate ?\n",
            "Patients aged @ or over who have persistent persecutory delusions and have a diagnosis of non-affective psychosis ( e.g. schizophrenia ) .\n",
            "What does the study involve ?\n",
            "Participants are randomly allocated to one of two groups .\n",
            "Those in the first group receive a new psychological treatment called   The Feeling Safe Programme  .\n",
            "Those in the second group receive an existing psychological treatment called   Befriending  .\n",
            "All participants continue with their usual care ( e.g. taking medication ) .\n",
            "Both treatments involve around @ meetings with a clinical psychologist over a period of @ months .\n",
            "At the start of the study and then again after @ and @ months , participants in both groups complete assessments in order to find out if there have been any changes .\n",
            "What are the possible benefits and risks of participating ?\n",
            "All participants will have approximately @ meetings with a clinical psychologist .\n",
            "It is hoped that this will lead to an improvement in their mental well-being .\n",
            "There are no notable risks of taking part in this study .\n",
            "OBJECTIVE : The efficacy and safety of lurasidone in schizophrenia has been demonstrated in multiple controlled trials , primarily in US and European populations .\n",
            "The aim of the current study was To evaluate lurasidone for the treatment of schizophrenia among patients in Japan , Korea , and Taiwan .\n",
            "METHODS : Hospitalized patients ( N = @ ) with schizophrenia were randomized to @ weeks of fixed-dose lurasidone @ mg/d , lurasidone @ mg/d , risperidone @ mg/d , or placebo .\n",
            "Efficacy was assessed using the Positive and Negative Syndrome Scale ( PANSS ) and Clinical Global Impression-Severity ( CGI-S ) .\n",
            "RESULTS : No significant endpoint differences in PANSS total score were found for lurasidone or risperidone vs placebo .\n",
            "Lurasidone was safe and well tolerated , with minimal effects on weight and metabolic parameters .\n",
            "DISCUSSION : The current study was inconclusive regarding the efficacy of lurasidone in schizophrenia but further confirmed its safety and tolerability .\n",
            "The purpose of this report is to describe the impact of a videogame-based physical activity program using the Kinect for Xbox @ game system ( Microsoft , Redmond , WA ) on walking speed in adults with schizophrenia .\n",
            "In this randomized controlled trial , @ participants played either an active videogame for @ min ( intervention group ) or played a sedentary videogame for @ min ( control group ) , once a week for @ weeks .\n",
            "Walking speed was measured objectively with the Short Physical Performance Battery at enrollment and at the end of the @-week program .\n",
            "The intervention group ( n = @ ) showed an average improvement in walking speed of @ m/s and the control group ( n = @ ) showed an average improvement in walking speed of @ m/s .\n",
            "Although the change in walking speed was not statistically significant , the intervention group had between a small and substantial clinically meaningful change .\n",
            "The results suggest a videogame based physical activity program provides clinically meaningful improvement in walking speed , an important indicator of health status .\n",
            "\" AIM : Family psychoeducation is an effective adjunct to pharmacotherapy in delaying relapse among patients with schizophrenia and bipolar disorder .\n",
            "This study tested the treatment adherence and competence of newly trained clinicians to an adaptation of family-focused therapy for individuals at clinical high risk for psychosis ( FFT-CHR ) .\n",
            "METHODS : The sample included @ youth or young adults ( ages @-@ years ) who had attenuated positive symptoms of psychosis .\n",
            "Families participated in a randomized trial comparing two psychosocial interventions : FFT-CHR ( @ sessions over @ months ) and enhanced care ( EC ; @ sessions over @ month ) .\n",
            "Following a @-day training seminar , @ clinicians from eight study sites received teleconference supervision in both treatment protocols for the @-year study period .\n",
            "Treatment fidelity was rated with the @-item Therapy Competence and Adherence Scales , Revised .\n",
            "RESULTS : Supervisors classified @ % of treatment sessions as above acceptable fidelity thresholds ( ratings of @ or better on a @-@ scale of overall fidelity ) .\n",
            "As expected , fidelity ratings indicated that FFT-CHR included a greater emphasis on communication and problem-solving skills training than EC , but ratings of non-specific clinician skills , such as maintaining rapport and appropriately pacing sessions , did not differ between conditions .\n",
            "Treatment fidelity was not related to the severity of symptoms or family conflict at study entry .\n",
            "CONCLUSIONS : FFT-CHR can be administered with high levels of fidelity by clinicians who receive training and supervision .\n",
            "Future studies should examine whether there are more cost-effective methods for training , supervising and monitoring the fidelity of FFT-CHR . \"\n",
            "BACKGROUND : Schizoaffective disorder ( SCA ) is a complex illness for which optimal treatment is not well established .\n",
            "A @-month randomized , double-blind , placebo-controlled , parallel-group study of paliperidone palmitate evaluated time to relapse in patients with schizoaffective disorder .\n",
            "OBJECTI VE : The objective of this study was to estimate the difference in medical costs among patients treated with once-monthly paliperidone palmitate ( PP@M ) versus placebo based on clinical event rates reported in the @-month study .\n",
            "METHOD ( S ) : Rates of relapses and serious and non-serious treatmentemergent adverse events ( TEAEs ) were obtained from the trial .\n",
            "The incremental annual medical cost for a relapse from a U.S. payer perspective was obtained from published literature and the costs for serious and non-serious TEAEs were based on Common Procedure Terminology codes and obtained from Medical Expenditure Panel Survey data and the Medicare Reimbursement Benefit Guideline , respectively .\n",
            "Differences in total annual medical costs for patients treated with PP@M vs. placebo were then estimated .\n",
            "Additionally , oneway and Monte Carlo sensitivity analyses were conducted .\n",
            "RESULT ( S ) : A lower rate of relapse ( -@ % ) and serious TEAEs ( -@ % ) were associated with use of PP@M vs. placebo .\n",
            "As a result of the reduction in these clinical event rates the total annual medical cost was reduced by $ @ per patient treated with PP@M vs. placebo .\n",
            "Oneway sensitivity analysis showed that variations in relapse rates had the greatest impact on the estimated medical cost off-set ( range : $ @ , $ @ ) .\n",
            "Even greater medical cost offset was seen in the patients treated with PP@M monotherapy .\n",
            "The Monte Carlo simulations results demonstrated that the original estimated medical cost differences were relatively robust to random variations .\n",
            "CONCLUSION ( S ) : Use of PP@M for treatment of patients with schizoaffective disorder is associated with a significantly lower rate of relapse and consequently a substantial reduction in medical costs compared to placebo .\n",
            "Further cost evaluation in the real-world setting is warranted .\n",
            "Purpose : Although the Individual Placement and Support ( IPS ) strategy has achieved ' gold standard ' status for enhancing employment among older clients in the later stages of mental illness , the nature and timing of its contributions to younger clients in the early stages of illness is less understood .\n",
            "This randomized controlled trial assesses the effectiveness of the IPS model of employment support in a population-based sample of early-psychosis clients .\n",
            "Methods : We have recruited @ clients from the Fraser Health Early Psychosis program ; @ clients received one year of IPS support and @ received ' treatment as usual ' ( TAU ) .\n",
            "A variety of employment , clinical , and service-use outcomes were assessed at @ - and @-months ; this presentation describes employment outcomes .\n",
            "Results : Over @ months , clients who received IPS in addition to TAU more often worked ( @ % ) than did those receiving TAU alone ( @ % ; chi-square = @ , p = .@ ) .\n",
            "However , there was no significant difference in the number of days worked ( @ days in IPS , versus @ in TAU ; p = .@ ) .\n",
            "Conclusions : When EPI clients are ready to look for work many are successful , compared to clients in later stages of illness .\n",
            "In our early psychosis clients , IPS increased the likelihood of getting work , but did not significantly affect job tenure .\n",
            "Further analyses will assess the nature and timing of differential employment outcomes attributable to IPS .\n",
            "Examined the effects of the @-hydroxytryptamine ( @-HT ) antagonist mianserin ( @ mg/day ) , the anticholinergic drug procyclidine ( @ mg/day ) , and placebo in @ @-@ yr old males with chronic neuroleptic-induced parkinsonism in a double-blind crossover trial .\n",
            "The effect of mianserin did not significantly differ from that of placebo , while parkinsonian symptoms were significantly reduced during treatment with procyclidine .\n",
            "Although mianserin was ineffective in chronic neuroleptic-induced parkinsonism , it is possible that @-HT antagonists may be effective in the treatment of acute extrapyramidal side effects .\n",
            "( @ ref )\n",
            "Background Studies of schizophrenic outpatients taken off maintenance medication show that early intervention ( giving antipsychotic medication only when prodromal symptoms appear ) is not as effective in relapse prevention as maintenance medication .\n",
            "However ( there have been no controlled studies evaluating the effectiveness of early intervention ( increasing antipsychotic medication when prodromal symptoms appear ) for outpatients maintained on standard doses of antipsychotic medication .\n",
            "Method Eighty-two outpatients with schizophrenia maintained on antipsychotic medication were randomly assigned to receive either early intervention treatment ( experimental ) or treatment as usual with no emphasis on early intervention ( control ) and were followed over eighteen months .\n",
            "Results For patients who complied at least minimally with maintenance antipsychotic medication , early intervention was effective with fewer relapses and rehospitalizations and fewer total hospital days compared to the control group .\n",
            "Conclusions An early intervention approach can reduce relapse and rehospitalization rates in schizophrenic outpatients who are compliant with maintenance medication . )\n",
            "ABT-@ , a selective dopamine D@ receptor ( DRD@ ) antagonist , was tested in schizophrenia .\n",
            "A DRD@ gene polymorphism results in an S@G amino-acid change that has been associated with lower risk of schizophrenia , higher affinity for dopamine and some antipsychotics , and differential response to some antipsychotics .\n",
            "The effect of S@G genotype on response to ABT-@ was examined .\n",
            "DNA samples ( N = @ ) were collected in a proof-of-concept , double-blind , randomized , placebo-controlled study of ABT-@ ( @ or @ mg QD ) in acute exacerbation of schizophrenia .\n",
            "A pre-specified analysis assessed impact of genotype ( SS versus SG+GG ) on change from baseline to final evaluation for the Positive and Negative Syndrome Scale ( PANSS ) total score using analysis of covariance with genotype , treatment and genotype-by-treatment interaction as factors , and baseline score as covariate .\n",
            "Significant genotype-by-treatment interaction ( P = @ ) was observed for change from baseline to final evaluation for the PANSS total score .\n",
            "Within subgroup analyses showed significant improvement from placebo in the SG+GG group treated with ABT-@ @ mg .\n",
            "More favorable clinical outcomes were observed in patients treated with ABT-@ @ mg who carried the DRD@ G allele than in those who carried the DRD@ SS genotype .\n",
            "Objective To exp ore the effects of health education on complication and rehabilitation of patients with schizophrenia in community .\n",
            "Methods@ patients with schizophrenia in community were randomly divided into two groups : education group and control group .\n",
            "Education group was given regular strengthen health education , such as telephone counseling and group therapy , etc ; and was evaluated the complication behavior regularly , modified non complication behavior and give at instruction ; No intervention was applied to control group .\n",
            "complication behavior , BPRS and SDSS of both group w ere evaluated at @ months , @ months and @ months after discharged from hospital respectively .\n",
            "Resul ts @ month and @ months after discharged , complication of education group is significantly h igher than that of control group ( P < @ .\n",
            "@ ) ; Results of BPRS and SDSS is significantly lower than control group ( P < @ .\n",
            "@ ) ; Relapse rate is significantly lower than control group ( P < @ .\n",
            "@ , < @ .\n",
            "@ ) .\n",
            "Conclusion Health education can promote complication behavior of patients with schizophrenia in community , and promote rehabilitation of mental and social function , decrease the relapse rate .\n",
            "RATIONALE : Hyperprolactinemia is considered a troubling adverse effect of antipsychotics .\n",
            "Direct comparisons among second generation antipsychotics are scant in clinical practice .\n",
            "We hypothesize prolactin-sparing second-generation antipsychotics may have differential effects on prolactin levels and that they may be influenced by sex .\n",
            "OBJECTIVES : To explore the differential effect of three widely used prolactin-sparing antipsychotics , aripiprazole , quetiapine and ziprasidone , on prolactin plasma levels in first episode non-affective psychosis during a @ year of treatment .\n",
            "METHOD : From October @ to January @ a prospective , randomized , open-label study was undertaken .\n",
            "@ patients who were randomly allocated to aripiprazole ( N = @ ) , quetiapine ( N = @ ) or ziprasidone ( N = @ ) were analyzed .\n",
            "The main outcome was differences in prolactin plasma levels over @ year follow-up among the three antipsychotics .\n",
            "Prolactin levels had a skewed distribution and therefore they were log-transformed before statistical analyses .\n",
            "RESULTS : Male patients on aripiprazole had a lower risk of suffering an increase on prolactin plasma levels ( N = @ ; F = @ ; p < @ ) .\n",
            "There was a gender effect with smaller changes in mean prolactin values only in males .\n",
            "Aripiprazole had a reduced risk of hyperprolactinemia ( aripiprazole @ % ) compared to quetiapine ( @ % ) and ziprasidone ( @ % ) ( p = @ ) ; and quite similar findings were found when investigating males ( p = @ ) .\n",
            "No significant differences were found in females .\n",
            "The percentages of mild prolactin excess were : @ % on aripiprazole , @ % on quetiapine and @ % on ziprasidone ( chi@ = @ p = @ ) .\n",
            "CONCLUSIONS : Our findings provide additional evidence of differential effects of three sparing-prolactin antipsychotics on prolactin release and may help clinicians to decide among therapeutic options .\n",
            "@ chronic schizophrenics who had been stabilized on neuroleptic medication were transferred to sustained-release chlorpromazine or pimozide under double-blind conditions .\n",
            "Both drugs demonstrated effectiveness not only in maintaining adequate control of the patients ' symptomatology , but also in eliciting further remission of the manifestations of their psychosis .\n",
            "Of particular interest was the effectiveness of pimozide for the reduction or elimination of emotional withdrawal .\n",
            "The type and incidence of side effects were similar for both drug groups .\n",
            "Results indicate that both sustained-release chlorpromazine and pimozide provide optimal therapeutic effectiveness at the convenient once-a - day administration schedule .\n",
            "OBJECTIVE : This study evaluated the six-month outcomes of incorporating the principles of supported employment , specifically Individual Placement and Support ( IPS ) , into the About Face program , an existing standardized group-based vocational program for previously incarcerated veterans .\n",
            "METHODS : Participants ( N = @ ) with a history of at least one felony conviction and a substance use disorder ( @ % ) or mental illness or combination ( @ % ) were recruited from a large urban veterans hospital .\n",
            "Veterans were randomly assigned to either the About Face program ( AF ) or to that program plus a modification of IPS ( AF+IPS ) .\n",
            "Veterans were followed for six months .\n",
            "Employment outcomes , including time to employment , hours worked , and income earned , were evaluated with survival analyses and nonparametric tests .\n",
            "RESULTS : Rates of employment over the follow-up period were significantly higher for those receiving AF+IPS , with @ of @ ( @ % ) finding employment , compared with only eight of @ ( @ % ) who received AF alone .\n",
            "As a group , those receiving AF+IPS worked more hours and earned more wages than those receiving AF alone .\n",
            "CONCLUSIONS : Incorporating many of the principles and techniques of IPS into an existing vocational program was associated with improved employment outcomes over the six-month follow-up period and should be considered a viable rehabilitation option when working with this vulnerable population .\n",
            "In this multicenter , double-blind , placebo-controlled , randomized , four way cross-over proof-of-mechanism study , we tested the effect of the positive allosteric @ nicotinic acetylcholine receptor ( nAChR ) modulator JNJ-@ in a key translational assay ( sensory P@ gating ) in @ regularly smoking male patients with schizophrenia .\n",
            "All patients were clinically stable and JNJ-@ was administered as an adjunct treatment to antipsychotics .\n",
            "No indication was found that JNJ-@ has the potential to reverse basic deficits of information processing in schizophrenia ( sensory P@ gating ) or has a significant effect on other tested electrophysiological markers ( MMN , P@ and quantitative resting EEG ) .\n",
            "Sensitivity analyses including severity of disease , baseline P@ gating , medication and gene variants of the CHRNA@ gene did not reveal any subgroups with consistent significant effects .\n",
            "It is discussed that potential positive effects in subgroups not present or not large enough in the current study or upon chronic dosing are possible , but unlikely to be developed .\n",
            "( PsycINFO Database Record ( c ) @ APA , all rights reserved ) ( journal abstract )\n",
            "Objectives : The RAISE-ETP ( Recovery After an Initial Schizophrenia Episode Early Treatment Program ) study compared NAVIGATE , a comprehensive , multidisciplinary , team-based treatment approach for first-episode psychosis ( FEP ) to clinician-choice community care ( CC ) .\n",
            "The primary outcome was quality of life ; secondary outcomes included symptoms and work and school participation .\n",
            "Methods : Thirty-four community treatment clinics in @ states were randomly assigned to provide either NAVIGATE or CC care .\n",
            "NAVIGATE treatment included four core interventions : @ ) personalized medication management ( assisted by COMPASS , a web-based decision support system developed for RAISE-ETP ) ; @ ) family psychoeducation ; @ ) resilience-focused individual therapy ; and @ ) supported employment and education .\n",
            "Diagnosis , duration of untreated psychosis ( DUP ) , and clinical outcomes were assessed live and remotely by two-way video of centralized raters masked to treatment allocation .\n",
            "Participants ( N = @ ; mean age @ years , @ % @ years or younger ; @ % @ years or younger ) , with schizophrenia spectrum disorders and lifetime treatment for antipsychosis ( < @ months ) , were enrolled and followed for at least two years .\n",
            "The primary outcome measure was the total score of the Heinrichs-Carpenter Quality of Life Scale ( QLS ) .\n",
            "Results : Over the first two years , the @ participants at NAVIGATE sites remained in treatment longer ( P < @ ) ; experienced greater improvement in quality of life ( P < @ for QLS total score ) and psychopathology ( P < @ for PANSS total scores ; P < @ for Calgary Depression Scale for Schizophrenia scores ) ; and more involvement in work or school ( P < @ ) compared with the @ participants at CC sites .\n",
            "The sample median DUP was @ weeks .\n",
            "NAVIGATE participants with DUP of @ weeks or less had greater improvement on quality of life and psychopathology compared with those with DUP greater than @ weeks .\n",
            "Subgroup analysis of outcomes for younger participants in the trial will be presented at the meeting .\n",
            "Conclusions : Comprehensive care for FEP can be implemented at community mental health clinics , with associated improvement in functional and clinical outcomes .\n",
            "Effects are more pronounced for those with shorter DUP .\n",
            "Attention to strategies to reduce DUP could improve outcomes for patients early in the course of illness .\n",
            "BACKGROUND : Evidence from preclinical and human studies indicates the presence of reduced dopamine-@ receptor ( D@R ) signaling in the cortex , where D@Rs predominate , in patients with schizophrenia ( SCZ ) , which may contribute to their cognitive deficits .\n",
            "Furthermore , studies in nonhuman primates ( NHP ) have suggested that intermittent administration of low doses of D@R agonists produce long-lasting reversals in cognitive deficits .\n",
            "The purpose of this trial was to test whether a similar design , involving subacute intermittent administration of low doses of a full , selective agonist at D@Rs , DAR-@A , would improve cognitive deficits in SCZ .\n",
            "METHODS : We randomized @ clinically stable individuals with SCZ to three weeks of intermittent treatment with @ mg or @ mg of DAR-@A , or placebo ( normal saline ) .\n",
            "Functional magnetic resonance imaging ( fMRI ) BOLD was used to evaluate the effects of drug administration on brain activity during a working memory ( WM ) task .\n",
            "Effects on cognition were also assessed using the MATRICS and the N-back task as primary endpoints .\n",
            "The CogState battery was used as a secondary endpoint .\n",
            "RESULTS : There were no observed treatment effects on either the BOLD fMRI signal during WM tasks or the WM domains of the MATRICS .\n",
            "Moderate improvement was detected on the CogState battery and on the attention domain of the MATRICS .\n",
            "CONCLUSION : These results suggest that low doses of D@ agonists that do not result in measureable occupancy of the D@R do not reliably improve cognition in SCZ , unlike the observations in NHP .\n",
            "As this drug is limited by its pharmacokinetic profile , better D@R agonists that can achieve adequate levels of D@R occupancy are needed to test the efficacy of this mechanism for cognitive enhancement in SCZ .\n",
            "Objective To study the efficacy of living skill training in improving the life quality of patients with negative symptoms of schizophrenia .\n",
            "Method @ patients with schizophrenia were treated by life skill training , and the efficacy was assessed with NOSIE-@ and SANS .\n",
            "Result The life quality of study group was improved greatly .\n",
            "Negative factors in study group were obviously higher than that in control group ( P < @ .\n",
            "@ ) .\n",
            "the total scores of SANA were lower than that of another group ( P < @ .\n",
            "@ ) .\n",
            "Conclusion Living s\n",
            "Background : In patients with serious mental illness , high prevalence of smoking and obesity-related risk factors contribute to high rates of cardiovascular disease ( CVD ) and premature mortality .\n",
            "The impact of smoking cessation on weight gain , obesity-related risk factors , and overall cardiovascular risk among this population is unknown .\n",
            "Methods : We conducted secondary analyses to assess weight gain and change in CVD risk of @ smokers with serious mental illness ( schizophrenia , schizoaffective disorder , and bipolar disorder ) who participated in a randomized controlled trial to test the long-term effectiveness of varenicline on smoking cessation .\n",
            "Initially , @ smokers with serious mental illness were enrolled into an open-label @-week course of varenicline .\n",
            "Subjects who attained abstinence at the end of the open-label phase were eligible to participate in the randomized phase , and @ subjects were randomized to continue either varenicline or placebo for the following @ weeks .\n",
            "Smoking cessation at week @ ( end of treatment ) was defined as @-day point prevalence abstinence .\n",
            "We compared subjects who were abstinent at week @ ( N = @ ) to subjects who had relapsed to smoking ( N = @ ) on changes in weight and Framingham @-year CVD risk score over the @-week trial ; outcomes were modeled with repeated measures analyses of variance .\n",
            "Results : At baseline , subjects who achieved week @ abstinence were older ( @ vs. @ years , p = @ ) and had higher fasting serum glucose ( @ vs. @ mg/dL , p = @ ) than subjects who relapsed , but they did not differ on sex , race , smoking characteristics , blood pressure , lipids , treatment for diabetes , or treatment with antipsychotic medications .\n",
            "Baseline mean body mass index did not differ between abstinent and relapsed subjects ( @ vs. @ , p = @ ) , but the baseline mean Framingham risk score was higher for abstinent than relapsed subjects ( @ % vs. @ % , p = @ ) .\n",
            "Over the @ week study period , abstinent subjects gained more weight than relapsed subjects ( @ kg vs. @ kg , p = @ for time * abstinence interaction ) , but the mean Framingham risk score decreased substantially for abstinent subjects and not for relapsed subjects ( -@ % vs. @ % , p = @ for abstinence effect adjusting for sex , site , varenicline or placebo , and antipsychotic medications ) .\n",
            "Conclusion : Despite the high prevalence of obesity at baseline and substantial weight gain associated with long-term abstinence , smoking cessation resulted in a large reduction in the Framingham estimated @-year CVD risk among patients with serious mental illness .\n",
            "Purpose : The aim of this @-week study was to directly compare the efficacy and tolerability of the atypical antipsychotics quetiapine , olanzapine , and risperidone in patients with SCHIZophrenia .\n",
            "Methods : This was a multicentre , RANDOMised , parallel-group , rater-blinded study .\n",
            "Patients with a DSM-IV diagnosis of SCHIZophrenia and a Positive and Negative Syndrome Scale ( PANSS ) total score ?\n",
            "@ , were recruited .\n",
            "Antipsychotics were flexibly dosed as follows : quetiapine @-@ mg/day , olanzapine @-@ mg/day and risperidone @-@ mg/day .\n",
            "Efficacy measures included the PANSS and the Brief Psychiatric Rating Scale ( BPRS ) hostility cluster score ( sum of the items of anxiety , tension , hostility , suspiciousness , uncooperativeness and excitement ) .\n",
            "Extrapyramidal symptoms ( EPS ) were assessed using the Simpson-Angus Scale ( SAS ) and the Barnes Akathisia Scale ( BAS ) .\n",
            "Results after @ weeks of treatment are reported here ; all mean scores have been calculated on a last-observation-carried-forward basis .\n",
            "Results : In total , @ patients were RANDOMised to quetiapine , @ to olanzapine and @ to risperidone ( mean PANSS total scores at baseline were @ , @ and @ , respectively ) .\n",
            "Mean doses at week @ were @ mg/day ( quetiapine ) , @ mg/day ( olanzapine ) and @ mg/day ( risperidone ) .\n",
            "Drop-out rates were @ % in quetiapine group and @ % in olanzapine and risperidone groups .\n",
            "After @ weeks of treatment , patients receiving quetiapine , olanzapine or risperidone had a reduction in PANSS total score of @ % , @ % and @ % , respectively .\n",
            "Similar improvements in PANSS positive subscale scores were seen , with reductions of @ % ( quetiapine ) , @ % ( olanzapine ) and @ % ( risperidone ) .\n",
            "The improvements in PANSS negative subscale scores were @ % , @ % and @ % in quetiapine , olanzapine and risperidone groups , respectively .\n",
            "BPRS hostility cluster scores decreased by @ % ( quetiapine ) , @ % ( olanzapine ) and @ % ( risperidone ) .\n",
            "With regard to EPS , baseline SAS scores did not indicate the presence of drug-induced parkinsonian symptoms ; modest improvements were found for quetiapine ( ?\n",
            "@ ) and olanzapine ( ?\n",
            "@ ) , but an increase was observed with risperidone ( +@ ) .\n",
            "BAS scores decreased by @ points with quetiapine and by @ points with olanzapine , but increased by @ points with risperidone ( a score of @ represents no drug-induced akathisia ) .\n",
            "At week @ , the percentage of patients with weight gain ( > @ % from baseline ) was @ % with quetiapine , @ % with olanzapine and @ % with risperidone .\n",
            "With respect to acceptability of drugs , patients treated with quetiapine , olanzapine or risperidone had improvements in the Drug Attitude Inventory total score ( DAI-@ ) of @ , @ and @ , respectively , at week @ .\n",
            "Conclusions : These results suggest that quetiapine , olanzapine , and risperidone are comparable in short-term efficacy and may be selected as first-choice medications for the treatment of SCHIZophrenic patients with acute symptoms .\n",
            "Quetiapine , olanzapine and risperidone also share good global tolerability and acceptability , though with drug-specific differences in some adverse iatrogenic health effects .\n",
            "The differences in some specific safety areas are probably of limited relevance in the case of physically healthy patients , but may represent an acceptable basis for a rational algorithm aimed to select the first-choice atypical antipsychotics in the most vulnerable populations for these specific adverse events .\n",
            "@ chronic schizophrenic outpatients studied .\n",
            "Assigned randomly to placebo , promazine or chlorpromazine and treated under double-blind conditions continuously for periods up to @ months .\n",
            "Hospitalization rate for chlorpromazine signficiantly lower than that of placebo for first @ months .\n",
            "Findings support hypothesis that the effect of phenothiazines represents delay rather than prevention of hospitalization .\n",
            "Objective : To observe the Integrative Medicine clinical efficacy for the treatment of schizophrenia .\n",
            "Methods : @ cases were randomly divided into two groups of @ cases .\n",
            "Clozapine treatment control group , the treatment group in the control group on the basis of oral treatment of Chinese medicine Shun Qi Dao Tan Tang .\n",
            "@w for a course , statistical efficacy after two courses .\n",
            "Results : The control group after treatment , the total effective rate was @ % in the treatment group , the total effective rate of @ % , the two groups of patients after treatment efficacy significant difference ( P < @ ) .\n",
            "SUMMARY : Children and adolescents with chronic neuroleptic therapy are at risk for parkinsonism , tardive dyskinesia , and akathisia , with reported rates reported higher ( Wolf and Wagner , @ ) and lower ( Green , @ ) than for adults .\n",
            "These data are complicated by variation in reported adult rates ( Baldessarini , @ ) and nonpsychotic diagnoses of children given antipsychotic agents .\n",
            "As part of NIMH comparison studies of typical and atypical neuroleptics , neuroleptic-induced tardive dyskinesia and withdrawal dyskinesias were measured at baseline , after a four - week drug-free period ( n = @ ) , and after six weeks treatment with clozapine ( n = @ ) , haloperidol , and benztropine ( n = @ ) , and olanzapine ( n = @ ) using the Abnormal Involuntary Movement Scale ( AIMS ) .\n",
            "Abnormal movements emerging during previous treatment or drug withdrawal phases , and abnormal movements appearing during clozapine , olanzapine , or haloperidol treatment were rated by clinical judgment and by AIMS ( Schooler and Kane , @ ) .\n",
            "Dyskinesias were noted in @ ( @ % ) , eight males and six females , ( mean age @ , and mean neuroleptic exposure of @  @ months ) .\n",
            "Of these , one had preexisting and one a treatment emergent dyskinesia on haloperidol , while @ ( @ % ) had withdrawal dyskinesias .\n",
            "Subsequent treatment with Haldol improved only @/@ ( @ % ) cases , while open or blinded six-week treatment with clozapine produced complete improvement in eight of @ cases ( @ % ) .\n",
            "Thus , clozapine appears effective for treatment of dyskinesias in schizophrenic children .\n",
            "REFERENCES : @ .\n",
            "Casey DE : Motor & mental aspects of extrapyramidal syndromes .\n",
            "International Clinical Psychopharmacology @ ( Suppl .@ ) : @-@ , @ .\n",
            "@ .\n",
            "Crane GE : Pseudoparkinsonism and tardive dyskinesia .\n",
            "Arch Neurol @:@-@ , @ .\n",
            "@ .\n",
            "Jeste DV , Gladsjo JA , Lindamer LA , Lacro JP : Medical comorbidity in schizophrenia .\n",
            "Schizophrenia Bulletin @ ( @ ) : @-@ , @ .\n",
            "@ .\n",
            "Kumra S , et al : Childhood-onset schizophrenia : double-blind clozapine-haloperidol comparison .\n",
            "Arch Gen Psychiatry , in press .\n",
            "INDUSTRY SUPPORTED SYMPOSIUM @ - EXTRAPYRAMIDAL SIGNS IN SCHIZOPHRENIA AND THEIR INFLUENCE ON TREATMENT OUTCOME\n",
            "Objective : to compare cognitive changes between patients treated with ziprasidone or olanzapine .\n",
            "Methods : patients with schizophrenia were randomized to @ weeks ' double-blind therapy with olanzapine ( n = @ ) or ziprasidone ( n = @ ) .\n",
            "Cognitive tests - at baseline and endpoint - included measures of attention/vigilance , executive functioning , learning/memory , verbal fluency , and visuo-motor speed .\n",
            "Results : statistically significant improvements from baseline were seen with both ziprasidone and olanzapine in attention/vigilance , as measured by the ccpt ; visuo-motor speed , as measured by the trailmaking test ; verbal fluency ; and learning/memory .\n",
            "Improvement in executive function was noted for both groups by the trailmaking test , parts a and b , but not by the wcst .\n",
            "The improvements in all domains were comparable for both treatment groups .\n",
            "Conclusions : ziprasidone improves several domains of cognition known to affect functional outcome in schizophrenia .\n",
            "Few notable differences were detected between ziprasidone and olanzapine , suggesting that ziprasidone has cognition-enhancing effects similar to those of other newer antipsychotics .\n",
            "OBJECTIVE : In adults with chronic schizophrenia , most symptom decreases occur in the first few weeks of antipsychotic treatment , and nonresponse at week @ predicts a later nonresponse .\n",
            "The trajectory of antipsychotic response and the predictive value of early antipsychotic effects were investigated for ultimate outcome in adolescent schizophrenia , where such data are still lacking .\n",
            "METHOD : This post hoc analysis of a @-week , randomized , double-blinded trial of aripiprazole ( n = @ ) versus placebo ( n = @ ) evaluated if adolescents @ to @ years old with schizophrenia exhibited substantial symptomatic improvement to aripiprazole in the first few treatment weeks and whether early response ( ER ) versus early nonresponse ( ENR ) predicted clinically relevant outcomes .\n",
            "ER decreased at least @ % and ENR decreased less than @ % in Positive and Negative Syndrome Scale ( PANSS ) total score at week @ ( ER@/ENR@ ) or @ ( ER@/ENR@ ) .\n",
            "Ultimate response decreased at least @ % in PANSS score .\n",
            "RESULTS : Nearly @ % of the PANSS decrease was achieved by week @ and up to @ % by week @ .\n",
            "ER@/ER@ subjects showed significantly greater improvement than ENR subjects in PANSS total score , PANSS positive and negative subscale scores , and functionally relevant outcomes .\n",
            "In general , ER@ had better sensitivity , specificity , and positive and negative predictive values than ER@ for predicting ultimate response .\n",
            "ER@ subjects were @ times ( @ % confidence interval @-@ ) and ER@ subjects were @ times ( @ % confidence interval @-@ ) more likely to achieve remission at week @ ( p < .@ ) than ENR@ and ENR@ subjects , respectively , although adverse events were similar .\n",
            "CONCLUSIONS : Like adults with chronic schizophrenia , adolescents with early-phase schizophrenia exhibited most symptomatic improvement early during aripiprazole treatment , with week @ improvements having the best predictive power .\n",
            "Although requiring extension , these results may inform clinical decision making .\n",
            "Clinical trial registration information-Aripiprazole in Adolescents with Schizophrenia , http://clinicaltrials.gov/ , NCT@ .\n",
            "Background : Previous studies suggest that the serotonin-@ ( @-HT <inf> @ </inf> ) receptor antagonist ondansetron possesses the therapeutic potential for schizophrenia .\n",
            "This study was designed to determine whether ondansetron as an adjunct to haloperidol could enhance the clinical efficacy and reduce the adverse side effects in chronic treatment-resistant schizophrenia .\n",
            "Methods : Under double-blind , randomized conditions , @ treatment-resistant inpatients with chronic DSM-IV-diagnosed schizophrenia received haloperidol ( @-@ mg/day ) combined with either placebo ( N = @ ) or a fixed dose of @ mg/day of ondansetron ( N = @ ) for @ weeks .\n",
            "Efficacy was defined as the change from baseline to endpoint in score on overall scale and subscales of the Positive and Negative Syndrome Scale ( PANSS ) and Clinical Global Impression-Severity ( CGI-S ) .\n",
            "Side effects were evaluated using the Treatment Emergent Symptom Scale and Extrapyramidal Symptom Rating Scale .\n",
            "Results : Ondansetron combined with haloperidol produced a significantly greater improvement on PANSS overall scale and subscales for negative symptoms , general psychopathology , and cognition at endpoint compared to placebo with haloperidol , but no between-treatment group difference was observed on the subscale for positive symptoms and CGI-S .\n",
            "The ondansetron-treated group had a significantly higher proportion of patients with a @ % or greater baseline-to-endpoint reduction in PANSS total score than placebo .\n",
            "Patients in adjunctive ondansetron therapy also experienced significantly lower incidence and severity of parkinsonism and akathisia as well as fewer behavioral hyperactivity , cardiac , and gastrointestinal side effects .\n",
            "Conclusions : Ondansetron is an effective adjunctive agent in enhancing the effectiveness and reducing some adverse side effects of antipsychotic therapy for chronic , treatment-resistant schizophrenia , particularly for negative and cognitive symptoms .\n",
            "RN @ ( Antipsychotic Agents ) .\n",
            "@-@-@ ( Haloperidol ) .\n",
            "@-@-@ ( Ondansetron ) .\n",
            "BACKGROUND : Schizophrenia is associated with widespread cognitive deficits that have an impact on social function .\n",
            "Modafinil promotes wakefulness and is reported to enhance cognition .\n",
            "AIMS : To study the acute effects of modafinil administration upon brain activity and cognitive performance in people with chronic schizophrenia .\n",
            "METHOD : In a randomised double-blind placebo-controlled crossover design , @ patients received either modafinil ( @ mg ) or placebo prior to undertaking a working memory task with functional magnetic resonance imaging .\n",
            "RESULTS : Seventeen patients completed the study and another underwent acute relapse @ days post-drug .\n",
            "Modafinil administration was associated with significantly greater activation in the anterior cingulate cortex during the working memory task .\n",
            "The anterior cingulate cortex signal correlated with cognitive performance , although only a subset of patients exhibited ' enhancement ' .\n",
            "CONCLUSIONS : Modafinil modulates anterior cingulate cortex function in chronic schizophrenia but its beneficial cognitive effects may be restricted to a subset of patients requiring further characterisation .\n",
            "Objective In order to know influence of self - medication skill training on the first outbreak schizophrenia patients  compliance .\n",
            "Methods Divided @ first outbreak schizophrenia patients into the research group ( @ cases ) and control group ( @ cases ) randomly .\n",
            "Routine therapy and nursing were used in control group , while the @ - week self - medication skill training was used in the research group .\n",
            "Therapy compliance was evaluated by the ITAQ and BPRS between the two groups .\n",
            "Results The therapy compliance in the research group was significantly better than that of in control group , the selfmedication skills of patients in the research group was improved obviously .\n",
            "Conclusion Self - medication skill training can effectively improve the compliance of patients with schizophrenia .\n",
            "In @ , an EC-funded multi-site study on the efficacy of acute psychiatric day-hospital treatment ( EDEN-study ) started in five European centres : Dresden ( Germany ) , London ( UK ) , Wroclaw ( Poland ) , Prague ( Czech Republic ) and Michalovce ( Slovak Republic ) .\n",
            "The study utilises a RANDOMised controlled TRIAL and is the first spanning former western and eastern block countries .\n",
            "The prospective design defines repeated measures of objective and subjective outcome criteria at six different time points including a @-month post-treatment period .\n",
            "To guarantee the standard of RANDOMisation the study group ( besides initially agreed upon inclusion and exclusion criteria as well as practical details of the RANDOMisation procedure following the rules of the CONSORT statement ) uses a focus group methodology at the project meetings , continuous e-mail communication between the centres as well as monthly reports according to the CONSORT statement to the co-ordinator .\n",
            "Besides centre-specific measures for continuous training of interviewers ( e.g. for SCAN @ ) the study group e.g. performs video ratings for BPRS and monthly ratings of written vignettes for GSDS ( Groningen Social Disabilities Schedules ) .\n",
            "Details of the procedures and results ( e.g. GSDS role-specific interraterreliability ) will be reported .\n",
            "OBJECTIVE : To evaluate the cost-effectiveness of atypical antipsychotic treatment sequences for the management of stable schizophrenia in the UK .\n",
            "RESEARCH DESIGN AND METHODS : A Markov model was developed to assess the cost per quality-adjusted life year ( QALY ) gained from @ alternative treatment sequences each containing two of four atypical antipsychotics ( aripiprazole , olanzapine , quetiapine and risperidone ) , followed by clozapine .\n",
            "The main model parameters were populated with data from the Clinical Antipsychotic Trials of Intervention Effectiveness ( CATIE ) study and a recent trial comparing aripiprazole with olanzapine .\n",
            "Patients enter the model with stable schizophrenia and may relapse , discontinue or continue and experience adverse events ( AEs ) , or develop diabetes .\n",
            "Population mortality was adjusted for schizophrenia and diabetes .\n",
            "Utility decrements applied to stable schizophrenia , relapse , diabetes and treatment-related AEs were taken from a direct UK utility elicitation study .\n",
            "Resource use and unit costs were taken from published sources .\n",
            "A time horizon of @ years was adopted .\n",
            "Results are based on @ probabilistic iterations of the model .\n",
            "RESULTS : Aripiprazole followed by risperidone produced the greatest number of QALYs , an additional @ compared with risperidone followed by olanzapine , at an incremental cost of pound@ ( incremental cost/QALY : pound@ ,@ ) .\n",
            "Aripiprazole followed by risperidone had the greatest probability among evaluated sequences of being cost-effective at a threshold of > pound@ ,@ / QALY .\n",
            "All other strategies were dominated by at least one of these strategies .\n",
            "The impact of lower pricing for risperidone ( based on generic availability ) did not impact results .\n",
            "CONCLUSIONS : Modelling the cost-effectiveness of different treatment sequences for stable schizophrenia is appropriate given that patients rarely remain on one treatment for long periods .\n",
            "The treatment sequence aripiprazole followed by risperidone was the most cost-effective option for patients with stable schizophrenia in the UK .\n",
            "The selective sigma-ligand EMD @ ( ( @S ) - ( - ) -@ - [ @-hydroxy-@ - ( @-benzodioxol-@-yl ) - piperidin-@-yl-methyl ] -@ - ( @-methoxyphenyl ) - oxazolidin-@-one , HCl ) is a drug with pronounced functional antidopaminergic activity and efficacy in animal models ( Bartoszyk et al. , @ ) .\n",
            "In the dose range indicative for antipsychotic activity ( @mg/kg po ) EMD @ had no effects on general behavior in mice and rats .\n",
            "At higher doses ( @mg/kg po ) EMD @ showed some sedation , hypnotic effects , and weak anticholinergic effects ; EMD @ had no effects on the cardiovascular system .\n",
            "EMD @ showed low acute toxicity ( LD@-values in mg/kg : @ po and @ ip in rats , and @ po and @ ip in mice ) .\n",
            "Side effects in man ( @ male volunteers , double-blind , placebo-controlled , randomized trial ) were classified using the WHO Adverse Reaction Dictionary , Ciba-Geigy Version .\n",
            "Compared to placebo , no dose-dependency of the adverse events was observed for EMD @ after single oral administration ( @ mg ) .\n",
            "EMD @ was well tolerated up to the highest dose of @ mg .\n",
            "Drug-related events were mostly mild and consisted of headache ( @ subjects of @ at @ mg ) , tiredness ( @/@ at @ mg and @/@ at @ mg ) , thirst and flatulence ( @/@ at @ mg ) , diarrhoea ( @/@ at @ mg and @ mg ) , and nausea ( @/@ at @ mg ) .\n",
            "Pharmacokinetics are summarized in the table .\n",
            "Safety and tolerability of a dose of @ mg of EMD @ administered once daily for @ consecutive days was studied in @ male volunteers .\n",
            "Maximal plasma concentration were found after @h ; steady state was reached after the third administration .\n",
            "Compared to the first day , on day @ a slight increase in AUC and terminal half-life was determined .\n",
            "Adverse events ( @/@ subjects ) were the same as reported in the single administration study .\n",
            "In both phase @ clinical studies , the overall assessment by the investigators and the subjects was generally good or very good .\n",
            "The physical examinations , cardiovascular parameters , spirometry , and laboratory tests did not result in any clinically relevant changes .\n",
            "Pharmacokinetics of EMD @ were studied in various species including man after single oral administration .\n",
            "The pharmacokinetic parameters are summarized in the table .\n",
            "species dose Cmax tmax t@/@ AUC@-inf Bioavai - [ ng/ml ] [ h ] [ h ] [ hxng/ml ] lability mouse @ mg/kg @ @ @ @ @ % rat @ mg/kg @ @ @ @ @ % dog @ mg/kg @ @ @ @ @ % monkey @ mg/kg @ @ @ @ @ % man @ mg @ @ @ @ - man @ @ @ @ @ - man @ mg @ @ @ @ - man @ mg @ @ @ @ - man @ mg @ @ @ @ - EMD @ is a potential antipsychotic drug which is well tolerated in animals and man .\n",
            "EMD @ is currently evaluated in first phase II clinical studies .\n",
            "Reference : Bartoszyk , G.D. , Greiner , H.E. , Harting , J. , Stohrer , M. , Seyfried , C.A. ( @ ) .\n",
            "Pharmacological profile of the atypical neuroleptic drug EMD @ .\n",
            "Soc .\n",
            "Neurosci .\n",
            "Abstr .\n",
            "@ , @ .\n",
            "Purpose - The study aims to assess the effects of single dose and repeated weekly dosing of @ mg d-cycloserine versus placebo on cognitive and memory functioning in schizophrenia patients .\n",
            "The study will also examine the effects of @ mg d-cycloserine on positive symptoms and negative symptoms , as well as assess tolerability and side-effects .\n",
            "Massachusetts General Hospital - This is a ten-week , parallel-group , placebo-controlled trial examining the cognitive effects at weeks @ , @ , @ .\n",
            "@ , @ , @ , @ , @ & @ of once-weekly oral D-cycloserine @ mg added to a stable dose of antipsychotic for @ weeks in @ adult outpatients with schizophrenia .\n",
            "Specific aims - Assess the effects of a single dose of D-cycloserine @ mg on cognitive functioning compared to placebo .\n",
            "Assess the effects of repeated weekly dosing of D-cycloserine on cognitive functioning at week @ compared to placebo .\n",
            "Assess the effects of repeated weekly dosing of D-cycloserine on memory functioning once a week @ hour after medication administration compared to placebo .\n",
            "Assess the persistence of learned information in a no-treatment follow-up assessment at Week @ in the D-cycloserine group compared to the placebo group .\n",
            "Assess effects of weekly D-cycloserine dosing on positive & negative symptoms at week @ compared to placebo .\n",
            "Assess tolerability and side effects of weekly D-cycloserine compared to placebo .\n",
            "Assess the effects of d-cycloserine dosed weekly for seven weeks on reward responsiveness as measured with the response bias task compared with placebo .\n",
            "Assess the effects of d-cycloserine dosed weekly for seven weeks on measures of functioning .\n",
            "Eligibility - Ages Eligible for Study - @ Years - @ Years , Genders Eligible for Study - Both Criteria Inclusion Criteria - Male or female Age @-@ years Diagnosis of schizophrenia or schizoaffective disorder , depressed type Stable dose of antipsychotic for at least @ weeks .\n",
            "Able to provide informed consent Able to complete a cognitive battery Exclusion Criteria - Current treatment with clozapine Dementia Seizure disorder Unstable medical illness Active substance abuse Pregnancy , nursing , or unwilling to use appropriate birth control measures during participation if female and fertile .\n",
            "OBJECTIVE : To examine the effectiveness of quetiapine versus conventional antipsychotics in improving cognitive and functional outcomes .\n",
            "METHOD : Forty stable outpatients with DSM-IV schizophrenia treated in public outpatient clinics were randomly assigned to continue taking conventional antipsychotic medications or switch to quetiapine for @ months , beginning September @ and ending July @ .\n",
            "Neurocognitive and functional measures were obtained at study entry , @ months , and @ months by raters blinded to treatment .\n",
            "Group differences were examined using repeated-measures analyses of covariance for mixed models .\n",
            "RESULTS : The mean ( SD ) dose of conventional antipsychotics in chlorpromazine equivalents was @ ( @ ) mg/day ; the mean ( SD ) dose of quetiapine was @ ( @ ) mg/day .\n",
            "A cognitive function summary score improved in the quetiapine group relative to the group treated with conventional antipsychotics over the @-month period ( F = @ , df = @.@ ; p < .@ ) .\n",
            "Patients taking quetiapine did better with respect to both verbal fluency ( initiation ) and verbal memory .\n",
            "There were also statistically significant group differences with respect to quality of life favoring the quetiapine group ( F = @ , df = @ ; p < .@ ) .\n",
            "Differences were not found with respect to adaptive functioning .\n",
            "CONCLUSION : Quetiapine improved cognition relative to conventional agents .\n",
            "After @ months , groups differed by more than @ standard deviation when baseline cognitive functioning was taken into account .\n",
            "No group differences were found with respect to improvements in community functioning .\n",
            "Improvements in adaptive functioning may lag behind improvements in cognition .\n",
            "Psychosocial programming may be necessary to translate gains in cognition into improvements in adaptive functioning\n",
            "AIM : T o explore the influence of modified e lectroconvulsive therapy on serum interleukin-@in schizophrenic patients .\n",
            "METHOD : T esting change of serum IL-@in @cases treated with MECT and@control cases treated with clozap ine therapy by ELISA method .\n",
            "RESULTS : Serum IL-@level before treatment of both groups was positive related to S APS ; serum IL-@level wasn ' t related to BPRS total score , factor score and SA NS total fractions .\n",
            "IL-@level of clo zapine therapy group decrease apparently a fter treatment , and IL-@l\n",
            "Objective : Patients with schizophrenia exhibit impaired social cognition , especially in the recognition and expression of facial emotions , aspects of communication profoundly interlinked in an embodied approach of cognition .\n",
            "Nevertheless , many training programs have been developed that focus on either of these deficits but not both .\n",
            "We therefore designed a training program , Cinemotion , intended to remedy the @ deficits and investigated its feasibility and effects in patients with schizophrenia .\n",
            "Design : Thirty-one patients undergoing treatment for schizophrenia and presenting deficit in emotion recognition were randomized to a group of @ to undergo Cinemotion training , delivered in weekly group sessions , and to a control treatment group of @ .\n",
            "At the conclusion of training or after @ weeks in controls , we reassessed and compared original and final results to determine improvement .\n",
            "Methods : Facial emotions recognition ( TREF ) , empathy ( Questionnaire of Cognitive and Affective Empathy , QCAE ) , and attributional style ( Ambiguous Intentions Hostility Questionnaire , AIHQ ) were assessed before ( T@ ) and after ( T@ ) the program .\n",
            "External evaluators also assessed ability and accuracy of Cinemotion participants to self-generate facial emotion expression in response to verbal instruction .\n",
            "Results : Between T@ and T@ , Cinemotion participants significantly improved total TREF , sadness , disgust , and anger scores , compared to findings in control treatment group .\n",
            "They also improved their ability and accuracy to self-generate facial expressions , especially sadness and fear , with no significant improvement in other components of social recognition .\n",
            "Conclusions : Our findings show the apparent efficacy of training using the Cinemotion program to improve the recognition and expression of facial emotions in schizophrenia .\n",
            "AIMS : To assess the effectiveness of a motivational interview among hospitalized psychiatric patients with comorbid substance use disorder in reducing alcohol and other drug ( AOD ) use .\n",
            "DESIGN : Subjects were assigned randomly to receive an individual motivational interview ( n = @ ) or a self-help booklet ( control condition ; n = @ ) .\n",
            "SETTING : Subjects were volunteers recruited from a major public psychiatric hospital .\n",
            "PARTICIPANTS : Subjects met abuse or dependence criteria on the structured clinical interview for diagnosis ( SCID ) for alcohol , cannabis or amphetamine or they reported hazardous use during the last month of one or more of these drug types on the opiate treatment index ( OTI ) .\n",
            "INTERVENTION : Either one @-@-minute motivational interview or brief advice .\n",
            "MEASUREMENTS : The SCID and OTI were the main measures .\n",
            "FINDINGS : There was a modest short-term effect of the motivational interview on an aggregate index of alcohol and other drug use ( polydrug use on the OTI ) .\n",
            "Cannabis use remained high among the sample over the @-month follow-up period .\n",
            "CONCLUSION : Although motivational interviewing appears feasible among in-patients in psychiatric hospital with comorbid substance use disorders , more extensive interventions are recommended , continuing on an out-patient basis , particularly for cannabis use .\n",
            "A double-blind , parallel-group , randomized , @-day , multicenter study was conducted to compare the effects of placebo and single daily doses of @ mg and @ mg of risperidone in @ patients with schizophrenia .\n",
            "Clinical improvement ( ?\n",
            "@ % reduction in total PANSS scores ) at endpoint was reported in significantly more patients in the risperidone @ mg group ( @ % ) and @ mg group ( @ % ) than in the placebo group ( @ % ) .\n",
            "Furthermore , both risperidone dosing regimens were associated with greater mean decreases in PANSS total and subscale scores ; the differences versus placebo in PANSS total and the positive subscale were significant .\n",
            "Safety data for patients treated with risperidone were similar to those receiving placebo .\n",
            "The mean change in total Extrapyramidal Symptom Rating Scale scores from baseline to worst score was similar in all three groups .\n",
            "The percentages of patients reporting adverse experiences were similar in the three treatment groups .\n",
            "It is concluded that once-daily doses of @ mg and @ mg of risperidone are safe and effective .\n",
            "Clonazepam and artane double-blind control study was made in @ patients with akathisia by antipsychotics to explore the curative effect of the @ drugs .\n",
            "Results The curative effect of the @ drugs was similar , but antianxietic effect of clonazepam was better than that of artane .\n",
            "This showed that it deserve to spread that clonazepam treat akathisia by anlipsychotics .\n",
            "To evaluate whether a form of cognitive therapy ( recovery Intervention ) developed by the applicants is an effective intervention to promote personal adjustment to psychosis and reduce depression , trauma and other characteristic negative consequences of psychosis .\n",
            "Prospective randomised controlled trial .\n",
            "Two groups of patients are randomised to either the experimental group or the control group .\n",
            "The recovery group will receive the treatment over six months following first onset and treatment of psychosis .\n",
            "Post psychotic depression , Symptoms of post Traumatic stress disorder , Adaptation to psychosisCost utility of the latest antipsychotics in severe schizophrenia .\n",
            "Antipsychotic ( neuroleptic ) drugs remain central to the treatment of the symptoms of schizophrenia .\n",
            "Conventional drugs are effective in @ % of patients but have frequent neurological side effects .\n",
            "The atypical antipscyhotics are a new class of drugs with a lower risk of these side effects and , in the case of clozapine , better efficacy .\n",
            "The cost of these new drugs is @-@ times that of conventional drugs .\n",
            "There are currently no reliable data about their comparative effectiveness and cost-effectiveness in NHS settings on which to guide practice .\n",
            "If their use continues to expand , the annual drugs budget for schizophrenia in England will increase from @ million to @ million .\n",
            "A @-centre , prospective , randomised , controlled trial is proposed to evaluate the relative effectiveness of the new drugs compared to conventional drugs and to clozapine in a sample of @ people with schizophrenia who are resistant to or intolerant of usual treatment .\n",
            "The trial will aim to demonstrate important differences in quality of life and other outcomes at @ year , assess value for money and identify cost-effective management strategies .\n",
            "@ subjects ( PROJ @/@/@ )\n",
            "The primary aim of the project is to test the effectiveness of a cognitive remediation program , My Brain Solutions ( MBS ) , in addition to motivational interviewing ( MI ) in improving cognition and functional outcome of individuals at risk of SMI .\n",
            "A control treatment consisting of MI will be used .\n",
            "Hypotheses : @ .\n",
            "MBS+MI group will have improvements in cognition at the end of treatment and @ months post baseline compared to the MI group ; @ .\n",
            "Improved cognition will be associated with improved functional capacity and psychosocial functioning .\n",
            "Recently , increasing attention has been drawn to the potential diabetogenic effect of atypical antipsychotics .\n",
            "The goal of this prospective study is to evaluate the early effect of olanzapine and risperidone treatment on pancreatic beta-cell function in atypical-naive schizophrenic patients .\n",
            "Twenty-six subjects were assigned randomly to therapy with olanzapine or risperidone for @ days .\n",
            "The metabolic parameters were quantitatively assessed by using the intravenous glucose tolerance test .\n",
            "The levels of fasting glucose , fasting insulin , lipid profiles , and leptin were also assessed .\n",
            "There were no significant within-group changes in weight or body mass index for both groups after @ weeks of treatment .\n",
            "The levels of fasting glucose , fasting insulin , cholesterol , or leptin did not change in both groups .\n",
            "The triglyceride level significantly increased in olanzapine group .\n",
            "Glucose disappearance rate and insulin sensitivity did not change in both groups .\n",
            "Insulin secretion significantly decreased in olanzapine group .\n",
            "After @ weeks of olanzapine treatment , schizophrenic patients decreased insulin secretory response to a hyperglycemic challenge .\n",
            "The results of this study support the hypothesis that olanzapine might directly impair pancreatic beta-cell function .\n",
            "RN @ ( Antipsychotic Agents ) .\n",
            "@ ( Benzodiazepines ) .\n",
            "@ ( Blood Glucose ) .\n",
            "@ ( Lipids ) .\n",
            "@-@-@ ( Risperidone ) .\n",
            "@-@-@ ( Insulin ) .\n",
            "@-@-@ ( olanzapine ) .\n",
            "Purpose : To investigate the acupuncture plus small doses of antipsychotic drugs on the efficacy of adolescent schizophrenia Methods : @ cases of adolescent patients with schizophrenia were randomly divided into acupuncture plus a small dose of antipsychotic drug treatment group and control simple acupuncture group A simple traditional antipsychotics in the control group B. Brief Psychiatric Rating Scale ( BPRS ) positive symptoms rating scale ( SAPS ) , negative symptoms rating scale ( SANS ) , adverse reactions scale ( TESS ) and psychiatric clinical efficacy comprehensive assessment criteria .\n",
            "Results : after treatment , the BPRS , SAPS , SANS total score , each factor and efficacy of the two control groups have a very significant difference ( P < @ ) , and TESS scale assessment of the treatment group and control group B has a very significant difference ( P < @ ) Conclusion : acupuncture plus small doses of antipsychotic treatment of adolescent schizophrenia with good effect . \" \"\n",
            "Objective : A number of studies have shown that olanzapine and risperidone are more clinically effective than other antipsychotics .\n",
            "Consequently , if a treatment-resistant schizophrenic patient has not received them so far in their treatment history , it would be a sensible choice to use these drugs in treatment before beginning a clozapine regimen .\n",
            "In the present investigation the efficacy and safety of these two atypical antipsychotics were compared with each other .\n",
            "Method : Sixty schizophrenic patients , allocated randomly into @ matching groups to participate in a twelve-week , double-blind evaluation for random assignment to risperidone or olanzapine .\n",
            "The chief procedures used for assessment were Scale for Assessment of Negative Symptoms ( SANS ) ' and ' Scale for Assessment of Positive Symptoms ( SAPS ) ' .\n",
            "The Scale for Assessment of Negative Symptoms ( SANS ) ' and ' Scale for Assessment of Positive Symptoms ( SAPS ) ' were used as supplementary measures .\n",
            "Treatment efficacy was evaluated statistically by the use of the t statistic and repeated-measures analysis of variance ( ANOVA ) .\n",
            "Clinical response was defined as a decrease of at least twenty percent in total scores of SANS and/or SAPS .\n",
            "Results : Both risperidone and olanzapine were significantly beneficial for alleviation of positive symptoms ( p < @ & p < @ , respectively ) , but only olanzapine improved significantly the negative symptoms ( p < @ ) .\n",
            "In addition , SAI was boosted significantly by olanzapine ( p < @ ) .\n",
            "CGI-S had shown significant alterations by both of risperidone and olanzapine ( p < @ and p < @ , separately ) .\n",
            "Finally , risperidone triggered significant escalation of SAS in the related group ( p < @ ) .\n",
            "Conclusion : In this evaluation , risperidone and olanzapine were equally useful in control of clinical symptoms of schizophrenia , but olanzapine demonstrated higher efficiency in comparison with risperidone .\n",
            "Objective : To examine the relative effects of risperidone ( RIS ) and haloperidol ( HAL ) on newly emergent obsessive compulsive ( OCS ) and depressive symptoms ( DS ) in treatment refractory schizophrenic patients .\n",
            "Methods : a randomized , double-blind , prospective , parallel group .\n",
            "three phase study ( @ week placebo wash-in ; @ weeks fixed dose [ @ mg RIS vs @ mg HAL ] ; and @ weeks , clinican choice flexible dose [ @-@ mg RIS vs @-@ mg HAL ] ) .\n",
            "Patients were evaluated weekly using standard measures of psychopathology ( for example , PANSS ) and neurotoxicity and with modified Yale-Brown OCS scale and the Hamilton Depression Scale .\n",
            "Results : @ subjects have been randomized .\n",
            "More of the RIS subjects developed treatment emergent OCS than HDL treated subjects ( @ % vs @ % , x  = @ , p = .@ ) .\n",
            "While DS improved in both groups , the HAL treated group improved more ( t = @ , p = .@ ) .\n",
            "Both groups improved about @ % across all three subscales of the PANSS .\n",
            "Conclusions : These results suggest that treatment emergent OCS is greater in RIS treated sujbects .\n",
            "This effect is independent of the antipsychotic effect , HAL appeared to decrease DS slightly more than RIS .\n",
            "Overall , these preliminary data appear to confirm RIS 's theoretical OCS liability .\n",
            "They do not confirm RIS 's speculated antidepressant effect .\n",
            "Introduction : Daytime sleepiness associated with antipsychotic treatment may adversely impact treatment outcomes , functional performance , and quality of life [ @ ] .\n",
            "The aim of this post-hoc analysis was to compare the effects of @ atypical antipsychotic agents , lurasidone ( @ mg/d or @ mg/d ) and quetiapine XR ( @ mg/d ) , on daytime alertness , and to evaluate the effects of daytime sleepiness on treatment outcomes in patients with an acute exacerbation of schizophrenia .\n",
            "Methods : Subjects who met DSM-IV-TR criteria for schizophrenia were randomized to @-weeks of double-blind treatment with fixed doses of lurasidone @ mg/d ( n = @ ) , lurasidone @ mg/d ( n = @ ) , quetiapine XR @ mg/d ( n = @ ) , or placebo ( n = @ ) , all dosed once-daily in the evening , with food [ @ ] .\n",
            "Daytime sleepiness was assessed using the Epworth Sleepiness Scale ( ESS ) at baseline , week @ , and week @ visits [ @ ] .\n",
            "The ESS is a patient-reported questionnaire , which consists of @ items that describe various routine daily life situations .\n",
            "Subjects rate the likelihood of dozing or falling asleep ( distinguishing dozing behavior from feelings of tiredness ) in each of these situations , on a @-point scale from @ to @ .\n",
            "It has been validated in both case-control studies of normal subjects and several patient populations with different types of sleep disorders .\n",
            "In addition , the ESS has been utilized for the assessment of daytime sleepiness in patients with schizophrenia .\n",
            "A mediation regression approach was applied to explore the effect of daytime sleepiness on changes in agitation ( assessed by PANSSEC ) , cognition ( assessed by CogState Computerized Schizophrenia Battery ) , and functional capacity ( assessed by UPSA-B score ) .\n",
            "Results : Daytime sleepiness improved in the lurasidone and placebo-treated groups but worsened in the quetiapine XR treatment group when compared to placebo ( p = @ ) and to either dose of lurasidone ( both p < @ ) .\n",
            "Sedation associated with quetiapine XR treatment mediated an improvement in agitation and a worsening in functional capacity ; these mediating relationships were not observed for the lurasidone or placebo treatment groups .\n",
            "Structural equation models showed that high likelihood of ESS item ' dozing when talking ' was a significant mediator of re-duction in overall cognitive performance for quetiapine XR @ mg/d vs. placebo ( p = @ US sites ) and for quetiapine XR @ mg/d vs. lurasidone @ mg/d ( p = @ for US sites , and p = @ for all subjects ) .\n",
            "Conclusions : In this @-week double-blind study , treatment with lurasidone @ mg or @ mg , administered once-daily in the evening , was associated with a reduction in daytime sleepiness similar in magnitude to placebo , while quetiapine XR @ mg/d was associated with a significant increase in daytime sleepiness .\n",
            "Daytime sleepiness was associated with improvement in agitation and worsening in functional capacity for quetiapine XR , but not lurasidone or placebo-treated patients .\n",
            "Our findings suggest that daytime somnolence may have a significant impact on cognitive and functional outcomes in patients with schizophrenia .\n",
            "The article focuses on the metabolic consequences of long-term treatment with olanzapine , quetiapine and risperidone .\n",
            "Here the author contrasted the studies which showed that the antipsychotic drugs do not significant adverse effects on metabolic measures to that of a clinical trial of patients with schizophrenia or bipolar disorder currently in progress .\n",
            "In this study , patients who have not received olanzapine or risperidone for at least @ months were randomly assigned to either treatment and treated openly , without restricting concomitant mood stabilizers or antidepressant drugs .\n",
            "Data are available for approximately two thirds of the sample at @ months and @ % at @ months .\n",
            "In our study , body mass index ( BMI ) , at baseline , was @ + @ in the risperidone-treated and @ + @ in the olanzapine treated patients .\n",
            "Consistent with the literature , BMI increased in both groups over time , but the increase in the olanzapine-treated group was significantly greater .\n",
            "The ability of long-acting fluphenazine decanoate and oral fluphenazine hydrochloride to forestall relapse among newly discharge schizophrenic patients is examined in the context of high and low degrees of social therapy ( ST ) .\n",
            "A total of @ patients were randomly assigned to the various treatments and maintained under controlled conditions for two years or until relapse .\n",
            "Relapse rates for all treatments remained traditionally high .\n",
            "Relpase rates for long-acting fluphenazine decanoate and oral fluphenazine hydrochloride are nearly identical in the first year , indicating that drug noncompliance does not adequately explain early schizophrenic relapse .\n",
            "However , patients who received long - acting fluphenazine decanoate and ST have a reduced risk of relapse over time .\n",
            "Relapsers who received long-acting fluphenazine decanoate appeared more affectively disturbed than other relapsers , yet both groups were diagnostically and symptomatically equivalent prior to treatment .\n",
            "Personal discomfort and intrafamilial stress are important predictors .\n",
            "The purpose of study was to investigate the efficacy and safety of loxapine succinate for schizophrenia .\n",
            "Methods @ patients met the CCMD-@ randomized , double-blind , schizophrenia is divided into @ patients in each study group and the control group .\n",
            "Study group was given Loxapine starting dose of @ mg.d-@ , the highest dose of @ mg.d-@ , the average ( @  @ ) mg.d-@ ; control group was given risperidone , @ mg starting dose d-@ , the highest dose mg.d-@ , an average of ( @  @ ) mg.d-@ daily for @ weeks .\n",
            "To evaluate the efficacy of the Positive and Negative Syndrome Scale ( PANSS ) , the adverse reactions Scale ( TESS ) assessment of adverse reactions .\n",
            "Results of the two groups PANSS total score than before treatment significantly reduced , and no significant differences between the two groups ( P > @ ) .\n",
            "The research group was @ % and @ % in the control group , the difference between the two groups was no significant ( P > @ ) .\n",
            "The TESS that two sets of major adverse events were extrapyramidal reactions ( EPS ) sleep disorder of the control group was higher than in the study group .\n",
            "Conclusion loxapine treatment of schizophrenia with risperidone similar , but the rapid onset of low-dose atypical antipsychotics characteristics .\n",
            "Objective : To investigate the impact of the implementation of the rehabilitation training for patients with chronic mental recession .\n",
            "Methods : @ cases of long-term hospitalization of mental patients , random sampling divided into test and control groups , the implementation of the rehabilitation training before and after one year with the Nurses inpatient Observation Scale ( NOSIE ) assessment and analysis .\n",
            "Results : The total negative factors of the test group divided by @ % , the total positive factors points increased by @ % .\n",
            "Total of the negative factors of the control group decreased by @ % , the total of positive factors increased @ % , did not change significantly .\n",
            "Objective : To investigate the impact of the implementation of the rehabilitation training for patients with chronic mental recession .\n",
            "Methods : @ cases of long-term hospitalization of mental patients , random sampling divided into test and control groups , the implementation of the rehabilitation training before and after one year with the Nurses inpatient Observation Scale ( NOSIE ) assessment and analysis .\n",
            "Results : The total negative factors of the test group divided by @ % , the total positive factors points increased by @ % .\n",
            "Total of the negative factors of the control group decreased by @ % , the total of positive factors increased @ % , did not change significantly .\n",
            "Conclusion : The implementation of the rehabilitation training can reduce the the downturn degree of chronic mental patients .\n",
            "Objective : The purpose of the present study was to evaluate the efficacy and tolerability of olanzapine long-acting injection for maintenance treatment of schizophrenia .\n",
            "Method : Outpatients with schizophrenia who had maintained stability on an oral regimen of olanzapine ( @ , @ , or @ mg/day ) for @ to @ weeks were randomly assigned to @ weeks of double-blind treatment with \" low \" ( @ mg every @ weeks ; N = @ ) , \" medium \" ( @ mg every @ weeks ; N = @ ) , or \" high \" ( @ mg every @ weeks ; N = @ ) doses of olanzapine long-acting injection ; a very low reference dose of olanzapine long-acting injection ( @ mg every @ weeks ; N = @ ) ; or their stabilized dose of oral olanzapine ( N = @ ) .\n",
            "Rates of and time to psychotic exacerbation were estimated using Kaplan-Meier methodology .\n",
            "Results : At @ weeks , the majority of oral olanzapine-treated patients ( @ % ) , as well as most olanzapine long-acting injection-treated patients receiving high ( @ % ) , medium ( @ % ) , low ( @ % ) , and very low doses ( @ % ) , remained exacerbation free , with the therapeutic @-week regimen ( medium dose ) and pooled @-week regimen ( low and high doses ) demonstrating efficacy similar to that of oral olanzapine as well as to each other .\n",
            "The three standard long-acting doses were superior to the very low reference dose based on time to exacerbation .\n",
            "Incidence of weight gain [ greater-than or equal to ] @ % of baseline was @ % for oral olanza-pine compared with @ % , @ % , @ % , and @ % for the high , medium , low , and very low olanzapine long-acting treatment groups , respectively .\n",
            "No clinically significant differences were observed between the long-acting injection and oral olanzapine groups in general safety parameters .\n",
            "Few injection-site reactions occurred ( @ % ) .\n",
            "Two patients experienced sedation and delirium consistent with olanzapine overdose following possible accidental intravascular injection .\n",
            "Conclusions : Olanzapine long-acting injection was efficacious in maintenance treatment of schizophrenia for up to @ weeks , with a safety profile similar to oral olanzapine except for injection-related adverse events .\n",
            "A parallel group double-blind comparative trial was conducted to study the efficacy and safety of risperidone compared with haloperidol .\n",
            "After a one-week eashout , @ chronic schizophrenic patients ( @ males , @ females ) were randomly assigned to one of two groups for eight weeks of double-blind treatment .\n",
            "The patients ' psychopathology was assessed by means of the Positive and Negative Syndrome Scale for Schizophrenia ( PANSS ) and the Clinical Global Impression ( CGI ) .\n",
            "Safety assessment included the Extrapyramidal Symptom Rating Scale ( ESRS ) , the UKU Side Effect Rating Scale , vital signs , body weight , ECG and laboratory screening .\n",
            "thirty-two patients completed the trial : there were @ drop-outs in the risperidone group .\n",
            "The results on the PANSS and CGI indicate that the mean changes from baseline on the total PANSS score and on the total BPRS score were comparable in both treatment groups .\n",
            "The number of patients where a clinical improvement at least @ % reduction in baseline score was also similar in both treatment groups .\n",
            "Risperidone caused less extrapyramidal symptoms and less side effects in UKU scale than haloperidol .\n",
            "No significant ECG changes were induced , no relevant changes in blood pressure or clinical laboratory parameters were observed .\n",
            "This study has demonstrated that the combined serotonin @-HT@ and dopamine-D@ antagonist risperidone is an antipsychotic as potent as haloperidol .\n",
            "Risperidone causes less extrapyramidal symptoms , and is better tolerated than haloperidol .\n",
            "Antipsychotic effects on C-reactive protein ( CRP ) have received little attention .\n",
            "This randomized open-label study investigated the possible effects of antipsychotics on CRP levels after @ and @ months of treatment in a Spanish drug-naive sample taking haloperidol ( N = @ after @ months ) , olanzapine ( N = @ after @ months ) or risperidone ( N = @ after @ months ) .\n",
            "After @ months and adjusting for differences in baseline CRP levels , baseline smoking and high baseline triglyceride levels , patients on haloperidol treatment had CRP levels that were @ % higher than those of patients on risperidone treatment ( p = @ ) .\n",
            "After @ months , only smoking was associated with increased CRP levels .\n",
            "Future studies need to verify that different antipsychotics may have differential effects on CRP levels , particularly after @ months of treatment .\n",
            "( PsycINFO Database Record ( c ) @ APA , all rights reserved ) ( journal abstract )\n",
            "Objective To explore domestic Ziprasidone treatment on schizophrenia and the side effects .\n",
            "Methods Total @ cases of patients with schizophrenia were randomly divided into Ziprasidone group ( @ cases ) and Risperidone group ( @ cases ) .\n",
            "Carries on the clinical check experiment , Two groups of medicines therapeutic dose respectively is @  @mg/d and @  @mg/d , the treatment course is @ weeks .\n",
            "Indicators include the effect of positive and negative symptom scale ( PANSS ) and overall clinical imp ression scale ( CGI ) , adverse reactions indicators for adverse reactions Symp tom Rating Scale ( TESS ) and the laboratory .\n",
            "Results At the end of treatment , both group s PANSS score in the group , were significantly reduced ( P < @ ) .\n",
            "By PANSS total points : Ziprasidone group ( @  @ % ) , Risperidone group ( @  @ ) % ; The total efficiency : Ziprasidone group @ % , @ % of Risperidone group , Two groups of the difference was significant ( P < @ ) .\n",
            "Ziprasidone and Risperidone groups haue no significant difference in the overall adverse reactions , but there are similarities and differences between the performance of adverse reactions .\n",
            "Conclusion Domestic Ziprasidone treatment of schizophrenia is an effective , safe drugs , Although less effect on Risperidone , but adverse reaction and Risperidone have different performance , with the choice of medication and individual treatment guide .\n",
            "The purpose of evaluation of risperidone in the treatment of chronic schizophrenia and its effect on the rehabilitation of the social function of Methods randomized controlled fluphenanize .\n",
            "@ cases of patients with chronic schizophrenia were randomly divided into two groups of eight weeks of treatment , efficacy and functionality of the Brief Psychiatric Rating Scale , the Social Disability Scale ( SDSS ) , adverse drug reaction scale ( TESS ) were evaluated .\n",
            "The cure rate of @ % of the risperidone group was significantly higher than @ % of the fluphenazine group .\n",
            "The two drugs were efficient and the total effective rate was no significant difference ; SDSS score in the risperidone group after treatment was significantly lower than the fluphenazine group TESS total score was significantly lower than the fluphenazine group .\n",
            "SUMMARY : Introduction : Longitudinal studies of elderly patients have found that there may be a decrease in positive symptoms over time .\n",
            "This change in psychopathology , along with physiologic changes of aging ( affecting pharmacokinetics and pharmacodynamics ) complicate the evaluation of maintenance therapy in the elderly .\n",
            "We conducted a study to safely determine the lowest effective neuroleptic dosage in older psychotic patients and evaluate the clinical , neuropsychological , and psychosocial effects of neuroleptic dosage reduction .\n",
            "Methods : @ patients with schizophrenia and related psychotic disorders over the age of @ who met DSM-IV criteria for \" in remission '' were compared to age and education matched patients who were currently off neuroleptics ( n = @ ) or maintained on neuroleptics ( n = @ ) .\n",
            "The patients were assigned to EITHER a @ % or a @ % taper group and had their dosage decreased by @ % each month if no worsening of symptoms occurred .\n",
            "All groups were followed for @ months .\n",
            "Results : @ % of patients in the taper group , @ % of neuroleptic free patients , and @ % of the maintenance group experienced some increase in psychopathology over the follow-up period .\n",
            "Patients treated with neuroleptics ( taper group and maintenance group combined ) were maintained on approximately @ % of their original neuroleptic dosage after stabilization without an increase in psychopathology .\n",
            "Conclusion : Carefully selected older psychotic patients can be maintained on reduced dosages of neuroleptic medication without a significant increase in psychopathology .\n",
            "Neuropsychological and psychosocial findings will be discussed .\n",
            "Total Enrollment - @ People with schizophrenia have a large number of social and symptom management training programs available to them .\n",
            "Studies suggest that these training programs are effective , but their generalizability and effectiveness in outpatient settings has not been thoroughly examined .\n",
            "This study will examine the treatment outcomes of a skills training approach in schizophrenic individuals taking antipsychotic medication .\n",
            "Participants taking stable doses of risperidone , olanzapine , or quetiapine will be randomly assigned to receive either intensive symptom management and social skills training or group therapy for @ months .\n",
            "A verbal memory test will be used to stratify the randomization procedure and to control for neurocognitive functioning .\n",
            "Purpose - This study will determine the effectiveness of skills training in people with schizophrenia and the applicability of the acquired skills in the  real world . \n",
            "Eligibility - Ages Eligible for Study - @ Years - @ Years , Genders Eligible for Study - Both Criteria Inclusion Criteria - Diagnosis of schizophrenia or schizoaffective disorder for > @ years Use of stable dose risperidone , olanzapine , or quetiapine for at least @ month with no planned medication changes Social Behavior Scale ( SBS ) score > @ Willing and able to provide informed consent Exclusion Criteria - IQ < @ Use of more than one antipsychotic medication Use of benzodiazepines , tricyclic antidepressants , or anticholinergic medication commonly used to treat extrapyramidal symptoms DSM-IV criteria for alcohol or other substance dependence History of any traumatic brain injury leading to loss of consciousness for > @ minutes Diagnosis of a comorbid medical condition that could interfere with antipsychotic medication treatment or the ability to complete the study\n",
            "The \" CAJ purpose : comparison of national second class drug quetiapine tablets and risperidone ( Risperdal ) tablets in the treatment of schizophrenia efficacy and safety .\n",
            "METHODS : @ patients were randomly divided into two groups , the treatment group ( @ cases ) the oral quetiapine piece @ to @ mg / d , the control group ( @ cases ) of oral Risperdal tablets @ ~ @ mg / d , course of treatment was @ weeks .\n",
            "positive and Negative Syndrome scale ( PANSS ) to assess the clinical to Vice reaction scale ( TESS ) evaluation of adverse drug reactions and results : the remarkable efficiency of the treatment group was @ % , @ % in the control group , no significant difference in the two groups ; two sets of adverse reactions were less , but the treatment group is excited , lethargy the incidence significantly more than the control group ( P < @ ) .\n",
            "Conclusion : domestic quetiapine tablets in the treatment of schizophrenia is effective and safe , and the efficacy of Risperdal tablets / / WANFANG Objective : To compare national second class drug quetiapine tablets and risperidone ( Risperdal ) tablets in the treatment of schizophrenia in efficacy and safety .\n",
            "Methods : @ patients were randomly divided into two groups , the treatment group ( @ cases ) oral tablets of quetiapine @ to @ mg / d , the control group ( @ cases ) the oral Risperdal tablets @ to @ mg / d , the course of treatment was @ weeks .\n",
            "evaluate the efficacy positive and Negative Syndrome scale ( PANSS ) to Vice reaction scale ( TESS ) evaluation of adverse drug reactions .\n",
            "results : The remarkable efficiency of treatment group was @ % , @ % in the control group , no significant difference between the two groups ; two sets of adverse reactions were less , but the treatment group is excited , lethargy the incidence significantly more than the control group ( P < @ ) Conclusion : domestic quetiapine tablets in the treatment of schizophrenia and safety , and efficacy of Risperdal tablets .\n",
            "A small sample of adolescents hospitalized in a public mental health facility received family therapy while a control group received individual therapy .\n",
            "Follow-up at three months indicated that those treated in family therapy returned to functioning more rapidly and were rehospitalized less frequently than adolescent patients in individual therapy .\n",
            "Directions for further study are suggested\n",
            "Background .\n",
            "Disturbances of mnemonic function and language usage occur in a number of diseases associated with central cholinergic dysfunction ( eg .\n",
            "dementia of the Alzheimer 's type ) .\n",
            "Consequently , cholinergic agents have been developed which are effective for the enhancement of cognition in dementing conditions associated with central cholinergic dysfunction ( Knapp et al , @ ; Rogers et al , @ ) .\n",
            "Schizophrenic patients also show impairments of mnemonic function that affect both verbal and episodic memory as well as language usage ( Saykin et al , @ ; Goldberg et al , @ ; Tamlyn et al @ ) which may be cholinergically mediated as well .\n",
            "Although post mortem studies of schizophrenic patients have not identified gross abnormalities of the cholinergic system , subtle reductions of cholinergic function in the cortex of these patients has been found to significantly correlate with the severity of ante mortem cognitive impairment ( Haroutunian et al , submitted ) .\n",
            "This provides a rationale for a strategy to improve the cognitive performance of schizophrenic patients by enhancing cholinergic neurotransmission .\n",
            "We present here a double-blind , placebo controlled study of donepezil augmentation of novel antipsychotic treatment in schizophrenic patients .\n",
            "Methods .\n",
            "@ patients with schizophrenia will constitute the final sample in this trial .\n",
            "These patients are inpatients and outpatients who have been RANDOMized one to one to treatment with @-@ mg of donepezil or placebo for a @-week period .\n",
            "Patients were recruited on the basis of having memory deficits , as defined by performing at least @ SD below the age-corrected normal mean on the California Verbal Learning Test .\n",
            "All patients participated in the trial after demonstrating clinical stability for a minimum four week period and were receiving a stable dose of risperidone , with no changes in dose or fluctuations in their clinical symptoms prior to RANDOMization .\n",
            "Patients receiving anticholinergics , anidepressants , or any other standing psychotropic medications were excluded from the trial and benzodiazipine usage was not allowed @ hours prior to any assessments .\n",
            "Cognitive assessments , including learning and memory , working memory , attention , verbal fluency , and the WCST , was performed at baseline , week @ and week @ .\n",
            "Clinical assessments ( PANSS ) and assessments of movement disorders ( ESRS ) were performed on a weekly basis .\n",
            "Results .\n",
            "@ patients have currently completed the double blind trial and the remaining @ patients are far enough along in the protocol such that all patients will have completed the trial before presentation .\n",
            "Analyses of cognitive , clinical , and movement disorder response to donepezil will be performed .\n",
            "Among drugs used for the anesthesia of electroconvulsive therapy ( ECT ) , propofol reduces seizure duration to a greater degree than etomidate .\n",
            "The perceived difference between the @ anesthetics is smaller in patients with schizophrenia than in patients who suffer depression .\n",
            "In this study , propofol and etomidate were compared during the ECT of patients with schizophrenia , on the basis of their impact on seizure activity and on seizure-induced hemodynamic reactions .\n",
            "Schizophrenics ( n = @ ) who were treated with ECT participated in this randomized crossover study .\n",
            "Propofol ( @ mg/kg ) and etomidate ( @ mg/kg ) were used alternately .\n",
            "The @ drugs were compared on the basis of EEG - and EMG-registered seizure duration , mean arterial pressure ( MAP ) , pulse frequency , energy index , and postictal suppression .\n",
            "We also analyzed the number of necessary restimulations .\n",
            "In case of anesthesia with etomidate , both EEG - ( @ + / - @ s , @ + / - @ s P = @ ) and EMG - ( @ + / - @ s , @ + / - @ s P = @ ) registered seizure durations were significantly longer than in case of propofol .\n",
            "When using propofol , the increase in MAP was significantly lower than when etomidate was used ( @ + / - @ mm Hg , @ + / - @ mm Hg , P = @ ) .\n",
            "There were no significant differences found in the postseizure increase in pulse frequency , in postictal suppression , or in the energy index , nor did the numbers of necessary restimulations differ significantly .\n",
            "Propofol was found to reduce seizure duration to a significantly greater extent than etomidate .\n",
            "At the same time , in electrophysiological parameters that show a correlation with clinical efficacy , there was no significant difference found between the @ anesthetics .\n",
            "However , the seizure-induced increase in MAP was reduced by propofol to a significantly greater degree than by etomidate\n",
            "Background : While the issue of clozapine titration has frequently been addressed because of its numerous and potentially severe side effects , no study as of yet has assessed the comparability of gradual vs. immediate antipsychotic discontinuation in switching to clozapine .\n",
            "Methods : This study represents a pilot , @-week , double-blind , randomized controlled trial .\n",
            "Patients who met the following criteria were included in the study : ( @ ) outpatients with schizophrenia or schizoaffective disorder ; and ( @ ) candidacy for a trial of clozapine , defined as an inadequate clinical response to > two antipsychotics and/or intolerable side effects .\n",
            "Patients were randomly assigned to immediate discontinuation ( prior antipsychotics were discontinued at baseline ) or gradual discontinuation ( prior antipsychotics were reduced by @ % each week ) .\n",
            "For each group , clozapine was gradually increased to @ mg/day .\n",
            "The following assessments were completed at baseline , week @ , @ , @ , @ , and @ : the Brief Psychiatric Rating Scale ( BPRS ) , Clinical Global Impression - Severity scale ( CGI-S ) , Calgary Depression Scale for Schizophrenia ( CDSS ) , Drug Attitude Inventory , and Schedule for the Assessment of Insight ( SAI ) for efficacy ; side effect measures included the Simpson-Angus Scale , Barnes Akathisia Rating Scale , Abnormal Involuntary Movement Scale , and the UKU Side Effect Rating Scale .\n",
            "Results : A total of @ patients were enrolled ; @ and @ patients were assigned to the immediate and gradual discontinuation group , respectively .\n",
            "Three patients in the gradual discontinuation group discontinued the study due to side effects .\n",
            "While significant improvements were observed in the BPRS total , CGI-S , CDSS and SAI total scores after the switch to clozapine ( P < @ ) , no significant differences were found on any efficacy or side effect measure between groups ( P > @ ) .\n",
            "Conclusion : The findings indicate that ( @ ) a switch to clozapine improved psychopathology in patients with treatment-resistant schizophrenia and ( @ ) immediate and gradual antipsychotic discontinuation strategies are comparable with regard to efficacy and safety when switching to clozapine in patients with schizophrenia .\n",
            "Due to the small sample size , larger-scale trials are needed to confirm the findings .\n",
            "Background : Attentional dysfunctions constitute core cognitive symptoms in schizophrenia , but the precise underlying neurocognitive mechanisms remain to be elucidated .\n",
            "Methods : In this randomized , double-blind , sham-controlled study , we applied , for the first time , a theoretically grounded modeling approach based on Bundesen 's Theory of Visual Attention ( TVA ) to ( i ) identify specific visual attentional parameters affected in schizophrenia and ( ii ) assess , as a proof of concept , the potential of single-dose anodal transcranial direct current stimulation ( tDCS ; @ min , @ mA ) to the left dorsolateral prefrontal cortex to modulate these attentional parameters .\n",
            "To that end , attentional parameters were measured before ( baseline ) , immediately after , and @ h after the tDCS intervention in @ schizophrenia patients and @ healthy controls .\n",
            "Results : At baseline , analyses revealed significantly reduced visual processing speed and visual short-term memory storage capacity in schizophrenia .\n",
            "A significant stimulation condition x time point interaction in the schizophrenia patient group indicated improved processing speed at the follow-up session only in the sham condition ( a practice effect ) , whereas performance remained stable across the three time points in patients receiving verum stimulation .\n",
            "In healthy controls , anodal tDCS did not result in a significant change in attentional performance .\n",
            "Conclusion : With regard to question ( i ) above , these findings are indicative of a processing speed and short-term memory deficit as primary sources of attentional deficits in schizophrenia .\n",
            "With regard to question ( ii ) , the efficacy of single-dose anodal tDCS for improving ( speed aspects of visual ) cognition , it appears that prefrontal tDCS ( at the settings used in the present study ) , rather than ameliorating the processing speed deficit in schizophrenia , actually may interfere with practice-dependent improvements in the rate of visual information uptake .\n",
            "Such potentially unexpected effects of tDCS ought to be taken into consideration when discussing its applicability in psychiatric populations .\n",
            "The study was registered at http://apps.who.int/trialsearch/Trial@.aspx?TrialID=DRKS@ .\n",
            "Perceived criticism ( PC ) is a measure of how much criticism from @ family member \" gets through \" to another .\n",
            "PC ratings have been found to predict the course of psychotic disorders , but questions remain regarding whether psychosocial treatment can effectively decrease PC , and whether reductions in PC predict symptom improvement .\n",
            "In a sample of individuals at high risk for psychosis , we examined a ) whether Family Focused Therapy for Clinical High-Risk ( FFT-CHR ) , an @-session intervention that consists of psychoeducation and training in communication and problem solving , brought about greater reductions in perceived maternal criticism , compared to a @-session family psychoeducational intervention ; and b ) whether reductions in PC from baseline to @-month reassessment predicted decreases in subthreshold positive symptoms of psychosis at @-month follow-up .\n",
            "This study was conducted within a randomized controlled trial across @ sites .\n",
            "The perceived criticism scale was completed by @ families prior to treatment and by @ families at @-month reassessment .\n",
            "Evaluators , blind to treatment condition , rated subthreshold symptoms of psychosis at baseline , @ - and @-month assessments .\n",
            "Perceived maternal criticism decreased from pre - to posttreatment for both treatment groups , and this change in criticism predicted decreases in subthreshold positive symptoms at @-month follow-up .\n",
            "This study offers evidence that participation in structured family treatment is associated with improvement in perceptions of the family environment .\n",
            "Further , a brief measure of perceived criticism may be useful in predicting the future course of attenuated symptoms of psychosis for CHR youth .\n",
            "( PsycINFO Database Record\n",
            "A cluster randomised controlled trial will investigate the impact of the recovery intervention manual .\n",
            "It will use standard clinical outcomes , resource consequences , standardised recovery outcomes and individualised outcomes .\n",
            "Process evaluation will identify factors influencing implementation .\n",
            "Objective : To compare ziprasidone and the efficacy and safety of risperidone in the treatment of chronic schizophrenia .\n",
            ": CCMD-@ diagnostic criteria of schizophrenia @ patients with chronic schizophrenia , according to a randomized controlled programs were used ziprasidone and risperidone treatment , treatment of @ weeks .\n",
            "Positive symptoms and negative syndrome scale ( PANSS ) for efficacy evaluation , adverse reactions scale ( TESS ) Assessment of adverse reactions .\n",
            "Results : After @ weeks of treatment , ziprasidone group effective rate is @ % , the effective rate of @ % ; risperidone group effective rate is @ % , the effective rate was @ % .\n",
            "Two drug efficacy difference was not statistically significant ( x@ = @ , P > @ ) .\n",
            "PANSS scale of each factor reduction rate of the two groups before treatment and after the @nd week , the difference was statistically significant ( P < @ ) , the two drugs have a better effect .\n",
            "The final score of PANSS reduction rate , the difference between the two groups was not significant ( t = @ , P > @ ) , the efficacy of the two drugs .\n",
            "The ziprasidone group the overall incidence of adverse reactions was @ % in the risperidone group was @ % , a significant difference between the two groups sex ( x@ = @ , P < @ ) .\n",
            "The ziprasidone group more adverse reactions QT prolongation ; risperidone group more weight gain , menstrual disorders and lactation .\n",
            "Background : Schizophrenia patients experience debilitating cognitive dysfunctions that serve as a barrier in their returning to full work or social functioning .\n",
            "Current pharmacologic treatments in Schizophrenia have limited success in remediating cognitive deficits .\n",
            "Both aerobic exercise and cognitive training separately have been found to increase neuroplasticity and improve cognitive functioning to a moderate degree in Schizophrenia .\n",
            "This is the first study to examine the effects of a combined exercise and cognitive training intervention on brain plasticity in first-episode Schizophrenia patients .\n",
            "Methods : MRI scans were collected at UCLA to extrapolate cortical thickness and resting-state fMRI measurements at baseline and @-month follow-up in @ first-episode Schizophrenia patients randomly assigned to combined cognitive training and exercise ( CT&E , N@ ) or cognitive training without exercise ( CT , N@ ) for @ months .\n",
            "The MCCB cognitive battery was also administered at baseline and @ months .\n",
            "Results : Significant Group x Time interactions for cortical thickness were found in prefrontal regions ( left DLPFC , superior frontal gyrus and right medial orbitofrontal cortices ) .\n",
            "The CT&E group showed improved functional connectivity , compared to the CT group , between the right central executive network ( CEN ) and the ventral attention network and also between the left CEN and right CEN .\n",
            "Improved functional connectivity between the left and right CEN was associated with cognitive gains in Reasoning and Problem Solving at @-month follow-up .\n",
            "Conclusions : These structural and functional connectivity findings highlight the additive role of exercise to bolster increases in cortical thickness and lead to more efficient functional organization in the PFC , which was related to improvements in executive functioning .\n",
            "OBJECTIVE : Clozapine is the treatment of choice for refractory schizophrenia .\n",
            "The aim of this study was to compare the pharmacokinetics of the brand name ( Clozaril ) formulation and a generic formulation ( Clozapine ) of clozapine in Korean schizophrenic patients .\n",
            "METHODS : A prospective , randomized , crossover study was conducted to evaluate the steady-state pharmacokinetic profiles of Clozaril and Clzapine .\n",
            "Schizophrenic patients were randomized to receive either the brand name or generic formulation ( @ mg twice daily ) for @ days , followed by the other formulation for @ days .\n",
            "Plasma samples were collected on the last day of each treatment period .\n",
            "RESULTS : Twenty-two of @ patients ( @ % ) completed the study .\n",
            "The mean Cmax , ss values for Clzapine and Clozaril were @ and @ ng/mL , and the mean AUC@-@ values were @ hr.ng / mL and @ hr.ng / mL , respectively .\n",
            "The @ % CI values for the natural logarithmically transformed Cmax , ss and AUC@-@ ratios ( Clzapine to Clozaril ) after a single oral dose ( @ mg ) were @ ( @-@ ) and @ ( @-@ ) , respectively .\n",
            "Five patients ( @ % ) among @ patients who took Clzapine reported @ adverse events and six adverse events were reported by four patients ( @ % ) among @ who took Clozaril ; there were no significant differences on physical examination or in vital signs , ECG , and laboratory tests between groups .\n",
            "CONCLUSION : Generic clozapine ( Clzapine ) appears to be bioequivalent to brand name clozapine ( Clozaril ) .\n",
            "Objective : This study in patients with acute schizophrenia examined the efficacy , safety and effect on patient functioning of investigational paliperidone extended-release paliperidone ER tablets .\n",
            "Method This double-blind parallel group placebo and active-controlled dose-response study randomized patients n@ ; age @ ; @ years ) to receive paliperidone ER @ mg or @ mg , placebo or olanzapine @ mg daily .\n",
            "Olanzapine was included for assay sensitivity only and the study powered to assess efficacy of paliperidone ER vs placebo .\n",
            "Results : The intention-to-treat ITT set n@ ) was @ % black with mean age = @ y @ ; @ .\n",
            "Mean PANSS total score ( @ @ ; @ at baseline in ITT group ) improved at endpoint for paliperidone ER vs placebo ( @ mg = -@ @ ; @ [ p = @ ] , @mg-@ @ ; @ [ p @ ; @ ] , placebo-@ @ ; @ [ olanzapine change = -@ @ ; @ ] ) .\n",
            "Personal and Social Performance Scale scores improved at endpoint for both paliperidone ER groups vs placebo ( @ mg = @ @ ; @ [ p = @ ] , @mg@ .@ @ ; @ [ p = @ ] , placebo@ .@ @ ; @ ) .\n",
            "Treatment-emergent adverse events ( TEAEs ) occurring @ , and @ % more than with placebo were headache and dry mouth ( paliperidone ER ) , and somnolence anorexia and increased serum glutamic oxaloacetic transaminase olanzapine TEAE-EPS were comparable in the paliperidone ER @ mg olanzapine and placebo groups but higher with paliperidone ER @ mg .\n",
            "Serious AE frequency was @ % with paliperidone ER @ % with olanzapine and @ % with placebo .\n",
            "Conclusions : In this study paliperidone ER @ mg and @ mg was effective and generally well tolerated .\n",
            "The negative symptoms of schizophrenia remain a major clinical challenge .\n",
            "Mirtazapine is an antidepressant with antagonist properties at @HT@a , @HT@ and alpha @ receptors as well as indirect @HT@a agonist effects .\n",
            "Many of these pharmacological actions have clinical or preclinical evidence of efficacy in schizophrenia .\n",
            "This study was a @ week randomised placebo controlled trial of mirtzepine add on to haloperidol @ mg in the treatment of @ patients with DSM-IV schizophrenia .\n",
            "The primary finding of the trial was a @ % reduction in PANNS negative symptom scores in the mirtazepine group compared to placebo ( mirtazepine @ , SD @ placebo @ , SD@ .@ p = @ , F = @ DF = @ ) The PANNS total scores , CGI severity and improvement scales in addition showed superiority of mirtazepine over placebo .\n",
            "There was no difference between the groups on the HAMD scale , suggesting that the improvement in negative symptoms was not an artifact of mood improvement .\n",
            "These results suggest a potential role for mirtazepine in the negative symptoms of schizophrenia .\n",
            "\" Background : Negative symptoms of schizophrenia represent a significant unmet medical need as they do not respond to current antipsychotic treatment .\n",
            "One way to improve negative symptoms of schizophrenia may be through enhancement of NMDA receptor functioning .\n",
            "Bitopertin is an oral investigational glycine reuptake inhibitor that may improve NMDA receptor function .\n",
            "Methods : FlashLyte ( NCT@ ; NN@ ) is a multi-center , randomized , @ week , double-blind , parallel-group , placebo-controlled study to evaluate the efficacy and safety of adjunctive bitopertin in stable patients with persistent , predominant negative symptoms of schizophrenia treated with antipsychotic drugs .\n",
            "Key inclusion criteria were : age ?\n",
            "@ years , DSM-IV-TR diagnosis of schizophrenia ; score ?\n",
            "@ on sum of the @ Positive and Negative Syndrome Scale ( PANSS ) negative symptoms and disorganized thought factors ( items scored @  @ for a maximum possible score of @ ) ; and clinical and antipsychotic treatment stability .\n",
            "Potential confounding factors ( positive , depressive and motor symptoms ) were limited to low to moderate severity .\n",
            "Following a @-week observation period to establish prospectively clinical stability , patients were randomized @:@:@ to receive bitopertin @ mg , @ mg or placebo once daily for @ weeks .\n",
            "The primary efficacy endpoint was mean change from baseline in PANSS negative symptoms factor score ( NSFS ) after @ weeks of treatment .\n",
            "The key secondary endpoint was mean change from baseline in Personal and Social Performance ( PSP ) total score after @ weeks of treatment .\n",
            "Assessment of PANSS NSFS and PSP in the biomarker CFHR@ high subpopulation was a key secondary analysis .\n",
            "Results : Of the @ patients randomized , @were included in the ITT population and were equally distributed across bitopertin @ mg and @ mg , and placebo groups .\n",
            "Baseline demographics and characteristics were comparable across treatment arms .\n",
            "Baseline PANSS NSFS ( transformed from the original @  @ to a @  @ point scale , where @ is absent and @ is extreme ) were @ , @ , and @ for bitopertin @ mg and @ mg and placebo groups respectively .\n",
            "Over @ % of patients in each group completed @ weeks of treatment .\n",
            "After @ weeks of treatment , change from baseline in mean PANSS NSFS showed improvements in all arms but no statistically significant separation from placebo : bitopertin @ mg ?\n",
            "@ ( standard error [ SE ] @ ; p = @ ) , @ mg ?\n",
            "@ ( SE @ ; p = @ ) , placebo ?\n",
            "@ ( SE @ ) .\n",
            "Similar findings were noted consistently across the other endpoints including PSP total score at @ weeks : bitopertin @ mg +@ ( SE @ ; p = @ ) , bitopertin @ mg +@ ( SE @ ; p = @ ) , placebo +@ ( SE @ ) .\n",
            "Subgroup analyses of race , region , sex and primary antipsychotic type did not evidence differences in any of the subgroups .\n",
            "In addition , no effect of biomarker CFHR@ status was observed .\n",
            "Overall , bitopertin was well tolerated .\n",
            "The adverse event ( AE ) profile was similar to placebo ; the number of patients reporting ?\n",
            "@ AEwas @ ( @ % ) , @ ( @ % ) and @ ( @ % ) for bitopertin @ mg , @ mg and placebo groups , respectively .\n",
            "There were fewer withdrawals due to AE , including those due to psychiatric disorders on active arms compared with placebo .\n",
            "There were no effects on vital signs , weight or metabolic parameters .\n",
            "As expected a dose  response was observed in reduction of hemoglobin , but there were no associated withdrawals in bitopertin groups .\n",
            "Discussion : In this study in patients with persistent predominant negative symptoms receiving antipsychotics therewas no statistically significant effect of adjunctive bitopertin @ or @ mg compared with placebo on primary or key secondary endpoints after @ weeks of treatment .\n",
            "Bitopertin was well tolerated . \"\n",
            "The potential therapeutic utility of estrogens in schizophrenia is increasingly being recognized .\n",
            "Raloxifene , a selective estrogen receptor modulator , appears to act similarly to estrogens on dopamine and serotonin brain systems .\n",
            "One previous trial by our team found that raloxifene was useful to improve negative , positive , and general psychopathological symptoms , without having the negative side effects of estrogens .\n",
            "In this study , we assess the utility of raloxifene in treating negative and other psychotic symptoms in postmenopausal women with schizophrenia exhibiting prominent negative symptoms .\n",
            "This was a @-week , randomized , parallel , double-blind , placebo-controlled study .\n",
            "Patients were recruited from the inpatient and outpatient departments of Parc Sanitari Sant Joan de Deu , Hospital Universitari Institut Pere Mata , and Corporacio Sanitaria Parc Tauli .\n",
            "Seventy postmenopausal women with schizophrenia ( DSM-IV ) were randomized to either adjunctive raloxifene ( @ women ) or adjunctive placebo ( @ women ) .\n",
            "Psychopathological symptoms were assessed at baseline and at weeks @ , @ , and @ with the Positive and Negative Syndrome Scale ( PANSS ) and the Scale for the Assessment of Negative Symptoms ( SANS ) .\n",
            "The addition of raloxifene ( @mg/d ) to regular antipsychotic treatment significantly reduced negative ( P = .@ ) , general ( P = .@ ) , and total symptomatology ( P = .@ ) measured with the PANSS during the @-week trial , as compared to women receiving placebo .\n",
            "Also Alogia SANSS subscale improved more in the raloxifene ( P = .@ ) than the placebo group .\n",
            "In conclusion , raloxifene improved negative and general psychopathological symptoms , compared with antipsychotic medication alone , in postmenopausal women with schizophrenia .\n",
            "These data replicate our previous results with a larger sample and a longer follow-up .\n",
            "TRIAL REGISTRATION : NCT@ .\n",
            "Objective : The purpose of this double-blind study was to compare medical resource use and work and social outcomes in patients treated with olanzapine or haloperidol .\n",
            "Method : Patients with DSM-III-R schizophrenia , or schizophreniform , or schizoaffective disorders received either double-blind olanzapine ( N = @ ) or haloperidol ( N = @ ) @ to @ mg/day for @ weeks .\n",
            "A total of @ patients continued into a double - blind responder extension .\n",
            "Medical resources and work and social outcomes ( work status , amount of useful work , social participation , and living arrangements ) were measured approximately every two months for up to @ weeks of treatment .\n",
            "Medical resource use was aggregated and divided by patient-month exposure to treatment .\n",
            "Treatment group comparisons of social outcomes at endpoint were assessed using the Chi-square test .\n",
            "Results : There were @ fewer hospital days per year of treatment exposure in olanzapine-treated patients compared with haloperidol-treated patients .\n",
            "Other medical resource use tended to decrease over time in the olanzapine group , whereas in the haloperidol group it fluctuated .\n",
            "More patients treated long-term with olanzapine compared with haloperidol were working at least part-time , engaging in useful work , and socializing more than once a month .\n",
            "Conclusions : This study shows that olanzapine has a positive impact on medical resource use and work and social outcomes , and in turn , may contribute to reintegration of patients into society .\n",
            "In addition , these benefits may lead to savings in schizophrenia - related hospital costs and lost work productivity costs .\n",
            "Objective : To compare the effectiveness of family therapy based on the Satir model vs. family psychoeducation on family function , self-esteem , and depressive symptoms in family members ( including the patient ) , and the social functioning and severity of symptoms in patients with schizophrenia .\n",
            "Material and Method : A randomized control trial was conducted .\n",
            "The authors recruited @ families to a family therapy group and @ to psychoeducation group .\n",
            "Each group received six sessions of intervention .\n",
            "The effectiveness of the interventions was assessed using the Chulalongkorn Family Inventory , the Clinical Global Impression Severity Scale ( CGI-S ) , the Personal and Social Performance Scale-Thai version , the Self-esteem visual analog scale ( SVAS ) , the Rosenberg Self Esteem Scale-Thai version ( RSES-T ) , and the KKU-Depression Inventory .\n",
            "The effectiveness of each intervention was measured four times : a ) baseline , b ) one month after the fourth session ( the third month ) , c ) one month after the last session ( the fifth month ) , and d ) one year after the last session ( the sixteenth month ) .\n",
            "Results : Both interventions helped to improve the perception of family functioning , self-esteem , and depressive symptoms among family members , and decreased the severity of symptoms and improved social functioning in patients with schizophrenia .\n",
            "The family therapy group had more significant results on the improvements of the SVAS , the RSES-T , and the CGI-S score .\n",
            "Conclusion : Both interventions produced positive results in almost all of the follow-up measurements , but the family therapy group had more significant results , particularly with respect to self-esteem scores .\n",
            "A questionnaire was given following test administration in either a standard or computerized form , to @ psychiatric patients who completed up to eight psychometric tests .\n",
            "Patients responded in the computerized versions by using either a keyboard or a touch-screen .\n",
            "In general , the evaluation of both test forms was positive and fewer differences were detected than had been expected .\n",
            "Where differences existed , the computerized forms were found more enjoyable , especially in the case of the simpler tests , but were also reported to be less comprehensible and less clear in the case of some of the more complex ones .\n",
            "Subjective estimates of attainment and willingness to undergo further testing were largely unaffected by test form .\n",
            "The touch-screen was preferred to the keyboard in the simpler tests , but in other cases there was evidence that prior experience of the standard form of the test facilitated performance .\n",
            "The findings support the feasibility of creating computerized tests which are essentially parallel to standard original forms , but point to the need to understand the complex factors which govern the users ' evaluation of human-computer interaction .\n",
            "However , computerized assessment seems to be entirely acceptable to clinical psychiatric patients .\n",
            "Objective To evaluate the efficacy and safety of domestic Chouteau will facilitate the treatment of schizophrenia .\n",
            "The method of multi-center double-blind , randomized controlled study with sulpiride for the control drug .\n",
            "Results @ patients completed six weeks of trial , no significant difference in treatment at each time point Chouteau cisapride and sulpiride group , total scores of BPRS , SAPS , SANS and TESS scores , Chouteau will be on the positive and negative symptoms markedly effective rate were @ % and @ % , no significant difference in the sulpiride group .\n",
            "No significant difference in the incidence and severity of two sets of adverse reactions .\n",
            "Background : About @ % of patients with schizophrenia have cognitive impairments , executive functions being particularly affected .\n",
            "Executive dysfunctions are important predictors of functional outcomes .\n",
            "Unlike psychotic symptoms , cognitive deficits do not improve during periods of remission and change only minimally with antipsychotic medications .\n",
            "Thus , effective interventions aimed at improving executive functions in this population are needed .\n",
            "One of the most validated interventions for executive dysfunction is Goal Management Training ( GMT ) .\n",
            "GMT is a compensatory intervention that relies on metacognitive strategies for improving participants ' ability to organize and achieve goals in everyday life .\n",
            "GMT has received empirical support in studies of other populations , such as people with neurological conditions and in healthy elderly .\n",
            "To our knowledge no previous studies have investigated the effect of group-based GMT in patients with schizophrenia spectrum disorders or with high risk of schizophrenia .\n",
            "Thus , this is the main objective of the study .\n",
            "Baseline characteristis and preliminary results from the first patients will be presented .\n",
            "Methods : Participants ( @-@ years , males and females , IQ > @ ) with executive dysfunction , will be recruited among patients referred for treatment at Innlandet Hospital Trust in Norway from @ to @ .\n",
            "The study aims to include patients treated for psychotic disorder for less than @ years and new patients who either have symptoms that meet the DSM-IV criteria for a diagnosis of broad schizophrenia spectrum disorder or who are considered at high risk of psychosis .\n",
            "We aim to recruit one hundred participants for the current randomized controlled trial ( RCT ) , with efficacy of GMT ( n = @ ) being compared with results of subjects in a wait-list condition ( WL , n = @ ) .\n",
            "Measurements include self-report of executive function , emotional health , and social - and everyday function .\n",
            "Informant reports of executive function will also be collected .\n",
            "Furthermore , neuropsychological tests designed specifically to measure areas of executive function will be utilized , as well as role-playing tasks thought to have good ecological validity .\n",
            "Symptoms of psychosis will also be assessed .\n",
            "GMT will be administered in @ ( twice weekly ) x @ hour sessions in accordance with the GMT research protocol .\n",
            "A general linear model with repeated measures analysis of variance ( RM ANOVA ) will be used to examine differential group treatment effects .\n",
            "A @ x @ mixed-design will be applied , with Group ( GMT , WL ) as betweensubjects factor , and Session ( baseline [ T@ ] , post-intervention [ T@ ] , and @ months follow-up [ T@ ] ) as within-subjects factor .\n",
            "Interpretation of the strength of experimental effects will be provided with effect size statistics .\n",
            "Results : Baseline characteristics and preliminary results from the first participants will be presented .\n",
            "Discussion : Based on findings from previous GMT-studies , we hypothesize that post-intervention changes will be reflected in improved scores on selfreported and/or objective measures of executive functions ( particularly in the areas of planning and attentional control ) compared to patients in WL .\n",
            "We also expect that GMT participants will improve their goal attainment in everyday life and social functioning after the intervention .\n",
            "Additionally , we expect post-intervention changes to be reflected in improved scores on measures of emotional health .\n",
            "Trial Status : Registered .\n",
            "Date Registered : @/@/@ .\n",
            "Health condition ( s ) or problem ( s ) studied : First-episode psychosis , Condition category : Condition code : Mental Health Psychosis and personality disorders Description of intervention ( s ) / exposure : An individual peer support program delivered to young people from @ months prior to , until @ months post discharge from a specialist first episode psychosis center .\n",
            "People will receive @ hours of contact per fortnight from the peer support worker which will include an in-reach and out-reach service and will include supportive informal contact , assistance making health related appointments , assistance with public transport to appointments and support in accessing new services .\n",
            "Participants will receive the peer support intervention plus standard care .\n",
            "Intervention code : Rehabilitation Comparator / control treatment : Standard care as determined by the case manager , Control group : Active .\n",
            "Primary outcome @ : Increased engagement and treatment adherence , as measured by The Psychosocial Treatment Compliance Scale ( Tsang , et al. , @ ) , by specific questions included in a treatment questionnaire and via a telephone call made by the Research Assistant ( RA ) to the new treating clinician asking about attendance at appointments and medication compliance Timepoint : Baseline @ months ( post intervention ) Primary outcome @ : Increased perceived social support and increased quantity and improved quality of information provided , as measured by the Multi-dimensional Scale of Perceived Social Support ( Zimet et al. , @ ) .\n",
            "Timepoint : Baseline @ months ( post intervention ) Primary outcome @ : Increased service satisfaction , as measured by the Verona Service Satisfaction Scale .\n",
            "Timepoint : Baseline @ months ( post intervention ) Secondary outcome @ : Reduced risk of suicide , as measured by The Reynolds Suicidal Ideation Questionnaire ( Reynolds , @ ) .\n",
            "Timepoint : Baseline @ months ( post intervention ) Secondary outcome @ : Increased quality of life as measured by the World Health Organisation Quality of Life Scale ( Heinrichs et al. , @ ) .\n",
            "Timepoint : Baseline @ months ( post intervention ) .\n",
            "Key inclusion criteria : Aged @-@ and being discharged from a specialist first-episode psychosis center ; the Early Psychosis Prevention and Intervention Center ( EPPIC ) having been treated for first-episode psychosis .\n",
            "Minimum Age : @ Years .\n",
            "Maximum Age : @ Years .\n",
            "Gender : Both males and females .\n",
            "Healthy volunteers ?\n",
            "No .\n",
            "Key exclusion criteria : A recent history of violence against the person An inability to provide informed consent Inability to speak English .\n",
            "Purpose of the study : Treatment .\n",
            "Allocation to intervention : Randomised controlled trial .\n",
            "Describe the procedure for enrolling a subject and allocating the treatment ( allocation concealment procedures ) : The study team comprises researchers and representatives from the clinical program .\n",
            "The research assistant ( RA ) will attend the regular clinical meetings held at EPPIC in order to identify young people who are about to commence the discharge planning period .\n",
            "Once the discharge planning process is about to begin the RA will contact the young person and see if they are interested in the study .\n",
            "If so they will obtain written consent and conduct the baseline assessment .\n",
            "Once the baseline assessment is conducted the young person   s details will be passed to an independent statistician who will randomise them into either the treatment or control group .\n",
            "Those in the control group will receive treatment as usual ( TAU ) whilst those in the treatment group will receive treatment as usual plus the peer support intervention ( TAU+PSI ) .\n",
            "Once randomisation has taken place the statistician will contact either the project supervisor or the Peer Support Coordinator directly that the intervention can begin .\n",
            "The Peer Support Coordinator will allocate a peer support worker ( PSW ) who will make contact with the participant and will deliver the intervention .\n",
            "By doing this in this way the RA can remain blind to treatment .\n",
            "Describe the methods used to generate the sequence in which subjects will be randomised ( sequence generation ) : The randomisa ion procedure will follow the consort guidelines .\n",
            "The subjects will be randomized to the treatment group or control group with equal allocation .\n",
            "Computer generated random numbers will be used to carry out the randomization .\n",
            "Masking / blinding : Blinded ( masking used ) .\n",
            "Who is/are masked/blinded : The people assessing the outcomes .\n",
            "Assignment : Parallel .\n",
            "Type of endpoint ( s ) : Safety/efficacy .\n",
            "Anticipated or actual date of first participant enrolement : Target sample size : @ .\n",
            "Recruitment status : Not yet recruiting .\n",
            "Has the study received approval from at least one ethics committee ?\n",
            "No , Ethics Committee name : Mental Health Research and Ethics Committee , The Royal Melbourne Hospital Parkville , VIC @ Australia .\n",
            "Countries of recruitment : Australia .\n",
            "Brief summary : Participants will be approximately @ young people , aged @-@ , who are being discharged from EPPIC .\n",
            "EPPIC is a government funded public mental health service serving North West Metropolitan Melbourne .\n",
            "All participants will be recruited through the service .\n",
            "Background : Our previous RR&D funded study demonstrated significantly better vocational outcomes for people with schizophrenia when cognitive training augmented their participation in Incentive Therapy .\n",
            "We have found in a subsequent NIMH funded study involving cognitive training and supported employment that competitive employment outcomes were better for those who received cognitive training .\n",
            "Moreover , we found that patients with the poorest community function at intake were very unlikely to obtain competitive employment unless they received the cognitive training .\n",
            "The current study tests the effectiveness of cognitive training by extending it to a broader range of participants with psychotic disorders participating in all types of work programs including Incentive Therapy , Compensated Work Therapy , and Supported Employment .\n",
            "We also compare two types of cognitive training to determine whether cognitive game software ( Nintendo BrainAge ) works as well as narrowly focused cognitive exercises ( PositScience BrainFitness and Insight ) .\n",
            "Methods : @ participants from VA CT and CMHC were randomized to one of two types of cognitive training-PositScience or Nintendo BrainAge .\n",
            "Intake included psychosocial , neuropsychological , and psychiatric assessments .\n",
            "Assessments were repeated at @-months and @ month follow-up .\n",
            "Cognitive training consisted of computer-based cognitive exercises and a weekly group that focused on improving work behaviors .\n",
            "BrainAge employed engaging cognitve game software and PositScience used specially designed exercises that narrowly focus on discrete cognitive processes .\n",
            "Work services were provided as usual to both conditions .\n",
            "Results : Adherence was significantly better for PositScience than Nintendo .\n",
            "Comparsions of neurocognitive , vocational and quality of life outcomes will be presented for the first time at this symposium .\n",
            "Conclusion : This is the first study to compare two active cognitive training programs as augmenting procedures for work rehabilitation programs .\n",
            "Findings will be presented in light of the growing interest in cognitive interventions in recovery .\n",
            "Background : It is common for people with psychosis to have co-occurring drug or alcohol problems .\n",
            "This combination of problems is associated with poor outcomes for clients and presents many challenges for services .\n",
            "Aims : This review aims to discuss contextual issues underlying treatment difficulties , to briefly review the treatment literature to date and to describe a randomized controlled treatment trial ( RCT ) currently being conducted in the UK .\n",
            "Methods : A descriptive review .\n",
            "Results : Consensus agreement emphasizes the need for integrated treatment strategies that match the client s current level of motivation .\n",
            "There have been encouraging results from recent studies evaluating motivational strategies , either alone or in combination with CBT .\n",
            "Whilst for many clients with established illness and substance using histories , brief therapy does not seem to be adequate , longer term interventions show promise .\n",
            "A current RCT evaluating motivational interviewing with CBT is described .\n",
            "Conclusions : The evidence base for treatment recommendations is still quite small .\n",
            "The MIDAS trial will hopefully make a significant contribution to the literature on treatment options for this high risk group .\n",
            "Declaration of interest : The MIDAS trial is funded by the Medical Research Council and the Department of Health .\n",
            "Objective : Nonadherence to medication is a major factor contributing to poor outcomes in patients with schizophrenia .\n",
            "Depot antipsychotics may improve outcomes for patients who have difficulty maintaining adherence by assuring medication delivery [ @ ] .\n",
            "This study examined the efficacy and safety of olanzapine long-acting injection ( OLAI ) for maintenance treatment of patients with schizophrenia .\n",
            "Method : Adult outpatients @-@ years of age with schizophrenia who maintained clinical stability on open-label oral olanzapine ( @ , @ , or @ mg/day ) for @ consecutive weeks were randomized to @ weeks of double-blind treatment with OLAI at doses of @ mg/@ weeks ( N = @ ) , @ mg/@ weeks ( N = @ ) , or @ mg/@ weeks ( N = @ ) ; to a low reference dose of @ mg/@ weeks ( N = @ ) ; or to oral olanzapine at their previously stabilized dose ( N = @ ) .\n",
            "No oral antipsychotic supplementation was permitted .\n",
            "Clinical stability was defined as @ ) no change of oral olanzapine dose ; @ ) Clinical Global Impressions-Improvement of Illness ( CGI-I ) score @ ; and @ ) Brief Psychiatric Rating Scale ( BPRS ) Positive score @ on each of the following items : conceptual disorganization , suspiciousness , hallucinatory behavior , and unusual thought content .\n",
            "Symptom severity was assessed using the Positive and Negative Syndrome Scale ( PANSS ) total and subscales , PANSS-derived BPRS total score and subscales , and the Clinical Global Impressions-Severity of Illness ( CGI-S ) and CGI-I scales .\n",
            "Results : Mean baseline-to-endpoint changes in PANSS total scores using last observation - carried forward ( LOCF ) methodology for patients treated with therapeutic OLAI doses ( @ mg/@ weeks , @ mg/@ weeks , @ mg/@ weeks ) differed significantly from those treated with OLAI @ mg/@ weeks ( respectively , -@ , -@ , @ vs. @ ; all p < @ ) .\n",
            "Significant separation between the OLAI @ mg/@ weeks , @ mg/@ weeks , @ mg/@ weeks groups versus the @ mg/@ weeks group in PANSS total scores was observed starting at @ , @ , and @ weeks , respectively , and maintained through the end of the study ( p < @ ) .\n",
            "Similar differences between therapeutic OLAI doses and the @ mg/@ weeks dose were observed for the BPRS total , CGI-I , and CGI-S scores .\n",
            "Mean baseline-to-endpoint change in PANSS total score for the oral olanzapine group was -@ , which was not significantly different from that of the highest OLAI dose group ( @ mg/@ weeks = -@ ; p = @ ) but superior to the other OLAI doses ( p s < @ ) .\n",
            "Incidence of weight gain @ % of baseline was significantly greater for oral olanzapine ( @ % ) , OLAI @ mg/@ weeks ( @ % ) , @ mg/@ weeks ( @ % ) , and @ mg/@ weeks ( @ % ) , compared with OLAI @ mg/@ weeks ( @ % , all p .@ ) .\n",
            "There were no clinically meaningful differences between OLAI and oral olanzapine with respect to laboratory measures , vital signs , ECGs , or extrapyramidal symptoms .\n",
            "Incidence of injection-site reactions was low ( @ % ) .\n",
            "Two patients treated with OLAI experienced post-injection delirium/sedation syndrome following possible inadvertent intravascular injection .\n",
            "Conclusions : Maintenance treatment with OLAI at doses of @ mg/@ weeks , @ mg/@ weeks , and @ mg/@ weeks was more efficacious than a @ mg/@ weeks dose in preventing the deterioration of symptoms in patients with schizophrenia for up to @ weeks .\n",
            "The safety profile for these OLAI doses was consistent with that of oral olanzapine [ @ ] except for injection-related events .\n",
            "Double-blind , comparative studies examined the effect of @ months ' of quetiapine in chronic schizophrenia .\n",
            "Velligan et al showed in @ patients that quetiapine ( @ mg/d ) was significantly superior to haloperidol ( @ mg/d ) at improving performance on executive and mnemonic function tests .\n",
            "Quetiapine significantly improved cognitive performance , with a mean difference likely to be clinically important .\n",
            "Improvement in cognitive performance with quetiapine was not attributable solely to improvements in symptoms and side effects or to anticholinergic use .\n",
            "In a separate cohort of @ patients with chronic schizophrenia treated for up to @ months with quetiapine or haloperidol , Purdon et al showed significant improvements with quetiapine on tests of verbal fluency and reasoning , immediate recall , and executive and visuomotor skill .\n",
            "In a study of @ patients with advanced Parkinson 's and psychosis , @ months ' quetiapine treatment resulted in improvements in sustained attention and delayed story recall and preservation of motor performance and other cognitive and clinical function , suggesting positive effects on cognition may extend to other neurodegenerative disorders .\n",
            "We now have converging evidence of substantial and clinically significant improvement in schizophrenia with quetiapine .\n",
            "of @ patients with advanced Parkinson 's and psychosis , @ months ' quetiapine treatment resulted in improvements in sustained attention and delayed story recall and preservation of motor performance and other cognitive and clinical function , suggesting positive effects on cognition may extend to other neurodegenerative disorders .\n",
            "We now have converging evidence of substantial and clinically significant improvement in schizophrenia with quetiapine .\n",
            "To assess the role of blockade of beta-receptor subpopulations in the treatment of neuroleptic-induced akathisia ( NIA ) , the specific beta @-antagonist ICI @ was compared to placebo in a double-blind study .\n",
            "After a baseline evaluation on placebo , patients were treated with ICI @ or placebo .\n",
            "Five of six patients treated with ICI @ showed treated with ICI @ or placebo .\n",
            "Five of six Ss treated with ICI @ showed improvements in NIA , while only @ of @ Ss improved on placebo .\n",
            "Ss were then treated openly with propranolol , a mixed beta-sub-@ , beta-sub-@-antagonist .\n",
            "Compared with ICI @ , no further improvement on objective measures of NIA was seen on propranolol .\n",
            "Mean subjective assessments of NIA declined on propranolol , but changes were variable and not significant .\n",
            "In this study , investigators will examine the behavioral effects and neurophysiological mechanisms of the pro-social neuropeptide oxytocin in patients with recent-onset schizophrenia .\n",
            "Such research is a necessary first step towards identifying whether intranasal oxytocin administration can serve as an adjunct treatment for social impairments in schizophrenia .\n",
            "Aim @ : To examine the effects of exogenous oxytocin on patterns of neural activation as measured by fMRI during a well-characterized affect-labeling task in patients with recent-onset schizophrenia and healthy comparison subjects .\n",
            "Hypothesis A : Patients will exhibit amygdalar hyperactivity and PNS hypo-activity when passively viewing faces , which will be normalized by administration of oxytocin .\n",
            "Hypothesis B : Patients will exhibit hypo-activity of the vPFC when affectively labeling faces and this hypo-activity will be normalized by oxytocin administration .\n",
            "The negative symptoms of schizophrenia remain a major clinical challenge .\n",
            "Mirtazapine is an antidepressant with antagonist properties at @-HT@A , @-HT@ and alpha @ receptors as well as indirect @ HT@a agonist effects .\n",
            "Many of these pharmacological actions have clinical or preclinical evidence of efficacy in schizophrenia .\n",
            "This study was a @ week randomized placebo controlled trial of mirtazapine add on to haloperidol @ mg in the treatment of @ patients with DSM-IV schizophrenia .\n",
            "The primary finding of the trial was a @ % reduction in PANNS negative symptom scores in the mirtazapine group compared to placebo ( mirtazapine @ , SD @ ; placebo @ , SD @ ; P = @ , F = @ , DF = @ ) .\n",
            "The PANNS total scores , CGI severity and improvement scales in addition showed superiority of mirtazapine over placebo .\n",
            "There was no difference between the groups on the HAMD scale , suggesting that the improvement in negative symptoms was not an artifact of mood improvement .\n",
            "These results suggest a potential role for mirtazapine in the negative symptoms of schizophrenia .\n",
            "Mirtazepine Negative symptoms Haloperidol Schizophrenia : drug therapy\n",
            "OBJECTIVE : The ability of patients with schizophrenia to give informed consent for participation in clinical trials research has been a subject of some scrutiny .\n",
            "Indeed , the ability of patients without mental illness to fully appreciate the implications of research partic - ipation may also need improvement .\n",
            "The goal of this project is to develop an educational intervention that enhances patients ' partici - pation and understanding of the informed consent process .\n",
            "METH - ODS : Schizophrenia patients considering participation in clinical tri - als and medical patients awaiting appointments ( not necessarily in research protocols ) were randomly assigned to view one of two videotapes .\n",
            "One of the videos ( \" experimental \" ) teaches about the informed consent process , covering participant and investigator responsibilities , typical content of informed consent in treatment research and elements of good decision making , and to encourage active participation in the consent process .\n",
            "The other video ( \" con - trol \" ) had no specifics about the informed consent process itself , instead presenting information on the history of the issues of human subject protection and the regulatory apparatus including IRBs .\n",
            "Both videos take about @ minutes .\n",
            "An eighty item true and false quiz about the informed consent procedure was administered before and after viewing the videos .\n",
            "RESULTS : Seventy-eight schizophrenia patients have viewed the videos ( @ viewed the experimental video and @ the control video ) .\n",
            "@ medical patients ( some with self-report - ed psychiatric comorbidities ) viewed the experimental teaching video and @ viewed the control video .\n",
            "Schizophrenia patients who viewed the experimental tape improved more in knowledge of the consent process than those viewing the control tape ( t = @ , df = @ , p = @ ) .\n",
            "A similar result was obtained among medical patients ( t = @ , df = @ , p = .@ ) .\n",
            "Those viewing the experimental tape ~ howed greater increases in knowledge of the @C process than those viewing the control video , whether they reported co-morbid psychi - atric illness ( t = @ .\n",
            "df = @ , p = .@ ) or not ( t = @ , df = @ , p = .@ ) .\n",
            "CONCLUSIONS : These results suggest that an educational video - tape increases knowledge of the informed consent process among schizophrenia patients who are actively considering treatment research participation as well as among medical patients who are not being recruited for research .\n",
            "The intervention is simple to use and can readily be integrated into any clinical trial .\n",
            "AIMS : Nidotherapy is the systematic modification of the environment to create a better fit for people .\n",
            "This is the first randomized controlled trial of its efficacy in an assertive community team .\n",
            "METHODS : Patients in an assertive outreach team with continued management problems together with comorbid personality disturbance and severe mental illness were randomized to nidotherapy enhanced assertive treatment ( up to @ sessions ) or to continued assertive outreach care .\n",
            "Use of psychiatric beds over one years ( primary outcome ) and change from base-line in other health service resources , psychiatric symptoms , social functioning and engagement with services were measured at @ and @ months ( secondary outcomes ) .\n",
            "RESULTS : @ patients were recruited over @ months , with @ and @ assessed at @ and @ months .\n",
            "Patients referred to nidotherapy had a @ % reduction in hospital bed use after one year compared with control assertive care ( P = @ ) and showed non-significant improvement in psychiatric symptoms , social functioning and engagement than the control group .\n",
            "The mean cost savings for each patient allocated to nidotherapy was @ pounds sterling per year , mainly as a consequence of reduced psychiatric bed use .\n",
            "CONCLUSION : Nidotherapy may be a cost-effective option in the management of comorbid serious mental illness and personality disorder , but larger confirmatory trials are necessary .\n",
            "Background : Search for safe and effective strategies to diminish weight gain associated with second generation antipsychotics ( SGAs ) is imperative .\n",
            "In the present study we sought to replicate our preliminary findings which indicated that co-administration of the selective norepinephrine reuptake inhibitor reboxetine attenuates olanzapine-induced weight gain .\n",
            "Methods : Fifty-nine patients hospitalized for first-episode DSM-IV schizophrenic disorder participated in this randomized double-blind study .\n",
            "Reboxetine ( @mg/day ; @ patients ) or placebo ( @ patients ) was co-administered with olanzapine ( @mg/day ) for @ weeks .\n",
            "Analysis was by intention-to-treat .\n",
            "Results : Nine patients in each group prematurely discontinued the trial .\n",
            "Olanzapine/reboxetine-treated patients showed a significantly lower increase in body weight ( mean = @ kg , SD = @ ) than their olanzapine/placebo-treated counterparts ( mean = @ kg , SD = @ ) .\n",
            "Significantly fewer olanzapine / reboxetine-treated patients gained at least @ % of their initial weight , the cutoff for clinically significant weight gain [ @ ( @ % ) of @ patients vs. @ ( @ % ) of @ patients ] .\n",
            "Seven ( @ % ) olanzapine/reboxetine-treated patients compared to only one patient ( @ % ) in the olanzapine/placebo group revealed no weight change or even modest weight loss .\n",
            "Appetite increase was significantly lower in the olanzapine/reboxetine than olanzapine/placebo group and was correlated with attenuation of weight gain .\n",
            "Reboxetine addition was safe and well-tolerated .\n",
            "Conclusions : The results confirm that co-administration of reboxetine promotes a clinically meaningful attenuation of olanzapine-induced weight gain in schizophrenia patients .\n",
            "If substantiated in long-term studies , along with behavioral management and diet counseling , reboxetine may have clinical utility in controlling SGA-induced weight gain .\n",
            "Supported in part by grant # @T-@ from the Stanley Medical Research Institute .\n",
            "The Community Re-Entry Program ( CREP ) is a psycho-educational program designed to teach schizophrenic patients self-management skills .\n",
            "This program was implemented during brief hospitalizations for psychotic exacerbations .\n",
            "Our goal was to determine the effectiveness of the CREP in decreasing re-hospitalizations , and increasing adherence with outpatient appointments .\n",
            "Ninety-four inpatients with acute psychosis were randomized to either the CREP , or to a standard series of illness education ( IE ) classes .\n",
            "Post-discharge , CREP participants were more knowledgeable about illness self-management .\n",
            "Attendance to first psychiatric appointment post-discharge improved for both for both groups .\n",
            "Hospital days were reduced for CREP patients over the year post-discharge .\n",
            "Cognitive dysfunctions ( as in memory , attention and executive function ) have been recognized as fundamental features of schizophrenia .\n",
            "Executive dysfunction is a major obstacle to functional outcome , community functioning and rehabilitation success and it is crucial to assess the effects of so-called neuroleptic ( NLP ) medications in this domain of cognitive functioning .\n",
            "Risperidone , an atypical NLP , has been reported to improve executive function in schizophrenia ( SZ ) , but there is controversy regarding these findings .\n",
            "The aim of the current study was to assess the differential effects of risperidone ( @-@ mg ) and conventional ( @-@ mg haloperidol ) NLPs on executive skills in @ individuals with SZ over a @-month period .\n",
            "The performance of both NLP groups was compared to the performance of @ age - and education-matched healthy controls .\n",
            "In this randomized , double blind study , the Wisconsin Card Sorting Test ( WCST ) was administered at baseline , @ , @ , and @ months after initiating medication .\n",
            "The relationship between executive functioning and the course of clinical symptoms , as assessed by the Positive and Negative Syndrome Scale ( PANSS ) was also investigated .\n",
            "Results showed that , relative to healthy controls , individuals with SZ showed marked impairment in WCST from baseline through @ months of treatment .\n",
            "Also , participants under haloperidol or risperidone NLP medication performed similarly on the WCST at all assessment periods showing that risperidone and haloperidol do not differ in their effect on executive functioning .\n",
            "Risperidone treatment , however , was more effective in the reduction of negative symptoms .\n",
            "The differential efficacy of risperidone over negative symptoms and WCST performance strongly suggests that the executive impairments are to some extent the result of brain abnormalities independent of those that produce the major psychopathology manifestations seen in SZ .\n",
            "Objective : To compare the effectiveness and side effect of risperidone and haloperidol in the treatment of chronic inpatients with schizophrenia and to examine the effect of these two antipsychotics on the neuroendocrine responses and free radical metabolism .\n",
            "Methods : A fixed-dose risperidone ( @ mg/day ) was compared with haloperidol ( @ mg/day ) for @-week in the treatment of @ chronic inpatients with schizophrenia in a randomized , double-blind trial .\n",
            "The PANSS rating scale was used as the efficacy variable before and after treatment , and TESS as side effect variable after treatment .\n",
            "Blood superoxide dismutase ( SOD ) level , and cortisol ( COR ) and prolactin ( PRL ) responses to oral @ mg paroxetine were measured in patients before and after treatment , and in @ normal controls .\n",
            "Results : @ .\n",
            "Both risperidone and haloperidol were effective in reducing schizophrenic symptoms ; however , risperidone was found to be superior to haloperidol in positive and negative symptoms on the basis of PANSS .\n",
            "And risperidone also had fewer side effects .\n",
            "@ .\n",
            "Blood SOD and plasma cortisol levels and paroxetine - challenge responses at the baseline were significantly higher in schizophrenic subjects as compared with controls .\n",
            "@ .\n",
            "Blood SOD and plasma baseline COR levels and COR response to paroxetine were significantly decreased after risperidone treatment ; blood SOD level was significantly lower but plasma baseline PRL and PRL response to paroxetine stimulation test were significantly higher after haloperidol treatment .\n",
            "@ .\n",
            "A more effective outcome was noted in patients who had a lower baseline COR level and COR response to paroxetine , and whose COR responses were closer to normal at the end of treatment ; and in those whose baseline SOD level were lower and whose SOD levels were closer to normal at the post-treatment .\n",
            "Conclusions : The disturbances of serotonin function and the increase of free radical activity might present in chronic schizophrenia .\n",
            "And the pharmacological mechanisms of haloperidol and risperidone were different .\n",
            "Risperidone produced more effective outcome and fewer side effects possibly due to its preferable regulation to serotonin function , which might lead to normalization of neuroendocrine function in schizophrenia .\n",
            "Background and aims : To evaluate efficacy and safety of intramuscular ( IM ) aripiprazole and IM haloperidol in patients with acute agitation associated with schizophrenia .\n",
            "Methods : Patients ( n = @ ) were randomized to IM aripiprazole @-mg ( @ ml of a @-mg/ml solution ) , @-mg ( @ ml of a @-mg / ml solution to approximate @-mg ) , @-mg ( @ ml of a @-mg / ml solution to approximate @-mg ) , or @-mg ( @ ml of a @-mg / ml solution ) , IM haloperidol @-mg ( @ ml of a @-mg/ml solution ) or IM placebo .\n",
            "Over @ hours , patients received up to three injections , administered _ @ hours apart .\n",
            "Primary endpoint was mean change from baseline in Positive and Negative Syndrome Scale Excited Component ( PEC ) score at @ hours .\n",
            "Secondary endpoints included CGI-I , CGI-S and ACES scores .\n",
            "Results : Mean PEC improvements at @ hours were significantly greater with IM aripiprazole @ - , @ - and @-mg , and IM haloperidol versus IM placebo ( Table ) .\n",
            "Compared with IM placebo , mean improvements were significantly greater in CGI-S with IM aripiprazole @ - and @-mg , and in ACES with IM aripiprazole @-mg and IM haloperidol ( Table ) .\n",
            "Mean CGI-I was significantly better with IM aripiprazole @ - , @ - and @-mg , and IM haloperidol versus IM placebo ( Table ) .\n",
            "Overall , IM aripiprazole was well tolerated , with fewer extrapyramidal side effects versus IM haloperidol .\n",
            "Conclusion : IM aripiprazole @-mg is effective and well-tolerated for acute agitation associated with schizophrenia .\n",
            "BACKGROUND : Antipsychotics remain the mainstay of drug intervention in the management of SCHIZOphrenia .\n",
            "However , long-term treatment with antipsychotics is associated with a variety of movement disorders , the most disabling of which is tardive dyskinesia ( TD ) , which occurs in up to @ % of patients hospitalized with chronic SCHIZOphrenia .\n",
            "The pathophysiology of TD is still unclear and no definite treatment exists .\n",
            "Both dopamine receptor supersensitivity and oxidative stress - induced neurotoxicity in the nigrostriatal system are apparently implicated .\n",
            "The pineal hormone melatonin is a potent antioxidant and attenuates dopaminergic activity in the striatum and dopamine release from the hypothalamus .\n",
            "Thus , it may have a beneficial effect for both the treatment and prevention of TD .\n",
            "METHODS : Using a double-BLIND , placebo-controlled , crossover study , we evaluated the efficacy of @ mg/d of melatonin for @ weeks in @ patients with SCHIZOphrenia and TD .\n",
            "The primary outcome measure was the change from baseline in Abnormal Involuntary Movement Scale ( AIMS ) score .\n",
            "RESULTS : The decrease ( mean + / - SD ) in AIMS score was @ + / - @ for the melatonin and @ + / - @ for the placebo treatment groups ( P < .@ ) .\n",
            "No adverse events or side effects were noted .\n",
            "CONCLUSION : This is the first clinical evidence for efficacy of melatonin in the treatment of TD .\n",
            "Therapeutic and adverse effects of three dosages ( @ , @ and @ mg daily ) of flutroline , a new gamma-carboline with a preclinical pharmacological profile similar to active neuroleptic agents , were compared in a double-blind clinical trial in @ newly-admitted schizophrenic patients .\n",
            "Therapeutic effects and extrapyramidal signs were seen at the @ and @-mg daily dosages , but not at the @-mg dosage .\n",
            "Serum prolactin levels were significantly elevated only at the @-mg daily dose .\n",
            "Carphenazine and piperacetazine , two new phenothiazines , were given to @ chronic schizophrenic patients for @ to @ months .\n",
            "These patients had previously served as control subjects in a controlled drug evaluation and had not improved .\n",
            "A global rating of moderate or marked improvement over their pre-study status was observed in @ % of the patients .\n",
            "There were no statistically significant differences between the drugs in degree of improvement or incidence of extrapyramidal reactions .\n",
            "Both drugs were considered effective phenothiazines for the chronic schizophrenic patient .\n",
            "EDUCATIONAL OBJECTIVES : At the conclusion of this session , the participant should be able to understand a significant association between the change of psychopathological score and the change of prolactin level after aripiprazole administration , which might be a good biomarker to follow up the efficacy of medication intervention .\n",
            "SUMMARY : Background : Aripiprazole as a partial dopaminergic agonist seems to reduce prolactin level in people treated with other antipsychotics previously on the basis of its pharmacological characteristics .\n",
            "Whether this trend correlates with other clinical observations such as psychopathological change or other side effects is not well defined .\n",
            "Methods : This is a randomized open-label trial on serum prolactin monitoring in schizophrenic subjects within @ weeks aripiprazole treatment .\n",
            "We enrolled @ inpatients ( @ Males , @ Females ) meeting DSM-IV criteria for schizophrenia in Taiwan .\n",
            "With consent form completed , participants were then randomly assigned to three different treatment groups : ( @ ) A - @ ~ @ mg aripiprazole per day ; ( @ ) B - @ ~ @ mg aripiprazole per day ; ( @ ) C - @ mg aripiprazole augmented with @ mg risperidone per day .\n",
            "All subjects were evaluated by using PANSS scale , CGI scale , UKU scale , AIMS scale , and serum prolactin level at baseline , @th week , @th week , and @th week .\n",
            "Results : The mean serum prolactin level reduced from @   @ ng/ml ( baseline ) to @   @ ng/ml ( @th week ) with a significant p-value < @ .\n",
            "The comparison of prolactin level between three groups of aripiprazole intervention shows no significant difference in the same direction , although the reduction trend of Group C was more than the other two Arms .\n",
            "The maximal prolactin level reduction was observed in the third week of aripiprazole intervention , and remains a normal level till the end of this study .\n",
            "The association between CGI scale and serum prolactin level shows statistically significant even after adjusted for sex and age .\n",
            "Conclusions : It is suggested that prolactin level returns to the normal range after @ weeks of aripiprazole intervention progressively and remains until the @th week .\n",
            "The reduction of prolactin level seems to predict the improvement of CGI in our schizophrenic patients .\n",
            "Open and small double blind studies suggest adding omega-@ fatty acids to neuroleptic medications may improve residual symptoms in patients with schizophrenia .\n",
            "Methods : Patients ( N = @ ) meeting criteria for schizophrenia / schizoaffective disorder who had significant residual symptoms of psychosis despite adequate neuroleptic treatment were randomized to eicosapentaenoic acid ( EPA ) @ gms daily ( N = @ ) or placebo ( N = @ ) in a @ week double blind supplementation trial .\n",
            "Clinical assessments were performed at baseline and weeks @ , @ , @ , @ , @ and @ ; cognitive battery at baseline and week @ .\n",
            "Results : Data for the intention to treat sample indicated baseline to week @ mean total PANSS change score was @ + / @ ( @ % ) for EPA and @ + / @ @ for placebo patients ; mean CGI-I score at week @ ( @ + / @ @ ) was identical for both groups .\n",
            "MANOVA indicated small statistically significant symptom improvement for both groups , but no time by treatment interaction .\n",
            "No treatment effect was found for mood ( MADRAS ) or cognitive functioning ( RBANS ) .\n",
            "Conclusions : Fatty acid supplementation did not improve symptoms in patients with longstanding schizophrenia .\n",
            "Weight gain is commonly observed with olanzapine treatment .\n",
            "Zonisamide is an antiepileptic drug associated with weight loss .\n",
            "This study examined the effectiveness of zonisamide in preventing weight gain in @ patients beginning olanzapine for bipolar disorder or schizophrenia .\n",
            "Each patient had a body mass index of @ mg/kg <sup> @ </sup> or greater and was randomized to taking olanzapine with either zonisamide ( n = @ ) or placebo ( n = @ ) for @ weeks .\n",
            "The primary outcome measure was change in body weight in kilograms from baseline .\n",
            "In the primary analysis using longitudinal regression , patients who received zonisamide had a significantly slower rate of weight gain and increase in body mass index than those who received placebo .\n",
            "The patients treated with zonisamide gained a mean ( SD ) of @ ( @ ) kg , whereas those treated with placebo gained a mean ( SD ) of @ ( @ ) kg ; P = @ .\n",
            "None of the patients in the zonisamide group , compared with @ patients ( @ % ) in the placebo group , gained @ % of body weight or greater from baseline ( Fisher exact test , P = @ ) .\n",
            "The zonisamide group , however , reported significantly more cognitive impairment as an adverse event than the placebo group ( @ % vs @ , respectively ; P = @ ) .\n",
            "Zonisamide was effective for mitigating weight gain in patients with bipolar disorder or schizophrenia initiating treatment with olanzapine but was associated with cognitive impairment as an adverse event .\n",
            "Copyright @ by Lippincott Williams & Wilkins .\n",
            "Purpose - The purpose of this study is to compare three strategies for switching patients with schizophrenia or schizoaffective disorder to the atypical antipsychotic , risperdone , after they have been unsuccessfully treated with another atypical antipsychotic , olanzapine .\n",
            "In the second phase of this study , investigators will assess the effectiveness of behavioral therapy in reducing body weight in risperdone-treated patients who are overweight or have problems with diabetes or blood sugar .\n",
            "Condition Intervention Phase Schizoaffective Disorder Schizophrenia Drug - risperidone Phase IV Primary Outcome Measures - The change in total Positive and Negative Syndrome Scale ( PANSS ) score from baseline at week @ of Phase @ .\n",
            "Secondary Outcome Measures - The change from baseline in Client Satisfaction Questionnaire ( CSQ-@ ) score at week @ of Phase @ and the change from baseline in Global Assessment of Functioning ( GAF ) score at week @ of Phase @ .\n",
            "Total Enrollment - @ Study start - February @ ; Study completion - May @ Data regarding the safety and effectiveness of different strategies for switching subjects with schizophrenia from one antipsychotic medication to another are very rare .\n",
            "Studies that have examined various switching designs , especially with regard to the newer atypical antipsychotic agents , suggest that either abrupt or gradual discontinuation does not inevitably lead to worsening of symptoms .\n",
            "This study is randomized ( patients are assigned different treatments based on chance ) , open-label , with a parallel group design to assess the safety and effectiveness of each of three strategies of discontinuing olanzapine and starting risperidone .\n",
            "The first strategy is the discontinuation of olanzapine on the day risperidone is started .\n",
            "The second strategy involves a reduction in the dose of olanzapine to one half of the study entry dose on the day risperidone is started .\n",
            "The reduced dose of olanzapine is to be given for one week and then discontinued .\n",
            "In the third strategy , the dose of olanzapine remains unchanged for the first week , then is reduced by one half of the study entry dose , and at the end of the second week is discontinued .\n",
            "In all three strategies , patients take the same dose of risperidone - @ mg by mouth twice a day for @ days , then @ mg twice a day for the next @ days .\n",
            "Further increase or decrease of risperidone dose and/or changing to a single daily dose can be carried out at the end of the first week .\n",
            "Additionally , after @ weeks of risperidone therapy , patients who are overweight or have problems with diabetes or blood sugar may enter a second phase of the study that examines weight loss .\n",
            "In this phase , patients are randomized to receive routine clinical care or training on weight management behavioral techniques while continuing to take risperidone for an additional @ weeks .\n",
            "At the end of @ weeks , total weight loss , changes in lipids , cholesterol and other laboratory measures will be compared between the two groups .\n",
            "The study hypothesis is that symptom improvement or worsening at week @ , as measured by total score on the Positive and Negative Syndrome Scale ( PANSS ) , should not differ depending on the method of switching from olanzapine to risperidone .\n",
            "Safety evaluations incude collection of adverse events , clinical laboratory tests and assessment of vital signs .\n",
            "The patients will receive oral tablets of risperidone @ to @ milligram [ mg ] twice a day ( higher or lower dose and/or changing to single daily dose allowed at end of the first week ) for the duration of @ weeks in phase @ , and then for @ more weeks in phase @ of the study .\n",
            "Olanzapine - none ; or half of the study entry dose for @ week ; or study entry dose for @ week , then half of the study entry dose for an additional week .\n",
            "Eligibility - Ages Eligible for Study - @ Years - @ Years , Genders Eligible for Study - Both Criteria Inclusion Criteria - Patients who have a DSM-IV ( Diagnostic and Statistical Manual of Mental Disorders , Fourth Edition ) diagnosis of schizophrenia or schizoaffective disorder Taking a stable dose of olanzapine for at least @ days Have not experienced an acute exacerbation of their psychotic symptoms in the preceding @ months Either had only a marginal clinical response to olanzapine , or had unacceptable side effects related to weight gain including obesity , diabetes or abnormal glucose metabolism Exclusion Criteria - Patients with a history of treatment failure with , or significant adverse events attributable to , risperidone , or known sensitivity to risperidone A history of antipsychotic therapy other than olanzapine in the @ days preceding randomization Presence of serious or unstable illnesses - liver or renal insufficiency , significant cardiac , vascular , pulmonary , gastrointestinal , endocrine , neurological , psychiatric or metabolic disturbances Diagnosis of substance dependence Pregnant or nursing female , or those lacking adequate contraception\n",
            "We examined the serotonergic system in drug free inpatients ( schizophrenia ( n = @ ) and schizoaffective ( n = @ ) by administering dl - fenfluramine in a random assignment double blind placebo controlled angiocatheter study .\n",
            "Response to fenfluramine was examined by peak-delta and AUC 's of the serum cortisol and prolactin response .\n",
            "Initial analyses indicate significant positive correlations between the prolactin AUC and negative symptoms ( r = @ ; n = @ ; p < @ ) , and the cortisol peak-delta response and positive symptoms ( r = @ ; n = @ ; p < @ ) .\n",
            "Objective : To understand the influence of chlorpromazine , clozapine and risperidone on weight and blood sugar .\n",
            "Methods : @ cases of first episode schizophrenia patients were randomly divided into three groups , single use of chlorpromazine , clozapine and risperidone in the treatment for @ weeks , respectively , observed in @,@ weekend before treatment and after treatment , changes in body weight and blood sugar .\n",
            "Results : @ patients after treatment , body weight have a very significant increase , including chlorpromazine , clozapine treatment , @ weeks , the risperidone group therapy @ weeks body weight than the pre-treatment significantly increased .\n",
            "Clozapine treatment , blood glucose after @ weeks significantly increased body weight and blood sugar has a very significant positive correlation .\n",
            "Background : Clozapine is currently the drug of choice in the treatment of schizophrenic patients who fail to respond to other antipsychotic drugs , but about half of these patients achieve an insufficient response even for clozapine .\n",
            "Furthermore , there is no evidence from randomized , controlled trials that demonstrate an effectiveness for any pharmacological treatment in clozapineresistant schizophrenia .\n",
            "Methods : The hypothesis tested was that lamotrigine is more effective than a placebo in the treatment of positive schizophrenic symptoms when combined with clozapine .\n",
            "Thirty-four treatmentresistant patients having chronic schizophrenia participated in a double-blind , placebo-controlled , @-week , crossover trial where @ mg/day lamotrigine was gradually added to their ongoing clozapine treatment .\n",
            "Clinical assessments were made by BPRS and PANSS at the beginning and end of each treatment period .\n",
            "Results : BPRS scores decreased @ + -@ ( mean + - S.D. ) points during lamotrigine treatment and @ + -@ points during the placebo phase of the study ( effect size @ , p < @ ) .\n",
            "There was a substantial negative correlation between the change in BPRS during lamotrigine treatment vs. baseline BPRS score ( r = -@ , p = @ ) , and the most robust effect between lamotrigine vs. placebo was observed among patients with baseline BPRS score ~ > @ ( effect size @ , p < @ ) .\n",
            "According to PANSS , lamotrigine treatment was markedly more effective in reducing positive ( effect size @ , p < @ ) and general psycho-pathological ( effect size @ , p < @ ) symptoms , whereas no significant improvement was observed in negative symptoms .\n",
            "In intention-to-treat analysis , lamotrigine was superior to placebo throughout the full range of outcome scores .\n",
            "Conclusions : These results provide the first evidence from a randomized controlled trial of an effective pharmacological treatment in clozapine-resistant schizophrenia , and indicate that both positive and general psychopathological symptoms in these schizophrenic patients can be controlled by a drug that is not a dopamine antagonist .\n",
            "Lamotrigine augmentation especially decreased positive symptoms , and the beneficial effect was extremely robust among the most ill patients .\n",
            "This indicates that excessive glutamate neurotransmission contributes to the symptomatology of severely ill schizophrenic patients .\n",
            "OBJECTIVE : Antisaccade errors are consistently increased in SCHIZOphrenia .\n",
            "As they have been demonstrated only in cross sectional studies , it is unclear how they vary longitudinally or with different medications .\n",
            "In a previous cross sectional study , we reported a trend towards a reduction in error rates in a patient group treated with risperidone , compared with clozapine and sulpiride treated groups .\n",
            "METHODS : Gap RANDOM and antisaccade paradigms were performed on two occasions in the same sample of DSM-IV SCHIZOphrenic patients ( n = @ ) in transition between conventional antipsychotic drugs and risperidone .\n",
            "A cross over design was used with six patients switching from risperidone to conventional ( group I ) and six in the opposite direction ( group II ) .\n",
            "A control sample ( n = @ ) was also tested on two occasions and their performance compared .\n",
            "The effects of practice between first and second testing and of switching between conventional antipsychotic drugs and risperidone and vice versa was also evaluated .\n",
            "RESULTS : A significant reduction in error rate was demonstrated during risperidone treatment ( n = @ ) , compared with conventional APD treatment .\n",
            "Switching from conventional to risperidone produced a reduction in errors , and vice versa .\n",
            "CONCLUSIONS : Treatment with risperidone was associated with improvement in antisaccade errors .\n",
            "CAS Registry/EC Number @ ( Antipsychotic Agents ) .\n",
            "@-@-@ ( Risperidone )\n",
            "Background : Cognitive impairment is the most important feature of schizophrenia that leads to severe social and functional disability .\n",
            "Improving neurocognitive physiopathologic aspect of schizophrenia is a current challenge to identify the pathway to develop goal directed clinical interventions in practice .\n",
            "In the current study we investigated the effect of raloxifine as a selective estrogen modulator and isradipine as a voltage gated L type calcium channel blocker on the enhancement of schizophrenic patients ' cognitive deficits .\n",
            "Methods : We designed a double blind randomized , parallel , placebo controlled clinical trials .\n",
            "@ patients with schizophrenia randomized in @ specific groups .\n",
            "The first group received isradipine @ mg , the second raloxifine @ mg and the third placebo for @ consequent weeks , in the same shape capsules , @ times a day , alongside treatment with the conventional antipsychotics .\n",
            "The initial and final lab tests , ECG , as well as cognitive tests in specific domains such as attention , processing speed , executive function and verbal memory were carried out .\n",
            "Results : Our findings , revealed a remarkable association between adjunctive treatment of raloxifine in verbal memory deficits .\n",
            "moreover , isradipine treatment indicated significant improvement relative to placebo in verbal memory as well as attention dysfunction in some variables of the Stroop test .\n",
            "However , no effect was observed in processing speed and executive function deficits .\n",
            "Discussion : The study provides the first evidence to our knowledge , which isradipine as a novel therapy was associated with improvement in verbal memory and attention , both related to hippocampal and cerebellar activity .\n",
            "Overall , further investigation is necessary to determine the various ways of the both drugs performance in the brain .\n",
            "The efficacy of ECT in the treatment of Schizophrenia was investigated in a double blind controlled trial .\n",
            "The ICD-@ criteria for Schizophrenia were fulfilled by the @ patients who entered the trial .\n",
            "Consecutive individuals who satisfied the inclusion criteria were RANDOMly allocated to a course of ( bilateral ) six real or simulated ECTs each as applicable .\n",
            "Sixteen patients completed the ECT treatment and @ weeks follow up period .\n",
            "Analysis of measures of clinical change ( BPRS and SANS Scores ) showed that both groups of patients improved , but the improvement of patients receiving ECT was not significantly greater than that of the control group .\n",
            "CAS Registry/EC Number @ ( Antipsychotic Agents )\n",
            "Urinary MHPG excretion in patients with acute schizophrenia was studied before and during a trial of the isomers of flupenthixol and placebo .\n",
            "Pretrial MHPG excretion was not related to severity of illness before the trial or to other pretrial clinical variables .\n",
            "In male subjects higher pretrial MHPG excretion was associated with a better outcome @ year post-trial .\n",
            "However in females no relationship between MHPG excretion and outcome was established .\n",
            "During the trial there was a reduction in MHPG excretion in patients treated with beta-flupenthixol but no decrease in the group treated with alpha-flupenthixol or chlorpromazine .\n",
            "In patients on placebo there was a reduction in MHPG excretion in those who did well clinically , but not in those who did poorly .\n",
            "Thus low MHPG excretion may be a predictor of poor outcome in schizophrenia , but MHPG excretion also changes both as a function of clinical state and of neuroleptic drug administration .\n",
            "Ginkgo biloba extract matter Shuxuening double-blind control the treatment of schizophrenia II clinical observation of Zhong Hongwen , spring Luo , Jia Yunkui , Zhao Xueying Ginkgo biloba extract Shuxuening original drugs for the treatment of cardiovascular and cerebrovascular diseases , able to scavenge oxygen free radicals , increase red blood cells SOD ( superoxide dismutase ) activity , inhibition of lipid peroxidation .\n",
            "According to these pharmacological effects , from March to September @ , with its double-blind controlled treatment observation on @ schizophrenia ( hereinafter referred to Sob ) , are reported below .\n",
            "Information , clinical data : Outpatient treatment in @ patients .\n",
            "Treatment group @ cases , five men and @ females .\n",
            "Age : @ ~ @ years old , an average of @ .\n",
            "sl soil @ years old .\n",
            "Disease duration : @-Tian , an average of @  @ .\n",
            "Objective : To investigate the effect of health education intervention on the rehabilitation of patients with schizophrenia .\n",
            "Methods : @ cases of rehabilitation of patients with schizophrenia were randomly divided into @ cases of the study group and the control group , @ cases in the control group patients only received regular health education , the study group patients receive health education targeted .\n",
            "Health education before and after the application of the Brief Psychiatric Rating Scale ( bprs ) , to evaluate the efficacy of Inpatient Observation Scale ( nosie ) .\n",
            "Results : After the intervention the research group bprs , nos-ie each factor and total scores were significantly better than the control group , and the differences were statistically significant differences ( p < @ ) .\n",
            "SIGNIFICANCE : Young adults with schizophrenia , bipolar disorder and other severe mental illnesses ( SMI ) have high rates of smoking , but little research has evaluated predictors of cessation activity and treatment utilization in this group .\n",
            "METHODS : We assessed attitudes , beliefs , social norms , perceived behavioral control , intention , quit attempts , treatment utilization , and cessation among @ smokers with SMI , age @-@ , enrolled in a randomized pilot study comparing a brief interactive/motivational vs. a static/educational computerized intervention .\n",
            "Subjects were assessed at baseline , post intervention , and @-month follow-up .\n",
            "RESULTS : Over follow-up , one-third of participants self-reported quit attempts .\n",
            "Baseline measures indicating lower breath CO , greater intention to quit , higher perceptions of stigma , higher perceptions of psychological benefits of smoking , and greater symptom distress were associated with quit attempts , whereas gender , diagnosis , social support , attitudes about smoking , and use of cessation treatment were not .\n",
            "In the multivariate analysis , lower breath CO , higher intention to quit and symptom distress were significantly related to quit attempts .\n",
            "Only @ % of participants utilized verified cessation treatment during follow-up .\n",
            "Consistent with the Theory of Planned Behavior , attitudes , social norms and perceived behavioral control regarding cessation treatments correlated significantly with intention to use treatment .\n",
            "Norms and beliefs about treatment were somewhat positive and some improved after intervention , with a pattern significantly favoring the interactive intervention , but intentions to use treatments remained low , consistent with low treatment utilization .\n",
            "CONCLUSIONS : Perceptions of traditional cessation treatments improved somewhat after brief interventions , but most young adult smokers with SMI did not use cessation treatment .\n",
            "Instead , interventions led to quit attempts without treatment .\n",
            "Background : Partial or nonadherence to antipsychotic treatment for schizophrenia ( SCZ ) is a major challenge resulting in increased relapse and rehospitalization [ @-@ ] .\n",
            "Paliperidone palmitate @-monthly ( PP@M ) is a long-acting injectable ( LAI ) atypical antipsychotic medication , approved in the US and many other countries for the management of SCZ in adults [ @ ] .\n",
            "A new formulation , PP @-monthly ( PP@M ) , provides extended sustained release of paliperidone , requiring only @ doses/year and is approved in the US for treatment of SCZ [ @-@ ] .\n",
            "Objective : To assess noninferiority of PP@M to PP@M in patients with SCZ previously stabilized on PP@M , and to compare efficacy and safety outcomes for European and non-European subgroups .\n",
            "Methods : This randomized , double-blind ( DB ) , parallel-group , multicenter , noninferiority , phase-@ study ( EudraCT no : @ - @-@ ) enrolled patients of either sex ( @-@ years ) , diagnosed with SCZ ( DSM-IV-TR ) , and a PANSS total score between @ and @ .\n",
            "After screening , patients entered a @-week , flexibledose , open-label ( OL ) phase to receive PP@M .\n",
            "Stabilized patients entered a @-week DB phase and were randomized ( @:@ ) to fixed dose of PP@M ( @ , @ , @ , or @ mg eq .\n",
            "deltoid/gluteal ) or PP@M ( @ , @ , @ , or @ mg eq .\n",
            "deltoid/gluteal [ @ multiple of PP@M ] ) .\n",
            "Primary efficacy endpoint was percentage of relapsefree patients at the end of the @-week DB phase .\n",
            "Cumulative survival was estimated using Kaplan-Meier method .\n",
            "Continuous variables were analyzed using ANCOVA with factors for treatment and country with baseline score as a covariate .\n",
            "Noninferiority of PP@M to PP@M was to be concluded if the lower limit of the @-sided @ % CI ) of the difference in relapse-free rates between PP@M and PP@M exceeded the prespecified margin of -@ % .\n",
            "Results : Overall , @ patients were enrolled and dosed in OL phase , of which @ were randomized to DB phase .\n",
            "Of patients who entered the DB phase , @ ( @ % ) were Europeans ( PP@M , n = @ ; PP@M , n = @ ) and @ ( @ % ) were non-Europeans ( PP@M , n = @ ; PP@M , n = @ ) .\n",
            "Mean [ SD ] age ( years ) was similar in Europeans ( @ [ @ ] ) vs. non-Europeans ( @ [ @ ] ) .\n",
            "A similar percentage of patients in both groups ( Europeans : PP@M , n = @ [ @ % ] ; PP@M , n = @ [ @ % ] ; non-Europeans : PP@M , n = @ [ @ % ] ; PP@M , n = @ [ @ % ] ) experienced a relapse during the DB phase .\n",
            "Kaplan-Meier estimate of difference ( @ % CI ) between PP@M and PP@M groups in the percentage of patients who remained relapse-free at the end of DB were ( @ % [ -@ % ; @ % ] ) in Europeans and ( @ % [ -@ % ; @ % ] ) in non-Europeans .\n",
            "The lower bound of CIs for both groups was larger than the prespecified margin of -@ % .\n",
            "During DB phase , the incidence of treatment-emergent adverse events ( TEAEs ) was higher among Europeans ( PP@M : @ % , PP@M : @ % ) vs. non - Europeans ( PP@M : @ % , PP@M : @ % ) .\n",
            "Weight gain was the most common TEAE across both subgroups .\n",
            "A similar percentage of patients experienced serious TEAEs among both European ( PP@M : @ % ; PP@M : @ % ) and non-European ( PP@M : @ % ; PP@M : @ % ) subgroups .\n",
            "The PK profiles for the corresponding PP@M and PP@M doses completely overlapped in the DB phase .\n",
            "Conclusion : PP@M was non-inferior to PP@M in both European and non-European subgroups .\n",
            "PP@M was generally tolerable and exhibited similar tolerability and efficacy in European and non - European population .\n",
            "Objective To investigate the efficacy of risperidone in the treatment of patients with schizophrenia with clozapine for comparison , at the same time to explore both the P@ .\n",
            "Methods @ patients with schizophrenia were randomly divided into a treatment group and the control group , @ cases for each treatment group were treated with risperidone : an initial dose of @ mg / d , @ weeks , increase the dose to the ( @ to @ ) mg / d. Control group using clozapine : ( @ to @ ) mg / d in two divided doses .\n",
            "Using PANSS before treatment , after the assessment of the efficacy observed compared between the two groups of P@ latency , P@ amplitude changes .\n",
            "The treatment group was @ % , the effective rate of @ % of the control group , the difference was not significant sex ( P > @ ) .\n",
            "Before treatment , the PANSS score comparison , the difference was not statistically significant ( P > @ ) .\n",
            "After treatment , the treatment group and the control group of PANSS were significantly lower than before treatment , the difference was significant ( P < @ ) , compared with the control group , the difference was not significant ( P > @ ) .\n",
            "Before treatment , P@ latency , P@ amplitude were compared , the difference was not significant sex ( P > @ ) .\n",
            "P@ latency of treatment , the treatment group compared with before treatment significantly reduced , and decrease when compared to the control group ; treatment group P@ amplitude was significantly higher compared with before treatment , and compared with the control group was significantly higher amplitude .\n",
            "OBJECTIVE : To evaluate whether blister packing medications would improve prescription medication adherence in psychiatric patients .\n",
            "It was hypothesized that patients in the blister pack ( BP ) condition would be more adherent to their daily medications than those in the dispense as usual condition .\n",
            "METHODS : This was a randomized trial involving up to @ year of monthly follow-up assessments .\n",
            "Participants were recruited from an urban Veterans Affairs ( VA ) Medical Center in the Western United States .\n",
            "Inclusion criteria for participants included being diagnosed with a major affective disorder , posttraumatic stress disorder , schizophrenia , or a combination of these disorders ; being @ to @ years of age ; receiving prescription medications from the VA pharmacy ; and being considered competent to manage their own medications .\n",
            "Of the @ patients who consented to participate , @ were randomized to @ of the @ study conditions , and @ were retained in the study .\n",
            "The sample was @ % male , @ % white , with a mean age of @ years .\n",
            "All medications prescribed and dispensed by the VA were either repackaged in monthly BPs or dispensed in standard pill vials .\n",
            "RESULTS : The primary hypothesis was supported .\n",
            "Patients in the BPs condition showed evidence of better adherence at @-month follow-up , as well as larger increases in adherence from @ month to @ months .\n",
            "CONCLUSIONS : Psychiatric patients adhere better to prescription medication regimens when receiving their medications in BP .\n",
            "The increasing use of randomised controlled trials in the evaluation of mental health services requires the \" representativeness \" of a sample to be addressed as a key methodological issue .\n",
            "Method - In a UK trial evaluating intensive case management for the severely mentally ill one step taken to ensure \" representativeness \" was to use a criteria based sampling frame .\n",
            "All subjects identified as meeting the following criteria were approached for interview : aged @ - , a diagnosis of psychosis , at least two psychiatric admissions one of which was within the last two years .\n",
            "Basic demographic information and data regarding psychiatric history was collected for all subjects identified and the \" representativeness \" of the subjects who entered the study was analysed .\n",
            "Results - @ subjects were identified and of those @ entered the study .\n",
            "Preliminary findings suggest that there were no significant differences between the subjects who entered the study and the identified population .\n",
            "Conclusions - While this approach enabled the \" representativeness \" of the study population to be assessed it was achieved at the cost of targeting the clinically most relevant group who would be identified by asking \" which of your patients is most difficult to maintain outside hospital ? \"\n",
            "Objective To investigate transcranial magnetic stimulation ( rTMS ) treatment of antipsychotic-induced hyperprolactinemia efficacy and safety .\n",
            "Methods @ cases of risperidone-induced hyperprolactinemia chronic schizophrenia were randomly divided into two groups , the study group ( @ cases ) sham rTMS stimulation treatment to be the low-frequency rTMS stimulation in the control group ( @ cases ) ; and observe serum prolactin , PANSS table , @ Hamilton Depression Rating Scale .\n",
            "Results  Study Group rTMS stimulation PRL levels ( @  @ ) g / L ] than before treatment [ ( @  @ ) g / L ] decreased , the difference was statistically significant ( P < @ ) ; control group showed no statistical significance ( P > @ ) ; study group therapy a retest of PRL ( @  @ ) g / L ] , has been restored to the level before treatment ( P > @ ) .\n",
            " treatment before and after the two groups of patients the PANSS and HAMD@ score changes were not statistically significant ( P > @ ) .\n",
            "Conclusions of low-frequency rTMS treatment serum of patients with chronic schizophrenia can be the high prolactin short-term decline .\n",
            "STUDY OBJECTIVE : The clinical adequacy of electroconvulsive therapy ( ECT ) depends on not only seizure duration but also seizure amplitude and postictal suppression .\n",
            "The objective of this study was to evaluate the effects of combination of a reduced dose of propofol and moderate hyperventilation on seizure duration and electrical stimulus requirement for adequate ictal amplitude and postictal suppression .\n",
            "DESIGN : Prospective , randomized , controlled trial .\n",
            "SETTING : Operating room at a municipal hospital .\n",
            "PATIENTS : Sixty ASA physical status I or II patients scheduled to receive a total of > @ ECT treatments .\n",
            "INTERVENTIONS : Patients were randomly assigned to have the three interventions : the use of a standard dose ( @mg/kg ) of propofol and normoventilation ( ETCO@ of @-@mmHg ) ( group P/N ) , the use of a reduced dose ( @ mg/kg ) of propofol with divided remifentanil injections and normoventilation ( group RP/N ) , and the use of a reduced dose of propofol with divided remifentanil injections and moderate hyperventilation ( ETCO@ of @-@mmHg ) ( group RP/H ) .\n",
            "Patients in groups RP/N and RP/H received remifentanil @mug/kg followed by propofol @ mg/kg for unconsciousness and thereafter remifentanil @mug/kg immediately before the electrical stimulus .\n",
            "MEASUREMENTS AND MAIN RESULTS : Patients in group RP/H had significantly longer durations of electroencephalographic ( EEG ) seizures in the early phase of the ECT course ( P < @ ) and lower intensities of electrical stimulus in the late phase of the ECT course ( P < @ ) than those in groups P/N and RP/N .\n",
            "CONCLUSION : A reduced dose of propofol combined with divided supplemental remifentanil under moderate hyperventilation during ECT may contribute to reduced electrical dosage due to the ability of its augmentation of seizure amplitude and postictal suppression in the late phase of the ECT course .\n",
            "Not Recruiting Both male and female @ interventional Iran , Islamic Republic Of Inclusion criteria : Inclusion criteria : patients with schizophrenia admitted in Hejazi and Ibn Sina hospital in Mashhad that treated with clozapine and valproate at least @ months ( clozapine dose of @ to @ mg ) ; Age @ years or older ; triglyceride levels in the morning between @ to @ Milligrams per deciliter ; metabolic indices of patients before starting treatment with clozapine and valproate are normal .\n",
            "Exclusion criteria : Pregnancy or Lactation ; history of sensitivity to fish oil ; use of omega-@ in the past few months ; Having obvious bleeding disorders or a history of using heparin and coumarin ; The reluctance of patients participating in the study ; use of other drugs such as statins ; history of consumption or abuse of alcohol or drugs within @ months from baseline .\n",
            "Exclusion criteria : Intervention @ : In the intervention group all patients who received clozapine daily @ to @ mg a day for @ months receive omega-@ ( @ gr/day ) for @ weeks .\n",
            "Intervention @ : In the control group patients who received clozapine @ to @ mg a day for @ months received placebo for @ weeks .\n",
            ".\n",
            "height .\n",
            "Timepoint : baseline and week @ .\n",
            "Method of measurement : meter ; Weight .\n",
            "Timepoint : baseline and week @ .\n",
            "Method of measurement : scale ; abdominal circumference .\n",
            "Timepoint : baseline and week @ .\n",
            "Method of measurement : meter ; BMI .\n",
            "Timepoint : baseline and week @ .\n",
            "Method of measurement : kg/m@ ; Triglyceride levels .\n",
            "Timepoint : baseline and week @ .\n",
            "Method of measurement : blood test ; Cholesterol .\n",
            "Timepoint : baseline and week @ .\n",
            "Method of measurement : blood test ; LDL .\n",
            "Timepoint : baseline and week @ .\n",
            "Method of measurement : blood test ; HDL .\n",
            "Timepoint : baseline and week @ .\n",
            "Method of measurement : blood test ; CRP .\n",
            "Timepoint : baseline and week @ .\n",
            "Method of measurement : blood test ; Inflammatory Mediators .\n",
            "Timepoint : baseline and week @ .\n",
            "Method of measurement : blood test ; CBC .\n",
            "Timepoint : baseline and week @ .\n",
            "Method of measurement : blood test\n",
            "Objective To investigate the clinical efficacy and side effects of the merger buspirone treatment of schizophrenia risperidone .\n",
            "@ patients with schizophrenia were randomly divided into research group ( risperidone merger buspirone in the treatment of @ cases ) of @ cases and a control group ( risperidone treatment ) , the course of eight weeks , the use of positive and negative symptom Scale ( panss ) to evaluate the efficacy , side effects scale ( tess ) and laboratory tests to assess a variety of side effects .\n",
            "The results of the study group @ the weekend panss average reduction rate compared with the control group decreased significantly ( p < @ ) , and other the weekend panss average reduction rate reduce quite .\n",
            "The incidence of side effects in the two groups were @ % of the study group and the control group ( @ % ) , the severity of the most mild , moderate minority .\n",
            "The total amount of the risperidone group compared with the control group less .\n",
            "HYPOTHESIS : Children of parents with a mental illness or substance use disorder have high elevated risks to develop ( mental and behavioural ) problems themselves .\n",
            "Hypothesis is that the online Kopstoring intervention will be effective and cost-effective preventing futire problems and illnesses compared to care as usual .\n",
            "HEALT CONDITION ( S ) OR PROBLEM ( S ) STUDIED : Mental health problems , Prevention , Substance abuse INCLUSION CRITERIA : The adolescent : @ .\n",
            "Has to have at least one parent suffering from a mental illness or substance use disorder ; @ .\n",
            "Has to be qualified as child who fits the cut-off scores of the Youth Self Report questionnaire .\n",
            "The child has to fit in the scores to the groups that are equivalent to the child barely having symptoms and having medium symptoms ; @ .\n",
            "Sufficiently fluent in the Dutch language ; @ .\n",
            "Has access to the internet ; @ .\n",
            "Ability to use a chat box : able to participate actively and able to listen to other participants ; @ .\n",
            "When aged @-@ years informed consent of both child and parent ; when aged @ and over , informed consent of the adolescent only ( mandatory under the Dutch law ) .\n",
            "EXCLUSION CRITERIA : @ .\n",
            "Children younger that @ and adults older than @ years old ; @ .\n",
            "Too heavy symptoms and already developed psychological problems .\n",
            "- MEC APPROVAL RECEIVED : no - MULTICENTER TRIAL : yes - RANDOMISED : yes - MASKING/BLINDING : Single - CONTROL : Active - GROUP : Parallel - TYPE : @ or more arms , randomized - STUDYTYPE : intervention - PLANNED STARTDATE : @-jan-@ - PLANNED CLOSINGDATE : @-dec-@ - TARGET NUMBER OF PARTICIPANTS : @ - INTERVENTIONS : @ .\n",
            "Kopstoring : Online psycho-educative program .\n",
            "The program exists of @ online sessions over @ weeks and an evaluation session in a protected chat box ( chat room ) .\n",
            "The aim of the intervention is to strengthen social and emotional functioning , coping skills and the relationship of the child with the parent .\n",
            "This will be achieved by interaction , self-assessments and education ; @ .\n",
            "Care-As-Usual : This will be a   waiting-list control group with unrestricted access to Care-as-Usual  .\n",
            "The Care-As-Usual will consist of preventive CBT sessions in groups under professional guidance , help offered by psychologists , etc , but the choices are not regulated by guidelines and remains the responsibility of the family   s GP .\n",
            "Often , the problems go undetected and the child receives nothing .\n",
            "- PRIMARY OUTCOME : For the Effectiveness study and Cost-effectiveness study : Reduction of symptoms and complaints as measured by the Youth Self Report Questionnaire will be used this is a self reported version of Child Behaviour Checklist .\n",
            "- SECONDARY OUTCOME : For the Cost-utility analysis : QALYs and Utilities will be based on the utilities derived from the EuroQol ( EQ-@d ) .\n",
            "- TIMEPOINTS : @ .\n",
            "Baseline ; @ .\n",
            "@ Weeks ; @ .\n",
            "@ Months ; @ .\n",
            "@ Months .\n",
            "- TRIAL WEB SITE : www.kopstoring.nl - STATUS : planned BRIEF SUMMARY : DESIGN : We will conduct a pragmatic randomized controlled trial ( RCT ) in two parallel groups .\n",
            "The Kopstoring program will be compared with a waiting list control condition which reflects Care-As-Usual .\n",
            "The duration of the interventions is @ weeks and the total time frame of the study will be six months , with a prolonged measurement of outcomes in the intervention group after @ months .\n",
            "@ % of the participants receive the Kopstoring program ; the others receive Care-As-Usual which usually consists of non-standardized care while they are waiting for six months .\n",
            "In the economic evaluations the additional costs and additional outcomes of the Kopstoring will be compared with Care-As-Usual .\n",
            "This economic evaluation will involve a combination of a cost-effectiveness analysis ( CEA ) and a cost-utility analysis ( CUA ) .\n",
            "In a CEA effects are presented in clinical outcomes , in this case the YSR .\n",
            "The primary outcomes measure for the cost-utility analysis will be Quality Adjusted Life Years ( QALYs ) , based on the EQ-@D utility scores .\n",
            "This economic evaluation will be performed from a societal perspective .\n",
            "Cognitive impairments associated with schizophrenia are very frequent .\n",
            "They concern both neurocognition and social cognition , including facial emotion recognition .\n",
            "These impairments have a negative impact on the daily functioning , in particular the social and vocational rehabilitation of people with schizophrenia .\n",
            "Previous studies in this area clearly demonstrated the interest of cognitive remediation to improve neurocognitive and social cognitive functioning in schizophrenia .\n",
            "They also established clear links between facial emotion recognition skills and attentional processes .\n",
            "The present study compares the GAIA s-face program ( GAIA arm ) , which focuses on facial emotion recognition processes , with the RECOS program ( RECOS arm ) , a neurocognitive remediation therapy focusing on selective attention .\n",
            "Forty people with schizophrenia were randomly distributed between each study arm and assessed pre - ( T@ ) and post - ( T@ ) therapy .\n",
            "The single-blind assessment focused on facial emotion recognition ( the main criteria ) , symptoms , social and subjective functioning , and neurocognitive and social cognitive performance .\n",
            "Both programs were conducted by nurses after a @-day training session .\n",
            "The study showed a significant improvement in facial emotion recognition performance in both groups , with a significantly larger effect in the GAIA arm .\n",
            "Symptoms and social functioning also improved in the GAIA arm , and certain neurocognitive and social cognitive processes improved in both study arms .\n",
            "Further studies are recommended , with larger population samples and a follow-up assessing the long-term preservation of these improvements .\n",
            "The purpose for the study of occupational and recreational therapy adjuvant therapy for patients with chronic schizophrenia .\n",
            "Methods @ patients with chronic schizophrenia were randomly divided into two groups , to SANS assessed in each patient before treatment and after treatment , patients in both groups to maintain the original psychiatric medication unchanged ; occupational and recreational therapy group ( n = @ ) auxiliary implementation of the occupational and recreational therapy , the control group only treated with drugs for @ weeks .\n",
            "Results before and after treatment SANS ratings were significant differences ( P < @ ) ; occupational and recreational treatment group than the control group ( P < @ ) .\n",
            "Objective To explore the effect of comprehensive intervention in the rehabilitation of patients with chronic schizophrenia .\n",
            "@ inpatients with chronic schizophrenia were randomly divided into @ cases of the observation group , @ cases and the control group were given conventional drug treatment , health education and occupational and recreational activities .\n",
            "The observation group based on the implementation of a comprehensive rehabilitation intervention program , intervention period of @ to @ weeks .\n",
            "Psp score of @ groups of patients before and after intervention .\n",
            "Results after the intervention of the personal and social functions of the observation group was significantly higher , and the difference was statistically significant ( p < @ ) .\n",
            "Conclusion The comprehensive rehabilitation intervention can improve daily living skills and social function of patients with chronic schizophrenia .\n",
            "Background : Over the past @ years , attention has turned increasingly to dysfunction of the N-methyl-D-aspartate ( NMDAR ) - type glutamate receptors as a fundamental deficit underlying pathophysiology in major psychiatric disorders such as schizophrenia and affective illnesses .\n",
            "In schizophrenia , a major focus has been on development of compounds to enhance NMDAR function .\n",
            "Proof-of-principle trials have been conducted with glycine-site agonists including glycine and D-serine , and with high affinity glycine transport inhibitors .\n",
            "Although significant improvement has been observed on negative and total symptoms in some , but not all , studies , effects of these compounds on cognition remain relatively understudied .\n",
            "Furthermore , relatively low doses of D-serine have been used because of concerns regarding nephrotoxicity .\n",
            "Two studies have been done to assess potential effects of D-serine on cognitive function .\n",
            "The first investigated effects of high dose ( @ mg / kg/d ) D-serine > @ weeks on neurocognition as assessed both with neurophysiological and neurocognitive measures .\n",
            "A second piloted effects of acute D-serine treatment in the enhancement of cognitive plasticity during an auditory learning task .\n",
            "In affective disorders , NMDAR antagonists represent a potential treatment modality for treatment resistant major depression and bipolar depressive disorders .\n",
            "Acute treatment with intravenous ketamine induces near-immediate relief for treatment resistant depressive symptoms that last for up to @ weeks .\n",
            "However , practical approaches to prolong this acute benefit are still being developed .\n",
            "D-Cycloserine ( DCS ) is an antibiotic hat cross reacts with the glycine site of the NMDAR , and , at high dose , acts as a net NMDAR antagonist .\n",
            "Antidepressant effects of DCS were first described in the @ 's and have recently been confirmed in a double blind RCT of treatment resistant MDD .\n",
            "The present study investigates utility of acute ketamine challenge , added to ongoing treatment , to induce improvement followed by high-dose DCS to maintain improvement , as a potential near-term , practical approach for MDD treatment .\n",
            "A concern with use of NMDAR antagonists is a risk of treatment emergent psychosis .\n",
            "In this study , DCS is added to ongoing treatment with antipsychotics ( Seroquel , fluoxetine/olanzapine , lurasidone ) also approved for treatment of bipolar depression .\n",
            "Methods : We will present data from three NMDAR modulator studies , as follows : @ .\n",
            "ERP biomarker : In this study , neurophysiological and neurocognitive data were collected during a double blind , crossover study of high dose ( @ mg/kg/d ) D-serine vs placebo added to existing antipsychotic medication ( n = @ ) .\n",
            "These neurophysiological data were combined with previously unpublished measures obtained as part of a previously reported open label dose finding study ( Kantrowitz @ ) ( n = @ ) .\n",
            "Primary outcome measures for neurophysiology included amplitude of the mismatch negativity ( MMN ) and visual P@ potentials , analyzed as described previously ( Friedman @ ) .\n",
            "The primary neurocognitive outcome measure was composite score on the MATRICS neuropsychological battery .\n",
            "Clinical symptoms were assessed using the PANSS .\n",
            "@ .\n",
            "D-serine + cognitive remediation : In this study , MMN was measured before and after subjects completed an auditory training program ( coinciding with peak d-serine levels ) and post intervention ERP ( NCT@ ) .\n",
            "Cognitive remediation consisted of an auditory frequency discrimination task shown to promote learning in healthy controls ( Ahissar @ ) .\n",
            "Outcome measures included tone matching accuracy and MMN .\n",
            "@ .\n",
            "DCS in bipolar depression : DCS has been reported to be effective in treatment of refractory MDD .\n",
            "This study evaluates effectiveness of DCS as maintenance treatment for bipolar depression after acute ketamine administration .\n",
            "DCS ( @ mg ) was added to standard treatment for @ weeks in an open label tolerability investigation .\n",
            "Results : ERP biomarker : @ subjects with a mean age of @ +@ and a mean chlo\n",
            "The Problem .\n",
            "The problem of the study was to find if the Minimult could be used accurately and reliably with psychotic delinquent adolescents .\n",
            "The main objectives of the research were to determine if the Minimult would yield high correlations and similar diagnosis as the standard MMPI .\n",
            "Method .\n",
            "All data were secured from @ incarcerated criminal male offenders ranging in age from @ to @ who were committed to the California Youth Authority .\n",
            "Each subject was randomly assigned to one of two test-retest sequences .\n",
            "One group was administered the MMPI followed by the Minimult .\n",
            "The other group was administered the two instruments in reverse order .\n",
            "The tests were administered within @ hours of each other in both groups .\n",
            "The null hypotheses were as follows : The Minimult scales do not show a significant correlation to the standard MMPI .\n",
            "The Minimult and the MMPI T-scales are not the same and are responded to differently by subjects .\n",
            "The Minimult and the standard MMPI do not render similar diagnosis .\n",
            "The Minimult does not discriminate between valid and invalid profiles .\n",
            "Results .\n",
            "Analysis of the data resulted in low Pearson product moment correlation coefficients ranging from .@ to .@ .\n",
            "t-tests were conducted which showed significant differences at the .@ level between the MMPI and the Minimult .\n",
            "Scales that did not show significant differences were the L , K , @ , and @ scales .\n",
            "The Minimult and the MMPI yielded different diagnosis and code-types .\n",
            "Furthermore , the Minimult did not discriminate between valid and invalid profiles .\n",
            "BACKGROUND : We set out to determine whether and to what degree life events independent of illness increase the risk of relapse in schizophrenia following withdrawal from medication in the previous @ months , either by triggering a relapse in the following @ weeks or by acting cumulatively over time .\n",
            "METHOD : Seventy-one patients fulfilling DSM-III-R criteria for schizophrenia with chronic illness were followed for @ weeks and assessed on the LEDS scale .\n",
            "Half were treated with regular neuroleptic medication and half had been recently withdrawn from medication .\n",
            "A subgroup was RANDOMised DOUBLE-blind to treatment or placebo .\n",
            "RESULTS : A proportional hazards regression model showed that life events made a significant cumulative contribution over time ( P < @ ) to the risks of relapse and that ceasing medication made an independent contribution .\n",
            "The risk of relapse increased in proportion to the number of life events but no interaction between medication status and events could be detected , i.e. life events were not more closely associated with relapse on medication than off medication .\n",
            "For those of the sample exposed to the mean rate of life events during the study period , it was estimated that @ % of the relapse risk could be attributed to life events , and for those with twice the mean rate of events , @ % .\n",
            "In contrast , patients who continued on regular medication had @ % less risk of relapse than those who had been withdrawn from medication either by choice or under DOUBLE-blind controlled conditions .\n",
            "CONCLUSIONS : A contribution of life events to the risk of relapse in schizophrenia was confirmed by this study but the hypothesis that life events trigger relapse was not supported , nor was the hypothesis that life events are more relevant to relapse in patients on maintenance medication than in patients off medication .\n",
            "OBJECTIVE : Forensic assertive community treatment ( FACT ) is an adaptation of the assertive community treatment model and is designed to serve justice-involved adults with serious mental illness .\n",
            "This study compared the effectiveness of a standardized FACT model and enhanced treatment as usual in reducing jail and hospital use and in promoting engagement in outpatient mental health services .\n",
            "METHODS : Seventy adults with psychotic disorders who were arrested for misdemeanor crimes and who were eligible for conditional discharge were recruited from the Monroe County , New York , court system .\n",
            "Participants were randomly assigned to receive either FACT ( N = @ ) or enhanced treatment as usual ( N = @ ) for one year .\n",
            "Criminal justice and mental health service utilization outcomes were measured by using state and county databases .\n",
            "RESULTS : Forty-nine participants ( @ % ) completed the full one-year intervention period .\n",
            "Nineteen ( @ % ) were removed early by judicial order , one was removed by county health authorities , and one died of a medical illness .\n",
            "Intent-to-treat analysis for all @ participants showed that those receiving the FACT intervention had fewer mean + / - SD convictions ( .@ + / -.@ versus .@ + / -@ , p = .@ ) , fewer mean days in jail ( @ + / -@ versus @ + / -@ , p = .@ ) , fewer mean days in the hospital ( @ + / -@ versus @ + / -@ , p = .@ ) , and more mean days in outpatient mental health treatment ( @ + / -@ versus @ + / -@ , p < .@ ) compared with participants who received treatment as usual .\n",
            "CONCLUSIONS : The Rochester FACT model was associated with fewer convictions for new crimes , less time in jail and hospitals , and more time in outpatient treatment among justice-involved adults with psychotic disorders compared with treatment as usual .\n",
            "Background : Two tests commonly used in clinical trials to assess changes in cognition and cognitive functioning , respectively , in patients with schizophrenia are the MATRICS Consensus Cognitive Battery ( MCCB ) and University of California Performance-Based Skills Assessment-@ ( UPSA-@ ) .\n",
            "The MCCB contains ten tests covering seven cognitive domains while the UPSA-@ uses six role-play tests to evaluate cognitive functional capacity .\n",
            "Baseline correlations between the MCCB and UPSA are consistently reported to be ~ @ ; however , correlations between specific MCCB domain scores and UPSA total scores have not been reported .\n",
            "This analysis evaluated baseline and change score correlations between the MCCB and UPSA-@ total and domain scores in two @-week , Phase @ clinical trials .\n",
            "Methods : Two multicenter trials at @ U .\n",
            "S. sites in stable subjects with schizophrenia receiving antipsychotics were conducted to investigate procognitive effects : Trial A ( N = @ ) with the histamine-@ antagonist ABT-@ , and Trial B ( N = @ ) with the selective alpha-@ nicotinic acetylcholine agonist ABT-@ .\n",
            "Each trial employed a placebo and two active dose groups .\n",
            "Eligibility criteria were consistent with MATRICS guidelines .\n",
            "The MCCB , the primary endpoint , was administered at screening , baseline , Week @ , and Week @ ; while the UPSA-@ , a secondary endpoint , was administered at baseline and Week @ .\n",
            "Data from the two studies were combined for these analyses .\n",
            "Results : The overall correlation ( r ) between the MCCB and UPSA-@ total scores at baseline was @ ( n = @ ) .\n",
            "The correlations between the MCCB domains and UPSA-@ total score were @ , @ , @ , @ , @ , @ , and @ for Speed of Processing , Verbal Learning , Working Memory , Reasoning and Problem Solving , Visual Learning , Attention/Vigilance , and Social Cognition , respectively .\n",
            "Change score correlation between MCCB composite and UPSA-@ total scores ( baseline to Week @ ) was @ ( N = @ ) , while change score correlations between MCCB domains and UPSA-@ total scores ranged from -@ ( Speed of Processing ) to @ ( Attention/Vigilance ) .\n",
            "Correlations between MCCB domain and UPSA-@ domain scores ranged from @ ( MCCB Reasoning and Problem Solving with UPSA-@ Household Skills ) to @ ( MCCB Working Memory with UPSA-@ Financial Skills ) .\n",
            "Conclusion : While the overall correlation between MCCB and UPSA-@ total scores was strong , the individual MCCB domain scores correlated more weakly to the UPSA-@ total scores .\n",
            "The highest correlation was detected with Working Memory .\n",
            "OBJECTIVE : To compare the therapeutic effects of subject-chosen and therapist-chosen activities in occupational therapy for inpatients with chronic schizophrenia .\n",
            "DESIGN : Prospective comparative study .\n",
            "SETTING : A psychiatric hospital in Japan .\n",
            "SUBJECTS : Fifty-nine patients with chronic schizophrenia who had been hospitalized for many years .\n",
            "Interventions : The subjects received six-months occupational therapy , participating in either activities of their choice ( subject-chosen activity group , n = @ ) or activities chosen by occupational therapists based on treatment recommendations and patient consent ( therapist-chosen activity group , n = @ ) .\n",
            "MAIN MEASURES : The Positive and Negative Syndrome Scale and the Global Assessment of Functioning ( GAF ) Scale were used to evaluate psychiatric symptoms and psychosocial function , respectively .\n",
            "RESULTS : After six-months occupational therapy , suspiciousness and hostility scores of the positive scale and preoccupation scores of the general psychopathology scale significantly improved in the subject-chosen activity group compared with the therapist-chosen activity group , with @ ( @ ) ( median ( interquartile range ) ) and @ ( @ ) , @ ( @ ) and @ ( @ ) , and @ ( @ ) and @ ( @ ) , respectively .\n",
            "There were no significant differences in psychosocial functions between the two groups .\n",
            "In within-group comparisons before and after occupational therapy , suspiciousness scores of the positive scale , preoccupation scores of the general psychopathology scale , and psychosocial function significantly improved only in the subject-chosen activity group , with @ ( @ ) to @ ( @ ) , @ ( @ ) to @ ( @ ) , and @ ( @ ) to @ ( @ ) respectively , but not in the therapist-chosen activity group .\n",
            "CONCLUSIONS : The results suggested that the subject-chosen activities in occupational therapy could improve the psychiatric symptoms , suspiciousness , and preoccupation of the inpatients with chronic schizophrenia .\n",
            "Objective quetiapine , sulpiride first episode schizophrenia patients serum prolactin ( Prl ) and weight of men .\n",
            "Methods @ patients with first episode schizophrenia patients were randomly divided into quetiapine group and sulpiride group , a total of six weeks of treatment .\n",
            "Serum prl levels and body weight were measured before and after treatment .\n",
            "Results After treatment , the serum prolactin levels and body weight of the quetiapine group had no significant increase in the sulpiride group were significantly increased .\n",
            "Changes in body weight and prl level was positively related to relative .\n",
            "Conclusion quetiapine prl and body weight of patients had no significant effect , sulpiride prl and weight of patients increased significantly .\n",
            "Background : Schizophrenia spectrum disorders have major implications for the individuals , their families and society .\n",
            "Antipsychotic medication is the cornerstone in the treatment of psychotic symptoms and is effective in the reduction of psychotic symptoms and of relapse after remission of psychotic symptoms .\n",
            "This is the reason for recommending maintenance treatment with antipsychotic medication in national and international guidelines for the treatment of schizophrenia , one year after remission of psychotic symptoms in first episode psychosis .\n",
            "The aim of the study is to investigate the effect of tapered discontinuation versus maintenance therapy with antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder and with minimum three months remission of psychotic symptoms , and to find minimal effective dose of antipsychotic medication .\n",
            "Negative symptoms , cognitive impairments and the side effects of antipsychotic medication can cause a serious and long-term burden for patients and can reduce their quality of life .\n",
            "The TAILOR study will investigate these important aspects .\n",
            "Methods : The study is a randomized multicenter single blinded clinical trial .\n",
            "The aim is to include @ patients from the outpatient early intervention program , OPUS , a @ years manualized psychiatric treatment programme .\n",
            "At baseline patients must have @ months remission of psychotic symptoms as documented by the SAPS ( Schedule for Assessment of Positive Symptoms in Schizophrenia ) .\n",
            "The patients will be randomized to either tapered discontinuation or dose reduction of antipsychotic medication or treatment as usual stratified according to substance abuse .\n",
            "The intervention will last for @ year , and follow up interviews will be made after @ and @ years .\n",
            "The patients will receive a user-developed mobile phone application to make daily registrations .\n",
            "Results : The study has been including patients since May @ .\n",
            "The first data is expected in @ .\n",
            "Discussion : The TAILOR trial will contribute to knowledge about the effect of tapering/discontinuation of antipsychotic medication in early phases of schizophrenia spectrum disorders and hopefully the results may guide future clinical treatment regimens of antipsychotic medication .\n",
            "The trial is a complex medical intervention , and it raises ethical , practical and organizational challenges .\n",
            "When designing the TAILOR trial ethical questions were raised regarding blinding and the design of the intervention .\n",
            "In the trial only the researchers are blinded , neither clinicians nor patients , because they should be attentive of the high risk of relapse in the discontinuation group .\n",
            "The design gives the clinicians the possibility to adjust the dose of the antipsychotic medication to ensure sufficient treatment .\n",
            "Therefore , the trial only includes assessor blinding and the groups might end up being more similar than intended .\n",
            "In general , it is of ethical consideration that the trial participants in the tapering/discontinuation group will be subjected to a higher risk of relapse .\n",
            "On the other hand , it seems unethical if research were not to discover the group of patients who can discontinue antipsychotic medication without relapsing .\n",
            "Practical challenges will be sufficient recruitment or patient motivation and dropout .\n",
            "Health Condition ( s ) or Problem ( s ) studied Schizophrenia resistant to clozapine Intervention ( s ) In this study , the efficacy and tolerability @g daily of oral N-acetyl cysteine ( NAC ) will be compared to placebo as an augmenting strategy in patients with SZ who have proven   resistant   to clozapine .\n",
            "All participants will remain on clozapine for the duration of the trial ( i.e. @ weeks ) .\n",
            "Adherence will be monitored with pill checks at each visit and the supervision of all doses .\n",
            "Primary Outcome ( s ) Negative symptoms as assessed with the Positive and Negative Symptoms Scale ( PANSS ) Secondary Outcome ( s ) Biomarkers pertinent to glutathione ( including thiols ( such as GSH , cysteine , cysteinyl-glycine , N-acetylcysteine ) and corresponding disulphides ( such as glutathione disulphide ( GSSG ) and cysteine ) , other markers of oxidative stress ( lipid peroxidation    thiobarbaturic acid - TBARS , DNA damage - @-oxoguanine and protein carbonylation ) and antioxidant levels ) .\n",
            "Cognition as assessed by the MATRICS .\n",
            "Peripheral and cortical glutathione concentrations as assessed through blood samples and magnetic resonance spectroscopy , respectively .\n",
            "Quality of life as assessed by the Lancashire Quality of Life Profile Assessment of Quality of Life\n",
            "Objective : Cognitive remediation is an efficacious treatment for schizophrenia and , when used within broader psychosocial treatments , improves transfer to real-world behavior change .\n",
            "The authors examined whether cognitive remediation effectively generalizes to functional competence and real-world functioning as a standalone treatment and when combined with a functional skills treatment.Method : Outpatients with schizophrenia ( N = @ ) were randomly assigned to receive cognitive remediation , functional adaptation skills training , or combined treatment , with cognitive remediation preceding functional skills training .\n",
            "Clinical symptoms , neurocognition , social competence , functional competence , and case-manager-rated real-world behavior were assessed at baseline , at end of treatment , and at a @-week durability assessment.Results : Neurocognition improved , with durable effects , after cognitive remediation but not after functional skills training .\n",
            "Social competence improved both with functional skills training and with combined treatment but not with cognitive remediation alone .\n",
            "Improvements in functional competence were greater and more durable with combined treatment .\n",
            "Cognitive remediation alone did not produce significant improvements in real-world behavior , but when combined with functional skills training , statistically significant improvements from baseline to end of treatment and follow-up were observed in community or household activities and work skills .\n",
            "Number-needed-to-treat analyses suggest that as few as three cases are required for treatment to induce a meaningful improvement in functional skills.Conclusions : In a short intervention , cognitive remediation produced robust improvements in neurocognition .\n",
            "Generalization to functional competence and real-world behavior was more likely when supplemental skills training and cognitive remediation were combined .\n",
            "OBJECTIVE/INTRODUCTION : Lurasidone is an atypical antipsychotic medication approved for the treatment of schizophrenia over a dose range of @-@ mg/day .\n",
            "This study examined D@ receptor occupancy and its association with clinical improvement and side effects in patients with schizophrenia or schizoaffective disorder following repeated doses of @ , @ , or @ mg/day of lurasidone .\n",
            "METHODS : Twenty-five patients with The Diagnostic and Statistical Manual of Mental Disorders , @th ed .\n",
            "( DSM-IV ) diagnoses of schizophrenia or schizoaffective disorder were washed out of their antipsychotic medications ( @ half-lives ) and randomly assigned to @ , @ , or @ mg/day of lurasidone .\n",
            "Subjects were imaged with @F-fallypride at baseline and at steady-state lurasidone treatment to determine D@ receptor occupancy .\n",
            "RESULTS : Blood lurasidone concentration ( plus major metabolite ) , but not dose , significantly correlated with D@ receptor occupancy .\n",
            "D@ receptor occupancy in several subcortical structures is associated with positive but not negative symptom improvement or the presence of movement symptoms .\n",
            "DISCUSSION : Blood concentrations greater than @ ng/mL may be required to achieve a @ % occupancy level in subcortical areas .\n",
            "Intersubject blood concentrations at fixed dose were highly variable and may account for the lack of dose correlations .\n",
            "CONCLUSIONS : Positron emission tomography ( PET ) occupancy data suggest that greater than @ % occupancy can be achieved across the dose range of @-@ mg/day and that some patients require higher doses to achieve antipsychotic efficacy ; this finding supports prior randomized clinical trial results .\n",
            "Objective - At low-doses , l-sulpiride is effective mostly on negative symptoms in schizophrenia .\n",
            "At high-doses , however , @-sulpiride is as effective as haloperidol on positive symptoms .\n",
            "The aim of this study was to investigate whether response of positive symptoms to treatment in schizophrenics is related to l-sulpiride plasma levels.Method - Forty-six acutely relapsed , chronic schizophrenic patients ( DSM-III-R ) received l - sulpiride @ mg/day in a double-blind study .\n",
            "BPRS , SAPS and SANS were administered at admission ( T@ ) and after @ days of treatment ( T@ ) .\n",
            "Factors and correlation analyses were employed to identify the score changes ( T@ vs T@ ) that clustered together and that correlated with T@ l - sulpiride plasma levels.Results - BPRS , SAPS and SANS all improved significantly .\n",
            "The @ identified factors accounted for @ % of the variance in score change .\n",
            "Factor III was comprised of the \" bizarre behavior \" SAPS subarea items , that also were positively correlated with l - sulpiride plasma levels.Conclusion - Because of its receptor affinity , l-sulpiride preferentially binds to D@ and D@ receptors in the limbic areas .\n",
            "The clinical effects on bizarre behavior reported here positively correlated with l-sulpiride plasma concentration , suggesting that dopaminergic modulation induced by l-sulpiride high-doses in these brain areas is involved in the improvement of positive symptoms of these schizophrenic patients.Reference - Mucci A. , et al. - Levosulpiride - A review of its clinical use in psychiatry .\n",
            "Pharmacol Res , @ - @ - , @ .\n",
            "Guazelli M. , et al. - Clinical effects of @-sulpiride vs haloperidol in acutely relapsed chronic schizophrenics - therapeutic efficacy on \" disorganization \" ?\n",
            ".\n",
            "Eur Neuropsychopharmacol , @ - @ , @ .\n",
            "OBJECTIVE : The authors sought to determine if there were gender differences in neuroleptic response in male and female patients with schizophrenia who were matched for clinical and demographic variables and participated in a double-blind trial of traditional antipsychotic drugs .\n",
            "METHODS : @ males ( m ) and @ females ( f ) with schizophrenia or schizoaffective disorder who did not differ in clinical characteristics ( age of onset , course of illness , prior hospitalizations , premorbid functioning ) participated in an extended drug-free period followed by a neuroleptic trial under double-blind , placebo-controlled conditions .\n",
            "RESULTS : Males and females showed significant improvement in total , positive and negative BPRS symptoms during neuroleptic treatment .\n",
            "However , there were no significant differences in treatment response between sexes .\n",
            "No sex differences were found in baseline drug-free symptomatology , neuroleptic dose or dosage by weight .\n",
            "CONCLUSIONS : There were no significant sex differences in neuroleptic treatment response in male and female patients well-matched for clinical , treatment and demographic characteristics .\n",
            "Methodological issues which distinguish this study from prior studies reporting gender differences in neuroleptic response are examined .\n",
            "Cognitive impairments are one of the main contributors to disability and poor long-term outcome in schizophrenia .\n",
            "Proof-of-concept trials indicate that repetitive transcranial magnetic stimulation ( rTMS ) applied to the left dorsolateral prefrontal cortex ( DLPFC ) has the potential to improve cognitive functioning .\n",
            "We analyzed the effects of @-Hz rTMS to the left DLPFC on cognitive deficits in schizophrenia in a large-scale and multicenter , sham-controlled study .\n",
            "A total of @ schizophrenia patients with predominant negative symptoms were randomly assigned to a @-week intervention ( @-Hz rTMS , @ sessions , @ stimuli per session ) with either active or sham rTMS .\n",
            "The Rey Auditory Verbal Learning Test , Trail Making Test A and B , Wisconsin Card Sorting Test , Digit Span Test , and the Regensburg Word Fluency Test were administered before intervention and at day @ , @ , and @ follow-up .\n",
            "From the test results , a neuropsychological composite score was computed .\n",
            "Both groups showed no differences in any of the outcome variables before and after intervention .\n",
            "Both groups improved markedly over time , but effect sizes indicate a numeric , but nonsignificant superiority of active rTMS in certain cognitive tests .\n",
            "Active @-Hz rTMS applied to the left DLPFC for @ weeks was not superior to sham rTMS in the improvement of various cognitive domains in schizophrenia patients with predominant negative symptoms .\n",
            "This is in contrast to previous preliminary proof-of-concept trials , but highlights the need for more multicenter randomized controlled trials in the field of noninvasive brain stimulation .\n",
            "Objective : To observe the systemic family therapy treatment of patients with schizophrenia , and personality characteristics change .\n",
            "Methods : @ cases of schizophrenic patients met inclusion criteria were randomly divided into family therapy and control groups on the basis of antipsychotic drug treatment in both groups , the only research group supported by family therapy , @ a course of treatment , and BPRS scales and MMPI scales to check the efficacy evaluation and personality traits of the two groups measured before and after treatment .\n",
            "Results : The family group and the control group there are significant differences .\n",
            "Antiparkinsonian drugs used for @ chronic schizophrenic patients receiving long-term neuroleptic treatment were withdrawn .\n",
            "Seventy - eight ( @ % ) of the @ patients were without akathisia and/or parkinsonism at least for @ weeks after the antiparkinsonian drug withdrawal .\n",
            "A double-blind study of clonazepam was carried out for @ patients and clonazepam was effective on @ patients ( @ % ) with akathisia and on @ patients ( @ % ) with parkinsonism .\n",
            "The authors conclude that these data support the need for discontinuous use of antiparkinsonian medication during the long-term neuroleptic therapy of chronic schizophrenic patients and the effectiveness of clonazepam in managing antiparkinsonian drug withdrawal-induced akathisia and parkinsonism .\n",
            "Objective : To evaluate the impact on the quality of life of elderly patients with schizophrenia , aripiprazole .\n",
            "Methods : @ elderly patients with schizophrenia were randomly divided into two groups ( aripiprazole treatment ) and the control group ( sulpiride ) , in each group , @ cases were observed for @ weeks .\n",
            "Scale of the Positive and Negative Syndrome Scale ( panss ) and side effects ( tess ) to evaluate the efficacy and adverse reactions , and to assess changes in the quality of life in patients with World Health Organization Quality of Life Scale ( qol-@ ) .\n",
            "For : panss rated the two groups since the treatment decreased significantly ( p < @ ) ; earlier , in the beginning of the weekend than before treatment between the two groups was not statistically significant ( p > @ ) ; @ weeks after treatment , @ weeks and @ weeks tess rated The observation group was significantly lower than the control group ( p < @ ) ; qol-@ score , two groups in addition to the spiritual pillar of factors , other factors integral treatment than before treatment increased significantly ; weekend @ In addition to the independence of the field and the spiritual pillar factor , other factors integral observation group than the control group increased ( p < @ to @ ) .\n",
            "Adverse reactions observed group , the total incidence of @ % ( @/@ ) was significantly lower than the control group , @ % ( @/@ ) ( p < @ ) .\n",
            "Objective : To investigate the effect of Yi Shen Pin Gan Fang-a Chinese Herb Formula in treating the Ultra High Risk for Psychosis population compared with aripiprazole .\n",
            "Method ( s ) : @ Ultra High Risk for Psychosis population , matched for age , gender , handedness and education , were randomly assigned to receive either Yi Shen Pin Gan Fang and aripiprazole placebo or aripiprazole ( @-@ mg/day ) and Yi Shen Pin Gan Fang placebo for a @-week period .\n",
            "At baseline , @th week , @th week , @th week , clinical effect was evaluated with the Structured Interview for Prodromal Syndromes ( SIPS ) , Positive and Negative Syndrome Scale ( PANSS ) and the Global Assessment of Functioning Scale ( GAF ) , side effect was measured by Udvalg for Kliniske Undersogelser ( UKU ) .\n",
            "Neurocognitive function was assessed at baseline and @th week.Repeated ANOVA was used to analyze drug 's effect between group and intra group .\n",
            "Result ( s ) : For GAF , PANSS and SIPS , there was no difference between two groups ( F = @,@ , @ , P > @ ) , there was significant improvement since @th week till @th week in each group compared with baseline ( F = @,@ , @,@ , @ , P < @ ) .\n",
            "Compared with baseline , for the Trail Making test , there is no difference between and intra groups ( P > @ ) ; In Chinese Medicine Treatment group , Verbal Learning test , Visual Memory test , CPT and Stroop - ( colour/word ) test were significant improved ( P < @ ) ; For Aripiprazole Treatment group , only Verbal Learning test , Stroop-word test were significant improved ( P < @ ) .\n",
            "No obvious side effects were found in Yi Shen Pin Gan Fang treatment group .\n",
            "Conclusion ( s ) : Yi Shen Pin Gan Fang was effective in treating Ultra High Risk for Psychosis population .\n",
            "Introduction : In SCHIZophrenia , co-morbid substance abuse increases medication non-adherence and psychiatric hospitalization risk .\n",
            "Antipsychotic cost-effectiveness trials will have greater generalizability if patients with substance use disorders are included .\n",
            "It is important to describe this sub-population and how it may differ from the larger study population .\n",
            "Methods : From a prospective , RANDOMized , antipsychotic cost-effectiveness trial ( n = @ ) for SCHIZophrenia , selected baseline variables were examined .\n",
            "Results : Participants had SCHIZophrenia ( @ % ) or SCHIZoaffective disorder ( @ % ) , and an average age of @ .\n",
            "Sixty three percent were male .\n",
            "Medicaid or Medicare was the primary insurance for @ % ; with @ % having private insurance , and @ % no insurance .\n",
            "Subjects with a ( lifetime ) diagnosis of a substance use disorder ( @ % ) were younger ( p < .@ ) than those without this diagnosis , and a greater proportion were male ( p < .@ ) .\n",
            "They were more likely to be unemployed ( p = .@ ) and to have been incarcerated at least once ( p < .@ ) .\n",
            "They were more likely to have had a psychiatric hospitalization in the prior year ( p = .@ ) , and to lack any type of insurance coverage ( p = .@ ) Conclusions : Results support the salience of co-morbid substance abuse in SCHIZophrenia treatment research , and the need to understand its potential influence on interpretations of antipsychotic cost effectiveness .\n",
            "Tunis SL , Johnstone BM , Kinon BJ , et al ( @ ) .\n",
            "Designing naturalistic prospective studies of economic and effectiveness outcomes associate with novel antipsychotic therapies , Value in Health , @ , @-@ .\n",
            "Several explorative studies on what helps recovery processes have shown the importance of self-determination , self-help and mutual support , the creation of new roles based on positive labelling of psychiatric experiences and developing personalized meaning to experiences of distress instead of complying to \" the doctor 's view \" .\n",
            "Yet , until now these factors have not been studied on their effect .\n",
            "The symposium presents the results of three randomized trials of recovery programs : ( @ ) a comprehensive user-run recovery program , ( @ ) a @-months user-run recovery course , and ( @ ) a training program promoting recovery oriented working for professionals .\n",
            "In the first paper , Hans Kroon will present the program TREE ( Towards Recovery Empowerment and Experiential Expertise ) and discuss the results of a @-year multi-site randomised controlled trial ( N = @ ) .\n",
            "The program consisted of a user run recovery group and short recovery courses , added to care as usual .\n",
            "Participants of the TREE program had positive effects on mental health confidence , depressive symptoms , negative symptoms and self esteem , compared to a waitlist control group .\n",
            "In the second paper , Hanneke van Gestel-Timmermans will present the results of a feasibility and outcome study of the peer-run recovery course \" Recovery is up to you \" .\n",
            "The feasibility study showed that participants especially valued three aspects of the course : modelling , the group process and the course material .\n",
            "Instructors adhered to the protocol .\n",
            "In a multi-site randomised trial ( N = @ ) assessments took place at baseline , after @ months ( at the end of the course ) , and at @ months .\n",
            "Compared to a waitlist control , group participants had higher scores on several key elements of recovery .\n",
            "In the third paper , Greet Wilrycx followed-up the phased implementation of a training program for mental health professionals to promote recovery oriented working using the stepped-wedge trial methodology ( N = @ professionals and @ clients ) .\n",
            "Assessments took place at five time points during two years .\n",
            "Results show a positive change in attitude and knowledge about recovery processes among professionals and clients .\n",
            "Preliminary data show no change in client outcomes .\n",
            "Finally , Wilma Boevink will discuss the results of these studies in the light of international developments in recovery empowerment and experiential expertise .\n",
            "The effects of intranasal oxytocin , a neuropeptide involved in prosocial behavior and modulation of neural networks underlying social cognition and emotion regulation , have been studied in schizophrenia .\n",
            "We tested the hypothesis that twice-daily intranasal oxytocin administered for @-weeks would improve tertiary and exploratory outcomes of self-reported social symptoms , empathy and introspective accuracy from the Jarskog et al. ( @ ) randomized controlled trial .\n",
            "Sixty-eight stable outpatients with schizophrenia or schizoaffective disorder were randomized to receive oxytocin ( @IU twice daily ) or placebo .\n",
            "Introspective accuracy was assessed with the Specific Level of Functioning Scale and the Interpersonal Perception Task .\n",
            "Empathy was assessed with the Interpersonal Reactivity Index ( IRI ) , and social symptoms were assessed with the Liebowitz Social Anxiety Scale and the Green et al .\n",
            "Paranoid Thoughts Scales .\n",
            "Outcomes were assessed at baseline , six , and twelve weeks .\n",
            "Results demonstrated limited effect of oxytocin with some improvement on the IRI Perspective-Taking Subscale .\n",
            "No additional between-group differences emerged on self-reported symptoms , empathy , or introspective accuracy .\n",
            "The article reported their clinical results of treating the schizophrenia patients with risperdone and chlorpromazine .\n",
            "In the sampling , there were @ cases each in the risperdone group and the chlorpromazine group .\n",
            "The results after @ weeks of treatment shown that risperdone and chlorpromazine had similar effects .\n",
            "However , compared to the chlorpromazine risperdone took less time to be effective , had better effects for negative symptom , less side effects on extrapyramid and vegetative nerve system and also led\n",
            "Background : Approved treatments are lacking for negative symptoms of schizophrenia ( NSS ) .\n",
            "This multicenter study examined adjunctive treatment with lisdexamfetamine dimesylate ( LDX ) , a d-amphetamine prodrug , to antipsychotics in clinically stable adults with predominant NSS .\n",
            "Methods : Outpatients with stable schizophrenia ( > @ years ) , predominant NSS ( SANS-@ [ items @-@ , @-@ , @-@ , @-@ ] score > @ , score > @ on > @ SANS Global items , PANSS positive score < @ ) , and maintained on stable atypical antipsychotic ( > @ weeks ) underwent @ weeks open-label ( OL ) adjunctive LDX ( @-@mg / d ) , and @ weeks randomized withdrawal ( RW ) .\n",
            "Eligible participants ( any SANS-@ improvement at week @ ) entered double-blind , placebo-controlled RW .\n",
            "Efficacy measures included SANS-@ ( primary ) , SANS Global items , composite of @ SANS items ( SANS-@ ) , PANSS total , positive , negative , and general psychopathology scales .\n",
            "Safety evaluations included treatment-emergent adverse events ( TEAEs ) , vital signs , and Calgary Depression Scale for Schizophrenia ( CDSS ) .\n",
            "Withdrawal criteria included > @ % increase in PANSS total or > @-point increase on positive items at @ consecutive visits , increase in suicidal ideations , or positive drug screen .\n",
            "Results : @ participants received OL LDX ; @ entered RW to continue LDX ( n = @ ) or placebo ( n = @ ) ; @ were discontinued during RW .\n",
            "At baseline ( week @ ) , mean ( SD ) SANS-@ score was @ ( @ ) .\n",
            "Mean change ( @ % CI ; weeks @-@ OL ) was -@ ( -@ , -@ ) ( primary endpoint ; P < @ ) .\n",
            "@ % were SANS-@ responders ( > @ % reduction from baseline ) .\n",
            "All SANS Global items showed significant decreases ( P < @ for each ) .\n",
            "Mean change ( @ % CI ) in SANS-@ was -@ ( -@ , -@ ) from a baseline mean ( SD ) of @ ( @ ) .\n",
            "PANSS total , positive , negative , and general psychopathology scores mean changes ( @ % CI ) were -@ ( -@ , -@ ) , -@ ( -@ , -@ ) , -@ ( -@ , -@ ) , and -@ ( -@ , -@ ) .\n",
            "During RW ( weeks @-@ ) , no differences ( change from randomization baseline ) were found between LDX and placebo in SANS-@ , SANS Global items , SANS-@ , or PANSS total and subscale scores .\n",
            "Change ( week @-@ ) in systolic and diastolic BP were @ ( @ ) and @ ( @ ) mmHg and pulse was @ ( @ ) bpm .\n",
            "There was no meaningful change in CDSS ( week @-@ ) for LDX and placebo .\n",
            "In OL , TEAE incidence was @ % and TEAEs > @ % were headache ( @ % ) , decreased appetite ( @ % ) , insomnia ( @ % ) , dizziness ( @ % ) , dry mouth ( @ % ) , and diarrhea ( @ % ) .\n",
            "Serious TEAEs occurred in @ % ; @ % discontinued due to TEAEs in OL .\n",
            "Discussion : NSS , assessed by SANS scores , significantly decreased and PANSS total and general psychopathology scores improved with OL LDX without positive symptom worsening .\n",
            "There was no overall symptom worsening with abrupt LDX discontinuation .\n",
            "LDX may be safely administered to carefully selected patients with clinically stable schizophrenia and maintained on antipsychotics .\n",
            "Confirmation with additional trials is needed .\n",
            "OBJECTIVE : This study aimed to compare the efficacy of long-acting risperidone and zuclopenthixol in subjects with schizophrenia and substance abuse .\n",
            "METHOD : A total of @ subjects with schizophrenia and substance use disorders were enrolled for an open , randomized , controlled , @-month follow-up study .\n",
            "Fifty-seven subjects were selected for treatment with long-acting injectable risperidone , while another @ were treated with zuclopenthixol-depot .\n",
            "RESULTS : Long-acting risperidone patients presented fewer positive urine tests ( @ compared with @ , P = @ ) , showed improved scores on the Positive and Negative Syndrome Scale , and showed better compliance with the Substance Abuse Management program .\n",
            "The use of long-acting risperidone and less severe dependence explained the outcome at the end of the follow-up .\n",
            "CONCLUSIONS : Long-acting injectable risperidone was more effective than zuclopenthixol-depot in improving substance abuse and schizophrenia symptoms in subjects with dual diagnosis .\n",
            "RN @ ( Antipsychotic Agents ) .\n",
            "@ ( Delayed-Action Preparations ) .\n",
            "@-@-@ ( Risperidone ) .\n",
            "@-@-@ ( Clopenthixol ) .\n",
            "@ @-@ yr old schizophrenic inpatients were assigned to treatment either with trebenzomine or thioridazine in a study of clinical antipsychotic efficacy following a @ wk placebo treatment .\n",
            "Psychopathology was rated using the Brief Psychiatric Rating Scale and Clinical Global Impressions .\n",
            "There was a significant difference in therapeutic response to the @ drugs in that psychopathology decreased significantly in the thioridazine but not the trebenzomine group .\n",
            "( @ ref )\n",
            "Objective To investigate the mirtazapine combination of efficacy and adverse effects of the Depression Guipi treatment of schizophrenia .\n",
            "Methods @ patients with schizophrenia and depression patients were randomly divided into Integrative Medicine group with mirtazapine group treatment for six weeks , before treatment , @ weeks , @ weeks of treatment Positive and Negative Syndrome Scale ( PANSS ) and the Hamilton depression Scale ( HAMD ) score , adverse reactions assessed side effects scale ( TESS ) assessment .\n",
            "The results of the treatment of the second weekend , the PANSS total score compared with the control group statistically significant difference ( t = @ , P < @ ) ; negative symptom score study group compared with the control group a significant difference ( t = @ , P < @ ) ; HAMD score score significant difference in the treatment of the sixth week the two groups ( t = @ , P < @ ) , during treatment , no significant adverse reactions .\n",
            "Objective To evaluate aripiprazole female schizophrenic efficacy and side effects .\n",
            "Methods @ female patients with schizophrenia were randomly divided into two groups , were given aripiprazole and risperidone for @ weeks , and the effects were evaluated using the Positive and Negative Syndrome Scale rating scale of adverse reactions adverse reactions .\n",
            "Results aripiprazole group and risperidone group have a good effect in the treatment of schizophrenia in eight weeks , and their positive and negative symptoms improved significantly fewer adverse reactions aripiprazole group .\n",
            "Background .\n",
            "It has been proposed that schizophrenia is associated with underactivity of brain glutamatergic neurotransmission , especially at the level of the N-methyl-D-aspartate ( NMDA ) subtype of glutamate receptor .\n",
            "Glycine potentiates NMDA receptor-mediated neurotransmission , indicating that it may serve as an effective therapeutic agent in the treatment of schizophrenia .\n",
            "Method .\n",
            "Eleven treatment - resistant patients with chronic schizophrenia completed a double-blind , placebo-controlled , six-week , randomly assigned , crossover treatment trial of @ g/kg body weight/day of glycine , added to their prior antipsychotic treatment .\n",
            "Results .\n",
            "Glycine was well tolerated , resulted in significantly increased serum glycine levels and induced a mean @ ( @ % ) reduction in negative symptoms ( P < @ ) .\n",
            "Significant improvements were also induced in depressive and cognitive symptoms .\n",
            "The greatest reduction in negative symptoms was registered in the patients who had the lowest baseline serum glycine levels .\n",
            "Conclusions .\n",
            "These results extend previous findings and suggest an additional approach to the pharmacotherapy of negative symptoms and cognitive deficits in schizophrenia .\n",
            "\" Objective : To understand the difference of of childhood schizophrenia patients taking risperidone oral solution and tablet Methods : @ outpatients with childhood schizophrenia were randomly divided into risperidone oral solution group and tablet group , @ weeks of follow-up of the two groups were compared efficacy , adverse reactions and adherence to similar results : the efficacy and adverse effects of risperidone oral solution and tablets , oral solution easier patients received good compliance .\n",
            "Conclusions : The pharmaceutical dosage forms childhood schizophrenia patient compliance related . \"\n",
            "BACKGROUND : People with severe mental illnesses , including psychosis , have an increased risk of cardiovascular disease .\n",
            "We aimed to evaluate the effects of a primary care intervention on decreasing total cholesterol concentrations and cardiovascular disease risk in people with severe mental illnesses .\n",
            "METHODS : We did this cluster randomised trial in general practices across England , with general practices as the cluster unit .\n",
            "We randomly assigned general practices ( @:@ ) with @ or more patients with severe mental illnesses using a computer-generated random sequence with a block size of four .\n",
            "Researchers were masked to allocation , but patients and general practice staff were not .\n",
            "We included participants aged @-@ years with severe mental illnesses ( schizophrenia , bipolar disorder , or psychosis ) , who had raised cholesterol concentrations ( @ mmol/L ) or a total : HDL cholesterol ratio of @ mmol/L or more and one or more modifiable cardiovascular disease risk factors .\n",
            "Eligible participants were recruited within each practice before randomisation .\n",
            "The Primrose intervention consisted of appointments ( < / = @ ) with a trained primary care professional involving manualised interventions for cardiovascular disease prevention ( ie , adhering to statins , improving diet or physical activity levels , reducing alcohol , or quitting smoking ) .\n",
            "Treatment as usual involved feedback of screening results only .\n",
            "The primary outcome was total cholesterol at @ months and the primary economic analysis outcome was health-care costs .\n",
            "We used intention-to-treat analysis .\n",
            "The trial is registered with Current Controlled Trials , number ISRCTN@ .\n",
            "FINDINGS : Between Dec @ , @ , and Sept @ , @ , we recruited general practices and between May @ , @ , and Feb @ , @ , we recruited participants and randomly assigned @ general practices with @ participants to the Primrose intervention ( n = @ with @ patients ) or treatment as usual ( n = @ with @ patients ) .\n",
            "Total cholesterol concentration data were available at @ months for @ ( @ % ) participants in the Primrose intervention group and @ ( @ % ) participants in the treatment-as-usual group .\n",
            "The mean total cholesterol concentration did not differ at @ months between the two groups ( @ mmol/L [ SD @ ] for Primrose vs @ mmol/L [ @ ] for treatment as usual ; mean difference estimate @ , @ % CI -@ to @ ; p = @ ) .\n",
            "This result was unchanged by pre-agreed supportive analyses .\n",
            "Mean cholesterol decreased over @ months ( -@ mmol/L [ @ ] for Primrose vs -@ mmol/L [ @ ] for treatment as usual ) .\n",
            "Total health-care costs ( pound@ [ SE @ ] in the Primrose intervention group vs pound@ [ @ ] in the treatment-as-usual group ; mean difference - pound@ , @ % CI -@ to -@ ; p = @ ) and psychiatric inpatient costs ( pound@ [ @ ] vs pound@ [ @ ] ; - pound@ , -@ to -@ ; p = @ ) were lower in the Primrose intervention group than the treatment-as-usual group .\n",
            "Six serious adverse events of hospital admission and one death occurred in the Primrose group ( n = @ ) and @ , including three deaths , occurred in the treatment-as-usual group ( n = @ ) .\n",
            "INTERPRETATION : Total cholesterol concentration at @ months did not differ between the Primrose and treatment-as-usual groups , possibly because of the cluster design , good care in the treatment-as-usual group , short duration of the intervention , or suboptimal focus on statin prescribing .\n",
            "The association between the Primrose intervention and fewer psychiatric admissions , with potential cost-effectiveness , might be important .\n",
            "FUNDING : National Institute of Health Research Programme Grants for Applied Research .\n",
            "Objective : Information about the cost-effectiveness of aripiprazole relative to other atypical antipsychotics in the treatment of patients with schizophrenia is limited .\n",
            "This information is needed to better inform drug formulary managers and population-based health care decision makers .\n",
            "The objective of this study was to compare the cost-effectiveness of olanzapine to aripiprazole in the treatment of schizophrenia from the perspective of public payers in the United States .\n",
            "Methods : Data for this post-hoc analysis came from a @-week double-blind , randomized trial of individuals with schizophrenia who were treated with olanzapine or aripiprazole ( clinicaltrial.gov identifier NCT@ ) .\n",
            "Two-thirds ( @ ) of the patients were male and the patients ' mean age was @ years .\n",
            "Utilities were calculated based on previously published methods using the Positive and Negative Syndrome Scale ( PANSS ) and treatment-emergent adverse events .\n",
            "Treatment costs were calculated based on previously published methods and were inflated to @ US dollars .\n",
            "A mixed model was used to compare outcomes on utilities .\n",
            "Propensity score-adjusted analysis of covariance was used for the cost analysis .\n",
            "Results : Olanzapine treatment was associated with statistically significantly greater total utility scores relative to aripiprazole ( @ vs. @ ; p@ .@ ) and lower total treatment costs ( $ @ vs. $ @ ; p@ .@ ) , although medication acquisition cost was significantly higher for olanzapine than aripiprazole ( $ @ vs. $ @ ; p < @ ) .\n",
            "An incremental cost-effectiveness ratio was not calculated because olanzapine was found to be the dominant choice ( i.e. , greater effectiveness and lower total costs ) .\n",
            "Conclusions : This cost-effectiveness analysis is the first to use patient-level data from a randomized , double-blind study comparing olanzapine and aripiprazole in the treatment of patients with schizophrenia .\n",
            "Olanzapine was found to be a dominant cost-effective choice , as it was associated with greater effectiveness at lower total costs relative to aripiprazole .\n",
            "@ Informa UK Ltd .\n",
            "We hypothesise that rTMS is an effective treatment for schizophrenic auditory hallucinations .\n",
            "We predict that the administration of rTMS , in addition to current medication , will produce a significant improvement in the level of auditory hallucinations in subjects with schizophrenia who are experiencing persistent auditory hallucinations .\n",
            "Design/methodology : Randomised controlled trial Participants - inclusion criteria : @ .\n",
            "Male and female , aged @ to @ Participants - exclusion criteria : @ .\n",
            "Organic brain disorder Anticipated start date : @/@/@ Anticipated end date : @/@/@ Status of trial : Completed Interventions : Participants : Current status of trial - Ongoing Main research question - We hypothesise that rTMS is an effective treatment for schizophrenic auditory hallucinations .\n",
            "We predict that the administration of rTMS , in addition to current medication , will produce a significant improvement in the level of auditory hallucinations in subjects with schizophrenia who are experiencing persistent auditory hallucinations .\n",
            "Design/methodology - The study will be a factorial , double-blind , randomised controlled trial.Throughout the trial , all subjects will continue to receive standard care from their responsible consultant psychiatrist .\n",
            "No restrictions will apply to the changes that may be made to standard care during the study .\n",
            "Subjects will be randomised into one of the four arms of the factorial design .\n",
            "Randomisation will proceed in a stratified manner , matching the groups for age , sex , handedness and severity of auditory hallucinations .\n",
            "Subjects will be blind to their experimental allocation .\n",
            "The procedure in each of the four arms will be administered to the subjects once daily for @ consecutive working days .\n",
            "Prior to commencing treatment each subject in an active rTMS arm will have their motor threshold ( MT ) determined by the application of single pulses of TMS over the motor cortex .\n",
            "All rTMS will be administered by a doctor in the ECT suite or comparable environment .\n",
            "The four arms of the trial and the associated interventions are : A Left only : rTMS at a frequency of @ Hz and amplitude @ % MT applied to left temporal cortex for @ minutes .\n",
            "B Right only : rTMS at a frequency of @ Hz and amplitude @ % MT applied to right temporal cortex for @ minutes .\n",
            "C Left and right : rTMS at a frequency of @ Hz and amplitude @ % MT applied to left temporal cortex for @ minutes followed by right temporal cortex for @ minutes .\n",
            "D Sham ( placebo ) stimulation , using a modified coil which produces no magnetic field but has an acoustic signature similar to that of an active coil , applied to left temporal cortex for @ minutes .\n",
            "The parameters ( frequency , intensity and duration ) of clinically useful rTMS have not yet been firmly established .\n",
            "The range of parameters described in the literature is diverse ( @ ) .\n",
            "The parameters in this study are based upon those found to be effective in reducing auditory hallucinations by Hoffman et al ( @ ) .\n",
            "The study parameters are all within the limits recommended by the international safety guidelines for rTMS ( @ ) .\n",
            "Outcome measure - s A second ( or more ) psychiatrist ( s ) who is blind to their experimental allocation will assess the level of auditory hallucinations experienced by all subjects .\n",
            "A description of the measurements to be made , and a timetable for these , is given below .\n",
            "Prior to commencing the main study , a pilot period will allow reliability to be checked and established .\n",
            "Each subject is assessed over a twenty five week cycle .\n",
            "rTMS sessions take place in the weeks designated @ and +@ .\n",
            "Primary AB Outcome measure - s : @ .\n",
            "Change from baseline in auditory hallucinations score according to a visual analogue measure of current intensity , as used by Hoffman et al ( @ ) .\n",
            "@ .\n",
            "Change from baseline in the auditory hallucinations sub-scale score from SAPS as a measure of frequency of auditory hallucinations over the past week .\n",
            "Secondary AB Outcome measure - s : @ .\n",
            "Complete SAPS and Scale for the Assessment of Negative Symptoms ( SANS ) ( @ ) scores as a measure of change in total schizophrenic symptoms .\n",
            "@ .\n",
            "@-item Hamilton Depression Rating Scale ( HAMD ) ( @ ) as a measure of change in mood .\n",
            "The HAMD is the most commonly used measure for treatment trials of depression , and has been widely applied to this end in reported trials using rTMS .\n",
            "@ .\n",
            "Changes in physical , psychological and social functioning are assessed with the Short Form @ Health Survey Questionnaire ( SF-@ ) ( @ ) .\n",
            "@ .\n",
            "Medication type and levels are recorded at all assessment points .\n",
            "@ .\n",
            "rTMS side effects are recorded at all assessment points .\n",
            "@ .\n",
            "Neuropsychological and audiometric tests are carried out before and after the treatment phase of the trial .\n",
            "@ .\n",
            "Patient satisfaction will be assessed after the treatment phase .\n",
            "@ .\n",
            " Blindness  of subjects and assessors will be assessed after the treatment phase .\n",
            "Analyses The data obtained will be subject to a primary intention to treat analysis .\n",
            "A secondary per-protocol analysis will also be undertaken .\n",
            "The two main comparisons in the primary analysis will be : @ .\n",
            "Left rTMS vs. control ( A+C vs. B+D ) .\n",
            "@ .\n",
            "Active rTMS vs. sham ( A+B+C vs. D ) .\n",
            "A repeated measures analysis with a random effects model will be used to test the significance of the between groups comparisons .\n",
            "Before and after within group comparisons will also be made and tested .\n",
            "In addition to these continuous measures , outcomes will also be analysed in dichotomous terms .\n",
            "The main a priori dichotomous outcome will be defined as a @ % reduction in baseline auditory hallucinations as measured by the visual analogue scale .\n",
            "Rational post-hoc analysis of dichotomous outcomes will be permitted .\n",
            "Estimates of the true magnitude of differences in the comparisons , and of the relative event rate for a positive outcome , will be calculated using confidence intervals for the differences between means and for proportions .\n",
            "Sample group description - Hoffman et al ( @ ) found a change of @ from baseline in the hallucination score with standard deviation @ , comparing sham and active treatments .\n",
            "To detect this will require about @ patients in each cell for @ % power and @ % significance .\n",
            "To compare left rTMS against control , assuming that right rTMS is ineffective will then yield @ patients per arm .\n",
            "To compare any active treatment with sham will yield @ patients in the active arm and @ in the control .\n",
            "This @:@ ratio will reduce the power slightly to give @ % confidence in detecting a change of @ units of hallucination score .\n",
            "The statistical power calculation requires a total of @ subjects to enable the study to detect the predicted outcomes .\n",
            "All Sheffield general psychiatry consultant teams will be contacted and invited to refer from their in-patient and out-patient caseload .\n",
            "A drop-out rate of @ % is predicted .\n",
            "We will , therefore , recruit @ % more subjects than is required by the power calculation ( @ in total ) in order to take account of this and any compliance problems .\n",
            "We aim to recruit patients at a rate of @ per month , which will give a total of @ patients over @ months .\n",
            "In Sheffield , between April @-April @ , there were @ patients with schizophrenia aged > @ years who had recorded clinical contact with mental health services .\n",
            "The planned recruitment is compatible with this number of potential subjects , and is particularly facilitated by the closeness of contact between such patients and mental health services .\n",
            "Divergence from target rates by month @ will prompt possible extension of trial to other local Trusts , e.g. Rotherham and Doncaster , which will expand the total population to in excess of @ million and give an estimated total of @ potential subjects .\n",
            "Inclusion criteria Subjects will be male and female , aged @ to @ .\n",
            "Subjects will fulfil the DSM-IV ( @ ) diagnostic criteria for schizophrenia .\n",
            "They will also continue to experience auditory hallucinations  defined as a score of > @ on the auditory hallucinations sub-scale of the Scale for the Assessment of Positive Symptoms ( SAPS ) ( @ ) for > @ weeks  despite standard clinical treatment by a psychiatric team .\n",
            "Exclusion criteria Exclusion criteria will include : organic brain disorder ; previous documented unconsciousness ; unstable coronary heart disease ; contra-indications to rTMS , e.g. history of fits , recent cerebro-vascular accident , history of epileptic seizures , metal implants , cardiac pacemakers .\n",
            "Multi-centre trial ?\n",
            "This is not a multi-centre trial .\n",
            "Start date - @/@/@ End date - @/@/@\n",
            "Objective To assess the treating symptoms of EPS caused by antipsychotics with Jiejing decoction .\n",
            "Methods @ patients with schizophrenia were randomly divided into two groups .\n",
            "Patients in control group ( n = @ ) were treated by Artane .\n",
            "Patients in treatment\n",
            "Background : The aim of preventing schizophrenia and other psychotic disorders has led researchers to focus on early detection of individuals at risk for psychosis and to treat at-risk symptoms in the pre-psychotic period .\n",
            "While at-risk symptoms for psychotic disorder are common in adolescence and associated with a significant reduction in functioning , the evidence base required to guide effective interventions in this vulnerable age group is limited .\n",
            "\" Robin \" is a newly developed treatment approach for adolescents at high risk of developing a psychotic disorder combining a standardized manual with a smartphone application combining a standardized manual with a smartphone application .\n",
            "The manual is targeting coping with at-risk symptoms and comorbid symptoms , improvement of quality of life and daily functioning in our specialized outpatient care unit for early intervention in psychosis .\n",
            "The smartphone application targets medication adherence , real-time symptom assessment and provides help in coping with symptoms and stressful situations in daily life .\n",
            "Methods : In August @ , we started a systematic clinical intervention trial for testing the efficacy of the combined treatment approach .\n",
            "One goal is to compare efficacy of a @-week intervention in @ patients with at-risk symptoms ( age range @-@ ) with an active control group ( treatment as usual ) .\n",
            "Participants from a former early recognition study are included for the control condition .\n",
            "Outcome measures are at-risk and comorbid symptoms , functioning , self efficacy , quality of life and treatment satisfaction .\n",
            "Data will be collected at baseline , during the treatment period and at the end of the combined therapy .\n",
            "There will be also follow up assessments @ , @ and @ months after baseline .\n",
            "Results : At the Conference , we will be able to present baseline data of the first patients in the intervention group .\n",
            "Further , preliminary results will comprise a comparison of baseline data with the control group ( @ patients ; @ % female , mean-age @ ) and first follow-up data .\n",
            "We will discuss the results showing ( @ ) intraindividual changes in symptomatology and well-being after @ months of treatment in the intervention group and ( @ ) differences between the intervention group and the control group .\n",
            "Conclusion : Even though young patients with at-risk symptoms may profit best of specialised treatment approaches , there is an on-going lack of investigation about age-appropriate treatment strategies in this vulnerable age group .\n",
            "To our knowledge , this is the first controlled trials to test the efficacy of a specific treatment manual in combination with a smartphone application for minor patients at high risk for psychosis .\n",
            "OBJECTIVE : To evaluate the effect of metformin treatment on the risperidone-induced body weight gain in patients .\n",
            "METHODS : In a @-weeks , double-blind , placebo controlled , randomized trial between October @ and October @ which was conducted in the Child and Adolescent Psychiatric Consultation Center of Isfahan University of Medical Sciences , @ patients were entered the study with schizophrenia diagnosis .\n",
            "Then metformin ( @ mg bid ) or placebo was administrated with risperidone ( @ mg ) for the patients .\n",
            "Weight , height , and body mass index BMI were measured at the beginning , at @ weeks , and at @ weeks of the study .\n",
            "Changes in weight and BMI were evaluated by using repeated measures analysis of variance .\n",
            "RESULTS : Seventeen patients were excluded from the study .\n",
            "Repeated measure analysis of variances showed a significant difference between weight and BMI in both metformin ( p < @ , p < @ ) and placebo group ( p < @ , p < @ ) .\n",
            "CONCLUSION : Metformin treatment did not show a significant effect to control the body weight of patients after @ weeks .\n",
            "RN @ ( Antipsychotic Agents ) .\n",
            "@ ( Hypoglycemic Agents ) .\n",
            "@-@-@ ( Risperidone ) .\n",
            "@-@-@ ( Metformin ) .\n",
            "Background : The initial phase of a trial of cognitive-behavioural therapy ( CBT ) for acutely ill patients with schizophrenia of recent onset showed that it speeded recovery .\n",
            "Aims : To test the hypothesis that CBT in addition to treatment as usual ( TAU ) during the first or second acute episode of schizophrenia will confer clinical benefit over a follow-up period .\n",
            "Method : This was an @-month follow-up of a multicentre prospective trial of CBT or supportive counselling administered as an adjunct to TAU , compared with TAU alone , for patients hospitalised for an acute episode of schizophrenia of recent onset .\n",
            "Primary outcomes were total and positive symptom scales , time to relapse and re-hospitalisation .\n",
            "Results : There were significant advantages for CBT and supportive counselling overTAU alone on symptom measures at @ months but no group difference was seen for relapse or re-hospitalisation .\n",
            "There was a significant centre-treatment interaction , reflecting centre differences in the effect of introducing either treatment , but not in the comparison of CBT and supportive counselling .\n",
            "Medication dosage and compliance did not explain group differences .\n",
            "Conclusions : Adjunctive psychological treatments can have a beneficial long-term effect on symptom reduction\n",
            "Schizophrenia patients ( SCZ ) show increases in perseverative responses ( PSV ) and decreases in the number of categories achieved ( CAT ) on the Wisconsin Card Sorting Test ( WCST ) .\n",
            "One means of assessing the extent or ' density ' of their impairment is to utilize remediation or training strategies .\n",
            "These training procedures typically result in reduced PSV and increased CAT .\n",
            "However , one possible confounding factor in all of the WCST training studies is the significant alteration of the integrity of the WCST .\n",
            "In this study , @ SCID-IV diagnosed schizophrenia patients were randomly assigned to one of two conditions .\n",
            "One group ( S-M ) received the standard WCST ( S ) for @ cards followed by a modified version ( M ) for @ cards .\n",
            "The other group received the modified followed by the standard version ( M-S ) .\n",
            "The modified version consisted of asking the patients , after each card sort , to verbally express the reason that they placed the card where they did .\n",
            "No additional feedback was given .\n",
            "We hypothesized that this intervention would aid SCZ 's impaired executive functioning and assist in characterizing the ' density ' or remediation of their impairment .\n",
            "The results were significant and supported the hypotheses , indicating that strategy verbalization was an effective method to improve executive functioning performance ( PSV and CAT ) in patients with schizophrenia .\n",
            "The findings were discussed within the framework of the information-processing Supervisory Attentional System ( SAS ) model proposed by Norman and Shallice ( @ ) .\n",
            "In addition , the findings of this study suggest that with an increase in negative symptomatology , in schizophrenia patients , comes a decrease in WCST ( executive functioning ) performance .\n",
            "Overall , the strategy verbalization intervention utilized in this study was able to demonstrate significant effects without contaminating the integrity of the WCST in doing so .\n",
            "Therefore , this study allowed for an optimal assessment of the issue of the ' density ' or fixedness of executive impairment in patients with schizophrenia .\n",
            "However , future studies are encouraged to further examine the strategy verbalization intervention with other measures of executive functioning .\n",
            "Objective : The authors identified patient characteristics that increased risk of hospital admission among adults with schizophrenia .\n",
            "Methods : A total of @ participants in the Clinical Antipsychotic Trials of Intervention Effectiveness ( CATIE ) clinical trial were followed from the time they began a randomized trial of medication to first schizophrenia-related hospital admission .\n",
            "Results : In @ person-years of follow-up , @ patients were hospitalized .\n",
            "Increased risk of hospital admission was associated with early age ( < / = @ years ) of first antipsychotic treatment ( adjusted hazard ratio [ AHR ] = @ , @ % confidence interval [ CI ] = @-@ ) , psychiatric hospitalization in past year ( AHR = @ , CI = @-@ ) , having had DSM-IV alcohol ( AHR = @ , CI = @-@ ) or drug ( AHR = @ , CI = @-@ ) use disorders in the past five years , and baseline severe symptoms according to the Clinical Global Impressions Scale ( AHR = @ , CI = @-@ ) , presence of tardive dyskinesia ( AHR = @ , CI = @-@ ) , a high score on the positive symptoms subscale of the Positive and Negative Syndrome Scale ( AHR = @ , CI = @-@ ) , and low social function ( AHR = @ , CI = @-@ ) .\n",
            "As compared with olanzapine , the drugs quetiapine ( AHR = @ , CI = @-@ ) , perphenazine ( AHR = @ , CI = @-@ ) , and ziprasidone ( AHR = @ , CI = @-@ ) were associated with increased hospitalization risk .\n",
            "Risperidone was associated with a lower hospitalization risk than quetiapine ( AHR = @ , CI = @-@ ) and ziprasidone ( AHR = @ , CI = @-@ ) .\n",
            "Conclusions : Efforts to lower hospital admission risk among individuals with schizophrenia should focus on history of early onset , recent inpatient admission , severe positive symptoms , poor social function , high global illness severity , and comorbid substance use disorders and on selection of an appropriate antipsychotic medication .\n",
            "( Psychiatric Services @:@-@ , @ ) .\n",
            "Substance dependence ( SD ) disorders are prevalent and pernicious for severe and persistently mentally ill ( SMI ) adults .\n",
            "SD disorders in SMI adults may exacerbate psychotic symptoms , hinder medication compliance , and cause crisis episodes .\n",
            "As part of a clinical trial , we compared @ SD and @ non-dependent ( ND ) SMI adults .\n",
            "We hypothesized that SD subjects would have poorer psychosocial , and drug use outcomes than ND subjects , and that the primary drug dependence disorder would moderate these effects .\n",
            "Subjects were recruited at discharge from an acute inpatient episode and RANDOMly assigned to one of two case management programs .\n",
            "These data are results of the first @ months of case management treatment .\n",
            "SD subjects reported lower levels of quality of life ( p = .@ ) , higher levels of psychological distress ( p < .@ ) received fewer outpatient services ( Mean = @ versus @ visits ) and were @ times more likely to require a psychiatric emergency visit .\n",
            "The most prevalent DSM III-R SD diagnoses were alcohol ( @ % ) , cocaine ( @ % ) , stimulants ( @ % ) and marijuana ( @ % ) .\n",
            "SD subjects were divided into @ subgroups based on the prevalence of dependence diagnoses : cocaine-dependent ( including those dependent on other drugs as well ) ; one or more drugs other than cocaine , and alcohol-dependent only .\n",
            "Main findings revealed that cocaine-depen dent subjects experienced more adverse events and more negative outcomes than ND subjects .\n",
            "For example , cocaine-dependent were more likely than ND subjects to have been homeless in the @ months prior to study entry ( OR , @ ) and at @ months follow-up ( OR , @ ) and they had significantly higher levels of psychological distress and lower levels of life satisfaction at @ months follow-up ( p < @ ) than ND subjects .\n",
            "A majority of the analyses revealed that other drug dependent and alcohol-only subjects were not significantly different than ND subjects in the domains of adverse events , drug use , and psychosocial functioning .\n",
            "The immediate clinical significance of these findings is that it is important for those who treat SD adults with SMI to differentiate among dependence diagnoses because cocaine-dependent patients are more likely to have more severe problems than ND patients and to require specialized interventions .\n",
            "PD : @\n",
            "BACKGROUND : Randomized trials targeting cannabis use disorders in patients with psychosis have generally been unsuccessful .\n",
            "One of the largest such trials was the CapOpus trial , which had an impact on the number of monthly joints used , but not on the number of days with cannabis use or positive or negative symptoms .\n",
            "OBJECTIVE : To investigate the effects of CapOpus on psychiatric treatment .\n",
            "METHODS : Six-month randomized trial on participants meeting ICD-@ criteria for cannabis use disorder and schizophrenia-spectrum psychosis .\n",
            "Participants were randomized to treatment as usual ( TAU , n = @ ) alone versus TAU plus CapOpus ( n = @ ) consisting of motivational interviewing and cognitive behavior therapy .\n",
            "Data regarding psychiatric treatment was obtained from complete nationwide registers .\n",
            "Analyses were intention-to-treat .\n",
            "Cox and poisson regression were used as appropriate .\n",
            "RESULTS : Compared with treatment as usual , participants in the CapOpus group had an overall higher risk of having a psychiatric emergency room contact ( hazard ratio @ , @ % confidence interval @-@ ) .\n",
            "Participants in CapOpus also had more contacts with psychiatric emergency rooms ( incidence rate ratio @ ( @-@ ) ) and more admissions to psychiatric hospitals ( incidence rate ratio @ ( @-@ ) ) ; conversely , CapOpus-participants spent fewer days admitted to psychiatric hospitals than treatment-as-usual participants ( incidence rate ratio @ ( @-@ ) ) .\n",
            "CONCLUSIONS : CapOpus led to earlier and more psychiatric emergency room contacts and admissions that , however , were of fewer days .\n",
            "This pattern could indicate that participants receiving treatment as usual were inadequately treated .\n",
            "However , it can not be excluded that the differences might be an adverse reaction to the psychosocial intervention .\n",
            "( PsycINFO Database Record ( c ) @ APA , all rights reserved ) ( journal abstract )\n",
            "AIM : Previous research indicates that preventive intervention is likely to benefit patients \" at risk \" of psychosis , in terms of functional improvement , symptom reduction and delay or prevention of onset of threshold psychotic disorder .\n",
            "The primary aim of the current study is to test outcomes of ultra high risk ( UHR ) patients , primarily functional outcome , in response to a sequential intervention strategy consisting of support and problem solving ( SPS ) , cognitive-behavioural case management and antidepressant medication .\n",
            "A secondary aim is to test biological and psychological variables that moderate and mediate response to this sequential treatment strategy .\n",
            "METHODS : This is a sequential multiple assignment randomised trial ( SMART ) consisting of three steps : Step @ : SPS ( @ months ) ; Step @ : SPS vs Cognitive Behavioural Case Management ( @ months ) ; Step @ : Cognitive Behavioural Case Management + Antidepressant Medication vs Cognitive Behavioural Case Management + Placebo ( @ months ) .\n",
            "The intervention is of @ months duration in total and participants will be followed up at @ months and @ months post baseline .\n",
            "CONCLUSION : This paper reports on the rationale and protocol of the Staged Treatment in Early Psychosis ( STEP ) study .\n",
            "With a large sample of @ UHR participants this study will investigate the most effective type and sequence of treatments for improving functioning and reducing the risk of developing psychotic disorder in this clinical population .\n",
            "Educational objective - At the conclusion of this session , the participant should be able to understand that deltoid and gluteal administration of longacting injectable risperidone , an antipsychotic agent for the treatment of schizophrenia , are bioequivalent with respect to peak and total plasma exposure .\n",
            "SUMMARY : Introduction : Long-acting injectable ( LAI ) risperidone is approved for treatment of schizophrenia via gluteal muscle ( GM ) administration .\n",
            "Deltoid muscle ( DM ) may provide a more accessible injection site .\n",
            "This study compared the pharmacokinetics ( PK ) of LAI risperidone following DM and GM injection .\n",
            "Methods : In a single-dose @-way crossover Phase study , stable chronic schizophrenia subjects were randomized to of @ Panels and of @ sequences within Panel and received LAI risperidone injections into GM ( @ mg in Panel I , @ mg in Panel II ) and DM ( @ mg in Panel I , @ mg in Panel II ) , separated by an @-day washout period .\n",
            "Blood samples were collected predose and up to @ days postdose in each treatment period .\n",
            "Plasma PK parameters of risperidone , @-hydroxy-risperidone and the active antipsychotic fraction ( sum of risperidone and @ - hydroxyrisperidone ) were estimated using non-compartmental analysis .\n",
            "Estimated DM/GM ratios of mean PK parameters ( Cmax , AUC ) and their @ % confidence intervals ( CI ) were calculated .\n",
            "Bioequivalence was concluded if @ % CI were within @  @ % limits .\n",
            "Safety and tolerability were assessed .\n",
            "Results : @ subjects were enrolled , @ completed both treatments .\n",
            "Bioequivalence was demonstrated between DM and GM after a single dose injection of @ mg LAI risperidone .\n",
            "After dose-normalization , bioequivalence was demonstrated for @ mg DM vs. @ mg GM .\n",
            "Median time to peak concentrations and terminal half-lives of active antipsychotic fraction and risperidone were ~ @ and @  @ days , respectively , for each injection site and dose .\n",
            "Graphical and statistical analysis showed dose-proportional PK for DM of @ and @ mg LAI risperidone and for GM of @ and @ mg LAI risperidone .\n",
            "LAI risperidone was safe and well tolerated , regardless of injection site or dose .\n",
            "Conclusion : DM and GM LAI risperidone injections are bioequivalent administration routes with respect to peak and total plasma exposure .\n",
            "DM injection was well tolerated .\n",
            "Funded by J&J PRD .\n",
            "Last Refresh Date@ February @ / / Primary Sponsor : / / Registration Date : @/@/@ / / Export Date : @/@/@ @:@:@ PM / / Recruitment Status : Not recruiting / / Inclusion Age ( min ) : @ Years / / Inclusion Age ( max ) : @ Year / / Inclusion Gender : Both / / Date Enrollement : February @ / / Target Size : @ / / Phase : Phase @ / / Inclusion Criteria : - @ to @ years of age , inclusive , at the time of informed consent with a diagnosis of schizophrenia as defined by the Diagnostic and Statistical Manual of Mental Disorders , Fourth Edition , Text Revision ( DSM-IV-TR ) and confirmed by the Mini International Neuropsychiatric Interview ( M.I.N.I ) for Schizophrenia and Phychotic Disorders Studies - Would benefit from hospitalization or continued hospitalization for treatment of a current acute relapse of schizophrenia at trial entry - Are experiencing an acute exacerbation of psychotic symptoms and marked deterioration of usual function as demonstrated by all of the following : - Positive and Negative Syndrome Scale ( PANSS ) Total Score of = @ - Score of = @ on two or more of the following PANSS items at screening : hallucinatory behavior , unusual thought content , conceptual disorganization , or suspiciousness - Clinical Global Impression - Severity of Illness Scale ( CGI-S ) score = @ ( moderately ill ) / / Exclusion Criteria : - Are presenting with a first episode of schizophrenia based on the clinical judgment of the investigator - Have been hospitalized > @ days for the current acute episode at the time of the baseline visit - Have a current DSM-IV-TR Axis I diagnosis other than schizophrenia , including , but not limited to , schizoaffective disorder , major depressive disorder ( MDD ) , bipolar disorder , post-traumatic stress disorder , anxiety disorders , delirium , dementia , amnestic , or other cognitive disorders ; also borderline , paranoid , histrionic , schizotypal , schizoid , antisocial personality disorders or mental retardation .\n",
            "- Improvement of = @ % in total PANSS score between the screening and baseline assessments .\n",
            "/ / Condition : Schizophrenia / / Intervention : Drug : Brexpiprazole ; Drug : Aripiprazole / / Primary Outcome : The change from baseline to Week @ in PANSS Total Score / / Secondary Outcome : Cognitive test battery composite score change from baseline to Week @ change from baseline to Week @ in cognitive test battery composite score change from baseline to Week @ in cognitive test battery CGI-S score change from baseline to Week @ ; CGI-I score at Week @ ; Response rate ; SLOF Total Score change from baseline to Week @ ; BIS-@ total score change from baseline to Week @ / / Secondary ID : @-@-@ / / Source Support : Please refer to primary and secondary sponsors / / Secondary Sponsor : Otsuka Pharmaceutical Co. , Ltd .\n",
            "The aim of this study was to investigate the effectiveness of specialized hospital treatment vs. outreach treatment of patients with mental retardation and serious mental illness .\n",
            "A total of @ patients were randomly assigned to either the hospital treatment ( n = @ ) or the outreach treatment group ( n = @ ) .\n",
            "The outcome measures included psychiatric symptoms , family burden , costs and hospital admissions .\n",
            "At most observation points ( up to @ weeks ) and at all endpoints the two groups were equivalent with regard to psychiatric symptoms .\n",
            "The burden on carers did not increase significantly during the outreach treatment .\n",
            "Treatment costs were lower for the outreach treatment .\n",
            "Of the @ patients who received outreach treatment , four had to be admitted to the specialized hospital .\n",
            "Aggressive behaviour , social competence and number of previous psychiatric hospitalizations were found to be predictors of treatment outcome .\n",
            "It is concluded that outreach treatment represents an effective and efficient alternative to hospital treatment for patients with mental retardation and psychiatric disorders .\n",
            "Objective To investigate the impact of cognitive behavioral therapy on the first episode schizophrenia treatment adherence , insight , and relapse rate .\n",
            "Methods @ patients with first episode schizophrenia patients were randomly divided into study group and control group ( @ cases ) , both groups the system of antipsychotic drug treatment and general health education , the study group on the basis of cognitive behavioral therapy insight and treatment attitude questionnaire before the enrollment , treatment in March , the treatment in June , using the Brief Psychiatric Rating Scale ( BPRS ) , scale ( ITAQ ) , rehabilitation status with scale ( MRSS ) and self treatment compliance questionnaire assessed and compared .\n",
            "BPRS score of the results of the study group than the control group ( P > @-@ ) , research the group ITAQ score higher than that of the control group ( P < @ ) MRSS score of the study group than the control group ( P < @ .@ ) , the Group treatment June relapse rate is lower than the control group ( P < @ ) .\n",
            "Objective To investigate the impact of cognitive behavioral therapy on the first episode schizophrenia treatment adherence , insight , and relapse rate .\n",
            "Methods @ patients with first episode schizophrenia patients were randomly divided into study group and control group ( @ cases ) , both groups the system of antipsychotic drug treatment and general health education , the study group on the basis of cognitive behavioral therapy insight and treatment attitude questionnaire before the enrollment , treatment in March , the treatment in June , using the Brief Psychiatric Rating Scale ( BPRS ) , scale ( ITAQ ) , rehabilitation status with scale ( MRSS ) and self treatment compliance questionnaire assessed and compared .\n",
            "BPRS score of the results of the study group than the control group ( P > @-@ ) , research the group ITAQ score higher than that of the control group ( P < @ ) MRSS score of the study group than the control group ( P < @ .@ ) , the Group treatment June relapse rate is lower than the control group ( P < @ ) .\n",
            "Conclusion Cognitive behavior therapy can improve the first treatment compliance of patients with schizophrenia , and promote the recovery of insight , reduce the relapse rate , raise the overall level of rehabilitation .\n",
            "Background : Cognitive dysfunctions being core features of schizophrenia ( SZ ) , cause disability , increase burden and are refractory to treatment .\n",
            "Viral infections are not risk factors for SZ , but growing evidence indicates infection with some neurotropic viruses , particularly Herpes simplex virus type @ ( HSV -@ ) as a risk factor for cognitive dysfunction .\n",
            "Studies in India : Three research studies in India are described .\n",
            "In the first , participants were evaluated for HSV-@ infection and cognitive functions ( cases @ and controls @ ) .\n",
            "In the second , patients and normal nonpsychotic control individuals were examined at baseline and followed up over @-@ years ( cases @ and controls @ ) .\n",
            "In the third , a randomized , double-blind placebo-controlled antipsychotic adjunctive trial was conducted to examine the effect of anti-viral drug valacyclovir over @ weeks on cognitive functioning ( valacyclovir @ ; placebo @ , treatment for @ weeks ) .\n",
            "Results of Indian Studies : Cross-sectional study : HSV-@ infection was associated with modest dysfunction , especially on attention ( accuracy ) and spatial processing ( speed ) .\n",
            "Longitudinal Study : HSV-@ seropositive participants had lower scores at baseline on @/@ measures , regardless of SZ diagnoses .\n",
            "At follow-up , there was a significant decline in HSV-@-positive participants for abstraction and mental flexibility and emotion discrimination .\n",
            "Randomized Controlled Trial : Significantly , greater improvement in accuracy index of emotion discrimination in the valacyclovir-treated versus placebo sample was found .\n",
            "Conclusions : Indian studies are consistent with a causative role for HSV-@ in cognitive dysfunction regardless of SZ diagnosis ; more rigorous studies of the causal hypothesis are needed , particularly larger randomized controlled trials .\n",
            "Objective To compare the different management methods of long-term cognitive functioning of schizophrenic patients .\n",
            "Methods @ patients recovering from schizophrenia patients were randomly divided into two groups .\n",
            "Take closed-end management group to take a semi-open management , which give playing chess , handmade , shopping , and other occupational and recreational therapy .\n",
            "Packet before packet after @ weeks and @ weeks , respectively Wechsler Adult Memory Scale Amendment ( wmsrc ) , cancellation test ( ct ) the WCST ( wcst ) and digital determination .\n",
            "Semi-open group ( experimental group ) and closed ( control group ) cognitive function changes .\n",
            "Indicators in the control group after eight weeks no significant improvement in the calculation of the test group , digit span , the error rate , the number of perseverative errors and random number of errors has significantly improved .\n",
            "BACKGROUND : Antipsychotic drugs improve schizophrenia symptoms and reduce the frequency of relapse , but treatment response is highly variable .\n",
            "Little is known about the genetic factors associated with treatment response .\n",
            "We did a genome-wide association study of antipsychotic treatment response in patients with schizophrenia .\n",
            "METHODS : The discovery cohort comprised patients with schizophrenia from @ psychiatric hospitals in China that are part of the Chinese Antipsychotics Pharmacogenomics Consortium .\n",
            "Patients who met inclusion criteria were randomly assigned ( @:@:@:@:@:@ ) to six groups ( olanzapine , risperidone , quetiapine , aripiprazole , ziprasidone , and haloperidol or perphenazine ; those assigned to haloperidol or perphenazine were subsequently assigned [ @:@ ] to one or the other ) for @ weeks .\n",
            "Antipsychotic response was quantified with percentage change on the Positive and Negative Syndrome Scale .\n",
            "Single-nucleotide polymorphisms ( SNPs ) were tested for their association with treatment response .\n",
            "Linkage-disequilibrium-independent SNPs that exhibited potential associations ( ie , p < @ x @ ( -@ ) ) were tested in a validation cohort comprising patients from the Chinese Antipsychotics Pharmacogenetics Consortium from five collaborative hospitals , who were treated with olanzapine , risperidone , or aripiprazole for @ weeks .\n",
            "FINDINGS : The discovery cohort contained @ patients and the validation cohort @ patients .\n",
            "In the discovery cohort , we identified three novel SNPs ( rs@ in MEGF@ [ p = @ x @ ( -@ ) ] , rs@ in SLC@A@ [ p = @ x @ ( -@ ) ] , and rs@ in PCDH@ [ p = @ x @ ( -@ ) ] ) that were associated with antipsychotic treatment response at a genome-wide significance level .\n",
            "These associations were confirmed in the validation cohort ( p < @ ) .\n",
            "In the combined sample of the discovery and validation cohorts , we identified five novel loci showing genome-wide significant associations with general antipsychotic treatment response ( rs@ in MEGF@ [ p = @ x @ ( -@ ) ] , rs@ in SLC@A@ [ p = @ x @ ( -@ ) ] , rs@ in PCDH@ [ p = @ x @ ( -@ ) ] , rs@ in CNTNAP@ [ p = @ x @ ( -@ ) ] , and rs@ in TNIK [ p = @ x @ ( -@ ) ] ) .\n",
            "In antipsychotic-specific groups , after the combination of results from both samples , the rs@ SNP in CACNA@C was associated with treatment response to olanzapine ( p = @ x @ ( -@ ) ) , rs@ in SLC@A@ was associated with treatment response to risperidone ( p = @ x @ ( -@ ) ) , and rs@ in CNTN@ was associated with treatment response to aripiprazole ( p = @ x @ ( -@ ) ) .\n",
            "INTERPRETATION : We have identified genes related to synaptic function , neurotransmitter receptors , and schizophrenia risk that are associated with response to antipsychotics .\n",
            "These findings improve understanding of the mechanisms underlying treatment responses , and the identified biomarkers could eventually guide choice of antipsychotic in patients with schizophrenia .\n",
            "FUNDING : National Key Technology R&D Program of China , National Natural Science Foundation of China .\n",
            "Objective To compare the A Leekpai azole risperidone adverse reactions to the treatment of male schizophrenia .\n",
            "@ male patients with schizophrenia were randomized to @ weeks of treatment , respectively , to the A Leekpai Uniconazole and the risperidone tess ( adverse reaction symptom scale ) in the treatment of @,@ weekend to assess adverse reactions , at the same time serum prolactin levels were measured before and after treatment , and understand the change of the patient 's sexual function .\n",
            "The results of two adverse reaction total was no significant difference between A Leekpai azole less likely to cause extrapyramidal reactions ( eps ) and sexual dysfunction , serum prolactin levels significantly lower than the risperidone group .\n",
            "Investigated the anticholinergic effect of trihexphenidyl ( TRX ) on memory function of @ schizophrenic patients ( aged @-@ yrs ) in a double-blind crossover design .\n",
            "Impairment of immediate memory and short-term memory was evident after TRX treatment in comparison with placebo .\n",
            "Sensory short-term memory tested by visual tasks and remote memory showed no significant differences .\n",
            "Data suggest that TRX , due to its anticholinergic effect , might impair memory function .\n",
            "Purpose - Standard antipsychotic drug regimens do not fully address the impact of cognitive symptoms associated with schizophrenia .\n",
            "The NMDA receptor has been connected to the pathophysiology of schizophrenia .\n",
            "Memantine is an uncompetitive NMDA receptor antagonist .\n",
            "It is hypothesized that adjunctive therapy with memantine will reduce NMDA receptor hyperactivity , improving signal to noise ratio and thereby improving cognitive symptoms .\n",
            "Primary Outcome Measures - Positive and Negative Symptom Scale ( PANSS ) - Total Score Secondary Outcome Measures - Clinical Global Impression - Severity ( CGI-S ) PANNS - Positive Score PANSS - Negative Score Calgary Depression Scale for Schizophrenia Brief Assessment of Cognition Clinical Global Impression - Improvement Total Enrollment - @ Study start - August @ Eligibility - Ages Eligible for Study - @ Years - @ Years , Genders Eligible for Study - Both Criteria Inclusion Criteria - DSM-IV diagnosed Schizophrenia or schizoaffective disorder who are on a stable antipsychotic regimen with Brief Psychiatric Rating Scale ( BPRS ) total score greater than or equal to @ and greater than or equal to @ on at least one item Exclusion Criteria - Secondary diagnosis of Bipolar I disorder Suicidal history Organic brain disease Dementia History of substance abuse\n",
            "Objective To investigate the effect of psychological intervention rehabilitation of convalescent patients with schizophrenia and depression .\n",
            "The method will be @ cases of Mudanjiang the neuropsychiatric hospital 's convalescent patients with schizophrenia were randomly divided into observation group and control group .\n",
            "The control group was given conventional psychiatric care , observation group to give psychological interventions in the control group on the basis of routine care .\n",
            "Hamilton depression rating scale ( hamd ) was measured to compare the two groups effect of rehabilitation before and after all patient care .\n",
            "Results before and after the two groups of nursing hamd score decrease was statistically significant ( p < @ ) , especially observation group significantly decreased .\n",
            "The observation group after the intervention the hamd points compared with the control group , the difference was statistically significant ( p < @ ) .\n",
            "The valid observation group , @ cases ( @ % ) , control group @ ( @ % ) , two sets of efficiency compared to the difference was statistically significant ( p < @ ) .\n",
            "Purpose - A short term post-market monitoring of serum prolactin level change among patients with schizophrenia shifting from other antispychotics to different dosages of aripiprazole .\n",
            "Primary Outcome Measures - prolactin level drops after shifting to aripiprazole [ Time Frame - @ months ] Secondary Outcome Measures - correlations between prolactin and other clinical outcomes [ Time Frame - @ months ] Total Enrollment - @ Study start - May @ ; Expected completion - July @ This is an open-label clinical trial of adult inpatients or outpatients with a diagnosis of schizophrenia , schizoaffective disorder , or schizophreniform disorder as measured by the Diagnostic and Statistical Manual of Mental Disorders , Fourth Edition , Text Revision ( DSM-IV-TR ) .\n",
            "Eligible patients will have laboratory and clinical assessments completed .\n",
            "All procedures in this study are considered standard care and impose no additional risks to the patients .\n",
            "Participation is voluntary and recruitment will be on an  as come  basis .\n",
            "Study Visits Schedule Visit @ Visit @ Visit @ Visit @ Visit @ Visit @ Day -@ Day @ Day @ Day @ Day @ Day @ Baseline Initiation Endpoint prolonged f/u Discussion of Design and Control Because of the ethical concerns regarding withholding medication from seriously ill patients , this study does not employ a washout period .\n",
            "Though patients may have their antipsychotic drug held for up to @ hours , this should not present any clinical problems in the majority of patients .\n",
            "This one day prevalence trial allows for clinical data to be collected in a timely manner .\n",
            "Study Population Most subjects recruited in this study are originated from a chronic psychiatric residential community .\n",
            "They are characterized by a regular medication with reliable drug compliance under a well-controlled diet in the unit .\n",
            "The subject of drug nave will be denoted and analyzed separately in the later stage .\n",
            "Entry Procedures The patient and/or the patient s authorized legal representative prior to the patient s participation in the study will sign an informed consent document approved by an ethical review board , or similar body .\n",
            "Inclusion Criteria Patients may be included in the study if they meet the following criteria - Males and females @-@ years of age Diagnosis of schizophrenia , schizoaffective or schizophreniform disorder Each individual must have a level of understanding sufficient to perform all tests and examinations required Individuals must be willing to fast after midnight the evening prior to study visit Individuals must be willing to provide a small sample of blood for evaluation Individuals must be willing to participate in a short @-@ minute clinical interview Exclusion criteria Patients may be excluded from the study for any of the following reasons - A current diagnosis of diabetes mellitus Serious unstable illness such that death is anticipated within @ year or intensive care unit hospitalization for the condition is anticipated within @ months Uncorrected hypothyroidism or hyperthyroidism Uncorrected tumor secreting ectopic prolactinemia Dosage and Administration The dosage of aripiprazole will be co-administrated since day @ with the fixed dosage of @ mg aripiprazole per day for @ week with the full dosage of previously used antipsychotics .\n",
            "The previous antipsychotics will be removed on day @ , and each individual will be assigned to either @-@ mg aripiprazole per day ( A arm ) or @-@ mg aripiprazole per day ( B arm ) or @ mg aripriprazole plus @ mg haldol per day ( C arm ) via the randomized procedure .\n",
            "Visit @ Visit @ Visit @ Visit @ Visit @ Visit @ Visit @ Day -@ Day @ Day @ Day @ Day @ Day @ Day @ Previous antispychotics Full dosage stop - - - A arm ( N = @ ) @ mg @-@mg @-@mg @-@mg @-@mg @-@mg B arm ( N = @ ) @ mg @-@ mg @-@ mg @-@ mg @-@ mg @-@ mg C arm ( N = @ ) @ mg @ mg ( + @-@ mg haldol ) @ mg ( + @-@ mg haldol ) @ mg ( + @-@ mg haldol ) @ mg ( + @-@ mg haldol ) @ mg ( + @-@ mg haldol ) Denotation - C arm is designed for the purpose of evaluation on add-on effect from typical antipsychotics with a high potency such as haldol .\n",
            "The difference between C arm and the other two might be minimal or significant due to different reaction in Asian population or Chinese population .\n",
            "In addition to the necessary prescription of antipsychotics described as above listed , adequate amount of benzodiazepines and anticholinergics are permitted to give to alleviate the possible anxiety , insomnia , and EPS as an adjunctive agent simultaneously .\n",
            "Table @ Visit @ Visit @ Visit @ Visit @ Visit @ Visit @ Visit @ Day -@ Day @ Day @ Day @ Day @ Day @ Day @ CGI x x x x x x x DRA x x x x PANSS x x x x AIMS x x x x SAS x x x x SWN x x x x Demographic Sheet x Clinical Laboratory Tests Clinical laboratory testing will be performed at Visit @ , @ , @ , @ , @ , @ .\n",
            "See Table@ for a complete list of tests to be performed .\n",
            "Patients will be asked to fast after midnight ( at least @ hours ) prior to labwork .\n",
            "If a patient is to take morning medications , he/she is asked to hold the morning medications until after the labwork is drawn .\n",
            "He or she may take the medication immediately after the labs have been drawn .\n",
            "Note - A patient is permitted to go off site to have his/her labs drawn .\n",
            "Labwork must be drawn within @ days of time the demographic and other data is/was gathered .\n",
            "Table @ Visit @ Visit @ Visit @ Visit @ Visit @ Visit @ Visit @ Day -@ Day @ Day @ Day @ Day @ Day @ Day @ Prolactin x x x x x x x Leptin x x x x Estrogen x x x x Glusoce x x x x x x x Insulin x x x x x x x Total cholesterol x x x x HDL x x x x LDL x x x x Triglycerides x x x x Other Clinical Assessments Hypertension is defined as systolic blood pressure ( SBP ) of @ mm Hg or greater , diastolic blood pressure ( DBP ) of @ mm Hg or greater , or taking antihypertension medication .\n",
            "Obesity is defined as a Body Mass Index ( BMI ) of @ or greater .\n",
            "Eligibility - Ages Eligible for Study - @ Years - @ Years , Genders Eligible for Study - Both Criteria Inclusion Criteria - Patients may be included in the study if they meet the following criteria - Males and females @-@ years of age Diagnosis of schizophrenia , schizoaffective or schizophreniform disorder Each individual must have a level of understanding sufficient to perform all tests and examinations required Individuals must be willing to fast after midnight the evening prior to study visit Individuals must be willing to provide a small sample of blood for evaluation Individuals must be willing to participate in a short @-@ minute clinical interview Exclusion Criteria - Patients may be excluded from the study for any of the following reasons - A current diagnosis of diabetes mellitus Serious unstable illness such that death is anticipated within @ year or intensive care unit hospitalization for the condition is anticipated within @ months Uncorrected hypothyroidism or hyperthyroidism Uncorrected tumor secreting ectopic prolactinemia\n",
            "Penfluridol is a diphenylbutylpiperidine derivative with a half-life of @ hrs .\n",
            "The present study was designed to determine its efficacy for the maintenance of schizophrenia .\n",
            "In a @-wk DOUBLE-blind study , once weekly doses of penfluridol ( maximum dosage @ mg/wk ) were compared with once daily doses of chlorpromazine ( maximum dosage @ mg/wk ) in @ schizophrenic patients receiving maintenance treatment on an outpatient basis .\n",
            "Assessment instruments included the Brief Psychiatric Rating Scale , Evaluation of Social Functioning Rater Scale , and Clinical Global Impressions .\n",
            "The drugs were similar in their clinical effectiveness , and no major side effects occurred with either drug .\n",
            "( @ ref )\n",
            "The effectiveness of a once-weekly i.m. injection of ceruletide ( @ microgram/kg ) in suppressing the symptoms of neuroleptic-induced tardive dyskinesia ( TD ) was evaluated in a double-blind , placebo-controlled , matched-pairs study .\n",
            "Global evaluation of the severity of TD symptoms over the @-week study period revealed a significant improvement with ceruletide as compared with placebo .\n",
            "Analysis of the therapeutic response to ceruletide over the course of treatment revealed a slow , but long-lasting improvement of TD symptoms .\n",
            "Side effects , which were mild and transient , consisted mainly of nausea and epigastric discomfort .\n",
            "The incidence of side effects did not differ between the ceruletide - and placebo-treated groups .\n",
            "Ceruletide appears to be a novel and practical treatment that can substantially alleviate the symptoms of dyskinesia .\n",
            "BACKGROUND : Acute psychiatric wards manage patients whose actions may threaten safety ( conflict ) .\n",
            "Staff act to avert or minimise harm ( containment ) .\n",
            "The Safewards model enabled the identification of ten interventions to reduce the frequency of both .\n",
            "OBJECTIVE : To test the efficacy of these interventions .\n",
            "DESIGN : A pragmatic cluster randomised controlled trial with psychiatric hospitals and wards as the units of randomisation .\n",
            "The main outcomes were rates of conflict and containment .\n",
            "PARTICIPANTS : Staff and patients in @ randomly chosen wards at @ randomly chosen hospitals .\n",
            "RESULTS : For shifts with conflict or containment incidents , the experimental condition reduced the rate of conflict events by @ % ( @ % CI @-@ % ) [ corrected ] relative to the control intervention .\n",
            "The rate of containment events for the experimental intervention was reduced by @ % ( @ % CI @-@ % ) .\n",
            "[ corrected ] CONCLUSIONS : Simple interventions aiming to improve staff relationships with patients can reduce the frequency of conflict and containment .\n",
            "TRIAL REGISTRATION : IRSCTN@ .\n",
            "Objective To evaluate the effect and safety of ziprasidone in the treatment of first - episode schizophrenia .\n",
            "Methods @ patients with first - episode schizophrenia were randomly divided into two groups ( A&B ) to conduct a @ - week double - blind contrast study , among which @ patients in group A were treated with ziprasidone , and the other @ in group B were treated with risperidone.PANSS , CGI , TESS and related laboratory test were adopted to evaluate the effect and safety .\n",
            "Results After the treatment , PANSS scores of the two groups dropped dramatically from the very beginning ( P < @ ) , with a rate of ( @  @ ) % in group A and ( @  @ ) % in group B .\n",
            "The clinical total effective rate was @ % with group A and @ % with group B. Rate of side effects was @ % in group B , higher than that in group A which was @ % .\n",
            "No statistical differences were found between the two groups .\n",
            "Conclusion The effect of domestic ziprasidone in the treatment of first - episode schizophrenia is similar with that of risperidone .\n",
            "Ziprasidone is an effective and safe antipsychotics\n",
            "Individual differences in serotonin @A ( @-HT@A ) receptor may result in variable response to antipsychotics with @-HT@A receptor partial agonism .\n",
            "We investigated the relationship between @-HT@A receptor gene ( HTR@A ) single nucleotide polymorphisms ( SNPs ) and efficacy of antipsychotics with @-HT@A receptor partial agonism in Japanese patients with schizophrenia .\n",
            "Perospirone or aripiprazole was administered to @ patients with schizophrenia in a randomized controlled study .\n",
            "Candidate SNPs were rs@ ( which affects HTR@A expression and function ) , rs@ , rs@ , and rs@ .\n",
            "Efficacy at week @ of treatment was evaluated using the Positive and Negative Syndrome Scale ( PANSS ) @-factor subscales ( excitement/hostility , depression/anxiety , cognition , positive , and negative ) .\n",
            "Rs@ T allele was correlated with the percent change in the PANSS @-factor negative score ( P < @ ) .\n",
            "Haplotype analysis showed that the rs@-rs@-rs@ T-C-G haplotype was correlated with worse negative score improvement ( haplotype frequency , @ ; P = @ ) , and the relatively rare T-G-T haplotype correlated with better efficacy ( haplotype frequency , @ ; P = @ ) .\n",
            "This is the first study to show that rs@-rs@-rs@ HTR@A variants may be correlated with the improvement of the PANSS @-factor negative score during treatment with @-HT@A partial agonist antipsychotics .\n",
            "Studies with larger sample sizes and in different ethnic groups are warranted .\n",
            "Background : A study of the impact of yoga and aerobic exercise and psychosis was conducted in @ by Lin et al. , from The University of Hong Kong .\n",
            "The study indicated significant improvement in the aspects of physical fitness , cognitive functions , psychosocial and emotional functioning in patients with psychosis after a @-week yoga or aerobic intervention program .\n",
            "Long-term effect of exercise intervention , however , had yet been determined .\n",
            "The aim of the present study was to evaluate the long-term effects of yoga and aerobic exercise on cognitive functioning and clinical symptoms in early psychosis .\n",
            "Patients who originally participated in Lin et al.    s @ study were recruited and re-assessed in this current @-month follow-up study .\n",
            "Methods : Two intervention groups ( yoga and aerobic exercise group ) and one control group ( wait-list control group ) of a total @ subjects from the initial study were recruited in this follow-up study .\n",
            "Cognitive functioning and clinical symptoms were assessed at three time points ( T@ : Baseline , T@ : @-week , T@ : @-month ) .\n",
            "Results : No significant changes or significant deterioration were found in cognitive functioning , clinical symptoms and depression between T@ ( @-week ) and T@ ( @-month ) in both intervention groups ( yoga and aerobic group ) .\n",
            "Significant improvement of clinical symptoms was observed in wait-list control group at T@ .\n",
            "Conclusions : Although there is no significant finding in this current study , it is still recommended that further study on the relationship between physical exercise intervention and psychosis should carried out in order to explore other adjunct , and especially low cost , treatment to antipsychotics in treating people with psychosis .\n",
            "The schizophrenic patient 's early psychological response to neuroleptic treatment has been demonstrated to be a significant predictor of treatment response .\n",
            "The validity of the construct of subjective response is evaluated by comparison of two measures .\n",
            "Fifty-five recently admitted and unmedicated schizophrenic patients were randomly allocated to chlorpromazine or haloperidol .\n",
            "Subjective responses at @ and @ hours as assessed by two different scales , the Van Putten & May scale and the self-administered Drug Attitude Inventory , were strongly correlated with outcome at three weeks .\n",
            "Early emergence of extrapyramidal symptoms was not related to subjective response , but dysphoric patients had a greater incidence of EPS by the end of treatment than did non-dysphoric patients .\n",
            "The two measures showed high concordance in identification of early drug dysphoria .\n",
            "BACKGROUND : The high smoking rate among patients with schizophrenia is an important public health problem , and researchers have been studying how to change the status quo .\n",
            "OBJECTIVE : We investigated the effects of high frequency ( @Hz ) repetitive transcranial magnetic stimulation on the amount of cigarette smoking in patients with schizophrenia .\n",
            "METHOD : This study enrolled @ male patients with schizophrenia who were at a stable stage of treatment .\n",
            "Patients were randomly divided into a treatment group ( n = @ ) and a control group ( n = @ ) .\n",
            "The treatment group received repetitive transcranial magnetic stimulation ( rTMS ) on the left prefrontal dorsolateral cortex ( DLPFC ) , and the control group received placebo treatment .\n",
            "The number of cigarettes smoked were recorded at @ days before treatment , during the course of treatment ( i.e. for @ days ) , and @ weeks after treatment had ended .\n",
            "Assessments using the Positive and Negative Syndrome Scale ( PANSS ) , Wisconsin Card Sorting Test ( WCST ) , and Montgomery Asberg Depression Rating Scale ( MADRS ) were applied before and after treatment .\n",
            "RESULT : Compared to the control group , the number of cigarettes smoked in the treatment group showed a statistically significant reduction in the first week after treatment .\n",
            "However , there was no significant correlation between the scores on PANSS , WCST and MADRS and the number of cigarettes smoked before and after treatment in both groups .\n",
            "DISCUSSION : High frequency ( @Hz ) repetitive transcranial magnetic stimulation on the left prefrontal cortex can reduce the number of cigarettes smoked in patients with schizophrenia .\n",
            "Background : The caregivers of people who experience psychosis are themselves at risk of developing physical and mental health problems .\n",
            "This risk is increased for older adult caregivers who also have to manage the lifestyle and health changes associated with ageing .\n",
            "As a consequence , older adult caregivers are in particular need of support ; we propose a Written Emotional Disclosure ( WED ) intervention , called Positive Written Disclosure ( PWD ) .\n",
            "Methods/design : This is a pilot randomised controlled trial of PWD compared to a neutral writing control and a no writing condition .\n",
            "We aim to recruit @ participants , @ in each arm .\n",
            "This study will utilise a mixed-methods approach and collect quantitative ( questionnaires ) and qualitative ( interviews ) data .\n",
            "Quantitative data will be collected at baseline and @ , @ , and @ months post baseline .\n",
            "Participants who complete a writing task ( PWD or neutral writing control ) will be invited to complete an exit interview to discuss their experiences of the intervention and study .\n",
            "The study is supported by a patient and public involvement group .\n",
            "Discussion : The results of this trial will determine whether a definitive trial is justified .\n",
            "If so , the quantitative and qualitative findings will be used to refine the intervention and study protocols .\n",
            "Trial registration : ISRCTN , ISRCTN@ .\n",
            "Registered on @ January @ .\n",
            "STUDY OBJECTIVES : The utility of intravenous prochlorperazine as an antiemetic agent and abortive therapy for headache may be limited by the frequent occurrence of akathisia , the distressing effects of which have been shown to disrupt patient care .\n",
            "We tested the hypothesis that adjuvant diphenhydramine reduces the incidence of akathisia induced by prochlorperazine .\n",
            "METHODS : This randomized , double-blind , placebo-controlled trial was conducted in the emergency department of an academic tertiary care medical center with an annual census of @ emergency patient visits .\n",
            "We enrolled a convenience sample of @ adult patients who received @ mg of intravenous prochlorperazine for the treatment of nausea/vomiting or headache .\n",
            "Subjects were randomly assigned to receive a @-minute infusion of prochlorperazine with either @ mg of diphenhydramine or placebo .\n",
            "The incidence of akathisia at @ hour was measured by using explicit diagnostic criteria .\n",
            "To measure the influence of treatment on sedation , the subjects noted , on a @-mm visual analog scale , their degree of sedation before and after treatment .\n",
            "RESULTS : Akathisia developed in @ ( @ % ) of @ subjects in the control group and in @ ( @ % ) of @ subjects in the diphenhydramine group , a @ % relative reduction .\n",
            "The addition of adjunct diphenhydramine resulted in an absolute reduction of @ % in the incidence of akathisia ( @ % confidence interval [ CI ] @ % to @ % ; P = .@ ) .\n",
            "The odds ratio for akathisia with the use of adjuvant diphenhydramine was @ ( @ % CI @ to @ ) .\n",
            "Mean sedation scores increased @ mm after infusion of prochlorperazine alone ( @ % CI @ to @ mm ) compared with a @-mm increase after infusion of prochlorperazine with adjuvant diphenhydramine ( @ % CI @ to @ mm ) .\n",
            "The @-mm difference between the groups was statistically significant ( @ % CI @ to @ mm , P < .@ ) .\n",
            "CONCLUSION : Adjuvant diphenhydramine reduces the incidence of akathisia induced by prochlorperazine and is associated with an increase in sedation .\n",
            "This paper explores the relationship between direct support from family members and friends and substance use outcomes for people with co-occurring severe mental illness and substance use disorders .\n",
            "Data are from a @-year randomized trial of @ patients in treatment for dual disorders .\n",
            "Informal ( family ) caregivers for @ participants were asked about economic assistance and direct care that they provided to participants .\n",
            "Associations between family support and substance use outcomes were examined with bivariate comparisons of abstainers and nonabstainers and with regression models using change in substance use and cumulative substance use as dependent measures .\n",
            "Family economic support was associated with substance abuse recovery in bivariate and regression analyses .\n",
            "Caregiving hours were significantly associated with substance use reduction but not with cumulative substance use .\n",
            "Informal support was not associated with changes in psychiatric symptoms .\n",
            "The findings suggest that direct family support may help people with dual disorders to reduce or eliminate their substance use .\n",
            "Further research is needed to confirm this connection and to establish the mechanisms by which support is useful .\n",
            "Objective To compare the efficacy of ziprasidone with perphenazine schizophrenia patients and the impact on quality of life .\n",
            "@ schizophrenic patients were randomly divided into two groups , respectively , treated with ziprasidone , and perphenazine , for @ weeks .\n",
            "Positive and Negative Syndrome Scale ( panss ) to assess the clinical evaluation of the treatment emergent symptom scale ( tess ) adverse reactions to assess the quality of life , a comprehensive assessment of the quality of life questionnaire ( gqolt-@ ) .\n",
            "Results The two groups were significant , The ziprasidone adverse reactions , and can significantly improve the quality of life , less than perphenazine .\n",
            "Objective : To investigate the efficacy of quetiapine alone and combination treatment of schizophrenia .\n",
            "Methods : @ cases of first episode schizophrenia patients were randomly divided into two groups , were given quetiapine ( single group ) and consolidation of sulpiride ( combination group adverse reactions ) , for @ weeks using the positive and Negative Syndrome scale ( PANSS ) and side effects scale ( TESS ) to assess the efficacy and adverse reactions .\n",
            "Objective : To investigate the psychological care of hospitalized patients with long-term schizophrenic attitude and compliance .\n",
            "Methods : @ cases of long-term hospitalized patients with schizophrenia were randomly divided into two groups , to maintain original drugs and general supportive treatment ( @ cases ) , Study Group merged based on individualized psychological care ( @ cases ) .\n",
            "Enrolled ?\n",
            "@ weeks of treatment , the Insight and Treatment Attitudes Questionnaire ( itaq ) and inpatient treatment compliance assessment .\n",
            "In Results : the study group itaq rated significantly higher ( p < @ ) .\n",
            "The adherence study group was significantly better than the control group ( p < @ ) .\n",
            "Objective To compare effectiveness and compliance of risperidone and clozapine while treating resistant schizophrenia .\n",
            "Methods @ cases of resistant schizophrenic outpatients or inpatients were collected , among which @ cases were sensitive to risperidone treatment ( n = @ ) and @ to clozapine treatment ( n = @ ) .\n",
            "Effects of the two treatments were assessed before and during ( @ , @ , @ and @ months ) using BPRS , SANS , SDSS and CGI .\n",
            "Results In the risperidove treated group , @ patients finished the trial , among whic\n",
            "Objective .\n",
            "This study was undertaken to compare the efficacy of lorazepam with clothiapine in the behavioural control of acutely behaviourally disturbed patients who are on antipsychotic treatment with haloperidol .\n",
            "Design .\n",
            "This was a double-blind , controlled RANDOMised trial .\n",
            "Patients .\n",
            "Sixty patients consecutively admitted to Sterkfontein Hospital aged between @ and @ years with AGGRESSive and disorganised behaviour were selected for the study .\n",
            "Methods .\n",
            "All the patients were treated with haloperidol @ mg orally , and either clothiapine @ mg or lorazepam @ mg intramuscularly .\n",
            "Efficacy was measured using the Brief Psychiatric Rating Scale ( BPRS ) on admission , day @ and day @ .\n",
            "Levels of AGGRESSion were assessed by the Overt AGGRESSion Scale ( OAS ) .\n",
            "This was done on admission and on days @ , @ and @ .\n",
            "The presence of extrapyramidal side-effects was assessed by the Simpson Angus Scale ( SAS ) on days @ , @ and @ .\n",
            "Results .\n",
            "There were no significant differences between the two groups in respect of onset of sedation , demographics or rating scale scores on each visit .\n",
            "However , lorazepam treatment was associated with fewer extrapyramidal side-effects as measured by the SAS .\n",
            "Conclusion .\n",
            "Lorazepam and clothiapine are of equivalent efficacy in the control of acutely behaviourally disturbed patients .\n",
            "Lorazepam treatment is associated with fewer extrapyramidal side-effects .\n",
            "Improvement of acute psychotic exacerbations under neuroleptic therapy can depend on the time course of the disease itself , on the individual patient or on the specific neuroleptic applied .\n",
            "Previous studies demonstrated that neither the characteristics of the patients nor the disease qualities could predict the outcome of neuroleptic therapy ( review by May and Goldberg @ ) .\n",
            "In this study the initial improvement after the onset of neuroleptic treatment was tested for its predictive value .\n",
            "In @ patients treated with constant doses of butyrophenones the decrease of psychotic symptomatology during the first @ days of treatment not only accounted for the major part of the overall improvement , but was also a relatively reliable predictor for the further course of the therapy .\n",
            "Evaluated the administration of fluphenazine and haloperidol on a double-blind basis for a @-wk period in an outpatient group of @ @-@ yr old schizophrenic children .\n",
            "Mean dosage for both treatment groups was @ mg/d , with a maximum dose of @ mg/d .\n",
            "All Ss were administered the Children 's Psychiatric Rating Scale after completion of treatment .\n",
            "Both fluphenazine and haloperidol proved highly effective , with the @ drugs indistinguishable in overall efficacy .\n",
            "Both drugs were characterized by low incidence of side effects with a tendency for fluphenazine treatment to induce extrapyramidal symptoms with greater frequency than haloperidol .\n",
            "Side effects were easily managed by dose reduction or contramedication .\n",
            "No S had to be terminated due to an adverse reaction .\n",
            "Findings indicate that fluphenazine and haloperidol deserve consideration in the treatment of schizophrenic children .\n",
            "( @ ref )\n",
            "For this study , we evaluated the effectiveness of a cognitive training program in improving cognitive function in patients with alcoholism comorbid with another neuropsychiatric disorder and going through the subacute phase of detoxication .\n",
            "We employed a randomized clinical trial design in which @ subjects were assigned to a five-session cognitive rehabilitation program and @ subjects were assigned to an attention placebo control condition .\n",
            "All subjects received a battery of cognitive tests for reasoning , attention , and visual-spatial abilities .\n",
            "These tests were repeated at the completion of the study .\n",
            "The training consisted of a number of component tasks designed to improve attention , speed of information processing , perceptual analysis , and visual-spatial cognition .\n",
            "We plotted performance on training results across sessions to detect evidence of learning effects .\n",
            "Comparisons of the cognitive tests revealed greater improvement in the training as compared to the attention placebo group on measures of attention and conceptual flexibility .\n",
            "We concluded that the training produced significant improvement over and above natural recovery during detoxication .\n",
            "Neurotrophic factors like Brain-Derived Neurotrophic Factor ( BDNF ) , Neurotrophin @ ( NT@ ) and Nerve Growth Factor ( NGF ) , play a role in neuroplasticity and neurogenesis contributing to the pathogenesis of schizophrenia .\n",
            "The objective of the present study was to investigate and compare the effect of olanzapine and lurasidone on the change in serum neurotrophins in patients with schizophrenia .\n",
            "The present study was a randomized , open-label , active-controlled , parallel design clinical trial .\n",
            "After randomization baseline evaluations of serum BDNF , NGF , NT@ , Positive and Negative Syndrome Scale ( PANSS ) scoring , Social and Occupational Functioning Assessment Scale ( SOFAS ) scoring of @ unmedicated schizophrenia patients were done .\n",
            "Patients were reassessed after @ weeks of monotherapy with olanzapine or lurasidone .\n",
            "Serum BDNF increased after treatment with both the drug groups but rise with olanzapine was found to be significantly higher ( @ ; @ % CI : @ to @ ; p < @ ) in comparison to lurasidone .\n",
            "Increase in levels NGF and NT@ was also observed but there was no significant difference between the groups ( NGF : @ ; CI : @ to -@ ; p = @ and NT@ : @ ; CI : @ to @ ; p = @ ) .\n",
            "The difference in improvement in PANSS and SOFASS with both the drugs was not statistically significant .\n",
            "Both the drugs alleviate the symptoms of schizophrenia but olanzapine was better tolerated .\n",
            "Our findings suggest that increase in serum BDNF with olanzapine monotherapy is significantly higher than that with lurasidone but there is no significant difference in change in serum NGF and NT@ .\n",
            "TRIAL REGISTRATION : ClinicalTrials.gov identifier : ( NCT@ ) .\n",
            "Background : Both neurocognitive impairments and negative symptoms of schizophrenia ( NSS ) are believed related to mesocortical dopaminergic hypofunction .\n",
            "This analysis examined the hypothesis that the dopamine agonist , d-amphetamine prodrug , lisdexamfetamine dimesylate ( LDX ) , would improve neurocognition along with NSS in adults with clinically stable schizophrenia maintained on atypical antipsychotics .\n",
            "Methods : Outpatients with schizophrenia ( > = @ years ) and predominant NSS , on antipsychotics ( > = @ weeks ) , underwent @-week open-label ( OL ) LDX augmentation ( @-@mg / d ) .\n",
            "Eligible participants ( any SANS-@ improvement at week @ ) entered @-week , double-blind , placebo-controlled randomized withdrawal ( RW ) .\n",
            "Efficacy measures included SANS-@ ( primary ) , Brief Assessment of Cognition in Schizophrenia-Symbol Coding Subtest ( BACS-SC ) , Hopkins Verbal Learning Test-Revised , Immediate Recall ( HVLT-R ) , and Letter Number Span Test ( LNS ) .\n",
            "Safety evaluations included treatment-emergent adverse events ( TEAEs ) .\n",
            "Results : In @ participants receiving OL LDX , SANS-@ mean change ( @ % CI ; weeks @-@ OL , LOCF ) was -@ ( -@ , -@ ) ( P < .@ ) .\n",
            "Mean change ( @ % CI ) in BACS-SC T-score was @ ( @ , @ ) ( P = .@ ) ; mean change in HVLT-R and LNS T-scores were @ ( -@ , @ ) and @ ( -@ , @ ) , respectively ( both P = NS ) .\n",
            "During RW , no significant differences were noted ( LDX vs placebo ) for these outcomes .\n",
            "In the OL phase , @/@ ( @ % ) reported TEAEs ; @/@ ( @ % ) reported serious TEAEs .\n",
            "Conclusions : LDX improved NSS without worsening positive symptoms of schizophrenia .\n",
            "This was accompanied by small but significant improvements in BACS-SC .\n",
            "Confirmation with larger placebo-controlled trials , various doses , and additional cognitive measures is warranted given the significant unmet need for treating negative and cognitive symptoms in schizophrenia .\n",
            "Schizophrenia is a chronic and severe mental illness that poses significant challenges .\n",
            "While many pharmacological and psychosocial interventions are available , many treatment-resistant schizophrenia patients continue to suffer from persistent psychotic symptoms , notably auditory verbal hallucinations ( AVH ) , which are highly disabling .\n",
            "This unmet clinical need requires new innovative treatment options .\n",
            "Recently , a psychological therapy using computerized technology has shown large therapeutic effects on AVH severity by enabling patients to engage in a dialogue with a computerized representation of their voices .\n",
            "These very promising results have been extended by our team using immersive virtual reality ( VR ) .\n",
            "Our study was a @-week phase-II , randomized , partial cross-over trial .\n",
            "Nineteen schizophrenia patients with refractory AVH were recruited and randomly allocated to either VR-assisted therapy ( VRT ) or treatment-as-usual ( TAU ) .\n",
            "The group allocated to TAU consisted of antipsychotic treatment and usual meetings with clinicians .\n",
            "The TAU group then received a delayed @weeks of VRT .\n",
            "A follow-up was ensured @ months after the last VRT therapy session .\n",
            "Changes in psychiatric symptoms , before and after TAU or VRT , were assessed using a linear mixed-effects model .\n",
            "Our findings showed that VRT produced significant improvements in AVH severity , depressive symptoms and quality of life that lasted at the @-month follow-up period .\n",
            "Consistent with previous research , our results suggest that VRT might be efficacious in reducing AVH related distress .\n",
            "The therapeutic effects of VRT on the distress associated with the voices were particularly prominent ( d = @ ) .\n",
            "VRT is a highly novel and promising intervention for refractory AVH in schizophrenia .\n",
            "Objective : Metabolic syndrome , diabetes , heart disease , and obesity are all prevalent in schizophrenia patients ( Sz ) at rates @-@ times that in the general public .\n",
            "Weight reduction , by lifestyle change is the foundation of all risk prevention in heart disease and diabetes , since the other risk factors for both diseases are strongly correlated with obesity .\n",
            "We report on a randomized controlled clinical trial ( RCT ) of behavior therapy for weight loss in Sz .\n",
            "Materials and Methods : Community dwelling , obese and overweight Sz patients ( N = @ ) were randomly assigned to either a @ week behavior therapy for weight loss ( BT ) , to usual care ( TAU ) or to @ weeks of behavioural treatment for enhancing social skills ( SST ) .\n",
            "Randomization was stratified by type of antipsychotic medication and initial BMI .\n",
            "This was designed to be a pragmatic trial , hence patients with medical , psychiatric , or substance misuse co-morbidities were not excluded .\n",
            "Both interventions ( BT & SST ) were manualized into a @ session format , to be delivered over @ weeks , by mental health clinicians , who were familiar with running groups for this population .\n",
            "Results : There was mean weight loss in subjects assigned to BT ( -@ lb ) , while the SST patients lost no weight , and those in the TAU group gained weight ( +@ lb ) , at @ weeks .\n",
            "The differences were highly statistically significant ( F @ , @ = @ ; P < @ ) in both intent-to-treat and \" on treatment \" analyses .\n",
            "The effect size of the difference between BT and SST was @-@ and @-@ versus TAU .\n",
            "Fifty percent of patients lost at least @ % of baseline weight and @ % lost at least @ % of baseline weight in the BT group .\n",
            "Conclusions : Obese and overweight Sz patients want to lose weight , and are able to do so when offered group behavioural treatment .\n",
            "The finding shows that this is not a non-specific effect of increased attention and clinician contact .\n",
            "The large effect size also suggests that the treatment effect is robust .\n",
            "These results which were obtained by mental health clinicians , using a manual to conduct group therapy , suggests that it should be possible to implement the treatment in the usual settings of care .\n",
            "We are following subjects who lost weight to see whether treatment benefits can be maintained by subjects , over a two year period .\n",
            "In a multicentre , international , open randomised , long-term study , amisulpride ( AMI ) was compared with haloperidol ( HALO ) .\n",
            "Patients with acute exacerbation of schizophrenia ( DSM III-R ) were treated for @ months .\n",
            "A total of @ patients were exposed to the study drug : @ to AMI and @ to HALO .\n",
            "Flexible doses of @ to @ mg/d ( up to @ mg/d ) were used for AMI and @ to @ mg/d ( up to @ mg/d ) for HALO .\n",
            "At the end of the study , mean daily doses were : @  @ for AMI and @  @ mg for HALO .\n",
            "Completers were @ % in AMI group and @ % in HALO group .\n",
            "The drop-out rate for safety reasons was higher with HALO ( @ % vs @ % ) .\n",
            "Incidences of open reporting of side effects were similar for both compounds .\n",
            "Extrapyramidal side effects were reported at a higher frequency in HALO group ( @ % vs @ % ) .\n",
            "Endocrine events were low for both drugs ( @ % AMI and @ % HALO ) , and weight increase was higher in AMI group ( increase of > @ % from basal weight : AMI @ % and HALO @ % ) .\n",
            "Simpson Angus scale showed statistically significant differences in favour of AMI , either at the endpoint and at the maximal score ( p = @ ) .\n",
            "The difference was also observed with Barnes Akathisia scale at the endpoint ( p < @ ) .\n",
            "Tardive dyskinesia ( AIMS ) was less induced by AMI ( p = @ ) .\n",
            "Prolactin levels were increased with both drugs , but higher levels were obtained with AMI .\n",
            "Neither AMI , nor HALO increased above @ ms the QTc , and only @ patients in AMI group had a QTc increase of at least @ ms compared with baseline .\n",
            "Laboratory parameters did not show relevant differences between two drugs .\n",
            "In conclusion , amisulpride showed similar incidence of adverse events compared with haloperidol but a better neurological side-effect profile .\n",
            "Safety in long-term exposure did not differ from that observed in short-term trials .\n",
            "Introduction : People with serious mental illness ( SMI ) use cannabis more than any other illicit drug .\n",
            "Cannabis use is associated with increased psychotic symptoms and is highly comorbid with alcohol use disorders ( AUDs ) .\n",
            "Despite the national trend toward decriminalization , little is known about the prevalence , correlates , and impact of cannabis use on those with SMI receiving treatment for substance use disorders , a group at high risk for the negative effects of cannabis use .\n",
            "Methods : In this secondary data analysis , cannabis use prevalence , correlates , and impact on treatment outcomes were examined in @ adults with cooccurring SMI and AUDs receiving outpatient addiction treatment in a randomized trial of contingency management ( CM ) for alcohol .\n",
            "Prevalence and frequency of cannabis use were calculated across the @-month study period using self-report and urine tests .\n",
            "Cannabis users were compared with nonusers by SMI diagnosis , psychiatric symptoms , medical problems , legal problems , and HIV-risk behavior .\n",
            "The relationship between cannabis use and longest duration of alcohol abstinence in participants randomized to CM ( n = @ ) was assessed .\n",
            "Results : Fifty-seven ( @ % ) of participants submitted at least one cannabis-positive urine sample during the study .\n",
            "Out of the @ total samples submitted , @ ( @ % ) were positive for cannabis .\n",
            "Cannabis users were @ times more likely to submit an alcohol-positive sample , and @ times more likely to submit a cocaine-positive sample at baseline , relative to noncannabis users ( p = @ ) .\n",
            "Cannabis users were more likely to engage in risky sexual behavior ( p = @ ) and to report being homeless ( p = @ ) than nonusers .\n",
            "When controlling for pretreatment alcohol use , the relationship between comorbid cannabis use and alcohol abstinence during CM was not significant ( p = @ ) .\n",
            "Conclusion : Rates of comorbid cannabis use were high in this sample of adults with SMI and AUDs .\n",
            "Cannabis use was correlated with recent alcohol and cocaine use , risky sexual behavior , and homelessness , but not with alcohol abstinence during CM .\n",
            "Anxiety symptoms are common during the course of schizophrenia .\n",
            "Generalized anxiety symptoms were observed by Kraepelin in @ % of his dementia praecox sample in @ ( Jablensky et al @ ) .\n",
            "The prevalence of comorbid anxiety in patients with schizophrenia is reported to range from @ to @ % .\n",
            "In a @-week , DOUBLE blind study that compared olanzapine to fluphenazine in the treatment of patients with schizophrenia PANSS total score was the primary efficacy variable .\n",
            "In this study , olanzapine was numerically superior to fluphenazine on the PANSS total score , -@ versus -@ , respectively ( p = @ ) ( Jakovljevic et al , @ ) .\n",
            "As a secondary efficacy variable the Hamilton Anxiety Rating Scale ( HAMA ) was also measured .\n",
            "At the @-week endpoint olanzapine had a statistically significantly greater response on the HAMA than fluphenazine ( -@ versus -@ , respectively ; p = @ ) .\n",
            "Additional analyses were completed to determine if there was any correlation between the HAMA response and overall PANSS response .\n",
            "Patients with < = @ % ( non-responsive ) , or who demonstrated a @ % , @ % , or @ % improvement on the HAMA after the first week of olanzapine treatment showed improvement on the PANSS total score at week @ of @ , @ , @ , and @ , respectively .\n",
            "The differences in the long-term antipsychotic effects between olanzapine patients with no early antianxiety effect ( < = @ % ) and antianxiety effects of @ % , @ % and @ % were significant for the @ % and @ % improvement patient group ( p = @ and @ and close to significant for the @ % improvement group @ respectively .\n",
            "There was no predictive value of early antianxiety effect on the @-week antipsychotic effect in the fluphenazine treatment group .\n",
            "Antianxiety effect of olanzapine could be a predictor of the acute antipsychotic effect\n",
            "Objective : Cognitive therapy ( CT ) has been shown to be an efficacious treatment for persistent psychotic symptoms .\n",
            "However , following debate as to transportability , this study aimed to evaluate the effectiveness of CT for psychosis in a community mental health team .\n",
            "Methods : Patients referred for CT for psychosis were allocated to CT or waiting-list ( WL ) / treatment-as-usual .\n",
            "Outcome assessments were performed at WL , pre-CT , post-CT and @-year follow-up .\n",
            "Results : Random effects regression analyses showed significant improvement , attributable to CT , on most outcome measures , with symptomatic improvements maintained at follow-up .\n",
            "Wilcoxon signed ranks tests indicated significant reduction in psychiatric hospital use following CT .\n",
            "Shorter length of illness predicted lower post-CT PANSS scores .\n",
            "This is consistent with suggestion of a critical period for intervention in psychosis and suggests this may be applicable for psychological interventions .\n",
            "The finding that increased severity of symptoms prior to treatment is associated with good outcome suggests that psychotic symptom severity does not contraindicate psychological intervention .\n",
            "Conclusion : These results confirm that CT is an effective treatment for psychosis that is generalizable to community setting and in keeping with initiatives of early intervention .\n",
            "\" We have developed a novel therapy based on a computer program , which enables the patient to create an avatar of the entity , human or non-human , which they believe is persecuting them .\n",
            "The therapist encourages the patient to enter into a dialogue with their avatar , and is able to use the program to change the avatar so that it comes under the patient 's control over the course of six @-min sessions and alters from being abusive to becoming friendly and supportive .\n",
            "The therapy was evaluated in a randomised controlled trial with a partial crossover design .\n",
            "One group went straight into the therapy arm : \" \" immediate therapy \" \" .\n",
            "The other continued with standard clinical care for @ weeks then crossed over into Avatar therapy : \" \" delayed therapy \" \" .\n",
            "There was a significant reduction in the frequency and intensity of the voices and in their omnipotence and malevolence .\n",
            "Several individuals had a dramatic response , their voices ceasing completely after a few sessions of the therapy .\n",
            "The average effect size of the therapy was @ .\n",
            "We discuss the possible psychological mechanisms for the success of Avatar therapy and the implications for the origins of persecutory voices . \"\n",
            "Background : Recent evidence @ @ suggests that certain atypical antipsychotics are associated with metabolic adverse events such as weight gain and dyslipidemia .\n",
            "These adverse events may contribute to increased risk of cardiovascular disease .\n",
            "The STAR naturalistic trial provides the opportunity for a comparison of metabolic adverse events between aripiprazole and SOC treated patients .\n",
            "Methods : A total of @ patients were equally randomized to open-label treatment of aripiprazole @-@ mg day or Standard of Care SOC olanzapine @ @ mg day or quetiapine @ @ mg day or risperidone @ @ mg day Clinicians were free to select the Standard of Care agent most appropriate for the patient a switch was however mandatory .\n",
            "Changes from baseline to Week @ LOCF in levels of total HDL LDL cholesterol triglycerides glucose and weight were analyzed using ANCOVA including treatment fasting status and baseline value .\n",
            "Results : At Week @ a statistically significant larger mean decreases from baseline was observed in the aripiprazole group @ .\n",
            "@ mg dL vs. the SOC group @ .\n",
            "@ mg dL p @ ; @ ) .\n",
            "HDL-C rose by @ mg/dl among aripipiprazole patients and @ md/dl among SOC ( p = @ ) .\n",
            "Triglycerides decreased by @ mg/dl and @ mg/dl for aripiprazole and SOC respectively ( p @ ; @ ) .\n",
            "LDL-C decreased by @ mg/dl and @ mg/dl for aripipiprazole and SOC respectively ( p @ ; @ ) .\n",
            "Body weight decreased by @ kg among aripiprazole patients and increased by @ kg among SOC patients ( p @ , and @ ) .\n",
            "Glucose changes were not significantly different ( @ mg/dl for aripiprazole versus @ mg/dl for SOC , p@ .@ ) .\n",
            "Conclusion : Patients treated with aripiprazole experienced greater improvement versus SOC in the metabolic profile .\n",
            "This may correspond to clinically relevant reductions in subsequent diabetes and cardiovascular risk .\n",
            "hronic schizophrenia was treated byHD and penfluridol and assessed with stan-dardized mental illness assessment scale ( briefly called Wufen scalel ) and TESS .\n",
            "The result showed the curative effect of IIDwas closed to that of penfluridol .\n",
            "Theycould both control hallucinations , delusionsand other mental symptoms of chronicschizophrenic patients , develop their self-care ability and delay their regression .\n",
            "Theincident frequency of EPS in penfluridolgroup was little higher than IID group .\n",
            "andthey were both not\n",
            "The stability of parental expressed emotion ( EE ) is analysed over about @ years , and related to course of illness in patients with recent-onset schizophrenia .\n",
            "Families , who participated in a @-month intervention , were randomised over two intervention conditions .\n",
            "Psychotic episodes were measured over @ years after discharge .\n",
            "The Five Minute Speech Sample ( FMSS ) EE was elicited two times during the @-month outpatient intervention and two times over @ years after discharge on average .\n",
            "EE is expressed as criticism/dissatisfaction ( CRIT ) , emotional overinvolvement ( EOI ) , and as the classical dichotomous index .\n",
            "EE is not stable over the years .\n",
            "Intervention condition had no differential effect on EE as measured with CRIT and the dichotomous index .\n",
            "For EOI , an interaction between intervention condition and time was found .\n",
            "EE as assessed during intervention does not predict psychotic episodes during follow-up .\n",
            "An association was found between psychotic episodes and CRIT as assessed at @ months after discharge .\n",
            "Family intervention may inhibit the development of high EOI for a limited period .\n",
            "Our results may be in support of the hypothesis that psychotic episodes in patients can affect the critical attitude in parents .\n",
            "Objective : To evaluate the clinical , biological and cognitive effects of transcranial Direct Current Stimulation ( tDCS ) applied over the left prefrontal and the left temporoparietal cortex in patients with schizophrenia .\n",
            "Methods : In a first randomized controlled clinical study , we evaluated the effects of ten sessions of active ( @ mA , @ min ) or sham tDCS with the anode placed over the left prefrontal cortex and the cathode placed over the left temporoparietal cortex on auditory verbal hallucinations and symptoms severity in @ patients with treatment resistant symptoms .\n",
            "@ patients were included in a cognitive study evaluating the effects of tDCS on self-monitoring performance .\n",
            "@ patients were included in a resting-state fMRI study evaluating the effect of @ sessions of tDCS on temporoparietal functional connectivity .\n",
            "In two crossover studies , we evaluated the effects of a single session of active and sham tDCS applied over either the left prefrontal or the left temporoparietal cortex in @ healthy volunteers .\n",
            "Results : We reported a @ % reduction in auditory verbal hallucinations and a @ % reduction in general symptoms after active tDCS in patients with schizophrenia .\n",
            "The reduction in auditory verbal hallucinations correlated with a decrease of functional connectivity between the left temporoparietal junction and the left insula and with an increase in self-monitoring performance in patients .\n",
            "Conversely , we reported that a single session of anodal tDCS applied over the left temporoparietal cortex impairs self-monitoring performance in healthy volunteers .\n",
            "Conclusion : Fronto-temporal tDCS is a useful tool to alleviate auditory verbal hallucinations and improve self-monitoring performance in patients with schizophrenia .\n",
            "These improvements may be underlied by a modulation of the functional connectivity of the left temporoparietal cortex .\n",
            "Educational objective - At the conclusion of this session , the participant should be able to use antipsychotics effectively .\n",
            "SUMMARY : PURPOSE : To investigate the drug interactions between aripiprazole and haloperidol including the comparisons of plasma concentration of haloperidol and aripiprazole as genotypes of CYP@D@ and @A@ .\n",
            "METHODS : Fifty six patients with a confirmed DSM-IV diagnosis of schizophrenia were enrolled in this eight-week , double blind , placebo-controlled study .\n",
            "Twenty-eight patients received adjunctive aripiprazole treatment and twenty-eight patients received placebo while being maintained on haloperidol treatment .\n",
            "Aripiprazole was dosed at @mg/day for the first @ weeks then @ mg for next @ weeks .\n",
            "The haloperidol dose remained fixed throughout the study .\n",
            "Serum haloperidol and aripiprazole levels were measured by high-performance liquid chromatography  tandem mass spectrometry ( LC-MS/MS ) at the baseline , week , @ , @ and @ .\n",
            "* , * @ , and * @B alleles of CYP@D@ and * and * @ alleles of CYP@A@ were determined .\n",
            "The Student s T-test , Pearson s Chisquare test , Wilcoxon Rank Sum test and Logistic Regression analysis were used for data analysis .\n",
            "All tests were two-tailed and significance was defined as an alpha < @ .\n",
            "RESULTS : In the frequency of CYP@D@ genotype , * / * @B type was a most frequent ( @ % ) and * / * ( @ % ) , * @B / * @B ( @ % ) types were followed .\n",
            "In the frequency of CYP@A@ genotype , * @ / * @ type was found in @ % of subjects , and * / * @ type and * / * were @ % and @ % respectively .\n",
            "Plasma level of haloperidol and its metabolites did not demonstrate significant time effects and time-group interactions after adjunctive treatment of aripiprazole .\n",
            "Plasma levels of aripiprazole at week @ was significantly higher than those at week @ ( p = @ ) .\n",
            "The concentration of haloperidol and aripiprazole were not significantly different among genotypes of CYP@D@ and @A@ .\n",
            "No serious adverse event was found affter adding aripiprazole on haloperidol .\n",
            "CONCLUSIONS : Genotypes of CYP@D@ and @A@ did not affect concentration of both haloperidol and aripiprazole .\n",
            "Background Psychiatry inpatients frequently have co-occurring substance use and mental health disorders , which are related to poor post-discharge outcomes .\n",
            "Telephone monitoring is effective in specialty substance use disorder treatment settings in increasing continuing care and @-step program utilization and improving substance use outcomes .\n",
            "This study examined the effectiveness of telephone monitoring among psychiatry inpatients with co-occurring substance use and mental health disorders .\n",
            "Methods This randomized controlled trial ( n = @ ) compared usual care to usual care plus telephone monitoring ( one in-person session during the inpatient stay , followed by weekly telephone contact for three months post-discharge ) .\n",
            "Follow-ups were conducted at end-of-intervention ( three months post-baseline ) and nine and @ months post-baseline ( @ % followed ) .\n",
            "Primary outcomes were number of days out of the past @ of drinking alcohol , using drugs , and experiencing psychological problems .\n",
            "Secondary outcomes were outpatient substance use treatment , and @-step group , utilization .\n",
            "Results Longitudinal modeling found that patients in both conditions improved over time on each primary outcome .\n",
            "Improvement was comparable between conditions on alcohol and drug use and psychological problems .\n",
            "Receipt of outpatient treatment decreased over the follow-up period and was not related to condition .\n",
            "Likelihood of attending @-step group meetings did not change over follow-ups , and was not related to condition .\n",
            "Conclusions Improvement over time was evident regardless of condition assignment .\n",
            "Patients maintained attendance at @-step groups from pre - to post-discharge .\n",
            "Short-term telephone monitoring in addition to usual care for patients with co-occurring substance use and mental health disorders may not be sufficiently intensive to achieve additional improvements on outcomes .\n",
            "Objective : To evaluate the efficacy and safety of high dose transcranial magnetic stimulation ( rTMS ) in patients with schizophrenia with refractory negative symptoms .\n",
            "Methods : From January @ to April @ at our institute , @ hospitalized patients of schizophrenia , according to the diagnostic criteria of Diagnostic and Statistical Manual of Mental Disorders-@th Edition ( DSM-IV ) , aged from @ to @ were randomly divided into study group ( n = @ ) and control group ( n = @ ) .\n",
            "Both kinds and dosages of antipsychotics were preserved as before .\n",
            "All patients were treated with @ Hz rTMS .\n",
            "rTMS was delivered to the left dorsolateral prefrontal cortex ( DLPFC ) with a figure-eight solid core coil at @ % motor threshold , @ times daily for @ days within @ weeks .\n",
            "Sham stimulation was used in control group .\n",
            "In both groups , Positive and Negative Syndrome Scale ( PANSS ) and Treatment Emergent Symptom Scale ( TESS ) were used to evaluate the efficacy and safety before treatment , at week @ and week @ , and subjective visual analogue scale ( VAS ) score was checked after each rTMS session .\n",
            "PANSS was performed @ times at follow up visits of week @ , week @ and week @ .\n",
            "Results : Compared with before treatment , the total score of PANSS and the score of negative symptoms at week @ declined in study group ( q = @ .\n",
            "@ , @ .\n",
            "@ , P < @ .\n",
            "@ ) , especially the factors of blunted affect , emotional withdrawal and passive/apathetic social withdrawal ( q = @ .\n",
            "@ , @ .\n",
            "@ , @ .\n",
            "@ , P < @ .\n",
            "@ ) .\n",
            "At the follow-up of week @ , week @ and week @ after treatment , none of the above factors got significant changes in study group ( P > @ .\n",
            "@ ) .\n",
            "After @ weeks ' treatment , the effective rates were @ .\n",
            "@ % and @ .\n",
            "@ % in study group and control group , respectively , and there was a significant difference between two groups ( x <sup> @ </sup> = @ .\n",
            "@ , P = @ .\n",
            "@ ) .\n",
            "The incidence of headache in study group was higher than that in control group ( @ .\n",
            "@ % vs @ .\n",
            "@ % , x <sup> @ </sup> = @ .\n",
            "@ , P = @ .\n",
            "@ ) .\n",
            "The highest score of pain was ( @ + / - @ ) in study group , which occurred after the first rTMS treatment .\n",
            "Along with the treatment , the score gradually became lower , and the lowest was ( @ + / -@ ) after @ <sup> th </sup> treatment .\n",
            "Conclusion : Among schizophrenia patients with refractory negative symptoms , @ Hz rTMS applied @ times daily within @ weeks is effective and safe , especially , may improve blunted affect , emotional withdrawal and passive/apathetic social withdrawal .\n",
            "Objective The aim of this study was to examine the the effectiveness of psycho-education delivered via a printed booklet for Schizophrenia patients and their primary caregivers ' in Jordan .\n",
            "It was hypothesised that treatment as usual and psycho-education delivered by a booklet would improve patients ' and primary caregivers ' knowledge of schizophrenia , improve patients ' positive and negative symptoms and reduce their relapse rates , and improve primary caregivers ' burden of care and quality of life better than treatment as usual alone .\n",
            "Method A single blind parallel randomized controlled trial was conducted between September @ and September @ at four mental outpatient clinics in Amman , Jordan .\n",
            "@ patients with their primary caregivers were allocated randomly to an experimental ( Psycho-educational intervention plus TAU in outpatient clinic ) group ( n = @ ) or control ( TAU alone ) group ( n = @ ) .\n",
            "Outcomes , measured prior randomization ( pre-test ) , immediately post-intervention and at three months after intervention were patients and primary caregivers ' knowledge of schizophrenia , patients ' positive and negative symptoms and relapse rates , primary caregivers burden of care and quality of life .\n",
            "Results Participants receiving psycho-education and treatment as usual had better knowledge of schizophrenia at both post-tests , reduced positive and negative symptoms at post-test @ and further reduction at post-test @ compared with participants in control group .\n",
            "Patients hospitalisation and caregivers outcomes had reduced burden of care and better quality of life ( P < @ , all outcomes ) .\n",
            "Conclusion Psycho-education delivered via printed booklets improves outcomes patients and their primary caregivers in Jordan better than treatment as usual .\n",
            "Our hypothesis is supported .\n",
            "Objective : This study was designed to test the practical utility of haloperidol plasma level determinations in the management of schizophrenic patients who show poor initial responses to haloperidol .\n",
            "Method : Inpatients with acute exacerbations of DSM-III schizophrenia ( N = @ ) were randomly assigned to receive fixed haloperidol doses intended to achieve plasma levels of @-@ ng/ml or of @-@ ng/ml .\n",
            "Patients whose scores on the Brief Psychiatric Rating Scale ( BPRS ) failed to improve by at least @ % at the end of @ weeks were then subject to dose reassignment .\n",
            "Results : Among the patients who completed the first phase of the protocol , @ bad steady-state haloperidol plasma levels of less than @ ng/ml , and @ had levels that exceeded @ ng/ml ; @ bad intermediate plasma levels of @-@ ng/ml .\n",
            "A survival analysis of time to @ % improvement significantly favored the two lower plasma level groups , although side effect ratings did not differ .\n",
            "Of the @ patients whose BPRS scores failed to improve by @ % after @ weeks , @ and five were randomly assigned to receive lower and higher doses , respectively .\n",
            "Those whose dose was lowered experienced significantly more improvement in the subsequent weeks than did those whose dose was increased .\n",
            "Conclusions : Haloperidol plasma levels that substantially exceed @ ng/ml may be countertherapeutic .\n",
            "In particular , increases in dose beyond this level are not efficacious for patients who have not responded to lower doses .\n",
            "Background : Transcranial direct current stimulation ( tDCS ) has been reported to improve cognition and symptoms in schizophrenia .\n",
            "The brain mechanisms underlying these effects have not been systematically explored .\n",
            "We report a doubleblind study which measured effects of tDCS on cognition , symptoms , and brain activation in schizophrenia .\n",
            "Methods : @ Chinese schizophrenics were randomized to receive @ sessions of Active or Sham tDCS .\n",
            "Cognition was evaluated with the MATRICS ( MCCB ) , Paced Auditory Serial Addition Task and CogState .\n",
            "Psychiatric symptoms were evaluated with PANSS .\n",
            "Brain function were evaluated with fMRI at baseline and after @ tDCS sessions for resting state changes in brain activation .\n",
            "Results : There were no strong effects ( P < .@ ) of Active vs Sham tDCS on cognition , but there were significant ( P < .@ ) effects on differences in brain activation assessed by fMRI .\n",
            "On MCCB , there were trends ( P = .@ ) for Active tDCS vs. Sham tDCS to improve Speed of Processing .\n",
            "There were no effects of active vs sham tDCS on psychiatric symptoms .\n",
            "There were significant differences between active vs sham tDCS on resting state activation in several brain areas including middle frontal gyrus , superior frontal gyrus and superior and inferior parietal gyrus ; active tDCS increased and sham tDCS decreased activation .\n",
            "There were significant relationships between changes in several MCCB scores and changes in brain activation in specific areas .\n",
            "Conclusions : tDCS had significant effects on resting state brain activation which were significantly related to changes in MCCB .\n",
            "However , in this sample @ sessions of active vs sham tDCS did not show marked effects on overall cognitive function .\n",
            "With the emergence of second generation antipsychotic medications came the hypothesis that these new medications could improve the cognitive dysfunction associated with schizophrenia .\n",
            "Although initial reports were promising , subsequent studies raised doubts about the potential of atypical antipsychotics to improve cognitive function .\n",
            "In this study , patients with schizophrenia or schizoaffective disorder who had been stable on a conventional antipsychotic for at least one month , were randomized , double-blind , to either haloperidol or quetiapine .\n",
            "Dosing was flexible based on a medication algorithm from @-@mg / day of haloperidol or @-@mg / day of quetiapine , in order to find the optimal dose of medication for each subject .\n",
            "Subjects were given a battery of cognitive tests at baseline and @ weeks , including measures of attention , memory , and executive function .\n",
            "The measures of attention included a computerized continuous performance test and trail-making .\n",
            "Measures of memory included list learning , paragraph recall , and letter-number sequencing , a measure of working memory .\n",
            "Measures of executive functioning included a card sorting task and verbal fluency .\n",
            "Additional testing consisted of the Positive and Negative Syndrome Scale ( PANSS ) and measures of common side effects associated with antipsychotic medications .\n",
            "Subjects were all veterans being treated for chronic psychiatric symptoms related to schizophrenia or schizoaffective disorder .\n",
            "Average age was @ years and average number of years since first diagnosis was @ .\n",
            "Neither the haloperidol group ( N = @ ) nor the quetiapine group ( N = @ ) demonstrated any significant improvements on the battery of cognitive tests between baseline and @ weeks .\n",
            "Both groups had modest improvements on the PANSS ; the haloperidol group showed significant improvements on the positive subscale ( p &lt; .@ ) and the quetiapine group showed significant improvements on the general psychopathology subscale ( p = .@ ) .\n",
            "The quetiapine group showed additional improvements on a measure of akathisia ( p &lt; .@ ) .\n",
            "The results support the conclusion that quetiapine does not improve cognitive function in schizophrenia .\n",
            "However , the significant chronicity of this sample may make the population tested less able to experience improvements in cognitive domains .\n",
            "In conclusion , while quetiapine may be able to improve psychiatric symptoms without the same risk of side effects as haloperidol , it did not improve cognition in this sample .\n",
            "BACKGROUND : There is a clear need for effective interventions to reduce cannabis use in patients with first-episode psychosis .\n",
            "This follow-up of a randomized trial examined whether an intervention for parents , based on motivational interviewing and interaction skills ( Family Motivational Intervention , FMI ) , was more effective than routine family support ( RFS ) in reducing cannabis use in patients with recent-onset schizophrenia .\n",
            "METHOD : In a single-blind trial with @ patients in treatment for recent-onset schizophrenia , @ parents were randomly assigned to either FMI or RFS .\n",
            "Assessments were conducted at baseline and at @ and @ months after the interventions had been ended .\n",
            "Analyses were performed on an intention-to-treat basis using mixed-effect regression models .\n",
            "RESULTS : From baseline to the @-month follow-up , there was a significantly greater reduction in FMI compared to RFS in patients ' quantity ( p = @ ) and frequency ( p < @ ) of cannabis use .\n",
            "Patients ' craving for cannabis use was also significantly lower in FMI at @ months follow-up ( p < @ ) .\n",
            "Both groups improved in parental distress and sense of burden ; however , only FMI parents ' appraisal of patients ' symptoms showed further improvement at the @-month follow-up ( p < @ ) .\n",
            "CONCLUSIONS : The results support the sustained effectiveness of FMI in reducing cannabis use in patients with recent-onset schizophrenia at @ months follow-up .\n",
            "Findings were not consistent with regard to the long-term superiority of FMI over RFS in reducing parents ' distress and sense of burden .\n",
            "Examined the reaction of @ schizophrenic patients ( aged @-@ yrs ) to a change from a @-wk regimen of perphenazine enantate ( PE ) to a @ - wk regimen of haloperidol decanoate ( HD ) during a @-wk double-blind crossover study .\n",
            "There were no significant differences in efficacy or side-effects between the @ drug regimens .\n",
            "Ss well-adjusted to a regimen of PE every @ wks may be transferred to HD every @ wks ; the longer period between injections may result in reduced health care costs .\n",
            "Background : Neurosteroids are endogenous molecules synthesized de novo in brain , adrenals , and other tissues .\n",
            "They demonstrate pleiotropic actions that are highly relevant to the neurobiology of schizophrenia .\n",
            "Clozapine markedly elevates neurosteroids in rodent hippocampus , potentially contributing to its superior therapeutic effcacy .\n",
            "Clinical evidence from a randomized controlled trial ( RCT ) conducted in Singapore suggests that pregnenolone signifcantly enhances functional capacity ( as demonstrated by improvements in the UPSA Total Score and UPSA Communication Subscale Score ) and that neurosteroid changes posttreatment predict therapeutic response ( Marx et al @ ; Psychopharmacology ) .\n",
            "We thus conducted an RCT investigating adjunctive pregnenolone in schizophrenia .\n",
            "Methods : After a @-week placebo lead-in , @ participants with schizophrenia were randomized to pregnenolone ( n = @ ) or placebo ( n = @ ) for @ weeks .\n",
            "Neurosteroids were quantifed at baseline and posttreatment by mass spectrometry .\n",
            "Functional end points included the UPSA Total Score and UPSA Communication Subscale .\n",
            "Cognitive end points included the MCCB Composite Score and MCCB Subscales .\n",
            "Modifed intent-to-treat analyses were conducted .\n",
            "Results : Participants randomized to the pregnenolone group did not out-perform placebo on the UPSA Total Score or MCCB Composite Score .\n",
            "However , the pregnenolone group demonstrated signifcantly greater improvement in the UPSA Communication Subscale compared to participants randomized to placebo ( P = .@ ) , replicating prior RCT fndings from Singapore .\n",
            "Elevations in pregnenolone post-treatment also predicted improvements in UPSA Total Score ( r = .@ ; P = .@ ) , again replicating prior efforts .\n",
            "In addition , the pregnenolone group demonstrated sig-nifcantly greater improvement in the MCCB Verbal Learning Subscale compared to placebo ( P = .@ ) .\n",
            "Pregnenolone did not outperform placebo in the BACS Composite Score , SANS Total Score , or PANSS Total Score .\n",
            "Pregnenolone was well tolerated .\n",
            "Conclusion : Treatment with pregnenolone appears to improve functional capacity in a US population with schizophrenia , as assessed by the UPSA Communication Subscale and also supported by a signifcant positive correlation between pregnenolone changes and UPSA Total Score improve-ments-thus replicating fndings from a prior RCT conducted in Singapore .\n",
            "Pregnenolone may also improve verbal memory .\n",
            "Given the positive correlation between pregnenolone increases posttreatment and UPSA Total Score improvements , it is possible that higher doses of pregnenolone may be clinically effcacious , and that neurosteroid quantifcation has biomarker potential for the predication of therapeutic response .\n",
            "Additional dose-fnd-ing investigations will be required to test these hypotheses .\n",
            "A pregnenolone decanoate formulation is currently in preclinical development .\n",
            "Background : We examined predictors of outcome after @ months of treatment for a first episode of schizophrenia .\n",
            "Method : @ subjects ( @ % male ; mean age @ years ) with first-episode schizophrenia , schizophreniform disorder or schizoaffective disorder were randomly assigned to olanzapine ( @ to @ mg daily ) or risperidone ( @ to @ mg daily ) .\n",
            "Response criteria required ratings on @ consecutive visits of mild or better on the SADS-C + PD psychosis items plus a rating of much or very much improved on the CGI .\n",
            "Potential predictors examined were : sex ; age ; education ; social class ; premorbid social functioning ; duration of psychiatric symptoms ; duration of untreated psychosis ( DUP ) ; baseline positive , negative and depressive symptoms ; alcohol , marijuana or other substance use before study entry and during treatment ; motor side effects ( Parkinsonism , EPS , akathisia ) during treatment .\n",
            "Results : @ % ( @ % CI : @ % , @ % ) of patients met response criteria and among those @ % ( @ % CI : @ % , @ % ) failed to maintain their response .\n",
            "In univariate analyses , poor premorbid social functioning , longer DUP , alcohol use before study entry and EPS during treatment were significantly ( p < @ ) associated with less likelihood of response .\n",
            "In a multivariate model including sex and medication assignment as factors , alcohol use ( p < @ ) and EPS ( p < @ ) remained significant predictors of response but DUP ( p < @ ) and premorbid functioning ( p < @ ) did not .\n",
            "In univariate analyses , alcohol use and marijuana use during treatment were significantly associated with failure to maintain response ; poor premorbid social functioning was associated with response instability but the difference was not significant ( p < @ ) .\n",
            "Alcohol and marijuana use during treatment were highly correlated , thus we used a composite measure for our multivariate model .\n",
            "In this model that included sex and medication assignment , both the composite substance use measure ( p < @ ) and poor premorbid social functioning ( p < @ ) were significant predictors of response instability .\n",
            "Discussion : Our finding that substance use occurring before or during the trial affected outcome emphasizes the negative impact of substance use on the outcome of first episode schizophrenia .\n",
            "Our finding that poor premorbid social adjustment is associated with short-term response instability complements data from a previous study that poor premorbid social adjustment is associated with higher relapse risk over the first @ years of illness .\n",
            "This presentation will discuss the first year outcomes from a @-year Centre for Mental Health Services funded research demonstration project that is a joint collaboration between consumers , researchers and state government .\n",
            "@ persons with major mental illness participating in a randomised trial are receiving mental health services from one of three conditions - a ) a consumer-staffed Assertive Community Treatment ( ACT ) team b ) a non-consumer staffed ACT team or c ) traditional community mental health programmes .\n",
            "Data is collected through client and case manager interviews every six months .\n",
            "Some of the client outcomes being measured are ( a ) quality of life ; ( b ) consumer empowerment ; c ) utilisation of mental health services ; ( d ) satisfaction with services ; ( e ) housing and employment status ; ( f ) hospital and emergency room usage ; ( g ) symptomatology ; ( h ) arrests and victimisation ; ( i ) substance use as well as other psychosocial variables .\n",
            "Potential explanatory variables such as the therapeutic alliance and service co-ordination are also being measured .\n",
            "The presentation will also explore the differential effectiveness of the ACT model for different diagnoses , particularly Schizophrenia , Unipolar Depression , and Bipolar Disorder .\n",
            "OBJECTIVE : Self-esteem is widely used as an outcome variable in studies of psychiatric rehabilitation , based on the assumption that improved functional status leads to higher self-esteem .\n",
            "Little is known , however , about the determinants of self-esteem among adults with severe mental illness .\n",
            "The utility of a popular measure of global self-esteem-the Rosenberg Self-Esteem Scale-as an outcome measure was examined in this population .\n",
            "METHODS : A total of @ participants enrolled in a study of vocational rehabilitation were assessed at baseline and six , @ , and @ months later using measures of self-esteem , symptoms , life satisfaction , work status , housing status , and total income .\n",
            "RESULTS : Scores on the Rosenberg Self-Esteem Scale did not vary with work status or other functional outcomes but instead were strongly related to measures of life satisfaction and affective symptoms .\n",
            "CONCLUSIONS : The hypothesis that working leads to improved self-esteem for people with severe mental illness was not supported .\n",
            "For this population , self-esteem , as measured by the Rosenberg Self-Esteem Scale , appears to be a relatively stable trait that reflects general life satisfaction and affective symptoms rather than objective functional status .\n",
            "The effects of d-amphetamine ( @ mg/kg orally ) on regional cerebral glucose utilization were measured with positron emission tomography ( PET ) in @ schizophrenics ( along with a placebo-control group of an additional six schizophrenic patients ) .\n",
            "The acute d - amphetamine challenge tended to decrease glucose utilization throughout much of the brain , with a regional effect that was statistically significant in the left temporal cortex .\n",
            "There was no apparent relationship between the effects of amphetamine-induced changes in regional cerebral metabolism and psychotic symptom exacerbation .\n",
            "An exploratory analysis suggested that features characteristic of Crow 's type II syndrome were significant predictors of cerebral hyporesponsivity to stimulant challenge , however .\n",
            "Background : Non-adherence to antipsychotics is often problematic , particularly among patients with psychotic disorders and co-morbid substance abuse .\n",
            "In a pilot-study , our study-group investigated the feasibility and possible effects of providing financial incentives for acceptance of antipsychotic depot-medication : Money for Medication .\n",
            "Aim : In a randomized controlled trial we will more thoroughly assess both the effectiveness and side-effects of Money for Medication .\n",
            "The primary aim is to improve adherence to antipsychotics in patients with psychotic disorders and substance abuse .\n",
            "Methods : @ patients will be randomly assigned to the Money for Medication group ( n = @ ) or the control group ( n = @ ) during @ months .\n",
            "The latter will receive treatment as usual without financial rewards .\n",
            "Effects of discontinuing the intervention will be monitored during @ months follow-up .\n",
            "Outcome measures include : depot acceptance ( during and after the intervention , the longest period of uninterrupted depot acceptance , time expired before the depot is taken , effort of clinicians , attitudes towards medication and intervention ) , psychosocial functioning ( including number and days of admissions , symptomatology , substance use , sideeffects , and quality of life ) , and cost-utility .\n",
            "Results : Pilot-study ( n = @ ) .\n",
            "In the year financial rewards were offered , the percentage accepted depots of @ patients increased from @ % to @ % .\n",
            "While patients were hospitalized for an average of @ days in the previous year , only @ was re-admitted for @ days during the intervention-year .\n",
            "Conclusion : Our pilot-study revealed a large effect of Money for Medication on medication acceptance and hospitalizations .\n",
            "A randomized controlled trial is currently being executed to further assess the effectiveness of this intervention .\n",
            "There is a shortage of research on the psychosocial treatment of negative symptoms in schizophrenia .\n",
            "Negative symptoms are associated with profound functional impairments including social isolation , unemployment , cognitive dysfunction , and family distress .\n",
            "Multifamily Group Treatment ( MFG ) , perhaps more than other psychosocial interventions for schizophrenia , is well-suited to treat the negative symptoms .\n",
            "MFG provides schizophrenia patients and caregivers with social support , teaches active strategies of coping , and is considered a ' best practice ' for the treatment of schizophrenia by the American Psychiatric Association .\n",
            "The current study was a @-year randomized clinical trial that examined the effectiveness of MFG compared with Standard Care ( SC ) on negative symptoms .\n",
            "Results revealed that , among year @ treatment completers , MFG was more effective than SC at managing negative symptoms , particularly avolition-apathy and anhedonia-asociality .\n",
            "At the @-month follow-up , although MFG patients had less severe negative symptom than SC patients , differences were no longer evident .\n",
            "Cognitive impairment is a core feature of schizophrenia .\n",
            "Previous studies have indicated that exposure to neurotropic infectious agents such as Herpes Simplex Virus type @ may contribute to cognitive deficits and neuroanatomical abnormalities in individuals with schizophrenia .\n",
            "We examined the association between exposure to neurotropic infectious agents and cognitive function in @ participants in the Clinical Antipsychotic Trials of Intervention Effectiveness ( CATIE ) trial .\n",
            "This sample included all of the individuals in the CATIE trial for whom baseline blood samples were available .\n",
            "Cognition was evaluated at baseline by a test battery which yielded composite scores in the domains of processing speed , verbal memory , vigilance , reasoning , and working memory as well as a summary neurocognitive score .\n",
            "Solid phase immunoassay techniques were used to measure IgG class antibodies to Herpes Simplex Virus type @ ( HSV-@ ) , Herpes Simplex Virus type @ ( HSV-@ ) , Cytomegalovirus ( CMV ) , and to Toxoplasma gondii ( T gondii ) in the sera of the study individuals .\n",
            "We found a significant association between the neurocognitive summary score and antibodies to HSV-@ but not to HSV-@ , CMV , or T. gondii .\n",
            "There was also a significant association between HSV-@ exposure and the Verbal Memory , Vigilance , and Processing Speed composite scores .\n",
            "HSV-@ may modulate the neurocognitive function of individuals with schizophrenia through its ability to establish latency in the central nervous system and undergo periodic reactivation .\n",
            "A better understanding of the role of HSV-@ may lead to better methods of treatment for the cognitive impairments associated with schizophrenia .\n",
            "( C ) @ Elsevier B.V. All rights reserved .\n",
            "Shuxuening merge the treatment of chronic schizophrenic double-blind study Zhang Gang , Du Xiwen , stone Admiralty Xiuying Liu Chi Chang Zhijie Ma Dongfang Chenke Zheng Wang Shiqiang Li Deen of @ November @ , collected to meet the diagnostic criteria of CCMD-@-R schizophrenia hospitalized @ patients symptoms with predominantly negative symptoms , at least three years of complete remission , the disease did not change nearly March , BPRS > @ , there was no serious somatic disorders are taking a certain dose of antipsychotics .\n",
            "@ patients were equally divided into two groups , one group received service Shuxuening the ( Shuxuening group ) @ mg , @ times a day , a week later @ mg , @ times a day ; @ males and @ females , aged @ to @ years old ( mean @  @ years ) , duration of @ to @ years ( mean @  @ years ) .\n",
            "Conducted an @-mo double blind , placebo-controlled study comparing fluphenazine decanoate ( FLU ) with haloperidol decanoate ( HAL ) in @ schizophrenic outpatients ( aged @-@ yrs ) on long-term FLU maintenance treatment .\n",
            "A parallel groups design was used , with stratification by sex and injection interval ( @ , @ , or @ wks ) .\n",
            "There were no significant differences in therapeutic effect between the drugs .\n",
            "Both HAL and FLU had a similar profile for drug-induced parkinsonism , but there was a trend for differences in masking tardive dyskinesia .\n",
            "HAL and prolactin plasma concentrations were well correlated with dosage , with the exception of HAL concentrations in Ss receiving injections at @-wk intervals .\n",
            "AIM : To investigate whether differential influence on the QTc interval exists among four second generation antipsychotics ( SGAs ) in psychosis .\n",
            "METHODS : Data were drawn from a pragmatic , randomized head-to-head trial of the SGAs risperidone , olanzapine , quetiapine , and ziprasidone in acute admissions patients with psychosis , and with follow-up visits at discharge or maximally @-@ wk , @ , @ , @ and @ mo .\n",
            "Electrocardiograms were recorded on all visits .\n",
            "To mimic clinical shared decision-making , the patients were randomized not to a single drug , but to a sequence of the SGAs under investigation .\n",
            "The first drug in the sequence defined the randomization group , but the patient and/or clinician could choose an SGA later in the sequence if prior negative experiences with the first one ( s ) in the sequence had occurred .\n",
            "The study focuses on the time of , and actual use of the SGAs under investigation , that is until treatment discontinuation or change , in order to capture the direct medication effects on the QTc interval .\n",
            "Secondary intention-to-treat ( ITT ) analyses were also performed .\n",
            "RESULTS : A total of @ patients , with even distribution among the treatment groups , underwent ECG assessments .\n",
            "About @ % were males and @ % had never used antipsychotic drugs before the study .\n",
            "The mean antipsychotic doses in milligrams per day with standard deviations ( SD ) were @ ( @ ) for risperidone , @ ( @ ) for olanzapine , @ ( @ ) for quetiapine , and @ ( @ ) for ziprasidone treated groups .\n",
            "The time until discontinuation of the antipsychotic drug used did not differ in a statistically significant way among the groups ( Log-Rank test : P = @ ) .\n",
            "The maximum QTc interval recorded during follow-up was @ ms. Based on linear mixed effects analyses , the QTc interval change per day with standard error was -@ ( @ ) for risperidone ; -@ ( @ ) for olanzapine ; -@ ( @ ) for quetiapine , and -@ ( @ ) for ziprasidone .\n",
            "There were no statistically significant differences among the groups in this regard .\n",
            "LME analyses based on ITT groups ( the randomization groups ) , revealed almost identical slopes with -@ ( @ ) for risperidone , -@ ( @ ) for olanzapine , -@ ( @ ) for quetiapine , and -@ ( @ ) for ziprasidone .\n",
            "CONCLUSION : None of the SGAs under investigation led to statistically significant QTc prolongation .\n",
            "No statistically significant differences among the SGAs were found .\n",
            "Weight gain represents a frequent side effect of antipsychotic drug treatment .\n",
            "The current trial investigated the effect of add-on treatment with sibutramine in schizophrenia outpatients who had gained more than @ % of weight during the course of treatment .\n",
            "This @-week placebo-controlled study evaluated the effects of sibutramine added to ongoing antipsychotic treatment .\n",
            "Weight , waist-hip ratio , BMI , blood pressure/pulse and ECG were monitored regularly .\n",
            "In addition , several laboratory tests were performed .\n",
            "Psychopathological symptoms and side effects were assessed frequently .\n",
            "Fifteen patients were assigned randomly to add-on treatment with sibutramine @ mg or placebo .\n",
            "The two groups did not differ in weight , sociodemographic , or clinical data .\n",
            "Eleven patients were considered for statistical analysis .\n",
            "Significant weight loss was observed in the sibutramine group ( mean = -@ kg ) , whereas patients on placebo experienced a mean weight gain of @ kg .\n",
            "A reduction in HbA@c was apparent in the sibutramine but not in the placebo group .\n",
            "No significant between-group differences were found in changes in psychopathology or drug safety .\n",
            "This pilot trial suggests that adjunctive treatment with sibutramine may be safe and effective in schizophrenic patients with antipsychotic-induced weight gain .\n",
            "Objective : To explore the effects of risperidone and olanzapine on mood symptoms in patients with SCHIZophrenia and SCHIZoaffective disorder , and to correlate symptom changes with measures of outcome.Methods : An exploratory analysis of mood symptoms from an eight-week , RANDOMized , DOUBLE-blind study comparing risperidone ( n = @ ) and olanzapine ( n = @ ) .\n",
            "Efficacy assessments included the PANSS total score , anxiety/depression cluster and item scores ( depression , anxiety , guilt , somatic preoccupation ) , excitement/hostility cluster score , _ mania _ cluster and item scores ( excitement , grandiosity ) , and Hamilton Depression Rating Scale total score .\n",
            "Correlations between mood symptom improvement and quality-of-life measures ( B-QOL ) were assessed.Results : Mean modal doses were @ mg/day risperidone and @ mg/day olanzapine .\n",
            "Both groups showed significant improvement on all measures of mood symptoms .\n",
            "Risperidone was associated with significantly greater improvement than olanzapine at week @ on the PANSS anxiety/depression cluster and the depression and grandiosity items ( p < @ ) .\n",
            "Improvement in the depression item with risperidone positively correlated with improvement on several B-QOL subscales ( p < @ ) .\n",
            "Conclusions : Risperidone was associated with greater improvement than olanzapine for depression and grandiosity in these patients .\n",
            "The improvement in depression had a perceived beneficial effect on several aspects of quality of life .\n",
            "Results suggest that risperidone may be superior for affective symptoms in patients with SCHIZophrenia and SCHIZoaffective disorder .\n",
            "CN : NR@ Tuesday , May @ , @:@ p.m.-@ : @ p.m. PT : CSG CODE conference USA\n",
            "OBJECTIVE : There is a clear need to develop psychosocial rehabilitation methods that compensate for neurocognitive deficits common to persons with severe and persistent mental illness .\n",
            "Errorless learning , a compensatory training intervention , has been successful in teaching entry-level job tasks .\n",
            "However , errorless learning 's applicability to broader , more complex functions is unknown .\n",
            "The present study tested the extension of errorless learning for deficits in social problem-solving skills in patients with schizophrenia .\n",
            "METHOD : Sixty clinically stable outpatients with schizophrenia or schizoaffective disorder were stratified by gender and level of memory impairment before being randomly assigned to one of two training programs : errorless learning or symptom management .\n",
            "Groups were matched for training time , format and structure of training , and types of teaching aids used .\n",
            "Social problem-solving ability , measured by the Assessment of Interpersonal Problem-Solving Skills , was assessed at baseline , within @ days of training completion , and after @ months .\n",
            "Dependent measures were the scores for the receiving , processing , and sending skills areas from the Assessment of Interpersonal Problem-Solving Skills .\n",
            "RESULTS : A repeated-measures analysis of covariance was conducted for each dependent measure with baseline Assessment of Interpersonal Problem-Solving Skills score entered as a covariate .\n",
            "For all three skills , there was a significant training group effect favoring errorless learning .\n",
            "Durability of errorless learning training effects extended to the @-month follow-up assessment for processing and sending skills but not receiving skills .\n",
            "CONCLUSIONS : Results support the extension of errorless learning to complex functions such as social problem-solving skills in the rehabilitation of persons with schizophrenia\n",
            "Paliperidone palmitate is a long-acting injectable antipsychotic agent .\n",
            "This @-week , multicenter , randomized ( @ : @ : @ : @ ) , double-blind , parallel-group study evaluated the efficacy , safety , and tolerability of fixed @ , @ , and @ milligram equivalent ( mg equiv . )\n",
            "doses of paliperidone palmitate vs placebo administered as gluteal injections on days @ and @ , then every @ weeks ( days @ and @ ) in @ adult patients with schizophrenia .\n",
            "The intent-to-treat analysis set ( N@ ) was @ % men and @ % White , with a mean age of @ years .\n",
            "All paliperidone palmitate dose groups showed significant improvement vs placebo in the Positive and Negative Syndrome Scale ( PANSS ) total score ( primary efficacy measure ; @ and @ mg equiv. , p@ = ; .@ ; @ mg equiv. , p < .@ ) , as well as Clinical Global Impression Severity scores ( p < = .@ ) and PANSS negative and positive symptom Marder factor scores ( p < = .@ ) .\n",
            "The Personal and Social Performance scale showed no significant difference between treatment groups .\n",
            "The overall incidence of treatment-emergent adverse events was similar between groups .\n",
            "Parkinsonism , the most frequently reported extrapyramidal symptom , was reported at similar rates for placebo ( @ % ) and paliperidone palmitate ( @-@ % across doses ) .\n",
            "The mean body mass index and mean weight showed relatively small dose-related increases during paliperidone palmitate treatment .\n",
            "Investigator-evaluated injection-site pain , swelling , redness , and induration were similar across treatment groups ; scores for patient-evaluated injection-site pain ( visual analog scale ) were similar across groups and diminished with time .\n",
            "All doses of once-monthly paliperidone palmitate were efficacious and generally tolerated , both locally and systemically .\n",
            "Paliperidone palmitate offers the potential to improve outcomes in adults with symptomatic schizophrenia .\n",
            "@ Nature Publishing Group All rights reserved .\n",
            "Recently hospitalized poor premorbid schizophrenics and alcoholics were compared on a visual discrimination task under censure and censure-free conditions .\n",
            "A DOUBLE-blind , chlorpromazine vs. placebo crossover design was employed with the schizophrenics ; alcoholics were kept drug-free .\n",
            "There were no differences in accuracy scores between groups or conditions , and no evidence of avoidance/deficit responding by any of the groups .\n",
            "Ss were most accurate on those trials following censure and least accurate following no signal in the censured area .\n",
            "Task conditions which determine the effects of censure on performance are discussed .\n",
            "Objective To explore the role of the rehabilitation training care for chronic mental patients return to society .\n",
            "Methods @ patients with chronic psychiatric patients , randomized into two groups , experimental group treated with medicine and rehabilitation training , the control group was treated with drug therapy , compared observed and assessed the efficacy of rehabilitation of psychiatric patients Scale ( IPROS , ) .\n",
            "The results of the social function of the two groups of patients before and after rehabilitation training and the difference was significant ( P < @ ) .\n",
            "The relative efficacy of @ tranquilizers ( chlorpromazine , trifluoperazine , thiothixene , haloperidol ) was investigated in a double-blind study with @ chronic schizophrenic inpatients ( mean hospitalization time , @ yrs ) .\n",
            "The role of adding an anti-depressant was also studied .\n",
            "Following a @-wk placebo period , high dosage tranquilizers were given for @ wks , and a maximum dose of @ mg amitriptyline was added for the following @ wks .\n",
            "Statistical analyses of the various change measures ( physicians ' assessment of mental status and global clinical change , the Brief Psychiatric Rating Scale , and weekly ratings by nurses aides on the Burdock Word Behavior Scale ) revealed that Ss worsened significantly on placebo ; all tranquilizers were significantly better than placebo for symptom reduction , and maximum improvement was attained within @ wks of tranquilizer administration .\n",
            "No significant differences in efficacy was observed among the @ tranquilizers , and addition of amitriptyline did not indicate any additional therapeutic advantage .\n",
            "( @ ref )\n",
            "Objective To study the therapeutic effect of M engsh i D itan Decoction ( M ica Ph egm-Flush ing Decoction ) for schizophrenia .\n",
            "Methods Totally @ cases of sch izophrenia were randomly divided into @ groups .\n",
            "The control group was treated by western medicine , while M engsh iD itan Decoction w as added in the treatment group .\n",
            "Positive and N egative Symptoms Scale ( PANSS ) , Brief Psychiatric Rating Scale ( BPRS ) and Treatment Emergent Symptom Scale ( TESS ) were used to identify the therapeutic and adverse effect after @ week s  treatment .\n",
            "Resul ts The excellence rate in treatment group w as @ .\n",
            "@ % , w h ile @ .\n",
            "@ % in control group ( P < @ .\n",
            "@ ) .\n",
            "The adverse effect in treatment group was less than that in control group ( P < @ .\n",
            "@ or P < @ .\n",
            "@ ) .\n",
            "Conclusion M engsh iDitan Decoction has therapeutic effect for schizophrenia .\n",
            "The therapeutic effect of integrated Chinese and western medicine treatment is superior to western medicine with less adverse effect and shorter treatment course .\n",
            "Aberrant gamma-band ( @-@ Hz ) oscillations may underlie cognitive deficits in schizophrenia ( SZ ) .\n",
            "Gamma oscillations and their regulation by NMDA receptors can be studied via their evoked power ( gammaEP ) and phase locking ( gammaPL ) in response to auditory steady-state stimulation ; these auditory steady-state responses ( ASSRs ) may be biomarkers for target engagement and early therapeutic effects .\n",
            "We previously reported that memantine , an NMDA receptor antagonist , enhanced two biomarkers of early auditory information processing : prepulse inhibition and mismatch negativity ( MMN ) in SZ patients and healthy subjects ( HS ) .\n",
            "Here , we describe memantine effects on gammaEP and gammaPL in those subjects .\n",
            "SZ patients ( n = @ ) and HS ( n = @ ) received memantine @ mg ( p.o. ) and placebo over @ test days in a double-blind , randomized , counterbalanced , cross-over design .\n",
            "The ASSR paradigm ( @ ms , @ dB clicks in @-@ s trains at a frequency of @ Hz ; @ s inter-train interval ) was used to assess gammaEP and gammaPL .\n",
            "SZ patients had reduced gammaEP and gammaPL ; memantine enhanced gammaEP and gammaPL ( p < @ and @ , respectively ) in both SZ and HS .\n",
            "In patients , significant correlations between age and memantine effects were detected for gammaEP and gammaPL : greater memantine sensitivity on gammaEP and gammaPL were present in younger SZ patients , similar to our reported findings with MMN .\n",
            "Memantine acutely normalized cortical oscillatory dynamics associated with NMDA receptor dysfunction in SZ patients .\n",
            "Ongoing studies will clarify whether these acute changes predict beneficial clinical , neurocognitive and functional outcomes .\n",
            "These data support the use of gamma-band ASSR as a translational end point in pro-cognitive drug discovery and early-phase clinical trials .\n",
            "This study is a randomized double-blind clinical trial which is performed on patients with schizophrenia diagnosis admitted in Goolestan hospital psychiatric ward .\n",
            "@ male and female patients , who are diagnosed as schizophrenics during interviews done by at least two psychiatrists according to DSM-IV TR and have inclusion criteria , will be divided randomly to intervention and control groups ( Atorvastatin plus Risperidone and placebo plus Risperidone ) .\n",
            "Researcher and person who evaluates will be unaware of this choice .\n",
            "In both groups , @ mg of Risperidone per day will be started and will be increased to @ mg per day if it is necessary .\n",
            "In intervention group , Atorvastatin at a dose of @ mg per day and in control group placebo prepared like Atorvastatin will be added to Risperidone .\n",
            "These two groups will receive placebo or drug for @ weeks , Biperiden up to @ mg per day will be permitted if motor complications occur or if it is necessary .\n",
            "Patients can receive up to @ mg Clonazepam per day .\n",
            "All patients will be checked at the start and weeks @ , @ , @ and @ with PANSS criteria to evaluate negative symptoms of schizophrenia and two groups will be compared .\n",
            "Objective To investigate the effect of quetiapine and haloperidol on the life quality of patients with schizophrenia .\n",
            "Methods The patients with schizophrenia treated respectively with quetiapine and haloperidol were compared .\n",
            "The efficacy was measured with Positive and Negative Symptoms Scale ( PANSS ) , and the life quality was evaluated with General Quality of Life Inventory ( GQOLI ) .\n",
            "Results After treatment , the scores of PANSS of both groups were significantly decreased .\n",
            "The quetiapine group had significantly b\n",
            "Objectives : During the ongoing multicenter RANDOMized , controlled TRIAL EDEN ( European Day Hospital EvaluatioN ) , which evaluating treatment and costs of psychiatric day hospital comparing to inpatient care , the dynamics of psychopathology and social functioning of patients are assessed .\n",
            "Method : The sample consists of @ acute adult psychiatric patients hospitalized RANDOMly in day hospital or inpatient care in five European centers : Dresden , London , Michalovce , Prague and Wroclaw .\n",
            "They were assessed after initial periods of three days , one week and four weeks as well as at discharge using the Brief Psychiatric Rating Scale ( BPRS ) and the Groningen Social Disabilities Schedule ( GSDS ) .\n",
            "Total BPRS scores and GSDS sum scores of each @ social roles were used in the data analysis .\n",
            "Results : Considering the ongoing study , preliminary results will be presented on the conference .\n",
            "Conclusions : We expected to confirm the hypothesis that there were no difference in reduction of overall psychopathology between day hospital and inpatient group , but day hospital is associated with better social functioning .\n",
            "EDUCATIONAL OBJECTIVE - At the conclusion of this presentation , the participant should be able to recognize that clozapine appears to have specific antiaggressive properties , and that neither risperidone nor olanzapine showed a superiority over haloperidol in reducing hostility .\n",
            "Objective - To compare the specific antiaggressive effects of clozapine compared with olanzapine , risperidone , and haloperidol .\n",
            "Method : Treatment-resistant inpatients ( N = @ ) with chronic schizophrenia or schizoaffective disorder were assigned to clozapine , olanzapine , risperidone , or haloperidol in a DOUBLE-blind , RANDOMized , @ - week trial .\n",
            "The trial consisted of Period @ ( @ weeks , escalation and fixed dose ) and Period @ ( @ weeks , variable dose ) .\n",
            "The PANSS hostility item was the principal outcome measure .\n",
            "Covariates included the PANSS items that reflect positive symptoms of schizophrenia ( delusions , suspiciousness / persecution , grandiosity , unusual thought content , conceptual disorganization , and hallucinatory behavior ) , and the NOSIE sedation item .\n",
            "Results : The four treatment arms differed in their effect on the hostility item of the PANSS .\n",
            "Clozapine had significantly greater antihostility effect than haloperidol or risperidone .\n",
            "The effect on hostility appears independent of antipsychotic effect on other PANSS items that reflect delusional thinking , disorganized behavior , or hallucinations , and independent of sedation as measured by the NOSIE .\n",
            "Neither risperidone nor olanzapine showed a superiority over haloperidol .\n",
            "Conclusion : Clozapine retains a relative advantage over other antipsychotics as a specific antiaggressive agent whose effects on hostility appears independent of its effects on other symptoms of psychosis , and of its sedative effect .\n",
            "Funding Source : NIMH grant ( R@ MH@ ) provided the principal support for this project .\n",
            "Eli Lilly and Company contributed supplemental funding .\n",
            "Janssen Pharmaceutica Research Foundation , Eli Lilly and Company , Novartis Pharmaceuticals Corporation , and Merck and Co. , Inc. provided medications\n",
            "Objective : To determine whether augmenting work therapy ( WT ) with neurocognitive enhancement therapy ( NET ) yields greater improvement in working memory performance than WT alone and whether there is an interaction with severity of impairment .\n",
            "Method : A total of @ participants with schizophrenia or schizoaffective disorder were categorized as severely or less severely cognitively impaired and randomly assigned to receive NET + WT or WT alone .\n",
            "NET consisted of cognitive training exercises in attention , memory , executive function , and social information processing , and WT was a @-month work program .\n",
            "Results : Comparison on Digits Backwards from intake to follow-up revealed significantly greater improvement for participants receiving NET + WT , but there was no interaction with severity group .\n",
            "Follow-up @ months after training showed that training effects endured .\n",
            "Conclusion : NET + WT improved working memory for most participants regardless of impairment severity .\n",
            "Intensity and duration of training may have contributed to duration of effects .\n",
            "Findings support continued exploration of cognitive remediation\n",
            "The present study was designed to evaluate the effects of two atypical antipsychotic agents ( ziprasidone , risperidone ) on cognitive functioning in outpatients with schizophrenia or schizoaffective disorder over @ weeks .\n",
            "The study utilized an open-label , randomized treatment design .\n",
            "Following a @-@ day stabilization period ( baseline ) , patients were treated with either ziprasidone ( @-@ mg , BID ) or risperidone ( @-@ mg , BID ) .\n",
            "Neuropsychological tests were administered at baseline ( N = @ ) , after six weeks of drug treatment ( N = @ ) , and after one year or at premature termination ( N = @ ) .\n",
            "Tests included measures of general cognitive functioning ( NAART-R , WAIS-R ) , verbal fluency ( ' F , A , S ' ) , attention ( PASAT : TrailMaking Tests , Part A ) , memory ( BVRT , CVLT ) , and executive functioning ( TrailMaking Test , Part B , WCST ) .\n",
            "Results suggest some improvement in cognitive functioning in patients receiving ziprasidone .\n",
            "Trends towards improvement were noted in executive functioning , memory , attention/concentration , and visual-spatial abilities .\n",
            "However , due to the small sample size , these results are presented as mean performance over the three assessment points .\n",
            "These results indicate more trends toward improvement in cognitive functioning in schizophrenic and schizoaffective patients receiving ziprasidone than in those receiving risperidone .\n",
            "Patients in the ziprasidone group demonstrated slight improvement on almost all measures after @ weeks of treatment while such improvements were not observed in the risperidone group .\n",
            "While these results are encouraging , more patients need to be tested to establish whether the observed differences are significant .\n",
            "Compared the im preparation of molindone with im trifluoperazine in maximum doses of @ mg and @ mg each day , respectively , in @ chronic schizophrenic inpatients ( mean age @ yrs ) in acute exacerbation .\n",
            "Effects of the @ injectable drugs were evaluated at baseline , and at the end of @ wk of medication , using the Brief Psychiatric Rating Scale , Clinical Global Impressions , Nurses ' Observation Scale for Inpatient Evaluation , and independent global ratings .\n",
            "Evaluation of the pooled global ratings of improvement and analysis of covariance of the psychometric measurements showed that molindone injectable displayed clinical efficacy equal to the im preparation of the reference compound , trifluoperazine .\n",
            "In the doses given , molindone showed a trend toward exhibiting greater incidence of extrapyramidal symptoms and akathesia , while trifluoperazine induced more drowsiness .\n",
            "Both im drugs were very well tolerated with respect to local tissue reaction .\n",
            "( PsycINFO Database Record ( c ) @ APA , all rights reserved )\n",
            "Principal research question : The project proposes to test the feasibility of a randomised controlled trial to evaluate the cost-effectiveness of shared care for patients with serious mental illness by randomly allocating GP practices to ( i ) general practices with a mental health worker ( experimental group ) and ( ii ) general practices without a mental health worker ( control group ) .\n",
            "Methodology description : Cost-benefit-analysis , Interviews , Randomized-controlled-trial Sample group description : All patients aged @ - @ who are under CA and who are registered at a participating practice are eligible .\n",
            "Interviews will be conducted with carers including support workers .\n",
            "Outcome measure description : It is expected that the main study will a ) determine whether there are any significant differences in outcomes ( clinical , organisational , costs and satisfaction ) by an intervention designed to enhance shared care between primary and secondary care , b ) establish the factors associated with the successful introduction of the intervention , c ) assess and deliver primary health care training in SMI .\n",
            "There will be particular emphasis on ensuring that there are clear benefits for the general practices and community mental health professionals involved in this study .\n",
            "The long term objectives at the end of the project are that each practice and CMHT will have agreed on i ) a clear written policy for the identification , assessment and treatment of people with SMI ii ) a protocol for monitoring people taking psychotropic drugs including a written policy on repeat prescriptions - and for primary care iii ) a comprehensive list of services that includes the target group , main skill areas , costs , and referral criteria iv ) an appropriate records system for people on CPA including a user-friendly classification system of mental illness , and a training plan for the primary health care team on mental health issues .\n",
            "The pilot study will assess the feasibility of a full randomised controlled trial by testing the proposed plan for investigation .\n",
            "Research results : Research results are not currently collected by the NRR\n",
            "OBJECTIVE : This study was designed to evaluate the short-term efficacy and safety of once-daily lurasidone ( @ mg/day and @ mg/day ) in the treatment of an acute exacerbation of schizophrenia .\n",
            "METHODS : Participants , who were recently admitted inpatients with schizophrenia with an acute exacerbation of psychotic symptoms , were randomly assigned to @ weeks of fixed-dose , double-blind treatment with lurasidone @ mg ( n = @ ) , lurasidone @ mg ( n = @ ) , quetiapine XR @ mg ( QXR-@ mg ; n = @ ; active control included to test for assay sensitivity ) , or placebo ( n = @ ) , all dosed once daily in the evening .\n",
            "Efficacy was evaluated using a mixed-model repeated-measures analysis of the change from Baseline to Week @ in Positive and Negative Syndrome Scale ( PANSS ) total score ( the primary efficacy measure ) and Clinical Global Impressions severity ( CGI-S ) score ( the key secondary efficacy measure ) .\n",
            "RESULTS : Treatment with both doses of lurasidone or with QXR-@ mg was associated with significantly greater improvement at Week @ on PANSS total score , PANSS positive and negative subscale scores , and CGI-S score compared with placebo .\n",
            "The endpoint responder rate ( > / = @ % improvement in PANSS total score ) was higher in subjects treated with lurasidone @ mg ( @ % ; p < @ ) , lurasidone @ mg ( @ % ; p < @ ) , and QXR-@ mg ( @ % ; p < @ ) compared with placebo ( @ % ) .\n",
            "The proportion of patients experiencing > / = @ % weight gain was @ % for each lurasidone group , @ % for the QXR-@ mg group , and @ % for the placebo group .\n",
            "Endpoint changes in levels of cholesterol , triglycerides , and low-density lipoprotein ( LDL ) cholesterol were comparable for both lurasidone groups and placebo , while the QXR-@ mg group showed a significant median increase compared with the placebo group in levels of cholesterol ( p < @ ) , LDL cholesterol ( p < @ ) , and triglycerides ( p < @ ) .\n",
            "CONCLUSIONS : Lurasidone @ mg and @ mg doses administered once-daily in the evening , were safe and effective treatments for subjects with acute schizophrenia , with increased response rates observed at the higher dose .\n",
            "Dose-related adverse effects were limited , and both doses were generally well-tolerated .\n",
            "Persons with serious mental illnesses who participated in the consumer-run course show higher scores on subjective measures of recovery after three and six months than waiting-list controls .\n",
            "Study design Randomised , controlled , parallel group , multicentre trial Disease/condition/study domain Mental health problems Participants - inclusion criteria Persons recovering from serious mental illnesses Participants - exclusion criteria Interventions @ .\n",
            "Experimental group : participate in course on mental health recovery , @ weekly meetings and one follow-up meeting .\n",
            "@ .\n",
            "Waiting-list control group : will enter the next course ( six months after having been randomised ) .\n",
            "Primary outcome measure ( s ) Mental health recovery measured by questionnaires Secondary outcome measure ( s ) @ .\n",
            "Care consumption @ .\n",
            "Health status\n",
            "Objective : To investigate how integrated treatment , social network , DUP , age and gender influences the course of negative symptoms .\n",
            "Methods : A randomized controlled study was conducted including @ patients , aged @  @ , with first-episode psychosis , mainly schizophrenia ( @ % ) .\n",
            "Integrated psychosocial treatment consisted of assertive community treatment with multifamily groups , social skills training and psycho education ; standard treatment offered contact with a community mental health centre .\n",
            "Independent researchers made assessments at baseline and after @ and @ months with SCAN , SAPS , SANS , GAF etc .\n",
            "Results : Male gender and small social network strongly correlates with high scores on the negative dimension , while no associations are found with DUP or age , as hypothesized .\n",
            "The level of negative symptoms at baseline is a strong predictor for the symptom level at @ years .\n",
            "The integrated treatment had a significant superior effect on the negative dimension scores .\n",
            "Conclusion : Negative symptoms can be reduced more effectively by integrated treatment , but social network and gender have high impact too .\n",
            "Background Effective treatment options for patients with high levels of negative symptoms of schizophrenia are lacking .\n",
            "Brexpiprazole is a serotonin-dopamine activity modulator that is a partial agonist at @-HT@A and dopamine D@ receptors , and an antagonist at @-HT@A and noradrenaline alpha@B/@C receptors , all with subnanomolar potency .\n",
            "We have previously shown that long-term treatment with brexpiprazole resulted in broad efficacy across all five Marder factor groupings , including positive , negative , disorganized thoughts , uncontrolled hostility/excitement , and anxiety/depression [ @ ] .\n",
            "Here , we describe the long-term effects of brexpiprazole in patients with clinically relevant levels of negative symptoms of schizophrenia based on data from patients who participated in two short-term , placebo-controlled studies ( Vector ; NCT@ [ @ ] or Beacon ; NCT@ [ @ ] ) and continued in the open-label extension study ( Zenith ; NCT@ ) [ @ ] .\n",
            "Methods In two similarly designed short-term studies , patients with acute schizophrenia were randomly assigned to fixed once-daily doses of brexpiprazole @ mg ( Vector only ) [ @ ] , @ mg ( Beacon only ) [ @ ] , @ mg , @ mg or placebo for @ weeks .\n",
            "The long-term study was an open-label , @-week ( amended to @ weeks ) , safety extension study with flexible-dose ( @ to @ mg/day ) brexpiprazole .\n",
            "The post-hoc analyses were performed on patients with clinically relevant levels of negative symptoms , defined as Positive and Negative Syndrome Scale factor score for negative symptoms ( PANSS-FSNS , N@ , N@ , N@ , N@ , G@ , G@ ) of @ or more , and score of @ or more on at least two of three core negative PANSS items ( blunted affect , passive or apathetic social withdrawal , lack of spontaneity , and flow of conversation ) at baseline ( randomization in parent study ) .\n",
            "The outcome of the analysis included change from baseline to up to @ weeks in PANSS for negative symptoms ( PANSS-FSNS ) , PANSS total score , and PSP .\n",
            "The data were analyzed using a mixed model repeated measures ( MMRM ) approach .\n",
            "Safety was assessed in all patients who received at least one dose of study drug .\n",
            "Result ( s ) : A total of @ patients with clinically relevant levels of negative symptoms in the parent study rolled-over into the open-label extension study and were available for analysis .\n",
            "Eighty-three of these patients remained in the studies for @ weeks .\n",
            "Since the long-term study was amended from @ to @ weeks in duration , not all patients had the opportunity of complete @ weeks of open-label treatment .\n",
            "Baseline PANSS total score was @ , while baseline PANSS-FSNS was @ and baseline PSP total score was @ .\n",
            "Mean change ( SD ) from baseline in PANSS-FSNS was -@ ( @ ) , and -@ ( @ ) for PANSS total score at Week @ .\n",
            "Change from baseline ( SD ) to Week @ for PSP total score was @ ( @ ) with improvement seen in all @ domains ( socially useful activities , personal and social relationship , self-care , and disturbing and aggressive behaviors ) .\n",
            "The TEAEs reported > = @ % were schizophrenia ( @ % - worsening of the underlying disease ) , insomnia ( @ % ) , weight increased ( @ % ) and akathisia ( @ % ) .\n",
            "Conclusion ( s ) : This post-hoc analysis suggests that brexpiprazole has long-term effectiveness on negative symptoms and functioning in patients with schizophrenia and clinically relevant levels of negative symptoms .\n",
            "Disclosure statement : Catherine Weiss is a full-time employee of Otsuka Pharmaceutical Development & Commercialization Inc .\n",
            "Copyright   @\n",
            "This study compared the long-term ( @ months ) effectiveness of risperidone ( RP ) with that of conventional neuroleptics ( CNs ) in a population with chronic schizophrenia who had shown suboptimal response to CNs .\n",
            "A randomized , open , parallel , multicenter design was used .\n",
            "One hundred eighty-four subjects meeting DSM-IV criteria for schizophrenia were randomly assigned to receive either RP or a CN , and @ of them completed the follow-up .\n",
            "Outcome measures were taken at @ , @ , and @ months and included the Positive and Negative Syndrome Scale ( PANSS ) and the Extrapyramidal Symptom Rating Scale .\n",
            "Within this @-month follow-up , RP was found to be superior to CNs in terms of both the average change in score from baseline on the PANSS ( p = @ ) and the proportion of good responders ( as defined by a @ % decrease in total PANSS scores ;p = @ ) .\n",
            "For positive symptoms , the effectiveness of the RP treatment tended to increase over time .\n",
            "At @ months , the percentage of good responders in the RP group was twice as large as that in the CN group ( @ % vs. @ % ;p = @ ) .\n",
            "The superiority of RP over CNs was constant over the three dose categories .\n",
            "In both the RP and the CN groups , the maximum decrease in psychopathology was achieved with the lowest dose range .\n",
            "A worsening of akathisia was less frequent in subjects receiving RP than in those receiving CNs ( p = @ ) .\n",
            "In conclusion , this study showed that , compared with CNs , RP is beneficial in the treatment of patients with chronic schizophrenia and that some of these benefits may appear only after longer-term treatment .\n",
            "Real-world decision-makers need to understand the outcomes patients may expect under \" naturalistic \" conditions of usual care .\n",
            "These may not be accurately predicted by results obtained in the contrived setting of ordinary clinical trials of drug efficacy .\n",
            "The usual care setting can maximally challenge a new drug by introducing a broad array of patients , providers , and treatment practices as well as effects of insurance and cost .\n",
            "No atypical antipsychotic has demonstrated clinical benefit over conventional agents in a large trial of this type .\n",
            "We report long-term clinical and quality of life outcomes from a @-patient , multicenter , prospective , randomized effectiveness trial of the decision to treat with risperidone ( RIS ) vs. conventional ( CON ) antipsychotics after relapse .\n",
            "Patients were followed for one year with minimal protocol-induced interference in psychiatric care to best approximate the \" natural \" conditions faced by decision-makers .\n",
            "Despite a surprising magnitude of no-drug intervals and homogenization of drug therapy , both of which would be expected to minimize differences between treatment arms , patients randomized to RIS had statistically superior PANSS ( total , general psychopathology , positive , and negative symptoms ) , Barnes Akathisia , Simpson-Angus EPS , and mental quality of life scores ( SF-@ MCS ) when compared with CON patients over one year .\n",
            "The QOLI ( Lehman ) and SF-@ physical scale showed no difference .\n",
            "NEW RESEARCH ER :\n",
            "Group Person-Based Cognitive Therapy ( PBCT ) integrates cognitive therapy and mindfulness to target distinct sources of distress in psychosis .\n",
            "The present study presents data from the first randomised controlled trial investigating group PBCT in people distressed by hearing voices .\n",
            "One-hundred and eight participants were randomised to receive either group PBCT and Treatment As Usual ( TAU ) or TAU only .\n",
            "While there was no significant effect on the primary outcome , a measure of general psychological distress , results showed significant between-group post-intervention benefits in voice-related distress , perceived controllability of voices and recovery .\n",
            "Participants in the PBCT group reported significantly lower post-treatment levels of depression , with this effect maintained at six-month follow-up .\n",
            "Findings suggest PBCT delivered over @weeks effectively impacts key dimensions of the voice hearing experience , supports meaningful behaviour change , and has lasting effects on mood .\n",
            "\" INTRODUCTION : This pilot study examined , whether long-term exposure of psychiatric patients to music that was individually adapted to brain rhythm disorders associated with psychoticism could act to ameliorate psychiatric symptoms .\n",
            "METHODS : A total of @ patients with various psychiatric diagnoses were randomised in a @:@ ratio to listen to CDs containing either music adapted to brain rhythm anomalies associated with psychoticism - measured via a specific spectral analysis - or standard classical music .\n",
            "Participants were instructed to listen to the CDs over the next @ months .\n",
            "Psychiatric symptoms in both groups were assessed at baseline and at @ , @ and @ months , using the Brief Symptom Inventory ( BSI ) .\n",
            "RESULTS : At @ months , patients in the experimental group showed significantly decreased BSI scores compared to control patients .\n",
            "Intriguingly , this effect was not only seen for symptoms of psychoticism and paranoia but also for anxiety , phobic anxiety and somatisation .\n",
            "CONCLUSIONS : Exposure to the adapted music was effective in ameliorating psychotic , anxiety and phobic anxiety symptoms .\n",
            "Based on the theories of neuroplasticity and brain rhythms , it can be hypothesised that this intervention may be enhancing brain-rhythm synchronisation and plasticity in prefrontal-hippocampal circuits that are implicated in both psychosis/paranoia and anxiety/phobic anxiety . \"\n",
            "BACKGROUND : Because early illness course and outcome may affect the long-term outcome of schizophrenia-spectrum disorders , it is especially important to address poor outcome in this early critical period .\n",
            "AIMS : To evaluate whether integrated treatment compared with standard treatment reduced the proportion of patients with poor clinical and social outcome after @ year .\n",
            "METHOD : A total of @ patients with first-episode psychosis were included in the study , @ randomly assigned to integrated treatment and @ to standard treatment .\n",
            "Measures assessed psychotic symptoms and social functioning .\n",
            "RESULTS : There was a significant beneficial effect of integrated treatment v. standard treatment on \" any poor outcome \" .\n",
            "Integrated treatment had a significantly better effect on \" any poor outcome \" in patients with schizophrenia compared with patients in standard treatment .\n",
            "CONCLUSIONS : The integrated treatment significantly reduced the proportion of patients with poor clinical and social outcome compared with standard treatment\n",
            "Background : Omega-@ Fatty Acids ( FAs ) , EPA ( eicosapentaenoic acid ) and DHA ( Docosahexaenoic acid ) , are essential for normal brain development and may also have neuroprotective properties .\n",
            "Dietary supplementation of EPA and DHA has benefcial effects in medical illnesses as well as depression , bipolar disorder , and dementia .\n",
            "Abnormal FA metabolism may play a role in the etiology of psychiatric illness .\n",
            "Studies of erythrocytes and skin fbroblasts have shown reduced levels of FAs and phospholipids in schizophrenia .\n",
            "Studies of Omega-@FA supplementation in schizophrenia have been mixed .\n",
            "Amminger et al performed a randomized , double-blind , placebo-controlled trial in @ subjects with prodromal symptoms of psychosis .\n",
            "The treatment consisted of @ g/day of Omega-@FAs ( @ mg EPA , @ mg DHA ) .\n",
            "After @ weeks , @ ( @ % ) of @ individuals in the Omega-@FA group and @ of @ ( @ % ) in the placebo group converted to a psychotic disorder .\n",
            "Omega-@FAs also signifcantly reduced symptoms and improved functioning .\n",
            "The Aims of the current study were to replicate the Amminger study in Clinical High Risk ( CHR ) subjects from the NAPLS consortium .\n",
            "Methods : This was a @-week , randomized , double-blind , placebo , fxed dose-controlled study of Omega-@FA versus placebo in @ CHR subjects .\n",
            "The Omega-@FA compound contained a @:@ proportion of EPA to DHA .\n",
            "The total dose was @ mg of EPA and @ mg of DHA .\n",
            "Baseline diet char-acterization was assessed using a systematic checklist that includes Omega-@FA foods .\n",
            "In addition , fasting erythrocyte FA composition was assessed .\n",
            "Results : Of the @ CHR subjects recruited into the trial , @ completed baseline assessment , and @ ( @ % ) completed the @-month trial .\n",
            "Seven ( @ % Kaplan-Meier ) subjects converted to psychosis during the @ months .\n",
            "The rate of psychotic conversion did not differ in the Omega-@FA ( @ % ) versus Placebo ( @ % ) samples .\n",
            "Conversion to psychosis was predicted by low Omega-@FA rich foods in the diet ( Wald Statistic = @ , P < .@ ) .\n",
            "Although there were signifcant improvements in symptom and functioning over time in Mixed Model analyses , there were no signifcant group or Group x Time interaction effects .\n",
            "Conclusion : The rate of conversion to psychosis in the present sample was lower than is typically observed in an at-risk population .\n",
            "Given the study attrition and low rate of conversion to psychosis , the trial was underpowered to replicate the conversion effect in the Amminger et al. 's study .\n",
            "Despite the overall improvement in symptoms and functioning over time in all subjects , there was no clear evidence of a differential effect in the sample on Omega-@FA vs Placebo .\n",
            "Further work is needed to better tease out the role of diet and Omega-@FA in mental illness .\n",
            "The fnding of a signifcant association between baseline diet low in Omega-@FA rich foods and later conversion to psychosis raises the question of whether it is possible to infu-ence both physical and mental health with lifestyle choices including diet .\n",
            "OBJECTIVE : : Lamotrigine previously was found to attenuate ketamine-induced behavioral changes and , in @ placebo-controlled trials , to improve psychosis when added to antipsychotic medication .\n",
            "We sought to evaluate the potential role of lamotrigine augmentation in schizophrenia patients resistant to atypical antipsychotic medication .\n",
            "METHODS : : Two multicenter , randomized , double-blind , @-week , parallel-group trials were conducted to compare flexibly dosed lamotrigine ( @-@ mg/d ) with placebo as add-on treatment in schizophrenia patients with stable , residual psychotic symptoms .\n",
            "The primary end point was changed in Positive and Negative Syndrome Scale total score at week @ .\n",
            "RESULTS : : Two hundred seventeen patients were enrolled in study @ and @ in study @ ; completion rates in the intent-to-treat samples were @ % and @ % , respectively , and did not differ between treatment groups .\n",
            "Overall , mean Positive and Negative Syndrome Scale total scores improved in both studies and did not differ between treatment groups .\n",
            "In study @ , the Scale for Assessment of Negative Symptoms total score and Clinical Global Impression improved more with placebo than with lamotrigine ; in study @ , the cognitive composite score improved more with lamotrigine than with placebo .\n",
            "CONCLUSIONS : : Results from these @ studies do not support the use of lamotrigine as an adjunct to atypical antipsychotics in patients with refractory psychosis .\n",
            "It is unclear why positive results from previous lamotrigine trials were not replicated .\n",
            "The positive effect of lamotrigine on cognition in one trial , while of uncertain significance , may merit further study .\n",
            "RN @ ( Anticonvulsants ) .\n",
            "@ ( Antipsychotic Agents ) .\n",
            "@ ( Triazines ) .\n",
            "@-@-@ ( Clozapine ) .\n",
            "@-@-@ ( lamotrigine ) .\n",
            "The majority of patients with schizophrenia display neurocognitive deficits ( e.g. , memory impairment ) as well as inflated cognitive biases ( e.g. , jumping to conclusions ) .\n",
            "Both cognitive domains are implicated in the pathogenesis of the disorder and are known to compromise functional outcome .\n",
            "At present , there is a dearth of effective treatment options .\n",
            "A total of @ patients with schizophrenia were recruited online ( a diagnosis of schizophrenia had been confirmed in a large subgroup during a previous hospital admission ) .\n",
            "Subsequent to a baseline assessment encompassing psychopathology , self-reported cognition as well as objective memory and reasoning tests , patients were randomized to one of three conditions : standard cognitive remediation ( mybraintraining ) , metacognition-augmented cognition remediation ( CR ) condition ( variant of mybraintraining which encouraged patients to reduce speed of decision-making and attenuate response confidence when participants made high-confidence judgements and hasty incorrect decisions ) and a waitlist control group .\n",
            "Patients were retested after @ weeks and again @ months after the second assessment .\n",
            "Groups did not differ on psychopathology and neurocognitive parameters at any timepoint .\n",
            "However , at follow-up the metacognitive-augmented CR group displayed a significant reduction on jumping to conclusions and overconfidence .\n",
            "Treatment adherence correlated with a reduction of depression ; gains in the training exercises from the standard mybraintraining condition were correlated with improved objective memory performance .\n",
            "The study suggests that metacognition-augmented CR may ameliorate cognitive biases but not neurocognition .\n",
            "The study ties in well with prior research showing that neurocognitive dysfunctions are rather resistant to change ; the failure to detect significant improvement of CR or metacognition-augmented CR on psychopathology and neurocognition over time may partly be attributed to a number of methodological limitations of our study ( low psychopathology and chronicity of participants , low \" dosage , \" narrow range of tests , self-report psychopathology scales ) .\n",
            "Objective To observe the occupational and recreational therapy on the social function of patients with chronic schizophrenia .\n",
            "Nosie ( Inpatient Nurses Observation Scale ) of @ patients with chronic schizophrenia randomized controlled design , enrolled patients were divided into observation group and the control group , the control group patients be psychiatric routine care , observation group patients in the conventional care based on the use of the method of treatment of a set of work entertainment , work entertainment before treatment and after @ months , using ( nosie ) assessed analysis .\n",
            "Results Two groups the nosie have significant differences observed group than the control group ( p < @ ) .\n",
            "The therapeutic effects , safety and side-effects of clocapramine and sulpiride were evaluated in @ hospitalized chronic schizophrenic patients using a single-blind method during an @-week trial period .\n",
            "While the final global improvement rating showed clocapramine to be superior to sulpiride , the differences were not statistically significant .\n",
            "The time course of the total psychiatric rating scales ( PRS ) showed a progressive decline during treatment for both drugs , and at the end of treatment clocapramine proved significantly lower in total PRS than did sulpiride .\n",
            "In the improvement of psychotic symptoms , clocapramine seemed to be superior to sulpiride with respect to motor retardation , delusion , hallucination or disturbance of self-consciousness , social isolation or withdrawal , and recreation or work .\n",
            "Side-effects appeared more frequently with clocapramine than with sulpiride , but abnormal laboratory-test results appeared less in clocapramine-treated patients than in sulpiride-treated ones .\n",
            "Neither side-effects nor abnormal laboratory-test results induced by the two drugs were severe enough to terminate administration .\n",
            "Clocapramine is concluded to have a more favourable effect on negative symptoms , as well as on some positive symptoms of chronic schizophrenia , than sulpiride .\n",
            "Background : Negative symptoms of schizophrenia ( flattened affect , impoverished speech , apathy , avolition , anhedonia ) represent the absence or blunting of normal intellectual and emotional function and expression .\n",
            "Although these symptoms can be severe enough to cause persistent impairment , many patients experience only little or no control of negative symptoms .\n",
            "We have previously shown that brexpiprazole treatment resulted in broad efficacy across all five Marder factor groupings , including positive , negative , disorganized thoughts , uncontrolled hostility/excitement , and anxiety/depression [ @ ] .\n",
            "The aim of this post-hoc analysis was to evaluate the short-term efficacy of brexpiprazole in adult patients with an acute exacerbation of schizophrenia and clinically relevant levels of negative symptoms .\n",
            "Method ( s ) : The post-hoc analysis was performed on the pooled data from three Phase @ , @-week , double-blind , placebo-controlled studies of patients with schizophrenia ( NCT@ , NCT@ , and NCT@ ) .\n",
            "The patients were randomly assigned to treatment with either brexpiprazole ( as fixed doses of @ or @ mg or as flexible doses of @-@ mg ) or placebo .\n",
            "Clinically relevant levels of negative symptoms were defined as Positive and Negative Syndrome Scale factor score for negative symptoms ( PANSS-FSNS , N@ , N@ , N@ , N@ , G@ , G@ ) of @ or more , and score of @ or more on at least two of the core negative PANSS items ( blunted affect , passive or apathetic social withdrawal , lack of spontaneity , and flow of conversation ) at baseline .\n",
            "These analyses evaluated the efficacy of @ weeks ' treatment with brexpiprazole in patients with clinically relevant levels of negative symptoms on the PANSS-FSNS score , the PANSS total score , and the PANSS negative subscale score , as well as the PSP score and the CGI-I score .\n",
            "The data were analyzed using a mixed model repeated measures ( MMRM ) approach .\n",
            "Result ( s ) : A total of @ patients fulfilled the criteria for having clinically relevant levels of negative symptoms at baseline ( @ for brexpiprazole and @ for placebo ) .\n",
            "@ patients in the brexpiprazole group and @ patients in the placebo group were included in the efficacy population .\n",
            "Baseline PANSS-FSNS scores + / - standard deviation ( SD ) were similar between groups ( @ + / - @ brexpiprazole ; @ + / - @ placebo ) .\n",
            "Pooled brexpiprazole was superior to placebo in change from baseline in PANSS-FSNS total score at week @ ( least square mean difference [ LSMD ] -@ , p < @ ) .\n",
            "The LSMD at week @ was also significant for brexpiprazole on the PANSS total score ( least squares mean difference [ LSMD ] : -@ , p < @ ) and PANSS negative subscale scores ( LSMD : -@ , p < @ ) .\n",
            "On the PSP total score , the LSMD at Week @ was significant ( LSMD : @ ; p < @ ) , with similar baseline scores ( SD ) between the groups ( @ + / - @ brexpiprazole ; @ + / - @ placebo ) .\n",
            "There were no TEAEs occurring in > = @ % of patients and twice the rate of placebo .\n",
            "Conclusion ( s ) : Our results support the short-term efficacy of brexpiprazole in the treatment of negative symptoms in patients with schizophrenia with clinically relevant levels of negative symptoms .\n",
            "Disclosure statement : Stine R Meehan is a full-time employee of H. Lundbeck A/S .\n",
            "Copyright   @\n",
            "Developed an aftercare program based on G. Kielhofner 's ( @ ) model of human occupation for chronic psychiatrically disabled young adults .\n",
            "This @-wk program involved a series of @ small-group sessions with structured objectives and activities .\n",
            "An experimental study and a program evaluation were implemented to examine the program 's effectiveness .\n",
            "Ss were @ adults ( aged @-@ yrs ) selected from among psychiatric inpatients terminating hospital care .\n",
            "While no significant differences between the experimental and control groups were found , trends in the experimental data suggest that the program had a positive effect on recidivism and quality of everyday life .\n",
            "Strengths and weaknesses of the program and recommendations for further program development and efficacy research are noted .\n",
            "Employment has been increasingly recognized as an important goal for individuals with schizophrenia .\n",
            "Previous research has shown mixed results on the relationship of specific antipsychotic medications to employment outcomes , with some studies finding greater benefits for second-generation antipsychotic medications ( SGAs ) over first-generation antipsychotic medication ( FGAs ) .\n",
            "A randomized controlled trial ( CATIE ) examined medication assignment and both employment outcomes and participation in psychosocial rehabilitation ( PSR ) among @ individuals with a diagnosis of schizophrenia randomized to SGAs ( olanzapine , quetiapine , risperidone , ziprasidone ) or one FGA ( perphenazine ) .\n",
            "Service use and employment were assessed at quarterly interviews .\n",
            "There were no differences between medication groups on employment outcomes or participation in PSR .\n",
            "Consistent with other CATIE results , there were no differences in employment or participation in PSR among these five medications , including the FGA perphenazine .\n",
            "Objective To evaluate quetiapine treatment of schizophrenia and adverse reactions .\n",
            "Methods @ patients were randomly divided into quetiapine and chlorpromazine group , eight weeks of treatment .\n",
            "Positive and Negative Syndrome Scale ( PANSS ) , the Clinical Global Impression ( cgi-gi ) , side effects scale ( tess ) to assess the efficacy and adverse reactions .\n",
            "Results quetiapine and chlorpromazine on schizophrenia have a better effect , but the former adverse significantly less .\n",
            "Objective To investigate the day rehabilitation training on rehabilitation of first episode schizophrenia patients recovering .\n",
            "Methods @ patients with first episode psychosis convalescent patients were randomly divided into study group and the control group , @ patients in the control group received conventional Risperdal treatment , day rehabilitation training group on the basis of accepted .\n",
            "Overall happiness scale ( gws ) , the Clinical Global Impression Scale ( cgi ) , personal and social scale ( psp ) rehabilitation assessment of the state before and after the training of the two groups of patients .\n",
            "Eight weeks after the study group gws , cgi , psp score was significantly better than the control group ( p < @ ) .\n",
            "The relative efficacy of three oral regimens of haloperidol was compared in a ten-day , double-blind study of @ acutely ill schizophrenic patients newly admitted to the hospital .\n",
            "One group of patients received @ mg of haloperidol on day @ , then increasing increments of @ mg a day , reaching a maximum dosage of @ mg daily on day @ .\n",
            "Another group received @ mg of haloperidol on day @ , then increasing increments of @ mg daily , reaching @ mg daily on day @ .\n",
            "A third group of patients received a fixed dosage of @ mg daily for ten days .\n",
            "Haloperidol was well tolerated by the patients ; there were no serious adverse reactions .\n",
            "The data indicated that the regimens had similar therapeutic efficacy , suggesting that acutely ill schizophrenic patients respond to a wide range of doses of haloperidol but that onset of response and efficacy are not increased in most patients by providing a high initial loading dosage .\n",
            "Adequate , safe dosage must be determined in each case .\n",
            "Background : Severe mental illness is responsible for a significant proportion of burden of diseases in Iranian population .\n",
            "People with severe mental illnesses are more likely to have high rates of non-attendance at follow-up visits , and lack of an active follow-up system , particularly in the country 's urban areas that has resulted in the revolving door phenomenon of rehospitalizations .\n",
            "Therefore , there is an increasing need for implementation of effective and cost-effective aftercare services.Method / Design : This is a randomized control trial with the primary hypothesis that aftercare services delivered to patients with severe mental illnesses in outpatient department and patient 's home by a community care team would be more effective when compared to treatment as usual ( TAU ) in reducing length of hospital stay and any psychiatric hospitalization .\n",
            "Patients were recruited from three psychiatric hospitals in Iran .\n",
            "After obtaining informed written consent , they were randomly allocated into aftercare intervention and control ( TAU ) groups .\n",
            "Aftercare services included treatment follow-up ( through either home care or telephone follow-up prompts for outpatient attendance ) , family psychoeducation , and patient social skills training that were provided by community mental health teams .\n",
            "Patients were followed for @ months after discharge .\n",
            "The primary outcome measures were length of hospital stay and any hospitalization in the @ month follow-up .\n",
            "Secondary outcome measures included patients ' clinical global impression , global functioning , quality of life , and patient 's satisfaction .\n",
            "The trial also allowed an assessment of direct cost-effectiveness of the aftercare services.Discussion : This paper presents a protocol for an RCT of aftercare services delivered to patients with severe mental illnesses within patients ' home or outpatient department .\n",
            "The findings of this study can influence policy and program planning for people with severe mental illnesses in Iran .\n",
            "@ Hajebi et al. ; licensee BioMed Central Ltd .\n",
            "To assess the effect of the long-acting antipsychotic aripiprazole lauroxil ( AL ) on social and functional outcomes compared with placebo in patients with acute schizophrenia , a post-hoc analysis was conducted .\n",
            "Patients with acute schizophrenia were enrolled in a @-week , double-blind , placebo-controlled efficacy trial , and randomized @:@:@ to receive AL @ mg , AL @ mg , or placebo every @ weeks .\n",
            "Changes in social functioning using the @ - and @-item Positive and Negative Syndrome Scale ( PANSS ) Prosocial subscales were evaluated .\n",
            "The Personal and Social Performance ( PSP ) total score evaluated patients ' global improvement .\n",
            "Changes from baseline were analyzed using mixed-effect models repeat measurements .\n",
            "PANSS Prosocial subscale scores and PSP total score improved significantly with AL vs. placebo , without any dose-related difference in magnitude of response .\n",
            "Significant mean + / - SE improvements in @-item PANSS Prosocial scores from baseline to Day @ were observed for both individual active treatment groups ( e.g. , AL @ mg and AL @ mg groups ) vs. placebo .\n",
            "There were significant changes in PSP total score from baseline to Day @ for both AL doses vs. placebo .\n",
            "This post-hoc analysis demonstrated a significant improvement in social functioning with AL vs. placebo , as assessed by the PANSS Prosocial subscale and PSP total score .\n",
            "Fluoxetine was auxiliary use at the same time of routine using clozap-ine in the negative symptoms of schizophrenia , and the curative effect , treating time and safety were observed .\n",
            "Eighty-two in-patient patients were randomly divided into treating group ( n = @ ) and control group ( N -@ ) .\n",
            "Results : There was significant difference between the two groups , the effectual time of the former was @ weeks earlier than that of the later , there was no difference in safety between the @ groups .\n",
            "Conclusions\n",
            "Trial Purpose : The purpose of this study is to examine the clinical therapeutic dose in Japanese agitated patients with schizophrenia .\n",
            "Primary Outcome Measure : The primary objective is to examine the safety and efficacy of the clinical therapeutic dose of IM olanzapine ( @ mg/inj and @ mg/inj ) in Japanese agitated patients with schizophrenia Secondary Outcome Measure : To examine the efficacy of IM olanzapine by evaluating change from baseline to @ hours following the first IM injection in the PANSS Excited Component Total Score and the ACES .\n",
            "To examine the characteristics of sedation for each treatment group based on the ACES score .\n",
            "To examine a frequency of patients who needed second injection .\n",
            "Expected Total Enrollment : @ Participant Eligibility : Ages Eligible for Study : @ Years - @ Years .\n",
            "Genders Eligible for Study : Both Inclusion Criteria : Male or female patients at least @ years of age and less than @ years old .\n",
            "Patients must be inpatients during the study .\n",
            "Patients must have a diagnosis of schizophrenia as per the DSM-IV , as determined by the investigator .\n",
            "Patients must be considered by the investigator to be clinically agitated and to be clinically appropriate candidates for the treatment with intramuscular ( IM ) medication .\n",
            "Patients must have a minimum total score of greater than or equal to @ on the @ items of the PANSS-EC and at least one individual item score of greater than or equal to @ using the @-@ scoring system , prior to the first IM injection of study drug Exclusion Criteria : Serious , unstable illnesses such that death is anticipated within @ year or intensive care unit hospitalization for the disease is anticipated within @ months .\n",
            "This includes hepatic ( specifically any degree of jaundice ) , renal , gastroenterologic , respiratory , cardiovascular ( including ischemic heart disease ) , endocrinologic , neurologic , immunologic , or hematologic diseases .\n",
            "Known history of seizures ; however , a patient whose etiology is identifiable and has been resolved may be enrolled .\n",
            "Known history of diabetes mellitus , complications of diabetes mellitus , or potential diabetes mellitus as defined by patients with single blood glucose measurement based on site tests ; patients with values greater than or equal to @ mg/dL ( non-fasting ) or greater than or equal to @ mg/dL ( fasting ) must be excluded from the study .\n",
            "History of allergic reaction or intolerance to olanzapine .\n",
            "Have received treatment with psychostimulants or reserpine within @ week prior to study drug administration .\n",
            "OBJECTIVES : o study the impact of Pharmacist-Psychiatrist Collaborative customized Patient Education in patients with depression , Bipolar Affective Disorder ( BPAD ) , Schizophrenia and alcohol dependent Syndrome ( ADS ) in an Ambulatory Care Setting .\n",
            "METHODS : A prospective randomized control study was conducted in the psychiatry out-patient department of a tertiary care hospital for a period of @ months .\n",
            "Eligible patients ( @ ) were randomized into test group and control groups by simple randomization in each disease and followed for a period of six months .\n",
            "Customized patient education was provided to the test group with the help of patient education materials while the control group was on usual care .\n",
            "The medication adherence and quality of life ( QOL ) of both the groups were assessed and compared once in every two months by using Medication Adherence Rating Scale ( MARS ) and World Health Organization Quality of Life ( WHOQOL ) - BREF questionnaire respectively .\n",
            "RESULTS : Among the study population @ completed all the follow-ups out of which @ were in control group and @ in test group .\n",
            "Mean age was found to be @ + / - @ .\n",
            "Majority [ n = @ ( @ % ) ] of patients were diagnosed to have had depression followed by BPAD [ n = @ ( @ % ) ] .\n",
            "A statistically significant increase in the mean medication adherence score of test group was observed in all the follow-ups .\n",
            "The mean medication adherence scores was high in BPAD ( @ ) and depression ( @ ) compared to schizophrenia and ADS .\n",
            "Upon the analysis QOL , the difference in the overall mean score between test group and control was @ which was statistically significant .\n",
            "Comparison of mean medication adherence scores of all patients in each disease showed that BPAD patients had a mean increase of @ than depression , @ than ADS and @ than schizophrenia patients .\n",
            "CONCLUSIONS : Provision of customized patient education by pharmacist and psychiatrist improved the patient medication adherence and QOL .\n",
            "Objective : To investigate the family of psychological intervention on social function and the relapse rate in patients with first-episode schizophrenia .\n",
            "Methods : A random sampling method @ patients with first-episode schizophrenia inpatients were randomly divided into intervention group and drug group .\n",
            "Intervention group on the basis of the medication from the patient 's psychiatric symptoms almost relieved to start the implementation of family psychological intervention .\n",
            "The drug group received drug treatment .\n",
            "Enrollment and @ months of treatment , the Brief Psychiatric Rating Scale ( bprs ) and Social Disability Screening Scale ( sdss ) assessed after @ year , respectively .\n",
            "Results : After nine months after the family psychological intervention the intervention group bprs score and the insight factor scores significantly lower compared to the drug group .\n",
            "The cure rate of patients after @ year , the relapse rate and disability rate was significantly better in the intervention group .\n",
            "Objective : Many people with schizophrenia ( @-@ % ) demonstrate impaired insight .\n",
            "A number of interventions aiming to improve insight have been proposed and evaluated , for example cognitive behavioral therapy and psycho-education .\n",
            "Results of these interventions leave room for improvement .\n",
            "Therefore , we proposed a new intervention to improve insight in people with schizophrenia : REFLEX .\n",
            "REFLEX focuses on insight in one 's functioning in everyday life and changes in general functioning after psychosis by improving metacognitive acts necessary for insight ( self-reflectiveness , idiosyncratic self-certainty ) and reducing stigma-sensitivity .\n",
            "The primary objective was to improve insight .\n",
            "By improving insight , we hoped to improve functional outcome and symptoms .\n",
            "Methods : @ patients diagnosed with schizophrenia with poor insight were included in a multicenter randomized controlled trial .\n",
            "REFLEX was compared to an active control condition consisting of group wise simplified drill and practice cognitive remediation training ( CRT ) .\n",
            "Results : Clinical insight improved significantly in the REFLEX condition , but also in the control group .\n",
            "Self-stigma remained stable in both conditions .\n",
            "Self-reflectiveness , idiosyncratic self-certainty did not change during treatment .\n",
            "Improved insight was associated with significantly less depression .\n",
            "Conclusion : REFLEX leads to better insight , but this effect was not specific .\n",
            "Given that previous studies have shown that insight usually not improves with treatment as usual , it may be that simplified CRT also stimulates insight .\n",
            "Probably due to our recruitment strategy ( i.e. , selecting people with impaired insight ) , baseline self-stigma was already low , which may have left little room for improvement .\n",
            "The resocializing and activating properties of halopemide were investigated in an open study and a double-blind study in @ patients who had been hospitalized on account of various psychiatric disorders .\n",
            "The results of the open study showed a significant improvement in contact and activity , regardless of the nosological characteristics .\n",
            "There was no significant difference in therapeutic effect between the single ( @ x @ mg/day ) and the double ( @ x @ mg/day ) dose .\n",
            "The patients were more approachable , sought contact with their surroundings and showed a greater interest in their work .\n",
            "However , these results were not confirmed by the double-blind study , which for these target symptoms showed no significant difference between the placebo phase and halopemide phase .\n",
            "Two factors that might explain the discrepancy between the results of the open study and the double-blind study are postulated - the difference in experimental methods and the short duration of the study phases .\n",
            "Objective Investigation and discussion of the curative effect and security of aripiprazole on schizophrenia .\n",
            "Methods @ cases of schizophrenia patient s were randomly divided into two groups of the @ cases , the Study Group for aripiprazole treatment , the control group given risperidone in the t reatment , treatment @ w. Using PANSS scale , the overall impression of scale ( CGI ) and Deputy Scale ( TESS ) to inform the clinical efficacy and side effects .\n",
            "Results Aripiprazole group , the total efficiency of @ .\n",
            "@ % , @ % risperidone group , the two groups showed no significant difference ( P > @ .\n",
            "@ ) .\n",
            "Two groups of adverse reactions , aripiprazole EPS rate was less than risperidone .\n",
            "Conclusions Domestic aripiprazole is effective in the treatment of schizophrenia , security , economic , adverse reactions is light .\n",
            "A second generation of ( atypical ) antipsychotic drugs was introduced in the @s that now accounts for the vast majority of prescriptions for treating schizophrenia in the United States .\n",
            "The relative effectiveness of these new drugs is not known , and they have not been proven more effective than the first generation of antipsychotic drugs .\n",
            "To address this question , a comparison of an older drug , perphenazine , and the newer drugs olanzapine , quetiapine , risperidone , and ziprasidone was conducted supported by an NIMH contract .\n",
            "@ subjects with schizophrenia recruited at @ U.S. sites were randomly assigned in phase I of the study to flexibly-dosed treatment with olanzapine @ - @ mg/day , perphenazine @-@ mg/day , quetiapine @-@ mg/day , or risperidone @-@ mg/day under double-blind conditions and followed for up to @ months .\n",
            "Ziprasidone @-@ mg/day was included after its approval by the FDA when @ % of the sample had already been randomized .\n",
            "The primary aim was to determine if there were differences between the treatments in overall effectiveness , efficacy and tolerability .\n",
            "Subsequent phases of the study allowed for rerandomization to other treatments not received in phase I. Cost and service utilization was assessed throughout all phases of the study .\n",
            "The results and conclusions of phase I in will be presented and discussed\n",
            "Individualized metacognitive training ( MCT + ) is a novel psychotherapy that has been designed to specifically target delusional beliefs in people with psychosis .\n",
            "It works by developing an awareness of the implausible content of delusional beliefs , while also targeting the cognitive biases that contribute to their formation and maintenance .\n",
            "It was expected that MCT + would lead to significantly greater reductions in delusional severity compared to a cognitive remediation ( CR ) active control condition .\n",
            "A total of @ patients with a schizophrenia spectrum disorder and active delusions were randomized into four @-hourly sessions of MCT + ( n = @ ) or CR ( n = @ ) .\n",
            "All participants completed posttreatment assessment , and only @ participants did not complete @-month follow-up assessment , resulting in MCT + ( n = @ ) and CR ( n = @ ) for final analysis .\n",
            "The primary outcome measures of delusional and positive symptom severity were assessed rater-blind ; secondary outcome assessment was non-blinded and included clinical and cognitive insight , the jumping to conclusions ( JTC ) bias , and cognitive functioning .\n",
            "Participants in the MCT + condition showed significant reductions in delusional and overall positive symptom severity ( large effect ) and improved clinical insight ( moderate effect ) relative to CR controls .\n",
            "In contrast , CR controls showed moderate improvement in problem-solving ability relative to MCT + , but no other cognitive domain .\n",
            "Importantly , these findings were maintained at @-month follow-up .\n",
            "The study adds further efficacy to the MCT program , and suggests that even brief psychotherapy can help to ameliorate the symptoms of psychosis .\n",
            "BACKGROUND : Psychomotor agitation can be associated with a wide range of medical conditions .\n",
            "Although clinical practice advocates the use of several drugs for the management of psychomotor agitation , there are still very few controlled studies comparing the profiles of action and the adverse effects of different drugs that induce tranquilization .\n",
            "OBJECTIVES : The purpose of this study was to compare the efficacy and safety of @ low-dose pharmacological interventions used to control psychomotor agitation guided by the clinical response .\n",
            "METHODS : Using a randomized , rated-blind design , @ agitated patients were assigned to receive @ of @ treatments : haloperidol ( @ mg ) + promethazine ( @ mg ) ( HLP + PMZ ) , haloperidol ( @ mg ) + midazolam ( @ mg ) ( HLP + MID ) , ziprasidone ( @ mg ) ( ZIP ) , or olanzapine ( @ mg ) ( OLP ) .\n",
            "Patients were evaluated just before the intervention and after @ , @ , and @ minutes , using the Agitation-Calmness Evaluating Scale .\n",
            "Adverse effects were assessed within @ hours after the intervention , using selected items from the UKU Scale ( Ugvalg Klinisk Undersgelser Side Effect Scale ) .\n",
            "According to the clinical indication , medication could be repeated twice after the first injection .\n",
            "Data were analyzed using general linear model with repeated measures and logistic regression .\n",
            "RESULTS : All treatment options promoted a reduction in agitation , without causing excessive sedation , although a lower reduction in agitation was observed with HLP + PMZ and ZIP compared with HLP + MID and OLZ .\n",
            "The need for an additional dose of medication was observed in @ patients , and only @ remained agitated during the entire @-minute period .\n",
            "A higher risk for the development of extrapyramidal symptoms within the following @ hours was observed with HLP + PMZ .\n",
            "DISCUSSION : Low doses of haloperidol combined with midazolam can be as effective as olanzapine in reducing psychomotor agitation without increasing the risk of extrapyramidal effects .\n",
            "Because of the higher risk for the occurrence of extrapyramidal symptoms , the combination of haloperidol with promethazine should be considered a second-line treatment option .\n",
            "Caffeine and nicotine are widely used by schizophrenia patients and may worsen psychosis and affect antipsychotic therapies .\n",
            "However , they have also been accounted as augmentation strategies in treatment-resistant schizophrenia .\n",
            "Despite both substances are known to modulate dopamine and glutamate transmission , little is known about the molecular changes induced by these compounds in association to antipsychotics , mostly at the level of the postsynaptic density ( PSD ) , a site of dopamine-glutamate interplay .\n",
            "Here we investigated whether caffeine and nicotine , alone or combined with haloperidol , elicited significant changes in the levels of both transcripts and proteins of the PSD members Homer@ and Arc , which have been implicated in synaptic plasticity , schizophrenia pathophysiology , and antipsychotics molecular action .\n",
            "Homer@a mRNA expression was significantly reduced by caffeine and nicotine , alone or combined with haloperidol , compared to haloperidol .\n",
            "Haloperidol induced significantly higher Arc mRNA levels than both caffeine and caffeine plus haloperidol in the striatum .\n",
            "Arc mRNA expression was significantly higher by nicotine plus haloperidol vs. haloperidol in the cortex , while in striatum gene expression by nicotine was significantly lower than that by both haloperidol and nicotine plus haloperidol .\n",
            "Both Homer@a and Arc protein levels were significantly increased by caffeine , nicotine , and nicotine plus haloperidol .\n",
            "Homer@b mRNA expression was significantly increased by nicotine and nicotine plus haloperidol , while protein levels were unaffected .\n",
            "Locomotor activity was not significantly affected by caffeine , while it was reduced by nicotine .\n",
            "These data indicate that both caffeine and nicotine trigger relevant molecular changes in PSD sites when given in association with haloperidol .\n",
            "CAJ To Probe into the influence of nursing intervention on the self-knowledge recovery of patients with schizophrenia , @ cases of patients were selected randomly as test group and effective nursing intervention including @ steps of orientation , approval , deep-going , and direction were given based on routine treatment and nursing .\n",
            "However patients in control group only received routine treatment and nursing .\n",
            "NORS was adopted to determine the self-knowledge recovery of patients .\n",
            "Introduction : In schizophrenia ( SZ ) , the rates of metabolic syndrome , diabetes , heart disease , and obesity are two to five times greater than in the general public .\n",
            "Weight reduction by lifestyle change is the foundation of risk prevention in heart disease and diabetes .\n",
            "We report on a randomized controlled clinical trial ( RCT ) of behaviour therapy for weight loss in Sz .\n",
            "Methods : Community-dwelling , obese , and overweight Sz patients ( n = @ ) were randomly assigned to either a @-week behaviour therapy for weight loss ( BT ) , to usual care ( TAU ) , or to @ weeks of behavioural treatment for enhancing social skills ( SST ) .\n",
            "Randomization was stratified by type of antipsychotic medication and initial BMI .\n",
            "This was designed to be a pragmatic trial , hence patients with medical , psychiatric , or substance misuse comorbidities were not excluded .\n",
            "Both interventions ( BT and SST ) were manualized into a @-session format to be delivered over @ weeks by mental health clinicians who were familiar with running groups for this population .\n",
            "Results : There was mean weight loss in subjects assigned to BT ( -@ lb ) , while the SST patients lost no weight , and those in the TAU group gained weight ( +@ lb ) , at @ weeks .\n",
            "The differences were highly statistically significant ( F @ , @ = @ ; p < .@ ) in both intentto - treat and on treatment analyses .\n",
            "The effect size of the difference between BT and SST was @-@ and @-@ versus TAU .\n",
            "Fifty per cent of patients lost at least @ % of baseline weight , and @ % lost at least @ % of baseline weight in the BT group .\n",
            "Conclusions : Obese and overweight Sz patients want to lose weight , and are able to do so when offered group behavioural treatment .\n",
            "The findings show that this is not a non-specific effect of increased attention and clinician contact .\n",
            "The large effect size also suggests that the treatment effect is robust .\n",
            "These results were obtained by mental health clinicians , using a manual to conduct group therapy , further suggesting that the treatment is feasible in most usual settings of care .\n",
            "Objective quetiapine combined clonazepam with typical antipsychotic haloperidol efficacy and adverse effects of treatment of patients with schizophrenia accompanied by excited agitation .\n",
            "The method in accordance with Ccmd-@ diagnostic criteria for schizophrenia hospitalized patients randomly assigned to quetiapine combined clonazepam and haloperidol group , observed for @ days .\n",
            "Assessment of adverse side effects scale to assess the efficacy of the Positive and Negative Syndrome Scale .\n",
            "Results of the combined group and haloperidol group @ days , to @ days panss and excitement factor score after treatment compared with before treatment were p < @,@ day p < @ significant difference ; combination group and haloperidol group The ratings comparison was no significant difference , p > @ .\n",
            "Combination group akathisia , muscle rigidity , tremor , reversing exercise was significantly lower than the haloperidol group , and the difference was statistically significant ( p < @ ) .\n",
            "Conclusion quetiapine combination of clonazepam may be effective in treating patients with acute phase of schizophrenia degree of excitement , its efficacy with haloperidol treatment , but fewer adverse reactions , the security is better than haloperidol .\n",
            "Background : Several placebo controlled studies investigating lamotrigine augmentation of clozapine in schizophrenia patients with partial response have shown varying results .\n",
            "The aim of this study was to further investigate the efficacy and safety of this augmentation strategy , and its effect on the glutamatergic system through utilizing mismatch negativity ( MMN ) component of auditory event related potentials .\n",
            "Methods : The study was designed to evaluate the efficacy and safety of lamotrigine augmentation of clozapine in a @-week , double-blind , placebo-controlled , prospective , randomized design .\n",
            "Thirty-four patients diagnosed according to DSM-IV schizophrenia criteria and with partial response to clozapine were included .\n",
            "Patients were randomized to @ .\n",
            "mg/day of lamotrigine or placebo , gradually increasing up to @ .\n",
            "mg/day on the @th week .\n",
            "The change in psychopathology was assessed with Positive and Negative Syndrome ( PANSS ) , Calgary Depression ( CDS ) and Clinical Global Impression-Severity ( CGI-S ) scales .\n",
            "A neuropsychological test battery was administered and MMN measurements were also obtained at baseline and endpoint .\n",
            "Safety evaluation included physical examination , UKU Side Effect Rating Scale ( UKU ) assessment and serum drug level measurements .\n",
            "Results : No significant differences were found between the two treatment groups in PANSS Positive and General Psychopathology , CDS , neurocognitive test and UKU scores , as well as MMN measurements .\n",
            "PANSS Total , Negative and CGI-S scores showed significant improvement compared to lamotrigine in the placebo group .\n",
            "Conclusion : This study did not show any benefit of augmentation of clozapine with lamotrigine in schizophrenia patients with partial response .\n",
            "The need for further investigation of other augmentation strategies of clozapine in partially responsive schizophrenia patients is evident .\n",
            "@ Elsevier B.V.\n",
            "In their recent report in Neuropsychopharmacology , Casey et al ( @ ) conclude ' combination therapy with divalproex plus either olanzapine or risperidone improved PANSS total and positive scores compared with antipsychotic monotherapy ' .\n",
            "Given the failure of the trial to show efficacy at the primary end point , the statement seems ill founded : apparent early gains were not sustained at @ days .\n",
            "They also conclude that ' divalproex was as well tolerated as antipsychotic monotherapy ' , but their analysis is biased .\n",
            "Study groups were analyzed separately ( risperidone vs risperidone/divalproex , olanzapine vs olanzapine/divalproex ) or in combination ( antipsychotic monotherapy vs antipsychotic/divalproex ) in ways that enhanced the appearance of benefit and reduced evidence of risk .\n",
            "The study was not designed or powered to detect equivalency between the two antipsychotics yet combined them in the efficacy analysis .\n",
            "The authors justify this combined analysis on the basis of a test for interaction that is underpowered to detect a meaningful difference in a study of this size .\n",
            "Studies directly comparing the two have indeed identified differences in efficacy ( Conley and Mahmoud , @ ) .\n",
            "As shown in Figure @ of the paper , the analysis of uncombined data failed to demonstrate statistically significant benefit for adjunctive divalproex with either antipsychotic .\n",
            "At the same time , the authors emphasize the difference between the two drugs in the safety analysis .\n",
            "The net result is that the safety analysis has less power than the efficacy analysis .\n",
            "If instead the groups are combined for the analysis of adverse events , there is significantly more somnolence among patients treated with divalproex adjunctive therapy ( Mantel  Hanzel chi@ , p = @ , data obtained from Table @ ) .\n",
            "The authors assert that there was no increased somnolence on the basis of evaluating uncombined data .\n",
            "This , the largest randomized control trial to date for the use of divalproex in schizophrenia is an important study .\n",
            "The authors discuss several possible explanations for the failure to find benefit at @ days , but do not entertain the possibility that it was a ' true negative ' or that any initial benefit was transient or merely random .\n",
            "One alternative explanation suggested by the data is that accelerated improvement in symptom rating scores is achieved through nonspecific sedation .\n",
            "Was significant improvement found among patients without somnolence ?\n",
            "Regardless , the failure of the study to attain its primary end point is a major finding and should have been included in the abstract .\n",
            "This negative finding has important clinical implications .\n",
            "Added to the mixed results of smaller previous randomized trials ( Dose et al , @ ; Hesslinger et al , @ ; Wassef et al , @ ) , it further weakens support for the widespread use of divalproex for chronic schizophrenia .\n",
            "EDUCATIONAL OBJECTIVE - At the conclusion of this presentation , the participant should be able to recognize prolactin elevations with atypical antipsychotic drugs ; to appreciate differences between drugs in elevating prolactin ; to understand that prolactin elevation continues over years SUMMARY-In a @-week , DOUBLE-blind study , @ patients with schizophrenia ( @ male and six female ) were RANDOMized to the ziprasidone group and @ patients ( eight male and three female ) to the risperidone group with serial estimation of prolactin .\n",
            "The mean baseline prolactin level was @ ng/ml in the ziprasidone group , decreased to @ at the end of week @ , and @ ng / ml at the end of week @ .\n",
            "The mean baseline prolactin value of @ ng / ml in the risperidone group increased to @ ng/ml at the end of week @ , and to @ ng/ml at the end of week @ .\n",
            "Four of the @ patients had normal baseline prolactin , which increased in all of them .\n",
            "Of the seven patients who had normal baseline prolactin in the risperidone group , the level decreased in four , did not change in one , and increased in two .\n",
            "These results indicate that ( a ) both groups had high baseline prolactin levels , ( b ) during the treatment , prolactin levels decreased in ziprasidone group and increased in the risperidone group , ( c ) in patients with normal prolactin levels at the baseline , the levels increased only in the risperidone group , and ( d ) based on our data , ziprasidone @ - @ mg has little effect on prolactin levels\n",
            "This study examines the cost effectiveness of three intervention strategies for people with severe mental illness who are dually diagnosed clients in terms of service use and costs .\n",
            "The interventions represent three primary approaches to treating these disorders : @-step recovery , case management , and behavioural skills training .\n",
            "Interim findings from the study indicate that all three approaches are reducing acute and subacute service use and increasing involvement with the outpatient and case management treatments .\n",
            "However , both the case management and the behavioural skills approaches reduce costs more than the @-step recovery approach , although not to a statistically significant degree in the data collected thus far .\n",
            "Overall , the societal costs for these clients are reduced by @ % without increasing the burden on client families or on the criminal justice system .\n",
            "Objective To compare the efficacy and the quality of life of schizophrenic patients treated with quetiapine and Chlorpromazine .\n",
            "Mehtods The schizophrenic patients were randomly divided into quetiapine group and Chlorpromazine group .\n",
            "Treated for @ weeks , the efficacy was measured with the positive and negative symptoms scale ( PNSS ) , the side effects was assessed with TESS , while the quality of life was assessed with WHO QOL - @ .\n",
            "Results There was significant difference between the score of PANSS in two groups after two weeks ( P < @ .\n",
            "@ ) , and the significant difference still existed affter @weeks ( P < @ .\n",
            "@ ) ; There was significant difference in two groups in the treatment of negative symptoms for @ weeks ( P < @ .\n",
            "@ ) .\n",
            "The difference was very signficant after @ weeks ; There was significant difference between the score of TESS in two groups at the end of @ weeks , @ weeks , @ weeks and @ weeks ( P < @ .\n",
            "@ ) ; There was significant difference between the score of WHOQOT - @ in two groups except circumstance ( P < @ .\n",
            "@ or P < @ .\n",
            "@ ) .\n",
            "Conclusion Schizophrenic patients treaded with quetiapine mend better and more quickly , and their quality of life is more improved .\n",
            "POLISH - Badanie mia?o na celu por  wnanie skuteczno?ci opieki zespo?  w leczenia ?\n",
            "rodowiskowego i leczenia tradycyjnego ( ambulatoryjnego ) u przewlekle chorych na psychozy ( g?  wnie na schizofreni ?\n",
            ".\n",
            "Przebadano @ pacjent  w , kt  rzy losowo zostali przydzieleni do grup eksperymentalnych i kontrolnych , oraz przedstawicieli ich rodzin .\n",
            "Wszystkie te osoby by?y badane trzykrotnie - na pocz?tku , po @ miesi?cach i po @ miesi?cach .\n",
            "Wykazano , ?\n",
            "e efekty uzyskane po @ miesi?cach opieki ?\n",
            "rodowiskowej s ?\n",
            "istotnie lepsze od efekt  w opieki tradycyjnej w wi?kszo?ci zastosowanych miar .\n",
            "Wy?sz ?\n",
            "skuteczno ??\n",
            "zespo?  w ?\n",
            "rodowiskowych stwierdzono w nast?puj?cych miarach ; czas hospitalizacji , cztery obszary funkcjonowania spo?ecznego ( og  ?\n",
            "em , kontakty interpersonalne , niezale?no ??\n",
            ", praca ) , satysfakcja chorych z us?ug , zachowania uci ??\n",
            "liwe pacjent  w i obci ??\n",
            "enie rodziny .\n",
            "Nie stwierdzono wi?kszej skuteczno?ci zespo?  w w nast?puj?cych miarach : liczba przyj ??\n",
            "i trzy obszary funckcjonowania spo?ecznego ( wycofanie , rekreacja , prospo?eczno ?? )\n",
            ".\n",
            "Efekty pracy zespo?  w leczenia po @ miesi?cach s ?\n",
            "wyra?nie lepsze ni ?\n",
            "uzyskane po @ miesi?cach , zw?aszcza w zakresie obci ??\n",
            "enia rodziny , zachowa ?\n",
            "uci ??\n",
            "liwych oraz czasu hospitalizacji chorych - po @ miesi?cach nie by?o r  ?\n",
            "nic mi?dzy grupami , a po @ miesi?cach uzyskano istotnie wi?ksz ?\n",
            "popraw ?\n",
            "u chorych obj?tych opiek ?\n",
            "?\n",
            "rodowiskow ?\n",
            "ni ?\n",
            "tradycyjn ?\n",
            ".\n",
            "ENGLISH - The aim of the study was to compare effectiveness of mobile community teams and traditional outpatients psychiatric care provision to patients with chronic psychoses , schizophrenia mostly .\n",
            "Participants were @ patients ( randomly assigned to either experimental or control conditions ) , and their family members .\n",
            "All the participants were examined thrice : at baseline , at @ months and at @ months .\n",
            "Effects attained after @ months of community-based care were found to be significantly better than those of traditional care on the majority of measures used in the study .\n",
            "The following indicators evidence a higher effectiveness of care provided by mobile community teams : duration of hospitalization , hour areas of social functioning ( general , interpersonal contacts , independence , work ) , patients   satisfaction with services , patients   troublesome behaviors , and family burden .\n",
            "Effectiveness of mobile community teams was not found to be higher on the following measurIS : number of hospital admissions , and three areas of social functioning ( withdrawal , recreation , pro-social activities .\n",
            "Effects of mobile community teams   work were evidently better after @ months than these at @ months , especially as regard family burden , troublesome bahavioiurs and duration of hospitalization - at @ months there were no intergroup differences , while at @ months a significantly higher improvement was attained in patiens receiving community-based care than in those provided with traditional outpatient care . )\n",
            "The acute pharmacological actions of methylphenidate , a potent psychotogenic stimulant , were studied by measuring plasma homovanillic acid ( HVA ) and serum growth hormone ( GH ) as indices of presynaptic and postsynaptic functions , respectively .\n",
            "Twenty psychiatric inpatients participated in a double-blind , placebo-randomized study of methylphenidate infusion .\n",
            "Multiple samples of plasma HVA and GH were measured before and up to @ hours after both methylphenidate and placebo infusions .\n",
            "There was a robust and significant GH response during the @-hour postmethylphenidate period when compared to placebo .\n",
            "The peak response was significantly greater in male patients than in female patients .\n",
            "Although there were no changes in plasma HVA during the @ hours following the infusion , there was a significant decrease in HVA @ hours after methylphenidate as compared to preinfusion baseline values .\n",
            "Plasma HVA values also tended to be lower @ hours after methylphenidate when compared to the corresponding postplacebo value .\n",
            "SCHIZophrenic patients did not differ significantly from nonSCHIZophrenic patients in their physiological or biochemical responses .\n",
            "Objective To investigate the electric convulsive effect of refractory schizophrenia .\n",
            "@ cases of hospitalized patients with refractory schizophrenia were randomly divided into two groups , the control group , @ cases were treated with conventional antipsychotic treatment , the test group of @ cases in the conventional antipsychotic therapy based on the use of electroconvulsive shock therapy , @d positive symptom assessment Scale ( SAPS ) and Negative Symptom assessment Scale ( SANS ) test results .\n",
            "Results of electric convulsive before the control group and the experimental group , no significant difference .\n",
            "Symptoms factor equipartition of the test group after treatment compared with the control group had a significant effect .\n",
            "The purpose of this study is to assess the efficacy , safety , and tolerability of fixed doses of OPC-@ versus placebo for the treatment of adult subjects with an acute relapse of schizophrenia .\n",
            " Primary Purpose : Treatment ; @-@-@ ; The change in Positive and Negative Syndrome Scale Total Score .\n",
            " Change in Clinical Global Impression - Severity of Illness scale score\n",
            "A double-blind placebo ( PB ) - controlled trial of Meclofenoxate Hydrochloride ( MF ) was done in order to prove the efficacy for tardive dyskinesia ( TD ) in which any existing therapeutic agents had resulted refractory ; it is expected to exhibit its efficacy from the chemical structure and the cholinergic pharmacology .\n",
            "The subjects consisted of @ patients with possibly typical TD ( @ in MF group and @ in PB group ) .\n",
            "Most of them were by in-patients with schizophrenia at the age of more than @ years with a past history of illness for more than @ years and of long-term use of psychotropic drugs .\n",
            "There were no significant differences in background factors between both groups .\n",
            "The test agent was given by @ tablets ( each containing @ mg of MF ) daily for @ weeks .\n",
            "No subjects discontinued nor dropped out from the study .\n",
            "All subjects completed the trial .\n",
            "Synthetic assessment resulted in FGIR of \" moderate improved \" and \" markedly improved \" by @ % in MF group and @ % in PB group ( OSR of \" appearance of adverse reactions and abnormal laboratory values \" by @ % in MF group and @ % in PB group , and GUR of \" useful \" and \" much useful \" by @ % in MF group and @ % in PB group .\n",
            "In addition , according to video assessments , it resulted in \" moderately improved \" and \" markedly improved \" by @ % in MF group and @ % in PB group and aggravation rate by @ % in MF group and @ % in PB group .\n",
            "Time-course analyses on GIR showed no significant differences at the @nd week but significantly higher improvement rate of \" slightly improved \" , \" moderately improved \" and \" markedly improved \" in MF group ( @ % ) than PB group ( @ % ) at the @th week .\n",
            "Incidence rate and aggravation rate of adverse reactions and abnormal laboratory values were @ % and @ % , respectively , in MF group and @ % and @ % , respectively , in PB group .\n",
            "From the results obtained in the present study , MF could not be regarded as a powerful therapeutic agent for TD .\n",
            "However , MF might be an agent worthy to be tried for administration over a for short period of time .\n",
            "It has extremely superior safety even in psychotic patients who are receiving psychopharmacotherapy .\n",
            "( author abst . ) )\n",
            "Medical and psychological studies of @ patients , before , during , and after the experimental administration of reserpine ( with appropriate control groups ) for @ days indicated no evidence for improvement as measured by the L-M Fergus Falls Behavior Rating Scale and by The Minnesota Multiphasic Personality Inventory .\n",
            "\" Awarding of open-ward privileges did not result in improved interpersonal relationships or behavioral improvement \" among patients receiving reserpine , placebo , or no medication .\n",
            "Drug therapy , however , was accompanied by a lowering of blood pressure and slight gain in weight .\n",
            "These results are discussed in relation to other studies wherein findings have been , behaviorally speaking , the reverse .\n",
            "Not available Design/methodology : Randomised controlled trial Participants - inclusion criteria : @ .\n",
            "Written informed consent Participants - exclusion criteria : Not available Status of trial : Completed Interventions : @ .\n",
            "Four groups randomly allocated to placebo or @ g , @ g or @ g ethyl-EPA/day on a double blind basis\n",
            "To assess the cost and effectiveness of risperidone , olanzapine , and conventional antipsychotic medications under ' usual practice ' conditions in a large , public mental health system , @ persons diagnosed with schizophrenia or schizoaffective disorder were RANDOMly assigned to one of these three medication groups and followed prospectively over a @-month period using standard instruments and procedures .\n",
            "Psychiatric medication costs increased more over time in both the olanzapine and risperidone groups than in the conventional medication group .\n",
            "Compliance with the prescribed medication was higher in the olanzapine group than in the conventional group .\n",
            "No differential effects by medication group were evident in this sample on the symptoms of schizophrenia , side effects , psychosocial functioning , time to discharge for index hospitalization , survival to initial rehospitalization , or client satisfaction with services .\n",
            "These results extend findings from previous efficacy and naturalistic studies in several ways but are limited chiefly by the small number of subjects who completed @ to @ months of the clinical trial , and the resulting power to detect differences in the statistical analyses\n",
            "Objective : To observe the the aripiprazole clinical efficacy and safety in the treatment of schizophrenia .\n",
            "Methods : @ patients with schizophrenia were randomly divided into two groups , aripiprazole group of @ cases , @ cases risperidone group .\n",
            "Taking aripiprazole and risperidone , respectively , for @ weeks .\n",
            "Respectively before treatment @,@ weekend using the Positive and Negative Syndrome Scale ( panss ) to assess the efficacy , side effects scale ( tess ) assessment of adverse reactions .\n",
            "Results : Both efficacy differences not statistically significant ( p > @ ) , the incidence of adverse drug reactions are similar ( p > @ ) .\n",
            "Despite recent advances , the treatment of schizophrenic psychoses remains a considerable challenge when remission is the goal .\n",
            "Although acute psychotic symptoms respond quite well to current antipsychotics , their limited effects on negative symptoms and cognitive decline as well as their side-effect profile are still problematic regarding full recovery of social and vocational performance and integration for a substantial number of patients .\n",
            "The ESPRIT research network is focussed on early stages of psychosis and will examine the therapeutic potential of cannabidol as an add-on treatment in post-acute schizophrenia .\n",
            "In this double blind randomized clinical trial , longer-term efficacy and safety of the compound will be investigated .\n",
            "Cannabidiol acts by modulating the function of the endocannabinoid system .\n",
            "Thereby , it represents a potentially new class of antipsychotic compounds , hopefully effective to improve recovery of schizophrenic patients .\n",
            "Objective : Patients with schizophrenia have poor insight into their illness .\n",
            "This lack of awareness reaches its peak during acute episodes and persists in approximately half of patients throughout their illness .\n",
            "Prior findings suggest insight is associated with improvement of positive negative and affective symptoms .\n",
            "We explored the relationship between insight symptoms duration of treatment cognition and social functioning in a @-year study of patients with schizophrenia or schizoaffective disorder .\n",
            "Methods : Stable patients received @ or @ mg of long-acting injectable risperidone every @ weeks for @ year .\n",
            "The Positive and Negative Syndrome Scale PANSS item G@ @ no impairment , @ = severe impairment ) measured insight .\n",
            "Other measures included PANSS negative symptoms factor , Clinical Global Impression of Severity ( CGI-S ) , Strauss-Carpenter Levels of Functioning ( LOF ) , Personal and Social Performance ( PSP ) , and a cognitive test battery .\n",
            "Correlation/regression post-hoc analyses examined associations between insight , treatment duration , and clinical/functional measures .\n",
            "Results : Baseline insight correlated significantly ( P @ ; @ ) with baseline CGI-S ( r = @ ) , PANSS subscales range r @-@ ) , and functioning scores ( LOF , r = -@ ; PSP , r -@ ) .\n",
            "There was significant correlation between insight and attention ( r = -@ ; P @ ; @ ) and declarative memory ( r = -@ , P @ ; @ ) ; and weaker correlations with visual motor ( r = -@ ; P = @ ) and social cognition ( r = -@ ; P = @ ) .\n",
            "Regression models identified significant predictors ( P @ , and @ ) of PSP variance as change in insight ( -@ PSP point/insight point ) as well as change in negative symptoms ( -@ PSP point/negative symptom point ) , and treatment duration @ .\n",
            "@ PSP point month .\n",
            "Conclusion : These findings support a relationship between insight duration of treatment and social functioning .\n",
            "The interaction between insight cognition and overall functioning will be discussed .\n",
            "Sponsored by Janssen LP .\n",
            "AIM : This post hoc analysis of a double-blind ( DB ) , randomized , placebo-controlled , relapse-prevention study evaluated the effects of paliperidone palmitate once-every-@-months ( PP@M ) in a subpopulation of adults with early illness schizophrenia ( duration < / = @ years ) from a clinical trial .\n",
            "METHODS : Patients received either PP@M or placebo every @ months in the DB phase .\n",
            "The primary efficacy variable was time from randomization to first relapse .\n",
            "Symptom severity , patient functioning , and safety were also assessed .\n",
            "RESULTS : A total of @ patients who entered the DB phase met the criteria for early illness schizophrenia ( PP@M , n = @ ; placebo , n = @ ) .\n",
            "PP@M significantly delayed time to relapse vs placebo ( P = .@ ; hazard ratio , @ ; @ % CI , @-@ ) .\n",
            "Symptomatic control and patient functioning were maintained in the PP@M group but significantly worsened in the placebo group .\n",
            "There were no unexpected tolerability findings .\n",
            "CONCLUSIONS : PP@M reduced relapse risk and maintained symptomatic and functional improvements compared with placebo in patients with early illness schizophrenia .\n",
            "Allocation : cognitive traning programme and controlled treatment study .\n",
            "Participants : schizophrenia .\n",
            "Interventions : battery of cognitive tasks used to try to remediate the following : cognitive differentiation , attention , memory and social perception .\n",
            "Outcomes :\n",
            "Objective : To investigate the drug self-disposal and symptoms of self-monitoring of the two kinds of skills training on the prevention of relapse of schizophrenic patients and rehabilitation of their mental disabilities .\n",
            "Methods : @ cases after discharge in patients with schizophrenia were randomly divided into skills training group ( hereinafter referred to as the training group , @ cases ) and control group ( @ cases ) , the subgroup of patients of the training group skills training , a total of @ weeks ; both groups @ patients completed @ year follow-up .\n",
            "Assessed with the Brief Psychiatric Rating Scale ( BPRS ) , social function rating scale ( SSSI ) and homemade guardian and patient drug compliance score sheet .\n",
            "Results : The guardian of the training group and patient drug compliance score , relapse rate , readmission rate and degree of mental disability to reduce the efficiency of both were significantly better than the control group ( P < @ ) .\n",
            "Under double-blind conditions , effects of thiothixene , a thioxanthene derivative , were compared with effects of thioridazine in @ chronic schizophrenic patients who had received no medication for at least @ days .\n",
            "It should be noted that these patients were selected from a special chronic schizophrenic population in which no group of subjects has shown a statistically significant placebo response in previous double-blind studies during the past @ years .\n",
            "The average maximum dosage of thiothixene was @ mg .\n",
            "daily , and of thioridazine , @ mg .\n",
            "daily .\n",
            "The global ratings of improvement and @ individual measures derived from the objective psychologic tests and rating scales showed no significant differences in therapeutic efficacy between the @ drug groups .\n",
            "Extrapyramidal side effects were more frequently associated with administration of thiothixene , while lethargy and orthostatic hypotension were observed only in the thioridazine group .\n",
            "Thiothixene is a compound that has definite antipsychotic properties and can be administered with relative safety .\n",
            "DESCRIPTION : ( Applicant 's Abstract ) Cannabis use disorder contributes to the morbidity of schizophrenia , leading to , poorer overall functioning .\n",
            "The typical antipsychotic drugs are of limited value in controlling cannabis use in these \" dual diagnosis \" patients .\n",
            "This study will assess whether new antipsychotic medications , introduced into clinical practice in the past decade , are of value for this purpose .\n",
            "Preliminary data suggest that the atypical antipsychotic drug clozapine ( CLOZ ) , currently used primarily for treatment resistant patients , may limit cannabis use in \" dual diagnosis \" patients with schizophrenia much more effectively than do either typical antipsychotics or the \" novel \" ( post-CLOZ ) antipsychotic risperidone ( RISP ) .\n",
            "In a recently published paper , we have hypothesized ( a ) that CLOZ will lessen substance use in such \" dual diagnosis \" patients in part because of its mechanism of action that includes release of dopamine ( DA ) in the prefrontal cortex ( PFC ) , and ( b ) that the CLOZ-induced release of DA in the PFC will decrease negative symptoms ( an effect shared especially by the novel antipsychotic RISP ) .\n",
            "Moreover , we have further hypothesized , ( c ) that through its diverse effects on both dopaminergic and noradrenergic systems , CLOZ ( but not RISP or typical antipsychotics ) will help to normalize dysfunctional brain reward circuits that may underlie the comorbid substance use in patients with schizophrenia .\n",
            "In the proposed study , patients comorbid for both schizophrenia and a cannabis use disorder will be randomly assigned to double-blind treatment ( for @ weeks ) with either CLOZ or RISP .\n",
            "The primary aim of this study is to launch a carefully controlled pharmacological trial of the short-term effects of CLOZ and RISP on cannabis use in this population to test the hypothesis that patients treated with CLOZ will have decreases in cannabis use as compared to patients treated with RISP .\n",
            "A secondary aim is to begin to investigate the process by which CLOZ produces its effects on cannabis use through study of negative symptoms .\n",
            "A subsidiary aim is to begin to address key auxiliary measures of the effects of CLOZ in this \" dual diagnosis \" population : psychiatric symptoms , quality of life , and measures of neuropsychological functions .\n",
            "If the results of this study confirm the preliminary data , they could suggest a new use for CLOZ , one that could have important public health implications .\n",
            "Experimental tests of whether an individual neuroleptic treatment for compensation of acute schizophrenic disorders is more effective and has fewer side effects than a standard therapy were performed under double-blind conditions .\n",
            "For this purpose , a group of @ patients was treated with @ mg haloperidol/day for the duration of @ days , and another group of @ patients was treated with @ mg haloperidol/day for the same period .\n",
            "@ patients of a third group were treated for @ days with an individual haloperidol dose adapted to the psychopathological findings .\n",
            "Patients were randomly allocated to the treatment groups .\n",
            "The medication was laid down in accordance with the randomization plan without informing the ward staff and raters by a leading physician of the hospital who was not involved in the data collection in the investigation .\n",
            "The psychological findings were registered by means of the BPRS and the global appraisal by the doctor ( CGI ) on days @ , @ and @ .\n",
            "Extrapyramidal side effects were registered by means of the Simpson scale on days @ , @ and @ .\n",
            "A superiority of the individually adapted treatment over standardized treatment could be demonstrated neither for the therapeutic target parameters nor for the side effect variables .\n",
            "On the contrary , a tendency to superiority in the groups treated with fixed doses was found .\n",
            "The results are discussed in terms of their significance for treatment practice .\n",
            "Background : Lack of insight in schizophrenia was first described in terms of reduced awareness of the presence and significance ofpsychotic symptoms .\n",
            "However , unawareness is frequently associatedwith deficits in self-assessment of cognitive and functional abilities , aswell as outcome of rehabilitation-oriented interventions .\n",
            "The relationshipbetween reduced awareness of illness and the ability to performcognitive tests was evaluated in a controlled clinical study .\n",
            "The extent towhich treatment-related improvement in awareness was related toimprovement in cognition was also examined.Methods : Patients with acute exacerbation of Lack of insight inschizophrenia was first described in terms of reduced awareness of thepresence and significance of psychotic symptoms .\n",
            "However , unawarenessis frequently associated with deficits in self-assessment of cognitiveand functional abilities , as well as outcome of rehabilitation-orientedinterventions .\n",
            "The relationship between reduced awareness of illnessand the ability to perform cognitive tests was evaluated in a controlledclinical study .\n",
            "The extent to which treatment-related improvement inawareness was related to improvement in cognition was alsoexamined.schizophrenia were randomized to once-daily treatment withlurasidone @ mg ( N = @ , LUR@ ) , lurasidone @ mg ( N = @ , LUR@ ) , quetiapine XR @ mg ( N = @ , QXR ) or placebo ( N = @ , PBO ) in a @-week , double-blind study , followed by a@-month , double-blind extension .\n",
            "Cognitive performance was examinedwith the computerized CogState system and functional capacity wasassessed with the UPSA-B at baseline , after @ weeks , and at @ and @ months in the extension phase .\n",
            "Impairment of insight was assessed byPANSS item G@ \" lack of judgment and insight \" at baseline and at eachof the post-randomization visits.Results : A total of @ patients ( @ CogState battery neurocognitiveassessments ) were tested during the acute phase .\n",
            "Of these assessments ,@ neurocognitive tests failed the completion or prespecified evaluabilitycriteria ( n = @ patients ) .\n",
            "In this non-evaluable cohort , baselinetotal PANSS scores , insight scores ( G@ ) , and neurocognitive compositescores were @ ( SD @ ) , @ ( SD @ , median @ ) , and z = -@ ( SD @ ) , respectively , compared to normative standards .\n",
            "The remaining twohundred and sixty-seven patients provided evaluable neurocognitivecomposite scores at both baseline and week @ assessments ( LOCF ) , withthe proportion of subjects with evaluable domain Z-scores ranging fromn = @/@ ( @ % ) for the visual learning task to n = @/@ ( @ % ) forthe verbal learning task .\n",
            "Lower levels of impairment in insight at baselinepredicted increased likelihood of completion of the study and anincreased likelihood of providing evaluable neurocognitive testing scoresat @ weeks ( po = @ ) in the full ITT sample ( N = @ ) .\n",
            "In patientswhose testing results met the prespecified evaluability criteria ( n = @ ) , LUR@ was superior to both placebo ( p = @ ) and quetiapine XR ( p = @ ) for the composite cognitive functioning measure at week @ .\n",
            "Compared to placebo , patients receiving LUR@ also had superiorperformance in the verbal learning ( p = @ ) , social cognition ( p < @ ) , and memory delayed recall domains ( p = @ ) .\n",
            "In contrast , treatment with QXR , led to significant worsening in attention/vigilancedomains , but not the total score , when comparing to placebo .\n",
            "PANSStotal and Insight item scores were significantly improved in LUR@ , LUR@ and QXR compared to placebo .\n",
            "Improved insight ( lower PANSSitem G@ scores ) during the acute phase was a significant mediator forthe effect of LUR@ ( vs. placebo ) on the neurocognitive composite score ( p < @ ) , UPSA-B total score ( p < @ ) , and the domain scores forverbal learning ( p < @ ) and social cognition ( p < @ ) but not fordelayed recall memory ( p = @ ) , during the acute treatment period.Conclusions : Lower insight predicted reduced ability to validlycomplete cognitive assessments .\n",
            "Conversely , gain in insightpredicted improvements in cognitive functioning and performance-based measures of functional capacity .\n",
            "These resultssuggest that even objective performance-based assessments canbe affected by changes in awareness of illness , consistent with priorresearch in this area .\n",
            "Although the current findings suggest thatgain in insight is associated with improved cognitive andfunctional capacity , the directionality of this change remains tobe established .\n",
            "Future research will need to examine the extent towhich impaired awareness impacts the willingness to accepttreatments for cognitive and functional deficits and the extent towhich these deficits can be ameliorated by direct interventions .\n",
            "Objective To analyse the effect of @ possible predictor variables on four outcome variables in young patients with early onset schizophrenia and related disorders .\n",
            "Method Patients who participated in a @-month intervention programme , were stratified into low and high parental expressed emotion and randomized over two conditions : standard intervention and standard plus family intervention .\n",
            "Baseline variables were measured during intervention .\n",
            "Outcome variables were measured over @ years after discharge , and comprised : duration of psychotic episodes , living institutions for psychiatric patients , structural activities and help from the family .\n",
            "Results From the @ baseline variables , six had possible predictive value and were entered in a multivariate analysis .\n",
            "The resulting path model indicated that the score on the Strauss & Carpenter prognostic scale is predictive for duration of psychotic episodes .\n",
            "Diagnosis ( schizophrenia vs. schizophrenia-related disorder ) predicts help from the family .\n",
            "Age at first psychotic episode predicts living in institutions for psychiatric patients .\n",
            "Conclusion Long-term outcome variables can be predicted from baseline variables only moderately .\n",
            "A composite scale ( Strauss & Carpenter prognostic scale ) predicts psychotic episodes better than single demographic or illness variables .\n",
            "As part of an open clinical trial currently underway at the Max Planck Institute of Psychiatry in Munich , the feasibility of behavioral family management ( Falloon et al. @ ) for schizophrenia in combination with two different neuroleptic medication strategies was investigated .\n",
            "The treatment approaches were psychoeducational family management with a standard dose or with targeted medication .\n",
            "In this article the following questions were addressed : ( @ ) What proportion of the total schizophrenia population admitted as inpatients might be eligible for psychoeducational family treatment ( assessment based on n = @ over a @-month period ) ?\n",
            "( @ ) How representative of this population are the patients who were RANDOMized to the experimental groups ?\n",
            "( @ ) How many patients dropped out of treatment after entering the trial ?\n",
            "The results show that about @ percent ( @ ) of the patients were eligible for a psychoeducational treatment approach .\n",
            "of these , @ percent ( @ ) participated in the trial and were RANDOMized to the treatments .\n",
            "Only @ percent of the relatives but @ percent of the patients refused to take part in the study .\n",
            "The @ trial patients did not differ from the total eligible on the numerous socioeconomic and symptom variables assessed .\n",
            "The treatment dropout rate was @ percent .\n",
            "Those patients who accepted treatment did not differ from those patients who dropped out on socioeconomic or illness variables .\n",
            "The results indicate that early identification of dropouts is not possible at least with the methods used in this study .\n",
            "BACKGROUND : The effect of antipsychotic drugs on brain morphology is under debate .\n",
            "Here we investigate the effects of risperidone , olanzapine and low doses of haloperidol on cortical and subcortical morphometry in first episode drug naive patients with non-affective psychosis .\n",
            "METHODS : Morphological variables were measured in three treatment groups ( haloperidol = @ ; risperidone = @ ; olanzapine = @ ) and in healthy subjects ( N = @ ) at baseline and after one year .\n",
            "The relationship between brain morphometric changes and changes in clinical scores was also assessed .\n",
            "RESULTS : At one year , the three antipsychotics had had an equal effect on the gray matter cortical structure , overall and lobes ( all p 's > @ . )\n",
            ".\n",
            "A significant time-by-group interaction was found in lateral ventricle volume ( F@ ,@ = @ ; p = @ ) .\n",
            "Post-hoc comparisons revealed a significant increase in lateral ventricles in patients treated with risperidone ( p = @ ) .\n",
            "Patients exposed to atypicals ( olanzapine and risperidone ) exhibited a decrease in caudate nucleus volume ( p = @ ) .\n",
            "In general , brain changes did not account in any significant manner for clinical changes over time in any treatment group .\n",
            "CONCLUSIONS : We conclude that low doses of haloperidol , risperidone and olanzapine seem to have an equal effect on the gray matter cortical structure after @ year of treatment .\n",
            "In contrast to typical antipsychotics , atypicals have differential effects on lateral ventricle and caudate nucleus volumes .\n",
            "BACKGROUND : Housing First has become a popular treatment model for homeless adults with mental illness , yet little is known about program participants ' early experiences or trajectories .\n",
            "This study used a mixed methods design to examine participant changes in selected domains @ months after enrollment in a Canadian field trial of Housing First .\n",
            "METHODS : The study sample included @ participants receiving the Housing First intervention at the Toronto site of the At Home/Chez Soi project .\n",
            "This study used a pre-post design to compare quantitative @-month outcome data to baseline values in key domains and multivariate regression to identify baseline demographic , clinical or service use variables associated with observed changes in these domains .\n",
            "In addition , qualitative data exploring participant and service provider perspectives and experiences was collected via stakeholder interviews and focus groups , and analyzed using thematic analysis .\n",
            "RESULTS : The majority ( @ to @ % ) of participants followed the expected trajectory of improvement , with the remaining experiencing difficulties in community integration , mental health symptom severity , substance use , community functioning and quality of life @ months after program enrollment .\n",
            "Diagnosis of psychotic disorder was associated with a reduction in quality of life from baseline to @-months , while substance use disorders were associated with reduced mental illness symptoms and substance use related problems and an improvement in quality of life .\n",
            "Participants housed in independent housing at @-months had greater improvements in community integration and quality of life , and greater reduction in mental illness symptoms , compared to those not independently housed .\n",
            "The quality of the working alliance was positively associated with improvements in physical and psychological community integration and quality of life .\n",
            "Qualitative data provided a unique window into the loneliness and isolation experienced by Housing First participants , as well as problems related to substance use and a need for life skills training and support .\n",
            "CONCLUSIONS : Additional strategies can help support Housing First participants in the early stages of program participation and address potential causes of early difficulties , including lack of life skills and social isolation .\n",
            "This study highlights the importance of early and ongoing evaluation , monitoring and program adaptations to address consumer support needs .\n",
            "TRIAL REGISTRATION : Current Controlled Trials ISRCTN@ .\n",
            "Standard antipsychotics can reduce aggression and hostility in acutely psychotic patients by improving positive symptoms of psychosis , but can also produce side effects such as akathisia or other extrapyramidal symptoms ( EPS ) , sedation , dysphoria , or cognitive dysfunction .\n",
            "Therapies that reduce aggression and hostility without worsening negative or cognitive symptoms or inducing EPS would represent an important advance .\n",
            "Quetiapine ( quetiapine fumarate ) , a recently approved antipsychotic , is effective in treating the positive and negative symptoms of psychosis , is well tolerated , and does not produce treatment-emergent or dose-related EPS or elevatations of plasma prolactin .\n",
            "We present results from a @ - week , placebo-controlled , double-blind , randomized trial ( n = @ ) in hospitalized patients with acute exacerbation of schizophrenia that evaluated five fixed doses of quetiapine ( @ , @ , @ , @ , @ mg/day ) and a single haloperidol dose ( @ mg/day ) .\n",
            "Aggression and hostility were assessed using the BPRS factor V score ( mean of hostility , excitement , suspiciousness , uncooperativeness ) , the BPRS hostility item , and a BPRS hostility cluster score ( mean of anxiety , tension , hostility , suspiciousness , uncooperativeness , excitement ) .\n",
            "Positive symptoms were assessed using the BPRS positive symptom cluster score ( mean of conceptual disorganization , hallucinatory behavior , suspiciousness , unusual thought content ) .\n",
            "Quetiapine and haloperidol were both superior to placebo in reducing positive symptoms ; however , only quetiapine was superior to placebo on all three measures of aggression and hostility ( at a dose of @ mg/day ) .\n",
            "This provides initial evidence that quetiapine is effective in the treatment of aggression and hostility in patients with acute exacerbation of schizophrenia .\n",
            "In another trial of elderly patients with organic and idiopathic psychoses , quetiapine proved effective in reducing positive and negative symptoms , as assessed by the BPRS .\n",
            "Additional analyses of BPRS hostility measures will be presented .\n",
            "Quetiapines favorable safety and tolerability profile across the dose range in addition to data supporting efficacy in the treatment of positive , negative , and affective symptoms of schizophrenia , suggest that quetiapine may represent a new first-line treatment for psychotic disorders , including schizophrenia .\n",
            "Thirty acutely hospitalized schizophrenic patients were treated under double blind condition with either haloperidol ( @-@ mg/day ) or pimozide ( @-@ mg/day ) for @ days .\n",
            "Ten patients in the pimozide and eleven in the haloperidol group showed a very good or good clinical response .\n",
            "There were no definite differences of treatment results as assessed by the Global Clinical Impression .\n",
            "Both groups showed a statistically significant decrease of the global scores of the Brief Psychiatric Rating Scale ( p less than @ ) .\n",
            "There was a significant decrease of affective bluntedness and anergia in the pimozide but not in the haloperidol group .\n",
            "Extrapyramidal side effects were more pronounced in patients on pimozide who therefore needed more anticholinergic drugs .\n",
            "There was no consistent correlation between drug serum levels and global scores or single factors of the BPRS in either treatment group .\n",
            "It is concluded that pimozide in dose ranges from @-@ mg has powerful antipsychotic properties indistinguishable from those of haloperidol but exerts stronger extrapyramidal side effects .\n",
            "\" Klinik fur Psychiatrie , Psychotherapie und Psychosomatik der LMU Munchen Recruiting @ Years @ Years Both , male and female @ Allocation : Randomized controlled trial ; .\n",
            "Masking : Blinded ( patient/subject , investigator/therapist , assessor ) .\n",
            "Control : Placebo .\n",
            "Assignment : Parallel .\n",
            "Study design purpose : Treatment ; Germany <Contact_Firstname> Jana <Contact_Lastname> Nolden <Contact_Address> Nux baumstr .\n",
            "@ <Contact_Email> jana.nolden@med.uni-muenchen.de Inclusion criteria : Diagnosis of a paranoid or hebephrenic schizophrenia according to ICD-@ criteria .\n",
            "<br> Basline stability of medication for at least one week .\n",
            "Baseline stability of psychopathological symptoms for at least one week .\n",
            "Exclusion criteria : Other psychiatric diagnoses , severe internal or neurologic disorders , seizures , implants , cancers .\n",
            "; F@ .@ - Paranoid schizophrenia ; F@ .@ - Hebephrenic schizophrenia <Intervention> Intervention @ : active transcranial random noise stimulation .\n",
            "@ min duration/intervention , @ interventions in two weeks .\n",
            "technical aspects : High frequency ( hf ; @-@ Hz ) , current strength @ mA , offset at @ mA .\n",
            "Intervention @ : sham transcranial random noise stimulation .\n",
            "@ min duration/intervention , @ interventions in two weeks , technical aspects : high frequency ( hf ; @-@ Hz ) , current strength @ mA , offset at @ mA .\n",
            "( I ) Significant improvement of verbal learning and memory test ( VLMT ) and n-back-test and ( II ) reduction of score in the Positive and Negative Symptom Scale ( PANSS ) from Baseline to immediately after the @th intervention .\n",
            "( I ) Reduction of score in the Scale for the Assessment of Negative Symptoms ( SANS ) and ( II ) improvement in the self ordered pointing task ( SOPT ) and trail making test ( TMT ) from Baseline to immediately after the @th intervention .\n",
            "<Secondary_ID> @-@ <Source_Support> Klinik f  r Psychiatrie , Psychotherapie und Psychosomatik der LMU M  nchen </Trial> \"\n",
            "The efficacy of implementing a clinically feasible psychosocial intervention which addresses the needs of carers of the long-term mentally ill is reported .\n",
            "All the relatives of patients in continuous high contact with one clinical team in a local day-care facility were offered the intervention .\n",
            "An interactive education session at home was followed by a monthly relatives group which aimed to reduce components of expressed emotion and to alleviate burden .\n",
            "Patients and relatives were assessed .\n",
            "The controls were the patients in contact with the other teams in the day-care facility , and their relatives .\n",
            "The intervention was effective at reducing EE and improving family relationships .\n",
            "Offering this kind of support to people who are providing long-term care for the severely mentally ill can contribute significantly to the quality of life of both supporters and patients .\n",
            "Background : Schizophrenia is a debilitating , life-long disease for which full recovery is typically not considered as a realistic treatment endpoint .\n",
            "Symptomatic remission , however , may be an objectively attainable treatment goal .\n",
            "We studied symptomatic remission rates within a @-week period for patients diagnosed with schizophrenia and randomized to double-blind treatment with either aripiprazole or haloperidol .\n",
            "Methods : Remission rates were calculated using data from a @-week trial in which patients diagnosed with acute schizophrenia were stabilized and randomly assigned in a @:@ ratio to aripiprazole ( n = @ ; dose = @-@ mg/d ) or haloperidol ( n = @ ; @-@ mg/d ) .\n",
            "For this analysis , remission was operationalized according to the consensusbased symptomatic remission criteria established by the Remission in Schizophrenia Working Group ( Andreasen et al , @ ) .\n",
            "Accordingly , patients were required to achieve scores  @ on eight specific Positive and Negative Syndrome Scale ( PANSS ) items ( delusions , unusual thought content , hallucinatory behavior , conceptual disorganization , mannerisms/posturing , blunted affect , social withdrawal , lack of spontaneity ) and to maintain the item score threshold for at least six consecutive months.We also evaluated differences between remitters and non-remitters on the Clinical Global Impressions-Improvement ( CGI-I ) scale .\n",
            "In order to assess whether tolerability issues might be affecting remission , we examined discontinuation rates due to adverse events and use of concomitant medication to treat EPS .\n",
            "Results : Thirty-two percent of aripiprazole-treated patients and @ % of haloperidol-treated patients satisfied the criteria for symptomatic remission within the @-week trial period .\n",
            "These rates were significantly different in favor of aripiprazole ( p < @ ) .\n",
            "In both groups , mean time to achieve the PANSS item threshold was @ months , and on average , patients on maintained remission status for similar lengths of time ( aripiprazole @ months ; haloperidol @ months ) .\n",
            "Approximately @ % of aripiprazole-treated patients and @ % of haloperidol-treated patients subsequently lost their remission status prior to the trial end , with mean time in remission of @ months .\n",
            "Forty-six percent of patients on aripiprazole never met the PANSS item threshold compared to @ % of patients on haloperidol ( p > @ ) .\n",
            "In both the aripiprazole and haloperidol groups , patients who achieved remission showed significant improvement on the CGI-I at endpoint compared to those who did not remit ( p < @ for both ) .\n",
            "During the @-week trial , significantly fewer aripiprazole-treated patients discontinued the study for adverse events other than worsening of symptoms ( @ % ) or received concomitant EPS medication ( @ % ) compared to haloperidol-treated patients ( @ % and @ % respectively ; p < @ for both ) .\n",
            "Discussion : Nearly one-third of the patients treated with aripiprazole achieved remission status within a one-year period , a significantly higher rate than for patients treated with haloperidol .\n",
            "Most patients who achieved remission also remained in remission for more than nine months until trial termination .\n",
            "Overall clinical impressions of these patients were significantly better than for patients who did not remit .\n",
            "Compared to haloperidole , aripiprazole was associated with a higher remission rate , fewer adverse events , and less EPS medication use , suggesting that both efficacy and tolerability may have accounted for group differences in remission rates .\n",
            "STUDY DESIGN Design : randomised placebo controlled trial .\n",
            "Allocation concealment : concealed .\n",
            "* Blinding : blinded ( data collectors , { patients , data analysts , safety committee , and manuscript writers }  ) .\n",
            "* STUDY QUESTION Setting : schizophrenia outpatient clinic in China .\n",
            "Patients : @ patients @  @ years of age ( mean age @ y , @ % men ) who were diagnosed with a first psychotic episode of schizophrenia , gained .@ % of predrug weight in year @ of antipsychotic treatment ( clozapine , olanzapine , sulpiride , or risperidone ) , were taking only @ antipsychotic with ( @ % change in dose in the past @ months , first attended the clinic or were discharged from an inpatient unit ,@ year before enrolment , had relatively stable improvement ( Positive and Negative Symptom Scale total score ( @ ) , and had an adult caregiver who could monitor adherence .\n",
            "Exclusion criteria were liver or renal dysfunction , cardiovascular disease , diabetes mellitus , history of substance abuse , pregnancy or lactation , inability to perform the lifestyle intervention ( LSI ) , and psychiatric diagnoses other than schizophrenia .\n",
            "Intervention : metformin , @ mg/day for @ days , then @ mg/day ( n = @ ) ; placebo ( n = @ ) ; LSI plus metformin ( combination group , n = @ ) ; or LSI plus placebo ( n = @ ) for @ weeks .\n",
            "The LSI had psychoeducational , dietary , and exercise components .\n",
            "Outcomes : included body mass index , waist circumference , fasting insulin concentration , and insulin resistance index .\n",
            "Follow-up period : @ weeks .\n",
            "Patient follow-up : @ % completed the study ( @ % in the intention-to-treat analysis ) .\n",
            "MAIN RESULTS Groups differed for all outcomes ( table ) , and each treatment was better than placebo ( p < @ ) .\n",
            "Metformin had better outcomes than LSI ( p < @ ) , and the combination had better weight-related outcomes than metformin or LSI ( p < @ ) and better insulin outcomes than LSI ( p < @ ) .\n",
            "The combination and metformin did not differ for insulin outcomes .\n",
            "CONCLUSION In patients with schizophrenia , metformin plus a lifestyle intervention was better than placebo or either intervention alone for antipsychotic-associated weight gain .\n",
            "Background : For a therapy to be considered successful in schizophrenia , it must positively influence a variety of domains beyond positive and negative symptoms .\n",
            "Symptomatic treatment alone is not sufficient for successful longterm occupational performance and interpersonal relations .\n",
            "One such domain is patient functioning , which may be defined as a patient 's ability to perform his/her role in society as a member of a family and/or career fulfillment .\n",
            "Functional benefits are unlikely to be maximized during short-term treatment with antipsychotics , and progress achieved after @ to @ weeks of treatment is important for clinicians , patients , and caregivers , to ascertain when deciding on a future course of treatment .\n",
            "There are relatively simple instruments available to measure patient functioning .\n",
            "The Personal and Social Performance ( PSP ) scale is a single-score , clinician-rated scale designed to measure the severity of dysfunction in four sub-domains of personal and social performance ( @ : socially useful activities , @ : personal and social relationships , @ : self-care , and @ : disturbing and aggressive behavior ) .\n",
            "Its validity and reliability has been described in patients with schizophrenia during the acute phase of the illness .\n",
            "The present analyses investigated the effect of brexpiprazole , a serotonin-dopamine activity modulator that is a partial agonist at @-HT@A and dopamine D@ receptors , and an antagonist at @-HT@A and noradrenaline alpha@B/@C receptors , all at similar potency , on patient functioning during short-term treatment in patients with acute exacerbation of schizophrenia .\n",
            "Methods : Patient functioning data were pooled from three @ - week , double-blind , placebo-controlled trials conducted in hospitalized patients with acute exacerbation of schizophrenia ( Vector [ NCT@ , Beacon [ NCT@ ] , Lighthouse [ NCT@ ] ) .\n",
            "These studies demonstrated the efficacy , safety , and tolerability of brexpiprazole for the short-term treatment of schizophrenia at doses between @ and @mg/day .\n",
            "The following analyses were performed on the same dataset to comprehensively estimate the effect of brexpiprazole versus placebo on patient functioning as measured by the PSP scale : * Least squares ( LS ) mean change from baseline to Week @ in PSP score ( Mixed Model Repeated Measures [ MMRM ] analysis with fixed factors of study , treatment , visit , treatment visit interaction , baseline value , and baseline visit interaction as covariates ) * LS mean change from baseline to Week @ in PSP subdomain scores ( MMRM ) * Descriptive proportion of patients achieving PSP score thresholds at baseline of < = @ , @-@ , @-@ , and > = @ and descriptive proportion of patients having improved or deteriorated at least one PSP threshold category at Week @ ( Last Observation Carried Forward [ LOCF ] analysis ) * Proportion of patients achieving an increase in PSP score of at least @ points ( functional response ) between baseline and Week @ and Week @ ( LOCF ) * Proportions were compared using a Cochran-Mantel - Haenszel row mean scores differ test stratified by study .\n",
            "Results : A total of @ patients were included in the present analysis ( brexpiprazole @-@ mg , n = @ ; placebo , n = @ ) .\n",
            "Brexpiprazole produced a significant benefit versus placebo on mean PSP scores with LS mean increases of @ for brexpiprazole and @ points for placebo at Week @ ( p < @ ) .\n",
            "PSP sub-domain analyses revealed significant improvements across all four domains in patients randomized to brexpiprazole relative to placebo ( p < @ ) .\n",
            "Of patients receiving brexpiprazole , @ % improved at least one PSP score threshold category at endpoint compared to @ % of patients receiving placebo .\n",
            "The proportions of patients meeting criteria for functional response were significantly higher in the brexpiprazole group at both Week @ ( @ % versus @ % , p < @ ) and Week @ ( @ % versus @ % , p < @ ) .\n",
            "Conclusions : It is necessary to not only consider the reduction in symptoms but also the improvement of patient functioning when defining positive outcomes in the shortterm treatment of schizophrenia .\n",
            "The present com rehensive analyses demonstrate that brexpiprazole treatment is associated with a clinically relevant short-term improvement in symptoms of schizophrenia and the level of patient functioning relative to placebo .\n",
            "Objective To evaluate the clinical efficacy and adverse effects of the the mesylate ziprasidone injection on the symptoms of schizophrenia with acute agitation .\n",
            "Methods @ cases of hospitalized patients were randomly assigned to treatment group ( @ cases , I mesylate ziprasidone injection ) with the control group ( @ cases , to the haloperidol injection ) , the course of @d .\n",
            "Reduction rate with schizophrenia positive with the Assessment of Negative Symptoms Scale ( PANSS ) , Clinical Global Impression ( CCI ) to evaluate the efficacy and side effects scale ( TESS ) the end of treatment to assess safety .\n",
            "The results of PANSS at the end of treatment minus the fraction of the treatment group ( @  @ ) % , control group ( @  @ ) % , the treatment group of clinical improvement rate of @ % in the control group was @ .\n",
            "@ % efficacy between the two groups there were no significant differences ; adverse reaction incidence of treatment group was @ % and @ % in the control group , there were no significant differences ( P > @ ) , but the control group The incidence of extrapyramidal reactions ( muscle rigidity , tremor , akathisia , and torsion spasm ) was significantly higher than the treatment group ( P < @ ) .\n",
            "Objective To evaluate the clinical efficacy and adverse effects of the the mesylate ziprasidone injection on the symptoms of schizophrenia with acute agitation .\n",
            "Methods @ cases of hospitalized patients were randomly assigned to treatment group ( @ cases , I mesylate ziprasidone injection ) with the control group ( @ cases , to the haloperidol injection ) , the course of @d .\n",
            "Reduction rate with schizophrenia positive with the Assessment of Negative Symptoms Scale ( PANSS ) , Clinical Global Impression ( CCI ) to evaluate the efficacy and side effects scale ( TESS ) the end of treatment to assess safety .\n",
            "The results of PANSS at the end of treatment minus the fraction of the treatment group ( @  @ ) % , control group ( @  @ ) % , the treatment group of clinical improvement rate of @ % in the control group was @ .\n",
            "@ % efficacy between the two groups there were no significant differences ; adverse reaction incidence of treatment group was @ % and @ % in the control group , there were no significant differences ( P > @ ) , but the control group The incidence of extrapyramidal reactions ( muscle rigidity , tremor , akathisia , and torsion spasm ) was significantly higher than the treatment group ( P < @ ) .\n",
            "Conclusion mesylate ziprasidone injection an effective treatment of schizophrenia , acute agitation symptoms , the efficacy of haloperidol injection , and extrapyramidal symptoms was significantly less than the latter .\n",
            "Cognitive impairments are cardinal features of schizophrenia and predictors of poor vocational and social outcome .\n",
            "Imaging studies with verbal fluency tasks ( VFT ) lead some to suggest that in schizophrenia , the combination of a failure to deactivate the left temporal lobe and a hypoactive frontal lobe reflects a functional disconnectivity between the left prefrontal cortex and temporal lobe .\n",
            "Others have theorized that an abnormal cingulate gyrus modulates such fronto-temporal connectivity .\n",
            "Thus addition of a cognitive enhancing medication to current antipsychotic therapy might improve functionality of networks necessary in working memory and internal concept generation .\n",
            "To test this hypothesis , we serially measured brain activity in @ subjects on stable atypical antipsychotics performing a VFT , using BOLD fMRI .\n",
            "Measurements were made at baseline and again after groups were randomized to receive @ weeks of donepezil ( an acetylcholinesterase inhibitor ) and placebo in a blind cross-over design .\n",
            "Donepezil addition provided a functional normalization with an increase in left frontal lobe and cingulate activity when compared to placebo and from baseline scans .\n",
            "This pilot study supports the cingulate 's role in modulating cognition and neuronal connectivity in schizophrenia\n",
            "Two hundred and four schizophrenics were treated using li 's mental rehabilitation capsule , and compared with @ patients who took classical antipsychotic chlorpramazine .\n",
            "Result showed that the curative effect of the @group was equivalent and had no significant difference ( P > @ .\n",
            "@ ) .\n",
            "According to BPRS factor analysis , the retardation , activation and hostile suspiciousness was more obvious than other factors .\n",
            "There was extremely significant difference in the EI of EGI curative effect ( P < @ .\n",
            "@ ) , the side effect\n",
            "Background : Various forms of psychosocial interventions for people with severe mental illness ( SMI ) exist .\n",
            "These interventions include verbal interventions as well as activity-based interventions .\n",
            "Aims : To compare three psychosocial interventions with persons with SMI using qualitative assessment .\n",
            "The interventions tested were : ( a ) a psycho-educational recovery oriented verbal intervention , ( b ) training in karate ( an activity-based intervention ) , and ( c ) aerobic exercises ( a control intervention ) .\n",
            "Method : @ people with a diagnosis of a SMI ( schizophrenia , schizoaffective , affective disorder , severe personality disorders ) were randomly assigned to the above three interventions .\n",
            "Sixty-four participants who had participated in @ or more sessions were interviewed during the last week of each intervention .\n",
            "Participants ' accounts of the intervention process and outcome were analyzed qualitatively .\n",
            "Results : Training in karate improved the cognitive and physical status of the participants and increased their self-control and sense of empowerment , more than the verbal intervention .\n",
            "Conclusions : An activity-based intervention might be more effective than a psycho-educational verbal intervention .\n",
            "BACKGROUND : Cognitive remediation therapy ( CRT ) is one of the promising new non-drug approaches to reducing cognitive deficits of patients with schizophrenia that has not yet been fully evaluated in China .\n",
            "AIM : Assess the efficacy of CRT in improving the cognitive functioning , social functioning and insight of patients with chronic schizophrenia .\n",
            "METHODS : @ clinically stable inpatients with chronic schizophrenia were randomly allocated to an intervention group ( with CRT ) and a treatment as usual group ( TAU ) ( which used standard occupational and recreational therapy methods ) .\n",
            "The treatment frequency and duration were the same for the two groups : five times per week for three months .\n",
            "The Wisconsin Card Sorting Test ( WCST ) was used to evaluate before versus after changes in cognitive function , the Scale of Social Skills of chronic schizophrenia Inpatients ( SSSI ) was used to assess social functioning , and the Insight and Treatment Attitude Questionnaire ( ITAQ ) was use to assess insight .\n",
            "RESULTS : Four patients dropped out during the study leaving @ in the CRT group and @ in the TAU group in the final analysis .\n",
            "Both groups showed significant improvement in WCST measures over the three-month trial but the improvement in the CRT group was significantly greater than that for the TAU group on all of the WCST measures assessed .\n",
            "The total SSSI score improved significantly in both groups over the three months , but the improvement in the two groups was not significantly different .\n",
            "The total ITAQ score also showed significant improvement in both groups over the three months and the degree of improvement was significantly greater in the CRT group than in the TAU group .\n",
            "CONCLUSION : As an adjunctive treatment to antipsychotic medication , a three month course of CRT is more effective at improving the cognitive functioning and insight of hospitalized patients with chronic schizophrenia than routine occupational and recreational therapy .\n",
            "Objective To compare the domestic quetiapine and perphenazine in the treatment of elderly schizophrenia clinical efficacy and safety .\n",
            "@ elderly patients with schizophrenia were randomly divided into two groups , respectively , taking the domestic quetiapine and perphenazine daily for @ weeks .\n",
            "The effects were evaluated using the Positive and Negative Syndrome Scale ( panss ) , treatment emergent symptom scale ( tess ) assessed adverse reactions .\n",
            "Results of considerable domestic quetiapine and perphenazine efficacy the former faster onset of negative symptoms .\n",
            "Purpose - The primary purpose of the study is to assess whether a planning and problem-solving training is more effective in improving work therapy performance in patients with schizophrenia than traditional training programs addressing basic cognitive functions .\n",
            "Primary Outcome Measures - Functional Capacity as assessed by Osnabrcker Arbeitsfhigkeitsprofil \" learning ability \" subscale [ Time Frame - @ weeks ] Secondary Outcome Measures - Functional Capacity as assessed by the Osnabrcker-Arbeitsfhigkeitsprofil summary score [ Time Frame - @ weeks ] BADS Zoo Map Score ( Neuropsychological Test ) [ Time Frame - @ weeks ] Planungstest ( Tower of London ) Summary Score ( Neuropsychological Test ) [ Time Frame - @ weeks ] Plan-A-Day S Solution Time ( Neuropsychological Test ) [ Time Frame - @ weeks ] Total Enrollment - @ Study start - August @ Arms Assigned Interventions A - Experimental Complex Problem Solving Training Behavioral - Complex Problem Solving Training @ sessions of @ minutes complex problem solving training over @ weeks ( including @ minutes of computerized planning and problem-solving training with Plan-A-Day and @ minutes group session for transfer to everyday situations ) B - Active Comparator Basic Cognitive Training Behavioral - Basic Cognitive Training @ sessions over @ weeks of @ min basic cognitive training ( including @ min computerized training of attention , processing speed , memory ) In patients with schizophrenia , cognitive deficits often lead to an impairment in daily life .\n",
            "This observation has led to the development of cognitive training packages aiming a improving these deficits .\n",
            "However , it is far from clear which level of cognitive functioning provides the best target for cognitive interventions .\n",
            "Traditionally , training has aimed a basic cognitive functions like attention and memory .\n",
            "In the present study we aim at a higher-level of function , namely planning and problem-solving skills , which are trained using the software package Plan-A-Day .\n",
            "The primary hypothesis is that complex problem solving training improved functional capacity more than traditional training programs addressing basic cognitive function .\n",
            "Eligibility - Ages Eligible for Study - @ Years - @ Years , Genders Eligible for Study - Both Criteria Inclusion Criteria - Patients with schizophrenic or schizoaffective Disorder ( DSM IV ) Remitted positive symptoms ( PANSS positive all ?\n",
            "@ ) , clinical stability Native German speaker Verbal IQ > @ Visual acuity normal or corrected to normal Exclusion Criteria - Concurrent Axis-I disorder Drug abuse during last @ months Neurological or medical conditions potentially affecting cognition\n",
            "Experiential negative symptoms-including diminished motivation-have a profound impact on functional outcomes in schizophrenia .\n",
            "Animal research suggests that abnormalities in dopaminergic regulation can negatively impact effort exertion , a translational model that has been applied to individuals with schizophrenia .\n",
            "Paradigms that assess effort-based decision making , for example , suggest less likelihood of choosing high effort tasks that are high in probability of success , and this preference varies with negative symptoms and impaired functioning .\n",
            "Although asociality is another well-documented component of experiential negative symptoms , it is unclear whether diminished motivation for monetary reward extends to the social domain .\n",
            "To test this question , the authors designed the Social Vigor Task ( SVT ) - a measure of effort exertion in the context of live social encouragement .\n",
            "They further examined the effect of oxytocin , a neuropeptide implicated in social behavior , on vigor .\n",
            "Forty-two individuals with schizophrenia and @ healthy controls completed the SVT twice : once after intranasal administration of saline placebo and again after oxytocin .\n",
            "Both groups showed similar increases in vigor in response to social encouragement , suggesting effort in the social context is spared in schizophrenia .\n",
            "Group differences in the effect of social encouragement on vigor varied by point-based reward rate and trial length .\n",
            "Oxytocin did not increase vigor during social encouragement in either group .\n",
            "Within the schizophrenia group , clinician-rated passive social withdrawal , but not active social avoidance , was negatively associated with vigor .\n",
            "Results suggest that people with schizophrenia show normative levels of effort in the context of social encouragement ; low approach motivation , however , relates to lower effort .\n",
            "This chapter discusses the CapOpus trial for cannabis use disorders .\n",
            "CapOpus was a randomized trial of @ months ' specialized psychosocial intervention compared to treatment as usual ( TAU ) for cannabis use disorder in people with schizophrenia and other psychoses .\n",
            "There was no effect on the primary outcome , that is , no reductions in frequency of cannabis use .\n",
            "People receiving CapOpus reduced the quantity of cannabis used , namely using less per day , albeit on the same number of days .\n",
            "People receiving CapOpus had more psychiatric treatment contacts , but admissions were shorter , probably indicating a more adequate level of treatment .\n",
            "CapOpus does not appear to be sufficient to implement as a treatment , but it may be useful in future combination treatment paradigms .\n",
            "( PsycINFO Database Record ( c ) @ APA , all rights reserved )\n",
            "Acute administration of the primary psychoactive constituent of cannabis , DELTA-@-tetrahydrocannabinol ( THC ) , impairs human facial affect recognition , implicating the endocannabinoid system in emotional processing .\n",
            "Another main constituent of cannabis , cannabidiol ( CBD ) , has seemingly opposite functional effects on the brain .\n",
            "This study aimed to determine the effects of THC and CBD , both alone and in combination on emotional facial affect recognition .\n",
            "@ volunteers , selected for high and low frequency of cannabis use and schizotypy , were administered , THC ( @ mg ) , CBD ( @ mg ) , THC+CBD ( @ mg +@ mg ) and placebo , by inhalation , in a @-way , double-blind , placebo-controlled crossover design .\n",
            "They completed an emotional facial affect recognition task including fearful , angry , happy , sad , surprise and disgust faces varying in intensity from @ % to @ % .\n",
            "A visual analogue scale ( VAS ) of feeling ' stoned ' was also completed .\n",
            "In comparison to placebo , CBD improved emotional facial affect recognition at @ % emotional intensity ; THC was detrimental to the recognition of ambiguous faces of @ % intensity .\n",
            "The combination of THC+CBD produced no impairment .\n",
            "Relative to placebo , both THC alone and combined THC+CBD equally increased feelings of being ' stoned ' .\n",
            "CBD did not influence feelings of ' stoned ' .\n",
            "No effects of frequency of use or schizotypy were found .\n",
            "In conclusion , CBD improves recognition of emotional facial affect and attenuates the impairment induced by THC .\n",
            "This is the first human study examining the effects of different cannabinoids on emotional processing .\n",
            "It provides preliminary evidence that different pharmacological agents acting upon the endocannabinoid system can both improve and impair recognition of emotional faces .\n",
            "Copyright   @ The Authors .\n",
            "Published by Elsevier B.V. All rights reserved .\n",
            "This study examined the effectiveness of cognitive training ( the Thinking Skills for Work Program ) for improving competitive employment outcomes in persons with severe mental illness who have a history of job failure .\n",
            "Forty-four clients receiving services at @ inner-city community mental health agencies were randomly assigned ( within each site ) to receive either cognitive training and supported employment ( CT + SE ) or supported employment only ( SE Only ) .\n",
            "Retention in the CT + SE program was high ( @ % ) .\n",
            "Baseline to @-month assessments showed significantly greater improvements in neurocognitive functioning , depression , and autistic preoccupation on the Positive and Negative Syndrome Scale for the CT + SE set compared to the SE Only group .\n",
            "Employment outcomes over @ year showed that clients who received CT + SE were significantly more likely to work ( @ versus @ % , respectively ) , worked more jobs , worked more hours , and earned more wages than clients with SE Only .\n",
            "The findings provide support for the feasibility of implementing the Thinking Skills for Work Program in the context of supported employment and its beneficial effects on cognitive functioning and competitive employment in persons with severe mental illness .\n",
            "Administered pentobarbital ( @ or @ mg ) , dextroamphetamine ( @ or @ mg ) , or a placebo to @ normal female @-@ yr olds .\n",
            "All drugs administered led to an increase in the definiteness of the body boundary ( barrier and penetration scores ) .\n",
            "The increase under both placebo and dextroamphetamine significantly exceeded that previously obtained under analogous nonspecific stress measures .\n",
            "All groups showed significant increases in feelings of depersonalization ( Body Distortion Questionnaire ) .\n",
            "Pentobarbital Ss had significantly greater increases in feelings of depersonalization and fatigue and decreases in concentration than the amphetamine or placebo groups .\n",
            "For all groups , depersonalization correlated significantly with increased fatigue and decreased concentration .\n",
            "The major finding was that the greater the potency of the drug , the more likely the pattern of body experience altered from the habitual baseline body landmark .\n",
            "( @ ref . )\n",
            "The great majority of studies on repetitive transcranial magnetic stimulation ( rTMS ) as a therapeutic tool for auditory verbal hallucinations ( AVH ) have used @-Hz stimulation with inconsistent results .\n",
            "Recently , it has been suggested that @-Hz rTMS has strong therapeutic effects .\n",
            "It is conceivable that this @-Hz stimulation is more effective than @-Hz stimulation .\n",
            "The aim of this preliminary study is to investigate the efficacy of @-Hz rTMS compared with @-Hz rTMS as a treatment for AVH .\n",
            "Eighteen schizophrenia patients with medication-resistant AVH were randomized over two treatment groups .\n",
            "Each group received either @ min of @-Hz rTMS or @ trains of @-Hz rTMS daily over @ week .\n",
            "After week @ , patients received a follow-up treatment once a week for @ weeks .\n",
            "Stimulation location was based on individual AVH-related activation patterns identified with functional magnetic resonance imaging .\n",
            "Severity of AVH was monitored with the Auditory Hallucination Rating Scale ( AHRS ) .\n",
            "Both groups showed a decrease in AVH after week @ of rTMS .\n",
            "This decrease was significant for the @-Hz group and the @-Hz group .\n",
            "When the two treatment types were compared , no treatment type was superior .\n",
            "Based on these results we can not conclude whether high frequency rTMS is more effective against AVH than is traditional @-Hz rTMS .\n",
            "More research is needed to optimize stimulation parameters and to investigate potential target locations for stimulation .\n",
            "OBJECTIVE : The aim of this analysis was to compare the effects of @ atypical antipsychotic agents , lurasidone ( @ mg/d or @ mg/d ) and quetiapine XR ( @ mg/d ) , on daytime alertness , and to evaluate the effects of daytime sleepiness on treatment outcomes in patients with an acute exacerbation of schizophrenia .\n",
            "METHODS : Patients who met Diagnostic and Statistical Manual of Mental Disorders , @th edition , text revision ( DSM-IV-TR ) criteria for schizophrenia were randomized to @ weeks of double-blind treatment with fixed doses of lurasidone @ mg/d ( n = @ ) , lurasidone @ mg/d ( n = @ ) , quetiapine XR @ mg/d ( n = @ ) , or placebo ( n = @ ) , all dosed once daily in the evening , with food .\n",
            "Daytime sleepiness was assessed using the Epworth Sleepiness Scale ( ESS ) .\n",
            "RESULTS : Daytime sleepiness improved in the lurasidone and placebo-treated groups but worsened in the quetiapine XR treatment group when compared to placebo ( p = @ ) and to either dose of lurasidone ( both p < @ ) .\n",
            "Sedation associated with quetiapine XR treatment mediated an improvement in agitation [ assessed by the Positive and Negative Syndrome Scale-Excitement ( PANSS-EC ) subscale ] and a worsening in functional capacity [ assessed by the University of California-San Diego ( UCSD ) Performance-Based Skills Assessment-Brief Version ( UPSA-B ) total score ] ; these mediating relationships were not observed for the lurasidone or placebo treatment groups .\n",
            "CONCLUSION : In this @-week double-blind study , treatment with lurasidone @ mg or @ mg , administered once daily in the evening , was associated with a reduction in daytime sleepiness similar in magnitude to placebo , while quetiapine XR @ mg/d was associated with a significant increase in daytime sleepiness , compared to both lurasidone dose groups and placebo .\n",
            "Daytime sleepiness was associated with improvement in agitation and worsening in functional capacity for quetiapine XR , but not lurasidone or placebo-treated patients .\n",
            "BACKGROUND : This study determined the effects of a novel combination of vitamin D and probiotic on metabolic and clinical symptoms in chronic schizophrenia .\n",
            "METHODS : This trial was conducted among @ patients with chronic schizophrenia to receive either @ IU vitamin D@ every @ weeks plus @ x @ ( @ ) CFU/day probiotic ( n = @ ) or placebo ( n = @ ) for @ weeks .\n",
            "RESULTS : Vitamin D and probiotic co-supplementation was associated with a significant improvement in the general ( - @ + / - @ vs. + @ + / - @ , P = @ ) and total PANSS scores ( - @ + / - @ vs. -@ + / - @ , P = @ ) .\n",
            "Vitamin D and probiotic co-supplementation also significantly increased total antioxidant capacity ( + @ + / - @ vs. -@ + / - @ mmol/L , P = @ ) , and significantly decreased malondialdehyde ( - @ + / - @ vs. + @ + / - @ mumol/L , P = @ ) and high sensitivity C-reactive protein levels ( - @ + / - @ vs. -@ + / - @ mg/L , P = @ ) compared with the placebo .\n",
            "Moreover , taking vitamin D plus probiotic significantly reduced fasting plasma glucose ( - @ + / - @ vs. -@ + / - @ mg/dL , P = @ ) , insulin concentrations ( - @ + / - @ vs. + @ + / - @ muIU/mL , P < @ ) , homeostasis model of assessment-estimated insulin resistance ( - @ + / - @ vs. + @ + / - @ , P < @ ) , triglycerides ( - @ + / - @ vs. + @ + / - @ mg/dL , P = @ ) and total cholesterol levels ( - @ + / - @ vs. + @ + / - @ mg/dL , P = @ ) and total - / HDL-cholesterol ratio ( - @ + / - @ vs. + @ + / - @ , P = @ ) .\n",
            "CONCLUSION : Probiotic and vitamin D for @ weeks to chronic schizophrenia had beneficial effects on the general and total PANSS score , and metabolic profiles .\n",
            "TRIAL REGISTRATION : This study was retrospectively registered in the Iranian website ( www.irct.ir ) for clinical trials registration ( http://www.irct.ir : IRCT@N@ ) .\n",
            "@-@-@ @ .\n",
            "The aims of the early detection and intervention programme of the German Research Network on Schizophrenia are to develop an evaluated assessment instrument for the detection of persons at risk , to explore biological indicators , which could predict the development of schizophrenia and to develop treatment strategies for persons at risk of psychosis .\n",
            "First preliminary results of the differential intervention approach to the initial prodromal state - a comprehensive cognitive-behavioural therapy for persons in the early initial prodromal state and clinical management and atypical neuroleptics combined in persons in the late initial prodromal state - are promising .\n",
            "However , although we have to await the final results of the ongoing trials , the preliminary data and findings from international studies are suggesting that indicated prevention may become a new perspective in the treatment of schizophrenia\n",
            "OBJECTIVE : Social Security Administration ( SSA ) disability benefits are an important source of income for people with psychoses and confer eligibility for health insurance .\n",
            "The authors examined the impact of coordinated specialty care on receipt of such benefits in first-episode psychosis , along with the correlates and consequences of receiving them .\n",
            "METHOD : The Recovery After an Initial Schizophrenia Episode-Early Treatment Program ( RAISE-ETP ) study , a @-site cluster-randomized trial , compared NAVIGATE , a coordinated specialty care program , to usual community care over @ years .\n",
            "Receipt of SSA benefits and clinical outcomes were assessed at program entry and every @ months for @ years .\n",
            "Piecewise regression analysis was used to identify relative change in outcome trajectories after receipt of disability benefits .\n",
            "RESULTS : Among @ RAISE-ETP participants , @ ( @ % ) were receiving SSA disability benefits at baseline ; of the remainder , @ ( @ % ) obtained benefits during the @-year study period .\n",
            "The NAVIGATE intervention improved quality of life , symptoms , and employment but did not significantly reduce the likelihood of receiving SSA disability benefits .\n",
            "Obtaining benefits was predicted by more severe psychotic symptoms and greater dysfunction and was followed by increased total income but fewer days of employment , reduced motivation ( e.g. , sense of purpose , greater anhedonia ) , and fewer days of intoxication .\n",
            "CONCLUSIONS : A @-year coordinated specialty care intervention did not reduce receipt of SSA disability benefits .\n",
            "There were some advantages for those who obtained SSA disability benefits over the @-year treatment period , but there were also some unintended adverse consequences .\n",
            "Providing income supports without impeding recovery remains an important policy challenge .\n",
            "Aim : To assess changes in insulin sensitivity in non-diabetic adults with schizophrenia or schizoaffective disorder treated with olanzapine or risperidone .\n",
            "Methods : One hundred and thirty patients were randomly assigned to @ weeks double-blind treatment with olanzapine or risperidone .\n",
            "Insulin sensitivity was measured using a two-step euglycaemic , hyperinsulinaemic clamp procedure .\n",
            "Whole-body adiposity was measured using dual-energy X-ray absorptiometry .\n",
            "The primary endpoint was the within-group change from baseline in insulin sensitivity normalized to fat-free mass ( M <sub> ffm </sub> / I ) during the clamp procedure 's low-insulin phase , using an analysis of covariance model including the covariate weight change .\n",
            "Results : Forty-one olanzapine-treated and @ risperidone-treated patients completed baseline and endpoint clamp measurements .\n",
            "Mean M <sub> ffm </sub> / I during the low-insulin phase declined @ % ( p = @ ) in olanzapine-treated patients and @ % ( p = @ ) in risperidone-treated patients ( between-group difference p = @ ) .\n",
            "During the high-insulin phase , M <sub> ffm </sub> / I declined @ % ( p = @ ) in olanzapine-treated patients and @ % ( p = @ ) in risperidone-treated patients ( between-group difference p = @ ) .\n",
            "Changes in M <sub> ffm </sub> / I correlated inversely with changes in body weight and adiposity , which were generally higher in olanzapine-treated patients .\n",
            "Significant within-group increases in fasting glucose , but not haemoglobin A@c ( HbA@c ) , were observed during olanzapine treatment .\n",
            "The fasting glucose change was not correlated with M <sub> ffm </sub> / I changes .\n",
            "Conclusions : Small , but statistically significant , decrements in insulin sensitivity were observed in olanzapine - and risperidone-treated patients at @ of @ insulin doses tested .\n",
            "Significant increases in fasting glucose and insulin and total fat mass were observed only in olanzapine-treated patients .\n",
            "Changes in insulin sensitivity correlated significantly with changes in weight or adiposity , but not with changes in glucose .\n",
            "@ Blackwell Publishing Ltd .\n",
            "Objective : To study the efficacy of traditional Chinese medicine in the prevention of hyperglycemia and hyperlipemia caused by antipsychotics .\n",
            "Method : @ male patients were randomly divided into two groups .\n",
            "@ patients were treated with antipsychotics and traditional Chinese medicine as the study group while @ patients were treated with antipsychotics as control group .\n",
            "Results : There were significantly differences in blood sugar and blood lipid at @ months after treatment .\n",
            "As part of a larger NIDA funded treatment adherence study , a manual driven program was developed to enhance medication adherence in individuals with co-occurring psychotic and substance abuse or dependence disorders ( EMAPS ) .\n",
            "The program combines aspects of : @ ) the Medications usage Skills for Effectiveness ( MUSE ) compliance program designed for individuals with severe mental illness ; @ ) the NIDA Compliance Enhancement Manual for Psychopharmacotherapy of Drug Abuse and Dependence designed for individuals with substance disorders ; and @ ) monitoring and advocacy regarding the comminication of side effects to the prescribing physician .\n",
            "In a randomized controlled trial of individuals with severe psychiatric disorders , the MUSE significantly increased medication adherence , measured by the Medication Event Monitoring system ( MEMS ) , as compared to controls at both @ month ( t = @ , P = @ , N = @ ) and @ months ( t = @ , P = @ , N@ ) .\n",
            "Aspects of the MUSE andthe NIDA manual were adapted for use with individuals who are dually diagnosed .\n",
            "The EMAPS will be compared to standard treatment , and EMAPS plus an Engagement program in a randomized controlled trial of @ participants with psychotic and substance disorders at three and nine months post baseline .\n",
            "Primary outcome measues include the MEMS , Treatment Compliance Interview ( TCI ) , and the rate , duration , and percentage of kept outpatient treatment appointments .\n",
            "Secondary outcome measuers include utine toxicology screens , Substance Clinical Global Impression Scale ( SCGI ) , Global Assessment of functioning Scale-Modified ( GAF-M ) , Positive and Negative Syndrome Scale ( PANSS ) , and the rate and duration of inpatient and detoxification admissions .\n",
            "Objective : The aim of the study was to evaluate the effectiveness and safety of Metformin along with Risperidone to prevent antipsychotic-induced metabolic syndrome in first-episode schizophrenia patients .\n",
            "Methods : This was a randomized , open labelled , prospective study conducted in the Department of psychiatry , Tirunelveli medical college .\n",
            "Around @ patients diagnosed with first episode schizophrenia were randomized into @ groups .\n",
            "Group @ patients were given T. Risperidone ( @ mg twice daily , n = @ ) and group @ patients were given T. Metformin ( @ mg twice daily , n = @ ) along with T. Risperidone for @ mo .\n",
            "The primary endpoint assessed was the proportion of patients developing metabolic syndrome at the end of @ mo in both the groups .\n",
            "The secondary endpoints were the changes in body mass index ( BMI ) , waist circumference ( WC ) , fasting blood sugar ( FBS ) and triglycerides ( TGL ) from baseline to the end point .\n",
            "Results : There was a significant reduction in BMI and WC at the end of @ mo ( p < @ ) and at the end of @ mo ( p < @ ) when compared to baseline in group II individuals .\n",
            "There was a significant reduction in FBS and TGL levels at the end of @ mo of treatment ( p < @ ) in group II individuals .\n",
            "There was the significant statistical difference between both the groups ( p < @ ) in terms of BMI , WC , FBS , triglycerides .\n",
            "The treatment emergent adverse effects with Metformin were generally mild and did not lead to any discontinuation .\n",
            "Conclusion : The use of Metformin along with Risperidone may have a better impact on the long-term cardiovascular morbidity and mortality of the schizophrenia patients .\n",
            "OBJECTIVE : Community Partners in Care ( CPIC ) was a group-randomized study of two approaches to implementing expanded collaborative depression care : Community Engagement and Planning ( CEP ) , a coalition approach , and Resources for Services ( RS ) , a technical assistance approach .\n",
            "Collaborative care networks in both arms involved health care and other agencies in five service sectors .\n",
            "This study examined six - and @-month outcomes for CPIC participants with serious mental illness .\n",
            "METHODS : This secondary analysis focused on low-income CPIC participants from racial-ethnic minority groups with serious mental illness in underresourced Los Angeles communities ( N = @ ) .\n",
            "Serious mental illness was defined as self-reported severe depression ( > / = @ on the Patient Health Questionnaire-@ ) at baseline or a lifetime history of bipolar disorder or psychosis .\n",
            "Logistic and Poisson regression with multiple imputation and response weights , controlling for covariates , was used to model intervention effects .\n",
            "RESULTS : Among CPIC participants , @ % had serious mental illness .\n",
            "Among those with serious mental illness , CEP relative to RS reduced the likelihood of poor mental health-related quality of life ( OR = .@ , @ % CI = .@-.@ ) but not depression ( primary outcomes ) ; reduced the likelihood of having homelessness risk factors and behavioral health hospitalizations ; increased the likelihood of mental wellness ; reduced specialty mental health medication and counseling visits ; and increased faith-based depression visits ( each p < .@ ) at six months .\n",
            "There were no statistically significant @-month effects .\n",
            "CONCLUSIONS : Findings suggest that a coalition approach to implementing expanded collaborative depression care , compared with technical assistance to individual programs , may reduce short-term behavioral health hospitalizations and improve mental health-related quality of life and some social outcomes for adults with serious mental illness , although no evidence was found for long-term effects in this subsample .\n",
            "Suicide is among the leading causes of death for adults diagnosed with schizophrenia , with risk estimates being over eight folds greater than the general population .\n",
            "While research has largely focused on the role of symptoms of depression , there is a lack of consensus and understanding of the role positive symptoms of psychosis ( i.e. hallucinations and delusions ) play in suicide risk .\n",
            "Further , suicide continues to be a major public health problem with an absence of effective evidence-based interventions .\n",
            "Guided by Williams   Theory of Suicide and Beck   s Cognitive Theory of Suicide , the current study aimed to increase understandings of suicide risk within this vulnerable population by testing a multi-level framework to identify the specific pathways of influence between symptoms of depression , positive symptoms of psychosis ( hallucinations and delusions ) , hopelessness , social support , and suicidal behavior ( ideation and attempt ) .\n",
            "Data were obtained from the Clinical Antipsychotic Trials of Intervention Effectiveness ( CATIE ) , a longitudinal randomized controlled trial comparing the effectiveness of antipsychotics among a sample of adults diagnosed with schizophrenia in the United States ( n = @ ) .\n",
            "Structural Equation Modeling ( SEM ) was used to analyze the proposed conceptual model at baseline , @ months , and @ months .\n",
            "Suicide attempt was not examined due to low base rates .\n",
            "Findings supported the consistently demonstrated role that symptoms of depression and hopelessness play in suicidal ideation at all three time points .\n",
            "Positive symptoms of psychosis were found to condition the way in which symptoms of depression and suicidal ideation related at baseline .\n",
            "Additionally , emotional social support served as a protective factor attenuating the effect of symptoms of depression on hopelessness at @ months .\n",
            "Implications for practice , policy , and research are identified and discussed .\n",
            "This research represents the first of several future prospective longitudinal studies that will ultimately inform the development of a suicide prevention-focused intervention tailored to adults diagnosed with schizophrenia .\n",
            "Background : Findings from both epidemiological and basic research point to the possibility that NSAIDS impede the deterioration in schizophrenia .\n",
            "Methods : To study the efficacy of acetylsalicylic acid we will perform a randomized placebo controlled double-blind add-on trial of @ inpatients and outpatients with schizophrenia , schizophreniform or schizoaffective disorder .\n",
            "Patients will be @:@ randomized to either @ months @ mg acetylsalicylic acid per day or @ months placebo , in addition to their regular antipsychotic treatment .\n",
            "All patients will receive pantoprazole treatment for gastroprotection .\n",
            "The outcomes of this study are @-month change in psychotic and negative symptom severity , cognitive function , and several immunological parameters .\n",
            "This trial may ( @ ) yield a new ( adjuvant ) therapy for schizophrenia and ( @ ) add to the knowledge on the pathogenesis of this major psychiatric disorder .\n",
            "OBJECTIVE : The premise of the National Institute of Mental Health Recovery After an Initial Schizophrenia Episode Early Treatment Program ( RAISE-ETP ) is to combine state-of-the-art pharmacologic and psychosocial treatments delivered by a well-trained , multidisciplinary team in order to significantly improve the functional outcome and quality of life for first-episode psychosis patients .\n",
            "The study is being conducted in non-academic ( ie , real-world ) treatment settings , using primarily extant reimbursement mechanisms .\n",
            "METHOD : We developed a treatment model and training program based on extensive literature review and expert consultation .\n",
            "Our primary aim is to compare the experimental intervention to \" usual care \" on quality of life .\n",
            "Secondary aims include comparisons on remission , recovery , and cost-effectiveness .\n",
            "Patients @-@ years old with a first episode of schizophrenia , schizoaffective disorder , schizophreniform disorder , psychotic disorder not otherwise specified , or brief psychotic disorder according to DSM-IV and no more than @ months of treatment with antipsychotic medications were eligible .\n",
            "Patients are followed for a minimum of @ years , with major assessments conducted by blinded , centralized raters using live , @-way video .\n",
            "We selected @ clinical sites in @ states and utilized cluster randomization to assign @ sites to the experimental treatment and @ to usual care .\n",
            "Enrollment began in July @ and ended in July @ with @ subjects .\n",
            "The results of the trial will be published separately .\n",
            "The goal of the article is to present both the overall development of the intervention and the design of the clinical trial to evaluate its effectiveness .\n",
            "CONCLUSIONS : We believe that we have succeeded in both designing a multimodal treatment intervention that can be delivered in real-world clinical settings and implementing a controlled clinical trial that can provide the necessary outcome data to determine its impact on the trajectory of early phase schizophrenia .\n",
            "TRIAL REGISTRATION : ClinicalTrials.gov identifier : NCT@.  Copyright @ Physicians Postgraduate Press , Inc .\n",
            "OBJECTIVE : The study objective was to test a smartphone-based MONEO platform designed to improve the clinical condition of paranoid schizophrenia patients .\n",
            "Telemedicine treatment is considered to be as effective as traditional treatment in outpatient clinics .\n",
            "METHOD : A total of @ patients with paranoid schizophrenia in the symptomatic remission state were recruited to this @-month multicenter , open-label randomized trial .\n",
            "A study group ( n = @ ) received a smartphone with the MONEO platform installed .\n",
            "Patients conducted cognitive training twice a week .\n",
            "Patients ' mental state was assessed every month via teleconference .\n",
            "A placebo group ( n = @ ) received a platform with functionality limited to monthly teleconsultation and performing cognitive training every @ months .\n",
            "The clinical status was measured using the Positive and Negative Syndrome Scale ( PANSS ) , Calgary , and Clinical Global Impression-Severity ( CGI-S ) clinical scales .\n",
            "RESULTS : After @ months , a significant reduction of symptoms was observed in the study group , as assessed using the Calgary ( @ % , P < @ ) and PANSS ( @ % , P < @ ) scales .\n",
            "Symptom reduction of @ % was also observed in the placebo group ( P < @ , Calgary scale ) .\n",
            "In the study group , depression , positive symptoms , excitement , general psychopathology and disorganization subscales decreased significantly , while in the placebo group , only the depression subscale decreased .\n",
            "The greatest improvement of @ % ( study group , P < @ ) , vs @ % ( placebo group , P < @ ) , was observed for the depression subscale .\n",
            "CONCLUSION : The MONEO platform was demonstrated to positively influence the clinical condition of individuals with paranoid schizophrenia .\n",
            "A lack of negative consequences associated with usage of the device was also reported .\n",
            "STUDY DESIGN This was an open-label , randomised , multicentre study to evaluate the efficacy and tolerability of quetiapine IR , following rapid titration versus conventional titration , in patients with acute schizophrenia or schizoaffective disorder over @ days ( Figure S@ ) .\n",
            "Patients were randomised with a @:@ ratio to quetiapine IR tablets administered either via a rapid titration regimen over @ days or via a conventional titration regimen over @ days .\n",
            "From Day @ onwards , the dose was adjusted depending on clinical response and tolerability as judged by the investigator .\n",
            "Objective To study clozapine and conventional neuroleptic medications if they can increase the risk of developing diabetes and impaired glucose tolerence ( IGT ) in the course of treating schizophrenic patients .\n",
            "Method The authors examined @ schizophrenic inpatients treated with clozapine and @ schizophrenic inpatients treated with conventional neurolepitc medications for fast blood glucose and oral glucose tolerance test .\n",
            "All inpatients are diagnosed according to WHO .\n",
            "Results In inpatients treated with cloz\n",
            "Background : Aripiprazole is a new antipsychotic agent associated with minimal weight gain .\n",
            "Methods : The effects of long-term aripiprazole treatment on metabolic parameters were examined in a @-week study comparing aripiprazole with placebo for prevention of relapse in patients with chronic stable schizophrenia .\n",
            "Glucose , plasma lipid , and glycosylated hemoglobin ( A@C ) levels were determined from fasted blood samples collected during the study .\n",
            "Results : Mean changes in fasting plasma glucose levels from baseline to endpoint were minimal with both aripiprazole ( @ mg / dL ) and placebo ( @ mg/dL ) .\n",
            "A@C showed similar decreases in the aripiprazole and placebo groups ( @ % and @ % , respectively ) during the study .\n",
            "Both fasting total cholesterol and fasting LDL cholesterol levels showed small decreases in the aripiprazole and placebo groups , while fasting plasma HDL cholesterol levels increased slightly in the two treatment groups .\n",
            "Fasting plasma triglycerides levels decreased from baseline in the aripiprazole and placebo groups over the @-week study period ( median decrease : aripiprazole , @ mg/dL ; placebo , @ mg/dL ) .\n",
            "Conclusion : In conclusion , long-term therapy with aripiprazole was not associated with adverse metabolic changes .\n",
            "The effects on glycemic control and plasma lipid profile were similar to those observed with placebo .\n",
            "SGS@ is a selective @ Hydroxytryptamine-@ ( @ HT@ ) receptor antagonist being developed as a treatment for Cognitive Impairment Associated with Schizophrenia ( CIAS ) .\n",
            "Cognitive dysfunction has been recognized as underlying the psychopathology of , and contributing to , impaired social and vocational function in schizophrenia .\n",
            "As a result , there is great interest in developing treatments for CIAS .\n",
            "Methods : This study will evaluate a @HT@ antagonist ( SGS@ ) in humans for treatment of cognition impairment associated with schizophrenia .\n",
            "Twenty ( @ ) patients with a DSM IV diagnosis of schizophrenia were enrolled in a Phase II , @ day randomized , placebo ( P ) - controlled , double blind study to evaluate the safety , pharmacokinetic profiles and preliminary effect of SGS@ on cognitive function .\n",
            "Patients were randomized into @ of @ cohorts of @ subjects each ( @ active : @ placebo ) and remained in residence for @ days .\n",
            "Patients randomized to SGS@ in Cohort @ received @ mg QD for @ days and then escalated to @ mg QD for @ days .\n",
            "Patients randomized to Cohort @ received @ mg QD for @ days and then escalated to @ mg QD for @ days .\n",
            "Cognition Testing using the Computerized Brief Assessment of Cognition Tests ( BACS ) was conducted prior to dosing , Day @ prior to escalation and after receipt of the last dose on Day @ .\n",
            "The total duration of treatment was @ days .\n",
            "A computerized version of the Brief Assessment of Cognition Scale ( BACS ) consists of tests for Verbal memory , Digit Sequencing , Symbol Coding , Semantic Fluency , Letter Fluency and Tower of London .\n",
            "Difference from Baseline z scores were used as the outcome variable .\n",
            "The assessment of the safety and tolerability of the study agent compared the incidence and severity of adverse events , and changes in laboratory , ECG , EEG or physical exam findings between the combined group of subjects receiving placebo ( up to @ subjects ) and the cohorts receiving the different doses of SGS@ .\n",
            "Pharmacokinetic samples were obtained daily with serial samples collected on Day @ , Day @ and Day @ of dosing .\n",
            "Results : @ male subjects ( mean age @ years ) with schizophrenia were enrolled with @ of the @ subjects completing the study .\n",
            "Concurrent treatment with anti-psychotic medication included : Risperdal , Zyperxa , Seroquel and Abilify .\n",
            "There were @ of the @ subjects ( @ in cohort @ ; @ in cohort @ ; @ subjects in the placebo group ) reporting a total of @ adverse events ( @ in cohort @ , @ in cohort @ and @ in the placebo group ) .\n",
            "The majority of the adverse events in cohort @ were reported when subjects were receiving the @ mg dose .\n",
            "All adverse events ( AEs ) were mild and resolved within @ hours after onset .\n",
            "No subjects discontinued from the trial due to an AE , and there were no deaths or serious adverse events .\n",
            "The mean AUC/dose results ranged from @ to @ hr ng/mL in a dose responsive fashion .\n",
            "The mean tmax was @ hours for all doses except @ mg ( @ hrs ) and the mean terminal elimination half life after @ days of dosing was @ hrs ( SD @ ) for cohort @ and @ hrs ( SD @ ) and consistent with the data seen in a prior healthy volunteer study .\n",
            "The approximate steady-state of plasma concentration for SGS@ was reached after @ days of dosing without evidence of accumulation .\n",
            "The analysis of the BACS data was ongoing at the time of the abstract deadline and will be presented at the meeting .\n",
            "Conclusions : This study demonstrated that SGS@ administered orally over @ days to patients with schizophrenia on concomitant antipsychotic treatment was well-tolerated .\n",
            "SGS@ represents a promising new therapy for treatment of cognition impairment associated with schizophrenia and further studies are warranted .\n",
            "Rational It has been suggested that phosphodiesterase @ inhibitors such as sildenafil may be effective in the treatment of negative symptoms of schizophrenia .\n",
            "Objective This study was designed to investigate the effect of sildenafil added to risperidone as augmentation therapy in patients with chronic schizophrenia and prominent negative symptoms in a double-blind and randomized clinical trial.Methods Eligible participants in the study were @ patients with chronic schizophrenia with ages ranging from @ to @ years .\n",
            "All patients were inpatients and were in the active phase of the illness and met DSM-IV-TR criteria for schizophrenia .\n",
            "Patients were allocated in a random fashion : @ to risperidone ( @ mg/day ) plus sildenafil ( @ mg/day ) and @ to risperidone ( @ mg/day ) plus placebo .\n",
            "The principal measure of outcome was Positive and Negative Syndrome Scale ( PANSS ) .\n",
            "Results Although both protocols significantly decreased the score of the positive , negative , and general psychopathological symptoms over the trial period , the combination of risperidone and sildenafil showed a significant superiority over risperidone alone in decreasing negative symptoms and PANSS total scores over the @-week trial ( between-subjects factor ; F = @ , df = @ ; P = @ ; F = @ , df = @ , P = @ respectively ) .\n",
            "Conclusion Therapy with @ mg/day of sildenafil was well tolerated , and no clinically important side effects were observed .\n",
            "The present study indicates sildenafil as a potential adjunctive treatment strategy for treatment of negative symptoms of schizophrenia .\n",
            "This trial is registered with the Iranian Clinical Trials Registry ( IRCT@N@ ) .\n",
            "Objective To study the loxapine clinical efficacy and safety of treatment of patients with schizophrenia .\n",
            "Methods @ patients with schizophrenia were randomly divided the Nei Luosha level group and the risperidone group , loxapine and risperidone were given @ weeks of treatment , and positive and negative symptom rating scale ( panss ) evaluate the clinical efficacy , adverse reactions scale ( tess ) evaluation of adverse reactions .\n",
            "Group efficacy differences not statistically significant ( p > @ ) , loxapine in the treatment of schizophrenia in the total effective rate of @ % , the risperidone total effective rate was @ % .\n",
            "Loxapine adverse reactions mainly extrapyramidal reactions , often seen in treatment after the first @ weeks , but the degree of light , soon after the addition of the appropriate drugs to reduce or disappear .\n",
            "Conclusions Loxapine for schizophrenia have a positive effect , adverse reactions , safe , suitable for clinical application .\n",
            "Background : The main aim of the guidelines for the treatment with antipsychotics of patients with a first episode psychosis is to reduce the risk of a relapse .\n",
            "Unfortunately the guidelines vary widely between countries , due to the lack of robust scientific underpinnings .\n",
            "Two approaches in the treatment with antipsychotics can be distinguished : targeted and maintenance treatment .\n",
            "The comparison between targeted and maintenance treatment was subject of only a few studies .\n",
            "None of them described in detail how these strategies were carried out in practice .\n",
            "Methods : The Medication Strategies In First Onset Schizophrenia study ( MESIFOS ) compares targeted treatment and maintenance treatment with regard to Quality of Life ( QoL ) .\n",
            "The target population are patients with a first onset non-affective psychosis , whose positive symptoms remitted within @ months after commencing antipsychotic treatment .\n",
            "After a stable remission phase of @ months , patients were randomly assigned to either maintenance treatment or targeted treatment with antipsychotics .\n",
            "These strategies had to be carried out during @ months following the remission phase , according to an intention to treat .\n",
            "In the trial @ patients were included .\n",
            "Among the data that were gathered of these patients were : medication prescription and use , side effects , symptom levels , social functioning and quality of life .\n",
            "Prescription and use ( compliance ) of antipsychotics and @-months outcome are our parameters for determining feasibility .\n",
            "Results : Both treatments are feasible in real life practice .\n",
            "In the initial phase the treatments differ significantly , but they coincide after @ months .\n",
            "Cumulative doses differed significantly .\n",
            "In spite of different relapse rates both groups have similar outcomes as regards quality of life .\n",
            "Conclusions : Both strategies should be considered in remitted first episode psychotic patients .\n",
            "The benefits and risks should be explained to patients .\n",
            "This will foster autonomy and enhance compliance and satisfaction .\n",
            "Introduction : Although antipsychotics improve positive symptoms effectively , their utility is limited by adverse effects and poor efficacy for the treatment of cognitive symptoms .\n",
            "Nevertheless , cognition is considered a core feature of schizophrenia .\n",
            "For this reason the focus of treatment research in schizophrenia has shifted towards cognitive enhancement the last ten years .\n",
            "Objectives : Earlier trials suggest that nicotine ameliorates attention and working memory deficits seen in schizophrenia .\n",
            "Aims : The present study aimed to replicate these earlier findings using a strict methodological design .\n",
            "Additionally , we assessed the effects of nicotine on measures of social cognition and psychomotor functioning , domains that has never been investigated before in this research field .\n",
            "Furthermore an additional study compared the effect of age in relation to the responsivity to nicotine .\n",
            "Methods : In a three-way crossover double blinded randomized placebo-controlled trial , we investigated the effect of @ , @ and @ mg nicotine on several cognitive domains ( standard cognition , arousal , psychomotor tasks , and social cognition ) in @ smoking and @ non-smoking schizophrenic patients and in @ young and @ elderly healthy volunteers .\n",
            "Results : Nicotine improves attention in both patients groups and has detrimental effects in the elderly in some cognitive and psychomotor tasks .\n",
            "There is no effect of nicotine on psychomotor functioning , working memory and emotion recognition in patients .\n",
            "Decision making seems to be influenced by nicotine in non smoking patients .\n",
            "Conclusion : This study brings us a step further in the delineation of the cognitive effect of nicotine .\n",
            "\" Study design Randomized Control Trial ( Single Site ) Countries of recruitment Canada Disease/condition/study domain Forensic mental health patients : verbal aggression and violence Participants - inclusion criteria @ .\n",
            "Has a primary clinical diagnosis of a serious mental illness ( SMI ) @ .\n",
            "Has a history of violence @ .\n",
            "Is proficient in the English language Participants - exclusion criteria @ .\n",
            "Has previously participated in the R&R @ program , or similar @ .\n",
            "Is actively psychotic @ .\n",
            "Has a significant cognitive impairment Anticipated start date @/@/@ Anticipated end date @/@/@ Status of trial Ongoing Patient information material Not available in web format , please use the contact details below to request a patient information sheet Target number of participants @ Interventions @ .\n",
            "Reasoning and Rehabilitation @ : Short Version for Adults ( R&R @ ; Ross , Hilborn , & Liddle , @ ) -@ session skill-based program targeting antisocial attitudes @ .\n",
            "Treatment as Usual ( TAU ) - includes various programs that target anger , trauma , sexual offending , and substance abuse @ .\n",
            "Control Group - no treatment Primary outcome measure ( s ) Official recidivism data ( charges and convictions ) : These are officially recorded and made available by our partner , the Ministry of Community Safety and Correctional Services .\n",
            "Recidivism data will be first collected at the @-year follow-up period .\n",
            "Secondary outcome measure ( s ) @ .\n",
            "Institutional Misconducts ( Verbal aggression and violence ) : A research assistant who is blind to group assignment will be reviewing the OTIS Client Profile of each participant in the study .\n",
            "The OTIS Client Profile provides information on each occurrence of an institutional misconduct for the present booking period , as well as historical misconducts including the date of the occurrence , what the incident was ( e.g. assault , threat ) , and the penalty given for the misconduct .\n",
            "The research assistant will take note of all of the information provided on any institutional misconducts .\n",
            "The research assistant will also gather information on institutional misconducts from the electronic information management system ( eIMS ) to corroborate information from the OTIS Profiles and to note any relevant additional information .\n",
            "@ .\n",
            "Pre-Post measures of antisocial attitudes : Pre-post measures include self-report questionnaires tapping into antisocial attitudes and clinician rated measures of risk to re-offend .\n",
            "These measures will be administered at baseline ( pre-treatment ) and after the final session ( post-treatment ) .\n",
            "Other measures ( e.g. , group engagement ) will be administered at post-treatment only . \"\n",
            "Impairments in social cognition are key determinants of poor functioning in psychosis and an important new target for treatment development .\n",
            "Initial studies support the feasibility and efficacy of training interventions for social cognition , but have been small and have had substantial methodological limitations .\n",
            "This report describes the largest rigorously controlled study of a social cognitive treatment to date .\n",
            "We evaluated the efficacy of a refined version of the @-session Social Cognitive Skills Training ( SCST ) program , and whether adding in vivo training sessions in community settings would enhance generalization to functional improvements .\n",
            "One hundred thirty-nine outpatients with psychotic disorders were randomly assigned to one of @ time - and format-matched conditions : ( @ ) SCST plus in vivo community-based training , ( @ ) SCST plus clinic-based training , or ( @ ) Illness management control condition .\n",
            "SCST targeted the domains of emotion processing , social perception , attributional bias , empathy , and mentalizing .\n",
            "Assessments of social cognition , nonsocial cognition , symptoms , and functioning were completed at baseline , mid-treatment , posttreatment , and @-month follow-up .\n",
            "On the primary social cognitive outcome measures , there was significant , durable SCST-related improvement in facial emotion identification .\n",
            "There was also a significant SCST benefit for emotional intelligence and an in vivo training effect for empathy , though these improvements were not durable .\n",
            "Further , there were no overall or in vivo-related changes in functioning .\n",
            "This study bolsters and extends support for the efficacy of SCST in a relatively large and rigorously controlled trial , although our effort to enhance generalization to functional improvements through in vivo community-based training was not successful .\n",
            "Examined the efficacy of a sustained-release form of thioridazine ( SRT ) that was developed as an aid to improving outpatient compliance with medication regimens and decreasing inpatient costs associated with medication distribution and administration .\n",
            "@ patients ( aged @-@ yrs ) with acute schizophrenia were entered into a placebo-controlled double-blind evaluation .\n",
            "The SRT was given once daily for @ wks .\n",
            "Tests of efficacy at endpoint revealed a significant medication effect that was already evident by the end of Week @ , showing improvement in psychosis .\n",
            "Ss receiving placebo continued to deteriorate .\n",
            "SRT was well-tolerated .\n",
            "Background : There is still debate on whether first and second generation antipsychotics differ in efficacy and in effectiveness .\n",
            "We investigate the interplay of intermediate factors that can explain antipsychotics effects on negative symptoms .\n",
            "Methods : In a comparative effectiveness trial of four atypical antipsychotics vs. perphenazine over @ months in @ patients ( Clinical Antipsychotic Trial of Intervention Effectiveness ) , we use multivariable regression analysis to compare drug effects on a primary outcome , PANSS negative symptoms and on secondary outcomes : PANSS positive and weight-gain .\n",
            "We then employ novel causal mediation analysis approaches to quantify how much of the relative efficacy on negative symptoms is due to the mediating and interactive role of the secondary outcomes .\n",
            "Results : Regression analyses show no difference between olanzapine and perphenazine in negative symptoms at @ months .\n",
            "Olanzapine displays higher weight-gain ( beta @ @ , CI @ @ , @ ) and positive symptoms ( beta @ @ , CI @ @ , @ ) at @ months relative to perphenazine .\n",
            "Regression models for PANSS negative adjusting for treatment , mediators , and confounders yield a positive relationship between secondary and primary outcomes ( weight-gain : beta @ @ , CI @ @ , @ ; PANSS positive : beta @ @ , CI @ @ , @ ) and a weight-gain treatment negative interaction ( beta @ @ , CI @ @ , @ ) .\n",
            "Mediation analyses reveal that assignment to olanzapine vs perphenazine leads to worsening of negative symptoms through the secondary outcomes ( IE @ @ , CI @ @ , @ ) and to improvement in symptoms through other pathways ( DE @ @ , CI @ @,@ ) .\n",
            "Conclusions : Augmented treatment strategies targeting weight-gain and positive symptoms are critical to improve negative symptoms .\n",
            "Background : Brain-derived neurotrophic factor ( BDNF ) plays a critical role in neurodevelopment and plasticity ; decreased BDNF functioning may contribute to the pathogenesis of schizophrenia .\n",
            "However , BDNF levels are not static ; in animal experiments , brain BDNF increases during spatial learning , and in clinical depression , successful antidepressant treatment raises serum BDNF .\n",
            "We asked : would neuroplasticity-based cognitive training in schizophrenia result in increased serum BDNF ?\n",
            "Methods : Fifty-six schizophrenia outpatients and @ matched healthy comparison subjects were assessed on baseline cognitive performance and serum BDNF .\n",
            "Schizophrenia subjects were randomly assigned to either @ hours ( @ weeks ) of computerized auditory training or a computer game control condition , followed by reassessment of cognition and serum BDNF .\n",
            "Results : At baseline , schizophrenia participants had significantly lower-than-normal serum BDNF .\n",
            "Schizophrenia subjects who engaged in computerized cognitive training designed to improve auditory processing showed significant cognitive gains and a significant increase in serum BDNF compared with subjects who played computer games .\n",
            "This increase was evident after @ weeks of training , and after @ weeks in the active condition , subjects \" normalized \" their mean serum BDNF levels , whereas the control group showed no change .\n",
            "In the active condition , change in BDNF was significantly associated with improved quality of life .\n",
            "Conclusions : Serum BDNF levels are significantly increased in clinically stable , chronically ill schizophrenia subjects after neuroplasticity-based cognitive training , but not after computer games .\n",
            "Serum BDNF levels may serve as a peripheral biomarker for the effects of intensive cognitive training and may provide a useful tool for the evaluation of cognitive enhancement methods in schizophrenia .\n",
            "Of @ schizophrenic patients followed up @ years after their first admission to hospital , @ % were well , @ % had been readmitted to hospital at some time over the @ years , and @ % showed schizophrenic symptoms at follow-up .\n",
            "A poor outcome at @ years was associated with male sex , poor outcome after the first @ weeks of the first admission , negative schizophrenic symptoms on first admission , and a diagnosis of definite or probable schizophrenia using the Feighner criteria .\n",
            "Only @ % were in employment .\n",
            "A small DOUBLE-blind discontinuation study of maintenance antipsychotic medication during the second year found more relapses in those switched to placebo medication .\n",
            "Repeat psychometric assessment at @ years confirmed modest improvements found at @ months ; that is , there was no evidence of intellectual decline .\n",
            "Relatives showed no more psychosocial distress than that found in a normal community sample ; what distress there was correlated with patients ' schizophrenic symptoms .\n",
            "Two hundred and sixty-two patients who met DSM-IV criteria for first episode psychotic disorder ( including schizophrenia , schizophreniform disorder , or schizoaffective disorder ) participated in a double-blind , RANDOMized , multicenter , international trial comparing treatment with olanzapine versus treatment with haloperidol .\n",
            "This trial included a @-week acute treatment period followed by a @-week maintenance treatment period .\n",
            "The patient 's mean age was @  @ years , and @ % were male ; @ % were Caucasian , @ % were Black , and @ % other .\n",
            "Forty-five percent were neuroleptic-naive at initial assessment , and no patient had had more than @ weeks of treatment with an antipsychotic prior to initial assessment .\n",
            "During the @-week acute treatment period , the mean-modal doses were @ mg daily for olanzapine , and @ mg daily for haloperidol .\n",
            "Fifty-two percent of haloperidol treated patients , but only @ % of olanzapine-treated patients received concomitant anticholinergic antiparkinson medication .\n",
            "Significantly more olanzapine-treated patients ( @ % ) than haloperidol-treated patients ( @ % ) completed the @-week acute treatment period ( p = .@ ) .\n",
            "Fifty-five percent of olanzapine-treated patients , but only @ % of haloperidol-treated patients , met predetermined criteria for treatment response .\n",
            "Olanzapine treated patients gained significantly more weight ( @ kg versus @ kg , p < .@ ) than did haloperidol-treated patients .\n",
            "Haloperidol-treated patients experienced significantly more extrapyramidal side effects , as measured by the Simpson-Angus Scale and Barnes Akathisia Rating Scale , and had significantly greater elevations of serum prolactin levels ( @ ng/ml versus @ ng/ml , p < .@ ) , than did olanzapine-treated patient .\n",
            "A Neurocognitive Composite Score improved significantly more in olanzapine-treated patients ( @ versus @ , p = .@ ) than in haloperidol-treated patients .\n",
            "Results from MRI/MRS examinations will also be presented and discussed .\n",
            "Objective : A two-site randomised controlled trial of psychosis team-treatment of patients @  @ years old with a diagnose of schizophrenia , delusional disorder and other paranoia states is conducted in Copenhagen and Aarhus , Denmark .\n",
            "Method : The treatment consist of assertive community treatment , psycho-educational treatment in McFarlane s multifamily groups and social skills training .\n",
            "Inclusion of patients started @ February @ .\n",
            "At @ October @ , @ patients were included .\n",
            "Patients were assessed comprehensively at baseline and at @ month follow-up .\n",
            "At @ , @ , @ month follow up SAPS-ratings were made .\n",
            "Results and conclusion : At @ and @ month assessment significantly more patients allocated to psychosis team remained in contact as compared with patients in standard treatment .\n",
            "Global ratings of delusions improved significantly for both patient groups , but significantly more so among patients treated in OPUS team .\n",
            "Results from @ and @ month follow - up will also be presented .\n",
            "Objective : To assess whether the serotonin @ receptor antagonist ondansetron could improve the anti-psychotic effect of haloperidol or relieve the side effect of haloperidol .\n",
            "Methods : After having undergone two-week 's selecting period , altogether @ subjects with treatment - resistant Schizophrenia who have signed an informed consent were randomly divided into the contrastive group and the experimental group by a multicenter , double-blind , placebo-controlled method abiding by the grouping standards and excluding standards strictly .\n",
            "During the selecting period , other anti-psychotic drugs were gradually stopped using beside haloperidol .\n",
            "As a result , @ subjects in the contrastive group were treated by haloperidol combined with double-blind and @ in the experimental group were treated by haloperidol combined with ondansetron for @ weeks .\n",
            "The subjects were visited five times in the @ , @ , @ , @ , @ week respectively .\n",
            "Each time the treating effect was evaluated according to Positive and Negative Syndrome Scale ( PANSS ) and Clinical Global Impression ( CGI ) ; the side effect was evaluated according to Treatment Emergent Symptom Scale ( TESS ) and Extra-pyramidal Symptom Rating Scale ( ESRS ) .\n",
            "Meanwhile , the living symptoms such as pulse , breath , temperature , blood pressure and all so on were checked and all the data were recorded and put into the SPSS system .\n",
            "The data was dealt with by the square analysis of repeated measurement design .\n",
            "Results : @ .\n",
            "It was found that there were no interaction between the interfering methods and the treating period ( P > @ ) and there were no statistic difference in the positive and negative symptoms of PANSS , the general psychopathology , the cognitive function , the factor scores of Brief Psychiatric Rating Scale BPRS , and the total score of CG I ( P > @ ) .\n",
            "Meantime , it was found that as the treating period prolonged , the total score of PANSS and the devaluing score of every factor score decreased gradually ( P@ .@ ) .\n",
            "It was also found that there were no statistic difference in the contrastive group and the experimental group ( P > @ ) and the evaluating scores of the two group did no change obviously as the treating period prolonged .\n",
            "Meanwhile , it was also found that there was no difference in the living symptoms between the contrastive group and the experimental group and the symptoms did not change as the treating period prolongs .\n",
            "Conclusion : Thus , the serotonin @ receptor antagonist ondanseetron could not improve the anti-psychotic effect of halperidol as well as decrease the side effect of halperidol .\n",
            "Increasing evidence suggests that the tetracycline antibiotic minocycline has neuroprotective effects and is a potential treatment for schizophrenia .\n",
            "However , the mechanisms of action of minocycline in the CNS remain elusive .\n",
            "The aim of this study was to investigate the effects of minocycline on brain morphology and cerebral perfusion in patients with recent-onset schizophrenia after @ months of a randomized double-blind , placebo-controlled clinical trial of minocycline add-on treatment .\n",
            "This study included @ outpatients with recent-onset schizophrenia randomized for @ months of adjuvant treatment with minocycline ( @mg/d ) or placebo .\n",
            "MRI ( @ T ) and [ ( @m ) Tc ] - ECD SPECT brain scans were performed at the end of the @-month of trial .\n",
            "Between-condition comparisons of SPECT and MRI brain images were performed using statistical parametric mapping and analyzed by voxel-based morphometry ( VBM ) .\n",
            "Minocycline adjuvant treatment significantly reduced positive and negative symptoms when compared with placebo .\n",
            "The VBM analysis of MRI scans showed that the patients in the placebo group had significant lower gray matter volumes in the midposterior cingulate cortex and in the precentral gyrus in comparison with the patients in the minocycline group .\n",
            "In addition , a decreased ECD uptake in the minocycline condition was observed in fronto-temporal areas .\n",
            "These results suggest that minocycline may protect against gray matter loss and modulate fronto-temporal areas involved in the pathophysiology of schizophrenia .\n",
            "Furthermore , minocycline add-on treatment may be a potential treatment in the early stages of schizophrenia and may ameliorate clinical deterioration and brain alterations observed in this period .\n",
            "Copyright @ Elsevier B.V. All rights reserved .\n",
            "To assess whether an assertive outreach intervention after suicide attempt could reduce the frequency of subsequent suicidal acts , compared with standard treatment .\n",
            "Randomised , parallel group , superiority trial with blinded outcome assessment .\n",
            "Outpatient intervention at one location at Copenhagen University Hospital , Denmark .\n",
            "Patients older than @ years admitted to regional hospitals in Copenhagen with a suicide attempt within the past @ days .\n",
            "We excluded patients diagnosed with schizophrenia spectrum disorders and patients living in institutions .\n",
            "Case management through assertive outreach that provided crisis intervention and flexible problem solving .\n",
            "This approach incorporated motivational support and actively assisted patients to scheduled appointments to improve adherence with after-treatment as an add on to standard treatment .\n",
            "Repeated suicide attempt and death by suicide , recorded in medical records and death register at @-year follow-up .\n",
            "@ patients were included .\n",
            "During @ months of follow-up , @/@ ( @ % ) patients in the intervention group had been registered in hospital records with subsequent suicide attempt , compared with @/@ ( @ % ) in the control group ( odds ratio @ , @ % confidence interval @ to @ ; P = @ ) .\n",
            "By contrast , self reported data on new events showed @/@ ( @ % ) in the intervention group versus @/@ ( @ % ) in the control group ( @ , @ to @ ; P = @ ) .\n",
            "By imputing missing data on the selfreported outcomes , we estimated @/@ ( @ % ) events in the intervention group and @/@ ( @ % ) in the control group ( @ , @ to @ ; P = @ ) .\n",
            "Assertive outreach showed no significant effect on subsequent suicide attempt .\n",
            "The difference in rates of events between register data and self reported data could indicate detection bias .\n",
            "ClinicalTrials.gov NCT@ .\n",
            "OBJECTIVE : To compare matched paliperidone-ER - and olanzapine-treated schizophrenic patients on measures of glucose and lipid metabolism .\n",
            "METHODS : Eighty hospitalized patients with schizophrenia ( DSM-IV ) were randomly assigned to treatment with paliperidone ER or olanzapine for a period of @ weeks .\n",
            "At baseline and every @ weeks , we assessed weight , subcutaneous fat , waist and hip circumferences , fasting glucose , insulin , glycohemoglobin A@ , cholesterol , triglycerides , high density lipoprotein ( HDL ) cholesterol , low density lipoprotein ( LDL ) cholesterol , and prolactin .\n",
            "We also assessed at every time point body mass index ( BMI ) , homeostasis insulin resistance ( HOMA-IR ) , and homeostasis beta-cell function ( HOMA-B ) .\n",
            "RESULTS : Thirty-three patients randomly assigned to paliperidone ER and @ patients randomly assigned to olanzapine groups completed the entire @-week treatment .\n",
            "Within-group analyses showed that fasting measures in both groups increased for weight , BMI , waist circumferences , hip circumference , subcutaneous fat , cholesterol , triglycerides , and prolactin .\n",
            "In contrast , fasting glucose , LDL , and HOMA-B increased during treatment only in the olanzapine group .\n",
            "We also detected significantly different serum prolactin levels at all time point between the paliperidone ER - and olanzapine-treated groups , as well as a statistical trend for HOMA-B to increase more in the olanzapine compared to paliperidone-ER group over the @ weeks of the trial .\n",
            "We did not detect , however , differential drug effects over the @ weeks of the trial on fasting measures of BMI , glucose , glycohemoglobin A@ , insulin , HDL , LDL , cholesterol , triglyceride , or HOMA-IR .\n",
            "CONCLUSION : This study reinforces the necessity of regularly monitoring metabolic parameters in patients with schizophrenia taking atypical antipsychotics , including paliperidone ER .\n",
            "Objective : To observe the efficacy of Tian Wang Bu Xin Dan on antipsychotic-induced sinus tachycardia .\n",
            "Methods : @ cases a result of taking antipsychotic Erzhi \" sinus tachycardia \" patients were randomly divided into two groups , treatment group , @ cases of oral Tian Wang Bu Xin Dan treatment ; control group of @ cases of oral propranolol therapy .\n",
            "Results : The recovery in @ cases , effective in @ cases , @ cases , total effective rate of @ % ; recovered to the control group @ cases were cured , @ cases , @ cases , total effective rate was @ % ; group , the total efficiency the difference was not significant ( P > @ ) .\n",
            "But the treatment group than the control group in improving the symptoms .\n",
            "The effect of mirtazapine on steady-state plasma concentrations of the newer atypical antipsychotics clozapine , risperidone and olanzapine was investigated in @ patients with chronic schizophrenia .\n",
            "In order to treat residual negative symptoms , additional mirtazapine ( @ mg per day ) was administered for six consecutive weeks to nine patients stabilized on clozapine therapy ( @-@ mg per day ) , eight on risperidone ( @-@ mg per day ) and seven on olanzapine ( @-@mg per day ) .\n",
            "There were only minimal and statistically insignificant changes in mean plasma concentrations of clozapine and its metabolite norclozapine , risperidone and its metabolite @-hydroxyrisperidone , and olanzapine during the study period .\n",
            "Mirtazapine co-administration with either clozapine , risperidone or olanzapine was well tolerated .\n",
            "In the overall sample , a slight improvement in negative symptomatology , as assessed by the Scale for Assessment of Negative Symptoms , was observed at final evaluation ( P < @ ) and six patients ( two in each treatment group ) were classified as responders .\n",
            "While double-blind , controlled studies are needed to evaluate the potential clinical benefits of mirtazapine in chronic schizophrenia , our findings indicate that mirtazapine has a negligible effect on the metabolism of clozapine , risperidone and olanzapine and can be added safely to an existing treatment with these antipsychotics\n",
            "Objective : To test the utility of risperidone and olanzapine in reducing both marijuana/cocaine craving and use in individuals with schizophrenia/schizoaffective disorder .\n",
            "Method : Twenty-two patients meeting DSM-IV criteria for schizophrenia , cocaine and/or marijuana use disorder were randomized to olanzapine/risperidone in a @ - week , double-blind trial which consisted of three phases : @ ) a @ week assessment phase when baseline data was collected while patients were maintained on their prescribed medication , @ ) a @ week cross-taper phase where patients were tapered off their previously prescribed medication and randomized onto the study medication and @ ) a @-week period in which patients were maintained on either study medication .\n",
            "Outcome variables included treatment retention , proportion of drug-free urines donated , marijuana/cocaine craving , self-reported drug use , and quantitative urine toxicology .\n",
            "Results : The olanzapine group showed a trend in reduction of cocaine craving ( p = @ ) from month @ to month @ , while the risperidone group did not .\n",
            "Both groups showed a decrease in marijuana craving , albeit not significant .\n",
            "The olanzapine group also showed a decrease in self-reported cocaine use from month @ to month @ ( p = .@ ) .\n",
            "A similar trend appeared in the risperidone group , showing a reduction of self-reported cocaine use from month @ to month @ ( p = .@ ) .\n",
            "The olanzapine group displayed a significant reduction ( p = .@ ) in self-reported marijuana use from month @ to month @ , while the risperidone group did not .\n",
            "However , there were no significant differences across groups between olanzapine and risperidone .\n",
            "Both groups exhibited an increase in proportion of cocaine/marijuana-negative urines provided , although not significant .\n",
            "Conclusions : Preliminary data suggest there may be a role for atypical neuroleptics in the treatment of schizophrenic substance abusers .\n",
            "Larger trials are needed to further determine the efficacy of atypical neuroleptics in treating this population .\n",
            "This study aimed to investigate remission following the treatment of schizophrenia patients with risperidone .\n",
            "Clinically stabilized patients with schizophrenia ( n = @ ) were randomly assigned to @-week , @-week , or no-dose-reduction groups , in which the baseline risperidone dose was continued for @ , @ , or all weeks during @-year period .\n",
            "The ' Positive and Negative Syndrome Scale ' ( PANNS ) was assessed at baseline and monthly for six months , followed by every two months until the last recruited patient completed @-year follow-up .\n",
            "Symptomatic remission was defined according to criteria established by the Schizophrenia Working Group .\n",
            "A Generalized Linear Mixed Model indicated significant variation in remission over time , which increased after baseline in the entire group ( F = @ , df = @ , @ , P < @ ) .\n",
            "The overall length of risperidone treatment ( F = @ , df = @ , @ , P = @ ) and the duration of illness ( F = @ , df = @ , @ , P = @ ) had significantly negative effects upon remission .\n",
            "Baseline remission patients were associated with a significantly increased time to relapse compared with the baseline of non-remission patients over a one year follow up period ( F = @ , df = @ , @ , P = @ ) .\n",
            "One-year risperidone maintenance treatment increased remission rates in schizophrenia .\n",
            "A shorter illness duration , risperidone treatment length , and a lower total PANSS score were clinically useful predictors of remission .\n",
            "Achieving remission may postpone relapse .\n",
            "Objective : To compare the therapeutic and side effects of chlorpromazine ( CPZ ) and clozapine in the treatment of schizophrenia .\n",
            "Method : @ patients with diagnosis of schizophrenia according to CCMD@R and positive symptoms according to SAPS by Andreason were randomly assigned to treatment with either CPZ or clozapine for eight weeks .\n",
            "Clinical improvement and side effects were monitored with the BPRS and TESS .\n",
            "Results : The mean response time was significantly shorter for the CPZ than clozapine\n",
            "Global mental health movements increasingly highlight the importance of social integration for individuals living with severe mental illnesses .\n",
            "However , this important individual-level outcome is rarely measured in programs .\n",
            "As part of RedeAmericas , a pilot regional randomized controlled trial of critical time intervention - task shifting - will be conducted , which includes social integration as an outcome measure .\n",
            "It is a time-limited care coordination model to enhance continuity of support for people with severe mental illness during critical periods of transition .\n",
            "Given the challenges of measuring social integration , particularly for a multi-country study with unique cultural contexts , this paper has described the measurement approach used to create a composite measure that uses items from disability and quality of life instruments in addition to other key items .\n",
            "Fifty-three hospitalized chronic schizophrenic patients were treated with either propranolol , chlorpromazine or placebo in a double-blind randomized trials for up to three months .\n",
            "Propranolol in a usual dose of @ mg/day , produced marked cardiovascular effects but no improvement in schizophrenic symptomatology relative to placebo .\n",
            "The effects of chlorpromazine were small and inconsistent .\n",
            "Administered carbamazepine ( CB ) to @ groups of psychiatric patients ( aged @-@ yrs ) over @ wks .\n",
            "@ received CB , while @ received placebo .\n",
            "Symptoms ( mostly psychotic ) of agitation and disruptive behavior , loss of impulse control ( e.g. , aggressiveness , impulsivity , perversity , suicide attempts , orality , and pseudomania ) , and extrapyramidal symptoms in Ss with a premorbid active-ambivalent personality pattern , in the absence of clinical and EEG signs of epilepsy , indicated the use of CB .\n",
            "This drug allowed a reduction , sometimes marked , of high doses of neuroleptics , as well as of many indications for Li .\n",
            "( French , Spanish , Italian & Dutch abstracts )\n",
            "This study sought to explore the impact of smoking reduction on suicidality ( suicide ideation and behaviour ) among people with a psychotic disorder ( n = @ ) who participated in a randomized trial of a healthy lifestyle intervention trial .\n",
            "Suicidality , measured by item -@ of the Brief Psychiatric Rating Scale ( BPRS ) was the main variable of interest .\n",
            "Measures were collected by research assistants blind to treatment allocation at baseline , at @ weeks ( mid-intervention ) and @ months after baseline .\n",
            "Mediation analysis , adjusted for confounders , was used to determine the relationship between smoking reduction and suicidality and to explore whether this was mediated through depression .\n",
            "At @ months , smoking reduction was found to be significantly associated with suicidality change ; an association was also seen between smoking reduction and depression and depression and suicidality .\n",
            "After adjusting for depression , the association between smoking reduction and suicidality was attenuated but remained statistically significant ; the proportion of the total effect that was mediated through depression was @ % .\n",
            "There was no significant association between suicidality and treatment group ( vs. controls ) over time .\n",
            "Our study suggests that smoking interventions may have benefits over and above those for improved physical health , by reducing suicidal ideation in people with psychosis .\n",
            "We report the first placebo-controlled treatment trial for prodromal symptoms .\n",
            "Sixty patients from four centres in North America were diagnosed using the Structured Interview for Prodromal Syndromes , gave informed consent , and were randomized to olanzapine @  @ mg daily vs. placebo .\n",
            "Treatment outcome was assessed over @ weeks with the Scale Of Prodromal Symptoms ( SOPS ) .\n",
            "The average prescribed olanzapine dose was @  @ mg  day .\n",
            "Twenty olanzapine and @ placebo ( n.s. ) patients completed @ weeks .\n",
            "The mixed-effects likelihood-based repeated - measures model treatment-by-time interaction for the SOPS total score was significant ( P  @ ) .\n",
            "Post-hoc analyses revealed that the difference between olanzapine and placebo reached a trend level by week @ and was statistically significant at weeks @ and @ ( least squares mean  SE ) @  @ vs. ) @  @ , respectively , P  @ ) .\n",
            "Endpoint EPS ratings were similar in the two groups .\n",
            "Olanzapine patients gained significantly more weight ( P  @ ) .\n",
            "The results suggest that prodromal patients obtain a symptomatic benefit from olanzapine over the short-term , but weight gain is a concern .\n",
            " Although vision is important for initiating change , it is not enough to organize and maintain a system of care .\n",
            "Vision must be translated into practical strategies  ( Rosen et al. @ , p. @ ) .\n",
            "The recognition and management of early psychosis has become a popular focus among clinicians , researchers and service reformers in recent years ( Edwards & McGorry , @ ) .\n",
            "Numerous early psychosis programs operate in Western countries and major projects are underway in Hong Kong and Singapore .\n",
            "A variety of decision points and obstacles are likely to be encountered when establishing early psychosis services .\n",
            "The focus of this presentation is on elements of  becoming real  such as specialist vs. generalist model considerations , evidence , and stafftraining .\n",
            "There is an urgent need for resource material to inform the striving towards best practice in this burgeoning and specialised field .\n",
            "Two randomized controlled trials completed at the Early Psychosis Prevention and Intervention Centre ( EPPIC ) during @  the Cannabis and Psychosis ( CAP ) Project and the Recovery Plus study  are presented to illustrate the efforts required to bridge the  high ground  and the  swamp  .\n",
            "References Edwards J , McGorry PD .\n",
            "Implementing Early Intervention in Psychosis : A Guide to Establishing Early Psychosis Services .\n",
            "London : Dunitz , @ .\n",
            "Rosen A , Diamond RJ , Miller V , Stein LI .\n",
            "ecoming real : from model programs to implemented services .\n",
            "In : Hollingsworth EJ , ed .\n",
            "The Successful Diffusion of Innovative Program Approaches : New Directions for Mental Health Services .\n",
            "San Francisco : Josey Bass , @ ; @  @ .\n",
            "Context : Patients with schizophrenia have a high rate of cigarette smoking and also exhibit profound deficits in sensory processing , which may in part be ameliorated by the acute actions of smoke-inhaled nicotine .\n",
            "The mismatch negativity ( MMN ) , a preattentive event-related potential index of auditory sensory memory , is diminished in schizophrenia .\n",
            "The MMN is increased in healthy controls with acute nicotine .\n",
            "Objective : To utilize the MMN to compare auditory sensory memory in minimally tobacco-deprived ( @ hours ) patients and matched tobacco-deprived smoking controls and to assess the effects of acute nicotine on MMN-indexed sensory memory processing in the patients .\n",
            "DESIGN : : Event-related potentials were recorded in @ auditory oddball paradigms , one involving tone frequency changes ( frequency MMN ) and one involving tone duration changes ( duration MMN ) .\n",
            "Controls were assessed once under nontreatment conditions , and patients were assessed twice under randomized double-blind treatment conditions involving placebo and nicotine ( @ mg ) gum .\n",
            "SETTING : : Outpatient mental health center .\n",
            "PATIENTS : : Twelve smokers with schizophrenia and twelve control smokers .\n",
            "RESULTS : : Compared with the controls , the patients showed reduced frequency-MMN ( P < @ ) and duration-MMN ( P < @ ) amplitudes .\n",
            "In addition to prolonging peak latency in duration MMN ( P < @ ) , nicotine , relative to placebo , increased the amplitude of the patients ' duration MMN ( P < @ ) , but not their frequency MMN , to a level comparable with that seen in the controls .\n",
            "Conclusions : These preliminary findings demonstrate for the first time that acute nicotine can normalize temporal aspects of sensory memory processing in patients with schizophrenia , an effect that may be mediated by activation of alpha@ nicotinic acetylcholine receptors , the function of which is diminished in schizophrenia .\n",
            "These ameliorating actions of nicotine may have implications for understanding the close relationship between tobacco smoking and schizophrenia and for developing nicotinic pharmacotherapies to alleviate sensory memory impairments in schizophrenia .\n",
            "@ Lippincott Williams & Wilkins .\n",
            "Forty-seven chronic hospitalized schizophrenics were treated in turn with placebos , pericyazine , and thioridazine for @-week periods in a double blind cross-over trial lasting one year in all .\n",
            "The Wing rating scale was used for assessment .\n",
            "Both drugs were more effective than placebo , but neither was better in general than the pre-trial treatment .\n",
            "Pericyazine seemed less effective against the individual symptom of coherent delusions , and thioridazine scored significantly better against the symptom group socially embarrassing behaviour .\n",
            "OBJECTIVE : Hyperprolactinemia and associated side effects often occur with antipsychotics .\n",
            "The authors investigated the effect of adjunctive treatment with aripiprazole on hyperprolactinemia and psychopathology in patients with schizophrenia maintained with haloperidol .\n",
            "METHOD : Fifty-six patients with hyperprolactinemia taking haloperidol were enrolled .\n",
            "Haloperidol dose was fixed ; aripiprazole was dosed at @ mg/day for the first @ weeks , then @ mg/day for the following @ weeks .\n",
            "Serum prolactin , haloperidol , and aripiprazole levels were measured .\n",
            "Symptoms and side effects were assessed with the Brief Psychiatric Rating Scale ( BPRS ) , Scale for the Assessment of Negative Symptoms , Clinical Global Impression symptom scale , Simpson-Angus Rating Scale , and Barnes Akathisia Rating Scale at weeks @ , @ , @ , @ , and @ .\n",
            "RESULTS : Prolactin levels of patients receiving aripiprazole significantly decreased over time , demonstrating a significant time effect and a time-by-group interaction .\n",
            "In the aripiprazole group , @ % of patients at week @ had prolactin levels normalize compared to @ % of patients receiving placebo .\n",
            "Among @ female patients with menstrual disturbances randomly assigned to aripiprazole , seven patients regained menstruation during the study , whereas none receiving placebo did .\n",
            "Plasma levels of haloperidol were not significantly altered .\n",
            "No significant time effect and time-by-group interactions on BPRS , Scale for the Assessment of Negative Symptoms , and Simpson-Angus Rating Scale scores were noted .\n",
            "CONCLUSIONS : Adjunctive aripiprazole treatment reversed hyperprolactinemia in both sexes , resulting in reinstatement of menstruation in female patients , with no significant effects on psychopathology and extrapyramidal symptoms .\n",
            "Aripiprazole has higher affinity to dopamine D ( @ ) receptors than haloperidol , which is the likely cause of this observation .\n",
            "RN @ ( Antipsychotic Agents ) .\n",
            "@ ( Dopamine Antagonists ) .\n",
            "@ ( Piperazines ) .\n",
            "@ ( Placebos ) .\n",
            "@ ( Quinolones ) .\n",
            "@ ( Receptors , Dopamine D@ ) .\n",
            "@-@-@ ( aripiprazole ) .\n",
            "@-@-@ ( Haloperidol ) .\n",
            "Objective : To investigate the impact of health education on the compliance of patients with schizophrenia medication .\n",
            "Methods : @ cases of hospitalized patients with schizophrenia were randomly divided into two groups , two groups of patients receiving conventional treatment and care , medication compliance of health education for the experimental group patients .\n",
            "Results : The patient medication adherence was significantly higher ( P < @ ) .\n",
            "Trial purpose : This is a randomized , double-blind study to determine how well intramuscular ( IM ) olanzapine depot works compared to oral olanzapine ; evaluate the safety and tolerability of IM olanzapine depot compared to oral olanzapine ; evaluate different doses of IM olanzapine depot ; and determine the blood levels of IM olanzapine depot in patients at different points in time after an injection .\n",
            "Primary outcome measure : Determine the comparative efficacy in patients with schizophrenia of @ ) non-inferiority of IM olanzapine depot high and low doses versus oral olanzapine based on exacerbation rates after @ months of maintenance treatment and @ ) superiority of IM olanzapine depot low , med and high doses versus very low dose based on time to exacerbation of symptoms of schizophrenia Secondary outcome measure : Demonstrate non-inferior efficacy in terms of exacerbation rates of high plus low dose IM olanzapine depot versus medium dose .\n",
            "Provide information on transition of patients stabilized on oral olanzapine @ , @ or @ mg/day to therapeutic doses of IM olanzapine depot .\n",
            "Demonstrate superiority of high dose , medium dose and low dose IM olanzapine depot compared with very low dose .\n",
            "IM olanzapine depot in change from baseline to endpoint in PANSS total , positive , negative and general subscales .\n",
            "Assess the safety and tolerability of high plus low dose IM olanzapine depot versus oral olanzapine .\n",
            "Assess the safety and tolerability of medium dose IM olanzapine depot versus oral olanzapine .\n",
            "Assess the safety and tolerability of each IM olanzapine depot treatment group versus very low dose IM olanzapine depot .\n",
            "Compare the efficacy of high plus low dose IM olanzapine depot versus oral olanzapine during maintenance treatment on quality of life , drug attitude inventory , resource utilization and hospitalization measures .\n",
            "Compare the efficacy of high , medium and low doses of IM olanzapine depot during maintenance treatment on quality of life , drug attitude inventory , resource utilization and hospitalization measures .\n",
            "Characterize the pharmacokinetics of olanzapine following multiple dosing with IM olanzapine depot at each of the prescribed dosing regimens and to compare IM olanzapine depot pharmacokinetics with oral olanzapine pharmacokinetics .\n",
            "Inclusion criteria : Patients must have schizophrenia .\n",
            "Patients must be clinically stable on antipsychotic medication .\n",
            "Patients must be retrospectively judged by investigators , based on clinical interview and impression , to have been stable ( with respect to their symptoms of schizophrenia ) for at least @ weeks entry into the study .\n",
            "Patients must be an outpatient and have BPRS positive items scores of @ or less to enter the study .\n",
            "Female patients of childbearing potential must be using a medically accepted means of contraception .\n",
            "Exclusion Criteria : Patients must not have participated in a clinical trial of another investigational drug , including olanzapine , within @ month ( @ days ) prior to study entry .\n",
            "Female patients must not be pregnant or breast-feeding .\n",
            "Patients must not be experiencing acute , serious , or unstable medical conditions other than schizophrenia .\n",
            "Patients must not require concomitant treatment with any other medication with primarily central nervous system activity , including antidepressants , mood stabilizers , and anticonvulsants .\n",
            "Patients must not have a substance ( except nicotine or caffeine ) dependence within the past @ days .\n",
            "Expected total enrollment : @ .\n",
            "Participant eligibility : Ages eligible for study : @ years - @ years .\n",
            "Genders eligible for study : both\n",
            "Objective - To establish whether a brief cognitive behavioral intervention as delivered by psychiatric nurses in the community can improve insight in schizophrenia as compared with treatment as usual .\n",
            "Method : A total of @ patients with established schizophrenia were RANDOMized to receive either CBT and psychoeducation ( @ patients ) or treatment as usual ( @ patients ) , @ carers also received CBT and psychoeducation .\n",
            "Independent raters blind to the patient 's treatment condition assessed patients and carers at baseline and at end of therapy ( mean = @ weeks ) .\n",
            "Insight was rated on the Insight Rating Scale , overall symptoms on the Comprehensive Psychopathological Rating Scale , and the burden of care on the Burden of Care Questionnaire .\n",
            "Clinical significance was set at @ % improvement .\n",
            "Results : Patients who received CBT and psychoeducation demonstrated a significant improvement in insight ( p = @ ) , overall symptoms ( p = @ ) , and in depression ( p = @ ) but not in the burden of care ( p = @ ) .\n",
            "There was no significant increase in suicidal ideation ( p = @ ) .\n",
            "Overall symptomatology alone has improved to a clinically significant degree .\n",
            "Conclusions : Community psychiatric nurses can be trained to safely and effectively deliver CBT and psychoeducation to patients with schizophrenia and their carers\n",
            "Purpose : Cognitive deficits related to working memory , executive function , and information processing , are commonly seen in patients with SCHIZophrenia .\n",
            "Improving this cognitive dysfunction is an important treatment outcome for psychiatrists .\n",
            "When treated with atypical antipsychotics , including risperidone , patients with SCHIZophrenia show improvements in cognition , both when switched from typical agents and treated de novo .\n",
            "This report examines endpoint results of cognitive measures from a @-month study of risperidone long-acting injectable in patients with SCHIZophrenia .\n",
            "Method : Clinically stable adults ( N = @ ) with SCHIZophrenia were RANDOMized to a @ or @ mg dose of long-acting risperidone .\n",
            "A computer-administered cognitive assessment battery ( CogTest , LLC ) was performed at baseline , and weeks @ , @ , and @ , and included measures of attention/impulsivity , processing speed , verbal learning and memory , working memory , social cognition , and executive functioning .\n",
            "Specific tests utilized included the Tapping Speed Test ( TST ) , Flanker Continuous Performance Test ( CPT-Flanker ) , Object Working Memory Test ( OWMT ) , Word List Memory Test ( WLMT ) , AX Continuous Performance Test ( CPT-AX ) , Identical Pairs Continuous Performance Test ( CPT-IP ) , Strategic Target Detection Test ( STDT ) , Set Shifting Test ( SST ) , and the Penn Emotional Acuity Test ( PEAT ) .\n",
            "@-week endpoint data on these cognitive measures were analyzed .\n",
            "Results : A total of @ patients completed the cognitive assessment battery .\n",
            "Change from baseline to endpoint was assessed for all cognitive measures .\n",
            "Significant improvements were noted in @ of the @ domains evaluated , with improvements of many domains occurring at time of first re-assessment ( week @ ) .\n",
            "These improved domains ( baseline to endpoint ) included attention/impulsivity [ CPT-Flanker , sum correct incongruent : @ to @ ( P < @ ) ] , processing speed [ STDT , strategic efficiency variable : @ to @ ( P < @ ) ] , working memory [ OWMT , titration : mean difficulty level : @ to @ ( P < @ ) ] , and verbal learning and memory [ WLMT , Percent Trial to Trial Transfer : @ to @ ( P < @ ) ] .\n",
            "Discussion : Improvements in cognitive functioning were observed in stable patients switched to maintenance treatment with long-acting risperidone over the course of one year .\n",
            "The magnitude of changes suggests that long-acting risperidone therapy may improve cognitive function to a level that is clinically relevant .\n",
            "Further analyses will look to explore the relationship between cognitive functioning and improvements in clinical and functional status .\n",
            "Aman , M , Singh , N , Stewart , A , Field , C. , The aberrant behavior checklist : a behavior rating scale for the assessment of treatment effects .\n",
            "Am J Mental Deficiency @ ; @ : @-@ .\n",
            "Compared an ultrasound detector ( UD ) with a clinical rating ( CR ) scale in the assessment of oro-facial movements in @ chronic schizophrenic adult patients and @ normal Ss over @ wks .\n",
            "The apparatus distinguished well between normal volunteers and dyskinetic patients .\n",
            "There were also highly significant correlations between UD scores and clinical ratings .\n",
            "Results confirm both the construct and concurrent validity of the technique .\n",
            "Nevertheless , there was significant variation in the UD scores for some patients between assessments ; the scores of the normal Ss were consistent .\n",
            "It is suggested that with further development and repeated @-sec assessments the technique might be of value in ( @ ) the ascertainment of early dyskinesia in patients at risk and ( @ ) measuring drug effects .\n",
            "This double-blind study evaluated the impact of treatment with olanzapine compared with haloperidol , and placebo on improvements in symptomatology and quality of life in patients with a DSM-III-R diagnosis of schizophrenia .\n",
            "A total of @ patients was randomized to five treatment groups ; olanzapine @ + / - @ mg/day , olanzapine @ + / - @ mg/day , olanzapine @ + / - @ mg/day , haloperidol @ + / - @ mg/day , and placebo .\n",
            "Patients responding to treatment during the @-week acute phase were eligible to enter a @-week extension .\n",
            "Efficacy measures included the brief psychiatric rating scale total , scale for assessment of negative symptoms summary , and clinical global impressions severity scores .\n",
            "Quality of life was evaluated using the quality of life scale .\n",
            "Data analyzed after @ weeks of therapy showed that olanzapine was significantly superior to placebo in reducing clinical severity and significantly superior to haloperidol in reducing negative symptoms in patients responding to acute treatment .\n",
            "Furthermore , improvement in quality of life was observed in olanzapine-treated responders .\n",
            "Objective To study the treatment efficacy of schizophrenia with Neo Morita therapy .\n",
            "Method The patients with schizophrenia were divided into Neo Morita therapy combined with drug therapy group ( NMG ) and drug therapy group ( DTG ) .\n",
            "Both groups were treated for @ months , and surveyed with BPRS , SANS , and SDSS before the treatment , @ months later , @ months later .\n",
            "Result ( @ ) The decrease rates of BPRS score in two groups were not obviously different but the amelioration rate of anxiety and depression in NMG was\n",
            "OBJECTIVE : To further define the metabolic profiles of second-generation antipsychotics during the treatment of young patients with early psychosis , with a view to better inform prescribing clinicians .\n",
            "METHOD : Weight , body mass index ( BMI ) , glucose , and serum lipids were measured in the @-week Comparison of Atypicals for First Episode ( CAFE ) study , in which olanzapine , quetiapine , and risperidone were evaluated , and whose primary outcomes have been reported elsewhere .\n",
            "These metabolic data were analyzed using a mixed random coefficients model for continuous longitudinal measures and a logistic regression model for categorical responses .\n",
            "RESULTS : Of the @ patients recruited , @ % were overweight and @ % were obese at baseline , and @ ( @ % ) patients met criteria for metabolic syndrome .\n",
            "After @ and @ weeks of treatment , weight gain > or = @ % from baseline was reported in @ % and @ % of quetiapine-treated patients , @ % and @ % of olanzapine-treated patients , and @ % and @ % of risperidone-treated patients , respectively .\n",
            "Weight gain after @ and @ weeks of treatment was estimated as [ Least Squares Mean ( SE ) ] @ ( + / -@ ) and @ ( + / -@ ) lb for olanzapine , @ ( + / -@ ) and @ ( + / -@ ) lb with risperidone and @ ( + / -@ ) and @ ( + / -@ ) lb for quetiapine respectively .\n",
            "In women , greater weight gain occurred during risperidone treatment compared with quetiapine treatment .\n",
            "By week @ , increases in BMI > or = @ unit occurred with significantly higher frequency in olanzapine-treated patients compared with quetiapine - or risperidone-treated patients .\n",
            "By @ weeks , treatment-emergent metabolic syndrome was reported in @ individuals ( @ % of the total population ) , of whom @ were receiving olanzapine , @ quetiapine , and @ risperidone .\n",
            "Risperidone was associated with the smallest elevations in triglyceride and total cholesterol levels .\n",
            "CONCLUSION : Weight gain and metabolic syndrome occur commonly even in young patients receiving antipsychotic treatment for early psychosis .\n",
            "Targeted interventions are therefore warranted from the onset of antipsychotic therapy .\n",
            "Purpose : Paliperidone palmitate is a once-monthly injectable atypical antipsychotic that delivers @-hydroxyrisperidone .\n",
            "The recommended initiation dose ( @ mg equivalents [ eq ] on day @ and @ mg eq on day @ , both deltoid ) was designed to rapidly attain symptom control without oral antipsychotic supplementation .\n",
            "This analysis examined the effects of paliperidone palmitate in patients with schizophrenia recently treated with oral risperidone but still experiencing an acute exacerbation .\n",
            "Methods : This represents a post hoc analysis of a @-week , double-blind , placebo-controlled study ( CRO@ ) of @ randomized subjects with an acute exacerbation of schizophrenia .\n",
            "Subjects were randomly assigned to paliperidone palmitate ( @ , @ , or @ mg eq of paliperidone ; or @ , @ , or @ mg , respectively ) or placebo .\n",
            "Paliperidone palmitate subjects received an initiation dose of @ mg eq on day @ , followed by their assigned dose on day @ and monthly thereafter , with no oral antipsychotic supplementation .\n",
            "This analysis focused on the subgroup of subjects who received oral risperidone within @ weeks prior to randomization .\n",
            "Assessments included Positive and Negative Syndrome Scale ( PANSS ) , Clinical Global Impressions - Severity ( CGI-S ) , Personal and Social Performance ( PSP ) scores , and adverse event ( AE ) reports .\n",
            "An analysis of covariance ( ANCOVA ) model and last-observation-carried-forward ( LOCF ) methodology evaluated change scores at the week @ end point .\n",
            "No adjustment was made for multiplicity .\n",
            "Results : Of @ subjects from the intent-to-treat population of the original study , @ ( @ % ) received oral risperidone within @ weeks prior to randomization ( paliperidone palmitate , n = @ ; placebo , n = @ ) and were included in this analysis .\n",
            "Their mean ( SD ) age was @ ( @ ) years , and @ % were male .\n",
            "Mean ( SD ) duration of previous risperidone use was @ ( @ ) days and mean ( SD ) modal daily dose of oral risperidone was @ ( @ ) mg .\n",
            "Mean ( SD ) PANSS total score at baseline was @ ( @ ) .\n",
            "Study completion rates were @ % with paliperidone palmitate and @ % with placebo .\n",
            "The most frequent cause of discontinuation was reported as lack of efficacy in @ % of subjects receiving paliperidone palmitate and in @ % receiving placebo .\n",
            "Paliperidone palmitate was associated with a significantly greater improvement in the least-squares ( LS ) mean ( SE ) PANSS total score compared with placebo from day @ ( -@ [ @ ] vs -@ [ @ ] ; P < @ ) through end point ( -@ [ @ ] vs -@ [ @ ] ; P < @ ) .\n",
            "Significantly greater improvement with paliperidone palmitate vs placebo was also observed for LS mean ( SE ) CGI-S ( -@ [ @ ] vs -@ [ @ ] ; P = @ ) and patient functioning ( PSP : @ [ @ ] vs @ [ @ ] ; P = @ ) scores at end point .\n",
            "The most common AEs ( > = @ % ) with a higher incidence with paliperidone palmitate than with placebo : insomnia ( @ % vs @ % ) , headache ( @ % vs @ % ) , and injection site pain ( @ % vs @ % ) .\n",
            "Conclusion : In patients with schizophrenia who had recent prior treatment with oral risperidone but still experienced enough symptoms for study enrollment , once-monthly dosing with paliperidone palmitate without oral antipsychotic supplementation significantly improved clinical symptoms , global ratings of illness , and functioning compared with placebo .\n",
            "No unexpected safety or tolerability findings were observed .\n",
            "Objectives .\n",
            "This study tested a psychiatric rehabilitation approach for organizing and delivering services to street-dwelling persons with severe mental illness .\n",
            "Methods .\n",
            "Street-dwelling persons with severe mental illness were randomly assigned to the experimental program ( called Choices ) or to standard treatment in New York City .\n",
            "We assessed study participants at baseline and at @-month intervals over @ months , using measures of service use , quality of life , health , mental health , and social psychological status .\n",
            "The average deviation from baseline summary statistic was employed to assess change .\n",
            "Results .\n",
            "Compared with persons in standard treatment ( n = @ ) , members of the experimental group ( n = @ ) were more likely to attend a day program ( @ % vs @ % ) , had less difficulty in meeting their basic needs , spent less time on the streets ( @ % vs @ % reduction ) , and spent more time in community housing ( @ % vs @ % increase ) .\n",
            "They showed greater improvement in life satisfaction and experienced a greater reduction in psychiatric symptoms .\n",
            "Conclusions .\n",
            "With an appropriate service model , it is possible to engage disaffiliated populations , expand their use of human services , and improve their housing conditions , quality of life , and mental health status .\n",
            "Objective To investigate olanzapine efficacy and safety of treatment of refractory schizophrenia .\n",
            "Methods @ patients with refractory schizophrenia were randomly divided into olanzapine treatment group ( study group , n = @ ) and clozapine treatment group ( control group , n = @ ) , before treatment and @ , @ , @,@ w end of the positive and Negative Syndrome Scale side effects rating scale to evaluate the efficacy , adverse reactions , and a comparative analysis .\n",
            "Results Before treatment , the two sets of positive and negative syndrome scale 's score was no significant difference ( P > @ ) ; After treatment , the total effective rate was no significant difference ( P > @ ) ; cognitive factors and negative symptoms reduction rate , there are significant differences between the two groups ( P < @ or P < @ ) ; adverse olanzapine than clozapine light .\n",
            "OBJECTIVE : This multicenter , randomized , double-blind , placebo-controlled study evaluated the efficacy and safety of intramuscular ( IM ) aripiprazole in patients with acute agitation with a DSM-IV diagnosis of schizophrenia , schizoaffective disorder , or schizo-phreniform disorder .\n",
            "METHOD : Patients were randomly assigned to IM aripiprazole @ mg , @ mg , @ mg , or @ mg ; IM haloperidol @ mg ; or placebo and observed for @ hours .\n",
            "The primary efficacy measure was mean change in the Positive and Negative Syndrome Scale-Excited Component ( PEC ) score from baseline to @ hours after initial dosing .\n",
            "Secondary measures included the Agitation-Calmness Evaluation Scale ( ACES ) score .\n",
            "The study was carried out at @ centers worldwide between April @ and January @ .\n",
            "RESULTS : A total of @ patients were randomly assigned to treatment .\n",
            "Intramuscular aripiprazole @ mg , @ mg , and @ mg and IM haloperidol @ mg demonstrated significantly greater reduction in the primary efficacy measure versus placebo .\n",
            "These changes were statistically significant as early as @ minutes for the IM aripiprazole @-mg group , with a trend toward significance ( p = .@ ) at @ minutes .\n",
            "Intramuscular haloperidol @ mg first showed a significant reduction in PEC score versus placebo at @ minutes .\n",
            "At @ minutes , significantly more patients responded ( defined as a greater than or equal to @ % reduction in PEC score ) to IM aripiprazole @ mg versus placebo ( @ % vs. @ % , p = .@ ) .\n",
            "Intramuscular aripiprazole @ mg significantly improved agitation , without oversedation , as measured by change in ACES score from baseline to @ hours versus placebo ( p = .@ ) .\n",
            "No patient discontinued the study because of treatment-emergent adverse events .\n",
            "Extrapyramidal symptoms occurred most frequently in the IM haloperidol group .\n",
            "The most common adverse event in IM aripiprazole recipients was headache .\n",
            "CONCLUSION : Intramuscular aripiprazole @ mg is a rapidly effective and well-tolerated alternative to IM haloperidol for the control of agitation , without oversedation , in patients with schizophrenia , schizo-affective disorder , or schizophreniform disorder .\n",
            "CLINICAL TRIALS REGISTRATION : ClinicalTrials.gov identifier NCT@ .\n",
            "RN @ ( Antipsychotic Agents ) .\n",
            "@ ( Piperazines ) .\n",
            "@ ( Quinolones ) .\n",
            "@-@-@ ( aripiprazole ) .\n",
            "OBJECTIVE : The Recovery After an Initial Schizophrenia Episode-Early Treatment Program compared NAVIGATE , a comprehensive program for first-episode psychosis , to clinician-choice community care over @ years .\n",
            "Quality of life and psychotic and depressive symptom outcomes were found to be better with NAVIGATE .\n",
            "Compared with previous comprehensive first-episode psychosis interventions , NAVIGATE medication treatment included unique elements of detailed first-episode-specific psychotropic medication guidelines and a computerized decision support system to facilitate shared decision making regarding prescriptions .\n",
            "In the present study , the authors compared NAVIGATE and community care on the psychotropic medications prescribed , side effects experienced , metabolic outcomes , and scores on the Adherence Estimator scale , which assesses beliefs related to nonadherence .\n",
            "METHOD : Prescription data were obtained monthly .\n",
            "At baseline and at @ , @ , @ , @ , and @ months , participants reported whether they were experiencing any of @ common antipsychotic side effects , vital signs were obtained , fasting blood samples were collected , and the Adherence Estimator scale was completed .\n",
            "RESULTS : Over the @-year study period , compared with the @ community care participants , the @ NAVIGATE participants had more medication visits , were more likely to receive a prescription for an antipsychotic and more likely to receive one conforming to NAVIGATE prescribing principles , and were less likely to receive a prescription for an antidepressant .\n",
            "NAVIGATE participants experienced fewer side effects and gained less weight ; other vital signs and cardiometabolic laboratory findings did not differ between groups .\n",
            "Adherence Estimator scores improved in the NAVIGATE group but not in the community care group .\n",
            "CONCLUSIONS : As part of comprehensive care services , medication prescription can be optimized for first-episode psychosis , contributing to better outcomes with a lower side effect burden than standard care .\n",
            "Introduction : This @-week , double-blind study investigated the effects of aripiprazole in combination with clozapine on metabolic ( primary endpoint = mean change inweight ) and efficacy parameters in patients with schizophrenia .\n",
            "We describe the results of patient-related secondary endpoints from this study to provide an overview ofthe effects of aspects relevant to the patient s well-being .\n",
            "Methods : Suboptimally controlled outpatients with schizophrenia on a stable dose of clozapine ( ??\n",
            "@ months ) and who gained ??\n",
            "@ kg of weight since starting clozapine were randomized to adjunctive aripiprazole ( @  @ mg/day , n = @ ) or placebo ( n = @ ) .\n",
            "Secondary endpointsincluded the Investigator Assessment Questionnaire ( IAQ , ANCOVA model with treatment and country as main effects and baseline CGI-S as covariate ) , GlobalAssessment of Functioning ( GAF ANCOVA model with treatment and country as main effects and baseline score as covariate ) , social cognition in schizophrenia scale ( GEOPTE , ANCOVA with treatment as main effect and baseline as covariate ) , Epworth Sleepiness Scale ( ESS , ANCOVA with treatment as main effect and baselineas covariate ) for Alertness , and Fatigue Syndrome Inventory ( FSI , ANCOVA with treatment as main effect and baseline as covariate ) .\n",
            "Results : At the end of @ weeks , aripiprazole was associated with a significant decrease in mean weight ( aripiprazole  @ kg , placebo  @ kg ; p < @ ) , and waist circumference ( aripiprazole  @ cm vs. placebo @ cm ; p < @ ) compared with clozapine alone .\n",
            "The adjusted mean IAQ Total Scores at Week @ ( LOCF ) were @ for placebo and @ foraripiprazole group at Week @ ( p = @ ) .\n",
            "The adjusted mean change from baseline in the GAF ( LOCF ) showed improvement in both treatment groups at Week @ ( placebo @ , aripiprazole @ ; p = @ ) .\n",
            "Improvements in GEOPTE score were also similar between groups ( placebo  @ , aripiprazole  @ ; p = @ ) .\n",
            "Improvementfrom baseline to all timepoints was reported in the ESS for alertness for both treatment groups up to Week @ ( placebo  @ , aripiprazole  @ ) ; a statistically significantdifference in favour of aripiprazole was seen at Week @ only ( placebo  @ , aripiprazole  @ ; p = @ ) .\n",
            "Similarly , improvements from baseline to all timepoints werereported in the FSI Disruption Index for both treatments , with a statistically significant difference in favour of aripiprazole at Week @ only.Conclusion : The addition of aripiprazole to clozapine may provide benefits to patients with schizophrenia by reducing metabolic risk factors associated with clozapinetreatment without deterioration in patient-related outcomes .\n",
            "Consideration of patient perspectives will help us to optimize care of patients with schizophrenia.Study funded by Bristol-Myers Squibb and Otsuka\n",
            "Targeted cognitive training ( TCT ) of auditory processing enhances higher-order cognition in schizophrenia patients .\n",
            "TCT performance gains can be detected after @ training session .\n",
            "As a prelude to a potential clinical trial , we assessed a pharmacological augmentation of cognitive therapy ( PACT ) strategy by testing if the psychostimulant , amphetamine , augments TCT gains in auditory processing speed ( APS ) in schizophrenia patients and healthy subjects ( HS ) .\n",
            "HS and schizophrenia patients were tested in a screening session ( test @ ) , followed by a double-blind crossover design ( tests @-@ ) , comparing placebo vs amphetamine ( @ mg ; @ d between tests ) .\n",
            "On each test day , @ hour of Posit Science \" Sound Sweeps \" training was bracketed by @ - to @-minute pre - and post-training assessments of APS .\n",
            "Training consisted of a speeded auditory time-order judgment task of successive frequency modulation sweeps .\n",
            "Auditory system \" learning \" ( APS post - vs pre-training ) was enhanced by amphetamine ( main effect of drug : P < .@ ; patients : d = @ , P < .@ ; HS : d = @ , nonsignificant ) , and this learning was sustained for at least @ week .\n",
            "Exploratory analyses assessed potential biomarker predictors of sensitivity to these effects of amphetamine .\n",
            "Amphetamine enhances auditory discrimination learning in schizophrenia patients .\n",
            "We do not know whether gains in APS observed in patients after @ hour of TCT predict clinical benefits after a full course of TCT .\n",
            "If amphetamine can enhance the therapeutic effects of TCT , this would provide strong support for a \" PACT \" treatment paradigm for schizophrenia .\n",
            "Ninety patients with schizophrenia or schizoaffective disorder according to DSM-III-R criteria participated in this double-blind , exploratory , dose-ranging trial .\n",
            "After a single-blind washout period of @ to @ days , patients were randomly assigned to receive one of four fixed doses of the new antipsychotic , ziprasidone @ ( N = @ ) , @ ( N = @ ) , @ ( N = @ ) , or @ ( N = @ ) mg/day or haloperidol @ mg/day ( N = @ ) for @ weeks .\n",
            "A dose-response relationship among ziprasidone groups was established for improvements in Clinical Global Impression Severity ( CGI-S ) score ( p = @ ) but not in Brief Psychiatric Rating Scale ( BPRS ) total score ( p = @ ) .\n",
            "The intent-to-treat analysis of mean changes from baseline in the BPRS total , BPRS Psychosis core , and CGI-S scores demonstrated that ziprasidone @ mg/day was comparable with haloperidol in reducing overall psychopathology and positive symptoms and was superior to ziprasidone @ mg/day .\n",
            "Despite the small sample size and short duration of the trial , the improvement in CGI-S with both ziprasidone @ mg/day and haloperidol @ mg/day was statistically significantly greater than with ziprasidone @ mg/day ( p = @ andp = @ , respectively ) .\n",
            "The percentage of patients classified as responders on both the BPRS total ( > or = @ % improvement ) and CGI-Improvement ( score of @ or @ ) scales in the ziprasidone @ mg/day group was similar to that in the haloperidol group and nonsignificantly greater than that in the ziprasidone @ mg/day group .\n",
            "On all assessments of clinical efficacy , the improvements associated with ziprasidone @ mg/day , @ mg/day , and @ mg/day were similar .\n",
            "Concomitant benztropine use at any time during the study was less frequent with ziprasidone @ mg/day ( @ % ) than with haloperidol ( @ % ) .\n",
            "Haloperidol was associated with a sustained hyperprolactinemia , unlike ziprasidone , where only transient elevations in prolactin that returned to normal within the dosing interval were observed .\n",
            "Ziprasidone was well tolerated , and the incidence of adverse events was similar in all groups .\n",
            "The results of this study suggest that ziprasidone @ mg/day is as effective as haloperidol @ mg/day in reducing overall psychopathology and positive symptoms of an acute exacerbation of schizophrenia or schizoaffective disorder but has a lower potential to induce extrapyramidal symptoms .\n",
            "Objective - To assess the efficacy , safety , and dose response relationship of intramuscular olanzapine to treat patients during acute psychosis .\n",
            "Methods : Patients were RANDOMly assigned to receive up to three injections within @ hours of olanzapine ( N = @ ) , haloperidol ( N = @ ) or PLACEBO ( N = @ ) .\n",
            "The primary endpoint was reduction in agitation measured by the PANSS Excited Component ( PANSS-EC ) at @ hours post first injection ( PFI ) .\n",
            "Results : Olanzapine therapy showed a dose-related alleviation of agitation across all treatment groups ( p < @ ) .\n",
            "Onset of action was rapid , with olanzapine @ , @ , and @ mg groups showing significant improvement versus PLACEBO as soon as @ minutes after the first injection .\n",
            "All olanzapine and haloperidol groups showed significant improvement versus PLACEBO at @ hours , and olanzapine @ , @ , and @ mg groups were significantly improved at all measured time points versus PLACEBO .\n",
            "Response rates were higher in all olanzapine and haloperidol groups .\n",
            "The alleviation of acute agitation by olanzapine but not haloperidol was sustained at @ hrs ( p < @ ) .\n",
            "Anticholinergics were rarely used .\n",
            "Benzodiazepine use was most common in the PLACEBO group .\n",
            "Hypotension , dizziness , and tremor were the most frequently reported adverse events .\n",
            "EPS improved in olanzapine and PLACEBO groups but worsened in the haloperidol group ( p < @ vs haloperidol ) .\n",
            "Conclusion : IM olanzapine provides a rapid , sustained , safe alleviation of acute agitation in patients with schizophrenia.Funding provided by Eli Lilly and Company\n",
            "Acronym - SCION Disease/condition/study domain - Psychiatric , mental disorders/illness Study hypothesis - @ .\n",
            "Clients in IPS will get more competitive jobs , work more hours , and earn more wages than clients in standard services .\n",
            "@ .\n",
            "IPS will be more cost-effective than standard services in terms of combined medical and non-medical costs .\n",
            "Design/methodology - RCT Ethics approval - Countries of recruitment - The Netherlands Participants - inclusion criteria - @ .\n",
            "Clients of mental health teams specifically focused at people with severe mental illness ( e.g. diagnosis of a serious mental illness ( schizophrenia and schizophrenia-like disorders , bipolar disorder , depression with psychotic features ) ; @ .\n",
            "Age @ - @ years ( i.e. age of retirement ) ; @ .\n",
            "Living in the community at baseline ( i.e. not hospitalised ) ; @ .\n",
            "Clear interest in competitive ; employment as a short - or long-term goal @ .\n",
            "No competitive work at inclusion ; @ .\n",
            "Willing to give informed consent .\n",
            "Participants - exclusion criteria - Not available Anticipated start date - @/@/@ Anticipated end date - @/@/@ Status of trial - Ongoing Target number of participants - @ Interventions - The study is located at four mental health agencies ( mentioned at  secondary sponsors  ) .\n",
            "IPS ( experimental condition ) is integrated within case management teams .\n",
            "These teams ( staff patient ratio of @:@ to @ ) deliver comprehensive treatment and care for severely mentally ill clients in their respective catchment areas .\n",
            "An employment specialist ( or IPS worker ) is added to the team to offer IPS .\n",
            "The employment specialist assists people in getting jobs , offers follow-along support after job placement , and spends most of the time in the community .\n",
            "The employment specialist works in close collaboration with the other team members and attends team meetings .\n",
            "Clients in the control condition use the same treatment and care facilities .\n",
            "In this condition the mental health staff or a counselor links eligible clients to separate vocational services , based on individual competencies and preferences .\n",
            "These services range from vocational services offered by the mental health agency ( in a separate rehabilitation center ) , a sheltered workshop and/or reintegration companies .\n",
            "In general these services focus more on getting people ready for competitive employment ( by assessment , training , prevocational activities and voluntary jobs ) instead of the rapid job search of IPS .\n",
            "The primary difference with IPS is that staff from the these control rehabilitation services are not part of the case management teams .\n",
            "Primary outcome measure ( s ) - @ .\n",
            "Proportion entering competitive employment during the follow-up period .\n",
            "- Competitive employment is defined as part or full-time work in competitive job market at prevailing wages with supervision provided by personnel employed by the business and in integrated work settings .\n",
            "@ .\n",
            "In a secondary analysis we will also include subsidized work in regular job settings ( including temporary competitive work without loss of benefits rights .\n",
            "Secondary outcome measure ( s ) - @ .\n",
            "Vocational : - hours in competitive employment , - jobs held , - duration of each job in days , - days from baseline to entering first job , - total earnings , - job satisfaction ( Indiana Job Satisfaction Scale ) , - generic work behaviour ( Generic Work Behaviour Questionnaire ) .\n",
            "@ .\n",
            "Hospitalisation : - admissions , - days in hospital .\n",
            "@ .\n",
            "Clinical : - psychiatric symptoms , - global functioning ( Global Assessment of Functioning Scale S-D ) , - self-esteem , - quality of life .\n",
            "@ .\n",
            "Costs : based on Client Socio-demographic and Service Receipt Inventory .\n",
            "Sources of funding - Rob Giel Research centre , Trimbos Institute - Netherlands Institute of Mental Health and Addiction , UWV ( Workers Insurance Authority )\n",
            "Objective : to investigate if trained community psychiatric nurses can effectively offer cbt to patients with schizophrenia , to improve disease insight and overall symptomology .\n",
            "Methods : a randomised trial compared brief cbt ( n = @ ) with treatment as usual ( n = @ ) in outpatients with schizophrenia .\n",
            "Intervention comprised @ sessions of cbt over @ months .\n",
            "The main carer received @ sessions .\n",
            "Nurses received @ days ' intensive cbt training .\n",
            "Primary outcome measures were changes from baseline in insight , overall symptomatology , and burden of care .\n",
            "Results : patients given cbt showed significant improvement in insight ( p = @ ) And overall symptomatology ( p = @ ) , But not in burden of care or psychotic symptoms .\n",
            "Depression improved significantly improved ( p = @ ) , With no significant increase in suicidal ideation .\n",
            "Conclusions : appropriately trained community psychiatric nurses can effectively deliver brief cbt to patients with schizophrenia and their carers .\n",
            "Further assessment of results will follow @ months after the end of therapy to assess the duration of effects .\n",
            "Alcohol and nicotine dependence are common in schizophrenia .\n",
            "Varenicline is effective in smoking cessation and has also been shown to decrease alcohol consumption in smokers .\n",
            "The present pilot study assessed the safety and effectiveness of varenicline for treatment of concurrent nicotine and alcohol dependence in schizophrenia .\n",
            "Outpatients with schizophrenia or schizoaffective disorder and concurrent alcohol and nicotine dependence were enrolled in this @-week , double-blind , randomized , placebo-controlled trial .\n",
            "Alcohol use and smoking were assessed using self-report ( Timeline Follow-Back ) and biological measures .\n",
            "Adverse events were recorded .\n",
            "Changes in the number of standard drinks per week and cigarettes per week were compared in the @ groups .\n",
            "Because of safety concerns or loss to follow-up , of @ patients enrolled , only @ started study medication , @ each on varenicline and placebo .\n",
            "Gastrointestinal adverse effects , such as severe abdominal pain , limited study completion to only @ subjects .\n",
            "Number of standard alcoholic drinks consumed per week decreased by [ mean ( SD ) ] @ ( @ ) in the varenicline group and by @ ( @ ) in the placebo group .\n",
            "Mean ( SD ) number of cigarettes smoked per week decreased by @ ( @ ) in the varenicline group and by @ ( @ ) in the placebo group .\n",
            "Varenicline treatment of concurrent alcohol and nicotine dependence in schizophrenia may be problematic because of safety concerns limiting recruitment and poor tolerability ( gastrointestinal adverse effects ) limiting retention .\n",
            "There was no increased number of serious neuropsychiatric adverse events in the varenicline group .\n",
            "Based on this small sample , concurrent alcohol and nicotine dependence in schizophrenia may present special obstacles to successful treatment with varenicline .\n",
            "Objective To explore the impact of rehabilitation intervention on recovery of social function in patients with schizophrenia .\n",
            "Methods @ patients with first-episode schizophrenia patients were randomly divided into observation group and the control group , @ cases in each .\n",
            "Two groups to maintain the drug treatment , the observation group receiving medication at the same time , to accept the system of rehabilitation intervention .\n",
            "Application Brief Psychiatric Rating Scale ( bprs ) , before treatment and after treatment hospitalized psychiatric patients rehabilitation efficacy rating scale ( ipros ) , Social Disability Screening Schedule ( sdss ) comprehensive evaluation of the patient 's rehabilitation .\n",
            "Results @ schizophrenic patients entered the final analysis , the Brief Psychiatric Rating Scale ( bprs ) before treatment , @  @ , @  @ after treatment before treatment of hospitalized psychiatric patients rehabilitation efficacy evaluation scale ( ipros ) and @  @ , treatment after @  @ , @  @ , before treatment , after treatment , @  @ , the difference was statistically significant ( p < @ ) social Disability Screening Schedule ( sdss ) .\n",
            "Schizophrenia self-care capacity and social adaptability conclusions comprehensive rehabilitation training , so that patients get recognized by the self-worth and self-efficacy , and improve the patient 's social function .\n",
            "Olanzapine exhibits a polyvalent receptor profile inclusive of @-HT , mACh , DA , and alpha-@ binding sites .\n",
            "The combination of high @-HT and mACh affinity , coupled with DA selectivity ( eg , D@/D@ ) is strongly suggestive of a low EPS potential .\n",
            "To date , in vitro electrophysiology , imaging , and animal behavioral pharmacology has been confirmatory .\n",
            "Data were integrated from the acute phase ( @ weeks ) of two double-blind , placebo-controlled studies in patients meeting DSM-IIIR criteria for schizophrenia and schizophreniform and schizoaffective disorders treated with olanzapine ( N = @ ; @ to @ mg/day , mean modal maintenance dose of @ mg/day ) and placebo ( N = @ ) .\n",
            "Evaluation of EPS was based on the analysis of treatment-emergent extrapyramidal events ( TEEPE ) and data obtained from the Simpson-Angus Scale ( SAS ) , Barnes Akathisia Scale ( BAS ) , and the Abnormal Involuntary Movement Scale ( AIMS ) .\n",
            "TEEPE were grouped into one of five event categories : @ ) dystonic , @ ) parkinsonian , @ ) akathisia , @ ) dyskinetic , @ ) residual , and an overall category of any extrapyramidal event .\n",
            "There were no statistically significant differences between olanzapine and placebo for any of the five categories or for the overall category .\n",
            "Data from the assessment scales reflecting change from baseline to endpoint and change from baseline to maximum for both the SAS and AIMS demonstrated no statistically significant difference between the two treatment groups .\n",
            "BAS data assessing change from baseline to maximum were also not statistically significantly different ; however , change from baseline to endpoint revealed a statistically significant decrease in the BAS endpoint score for the olanzapine treatment group compared with the placebo treatment group .\n",
            "These outcomes , utilizing treatment-emergent events and analyses of validated scales for drug-induced Parkinsonism , akathisia , and dyskinesia , corroborated preclinical predictions that olanzapine would have a very favorable EPS profile .\n",
            "EPS incidence did not statistically differ significantly from placebo and the significant reduction in baseline akathisia relative to placebo suggests that olanzapine holds promise as a better tolerated agent for the treatment of psychosis .\n",
            "Background : This study focuses on people with complex and severe mental health problems who require inpatient rehabilitation .\n",
            "The majority have a diagnosis of schizophrenia whose recovery has been delayed due to non-response to first-line treatments , cognitive impairment , negative symptoms and co-existing problems such as substance misuse .\n",
            "These problems contribute to major impairments in social and everyday functioning necessitating lengthy admissions and high support needs on discharge to the community .\n",
            "Engagement in structured activities reduces negative symptoms of psychosis and may lead to improvement in function , but no trials have been conducted to test the efficacy of interventions that aim to achieve this.Methods / design : This study aims to investigate the clinical and cost-effectiveness of a staff training intervention to increase service users ' engagement in activities .\n",
            "This is a single-blind , two-arm cluster randomised controlled trial involving @ inpatient mental health rehabilitation units across England .\n",
            "Units are randomised on an equal basis to receive either standard care or a \" hands-on \" , manualised staff training programme comprising three distinct phases ( predisposing , enabling and reinforcing ) delivered by a small team of psychiatrists , occupational therapists , service users and activity workers .\n",
            "The primary outcome is service user engagement in activities @ months after randomisation , assessed using a standardised measure .\n",
            "Secondary outcomes include social functioning and costs and cost-effectiveness of care.Discussion : The study will provide much needed evidence for a practical staff training intervention that has potential to improve service user functioning , reducing the need for hospital treatment and supporting successful community discharge .\n",
            "The trial is registered with Current Controlled Trials ( Ref ISRCTN@ ) .\n",
            "@ Killaspy et al. ; licensee BioMed Central Ltd .\n",
            "Objective To investigate the family intervention in of rural chronic schizophrenia relapse .\n",
            "@ patients with chronic schizophrenia were randomly divided into intervention group ( @ cases ) and control group ( @ cases ) .\n",
            "Intervention group psychoeducation , social and labor skills training-based comprehensive family intervention intervention guidance .\n",
            "The control group only knowledge of missionary intervention and psychiatric diseases .\n",
            "In @ , @ , and @ years after enrollment statistics of the two groups of patients repeated illness .\n",
            "Results of the @-year recurrence rate of the intervention group than the control group ( p < @ ) .\n",
            "Conclusion family intervention for rural patients with chronic schizophrenia , can reduce the relapse rate of schizophrenia .\n",
            "BACKGROUND : Negative symptoms of schizophrenia have a severe impact on functional outcomes and treatment options are limited .\n",
            "Arts therapies are currently recommended but more evidence is required .\n",
            "AIMS : To assess body psychotherapy as a treatment for negative symptoms compared with an active control ( trial registration : ISRCTN@ ) .\n",
            "METHOD : Schizophrenia out-patients were randomised into a @-session body psychotherapy or Pilates group .\n",
            "The primary outcome was negative symptoms at end of treatment .\n",
            "Secondary outcomes included psychopathology , functional , social and treatment satisfaction outcomes at treatment end and @-months later .\n",
            "RESULTS : In total , @ participants were randomised .\n",
            "The adjusted difference in negative symptoms was @ ( @ % CI -@ to @ ) , indicating no benefit from body psychotherapy .\n",
            "Small improvements in expressive deficits and movement disorder symptoms were detected in favour of body psychotherapy .\n",
            "No other outcomes were significantly different .\n",
            "CONCLUSIONS : Body psychotherapy does not have a clinically relevant beneficial effect in the treatment of patients with negative symptoms of schizophrenia .\n",
            "We investigated the efficacy of clozapine vs haloperidol in treatment refractory elderly inpatients with schizophrenia in a double-blind cross - over randomized trial .\n",
            "Ten patients were randomly assigned to receive clozapine or haloperidol for @ weeks ; after a washout period ( the drugs were switched for another @ weeks .\n",
            "Patients were assessed weekly with the Brief Psychiatric Rating Scale , Side Effects Profile , Abnormal Involuntary Movement Scale , Simpson-Angus Scale for Extrapyramidal Side Effects , and Scales for the Assessment of Positive and Negative Symptoms .\n",
            "Evaluations performed by analysis of covariance , analysis of variance with repeated measure and paired t-test showed no difference in effect on overall mental status between the medications .\n",
            "Analysis by individual symptoms yielded a significant and rapid improvement in severe depression , exaggerated self-esteem and motor retardation with clozapine .\n",
            "We conclude that clozapine is not more effective than haloperidol in elderly patients with chronic schizophrenia , though it may show some benefit in specific subgroups of patients .\n",
            "Further studies with larger samples and longer protocols are needed to confirm these preliminary findings . )\n",
            "Objective : To compare the efficacy and tolerability of ziprasidone and risperidone in patients with acute exacerbation of schizophrenia or schizoaffective disorder .\n",
            "Methods : In an @-week , multicenter , double-blind trial , @ patients were randomly assigned to ziprasidone @ to @ mg BID ( n = @ ) or risperidone @ to @ mg BID ( n = @ ) .\n",
            "Primary efficacy outcome measures were PANSS Total and CGI-S scores ; secondary measures included PANSS Negative Subscale score , BPRSd Total and Core items scores , and GAF .\n",
            "The primary analysis was based on evaluable patients ( ie , subjects receiving > @ days of treatment ) .\n",
            "Findings were judged to be equivalent if the lower limit of the @ % CI for the ratio of the mean change with ziprasidone to the mean change with risperidone exceeded @ .\n",
            "Results : Equivalent improvements were observed in both drug-treatment groups with regard to the PANNS Total score ( mean change ratio @ , lower limit @ ) and CGI-S ( mean change ratio @ , lower limit @ ) .\n",
            "Equivalent improvements were also seen in PANSS Negative score , BPRSd Total and Core scores , and GAF .\n",
            "Ziprasidone and risperidone proved comparable in tolerability assessments .\n",
            "However , patients receiving risperidone had a significantly higher movement disorder burden score and exhibited higher incidences of prolactin elevation and clinically significant weight gain .\n",
            "Conclusion : Ziprasidone demonstrated antipsychotic efficacy comparable to risperidone in patients with acute exacerbation of schizophrenia , but its use entailed a lower burden of movement disorders , less effect on prolactin levels , and a lower incidence of weight gain .\n",
            "Olanzapine was compared to clozapine in the treatment of patients with treatment resistant DSM-IV schizophrenia .\n",
            "There were @ patients treated with each agent in a double-blind randomised fashion for up to @ weeks .\n",
            "Based on the PANSS Total Score , the treatment effect favoured olanzapine by @ points with a one-sided lower @ % confidence limit of -@ points .\n",
            "A lower limit of -@ points for the treatment effect was defined a priori as the basis of declaring ' non-inferiority ' and since the one-sided lower @ % confidence limit was ?\n",
            "?\n",
            "@ , olanzapine was shown to be ' non-inferior ' to clozapine .\n",
            "There were six spontaneously reported adverse events that occurred with significantly different incidences between the two treatments ; for olanzapine-treated patients ( dry mouth ) and clozapine-treated patients ( constipation , increased salivation , dizziness , nausea , and tooth disorder ) .\n",
            "Treatment-emergent akathisia , parkinsonism , and dyskinesias occured at comparable incidence as assessed by the Barnes Akathisia Scale , Simpson-Angus Scale , and AIMS .\n",
            "Schizophrenia and other Psychotic Disorders\n",
            "Serum prolactin ( PRL ) level was assessed after challenges with apomorphine hydrochloride , saline , dopamine hydrochloride , or levodopa - carbidopa ( Sinemet ) in @ control and @ chronic schizophrenic subjects .\n",
            "Baseline PRL level varied inversely with age .\n",
            "High correlations existed between baseline PRL level and any subsequent absolute measure of PRL after administration of a dopamine agonist or placebo .\n",
            "Percent decrease was not a function of baseline concentrations and was therefore the only independent measure of drug response .\n",
            "Baseline PRL level was generally lower during exacerbation than remission in patients studied during two states of illness .\n",
            "Percent PRL level decrease after apomorphine administration was significantly greater in normal subjects than in schizophrenics .\n",
            "Correction of apomorphine responses for corresponding placebo ( saline ) values abolished differences between groups .\n",
            "Prolactin responses after dopamine or levodopa-carbidopa did not differ ; however , placebo correction was not possible .\n",
            "PURPOSE : Although schizophrenia can be treated effectively , acute aggravations and relapses occur often .\n",
            "Antipsychotic drug therapies are fairly effective for decreasing the rate of relapses in patients with schizophrenia .\n",
            "This study aimed to compare paliperidone palmitate and the second-generation oral antipsychotic drugs used to treat patients with schizophrenia in terms of medication adherence , side effects , and quality of life .\n",
            "METHODS : The study included @ patients diagnosed with schizophrenia who were treated with paliperidone palmitate and @ patients who were treated with second-generation oral antipsychotics .\n",
            "All the patients were administered the Positive and Negative Syndrome Scale , the Clinical Global Impression , the Extrapyramidal Symptom Rating Scale , the UKU ( Ugvalg for Kliniske Undersgelser ) Side Effect Rating Scale , the Short Form @ , the Morisky Medication Adherence Scale , and the Schedule for Assessing the Three Components of Insight .\n",
            "RESULTS : The medication adherence and perceived general health scores of the patients treated with paliperidone palmitate were significantly higher than those of the patients treated with second-generation antipsychotics , and the side effects of the medication on the patients ' daily performance were significantly lower .\n",
            "CONCLUSIONS : This study demonstrated that long-acting paliperidone palmitate therapy was associated with more favorable results in terms of medication adherence , drug side effects , and quality of life compared with second-generation oral antipsychotics .\n",
            "However , there is a need for further , more specific , and larger-scale studies in this field .\n",
            "After an initial episode of schizophrenia , return to school or work is typically a key goal of the individual who has experienced the episode , even more so than remission of psychotic symptoms .\n",
            "Furthermore , longitudinal studies suggest that early return to school and work is a good predictor of later work recovery and avoidance of disability .\n",
            "This presentation focuses on the use of supported education and supported employment to maximize recovery early in the course of schizophrenia .\n",
            "We examined the impact of Individual Placement and Support ( IPS ) in patients with a recent initial episode of schizophrenia .\n",
            "IPS was adapted to meet personally-relevant goals , whether those goals involved schooling or employment or both .\n",
            "IPS was combined with a group skills training approach , Workplace Fundamentals Module ( WFM ) , to enhance return to regular school or competitive employment .\n",
            "In a randomized controlled trial , this enhanced IPS-WFM strategy ( N = @ ) was contrasted with clinical treatment and conventional vocational rehabilitation by separate agencies ( N = @ ) .\n",
            "An IPS worker provided educational and employment services , facilitated a rapid search for work or schooling , used assertive outreach , and gave ongoing support .\n",
            "All @ patients in this @-month study were provided case management and psychiatric services by the same clinical team .\n",
            "During the initial six months of intensive treatment , @ % of recent-onset schizophrenia patients who participated in IPS-WFM returned to competitive work or school , compared to @ % in the comparison group ( p = @ ) .\n",
            "The IPS-WFM intervention continued to show significant advantages during the next year of less intensive treatment , with @ % of the IPS-WFM group at school or work at least part of that next year .\n",
            "Detailed analyses suggest that schooling showed the most immediate gains with IPS-WFM treatment , followed by gains in employment .\n",
            "The IPS-WFM intervention also led to a longer total duration of time in a job or in school ( p = @ ) .\n",
            "Examples of the application of IPS-WFM illustrate how these interventions maximize return to school or work in individuals with a recent onset of schizophrenia .\n",
            "The UCLA results indicate that recovery of patient 's participation in normative school and employment settings in the early course of schizophrenia is typically possible if an early , active intervention focused on supporting work recovery is vigorously pursued .\n",
            "The UK Department of Health made a commitment to improving outcomes in first-episode psychosis with significant investment in over @ early intervention ( EI ) services across the country in @ .\n",
            "The initiative fuelled vigorous national debate regarding an ideal EI service model that remains topical today .\n",
            "In Camden & Islington , an ethnically diverse , highly populated , inner London catchment area , two of the more popular EI service models with significant local support were selected for comparison .\n",
            "The aim of the study was to test opinion , broaden the evidence base and better inform the debate on an effective local EI service model .\n",
            "A ' Team Model ' , a specialist EI team offering a service for all first-episode psychosis patients from a randomly selected group of generic mental health services , was compared against an ' Augmented model ' , a demographically matched , second group of generic mental health services seeded with specialist EI clinicians who managed all first-episode psychosis referrals within the generic mental health service in a cluster randomized controlled trial .\n",
            "A qualitative investigation was also conducted of local experiences of each model .\n",
            "Outcomes from the study will be presented with discussion of the implications for service delivery in inner city settings .\n",
            "Objective : A multicenter , randomized , double-blind study of risperidone and haloperidol was conducted in outpatients with schizophrenia or schizoaffective disorder to compare the time to relapse in patients treated for ?\n",
            "@ year .\n",
            "Methods : Assessments were made weekly for the first @ weeks and at @-week intervals thereafter .\n",
            "Efficacy assessments included the PANSS and the CGI .\n",
            "Other measures included weight gain , quality of life , drug attitudes , and use of health care resources .\n",
            "A patient was judged to have relapsed if any one of the following occurred : psychiatric hospitalization ; an increase in level of care and a @ % increase in PANSS score from baseline ; deliberate self-injury ; suicidal or homicidal ideation ; violent behavior ; or significant clinical deterioration .\n",
            "Results : DSM-IV diagnoses were schizophrenia in @ % of patients and schizoaffective disorder in @ % .\n",
            "Of the @ patients who received study medication , @ were randomized to risperidone and @ to haloperidol , with no significant between-group differences in baseline characteristics .\n",
            "More patients in the risperidone group completed the study .\n",
            "Risperidone was associated with a significantly lower relapse rate than haloperidol ( @ % vs @ % , p = @ ) ; the @-year relapse rate was @ % in the risperidone group and @ % in the haloperidol group ( p = @ ) .\n",
            "Risperidone patients showed a significantly longer mean time to relapse than the haloperidol patients ( @ vs @ days , p = @ ) .\n",
            "Improvements in PANSS total scores and scores on four PANSS factors ( positive symptoms , negative symptoms , disorganized thought , and anxiety/depression ) were significantly greater in the risperidone than haloperidol patients ( p < @ ) .\n",
            "Conclusions : Risperidone was superior to haloperidol on measures of relapse and in symptom improvement in patients with schizophrenia or schizoaffective disorder .\n",
            "DS : SZ ; Not in mk CN : P. @\n",
            "Reduced brain N-acetyl-aspartate ( NAA ) has been repeatedly found in chronic schizophrenia and suggests neuronal loss or dysfunction .\n",
            "However , the potential confounding effect of antipsychotic drugs on NAA has not been resolved .\n",
            "We studied @ minimally treated schizophrenia patients and @ healthy subjects with single-voxel proton magnetic resonance spectroscopy ( <sup> @ </sup> H-MRS ) of the frontal and occipital lobes , caudate nucleus , and cerebellum .\n",
            "Concentrations of NAA , Choline , and Cre were determined and corrected for the proportion of cerebrospinal fluid ( CSF ) in the voxel .\n",
            "Patients were treated in a randomized-controlled double-blind manner with either haloperidol or quetiapine .\n",
            "<sup> @ </sup> H-MRS was repeated every @ months for up to @ years .\n",
            "There was a group main effect for baseline NAA with lower global NAA in schizophrenia subjects before treatment compared to healthy controls .\n",
            "Global NAA was directly related to measures of global cognitive performance in the whole subject sample .\n",
            "Following treatment with haloperidol or quetiapine , there were no changes in NAA in any of the regions studied .\n",
            "Early in the illness , schizophrenia patients already demonstrate subtle reductions in NAA .\n",
            "Treatment with typical or atypical antipsychotic medications for several months does not result in NAA changes .\n",
            "OBJECTIVES : To evaluate the @-week safety/tolerability of oral olanzapine for adolescents with schizophrenia or bipolar mania and compare effectiveness of a standard versus intense behavioral weight intervention in mitigating risk of weight gain .\n",
            "METHODS : Patients @-@ years old with schizophrenia ( Brief Psychiatric Rating Scale for Children [ BPRS-C ] total score > @ ; item score > / = @ for hallucinations , delusions , or peculiar fantasies ) or bipolar I disorder ( manic or mixed episode ; Young Mania Rating Scale [ YMRS ] total score > / = @ ) received open-label olanzapine ( @-@ mg/day ) and were randomized to standard ( n = @ ; a single weight counseling session ) or intense ( n = @ ; weight counseling at each study visit ) weight intervention .\n",
            "The primary outcome measure was mean change in body mass index ( BMI ) from baseline to @ weeks using mixed-model repeated measures .\n",
            "Symptomatology was also assessed .\n",
            "RESULTS : No statistically significant differences between groups were observed in mean baseline-to-@-week change in BMI ( standard : +@ kg/m ( @ ) ; intense : +@ kg/m ( @ ) ; p = @ ) or weight ( standard : +@ kg ; intense : +@ kg ; p = @ ) .\n",
            "Percentage of patients at endpoint who had gained > / = @ % of their baseline weight was @ % for the standard group and @ % for the intense group ( p = @ ) .\n",
            "Safety/tolerability results were generally consistent with those of previous olanzapine studies in adolescents , with the most notable exception being the finding of a mean decrease in prolactin .\n",
            "On symptomatology measures , patients with schizophrenia had a mean baseline-to-@-week change in BPRS-C of -@ ( standard deviation [ SD ] = @ ) , and patients with bipolar disorder had a mean change in YMRS of -@ ( SD = @ ) , with clinically and statistically significant improvement starting at @-@ days for each .\n",
            "CONCLUSIONS : Long-term weight gain was high in both groups , with no statistically significant differences between the standard or intense behavioral weight interventions in BMI or weight .\n",
            "Safety , tolerability , and effectiveness findings were generally consistent with the known profile of olanzapine in adolescents .\n",
            "Oral metachlorophenylpiperazine ( m-CPP ) as a direct-acting postsynaptic serotonergic agonist was used to study serotonergic dysfunction in treatment-refractory chronic schizophrenia based on the hypothesis that some Ss may show central serotonergic hypersensitivity .\n",
            "@ chronic schizophrenia patients with a history of neuroleptic nonresponse underwent double-blind challenge with oral m-CPP and placebo after medication washout .\n",
            "m-CPP significantly elevated both prolactin and cortisol levels as compared to placebo .\n",
            "There was a significant relationship between change in cortisol level and change in psychopathology , while an increase in cortisol response related to an increase in psychopathology .\n",
            "Similarly , decease in severity of the activation factor and the hostility factor was associated with a smaller cortisol response in the m-CPP condition .\n",
            "These results point to heterogeneity in central serotonergic sensitivity within the context of different subpopulations of serotonergic receptors .\n",
            "Objective - @ ) to determine , over a one-year follow-up , the relative effectiveness of group and individual psychotherapy ( plus haloperidol @ mg/day ) compared to drug only treatment ( haloperidol , @ mg/day ) for schizophrenic patients ; @ ) to analyze the role of psychotherapy in the outcome of schizophrenia ; @ ) to isolate the more specific effects of psychotherapy on schizophrenic patients .\n",
            "Method - Forty patients who met DSM-III criteria for schizophrenia and with a recent onset ( six months ) were included in this study and were randomly assigned to a group or individual ( n = @ ) one-year treatment with insight-oriented therapy plus haloperidol @ mg/day or drug therapy alone ( n = @ ) .\n",
            "Assessments were performed at the end of the run-in period ( baseline ) , six , and @ months after the beginning of the treatments .\n",
            "Severity of schizophrenia was assessed by the Brief Psychiatric Rating Scale , the Clinical Global Impressions Scale for Severity ( CGI-S ) .\n",
            "The Clinical Global Impressions Scale for Improvement ( CGI-I ) , the Symptom Checklist ( SCL - @ ) , the SADD , and the Zung scale were also used .\n",
            "The study protocol was approved by the ethics committees and informed consent was obtained from all patients .\n",
            "Results - Thirty patients had completed the @ weeks of treatment and were included in the analysis .\n",
            "Sociodemographic characteristics of the two treatment groups were very similar ( mean age = @ _ @ , @ women and @ men ) ; no statistically significant difference was found in the baseline scores of the CGI , while patients treated with psychotherapy reported higher mean values on the BPRS at the baseline .\n",
            "Overall improvement at CGI and improvement in the BPRS items of anxiety , conceptual disorganization , depressive mood , motor retardation , blunted affect , and excitement was higher in patients in the groups treated with psychotherapy plus neuroleptics .\n",
            "Differences between group and individual psychotherapy will be discussed in detail .\n",
            "Conclusions - Many studies found that psychodynamic treatment for schizophrenia failed to exert any beneficial effect on outcome and Strupp have pointed out that psychotherapy can sometimes lead to deleterious effects .\n",
            "Stone reported that @ % of the patients who received psychodynamic therapy committed suicide .\n",
            "In our study we observed in psychotherapy treated patients an improvement on depressive symptoms and on suicidal ideation ; furthermore , we noticed that psychodynamic treatment can have beneficial effects for patients with high levels of anxiety .\n",
            "Mueser wrote that \" The evidence that psychodynamic treatment worsens the outcome of schizophrenia is indirect and debatable \" and our preliminary data suggest that some schizophrenic patients may benefit from psychodynamic treatment .\n",
            "This study aimed to compare the clinical and social benefits associated with Optimal Case Management ( OCM ) treatment that employ cognitive-behavioural strategies to those associated with Routine Case Management ( RCM ) that is widely used in community health services .\n",
            "Hundred patients with schizophrenia were randomly allocated to OCM and RCM treatment conditions .\n",
            "Patients in the OCM condition showed significantly more improvement on all measures compared to patients in RCM condition .\n",
            "Improvement on clinical symptoms and social functioning achieved by OCM tended to show a regular and continuous pattern throughout the course of the study .\n",
            "The results of this study suggest that every optimal treatment should aim improvement in social functioning and therefore quality of life of the patients\n",
            "BACKGROUND : Trials in community psychiatry must balance rigour with generalisability .\n",
            "The UK@ trial failed to find a significant effect on hospitalisation , but its sample population contained significant heterogeneity of exposure to case management in the two groups .\n",
            "AIMS : To test whether patients successfully exposed to a minimum of @ months ' intensive case management over the @-year follow-up period achieved reduced hospitalisation .\n",
            "METHOD : Of @ participants with hospitalisation data , @ were identified as having < @ months ' exposure owing to prolonged hospitalisation , imprisonment or a combination of the two .\n",
            "These patients were excluded and outcomes tested for the remaining @ patients .\n",
            "RESULTS : Overall reduced case-load size did not reduce hospitalisation or treatment costs over @ years despite elimination of outliers .\n",
            "Age , previous hospitalisation and source of recruitment to the study all correlated with outcome .\n",
            "CONCLUSIONS : Case-load reduction is not in itself enough to reduce the need for hospital care in psychosis .\n",
            "Baseline patient characteristics ( in particular length of previous hospitalisation and recruitment from in-patient care ) have a significant influence and should be allowed for in power calculations .\n",
            "Identifying the optimal clinical profile for patients likely to benefit from intensive case management remains a pressing need for further studies\n",
            "OBJECTIVE : The objective of this study was to report the long-term remission results from the ConstaTRE relapse prevention trial , in which clinically stable adults with schizophrenia or schizoaffective disorder treated with oral risperidone , olanzapine , or oral conventional antipsychotics were randomized to risperidone long-acting injectable ( RLAI ) or oral quetiapine , dosed according to package-insert recommendations .\n",
            "METHODS : In the ConstaTRE trial , efficacy and tolerability were recorded for up to @ months .\n",
            "This post hoc analysis presents remission data , defined , according to the Schizophrenia Working Group criteria , as achieving and maintaining eight core symptoms of schizophrenia that are mild or less over @ months .\n",
            "Additional secondary outcome measures are also presented .\n",
            "RESULTS : A total of @ patients were randomized to RLAI ( n = @ ) or quetiapine ( n = @ ) .\n",
            "Mean mode + / - standard deviation ( SD ) drug doses were RLAI @ + / - @ mg every @ weeks and quetiapine @ + / - @ mg daily .\n",
            "Full remission was achieved by @ % of patients with RLAI and @ % with quetiapine ( p = @ ) .\n",
            "Mean + / - SD of full remission durations were not significantly different with RLAI ( @ + / - @ days ) and quetiapine ( @ + / - @ days ) .\n",
            "Overall tolerability was similar between treatment groups .\n",
            "CONCLUSIONS : Among stable patients with schizophrenia or schizoaffective disorder , remission was more likely after switching to RLAI than quetiapine .\n",
            "Background : This study evaluates the cost and costeffectiveness of a residential crisis program compared with treatment received in a general hospital psychiatric unit for patients who have serious mental illness in need of hospital-level care and who are willing to accept voluntary treatment .\n",
            "Methods : Patients in theMontgomeryCounty , Maryland , public mental health system ( N = @ ) willing to accept voluntary acute care were randomized to the psychiatric ward of a general hospital or a residential crisis program .\n",
            "Unit costs and service utilization data were used to estimate episode and @-month treatment costs from the perspective of government payors .\n",
            "Episodicsymptomreductionanddays residing in the community over the @ months after the episode were chosen to represent effectiveness .\n",
            "Results : Mean ( SD ) acute treatment episode costs was $ @ ( $ @ ) in the residential crisis program , @ % lower than the $ @ ( $ @ ) episode cost for the general hospital .\n",
            "Total @-month treatment costs for patients assigned to the @ programs were $ @ ( $ @ ) and $ @ ( $ @ ) , respectively .\n",
            "Treatment groups did not differ significantly in symptom improvement or community days achieved .\n",
            "Incremental cost-effectiveness ratios indicate that in most cases , the residential crisis program provides near-equivalent effectiveness for significantly less cost .\n",
            "Conclusions : Residential crisis programs may be a costeffective approach to providing acute care to patients who have serious mental illness and who are willing to accept voluntary treatment .\n",
            "Where resources are scarce , access to needed acute care might be extended using a mix of hospital , community-based residential crisis , and community support services .\n",
            "Sertindole is a novel antipsychotic with @-fold greater selectivity for dopamine D@ neurons within the VTA over the SNC as demonstrated by in vivo animal model studies .\n",
            "D@ blockade within the latter is thought responsible for the unwanted extrapyramidal syndrome ( EPS ) seen with currently available antipsychotics .\n",
            "Discovered and patented by H. Lundbeck ( Copenhagen ) and under development by Abbott Laboratories in the United States , Latin America and Canada , sertindole also demonstrates @HT@ and a@ antagonist activity .\n",
            "Sertindole does not , however , demonstrate affinity for muscarinic , histaminic or a@ receptors .\n",
            "This landmark Phase III , placebo-controlled , double-blind study ( M@ - @ ) assessed the dose-response profiles of three doses of sertindole and three doses of haloperidol in schizophrenic patients .\n",
            "Following a four - to seven-day , single-blind , placebo lead-in period , patients were randomly assigned to receive placebo , sertindole @ , @ or @ mg/day or haloperidol @ , @ , or @ mg/day for @ weeks .\n",
            "Efficacy evaluations included Positive and Negative Syndrome Scale ( PANSS ) , Scale for the Assessment of Negative Symptoms ( SANS ) , Brief Psychiatric Rating Scale ( BPRS ) , and Clinical Global Impression ( CGI ) .\n",
            "Extrapyramidal symptoms were evaluated by rating scales , the incidence of EPS-related adverse events , and the use of anti-EPS medications .\n",
            "Four hundred and ninety seven patients were recruited from @ centers ; no significant differences were observed between treatment groups for demographic characteristics .\n",
            "All active treatment groups were effective in treating psychosis as demonstrated by significant improvement over placebo for PANSS , BPRS and CGI scores .\n",
            "The @ mg sertindole and @ mg haloperidol groups showed the greatest improvement in total PANSS score .\n",
            "Only sertindole @ mg was effective in the treatment of negative symptoms as indicated by the PANSS negative symptom subscale and total SANS .\n",
            "Placebo Sert @ mg Sert @ mg Sert @ mg Halo @ mg Halo @ mg Halo @ mg ( n = @ ) ( n = @ ) ( n = @ ) ( n = @ ) ( n = @ ) ( n = @ ) ( n = @ ) PANSS tot Mn D ( SE ) @ ( @ ) -@ * ( @ ) -@ * ( @ ) -@ * ( @ ) - @ * ( @ ) -@ * ( @ ) - @ * ( @ ) PANSSneg Mn D ( SE ) -@ ( @ ) -@ ( @ ) -@ * ( @ ) -@ ( @ ) - @ ( @ ) -@ ( @ ) -@ ( @ ) SANS Mn D ( SE ) -@ ( @ ) -@ ( @ ) -@ * ( @ ) -@ ( @ ) -@ ( @ ) -@ ( @ ) -@ ( @ ) * statistically significant compared to placebo at the p  @ level Sertindole and placebo were statistically indistinguishable in EPS profiles as measured by all parameters .\n",
            "In contrast , all haloperidol doses caused significantly more EPS than either sertindole or placebo .\n",
            "Sertindole is effective in the treatment of the positive and negative symptoms of schizophrenia without producing EPS .\n",
            "Reference : Skarsfeldt , T. , Perregard , J. ( @ ) Sertindole , a new neuroleptic with extreme selectivity on A@ versus A@ dopamine neurones in rat .\n",
            "Eur J Pharmacol @ : @ - .\n",
            "Bunney , B.S. ( @ ) Antipsychotic drug effects on the electrical activity of dopaminergic neurons .\n",
            "TINS @ - , June .\n",
            "Objective To study the effect of nursing intervention on quality of life in patientsw ith first@ep isode sch izoph renia .\n",
            "Methods @ patientsw ith first ep isode sch izoph renia w ere random ly divided into observed group ( n = @ ) and control group ( n = @ ) .\n",
            "Patients in both group sw ere treated w ith antip sychoticmedication .\n",
            "Patients in observed group received nursing intervention for @ w eek s. Both group s w ere follow ed@up for half of a year .\n",
            "Patients w ere evaluated w ith PAN SS and GQOL I before intervention and at the end of follow @up .\n",
            "Resul ts Compared w ith the records before intervention , both the two group s reduced in PAN SS total score , negative and positive symp tom s score at the end of follow @up ( P < @ .\n",
            "@ ) .\n",
            "But the imp rovement in observed group w as significantly better than that of control group ( P < @ .\n",
            "@ ) , and the sore of GQOLI w as significantly h igher than that of the control group ( P < @ .\n",
            "@ ) .\n",
            "Conclusion N ursing intervention could help to imp rove the symp tom s of first@ep isode sch izophrenia and enhance their quality of life .\n",
            "Objective : To explore the role of cognitive behavioral therapy in the treatment of chronic schizophrenia from a nursing point of view .\n",
            "Methods : A total of @ cases meet the CCMD-@-R diagnostic criteria for chronic schizophrenia were randomly divided into @ cases of simple drug treatment group of @ patients ( control group ) and psychological care of drugs combined with cognitive behavioral treatment group ( treatment group ) to carry out control study , @ weeks of treatment , SANS , SAPS , NOSIE rating scale efficacy .\n",
            "Results : After treatment , the treatment group SANS total score and factor scores compared with those before treatment was significant ( P < @ ) , SAPS total score and factor scores no significant difference ( P > @ ) after treatment .\n",
            "the treatment group NOSIE total positive factors than the control group high , the total negative factors points higher than the control group , treatment group condition overall total points than the treatment differences ( < @ ) , before and after the control group differences without significantly with sex ( P > @ ) .\n",
            "Order to improve the patient 's quality of life , promote the speedy recovery of patients , we are active in the exploration of health education are as follows .\n",
            "Objects and methods of an object .\n",
            "Random sample of @ patients in a ward of the hospital into the group of objects .\n",
            "Inclusion criteria : ( @ ) meet the diagnostic criteria of CCMD--R schizophrenia .\n",
            "( @ ) duration of  @a , the length of stay  @a .\n",
            "( @ ) Assessment of Negative Symptoms Scale ( SANS ) total score < @ points [ @ ] can be an effective conversation .\n",
            "@ patients were randomly divided into experimental and control groups , two groups of patients were male , age , duration of hospital stay , educational level , SANS score , medication and other statistical difference was not significant ( P > @ ) .\n",
            "( @ ) method .\n",
            "Conventional medication , all patients were enrolled into the experimental group of health education @ weeks , the same care and control group .\n",
            "( @ ) assessment .\n",
            "@ .\n",
            "Objects and methods of an object .\n",
            "Random sample of @ patients in a ward of the hospital into the group of objects .\n",
            "Inclusion criteria : ( @ ) meet the diagnostic criteria of CCMD--R schizophrenia .\n",
            "( @ ) duration of  @a , the length of stay  @a .\n",
            "( @ ) Assessment of Negative Symptoms Scale ( SANS ) total score < @ points [ @ ] can be an effective conversation .\n",
            "@ patients were randomly divided into experimental and control groups , two groups of patients were male , age , duration of hospital stay , educational level , SANS score , medication and other statistical difference was not significant ( P > @ ) .\n",
            "( @ ) method .\n",
            "Conventional medication , all patients were enrolled into the experimental group of health education @ weeks , the same care and control group .\n",
            "( @ ) assessment .\n",
            "@ .\n",
            "Objective To investigate the efficacy of aripiprazole in the treatment of the negative symptoms of schizophrenia and security .\n",
            "@ cases and @ patients randomly assigned to enter the risperidone and aripiprazole treatment group to assess the efficacy and safety of the Positive and Negative Syndrome Scale ( PANSS ) , extrapyramidal side effects scale ( sas ) .\n",
            "Results after @ weeks of treatment , aripiprazole and risperidone no statistically significant differences on the efficacy and safety of the negative symptoms of schizophrenia .\n",
            "Conclusions Aripiprazole short-term treatment of the negative symptoms of schizophrenia may risperidone another safe and effective option .\n",
            "BACKGROUND : A randomised controlled trial of cognitive-behavioural therapy ( CBT ) for people with medication-resistant psychosis showed improvements in overall symptomatology after nine months of treatment ; good outcome was strongly predicted by a measure of cognitive flexibility concerning delusions .\n",
            "The present paper presents a follow-up evaluation @ months after baseline .\n",
            "METHOD : Forty-seven ( @ % of original n = @ ) participants were available for follow-up at @ months , and were reassessed on all the original outcome measures ( see Part I ) .\n",
            "An economic evaluation was also completed .\n",
            "RESULTS : Those in the CBT treatment group showed a significant and continuing improvement in Brief Psychiatric Rating Scale scores , whereas the control group did not change from baseline .\n",
            "Delusional distress and the frequency of hallucinations were also significantly reduced in the CBT group .\n",
            "The costs of CBT appear to have been offset by reductions in service utilisation and associated costs during follow-up .\n",
            "CONCLUSIONS : Improvement in overall symptoms was maintained in the CBT group @ months after baseline and nine months after intensive therapy was completed .\n",
            "CBT may be a specific and cost-effective intervention in medication-resistant psychosis .\n",
            "Forty individuals who were withdrawn from neuroleptic medication after the initiation of a minimal effective dose program at a residential facility for individuals with developmental disabilities were evaluated .\n",
            "Tardive dyskinesia ( TD ) was assessed using the Dyskinesia Identification System Condensed User Scale ( DISCUS ) .\n",
            "Half of the participants being treated with neuroleptic medication ( N ) were also being treated with anticonvulsant medication ( AC ) , so @ withdrawal groups were formed .\n",
            "The N only group manifested an increase in DISCUS scores after the withdrawal of neuroleptic medication , but the N + AC group did not .\n",
            "On the basis of this intriguing new finding , it was speculated that treatment with anticonvulsant medication might prevent the development or suppress the expression of TD .\n",
            "OBJECTIVE : Cognitive adaptation training is a psychosocial treatment that uses individually tailored environmental supports , such as signs , calendars , hygiene supplies , and pill containers , to cue and sequence adaptive behavior in the client 's home environment .\n",
            "Generic environmental supports offer a less costly treatment that provides a predetermined package of helpful supports to clients at the time of their routine clinic visit .\n",
            "Previous studies have demonstrated the efficacy of cognitive adaptation training .\n",
            "The study reported here examined the extent to which environmental supports are used by clients .\n",
            "METHODS : As part of an ongoing study , persons with schizophrenia were randomly assigned to one of three conditions : cognitive adaptation training , generic environmental supports , or assessment only .\n",
            "Rates of use of supports for the first three months of treatment were examined for the first @ patients assigned to the first two groups .\n",
            "RESULTS : Rates of overall use averaged approximately @ percent for cognitive adaptation training and @ percent for generic environmental supports .\n",
            "Specific categories of supports were also significantly more likely to be used by patients who were receiving cognitive adaptation training .\n",
            "More than @ percent of patients in cognitive adaptation training were classified as high users of supports ( used more than @ percent of supports provided appropriately ) , compared with only @ percent of those who were receiving generic environmental supports .\n",
            "CONCLUSIONS : Environmental supports have been found to improve functional behaviors for patients with schizophrenia .\n",
            "However , supports are not likely to be used unless they are customized for individual clients and set up in the home environment .\n",
            "Patients referred over @ months from nine medical centres for a trial of prophylactic neuroleptic medication following first episodes of schizophrenic illness ( @ ) were assessed with the Present State Examination , WHO scales for disability , past history , and sociodemographic factors , and a rating of disturbed behaviour ; @ fulfilled the study criteria ; of the @ who did not , @ did not meet the diagnostic criteria , @ had a history of a previous episode , and in @ the psychotic illness was found to have an organic basis .\n",
            "The interval between onset of illness and admission varied widely , but was often more than one year and associated with severe behavioural disturbance and family difficulty e.g. in arranging appropriate care .\n",
            "Current arrangements for initiating management of first schizophrenic illnesses are frequently unsatisfactory .\n",
            "Objective : To evaluate the efficacy and safety of the treatment of schizophrenia ziprasidone .\n",
            "Methods : @ patients with first episode of schizophrenia patients were randomly divided into @ cases of each of the ziprasidone group and the risperidone group .\n",
            "Were given ziprasidone and risperidone treatment , a six-week double-blind controlled study .\n",
            "Positive and Negative Syndrome Scale ( PANSS ) , the Clinical Global Impression ( cgi ) , treatment emergent symptom scale ( tess ) evaluate the efficacy and safety of .\n",
            "Results : the two groups panss rated each cycle after treatment than before treatment was significantly lower ( p < @ ) ; panss reduction rate ziprasidone group average ( @  @ ) % , average risperidone group ( @  @ % ) ; difference between the two groups no statistically significant ( p > @ ) .\n",
            "Two sets of adverse events was similar ( p > @ ) .\n",
            "Conclusion : Ziprasidone treatment of schizophrenia and security with risperidone considerable .\n",
            "Objective To evaluate the effect of health educat ion on the treatment of schizophrenia patient .\n",
            "Methods @ patients with schizophrenia were divided into two groups .\n",
            "A group ( Health education group , n = @ ) is treated with health education and medicine and B group ( control group , n = @ ) is treated with medicine only .\n",
            "The mental symp tom , efficacy , hospital day , compliance and recurrence rate was evaluated with the BPRS and the questionnaire we made at the leave-hospital time and the end of @ - year - revisit .\n",
            "Results  A t the leave-hospital time : The average hospital day of A group is shorter than that of B group ( @  @ and @  @ days ) , the efficacy of A group is h igher than that of B group ( excellence rate : @ .\n",
            "@ % and @ .\n",
            "@ % , effect ive rate : @ .\n",
            "@ % and @ .\n",
            "@ % ) , the scale of BPRS of A group is low er than that of B group ( @ .\n",
            "@  @ .\n",
            "@ and @ .\n",
            "@  @ .\n",
            "@ ) , comp liance of A group is bet ter than that of B group ( to tally compliance : @ .\n",
            "@ % and @ .\n",
            "@ % , partly compliance : @ .\n",
            "@ % and @ .\n",
            "@ % , none compliance : @ .\n",
            "@ % and @ .\n",
            "@ % , P < @ .\n",
            "@ ) .\n",
            " At the end of @ years : The efficacy of A group is higher than that of B group ( excellence rate : @ .\n",
            "@ % and @ .\n",
            "@ % , effect ive rate : @ .\n",
            "@ % and @ .\n",
            "@ % ) , the scale of BPRS of A group is lower than that of B group ( @ .\n",
            "@  @ .\n",
            "@ and @ .\n",
            "@  @ .\n",
            "@ ) , comp liance of A group is bet ter than that of B group ( to tally compliance : @ .\n",
            "@ % and @ .\n",
            "@ % , part ly comp liance : @ .\n",
            "@ % and @ .\n",
            "@ % , none compliance : @ .\n",
            "@ % and @ .\n",
            "@ % , P < @ .\n",
            "@ ) , recurernce rate of A group is lower than that of B group ( @ .\n",
            "@ % and @ .\n",
            "@ % , P < @ .\n",
            "@ ) , expulsion rate is equal ( P > @ .\n",
            "@ ) .\n",
            "Conclusion Health education is better for improvement of mental symptom of schizophrenia patient and makes shorter hospital day , better compliance and lower recurrence rate .\n",
            "In a @-week controlled study ethopropazine was compared to benztropine in the treatment of parkinsonism induced by fluphenazine enanthate in @ schizophrenic outpatients .\n",
            "Ethopropazine and benztropine were found to be equally effective in controlling parkinsonian symptoms and were as efficacious as procyclidine , their previous antiparkinsonian drug .\n",
            "However , benztropine treated patients had a significant increase in tardive dyskinesia compared to their condition during procyclindine treatment , and significantly more anxiety and depression than ethopropazine treated patients .\n",
            "This suggests that benztropine is not the anticholinergic drug of choice in the treatment of neuroleptic-induced parkinsonian symptoms , because of its more toxic central and peripheral atropinic effect .\n",
            "Objective : Compare the effectiveness of olanzapine , quetiapine , and risperidone in first-episode patients with schizophrenia from the CAF ( Comparison of Atypicals for First Episode ) study .\n",
            "Methods : Patients with schizophrenia ( n = @ ; > = @ years of age ) , comprising a subset of patients with schizophrenia , schizoaffective disorder , and schizophreniform disorder ( N = @ ) , were evaluated in a post hoc analysis of a @-week , randomized , double-blind , flexible-dose study of first-episode patients .\n",
            "Patients were randomized to olanzapine ( @-@ mg/day ) , quetiapine ( @-@ mg/day ) , or risperidone ( @-@ mg/day ) .\n",
            "Noninferiority between quetiapine and olanzapine or risperidone in all-cause treatment discontinuation rates up to @-weeks ( primary outcome measure ) was tested using a @ % noninferiority margin .\n",
            "Results : Patients received mean modal doses of @ , @ or @ mg/day of olanzapine , quetiapine , or risperidone , respectively .\n",
            "All-cause treatment discontinuation rates did not differ significantly between quetiapine ( @ % ) and olanzapine ( @ % ) or risperidone ( @ % ) .\n",
            "Psychopathology rating scale scores indicated symptom improvements for all treatments at week @ with no significant differences between groups .\n",
            "Treatment groups differed in their safety and tolerability profiles .\n",
            "Conclusions : Olanzapine , quetiapine , and risperidone , at mean modal doses of @ , @ , or @ mg/day , demonstrated similar effectiveness in the treatment of first-episode schizophrenia .\n",
            "Objective To evaluate the therapeutic and side effects of olanzapine in the treatment of schizophrenia .\n",
            "Methods @ patients with schizophrenia were randomly divided into the treatment groups of olanzapine or clozapine for @ weeks .\n",
            "PANSS , CGI and TESS scales were used to measure their efficacy and side effects .\n",
            "Results No significant difference of efficacy between olanzapine and clozapine group ,@ .\n",
            "@ % patients responded to olanzapine treatment while @ .\n",
            "@ % responded to clozapine ; the\n",
            "Objective : olanzapine as control , to explore aripiprazole in the treatment of the efficacy and safety of schizophrenia .\n",
            "Methods : @ patients met the diagnostic criteria of ccmd-@ in patients with schizophrenia were randomly divided into aripiprazole group and the olanzapine group of @ cases , were given aripiprazole and olanzapine treatment observation period of @ weeks .\n",
            "Before treatment , the treatment first @,@ weekend using positive and negative symptoms scale ( panss ) and to evaluate the efficacy , the need to deal with the adverse reactions in the treatment scale ( tess ) rating side effects , blood biochemical indicators security evaluation of treatment and ECG changes .\n",
            "Eventually into the analysis of @ cases ( @ cases the aripiprazole group of @ patients , the olanzapine group ) .\n",
            "Results : Aripiprazole group in the treatment of the first weekend ( in addition to the negative symptoms exceptionally ) @th weekend , the the olanzapine group of self-treatment panss positive and negative symptoms , symptoms of psychopathology points and total scores were significantly decreased ( p < @ , p < @ ) .\n",
            "Treatment of the sixth week , aripiprazole azole group panss positive symptoms points , negative symptoms , psychopathological symptoms sub-sub-score ( @  @ ) , with pre-treatment score differences were statistically significant ( p < @ ) and more effective than olanzapine group ( p < @ ) .\n",
            "Six weeks after treatment , the the aripiprazole group cure rate of @ cases ( @ % ) , a significant improvement in @ cases ( @ % ) , improved in @ cases ( @ % ) , symptoms invalid and the deterioration of a total of @ cases ( @ % ) ; cure rate of @ % , the effective rate of @ % ; effective rate of @ % , higher than the olanzapine group ( @ % ) .\n",
            "@ weeks of observation , found no significant weight gain caused by aripiprazole and ECG change significantly .\n",
            "Conclusion : aripiprazole and olanzapine for schizophrenia have a good effect , and a more rapid onset and better security .\n",
            "Objective : the mental disorders of old age , patients with diabetes to give full care intervention to improve clinical outcomes .\n",
            ": Matched control study , @ cases of old age mental disorders in patients with diabetes mellitus , according to the time of admission were randomly divided into experimental group and control group of @ cases , the experimental group given dietary intervention , exercise therapy , and prevention of infection care , collective and individual psychological intervention measures such as the control group , drug treatment and care , BPRS score to determine the efficacy of the experimental and control groups before and after intervention , determination of blood glucose levels .\n",
            "Results : The clinical efficacy of the experimental group and control group of mental disorders , blood glucose values were significant differences ( P < @ ) .\n",
            "The double-blind technique was used in short-term studies of the effects of reserpine and chlorpromazine in groups of @ to @ patients .\n",
            "Studies were made of the action of reserpine in normal individuals , in patients hospitalized with anxiety , and in patients with chronic schizophrenic reactions .\n",
            "Chlorpromazine was tested in combination with reserpine in patients hospitalized with anxiety and alone in patients with chronic schizophrenic reactions .\n",
            "These drugs were found to have distinct value in the treatment of psychiatric patients .\n",
            "Patients hospitalized with anxiety reactions and mild schizophrenic reactions responded well to reserpine and a combination of reserpine and chlorpromazine .\n",
            "There was no advantage noted from the combined use of these drugs , it was felt that use of these drugs in adequate doses possibly shortened the period of hospitalization of this group of patients , A parenteral oral dosage schedule of reserpine produced improvement ha two-thirds of treated patients with chronic schizophrenic reactions .\n",
            "A comparable dosage schedule of chlorpromazine to that of reserpine produced benefit in one half of the treated patients with chronic schizophrenic reactions , Both drugs produced marked improvement in one-fourth of these patients .\n",
            "This improvement far surpassed that accomplished by previous forms of treatment in these patients .\n",
            "The dose of drug used for the individual patient is of critical importance .\n",
            "It would appear that the optimum level of dosage is a function of the severity of the mental illness .\n",
            "The degree of sedative effects and side effects from a given level of reserpine dosage varies inversely with the degree of mental illness .\n",
            "Duration of treatment appears to be of lesser importance Use of these drugs promises to make more patients than ever before amenable to effective psychiatric rehabilitation - The trend toward making mental hospitals therapeutic , rather than custodial , institutions is bound to be accelerated by these agents .\n",
            "The purpose of this investigation was to determine the effectiveness of chlorpromazine as a therapeutic agent in the treatment of chronic , female , hospitalized schizophrenics .\n",
            "Two groups of patients were utilized : an experimental group of @ which received between @ and @ mg .\n",
            "of chlorpromazine daily , and a control group of @ which received @ mg .\n",
            "of placebo daily .\n",
            "The study was concerned with changes that occurred in intellectual functioning , the presence of anxiety and hostility , and overt behavioural patterns as a result of treatment .\n",
            "For this purpose , the Wechsler-Bellevue Intelligence Scale , the Rorschach , and the Multidimensional Scale for Rating Psychiatric Patients were administered prior to the onset of treatment and then repeated four months later at the conclusion of treatment .\n",
            "Data obtained from the psychological tests and rating scale were subjected to small sample statistical techniques .\n",
            "The chlorpromazine group and the placebo group were each studied separately and comparisons were made between the two groups .\n",
            "Objective To explore the efficacy of risperidone combining placebo and risperidone combining clomipramine in obsessive-compulsive symptoms of schizophrenia .\n",
            "Methods will be associated with obsessive-compulsive symptoms , @ cases of schizophrenic patients were randomly divided into treatment controlled study of risperidone combined placebo group , @ cases of risperidone combining clomipramine group of @ cases , carried out eight weeks before and after treatment with MMOCI , Y BOCS , PANSS , and TESS assessment .\n",
            "The results before and after treatment , two groups are significant .\n",
            "Risperidone with placebo for a total of obsessive-compulsive symptoms efficiency of @ % , effective rate @ % , risperidone combined with clomipramine hydrochloride group total effective rate was @ % , markedly effective rate was @ % the two groups were significantly different .\n",
            "Objective : To evaluate the feasibility of a telehealth psychoeducation intervention for persons with schizophrenia and their family members .\n",
            "Study Design : Randomized controlled trial .\n",
            "Participants : @ persons with schizophrenia and @ family members or other informal support persons .\n",
            "Interventions : Web-based psychoeducation program that provided online group therapy and education .\n",
            "Main Outcome Measures : Measures for persons with schizophrenia included perceived stress and perceived social support ; for family members , they included disease-related distress and perceived social support .\n",
            "Results : At @ months , participants with schizophrenia in the intervention group reported lower perceived stress ( p = .@ ) and showed a trend for a higher perceived level of social support ( p = .@ ) .\n",
            "Conclusions : The findings demonstrate the feasibility and impact of providing telehealth-based psychosocial treatments , including online therapy groups , to persons with schizophrenia and their families .\n",
            "A crossover experiment investigated the effects of repeated weekly @-day haloperidol ( HAL ) drug holidays on serum HAL concentrations , mental status , and neuroleptic-induced movement disorders in @ chronic male schizophrenic patients .\n",
            "HAL concentrations decreased about @ % during the initial @ hrs of drug holidays and subsequently increased slightly during the next @ hrs of drug holidays .\n",
            "Two-day weekly drug holidays for @ wks resulted in an average reduction of @ % in serum HAL concentrations at all drug holiday points .\n",
            "Mental status and movement disorders scores , rated by observers blind to the drug holiday condition , were not significantly affected by drug holidays .\n",
            "Objective : To evaluate the secondary efficacy outcomes of a double-blind , randomized , non-inferiority study of aripiprazole once-monthly - the first long-acting injectable dopamine partial agonist - versus oral aripiprazole for maintenance treatment in schizophrenia .\n",
            "Methods : Eligible patients required chronic antipsychotic medication for the treatment of schizophrenia .\n",
            "The study consisted of : screening phase , @-@-week conversion phase to oral aripiprazole ( Phase @ ) ; @-@-week oral stabilization phase with @-@ mg/day oral aripiprazole ( Phase @ ) ; and @-week , double-blind , activecontrolled , maintenance phase ( Phase @ ) in which patients were randomized ( @:@:@ ) to aripiprazole once-monthly @ mg ( aripiprazole once-monthly-@ , option to decrease to @ mg ) , oral aripiprazole ( @-@ mg/day ) , or aripiprazole once-monthly @ mg ( aripiprazole once-monthly-@ , option to decrease to @ mg ; a subthreshold therapeutic dose ) .\n",
            "Patients receiving aripiprazole oncemonthly ( -@ or -@ ) received concomitant oral aripiprazole ( @-@ mg/day ) for the first @ weeks of Phase @ .\n",
            "The principle study objective was to demonstrate the non-inferiority of aripiprazole once-monthly-@ to oral aripiprazole .\n",
            "Efficacy assessments included percentage of responders ( meeting stability criteria ) and percentage of subjects achieving remission at study endpoint , mean change from baseline to endpoint during Phase @ in Positive and Negative Syndrome Scale ( PANSS ) Total , positive and negative scores and Clinical Global Impressions - Severity ( CGI-S ) score , mean CGI - Improvement ( CGI-I ) score at endpoint , and time to all-cause discontinuation .\n",
            "Results : Of @ patients screened , @ entered Phase @ , and @ patients were randomized to double-blind treatment in Phase @ ( aripiprazole once-monthly-@ , n = @ ; oral aripiprazole , n = @ ; aripiprazole once-monthly-@ , n = @ ) .\n",
            "Response and remission rates are given in the table .\n",
            "( Table Presented ) Aripiprazole once-monthly-@ was associated with significant improvements from baseline in PANSS Total scores versus aripiprazole once-monthly-@ at Week @ and from Week @ onwards ( p < @ ) and versus oral aripiprazole at Weeks @-@ , @ , @ and @ ( last observation carried forward [ LOCF ] ; all p < @ ) .\n",
            "Aripiprazole once-monthly-@ was associated with significant improvements from baseline in CGI-S scores versus aripiprazole once-monthly-@ from Week @ onwards ( p < @ ) and versus oral aripiprazole at all study weeks from Week @ onwards ( p < @ ) except for Week @ ( LOCF ) .\n",
            "The mean CGI-I score remained relatively stable for the aripiprazole once-monthly - @ group whereas statistically significant increases ( representing worsening ) were observed for the oral aripiprazole and aripiprazole once-monthly-@ groups when compared with aripiprazole once-monthly-@ ( LOCF ) .\n",
            "Discontinuation rates ( all-cause ) were @ % ( n = @/@ ) for aripiprazole once-monthly-@ , @ % ( n = @/@ ; p < @ ) for oral aripiprazole and @ % ( n = @/@ ) for aripiprazole once-monthly-@ ; time to all-cause discontinuation favored aripiprazole once-monthly-@ versus oral aripiprazole ( p < @ ) .\n",
            "Conclusions : In the current study , aripiprazole once-monthly - @ was shown to be superior to aripiprazole once-monthly-@ in the majority of secondary efficacy outcomes .\n",
            "Improvements in PANSS Total , CGI-S and CGI-I symptom scores and time to allcause discontinuation favored patients receiving aripiprazole oncemonthly - @ compared with those receiving oral aripiprazole , suggesting potential benefits that warrant further study .\n",
            "Aripiprazole once-monthly offers a new treatment option for schizophrenia .\n",
            " @\n",
            "Patients with schizophrenia are severely impaired in crucial aspects of neurocognitive function .\n",
            "This impairment is the strongest clinical correlate of poor long-term outcome and adaptive dysfunction .\n",
            "Reports of neurocognitive enhancement with second generation antipsychotic medications have thus offered promise for improvement in the long-term outcome of patients with schizophrenia .\n",
            "However , the majority of these studies have had serious weaknesses in methodology , such as open-label design , small samples , or inappropriate dosing of medications .\n",
            "More recent studies have addressed these methodological issues but have been of short duration and have largely been sponsored by pharmaceutical companies .\n",
            "The Clinical Antipsychotic Trials of Intervention Effectiveness ( CATIE ) project is a unique opportunity to address the comparative neurocognitive effectiveness of available antipsychotic medications .\n",
            "This article describes the neurocognitive methods used in the schizophrenia trial of the CATIE project , including the selection and training of neurocognitive raters , patient inclusion criteria for assessment , rationale for the choice of neurocognitive instruments , and methodology for each neurocognitive test\n",
            "Pimozide and Chlorpromazine were compared in chronic schizophrenics for their therapeutic effectiveness and tolerance , for four-weeks in both cases and for twelve months for pimozide .\n",
            "The minimum and maximum doses were @ mg to @ mg single dose for pimozide and @ to @ mg thrice daily for chlorpromazine .\n",
            "No significant global differences between the range of therapeutic activity of the two regimens were observed .\n",
            "Slightly more improvement was observed in mood and motor activity with pimozide .\n",
            "Drowsiness and dizziness , and extrapyramidal effects were more prominent with clorpromazine .\n",
            "Other side effects were infrequent .\n",
            "A prolonged improvement in @ pimozide patients was maintained with mainly weight gain .\n",
            "The advantages of pimozide in chronic unsocialized schizophrenics appear to rest on its single oral daily dose regime , minimal undersirable effects , its specific enhancement of social integration and absence of undersirable effect on mental and physical performance .\n",
            "Purpose : This randomized , sham-controlled , double blind , multicentre clinical trial aims at providing evidence for the efficacy and safety of continuous theta burst stimulation ( cTBS ) in the treatment of auditory hallucinations in patients with schizophrenia .\n",
            "Overall , the study will include @ patients .\n",
            "Each patient will receive a three weeks course of daily ( @/week ) treatment ; @ % of the patients will be treated with cTBS ( @ impulses daily ) , the other half with a sham stimulation to the left and right temporoparietal cortex .\n",
            "Sham stimulation will be applied by an active sham-coil that allows for a double-blind treatment .\n",
            "Follow-up assessments @ , @ and @ months after treatment will investigate the stability of treatment effects .\n",
            "BACKGROUND : We evaluated the cross-sectional and longitudinal association of measures of both insight and attitudes toward medication to outcomes that included psychopathology and community functioning .\n",
            "METHODS : Clinical Antipsychotic Trial of Intervention Effectiveness ( CATIE ) was a large @-month follow-up study pharmacotherapy of people with schizophrenia .\n",
            "Insight was measured using the Insight and Treatment Attitudes Questionnaire and attitudes toward medication by the Drug Attitude Inventory .\n",
            "Widely known scales were used to assess symptoms of schizophrenia and depression and community functioning .\n",
            "Medication adherence was globally assessed by the treating psychiatrist using several sources of information .\n",
            "Bivariate correlations and mixed model regression analyses were used to test the relationship of insight and medication attitudes to outcomes at baseline and during the follow-up period .\n",
            "Regression models were used to evaluate the relationship between change in insight and medication attitudes and changes outcomes .\n",
            "RESULTS : There was a significant relationship at baseline between insight and drug attitudes and symptoms of schizophrenia and depression , as well as with community functioning .\n",
            "Higher levels of insight at baseline were significantly associated with lower levels of schizophrenia symptoms at follow-up while more positive medication attitudes were significantly associated with both lower symptom levels and better community functioning .\n",
            "Change in insight scores over time was associated with declining schizophrenia symptoms but increasing levels of depression .\n",
            "Change toward more positive medication attitudes was associated , independently of changes in insight , with significant decreases in psychopathology , improvement in community functioning , and greater medication compliance .\n",
            "CONCLUSION : Greater patient understanding of their illness and more positive attitudes toward medication may improve outcomes .\n",
            "Educational interventions that affect these attitudes may be an important part of psychosocial rehabilitation and/or recovery-oriented services .\n",
            "Compared the effectiveness of ( a ) group therapy stressing interpretive procedures intended to bring about client insight , and ( b ) a form of group therapy experience encouraging client * client interaction without the intentional development of insight .\n",
            "A total of @ male psychiatric inpatients ( @ diagnosed schizophrenic ) were randomly assigned to insight , interaction , insight-interaction , or control groups .\n",
            "Ss were given behavioral , psychometric , and self-rating measures ( e.g. , the MMPI ) before and after treatment .\n",
            "Although there were no significant differences between experimental conditions on any of the outcome measures , the insight-interaction group showed the most consistent indications of improvement on the @ measures assumed to assess \" personal functioning . \"\n",
            "None of the other group comparisons were statistically significant .\n",
            "( @ ref . )\n",
            "BACKGROUND : Quetiapine ( ICI @ , ' Seroquel ' ) is a new atypical antipsychotic agent with a similar binding profile to the original atypical antipsychotic , clozapine .\n",
            "Its clinical efficacy has already been demonstrated at multiple fixed doses ( @-@ mg/day ) and has been suggested to be comparable with haloperidol ( @ mg/day ) .\n",
            "METHODS : This international , @-week , multicentre , double-blind , randomized , parallel-group trial compared quetiapine with haloperidol ( @ mg and @ mg mean total daily doses , respectively ) in @ hospitalized patients with acute exacerbation of chronic or subchronic schizophrenia ( DSM-III-R ) , in order to establish their equivalence in terms of efficacy , and the nature of their tolerability profiles , especially in terms of extrapyramidal symptoms ( EPS ) and serum prolactin levels .\n",
            "RESULTS : Both quetiapine and haloperidol produced a clear reduction in the Positive and Negative Syndrome Scale ( PANSS ) scores and Clinical Global Impression ( CGI ) Severity of Illness and Global Improvement scores .\n",
            "At day @ , the PANSS total score was reduced by -@ + / -@ in the quetiapine group , and -@ + / -@ in the haloperidol group ( P = @ , between-treatment ) .\n",
            "Quetiapine was better tolerated than haloperidol in terms of EPS as demonstrated by the significant differences in the Simpson Scale and Abnormal Involuntary Movement Scale scores ( P < @ ) .\n",
            "Although patients in both groups had elevated serum prolactin concentrations at baseline , mean serum prolactin concentration decreased ( by @ microg/l ) in quetiapine-treated patients , yet increased ( by @ microg/l ) in patients treated with haloperidol .\n",
            "CONCLUSION : Quetiapine is an effective and well tolerated antipsychotic of comparable efficacy to haloperidol and lacks the latter compound 's effect on prolactin and EPS .\n",
            "This study examined the extent to which cognitive rehabilitation alleviates cognitive deficits in schizophrenia compared to treatment as usual , and explored the mediating and moderating effects on cognitive improvement .\n",
            "Two groups who received cognitive rehabilitation and treatment as usual were assessed at baseline , three months ( immediately post-intervention ) and at follow-up ( three months post-intervention ) .\n",
            "Cognitive rehabilitation focused on deficits in social knowledge and was conducted once a week for three months .\n",
            "The principles of errorless leaning and scaffolding informed the intervention .\n",
            "Outcomes were assessed using Script Test measures of social cognition .\n",
            "Other cognitive functions ( executive functions and memory ) and clinical symptoms were also assessed .\n",
            "Script Test for social knowledge and Rule Shift Test for cognitive flexibility scores were significantly better post-intervention in the cognitive rehabilitation group , while in the control group only free recall Script Test scores improved .\n",
            "Cognitive rehabilitation focused on social knowledge deficits can contribute to improvements in the social cognitive abilities of schizophrenic patients .\n",
            "Improvements in social cognitive functioning were durable at three-month follow-up .\n",
            "Cognitive rehabilitation can clearly benefit schizophrenic patients , at least when combined with atypical antipsychotic medication .\n",
            "Objective : The use of effective communication skills intervention stray schizophrenia patients to return to society as soon as possible .\n",
            "The : homeless schizophrenic patients , @ patients were randomly divided into @ groups of @ cases of schizophrenia according to conventional drug treatment and care , the intervention group at the same time according to the different manifestations of the illness in patients with different periods , symptomatic of the nurse-patient communication patients catharsis , to guide the self-adjustment .\n",
            "Be assessed before and after treatment using nurse Inpatient Observation Scale ( nosie ) @ group .\n",
            "Results : @ group , the average length of stay ( @  @ ) months .\n",
            "Compared with before treatment , the treatment of a group nosie positive factors , social interest , personal cleanliness and social competence are to improve ; negative factors , irritability , mental performance , retardation and depression scores were dropped , the intervention group showed more outstanding ( p < @,@ ) .\n",
            "@ months of treatment and @ month of treatment , compared with the intervention group there progress ( p < @ ) , and the control group did not change significantly .\n",
            "Effective , long-term treatment of schizophrenic patients has many remaining unsolved problems .\n",
            "Pharmacotherapy alone is insufficient to prevent relapses or to ensure recovery from functional disabilities in the illness course .\n",
            "In an attempt to improve the long-term outcome for individuals with schizophrenia , there is a growing interest in psychosocial interventions as an adjunct to facilitate recovery from an initial episode of psychosis and reduce the long-term disability resulting from schizophrenia .\n",
            "The aim of the Antipsychotic Combination with Psychosocial Intervention on the Outcome of Schizophrenia ( ACPIOS ) project is to compare antipsychotic medication combination with psychosocial intervention to antipsychotic medication alone on the outcome of schizophrenia .\n",
            "A total of @ patients with ages ranging between sixteen and fifty years who meet the Diagnostic and Statistical Manual of Mental Disorders , Fourth Edition ( DSM-IV ) criteria for schizophrenia and schizophreniform disorder for not more than five years are randomly assigned to either of the above two treatments .\n",
            "Relapse rates and the duration time from the start of treatment to the first relapse are recorded as a measure of the primary effectiveness of the respective treatment regimes .\n",
            "The study will be completed by mid-@ , and it is expected that the results will yield relevant clinical information on how antipsychotic combination with psychosocial intervention affects the outcome of schizophrenia .\n",
            "This paper sets out the rationale and the design of the trial .\n",
            "OBJECTIVE : This phase @ study evaluated the efficacy , safety , and tolerability of cariprazine in patients with acute exacerbation of schizophrenia .\n",
            "METHOD : This multinational , randomized , double-blind , placebo - and active-controlled study was conducted from April @ to December @ .\n",
            "Patients who met DSM-IV-TR criteria for schizophrenia were randomized to placebo ( n = @ ) , cariprazine @ mg/d ( n = @ ) , cariprazine @ mg/d ( n = @ ) , or aripiprazole @ mg/d ( n = @ ) for @ weeks of double-blind treatment .\n",
            "The primary and secondary efficacy parameters were mean change from baseline to week @ in Positive and Negative Syndrome Scale ( PANSS ) total score and Clinical Global Impressions-Severity of Illness ( CGI-S ) score , respectively .\n",
            "RESULTS : Least squares mean differences ( LSMDs ) in PANSS total score change at week @ significantly favored cariprazine @ and @ mg/d versus placebo ( LSMD [ @ % CI ] : @ mg/d , -@ [ -@ to -@ ] , adjusted P = .@ ; @ mg/d , -@ [ -@ to -@ ] , adjusted P < .@ ) .\n",
            "Cariprazine @ and @ mg/d were also associated with significant improvements relative to placebo in CGI-S scores ( LSMD [ @ % CI ] : @ mg/d , -@ [ -@ to -@ ] , adjusted P = .@ ; @ mg/d , -@ [ -@ to -@ ] , adjusted P < .@ ) .\n",
            "Significant differences from placebo were also observed with aripiprazole on the PANSS ( LSMD [ @ % CI ] : -@ [ -@ to -@ ] , P = .@ ) and CGI-S ( LSMD [ @ % CI ] : -@ [ -@ to -@ ] , P = .@ ) .\n",
            "Common treatment-emergent adverse events ( > / = @ % ) were insomnia ( all groups ) , akathisia ( cariprazine @ mg/d ) , and headache ( placebo , cariprazine @ mg/d ) .\n",
            "CONCLUSIONS : This study supports the efficacy , safety , and tolerability of cariprazine @ and @ mg/d in the treatment of patients with acute exacerbation of schizophrenia .\n",
            "TRIAL REGISTRATION : ClinicalTrials.gov identifier : NCT@ .\n",
            "Objective : This purpose of this study was to determine whether participation in the Work-Ordered Day program of the Clubhouse model has a positive effect on vocational outcomes .\n",
            "Method : The longitudinal study followed a group of individuals with severe mental illness who were randomly assigned either to a Clubhouse program or a Program of Assertive Community Treatment team .\n",
            "Study participants were tracked for @ weeks .\n",
            "These analyses evaluated the relationship between Work-Ordered Day participation and employment duration for the @ study participants enrolled in the Clubhouse program who were active throughout the study and competitively employed during the study .\n",
            "Results : Participation in the Work-Ordered Day program had a significant positive impact on average duration of employment .\n",
            "On average , a @-hr increase in participation prior to employment led to an increase of @ weeks in competitive employment .\n",
            "Conclusions and Implications for Practice : Participants with more Work-Ordered Day program participation prior to employment had significantly longer average competitive employment duration even when controlling for prior work history .\n",
            "Participation in the Work-Ordered Day program is likely to improve work readiness .\n",
            "Further research is warranted to study which elements of the program may foment employment success .\n",
            "This could lead to increased implementation of the Work-Ordered Day program and its elements as precursors to employment for adults with severe mental illness .\n",
            "( PsycINFO Database Record ( c ) @ APA , all rights reserved ) ( journal abstract )\n",
            "Objectives : Veterans with serious mental illness are at increased risk of obesity , sedentary lifestyle , and a host of related chronic diseases .\n",
            "Although evidence suggests that lifestyle interventions can help mental health consumers achieve modest weight loss , several studies have failed to show a benefit and most have concluded that significant challenges remain in delivering effective interventions .\n",
            "In @ , the Veterans Health Administration introduced MOVE !\n",
            ", a weight management program that includes behaviorally based dietary and physical activity self-management support .\n",
            "This article describes modifications used to manualize MOVE !\n",
            "for veterans with serious mental illness and reports findings from a randomized controlled trial of the new intervention .\n",
            "Methods : Between January @ and June @ , overweight or obese veterans with serious mental illness were randomly assigned to a sixmonth trial of MOVE !\n",
            "( N = @ ) , which includes both individual and group sessions , or to a control condition that offered basic information about diet and exercise every month ( N = @ ) .\n",
            "Weight and metabolic , attitudinal , behavioral , and functional variables were measured at baseline and six months , and weight was also measured monthly .\n",
            "Results : Thirty participants in MOVE !\n",
            "and @ participants in the control group completed the six-month assessment , and only seven lost @ % of their baseline weight ; there was no effect of group assignment on weight loss .\n",
            "There were no significant group @ time differences in any metabolic , dietary , physical activity , attitudinal , or functional measure .\n",
            "Conclusions : Despite the negative findings of this study , research is crucial to identify lifestyle interventions and related supports and services to help veterans with mental illness reduce overweight and obesity .\n",
            "The study was designed to explore the potential therapeutic effects of humor on hospitalized schizophrenics .\n",
            "For this purpose , in the first stage , we conducted a review of findings in regard to physical health , emotions , psychiatric state , and social behavior .\n",
            "In the second stage , we carried out an experiment with @ resident patients in two chronic schizophrenic wards who were exposed to @ movies during @ months .\n",
            "The experimental group was exposed to humorous movies only , and the control group to different kinds of movies .\n",
            "Before and after the exposure to films for @ months , both groups were tested on different health , emotional , social , and clinical measures using the Cognitive Orientation of Health Questionnaire , the Shalvata Symptom Rating Scale , blood pressure , heart rate , Perceived Verbal and Motor Aggression ( rated by nurses ) , the Multiple Affect Adjective Check List , the Social Support Questionnaire @ , and the Brief Psychiatric Rating Scale ( BPRS ; rated by psychiatrists ) .\n",
            "Covariance analyses yielded significant reductions in Perceived Verbal Hostility , BPRS scales ( total score , anxiety/depression ) , and significant increases in BPRS ( activation ) and degree of staff support experienced by the patients .\n",
            "The results indicate that the effects of exposure to humor may be mediated by the effects on the staff of the incidental exposure to humorous films .\n",
            "In this study ( @ schizophrenic patients , divided into two groups of @ , were treated with traditional Chinese medicine to invigorate the blood and relieve stasis and antipsychotic drugs , and were observed by the rating methods of BPRS , TESS , CGI scale and hemorheology test .\n",
            "The results show that such traditional Chinese medicine to invigorate blood and relieve stasis has fewer side effects on schizophrenic patients than do antipsychotic drugs , and there is objective evidence of hemorheology changes .\n",
            "Traditional Chinese medicine is superior to antipsychotic drugs in the effects of anti-anxiety-depression and antipsychomotor inhibition , but it is less effective in controlling psychomotor excitation compared with antipsychotic drugs . )\n",
            "Objective : To evaluate the efficacy and safety of treatment of acute schizophrenia injection ziprasidone .\n",
            "Methods : @ patients with schizophrenia were randomly divided into the ziprasidone group and haloperidol group , conducted a randomized single-blind controlled study .\n",
            "Treatment @d .\n",
            "Brief Psychiatric Rating Scale ( BPRS ) , Bech-Rafaelsen Mania Scale ( BRMS ) , treatment emergent symptom scale ( TESS ) extrapyramidal reactions scale ( RSESE ) and , respectively , to evaluate the efficacy and adverse reactions .\n",
            "Results : After treatment , BPRS and BRMS scores were significantly reduced , no statistically significant difference between the two groups of the reduction rate and significant efficiency .\n",
            "The ziprasidone group incidence of adverse events was significantly lower than the haloperidol group ( P < @ ) .\n",
            "Conclusion : Ziprasidone injection for acute schizophrenia treatment with haloperidol injection equivalent to less than haloperidol and adverse reactions .\n",
            "\" Background : Post-mortem and imaging studies suggest that early in the treatment of schizophrenia ( SZ ) , antipsychotics increase myelination and specifically intracortical myelin ( ICM ) .\n",
            "We used MRI to examine whether in SZ , the ICM trajectory is dysregulated , altered by oral antipsychotics , associated with cognitive performance , and whether antipsychotic formulation can modify the ICM trajectory .\n",
            "Methods : Frontal lobe ICM volume was estimated using a novel dual contrast MRI method .\n",
            "Study @ : Male SZ subjects ( N = @ ) taking oral antipsychotics for @-@ months and @ healthy male controls ( HCs ) participated .\n",
            "Study @ : Sixmonth randomized trial of risperidone long acting injectable ( RLAI , N = @ ) versus oral risperidone ( RisO , N = @ ) in first-episode SZ subjects .\n",
            "Results : Study @ : Plot of medication exposure versus ICM trajectory was highly quadratic peaking at one year .\n",
            "Cognitive scores were associated with ICM volume .\n",
            "Study @ : Compared to healthy controls , ICM volume increased significantly ( p = .@ ) in the RLAI and non-significantly ( p = .@ ) in the RisO groups .\n",
            "The RLAI group had more ICM increases ( chi-square p < .@ ) .\n",
            "Conclusions : The ICM trajectory on oral antipsychotics resembles clinical response with @ % remission in the first year followed by progressively lower remission rates ( < @ % ) .\n",
            "Better adherence with RLAI may modify this ICM trajectory through continuous inhibition of the constitutively active enzyme glycogen synthase kinase @ ( GSK@ ) .\n",
            "Dopamine and serotonin receptor blockade inhibit GSK@ and promote myelination .\n",
            "The results support post-mortem evidence of ICM deficits in SZ and suggest that correction of these deficits through GSK@ inhibition may be a shared mechanism of action of antipsychotics . \"\n",
            "Primary Drug / Intervention : Amoxapine Dosage : Secondary Drug / Intervention : Other Drug / Intervention : Illness : Schizophrenia Sample Size : @ Trial Design : Duration of Study Period for Each Subject : Outcome Measurements : Results : Amoxapine is an off-patent antidepressant that is thought to have antipsychotic properties at certain doses .\n",
            "Forty patients with schizophrenia were randomized to receive amoxapine ( up to @ mg/day ) or risperidone ( up to @mg/day ) for @ weeks .\n",
            "Thirty-nine patients completed the study .\n",
            "Amoxapine was equivalent to risperidone for positive , negative and depressive symptoms .\n",
            "Amoxapine produced fewer extrapyramidal side effects and less elevation of prolactin than risperidone .\n",
            "Amoxapine may be an attractive alternative to newer antipsychotics because it is very in expensive .\n",
            "Objective : This @-week , open-label study , conducted between November @ and September @ in a community setting , was designed to determine if weight gain during olanzapine treatment can be prevented or mitigated with adjunctive treatment algorithms that include amantadine , metformin , and zonisamide .\n",
            "Method : Outpatients with schizophrenia or schizoaffective disorder ( DSM-IV-TR criteria ) were randomly assigned to olanzapine alone ( n = @ ) , olanzapine plus algorithm A ( olanzapine + A [ amantadine @ mg/d with possible switches to metformin @-@ mg/d and then to zonisamide @-@ mg/d ; n = @ ] ) , or olanzapine plus algorithm B ( olanzapine + B [ metformin @-@ mg/d with possible switches to amantadine @ mg/d and then to zonisamide @-@ mg/d ; n = @ ] ) .\n",
            "Brief weight management education was provided at baseline .\n",
            "The primary outcome measure was comparison of mean weight gain between olanzapine and pooled olanzapine + A and olanzapine + B results .\n",
            "Results : Least squares mean + / - SE weight gain was @ + / - @ kg for olanzapine , @ + / - @ kg for olanzapine + A , and @ + / - @ kg for olanzapine + B. Mean weight gain during olanzapine treatment did not differ significantly from pooled results for olanzapine + A and olanzapine + B ( P = .@ ) .\n",
            "Participants treated with olanzapine + B experienced significantly less mean weight gain than olanzapine-treated participants ( P = .@ ) .\n",
            "Conclusions : Pooled treatment algorithm results were not significantly different from olanzapine monotherapy in mitigating weight gain .\n",
            "However , participants who received treatment with metformin with possible progression to amantadine and then zonisamide had significantly less mean weight gain than participants treated with olanzapine alone .\n",
            "Progression of some participants through the algorithm indicated that a single therapy solution may not be adequate for every patient .\n",
            "Patients treated with olanzapine should receive regular weight monitoring .\n",
            "Trial Registration : clinicaltrials.gov Identifier : NCT@ .\n",
            "Copyright @ Physicians Postgraduate Press Inc .\n",
            "BACKGROUND : The purpose of this study was to compare an early behavioral intervention ( EBI ) with nonstructured standard physical care ( routine care intervention [ RCI ] ) in preventing antipsychotic-induced weight gain in drug-naive first-episode psychosis patients .\n",
            "METHOD : Sixty-one patients with a DSM-IV-diagnosed psychotic disorder were first randomly assigned to @ different antipsychotic treatments ( risperidone [ N = @ ] , olanzapine [ N = @ ] , and haloperidol [ N = @ ] ) and subsequently randomly assigned to the intervention condition ( EBI , N = @ ) or RCI ( N = @ ) .\n",
            "EBI was specifically designed to teach strategies to enhance control over factors associated with antipsychotic-induced weight gain and consisted of @ flexible intervention modules that incorporated behavioral interventions , nutrition , and exercise .\n",
            "In the RCI group , patients were informed about potential weight gain and advised to increase their exercise and limit food intake .\n",
            "Body weight and body mass index were measured at baseline and then weekly for @ months .\n",
            "In addition to change in weight and body mass index , a third outcome measure was the proportion of patients who had gained more than @ % of their body weight at @ months .\n",
            "Participating patients were referred between August @ and September @ .\n",
            "RESULTS : All @ participants completed the study .\n",
            "Patients in the EBI group gained significantly less weight ( mean = @ kg , SD = @ ) than those allocated to the RCI group ( mean = @ kg , SD = @ ) ( p < .@ ) during the @-month follow-up period .\n",
            "Similar findings were obtained when both groups were compared on treatment-induced change in body mass index , which was significantly less in the EBI group than in the RCI group ( @ vs. @ kg/m@ ) ( p < .@ ) .\n",
            "Accordingly , significantly fewer patients in the EBI group ( N = @ ; @ % ) than in the RCI group ( N = @ ; @ % ) ( p < .@ ) increased their baseline weight by more than @ % , the cutoff for clinically meaningful weight gain .\n",
            "CONCLUSIONS : EBI was effective in attenuating antipsychotic-induced weight gain in a drug-naive first-episode psychosis cohort .\n",
            "Patients displayed good adherence to this type of preventive intervention .\n",
            "RN @ ( Antipsychotic Agents ) .\n",
            "Purpose ; to explore cognitive behavioral intervention ( psychotherapy ) efficacy in patients with first-episode schizophrenia .\n",
            "Methods : @ cases hospitalized for the first time since June @ , patients with schizophrenia , in the third stage of the treatment were randomly divided into of antipsychotics combined psychotherapy group ( study group , n = @ ) and with antipsychotics group ( control group , @ cases ) , the two groups were the same drug maintenance therapy .\n",
            "The clozapine study group ( @  @ ) mg / d ( @ patients ) , risperidone ( @  @ ) mg / d ( @ cases ) ; the control group clozapine ( @  @ ) mg / d ( @ patients ) , risperidone ( @  @ ) mg / d ( @ patients ) .\n",
            "@-year follow-up study , the recurrence rate of the two groups , respectively insight score , medication compliance , and yin and yang Symptom Assessment Scale ( PANSS ) total score compared .\n",
            "Results : The recurrence rate of the study group than the control group ( P < @ ) ; insight of the study group than the control group ( P < @ ) ; research group PANSS total score and factor scores were lower than the control group ( P < @-@ ) .\n",
            "Conclusion : The first episode schizophrenia cognitive behavioral intervention can improve the efficacy and medication adherence of patients to reduce the rate of recurrence of the disease .\n",
            "Total Enrollment - @ Study completion - September @ Background - Schizophrenia , a chronic psychiatric disorder , is the second most frequent VA discharge diagnosis .\n",
            "Medication management practices for schizophrenia often are not guideline-concordant and place patients at risk for adverse outcomes .\n",
            "This project tests a new strategy to standard implementation for VHA Schizophrenia Guidelines .\n",
            "Objectives - Research objectives are - ( @ ) to compare the effectiveness of a conceptually-based , enhanced intervention to that of a basic educational strategy with regard to improving guideline adherence and patient compliance ; ( @ ) to compare the effectiveness of the two strategies with regard to improving symptom and side effect outcomes ; ( @ ) to determine the effect of the enhanced intervention on service utilization for acute exacerbations of schizophrenia ; ( @ ) to determine the extent to which guideline-concordant medication management improves patient outcomes ; and ( @ ) to examine providers ' knowledge of and attitudes toward guidelines .\n",
            "Methods - Thirteen VA sites were considered for the study , and VistA data were extracted to assess baseline guideline performance .\n",
            "Seven sites were selected and received basic education about schizophrenia guidelines .\n",
            "Three of these sites were randomly selected to receive the enhanced intervention , employing a nurse coordinator to promote providers ' guideline adherence and patients ' treatment adherence .\n",
            "Subjects with an acute exacerbation of schizophrenia were enrolled and were interviewed at baseline and six months using the Positive and Negative Syndrome Scale , the Schizophrenia Outcomes Module , and the Barnes Akathisia Scale .\n",
            "Data on guideline adherence were collected from medical records and VistA files .\n",
            "When data collection is completed , analyses will be conducted to determine the effectiveness of the enhanced intervention with regard to improving guideline adherence and patient outcomes .\n",
            "Status - The project is ongoing .\n",
            "To date , @ subjects have been enrolled in the intervention study .\n",
            "The rate of completed follow-up assessments to date is @ percent .\n",
            "MD , Principal Investigator , Central Arkansas VHS Eugene J. Towbin Healthcare Ctr , Little Rock Purpose - Schizophrenia , a chronic psychiatric disorder , is the second most frequent VA discharge diagnosis .\n",
            "Medication management practices for schizophrenia often are not guideline-concordant and place patients at risk for adverse outcomes .\n",
            "This project tests a new strategy to standard implementation for VHA Schizophrenia Guidelines .\n",
            "Eligibility - Ages Eligible for Study - @ Years - @ Years , Genders Eligible for Study - Both Criteria Inclusion Criteria - @ .\n",
            "Subjects must have a diagnosis of schizophrenia .\n",
            "@ .\n",
            "Subjects must have been admitted to an inpatient psychiatry unit or seen in an ambulatory care clinic or the Emergency Room at a study site for symptoms of acute exacerbation .\n",
            "@ .\n",
            "Must be able to provide informed consent themselves or informed consent by a guardian .\n",
            "Exclusion Criteria -\n",
            "Objective To investigate the impact of health education on schizophrenia the accompanying relatives cognitive level , to improve guardianship quality basis .\n",
            "@ patients with schizophrenia accompanying relatives were randomly divided into observation group and control group , n = @ , the observation group to carry out one-to-one targeted health education and psychological care in the control group were given conventional health education seminars .\n",
            "Observed in patients hospitalized throughout .\n",
            "One day before the patient is discharged from the hospital self intends the questionnaire assessment team accompanying relatives known condition , Statistics @ groups of patients committed suicide outside walk , wounding ruined objects incidence .\n",
            "Results when the patient is discharged from the hospital , the observation group accompanying relatives of the concept of schizophrenia , treatment , prognosis and prevention of cognitive status scores were significantly higher than those in the control group ( p < @ ) ; patients attempted suicide outside walking behavior , outside walking attempts , wounding behavior , wounding tendency to destroy the physical phenomena , and the destruction of property tendency incidence was significantly lower than the control group ( p < @ or @ ) .\n",
            "Conclusion targeted health education can significantly improve the patients with schizophrenia to accompany the team to know the capacity and quality of guardianship of relatives , has a significant effect on the prevention of accidents occurred more conducive to helping patients return to society as soon as possible .\n",
            "Introduction : The Computerized Interactive Remediation of Cognition - Training for Schizophrenia [ CIRCuiTS ] is a computerized cognitive therapy program for people with a diagnosis of schizophrenia or schizoaffective disorder [ @ ] .\n",
            "It is a psychological treatment aimed at improving neurocognitive functions and metacognition in people with these diagnoses .\n",
            "It does not have the purpose of directly addressing the content of thought , beliefs or emotions but , through the use of non-emotional material , teaches basic thinking skills that could facilitate more complex social behaviors and life skills Acceptability and feasibility of the program have already been evaluated in previous research [ @ ] The findings of these research are encouraging , but more consistent data on the effectiveness of the program are necessary .\n",
            "Only one randomized controlled trial has been conducted showing that CIRCuiTS lead to an improvement in visual memory and may protect against cognitive decline [ @ ] .\n",
            "Aim ( s ) : The primary outcome of this study is to provide a first set of data of the feasibility and acceptability of the Italian version of the program ; the secondary outcome is to assess the efficacy of the Italian version of the program in a sample of outpatients of an Italian Mental Health Department .\n",
            "Method ( s ) : This study is a case series .\n",
            "Patients with a diagnosis of schizophrenia were assessed at baseline ( cognitive , psychopathological and functional assessment ) , received up to @ therapy sessions ( subjects could complete the whole treatment programme in advance depending on their abilities ) three times a week , for about an hour and for approximately three months and were reassessed at post-treatment using the same neuropsychological and clinical assessments .\n",
            "In the first three weeks , the therapist helped patients use the program to optimize the comprehension of the software .\n",
            "Subsequently , one session per week was independently handled by the patient from his home .\n",
            "To evaluate the participants ' level of satisfaction with the treatment , the Client Satisfaction Questionnaire-@ ( CSQ-@ ) was used [ @ ] .\n",
            "Scores for this measure range between @ and @ , with higher score indicating greater satisfaction .\n",
            "Result ( s ) : In total , @ patients were assessed as eligible and was offered the therapy .\n",
            "Eight consented to participate ( @ % ) .\n",
            "The remaining two patients refused to participate because of the impossibility of sustaining therapeutic engagement due to the many weekly sessions ( @-@ ) and the distance between their home and the Department of Mental Health .\n",
            "The @ participants all completed the intervention program .\n",
            "The participants ' average score reported for CIRCuiTS on the CSQ was @ indicating a high level of satisfaction .\n",
            "CIRCuiTS produced an improvement in several domains of neurocognition , disorganization , self-esteem , functional capacity and real-life functioning in the areas \" self-care \" , \" interpersonal relationships \" and \" working abilities \" .\n",
            "Conclusion ( s ) : This study showed that CIRCuiTS was feasible and well accepted by service users .\n",
            "CIRCuiTS lead to some benefits on cognition , disorganization and self-esteem and the effects are generalized to functional capacity and real-life functioning .\n",
            "This seems to confirm that metacognitive capacity training in association with neurocognitive training leads to a real improvement in patient abilities in the real world .\n",
            "Copyright   @\n",
            "TFZ efficacy in the treatment of schizophrenia is well documented , but the minimal effective dose is unknown .\n",
            "Objective - To explore the efficiency of TFZ threshold ( minimum extrapyramidal side effects , EPS ; TD ) , subthreshold ( no EPS ; STD ) , and conventional doses ( CD ) .\n",
            "Method - @ schizophrenics ( DSM-IV ) free of antipsychotics ( two weeks oral or four depot ) , participated .\n",
            "TD was determined starting with @ mg/d of TFZ increasing @ mg/day weekly until EPS appeared ( DiMascios 's scale ) , if psychopathology improved -- @ % in total PANSS -- without EPS , the patient continued with STD .\n",
            "Patients on TD were randomized to - group I ( TD + @ mg/day of TFZ ) or group II ( TD + placebo ) .\n",
            "The trial lasted six weeks .\n",
            "Subjects received biperiden p.r.n. Comparisons were performed with repeated measures ANOVA .\n",
            "Results - Twenty patients were in group I , @ in group II , and @ received STD ; age was similar ( overall mean _ sd ; @ _ @ years ) , as were basal PANSS total scores ( @ _ @ , @ _ @ and @ _ @ ) .\n",
            "At the end PANSS scores were similar , however DiMascio 's scores were CD > TD > STD ( F { @ , @ } = @ ; p < @ ) .\n",
            "Conclusion - CD , TD , and STD are equally effective in the treatment of schizophrenia , but EPS are different .\n",
            "Objective : To observe the clinical effect of ( PI ) acupuncture with electro-acupuncture ( EA ) and psychological intervention on the depression after schizophrenia .\n",
            "Methods : Totally @cases were randomized into a medicinal group and a medicine plus electro  acupuncture and psychological intervention ( the combined treatment group ) with @ in each .\n",
            "The medicinal group was administered Risperidone tablets for oral taking , @ Mg each time , @times a day and Paroxetine Hydrochloride tablets , @ mg , @ time a day .\n",
            "Based on the same medication , Combined treatment group was given electro  acupuncture at Baihui ( GV@ ) , Yintang ( EX  HN@ ) , HEgu ( L@ ) , Taichong ( LR@ ) , Neiguan ( PC@ ) .\n",
            "twice a week and cognitive behavioral therapy , once a week , Both groups were treated for @ weeks and then the effect was observed .\n",
            "The therapeutic effect was observed and compered before and after the treatment according to Hamilton Depression Rating scale for Depression ( HAMD ) and Center for Epidemiological Studies Depression Scale ( CES  D ) .\n",
            "Results : the total effective rate of the combined treatment group was @ % , which was superior to @ % of the medicinal group ( p < @ ) , After treatment , the average scores of HAMD and CES  D decreased significantly in the three groups ( p < @ ) , especially in the combined treatment group ( p < @ ) .\n",
            "Conclusion : The effect of EA and PI in the treatment of DAC is better in effectiveness and safety .\n",
            "Background : Patients with severe mental disorders have a higher prevalence of cardiovascular risk factors .\n",
            "Obesity and sedentarism are cardiovascular risk factors and their control reduces morbidity and mortality .\n",
            "Thus , interventions directed toward decreasing weight and/or increasing the level of physical activity are necessary .\n",
            "Objectives : The aim of this study would be to evaluate the effectiveness of an educational intervention focused on diet and physical activity in order to change the amount of physical activity , Body Mass Index and waist circumference in these patients .\n",
            "Design : Randomized clinical trial with a control group with one-year follow-up .\n",
            "Setting : Outpatient Mental Health Teams of Barcelona and a residence for patients with severe mental disorders .\n",
            "Participants : Patients between @ and @ years of age diagnosed with schizophrenia , a schizoaffective disorder or bipolar disorder in treatment with antipsychotic medication and a low level of physical activity ( @ patients in each randomized group ) .\n",
            "Intervention group : Physical activity group educational program of @ sessions over @ weeks and diet ( @ sessions in the first @ weeks ) carried out by nurses and physical activity specialists .\n",
            "Control group : Usual practice with regular checks and the usual treatment of their disease .\n",
            "Main outcome measures : Level of physical activity ( IPAQ questionnaire ) , weight , Body Mass Index and waist circumference .\n",
            "Other outcomes : Cardiovascular risk , quality of life ( SF-@ questionnaire ) , tobacco consumption , dietary habit ( PREDIMED questionnaire ) , blood pressure and laboratory parameters ( cholesterol , triglycerides , glucose ) .\n",
            "Evaluations will be masked and will be made at @ , @ , @ and @ months .\n",
            "Data analysis : Intention to treat analysis .\n",
            "Analysis of variance for repeated measures to adjust for differences attributable to the effect of the intervention for potential confounders ( drug treatment , care level of intervention and mental status of the patient ) .\n",
            "Ethical aspects : The project has been evaluated and approved by the ethics committee ( CEIC ) of the Primary Healthcare-University Research Institute IDIAP Jordi Gol , with registration number P@/@ .\n",
            "Trial registration : Clinicaltrials.gov NCT@ .\n",
            "The objective of this study was to evaluate the efficacy and tolerability of quetiapine in the treatment of first onset psychosis in older adolescents using risperidone as a comparator .\n",
            "Twenty-two patients with first onset psychosis were randomized to receive quetiapine ( up to @ mg/day ) or risperidone ( up to @ mg/day ) for @ weeks .\n",
            "Raters blind to treatment assignment performed outcome symptom ratings .\n",
            "No statistical differences emerged in terms of efficacy or tolerability between the two drugs .\n",
            "However , there were some clinically notable differences that seem to favour the efficacy of risperidone over quetiapine .\n",
            "Patients taking quetiapine , although improved , showed less clinical improvement on scores for total positive and negative symptoms , clinical global severity and depression at @ weeks than patients taking risperidone .\n",
            "Although both treatments were associated with weight gain and sedation , more patients on quetiapine experienced over @ % weight gain .\n",
            "However , fewer patients who were taking quetiapine required anticholinergic medication or experienced extrapyramidal side effects than patients taking risperidone .\n",
            "Risperidone was significantly more likely to be associated with elevation in serum prolactin levels in this population .\n",
            "In conclusion , the results in this small trial show that adolescent patients may benefit more from treatment with risperidone than quetiapine .\n",
            "However , those susceptible to side effects , particularly hyperprolactinaemia , may be more suitable for treatment with quetiapine .\n",
            "@ .\n",
            "The atypical antipsychotic risperidone may constitute an alternative to clozapine , the current treatment of choice for refractory schizophrenia .\n",
            "The objectives of this study were to evaluate the effectiveness of risperidone in comparison to clozapine in everyday practice and to assess the feasibility of a pragmatic trial procedure .\n",
            "@ .\n",
            "Patients were randomly assigned to open-label clozapine or risperidone treatment for @ weeks and treatment outcomes were assessed blindly .\n",
            "Twenty-one patients were recruited and nineteen entered the randomized phase .\n",
            "@ .\n",
            "Five of @ participants allocated to clozapine and one of nine risperidone participants dropped out before study completion .\n",
            "Five clozapine patients and six risperidone patients achieved clinical improvement , defined as a @ % decrease in the Positive and Negative Symptom Scale ( PANSS ) total score .\n",
            "No significant differences between the groups were detected in baseline or endpoint positive or negative symptoms , disease severity , or global or social functioning scores .\n",
            "Patients ' opinion on the drugs did not differ between groups .\n",
            "@ .\n",
            "The findings of the intention-to-treat analysis of this study corroborates previous findings that risperidone may be equally effective as clozapine , and supports the feasibility and need of a multicenter randomized pragmatic trial with sufficient power to detect differences between treatments .\n",
            "Objective : Data from an olanzapine double-blind placebo-controlled trial are presented .\n",
            "Methods : Adolescents @-@ years with schizophrenia received flexible doses of olanzapine @ .\n",
            "@-@mg day or placebo for six weeks .\n",
            "LOCF mean changes from baseline-to-endpoint were assessed from the BPRS-C and CGI-S .\n",
            "Response was defined as a @ ; @ % decrease in BPRS-C and a CGI Severity @ ; @ .\n",
            "Results : One-hundred-seven adolescents with schizophrenia ( olanzapine n = @ , age@ .@ @ ; @ ; placebo n = @ , age@ .@ @ ; @ ) were randomized ( @:@ ) .\n",
            "The mean dose of olanzapine was @ @ ; @ mg/day .\n",
            "Olanzapine-treated patients experienced significant improvements compared with placebo in BPRS-C ( P = .@ ) and CGI-S ( P = .@ ) .\n",
            "The treatment response rate was not significantly different between olanzapine - ( @ % ) and placebo-treated patients ( @ % ) .\n",
            "Treatment-emergent adverse events occurring significantly more often in olanzapine-treated patients included increased weight and somnolence .\n",
            "Olanzapine-treated patients gained significantly more weight ( @ @ ; @ kg vs. @ @ ; @ kg , P @ ; .@ ) .\n",
            "Significantly more olanzapine-treated patients experienced treatment-emergent high AST/SGOT , ALT SGPT prolactin , and low bilirubin , hematocrit at any time during treatment .\n",
            "There was a significant increase at endpoint in fasting triglycerides P. @ ) in olanzapine-treated patients .\n",
            "Conclusions : In adolescents , olanzapine compared with placebo treatment led to significant improvements on several efficacy measures .\n",
            "OBJECTIVE : The effect of smoking on daily doses and plasma levels of neuroleptics prescribed for schizophrenic patients was studied .\n",
            "METHODS : @ outpatients with schizophrenic disorder ( DSM-III-R ) who were on a stable regimen of psychotropic medication and showed a stable clinical state were included in a DOUBLE-blind placebo-controlled trial .\n",
            "Data were collected and blood tests taken at the baseline interview .\n",
            "The plasma levels were obtained for @ patients .\n",
            "RESULTS : Daily neuroleptic doses converted to chlorpromazine equivalents correlated significantly ( r = @ ) with the plasma levels of their unmetabolised fractions .\n",
            "The neuroleptic doses increased with age in smokers , while in nonsmokers they decreased .\n",
            "Neither sex , age nor smoking had a significant association with the neuroleptic plasma levels .\n",
            "CONCLUSIONS : Smoking seems to lead to increased neuroleptic dosages in postmenopausal schizophrenics by increasing hepatic metabolism and renal excretion of the drugs and possibly enhancing dopamine release .\n",
            "It is also possible that older smoking patients form a selected group of heavy smoker and they , therefore , need exceptionally high neuroleptic doses .\n",
            "Compared the efficacy and safety of @ low dosages ( @ , @ , and @ mg ) of haloperidol and thiothixene in @ @-@ yr old schizophrenic outpatients over a @-wk treatment period and @ yrs of after-care .\n",
            "Results show that relatively low doses of both drugs were equally safe and effective for maintenance of schizophrenic outpatients with moderate to moderately severe disturbances .\n",
            "Follow-up data further indicate that there may be a need for a reasonably prolonged period of management so that the anticipation that patients may require short periods of inpatient care is advisable .\n",
            "( @ ref )\n",
            "Background Regular physical activity promotes physical and mental health .\n",
            "Psychiatric patients are prone to a sedentary lifestyle , and accumulating evidence has identified physical activity as a supplemental treatment option .\n",
            "Methods This prospective , randomized , crossover study evaluated the effects of hiking in high-risk suicidal patients ( n = @ ) who performed @ weeks of hiking ( @-@ hikes/week , @-@ hours each ) and a @-week control period .\n",
            "Results All patients participated in the required @ hikes per week and thus showed a compliance of @ % .\n",
            "Regular hiking led to significant improvement in maximal exercise capacity ( hiking period : +@ + / - @ watt , P < .@ ; control period : P = .@ ) and in aerobic capability at @ % of the individual heart rate reserve ( hiking period : +@ + / - @ watt ; P = .@ ; control period : P = .@ ) .\n",
            "Cytokines , associated previously with suicidality ( tumor necrosis factor-alpha , interleukin-@ , S@ ) , remained essentially unchanged .\n",
            "Conclusions Hiking is an effective and safe form of exercise training even in high-risk suicidal patients .\n",
            "It leads to a significant improvement in maximal exercise capacity and aerobic capability without concomitant deterioration of markers of suicidality .\n",
            "Offering this popular mode of exercise to these patients might help them to adopt a physically more active lifestyle .\n",
            "BACKGROUND : Psychotic disorders affect up to @ % of the population and are often chronic and disabling .\n",
            "Innovation in the pharmacological treatment of psychosis has remained stagnant in recent decades .\n",
            "In order to improve outcomes for those with psychotic disorders , we present a protocol for the trial of a common food preservative , sodium benzoate , as an adjunctive treatment in early psychosis .\n",
            "METHODS : Persons experiencing early psychosis ( n = @ ) will be recruited through hospitals and community mental health services in Queensland , Australia .\n",
            "Patients will be randomized to receive either @-week treatment with @ mg ( @ mg twice daily ( BD ) ) sodium benzoate or placebo .\n",
            "Patients will undergo fortnightly outcome assessments , in addition to weekly ongoing capacity to consent , drug compliance and safety assessments .\n",
            "The primary outcome measure is the Positive and Negative Syndrome Scale ( PANSS ) total score .\n",
            "Secondary outcomes are Global Assessment of Function ( GAF ) , Assessment of Quality of Life Scale ( AQOL ) , the Activity and Participation Questionnaire ( APQ@ ) , International Physical Activity Questionnaires ( IPAQ ) , Simple Physical Activity Questionnaire ( SIMPAQ ) , Physical Activity Questionnaire , Clinical Global Impression ( CGI ) , Hamilton Depression rating Scale-@ items ( HDRS ) , Opiate Treatment Index ( OTI ) and the Patients ' Global Impression of Improvement ( PGI-I ) .\n",
            "As a tertiary objective , changes from baseline to endpoint in to serum markers related to D-alanine , L-alanine , D-serine , L-serine , glycine and glutamate will be investigated .\n",
            "DISCUSSION : Consumers and clinicians are keen to help develop better treatments for those with psychosis .\n",
            "This study , part of the wider Cadence clinical trials platform will examine if a safe and accessible food preservative can help optimize outcomes in those with psychosis .\n",
            "TRIAL REGISTRATION : Australian New Zealand Clinical Trials registry ( ANZCTR ) , ACTRN@ .\n",
            "Registered on @ February @ .\n",
            "This study examined the efficacy of an integrative cognitive remediation program ( REHACOP ) in improving cognition and functional outcome in patients with schizophrenia .\n",
            "The program combines cognitive remediation , social cognitive intervention , and functional skills training .\n",
            "Few studies have attempted this approach .\n",
            "One hundred and eleven patients diagnosed with schizophrenia were randomly assigned to either the cognitive remediation group ( REHACOP ) or an active control group ( occupational activities ) for @ months ( three sessions per week , @ min ) .\n",
            "Primary outcomes were change on general neurocognitive performance and social cognition , including theory of mind ( ToM ) , emotion perception ( EP ) , attributional style , and social perception ( SP ) .\n",
            "Secondary outcomes included changes on clinical symptoms ( Positive and Negative Syndrome Scale ) and functional outcome ( UCSD Performance-Based Skills Assessment and the Global Assessment of Functioning ) .\n",
            "The trial was registered with clinicaltrials.gov ( NCT@ ) .\n",
            "No baseline group differences were found .\n",
            "Significant differences were found in the mean change between the REHACOP group and control group in neurocognition ( [ Formula : see text ] ) , SP ( [ Formula : see text ] ) , ToM ( [ Formula : see text ] ) , EP ( [ Formula : see text ] ) , negative symptoms ( [ Formula : see text ] ) , emotional distress ( [ Formula : see text ] ) , Global Assessment of Functioning ( [ Formula : see text ] ) , and UCSD Performance-Based Skills Assessment ( [ Formula : see text ] ) .\n",
            "The combination of cognitive remediation , social cognitive intervention , and functional skills training demonstrated statistically significant and clinically meaningful changes in neurocognition , social cognition , negative , and functional disability .\n",
            "This paper presents the results from the application of a serious game called Stigma-Stop among a group of high school students with the aim of reducing the stigma toward mental illnesses .\n",
            "The video game features characters with various mental disorders ( schizophrenia , depression , bipolar disorder , and panic disorder with agoraphobia ) and provides information about these problems .\n",
            "Additionally , the game asks players about whether they have ever felt the same as the characters , if they believe the characters are psychologically well , and if they think they could help these individuals .\n",
            "Similarly , a variety of reactions are provided for players to choose from when they encounter the characters with these problems .\n",
            "A total of @ students between the ages of @ and @ participated in the study , and they were randomly assigned to either the experimental group , which used Stigma-Stop , or the control group , which utilized a video game completely unrelated to mental health .\n",
            "Both video games were used for similar lengths of time .\n",
            "Following the application of Stigma-Stop , a statistically significant decrease was obtained in levels of stigma toward schizophrenia , both in terms of stereotypes and , to a greater extent , its potential dangerousness .\n",
            "However , this was not the case in the control group .\n",
            "Results thus demonstrate the video game 's usefulness toward eradicating erroneous notions about serious mental disorders like schizophrenia .\n",
            "Women diagnosed with a serious mental illness ( SMI ) experience co-morbid medical problems due to multiple factors .\n",
            "Additionally , they frequently experience inadequate planning and delivery of medical services .\n",
            "This is a mixed-methods research study examining the health related quality of life ( HRQOL ) and pathways to healthcare for women with a SMI .\n",
            "The first component of this research is a secondary data analysis of @ adult women with a SMI who were recruited for a randomized controlled trial ( RCT ) and assessed at baseline .\n",
            "Determinants of physical HRQOL include income , housing , diagnosis of major depression , and chronic health conditions .\n",
            "Determinants of mental HRQOL include income and diagnosis of major depression .\n",
            "Findings suggest that improving HRQOL in this population will require addressing nonmedical domains in the lives of women with a SMI , such as income , housing , and symptoms of depression .\n",
            "The second component of this research is a qualitative study with a sub-sample of @ women diagnosed with a SMI , recruited from participants in the RCT .\n",
            "A complicated cycle of social disadvantage is evident among these women 's lives .\n",
            "Salient themes of their stories include experiencing loss , isolation , and a sense of a lack of control .\n",
            "Additionally , this study highlights how a variety of nonmedical factors influence women 's introduction to and engagement with the healthcare system .\n",
            "Findings indicate that support from mental health providers is an influential factor for women 's access and utilization of healthcare services .\n",
            "Social support from nonmedical entities such as religious communities , family , and friends is also a major determinant of women 's engagement with the healthcare system .\n",
            "This research provides a deeper understanding of the nonmedical factors that impact the health of women with a SMI .\n",
            "Specifically , income , housing , and social support emerged as important factors .\n",
            "Ultimately , public health policy needs to acknowledge the larger social context of the lives of women with a SMI to facilitate their engagement in the healthcare system .\n",
            "Gaining additional knowledge about the structural and social components of the lives of women with a SMI may result in effective health promotion strategies that enhance healthcare utilization via changes in women 's behavior and/or in the larger healthcare system .\n",
            "Administered the serotonin ( @-hydroxytryptamine ( @-HT ) ) blocking drug cyproheptadine or placebo to @ inpatients with chronic schizophrenia .\n",
            "No evidence was found that cyproheptadine improved negative symptoms of schizophrenia better than placebo .\n",
            "The cyproheptadine-related increase in suspiciousness and uncooperativeness is consistent with evidence implicating serotinergic systems in aggression and impulse control .\n",
            "Clozapine is an atypical antipsychotic drug with reduced risk of unwanted neurological effects in comparison with other drugs .\n",
            "In this multicenter study , @ hospitalized schizophrenic patients were randomly assigned to treatment under double-blind conditions to assess the antipsychotic efficacy and safety of clozapine versus chlorpromazine .\n",
            "All patients exhibited tardive dyskinesia or other extrapyramidal side effects associated with at least two prior neuroleptics .\n",
            "Eleven patients were dropped from treatment due to extrapyramidal symptoms while being treated with chlorpromazine ; only one clozapine patient 's treatment was terminated for this reason .\n",
            "Clozapine patients exhibited clinical improvement superior to that of chlorpromazine patients as assessed by the Brief Psychiatric Rating and Clinical Global Impression scales .\n",
            "These results suggest that clozapine is well tolerated and may be therapeutically superior to chlorpromazine in treating psychotic behavior .\n",
            "Agranulocytosis potential can be minimized by frequent white blood cell counts and removing nonresponding patients from treatment prior to the peak risk period ( months @ through @ ) .\n",
            "Presents a report on a randomized controlled trial of a compliance therapy intervention based on motivational interviewing principles including inductive questioning , reflective listening , regular summarizing , avoidance of blaming , and the reinforcement of adaptive attitudes and behaviors .\n",
            "Previous research focusing on cognitive interventions in psychosis and systematically tested psychoeducational approaches to compliance are reviewed .\n",
            "The contents of this new intervention is described with examples of the principle techniques used , together with a description of the progress of therapy in two case examples with a female @-yr-old and a male @-yr-old with schizophrenia .\n",
            "The present approach is explained as differing from other cognitive-behavioral treatments in that the Ss composed an acute , unselected , mixed psychotic sample ; and the focus was specifically on enhanced insight and adherence to treatment .\n",
            "Objective : To investigate the health education and behavior supervision of hospitalized patients with chronic schizophrenia .\n",
            "Methods : The patients enrolled according to the course of the disease and the age ratio of @ : @ block randomized randomly divided into experimental and control groups , supervision of health education and behavior for a period of eight weeks of the experimental group patients , nurses with inpatient observation Scale ( NOSIE ) score twice to observe the changes in condition .\n",
            "Results : no significant difference in addition to the the psychotic performance scores of health education and behavior before and after the Steering , the other factor scores and the total negative total positive and the condition total estimated score showed a significant difference ( t = @ @ to t = @ @ @ , P < @ @ @ ~ P < @ @ @ @ ) .\n",
            "Conclusion : We should actively carry out the supervision of a health education and behavior , to improve the patient 's social adaptability .\n",
            "Objective : This study compared the efficacy and safety of four strategies for switching patients from conventional antipsychotics ( APDs ) or risperidone to olanzapine .\n",
            "Method : In this study , @ outpatients with a diagnosis of schizophrenia or schizoaffective disorder who were clinically stable while being treated with a conventional APD or risperidone were openly randomised to either abrupt discontinuation or graduated withdrawal of their prior APD .\n",
            "Patients were further randomised in a double-blind fashion to : a ) olanzapine @ mg QD for @ weeks ; or b ) a sequence of one week each on placebo , olanzapine @ mg QD , and olanzapine @ mg QD .\n",
            "The efficacy of these @ switching paradigms was assessed using the CGI scale , PGI scale , and PANSS .\n",
            "Safety assessments included ratings for EPS , cognitive impairment , and adverse events .\n",
            "Results and Conclusions : Gradual APD discontinuation combined with full dose olanzapine @ mg had the greatest efficacy and tolerability evident as early as week @ .\n",
            "None of the @ switching paradigms was associated with overall clinical worsening .\n",
            "These data suggest that stable outpatients can be switched to olanzapine , if indicated , without experiencing an increased vulnerability to relapse or to occurrence of APD withdrawal symptoms .\n",
            "Schizophrenia and other Psychotic Disorders\n",
            "Objective To compare the clinical efficacy safety and the effect on congnitive function of ziprasidone and risperidone in the treatment of schizophrenia .\n",
            "Methods Sixty - three patientswith schizophrenia were randomly assigned to two groups , study group treated with ziprasidone ( n = @ ) and control group with risperdone ( n = @ ) for @ weeks .\n",
            "The positive and negative symptoms scale ( PANSS ) , Wechslermemery scale ( WMS - RC ) and TESS were used to evalute the effects and side effects before and after the treatment .\n",
            "Results After @ weeks treatment the marked imp rovement rate was @ % and effective rate was @ % in ziprasidone group , while @ % and @ % in risperdone group , and there were no significant differences between two groups .\n",
            "The short - memory , immediate memory and memory quotients ofWMS - RC increased significantly after treatment in both groups and no difference inWMS - RS was found between them .\n",
            "The incidence of adver effects in two groups had no significant difference and the side effects of both groups were less .\n",
            "Conclusion Ziprasidone is as effective as risperidone for the treatment of schizophrenia and has good compliance .\n",
            "It can improve the cognitive function in schizophrenia patients\n",
            "Background : Risperidone long-acting injectable was previously approved for treatment of schizophrenia as biweekly injections in the gluteal muscle only .\n",
            "We present data on local injection-site tolerability and safety of risperidone long-acting injectable and comparability of systemic exposure of deltoid versus gluteal injections .\n",
            "Methods : Risperidone long-acting injectable was administered in an open-label , single-dose , two-way crossover study , with patients randomized to receive either @ mg gluteal/@ .@ mg deltoid crossover in two treatment periods or @ mg gluteal/@mg deltoid injections crossover ; each treatment period was separated by an @-day observation period ( Study @ ) and an open-label , multiple-dose study ( @ sequential @ mg or @ mg deltoid injections every @ weeks ) ( Study @ ) .\n",
            "The pharmacokinetic results from both the studies have already been published .\n",
            "Results : In Study @ ( n = @ ) , the majority of patients had no local injection-site findings , based on investigator and patient-rated evaluations .\n",
            "In Study @ ( n = @ ) , seven of the @ patients who received at least two deltoid injections discontinued ( primary endpoint ) .\n",
            "However , none of the discontinuations were due to injection-site related reasons .\n",
            "The @-percent upper confidence limit of the true proportion of injection-site issue withdrawals was @ percent .\n",
            "No moderate or severe injection-site reactions were reported .\n",
            "Conclusion : Intramuscular injections via the deltoid and gluteal sites are equivalent routes of administration of risperidone long-acting injectable with respect to local injection-site tolerability .\n",
            "The overall safety and tolerability profile of risperidone long-acting injectable was comparable when administered as an intramuscular injection in the deltoid ( @ mg and @ mg ) and gluteal ( @ mg and @ mg ) sites .\n",
            "( PsycINFO Database Record ( c ) @ APA , all rights reserved ) ( journal abstract )\n",
            "\" OBJECTIVE : Patients suffering from psychosis are more likely than the general population to commit aggressive acts , but the therapeutics of aggressive behavior are still a matter of debate .\n",
            "METHODS : This pilot randomized , open-label study compared the efficacy of quetiapine versus olanzapine in reducing impulsive and aggressive behaviors ( primary endpoints ) and psychotic symptoms ( secondary endpoints ) from baseline to days @ , @ , @ , @ , @ , @ , and @ , in @ violent schizophrenic patients hospitalized in a maximum-security psychiatric hospital .\n",
            "RESULTS : Quetiapine ( @ + / -@ mg ) and olanzapine ( @ + / -@ mg ) were both efficacious in reducing Impulsivity Rating Scale from baseline to day @ .\n",
            "In addition , both treatments reduced the Brief Psychiatric Rating Scale , Positive and Negative Syndrome Scale , and Clinical Global Impression Scale scores at day @ compared to baseline , and no differences were observed between treatments .\n",
            "Moreover , quetiapine , but not olanzapine , yielded an improvement of depressive symptoms in the items \" \" depression \" \" in Brief Psychiatric Rating Scale and \" \" blunted affect \" \" in Positive and Negative Syndrome Scale .\n",
            "Modified Overt Aggression Scale scores were also decreased from baseline to the endpoint , but due to the limited number of patients , it was not possible to detect a significant difference .\n",
            "CONCLUSION : In this pilot study , quetiapine and olanzapine equally decreased impulsive and psychotic symptoms after @ weeks of treatment .\n",
            "Double-blind , large studies are needed to confirm the validity of these two treatments in highly aggressive and violent schizophrenic patients . \"\n",
            "Purpose - The purpose of this study is to demonstrate superior efficacy of sustained release quetiapine compared to placebo in patients with schizophrenia after receiving treatment for up to @ weeks .\n",
            "Primary Outcome Measures - Change from baseline of the Positive and Negative Syndrome Scale ( PANSS ) total score at the end of treatment .\n",
            "Secondary Outcome Measures - Evaluation of secondary PANSS efficacy variables and Clinical Global Impression ( CGI ) variables at all study visits compared to baseline .\n",
            "Total Enrollment - @ Study start - June @ Eligibility - Ages Eligible for Study - @ Years - @ Years , Genders Eligible for Study - Both Criteria Inclusion Criteria - Patient is able to provide written informed consent before beginning any study related procedures Patient has a documented clinical diagnosis of schizophrenia Patient is able to understand and comply with the requirements of the study , as judged by a study investigator Exclusion Criteria - Patients with a history of non-compliance as judged by the study investigator Patients with a known lack of response to previous treatment with quetiapine Patients who have participated in another drug study within @ weeks prior to enrollment into this study Patients who have previously participated in this study\n",
            "Trial purpose : The purpose of the study is to estimate drug preference of stable schizophrenic patients who will be treated with olanzapine orodispersible tablets for @ weeks then with olanzapine tablets for @ weeks and vice-versa .\n",
            "Primary outcome measure : patient preference measured by a simple preference question .\n",
            "Secondary outcome measure : better treatment adherence as measured by DAI-@ .\n",
            "Safety and tolerability as measured by AMDP-@ .\n",
            "Determine the predictors of drug compliance .\n",
            "Mean change from baseline to endpoint in body mass index ( BMI ) .\n",
            "Compare serum ghrelin levels .\n",
            "Differences in subjective appetite from baseline to endpoint using a visual analog scale ( VAS ) .\n",
            "Effect on the medication compliance , level of medication supervision , and willingness to remain on medication , as measured by Medication Adherence Form ( MAF ) .\n",
            "Patient preference of the paranoid sub population as measured by a simple preference question .\n",
            "Inclusion criteria : You are an outpatient diagnosed with stable schizophrenia .\n",
            "You are a male or female in the age of @ to @ years old .\n",
            "You are retrospectively judged by investigators , based on clinical interview and impression , to have been stable for at least @ weeks .\n",
            "You must be able to take olanzapine orodispersible in a single daily dose .\n",
            "You are treated with conventional oral olanzapine tablet ( as monotherapy ) for at least @ month .\n",
            "Exclusion Criteria : You have used olanzapine in the past and are no longer using it because of a bad reaction .\n",
            "You have known Human immunodeficiency virus positive ( HIV + ) status .\n",
            "You have known uncorrected , narrow angle glaucoma .\n",
            "You have known Leukopenia , ( abnormally low white blood cell count ) .\n",
            "You have a serious or uncontrolled illness ( for example : liver disease , history of heart disease , or inadequately controlled diabetes . )\n",
            "You have Parkinson 's disease .\n",
            "You are a female patient who is either pregnant or nursing You are taking medications that are not allowed in the study Expected total enrollment : @ .\n",
            "Participant eligibility : Ages eligible for study : @ years - @ years .\n",
            "Genders eligible for study : both .\n",
            "Context : Yoga therapy has been demonstrated to be useful in treatment of negative symptoms and improving the socio-occupational functioning and emotion recognition deficits in antipsychotic-stabilized schizophrenia patients .\n",
            "Oxytocin has been recently implicated in social cognition deficits in schizophrenia .\n",
            "The effect of yoga therapy on oxytocin levels in schizophrenia has not been studied .\n",
            "Aims : This study aimed to assess the effect of yoga therapy on symptoms , socio-occupational functioning , facial emotion recognition deficits and plasma oxytocin levels in antipsychotic stabilized schizophrenia patients .\n",
            "Settings and Design : Randomized controlled study on @ consenting , medication stabilized patients with schizophrenia in a tertiary psychiatric center using yoga intervention and waitlisted groups .\n",
            "Materials and Methods : A total of @ schizophrenia patients were randomized to yoga group ( n = @ ) or waitlist group ( n = @ ) .\n",
            "Patients in the yoga group received training in a specific yoga therapy module for schizophrenia .\n",
            "Patients in both groups were continued on stable antipsychotic medication .\n",
            "Assessments included scale for assessment of positive symptoms , scale for assessment of negative symptoms , socio-occupational functioning scale and tool for recognition of emotions in neuropsychiatric disorders ( TRENDS ) and plasma oxytocin levels ; performed at baseline and at the end of @ month .\n",
            "Results : A total of @ patients in the yoga group and @ in waitlist group completed the study .\n",
            "The yoga therapy group showed a significant improvement in socio-occupational functioning , performance on TRENDS ( P < @ ) and plasma increase in oxytocin levels ( P = @ ) as compared with the waitlist group .\n",
            "Conclusion : The study supported the role of add-on yoga therapy in management of schizophrenia and demonstrated an improvement in endogenous plasma oxytocin levels in schizophrenia patients receiving yoga therapy .\n",
            "Background : Aripiprazole is an investigational agent for treating schizophrenia that has a novel pharmacologic profile .\n",
            "The present study investigated the efficacy , safety , and tolerability of aripiprazole and haloperidol compared with placebo .\n",
            "Method : A @-week , double-blind , RANDOMized study , conducted at @ U.S. centers between July @ and June @ , compared aripiprazole ( @ mg/day , @ mg/day ) to placebo , with haloperidol ( @ mg/day ) as an active control .\n",
            "Fixed doses of each agent were administered from day @ throughout the study .\n",
            "A total of @ patients with a primary DSM-IV diagnosis of schizophrenia or schizoaffective disorder were RANDOMized .\n",
            "Efficacy measures included the Positive and Negative Syndrome Scale ( PANSS ) total , PANSS positive , PANSS negative , PANSS-derived Brief Psychiatric Rating Scale ( BPRS ) core , Clinical Global Impressions ( CGI ) - Severity of Illness , and mean CGI-Improvement scores .\n",
            "Safety and tolerability evaluations included extrapyramidal symptoms ( EPS ) , weight gain , serum prolactin level , and QTc interval .\n",
            "Results : Both doses of aripiprazole and haloperidol , @ mg , produced statistically significant ( p < = .@ ) improvements from baseline in PANSS total , PANSS positive , PANSS-derived BPRS core , and CGI-Severity scores and significantly lower CGI-Improvement scores at endpoint , compared with placebo .\n",
            "Aripiprazole , @ mg , and haloperidol , @ mg , significantly improved PANSS negative score compared with placebo .\n",
            "Both aripiprazole doses and haloperidol separated from placebo for PANSS total scores at week @ .\n",
            "Unlike haloperidol , aripiprazole was not associated with significant EPS or prolactin elevation at endpoint compared with placebo .\n",
            "There were no statistically significant differences in mean changes in body weight across the treatment groups versus placebo , and no patients receiving aripiprazole experienced clinically significant increases in QTc interval .\n",
            "Conclusion : Aripiprazole , effective against positive and negative symptoms , is a safe and welltolerated potential treatment for schizophrenia and schizoaffective disorder\n",
            "This report includes a statistical analysis of the results of a double BLIND comparative study between sultopride and thioproperazine .\n",
            "Two rating scales were used : the standard B.P.R.S. and a simplified scale including @ items : agitation -- delusion -- thought-disorganization -- anxiety -- aggressivity -- hallucinations -- autism .\n",
            "The comparison of the mean of the global scores obtained with the two rating scales shows a significant difference in activity in favour of sultopride .\n",
            "The analysis of the individual items shows regular modifications in favour of sultopride but these are not statistically significant .\n",
            "There are , also , no differences in the side-effects observed , particularly extra-pyramidal effects .\n",
            "Notes that there is a call for the implementation of outcomes management ( OM ) in mental health services , which involves routinely assessing individual patient outcomes to analyzes the effectiveness of treatment .\n",
            "The most important outcome criterion in mental health service research is quality of life , which is also the ' centerpiece ' of OM .\n",
            "A @-yr-long European multi-center randomized controlled trial is described that tests the effect of concurrent assessment and feedback of outcome data to the clinician and patient in the treatment of psychotic illness .\n",
            "It is hypothesized that the intervention will improve patient outcome by prompting explicit discussion about reasons for progress -- and lack of progress -- in treatment as a basis for further treatment decisions .\n",
            "If the intervention is effective , it is hypothesized that the effect will be mediated by more appropriate treatment decisions and/or a better therapeutic relationship .\n",
            "Focusing on the patient 's perspective in the therapeutic interaction may also facilitate patient involvement in decision-making .\n",
            "Finally , it is suggested that OM could benefit from further specification and development in order to exploit its potential for improving treatment processes in mental health care .\n",
            "A double-blind crossover study on the effects of deanol and lithium carbonate was conducted on a sample of @ chronic schizophrenic patients with tardive dyskinesia .\n",
            "In addition to his usual treatment with different neuroleptics , each patient received during an @-week period either deanol , lithium carbonate or placebo .\n",
            "A @-week wash-out period was inserted between each of the @-week periods of experimental treatment of the tardive dyskinesia .\n",
            "The administration of either deanol , lithium carbonate or placebo added to the neuroleptic treatment did not produce a statistically significant improvement of tardive dyskinesia in our patient population as a whole .\n",
            "Favorable and unfavorable responses are discussed .\n",
            "The main aims are : @ .\n",
            "To identify important concerns for carers of people with schizophrenia , and the degree to which these are acknowledged and incorporated into care plans by the multidisciplinary clinical team ; @ .\n",
            "To determine the extent to which communications between carers of those with schizophrenia and the multidisciplinary team are influenced by the carers ' understanding of aspects of the patient 's disorder and its management ; and @ .\n",
            "To determine whether , in the context of CPA meetings , a simple intervention for carers will provide any added benefits to communications between carers and the multidisciplinary team .\n",
            "Randomised controlled trial .\n",
            "Prior to their initial assessment , eligible families will be randomly allocated to either usual clinical care ( the Control group ) or usual clinical care plus the intervention for carers ( the Intervention group ) .\n",
            "The design will be single-blind - no one in the clinical team will be told to which group a particular family has been assigned .\n",
            "Individuals with schizophrenia demonstrate deficits in divergent thinking .\n",
            "This ability is indispensable for generating creative solutions and navigating the complexities of social interactions .\n",
            "In a pilot study , seventeen stable schizophrenia outpatients were randomly assigned to a training program for divergent thinking or a control program on convergent thinking .\n",
            "After eight weeks of training , participants in the divergent thinking program had significantly greater improvements on measures of idea fluency , negative symptoms , and interpersonal relations than did participants receiving the control program .\n",
            "These preliminary results suggest that interventions for divergent thinking in schizophrenia may lead to improvements in patients ' social functioning .\n",
            "Weight gain induced by antipsychotic drugs is one of the main concerns of antipsychotic therapy .\n",
            "In spite of the growing scientific literature focus on this issue , the independent effect of antipsychotic treatment on weight gain has not been established yet .\n",
            "Factors related with non-random design , previous exposure to antipsychotics and chronic schizophrenic study population are likely source of variability in results .\n",
            "The aim of this study is to assess the weight gain secondary to antipsychotic treatment in a cohort of drug-nave subjects .\n",
            "@ drug-nave first episode psychotic patients were included in a randomized , open label , prospective clinical trial .\n",
            "Patients were randomly assigned to haloperidol , olanzapine or risperidone .\n",
            "The main outcome was the weight gain and BMI change at @ months and at @ year follow-up .\n",
            "The analysis were performed on a per protocol ( PP ) basis as well as according to the intention to treat ( ITT ) basis .\n",
            "ANCOVA analysis was conducted using sex , age and BMI at baseline as covariates .\n",
            "After @ year follow-up @ patients were evaluated ( drop-out rate : @ % ) .\n",
            "Of them , @ % completed the protocol and @ % needed treatment change .\n",
            "Groups differed significantly in anticholinergic concomitant medication .\n",
            "Statistical significant differences in weight gain between treatments were found at @ months .\n",
            "In an ITT analysis the mean weight gain was @ kg for haloperidol , @ kg for risperidone and @ kg for olanzapine group ( F = @ ; p = @ ) .\n",
            "In a PP analysis the mean weight gain was @ kg for haloperidol , @ kg for risperidone and @ kg for olanzapine ( F = @ ; p = @ ) .\n",
            "After @ year follow-up the difference in weight gain had disappeared .\n",
            "In an ITT analysis mean weight gain was @ kg for haloperidol , @ kg for risperidone and @ kg for olanzapine group ( F = @ ; p = @ ) .\n",
            "In a PP analysis the mean weight gain was @ kg for haloperidol , @ kg for risperidone and @ kg for olanzapine ( F = @ ; p = @ ) .\n",
            "The distribution of weight gain in the study population was similar with the three treatments .\n",
            "In summary , drug-nave patients experience an extraordinary weight gain after @ year of treatment with haloperidol , olanzapine or risperidone .\n",
            "There is no difference in weight gain between treatments after @ months .\n",
            "Nevertheless , at @ months the variation in weight gain was very pronounced , which means the main difference among these antipsychotic treatments is the pattern of weight gain but not the final amount of weight gain .\n",
            "We studied @ male SCHIZophrenia patients in a @-week treatment trial comparing two neuroleptics and placebo .\n",
            "Efficacy in regard to negative symptoms was of interest , and Alpha ' Negative Symptom Assessment ( NSA ) was included .\n",
            "The NSA includes behaviorally anchored ratings such as ' prolonged time to response ' and ' restricted speech output . '\n",
            "Audio recordings of interviews with the patients were analyzed acoustically .\n",
            "In general , the behavioral anchors did not prevent the ratings from being influenced by global impressions.There was a strong correlation between each item and the total of other items , but a modest correlation with the relevant behavioral measure .\n",
            "Results suggest that , even with specific and behaviorally anchored items , the clinician 's assessment is confounded by global impressions.Treatment effects were greater for the acoustic measures than for the clinical measures .\n",
            "\" Objective : Alteration of oxidative stress markers has been reported in many studies , but with inconsistent results .\n",
            "Recently evidences show that oxidative stress could be involved in the pathophysiology of schizophrenia .\n",
            "Thus , accumulating evidence indicates that alterations in NO function may be involved in the pathophysiology of schizophrenia and these original findings motivate further investigations of the potential utility of NO modulation as a novel pharmacological treatment for schizophrenia .\n",
            "Objective : The objective of this study was to investigate the benefit of L-lysine , an aminoacid that occurs naturally in food and which interferes with nitric oxide production , as a treatment for schizophrenia .\n",
            "Methods : The study was designed as a duble-blinded , cross-over study where patients were randomly assigned to initial treatment with either L-lysine or placebo and screened at baseline , after four weeks when treatment was crossed over , and after eight weeks , when treatment was terminated .\n",
            "L-lysine , @ g/day , was administered to @ patients with schizophrenia as an add-on treatment to conventional antipsychotic medication .\n",
            "Results : The four-week L-lysine treatment caused a significant increased in blood concentration of the amino .\n",
            "The analysis of outcome measures from the remaining @ patients showed a significant decrease in symptom severity ( measured by PANSS ) .\n",
            "Furthermore , the patient 's ability to solve the Wisconsin Card Sorting Task was significantly improved indicating increased problem solving capacity and cognitive flexibility .\n",
            "Conclusion : These findings suggest potential beneficial effects of nitric oxide inhibitors on symptom severity and cognitive deficits in patients with schizophrenia . \"\n",
            "Objective To investigate the psychological care of patients with chronic schizophrenia , obsessive-compulsive symptoms intervention effect .\n",
            "@ patients with obsessive-compulsive symptoms in patients with chronic schizophrenia were randomly divided into study group ( @ cases ) and control group ( @ cases ) , the study group received a total of six months of psychological care at baseline , after the intervention of the end of March .\n",
            "The end of June after the intervention application Yale - Brown Obsessive Compulsive Scale ( y-bocs ) , the Hamilton Anxiety Scale ( hama ) to assess the clinical .\n",
            "Results after the intervention of the end of June , the study group and the control group the y-bocs score well hama score than before the intervention were significantly lower ( p < @ ) .\n",
            "After the intervention the end of March , the end of June , the intervention group the y-bocs ratings and hama ratings are significantly lower than the control group , and the differences were statistically significant ( p < @ ) .\n",
            "Conclusion psychological care can effectively improve the chronic schizophrenia patients with obsessive-compulsive symptoms .\n",
            "The study investigated the non-inferiority of flupentixol compared to risperidone in the treatment of negative symptoms .\n",
            "In addition , the effects of flupentixol on mood and cognitive symptoms were explored .\n",
            "In a randomized , double-blind multicenter study , @ non-acute schizophrenia patients with predominant negative symptoms were treated with a flexible dose of either flupentixol ( @-@ mg/d ) or risperidone ( @-@ mg/d ) for up to @ weeks .\n",
            "In addition to a non-inferiority analysis , a principal component analysis ( PCA ) of the PANSS was performed post hoc .\n",
            "Regarding negative symptoms , flupentixol proved to be non-inferior to risperidone .\n",
            "Both drugs improved depressed mood with effect sizes favoring flupentixol .\n",
            "PCA suggested a five-factor structure .\n",
            "Effect sizes for the cognitive factor were up to @ for flupentixol and up to @ for risperidone .\n",
            "EPS scores were rather low and Parkinsonism improved in both groups , but anticholinergic drugs were prescribed significantly more frequently in the flupentixol group , which generally showed significantly more adverse events .\n",
            "Results indicate that the @st generation antipsychotic flupentixol improves negative , affective and cognitive symptoms in chronic schizophrenia comparable to risperidone .\n",
            "Further studies should confirm the latter using neuropsychological performance tests and should investigate whether tolerability improves with a markedly lower dose range .\n",
            "Alpha@ nicotinic acetylcholine receptor ( alpha@ nAChR ) agonists may be valuable treatments for negative symptoms and cognitive impairment in schizophrenia .\n",
            "Unfortunately , chronic exposure to an agonist may reduce the receptor 's sensitivity .\n",
            "Therefore , we combined CDP-choline , a dietary source of the direct agonist choline , with galantamine , a positive allosteric modulator ( PAM ) of nicotinic acetylcholine receptors , to improve the efficiency of transducing the choline signal and , possibly , preserve the receptor in a sensitive state .\n",
            "We conducted a single-site , double-blind randomized clinical trial comparing galantamine/CDP-choline to placebos in schizophrenia patients with negative symptoms who were receiving second generation antipsychotics .\n",
            "Forty-three subjects received galantamine and CDP-choline or matching placebos for @weeks .\n",
            "The primary outcome measure was the @-item Marder negative-symptoms factor of the Positive and Negative Syndrome Scale ( PANSS ) .\n",
            "Cognition and functioning were also assessed .\n",
            "Trial completion was high ; @ % .\n",
            "There was no significant treatment effect on negative symptoms , other PANSS symptom factors , or the MATRICS Cognitive Consensus Battery .\n",
            "There were significant treatment effects in overall functioning and a test of free verbal recall .\n",
            "Three subjects discontinued treatment in the active treatment group for gastro-intestinal adverse events ( AE ) .\n",
            "The most common AE for galantamine/CDP-choline was abdominal pain ; for placebo it was headache and sweating .\n",
            "Although there was no significant treatment effect on negative symptoms , the direction of effect mirrored the effects on a cognitive measure and overall functioning .\n",
            "Further study of alpha@ nAChR agonist/PAMs is warranted in larger studies that will have greater power .\n",
            "\" OBJECTIVE : This study was conducted to determine whether augmenting supported employment with cognitive remediation can improve vocational outcomes and whether augmentation is more important for participants with lower community functioning .\n",
            "METHODS : In this secondary analysis of data from two related , single-blind , randomized controlled trials , @ participants with schizophrenia or schizoaffective disorder received supported employment or supported employment plus cognitive remediation and were classified into higher or lower community functioning according to a median split of their quality-of-life scores at baseline .\n",
            "Participants received one year of active intervention and follow-up a year later .\n",
            "Primary outcome measures were competitive employment rates and total hours of work .\n",
            "RESULTS : Employment rates over two years for participants with lower community functioning were significantly different for the two conditions ( supported employment = @ % , plus cognitive remediation = @ % , p < .@ ) , whereas participants with higher functioning showed equivalent rates of employment ( @ % versus @ % , ns ) .\n",
            "Among lower-functioning participants , those who received cognitive remediation also worked significantly more hours over two years than those who received supported employment only , but higher-functioning participants worked similar amounts of hours in both conditions .\n",
            "Improvements in cognitive functioning and intrinsic motivation were related to employment outcomes but only for the lower-functioning group in the supported employment plus cognitive remediation condition , suggesting possible mechanisms for the observed effects .\n",
            "CONCLUSIONS : Augmenting supported employment with cognitive remediation may boost vocational outcomes for participants with lower community functioning but may not be necessary for those functioning better in their communities . \"\n",
            "OBJECTIVES : Primary : To compare the efficacy of @ mg per day versus @ mg per day of quetiapine fumarate / in @ drug-nave first-episode psychosis patients .\n",
            "Secondary : To compare the tolerability and safety of @ mg per day versus @ mg per day quetiapine fumarate in @ drug-nave first-episode psychosis patients .\n",
            "METHODS : A naturalistic , randomized , single centre , double-blinded , fixed-dose , four-week comparison study of @ mg versus @ mg quetiapine fumarate per day was performed , investigating the efficacy , tolerability and safety in @ drug-nave first-episode psychosis patients aged @ to @ years ( part I ) .\n",
            "Patients received either @ mg or @ mg quetiapine fumarate per day for a period of four weeks .\n",
            "Patients who completed part I were unblinded and a single blind , naturalistic , flexible dose study ( part II ) was performed .\n",
            "Patients received quetiapine fumarate as prescribed by the treating psychiatrist for an additional @ weeks and during this time the treating psychiatrist could increase the dose as clinically indicated in weekly @ mg steps up to a maximum dose of @ mg quetiapine fumarate per day according to treatment response .\n",
            "Treatment response was assessed naturalistically by the clinician s experience .\n",
            "If no treatment response was achieved at @ mg quetiapine fumarate per day , the dose was maintained over a period of two weeks , and quetiapine fumarate was switched to another atypical antipsychotic .\n",
            "Main outcome measures were symptomatic change , functioning and tolerability measures .\n",
            "Data was collected from July @ until January @ .\n",
            "RESULTS : The estimated time trends of the linear mixed effects modelling indicate that efficacy between the two treatment groups is similar for most outcome measures except for five measures : SANS Anhedonia-Asociality Subscale ( p = @ ) , SOFAS ( p = @ ) , GAF ( p = @ ) , Affective Flattening or Blunting Subscale ( p = @ ) , and UKU Total ( p = @ ) suggesting that the @ mg group improves more for the SANS Anhedonia-Asociality Subscale , whereas the @ mg group shows a slight deterioration .\n",
            "Social and global functioning also improve more in the @ mg group than the @ mg group .\n",
            "Part II of the study revealed that independent of the initial target dose , when clinicians were able to adjust the dose flexibly , the dose at @ weeks was similar and averaged @ mg per day .\n",
            "OBJECTIVE : Studies show a high potential demand for psychiatric advance directives but low completion rates .\n",
            "The authors conducted a randomized study of a structured , manualized intervention to facilitate completion of psychiatric advance directives .\n",
            "METHOD : A total of @ patients with severe mental illness were randomly assigned to a facilitated psychiatric advance directive session or a control group that received written information about psychiatric advance directives and referral to resources in the public mental health system .\n",
            "Completion of an advance directive , its structure and content , and its short-term effects on working alliance and treatment satisfaction were recorded .\n",
            "RESULTS : Sixty-one percent of participants in the facilitated session completed an advance directive or authorized a proxy decision maker , compared with only @ % of control group participants .\n",
            "Psychiatrists rated the advance directives as highly consistent with standards of community practice .\n",
            "Most participants used the advance directive to refuse some medications and to express preferences for admission to specific hospitals and not others , although none used an advance directive to refuse all treatment .\n",
            "At @-month follow-up , participants in the facilitated session had a greater working alliance with their clinicians and were more likely than those in the control group to report receiving the mental health services they believed they needed .\n",
            "CONCLUSIONS : The facilitation session is an effective method of helping patients complete psychiatric advance directives and ensuring that the documents contain useful information about patients ' treatment preferences .\n",
            "Achieving the promise of psychiatric advance directives may require system-level policies to embed facilitation of these instruments in usual-care care settings .\n",
            "Objective : To compare the therapeutic effects and adverse reactions of clozapine and risperidone in the treatment of patients with schizophrenia .\n",
            "Methods : @ patients who met the CCMD-@ diagnostic criteria for schizophrenia were randomly divided into @ equal groups , the treatment group and the control group .\n",
            "Patients of the treatment group were given each an initial dose of @ mg  d-@ of clozapine PO .\n",
            "The dose was increased progressively to @ - @ mg  -@ in @ weeks .\n",
            "Patients of the control group\n",
            "Comments on an article by M. Berk et al. ( see record @-@-@ ) .\n",
            "The authors ' article is about the efficacy of N-acetyl cysteine ( NAC ) , a precursor of the antioxidant glutathione ( GSH ) , in patients with chronic schizophrenia .\n",
            "The findings provide genetic and functional evidence that an impaired capacity to synthesize GSH under conditions of oxidative stress is a vulnerability factor for schizophrenia .\n",
            "In conclusion , these findings suggest that oxidative stress associated with impaired GSH metabolism might be involved in the pathophysiology of schizophrenia and that NAC would be a promising novel therapeutic drug for schizophrenia .\n",
            "In the future , it will be of great interest to study whether NAC supplementation can increase GSH brain levels and lead to corresponding clinical improvement in schizophrenia patients .\n",
            "This study aimed to demonstrate efficacy of once-daily extended release quetiapine fumarate ( quetiapine XR ) versus placebo in patients with acute schizophrenia .\n",
            "In this @-week , randomized , double-blind study ( @IL/@ ) patients were randomized to receive quetiapine XR ( @ , @ , or @ mg/day ) , quetiapine fumarate immediate release ( quetiapine IR ) [ @ or @ mg/day ] , or placebo .\n",
            "Primary endpoint was change from baseline in the Positive and Negative Syndrome Scale ( PANSS ) total score at Day @ .\n",
            "Secondary variables included PANSS response rate at Day @ ( > / = @ % decrease in PANSS total score from baseline ) and Clinical Global Impressions Severity ( CGI-S ) and Improvement ( CGI-I ) ratings .\n",
            "Safety assessments included adverse event ( AE ) reporting and laboratory measures .\n",
            "Of @ patients randomized , @ ( @ % ) completed the study .\n",
            "Improvements in PANSS total scores from baseline to Day @ across treatment groups were : quetiapine XR @ mg/day -@ , @ mg/day -@ and @ mg/day -@ , quetiapine IR @ mg/day -@ and @ mg/day -@ , and placebo -@ ; the difference in change was statistically significant only for quetiapine XR @ mg/day ( p = @ ) .\n",
            "There were no statistically significant differences between active treatment groups and placebo for PANSS response rates .\n",
            "Several post hoc analyses were conducted to explain the study efficacy outcome but these were inconclusive .\n",
            "Quetiapine XR was generally well tolerated with the majority of AEs being mild or moderate in intensity and no unexpected AEs .\n",
            "Superior efficacy of quetiapine XR versus placebo in patients with schizophrenia was demonstrated for quetiapine XR @ mg/day .\n",
            "The safety and tolerability profile of quetiapine XR was similar to that of quetiapine IR .\n",
            "AIM : The current study aimed to investigate beliefs about help-seeking , treatment options and expected outcomes for people with alcohol abuse , dementia , depression , obsessive-compulsive disorder and schizophrenia , using a vignette-based approach , among a sample of nursing and medical students .\n",
            "METHODS : This was a cross-sectional online study among medical and nursing students ( n = @ ) who were randomly assigned @ of @ vignettes .\n",
            "Questions were asked about whom could best help the person in the vignette , the likely helpfulness of a broad range of interventions , and the likely outcome for the person in the vignette with and without appropriate help .\n",
            "RESULTS : A total of @ % of students recommended seeing a psychiatrist , which was the most common source of help reported for all @ vignettes .\n",
            "Help-seeking preferences were significantly associated with age , academic year and vignette type .\n",
            "Respondents rated seeing a psychiatrist as the most helpful intervention ( @ % ) and dealing with the problem on their own as the most harmful ( @ % ) .\n",
            "Then , @ % of students indicated that the condition of the person in the vignette would worsen if appropriate help was not sought .\n",
            "CONCLUSION : Medical and nursing students most commonly recommended seeking help from a psychiatrist for mental health-related problems , where help-seeking preferences were associated with various age , academic year and vignette type .\n",
            "As these students will be the future medical and nursing workforce , they need to be equipped with the skills and ability to recognize signs and symptoms of mental illness , to aid timely and appropriate treatment for people with mental illness .\n",
            "Many drugs have been associated with QTc prolongation and , in some cases , this is augmented by concomitant administration with metabolic inhibitors .\n",
            "The effects of @ antipsychotics on the QTc interval at and around the time of estimated peak plasma/serum concentrations in the absence and presence of metabolic inhibition were characterized in a prospective , randomized study in which patients with psychotic disorders reached steady-state on either haloperidol @ mg/d ( n = @ ) , thioridazine @ mg/d ( n = @ ) , ziprasidone @ mg/d ( n = @ ) , quetiapine @ mg/d ( n = @ ) , olanzapine @ mg/d ( n = @ ) , or risperidone @-@ mg/d increased to @ mg/d ( n = @/@ ) .\n",
            "Electrocardiograms ( ECGs ) were done at estimated C <inf> max </inf> at steady-state on both antipsychotic monotherapy and after concomitant administration of appropriate cytochrome P-@ ( CYP@ ) inhibitor ( s ) .\n",
            "Mean QTc intervals did not exceed @ milliseconds in any patient taking any of the antipsychotics studied , in the absence or presence of metabolic inhibition .\n",
            "The mean QTc interval change was greatest in the thioridazine group , both in the presence and absence of metabolic inhibition .\n",
            "The presence of metabolic inhibition did not significantly augment QTc prolongation associated with any agent .\n",
            "Each of the antipsychotics studied was associated with measurable QTc prolongation at steady-state peak plasma concentrations , which was not augmented by metabolic inhibition .\n",
            "The theoretical risk of cardiotoxicity associated with QTc prolongation should be balanced against the substantial clinical benefits associated with atypical antipsychotics and the likelihood of other toxicities\n",
            "Rationale : D-Cycloserine , a partial agonist at the glycine site of the N-methyl-d-aspartate receptor , has demonstrated inconsistent efficacy for negative and cognitive symptoms of schizophrenia .\n",
            "The strongest evidence for efficacy has come from studies using d-cycloserine at a dose of @ mg/day added to conventional antipsychotics in trials of @ weeks duration or less .\n",
            "Objective : To assess the efficacy for negative symptoms and cognitive impairment of d-cycloserine augmentation of conventional antipsychotics in a @-month trial .\n",
            "Methods : Fifty-five schizophrenia patients with prominent negative symptoms , treated with conventional antipsychotics , were randomly assigned to treatment with D-cycloserine @ mg/day or placebo for @ months in a double-blind , parallel group design .\n",
            "Results : Twenty-six subjects completed the @-month trial ; drop-out rates did not differ between treatment groups .\n",
            "D-Cycloserine treatment did not differ from placebo treatment on any primary outcome measure at @ or @ weeks , including response of negative symptoms and performance on a cognitive battery .\n",
            "Serum D-cycloserine concentrations did not correlate with response of negative symptoms .\n",
            "Conclusion : D-Cycloserine did not exhibit therapeutic effects in this trial , possibly reflecting the high drop-out rate , a narrow range of therapeutic serum concentrations , a modest magnitude of therapeutic effect for the selected outcome measures , or loss of efficacy over time .\n",
            "Because D-cycloserine is a partial agonist with relatively low affinity for the glycine site , the magnitude of potential therapeutic effect may be smaller than that achieved by the higher-affinity full agonists , glycine and d-serine .\n",
            "Chlorpromazine combined with lithium in treatment refractory schizophrenia randomized double-blind crossover study , Wang Qiang , Yuan wind , Ellie , Yinding Fu , Xiaoying Guang has been reported that antipsychotic with lithium salt treatment of refractory schizophrenia is worthy of study .\n",
            "When in November @ - January @ @ cases of refractory schizophrenia hospitalized randomized double-blind crossover study , diagnosis , comply with the provisions of CCMD-@ , duration of more than five years , at least after two hospital system in the treatment , the use of two types of chemical structure , sufficient quantities of adequate course of antipsychotic treatment had no significant effect , the social function never recovered , the total scores of BPRS-R score > @ points , and the concept of disorder , suspicion , hallucinations and unusual thought content ten symptoms in at least two scale score of @ points .\n",
            "Previous studies have variably reported the efficacy of apomorphine in treatment of schizophrenia and tardive dyskinesia .\n",
            "Stimulation of dopamine neuron autoreceptors is the presumed mode of action .\n",
            "Low-dose apomorphine ( @ mg subcutaneously ) and placebo were administered to @ male schizophrenics to evaluate the drug 's effect on psychotic and tardive dyskinetic symptoms .\n",
            "No significant improvement or deterioration was seen .\n",
            "Concomitant measurements of plasma prolactin and growth hormone levels and CSF homovanillic acid level indicated that the dose used was centrally active .\n",
            "These results indicate that an active though nonsedating dose of apomorphine does not ameliorate symptoms of schizophrenia or tardive dyskinesia .\n",
            "Background : Early intervention at the beginning of schizophrenia and related psychotic disorders can get better treatment response .\n",
            "Once symptoms subsided , the majority of patients wish to discontinue medications , yet currently the mainstream opinions still recommend maintenance antipsychotic therapy because non-adherence to medication is the most significant risk factor to predict a relapse .\n",
            "However , recent longitudinal studies assessing patients in community for a longer term found that discontinuation of antipsychotics might not necessarily be parallel to poorer functioning .\n",
            "Also there are studies suggesting a lower percentage of dopamine occupancy by antipsychotic is acceptable in stable patients with psychosis .\n",
            "To elucidate such discrepancies , a hypothetical compromised approach \" guided dose reduction , but not aiming at discontinuation \" was proposed and an observational clinical trial was initiated since July @ .\n",
            "Methods : Outpatients with schizophrenia-related psychotic disorders under remitted states will be recruited and randomized into guided dose reduction group ( GDR , target n = @ ) and maintenance treatment group ( MTG@ target n = @ ) , and those who eligible to dose reduction yet willing to continue medication will serve as a naturalistic observation group ( MTG@ target n = @ ) .\n",
            "Patients in the GDR will reduce no more than @ % of their current dose of antipsychotics and closely monitored every @ weeks for at least @ weeks before next dose reduction adjustment .\n",
            "Patients of both MTGs receive treatment as usual .\n",
            "All patients will be followed up for at least @ years .\n",
            "The main outcomes of interests are differences in relapse rates , personal social performance , quality of life , drug-related adverse reactions , medication satisfaction , and neurocognitive functioning between groups .\n",
            "Patient 's actual medication status will be monitored by keeping a log and therapeutic drug monitoring on selective antipsychotics .\n",
            "Patient 's demographics and clinical variables will be taken to test whether these variables are related to outcomes during follow-up .\n",
            "Results : Currently @ patients have participated in this study , including @ males and @ females , with a Mean ( SD ) age @ ( @ ) years old .\n",
            "Eleven of them were in GDR group , @ in MTG@ and @ in MTG@ .\n",
            "Their baseline PANSS scores were @ ( @ ) , @ ( @ ) , @ ( @ ) , CGI-S scores were @ ( @ ) , @ ( @ ) , @ ( @ ) , and Personal Social Performance ( PSP ) scores were @ ( @ ) , @ ( @ ) , @ ( @ ) in GDR , MTG@ and MTG@ respectively .\n",
            "So far one patient in the GDR group has resumed her original dose due to suspected early signs of relapse and no further worsening of symptoms noticed , while one patient of the MTG@ withdrew consent due to feeling unnecessary to receive comprehensive follow-up assessments .\n",
            "Most of patients endorsed no significant difference between ordinary dose and reduced dose at present time .\n",
            "Discussion : During the first @ months of this trial , we have not seen any unexpected happening yet .\n",
            "We will continue case recruitment and follow-up to test if the metaphor derived from Cantor 's Set and Sierpinski Triangle can serve a valid model for our dose reduction trial and see if such a slowpaced guided dose reduction approach a feasible solution for the debates between medication discontinuation and maintenance .\n",
            "PSYCHINFO @ @-@ yr old schizophrenics were assigned to ECT/placebo or simulated ECT/chlorpromazine ( @-@ mg ) groups ; @ age-matched depressives were assigned to ECT/placebo or simulated ECT/imipramine ( @-@ mg ) groups .\n",
            "Psychiatric evaluations ( including ratings on the Hamilton Rating Scale for Depression , the Beck Depression Inventory , and the Brief Psychiatric Rating Scale ) were conducted pretreatment and at the end of @ , @ , @ , and @ treatments .\n",
            "A cognitive test battery was administered pretreatment and @ hrs posttreatment .\n",
            "No cognitive deficits were observed in Ss who underwent ECT ; there was significant improvement in Ss ' scores on Koh 's Block-Design Test .\n",
            "This finding supports those of M. Fink ( see PA , Vol @:@ ) and M. Hamilton et al ( PA , Vol @:@ ) .\n",
            "Although they showed no memory impairment on the test battery , @ % of schizophrenics and @ % of the depressives who received ECT subjectively complained of forgetfulness .\n",
            "( @ ref ) / / IMSEAR The aim of present double blind controlled study is to evaluate the effects of ECT in schizoprhenia and depression .\n",
            "@ depressed and @ schizophrenic patients of either sex , in the age group of @ to @ years fulfilling the inclusion and exclusion criteria were taken for study .\n",
            "The psychiatric evaluation were carried out before the treatment , and at the end of @,@ and @ treat - ment Cognitive test battery was administered before the treat - ment and @ hours after the last treatment .\n",
            "No post ECT cogni - tive deficit was observed on the test battery though some patie - nts did complain of forgetfulness subjectively .\n",
            "Effects of co-occurring disorders on work outcomes were explored among individuals with severe mental illness who were participating in a multisite randomized study of supported employment .\n",
            "At seven sites , @ people were randomly assigned to an experimental supported employment program or a control condition and followed for @ years .\n",
            "Multivariate regression analysis examined work outcomes including earnings , hours worked , and competitive employment , as well as whether psychiatric disability was disclosed to coworkers and supervisors .\n",
            "Individuals with any comorbidity had lower earnings and were less likely to work competitively .\n",
            "Those with physical comorbidities had lower earnings , worked fewer hours , and were less likely to work competitively .\n",
            "Disclosure was more likely among those with both cognitive and physical comorbidities , as well as those with learning disabilities .\n",
            "Competitive employment was less likely among those with intellectual disability , visual impair ment , and human immunodeficiency virus/acquired immuno-deficiency syndrome .\n",
            "The experimental condition was positively related to all outcomes except disclosure .\n",
            "The results suggest that , with some exceptions , comorbidities affect employment outcomes , requiring tailored services and supports to promote vocational success .\n",
            "Background and Object : Risperidone is one of novel antipsychotic agents that block the dopamine ( e.g. , D@ ) as well as the serotonin ( e.g. , @HT@ ) families of receptors ( @-@ ) .\n",
            "Pimozide , a diphenylbutylpiperidine neuroleptic which is FDA-approved as a backup treatment for Gilles de la Tourette 's syndrome , has been used abroad for many years as a treatment of schizophrenia and has been reported to be particularly effective in treating monosymptomatic hypochondriacal psychosis and delusional jealousy ( @ ) .\n",
            "We want to compare the efficacy and safety of the two drugs on the treatment of monosymptomatic hypochondriacal psychosis .\n",
            "Subjects and Method : This study was a double blind and controlled study .\n",
            "Patients were randomly assigned to @ weeks ' treatment with @ mg of risperidone or @ mg of pimozide daily .\n",
            "There were @ patients in risperidone group and @ patients in pimozide group .\n",
            "After enrollment in the study , patients discontinued all antipsychotic and antiparkinsonian medications and began a @-week , single blind placebo washout period .\n",
            "The main efficacy variable was the Positive and Negative Syndrome Scale for Schizophrenia , chosen because it gives equal weight to both positive and negative symptoms .\n",
            "Other instruments were the Clinical Global Impression scale to determine the patient 's overall status and change from baseline , the Extrapyramidal Symptom Rating Scale to evaluate extrapyramidal symptoms , and the UKU scale to elicit side effects .\n",
            "The patients were assessed in baseline and after @ , @ , @ , and @ week of risperidone or pimozide treatment .\n",
            "Data analysis was performed by using Mann-Whitney U test and chi-square test .\n",
            "Results : Positive symptom scores were significantly lower ( P < @ ) after risperidone and pimozide treatments than the scores before treament .\n",
            "There was no significant difference ( P > @ ) with reference to positive symptom scores between two groups .\n",
            "Negative symptom scores were significantly lower ( P < @ ) after risperidone than pimozide .\n",
            "The incidence of extrapyramidal side effects was significantly higher in patients treated with pimozide than risperidone .\n",
            "Discussion : Thus , it may be suggested that risperidone may be a new , novel alternative to pimozide in the treatment of the cases of monosymptomatic hypochondriacal psychosis ( @ , @ , @ ) .\n",
            "OBJECTS : This large multicentre , double-blind , randomized study was designed to evaluate four doses of sertindole and haloperidol @ mg in the treatment of patients with DSM-III-R schizophrenia .\n",
            "METHOD : @ patients were randomized , of whom @ were included in an intention-to-treat analysis .\n",
            "@ patients completed the study .\n",
            "Patients were randomized to receive sertindole @ mg/day , sertindole @ mg/day , sertindole @ mg/day , sertindole @ mg/day or haloperidol @ mg/day for @days .\n",
            "Efficacy was assessed through the changes in score on the Positive and Negative Syndrome Scale ( PANSS ) , and the Clinical Global Impressions ( CGI ) scale .\n",
            "Improvement in all end-points was observed for all treatment groups .\n",
            "RESULTS : Sertindole @ mg showed significantly greater efficacy against negative symptoms than haloperidol @ mg .\n",
            "The optimal dose of sertindole was @ mg/day .\n",
            "Sertindole @ mg appeared to be suboptimal with respect to efficacy , and increasing the dose of sertindole above @ mg did not appear to offer any additional benefit .\n",
            "Sertindole at all doses caused significantly fewer extrapyramidal symptoms than haloperidol .\n",
            "CONCLUSION : Sertindole is effective against positive and negative symptoms of schizophrenia within the dose range @-@ mg daily , with an optimal starting dose of @ mg daily .\n",
            "Efficacy is comparable to @ mg of haloperidol with no difference in the time course of treatment response .\n",
            "The dose response relationship for efficacy with sertindole seems to plateau at about @ mg daily with no demonstrable difference in increasing doses above this point .\n",
            "OBJECTIVE : Interventions are required to redress the disproportionate tobacco-related health burden experienced by persons with a mental illness .\n",
            "This study aimed to assess the efficacy of a universal smoking cessation intervention initiated within an acute psychiatric inpatient setting and continued post-discharge in reducing smoking prevalence and increasing quitting behaviours .\n",
            "METHOD : A randomised controlled trial was undertaken across four psychiatric inpatient facilities in Australia .\n",
            "Participants ( N = @ ) were randomised to receive either usual care ( n = @ ) or an intervention comprising a brief motivational interview and self-help material while in hospital , followed by a @-month pharmacological and psychosocial intervention ( n = @ ) upon discharge .\n",
            "Primary outcomes assessed at @ and @ months post-discharge were @-day point prevalence and @-month prolonged smoking abstinence .\n",
            "A number of secondary smoking-related outcomes were also assessed .\n",
            "Subgroup analyses were conducted based on psychiatric diagnosis , baseline readiness to quit and nicotine dependence .\n",
            "RESULTS : Seven-day point prevalence abstinence was higher for intervention participants ( @ % ) than controls ( @ % ) at @ months post-discharge ( odds ratio = @ , p = @ ) , but not at @ months ( @ % and @ % , respectively ; odds ratio = @ , p = @ ) .\n",
            "Significant intervention effects were not found on measures of prolonged abstinence at either @ or @ months post-discharge .\n",
            "Differential intervention effects for the primary outcomes were not detected for any subgroups .\n",
            "At both @ and @ months post-discharge , intervention group participants were significantly more likely to smoke fewer cigarettes per day , have reduced cigarette consumption by @ % and to have made at least one quit attempt , relative to controls .\n",
            "CONCLUSIONS : Universal smoking cessation treatment initiated in inpatient psychiatry and continued post-discharge was efficacious in increasing @-day point prevalence smoking cessation rates and related quitting behaviours at @ months post-discharge , with sustained effects on quitting behaviour at @ months .\n",
            "Further research is required to identify strategies for achieving longer term smoking cessation .\n",
            "Objectives : Galantamine is an acetylcholinesterase inhibitor and an allosteric modulator of the alpha @beta @ and alpha @ nicotinic receptors .\n",
            "There are several case reports describing the potential benefits of galantamine for negative symptoms associated with schizophrenia .\n",
            "This secondary analysis describes the effects of galantamine on psychopathology in people with schizophrenia .\n",
            "Methods : Subjects with clinically stable chronic schizophrenia were randomized to adjunctive galantamine ( @ mg/d ) or placebo in a @-week double-blind trial .\n",
            "Symptomatology was assessed with the Brief Psychiatric Rating Scale ( BPRS ) and the Clinical Global Impression Scale .\n",
            "The Scale for the Assessment of Negative Symptoms ( SANS ) was used to measure negative symptoms .\n",
            "Results : Eighty-six patients with Diagnostic and Statistical Manual of Mental Disorders , Fourth Edition diagnosis of schizophrenia or schizoaffective disorder taking a stable dose of antipsychotic medications were randomized to adjunctive treatment with study drug ( galantamine , n = @ ; placebo , n = @ ) ; @ subjects completed the study ( galantamine , n = @ ; placebo , n = @ ) .\n",
            "No significant differences were found on BPRS total score ( P = @ ) or BPRS sub factor scores .\n",
            "Scale for the Assessment of Negative Symptoms total scores also did not decrease significantly ( P = @ ) in either group ; however , galantamine treatment was associated with a greater benefit in the SANS sub factor , alogia ( P = @ ) .\n",
            "Conclusions : The lack of robust significant effects of galantamine on negative , and other symptom domains , may be due to the relatively low baseline level of these symptoms in the tested population .\n",
            "Galantamine may have some benefit on certain negative symptoms , particularly alogia .\n",
            "Studies specifically designed to address the issue of the efficacy of galantamine for negative symptoms are needed to confirm this observation .\n",
            "Outcomes of an integrated inpatient treatment program for persons with serious mental illness and substance use disorders are examined in relationship to five stages of treatment -- stabilization , engagement , persuasion/awareness , active treatment , and relapse prevention .\n",
            "The study used a randomized design with participants assigned to an integrated mental health and substance abuse treatment program or standard psychiatric hospital treatment .\n",
            "At discharge , participants in the integrated treatment program indicated more active engagement in treatment and greater awareness of mental health issues , substance use issues , and the @-step program than those who received standard hospital treatment .\n",
            "Participants in the integrated treatment program also saw their treatment as being more effective and had more motivation to stay healthy and sober .\n",
            "The integrated treatment program was not equally effective at each treatment stage with all participants .\n",
            "The implications of the program 's success overall and at each treatment stage are discussed .\n",
            "@ hospitalised schizophrenics received the triflupromazine , chlorpromazine and the placebo during the @ months ' trial period .\n",
            "The study was run simultaneously in two hospitals .\n",
            "The two active drugs were given in equal amounts .\n",
            "The daily dose was increased each week by @ mg unless severe side effects occurred .\n",
            "The dosage started on @ mg the first week and increased to @ mg .\n",
            "Of the @ patients treated , @ improved on triflupromazine , @ on chlorpromazine and @ on placebo .\n",
            "@ showed side effects on triflupromazine , @ on chlorpromazine and @ on placebo .\n",
            "The results were comparable in the two hospitals .\n",
            "The triflupromazine appeared to have more than twice the potency of chlorpromazine .\n",
            "None of the @ patients improved sufficiently enough to be considered for discharge .\n",
            "It appeard that neither drug , in the dosage given , was sufficiently effective to be included in the routine treatment of the chronic patient .\n",
            "[ Abstract - CSG ]\n",
            "Rationale : Sedation is a common side effect of clozapine treatment and may exacerbate metabolic consequences of poor diet and exercise habits that are common in patients with schizophrenia .\n",
            "Modafinil has been proposed as a treatment for clozapine-induced sedation and metabolic abnormalities .\n",
            "Objective : To estimate the effect sizes and person-to-person variation in anthropometric measures , glucose and lipid metabolism , and diet on modafinil treatment for future randomized control trials .\n",
            "Methods : A double-blind , placebo-controlled , flexible-dosed @-week pilot trial was conducted , adding modafinil up to @ .\n",
            "mg/day to stabilized schizophrenia outpatients receiving clozapine .\n",
            "Blood pressure , weight , BMI , laboratory assays , and dietary intake were tracked to monitor changes in metabolic markers .\n",
            "Results : Thirty-five participants were randomly assigned to treatment with study drug or placebo and were included in the analysis .\n",
            "Modafinil did not improve blood pressure , weight , BMI , glucose or lipid metabolism compared to placebo .\n",
            "Modafinil was well tolerated and did not worsen psychosis .\n",
            "Conclusions : Results of this pilot trial do not support routine use of modafinil to counteract increased weight and metabolic diseases in patients taking clozapine .\n",
            "However , the effects of modafinil on weight and insulin regulation warrant further investigation with effect sizes of @ to @ .\n",
            "@ Elsevier B.V.\n",
            "Employment is central to the concept of recovery in severe mental illness .\n",
            "However , common comorbid conditions present significant obstacles to consumers seeking employment and benefiting from vocational rehabilitation .\n",
            "We review research on the effects of three common comorbid conditions on work and response to vocational rehabilitation , including cognitive impairment , substance abuse , and medical conditions , followed by research on vocational rehabilitation .\n",
            "We then present the results of a randomized controlled trial evaluating the effects of adding cognitive remediation to a vocational rehabilitation program compared with vocational rehabilitation alone in @ consumers with severe mental illness .\n",
            "Consumers who received both cognitive remediation and vocational rehabilitation demonstrated significantly greater improvements on a cognitive battery over @ months than those who received vocational rehabilitation alone and had better work outcomes over the @-year follow-up period .\n",
            "Substance abuse was associated with worse employment outcomes , but did not interact with treatment group , whereas medical comorbidity was not related to work outcomes .\n",
            "More research is warranted to evaluate the interactions between substance abuse and medical comorbidity with vocational rehabilitation and cognitive remediation .\n",
            "Objective : To investigate knot effect and feasibility of the rehabilitation model care for female patients with chronic schizophrenia .\n",
            "Methods : @ female patients with chronic schizophrenia were randomly divided into a treatment group ( rehabilitation ) and the control group ( general rehabilitation ) pair , each @ cases .\n",
            "The two levels of therapeutic ingredients paired First , the staff with patients , patients with patients .\n",
            "Rehabilitation measures include the open management ; activity groups ; behavior , skills training ; psychological care and health education ; medication .\n",
            "Psychiatric Nurses Observation Scale score once / week .\n",
            "Results : the average scoring of the treatment group and increased points rate significantly higher than that in the control group , the treatment group T score additional points > @ % of the @ patients ( @ % ) , the control group , only seven cases ( by @ % ) > @ % , the difference was significant ( x ^ @ = @ , P < @ ) .\n",
            "The serum concentrations of cis ( Z ) - and trans ( E ) - clopenthixol have been estimated in human volunteers by an HPLC-method after administration of a clopenthixol tablet , which contains the cis ( Z ) - and the trans ( E ) - isomers in the ratio @/@ , or a cis ( Z ) - clopenthixol tablet .\n",
            "The serum concentration curves obtained for the cis ( Z ) - isomer after administration of the two drug preparations were very similar , and thus independent of the presence of the trans ( E ) - isomer in one of the preparations .\n",
            "Likewise the biological half-lives and the areas under the serum concentration curves for cis ( Z ) - clopenthixol were similar after the two preparations .\n",
            "The biological half-life of cis ( Z ) - clopenthixol was as a mean @ hours ( @-@ hours ) indicating that from a pharmacokinetic point of view a dosage interval of @ hours is possible for most patients .\n",
            "The biological half-life of trans ( E ) - clopenthixol is found to be longer than that for cis ( Z ) - clopenthixol .\n",
            "Objective To evaluate the clinical efficacy and safety of treatment of first episode schizophrenia ziprasidone .\n",
            "Methods @ patients with first-episode schizophrenia patients were randomly divided equally into two groups of @ patients in the study group oral ziprasidone treatment , the control group was treated with perphenazine treatment for @ weeks .\n",
            "In the treatment of the first @,@ weekend using the Positive and Negative Syndrome Scale ( panss ) to evaluate the efficacy , adverse reactions Scale ( tess ) assessment of adverse reactions .\n",
            "Treatment of @ weeks , the study group total effective rate of @ % , @ % in the control group , the two groups showed no significant difference ( p > @ ) .\n",
            "The second weekend of the two groups of treatment of the positive and negative syndrome scale score points from the total score and factor than before treatment between the two groups over the same period was significantly decreased ( p < @ ) , and with the continuation of treatment was sustained decline ; scores showed no significant difference ( p > @ ) .\n",
            "The two sets of adverse reactions were mild , but extrapyramidal side effects and the total incidence of adverse reactions in the study group was significantly lower than the control group ( p < @ ) .\n",
            "OBJECTIVE : The study evaluated the effects of a brief manualized treatment program that taught patients skills to re-enter the community and actively follow through with their own care .\n",
            "METHODS : A total of @ recently admitted inpatients with schizophrenia or schizoaffective disorder were randomly assigned to either the community re-entry program or an equally intensive regimen of occupational therapy .\n",
            "The community re-entry program consisted of eight @-minute sessions conducted with groups of six to eight patients on a continuous , twice-a-day , four-day-a-week schedule .\n",
            "The effects were measured by a review of the records of aftercare services that patients received in the month after discharge from the inpatient facility .\n",
            "Patients ' knowledge and performance of the specific material taught in the community reentry program was ascertained through assessments conducted before and after training .\n",
            "RESULTS : Results indicated that patients in the community re-entry program significantly improved their knowledge and performance of the skills taught in the sessions , compared with patients in the occupational therapy group .\n",
            "Community re-entry participants were also significantly more likely to attend their first aftercare appointment than were occupational therapy participants ( @ percent versus @ percent ) .\n",
            "CONCLUSIONS : Not only can patients learn relatively complex material during a brief typical inpatient stay despite the acuteness of their illnesses , but they can also meaningfully improve the continuity of their own care by participating in a brief and highly structured training program .\n",
            "The program fits well within the time and staffing constraints of typical inpatient facilities .\n",
            "Sch-@ .\n",
            "Main Inclusion Criteria : Potential subjects must satisfy all of the following criteria to be enrolled in the study :    Man or woman between @ and @ years of age , inclusive    The subject has a current diagnosis of schizophrenia according to DSM-IV , and has been recently diagnosed , i.e. between @ and @ years before screening , and was receiving antipsychotics in the past ;    The subject has a history of two or more relapses requiring psychiatric hospitalization in the preceding @ months , which may include the current acute episode .\n",
            "Daytime hospitalization is acceptable in those countries where this reflects standard of care in acutely ill patients .\n",
            "In countries where hospitalization for relapse is not clinical standard , the requirement for hospitalization is not required ;    Subject must be experiencing at screening an acute schizophrenic episode with a PANSS total score at screening between @ and @ , inclusive ;    The subjects may benefit from a switch of antipsychotic medication to either paliperidone palmitate or one of the oral antipsychotics used in this study ;    Otherwise healthy on the basis of physical examination , medical history and vital signs performed at screening .\n",
            "If there are abnormalities , they must be consistent with the underlying illness in the study population .\n",
            "   Woman must be :    Premenarchal , or    postmenopausal ( for at least @ year ) , or    surgically sterile ( have had a hysterectomy or bilateral oophorectomy , tubal ligation , or otherwise be incapable of pregnancy ) , or    abstinent ( at the discretion of the investigator/per local regulations ) , or    if sexually active , be practicing an effective method of birth control ( e.g. , prescription oral contraceptives , contraceptive injections , contraceptive patch , intrauterine device , double-barrier method [ e.g. , condoms , diaphragm , or cervical cap with spermicidal foam , cream , or gel ] , male partner sterilization ) as local regulations permit .\n",
            "before entry , and must agree to continue to use the same method of contraception throughout the study .\n",
            "Prescription hormonal contraceptives ( the   pill  ) should not contain less than @ mg of estrogen and should not be used as the only method of birth control .\n",
            "Women using oral contraceptives should agree to use an additional birth control method .\n",
            "   Women of childbearing potential must have a negative urine pregnancy test at screening ;    Subjects must be willing and able to fill out self-administered questionnaires ;    Willing/able to adhere to the prohibitions and restrictions specified in this protocol ;    The subject is cooperative and reliable , and agrees to receive regular injections and complete all aspects of the protocol ;    Subjects must have signed an informed consent document indicating that they understand the purpose of and procedures required for the study and are willing to participate in the study .\n",
            "   Men must agree to use a double barrier method of birth control and to not donate sperm during the study and for @ months after receiving the last dose of study drug .\n",
            "Main Exclusion Criteria : Potential subjects who meet any of the following criteria will be excluded from participating in the study :    The subject   s psychiatric diagnosis is due to direct pharmacological effects of a substance ( e.g. , a drug of abuse or medication ) or a general medical condition ( e.g. , clinically notable hypothyroidism ) ;    First antipsychotic treatment ever ;    Subject can not be treated with an atypical oral antipsychotic ( except oral clozapine ) or oral haloperidol in monotherapy according to the investigator ;    The subject is treatment resistant in the judgment of the investigator and/or currently ( i.e. , within the last @ months ) treated with clozapine ;    The subject meets the DSM-IV definition of substance dependence ( except for nicotine and caffeine ) within @ months prior to entry ; subjects with current substance use or abuse , with the exception of intravenous drug use , will be allowed to enroll ;    Known allergies , hypersensitivity , or intolerance to risperidone or paliperidone or its excipients ( refer to Section @ , Physical Description of Study Drug ( s ) ;    Any condition that , in the opinion of the investigator , would compromise the well-being of the subject or the study or prevent the subjects from meeting or performing study requirements ;    The subject has received treatment with a long-acting injectable antipsychotic within three injection cycles prior to screening ;    The subject has begun a psychotherapy program within the two months preceding the treatment phase baseline .\n",
            "Psychosocial treatment is not considered psychotherapy ;    The subject received an investigational drug or used an investigational medical device within @ days before the planned start of treatment , or has participated in more than one investigational drug trial in the past @ months , or has planned use of other investigational drugs during the time frame of the trial , or is currently enrolled in an investigational study ;    The subject has evidence of clinically significant hepatic , renal , cardiac , vascular , pulmonary , gastrointestinal , endocrine , neurologic , hematologic , rheumatologic , psychiatric , or metabolic disturbances in the past @ months ( as determined by medical history , clinical laboratory or ECG results , or physical examination ) that would increase the risk associated with taking study medication or would confound the interpretation of the study ;    Subjects with a narrowing or blockage of their gastrointestinal tract ;    Inability to swallow the study medication whole with the aid of water ( subjects may not chew , divide , dissolve , or crush the Paliperidone ER study medication , if applicable , as this may affect the release profile ) ;    Contraindications , warnings and precautions for oral antipsychotics used in this study apply according to local Summaries of Product Characteristics ( SmPCs ) ;    History or current symptoms of tardive dyskinesia ;    History of neuroleptic malignant syndrome ;    Subject is involuntarily hospitalized ;    Subject is pregnant or breast-feeding ;    Employees of the investigator or study center , with direct involvement in the proposed study or other studies under the direction of that investigator or study center , as well as family members of the employees or the investigator .\n",
            "   Use of disallowed therapies : see section @ , Prestudy and Concomitant Therapy\n",
            "Objective : To investigate whether specially trained community psychiatric nurses could successfully deliver cognitive behavior therapy ( CBT ) and psycho-educational materials to patients with SCHIZophrenia to improve insight and overall symptomatology.Methods : A RANDOMized trial compared the Insight Programme with treatment as usual in a community sample of SCHIZophrenic patients at six U.K. sites .\n",
            "Patients ( N = @ ) were RANDOMly assigned to insight intervention and @ to treatment as usual ; @ and @ patients , respectively , completed the study .\n",
            "Intervention consisted of six sessions of CBT over @ months .\n",
            "The main caregiver was offered three sessions .\n",
            "Nurses were given @ days ' intensive CBT training .\n",
            "Primary outcome measures were changes from baseline in insight , overall symptoms , and burden of care.Results : Patients undergoing CBT experienced significant improvement in insight ( p = @ ) and overall symptomology ( p = @ ) but not in burden of care or PSYCHOTIC symptoms .\n",
            "Depression was also significantly improved ( p = @ ) , with no significant increase in suicidal ideation .\n",
            "Conclusions : Community psychiatric nurses with appropriate training and supervision can effectively deliver brief CBT intervention to patients with SCHIZophrenia and to their caregivers .\n",
            "Further assessment of results will be carried out @ months after end of therapy to assess the duration of effects.Study supported by Pfizer Inc .\n",
            "CN : NR@ Tuesday , May @ , @:@ p.m.-@ : @ p.m. PT : CSG CODE conference USA\n",
            "Flunitrazepam in @-mg and @-mg doses was compared with flurazepam @ mg and nitrazepam @ mg for hypnotic efficacy in a DOUBLE - blind , multiple cross-over trial involving @ psychiatric in-patients .\n",
            "In the vast majority of comparisons involving a number of sleep parameters differences did not reach significance level .\n",
            "Flunitrazepam @ mg tended to produce the shortest latency time and the longest duration of sleep but also the most side-effects .\n",
            "Nitrazepam @ mg appeared to have a slight advantage over the other drugs in terms of patient preference .\n",
            "For severe sleep disturbance flunitrazepam @ mg tended to be the most satisfactory drug in terms of efficacy and paucity of side-effects .\n",
            "Objective : To assess the effectiveness of an adherence counselling training package for case managers in reducing relapse rates in patients with schizophrenia .\n",
            "Methods : Pragmatic cluster randomised controlled trial .\n",
            "Fortysix ease managers ( the cluster ) were assigned randomly to adherence counselling training or a control training intervention .\n",
            "Five patients were randomly selected from each case managers caseload and were assessed at baseline and again after twelve months .\n",
            "The primary outcome of interest was relapse of psychosis .\n",
            "Secondary outcome measures included : compliance ; substance use ; and functioning Results : Forty-four case managers and @ patients were followed up at the trial end point .\n",
            "Conclusion : Training was acceptable and well evaluated by case managers .\n",
            "BACKGROUND AND OBJECTIVE : Clinical practice guidelines recommend antipsychotic monotherapy , including oral and long-acting formulations , in the treatment of schizophrenia .\n",
            "This open-label , randomized , controlled trial aimed to evaluate the efficacy and tolerability in patients with schizophrenia of once-monthly long-acting paliperidone palmitate ( PP@M ) compared with oral paliperidone extended release ( ER ) , with a particular focus on satisfaction , subjective well-being , and service engagement .\n",
            "METHODS : Seventy-two consecutive outpatients with schizophrenia ( DSM-@ ) were randomly assigned for @ months to : ( @ ) PP@M ( @-@ mg equivalent ) or ( @ ) paliperidone ER ( @-@ mg/day ) .\n",
            "Participants were assessed at baseline and after @ months with the Treatment Satisfaction Questionnaire for Medication ( TSQM ) ; the Subjective Well-being under Neuroleptics Scale ( SWN-K ) ; the Service Engagement Scale ( SES ) ; the Clinical Global Impression-Schizophrenia ( CGI-SCH ) ; and the Personal and Social Performance ( PSP ) score .\n",
            "ANOVA repeated measures was performed .\n",
            "Intention-to-treat analysis with last observation carried forward was conducted .\n",
            "RESULTS : We found a significant within-subjects effect ( trial duration ) for all rating scale except for cognitive symptoms and the TSQM domain \" side effects \" .\n",
            "A significant effect between subjects ( treatment modality ) was found for the CGI negative symptoms , the TSQM domains \" overall satisfaction \" and \" convenience , \" and the SES .\n",
            "There were seven drop-outs ( @ % ) : twi due to hyperprolactinemia and five for lack of compliance .\n",
            "CONCLUSIONS : Significant differences between the two formulations were found .\n",
            "PP@M was superior to paliperidone ER on global treatment satisfaction and convenience , on service engagement , and in reducing negative symptoms .\n",
            "The trial was registered in the Australian New Zealand Clinical Trials Registry ( ANZCTR ) with the code : ACTRN@ .\n",
            "It has been well established that patients with schizophrenia have impaired cognitive function on neuropsychological tasks related to memory .\n",
            "Previous studies also suggest serotonin 's central role in memory .\n",
            "This double-blind crossover study aimed to explore the effect of Ondansetron , a selective serotonin @ receptor ( @-HT ( @ ) ) antagonist , on a variety of memory tasks in schizophrenic patients .\n",
            "Clozapine-treated schizophrenic patients in remission ( N = @ ) were randomly treated with Ondansetron or placebo and then evaluated at three consecutive points .\n",
            "These evaluations included clinical measures ( including Positive and Negative Syndrome Scale for Schizophrenia , Clinical Global Impression and Extrapyramidal Symptoms Rating Scale ) and neuropsychological measures ( including Digit Span , Paired Association , Rey-Osterich Complex Figure Test , Digit Symbol and the Rivermead Behavioral Memory Tests ) .\n",
            "Ondansetron , when compared with placebo , did not affect the above clinical measures and most of the neuropsychological tests .\n",
            "Short-term administration of Ondansetron , however , was associated with significantly improved visuo-spatial memory as measured by the Rey-Osterich Complex Figure Test .\n",
            "These preliminary results suggest Ondansetron 's possible role in enhancement of memory function in schizophrenia\n",
            "SUMMARY : A randomized , multicenter , two-year trial ( N = @ ) was carried out in Quebec City to study the effects of psychoeducation in schizophrenia .\n",
            "The French version of the Medication and Symptom Management Modules , developed at the UCLA Clinical Research Center for Schizophrenia , were used for the patients ( N = @ ) in the psycho-education group .\n",
            "The psychoeducation program consisted of bi - weekly , one-and-a-half-hour sessions during @ weeks .\n",
            "The skills areas were : identifying warning signs of relapse , managing warning signs , coping with persistent symptoms , obtaining information about antipsychotic medication , knowing correct self-administration and evaluation of medication , identifying side effects of medication , negotiating medication issues with health care providers .\n",
            "Two control groups consisted of ( N = @ ) patients who participated in small group , @-minute , bi-weekly leisure activities for @ weeks ; and ( N = @ ) patients in a second control group who participated in their usual follow-up activities of supportive therapy and neuroleptic medication .\n",
            "Analyses showed that the three groups were similar regarding sociodemographic variables like sex , age , marital status , and income .\n",
            "Two-year results showed significantly greater improvements in the psychoeducation group for knowledge regarding medication and symptoms ( P = @ ) and behavioral skills as measured through role play tests ( p = @ ) .\n",
            "SYMPOSIUM @ -- INTERNATIONAL PERSPECTIVES ON SKILLS TRAINING Joint Session with the Association for Clinical Psychosocial Research EDUCATIONAL OBJECTIVES FOR THIS SYMPOSIUM\n",
            "Background : TAK-@ selectively inhibits phosphodiesterase @A and reverses ketamine effects on gamma EEG in rats and monkeys and normalizes impairments in PPI in rats .\n",
            "The effects of TAK-@ on neurophysiological biomarkers were explored in subjects with schizophrenia in a double blind , multiple rising dose study .\n",
            "Methods : @ subjects ( of @ total ) with complete neurophysiological data were included in the analysis ( @ placebo : @ TAK-@ ) .\n",
            "Subjects were dosed once daily for @ days .\n",
            "Assessments were made predose , @h post-dose Day @ , Day @ and consisted of resting EEG , EEG with high-frequency auditory stimuli , auditory MMN with duration deviants , and PPI .\n",
            "Baseline-adjusted data were compared to placebo ; either by MMRM or ANCOVA ; baseline was included as a covariate and treatment group as Axed factor in the model .\n",
            "Results : Deficits in gamma power during @Hz stimulus were present at baseline .\n",
            "Significant restoration of synchronized @Hz EEG was observed @h post dose Day @ for @ mg and @ mg doses ( p < @ ) ; no improvement on Day @ .\n",
            "On Days @ and @ , increases in ( eyes-closed ) resting alpha with coincident decreases in slow waves were observed , especially the @ mg dose ( globally ) , and more modestly at @ and @ mg ( posteriorly ) .\n",
            "Trends of improvement of moderate MMN deficits were observed in the peak analyses in the @ and @ mg dose groups .\n",
            "There was no improvement in PPI in any dose group .\n",
            "Conclusions : Improvements in gamma power and increases in alpha and coincident reductions in slow waves with TAK-@ may be indicative of improved sensory awareness and cognitive function .\n",
            "Background : Weight gain is a distressing side effect of antipsychotic medications in patients with schizophrenia@ .\n",
            "This naturalistic trial investigated mean changes in weight and weight-related quality of life in community-treated patients with schizophrenia .\n",
            "Methods : Weight and weight-related QOL were assessed at baseline and weeks @ @ and @ in patients with schizophrenia n @ ) participating in a randomized open-label study comparing aripiprazole treatment to standard-of-care .\n",
            "Weight-related quality of life was assessed with the Impact of Weight on Quality of Life-Lite ( IWQOL-Lite ) questionnaire , a @-item instrument that provides a total score and five domain scores ( Physical Function , Self-Esteem , Sexual Life , Public Distress , and Work . )\n",
            "@ .\n",
            "Adjusted mean changes from baseline was compared between groups using ANOVA .\n",
            "Results : Baseline characteristics were comparable between groups .\n",
            "Significant differences ( p @ ; @ ) were found in mean weight change , with aripiprazole decreasing @ .\n",
            "@ kg and standard-of-care increasing @ .\n",
            "@ kg by end of study .\n",
            "Significant improvements in quality of life were observed in aripiprazole relative to standard-of-care at weeks @ @ and @ for Physical Function p @ ; p = @ ; p = @ ) and Self-Esteem ( p = @ ; p @ ; @ .@ ; p @ ; @ .@ ) , and at weeks @ and @ for Sexual Life p @ ; p = @ ) , and Total Score p @ ; @ , and p = @ ) .\n",
            "No differences were observed between groups on the Public Distress or Work domains at any assessment .\n",
            "Conclusions : Compared to standard-of-care , patients with schizophrenia treated with aripiprazole experienced decreased weight and improved weight-related quality of life over @-weeks demonstrating that significant quality of life improvements are achieved in a brief time frame .\n",
            "Background : Evaluate the efficacy of the investigational partial dopamine agonist bifeprunox over @ months in post-acute , maintenance - phase schizophrenia .\n",
            "This presentation examines the secondary efficacy measure , change in PANSS total score ( TS ) , to support the study 's positive primary efficacy finding .\n",
            "Methods : A total of @ stable patients with schizophrenia were randomly assigned , double-blind , to once-daily bifeprunox @ mg ( n = @ ) , @ mg ( n = @ ) , or placebo ( n = @ ) .\n",
            "Bifeprunox was titrated from@ .@ mg on day @ and approximately doubled daily to target dosage .\n",
            "Primary inclusion criteria : schizophrenia diagnosis for ?\n",
            "@ years ; antipsychotic treatment unchanged for @-month pre-screening ; PANSS TS ?\n",
            "@ ; CGI-S ?\n",
            "@ ; PANSS single-item P@ ( hostility ) or G@ ( uncooperativeness ) ?\n",
            "@ ; residual symptoms or insufficient tolerance to current antipsychotic treatment .\n",
            "Primary efficacy assessment : time to deterioration ( TTD ) from randomization ; secondary assessments included baseline-to-endpoint change in PANSS TS .\n",
            "Results : Bifeprunox patients experienced significantly longer TTD than placebo ( @ mg : P = @ ; @ mg : P = @ ) .\n",
            "With bifeprunox , PANSS TS decreased from baseline to week @ then remained stable to month @ ; with placebo it decreased at week @ then steadily increased to above baseline by month @ .\n",
            "Adjusted mean changes from baseline in PANSS TS were significantly different for both bifeprunox groups versus placebo at week @ and all subsequent time-points , tomonth @ .\n",
            "Most common adverse events ( ?\n",
            "@ % , ?\n",
            "@  placebo ) included nausea , vomiting , anorexia , dizziness , akathisia , dyskinesia and asthenia .\n",
            "Conclusions : Bifeprunox @ and @ mg treatment of stable patients with schizophrenia initially decreased then stabilized PANSS TS , indicating long-term treatment viability in post-acute maintenancephase patients .\n",
            "Background : The Recovery After an Initial Schizophrenia Episode Early Treatment Program ( RAISE-ETP ) is a US NIMH-funded @ site cluster randomized controlled trial which evaluated the benefits of participation in a multicomponent intervention , entitled NAVIGATE , for first episode psychosis ( FEP ) .\n",
            "Previously , participation in NAVIGATE was reported to yield significant participant benefits , compared to customary care ( Kane et al , @ ) .\n",
            "NAVIGATE included tailored medication , individual resiliency training , family education , and supported education and employment .\n",
            "Here we examine the absolute rate of family engagement in professional support services in the intent to treat sample , as well identify predictors of participation .\n",
            "Methods : A total of @ individuals between ages @ and @ were enrolled .\n",
            "DSM-IV diagnoses of non-affective psychosis were included .\n",
            "All participants had experienced only one episode of psychosis , had been prescribed less than @ months of lifetime psychotic medication , spoke English , and provided informed consent .\n",
            "Participants were offered a minimum of two years of NAVIGATE or customary care ( CC ) .\n",
            "At baseline , participants provided demographic and clinical history information ; they were administered the Heinrichs-Carpenter Quality of Life Scale ( QOL ) and the Positive and Negative Symptom Scale ( PANSS ) .\n",
            "Site research assistants interviewed participants monthly to capture participation in the four types of NAVIGATE interventions , allowing treatment groups to be compared on receipt of key services .\n",
            "Results : One hundred nineteen of the @ participants ( @ % ) reported their relatives attending five or more family sessions within the first year of randomization ( @ families ( @ % ) in NAVIGATE ; @ ( @ % ) in CC ) .\n",
            "In a simultaneous logistic regression analysis predicting meeting this five family sessions threshold or not , significant independent predictors ( all p < .\n",
            "@ ) included treatment group , consumer negative symptoms , consumer self-reported quality of family relationship , race , and consumer residence .\n",
            "Relatives were more likely to attend family sessions if their loved one was @ ) randomized to NAVIGATE , @ ) had greater negative symptoms on the PANSS , @ ) self-reported as emotionally closer to the family , @ ) was Caucasian , and @ ) lived with family .\n",
            "Other consumer PANSS and QOL scores , consumer age , ethnicity , health insurance status , cigarette smoking status , and consumers ' mother education were not significant independent predictors .\n",
            "Discussion : Although the benefits of family support and education have been highlighted for persons with a recent onset of psychosis , the results here suggest that engaging relatives in these services , at least in the US , can be challenging .\n",
            "Even given a relatively low threshold of attendance at least @ family sessions in the first year of treatment , the majority of this sample did not meet the criterion , although participation rates were significantly higher in NAVIGATE .\n",
            "This increase likely reflects the effort NAVIGATE teams expended to engage relatives .\n",
            "It is perhaps not surprising that families of consumers who live with them and/or report feeling closer to them are more likely to attend clinic sessions .\n",
            "Interestingly , higher levels of consumer negative , but not positive symptoms , were also associated with greater attendance at family sessions ; this finding suggests that living with a consumer who appears unmotivated and withdrawn may be particularly challenging and prompt relatives to seek more assistance .\n",
            "Finally , our data on race suggest , as other have noted , that greater outreach may be needed to engage non-Caucasian families in services .\n",
            "CAJ ObjectiveTo research the efficiency of literature-art-therapy ( LAT ) using in the phrase of rehabilitation in the inpatients with schizophrenia .\n",
            "Methods@ inpatients were randomly divided into two groups , the trial and the control , @ patients respectively .\n",
            "The trial group was treated by LAT for @ to @ months , while both groups were routinely treated by neuroleptic .\n",
            "IPROS was used in assessment at the start and the end .\n",
            "ResultsThe degree of functional deficiency in trial group had significant decreased .\n",
            "Objective : To assess clozapine combined Shuxuening the treatment of long-term hospitalization of the efficacy and adverse effects of schizophrenia .\n",
            "Methods : The long-term hospitalization ( > @ years ) , @ patients were randomly divided into two groups of clozapine treatment of schizophrenia , clozapine therapy control group of @ patients continue to use , the study group of @ patients in the extension of clozapine simultaneously Jiashu Shengxuening treatment for @ weeks , the clinical Global Impression ( cg i ) positive symptoms and negative syndrome scale ( panss ) and adverse scale ( tess ) to evaluate the efficacy and adverse reactions .\n",
            "Results : The two groups Clinical Global Impression ( cg i ) efficacy index were @ to @ , no significant difference , panss saps the two groups no significant difference between the sans reduction rate of the study group than in the control group ( p < @ ) ; tess ratings study group than in the control group ( p < @ ) .\n",
            "Total Enrollment - @ Study start - February @ Many schizophrenia patients have serious difficulties that affect their quality of life .\n",
            "Cognitive Adaptation Training ( CAT ) may improve adaptive functioning , quality of life , and rates of relapse in schizophrenia patients .\n",
            "CAT , which involves compensatory strategies or environmental supports , is tailored to each individual and is based on executive functioning levels and other factors .\n",
            "Participants are randomly assigned to CAT , Minimal Environmental Supports ( MES ) , or treatment as usual for @ years .\n",
            "Participants receiving CAT will have a trained therapist make weekly visits to their home for @ months .\n",
            "Over the following @ months , the frequency of CAT visits will be slowly reduced to once a month .\n",
            "For the remaining @ months of treatment , patients receive CAT only once a month .\n",
            "Participants assigned to the MES group receive a generic set of supplies and equipment ( calendar , alarm clock , watch , bus passes , etc. ) at the beginning of the @-year period .\n",
            "Each month , the supplies are replenished as necessary during the patient 's scheduled clinic visit .\n",
            "In all groups , assessments of adaptive function and quality of life occur at study start and at @ , @ , @ , @ , and @ months .\n",
            "Ph.D. , Principal Investigator , University of Texas Purpose - This study will compare Cognitive Adaptation Training ( CAT ) to minimal schizophrenia treatment .\n",
            "This study will also determine whether the intensity of CAT can be reduced and still provide benefits to patients with schizophrenia .\n",
            "Eligibility - Ages Eligible for Study - @ Years - @ Years , Genders Eligible for Study - Both Criteria Inclusion Criteria - DSM-IV diagnosis of schizophrenia or schizoaffective disorder Treatment with an atypical antipsychotic medication Stable living environment Able to read , understand , and complete rating scales and neuropsychological testing Willing to participate in psychosocial treatments for schizophrenia that may involve home visits Exclusion Criteria - History of significant head trauma , seizure disorder , or mental retardation Alcohol or drug abuse that could interfere with participation in the study Treatment by an ACT team History of violence in the past year Score > @ on the SOFAS Hospitalized in the past year\n",
            "Purpose of this study : This study aimed to compare effectiveness and safety of intamuscular Haloperidol @ mg and intramuscular Olanzapine @ mg , intramuscular Haloperidol @ mg plus Lorazepam @ mg for psychotic patients with acute agitation state .\n",
            "Methods : Thirty seven psychotic patients with acute agitation were randomly assigned to Haloperidol @ mg intra muscular injection ( @ patients ) or Olanzapine @ mg intra muscular injection ( @ patients ) or Haloperidol @ mg intramuscular injection plus lorazepam @ mg intramuscular injection ( @ patients ) groups .\n",
            "The study subjects were male and female patients who were @ years old or older , who had a DSM-IV diagnosis of schizophrenia , schizophreniform disorder , brief psychotic disorder , or schizoaffective disorder , bipolar disordr and who had an excited component score greater than or equal to @ on the Positive and Negative Syndrome Scale with a score of @ or more on at least one item ( @-@-point scale ) .\n",
            "Psychotic disorders are brief psychotic disorder ( @ percent ) , schizophreniform disorder ( @ percent ) , schizophrenia ( @ percent ) , schizoaffective disorder ( @ percent ) , bipolar disorder ( @ percent ) .\n",
            "The Positive and Negative symptom Syndrome Scale excitement component ( PANSS EC , P@ - excitement , G@ - poor impulse control , P@ - hostility , G@ - tension , G@ - uncooperativeness ) and Clinical Global Impression-Severity ( CGI-S ) , Clinical Global Impression-Improvement ( CGI-I ) were assessed at baseline , @ minute , @ minute and @ minute after injection respectively .\n",
            "Side effect Checklist and blood pressure were used for the assessment of side effect at baseline , @ minute , @ minute and @ minute after injection .\n",
            "Summary of results : There are no difference in sex , age , education , illness duration , number of admission , psychiatric comorbidity .\n",
            "There were no between-group differences in baseline scores on the excited component of the Positive and Negative Syndrome Scale , CGI-S .\n",
            "PANSS EC scores ( excitement , poor impulse control , hostility , tension , uncooperativenes ) were significantly ( p < @ ) decreased over time ( @ minute , @ minute and @ minute after injection ) without any sigificant group differences .\n",
            "CGI-s were decreased over time in all three groups .\n",
            "CGI-I were improved in all groups .\n",
            "Intamuscular Haloperidol and intramuscular Olanzapine , intramuscular Haloperidol plus Lorazepam for psychotic patients with acute agitation state are all effective approach methods .\n",
            "At last point ( @ minutes ) , patients of seclusion state were @ percent in all groups , @ percent in haloperidol group , @ percent in combined group and @ percent in olanzapine group .\n",
            "There were no serious adverse events in Haloperidol @ mg intramuscular injection or Olanzapine intramuscular injection or Haloperidol @ mg intramuscular injection plus lorazepam @ mg intramuscular injection groups .\n",
            "Reported adverse events were @ case of dizziness , enuresis at haloperidol group and one case of dry mouth at combined group .\n",
            "Conclusions : This study showed that Haloperidol @ mg intramuscular injection , Olanzapine @ mg intramuscular injection and Haloperidol @ mg plus Lorazepam @ mg tintramuscular injection reatment would be effective and tolerable for treatment of psychotic patients with acute agitation state .\n",
            "Further study is needed for another rapid management approach of severe psychotic agitated state .\n",
            "Objectives : To observe therapeutic effect of Chinese herb syr .\n",
            "Anshengjianpi used in digestion system side effects caused by antypsychotic drugs-Chlorpromazine and Clozapine .\n",
            "These side effects included thirst , bitterness , nausea , vomit , anorexia , astriction , etc .\n",
            "Methods : The observation divides randomly @ sam - ples who were hospitalized in Wuhan Mental Health Center in Jan,@-Oct.@ into treatment group ( n = @ ) and controlled group ( n = @ ) .\n",
            "The assessment scales were TESS and patient Self -\n",
            "Measures of psychopathology among mentally ill chemical abusers ( MICAs ) were examined as predictors of levels of functioning in two types of community based , residential programs : therapeutic community ( TC ) and community residence ( CR ) .\n",
            "Non-significant associations were generally observed between scales of psychiatric symptoms ( e.g. , depression , psychotic ideation , cognitive disorientation , and hostility ) and counselors ' ratings of the residents ' capacity to meet the social and interpersonal expectations of the programs ( e.g. , personal care , involvement in interpersonal relationships , and development of work skills ) .\n",
            "The study suggests that individuals with moderately severe psychopathology can be successfully engaged in residential treatment , even in programs with relatively high expectations for interpersonal involvement and functioning , such as the therapeutic community .\n",
            "The psychotogenic actions of sigma receptor agonists , such as pentazocine , have led to the hypothesis that sigma receptor antagonists may be putative antipsychotic agents .\n",
            "In this study , BW@U , a selective but relatively weak sigma receptor antagonist was compared at two different dosage ranges with chlorpromazine and placebo in a double-blind randomized treatment trial in schizophrenic patients undergoing acute exacerbation .\n",
            "During the @-week blinded treatment period , there was a modest drop in Brief Psychiatric Rating Scale ( BPRS ) score in the chlorpromazine group , however , neither dosage range of BW@U , nor placebo produced a significant drop in the BPRS .\n",
            "Our results suggest that BW@U is an ineffective anti-psychotic agent in schizophrenics experiencing acute exacerbation of their illness .\n",
            "Due to BW@U 's relatively weak antagonism at the sigma recognition site , this does not rule out the possibility that more potent and equally selective sigma antagonists may possess antipsychotic efficacy .\n",
            "Objective : To evaluate the efficacy of quetiapine in the treatment of elderly patients with schizophrenia and security .\n",
            "Methods : @ elderly patients with schizophrenia were randomly divided into two groups , respectively quetiapine and perphenazine treatment for @ weeks .\n",
            "Positive and Negative Syndrome Scale ( panss ) to evaluate the efficacy , adverse reactions Scale ( tess ) assessment of adverse reactions .\n",
            "Results : There was no significant difference ( p > @ ) .\n",
            "Efficacy .\n",
            "Quetiapine group less adverse reactions .\n",
            "Objective : To evaluate efficacy of the Computerized Cognitive Remediation Therapy to adult patients with schizophrenia .\n",
            "Methods : In a randomized controlled trial , @ adult patients with schizophrenia received @ sessions of combined treatment of the Computerized Cognitive Remediation Therapy and antipsychotics or monotherapy of antipsychotic.Outcome measures included Brief Psychiatric Rating Scale ( BPRS ) and a set of computerized cognitive tests measuring processing speed , attention , verbal working memory , visual memory and selective inhibition .\n",
            "Results : Compared to monotherapy of antipsychotic , the combined therapy improved the patients on digital sequence test and Stroop-word task ( P < @ ) .\n",
            "While the combined therapy showed little efficacy on psychiatrical symptoms .\n",
            "Conclusion : the Computerized Cognitive Re-mediation Therapy may improve verbal working memory and selective attention of adult patients with schizophrenia .\n",
            "The development of effective cognitive training ( CT ) interventions is critical for improving the daily lives of people with schizophrenia .\n",
            "At this point , it is unclear whether a so-called \" bottom-up \" or \" top-down \" CT approach is more beneficial for inducing cognitive gains and generalization in this population .\n",
            "The aims of this randomized controlled trial were to : @ ) Compare the effects of these two types of training approaches on performance-based ( MATRICS Consensus Cognitive Battery , MCCB ) and neurophysiological ( mismatch negativity , MMN ) measures of cognition , and @ ) Evaluate MMN as a potential predictor of treatment response .\n",
            "Ninety-nine patients with persistent schizophrenia ( mean age of @ and illness duration of @ years ) were randomly assigned in a @:@:@ ratio to a \" bottom-up \" intervention that selectively targets basic auditory processing and verbal learning ( Brain Fitness ) , a \" top-down \" intervention that targets a broad range of higher-order cognitive functions ( COGPACK ) , or a control condition consisting of commercial computer games ( Sporcle ) .\n",
            "Participants completed on average @h of training over @ weeks .\n",
            "Despite demonstrated improvement on training tasks , we found no significant treatment effects on measures of neurocognition ( MCCB ) , MMN , or functional capacity from either intervention .\n",
            "Interestingly , there was an association between an enhanced MMN response at @ weeks and improved reasoning/problem solving at @ weeks in the COGPACK group .\n",
            "Although this study had several methodological strengths , the results were mainly negative .\n",
            "It suggests that CT trials in schizophrenia should try to better understand mediators and moderators of treatment response to develop more personalized interventions .\n",
            "Benzodiazepines have several advantages over other antidyskinetic drugs in treating tardive dyskinesia .\n",
            "The authors conducted a controlled study of clonazepam versus the active placebo of phenobarbital in @ psychiatric patients with tardive dyskinesia .\n",
            "Both drugs significantly reduced dyskinetic movements : clonazepam had a stronger effect on orofacial dyskinesia , and phenobarbital was more effective for limbs and axial movements .\n",
            "Clonazepam was also more effective for drug-free patients and those receiving low doses of neuroleptics than for all patients given phenobarbital and for clonazepam patients taking high doses of neuroleptics .\n",
            "The authors suggest that future treatment studies focus on the effects of antidyskinetic drugs on distinct body regions .\n",
            "BACKGROUND : The treatment of psychotic symptoms in patients with mood disorders is a complex challenge .\n",
            "Antipsychotic medications in these individuals may be associated with extrapyramidal symptoms ( EPS ) , worsening of depression , and functional impairment .\n",
            "Atypical antipsychotics such as quetiapine and risperidone are associated with a decreased incidence of adverse events such as EPS .\n",
            "The objective of this study was to compare the efficacy and tolerability of quetiapine and risperidone for the treatment of depressive symptoms in outpatients with psychosis .\n",
            "METHOD : In this @-month , multicenter , open-label trial , patients were RANDOMly assigned in a @:@ ratio of quetiapine to risperidone , and both drugs were flexibly dosed .\n",
            "Eligible patients had psychoses and demonstrated @ of several DSM-IV diagnoses , including SCHIZOaffective disorder , bipolar I disorder , major depressive disorder , delusional disorder , Alzheimer 's dementia , SCHIZOphreniform disorder , vascular dementia , and substance abuse dementia .\n",
            "Patients were classified as mood disordered if they had bipolar disorder , major depressive disorder , or SCHIZOaffective disorder .\n",
            "Efficacy was assessed using the Positive and Negative Syndrome Scale and the Clinical Global Impressions scale .\n",
            "The Hamilton Rating Scale for Depression ( HAM-D ) was used to assess the level of depressive symptoms .\n",
            "The primary tolerability assessment was presence or absence of substantial EPS , defined as EPS severe enough to require an alteration in treatment .\n",
            "RESULTS : A total of @ patients were RANDOMly assigned to quetiapine and @ to risperidone .\n",
            "Mean doses at @ weeks were @ mg for quetiapine and @ mg for risperidone .\n",
            "Although both agents produced improvements in mean HAM-D scores , quetiapine produced a greater improvement than risperidone in all patients ( p = .@ ) .\n",
            "Within the mood-diagnosed population , incidences of both substantial EPS ( p = .@ ) and at least moderate EPS ( p = .@ ) occurred significantly less frequently among patients taking quetiapine .\n",
            "For patients with non-mood diagnoses , incidences of substantial EPS were fewer for patients taking quetiapine than for those taking risperidone ( p = .@ ) ; however , this was not statistically significant .\n",
            "CONCLUSION : These results suggest that quetiapine may be a useful agent in the management of depressive symptoms in patients with psychosis .\n",
            "CAS Registry/EC Number @ ( Antipsychotic Agents ) .\n",
            "@ ( Dibenzothiazepines ) .\n",
            "@-@-@ ( Risperidone ) .\n",
            "@-@-@ ( quetiapine )\n",
            "OBJECTIVE : To examine the efficacy and safety of modafinil on parkinsonism and excessive daytime sleepiness ( EDS ) , as well as on negative symptoms and cognitive abilities in patients with schizophrenia or schizoaffective disorder ( DSM-IV criteria ) in a randomized double-blind placebo-controlled @-week study .\n",
            "METHODS : Twenty-four male patients , who were aged @-@ years and on stable dose of second generation antipsychotic medications and with a negative symptom score of > / = @ on the Positive and Negative Syndrome Scale ( PANSS ) , were randomized into either the modafinil ( n = @ ) or placebo ( n = @ ) group .\n",
            "The modafinil group received flexible does of modafinil @-@mg / day .\n",
            "Primary measurements were the Simpson-Angus Scale ( SAS ) for extrapyramidal side effects ( EPS ) , the Epworth Sleepiness Scale ( ESS ) , the PANSS and a neuropsychological ( NP ) test battery .\n",
            "Data were collected on Days @ , @ , @ , @ and @ for rating scales , and on Days @ , @ and @ for NP tests .\n",
            "RESULTS : Mixed model analyses showed a significant group-x-time interaction for total SAS scores ( P < @ ) , with scores decreasing in the modafinil group but remaining the same in the placebo group .\n",
            "There were no significant group-x-time interactions for scores of ESS ( total ) , PANSS ( total , positive and negative ) , and NP tests ( composite and domains ) ( all P 's > @ ) .\n",
            "No significant adverse events were observed .\n",
            "CONCLUSION : The data suggest that modafinil was a safe adjunctive treatment which improved parkinsonian symptoms and signs in patients with schizophrenia or schizoaffective disorder .\n",
            "Further studies in larger samples and with longer study time are needed to test/confirm the beneficial effects of modafinil on motor function .\n",
            "The MECCA study is a cluster randomised controlled trial following the same protocol in community mental health teams in six European countries .\n",
            "The trial tests the hypothesis that the new intervention  as compared to current best standard practice - will lead to a better outcome in terms of quality of life , compliance with medication , needs for care , treatment satisfaction , and the quality of the therapeutic relationship between keyworker and patients with psychotic disorders over a one year period .\n",
            "Changes in psychopathology are not hypothesised to differ between the two groups .\n",
            "The research question regarding costs is purely exploratory .\n",
            "Design/methodology : Randomised controlled trial Participants - inclusion criteria : Inclusion criteria for key workers are a professional qualification in mental Participants - exclusion criteria : Living in @ hour supported hostel type of accommodation ; severe physical handicap , organic psychiatric illness or primary substance abuse ( however , dual diagnosis as such is not an exclusion criterion ) ; expectation of clinicians to discharge the patient from the service within the next @ months .\n",
            "Anticipated start date : @/@/@ Anticipated end date : @/@/@ Status of trial : Completed Interventions : Key workers are randomly assigned to either the intervention or treatment as usual condition .\n",
            "Randomisation of key workers will be stratified by professional background ( ASW , CPN , psychiatrist etc. ) and by the number of patients within each key worker 's caseload consenting to participate .\n",
            "Patients would be asked for informed consent prior to their key worker being randomised .\n",
            "Whilst the control group will receive treatment as usual in line with current best practice , the intervention group will , in addition to treatment as usual , receive an innovative intervention .\n",
            "The key worker asks patients about their subjective quality of life , treatment satisfaction and wishes for additional/different support using a brief questionnaire .\n",
            "The questionnaire ( MECCA ) consists of satisfaction ratings with eight life domains ( satisfaction with mental and physical health , accommodation , job situation , leisure activities , friendships , relationship with family/partner , personal safety ) and three aspects of treatment ( satisfaction with practical help , psychological help and medication ) .\n",
            "Each satisfaction item will be rated on a @ to @ rating scale and followed by a question on whether the patient wishes for additional/different support in the given area reflecting subjective needs for change .\n",
            "The assessment is completed by the key worker and patient every two months .\n",
            "Key workers will enter patients answers onto a laptop or palm top computer using software specifically designed for the project , with patients  ratings presented in a user-friendly colour display detailing scores on each outcome measure .\n",
            "It is expected that the results will directly feed into the therapeutic dialogue and be discussed by the patient and key worker together .\n",
            "The discussion is intended to address in particular all areas where the patients expressed dissatisfaction and ratings that have changed since the previous assessment .\n",
            "Objective To investigate the Wuling capsule combination of Ginkgo biloba treatment efficacy and safety of chronic schizophrenia .\n",
            "@ patients with chronic schizophrenia were randomly divided into two groups for all of Wuling Capsule oral , @ / , @ times / d .\n",
            "The treatment group at the same time I Ginkgo biloba @ mg / orally , @ times / d. @ in @ weeks for a course of treatment .\n",
            "Evaluate the efficacy and safety of using positive and negative syndrome scale ( PANSS ) and adverse reactions Scale ( TESS ) .\n",
            "Results after @ weeks of treatment , the treatment group markedly effective rate was higher , the PANSS score compared with pre-treatment significantly decreased and lower than the control group , but TESS scores over the same period was no significant difference .\n",
            "Objectives : Prior research has suggested that there may or may not be a relationship between clinical response and the amount of weight gain in patients treated with atypical antipsychotics .\n",
            "In order to further explore this relationship we analyzed efficacy and weight change data from the InterSePT study .\n",
            "Method : The InterSePT study was a two-year , randomized study of clozapine and olanzapine in @ schizophrenic patients at high risk for suicide .\n",
            "Changes in weight from baseline to end of study were compared between treatments and were correlated with clinical response as measured by changes in PANSS scores , Calgary Depression Scores , Covi Anxiety Scores and measures of suicidality using ANOVA .\n",
            "Results : During the @-year study , patients treated with both clozapine and olanzapine gained weight .\n",
            "Clozapine was associated with a mean percent weight gain of ~ @ % while olanzapine was associated with a ~ @ % mean percent gain .\n",
            "Olanzapine patients gained significantly more weight and within a shorter period of time than clozapine patients .\n",
            "A significant correlation between weight gain and improvements in clinical response was observed for both treatment groups , however , the correlation was stronger for clozapine .\n",
            "Conclusions : These results suggest that there is greater risk for weight gain with olanzapine , but a stronger correlation between clinical improvement and weight gain with clozapine .\n",
            "Reference : Basile VS , Masellis M , Mcintyre RS , Meltzer HY , Lieberman JA , Kennedy JL .\n",
            "Genetic dissection of atypical antipsychotic - induced weight gain : novel preliminary data on the pharmacogenetic puzzle .\n",
            "J Clin Psychiatry .\n",
            "@ ; @ Suppl @ : @-@ .\n",
            "Simpson MM , Goetz RR , Devlin MJ , Goetz SA , Walsh BT .\n",
            "Weight gain and antipsychotic medication : differences between antipsychotic-free and treatment periods .\n",
            "J Clin Psychiatry .\n",
            "@ Sep ; @ ( @ ) : @-@ .\n",
            "Background : Cognitive deficits in schizophrenia are associated with psychosocial deficits that are primarily responsible for the poor long-term outcome of this disease .\n",
            "Auditory sensory gating P@ deficits are correlated with neuropsychological deficits in attention , one of the principal cognitive disturbances in schizophrenia .\n",
            "Our studies suggest that the alpha@ nicotinic acetylcholine receptor ( alpha@ nAChR ) agonist tropisetron might be a potential therapeutic drug for cognitive deficits in schizophrenia .\n",
            "Therefore , it is of particular interest to investigate the effects of tropisetron on the cognitive deficits in patients with schizophrenia.Methods : A randomised , placebo-controlled trial of tropisetron in patients with schizophrenia was performed .\n",
            "A total of @ patients with chronic schizophrenia who had taken risperidone ( @ to @ mg/day ) were enrolled .\n",
            "Subjects were randomly assigned to a fixed titration of tropisetron ( n = @ , @ mg/day ) or placebo ( n = @ ) in an @-week double-blind trial .\n",
            "Auditory sensory gating P@ deficits and Quality of Life Scale ( QLS ) , Cambridge Neuropsychological Test Automated Battery ( CANTAB ) , and Positive and Negative Syndrome Scale ( PANSS ) scores were measured.Results : In all , @ patients completed the trial .\n",
            "Tropisetron was well tolerated .\n",
            "Administration of tropisetron , but not placebo , significantly improved auditory sensory gating P@ deficits in non-smoking patients with schizophrenia .\n",
            "The score on the rapid visual information processing ( sustained visual attention ) task of CANTAB was significantly improved by tropisetron treatment .\n",
            "Total and subscale scores of PANSS were not changed by this trial .\n",
            "QLS scores in the all patients , but not non-smoking patients , were significantly improved by tropisetron trial.Conclusions : This first randomised , double-blind , placebo-controlled trial supports the safety and efficacy of adjunctive tropisetron for treatment of cognitive deficits in schizophrenia .\n",
            "@ Shiina et al ; licensee BioMed Central Ltd .\n",
            "Background : Thalamic projections to the prefrontal cortex ( PFC ) are critical for cognition , and disruptions in these circuits are thought to underlie the pathophysiology of schizophrenia .\n",
            "Cognitive remediation training ( REM ) is a behavioral intervention that holds promise for improving cognition and functioning in schizophrenia ; however , the extent to which it affects thalamo-prefrontal connections has not been researched .\n",
            "This study sought to determine whether patients with schizophrenia who undergo a placebo-controlled trial of REM show increased functional connectivity between the thalamus and PFC , and whether these changes correspond to improvements in cognition .\n",
            "Methods : Twenty-six patients with chronic schizophrenia were randomized to either @ hours ( over @ weeks ) of a drill-and-practice working memory-focused REM condition or an active placebo condition .\n",
            "All participants underwent cognitive assessment ( MATRICS ) , as well as both resting and task-based functional magnetic resonance imaging before and after their respective intervention .\n",
            "All clinicians , technicians , and raters were blinded to participant condition .\n",
            "Results : We observed changes in resting-state connectivity in the PFC for the REM group but not for the placebo group .\n",
            "Increased intrinsic connectivity between the thalamus and right middle frontal gyrus correlated with improvements in overall cognition .\n",
            "Additionally , lower baseline cognition correlated with greater increases in connectivity between the thalamus and PFC. Similar findings were observed when patients were scanned during a working memory task .\n",
            "Conclusions : These results suggest that increases in thalamo-prefrontal circuitry correspond with training-related improvements of the cognitive deficits associated with schizophrenia .\n",
            "Copyright   @ Society of Biological Psychiatry .\n",
            "The prospective single blind controlled design method was used to evaluate the clinical effect of clozapine and chlorpromazine in the treatment of @ negative symptom schizophrenic patients .\n",
            "The results were evaluated by SANS scores ?\n",
            "It indicated that total SANS scores and each of the five SANS factors were significantly reduced before and after clozapine treatment ( P < @ .\n",
            "@ or @ .\n",
            "@ ) .\n",
            "The effect of clozapine was much better than that of chlorpromazine , the difference is significant statistically ( P < @ .\n",
            "Cognitive Behavioral Therapy ( CBT ) is frequently used to attenuate the severity of positive schizophrenia symptoms ; however , few studies have focused on attenuating negative symptoms .\n",
            "Recently , researchers have become interested in the effects of mindfulness-based intervention ( MBI ) on schizophrenia , but the lack of evidence-based results from random clinical trials ( RCTs ) has limited their effectiveness .\n",
            "Moreover , longitudinal data must be examined using appropriate study designs .\n",
            "We recruited @ schizophrenia patients and randomly assigned them to an MBI or to a treatment-as-usual group .\n",
            "Negative symptoms , positive symptoms , mindfulness , and depression were assessed at baseline , post-course , and at a @-month follow-up .\n",
            "Descriptive analysis and generalized estimating equations ( GEEs ) were used to examine the effects of MBI .\n",
            "We found that MBI mitigated the severity of negative symptoms and of general schizophrenic psychopathology except for the positive symptoms and for those of depression .\n",
            "Unexpectedly , we did not find long-term effect of mindfulness on negative symptoms .\n",
            "Larger sample sizes , long-term practical course , more rigorous study procedures , and a double-blind design should be considered in future studies .\n",
            "Background : Many patients with mental illness receive psychotropic medicine in high dosages and from more than one drug .\n",
            "One of the consequences of this practice is obesity , which is a contributing factor to increased physical morbidity and premature death .\n",
            "Methods : Our study was a cluster-randomized intervention study involving @ facilities and @ patients diagnosed with severe mental illnesses ( @ % schizophrenia ) .\n",
            "The intervention period was @ months and consisted of teaching sessions with the staff and evaluating the patients ' intake of psychotropic medication .\n",
            "At index , @ % met criteria for obesity and @ % met criteria for overweight .\n",
            "Waist circumferences were @ cm for men and @ cm for women .\n",
            "Olanzapine , clozapine and quetiapine were the most common prescribed antipsychotics .\n",
            "Mean values of daily doses of antipsychotic were @ .\n",
            "Results : The intervention showed no significant differences between the intervention and control group regarding psychotropic treatment .\n",
            "At follow up , independent of intervention , patients receiving antipsychotic polypharmacy had a larger waist circumference compared with patients receiving antipsychotic monotherapy of @ cm ( @-@ ) ( p = @ ) .\n",
            "Discussion and conclusion : We found both a high prevalence of obesity and that the patients received treatment with antipsychotic polypharmaceutics in high dosages .\n",
            "Active awareness did not change practice and we must think of other ways to restrict treatment with psychotropics in this group of patients .\n",
            "Introduction : GBP , an anticonvulsant marketed as an add-on therapy for partial epilepsy , used as an anti-manic agent , has been shown to be effective in reducing manic symptoms ( in @ to @ % of patients ) at doses as high as @ mg/day , but generally below @ mg/day .\n",
            "This action , evident in the first @-@ weeks , was associated to few mild side-effects , like somnolence , short-term memory disturbances and ataxia , which tened to spontaneously resolve reducing the dose or within a few days of therapy .\n",
            "As the interpretation of the therapeutic role of GBP in previous reports was difficult because of the drug being always associated to a wide range of other agents in varying doses , we tried to assess efficacy and safety of GBP versus VPA as adjunct to a fixed dose of neuro-leptics ( NL ) in patients hospitalized because of acute manic symptomatology .\n",
            "Methods : After hospitalization patients were evaluated for eligibility and randomly assigned to receive BGP or VPA in adjunct to a fixed dose of NL .\n",
            "GBP was titrated in three days to @ mg/day , and VPA to @ mg/day .\n",
            "If the patient had not achieved a satisfactory response , the dose could be increased up to a maximum of GBP @ mg/day or VPA @ mg/day .\n",
            "Patients with a good response were discharged from hospital on day @ , with a schedule for NL tapering .\n",
            "Inclusion criteria were : males and females , age > @ , diagnosis of bipolar and schizoaffective disorder and schizophrenia , mean score on BPRS items No. @ and @ between @ and @ , informed consent .\n",
            "Exclusion criteria were current lithium therapy , previous use of GBP or VPA , renal insufficiency , chronic active hepathitis .\n",
            "Evalutation criteria : decrease in the score on the three BPRS items considered for inclusion ; total BPRS score at the end of the visit versus baseline ; score on the subsets of BPRS rating psychotic ( items @ , @ , @ , @ , @ , @ , @ , @ , @ ) , neurotic ( items @ , @ , @ , @ ) , depressive ( items @ , @ , @ , @ , @ , @ ) and manic ( items @ , @ , @ , @ , @ ) symptoms .\n",
            "Side effects were collected at every visit .\n",
            "A standard NL therapy was given to all patients at hospital admission .\n",
            "The preferred NL was haloperidol at a dose of @ mg/kg/day .\n",
            "At day @ , if a marked improvement in manic symptoms was observed , the patient was discharged and instructed to gradually reduce the NL dose during the two following weeks .\n",
            "Results : @ patients were enrolled , @ in the GBP and @ in the VPA group , and all terminated the study .\n",
            "Gender , age and diagnosis distributions were non-significantly different in the two groups .\n",
            "BPRS items @ , @ , @ mean score was significantly more reduced by GBP than VPA ( Delta of ?\n",
            "@ % with GBP and ?\n",
            "@ % with VPA , p < @ ) .\n",
            "Total BPRS score was reduced by @ % and @ % by GBP and VPA respectively , a not significant difference .\n",
            "While the score reduction in the psychotic and depressive subset of BPRS were insignificantly different in the two treatment groups , GBP was significantly better in reducing neurotic ( Delta of ?\n",
            "@ % versus ?\n",
            "@ % of VPA , p < @ ) and manic ( Delta of ?\n",
            "@ % versus ?\n",
            "@ % of VPA , p < @ ) symptom subsets .\n",
            "On four of the five items of the manic subset ( Elevated mood , grandiosity , excitement , motor hyperactivity ) GBP achieved significantly greater decreases , having day-@ decrease rates of @-@ % against @-@ % of VPA .\n",
            "Side-effects ( drowsiness , hypersomnia , ataxia , nausea , hypotension ) have been observed in about @ % of cases , without any significant incidence difference between the groups .\n",
            "Conclusions : Our data should be considered with caution because of the small numbers and the open label character of the study , but they give a further evidence of GBP 's efficacy in specifically reducing manic symptomatology , in an amount similar or even higher than VPA , and without important side-effects .\n",
            "DS : SZ ; Not in mk CN : P. @\n",
            "Is olanzapine more effective for treating neurocognitive deficits than risperidone or haloperidol in people with schizophrenia ?\n",
            ", METHODS , Design : Randomised controlled trial. , Allocation : Concealed .\n",
            "Blinding : Double blind .\n",
            "Follow up period : @ weeks. , Setting : @ sites , USA and Canada ; July @ to September @ .\n",
            ", Patients : @ people with schizophrenia or schizoaffective disorder ( DSM-IV ; mean age @ years ; @ % men ) .\n",
            "Exclusions : < @ or > @ years old ; fewer than two positive items on the Positive and Negative Symptoms scale with a score > / = @ ; score < @ on the Brief Psychiatric Rating Scale ; non-English speaking ; < @ years since first diagnosis , treatment or hospitalisation ; neurological disorder ; head injury ; serious illness ; untreated hypothyroidism or hyperthyroidism ; agranulocytosis ; pregnant or nursing ; substance dependence ; treatment with depot antipsychotics , reversible monoamine oxidase inhibitor , clozapine , fluvoxamine , or lithium ; prophylactic use of anticholinergics ; electroconvulsive therapy in previous month ; or allergic to study medication. , Intervention : Olanzapine ( @-@ mg/day , mean dose @ mg / day ) ; risperidone ( @-@ mg/day , mean dose @ mg/day ) ; haloperidol ( @-@ mg/day , mean dose @ mg/day ) .\n",
            ", Outcomes : Improved neurocognition measured by a composite score derived from individual domains of executive function ( Trails B , Wisconsin Card Sorting Task @-card version ) , learning and memory ( Rey Auditory Verbal Learning Test with Crawford Alternative , Rey-Osterrieth Complex Figure Test ) , processing speed ( Wechsler Adult Intelligence Scale ( WAIS ) -- Revised Digit Symbol , Trails A ) , attention/vigilance ( Continuous Performance Test ) , verbal working memory ( WAIS-@ Letter-number Sequencing ) , verbal fluency ( Controlled Oral Association Test , Category Instances ) , motor function ( Grooved Pegboard ) , and visuospatial ability ( Rey-Osterrieth Complex Figure Test ) .\n",
            "Executive functions and learning and memory were given twice the weighting of the other domains. , Patient follow up : Olanzapine @ % ; risperidone @ % ; haloperidol @ % .\n",
            ", MAIN RESULTS , In last observation carried forward analyses , there was no significant difference in neurocognition between the three groups .\n",
            "However , in analyses of people who completed @ weeks ' treatment , haloperidol improved neurocognition less than olanzapine ( p < @ ) and risperidone ( p = @ ) .\n",
            "There was no difference in improvement between olanzapine and risperidone ( p = @ ) .\n",
            ", CONCLUSION , Olanzapine and risperidone may improve ncurocognitive function more than haloperidol in people with schizophrenia who manage to continue treatment for @ weeks. , NOTES , Results should be interpreted with caution due to the high discontinuation rate .\n",
            "The main reasons for discontinuation were : poor compliance ( @ % ) , adverse events ( @ % ) , lack of efficacy ( @ % ) , participant decision ( @ % ) .\n",
            "Discontinuation was not significantly different between treatments .\n",
            "Background : The study was an investigation of the effects of a @-week cognitive remediation program ( NEUROCOM ) combined with a comprehensive psychosocial programme ( OPUS ) for patients with first episode schizophrenia compared with the comprehensive psychosocial programme alone .\n",
            "Methods : A total of @ stable outpatients ( aged @-@ ) with a first episode schizophrenia spectrum disorder were randomly assigned to cognitive remediation ( CRT ) combined with OPUS treatment or OPUS treatment alone .\n",
            "The CRT programme used computer-exercises , interaction-based compensatory exercises and competence dialogues .\n",
            "Statistical analysis of effect was based on the intention-to-treat principle .\n",
            "Results : At post-training @ patients were available for assessments : The NEUROCOM group had improved significantly on Rosenberg Self-Esteem scale , PANSS General Psychopathology , and the Verbal Learning domain .\n",
            "At follow-up assessment , @ patients were available for assessments : The NEUROCOM group retained the significant improvements on the Verbal Learning domain .\n",
            "Significant improvements were also observed on the Working Memory domain and PANSS positive symptoms , while improvement on the Composite Score was marginally significant .\n",
            "No effect was found on a measure of functional capacity .\n",
            "Discussion : The results correspond to meta-analytic evidence of small to moderate effects of cognitive remediation .\n",
            "Our data indicate that some effects are stable while others are only maintained if the treatment period is prolonged or alternatively replaced by booster sessions .\n",
            "The lack of effect on functional capacity may be due to a ceiling effect on the UPSA-B .\n",
            "The long-term effect on positive symptoms might reflect a direct effect of CRT or an effect of the combination of CRT and OPUS treatment .\n",
            "BACKGROUND : Trajectory studies highlight heterogeneity in treatment response , although they are yet to systematically differentiate between antipsychotic medications .\n",
            "AIMS : To compare treatment response trajectories across antipsychotic medication groups .\n",
            "METHOD : Data were analyzed from Phase @ of CATIE , an @-month double-blind randomized controlled trial of chronic schizophrenia .\n",
            "Change on recurrent Positive and Negative Syndrome Scale ( PANSS ) administrations for @ patients was used to index treatment response trajectories up to @ months .\n",
            "Trajectory groups were identified with mixed-mode latent class regression modeling .\n",
            "Groups were derived for all participants , and separately for completers , dropouts , and each antipsychotic medication ( olanzapine , perphenazine , quetiapine , risperidone , ziprasidone ) and then characterized .\n",
            "RESULTS : Trajectory analysis of the entire sample identified that @ % of participants belonged to a group of responders .\n",
            "This figure increased to @ % for completers , and fell to @ % for dropouts .\n",
            "Olanzapine treated patients were significantly more likely than other treatment groups to belong to the trajectory of responders ( n = @ , @ % ; Chi = @ , df = @ , p < .@ ) .\n",
            "Separate trajectory analyses of each medication group showed that all medication groups showed two trajectories except olanzapine that had three trajectories and the only trajectory that attained a @ % PANSS reduction by endpoint .\n",
            "CONCLUSIONS : Trajectories of treatment response differ between antipsychotic medications and demonstrate substantial heterogeneity in chronic schizophrenia .\n",
            "( PsycINFO Database Record ( c ) @ APA , all rights reserved ) ( journal abstract )\n",
            "The NAVIGATE program was developed for the Recovery After Initial Schizophrenia Episode-Early Treatment Program ( RAISE-ETP ) study , which compared NAVIGATE to usual Community Care in a cluster randomized design involving @ sites and @ patients .\n",
            "This article describes the approach to training and implementing the NAVIGATE program at the @ sites ( including @ practitioners ) randomized to provide it , and to evaluating the fidelity of service delivery to the NAVIGATE model .\n",
            "Fidelity was evaluated to five different components of the program , all of which were standardized in manuals in advance of implementation .\n",
            "The components included four interventions ( Individualized Resiliency Training , Family Education Program , Supported Employment and Education , Personalized Medication Management ) and the overall organization ( staffing and structure ) of the NAVIGATE team .\n",
            "Most of the sites demonstrated acceptable or higher levels of fidelity in their implementation of the four interventions and the organization of the program , with all @ sites demonstrating at least acceptable overall fidelity to the NAVIGATE program .\n",
            "The results indicate that the NAVIGATE program can be implemented with good fidelity to the treatment model in a diverse array of community mental health care settings serving persons with a first episode psychosis .\n",
            "Rationale : Weight gain and metabolic consequences associated with the use of antipsychotics have been a matter of concern and debate over the last decades .\n",
            "It is essential to identify patients in a higher risk to gain weight to prevent harm in an earlier stage .\n",
            "Previous data from RCTs have subject with lower body mass index ( BMI ) are more likely to gain weight when receiving Olanzapine .\n",
            "We report data from a long term , pragmatic , randomized controlled trials in which Olanzapine was compared to First Generation Antipsychotics ( FGAs ) .\n",
            "Methods : This is a multicenter , pragmatic , randomized study conducted in Brazil , comparing Olanzapine with FGAs , at hospitalization and during a @-month follow-up .\n",
            "Independent outcome assessors were blinded to treatment allocation .\n",
            "After hospital discharge , subjects were followed up for eleven months .\n",
            "Results : @ patients were allocated to Olanzapine ( n = @ ) and FGA ( n = @ ) .\n",
            "Most of participants were male , caucasians , single , and aged @ years-old on average .\n",
            "Attrition was low during follow-up ( @ % ) with no statistically significant differences ( p = @ ) between groups .\n",
            "Mean dose of olanzapina was @ mg/day ( SD @ mg ) and the median was @ mg/day .\n",
            "Haloperidol was the most prescribed FGA ( @ patients ) , with a mean dose of @ mg/day ( median @ mg/day ) .\n",
            "Half of patients ( @ % ) on olanzapine and @ % of those on FGAs used concomitant medications during hospitalization ( Pearson ?\n",
            "@ = @ ; df = @ ; p = @ ) .\n",
            "Patients on Olanzapine showed higher improvements in PANSS negative and general psychopathology subscales .\n",
            "Olanzapine was also associated to higher improvement in a number of health related quality of life outcomes .\n",
            "Patients on both groups gained weight during trial , with a higher mean in the Olanzapine group ( @ ; @ % CI @ - @ vs. @ ; @ % CI @-@ ) and a correspondent increase in the Body Mass Index ( BMI ) : @ ( @ % CI @-@ ) vs. @ ( @ % CI @-@ ) .\n",
            "It was found a strong significant linear trend : in both groups , participants with higher baseline BMI had higher endpoint values ( R = @ ; R@ = @ ; p < @ ) .\n",
            "Results from the linear regression of the effects of the main variables on the endpoint BMI showed that the main determinant factor was baseline BMI ( ?\n",
            "= @ , SD @ ) .\n",
            "The whole set of variables explain almost @ % of the variance ( R = @ ; R@ = @ ; p-value < @ ) .\n",
            "Conclusions : results from this effectiveness study differ substantially from those reported previously , where patients with lower BMI had higher rates of weight gain .\n",
            "In this trial , those with higher BMI were more likely to gain weight gain and increase their BMI at end of trial .\n",
            "If confirmed , current findings suggest special attention must be given to subjects with high BMI / body weight when starting antipsychotics , and interventions should address this problem at the very beginning of treatment .\n",
            "Background : Cannabis use is highly prevalent in people with schizophrenia spectrum disorders ( SSD ) , and correlates with increased levels of psychotic symptoms , more re-hospitalizations , reduced compliance to medication and therapy , etc .\n",
            "The Timeline Follow-Back ( TLFB ) instrument is often used to assess changes in alcohol and drug consumption over time .\n",
            "Little is known about the validity of self-reported cannabis use by TLFB , especially in the context of randomized trials .\n",
            "Our aim with this study is to validate self-reported cannabis use in SSD against blood-samples in a randomized trial of a psychosocial intervention .\n",
            "Methods : CapOpus is an ongoing , observer-blinded trial that has randomized @ patients with comorbid cannabis use disorder and SSD .\n",
            "Patients are randomized to receive ( i ) specialized treatment consisting primarily of motivational interviewing , cognitive behaviour therapy , and social skills training in addition to treatment as usual ( TAU ) , or ( ii ) TAU .\n",
            "Patients are interviewed at baseline , at @ months ( when treatment has finished ) and at @ months .\n",
            "TLFB is used to measure self-reported cannabis use in all patients , establishing both number of days in the past @ days with cannabis use and the amounts and types used on each day .\n",
            "THC level is measured by blood samples whenever possible and assented to .\n",
            "Correlations between TLFB and THC in blood will be presented at the conference .\n",
            "Primarily , self-reported number of days will be validated .\n",
            "Secondarily , a construct of amounts and days will also be validated , since the range of daily consumption may vary grossly both between and within patients .\n",
            "We investigated the tremolytic effect of long-acting propranolol ( propranolol-LA ) in six subjects with drug-induced parkinsonism ( DIP ) , using a double-blind , placebo-controlled , crossover experimental design .\n",
            "Subjects received propranolol-LA for @ weeks and placebo for @ weeks , with no change in neuroleptic treatment .\n",
            "Tremor frequency and amplitude were objectively quantified at the end of each @-week period by computerized tremorgram recording .\n",
            "There were no significant differences in attenuation of DIP tremor by propranolol-LA and placebo .\n",
            "Previous investigations reported in the literature have found propranolol to attenuate the tremor of idiopathic parkinsonism ( IPD ) .\n",
            "It is expected that DIP and IPD tremor would respond similarly to propranolol if a solely peripheral or spinal cord tremolytic action were operative .\n",
            "A possible differential attenuation of IPD tremor and DIP tremor provides support for the concept of a higher central tremolytic mechanism of beta - adrenergic receptor-blocking drugs .\n",
            "Recent research has shown that worry is associated with distressing paranoia .\n",
            "Therefore , the aim was to target worry in a therapeutic intervention for individuals with delusions .\n",
            "It was predicted that a worry intervention would reduce levels of worry and paranoia distress .\n",
            "Twenty-four individuals with persistent persecutory delusions and high levels of worry were randomly assigned to receive a four session cognitive-behavioural worry intervention ( W-CBT ) or treatment as usual ( TAU ) .\n",
            "The worry intervention was specifically designed not to target the content of delusions .\n",
            "In this open-label evaluation , assessments of worry and paranoia were conducted at baseline , at one month ( end of treatment ) and at two months .\n",
            "The worry intervention achieved a statistically significant reduction in worry which was maintained at two month follow up .\n",
            "A significant reduction in delusional distress was also reported .\n",
            "There was an indication that the worry intervention may also reduce the frequency of paranoid thoughts but this was not statistically significant .\n",
            "In the first trial specifically for persecutory delusions , a brief worry intervention was shown to have benefits .\n",
            "The results support a causal role for worry in paranoid experience .\n",
            "Background : Omega-@ fatty acids as supplements or primary treatments for psychotic disorders have been of considerable interest for over a decade but the overall results of studies with omega-@ treatments for psychotic disorders have been inconsistent .\n",
            "Our main study attempted to determine which patients would benefit by omega-@ supplementation of antipsychotic treatment .\n",
            "In this report , we present the clinical outcomes of the treatment trial component of the study .\n",
            "Methods : Inclusion criteria for subjects were : ( @ ) current DSM-IV-defined diagnosis of schizophrenia , schizophreniform , schizoaffective disorder or bipolar disorder with psychosis ; ( @ ) did not meet DSM-IV criteria for a current substance-induced psychotic disorder , a psychotic disorder due to a general medical condition , delusional disorder , brief psychotic disorder , shared psychotic disorder ; ( @ ) current positive symptoms rated = @ ( moderate ) on one or more of these BPRS items : conceptual disorganization , grandiosity , hallucinatory behavior , unusual thought content ; ( @ ) in a early phase of illness as defined by having taken antipsychotic medications for a cumulative lifetime period of @ years or less , ( @ ) age @ to @ ; ( @ ) competent and willing to sign informed consent ; and ( @ ) for women , negative pregnancy test and agreement to use a medically accepted birth control method .\n",
            "Exclusion criteria were : ( @ ) serious neurological or endocrine disorder or any medical condition or treatment known to affect the brain ; ( @ ) any medical condition which requires treatment with a medication with psychotropic effects ; ( @ ) significant risk of suicidal or homicidal behavior ; ( @ ) cognitive or language limitations , or any other factor that would preclude subjects providing informed consent ; ( @ ) medical contraindications to treatment with risperidone , omega-@ supplements ( e.g. bleeding disorder , seafood allergies ) or placebo capsules ( e.g. allergies to capsule components ) ; ( @ ) lack of response to a prior adequate trial of risperidone ; @ ) currently taking omega-@ supplements .\n",
            "The trial lasted @ weeks ; the primary outcome measure was the BPRS total score .\n",
            "All subjects received treatment with risperidone ; the target dose was @ mg daily but doses up to @ mg per day were permitted .\n",
            "Concomitant allowed medications included benztropine mesylate , lorazepam , propranolol , zolpidem and rozerem .\n",
            "Subjects were randomly assigned on a @:@ basis to treatment with omega-@ or placebo .\n",
            "Each omega-@ capsule contained @ mg EPA and @ mg DHA as well as @ mg/g Tocopherol .\n",
            "The placebo was a soybean/corn blend .\n",
            "Subjects took one capsule twice a day .\n",
            "Results : The sample included @ subjects ; @ ( @ % ) were men .\n",
            "The mean age of subjects assigned to placebo was @ ( SD = @ ) years and @ ( SD = @ ) years for those assigned to omega-@ .\n",
            "Four had bipolar disorder ; the rest non-affective psychotic disorders .\n",
            "The mean lifetime days of antipsychotic treatment prior to study entry was @ ( @ % CI : @ , @ ) and the median number of days was @ .\n",
            "@ % of subjects had taken antipsychotics for @ days or less in their lifetime .\n",
            "The mean length of time in controlled treatment was @ ( SD = @ ) weeks with placebo and @ ( SD = @ ) weeks with omega-@ ( p = @ ) .\n",
            "Longitudinal analyses of risperidone daily dose ( averaged separately for each treatment week ) revealed a effect of time ( F = @ , df = @ , @ , p = @ ) but no treatment by time interaction or effect of time .\n",
            "Longitudinal analyses of lorazepam daily dose ( averaged over each treatment week ) revealed a treatment by time interaction ( F = @ , df = @ , @ , p < @ ) .\n",
            "Lorazepam average dose was significantly lower in the placebo condition at week @ ( p < @ ) and week @ ( p = @ ) and at a trend level at week @ ( p = @ ) and week @ ( p = @ ) .\n",
            "Given the difference in lorazepam prescription , average lorazepam dose per week was included in the analysis model of BPRS scores over time .\n",
            "This analysis revealed a significant effect of treatment condition ( F = @ , df = @ , p = @ ) favoring omega-@ treatment .\n",
            "Least square mean est mates of baseline BPRS scores were @ ( SE = @ ) for omega-@ and @ ( SE = @ ) for placebo treatment ; corresponding week @ scores were @ ( SE = @ ) and @ ( SE = @ ) .\n",
            "Secondary analyses of BPRS factors revealed a trend ( p = @ ) difference in the hostilityuncooperativeness factor favoring omega-@ treatment but no difference on positive , negative or depression/anxiety factors .\n",
            "Conclusions : Our data suggest that omega-@ supplementation of antipsychotic treatment with early phase patients may be clinically useful , especially given the favorable side effect profile of omega-@ supplements .\n",
            "Prior omega-@ studies in psychotic disorders have often focused on positive symptom outcomes .\n",
            "Our data suggest that future studies should examine potential beneficial effects in other domains as well .\n",
            "INTRODUCTION : Despite clinical guidelines recommendations , many relatives of people with psychosis or bipolar disorder do not currently receive the support they need .\n",
            "Online information and support may offer a solution .\n",
            "METHODS AND ANALYSIS : This single-blind , parallel , online randomised controlled trial will determine clinical and cost-effectiveness of the Relatives Education And Coping Toolkit ( REACT ) ( including an online resource directory ( RD ) ) , compared with RD only , for relatives of people with psychosis or bipolar disorder .\n",
            "Both groups continue to receive treatment as usual .\n",
            "Independent , web-based variable , block , individual randomisation will be used across @ relatives .\n",
            "Primary outcome is distress at @ weeks ( measured by General Health Questionnaire ; GHQ-@ ) compared between groups using analysis of covariance , adjusting for baseline score .\n",
            "Secondary clinical outcomes are carer well-being and support .\n",
            "Cost-effectiveness analysis will determine cost of a significant unit change ( three-point reduction ) in the GHQ-@ .\n",
            "Costs include offering and supporting the intervention in the REACT arm , relevant healthcare care costs including health professional contacts , medications prescribed and time off ( or ability to ) work for the relative .\n",
            "Cost utility analysis will be calculated as the marginal cost of changes in quality-adjusted life years , based on EuroQol .\n",
            "We will explore relatives ' beliefs , perceived coping and amount of REACT toolkit use as possible outcome mediators .\n",
            "We have embedded two methodological substudies in the protocol to determine the relative effectiveness of a low-value ( pound@ ) versus higher value ( pound@ ) incentive , and an unconditional versus conditional incentive , on improving follow-up rates .\n",
            "ETHICS AND DISSEMINATION : The trial has ethical approval from Lancaster National Research Ethics Service ( NRES ) Committee ( @/NW/@ ) and is overseen by an independent Data Monitoring and Ethics Committee and Trial Steering Committee .\n",
            "Protocol version @ was approved on @ January @ .\n",
            "All updates to protocols are uploaded to the National Institute for Health Research ( NIHR ) Journals Library .\n",
            "A full statistical analysis plan is available at https://figshare.com/account/home#/projects/@ .\n",
            "Publications will be in peer-reviewed journals ( open access wherever possible ) .\n",
            "Requests for access to the data at the end of the study will be reviewed and granted where appropriate by the Trial Management Group .\n",
            "TRIAL REGISTRATION NUMBER : ISRCTN@ , pre-results .\n",
            "Introduction : Efficacy and safety of aripiprazole administered at doses lower than those previously studied systematically were investigated in patients with acute exacerbation of schizophrenia .\n",
            "Methods : In this double-blind , multicenter study , @ patients requiring inpatient hospitalization for acute relapse of schizophrenia were randomized to one of three fixed doses of aripiprazole ( @ , @ , or @ mg/day ) or placebo for @ weeks .\n",
            "Efficacy and safety parameters were assessed weekly .\n",
            "Primary outcome measure was mean change from baseline in Positive and Negative Syndrome Scale ( PANSS ) Total score at endpoint .\n",
            "Results : Aripiprazole @ mg/day produced statistically significantly greater improvements from baseline compared with placebo for PANSS Total at endpoint ( -@ vs -@ ; P = .@ ) and at weeks @-@ .\n",
            "Aripiprazole @ mg/day did not produce significantly greater improvement in PANSS Total compared with placebo at endpoint , although significant differences were seen at weeks @-@ .\n",
            "No statistically significant improvements compared with placebo were achieved with aripiprazole @ mg/day at any time points .\n",
            "All aripiprazole doses were well tolerated .\n",
            "Aripiprazole was not associated with significant extra pyramidal symptoms .\n",
            "Conclusion : While aripiprazole @ mg/day warrants further study , the @ mg/day dose provides effective and well-tolerated therapy for management of acute psychosis in patients with schizophrenia .\n",
            "Objective To investigate the health education of patients with schizophrenia hospitalized compliance .\n",
            "@ schizophrenic patients hospitalized in January @ @-@ randomly divided into two groups , Group A ( medication + health education ) @ cases , the admission that the implementation of health education , Group B ( control group ) medication + general care routine , the two groups were weeks of inpatient treatment compliance , assessment of the Brief Psychiatric Rating Scale ( bprs ) , insight and treatment attitude the questionnaire ( itaq ) and the inpatient observation Scale ( nosie ) .\n",
            "Results Group A of the assessment project the degree of improvement after four weeks of missionary were significantly higher than Group B , and improve time than Group B early , especially for hospital treatment compliance greatly improve .\n",
            "Objective : To exp lore the efficacy and safety of arip ip razole and clozap ine combination for the treatment of refractory schizophrenia .\n",
            "Methods : @ cases of chronic refractory schizophrenia were randomly assigned to two groups ( aripirazole with clozapine or clozapine alone ) for @ .\n",
            "months and were assessed with the brief psychiatric rating scale ( BPRS ) .\n",
            "Results : aripiprazole combined with clozapine was superior to clozapine alone , mored efficacy and less side effects .\n",
            "Conclusions :\n",
            "\" Background : Non-fatal suicide attempt is the most important risk factor for later suicide .\n",
            "Emergency department visits for attempted suicide are increasingly recognised as opportunities for intervention .\n",
            "However , no strong evidence exists that any intervention is effective at preventing repeated suicide attempts .\n",
            "We aimed to investigate whether assertive case management can reduce repetition of suicide attempts in people with mental health problems who had attempted suicide and were admitted to emergency departments .\n",
            "Methods : In this multicentre , randomised controlled trial in @ hospital emergency departments in Japan , we randomly assigned people aged @ years and older with mental health problems who had attempted suicide to receive either assertive case management ( based on psychiatric diagnoses , social risks , and needs of the patients ) or enhanced usual care ( control ) , using an internet-based randomisation system .\n",
            "Interventions were provided until the end of the follow-up period ( ie , at least @ months and up to @ years ) .\n",
            "Outcome assessors were masked to group allocation , but patients and case managers who provided the interventions were not .\n",
            "The primary outcome was the incidence of first recurrent suicidal behaviour ( attempted suicide or completed suicide ) ; secondary outcomes included completed suicide and all-cause mortality .\n",
            "This study is registered at ClinicalTrials.gov ( NCT@ ) and UMIN-CTR ( C@ ) .\n",
            "Findings : Between July @ , @ , and Dec @ , @ , @ eligible participants were randomly assigned , @ to the assertive case management group and @ to the enhanced usual care group .\n",
            "We noted no significant difference in incidence of first recurrent suicidal behaviour between the assertive case management group and the enhanced usual care group over the full study period ( log-rank p = @V % @ ) .\n",
            "Because the proportional hazards assumption did not hold , we did ad-hoc analyses for cumulative incidence of the primary outcome at months @ , @ , @ , @ , and @ after randomisation , adjusting for multiplicity with the Bonferroni method .\n",
            "Assertive case management significantly reduced the incidence of first recurrent suicidal behaviour up to the @-month timepoint ( @-month risk ratio @VP , @ % CI @V@  @V ; p = @V @ ) , but not at the later timepoints .\n",
            "Prespecified subgroup analyses showed that the intervention had a greater effect in women ( up to @ months ) , and in participants younger than @ years and those with a history of previous suicide attempts ( up to @ months ) .\n",
            "We did not identify any differences between the intervention and control groups for completed suicide ( @ [ @ % ] of @ vs @ [ @ % ] of @ , log-rank p = @Vf@ ) or all-cause mortality ( @ [ @ % ] of @ vs @ [ @ % ] of @ , log-rank p = @Vi@ ) .\n",
            "Interpretation : Our results suggest that assertive case management is feasible in real-world clinical settings .\n",
            "Although it was not effective at reducing the incidence of repetition of suicide attempts in the long term , the results of our ad-hoc analyses suggested that it was effective for up to @ months .\n",
            "This finding should be investigated in future research . \"\n",
            "Augmentation of dopaminergic neurotransmission has been suggested as a treatment strategy for negative symptoms of schizophrenia .\n",
            "On the basis of open studies that reported the potential benefit of deprenyl ( selegiline ) as augmentation to antipsychotic treatment ( this double-blind , controlled study was designed to further address this question .\n",
            "Sixteen schizophrenic patients with predominately negative symptoms , manifesting clinical stability on maintenance antipsychotic treatment , were randomly assigned to receive either deprenyl @ mg/day or placebo in addition to their antipsychotic treatment for @ weeks .\n",
            "Clinical follow-up and ratings were done during this period and for @ more weeks after deprenyl discontinuation .\n",
            "Both groups showed a statistically significant but clinically marginal improvement over the @ weeks of deprenyl or placebo treatment .\n",
            "This improvement was abolished during the postdiscontinuation follow-up period .\n",
            "Deprenyl at a dose of @ mg/day did not offer therapeutic benefit in our patients .\n",
            "A significant placebo effect was observed , which may be the result of increased patient-doctor contact during the study .\n",
            "Early and maintained treatment is important for better long-term outcomes in schizophrenia .\n",
            "We hypothesized that treatment with injectable risperidone long-acting therapy ( RLAT ) would be associated with improved outcomes in recently diagnosed patients compared with those having longer illness duration .\n",
            "Post-hoc analyses were conducted from a @-year study of stable patients receiving RLAT ( @ or @ mg every @ weeks ) to compare patients diagnosed with schizophrenia in [ less-than or equal to ] @ years ( recently diagnosed ; n = @ ) with those diagnosed more than @ years ( n = @ ) .\n",
            "Relapse rates were @ and @ % , respectively [ P = @ , chi ; hazard ratio @ ( @ % confidence interval = @ , @ ) ] .\n",
            "Both groups improved significantly in mean total Positive and Negative Syndrome Scale and Clinical Global Impressions-Severity ( CGI-S ) scores ( P < @ ) .\n",
            "Recently diagnosed patients showed greater improvement versus patients diagnosed for more than @ years in adjusted mean Positive and Negative Syndrome Scale total ( -@ + / -@ vs.-@ + / -@ ; P = @ ) and Clinical Global Impressions-Severity ( -@ + / -@ vs.-@ + / -@ ; P = @ ) scores .\n",
            "The most common adverse events were insomnia ( @ vs. @ % ) , psychiatric disorders ( @ vs. @ % ) , headache ( @ vs. @ % ) , anxiety ( @ vs. @ % ) , and influenza ( @ vs. @ % ) .\n",
            "These findings confirm the benefit of RLAT in patients with schizophrenia and suggest that earlier treatment with long-acting preparations is associated with better outcomes .\n",
            "The study aimed to identify patient characteristics associated with differences in outcomes of acute treatment in day hospitals and conventional hospital wards .\n",
            "Methods : Data were from the European Day Hospital Evaluation ( EDEN ) ( @a [ undefined ] \" @ ) , a multicenter randomized controlled trial comparing acute treatment in day hospitals and conventional wards in five European countries .\n",
            "All @ adult patients in the EDEN study who had a diagnosis of schizophrenia , mood disorders , neurotic disorders , and behavioral syndromes ( ICD-@ codes F@a [ undefined ] \" F@ ) and complete data on baseline variables were included .\n",
            "Outcomes were symptom levels ( Brief Psychiatric Rating Scale ) , subjective quality of life ( Manchester Short Assessment of Quality of Life ) , and social disability ( Groningen Social Disabilities Schedule ) assessed at discharge and at three and @ months postdischarge .\n",
            "Mixed - and main-effects models of interaction effects between patient characteristics and outcomes were generated .\n",
            "Results : Patientsa [ undefined ] ( TM ) age , diagnostic category , and living status ( alone or not ) did not predict differences in outcomes between the two settings .\n",
            "However , patients with higher symptom levels at baseline experienced greater symptom improvements after treatment on a ward , and those with more years of education had greater symptom improvements after day hospital treatment .\n",
            "Female patients had more favorable social disability outcomes after day hospital treatment , but no difference between the two settings was found for male patients .\n",
            "Conclusions : More severe symptoms may be a reason for admission to acute treatment on a conventional ward rather than a day hospital .\n",
            "Female patients and those with more education may benefit more from acute treatment in day hospitals .\n",
            "( PsycINFO Database Record ( c ) @ APA , all rights reserved ) ( journal abstract )\n",
            "Animal studies indicate that typical antipsychotics ( neuroleptics ) increase cocaine and amphetamine self-administration .\n",
            "Patients with psychiatric illnesses have high rates of substance abuse and frequently receive chronic typical antipsychotic therapy .\n",
            "This open , pilot study examined the effect of typical antipsychotic discontinuation on cocaine and amphetamine use in patients with psychiatric illnesses .\n",
            "Twenty-four evaluable outpatients were randomized to continue ( n = @ ) or discontinue ( n = @ ) chronic typical antipsychotic therapy .\n",
            "The atypical antipsychotic quetiapine was instituted , when necessary , for psychosis in the discontinuation group ( n = @ ) .\n",
            "Participants were assessed weekly over @ weeks with measures of psychiatric symptoms , drug use , and drug craving .\n",
            "Those discontinuing typical antipsychotics ( n = @ ) had significant reductions in drug craving compared with those continuing typical antipsychotics .\n",
            "No significant between-group differences in drug use were found .\n",
            "Typical antipsychotic discontinuation combined with a quetiapine switch for those with psychotic symptoms was associated with reduced drug craving .\n",
            "Definitive trials of typical antipsychotic discontinuation in dual-diagnosis patients are warranted\n",
            "Objective : Clinical trial using \" Omacor \" , a omega @ fatty acids containing EPA n ( @ mg ) and DHA ( @ mg ) as a suplement of antipsychotic medication to evaluate the clinical impact in schizophrenia patients .\n",
            "Methods : Simple-randomized clinical trial with two groups of @ Schizophrenic patients per group : control group with usual antipsichotic treatment and experimental group in which @ mg per day of \" Omacor \" was added to antipsychotic treatment .\n",
            "The study had a duration of @ months .\n",
            "Main outcome was PANSS value at @ and @ months and the need of hopitalisation related to clinical worsenig of schizophrenia .\n",
            "Other measures included depressive symptoms and somatic measures ( weight , blood presure ) .\n",
            "Results : @ patients were avaluated at the end of the trial ; @ from intervention group and @ from control .\n",
            "Results show a not significative tendency to reduce PANSS puntuation , especially negative and depressive symptoms in the Omacor group .\n",
            "Also somatic measures , as weight , blood presure and tryglicerids showed a significative reduction in the Omacor group .\n",
            "Conclusion : In our study , Omacor , a omega @ fatty acid medication used for hypertriglicidemia , added to standard antipsychotic traetment , has shown some promising results specially in metabolic risk variables .\n",
            "Limitations related to the sample size and the degree of adherence during the trial must be considered .\n",
            "Purpose : Asenapine is a novel psychopharmacologic agent being developed for the treatment of schizophrenia and bipolar disorder .\n",
            "In a double-blind trial , we evaluated the safety and tolerability of asenapine versus placebo and risperidone in patients with an acute exacerbation of schizophrenia .\n",
            "Methods : Patients were eligible for the study if they had a Positive and Negative Syndrome Scale ( PANSS ) score of at least @ at screening and baseline , a score of @ or higher on @ or more of the @ items of the PANSS positive subscale at screening and baseline , and a Clinical Global Impression score of @ or higher ( moderately ill ) at baseline .\n",
            "Patients meeting the inclusion criteria were randomly assigned to treatment with sublingual asenapine @ mg twice daily with oral placebo , oral risperidone @ mg twice daily with sublingual placebo , or double placebo for @ weeks .\n",
            "Adverse events and extrapyramidal symptoms were assessed weekly and @ days after study exit .\n",
            "Results : Of the @ patients who received study medication ( asenapine , n = @ ; risperidone , n = @ ; placebo , n = @ ) , @ patients ( @ % ) had @ or more adverse events .\n",
            "The most frequently reported events were headache and agitation ( placebo and risperidone ) , followed by transient sleep disturbances ( active medications ) .\n",
            "Although there were no significant between-group differences on formal ratings of extrapyramidal symptoms , hypertonia and hyperkinesia were more frequent with risperidone ( @ % and @ % , respectively ) than with placebo ( @ % , @ % ) or asenapine ( @ % , @ % ) , and concomitant use of antiparkinsonian drugs was more frequent with risperidone ( @ % ) than with asenapine ( @ % ) .\n",
            "Clinically significant weight gain ( @ % increase in body weight ) occurred more often with risperidone ( @ % ) than with asenapine or placebo ( @ % and @ % ; both P < @ vs risperidone ) .\n",
            "Mean weight gain was similar in all @ treatment groups among normal-weight patients but greater with risperidone among overweight patients .\n",
            "The incidence of hyperprolactinemia was higher with risperidone ( @ % ) than with asenapine or placebo ( @ % and @ % ) .\n",
            "Mean total cholesterol levels decreased from baseline to endpoint @ mmol/L for asenapine and @ mmol/L for placebo but increased from baseline to endpoint @ mmol/L for risperidone .\n",
            "Mean fasting glucose increased from baseline to endpoint @ mmol/L for asenapine , @ mmol/L for placebo , and @ mmol/L for risperidone .\n",
            "Changes in blood pressure and heart rate were comparably small in all @ treatment groups , and there were no cases of QTc prolongation > @ milliseconds in any group .\n",
            "Completion rates were higher in the asenapine and risperidone groups ( @ % and @ % , respectively ) than in the placebo group ( @ % ) .\n",
            "Withdrawal rates because of lack of efficacy and adverse events were , respectively , @ % and @ % with asenapine , @ % and @ % with placebo , and @ % and @ % with risperidone .\n",
            "Conclusions : Asenapine appears to be well tolerated by patients with acute schizophrenia , with little effect on total cholesterol or fasting glucose , and a low incidence of extrapyramidal symptoms , hyperprolactinemia , and clinically significant weight gain .\n",
            "Agitation is a major problem in acute schizophrenia .\n",
            "Still , only limited evidence exists on antipsychotic efficacy in severely agitated patients after the first @ hours .\n",
            "We aimed to investigate the efficacy of oral haloperidol , risperidone , and olanzapine in reducing psychotic agitation in severely agitated patients with schizophrenia or schizophreniform or schizoaffective disorder over @ hours using a prospective , randomized , rater-blinded , controlled design within a naturalistic treatment regimen .\n",
            "We enrolled @ severely agitated patients at acute care psychiatric units .\n",
            "Participants were randomly assigned to receive either daily haloperidol @ mg , olanzapine @ mg , or risperidone @ - @ mg over @ days .\n",
            "Positive and Negative Syndrome Scale psychotic agitation ( PANSS-PAS ) subscore was the primary outcome variable .\n",
            "A mixed model analyses was applied .\n",
            "All drugs were effective for rapid tranquillization within @ hours .\n",
            "Over @ days , the course differed between agents ( p < @ ) but none was superior .\n",
            "Dropouts occurred only in the risperidone and olanzapine groups .\n",
            "Men responded better to treatment than women during the initial @ hours ( p = @ ) as well as over the @ day course ( p < @ ) .\n",
            "No difference between drug groups was observed regarding diazepam or biperiden use .\n",
            "Oral haloperidol , risperidone , and olanzapine seem to be suitable for treating acute severe psychotic agitation in schizophrenia spectrum disorders .\n",
            "We observed a gender effect with poorer outcome in women .\n",
            " @\n",
            "Purpose : Although olanzapine may have advantages over other second-generation antipsychotics ( SGAs ) regarding longer time to treatment discontinuation among chronically ill patients , little evidence has been provided for the comparative effectiveness of SGAs in the acute phase .\n",
            "We aimed to determine if any of four SGAs were more effective in treating newly admitted acute schizophrenic patients .\n",
            "We performed a rater-blinded , randomized controlled trial of four SGAs in @ psychiatric emergency sites .\n",
            "Eligible patients were @-@ years old and met diagnostic criteria for schizophrenia , acute schizophrenia-like psychotic disorder , or schizoaffective disorder .\n",
            "A final total of @ patients were randomly assigned by means of sealed envelopes to receive risperidone ( @-@ mg/day ; n = @ ) , olanzapine ( @-@ mg/day ; n = @ ) , quetiapine ( @-@ mg/day ; n = @ ) , or aripiprazole ( @-@ mg/day ; n = @ ) , with follow-up at @ weeks .\n",
            "The primary outcome measure was all-cause treatment discontinuation .\n",
            "Results : Overall , @ % ( @/@ ) of patients discontinued the study medication before @ weeks : @ % for risperidone ; @ % for olanzapine ; @ % for quetiapine ; and @ % for aripiprazole .\n",
            "Time to treatment discontinuation for any cause was significantly longer in the olanzapine group than in the quetiapine ( p = @ ) or aripiprazole ( p = @ ) groups , but not compared to the risperidone group ( p = @ ) .\n",
            "Time to treatment discontinuation was significantly longer in the risperidone group than in the quetiapine group ( p = @ ) , but not compared to the aripiprazole group ( p = @ ) .\n",
            "However , the rate of p.r.n. intramuscular haloperidol use was significantly higher in the aripiprazole group than in other groups ( p = @ ) .\n",
            "Conclusion : Olanzapine and risperidone are superior to quetiapine and aripiprazole for the acute treatment of psychosis in hospitalized patients .\n",
            "This study compared the effects of haloperidol and perphenazine ( the most and the least potent high potency typical antipsychotics ) on serum total cholesterol ( TC ) and triglyceride ( TG ) levels in schizophrenic patients during @ wk of treatment .\n",
            "Thirty adult schizophrenics who complied with the study criteria were studied .\n",
            "Patients did not receive any medication that could affect weight , serum TC , or TG levels for @ wk .\n",
            "They were then randomly assigned to receive oral haloperidol or perphenazine for at least @ wk .\n",
            "TC and TG levels were measured @ wk before ( W-@ ) , at initiation of ( W-O ) , and @ wk after ( W-@ ) receiving antipsychotics .\n",
            "BACKGROUND : Elevated homocysteine is observed in schizophrenia and associated with illness severity .\n",
            "The aim of this study was to determine whether vitamins B@ , B@ , and folic acid lower homocysteine and improve symptomatology and neurocognition in first-episode psychosis .\n",
            "Whether baseline homocysteine , genetic variation , sex , and diagnosis interact with B-vitamin treatment on outcomes was also examined .\n",
            "METHODS : A randomized , double-blind , placebo-controlled trial was used .\n",
            "A total of @ patients with first-episode psychosis were randomized to an adjunctive B-vitamin supplement ( containing folic acid [ @ mg ] , B@ [ @ mg ] , and B@ [ @ mg ] ) or placebo , taken once daily for @ weeks .\n",
            "Coprimary outcomes were change in total symptomatology ( Positive and Negative Syndrome Scale ) and composite neurocognition .\n",
            "Secondary outcomes included additional measures of symptoms , neurocognition , functioning , tolerability , and safety .\n",
            "RESULTS : B-vitamin supplementation reduced homocysteine levels ( p = .@ , effect size = -@ ) .\n",
            "B-vitamin supplementation had no significant effects on Positive and Negative Syndrome Scale total ( p = .@ ) or composite neurocognition ( p = .@ ) .\n",
            "There were no significant group differences in secondary symptom domains .\n",
            "A significant group difference in the attention/vigilance domain ( p = .@ , effect size = @ ) showed that the B-vitamin group remained stable and the placebo group declined in performance .\n",
            "In addition , @ % of the sample had elevated baseline homocysteine levels , which was associated with greater improvements in one measure of attention/vigilance following B-vitamin supplementation .\n",
            "Being female and having affective psychosis was associated with improved neurocognition in select domains following B-vitamin supplementation .\n",
            "Genetic variation did not influence B-vitamin treatment response .\n",
            "CONCLUSIONS : While @-week B-vitamin supplementation might not improve overall psychopathology and global neurocognition , it may have specific neuroprotective properties in attention/vigilance , particularly in patients with elevated homocysteine levels , patients with affective psychosis , and female patients .\n",
            "Results support a personalized medicine approach to vitamin supplementation in first-episode psychosis .\n",
            "Despite its potential to provide clinically homogenous subgroups of schizophrenia for biological research , Karl Leonhard 's classification of schizophrenic psychoses ( Leonhard , @ ) receives little attention in modern psychiatry .\n",
            "The main reason for ignoring Leonhard schizophrenia subtypes has been the relative lack of methodologically well-designed clinical and biological studies that could validate the Leonhardian subdivision of schizophrenia .\n",
            "Apart from the pioneering efforts by Fish , Astrup , Ban and Beckmann , treatment response has seldom been used to establish the validity of the Leonhardian subtypes of schizophrenia .\n",
            "In order to determine the treatment response patterns of systematic catatonias , we conducted a series of randomized , double-blind , placebo-controlled , cross-over studies on the same group of patients .\n",
            "We attempted to augment the patients existing antipsychotic regime with benzhexol , lorazepam and amineptine in successive exploring the role of the cholinergic , GABA-ergic and dopaminergic neurotransmitter systems in the treatment response of systematic catatonias .\n",
            "Neither of the aforementioned agents had any major clinical effect on the subjects condition .\n",
            "In the present study we target the serotonergic system by adding citalopram as adjuvant to the patients antipsychotic medication .\n",
            "Method : All patients ( N = @ ) from two long-stay rehabilitation facilities who met research diagnostic criteria for systematic catatonia according to Leonhard ( Petho et al. @ ) enrolled a @-week long randomized , double-blind , placebo-controlled , cross-over study .\n",
            "Each subject received @-@ mg citalopram and an identical-looking placebo for @ weeks each , with a @ week wash-out period in-between .\n",
            "Other psychotropic medication was kept constant throughout the study .\n",
            "Assessment methods included BPRS , HDRS , SANS , CGI , AIMS , Simpson-Angus Scale , Barnes Akathisia Rating Scale , Van Putten Akinesia Scale , Bush-Francis Catatonia Rating Scale and the Modified Rogers scale .\n",
            "Assessments were made three times ( baseline , at the @th and @th week ) in both arms of the cross-over design .\n",
            "Results : In agreement with earlier findings ( Salokangas et al. @ ) , preliminary results have shown a noticeable decrease in the negative symptoms scores and a clinically significant increase in the subjects subjective well-being and activity .\n",
            "At this early point of evaluation , it seems , however , that no clinically significant changes have occurred in the subjects mental and psychomotor state .\n",
            "Citalopram was well-tolerated by all subjects .\n",
            "The results of our present and previous studies suggest that systematic catatonia characterized by persistent and severe deficit symptoms is a particularly treatment-resistant subgroup of chronic schizophrenia since drugs affecting the dopaminergic , cholinergic , GABA-ergic and serotonergic systems had no appreciable effects on the positive , negative and motor symptoms of subjects with systematic catatonia .\n",
            "Reference : Leonhard K. ( @ ) The Classification of Endogenous Psychoses .\n",
            "Irvington , New York .\n",
            "Reference : Petho B. , Ban T.A. ( @ ) DCR Budapest-Nashville in the diagnosis and classification of functional psychoses .\n",
            "Psychopathology @ : @-@ .\n",
            "Reference : Salokangas R.K.R. , Saarijarvi S. , Taiminen T. , Kallionemi H. , Lehto H. , Niemi H. , Tuominen J. , Ahola V. , and Syvalahti E. ( @ ) Citalopram as an adjuvant in chronic schizophrenia : a double-blind placebo-controlled study .\n",
            "Acta Psychiatr Scand @ : @-@ .\n",
            "Objective To study the Austrian treatment of schizophrenia cognitive function .\n",
            "Admission order , the method of stratified random method .\n",
            "Austrian Risperidone in the treatment of schizophrenia , @ cases of control In the @,@ weekend before treatment and after treatment , with positive symptoms and negative syndrome scale ( PANSS ) .\n",
            "Adverse reactions Scale ( TESS ) to evaluate the efficacy and side effects , the Wechsler Adult Intelligence Scale ( WAIS-R ) , Wechsler Memory Scale ( WMS ) and the Wisconsin Card Sorting Test ( WCST ) to assess cognitive function in patients before and after treatment changed .\n",
            "Prepare the field in the analysis of scale score .\n",
            "Results PANSS total score after treatment compared with before treatment , a significant difference ( P < @ ) .\n",
            "The Austrian group has @ % efficiency rate was @ % ; risperidone group was @ % , markedly effective rate of @ % .\n",
            "The two groups were no significant differences ( P > @ ) .\n",
            "And of two Verbal Scale , Performance Scale , Scale and Memory Scale significantly improved than before treatment .\n",
            "TESS scores , the study group were lower than the control group after treatment @ weekend .\n",
            "There are significant differences ( P < @ ) .\n",
            "BACKGROUND : As the age of the population in China rises , the occurrence of first-episode of schizophrenia in elderly persons is also gradually increasing .\n",
            "However , studies examining selection of therapeutic drugs for this population are relatively few .\n",
            "OBJECTIVE : To examine the therapeutic efficacy and metabolic influence on blood-glucose and serum lipid of ziprasidone in the treatment of elderly patients with first-episode schizophrenia .\n",
            "METHODS : Using randomized grouping , @ elderly patients with first-episode schizophrenia were randomly divided into the ziprasidone treatment group ( i.e. the study group ) and the olanzapine treatment group ( i.e. the control group ) , with @ cases in either group respectively .\n",
            "The positive and negative symptoms scale ( PANSS ) was used to evaluate the efficacy , and adverse drug reaction scale ( TESS ) was used to evaluate adverse drug reactions , at the points prior to the treatment , at the end of @th , @th , and @th weeks of treatment , respectively .\n",
            "Fasting blood glucose ( FBG ) , total cholesterol ( TC ) , triglyceride ( TG ) , and low density lipoprotein ( LDL-c ) were also measured .\n",
            "RESULTS : There was no significant difference between the two groups in PANSS score at the end of week @ , week @ and week @ .\n",
            "The curative effect on the two groups was similar .\n",
            "The results of repeated measure ANOVA showed that there were significant differences in FBG ( Ftimexgroup = @ , p = @ ) , TC ( Ftimexgroup = @ , p < @ ) , TG ( Ftimexgroup = @ , p < @ ) , and LDL-c ( Ftimexgroup = @ , p < @ ) between the study group and the control group across the different time points .\n",
            "CONCLUSION : Ziprasidone in the treatment of first episode schizophrenia in elderly patients has efficacy and less effect on blood-glucose and serum lipid metabolism .\n",
            "Seven outpatients already receiving neuroleptic drugs by depot intramuscular injections were treated in two consecutive @ - week periods with @ mg fluphenazine doses as enanthate and decanoate esters in a double-blind crossover study .\n",
            "They were assessed for incidence of akinesia , involuntary movement , autonomic disturbances and drowsiness , using a rating scale , and their blood pressures and pulse rates were recorded .\n",
            "Blood was collected for plasma fluphenazine and plasma prolactin assay .\n",
            "Additionally , a handwriting test was applied .\n",
            "A higher incidence of unwanted drug effects occurred when plasma fluphenazine concentrations were maximal , but this was not so with prolactin concentrations .\n",
            "No significant blood pressure changes occurred .\n",
            "Small increases in pulse rate and decreases in handwriting length occurred , but these changes were not associated with high fluphenazine levels .\n",
            "OBJECTIVE : Two studies compared the efficacy of standard-dose oral olanzapine ( @ to @ mg a day ) with placebo and with ineffective - dose olanzapine ( @ mg a day ) in maintenance therapy of schizophrenia .\n",
            "METHODS : The studies were @-week DOUBLE-blind extensions of multicenter studies that assessed the efficacy of olanzapine in the acute treatment of schizophrenia .\n",
            "Subjects were @ adults who met DSM-III-R criteria for schizophrenia with an acute exacerbation and who had a minimum score of @ on the Brief Psychiatric Rating Scale , who had responded to acute therapy ( defined as at least a @ percent reduction in the BPRS score from baseline or a score of @ or less during up to six weeks of treatment ) , and who were outpatients at their last acute-phase visit .\n",
            "Relapse was defined as hospitalization for psychopathology .\n",
            "Relapse risk was analyzed using Kaplan-Meier survival analysis and life table analysis .\n",
            "Patients who relapsed were discontinued from the studies .\n",
            "RESULTS : In the first study ( N = @ ) , patients in the standard-dose olanzapine group experienced a significantly lower relapse risk ( p = .@ ) over one year than patients treated with placebo .\n",
            "The estimated one-year risk of relapse with olanzapine was @ percent , compared with @ percent with placebo .\n",
            "Results were similar in the second study ( N = @ ) ; patients treated with standard-dose olanzapine had a significantly reduced risk of relapse ( p = .@ ) over one year compared with patients treated with ineffective-dose olanzapine .\n",
            "The estimated one-year risks of relapse were @ percent for standard-dose olanzapine and @ percent for ineffective-dose olanzapine .\n",
            "CONCLUSIONS : Olanzapine is superior to placebo and ineffective-dose olanzapine in the maintenance therapy of schizophrenia .\n",
            "Objective : To evaluate the efficacy of the hospital rehabilitation therapy on patients with chronic schizophrenia .\n",
            "Methods : @ patients with chronic schizophrenia in our hospital were randomly divided into intervention group and the control group , @ cases in each .\n",
            "Traditional conventional care control group , the intervention group on the basis of the usual care combined with rehabilitation training , guidance by trained psychiatric nurses .\n",
            "The effect of the two groups of patients before treatment and the treatment of @ months hospitalized schizophrenic patients the rehabilitation efficacy score rating scale ( ipros ) and nurses Inpatient Observation Scale ( nosie ) before and after the intervention evaluation , and observe two groups of patients with medication adherence .\n",
            "Results : The two groups of patients before treatment ipros rated nosie score results show that the difference was not statistically significant ( p > @ ) .\n",
            "@ months of treatment , ipros score and the nosie score results showed that the differences were statistically significant ( p < @ , p < @ ) .\n",
            "Medication adherence intervention group higher than that of the control group .\n",
            "Conclusion : hospital rehabilitation can significantly improve the patient 's psychiatric symptoms , improve treatment , improve patient medication compliance .\n",
            "@ groups of @ female patients were selected for the study .\n",
            "@ groups were made up of severely regressed schizophrenics ( one experimental and one control ) and one of moderately regressed schizophrenics .\n",
            "They were seen for one hour , @ times a week over a period of @ months .\n",
            "The treatment team consisted of a psychiatrist and an occupational therapist .\n",
            "The control group received routine occupational therapy .\n",
            "At each session objects were offered to the patients which were identical with , or similar to , those presented to babies , such as milk and a baby bottle .\n",
            "The purpose was to produce a symbolic miniature infantile situation in which appropriate feelings could be experienced .\n",
            "The majority of patients treated reached a higher level of psychosexual organisation and showed improvement in interpersonal relationships to allow them a fuller life outside or inside the hospital .\n",
            "No cure was anticipated , attempted or accomplished .\n",
            "[ Abstract - CSG ]\n",
            "Objective : Despite high prevalence of comorbid substance use disorders ( SUD ) in adolescent and young adult first-episode psychosis patients and the association of persisting SUD to poor outcome , there is insufficient evidence from randomized controlled trials that any psychosocial treatment is superior to others .\n",
            "Method : The present study employed a cluster randomized controlled single-blind experimental design to asses the efficacy of a new groupbased motivational behavioural therapy for drug abuse ( MOVE ) in comparison to a control condition ( supportive treatment for addiction recovery , STAR ) .\n",
            "Sixty-five participants were randomly assigned to @ weeks of @ treatment sessions in either MOVE ( n = @ , n = @ cluster ) or STAR ( n = @ , n = @ cluster ) and were assessed at baseline ( t@ ) , @ weeks ( t@ ) and @ months follow-up ( t@ ) .\n",
            "Treatment effects were analysed intention to treat with random effects mixed models .\n",
            "Results : There were no significant differences between MOVE and STAR with respect to reduction of days of alcohol and substance use as primary outcome .\n",
            "A significant reduction in alcohol and substance use was observed for both groups over time .\n",
            "There were also no significant differences with respect to functional outcome , quality of life , and client satisfaction .\n",
            "MOVE versus STAR intervention showed significant higher therapy session attendance and better treatment-compliance during follow-up and statistical trends were found for improvement in psychopathology and in depression at @ weeks and @ months follow-ups .\n",
            "Conclusions : Overall , simple interventions like STAR and specific motivational behavioural interventions are associated with similar reductions in substance use .\n",
            "Future studies should focus on specific interventions as part of need-adapted , long lasting and integrated care programs .\n",
            "Objective To investigate the health education affect medication compliance in schizophrenic patients .\n",
            "@ inpatients with schizophrenia to randomization into the health education group and the control group for each of the @ patients in the control group antipsychotics alone treatment , and general guidance , health education group to resist psychiatric medications and health education in a variety of ways to observe the two groups of patients before and after medication compliance changes in health education , and comparative analysis of assessment .\n",
            "The results of the health education group medication adherence was significantly higher than the health education group ( p < @ ) .\n",
            "Conclusion Health education can significantly improve medication compliance in schizophrenic patients .\n",
            "Reports an error in the original article by P. V. Tran et al ( Journal of Clinical Psychiatry , @ [ May ] , Vol @ [ @ ] , @-@ ) .\n",
            "The @st paragraph of the left column on page @ should read \" a baseline score of < = @ \" and the @rd paragraph of the left column of page @ should read \" > = @ at any postbaseline visit . \"\n",
            "( The following abstract of this article originally appeared in record @ - @-@ . )\n",
            "Compared the extrapyramidal symptom ( EPS ) profiles of the novel antipsychotic olanzapine ( OZP ) and the conventional antipsychotic haloperidol ( HAL ) in @ patients from @ well-controlled prospective clinical trials .\n",
            "Emergence of EPS was assessed by ( @ ) analysis of the incidence of extrapyramidal syndrome categories based on adverse events , ( @ ) the incidence of extrapyramidal syndromes based on categorical analysis of rating scale scores , ( @ ) analysis of mean maximum change in rating scale scores , and ( @ ) categorical analysis of anticholinergic medication use .\n",
            "Outcome of EPS was assessed by analysis of mean change in rating scale scores and mean anticholinergic use at endpoint .\n",
            "OZP was statistically significantly superior to HAL in all @ analyses related to emergence of EPS and in the @ analyses related to outcome .\n",
            "During acute treatment , statistically significantly\n",
            "In an integrated , dual disorder treatment program delivered at two sites , the authors address numerous barriers to delivering services to dually diagnosed consumers and employ a set of multidimensional indicators to assess outcome .\n",
            "Consumers who received services through the well-implemented , integrated services program for @ months were functioning better in the community .\n",
            "There was a cost shifting from mental health to drug and alcohol services , as well as a one-third increase in the total costs of care by the end of the first year of treatment .\n",
            "Program implementation issues are described and the clinical management implications for more effectively serving dually diagnosed consumers through integrated treatment programs are discussed .\n",
            "Objective To investigate the clinical efficacy and side effects of quesetiapine in the treatment of schizophrenia .\n",
            "Methods @ patients with schizophrenia by CCMD-@ were randomly allocated to @ groups treated with seroquel or risperidone for @ weeks .\n",
            "The P\n",
            "Background : We have recently reported the results of the multicenter \" Neuroleptic Strategy Study \" ( NeSSy ) , in which we compared the effects of first - ( FGAs ) versus secondgeneration antipsychotics on quality of life in schizophrenia ( Grunder et al , Lancet Psychiatry @ ; @ : @-@ ) .\n",
            "We demonstrated that quality of life ( as assessed with the SF-@ ) was statistically and clinically significantly more improved under treatment with SGA antipsychotics compared to FGAs .\n",
            "Here we report on relationships between doses and serum concentrations of the applied antipsychotics , which were systematically evaluated throughout the study , and clinical effects .\n",
            "Methods : In the multicenter , randomized , double-blind NeSSy study , we recruited participants ( aged @-@ years ) with schizophrenia ( ICD-@ : F@.X ) who required treatment initiation or a change in treatment , from @ psychiatric university hospitals and state hospitals in Germany .\n",
            "Double randomization allowed for restricted selection of a treatment within each antipsychotic drug group ( FGA or SGA ) for an individual patient : first , patients were assigned with a random number table to two of six possible drug pairs , each pair consisting of an FGA ( haloperidol [ @-@ mg ] or flupentixol [ @-@ mg ] ) given orally and an SGA ( aripiprazole [ @-@ mg ] , olanzapine [ @-@ mg ] , or quetiapine [ @-@ mg ] ) given orally , and the investigator then selected which pair was best suited to the patient ; a second , double-blind random assignment allocated either the FGA or the SGA from the investigator chosen pair to the patient .\n",
            "Treatment duration was @ weeks .\n",
            "Primary outcomes were change from baseline to week @ in quality of life ( SF-@ ) and clinical global impression ( CGI-I ) , analyzed in all randomly assigned patients who received at least one dose of the study drug .\n",
            "The administered doses were adjusted according to clinical efficacy and side-effects resulting in a wide range of doses for each of the investigational drugs .\n",
            "Serum levels were determined after @ weeks and at the end of treatment .\n",
            "Blood samples were taken from fasting patients in the morning .\n",
            "The serum concentrations were determined by high performance liquid chromatography tandem mass spectrometry ( LC-MS/MS ) .\n",
            "During the course of study , the results of serum analysis were communicated to the study centers without naming the compound itself and only in relation to the therapeutic reference range ( \" below \" , \" within \" or \" above \" ) but not by numeric value .\n",
            "By this procedure , both patient safety and concealment of allocation was guaranteed .\n",
            "Results : Between April @ , @ , and May @ , @ , @ patients were randomly assigned , @ to FGA treatment and @ to SGA treatment .\n",
            "@ patients received at least one dose of study drug ( @ in the FGA group , @ in the SGA group ) .\n",
            "A total of @ serum samples were collected and analyzed during the study .\n",
            "@ samples had to be excluded from the analysis , in most cases , because the measured values were below the limit of quantification , suggesting that the respective patients were non-compliant .\n",
            "The remaining @ measurements in valid relation to trial treatment constitute the core data analyzed here .\n",
            "These samples were taken from @ different patients , i.e. the mean number of samples per patient was @ .\n",
            "Mean and median serum concentrations of aripiprazole were @ and @ ng/mL ( range @-@ ng/mL ) , of flupentixol @ ng/mL and @ ng/mL ( @-@ ng/mL ) , of haloperidol @ ng/mL and @ ng/mL ( @-@ ng/mL ) , of olanzapine @ ng/mL and @ ng/mL ( @-@ ng/mL , and of quetiapine @ ng/mL and @ ng/mL ( @-@ ng/mL ) .\n",
            "If all compounds were taken together , regression analysis revealed a positive correlation between drug doses and serum concentrations ( po @ ) , which was even more pronounced when dose per kg body weight was taken into account ( po @ ) .\n",
            "This correlative relationship was also found for aripiprazole ( po @ ) , flupentixol ( po @ ) , and quetiapine ( po @ ) , but not for haloperidol ( po @ ) and olanzapine ( po @ ) .\n",
            "The same doses induced higher serum levels in females than in males and in non-smokers compared with smokers .\n",
            "@ % ( SF@ ) and @ % ( CGI ) , respectively , of the patients , who fulfilled the criteria for a clinically significant improvement with regard to the primary endpoints , presented with serum concentrations within the therapeutic reference ranges recommended by the AGNP Task Force Therapeutic Drug Monitoring ( Hiemke et al , Pharmacopsychiatry @ ; @ : @-@ ) .\n",
            "Conclusions : Doses of antipsychotic compounds used in this trial were clinically adjusted to improve the benefit/risk ratio of antipsychotic drug treatment .\n",
            "Two thirds of the obtained mean and median serum levels in our trial were within the therapeutic reference ranges recommended by an international guideline on TDM of psychotropic drugs ( Hiemke et al , @ ) .\n",
            "This provides empirical support for therapeutic drug monitoring of antipsychotic treatment .\n",
            "However , to further validate the clinical usefulness of TDM for broader clinical application , prospective trials with a fixed-dose design are needed .\n",
            "Objective To explore the influence of aripiprazole on schizophrenia serum prolactin level .\n",
            "Methods @ patients with schizophrenia were randomly divided into aripiprazole group ( n = @ ) and risperidone group ( n = @ ) for @ weeks .\n",
            "The positive and negative synodrome scale ( PANSS ) was evaluated before and after @  @  @ weeks .\n",
            "The PRL level was measured by radioimmunoassay Before , at the end of @ week and @ week .\n",
            "Results At the end @ th week , there were the most reduced significantly in the scores of PANSS between two groups than before evaluated ( P < @ ) , but compared of two groups was no significant differences ( P > @ ) ; There was no significant difference in serum level of PRL before and after treatment in arip ip razole group ( P > @ ) .\n",
            "However , the serum level of PRL increased highly after risperidone treatment ( P < @ ) .\n",
            "Compared with patients in risperidone group ( @ / @ , @ % ) , patients in arip ip razole group seldom had menstruation dysfunction and lactation ( P < @ ) .\n",
            "Conclusion Aripiprazole is better effective in the treatment of patients with schizophrenia , with less influence on serum PRL level .\n",
            "Aripiprazole is one of effective and safe drugs in the treatment of schizophrenia .\n",
            "BACKGROUND : The Early Detection and Intervention Programme of the German Research Network on Schizophrenia ( GRNS ) investigates the initial prodromal phase of psychosis in a multidimensional approach .\n",
            "Two intervention strategies are being studied by two large-scale multicentre projects .\n",
            "AIMS : To present the concept of the intervention studies , and to provide an interim report of the recruitment procedure .\n",
            "METHOD : Comprehensive cognitive-behavioural therapy has been developed for patients in the \" early initial prodromal state \" .\n",
            "For patients in the \" late initial prodromal state \" the atypical neuroleptic amisulpride is explored .\n",
            "Both interventions are evaluated in randomised controlled trials using clinical management as the control condition .\n",
            "RESULTS : Between January @ and March @ , @ individuals seeking help for mental health problems were screened for putative prodromal symptoms at four university centres .\n",
            "More than @ individuals fulfilled criteria for both interventions and @ ( @ % ) gave informed consent to participate in the trials .\n",
            "CONCLUSIONS : The screening procedure appears to be feasible and trial participation seems to be acceptable to a relevant proportion of people at increased risk of developing psychosis .\n",
            "The anti-oxidant vitamin E has been reported to be effective in the treatment of tardive dyskinesia .\n",
            "The present open label study examined the effect of supplemental therapy with vitamin E on acute extrapyramidal symptoms and cell enzymes in patients receiving neuroleptic drugs .\n",
            "Thirty-nine hospitalized schizophrenic patients were randomly assigned to two groups : group @ ( n = @ ) was treated with neuroleptics ( and group @ ( n = @ ) with neuroleptics combined with a fixed dose of vitamin E ( @ IU/day ) ( administered for two weeks .\n",
            "All patients were assessed with the Simpson-Angus Rating Scale ( Simpson and Angus , @ ) for neuroleptic induced Parkinsonism ( NIP ) , Barnes ' Akathisia Scale ( Barnes , @ ) , and Brief Psychiatric Rating Scale : laboratory parameters included serum creatine kinase ( CK ) activity , serum glutamate oxaloacetic transaminase ( SGOT ) and white blood cell count ( WBC ) .\n",
            "The addition of vitamin E to neuroleptic agents was associated with a trend ( p = @ ) towards prevention of the emergence of NIP compared to neuroleptic treatment alone .\n",
            "Addition of vitamin E to neuroleptics may reduce the severity of acute NIP in schizophrenic patients . ) )\n",
            "This study took place in Israel and examined the use of a local topical anesthetic cream to ameliorate the pain at the injection site caused by depot antipsychotic medications .\n",
            "Fifteen consecutive outpatients who had schizophrenia and who were under treatment with depot antipsychotic medications were enrolled in this randomized , double-blind , placebo-controlled crossover study .\n",
            "The patients received either lidocaine-prilocaine cream or a placebo one hour before the injection .\n",
            "The degree of pain at the injection site was quantified by the patients ' use of a visual analogue scale five minutes after the injection .\n",
            "The application of the lidocaine-prilocaine cream led to a significant reduction of pain compared with the placebo\n",
            "Objective : To study quetiapine , and risperidone in the treatment of first-episode schizophrenia with depressive symptoms , clinical efficacy and safety .\n",
            "Methods : @ cases of ccmd- first episode schizophrenia panss ( positive and negative symptom scale ) score  @ points , at least a factor of four factors of the panss depressive symptoms points score  @ points were randomly divided into quetiapine group and risperidone group , @ weeks of treatment , the use of panss effects were evaluated using panss factor scores assessed symptoms of depression and anxiety , the evaluation of the treatment emergent symptom scale ( tess ) adverse reactions .\n",
            "Results : the quetiapine group total effective rate of @ % , risperidone group was @ % , the difference was not statistically significant ( p > @ ) , quetiapine and risperidone panss depression factor scores after four weeks of treatment , both decline , the difference was statistically significant ( p < @ ) .\n",
            "Quetiapine adverse events were somnolence , weight gain .\n",
            "The risperidone extrapyramidal reactions , lactation , menstrual disorders , weight gain , agitation and other .\n",
            "Conclusion :  quetiapine of calm and risperidone treatment of first-episode schizophrenia have good efficacy ;  associated with depressive symptoms in patients with schizophrenia , quetiapine group than the risperidone group ;  The two sets of adverse drug reactions are light .\n",
            "Disease or condition - Mental/Behavioural Disorders Current Status of trial - Award Pending Design/methodology - COMMAND is a pragmatic , single blind , ITT , prospective randomised trial of a cognitive therapy ( CTCH ) to reduce harmful compliance with command hallucinations .\n",
            "It will compare CTCH with TAU in a sample of participants drawn from @ centres who are at risk of harmful compliance with command hallucinations .\n",
            "Participants will be identified and consented over @ months and receive treatment and follow-up over a further @ months .\n",
            "Primary outcome will be compliance and secondary outcomes will be the impact on the perceived power of the commanding voice , delusional distress , depression , amount and cost of treatment and service comsumption .\n",
            "The trial will : use geographically defined samples from different localities ; concealed randomisation ; blind , independent assessment of outcome at @ months ; characterisation and refusers and drop-outs ; intention to treat analysis .\n",
            "Topic/objectives/aim - To evaluate a treatment that will reduce harmful compliance with command hallucinations .\n",
            "Eligibility criteria - inclusion - ICD-@ schizophrenia , schizoaffective or delusionalschreniform disorders under care of the clinical team ( F@ ,@,@,@ : WHO ,@ ) , with a PANSS P@ ( hallucinations ) score > @ , ( ii ) age > @ , ( jjj ) history of command hallucinations of at least @ months with harmful compliance requiring a VCS score ( voice compliance scale - see @ ) of > @ which will include - harm to self , others or major social transgressions ; or harmful command hallucinations where the individual is distressed and appeasing the powerful voice , ( iv ) Treatment resistant , ( prescribed at least two neuroleptics without response but on a stable dose of medication for a period of @ months ) or ' treatment reluctant ' ( refusal to accept optimal medication ( eg Clozapine ) but willing to consent to randomisation ) .\n",
            "Eligibility criteria - exclusion - Exclusion Criteria : Primary organic impairment or addictive disorder considered to be the primary diagnosis .\n",
            "Groups/Interventions - An adapted form of cognitive behavioural therapy Endpoints/primary outcome ( s ) - Primary outcome will be compliance behaviour .\n",
            "This will be assess using the Voice Compliance Scale ( VCS : Beck-Sander et al , @ ; Trower et al ,@ ) .\n",
            "This is an observer related scale to measure the level of compliance / resistance with each command , using information form the participant and at least one of three other informants ( parent , spouse , keyworker ) and where possible all three .\n",
            "Each behaviour is the classified as : neither appasement nor complaint ( @ ) , symbolic appeasment , i.e. complaint with innocuous and/or harmless commands ( @ ) , actuall appeasement i.e. prepartory acts or gestures ( @ ) , partial complience with at least one severe command ( @ ) , full complience with at least one severe command ( @ ) Sample size - A sample size of @ per group would have @ % power to detect an absolute difference in the primary outcome of @ % ( @ % in TAU controls versus @ % in the CBT group ) Anticipated impact of results - Provide an effective treatment to reduce risk and improve community tenure among a high risk group .\n",
            "Objective To compare olanzapine and haloperidol in the treatment of schizophrenia efficacy and safety .\n",
            "Our hospital @ cases for the first time with schizophrenia were randomly divided into the olanzapine group and haloperidol group , haloperidol group was given haloperidol , olanzapine treatment group was given olanzapine .\n",
            "The ratings compare two sets of positive symptoms and negative symptoms rating scale ( panss ) after treatment , the efficacy and adverse reactions .\n",
            "Results After treatment and before treatment comparison panss total score and factor scores were significantly decreased ( p < @ ) ; olanzapine group decreased more significantly compared with the haloperidol group difference was statistically significant ( p < @ ) .\n",
            "Olanzapine group , the total effective rate of @ % , superior to haloperidol @ % .\n",
            "The difference was statistically significant ( p < @ ) .\n",
            "Adverse reactions was no significant difference ( p > @ ) .\n",
            "Conclusion olanzapine in the treatment of first episode schizophrenic patients , adverse reactions , easy to take , safety , good compliance .\n",
            "Befriending has been used as a control therapy in randomized controlled trials ( RCTs ) of cognitive behavioural therapy ( CBT ) for psychosis ( Sensky et al. , @ ) and has been recently manualized ( Bendall et al. , @ ) .\n",
            "As a control treatment , it aims to provide a treatment with : ( i ) high face validity for participants ; ( ii ) level of therapist contact matched to CBT condition ; ( iii ) nonspecific factors matched to the CBT condition ( e.g. , positive experiences of therapy and perceived helpfulness of therapy ) ; and also ( iv ) none of the specific elements of the CBT model ( e.g. , problem solving ) .\n",
            "The ACE Project is an RCT of CBT for first episode psychosis conducted at ORYGEN Research Centre in Melbourne , Australia .\n",
            "Participants ( n = @ ) were randomized to either the CBT condition ( Active Cognitive Therapy for Early Psychosis  ACE ) or to Befriending .\n",
            "This paper compares Befriending therapy with ACE on various measures of client satisfaction , time in therapy , and rate of dropout from therapy .\n",
            "The aim is to evaluate the utility of Befriending as a control treatment .\n",
            "Objective To investigate the feasibility , effectiveness , and then observe the effect of rehabilitation clinical path introduction of health education intervention schizophrenic patients .\n",
            "@ patients with schizophrenia were randomly divided into two groups , @ patients in the observation group while the medication , according to the clinical path impose health education ; health education control group routinely .\n",
            "Insight treatment attitude questionnaire ( itaq ) , self medication adherence questionnaire were assessed .\n",
            "Results of the observation group tiaq score , medication adherence and health education knowledge compliance rate was significantly better than the control group ( p < @ ) .\n",
            "Conclusion The health education path on patients in a planned , organized health education , has a positive effect to improve the patients insight and medication adherence .\n",
            "Preclinical research shows that compounds acting at alpha@ nicotinic receptors ( nAChRs ) can reduce nicotine self-administration , suggesting that a positive allosteric modulator ( PAM ) of alpha@ receptors , JNJ-@ , may aid smoking cessation .\n",
            "Moreover , individuals with schizophrenia , who have very high rates of smoking , have reduced expression of alpha@ nAChRs and may particularly benefit from this compound .\n",
            "In two parallel studies using a within-subject cross-over design , @ healthy smokers ( Study @ ) and @ smokers with schizophrenia ( Study @ ) , both groups high in quit interest , attempted to initiate quitting temporarily during each of two @-week phases .\n",
            "Treatments were the alpha@ nicotinic receptor PAM JNJ-@ ( @ mg b.i.d. ) or placebo ( double-blind , counter-balanced ) .\n",
            "In each phase , all smoked ad lib with no drug on week @ or during dose run-up on week @ , and then tried to quit every day during week @ .\n",
            "Abstinence ( confirmed by CO < @ p.p.m. ) and smoking reduction ( CO < @ ) , as well as cigarettes/day ( in Study @ ) , were assessed daily ( Monday-Friday ) each quit week and compared between conditions .\n",
            "Secondary outcomes included abstinence symptoms ( withdrawal and craving ) and cognitive test responding ( N-back ; continuous performance task ) .\n",
            "In both studies , compared with placebo , active JNJ-@ did not increase the number of abstinent days nor reduce total smoking exposure .\n",
            "We also found no significant improvements in craving , withdrawal , or cognitive function .\n",
            "With this dose and study duration , our findings do not support further testing of this alpha@ nAChR PAM compound for possible efficacy in smoking cessation , in smokers with or without schizophrenia .\n",
            "Rationale : There is growing evidence suggesting glutamatergic dysfunction in schizophrenia .\n",
            "The most robust finding to substantiate this is that phencyclidine and ketamine , which act at the NMDA glutamate receptor , can induce schizophrenia-like psychosis .\n",
            "Also , pharmacological strategies examining the effects of glycine , as an adjuvant to clozapine , have found that it reduced negative symptoms in open studies , but had no effect on or worsened the positive symptoms in some patients in controlled studies .\n",
            "Objective : This study was performed to examine the effects of glycine with respect to therapeutic efficacy and side-effect profile , when given as an adjuvant to clozapine .\n",
            "Method : In a @-week double-blind , placebo controlled cross-over trial , @ patients with treatment resistant schizophrenia received glycine ( @ g per day for @ weeks ) or placebo ( for @ weeks ) , in addition to clozapine which remained unchanged during the entire study .\n",
            "Efficacy of glycine was determined using the BPRS , PANSS , and the Global Assessment of Functioning Scale ( GAF ) .\n",
            "Side-effect profile was assessed using the Extrapyramidal Symptom Rating Scale ( ESRS ) and Simpson-Angus Scale for Extrapyramidal Symptoms , haematology and chemistry were determined every other week .\n",
            "Results : Participants showed no improvement with glycine as an adjuvant to clozapine , nor was there any significant worsening of symptoms except in one patient who dropped out after having serious upper GI symptoms .\n",
            "Conclusions : Glycine does not augment the antipsychotic effects of clozapine .\n",
            "Recruitment : Not yet recruiting .\n",
            "Conditions : First Episode Psychosis | Psychotic Disorders | Schizophrenia | Schizoaffective Disorder .\n",
            " Behavioral : @ years OPUS treatment .\n",
            "Gender : Both .\n",
            "Age Groups : Adult .\n",
            "Enrollment : @ .\n",
            "Study Types : Interventional .\n",
            " Efficacy Study .\n",
            "Start Date : July @ .\n",
            "Completion Date : January @ .\n",
            "Acronym : OPUS II\n",
            "OBJECTIVE : The study determined whether dispositions from an urban psychiatric emergency service would differ between patients who received a mandatory urine drug test and those who may or may not have had a test based on the attending psychiatrist 's clinical judgment .\n",
            "The accuracy of clinicians ' suspicion of substance use among mandatorily screened patients was also examined .\n",
            "METHODS : A total of @ consenting patients presenting to an urban psychiatric emergency service were randomly assigned to a mandatory-screen group ( N = @ ) or a usual-care group ( N = @ ) .\n",
            "Physicians ordered screens based on clinical judgment .\n",
            "Additional screens were performed without physicians ' knowledge for patients in the mandatory-screen group for whom no screen was ordered .\n",
            "Demographic and clinical information , results of drug screens , and information about dispositions were collected from clinical charts or hospital databases .\n",
            "RESULTS : No difference in dispositions was found between the mandatory-screen group and the usual-care group .\n",
            "Survival analysis did not reveal a difference between the two groups in length of stay in inpatient psychiatric units .\n",
            "As for accuracy of physicians ' suspicion of substance use , positive drug screens were recorded for @ percent of the @ patients in the mandatory-screen group who did not admit drug use or for whom physicians did not expect drug use .\n",
            "A total of @ percent of the patients who were suspected of use and @ percent of those who admitted use had positive drug screens .\n",
            "Only @ percent of patients who denied substance use had positive screens .\n",
            "CONCLUSIONS : Routine urine drug screening in a psychiatric emergency service did not affect disposition or the subsequent length of inpatient stays .\n",
            "The results do not support routine use of drug screens in this setting\n",
            "Background : IPS has been demonstrated to increase return to open employment significantly in individuals with mental health problems in the US .\n",
            "Previous experience ( e.g. with ACT ) has demonstrated the sensitivity of complex community mental health interventions to local social and healthcare cultures .\n",
            "Europe has conditions of generally greater employment security than the US and varying ( generally higher ) unemployment rates and welfare benefits .\n",
            "Evidence of the effectiveness of IPS in these conditions , and its potential variation across them , would guide local policy and provide possible insights into its mechanism .\n",
            "Methods : We conducted an RCT of IPS versus high-quality train-and-place vocational rehabilitation in six European centers with very different labor market and health and social care conditions .\n",
            "A sample of @ individuals with psychotic illness was randomly allocated ( @ per site ) .\n",
            "Inclusion criteria were a minimum of two years ' illness duration , with at least one year of continuous unemployment and six months contact with their current mental health services .\n",
            "Follow-up was @ months .\n",
            "The primary outcome was any open employment , and secondary outcomes included time to employment , duration of employment and hospital admission .\n",
            "Findings : IPS was more effective than the Vocational Services for all vocational outcomes .\n",
            "@ IPS patients ( @ % ) worked for at least one day compared to @ Vocational Service patients ( @ ) .\n",
            "They were significantly less likely to be rehospitalized .\n",
            "Local unemployment rates explained a significant amount of the variation in IPS effectiveness and both national economic growth and welfare systems influenced overall employment rates in both services .\n",
            "Conclusions : IPS doubles the access to work of people with psychotic illnesses , without any evidence of increased relapse .\n",
            "Its effectiveness is not independent of external circumstances , particularly local unemployment rates .\n",
            "BACKGROUND : P@ amplitude reduction in schizophrenia has been found by many investigators , but P@ latency generally has been reported to be normal ; however , conflicting findings are present in the literature , and interpretation has been confounded by medication effects and methodological differences .\n",
            "METHODS : This study used a standard auditory oddball paradigm to compare the latency , amplitude , and topographic distribution of P@s in neuroleptic-free schizophrenic patients with those of healthy controls .\n",
            "The patients then were treated for @ weeks with either remoxipride or haloperidol , and their P@s were reassessed .\n",
            "RESULTS : P@s were attenuated and delayed among neuroleptic-free patients .\n",
            "There was no evidence of peak lateralization or amplitude asymmetry over temporal areas .\n",
            "Subsequent neuroleptic medication normalized P@ latencies and increased P@ amplitudes , but the latter remained below normal limits over all except frontal areas .\n",
            "There were no correlations between P@ latency or amplitude and clinical symptomatology either before or after treatment .\n",
            "CONCLUSIONS : The finding of a P@ delay in neuroleptic-free schizophrenics that is normalized by neuroleptic medication has not been reported previously .\n",
            "Neuroleptic effects on P@ amplitude and latency appear to be independent of effects on clinical symptoms , and can not be attributed to anticholinergic activity .\n",
            "Objective To evaluate the effects of clozapine and chlorpromazine on serum glutamate ( Glu ) levels and their relationship with the therapeutic effectiveness .\n",
            "Methods Sixty inpatients with schizophrenia were treated with a fixed dose of either clozapine ( @mg/d ) or chlorpromazine ( @mg/d ) for @ weeks in a randomized , controlled design .\n",
            "The clinical symptoms were assessed using Brief Psychiatric Rating Scale ( BPRS ) , Scale for Assessment of Negative Symptom ( SANS ) , Scale for Assessment of Positive Symptom ( SAPS ) , Wi\n",
            "Objective : Perospirone ( PER ) and aripiprazole ( APZ ) , a second generation antipsychotics with similar effects on serotonergic receptors , partial agonistic activity at @-HT <sub> @A </sub> receptor and antagonistic activity at @-HT@A receptor as well as remarkably different effects on dopaminergic systems .\n",
            "PER acts as D <sub> @ </sub> antagonist , whereas APZ has partial agonistic activity on D <sub> @ </sub> receptor .\n",
            "We compared the therapeutic efficacy and tolerability , the effect by DRD@ Taq @A polymorphism of PER and APZ in patients with schizophrenia .\n",
            "Subjects and Method : All patients were diagnosed as schizophrenia according to DSM-IV-TR .\n",
            "The patients who gave the informed consent to this @-week and flexible-dose trial were randomly assigned to PER ( @-@ mg/day , n = @ ) or APZ ( @-@ mg/day , n = @ ) .\n",
            "The patients were between @ and @ years ( APZ groups : mean = @ + / -@ , @ males and @ females ; PER groups : mean = @ + / -@ , @ males and @ females ) .\n",
            "The clinical symptoms were evaluated using the Positive and Negative Syndrome Scale ( PANSS ) before and every @ weeks after treatment .\n",
            "The efficacy was assessed by changes from baseline for PANSS score .\n",
            "An intention-to-treat analysis was instead carried out for the @ patients who underwent a baseline and at least @ other PANSS assessments , out of @ subjects .\n",
            "Genotyping for DRD@ Taq @A polymorphism were analyzed by using polymerase chain reaction and restriction fragment length polymorphism method ( PCR-RFLP ) , and TaqMan .\n",
            "Repeated measures analysis was performed with PANSS baseline included in the model as covariate .\n",
            "The study was approved by the Ethical Review Board of Kansai Medical University .\n",
            "Result : Both groups showed significant improvement during the study with reduction of total PANSS scores .\n",
            "As for treatment , there were no significant differences in PANSS total , positive and negative subscale score change overtime between PER and APZ treatment group .\n",
            "As for tolerability , PER treated patients reported more extrapyramidal symptoms ( @ % ) than APZ treated patients ( @ % ) , especially rigidity .\n",
            "Furthermore more patients treated with APZ ( @ % ) completed the @-week study than those treated with PER ( @ % ) ; time to discontinuation was significantly in favor of APZ ( p = @ ) .\n",
            "The clinical efficacy of APZ and PER were almost the same , subsequently we combined these two drugs as dopamine modulator and evaluated the association between Taq@A polymorphism and APZ/PER in the combined sample .\n",
            "The patients with A@/A@ allele ( n = @ ) group showed significant improvement during the study with reduction of total PANSS scores ( p = @ ) and the negative subscale ( p = @ ) compared to A@/A@ and A@/A@ allele group ( n = @ ) .\n",
            "When divided by each drug , no significant efficacy of Taq@A polymorphism could be seen in PANSS reduction , may be due to small sample size .\n",
            "There is no correlation between Taq@A polymorphism and discontinuation rate or frequency of side effects .\n",
            "Conclusion : Our findings suggest that PER and APZ exhibit similar efficacy in the treatment of Japanese schizophrenia patients .\n",
            "However there is difference between the two drugs in discontinuation rate with favorable continuity of APZ .\n",
            "In addition , our data could lead that DRD@ Taq @A polymorphism play an important role in improvement of total symptom , among others negative symptom , of schizophrenia in PER and APZ treatment .\n",
            "Aims : Attempts to reduce high utilisation of mental health inpatient care by targeting the critical time of hospital discharge are rare .\n",
            "In this study , we test the effect of a needs-oriented discharge planning intervention on number and duration of psychiatric inpatient treatment episodes ( primary ) , as well as on outpatient service use , needs , psychopathology , depression and quality of life ( secondary ) .\n",
            "Methods : Four hundred and ninety-one adults with a defined high utilisation of mental health care gave informed consent to participate in a multicentre RCT carried out at five psychiatric hospitals in Germany ( Dusseldorf , Greifswald , Regensburg , Ravensburg and Gunzburg ) .\n",
            "Subjects allocated to the intervention group were offered a manualised needs-led discharge planning and monitoring intervention with two intertwined sessions administered at hospital discharge and @ months thereafter .\n",
            "Outcomes were assessed at four measurement points during a period of @ months following discharge .\n",
            "Results : Intention-to-treat analyses showed no effect of the intervention on primary or secondary outcomes .\n",
            "Conclusions : Process evaluation pending , the intervention can not be recommended for implementation in routine care .\n",
            "Other approaches , e.g. team-based community care , might be more beneficial for people with persistent and severe mental illness .\n",
            "( PsycINFO Database Record ( c ) @ APA , all rights reserved ) ( journal abstract )\n",
            "Objective : Demonstrate that IM aripiprazole improves agitation without excessive sedation in patients with schizophrenia placebo-controlled trials S@ and S@ or bipolar I disorder placebo-controlled trial BP@ .\n",
            "Methods : Efficacy data were obtained from trials S@ N @ ) and S@ ( N = @ ) of IM aripiprazole ( @ or @ mg ) and haloperidol ( @ or @ mg ) , and trial BP@ ( N = @ ) of IM aripiprazole ( @ or @ mg ) and lorazepam @ mg .\n",
            "PANSS Excited Component ( PEC ) and Agitation-Calmness Evaluation Scale ( ACES ) scores were assessed @ hour prior and @ hours following the first injection .\n",
            "Excessive sedation was defined as an ACES score @ ; @ .\n",
            "Results : In trials S@ and S@ , @ .\n",
            "@ % of aripiprazole-treated and @ .\n",
            "@ % of haloperidol-treated patients were not considered excessively sedated @ hours after injection .\n",
            "In trial BP@ @ .\n",
            "@ % of aripiprazole-treated and @ .\n",
            "@ % of lorazepam-treated patients were not considered excessively sedated .\n",
            "Across all studies @ .\n",
            "@ % of placebo-treated patients were not considered excessively sedated .\n",
            "In patients without excessive sedation in trials S@ and S@ aripiprazole @ mg and @ mg and haloperidol @ .\n",
            "@ mg and @ .\n",
            "@ mg significantly reduced PEC scores compared with placebo P @ ; @ ) .\n",
            "In patients without excessive sedation in trial BP@ , aripiprazole @ mg and @ mg and lorazepam @ mg significantly reduced PEC scores compared with placebo P @ , and @ ) .\n",
            "Conclusions : IM aripiprazole effectively reduced agitation in patients with schizophrenia or bipolar I disorder , independent of excessive sedation .\n",
            "Background : Schizophrenia is characterized by deficits affecting the ability to attain and maintain employment .\n",
            "Data from reviews , meta-analyses , and independent studies indicate unemployment rates in the @ % to @ % range in community samples of affected individuals not participating in any form of vocational rehabilitation or supported employment program .\n",
            "In examining factors related to employment status and work outcome , a number of studies have shown cognitive impairment to be a key determinant .\n",
            "Methods : The present findings were drawn from a recently completed VA study of cognitive rehabilitation and supported employment that included @ veterans with schizophrenia or schizoaffective disorder .\n",
            "All veterans were enrolled in the VA 's Veteran Community Employment Development ( VCED ) program which followed the Individual Placement and Support ( IPS ) model of supported employment .\n",
            "After job placement , study participants were randomized to one of two training groups ( errorless learning plus supported employment vs. supported employment alone ) for training to address work-related problems .\n",
            "Study participants were followed for up to @ months after initial job placement .\n",
            "All study participants received a baseline assessment of cognitive functioning using the MATRI CS Consensus Cognitive Battery ( MCCB ) .\n",
            "Results : Of the veterans in the study , @ % obtained competitive jobs and @ % transitional work .\n",
            "There was a non-significant trend favoring the EL group on work performance as measured by the Work Behavior Inventory .\n",
            "However , there were no significant differences between groups in number of weeks worked or wages earned .\n",
            "Of those participants who got jobs , @ % quit their jobs within @ weeks after placement .\n",
            "On the MCCB , a comparison of veterans who got jobs vs. those who did not revealed a significant group difference on the domain assessing social cognition .\n",
            "No other significant group differences were found .\n",
            "Conclusion : Interpretation of these findings is guarded due to the small number of veterans who got competitive jobs and remained employed long enough to receive training .\n",
            "These results highlight two key issues : a ) job placement of veterans with schizophrenia remains a challenge even for those receiving evidence-based models of supported employment ; b ) continuing efforts are needed to target additional factors other than cognition that contribute to low job placement rates and attenuated job tenure in persons with severe mental illness .\n",
            "Objective : To investigate human hospital environment and self-management training for the role in the rehabilitation of patients with schizophrenia .\n",
            "Methods : @ patients with schizophrenia were randomly divided into intervention group , @ cases and @ cases of the control group .\n",
            "The control group lived an ordinary ward to accept psychiatric conventional treatment and care ; intervention group endemic areas with calendar , temperature and humidity table clock , patients self-manage their change of clothes , on the basis of psychiatric treatment and care of , undergo a @ weeks living skills training and drug management capacity training .\n",
            "Satisfaction / comfort questionnaire , self-management skills measurement , Social Disability Screening Scale ( sdss ) , activities of daily living ( adl ) , the Brief Psychiatric Rating Scale ( bprs ) were assessed to compare .\n",
            "Results : The intervention group @ weekends patient satisfaction / comfort score ( @  @ ) points , the control group ( @  @ ) points .\n",
            "The two groups , there is a significant difference ( p < @ ) .\n",
            "The intervention group @ weekends patient 's self-management skills and significantly higher than the control group ( p < @ ) .\n",
            "Background .\n",
            "Several researchers have identified oral health problems in people with serious mental illness and have suggested that the cornerstone of any treatment strategy should be preventive dental education .\n",
            "The main purpose of this study was to investigate whether providing a brief Motivational Interviewing ( MI ) session before a dental education session would improve the oral hygiene routine of people with serious mental illness more than providing a dental education session ( that includes instruction in tooth brushing and a reminder session ) alone .\n",
            "A second purpose was to investigate whether providing a MI session before the dental education session would improve the internal motivation for performing regular tooth brushing in people with serious mental illness .\n",
            "A third purpose was to investigate whether providing a dental education session improves oral health knowledge in people with mental illness .\n",
            "Methods .\n",
            "Sixty individuals with serious mental illness were recruited to participate in an oral health promotion program , @ participants completed the study .\n",
            "Group A ( n = @ ) received a brief motivational interviewing session and dental education , Group B ( n = @ ) received dental education alone .\n",
            "Outcome measures included plaque index scores , an oral health knowledge questionnaire , and the treatment self regulation questionnaire .\n",
            "All measures were administrated at baseline , after @ weeks , and @ weeks .\n",
            "Results .\n",
            "There was a statistically significant improvement in the plaque index scores and the oral health knowledge scores across time for both groups but group A improved significantly more when compared to group B in a repeated measures ANOVA , ( p < @ ) .\n",
            "There @ was not a statistically significant improvement in the autonomous motivation scores for both groups across time but group A improved significantly more when compared to group B in a repeated measures ANOVA , ( P < @ ) .\n",
            "The autonomous motivation score increased @ points for group A and declined @ points for group B across time .\n",
            "Conclusion .\n",
            "The results of this study suggest that an oral hygiene program including brief MI session , dental education , oral hygiene instructions , and tooth brushing reminding system can improve the oral hygiene and the oral health knowledge of people with serious mental illness more than providing the same program without the brief MI session .\n",
            "INTRODUCTION : Prolongation of Q-Tc interval is commonly accepted as a surrogate marker for the ability of a drug to cause torsade de pointes .\n",
            "In the present study , safety of olanzapine versus risperidone was compared among a group of patients with schizophrenia to see the frequency of the electrocardiographic alterations induced by those atypical antipsychotics .\n",
            "METHOD : Two hundred and sixty-eight female inpatients with schizophrenia entered in one of the two parallel groups to participate in an open study for random assignment to olanzapine ( n = @ ) or risperidone ( n = @ ) .\n",
            "Standard @-lead surface electrocardiogram ( ECG ) was taken from each patient at baseline , before initiation of treatment , and then at the end of management , just before discharge .\n",
            "The parameters that were assessed included heart rate ( HR ) , P-R interval , QRS interval , Q-T interval ( corrected = Q-Tc ) , ventricular activation time ( VAT ) , ST segment , T wave , axis of QRS , and finally , interventricular conduction process .\n",
            "RESULTS : A total of @ % of cases in the olanzapine group and @ % in the risperidone group showed some Q-Tc changes ; @ % and @ % of the patients in the olanzapine group showed prolongation and shortening of the Q-Tc , respectively , while changes in the risperidone group were restricted to only prolongation of Q-Tc .\n",
            "Comparison of means showed a significant increment in Q-Tc by risperidone ( p = @ ) .\n",
            "Also , comparison of proportions in the olanzapine group showed significantly more cases with shortening of Q-Tc versus its prolongation ( p = @ ) .\n",
            "No significant alterations with respect to other variables were evident .\n",
            "CONCLUSION : Olanzapine and risperidone had comparable potentiality for induction of Q-Tc changes , while production of further miscellaneous alterations in ECG was more observable in the olanzapine group compared with the risperidone group .\n",
            "Also shortening of Q-Tc was specific to olanzapine .\n",
            "In a double-blind study lasting @ wks , @ schizophrenic inpatients were RANDOMly assigned to @ of @ treatments : chlorpromazine ( @ - @ mg/day ) or benserazide ( @-@ mg/day ) , a dopa decarboxylase inhibitor .\n",
            "A battery of tests ( including Brief Psychiatric Rating Scale , Clinical Global Impressions , and Nurses ' Observation Scale for Inpatient Evaluation ) was used , and results on each measure were subject to multifactorial analysis of covariance .\n",
            "Benserazide did not appear to be as effective an antipsychotic medication as chlorpromazine .\n",
            "In fact , chlorpromazine was significantly better on measures of tension , excitement , hallucinatory behavior , thinking disturbance , social interest , and drop-out rate .\n",
            "At the relatively low dosages used in this study , it would seem that benserazide had little effect on cerebral dopa decarboxylase , and it would be worthwhile trying higher dosages .\n",
            "( @ ref )\n",
            "Fifty-three married patients with a wide range of severe ( persisting psychiatric disorders were randomly allocated to a form of couples therapy ( spouse-aided therapy ) or to individual therapy .\n",
            "Both were outpatient , goal-oriented therapies , with an overall mean duration of @ hours .\n",
            "Before , during , immediately after , and three months after therapy , patients and spouses completed ratings of target and personal problems , sexual activity and attitudes , psychological symptoms , and marital satisfaction .\n",
            "Ratings were also conducted by independent assessors .\n",
            "Spouse-aided therapy proved superior to individual therapy at a statistically significant level on most outcome measures , with clinically worthwhile improvements in symptoms , problems , and marital satisfaction in both partners .\n",
            "Individual therapy was followed by improvement in some symptoms , but marital dissatisfaction increased and both partners were more depressed at three months follow - up than before treatment . )\n",
            "The objective of the present study was to examine the efficacy of group musical therapy for inpatients with DSM-IV SCHIZOphrenia or SCHIZOaffective psychosis .\n",
            "Thirty-four therapy group subjects in a ward for long-stay female patients received @ group musical therapy sessions over @ months , while @ waiting group subjects from another ward with the same function were to wait for the sessions until the studied course was completed .\n",
            "The assessment included measures of psychotic symptoms , objective quality of life and subjective musical experiences .\n",
            "Comparison of the groups indicated that significant advantages in the therapy group subjects were detected in some measures concerning personal relations and a subjective sense of participation in a chorus activity .\n",
            "However , the follow-up evaluation suggested that the improvement might not be durable .\n",
            "These findings suggested that the musical therapy had some , but possibly only short-lived , effects on personal relations and musical experiences of chronic psychotic patients\n",
            "In a @-month , multicentre , open-label trial , the tolerability and efficacy of quetiapine ( ' Seroquel ' ) and risperidone were compared in @ adult outpatients with psychotic disorders .\n",
            "Patients were randomised in a @:@ ratio ( quetiapine : risperidone ) and were flexibly dosed .\n",
            "Assessments included an extrapyramidal symptoms ( EPS ) Checklist , the Hamilton Rating Scale for Depression , the Clinical Global Impression , and the Positive and Negative Syndrome Scale .\n",
            "At the completion of the trial the mean quetiapine dose was @ mg and the mean risperidone dose was @ mg .\n",
            "The results showed that quetiapine was less likely than risperidone to require dose adjustment for EPS or concurrent anti-EPS medication .\n",
            "EPS symptoms rated as \" at least moderate , \" according to the EPS Checklist , occurred more frequently at each visit in risperidone patients .\n",
            "Quetiapine was more effective than risperidone in treating depressive symptoms , and was as effective as risperidone in improving the positive and negative symptoms of outpatients with psychosis .\n",
            "PURPOSE : Co-occurring schizophrenia spectrum disorder and International Statistical Classification of Diseases , @th Revision cocaine dependence present a particularly destructive constellation that is often difficult to treat .\n",
            "Both conditions raise dopamine transmission effects in the brain .\n",
            "Traditional neuroleptics block dopamine receptors , whereas aripiprazole modulates dopamine activity as an agonist/antagonist .\n",
            "We tested whether dopamine modulation is superior to dopamine blocking in dual-diagnosis patients .\n",
            "METHODS : In a randomized , double-blind , comparison design , cocaine-dependent schizophrenic subjects actively using cocaine received either aripiprazole or perphenazine in an @-week trial .\n",
            "Primary outcome targeted cocaine-free urine sample proportions , whereas cocaine craving scores were a secondary variable .\n",
            "RESULTS : Subjects ( N = @ ) randomized ( n = @ per group ) did not differ at baseline .\n",
            "The proportion of cocaine-free urine samples did not differ by medication group .\n",
            "Contrasting weeks @ to @ vs @ to @ revealed significant late reductions in craving with aripiprazole .\n",
            "On the respective @-point subscales , craving intensity decreased by @ + / - @ ( P < @ ) points , craving frequency by @ + / - @ ( P > @ ) points , and craving duration by @ + / - @ ( P > @ ) points .\n",
            "CONCLUSIONS : A drug effect of aripiprazole on craving items appeared at week @ of treatment , on average , and was not seen before that length of drug exposure .\n",
            "The data suggest that dopamine modulation reduces cocaine cravings but requires an acclimation period .\n",
            "To understand the mechanism of action better , a trial of depot aripiprazole may be useful .\n",
            "Clinically , a reduction in craving potentially offers a clearer focus for ongoing behavioral treatment .\n",
            "It may also offer a longer-term treatment effect with respect to the severity of relapse .\n",
            "Data were analysed from @ actively controlled and blind longterm responder studies .\n",
            "All Ss had a chronic disease course ( mean greater than @ years ) and there were no significant between-treatment group differences in demographic or disease characteristics .\n",
            "Findings support an atypical extrapyramidal symptom profile and the potential of a significantly lower risk of tardivee dyskinesia with olanzapine than with haloperidol among patients requiring maintenance antipsychotic treatment .\n",
            "( Original abstract-amended )\n",
            "Objective : Clinical reports suggest dose loading approaches with olanzapine may achieve faster therapeutic effect in acutely agitated patients .\n",
            "Method : @ acutely agitated inpatients ( Positive and Negative Syndrome Scale [ PANSS ] Excited@ @ ) with schizophrenia spectrum or bipolar I disorder were randomized to four days of double-blind oral olanzapine by \" Rapid Initial Dose Escalation \" ( RIDE ) : @ mg followed by @ or @ @ mg doses as needed on days @-@ and @-@ , respectively ; or \" Usual Clinical Practice \" ( UCP ) : @ mg followed by @ or @ lorazepam @ mg dose ( s ) as needed , days @-@ and @-@ , respectively .\n",
            "After four days of double-blind treatment , all patients received standard , open-label olanzapine doses ( @-@ mg on days @-@ ) .\n",
            "Primary efficacy measure was PANSS Excited subscale .\n",
            "Results : PANSS excited ratings improved significantly in both groups ( p < .@ within group at @ hours ) .\n",
            "Over the double-blind phase , RIDE dosing was significantly more effective than UCP ( p = @ ) and this difference was first significant at @ hours ( p = @ ) .\n",
            "No significant group differences existed in treatment-emergent adverse events or laboratory abnormalities .\n",
            "Final mean olanzapine dose was similar in both groups .\n",
            "Conclusions : Subjects experienced greater agitation improvement with a RIDE approach than standard dosing .\n",
            "Loading dose strategies merit further evaluation .\n",
            "In this presentation , two challenges , namely , failure to infl uence pathways to care and optimum length of EI service , will be addressed .\n",
            "Most patients with a first episode of psychosis ( FEP ) make their first contact with primary care services but few get into an EI service directly , resulting in systemic delay .\n",
            "We report the results of a study evaluating the impact of direct training of all potential points of contact by new patients on the referral portion of duration of untreated psychosis ( DUP-R ) .\n",
            "Following the intervention , the number of referrals from primary care services ( health and education ) increased substantially but majority of these did not have a FEP ; DUP-R remained longest for patients referred from primary care and shortest for patients presenting directly to the hospital emergency service ; there was little change in the pathways to care for patients who presented first to primary care ; and patients with very long DUP were younger and most likely to have been referred from primary care .\n",
            "For the challenge of duration of EI service , we will present the methodology and preliminary results of a single blind RCT comparing extension of an EI service ( N = @ ) from @ to @ years compared to routine care ( N = @ ) , following first @ years of EI service .\n",
            "Preliminary data suggest that a higher proportion of patients drop out of the routine care arm ( @/@ , @ % ) compared to the EI ( @/@ , @ % ) arm and obstacles in transferring patients to routine care and its signifi - cance for interpretation of results are discussed .\n",
            "Total Enrollment - @ Study start - March @ ; Study completion - June @ Primary Hypothesis - To determine if olanzapine is more cost effective than haloperidol for the treatment of schizophrenia .\n",
            "Secondary Hypothesis - Secondary objectives include evaluation of clinical efficacy , safety , social and vocational functioning , family burden , compliance and satisfaction for olanzapine relative to haloperidol .\n",
            "Intervention - Olanzapine ( @ mg to @ mg/day ) , haloperidol ( @ mg to @ mg/day ) .\n",
            "Primary Outcomes - Total inpatient hospital care costs are the primary outcome .\n",
            "Other major outcomes are total social costs ( cost of VA health care , non-VA services and other specified social costs ) , efficacy measures ( PANNS , BPRS , CGI Severity , and neurocognitive battery scores ) and safety measures ( adverse events , ECG?s ) .\n",
            "Study Abstract - Although currently marketed antipsychotic drugs are useful in the treatment of schizophrenia , efficacy and safety profiles need to be improved .\n",
            "Forty to eighty percent of patients either fail to respond or only partially respond to conventional antipsychotic agents .\n",
            "Secondary symptoms may be unimproved even in patients who respond to treatment .\n",
            "A variety of adverse events occur in patients receiving currently available agents .\n",
            "The severity of these events contributes to the poor compliance that is observed in this patient population .\n",
            "Olanzapine is a novel antipsychotic agent with a reduced incidence of extrapyramidal symptoms .\n",
            "Other side effects are minimal .\n",
            "Approximately @ patients with schizophrenia or schizoaffective disorder were randomly assigned to one of two treatment groups .\n",
            "One treatment group was prescribed olanzapine with daily dosage ranging from @ mg/day to @ mg/day .\n",
            "The other treatment group was prescribed haloperidol with daily dosage also ranging from @ mg/day to @ mg/day .\n",
            "A semi-structured psychosocial case management treatment program is provided for all study patients .\n",
            "Patients were recruited from @ VA medical centers over a @-month period and were followed for one year .\n",
            "@ patients were enrolled at one site that had its research program terminated during the study .\n",
            "Because of questions regarding the circumstances that led to the termination , these @ patients will not be included in study analyses .\n",
            "The major objective of the study is to determine if olanzapine is more cost effective than haloperidol .\n",
            "Secondary objectives include evaluation of clinical efficacy , safety , social and vocational functioning , family burden , compliance and satisfaction for olanzapine relative to haloperidol .\n",
            "MANUSCRIPT - Primary manuscript published in JAMA , November @ .\n",
            "Purpose - Although currently marketed antipsychotic drugs are useful in the treatment of schizophrenia , efficacy and safety profiles need to be improved .\n",
            "Forty to eighty percent of patients either fail to respond or only partially respond to conventional antipsychotic agents .\n",
            "Secondary symptoms may be unimproved even in patients who respond to treatment .\n",
            "A variety of adverse events occur in patients receiving currently available agents .\n",
            "The severity of these events contributes to the poor compliance that is observed in this patient population .\n",
            "Olanzapine is a novel antipsychotic agent with a reduced incidence of extrapyramidal symptoms .\n",
            "Other side effects are minimal .\n",
            "Condition Intervention Phase Schizophrenia Schizoaffective Disorder Drug - Olanzapine ( @ mg to @ mg/day Drug - Haloperidol ( @ mg to @ mg/day ) Phase IV Eligibility - Genders Eligible for Study - Both Criteria Patients with schizophrenia or schizoaffective disorder .\n",
            "Objective : To investigate risperidone combined with low dose clozapine efficacy and safety of treatment of refractory schizophrenia ( Trs ) .\n",
            "Methods : in the trs @ patients of our hospital from January @ to January @ , were randomly divided into the treatment group and the control group , the control group was given risperidone therapy alone , the treatment group based on joint dose of clozapine treatment .\n",
            "Results : panss score improved after treatment in each group was significantly better than before treatment , the difference was statistically significant ( p < @ ) .\n",
            "@ week after treatment , @ weeks of treatment group panss score improvement was significantly better than the control group , the difference was statistically significant ( p < @ ) .\n",
            "The total effective rate of @ % , @ % in the control group , the difference was not statistically significant ( p > @ ) .\n",
            "The treatment group extrapyramidal reactions , insomnia incidence was significantly lower than the control group , tachycardia incidence is significantly higher , the difference was statistically significant ( p < @ ) .\n",
            "OBJECTIVE : To determine the safety and efficacy of AMG @ , an oral inhibitor of glycine transporter type-@ ( GlyT@ ) , as an add-on to antipsychotic therapy in clinically stable people with schizophrenia with enduring negative symptoms .\n",
            "METHOD : Analysis of pooled data from two phase @ studies .\n",
            "Adults diagnosed with schizophrenia stabilized on antipsychotic medication randomized ( @:@:@:@ ) to orally receive daily AMG @ ( @ mg , @ mg , or @ mg ) or placebo .\n",
            "Primary endpoint was Negative Symptom Assessment ( NSA ) -@ total score change from baseline to week @ .\n",
            "RESULTS : Studies were terminated early after a report of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis ( SJS/TEN ) in one participant ( @-mg AMG @ ) .\n",
            "At termination , @ participants had enrolled and @ completed @weeks of treatment .\n",
            "At week @ , change from baseline NSA-@ total score showed no differences between groups .\n",
            "Mean decrease in Positive and Negative Syndrome Scale ( PANSS ) Negative Symptom Factor Score ( NSFS ) and NSA-@ global score were greater with @-mg AMG @ than placebo ( p < @ ) .\n",
            "Changes in PANSS-Positive Symptom Factor Scale were not significantly different for any group .\n",
            "Changes in patient-reported outcomes ( Sheehan Disability Scale and Quality of Life Enjoyment and Satisfaction Questionnaire ) showed trends consistent with greater efficacy of @-mg AMG @ compared with placebo ( p < / = @ ) .\n",
            "Adverse event rates were similar among all groups , with no clear differences observed .\n",
            "CONCLUSIONS : Significant treatment effects of @-mg AMG @ , but not higher or lower doses , were observed on secondary endpoints but not on the primary outcome .\n",
            "These results replicate previous reports of an inverted-U dose response curve and suggest further evaluation of GlyT@ inhibitors in schizophrenia negative symptoms is warranted .\n",
            "TRIAL REGISTRATION : Clinicaltrials.govNCT@ ( https://clinicaltrials.gov/ct@/show/NCT@ ) and NCT@ ( https://clinicaltrials.gov/ct@/show/NCT@?term=NCT@&rank=@ ) ; EudraCT number @-@-@ and @-@-@ .\n",
            "Objective : To evaluate aripiprazole merge venlafaxine sustained release agent efficacy and adverse effects of the treatment of the negative symptoms of chronic schizophrenia .\n",
            "Methods : @ patients with chronic schizophrenia were randomly divided into the combination group ( aripiprazole merger Venlafaxine extended release ) and group ( aripiprazole ) , positive and negative symptoms scale ( panss symptom Scale ) and negative Syndrome Scale ( sans ) and treatment ( tess ) before treatment , @ and @ weeks of treatment efficacy and adverse effects assessed .\n",
            "Results : eight weeks of treatment combination group panss score negative factor points sans score and subscale scores decreased than before treatment , and negative factor scores significantly lower than the single-use group .\n",
            "Tess score of @ , @ and @ weeks after treatment , the combination group than in a single group .\n",
            "Procedurally , @ chronic schizophrenic males participated in what they and their ward personnel believed to be a food metabolism study , in which placebos posed as drugs capable of altering ward behavior .\n",
            "A @ X @ X @ repeated-measurement design was applied in which @ matched groups of patients on each of @ psychiatric wards encountered @ successive study phases : observation , verbal instruction ( \" Be active \" or \" Be idle \" ) , and drug ( activating or enervating placebos ) .\n",
            "Findings : patients significantly altered their behavior to correspond to the type of verbal instructions provided ; patients ' subjective appraisals of \" drug \" effects were significantly correlated with their attitudes toward hospital medication as measured by the Sherman Medication Test .\n",
            "In a new approach to the interpretation of data from flexible-dose studies , we examined the safety and efficacy measurements that preceded and followed dose changes , to identify clinical factors that predict dose change as well as subsequent outcome of clinical status with dose change .\n",
            "This was a post hoc analysis of @ flexible-dosed olanzapine studies : acutely ill bipolar I patients with an index manic episode ( N = @ ) who received olanzapine ( @-@ mg/d ) or haloperidol ( @-@ mg/d ) ; acutely ill patients with schizophrenia ( N = @ ) who received olanzapine ( @-@ mg/d ) or risperidone ( @-@ mg/d ) for @ weeks ; and remitted bipolar I patients ( N = @ ) who received olanzapine ( @-@ mg/d ) or placebo for @ weeks .\n",
            "The major findings of this analysis were : an increase in dose was predicted by baseline illness severity in the acute studies , and a decrease in dose was predicted by illness symptom improvement or worsening of adverse events .\n",
            "Dose decrease was followed by significantly decreased efficacy for patients with acute mania treated with olanzapine or haloperidol , and olanzapine dose increases were followed by improved efficacy .\n",
            "Treatment-emergent extrapyramidal symptom adverse events and akathisia typically predicted dose decreases .\n",
            "Techniques used in this analysis may prove to be useful in assessing the relationship between dose change and safety and efficacy measures .\n",
            "Copyright copyright @ by Lippincott Williams & Wilkins\n",
            "Objective : To observe the Ginkgo biloba treatment of chronic schizophrenia .\n",
            "Methods : @ patients were randomly divided into a treatment group ( Ginkgo biloba group ) @ cases of @ cases and a control group .\n",
            "Two sets of original clothing antipsychotic change are used BPRS , SANS and TESS scale before treatment and after @ , @ and @ weeks for efficacy and side effects observed .\n",
            "The results : a significant improvement in negative symptoms of chronic schizophrenia treatment group .\n",
            "Conclusion : Ginkgo treatment of chronic schizophrenic patients , side effects , worthy of promotion .\n",
            "In an @-hospital collaborative study , @ newly admitted patients with a diagnosis of schizo-affective psychosis , excited state , were randomly assigned to lithium carbonate or chlorpromazine hydrochloride for a three-week period .\n",
            "Patients were classified as highly active or mildly active on the basis of degree of hyperactivity shown at admission .\n",
            "The results showed that lithium carbonate was less effective than chlorpromazine in treating highly active patients .\n",
            "This was due primarily to lithium carbonate 's relatively poor control of hostile , excited behavior .\n",
            "There was no major difference between lithium carbonate and chlorpromazine among mildly active patients ; both treatments showed a significant reduction in affective and schizophrenic behavior .\n",
            "The possibility that lithium carbonate may have neuroleptic properties is considered in a discussion of the therapeutic and diagnostic implications of these results .\n",
            "OBJECTIVES : People living with a psychotic illness have higher rates of cigarette smoking and face unique barriers to quitting compared to the general population .\n",
            "We examined whether self-reported reasons for smoking are useful predictors of successful quit attempts among people with psychosis .\n",
            "METHODS : As part of a randomized controlled trial addressing smoking and cardiovascular disease risk behaviors among people with psychosis , self-reported reasons for smoking were assessed at baseline ( n = @ ) , @ weeks ( n = @ ) , and @ months ( n = @ ) .\n",
            "Three factors from the Reasons for Smoking Questionnaire ( Coping , Physiological , and Stimulation/Activation ) were entered into a model to predict short - and long-term abstinence .\n",
            "The relationship between these factors and mental health symptoms were also assessed .\n",
            "RESULTS : Participants scoring higher on the Stimulation/Activation factor ( control of weight , enjoyment , concentration , and \" peps me up \" ) at baseline were just less than half as likely to be abstinent at @ weeks .\n",
            "Female participants were five times more likely to abstinent at @ weeks , and those with a higher global functioning at baseline were @ % more likely to be abstinent .\n",
            "There was a positive correlation between changes over time in the Stimulation/Activation factor from baseline to @-month follow-up and the Brief Psychiatric Rating Scale total score at @-month follow-up .\n",
            "This indicates that increasingly higher endorsement of the factor was associated with more psychological symptoms .\n",
            "There was also a negative correlation between the change over time in the Stimulation/Activation factor and global functioning at @ months , indicating that increasingly higher endorsement of the factor led to lower global assessment of functioning .\n",
            "CONCLUSIONS : The Stimulation/Activation factor may be particularly important to assess and address among smokers with psychosis .\n",
            "It is recommended that further research use the Reasons for Smoking Questionnaire among smokers with psychosis as a clinical tool to identify specific quit barriers .\n",
            "Further research into why females have higher smoking cessation rates in the short term and relapse prevention interventions seem worthy of further investigation .\n",
            "RATIONALE : Intramuscular ( IM ) conventional antipsychotics and/or benzodiazepines are effective in the short-term treatment of acutely agitated psychotic patients but may be associated with adverse effects .\n",
            "A short-acting IM formulation of the novel antipsychotic , ziprasidone , which may offer advantages over conventional agents , has been developed .\n",
            "OBJECTIVE : To compare ziprasidone IM @ mg ( n = @ ) and @ mg ( n = @ ) in the acute control and short-term management of agitated psychotic patients .\n",
            "METHODS : A prospective , randomized , double-blind , @-h study assessed efficacy using the Behavioral Activity Rating Scale ( BARS ) and the PANSS .\n",
            "The BARS is a validated rating scale for the assessment of treatment response in acute agitation associated with psychosis .\n",
            "Following the initial dose , three more doses could be given @ h apart if needed during the @-h period .\n",
            "RESULTS : The mean BARS score had decreased @ min after the first @ mg IM dose and was statistically significantly lower than the @ mg group at @ min post-dose .\n",
            "The improvement with the @ mg dose increased until @ h , and was maintained until at least @ h post-dose ( P < @ ) .\n",
            "Two hours after the first injection , almost all of the patients receiving ziprasidone @ mg were BARS responders compared with just one-third of those receiving @ mg ziprasidone ( P < @ ) .\n",
            "The calming effect of ziprasidone was also evident by the significant reduction in PANSS agitation items ( P < @ ) and CGI-severity at @ h ( P = @ ) .\n",
            "Both ziprasidone doses were very well tolerated .\n",
            "Ziprasidone IM @ mg was not associated with EPS , dystonia , akathisia , respiratory depression or with excessive sedation .\n",
            "CONCLUSIONS : Ziprasidone IM @ mg substantially and significantly reduced the symptoms of acute agitation in patients with psychotic disorders .\n",
            "Ziprasidone @ mg IM was very well tolerated and produced no dystonia or akathisia .\n",
            "There is uncertainty about the clinical usefulness of the dexamethasone suppression test ( DST ) .\n",
            "It is also unclear whether there are advantages to a @-mg or @-mg DST .\n",
            "Eighty-three consecutive psychiatric inpatients were randomly given a @-mg or @-mg DST within the first week of admission .\n",
            "Sensitivity , specificity , and diagnostic confidence are reported for this group , and also in combination with those for @ semi-consecutive psychiatric admissions .\n",
            "Although rates of nonsuppression were consistently higher in patients with affective disorders than in patients with other diagnoses , the diagnostic confidence of the DST for major depression in a diverse and unselected patient population was not greater than the prevalence of the disorder .\n",
            "The DST does not appear to be useful for clinical diagnostic decision-making .\n",
            "Nonetheless , the DST may still be an important biological marker in neuroendocrine psychiatric research .\n",
            "Three groups , @ on clozapine , @ on new atypical , and @ on typical antipsychotics , were entered into studies of pure ethyl-EPA as add-on therapy .\n",
            "Patients were randomised to one of four treatment groups , placebo or @g , @g or @g/d of EPA .\n",
            "@g/d always produced more improvement than @g/d .\n",
            "EPA has several effects on cell membranes .\n",
            "It is incorporated and converted to its metabolite docosahexaenoic acid ( DHA ) .\n",
            "It competes with DHA and with arachidonic acid ( AA , a cell signalling molecule released by both dopamine and serotonin ) and can lower their levels .\n",
            "It inhibits phospholipase A@ , an enzyme whose activity is elevated in schizophrenia , and which removes DHA and AA from membranes : by this mechanism it may raise AA and DHA levels .\n",
            "These different effects may operate at different EPA doses .\n",
            "To test the relationship between clinical response and membrane composition , the change in PANSS score from baseline to @ weeks was related to the change in red cell fatty acid concentration .\n",
            "There was no significant relationship between clinical improvement and either EPA or DHA but there was a highly significant positive correlation between improvement and AA level ( r = @ , p , @ ) .\n",
            "@g/d EPA elevated AA whereas @g/d suppressed it , explaining the clinical responses .\n",
            "A @-week , standard-controlled , DOUBLE-blind study was conducted to compare the efficacy of butaclamol with that of fluphenazine in the treatment of @ newly admitted schizophrenic patients .\n",
            "Statistically significant improvement occurred in the entire population in the total scores of the BPRS and PAS ; in the activation , anergia , thought disturbance and hostile/suspiciousness factor scores of the BPRS ; and in the scores of @ of the @ factors of the PAS .\n",
            "There were no statistically significant differences between the scores of the two treatment groups on the total or factor scores of either scale during the course of the clinical trial .\n",
            "The most frequently occurring adverse effects in the butaclamol group were rigidity , akathisia and excitement/agitation .\n",
            "The most frequently occurring adverse effects in the fluphenazine group were insomnia , decreased motor activity and tremor .\n",
            "It is concluded that butaclamol exerts potent neuroleptic effects on schizophrenic patients .\n",
            "Objective To explore the effects of Shuxuening combined with antipsychotics on chronic schizophrenia .\n",
            "Method Double blind controlled study was adopted in this paper .\n",
            "Results The curative effects of Shuxuening combined with antipsychotics treated patients ( n = @ ) were significantly higher than that of single antipsychotics treated patients ( n = @ ) , and it was also reduced the extrapyramidal symptoms of antipsychotics .\n",
            "Conclusion The effects of Shuxuening for the negative symptoms were better than for\n",
            "BACKGROUND : Comorbid depression is common in first-episode schizophrenia spectrum ( FES ) disorders .\n",
            "Both depression and FES are associated with significant deficits in facial and prosody emotion recognition performance .\n",
            "However , it remains unclear whether people with FES and comorbid depression , compared to those without comorbid depression , have overall poorer emotion recognition , or instead , a different pattern of emotion recognition deficits .\n",
            "The aim of this study was to compare facial and prosody emotion recognition performance between those with and without comorbid depression in FES .\n",
            "METHODS : This study involved secondary analysis of baseline data from a randomized controlled trial of vocational intervention for young people with first-episode psychosis ( N = @ ; age range : @-@ years ) .\n",
            "RESULTS : Those with comorbid depression ( n = @ ) had more accurate recognition of sadness in faces compared to those without comorbid depression .\n",
            "Severity of depressive symptoms was also associated with more accurate recognition of sadness in faces .\n",
            "Such results did not recur for prosody emotion recognition .\n",
            "LIMITATIONS : In addition to the cross-sectional design , limitations of this study include the absence of facial and prosodic recognition of neutral emotions .\n",
            "CONCLUSIONS : Findings indicate a mood congruent negative bias in facial emotion recognition in those with comorbid depression and FES , and provide support for cognitive theories of depression that emphasise the role of such biases in the development and maintenance of depression .\n",
            "Longitudinal research is needed to determine whether mood-congruent negative biases are implicated in the development and maintenance of depression in FES , or whether such biases are simply markers of depressed state .\n",
            "The effects of clozapine treatment on neuroendocrine responses induced by the serotonin agonist , m-chlorophenylpiperazine ( mCPP ) were examined .\n",
            "mCPP and placebo were administered after a @-week drug-free period and again after @ weeks of clozapine treatment in nine schizophrenic inpatients .\n",
            "Adrenocorticotropic hormone ( ACTH ) , prolactin , and mCPP levels were measured .\n",
            "Clozapine treatment completely blocked mCPP-induced ACTH and prolactin release suggesting that clozapine blocks serotonin receptors that mediate these hormone responses .\n",
            "OBJECTIVE : Self-directed care ( SDC ) offers flexibility in and control over mental health services .\n",
            "This study examined the types of goods and services that individuals with serious mental illness request in an SDC intervention .\n",
            "METHODS : Data were from a randomized controlled trial that enrolled adult participants receiving Medicaid-reimbursed services , with two years of expenditures at the @ % -@ % level of all Medicaid enrollees in the county and no hospitalizations within six months of the study .\n",
            "Data were analyzed for @ participants randomly assigned to an SDC intervention , who were allowed to make requests for and purchase nontraditional goods and services through a noncapitated fund .\n",
            "Requests were coded by using the section on activities and participation of the World Health Organization 's International Classification of Function , Disability , and Health ( ICF ) model .\n",
            "Descriptive statistics are presented for the categories of requests made by participants .\n",
            "RESULTS : The @ participants made a total of @ requests , representing @ ICF codes .\n",
            "Requests ranged from @ to @ requests per person , with a mean of @ requests .\n",
            "The average time to first request was @ days .\n",
            "Most codes were in the area of self-care ( @ % ) and general tasks and demands ( @ % ) .\n",
            "Among the @ participants who made requests , the mean was @ requests , which addressed an average of @ unique needs .\n",
            "CONCLUSIONS : Individuals with serious mental illness identified personal-medicine strategies to address needs that are currently unmet by traditional mental health services .\n",
            "Self-directed care may be a service delivery option that allows consumers to access their own personal medicine and better address their needs .\n",
            "The purpose of this study is to assess efficacy and safety of Staccato Loxapine in the treatment of acute agitation in schizophrenic patients .\n",
            "The study will be conducted in @ agitated schizophrenic patients - either newly admitted to a hospital setting or a research unit for acute agitation or already in hospital for chronic underlying conditions .\n",
            "Patients meeting entry criteria will be randomized to one of two doses of Staccato Loxapine or to Staccato Placebo .\n",
            "Following administration of study drug , assessment of agitation state will be conducted at serial time points using standard agitation scales over a @ hour period .\n",
            "Objective : To observe the schizophrenia patients with community-based rehabilitation , medical costs and disease severity changes .\n",
            "Methods : @ patients with schizophrenia were randomly divided into community-based study group and control group , each group of @ cases .\n",
            "A prospective controlled study , which lasted a year .\n",
            "@ before and after medical costs and other economic losses , and clinical efficacy .\n",
            "Results : community-based rehabilitation after the patient 's medical costs were significantly lower than the control group ( P < @ ) , the improvement rate was also significantly higher ( P < @ ) .\n",
            "Study hypothesis Cognition in patients with schizophrenia is enhanced using pro-cognitive drugs like pergolide or tolcapone compared to placebo .\n",
            "Ethics approval Ethics Committee of the Medical Faculty RWTH Aachen University approved on the @th January @ Study design Double-blind randomised placebo-controlled trial Countries of recruitment Germany Disease/condition/study domain Schizophrenia , cognitive functions Participants - inclusion criteria @ .\n",
            "@ patients suffering from schizophrenia using Diagnostic and Statistical Manual of Mental Disorders , @th Edition ( DSM-IV ) criteria @ .\n",
            "Signed informed consent @ .\n",
            "Aged @ - @ years , either sex @ .\n",
            "Negative pregnancy test @ .\n",
            "No drug addiction @ .\n",
            "No suicidality @ .\n",
            "Ability to understand and read German language Participants - exclusion criteria @ .\n",
            "Drug addiction @ .\n",
            "Severe medical problems @ .\n",
            "Long-QT-syndrome @ .\n",
            "Problems regarding the heart-valves @ .\n",
            "Seizures @ .\n",
            "Reduced liver or renal function @ .\n",
            "Pregnancy @ .\n",
            "Known incompatibility of the study-drugs Anticipated start date @/@/@ Anticipated end date @/@/@ Status of trial Ongoing Target number of participants @ Interventions TOCTAP is a randomised , three-armed double-blind study with @ patients suffering from schizophrenia , using DSM-IV diagnostic criteria .\n",
            "Patients are randomised in three groups of @ patients each .\n",
            "Patients either receive @ mg of tolcapone ( @ mg - @ mg - @ mg ) or @ mg of pergolide ( @ mg - @ mg - @ mg ) or placebo three times daily ( TID ) .\n",
            "Cognitive function is tested using the MATRICS Consensus Cognitive Battery ( MCCB ) at baseline and after a period of six weeks of pro-cognitive medication .\n",
            "Primary outcome measure ( s ) Change in Matrics Consensus Cognitive Battery ( MCCB ) , tested at baseline and after a treatment period of six weeks Secondary outcome measure ( s ) Improvement of clinical outcome regarding schizophrenic symptoms , tested at baseline and after a treatment period of six weeks\n",
            "Responds to comments by R. Balon and J. A. Mattes ( see records @-@-@ and @-@-@ , respectively ) on the original article by D. L. Zimbroff et al ( see record @-@-@ ) comparing sertindole and haloperidol in schizophrenia.With regard to the high dropout rate , the main reasons for dropout included lack of efficacy , adverse events , and noncompliance .\n",
            "Not enumerated in the article were other reasons , including lost to follow-up , personal , and other .\n",
            "The authors state that they never claimed superiority of sertindole for negative symptoms .\n",
            "Sertindole was found to be superior to placebo and that haloperidol was not superior to placebo in treating negative symptoms .\n",
            "Ultimately , multiple trials must be conducted to achieve the most comprehensive treatment models .\n",
            "The concurrent validity between the Berliner Lebensqualitatsprofil ( BELP ) and a new developed short form ( BELP-KF ) was tested in a sample of schizophrenia outpatients ( N = @ ) and turned out to be very high .\n",
            "The restriction to subjective quality of life questions did not lead to a greater halo-effect in the sense of an increasing similarity of single item values .\n",
            "Correlations with psychopathological symptoms were almost identical for both interview-versions .\n",
            "The same is true concerning the factorial structure of the satisfaction items which was nearly congruent .\n",
            "Two optional items on satisfaction with sexual life and with psychopharmacological treatment , which had been included into the short interview version , were attributable to an underlying general satisfaction dimension .\n",
            "Among @ variables satisfaction with psychopharmacological treatment had the second highest factor - loading on the resulting general satisfaction factor .\n",
            "OBJECTIVES : Schizophrenia is a debilitating chronic psychiatric illness with a considerable impact on the patient and the patient 's environment , in terms of morbidity , mortality , human suffering and societal costs .\n",
            "Currently , little is known of the exact cost of relapse in schizophrenia .\n",
            "Our objective is to estimate cost of relapse based on resource utilization data collected alongside a clinical trial .\n",
            "METHODS : \" Constatre \" is a multicenter , open-label , randomized , active-control , long-term study comparing risperidone long acting injectable treatment with oral quetiapine , conducted from October @ to November @ at @ sites in @ countries ( ClinicalTrials.gov identifier : NCT@ ) .\n",
            "Information regarding Medical Resource Utilization ( MRU ) during the three months following relapse was collected for a subset of patients .\n",
            "To estimate the associated relapse related costs , average purchase power parity adjusted country resource unit costs ( @ Euro ) were applied .\n",
            "RESULTS : Detailed MRU data were available for @ patients spread across Europe .\n",
            "The overall mean MRU cost per patient in the three months following the relapse was @ , of which @ % was related to psychiatric hospitalisation .\n",
            "@ % of the relapsed patients were hospitalized , for on average @ days , representing a total cost of @ ( range @ - @ ) per hospitalised patient .\n",
            "@ % of the patients were in day-clinic , on average for @ days , representing a cost of @ per patient .\n",
            "The majority ( @ % ) of the relapsed patients had outpatient visits , representing a mean cost per patient of @ , mainly to psychiatrists ( @ % of patients , average = @ visits ) and nurses ( @ % of patients , average = @ visits ) .\n",
            "CONCLUSIONS : Costs related to relapse of schizophrenic patients are considerable , and mainly driven by psychiatric hospitalisation .\n",
            "Antipsychotic treatment that prevents or reduces relapse and psychiatric hospitalisation can have a major impact on the total schizophrenia related treatment cost .\n",
            "Serum concentrations of clozapine , norclozapine , and clozapine-N-oxide were assayed in psychotic patients treated with clozapine alone ( N = @ ) , clozapine with fluoxetine added ( N = @ ) , or clozapine with valproic acid added ( N = @ ) .\n",
            "Subjects were matched for age and other treatments , and concentrations were corrected for daily dose of clozapine ( milligrams per kilogram of body weight ) .\n",
            "With valproic acid , there was a minor increase in total clozapine metabolites , which was even less with dose correction .\n",
            "Fluoxetine increased all clozapine analytes , in some cases to twice the levels in the subjects given only clozapine .\n",
            "The purpose of this study was to compare the effectiveness of four interventions in providing services to homeless clients with dual disorders : standard care ( SC ) , assertive community treatment only ( ACTO ) , integrated assertive community treatment ( IACT ) , and new integrated assertive community treatment ( NIACT ) .\n",
            "Participants had to be homeless , have a substance use disorder , and have a severe mental illness to be eligible for the study .\n",
            "One hundred ninety-six individuals were randomly assigned to SC , ACTO , or IACT .\n",
            "Approximately two years later , @ participants were assigned to NIACT .\n",
            "A quasi-experimental design was employed to analyze the data .\n",
            "Clients in the NIACT program had better outcomes on consumer satisfaction than clients in the other conditions .\n",
            "Clients in NIACT , IACT , and ACTO groups had better housing outcomes than clients in SC .\n",
            "Clients in NIACT reduced their use of drugs more than clients in the other programs , but there was no difference between conditions on the other substance abuse variables .\n",
            "There was no difference between conditions on psychiatric symptoms .\n",
            "IACT may need to be augmented with other services to reduce substance use and produce better psychiatric outcomes for dual-disorder homeless individuals .\n",
            "A randomized trial to evaluate day hospital care as an alternative to inpatient treatment in the acute phase of psychiatric illness was abandoned when too few patients were admitted to the trial to enable any valid generalization to be made concerning the total at-risk population .\n",
            "In accounting for the failure of the experimental design , attention is drawn to the inability of the research team to influence either the organization of the unit , whereby junior staff had no contact with the day hospital , or the prevailing belief among senior staff that the two treatment settings serve distinctive , not alternative , functions .\n",
            "The implications of our failure for the feasibility of conducting a successful and externally valid controlled trial in this research setting are explored .\n",
            "Objective To investigate the effect of the application of the standard theory in health education of patients with schizophrenia .\n",
            "Methods @ patients with first-episode schizophrenia patients were randomly divided into observation group and control group @ cases , both groups schizophrenia conventional health education , observation group to apply the standard theory based on the implementation of targeted health education , observation hospitalized throughout .\n",
            "Before and after health education , health knowledge to design evaluation form , adherence questionnaire , nursing job satisfaction questionnaire on two groups of patients with health education effect evaluation analysis .\n",
            "Results of the health knowledge evaluation form scores of the two groups of patients , treatment compliance , patients and their families on nursing job satisfaction than those before the health education improved significantly ( p < @ ) , but the observation group than in the control group increased more significantly ( p < @ ) .\n",
            "The conclusions apply the standard theory of health education , can significantly improve the effect of health education and the quality of care and job satisfaction .\n",
            "Objective To investigate the improvement of the comprehensive rehabilitation of chronic schizophrenia , cognitive function .\n",
            "Methods @ cases of patients with chronic schizophrenia were randomly divided into two groups , rehabilitation group applications antipsychotics plus comprehensive rehabilitation ; control group alone antipsychotics .\n",
            "Standardized psychiatric rating scale before and after treatment with people with chronic diseases .\n",
            "The mini-mental status checklist ( MMSE ) to assess cognitive function .\n",
            "The results standardized Psychiatric Rating Scale reduction rate of chronic mental patients in rehabilitation group and control group were @ % and @ % , there was significant difference between the two ( t = @ , P < @ ) ; the MMSE assessment Score rehabilitation group significantly increased ( P < @ ) after treatment .\n",
            "Antipsychotic-induced weight gain ( AIWG ) is a common side effect with a high genetic contribution .\n",
            "We reanalyzed genome-wide association study ( GWAS ) data from the Clinical Antipsychotic Trials of Intervention Effectiveness ( CATIE ) selecting a refined subset of patients most suitable for AIWG studies .\n",
            "The final GWAS was conducted in N = @ individuals .\n",
            "The top polymorphisms were analyzed in a second cohort of N = @ patients .\n",
            "None of the single-nucleotide polymorphisms was significant at the genome-wide threshold of @x@ ( -@ ) .\n",
            "We observed interesting trends for rs@ ( P = @ x@ ( -@ ) ) upstream of OGFRL@ , the intergenic variants rs@ ( P = @ x @ ( -@ ) ) and rs@ ( P = @ x @ ( -@ ) ) , and rs@ ( P = @ x@ ( -@ ) ) in IBA@ .\n",
            "In the second cohort , rs@ showed significant association with AIWG ( P = @ ) .\n",
            "The combined meta-analysis P-value for rs@ was @ x @ ( -@ ) .\n",
            "Our reanalysis of the CATIE GWAS data revealed interesting new variants associated with AIWG .\n",
            "As the functional relevance of these polymorphisms is yet to be determined , further studies are needed.The Pharmacogenomics Journal advance online publication , @ September @ ; doi : @ / tpj .@ .\n",
            "SUMMARY - Overview - Psychiatric and substance abuse services are typically provided separately to patients with comorbid mental illness and substance abuse .\n",
            "Yet , studies have clearly demonstrated that each disorder negatively effects the outcome of the other .\n",
            "We studied the effects of service integration on treatment retention ( TR ) , rehospitalization ( RH ) , substance use ( SU ) , and psychiatric symptom severity ( PS ) in @ patients with RDC schizophrenia and DSM-III-R psychoactive substance use disorders .\n",
            "Method - We compared manualized integrated psychiatric and substance abuse services ( COPAD ) with equally-intense nonintegrated treatment in a randomized clinical trial .\n",
            "To evaluate TR , we used Fisher 's Exact tests ; for RH , Kaplan-Meier plots & Cox proportional hazards regression ; and for SU and PS ( ASI composite scores ) , Generalized Estimating Equations ( GEE ) .\n",
            "Results - The early dropout after randomization was @ % ( N = @ attending < = @ outpatient session ) .\n",
            "For \" starters \" ( > = @ sessions ) , @ % of COPAD patients were retained in treatment at eight months versus @ % of control patients ( p = .@ , f = .@ ) , a moderate effect size .\n",
            "Between groups comparisons were obscured by high attrition among controls .\n",
            "A significant main effect for RH was found for Engagement Status , favoring starters ( h = @ ; p < .@ ) .\n",
            "Treatment-exposed subjects improved in PS over time ; GEE yielded no main Group effects .\n",
            "COPAD subjects showed trends toward less alcohol ( z = -@ , p < .@ ) and drug problems ( z = -@ , p < .@ ) at eight months vs. controls .\n",
            "Discussion - This controlled study provides evidence that patients with addiction and schizophrenia connect better with integrated treatment services , which can lead to better outcome in a variety of domains .\n",
            "A replication and other confirmatory studies will be discussed in presenting integrated treatment as the mode of choice for such patients .\n",
            "Background : One of the core objectives of antipsychotic therapy for patients with schizophrenia is to help improve their psychosocial functioning in the community .\n",
            "No information is currently available on the longterm functional improvements among patients treated with olanzapine long-acting injection ( olanzapine-LAI ) for schizophrenia .\n",
            "This study describes the changes in levels of functioning among patients treated with olanzapine-LAI duringa @-year , randomized , open-label study of outpatients with schizophrenia .\n",
            "A secondary objective was to compare olanzapine-LAI with oral olanzapine on changes in the functional measures .\n",
            "Methods : This was a secondary analysis of a multicenter , randomized , open-label , @-year study comparing the long-term treatment effectiveness of monthly olanzapine-LAI with that of daily oral olanzapine ( ClinicalTrials .\n",
            "gov registration number : NCT@ ) .\n",
            "Outpatients with > @ episodes of psychotic worsening in the past @ months with a Positive and Negative Syndrome Scale ( PANSS ) total score < @ were randomized to @mg/@ - weeks olanzapine-LAI ( N = @ ) or @mg/day oral olanzapine ( N = @ ) .\n",
            "Dosing was flexible following the initial randomization dose ( @-@mg / @-weeks LAI vs. @-@mg / day oral ) .\n",
            "Changes in patients ' levels of functioning were assessed in this analysis with the Heinrichs and Carpenter 's Quality of Life Scale ( QLS ) , which was assessed at baseline and at @ months intervals thereafter .\n",
            "Patients ' functional status was also classified - at baseline and endpoint , per QLS - as \" good , \" \" moderate \" or \" poor \" using a recent datadriven approach to defining levels of functioning in schizophrenia .\n",
            "Last Observation Carried Forward ( LOCF ) analysis was employed .\n",
            "Results : Over the @-year study , patients treated with olanzapine - LAIimproved their level of functioning - per QLS total score - from a mean ( + / - SD ) of @ ( + / -@ ) to @ ( + / -@ ) ( p < @ ) .\n",
            "At baseline , @ % of the olanzapine LAI-treated patients were identified as having a \" good \" level of functioning , which increased to @ % following up to @ years of therapy ( p = @ ) .\n",
            "There was a numerical decrease in the proportion of patients with a \" moderate \" level of functioning ( from @ to @ % ; p = @ ) and in the proportion of patients with a \" poor \" level of functioning ( from @ % to @ % ; p = @ ) .\n",
            "Results were not significantly different between the oral olanzapine and the olanzapine-LAI treatment groups .\n",
            "Discussion : In this @-year open label , randomized study of olanzapine-LAI , outpatients with schizophrenia had maintained their favorable baseline level of functioning or have further improved it over time .\n",
            "Results did not significantly differ between OLZ-LAI and oral olanzapine .\n",
            "BACKGROUND : Depressive symptoms are common in older patients with SCHIZOphrenia ; yet , few studies have examined the usefulness of antidepressants in this population .\n",
            "OBJECTIVE : We conducted a @-week single-BLIND trial of citalopram ( @-@ mg/day ) vs no citalopram augmentation in @ middle-aged and elderly patients with SCHIZOphrenia hospitalized for more than six of the last @ months .\n",
            "At study-entry , the patients had been on stable doses of antipsychotics for at least two weeks , and had a @-item Hamilton Depression Rating ( HAM-D ) scale score of @ or greater .\n",
            "Nine patients were RANDOMly assigned to citalopram augmentation , and @ to no augmentation of antipsychotics .\n",
            "RESULTS : Patients in both groups improved on positive and negative symptoms , but the citalopram group had significantly greater improvement in HAM-D and Clinical Global Impression Scale scores than the control group .\n",
            "There were no major side effects .\n",
            "CONCLUSION : Larger double-BLIND studies are needed to follow up on these preliminary findings .\n",
            "Circuits-@ .\n",
            "Research Summary - Cognitive difficulties are a limiting factor on the functional and quality of life outcomes for people with schizophrenia .\n",
            "Cognitive remediation therapy ( CRT ) is a psychological therapy shown to improve these thinking skills ( Wykes et al. @ ) .\n",
            "Currently therapy involves a considerable amount of therapist time but a new development , computerised CRT ( CIRCuiTS ) , may reduce the need for direct individual face to face therapy so that more people can access it .\n",
            "However , the efficacy of this form of therapy has yet to be determined .\n",
            "This trial is an exploratory @ group RCT : CIRCuiTS & Treatment as usual ( TAU ) compared to TAU .\n",
            "Outcomes are measured at weeks @ , @ , @ .\n",
            "Participants are independently randomised and raters blind to group allocation .\n",
            "Primary outcomes are measured in three cognitive domains : long-term memory , working memory , executive function .\n",
            "Secondary outcomes include social functioning , service use & self-esteem .\n",
            "Main Inclusion Criteria - Participants will be entered into the study if they have : a diagnosis of schizophrenia , have been in touch with the mental health services for at least one year , are between @ and @ years old , have a known cognitive deficit ( poor performance in memory ( digit span ) and/or cognitive flexibility ( WCST or Hayling Sentence Completion Test ) in addition to poor social functioning ( score of @ or more on Social Behaviour Schedule ) .\n",
            "Main Exclusion Criteria - Patients will be excluded if there is a plan to change their medication during the therapy phase of the study , has known substance dependence or evidence of an organic cause to their cognitive difficulties ( e.g. history of head injury )\n",
            "This study set out to evaluate the effectiveness of a sailing and learning-to-sail rehabilitation protocol in a sample of patients diagnosed with severe mental disorders .\n",
            "The study was a randomized , crossover , waiting-list controlled trial , following recruitment in the Departments of Mental Health of South Sardinia .\n",
            "Participants were outpatients diagnosed with severe mental disorders , recruited through announcements to the directors of the Departments of Mental Health of South Sardinia .\n",
            "Out of the @ patients enrolled in the study , those exposed to rehabilitation with sailing during a series of guided and supervised sea expeditions near the beach of Cagliari ( Sardinia ) , where the aim to explore the marine environment while sailing was emphasized , showed a statistically significant improvement of their clinical status ( measured by BPRS ) and , as well , of their general functioning ( measured by HoNOS Scale ) against the control group .\n",
            "The improvement was maintained at follow-up for some months only : after @ months , the patients returned to their baseline values on the measures of psychopathology and showed a worsening trend of their quality of life .\n",
            "Sailing can represent a substitute of important experiences that the patients with severe mental disorders miss because of their illness .\n",
            "Objective : To investigate quetiapine combined the clinical efficacy and safety of small doses of clozapine treatment of refractory schizophrenia .\n",
            "Methods : @ cases diagnosed of quetiapine combined small doses of clozapine ( later known as the combined group ) @ cases of clozapine group ( @ cases ) , PANSS and TESS to assess its efficacy for patients with refractory schizophrenia were randomly divided into side effects .\n",
            "Results : The two groups of eight weeks efficacy have significant differences , @ % of the efficiency of the combined group , @ % of the clozapine group and the group was superior in improving negative symptoms , clozapine group .\n",
            "Side effects of the combination group than the clozapine group .\n",
            "Objective : To investigate quetiapine combined the clinical efficacy and safety of small doses of clozapine treatment of refractory schizophrenia .\n",
            "Methods : @ cases diagnosed of quetiapine combined small doses of clozapine ( later known as the combined group ) @ cases of clozapine group ( @ cases ) , PANSS and TESS to assess its efficacy for patients with refractory schizophrenia were randomly divided into side effects .\n",
            "Results : The two groups of eight weeks efficacy have significant differences , @ % of the efficiency of the combined group , @ % of the clozapine group and the group was superior in improving negative symptoms , clozapine group .\n",
            "Side effects of the combination group than the clozapine group .\n",
            "Conclusion : Quetiapine associated with small doses of clozapine treatment of refractory schizophrenia safe and effective , and fewer side effects .\n",
            "Objective : Treatments for the cognitive impairments of schizophrenia are urgently needed .\n",
            "We developed and tested a @-week , group-based , manualized , compensatory cognitive training intervention targeting prospective memory , attention , learning/memory , and executive functioning .\n",
            "The intervention focused on compensatory strategies , such as calendar use , self-talk , note taking , and a @-step problem-solving method , and did not require computers .\n",
            "Method : In a randomized controlled trial , @ outpatients with DSM-IV primary psychotic disorders were assigned to receive standard pharmacotherapy alone or compensatory cognitive training + standard pharmacotherapy for @ weeks .\n",
            "Assessments of neuropsychological performance and functional capacity ( primary outcomes ) and psychiatric symptom severity , quality of life , social skills performance , cognitive insight , and self-reported everyday functioning ( secondary outcomes ) were administered at baseline , posttreatment , and @-month follow-up .\n",
            "Data were collected between September @ and August @ .\n",
            "Results : Hierarchical linear modeling analyses demonstrated significant compensatory cognitive training-associated effects on attention at follow-up ( P = .@ ) , verbal memory at posttreatment and follow-up ( P values < = .@ ) , and functional capacity ( University of California , San Diego Performance-based Skills Assessment ) at follow-up ( P = .@ ) .\n",
            "The compensatory cognitive training group also differentially improved in negative symptom severity at posttreatment and follow-up ( P values < = .@ ) and subjective quality of life at follow-up ( P = .@ ) .\n",
            "Conclusions : Compensatory cognitive training , a low-tech , brief intervention , has the potential to improve not only cognitive performance but also functional skills , negative symptoms , and self-rated quality of life in people with psychosis .\n",
            "Trial Registration : ClinicalTrials.gov identifier : NCT@ .\n",
            "Copyright @ Physicians Postgraduate Press , Inc .\n",
            "Levels of prolactin ( PRL ) in plasma were determined in schizophrenic women and men after i.m. injections of @-@ mg perphenazine enanthate ( PE ) .\n",
            "In both sexes PRL levels increased dose-dependently .\n",
            "In men the effect was significant for @ and in women for @ days .\n",
            "Biperiden treatment did not influence the effect of PE on the PRL levels .\n",
            "The data support the view that clinically used doses of PE induce a small but significant blockade of central dopamine receptors .\n",
            "BACKGROUND : There have been recent advances in the identification of people at high risk of psychosis and psychological treatments have shown promise for prevention .\n",
            "AIMS : To compare the longitudinal course of psychotic experiences and emotional dysfunction in high-risk participants receiving cognitive therapy with those receiving treatment as usual .\n",
            "METHOD : Data from a recent randomised controlled trial of cognitive therapy for people at risk of developing psychosis were utilised to examine three different statistical models that were based on @ measurements of psychotic experiences and @ of emotional dysfunction ( anxiety-depression ) contributed by @ participants across the @ measurement occasions ( monthly monitoring for a year ) .\n",
            "RESULTS : Psychotic experiences and emotional dysfunction were correlated and decreased significantly over the course of the study , with most improvement in the early months .\n",
            "The reduction in positive symptoms , but not emotional dysfunction , was enhanced by allocation to cognitive therapy .\n",
            "CONCLUSIONS : Psychotic experiences and emotional dysfunction appear to interact in people at risk of developing psychosis .\n",
            "There appears to be a specific benefit of cognitive therapy .\n",
            "Trial Status : Registered .\n",
            "Date Submitted : @/@/@ .\n",
            "Date Registered : @/@/@ .\n",
            "Health condition ( s ) or problem ( s ) studied : Schizophrenia .\n",
            "Description of intervention ( s ) / exposure : Glycine , @ g/kg oral administration per day for @ weeks , in conjunction with patient 's current antipsychotic medication .\n",
            "Intervention code : Treatment : drugs .\n",
            "Comparator / control treatment : Placebo ( @ g/kg glucose ) oral administration per day for @ weeks , in conjunction with patient 's current antipsychotic medication .\n",
            "Control group : Placebo .\n",
            "Primary outcome @ : Cognition as measured by the CogState Schizophrenia Cognitive Test Battery .\n",
            "Timepoint : at baseline , @ weeks , and @ weeks after treatment commencement .\n",
            "Primary outcome @ : Mismatch Negativity ( MMN ) amplitude as measured by electroencephalography ( EEG ) .\n",
            "Timepoint : at baseline and @ weeks after treatment commencement .\n",
            "Primary outcome @ : Positive and Negative Symptom Scale ( PANSS ) score .\n",
            "Timepoint : at baseline , @ weeks , and @ weeks after treatment commencement .\n",
            "Secondary outcome @ : Calgary Depression Rating Scale ( CDRS ) score .\n",
            "Timepoint : at baseline , @ weeks , and @ weeks after treatment commencement .\n",
            "Secondary outcome @ : Work and Social Adjustment Scale ( WSAS ) score .\n",
            "Timepoint : at baseline , @ weeks , and @ weeks after treatment commencement .\n",
            "Key inclusion criteria : * Currently meet Diagnostic & Statistical Manual of Mental Disorders - @th Edition ( DSM-IV ) criteria for a diagnosis of chronic schizophrenia * Aged @-@ years * Clinically stable for @ months * Currently on stable atypical antipsychotic ( other than Clozapine ) therapy , where type of medication has been unaltered for @ months and medication dose has been unaltered for @ month prior to start of study * Capacity to provide consent .\n",
            "Maximum Age : @ Years Gender : Both males and females .\n",
            "Healthy volunteers ?\n",
            "No .\n",
            "Key exclusion criteria : * Comorbid diagnosis of other Axis @ conditions including alcohol or substance dependence * Currently on Clozapine ( patients on Clozapine will not be used due its effects on the NDMA receptor ) * History of head injury * History of hearing difficulties ( patient report ) * Pregnant or breastfeeding * Use of prescription or non-prescription drugs ( other than antipsychotic drugs for schizophrenia patients ) , including vitamins , herbal and dietary supplements within @ days ( or @ days if the drug is a potential enzyme inducer ) or @ half-lives ( whichever is longer ) prior to the first study visit , unless in the opinion of the Investigator the medication will not interfere with the study procedures or compromise subject safety .\n",
            "Study type : Interventional .\n",
            "Purpose of the study : Treatment .\n",
            "Allocation to intervention : Randomised controlled trial .\n",
            "Describe the procedure for enrolling a subject and allocating the treatment ( allocation concealment procedures ) : The patient will be randomly allocated to either the glycine or placebo treatment by a member of the research team who is ' offsite ' and not involved in the recruitment or testing of study participants .\n",
            "Treatment will be counterbalanced amongst patients and both the patient and investigator will be blind to the assigned treatment .\n",
            "Descibe the methods used to generate the sequence in which subjects will be randomised ( sequence generation ) : Simple randomisation by using a randomization table created by a computer software ( i.e. , computerised sequence generation ) .\n",
            "Masking / blinding : Blinded ( masking used ) .\n",
            "Assignment : Factorial .\n",
            "Type of endpoint ( s ) : Efficacy .\n",
            "Target sample size : @ .\n",
            "Recruitment status : Not yet recruiting .\n",
            "Countries of recruitment : Australia .\n",
            "Brief summary :   Glycine   is an amino acid that can be purchased at health food shops in Australia .\n",
            "Some studies have suggested that glycine , when administered in conjunction with typical medications , improve schizophrenia symptoms .\n",
            "However , glycine doesn   t work in all patients .\n",
            "Much more research is needed to determine how and whether glycine affects brain activity , cognitive processes and other schizophrenia symptoms .\n",
            "The purpose of this project is to investigate the use of glycine as an adjunct treatment for improving cognition in schizophrenia .\n",
            "We will investigate whether glycine treatment , in combination with standard antipsychotic medication , is more effective at improving cognitive and clinical symptoms of schizophrenia than antipsychotic medication alone .\n",
            "We will measure schizophrenia patient 's baseline level of glycine and we will examine whether glycine treatment affects brain activity , cognition and clinical symptoms differently , depending on the patient 's baseline level of glycine .\n",
            "Objectives : To study the efficacy and associated serum prolactin levels of ziprasidone and olanzapine treatment in drug-na  ve schizophrenia patients .\n",
            "Methods : All @ inpatients with drug-na  ve schizophrenia were recruited from the Department of Psychology , The Third Affiliated Hospital of Sun Yat-sen University .\n",
            "They were divided into either olanzapine group ( n = @ [ @ men , @ women ] ; mean [ standard deviation ] age , @ [ @ ] years ) or ziprasidone group ( n = @ [ @ men , @ women ] ; mean [ standard deviation ] age , @ [ @ ] years ) , all of whom were treated for @ weeks .\n",
            "The serum prolactin level , the Positive and Negative Syndrome Scale ( PANSS ) , Clinical Global Impression-Severity ( CGI-S ) , and Clinical Global Impression-Improvement scores were measured before and at the end of treatment .\n",
            "Results : In the olanzapine group , the respective mean ( standard deviation ) PANSS and CGI-S scores after the treatment ( @     @ and @     @ ) were significantly lower than those before the treatment ( @     @ and @     @ ) [ p < @ ] .\n",
            "In the ziprasidone group , the corresponding scores after the treatment ( @     @ and @     @ ) were also significantly lower than those before the treatment ( @     @ and @     @ ) [ p < @ ] .\n",
            "The decreases in mean ( standard deviation ) PANSS total ( @     @ ) and PANSS positive scores ( @     @ ) in the olanzapine group were significantly higher than those in the ziprasidone group ( @     @ and @     @ , respectively ) [ p < @ ] .\n",
            "The increase of serum prolactin in the ziprasidone female group ( @     @   g/L ) was significantly higher than that in the ziprasidone male group ( @     @   g/L ) , the olanzapine male group ( @     @   g/L ) , and the olanzapine female group ( @     @   g/L ) [ p < @ ] .\n",
            "Conclusions : Both ziprasidone and olanzapine are effective for treating drug-na  ve acute schizophrenia , but olanzapine was superior to ziprasidone in terms of positive and general psychopathological symptoms .\n",
            "In women , ziprasidone was associated with greater changes in prolactin level than olanzapine .\n",
            "Examined the feasibility of using problem solving teaching techniques developed within educational psychology for remediating the problem-solving deficits of inpatients with schizophrenia spectrum disorders .\n",
            "These techniques rely on intrinsic motivation and task engagement , which are promoted through contextualization , personalization , and control of learning activities .\n",
            "A sample of @ patients who demonstrated problem-solving and memory deficits on psychometric testing were randomly assigned to a problem-solving group , a memory training group , or a control group .\n",
            "Results indicate that patients who received @ sessions of problem-solving remediation showed significantly more improvement on the outcome measure that assessed problem-solving skills required for independent living .\n",
            "Patients who received @ sessions of memory training did not improve on problem-solving measures .\n",
            "These results suggest that patients with schizophrenia spectrum disorders are responsive to problem-solving training techniques that promote intrinsic motivation and task engagement .\n",
            "PT : Journal-Article and Empirical-Study\n",
            "Background/Objectives : During the last years , process evaluations and cost-effectiveness analyses have become rather common when reporting results of randomized controlled trials in mental health .\n",
            "However , they are still rare when it comes to RCTs of complex interventions .\n",
            "This paper analyses effect moderators and cost-effectiveness of a cluster-randomized trial on the efficacy of feedback of outcome in inpatient psychiatric care .\n",
            "Process evaluation will especially focus on the variability of treatment outcomes attributable to therapists .\n",
            "Methods : Between September @ and March @ , @ patients admitted to inpatient treatment at a psychiatric hospital in rural Bavaria gave informed consent to participate in the cluster-randomized trial EMM ( \" Outcome monitoring and management in inpatient psychiatric care \" ) .\n",
            "Treatment was provided by @ clinicians .\n",
            "Outcome was monitored via patients completing the OQ-@ every week during inpatient treatment and at @ month follow-up .\n",
            "In addition , clinicians and their patients in the intervention group received weekly standardized feedbacks .\n",
            "ANOVAs and HLM with therapists as a random factor were used to identify moderators of effect and variability in outcome due to therapists .\n",
            "Furthermore , cost-effectiveness was ascertained via incremental cost-effectiveness ratios indicating the relation between incremental costs ( measured via the \" Client Sociodemographic and Service Receipt Inventory \" ) and effect ( measured via the \" Health of the Nation Outcome Scales \" ) .\n",
            "Results : Only few characteristics of patients , therapists , treatment , and/or intervention moderated the effect of outcome management and treatment outcome in general .\n",
            "Outcome attributable to therapist factors was much lower than reported in psychotherapy studies .\n",
            "Bootstrapped ICERs were spread out over all four quadrants of the cost effectiveness plane indicating no clear preference .\n",
            "Cost effectiveness will be further analyzed via cost-effectiveness acceptability curves taking into account willingness to pay for an additional outcome unit .\n",
            "Discussion/Conclusions : Implications of findings are discussed with a focus on specifics of the provision of care for people with severe mental illness including multiprofessional teams and frequent changes in service provision .\n",
            "Objective To investigate the psychological and behavioral intervention in the rehabilitation of chronic schizophrenia .\n",
            "Methods @ cases of chronic schizophrenia patients were randomly divided into two groups , of which @ cases of comprehensive psychological and behavioral intervention ( intervention group ) and were compared with the control group , psychiatric in-patient rehabilitation efficacy Scale ( IPROS , ) to assess the effect of .\n",
            "The results of the intervention group after the intervention @mo defect extent of its social function score was significantly lower ( P < @ ) .\n",
            "Objective : To assess the long-term effects of flexible-dose ziprasidone and olanzapine on cognitive functioning in patients with schizophrenia/schizoaffective disorder .\n",
            "Methods : A @-month continuation study enrolled @ patients who responded satisfactorily to ziprasidone or olanzapine in a @week , double-blind , randomized trial .\n",
            "Attention , memory , execu-tive-functioning , and verbal fluency domains were assessed .\n",
            "Results : Significant ( within group ) mean improvements were seen with ziprasidone ( n range , @ @ ) and olanzapine ( n range , @ @ ) in all domains .\n",
            "Ziprasidone produced greater improvement vs. olanzapine on most variablesparticularly , Trail Making Test ( TMT ) Part A = ?\n",
            "@ vs. ?\n",
            "@ ( effect size [ ES ] , @ vs. @ ; both P < @ ) ; RAVLT ( sum @ @ ) = @ vs. @ ( ES , @ vs. @ ; both P < @ ) ; Delayed Recall = @ vs. @ ( ES , @ vs. @ ; both P < @ ) ; WCST perseverative errors = ?\n",
            "@ vs. ?\n",
            "@ ( ES , @ vs. @ ; P = @ vs. P = @ ) ; and Letter Fluency = @ vs. @ ( ES , @ vs. @ ; P < @ vs. P < @ ) .\n",
            "Olanzapine showed greater improvement than ziprasidone on TMT Part B , Category Fluency , and CPTd  .\n",
            "MANOVA found no significant differences in cognitive performance between groups .\n",
            "Conclusion : Cognitive performance significantly improved with both agents and was more pronounced with ziprasidone on most tested variables .\n",
            "Background and study aims Approximately @ in @ people will experience mental health problems at some point in their lives .\n",
            "Bipolar disorder , previously known as   manic depression  , is a disorder characterised by extreme mood swings , alternating between mania ( extreme highs ) and depression ( extreme lows ) .\n",
            "People suffering from BD can also show signs of psychosis .\n",
            "Psychosis is a serious mental disorder in which thought and emotions are impaired , causing a person to lose touch with reality .\n",
            "These conditions are thought to affect more than @ million people in the UK , and it has been found that the majority of people who care for them are relatives , saving the NHS more than a billion pounds each year .\n",
            "This can be very frightening for relatives , as many do not really understand what is happening or how best to manage it .\n",
            "Although face-to-face sessions with relatives can help to lower distress and improve their understanding of BD and psychosis , many are unable to access this support because of a lack of resources in local health and social care services .\n",
            "REACT is an online resource which has been developed to provide relatives with the information and support they need .\n",
            "It works by providing information about how best to cope with a relative suffering from BD or psychosis , as well as providing a support network with other people in a similar situation .\n",
            "The aim of this study is to find out whether the REACT online toolkit is an effective and cost-effective way of supporting relatives of people suffering from BD or psychosis .\n",
            "Who can participate ?\n",
            "Objective : The calming versus sedative properties of intramuscular IM olanzapine were compared with IM haloperidol , lorazepam , and placebo .\n",
            "Methods : In three DOUBLE-BLIND studies , acutely agitated patients with schizophrenia , bipolar mania , or dementia were treated with @-@ IM injections of olanzapine @-@ mgr injection , haloperidol @ mg injection , lorazepam @ mgrinjection , or placebo over @ hours .\n",
            "Sedation was assessed using the Agitation-Calmness Evaluation Scale ACESq ; @-@s marked to mild agitation , @-@snormal to moderate calmness , awake , @-@s marked calmness with light to deep sleep , @sunarousable .\n",
            "Somnolence-related treatment-emergent adverse events were recorded .\n",
            "Results : Across all studies , only one patient lorazepam-treated , bipolar achieved an ACES score of @ .\n",
            "There were no significant between-group differences in ACES scores of @ or @ at any time across each study .\n",
            "When patients who were asleep ACES score @-@ were excluded from the agitation analyses , PANSS Excited Component scores remained significantly reduced with olanzapine compared to placebo .\n",
            "The incidence of somnolence-related adverse events during treatment with olanzapine was not significantly different from active comparator or placebo .\n",
            "Conclusions : IM olanzapine was no more sedating than haloperidol or lorazepam in the treatment of acute agitation associated with schizophrenia , bipolar mania , or dementia , and has distinct calming rather than non-specific sedative effects .\n",
            "The purpose of olanzapine for the control , comparison of aripiprazole efficacy and safety of the treatment of chronic schizophrenia .\n",
            "Methods @ cases of patients with chronic schizophrenia were randomized for the study group and control group @ cases , respectively , be the aripiprazole and olanzapine in the treatment of eight weeks , using positive and Assessment of Negative Symptoms Scale ( PANSS ) , condensed amount of psychiatric symptoms table ( BPRS ) and side effects scale ( TESS ) before treatment and after @ , @ , @ , @ , @ weekend to assess the efficacy and adverse reactions .\n",
            "Results aripiprazole group was the efficiency of @ % , the total efficiency of @ % ; olanzapine group efficiency of @ % , the total efficiency of @ % , both efficacy and the difference was not significant .\n",
            "The incidence of adverse reactions aripiprazole group @ % ; @ % in the olanzapine group , the difference was significant ( P < @ ) .\n",
            "The field of schizophrenia is redefining optimal outcome , moving beyond clinical remission to a more comprehensive model including functional recovery and improved subjective well-being .\n",
            "Although numerous studies have evaluated subjective outcomes within the domain of subjective quality of life in patients with schizophrenia , less is known about global evaluations of subjective well-being .\n",
            "This study examined the effects of antipsychotic medication on overall life satisfaction in patients with chronic schizophrenia .\n",
            "Data were drawn from the Clinical Antipsychotic Trial of Intervention Effectiveness ( CATIE ) study , where participants with a DSM-IV diagnosis of schizophrenia were randomized to receive olanzapine , perphenazine , quetiapine , risperidone or ziprasidone under double-blind conditions ( N = @ ) .\n",
            "The primary outcome measure was prospective change in subjectively evaluated overall life satisfaction scores following @ months of antipsychotic treatment .\n",
            "Psychopathology , medication side effects and functional status were also evaluated , among other variables .\n",
            "Patients experienced modest improvements in overall life satisfaction ( d = @ , p < @ ) , with no differences between antipsychotic medications ( all tests , p > @ ) .\n",
            "Change in severity of positive , negative , and depressive symptoms as well as functional status each demonstrated a small , albeit statistically significant , association with change in life satisfaction ( r = @-@ , ps < @ ) .\n",
            "In a multivariate regression model , change in clinical symptoms and functional status had limited independent predictive value for change in life satisfaction scores ( explained variance < @ % ) .\n",
            "These data suggest that despite antipsychotic medications being effective for symptom-based psychopathology , such clinical effectiveness does not necessarily translate to improved general satisfaction with life .\n",
            "Clinicians should be aware that these two domains are not inextricably linked .\n",
            "BACKGROUND : Negative symptoms are frequent in patients with schizophrenia and are associated with marked impairments in social functioning .\n",
            "The efficacy of drug-based treatments and psychological interventions on primary negative symptoms remains limited .\n",
            "The Positive Emotions Programme for Schizophrenia ( PEPS ) is designed to improve pleasure and motivation in schizophrenia patients by targeting emotion regulation and cognitive skills relevant to apathy and anhedonia .\n",
            "The main hypothesis of this study is that patients who attend @ one-hour sessions of PEPS and treatment as usual ( TAU ) will have lower total apathy-avolition and anhedonia-asociality composite scores on the Scale for the Assessment of Negative Symptoms ( SANS ) than patients who attend only TAU .\n",
            "METHODS : Eighty participants diagnosed with schizophrenia or schizoaffective disorder were randomized to receive either TAU or PEPS + TAU .\n",
            "The participants were assessed by independent evaluators before randomization ( T@ ) , in a post-test after @ weeks of treatment ( T@ ) and at a @-month follow-up ( T@ ) .\n",
            "RESULTS : The post-test results and @-month follow-up assessments according to an intention-to-treat analysis showed that the apathy and anhedonia composite scores on the SANS indicated statistically greater clinical improvements in PEPS participants than in non-PEPS participants .\n",
            "In the post-test , anhedonia but not apathy was significantly improved , thus favouring the PEPS condition .\n",
            "These results were sustained at the @-month follow-up .\n",
            "CONCLUSIONS : PEPS is an effective intervention to reduce anhedonia in schizophrenia .\n",
            "PEPS is a short , easy-to-use , group-based , freely available intervention that is easy to implement in a variety of environments ( ClinicalTrials.gov ID : NCT@ ) .\n",
            "BACKGROUND : Schizophrenia is characterized by prominent cognitive deficits , impacting on memory and learning ; these are strongly associated with the prefrontal cortex .\n",
            "OBJECTIVE/HYPOTHESIS : To combine two interventions , transcranial direct current stimulation ( tDCS ) over the prefrontal cortex and cognitive training , to examine change in cognitive performance in patients with schizophrenia .\n",
            "METHODS : A double blind , sham-controlled pilot study of @ patients with schizophrenia , randomized into real or sham tDCS stimulation groups .\n",
            "Subjects participated in @ days of cognitive training ( days @ , @ , @ , @ ) with tDCS applied at day-@ and day-@ .\n",
            "The primary outcome measure was change in accuracy on working memory and implicit learning tasks from baseline .\n",
            "The secondary outcome measure was the generalization of learning to non-trained task , indexed by the CogState neuropsychological battery .\n",
            "Data analysis was conducted using multilevel modelling and multiple regressions .\n",
            "RESULTS : @ participants were randomized to real tDCS and @ to sham .\n",
            "The working memory task demonstrated a significant mean difference in performance in the tDCS treatment group : at day-@ ( b = @ , CI @-@ ; p = @ ) and at day-@ ( b = @ , @-@ ; p = @ ) .\n",
            "There were no significant effects of tDCS on implicit learning .\n",
            "Trend evidence of generalization onto untrained tasks of attention and vigilance task ( b = @ , @-@ ; p = @ ) was found .\n",
            "CONCLUSIONS : This is the first study to show a significant longer-term effect of tDCS on working memory in schizophrenia .\n",
            "Given the current lack of effective therapies for cognitive deficits , tDCS may offer an important novel approach to modulating brain networks to ameliorate cognitive deficits in schizophrenia .\n",
            "Background : This study assessed the impact of a @ week outpatient intensive psychosocial and educative rehabilitation programme on the qulaity of life and symptomatology of persons with schizophenia .\n",
            "Method : Twenty nine patients with DSM-III-R schizophrenia ( mean age ( @  @ years ) were assessed using the Quality of Life scale ( QLS ) and Scales of Assessment of Negative ( SANS ) and Positive Symptoms ( SAPS ) .\n",
            "Nineteen patients underwent a @ week intensive psycholosocial and educative programmed .\n",
            "Ten patients continued conventional rehabilitation .\n",
            "Both groups were assessed at week @ .\n",
            "Results : At baseline the two groups did not differ in terms of total , QLS , summar SANS or SAPS scores .\n",
            "Neither did the two groups differ at completion in summary SANS or SAPS scores .\n",
            "Hwever , there was a @ % improvement in the mean total QLS score ( from @  @ to@  @ , p ,@ ) for those who underwent the intensive programmed but no chnage for those with conventiaonal rehabilitation .\n",
            "Conclusions : : This study highlights the ' quality of life ' benefits of psychosocial and educative rehabilitation for patients with schizophrenia .\n",
            "Acknowledgments .\n",
            "Supported by the Theodore and Vada Stanley Foundation .\n",
            "Objectives : Asenapine is indicated in the United States for acute treatment of adults with schizophrenia or manic or mixed episodes associated with bipolar I disorder with or without psychotic features .\n",
            "We describe the long-term safety and efficacy of asenapine versus olanzapine in schizophrenic or schizoaffective disorder patients treated for up to @ years .\n",
            "Methods : A @-year , double-blind , randomized core study tested the safety and efficacy of asenapine ( S or @ mg BID ) versus olanzapine ( @ or @ mg QD ) .\n",
            "Patients completing the core study could receive up to an additional @ years of double-blind treatment .\n",
            "Safety evaluations included adverse events ( AEs ) , body weight , and extrapyramidal symptoms ( EPS ) .\n",
            "Efficacy in observed cases from the intent-to-treat population was assessed as the change in Positive and Negative Syndrome Scale ( PANSS ) total score .\n",
            "Results : In @ enrolled patients ( asenapine , @ ; olanzapine , @S@ ) , mean  SD daily dose was @  @ S mg with asenapine and @  @ with olanzapine ; mean  SD total exposure duration ( including core study exposure ) was @  @ and @ .\n",
            "S  @ days for asenapine and olanzapine , respectively .\n",
            "Of the @ patient discontinuations ( asenapine , @ [ @ % ] ; olanzapine , @ [ @ % ] ) , the most common reasons were withdrawn consent ( asenapine , @ % ; olanzapine , @ % ) and treatment-emergent AEs ( @ % ; @ % ) .\n",
            "Mean weight gain from core study baseline was @ kg with asenapine and s.o kg with olanzapine ; incidence of clinically significant weight gain ( ~ @ ' @ increase from core study baseline ) was @ % and @ % , respectively .\n",
            "Incidence of EPS-related AEs during the entire treatment period was @ % with asenapine and @ % with olanzapine ( during extension alone : asenapine , @ .\n",
            "S % ; olanzapine , @ % ) .\n",
            "Mean  SD changes in PANSS total score during the extension study were @  @ with asenapine and - Q. @  @ .\n",
            "S with olanzapine .\n",
            "Conclusions : Asenapine and olanzapine were well tolerated and maintained efficacy in patients receiving up to @ years of treatment .\n",
            "Funding : Supported by Merck and by Pfizer Inc .\n",
            "Efficacy of tiapride was compared with placebo in @ groups of @ patients with tardive dyskinesia induced by long-term neuroleptic treatment .\n",
            "The study was conducted under double-blind conditions , patients being randomly allocated to tiapride @ mg/day for @ days and then @ mg/day for @ days , or placebo .\n",
            "Global reduction in symptoms was @ % in the group receiving tiapride and @ % in the control group .\n",
            "A @-week , double-blind , randomized , multicentre , parallel-group study was conducted to compare the efficacy of quetiapine ( ' Seroquel ' ) ( n = @ ) with that of chlorpromazine ( n = @ ) in hospitalized patients with acute exacerbation of subchronic or chronic schizophrenia , or schizophreniform disorder .\n",
            "The tolerabilities of the two treatments were also compared .\n",
            "The mean daily doses of quetiapine and chlorpromazine at the end of the study were @ mg and @ mg , respectively .\n",
            "Both treatments were effective in the treatment of positive and negative symptoms , with a trend towards superior efficacy for quetiapine .\n",
            "The quetiapine group had a lower incidence of adverse events than the chlorpromazine group , and a low incidence of treatment-emergent extrapyramidal symptoms .\n",
            "Quetiapine was not associated with a sustained increase in serum prolactin .\n",
            "These clinical data support the preclinical profile of quetiapine as an atypical antipsychotic agent .\n",
            "The neurosteroid , pregnenolone , is enriched in certain regions of the brain and is an indirect agonist of the NMDA receptor .\n",
            "For this reason , the authors hypothesize that it may improve negative and cognitive symptoms of schizophrenia .\n",
            "Method : The primary aim was to determine if patients could tolerate pregnenolone .\n",
            "Under double-blind conditions , patients were randomly assigned to one of four groups : placebo , low dose ( @ mg/d ) , slow titration to high dose ( @ mg/d ) , and rapid escalation to high dose .\n",
            "Patients are on study medication for @ weeks after a @-week , single blind lead in .\n",
            "Inclusion criteria included a diagnosis of schizophrenia or schizoaffective disorder , stable medications for @ weeks , and no substance abuse for @ months .\n",
            "Pregnenolone was added to existing medications .\n",
            "Symptoms and side effects were measured every two weeks .\n",
            "Cognitive symptoms were assessed at the beginning and end of the study .\n",
            "Steroid levels and blood tests were collected at the beginning , middle , and end of the study .\n",
            "Results : At present @ of @ patients have been enrolled .\n",
            "Pregnenolone has been well tolerated .\n",
            "No patients have dropped out of any of the pregnenolone treatment arms .\n",
            "Side effects have been similar across groups except for @ of @ patients in the high dose group having mild difficulty falling asleep .\n",
            "There have been no changes in blood levels of medications ( valproic acid and clozapine ) and no changes in blood counts or basic chemistries .\n",
            "Though analysis of the symptom measures ( PANSS and SANS ) and cognitive tests await study completion , patients who have been on the higher dose ( @ mg/d ) have felt better , with an improved sense of energy .\n",
            "Even when blinded to treatment , high-dose patients have asked to remain on pregnenolone .\n",
            "Conclusions : It is expected that the study will be completed in the next @ months .\n",
            "If the current results hold true , the primary aim of the study will be accomplished in that pregnenolone , even at high dose , is well tolerated in patients with schizophrenia .\n",
            "As more patients complete the study , we will determine if patients on high dose pregnenolone have any change in symptoms or cognition .\n",
            "Qualitatively , patients on @ mg/d of pregnenolone feel better and ask to remain on study medication .\n",
            "At present , we are continuing patients on an open labeled extension trial of @ mg/d pregnenolone with continued good tolerance .\n",
            "The study was supported by the Stanley Medical Research Foundation and the GCRC of Weill Medical College .\n",
            "What condition is being studied ?\n",
            "Misuse of drugs or alcohol by people with a diagnosis of schizophrenia .\n",
            "What is the trial about ?\n",
            "MIDAS is a randomised controlled trial .\n",
            "It is testing a psychological intervention that aims to help people reduce their substance misuse and their psychotic symptoms .\n",
            "The psychological intervention involves a series of motivational interviews and cognitive behavioural therapy .\n",
            "Why is this trial important ?\n",
            "\" It 's estimated that about @-@ % of people with schizophrenia misuse drugs or alcohol .\n",
            "These people are more likely to experience psychotic symptoms , depression and suicidal thoughts , are more likely to become violent and more likely to end up in hospital .\n",
            "Although this group is a priority for treatment , there is very little evidence about what works .\n",
            "The MIDAS trial is testing whether a joined-up approach to treating both substance misuse and schizophrenia will be effective .\n",
            "\" Where is the trial taking place ?\n",
            "At @ NHS Trusts in the North West : - Pennine Care Trust - Bolton Salford and Trafford Mental Health Trust - Lancashire Care Trust - Manchester Mental Health and Social Care Trust At @ NHS Trusts in London : - Oxleas - South London and Maudsley Who is funding the trial ?\n",
            "The Medical Research Council ( MRC ) Is the trial still recruiting ?\n",
            "People will be recruited from October @ - October @ .\n",
            "Who can join the trial ?\n",
            "People can join the trial if : - They have a fixed address in the local community . \"\n",
            "- They have a diagnosis of schizophrenia , schizophreniform , or schizoaffective disorder . \"\n",
            "- They misuse drugs or alcohol .\n",
            "- They are in contact with mental health services .\n",
            "- They are currently prescribed antipsychotic medication .\n",
            "What are the potential side effects ?\n",
            "There are no known side-effects to the treatment .\n",
            "For more information : \" To visit the MIDAS trial website , click here .\n",
            "\" Further details about taking part in the trial ______ What will happen if I get bad side-effects ?\n",
            "The therapy is n't expected to have side - effects .\n",
            "But if you receive therapy and become distressed at any time then you can withdraw from the study Will I need to come off existing medication ?\n",
            "The therapy offered in the trial is a talking therapy .\n",
            "This does not affect your medication .\n",
            "What happens if something goes wrong ?\n",
            "The study is carefully monitored to make sure that there are no adverse effects .\n",
            "If you felt that the therapy was unhelpful then you could withdraw from the trial .\n",
            "What will happen to me during the trial ?\n",
            "The MIDAS trial is a randomised controlled trial .\n",
            "This means you will be assigned to the treatment group or the control group at random .\n",
            "This process of randomisation is carried out by an external agency and is anonymous .\n",
            "\" The treatment group will receive up to @ appointments and will see a therapist over a period of one year in addition to their usual care .\n",
            "Everyone in the trial will be asked to complete assessments at the start of the trial , at @ months , @ months , and @ years .\n",
            "These will ask you about your symptoms and problems .\n",
            "The control group will be given their usual care .\n",
            "\" Will I receive check-ups after the study to check for long-term side effects Everyone in the trial will be followed up after one year and after two years .\n",
            "Will I get the new treatment at the end of the trial ?\n",
            "\" If the new treatment is found to be effective , we hope that NHS trusts will adopt the approach .\n",
            "However , this decision is entirely up to the Trusts . \"\n",
            "Will the people who took part be told of the results ?\n",
            "Yes participants will be told about the results .\n",
            "Who has looked at the design of this trial ?\n",
            "\" Before the MRC agreed to fund the trial , the protocol was reviewed by a group of independent scientists and also passed by an Ethics Committee .\n",
            "There is a Trial Steering Group , which has a service user member , who oversee the running of the trial .\n",
            "At each site there is a Site Management Committee that also includes service users .\n",
            "These committees will ensure the trial runs smoothly on a day-to-day basis at each of the trial sites . \"\n",
            "How many people are taking part ?\n",
            "\" A total of @ people will be recruited , @ in the treatment group and @ in the control group .\n",
            "\" How will researchers ensure my details are kept confidential ?\n",
            "\" All the data has been anonymised - so that numbers are used to identify people instead of their names .\n",
            "Paper copies of participant details are kept in locked cabinets , or password-protected if kept in electronic form .\n",
            "\" How can I withdraw from the trial ?\n",
            "You can withdraw from the trial at any time without giving a reason and without it affecting the quality of your care .\n",
            "You will be given names of people to contact if you have any concerns about the trial .\n",
            "Dysregulation of the Mirror Neuron System ( MNS ) in schizophrenia ( SCZ ) may underlie the cognitive and behavioral manifestations of social dysfunction associated with that disorder .\n",
            "In healthy subjects intranasal ( IN ) oxytocin ( OT ) improves neural processing in the MNS and is associated with improved social cognition .\n",
            "OTs brain effects can be measured through its modulation of the MNS by suppressing EEG mu-band electrical activity ( @-@Hz ) in response to motion perception .\n",
            "Although IN OTs effects on social cognition have been tested in SCZ , OTs impact on the MNS has not been evaluated to date .\n",
            "Therefore , we designed a study to investigate the effects of two different OT doses on biological motion-induced mu suppression in SCZ and healthy subjects .\n",
            "EEG recordings were taken after each subject received a single IN administration of placebo , OT-@IU and OT-@IU in randomized order in a double-blind crossover design .\n",
            "The results provide support for OTs regulation of the MNS in both healthy and SCZ subjects , with the optimal dose dependent on diagnostic group and sex of subject .\n",
            "A statistically significant response was seen in SCZ males only , indicating a heightened sensitivity to those effects , although sex hormone related effects can not be ruled out .\n",
            "In general , OT appears to have positive effects on neural circuitry that supports social cognition and socially adaptive behaviors .\n",
            "AIM : To evaluate the effects and adverse reactions of diphenhydramine on clozapine-induced salivation .\n",
            "METHODS : Ninety patients of schizophrenics exposed to clozapine were divided into @ groups , each containing @ patients .\n",
            "Oral diphenhydramine was given daily for @ wk to group diphenhydramine ( @ mg/d ) and group diphenhydramine ( @ mg/d ) .\n",
            "Controlled group was for clinical observation and was not exposed to other drugs additionally .\n",
            "RESULTS : Compared with the controlled group , The overall clinical\n",
            "To address the question of comparative efficacy of classical and atypical antipsychotic drugs in treatment na \" ve psychosis , we conducted a randomized double blind @-week trial of clozapine and chlorpromazine with fist episode patients .\n",
            "This question has considerable importance since the first treatment intervention in drug na \" ve patients is a critical therapeutic opportunity that has the potential to influence the course and outcome of what could be a chronic and life-long illness .\n",
            "The sample ( N = @ ) included @ % male , had a mean age of @ yrs and had been ill for @ months prior to study entry .\n",
            "The mean ( SD ) does ( mg/d ) were for CLZ @ ( @ ) and CPZ @ ( @ ) .\n",
            "Thirteen percent of patients dropped out of the CLZ group versus @ % from the CPZ group .\n",
            "The cumulative response rates of patients at @ weeks and @ weeks respectively were @ % and @ % for CLZ and @ % and @ % for CPZ .\n",
            "Adjusting for baseline , gender and duration of symptoms , the CLZ was @ % faster to remission than CPZ ( p = @ ) .\n",
            "CPZ was also associated with greater EPS ( p = @ ) .\n",
            "These results indicate that CLZ is well tolerated in first episode patients and has some potential benefits in comparison to CPZ .\n",
            "These include more rapid response , fewer neurologic side effects and higher treatment retention and relapse prevention .\n",
            "Current status of trial - Ongoing Main research question - Is Cognitive Behaviour Therapy in group format effective for Schizophrenic patients with persistent positive symtpoms ( especially Hallucinations and delusions .\n",
            "Design/methodology - A group @ A @ Group randomised design where the experimental group will receive group CBT treatment in addition to medication and standard care and the control group will receive treatment as usual .\n",
            "The group intervention will consist of @ sessions of weekly treatment followed by @ follow up sessions at monthly intervals .\n",
            "The sessions will follow the Manchester University CBT approach .\n",
            "This includes psychoeducational issues , formulation of patient 's individual problems and development of cognitive and behavioural coping skills .\n",
            "There will be two therapists per group .\n",
            "Sample group description - @ groups of @ - @ ( allowing for refusal and attrition ) .\n",
            "Patients will be identified from hospital databases , keyworkers and consultants .\n",
            "Patients will be asked for informed consent and then will be randomly allocated to either the control condition or the Group CBT condition .\n",
            "Multi-centre trial ?\n",
            "This is not a multi-centre trial .\n",
            "Participating organisations Rochdale , North M/cr and RBH Outcome measure - Independent assessors who are blind to treatment allocation will assess patients on @ occasions : pre-treatment , post-treatment ( @ months ) and follow-up ( @ months ) .\n",
            "The primary AB Outcome measure - will be symptom improvement measured by the Positive and Negative Syndrome Scales ( PANSS ) .\n",
            "Secondary outcomes include measures of social functioning , depression , quality or life and relapse .\n",
            "Start date - @/@/@ End date - @/@/@\n",
            "BACKGROUND : The Individual Placement and Support ( IPS ) model of supported employment is an evidence-based practice for individuals with psychiatric disabilities .\n",
            "To be financially viable , IPS programs require funding from the state-federal vocational rehabilitation ( VR ) system .\n",
            "However , some observers have questioned the compatibility of IPS and the VR system .\n",
            "METHOD : Using a randomized controlled trial comparing IPS to a well-established vocational program called the Diversified Placement Approach ( DPA ) , we examined rates of VR sponsorship and successful VR closures .\n",
            "We also describe the establishment of an active collaboration between a psychiatric rehabilitation agency and the state VR system to facilitate rapid VR sponsorship for IPS clients .\n",
            "FINDINGS : Both IPS and DPA achieved a @ % rate of VR Status @ closure when considering all clients entering the study .\n",
            "IPS and DPA averaged similar amount of time to achieve VR sponsorship .\n",
            "Time from vocational program entry to Status @ was @ days longer on average for IPS .\n",
            "CONCLUSIONS : Even though several IPS principles seem to run counter to VR practices , such as zero exclusion and rapid job search , we found IPS closure rates comparable to those for DPA , a vocational model that screens for readiness , provides prevocational preparation , and extensively uses agency-run businesses .\n",
            "The current study aims to investigate to what extent a cognitive training program can provide a positive clinical supplement to a previously documented psychoeducational program ( Rund et al. , @ ) .\n",
            "Subjects are randomly assigned to @ of @ treatment groups .\n",
            "The first group participates in a psychoeducational program alone , whereas the second group receives an identical program and training in cognitive tasks .\n",
            "Subjects are assessed at @ intervals baseline , @ months , and @ month follow-up ) using a broad neuropsychological test battery as wellas several clinical instruments , including the Brief Psychiatric Rating Scale ( BPRS ) .\n",
            "Preliminary results ( n = @ ) address only symptom change and demonstrate a significant reduction in symptoms from baseline to @-month follow-up testing .\n",
            "This is the case fo the total BPRS score ( t = @ , p = @ ) .\n",
            "No significant difference was found between the experimental and comparison group , although a tendency appears toward a greater reduction of positive symptoms in the experimental group .\n",
            "Additional clinical and neuropsychological data will be further analysed .\n",
            "BACKGROUND : A randomized controlled trial ' Money for Medication ' ( M@M ) was conducted in which patients were offered financial incentives for taking antipsychotic depot medication .\n",
            "This study assessed the attitudes and ethical considerations of patients and clinicians who participated in this trial .\n",
            "METHODS : Three mental healthcare institutions in secondary psychiatric care in the Netherlands participated in this study .\n",
            "Patients ( n = @ ) , @-@ years , diagnosed with schizophrenia , schizoaffective disorder or another psychotic disorder who had been prescribed antipsychotic depot medication , were randomly assigned to receive @ months of either treatment as usual plus a financial reward for each depot of medication received ( intervention group ) or treatment as usual alone ( control group ) .\n",
            "Structured questionnaires were administered after the @-month intervention period .\n",
            "Data were available for @ patients ( @ control and @ intervention ) and for @ clinicians .\n",
            "RESULTS : Patients ( @ % ) and clinicians ( @ % ) indicated that financial incentives were a good approach to improve medication adherence .\n",
            "Ethical concerns were categorized according to the four-principles approach ( autonomy , beneficence , non-maleficence , and justice ) .\n",
            "Patients and clinicians alike mentioned various advantages of M@M in clinical practice , such as increased medication adherence and improved illness insight ; but also disadvantages such as reduced intrinsic motivation , loss of autonomy and feelings of dependence .\n",
            "CONCLUSIONS : Overall , patients evaluated financial incentives as an effective method of improving medication adherence and were willing to accept this reward during clinical treatment .\n",
            "Clinicians were also positive about the use of this intervention in daily practice .\n",
            "Ethical concerns are discussed in terms of patient autonomy , beneficence , non-maleficence and justice .\n",
            "We conclude that this intervention is ethically acceptable under certain conditions , and that further research is necessary to clarify issues of benefit , motivation and the preferred size and duration of the incentive .\n",
            "TRIAL REGISTRATION : Nederlands Trial Register , number NTR@ .\n",
            "BackgroundIndividual placement and support ( IPS ) has been repeatedly demonstrated to be the most effective form of mental health vocational rehabilitation .\n",
            "Its no-discharge policy plus fixed caseloads , however , makes it expensive to provide.AimsTo test whether introducing a time limit for IPS would significantly alter its clinical effectiveness and consequently its potential cost-effectiveness .\n",
            "MethodReferrals to an IPS service were randomly allocated to either standard IPS or to time-limited IPS ( IPS-LITE ) .\n",
            "IPS-LITE participants were referred back to their mental health teams if still unemployed at @ months or after @ months employment support .\n",
            "The primary outcome at @ months was working for @ day .\n",
            "Secondary outcomes comprised other vocational measures plus clinical and social functioning .\n",
            "The differential rates of discharge were used to calculate a notional increased capacity and to model potential rates and costs of employment.ResultsA total of @ patients were randomised and data were collected on @ patients at @ months .\n",
            "The two groups ( IPS-LITE = @ and IPS = @ ) were well matched at baseline .\n",
            "Rates of employment were equal at @ months ( IPS-LITE = @ ( @ % ) and IPS = @ ( @ % ) ) at which time @ ( @ % ) had been discharged from the IPS-LITE service and @ ( @ % ) from IPS .\n",
            "Only @ patients ( @ IPS-LITE and @ IPS ) obtained their first employment after @ months .\n",
            "There were no significant differences in any other outcomes .\n",
            "IPS-LITE discharges generated a potential capacity increase of @ % compared to @ % in IPS which would translate into @ returns to work in IPS-LITE compared to @ in IPS over an @-month period if the rates remained constant.ConclusionsIPS-LITE is equally effective to IPS and only minimal extra employment is gained by persisting beyond @ months .\n",
            "If released capacity is utilised with similar outcomes , IPS-LITE results in an increase by @ % in numbers gaining employment within @ months compared to IPS and will increase with prolonged follow-up .\n",
            "IPS-LITE may be more cost-effective and should be actively considered as an alternative within public services .\n",
            "Introduction : Although command hallucinations are among the most distressing , high risk and treatment resistant symptoms among people with psychosis , currently , for this vulnerable group of patients there are no evidence-based treatment options .\n",
            "The aim of this trial is to test the effectiveness of a cognitive therapy ( CTCH ) in reducing harmful compliance with command hallucinations .\n",
            "Design : In this single blind , pragmatic , RCT using intention to treat , participants drawn from @ centres ( Birmingham , London and Manchester ) will be randomly allocated to the CTCH group in the context of treatment as usual or TAU alone .\n",
            "The inclusion criteria are : ( @ ) @   @ years , ( @ ) ICD - @ diagnosis of schizophrenia or related disorder , and ( @ ) command hallucinations for at least @ months with risk of harm to self or others .\n",
            "Participants will be identified and consented over @ months and receive treatment and follow-up over a further @ months .\n",
            "Hypotheses : @ .\n",
            "In patients with CHs , CTCH will prevent harmful compliance behaviour , and thereby reduce risk .\n",
            "@ .\n",
            "CTCH compared with TAU will lead to lower conviction in the power of voice , lower distress and depression .\n",
            "Measures : Assessments will include the Cognitive Assessment of Voices Interview Schedule to target compliance , PANSS , Calgary Depression Scale , and economic evaluation of the relative costs and outcomes of the intervention .\n",
            "Conclusion : Recruitment for this project is ongoing .\n",
            "If successful , the results will mark a ignificant breakthrough in the evidence sbase for service users and clinicians .\n",
            "The focus of this study was the systematic evaluation of the clinical effects of the extract of ginkgo biloba ( EGb ) as an adjunct to the atypical antipsychotic clozapine in the treatment of refractory schizophrenia .\n",
            "In a placebo-controlled study , @ patients with chronic , treatment-resistant schizophrenia , who were maintained on optimal doses of clozapine , were administered either @ mg/day of EGb ( N = @ ) or placebo ( N = @ ) for @ weeks .\n",
            "Clinical evaluations with the Brief Psychiatric Rating Scale , the Scale for the Assessment of Positive Symptoms , and the Scale for the Assessment of Negative Symptoms were completed biweekly .\n",
            "The use of EGb as an adjunct to clozapine was effective in decreasing negative symptoms , but not positive and overall psychopathology symptoms .\n",
            "EGb produced a mean @ @ point reduction in the total Scale for the Assessment of Negative Symptoms score compared with a mean @ @ point reduction in the placebo group ( P = @ ) .\n",
            "These preliminary data suggested that EGb was found useful for enhancing the effect of clozapine on negative symptoms in patients with treatment-resistant schizophrenia .\n",
            "Risperidone represents a unique pharmacology of potent antagonism of both serotonin@ and dopamine@ receptors .\n",
            "In a randomized , parallel - group , double-blind trial of risperidone vs. haloperidol and placebo in @ schizophrenic patients in acute exacerbation , risperidone showed a quicker onset of antipsychotic activity than did haloperidol .\n",
            "Risperidone treatment was statistically superior to placebo , with a trend toward superiority to haloperidol .\n",
            "Risperidone did not differ from placebo on assessment scales of extrapyramidal side effects , but produced significantly less than did haloperidol .\n",
            "There were no major adverse reactions associated with risperidone use , but it was noted to reduce the signs of tardive dyskinesia .\n",
            "This study suggests that risperidone may offer a superior side-effect profile , and possibly greater efficacy , than a standard neuroleptic such as haloperidol .\n",
            "Until recently it has been impossible to identify and engage a cohort of young people at substantially increased risk of early transition to first episode psychosis .\n",
            "This paper describes operational criteria for such a high risk group , the case-finding and engagement strategies employed , and the service model and context , known locally as the \" PACE Clinic \" .\n",
            "A randomised controlled trial of intervention in young people with an \" at risk mental state \" is being carried out in this clinic and we expect to report outcome data on approximately @ subjects who accept randomisation to either supportive psychotherapy alone ( control group ) or specific cognitive psychotherapy plus low dose risperidone ( experimental group ) .\n",
            "Data from the first @ subjects randomised shows a trend favoring the experimental group .\n",
            "More definitive results will be reported and the implications discussed in the symposium .\n",
            "Schizophrenia and other Psychotic Disorders\n",
            "Objective : The main goal was to assess quality of life and social functioning of psychiatric day hospital and inpatients in Poland .\n",
            "The ongoing study is a part of EU multicentre , randomized control trial EDEN ( European Day Hospital Evaluation ) .\n",
            "Method : Manchester Short Assessment of Quality of Life ( MANSA ) , Groningen Social Disabilities Schedule ( GSDS ) and Brief Psychopathological Rating Scale ( BPRS ) were used .\n",
            "Over @ patients randomly admitted to day and conventional wards fulfilled questionnaires @-@ days after admission and at discharge .\n",
            "Results : The general hypothesis is that day hospital care is associated with more favourable subjective quality of life and social functioning than inpatient treatment .\n",
            "Considering the ongoing study , preliminary results will be presented during the symposium .\n",
            "Conclusion : Day hospitals may become a more acceptable form of acute psychiatric treatment .\n",
            "Results may support the idea of community psychiatry and development of day hospitals , which is particularly important during health care reforms in Poland .\n",
            "Treated @ schizophrenic ( SCZ ) patients ( aged @-@ yrs ) with @ million units of human leukocyte interferon ( IFN ) administered daily for @ wks .\n",
            "@ age-matched control SCZ patients received placebo treatment .\n",
            "Eight Ss improved during IFN treatment without the administration of any other psychopharmacological medication , and they remained in remission for @-@ mo .\n",
            "Although @ other Ss deteriorated during treatment , they later responded to relatively small doses of chlorpromazine better than did controls .\n",
            "Only @ control S improved spontaneously , whereas @ deteriorated .\n",
            "A significant proportion of IFN-treated Ss improved relatively quickly or deteriorated depending on the character of their mental disease .\n",
            "IFN treatment may thus have the diagnostic value of differentiating between SCZ patients in IFN-sensitive and IFN-resistant groups .\n",
            "Recruitment : Recruiting .\n",
            "Conditions : Schizophrenia .\n",
            " Other : Standard care .\n",
            "Gender : Both .\n",
            " Senior .\n",
            "Enrollment : @ .\n",
            "Study Types : Interventional .\n",
            " Parallel Assignment .\n",
            "Start Date : January @ .\n",
            "Completion Date : March @ .\n",
            "Acronym : MSG\n",
            "Changes in serum creatine phosphokinase have been associated with exacerbation of tardive dyskinesia .\n",
            "Vitamin E , a drug suggested to be effective in the treatment of tardive dyskinesia , has been implicated as a possible cause of increased creatine phosphokinase levels .\n",
            "Ten patients with long-term tardive dyskinesia were treated with vitamin E in a double-blind , placebo-controlled crossover study .\n",
            "Vitamin E blood levels and creatine phosphokinase serum levels were monitored at various phases during the study .\n",
            "There were no significant differences between vitamin E and placebo treated patients in their abilities to affect tardive dyskinesia or to influence creatine phosphokinase levels .\n",
            "These data do not support the hypothesis that administration of vitamin E may alter creatine phosphokinase levels in patients with long-term tardive dyskinesia .\n",
            "Background : Drug effects on laboratory measures of brain function provide evidence for target engagement that can be used in an experimental medicine strategy to identify novel therapeutics .\n",
            "Sensorimotor gating of startle , measured by prepulse inhibition ( PPI ) , is regulated by forebrain circuitry , and is impaired in specific brain disorders , including schizophrenia ( SZ ) ; it is also sensitive to acute drug effects , can provide evidence for target engagement , and is a stable , reliable , quantitative measure suitable for repeated testing designs .\n",
            "We recently reported that amphetamine ( AMPH : @ mg , po ) enhanced simple auditory learning in both healthy subjects ( HS ) and antipsychotic ( AP ) - medicated SZ patients , using a frequency modulation task from a targeted cognitive training ( TCT ) suite for SZ ; enhanced TCT learning among SZ patients after acute AMPH was retained for at least one week .\n",
            "We now report the effects of AMPH on PPI and MATRICS Comprehensive Cognitive Battery ( MCCB ) performance in an extended sample of the HS and APmedicated SZ patients tested in the TCT suite .\n",
            "Past findings suggest that AMPH elevates PPI in subjects with low PPI baselines , and elevates MCCB scores in subjects with low baseline MCCB performance ; thus , we predicted that AMPH would elevate PPI and MCCB performance in AP-medicated SZ patients .\n",
            "Methods : Subjects ( HS = @ ; SZ = @ ) were carefully screened .\n",
            "Patients were on stable AP doses for > @ month ; all were taking atypical APs .\n",
            "Three laboratory sessions ( screen day +@ test days ) were each separated by @ week .\n",
            "PPI and MCCB were assessed at each visit .\n",
            "Test days began with administration of placebo or AMPH ( @ mg po ) in a doubleblind , cross-over design ; PPI , MCCB , autonomic and subjective measures followed , along with measures of TCT learning , reported previously .\n",
            "The rs@ polymorphism of catechol-O-methyltransferase gene was determined for all subjects .\n",
            "Parallel PPI testing in Long Evans rats was used to assess potential interactions of AMPH with AP medications .\n",
            "Results : All testing was well tolerated ; bioactivity was confirmed via autonomic and subjective changes , both of which were blunted in patients vs. HS .\n",
            "Startle magnitude and habituation did not differ based on diagnosis or drug .\n",
            "After placebo , SZ patients exhibited PPI deficits with @ ms prepulse intervals ( diagnosis x interval : p < @ ; effect of diagnosis at @ ms : p = @ , d = @ ) ; these deficits were absent in patients after AMPH ( F < @ ) .\n",
            "The magnitude of AMPH-enhanced PPI was significantly greater in patients than in HS ( p < @ ) , and was associated with positive symptoms ( r = @ ; p < @ ) , AP load ( r = @ ; p < @ ) and amphetamine-increased \" happy \" ratings ( r = -@ , p < @ ) but not other demographic or clinical variables .\n",
            "There was a significant main effect of genotype ( F = @ , df @ , p < @ ) , independent of diagnosis .\n",
            "PPI AMPH sensitivity was greatest among \" AA \" individuals ( p < @ ) and was greater among individuals carrying at least one methionine allele vs. \" GG \" subjects ( p < @ ) .\n",
            "Rodent PPI testing demonstrated dose-dependent interactions of AMPH with haloperidol , quetiapine and the D@ antagonist , SCH @ , resulting in both increases ( haloperidol , quetiapine ) and decreases ( SCH @ ) in PPI , along with robust changes in startle magnitude .\n",
            "Patients exhibited significant MCCB deficits ; no significant main effects of AMPH on MCCB scores were noted in either patients or HS , even after correcting for significant order ( practice ) effects .\n",
            "The MCCB did not detect pro-attentional effects of AMPH ; nonetheless , AMPH-induced attentional changes correlated significantly ( p < @ ) with AMPH-induced gains in TCT learning .\n",
            "Conclusions : AMPH acutely normalized PPI in AP-medicated SZ patients ; despite evidence of enhanced PPI and TCT learning in these patients , no concurrent neurocognitive changes were detected by the MCCB .\n",
            "Thus , in the context of stable AP medication , a low dose of AMPH enhances brain processes associated with higher function in SZ patients , without accompanying changes in MCCB performance .\n",
            "Both rs@ and AP med cations may be important moderators of AMPH effects on PPI .\n",
            "These findings do not support the clinical use of AMPH to treat neurocognitive deficits in SZ patients , but do provide evidence that : @ ) substantial neuroplasticity exists in brain mechanisms regulating sensorimotor gating in SZ patients ; @ ) pro-attentional drugs can acutely normalize deficient brain mechanisms ( sensorimotor gating ) and enhance learning in AP-medicated SZ patients , and @ ) MCCB may not be sensitive at detecting such acute pro-attentional drug effects .\n",
            "Objective : To compare the safety and efficacy of risperidone ( RIS ) and haloperidol ( HAL ) in treatment-refractory patients with schizophrenia .\n",
            "Method : @ subjects with a history of nonresponse to conventional antipsychotics participated in a double-blind , three-phase study ( @ week placebo wash-in ; @ weeks fixed dose [ @ mg RIS vs @ mg HAL ] ; and @ weeks clinician-choice flexible dose [ @-@ mg RIS vs @-@ mg HAL ] ) .\n",
            "Patients were evaluated weekly .\n",
            "Results : RIS was associated with a greater improvement than HAL from baseline on measures of overall psychopathology ( @ % vs @ % , p = @ ) .\n",
            "RIS showed no significant liability for either OCD or depressive symptoms .\n",
            "More of the HAL group than the RIS group required side - effect medication ( @ % vs @ % , p = @ ) .\n",
            "Subjective response to RIS was largely positive , while it was predominantly dysphoric to HAL ( p = @ ) .\n",
            "Conclusions : These results suggest that RIS is more efficacious , causes less EPS , requires less adjunctive medication , and results in substantially less subjective dysphoria than HAL in treatment-refractory patients .\n",
            "Objective To observe the Community interventions efficacy of social rehabilitation of schizophrenic patients after discharge .\n",
            "Take a random sampling method , @ cases discharged schizophrenic patients were randomly divided into intervention group ( @ cases ) and control group ( @ cases ) , health education intervention group , medication guide , skills training , family therapy intervention control group only outpatient follow-up for @ year ; Enrolled at the end of six months , at the end of the two groups of patients with social disability Screening Scale ( sdss ) to assess and compare the positive and negative syndrome scale ( panss ) .\n",
            "Results into the group , the intervention group and the control group of sdss panss score differences without significantly with sex ; @-year intervention , the intervention group sdss score ( @  @ ) was significantly lower than the control group ( @  @ ) , a very significant difference ( p < @ ) .\n",
            "The intervention group panss score ( @  @ ) , positive scale score ( @  @ ) , negative scale score ( @  @ ) , general psychopathology scale score ( @  @ ) were lower than the control group ( @  @ , @  @,@  @,@  @ ) , the difference was highly significant ( p < @ ) .\n",
            "The recurrence rate of @ % ( n = @ ) of the intervention group than the control group , @ % ( @ cases ) , the difference was highly significant ( @ = @ , p < @ ) .\n",
            "Conclusion interventions conducive to the social rehabilitation of patients with schizophrenia after discharge .\n",
            "Twenty-eight DSM-IV schizophrenic inpatients ( mean age @ years ; mean duration of illness @ years ) with a history of neuroleptic nonresponse were treated in a prospective , @-week , open trial with EITHER clozapine or risperidone ( clozapine mean dose @ mg ; risperidone mean dose @ mg ) .\n",
            "Response was assessed biweekly with PANSS , CGI , and Simpson-Angus Scale .\n",
            "In order to explore the specific effect on neuropsychological functioning by each drug and the relationship of baseline neurological soft signs ( NSS ) with response , patients received a battery of neuropsychological tests measuring attention , memory , and executive functions at baseline and week @ together with baseline measures of NSS .\n",
            "Overall , the cognitive effects of clozapine and risperidone were modest over the course of this trial .\n",
            "Risperidone improved some attention measures ( Symbol Digit Test ; p .@ ) , while patients on clozapine showed a decline in short-term memory ( Hopkins Verbal Learning Test ; p .@ ) .\n",
            "Total NSS score was associated at baseline with concurrent negative symptom score for the total group , while total NSS score and Sequencing score predicted poorer response on negative symptoms for clozapine only ( p .@ ) .\n",
            "Possible implications of these results for the long-term rehabilitation of these patients will be discussed .\n",
            "Context : The efficacy of yoga as an intervention for in-patients with psychosis is as yet unknown ; although , previous studies have shown efficacy in stabilized out-patients with schizophrenia .\n",
            "Aim : This study aimed to compare the effect of add-on yoga therapy or physical exercise along with standard pharmacotherapy in the treatment of in-patients with psychosis .\n",
            "Settings and Design : This study was performed in an in-patient setting using a randomized controlled single blind design .\n",
            "Materials and Methods : A total of @ consenting in-patients with psychosis were randomized into yoga therapy group ( n = @ ) and physical exercise group ( n = @ ) .\n",
            "Sixty patients completed the study period of @ months .\n",
            "Patients who completed in the yoga group ( n = @ ) and in the exercise group ( n = @ ) were similar on the demographic profile , illness parameters and psychopathology scores at baseline .\n",
            "Results : The two treatment groups were not different on the clinical syndrome scores at the end of @ weeks .\n",
            "At the end of @ weeks , patients in the yoga group however had lower mean scores on Clinical Global Impression Severity ( CGIS ) , Positive and Negative Syndrome Scale ( total and general psychopathology subscale ) and Hamilton Depression Rating Scale ( HDRS ) ( P < @ ) .\n",
            "Repeated measure analysis of variance detected an advantage for yoga over exercise in reducing the clinical CGIS and HDRS scores .\n",
            "Conclusion : Adding yoga intervention to standard pharmacological treatment is feasible and may be beneficial even in the early and acute stage of psychosis .\n",
            "Objective : To study the effect of aipirazol on compliance of schizophrenia patients .\n",
            "Methods : @ schizophrenia patients according with CCMD - @ were randomly divided into two groups : group A were treated with aipirazol and group B treated with clozapine .\n",
            "BPRS and TESS were administered to test effect and side effect .\n",
            "Results : The compliance were significantly higher and side effect were significantly lower in group A than group B ( \" < @ ) .\n",
            "Conclusion : Aipirazol can elevate the compliance of schizophrenia so as to reduce its recurrence and gain notable social and economic effects .\n",
            "Objective : concept Chali Pei ketone treatment of refractory schizophrenia , the efficacy and adverse reactions , and for comparison with clozapine .\n",
            "Methods : @ cases ineffective in patients with schizophrenia previously on conventional antipsychotic medications were randomly divided into treatment group and control group of @ cases .\n",
            "Treatment group received risperidone @ mg  d @ , po ; control group received clozapine @ @ to @ mg  d @ , po .\n",
            "Two groups according to different individual dose adjustment .\n",
            "The final treatment group the mean dose of risperidone @ mg  d @ , the average dose in the control group clozapine for @ @ mg  d @ , the treatment lasted @ weeks .\n",
            "Two groups was assessed using the Positive and Negative Syndrome Scale ( PANSS ) , adverse reactions adverse reactions Scale ( TESS ) assessment .\n",
            "Results : The treatment group , @ cases , @ cases improved , @ cases .\n",
            "Objective : To investigate the telephone follow health education on rehabilitation of patients with schizophrenia to improve compliance behavior , reduce the relapse rate .\n",
            "Methods : @ cases discharged schizophrenic patients were randomly divided into control and experimental groups , each of @ cases .\n",
            "The control group received routine discharge instructions , one week after the experimental group in addition to the routine discharge instructions and discharge from the hospital , one month , three months of telephone follow-Health Education survey , six months after the two groups of patients .\n",
            "Results : compliance behavior of the experimental group was higher than that in control group , the difference between the two was significant ( p < @ ) .\n",
            "Social adaptability of the experimental group was higher than that in control group , the difference between the two groups was significant ( p < @ ) .\n",
            "The number of withdrawal in the experimental group was significantly lower than the control group , the difference was highly significant ( p < @ ) , the experimental group were re-admitted number lower than the control group , the difference between the two was significant ( p < @ ) .\n",
            "Conclusion : schizophrenia patients discharged return visit health education , improve patient compliance behavior , enhance the ability of social adaptation , improved quality of life , reduce the relapse rate to the maximum extent .\n",
            "Subjects were patients with schizophrenia or schizoaffective disorder enrolled in extension studies ( Study A and Study B ) after participating in @-week studies of long-acting injectable risperidone [ Kane , J.M. , Eerdekens , M. , Lindenmayer , J.-P. , Keith , S.J. , Lesem , M. , Karcher , K. , @ .\n",
            "Long-acting injectable risperidone : efficacy and safety of the first long-acting atypical antipsychotic .\n",
            "Am .\n",
            "J. Psychiatry @ , @-@ ; Lindenmayer , J.-P. , Eerdekens , L. , Berry , S. , Eerdekens , M. , @ .\n",
            "Safety and efficacy of long-acting risperidone in schizophrenia : a @-week , multicenter , open-label study in stable patients switched from typical and atypical oral antipsychotics .\n",
            "J. Clin .\n",
            "Psychiatry @ , @-@ ] .\n",
            "Twelve months of treatment were completed by @ % of Study A patients and @ % of Study B patients .\n",
            "The median modal dose of long-acting injectable risperidone was @ mg/@ days in both studies .\n",
            "Most frequent adverse events were psychosis , headache , insomnia , agitation , and rhinitis .\n",
            "EPS-related adverse events were reported in @ % of patients in Study A and @ % in Study B. Patients with Clinical Global Impressions ratings of \" not ill \" and \" mild \" increased from @ % at baseline to @ % at endpoint in Study A and from @ % to @ % in Study B .\n",
            "It is concluded that treatment with long-acting injectable risperidone for @ year or longer appeared to be safe and well tolerated in patients with schizophrenia or schizoaffective disorder .\n",
            "RN @ ( Serotonin Antagonists ) .\n",
            "@-@-@ ( Risperidone ) .\n",
            "The aim of this study was to determine the effectiveness of foster care preparation and placement .\n",
            "Five hundred seventy-two patients from five hospitals were randomly assigned to foster care preparation ( experimentals ) or continued hospitalization ( controls ) .\n",
            "They were studied before assignment , at placement of experimental subjects , and four months later regarding social functioning , mood , activity , and overall adjustment .\n",
            "Hospitals averaged two months preparing experimental subjects , resulting in @ % placed in foster care .\n",
            "Little change was observed between referral and placement .\n",
            "However , four months after placement , experimental subjects were significantly improved over controls , particularly in social functioning and adjustment .\n",
            "After four months , @ % of the foster care subjects were in the community .\n",
            "Findings suggest that attention should be given to selection criteria , that lengthy preparation may be unnecessary , and that foster care is superior to hospitalization for patients who can not return to their own homes .\n",
            "Objective It is to approach the therapeutic effect and safety of Jieyu Anshen broth combined with Risperidone in treatment of the chronic schizophrenia.Methods @ patients with chronic schizophrenia were randomly assigned to study group ( treated with Jieyu Anshen broth combined with Risperidone ) and control group ( treated with Risperidone alone ) , each had @ cases , and all treated for @ weeks .\n",
            "The Positive and Negative Syndrome Scale ( PANSS ) and Treatment Emer@ gent Side effect Scale ( TESS ) were used to evaluate the effect and safety respectively .\n",
            "Results After @ weeks , the clinical effect in the study group was significantly better than that in the control group .\n",
            "The scores of PANSS in the study group were lower significantly than those in the control group and after @ weeks , so as before treatment .\n",
            "But the scores of TESS had no significant difference between the two groups .\n",
            "Conclusion P Jieyu Anshen broth combined with Risperidone is more effective than Risperidone alone in treatment of the chronic schizophrenia .\n",
            "It is the same safe as Risperidone .\n",
            "Objective : To analyze Integrative Medicine for long-term institutional schizophrenia combined bedsores efficacy .\n",
            "METHODS : @ patients met inclusion criteria long-term hospitalization of schizophrenia merger bedsores patients , according to the order of admission were randomly divided into a treatment group and a control group , treatment group , in addition to conventional antipsychotic treatment for the merger bedsores accept Integrative six months of treatment , the two groups of patients sync comparative study .\n",
            "Results : The treatment group was significantly better than the control group , the cure rate of the treatment group reached @ % , the deterioration rate was only @ % .\n",
            "The control group cure rate of only @ % , the deterioration rate of @ % .\n",
            "Conclusion : Integrative treatment of non-surgical treatment of long-term hospitalized patients of schizophrenia merger bedsores method is an effective means to promote early recovery of patients .\n",
            "Objective : To evaluate the efficacy and adverse effects of treatment of schizophrenia risperidone control with aripiprazole .\n",
            "Methods : @ patients met the diagnostic criteria of ccmd-@ episode schizophrenia patients were randomly divided into two groups , were given aripiprazole and risperidone for @ weeks .\n",
            "Positive and negative symptoms scale ( panss ) to assess the clinical efficacy and side effects of scale ( ( tess ) assessment of adverse drug reactions .\n",
            "Results : The efficacy of @ weeks of treatment , the aripiprazole group and the risperidone group differences in the efficiency of was not statistically significant ( p > @ ) , aripiprazole group the incidence of adverse reactions ( extrapyramidal , weight gain , menstrual disorders ) was significantly lower than the risperidone group ( p < @ ) .\n",
            "Conclusions : aripiprazole azole and risperidone treatment of schizophrenia is quite small adverse reactions .\n",
            "Few studies have assessed the comparative efficacy and safety of atypical and typical antipsychotic medications in patients within their first episode of psychosis .\n",
            "This study examined the effectiveness of the atypical antipsychotic olanzapine and the typical antipsychotic haloperidol in patients experiencing their first episode of a schizophrenia-related psychotic disorder over a @-year treatment period .\n",
            "Two hundred and sixty-three patients were randomized to olanzapine or haloperidol in a doubleblind , multisite , international @-year study .\n",
            "Clinical symptoms and side effects were assessed at baseline and longitudinally following randomization for the duration of the study .\n",
            "Olanzapine and haloperidol treatment were both associated with substantial and comparable reductions in symptom severity ( the primary outcome measure ) over the course of the study .\n",
            "However , the treatment groups differed on two secondary efficacy measures .\n",
            "Patients were less likely to discontinue treatment with olanzapine than with haloperidol : mean time ( in days ) in the study was significantly greater for those treated with olanzapine compared to haloperidol ( @ vs. @ , p < @ ) .\n",
            "Moreover , remission rates were greater in patients treated with olanzapine as compared to those treated with haloperidol ( @ % vs. @ % , p < @ ) .\n",
            "While extrapyramidal side effects were greater in those treated with haloperidol , weight gain , cholesterol level and liver function values were greater in patients treated with olanzapine .\n",
            "The data from this study suggest some clinical benefits for olanzapine as compared to haloperidol in first episode patients , which must be weighed against those adverse effects that are more likely with olanzapine .\n",
            "Background : Relapse is common in schizophrenia ; identifying charac-teristics associated with relapse may help improve disease management .\n",
            "Cariprazine , a D@/D@ receptor partial agonist , is approved in the United States for the treatment of schizophrenia .\n",
            "Post hoc analyses of a long-term , randomized , double-blind ( up to @ weeks ) , relapse prevention trial ( NCT@ ) were performed to identify characteristics associated with relapse in placebo-and cariprazine-treated patients .\n",
            "Methods : Baseline characteristics in cariprazine-treated ( @ , @ , or @ mg/d ) or placebo-treated patients were evaluated in relation to relapse status .\n",
            "Demographic variables included age , sex , race , weight , and BMI .\n",
            "Psychiatric history variables included mean age at illness onset , duration of schizophrenia , duration of current episode , number of lifetime psychotic episodes , previous hospitalizations , and acute exacerbations in the past year .\n",
            "Baseline rating scale severity scores ( eg , Positive and Negative Syndrome Scale [ PANSS ] and Clinical Global Impressions-Severity [ CGI-S ] ) were evaluated .\n",
            "Differences in demographic and psychiatric history variables were evaluated using the Student t test ( categorical variables ) or Fisher exact test ( continuous variables ) ; rating scale severity scores were evaluated with @-way ANOVA with relapse and study center as factors .\n",
            "Results : Relapse occurred in nearly twice as many placebo-treated ( @ % ) as cariprazine-treated patients ( @ % ) ( hazard ratio [ @ % CI ] = @ [ @ , @ ] ) .\n",
            "For cariprazine-treated patients who relapsed vs those who did not , signifcant differences were seen in baseline age ( mean , @ vs @ y ) , weight ( @ vs @ kg ) , BMI ( @ vs @ kg/m <sup> @ </sup> ) , and race ( all , P < .@ ) ; for placebo-treated patients , there were no signifcant differences in demographic variables based on relapse status .\n",
            "In both treatment groups , patients who relapsed vs patients who did not relapse had a greater mean number of previous hospitalizations ( carip-razine = @ vs @ [ P = .@ ] ; placebo = @ vs @ [ P = .@ ] ) .\n",
            "Cariprazine patients who relapsed vs those who did not had longer illness duration ( @ y vs @ [ P = .@ ] ) ; the number of lifetime episodes also differed by relapse status ( P = .@ ) , with a greater percentage of relapsed patients experiencing > = @ episodes .\n",
            "Baseline PANSS total score and CGI-S scores were not signif-cantly different in relapsed vs nonrelapsed patients in either treatment group .\n",
            "Conclusion : While patients treated with cariprazine had a lower rate of relapse than placebo overall , the results suggest that patients who were older , heavier , or had a later stage of illness may be more prone to relapse during cariprazine treatment .\n",
            "In patients randomized to placebo , demographic characteristics and psychiatric history were not as meaningful in predicting relapse .\n",
            "Greater symptom severity at baseline did not appear to be associated with relapse .\n",
            "BACKGROUND : It is difficult to improve negative symptoms and cognitive impairments in schizophrenia .\n",
            "A previous pilot study has shown that minocycline , a semi-synthetic second-generation tetracycline , is effective in treating for negative and/or cognitive symptoms in schizophrenia .\n",
            "OBJECTIVES : The present study was designed to examine the efficacy and safety of minocycline for the treatment of negative symptoms and cognitive impairments in patients with schizophrenia .\n",
            "METHODS : Ninety-two patients with early stage schizophrenia treated with risperidone entered this @-week , double blind , randomized , placebo-controlled clinical trial .\n",
            "Subjects were randomly assigned to receive minocycline ( @ mg per day ) or the placebo .\n",
            "The primary outcome was evaluated using the Scale for the Assessment of Negative Symptoms ( SANS ) .\n",
            "Secondary outcomes included the response rate of SANS , the Positive and Negative Syndrome Scale ( PANSS ) , the Clinical Global Impression Scale ( CGI ) , and cognitive tests .\n",
            "RESULTS : Subjects receiving minocycline had greater improvements on SANS total scores and PANSS negative subscale scores ( P < @ ) when compared with those receiving the placebo .\n",
            "Rates of treatment response ( @ % ) in the minocycline group were significantly higher than those in the placebo group ( @ % ) after @weeks of treatment .\n",
            "There was no significant difference between the seven cognitive domains ( P > @ ) , except for the attention domain ( P = @ ) .\n",
            "CONCLUSIONS : The addition of minocycline to atypical antipsychotic drugs in early schizophrenia had significant efficacy on negative symptoms but had a slight effect on the attention domains of patients with schizophrenia .\n",
            "It may be considered as a new adjunct treatment for negative symptoms of schizophrenia .\n",
            "Clinical trials.gov identifier : NCT@ .\n",
            "Objective To detect the forward therapeutic efficacy of treating schizophrenia with clopixol .\n",
            "Method @and @ with schizophrenic patients used sustaining dosage clopixol and CPZ for two years follow-up and control studies .\n",
            "Results The therapeutic efficacy of clopixol and CPZ was similar , and the recurrent ratio was small .\n",
            "side effects were light .\n",
            "Conclusions The finding indicated that the forward therapeutic dffect of clopixol is ideal .\n",
            "So clopixol was recommended in the clinical treatment of\n",
            "To develop , and then compare use , effect and cost of personalised computer education with community psychiatric nurse ( CPN ) education , for patients with schizophrenia .\n",
            "Design/methodology : Randomised controlled trial Participants - inclusion criteria : @ patients with schizophrenia , in contact with community services ; @ completed follow up .\n",
            "Participants - exclusion criteria : Not available Anticipated start date : @/@/@ Anticipated end date : @/@/@ Status of trial : Completed Interventions : Randomised trial with three groups :\n",
            "Introduction : Although atypical antipsychotics are thought to be more effective than conventional agents in treating negative symptoms in schizophrenia , there have been few direct comparisons ( @ ) .\n",
            "Therefore , we investigated the efficacy of risperidone and quetiapine against negative symptoms .\n",
            "Methods : A @-week , DOUBLE-blind , parallel group comparison of risperidone versus quetiapine , conducted in @ patients with schizophrenia with predominantly negative symptoms , as defined by Positive and Negative Syndrome Scale ( PANSS ) scores .\n",
            "The Scale for the Assessment of Negative Symptoms ( SANS ) and the Simpson-Angus Scale ( SAS ) were also used .\n",
            "Assessments were performed at Weeks @-@ , @ , and @ .\n",
            "Data were analyzed using an LOCF approach and MANOVA .\n",
            "Results : Twenty-five patients completed the study .\n",
            "Quetiapine ( mean dose @ mg/day ) and risperidone ( mean dose @ mg/day ) produced significant decreases in PANSS total , positive and negative scores , and SANS scores .\n",
            "Efficacy was comparable , except for a significant advantage for quetiapine ( p = @ ) on the SANS attention subscale .\n",
            "Risperidone had a significantly greater incidence of EPS ( p < / = @ at Weeks @ , @ , @ , and @ ; p < @ ) .\n",
            "Conclusion : Quetiapine is as efficacious as risperidone against the negative symptoms of schizophrenia ; however , quetiapine also improves attention and is better tolerated , with a lower incidence of EPS and anticholinergic medication requirement .\n",
            "RF : @ .\n",
            "Arvanitis LA , Rak IW ( @ ) : The long-term efficacy and safety of  Seroquel  ( quetiapine ) .\n",
            "Schizophr Res @ : @-@ @ .\n",
            "Dyck DG et al ( @ ) : Management of negative symptoms among patients with schizophrenia attending multiple-family groups .\n",
            "Psychiatr Serv @ : @-@ .\n",
            ".\n",
            "IMPORTANCE : Treatment nonadherence and relapse are common problems in patients with schizophrenia .\n",
            "The long-acting @-month formulation of paliperidone palmitate , owing to its extended elimination half-life , may offer a valuable therapeutic option for these patients .\n",
            "OBJECTIVE : To evaluate the efficacy and safety of the @-month formulation of paliperidone palmitate vs placebo in delaying time to relapse of schizophrenia symptoms .\n",
            "DESIGN , SETTING , AND PARTICIPANTS : This randomized , multicenter trial conducted from April @ , @ , through April @ , @ , in @ countries consisted of @ phases : @-week screening phase , flexible-dose @-week open-label transition phase , @-week open-label maintenance phase , and open-ended double-blind ( DB ) phase .\n",
            "Of the @ patients enrolled ( aged @-@ years ; DSM-IV-TR diagnosis of schizophrenia ) , @ were randomized to @-month paliperidone palmitate ( n = @ ) or placebo ( n = @ ) in the DB phase .\n",
            "INTERVENTIONS : Patients received once-monthly doses of the @-month formulation of paliperidone palmitate ( @ , @ , @ , or @ mg eq ) during the transition phase , followed by a single dose of the @-month formulation ( @ times the stabilized dose of once-monthly paliperidone palmitate ) during the maintenance phase .\n",
            "Stabilized patients were randomized to receive either a fixed dose of @-month paliperidone palmitate ( @ , @ , @ , or @ mg eq ) or placebo once every @ months during the DB phase .\n",
            "MAIN OUTCOMES AND MEASURES : Time from randomization to the first relapse event ( time to relapse ) in the DB phase .\n",
            "RESULTS : In the interim analysis , time to first relapse was significantly different in favor of the paliperidone palmitate group vs the placebo group ( hazard ratio = @ ; @ % CI , @-@ ; P < .@ ) ; median time to relapse was @ days for placebo but not estimable for @-month paliperidone palmitate .\n",
            "An independent data monitoring committee recommended early study termination due to efficacy .\n",
            "In the DB phase , @ of @ patients ( @ % with @-month paliperidone palmitate ; @ % with placebo ) had at least @ treatment-emergent adverse event ; those noted more frequently in the group receiving paliperidone palmitate than in the placebo group were headache ( @ % vs @ % ) , weight increased ( @ % vs @ % ) , nasopharyngitis ( @ % vs @ % ) , and akathisia ( @ % vs @ % ) .\n",
            "CONCLUSIONS AND RELEVANCE : Compared with placebo , the @-month formulation of paliperidone palmitate administered @ times yearly significantly delayed time to relapse in patients with schizophrenia .\n",
            "The @-month formulation was generally tolerable and has a safety profile consistent with other marketed paliperidone formulations .\n",
            "TRIAL REGISTRATION : clinicaltrials.gov Identifier : NCT@ .\n",
            "Schizophrenia is a disease of the brain dysfunction , longer duration , recurrence , most of the decline trend .\n",
            "To explore the impact of nursing interventions on the social function of female patients with schizophrenia , in January @ to December @ , our hospital will not receive live the spirit of the three subjects of @ cases of female patients with schizophrenia were randomly divided into study group and control group @ cases of nursing interventions , the study group patients .\n",
            "The results showed that nursing interventions can alleviate the psychiatric symptoms of female patients with schizophrenia , shorten the hospital schedule to promote the recovery of social function , and improve their quality of life , are reported below .\n",
            "Materials and Methods ( @ ) general information .\n",
            "@ patients were female ; average age : The study group ( @  @ ) years old , in the control group ( @  @ ) years ; Occupation : study group of cadres of five cases , @ cases of workers , peasants @ cases , @ cases of students ; control .\n",
            ".\n",
            ".\n",
            "A multi-institutional double-blind study comparing the therapeutic effect of adjunctive carbamazepine and placebo with standard neuroleptic treatment was performed on @ patients with DSM-III diagnosis of schizophrenic ( n = @ ) or schizoaffective disorders ( n = @ ) who had excited states or aggressive/violent behavior that responded unsatisfactorily to neuroleptic treatment .\n",
            "The patients participated in a @ - week trial of carbamazepine plus neuroleptics ( n = @ ) or placebo plus neuroleptics ( n = @ ) .\n",
            "The sum of patients with marked and moderate improvement was modestly larger in the carbamazepine group ( @ vs. @ % , P less than @ ) .\n",
            "There was no significant difference between the carbamazepine and placebo groups in the changes of total BPRS scores , although the carbamazepine group showed more improvement on the items suspiciousness , uncooperativeness and excitement .\n",
            "The results suggest that carbamazepine , when used in combination with neuroleptics , is a useful drug for the treatment of excited states of patients with schizophrenic and schizoaffective disorders .\n",
            "Not Recruiting @ Ba/be India Inclusion criteria : A subject fulfilling all the following criteria will be included in the present study : &lt; br / &gt; @ .\n",
            "Subjects and his/her legally acceptable representatives ( LAR )   ??\n",
            "&lt; br / &gt; a. Willing to provide written informed consent for participation in the study ; &lt; br / &gt; b. Having ability to comprehend the nature and purpose of the study ; &lt; br / &gt; c. Willing to be available for the entire study period and to comply protocol requirements .\n",
            "&lt; br / &gt; @ .\n",
            "Disease population and treatment condition   ??\n",
            "&lt; br / &gt; a. Subjects with documented clinical diagnosis of Schizophrenia as per DSM-IV-TR Criteria ; &lt; br / &gt; b. Subjects with Treatment-resistant Schizophrenia defined as failure to respond to two or more antipsychotic medications given in therapeutic dose for   ?\n",
            "  six weeks ) ; &lt; br / &gt; c. Currently stable on a regimen consisting of single or multiples of Clozapine tablets @ mg twice daily for at least @ months .\n",
            "&lt; br / &gt; @ .\n",
            "Age of @-@ years ( both inclusive ) ; &lt; br / &gt; @ .\n",
            "Body mass index ( BMI ) in the range of @   ??\n",
            "@ kg/m@ ( both inclusive ) ; &lt; br / &gt; @ .\n",
            "Non-smoker and willing to abstain from chewing any tobacco containing product during housing period in clinical facility ; &lt; br / &gt; @ .\n",
            "Willing to abstain from alcohol or alcoholic products , xanthine or its derivative containing food or beverages ( e.g. chocolates , tea , coffee or cola drinks ) , and grapefruit or its juice during housing period in clinical facility ; &lt; br / &gt; @ .\n",
            "Adequate hematological reserves , particularly   ??\n",
            "&lt; br / &gt; a .\n",
            "A total WBC count   ?\n",
            "  @/  L ; &lt; br / &gt; b. ANC   ?\n",
            "  @/mL ; &lt; br / &gt; @ .\n",
            "Clinically non-significant serum electrolytes ( sodium , potassium , magnesium and chloride ) ; &lt; br / &gt; @ .\n",
            "With normal or clinically non-significant laboratory values as determined by hematological , biochemistry tests and urine analysis ; &lt; br / &gt; @ .\n",
            "With a normal or clinically non-significant @-lead ECG ( including QTc interval   ?\n",
            "  @ milliseconds ) ; &lt; br / &gt; @ .\n",
            "In case of female subjects : &lt; br / &gt; a. Negative urine pregnancy test during screening and , negative serum   - HCG test at baseline visits and at check-in for housing during each study period ; &lt; br / &gt; b. Female subjects with child bearing potential or those within their first two years of onset of menopausal syndrome must either abstain from sexual intercourse , or using acceptable methods of birth control during the study ( Acceptable birth control methods include barrier methods such as diaphragm/condom with spermicide or who are surgically sterile ( bilateral tubal ligation , bilateral oophorectomy or hysterectomy has been performed ) .\n",
            "&lt; br / &gt; Exclusion criteria : A subject fulfilling any one of the following criteria will be excluded from the study : &lt; br / &gt; @ .\n",
            "Institutionalized subjects ; &lt; br / &gt; @ .\n",
            "A history of allergic or hypersensitive reactions to clozapine or other chemically related psychotropic drugs or to any of the excipients of formulation which in the opinion of an investigator , would compromise the safety of the subject or the study ; &lt; br / &gt; @ .\n",
            "Concurrent primary psychiatric or neurological diagnosis , including organic mental disorder , severe tardive dyskinesia , or idiopathic Parkinson  ??\n",
            "s disease ; &lt; br / &gt; @ .\n",
            "Acute psychotic exacerbations within @ months of start of study ; &lt; br / &gt; @ .\n",
            "Elder subjects with dementia-related psychosis ; &lt; br / &gt; @ .\n",
            "History of suicidal thinking , imminent risk of suicide , or a danger to self or others as judged by the investigator ; &lt; br / &gt; @ .\n",
            "A history of granulocytopenia or myeloproliferative disorders ( drug-induced or idiopathic ) ; &lt; br / &gt; @ .\n",
            "Concurrent use of other drugs known to suppress bone marrow function ; &lt; br / &gt; @ .\n",
            "Significant orthostatic hypotension ( i.e. , a drop in systolic blood pressure of @ mm Hg or more and/or a drop in diastolic blood pressure of @ mm Hg or more on standing ) ; &lt; br / &gt; @ .\n",
            "History of multiple syncopal episodes ; &lt; br / &gt; @ .\n",
            "Concurrent use of antihypertensive medication or any medication that might pre    dispose to orthostatic hypotension ; &lt; br / &gt; @ .\n",
            "A medical or surgical condition that might interfere with the absorption , metabolism , or excretion of clozapine ; &lt; br / &gt; @ .\n",
            "A history of epilepsy or risk for seizures ; &lt; br / &gt; @ .\n",
            "Significant history or current evidence of malignancy or chronic - infectious , cardiovascular , renal , hepatic , ophthalmic , pulmonary , neurological , metabolic ( endocrine ) , hematological , gastrointestinal , immunological or psychiatric diseases , or organ dysfunction , which in the opinion of an investigator , would compromise the safety of the subject or the study ; &lt; br / &gt; @ .\n",
            "Expected changes in concomitant medications during the study periods ; &lt; br / &gt; @ .\n",
            "Expected incompliance with outpatient medications ; &lt; br / &gt; @ .\n",
            "A history of alcohol or drug dependence by DSM-IV-TR criteria during the @-month period immediately prior to study entry ; &lt; br / &gt; @ .\n",
            "Positive alcohol breath or urine drug of abuse tests during baseline visits , or at check-in for housing during each study period ; &lt; br / &gt; @ .\n",
            "Positive test for Human Immunovirus ( HIV ) type I/II antibodies or Hepatitis B surface antigen ( HBsAg ) or Hepatitis C virus ( HCV ) antibodies ; &lt; br / &gt; @ .\n",
            "In case of female subjects : &lt; br / &gt; a. Planning to become pregnant ; &lt; br / &gt; b. Lactating or nursing subjects ; &lt; br / &gt; c. Using hormonal contraceptive ( either oral/implants ) ; &lt; br / &gt; @ .\n",
            "Participated in any clinical investigation requiring repeated blood sampling , blood donation , or have blood loss of &gt; @ mL in past @ weeks or participated in any clinical study within the past @ months prior to first dosing of the study ; &lt; br / &gt; @ .\n",
            "Any major illness or hospitalization within @ days prior to first dosing of the study ; &lt; br / &gt; @ .\n",
            "History of difficulty in accessibility of veins in arms .\n",
            "&lt; br / &gt; Intervention@ : Clozapine Tablets USP @ mg of Micro Labs Limited , India. : As per randomization schedule , subjects will be instructed to receive test or reference products according to their stabilized dose of Clozapine ( single or multiples of @ mg tablets ) , equally divided at fixed @-hour intervals for @ days in each study period.Control Intervention@ : CLOZARIL    ( Clozapine ) @ mg Tablets ; Manufactured by - Novartis Pharma Corp. , Suffern , NY @ ; Distributed by - Novartis Pharma Corp. , East Hanover , NJ @ .\n",
            ": As per randomization schedule , subjects will be instructed to receive test or reference products according to their stabilized dose of Clozapine ( single or multiples of @ mg tablets ) , equally divided at fixed @-hour intervals for @ days in each study period .\n",
            "The primary objective of the study is to assess whether the test product is bioequivalent to reference product based on the evaluation of Cmax , ss and AUC@- ?\n",
            ", ss.Timepoint : During each study period , pre-dose samples will be collected on days - @,@ and @ for morning dose .\n",
            "On day @ of each study period , post-dose samples will be collected at @ , @ , @ , @ , @ , @ , @ , @ , @ , @ , @ , @ , @ and @ hours post morning dose .\n",
            "Assessment of safety and tolerability profile of test and reference products.Timepoint : During each study period , pre-dose samples will be collected on days - @,@ and @ for morning dose .\n",
            "On day @ of each study period , post-dose samples will be collected at @ , @ , @ , @ , @ , @ , @ , @ , @ , @ , @ , @ , @ and @ hours post morning dose. ; Descriptive statistics for PK parameters - Cmin , ss , Cavg , ss Degree of Fluctuation , Swing , Cpd and Tmax , ss ; Timepoint : During each study period , pre-dose samples will be collected on days - @,@ and @ for morning dose .\n",
            "On day @ of each study period , post-dose samples will be collected at @ , @ , @ , @ , @ , @ , @ , @ , @ , @ , @ , @ , @ and @ hours post morning dose .\n",
            "This randomised , controlled trial aims to evaluate the relative effectiveness of the new antipsychotic drugs compared to conventional antipsychotic drugs and to clozopine in a sample of seven hundred and two people with schizophrenia who are resistant to or intolerant of , usual treatment .\n",
            "The trial will aim to demonstrate important differences in quality of life and other outcomes at one year , assess value for money , and identify cost-effective management strategies .\n",
            "The trial aims to answer the following questions .\n",
            "Do the atypical drugs lead to better outcomes for treatment-resistant patients ?\n",
            "What is the cost of this improvement ( cost utility ) ?\n",
            "Are these drugs cheaper for the NHS overall ?\n",
            "Randomised controlled trial .\n",
            "The study design will be a multi-centre , pragmatic , single blind , randomised , controlled trial , comparing conventional antipsychotic drugs with clozapine with the new atypical drugs in treatment-resistant schizophrenia and treatment-intolerant schizophrenia .\n",
            "The trial will include and integrate clinical and economic evaluation .\n",
            "A pragmatic trial design was chosen to test effectiveness in the context of current , informed clinical practice .\n",
            "The characteristics for a pragmatic trial in this context are : @ .\n",
            "Trial entry defined by the clinician making a decision to change drug management ; @ .\n",
            "Naturalistic : reflects clinical practice with an un-restrictive entry criteria ; The choice of which conventional or which atypical drug to use within the randomly-selected treatments is made by the clinician , with access to the best current data .\n",
            "@ .\n",
            "Clinician and patient are not blind to treatment allocation ; @ .\n",
            "The follow-up is non-intensive The characteristics will be set in a formal RCT framework which will include the following characteristics : @ .\n",
            "Concealed randomisation ; @ .\n",
            "Blind independent assessment of outcome ; @ .\n",
            "Characterisation and follow-up of refusers and dropouts ; @ .\n",
            "Intention-to-treat analysis The study will be conducted at four centres in the UK Participants : The study sample population can be described as patients that are having medication changes due to intolerance or resistance to existing medication .\n",
            "Outcomes : Clinical , quality of life and economic assessments .\n",
            "Standardised rating of scales of symptoms , side effects , quality of life , social functioning and economic service utilisation will be administered at baseline and @ weeks .\n",
            "In addition , at weeks @ and @ , subsets of these instruments will be administered by the blind , independent rater .\n",
            "Recruiting @ Interventional India Inclusion criteria : @ .\n",
            "Diagnosis of Schizophrenia ( F@-F@ ) according to &lt; br / &gt; ICD-@-DCR &lt; br / &gt; @ .\n",
            "Patients on a stable dose of antipsychotic medication &lt; br / &gt; @ .\n",
            "Patients of either sex aged between @-@ years .\n",
            "&lt; br / &gt; @ .\n",
            "Right handed , normotensive patients .\n",
            "&lt; br / &gt; @ .\n",
            "Patients giving written informed consent .\n",
            "&lt; br / &gt; @ .\n",
            "Screened eligible for rTMS .\n",
            "Exclusion criteria : @ .\n",
            "Current neurological or any comorbid psychiatric disorders .\n",
            "&lt; br / &gt; @ .\n",
            "History of substance abuse ( Except nicotine and caffeine ) in the &lt; br / &gt; past one month .\n",
            "&lt; br / &gt; @ .\n",
            "History of epilepsy , significant head injury or any neurosurgical &lt; br / &gt; procedure .\n",
            "&lt; br / &gt; @ .\n",
            "Subjects with cardiac pacemakers or other metal parts in the &lt; br / &gt; body .\n",
            "&lt; br / &gt; @ .\n",
            "Subjects who have received ECT in past @ months Intervention@ : Active repetitive Transcranial Magnetic Stimulation ( rTMS ) : Active continuous theta burst repetitive Transcranial Magnetic Stimulation ( rTMS ) delivered using Magstim    Rapid@ device ( The Magstim Company Limited , Whitland , UK ) to left dorsolateral prefrontal cortex identified using MRI based neuronavigation by VisorTM Neuronavigation System ( Advanced Neuro Technology ( ANT ) B.V. , Enschede , The Netherlands ) A total of @ sessions over a period of @ weeks ( @/week ) Stimulus type-Continuous theta-burst i.e. @ pulses at @ % MT applied as bursts of three pulses ( @ Hz ) repeated at @ Hz in each session Control Intervention@ : Sham repetitive Transcranial Magnetic Stimulation ( rTMS ) : Sham continuous theta burst repetitive Transcranial Magnetic Stimulation ( rTMS ) delivered by a sham coil using Magstim    Rapid@ device ( The Magstim Company Limited , Whitland , UK ) to left dorsolateral prefrontal cortex identified using MRI based neuronavigation by VisorTM Neuronavigation System ( Advanced Neuro Technology ( ANT ) B.V. , Enschede , The Netherlands ) A total of @ sessions over a period of @ weeks ( @/week ) Stimulus type-Continuous theta-burst i.e. @ pulses at @ % MT applied as bursts of three pulses ( @ Hz ) repeated at @ Hz in each session Working Memory , Emotion Recognition and Social FunctioningTimepoint : Baseline and at the end of @ weeks of post rTMS intervention\n",
            "Background : Physical exercise may change brain function and structure and increase grey matter volume in humans .\n",
            "In patients with schizophrenia the volume of certain brain regions ( i.e. the hippocampus ) is reduced .\n",
            "We investigated the effects of physical training on brain morphology and clinical features in a randomized , controlled trial .\n",
            "Methods : A sample size of sixteen male patients with schizophrenia were either randomized to perform cycle ergometry ( SP ) or tabletop football ( CP ) for @ minthree times a week for @ months .\n",
            "Eight healthy volunteers ( SV ) matched for age , socio-demographic variables and Body Mass Index also underwent physical exercise .\n",
            "Before and after the intervention incremental exercise testing , MRI scanning , and psychopathological rating , including Positive and Negative Syndrome Scale ( PANSS ) were performed .\n",
            "Results were controlled for a variety of clinical parameters .\n",
            "Results : The left ( LH ) and right ( RH ) hippocampus volume increased significantly in both exercise groups ( SP : LH +@ % , RH +@ % , pb@ .@ ; SV : LH +@ % , RH +@ % , p ?\n",
            "@ ) but not in the CP group .\n",
            "The increase was correlated with the training intensity .\n",
            "In the SP group a significant reduction in the PANSS cognition subscore was found ( @  @ pts .\n",
            "vs. @  @ pts ; pb@ .@ ) .\n",
            "Differences in the changes from baseline to endpoint between the SP and CP group were significant in the PANSS total score , negative , cognition and agitation subscores in favor of the SP group .\n",
            "Conclusions : Physical exercise in patients with schizophrenia was found to increase the hippocampus volume and to improve psychopathology .\n",
            "Objective To explore the two different treatment treatment of schizophrenia .\n",
            "@ patients with schizophrenia were randomly divided into observation group and control group , electric shock treatment and the spirit of the single with anti-drug treatment .\n",
            "Electric shock results with small doses of antipsychotic drug treatment is better than with antipsychotic treatment ( P < @ ) .\n",
            "The conclusions can recommend the electric shock treatment of schizophrenia , especially serious antifeeding refuse drugs , depression , behavioral disorders in patients with a treatment method .\n",
            "Background and Purpose : Agitation in schizophrenia or bipolar disorder is common and requires immediate intervention .\n",
            "Current treatments for agitation have limitations in onset of action , invasiveness , and tolerability .\n",
            "Staccato loxapine ( AZ-@ ) is a rapidly acting noninvasive treatment designed for agitation that delivers thermally-generated drug aerosol to the deep lung for rapid systemic absorption with intravenous-like kinetics .\n",
            "Two clinical trials analyzed the efficacy and safety of AZ-@ in treating agitation in patients with schizophrenia or bipolar disorder .\n",
            "Methods : Each trial was randomized , double-blind , and placebo-controlled .\n",
            "Loxapine was administered via inhalation using the Staccato system , which delivers thermally-generated drug aerosol to the deep lungs for rapid systemic absorption with IV-like kinetics .\n",
            "Consenting male and female adults , @ to @ years of age , who met DSM-IV criteria for schizophrenia ( N = @ ) or bipolar disorder type @ ( N = @ ) who presented with clinically relevant agitation were enrolled .\n",
            "Patients received a single inhalation of @ or @ mg AZ-@ or placebo in an in-patient facility with up to @ additional doses beyond @ hours if required .\n",
            "Rescue drug ( intramuscular lorazepam ) was allowed after dose @ .\n",
            "The primary efficacy endpoint was the absolute change in Positive and Negative Syndrome Scale Excited Component ( PEC ) score from baseline to @ hours following treatment .\n",
            "Additional endpoints included : PEC time course ( at @ , @ , @ , @ , @ and @ minutes , and @ , @ and @ hours ) , Clinical Global Impression-Improvement ( CGI-I ) , CGI-I Responders ( proportion of subjects who had CGI-I scores of @ = very much improved or @ = much improved ) , and time to subsequent dose of AZ-@ .\n",
            "Results : In each trial , both @ and @ mg AZ-@ were significantly superior to placebo for the primary endpoint ( P = @ and P < @ , respectively , for patients with schizophrenia ; and both P < @ for patients with bipolar disorder ) .\n",
            "Statistically significant improvements in PEC were noted for each AZ-@ dose versus placebo at the first post-baseline evaluation ( @ minutes ) and maintained for @ hours .\n",
            "( Table presented ) CGI-I at @ hours post-dose was statistically significantly different for each AZ-@ dose versus placebo in both studies .\n",
            "Responder analysis for CGI-I ratings showed significant differences versus placebo for both doses for both schizophrenia patients ( @ % for placebo versus @ % for @ mg and @ % for @ mg ) and bipolar disorder patients ( @ % for placebo vs. @ % for @ mg and @ % for @ mg ) .\n",
            "Adverse events observed most often in patients receiving AZ-@ were dysgeusia , dizziness , and sedation .\n",
            "Conclusions : AZ-@ produced rapid ( within @ minutes ) and significant improvement in agitated patients with bipolar disorder or schizophrenia .\n",
            "Describes the behavioral treatment of auditory hallucinations in @ female chronic schizophrenic patients aged @-@ yrs .\n",
            "Two treatment conditions , one in which white noise followed hallucinations and a @nd in which white noise was presented during reported hallucinations , were contrasted in a crossover design with a control condition in which white noise was presented randomly .\n",
            "All Ss improved , although reported reductions in hallucinations were more marked in @ cases than in the @rd case .\n",
            "Some generalization of treatment effects was observed in all Ss .\n",
            "White noise presented concurrently with hallucinatory reports was the most effective .\n",
            "The implication for a theory of auditory hallucinations is discussed .\n",
            "( @ ref )\n",
            "Studied @ male schizophrenics ( aged @-@ yrs ) with neuroleptic-induced akathisia ( NIA ) .\n",
            "Ss were treated for more than @ days with benztropine without improvement in NIA .\n",
            "@ Ss received @ days of placebo , followed by @ days of propranolol ; the remaining @ Ss received @ days of propranolol , followed by @ days of placebo .\n",
            "Ss were rated before treatment , after completion of the @st treatment phase , and at the end of the crossover phase .\n",
            "Data support previous reports ( e.g. , L. Adler at al ( @ , @ ) ) of propranolol 's beneficial effect in patients with NIA .\n",
            "The purpose is to describe the continuity of care for patients ( age @-@ years ) with first-episode psychosis ( ICD-@ F@ ) requiring in-patient administration and admitted by randomisation to a special unit ( U@ ) for early , integrated treatment .\n",
            "The treatment protocol of U@ includes minimum @ month in-patient stay and at least @ years aftercare , a standard low-dose medication regimen , individual psychotherapy and milieu therapy based on an integrated psychodynamic model and psychoeducative multi-family groups .\n",
            "@ patients were fully evaluated regarding the continuity of care ( data from register and records ) during the first two-year period of the special unit .\n",
            "During this period @ had no lack of continuity of care .\n",
            "The re-admission rate of those patients were @ % at @-month and @ % at @-year follow-up after discharge .\n",
            "It seems as if early , integrated treatment of patients with first-episode psychosis requiring in-patient administration gives better continuity of care than treatment as usual .\n",
            "Weight gain is a common side effect of clozapine treatment .\n",
            "The authors proposed that concomitant treatment with an appetite suppressant such as phenylpropanolamine ( PPA ) would lead to a decrease in appetite and therefore loss of weight .\n",
            "This was a @-wk , DOUBLE-blind , RANDOMized , placebo-controlled trial of PPA , @ mg/day , in outpatients with treatment-refractory schizophrenia who were stable on clozapine treatment for at least @ mo and had gained > @ % of their baseline body weight since starting clozapine .\n",
            "Ss were evaluated for adverse effects and weighed weekly .\n",
            "A Positive and Negative Syndrome Scale ( PANSS ) assessment , a short dietary quiz , and blood indices were completed monthly .\n",
            "@ Ss were equally RANDOMly assigned to receive PPA or placebo .\n",
            "The groups did not differ in mean age , baseline weight , dose of clozapine , baseline PANSS scores , or the percent of weight gained since the start of clozapine .\n",
            "There was no significant effect of treatment on weight .\n",
            "There was no significant change in either the total PANSS scores , the positive or negative symptom cluster scores , or any of the remaining variables .\n",
            "Thus PPA @ mg/day was well tolerated but was not effective in reversing established weight gain associated with clozapine treatment in stable outpatients with schizophrenia .\n",
            "This prospective study measured adherence to conventional and atypical antipsychotics after hospital discharge in patients with a diagnosis of schizophrenia and schizoaffective disorder .\n",
            "We examined the interaction of several predictors such as gender , severity of illness , attitudes toward medications , side effects , and dose frequency .\n",
            "The sample consisted of consecutive randomized and nonrandomized patients who were discharged from an inpatient unit with a DSM-IV diagnosis of schizophrenia or schizoaffective disorder between December @ and July @ .\n",
            "All patients were taking oral antipsychotics and consented to the use of an electronic adherence monitor at discharge .\n",
            "Medications were prescribed by usual care providers , and medication adherence was followed weekly for @ months .\n",
            "The outcome measure was the medication adherence rate registered in the electronic monitors .\n",
            "We found no significant difference in adherence between the combined groups of atypical and conventional antipsychotics .\n",
            "Individual medication analysis found better medication adherence with olanzapine in comparison with risperidone and conventional antipsychotics , but the difference disappeared in the final model controlling for dose frequency .\n",
            "Dose frequency , gender , and akathisia predicted adherence .\n",
            "Caudate dysfunction is implicated in schizophrenia .\n",
            "However , little is known about the relationship between aggression and caudate volumes .\n",
            "Forty-nine patients received magnetic resonance imaging scanning in a double-blind treatment study in which aggression was measured .\n",
            "Caudate volumes were computed using a semiautomated method .\n",
            "The authors measured aggression with the Overt Aggression Scale and the Positive and Negative Syndrome Scale .\n",
            "Larger caudate volumes were associated with greater levels of aggression .\n",
            "The relationship between aggression and caudate volumes may be related to the iatrogenic effects of long-term treatment with typical antipsychotic agents or to a direct effect of schizophrenic processes on the caudate .\n",
            "Background : Neurocognitive deficits are an important predictor of functional outcome , and cognitive improvement may be associated with treatment effectiveness .\n",
            "The CATIE schizophrenia trial was designed to compare the effectiveness of currently available atypical and conventional antipsychotic medications through a randomized clinical trial involving @ patients treated for schizophrenia at multiple sites , including academic and community providers .\n",
            "Methods : Prior to the initiation of study medication , @ patients were assessed with a battery of neurocognitive tests , and @ patients met criteria for completeness in that meaningful data were collected on at least eight of the eleven tests , listed here by domain : processing speed ( Letter fluency , Category instances , Grooved pegboard , WAIS-R digit symbol ) , reasoning and problem solving ( Wisconsin Card Sorting Test , WISC-III Mazes ) , verbal memory ( Hopkins Verbal Learning Test ) , working memory ( Computerized visuospatial working memory test , Letter-number sequencing ) , vigilance ( Identical Pairs CPT ) , and social cognition ( Facial Emotion Discrimination Test ) .\n",
            "Z-scores were created for each test measure based on the baseline sample .\n",
            "Domain scores and a composite score were calculated from these z-scores .\n",
            "Results : Compared to published norms , schizophrenia patients performed worse on all measures , with z-scores ranging from @ to @ ( all P &lt; .@ ) .\n",
            "The Pearson correlations of the cognitive domain scores and the overall composite with demographic factors and clinical factors varied very little between cognitive domains .\n",
            "The size of correlations with age , education , and duration of illness were medium ( r .@ ) , while correlations with PANSS negative symptoms were small to medium ( .@ to .@ ) .\n",
            "The correlations of the neurocognitive measures with PANSS positive symptoms were less than .@ ( n.s. ) .\n",
            "The following variables significantly differentiated the composite scores : employment ( F = @ , df = @ , @ , P &lt; .@ ) , with full-time and part-time employed patients performing .@ and .@ standard deviations better than unemployed patients ; and antipsychotic medication status at baseline ( F = @ , df = @ , @ , P &lt; .@ ) , with patients on no antipsychotic medication or atypicals performing similarly , and those on typicals performing about .@ standard deviations below the others .\n",
            "Composite scores did not significantly differ by sex or whether a patient had an acute exacerbation in the past @ months .\n",
            "Objective : To investigate the long-term efficacy of modified Morita therapy for chronic schizophrenia .\n",
            "Methods : @ cases of hospitalized patients with chronic schizophrenia were randomly divided into the Morita groups and the control group were given @ weeks improved Morita therapy and general treatment , @-year follow-up was made after the end of treatment ; prior to treatment , after the end of follow-up with negative Symptom Scale ( sans ) , social Disability Screening the scale ( sdss ) and insight in table ( itaq ) related assessment .\n",
            "Results : equipartition differences between the two groups before treatment were not significantly significant ( p > @ ) after treatment the MORITA group the sans , itaq ratings and plain lack of interest or social emotional , pay attention to the lack of points with the control group , a significant difference in sex ( p < @ ) ; between the two groups when the end of the follow-up emotions dull , interest or social lack of differences significant sex ( p - < @ ) , itaq , sans , sdss ratings and attention to the lack of points the difference there is significant with sex ( p - < @ ) , Morita group of The relapse rate and readmission rates significantly lower than the control group ( p < @ ) .\n",
            "Conclusion : The modified Morita therapy can reduce psychiatric symptoms in patients with chronic schizophrenia , recovery of insight and social function , reduce the relapse rate of positive significance to the long-term rehabilitation of patients with chronic schizophrenia , worthy of its long-term efficacy .\n",
            "The purpose of this study was to determine the effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia .\n",
            "This was a longitudinal study and sixty-eight schizophrenic patients were assigned to @ weeks of a nicotine-patch therapy program or a control group .\n",
            "The generalized estimating equation analysis revealed that there were significant reductions in the subjects ' nicotine dependence ( Fagerstrom Tolerance Questionnaire ) , the number of cigarettes per day , and CO levels over an @-week period of nicotine-patch therapy and @-month follow-up .\n",
            "The point-prevalence rates of abstinence from smoking were an abstinence of @ % at @ weeks and @ % at a @-month follow-up .\n",
            "At the @-month follow-up , the rate of continuous smoking abstinence in the nicotine-patch group was @ %\n",
            "Objective This study assessed lay people and clinicians ' recognition of an at risk mental state ( ARMS ) for psychosis , their intentions to recommend help , and the equivalence of written and videotaped vignettes when detecting the problem .\n",
            "Methods In an Australian online survey , @ lay people and @ psychologists with provisional or full registration were randomly assigned to either a videotaped or written vignette of someone with an ARMS .\n",
            "Measures assessed detection and labelling of the mental health problem , and lay people 's intentions to recommend help .\n",
            "Results Data were analysed with Chi-Square statistics , Fisher 's Exact tests , and Multinomial Logistic Regression .\n",
            "Lay people frequently detected that a mental health problem existed but labelled it incorrectly .\n",
            "All clinicians detected that a mental health problem existed and most labelled it correctly .\n",
            "Lay people 's detection that a mental health problem existed was not associated with vignette type but videotaped vignettes produced significantly more correct labelling .\n",
            "Clinicians had poorer labelling when the vignette was videotaped .\n",
            "Correct labelling was associated with intentions to recommend help to a doctor , psychiatrist , and psychologist/counsellor but not with other help sources or with \" no help . \"\n",
            "Conclusions Results indicated that if lay people received further education about ARMS , they may be more likely to recommend help to certain mental health professionals .\n",
            "They further highlight the need to use multiple vignette methods in mental health literacy research and the importance of simulated learning about ARMS in professional training environments .\n",
            "Replication of these results in larger samples is required .\n",
            "( PsycINFO Database Record ( c ) @ APA , all rights reserved )\n",
            "This is a six week , double blind , placebo controlled study for patients with schizophrenia or schizoaffective disorder treated with an atypical antipsychotic for at least two months .\n",
            "Subjects will be randomized to take modafinil ( Provigil ) or placebo along with their current antipsychotic and tested at baseline and week @ for differences in memory , attention and problem-solving ability .\n",
            "Changes in weight during the six week study will also be tracked .\n",
            "Long-chain omega-@ polyunsaturated fatty acids ( PUFAs ) are essential for neural development and function .\n",
            "As key components of brain tissue , omega-@ PUFAs play critical roles in brain development and function , and a lack of these fatty acids has been implicated in a number of mental health conditions over the lifespan , including schizophrenia .\n",
            "We have previously shown that a @-week intervention with omega-@ PUFAs reduced the risk of progression to psychotic disorder in young people with subthreshold psychotic states for a @-month period compared with placebo .\n",
            "We have now completed a longer-term follow-up of this randomized , double-blind , placebo-controlled trial , at a median of @ years .\n",
            "Here we show that brief intervention with omega-@ PUFAs reduced both the risk of progression to psychotic disorder and psychiatric morbidity in general in this study .\n",
            "The majority of the individuals from the omega-@ group did not show severe functional impairment and no longer experienced attenuated psychotic symptoms at follow-up .\n",
            "Objective : This study compares the efficacy of risperidone and olanzapine to that of first-generation antipsychotics ( FGAs ) in patients with schizophrenia , who failed to show a response to initial trials of FGAs .\n",
            "Method : This study was an @-week treatment , randomized , rater-blind , active-control study with @ treatment arms .\n",
            "@ patients , who showed inadequate response to @ FGA , were enrolled and randomized into risperidone , olanzapine , or FGA ( haloperidol or trifluoperazine ) groups .\n",
            "They were blindly assessed with the Positive and Negative Syndrome Scale ( PANSS ) , the Clinical Global Impression Scale-Severity , and the Extrapyramidal Symptom Rating Scale ( ESRS ) at baseline and biweekly .\n",
            "Results : All @ groups demonstrated a significant decrease in the PANSS total , positive , and general scores from baseline to endpoint ( p-values range from @ to @ ) .\n",
            "There were no significant differences among the @ groups in score changes .\n",
            "The olanzapine group had significant score reductions than the risperidone and FGAs groups in terms of the ESRS subjective total score and did not experience a significant increase in the dose of anticholinergics .\n",
            "The FGA group demonstrated that extrapyramidal syndrome ( EPS ) worsened under an increased dosage of anti-EPS drugs .\n",
            "Olanzapine was associated with significant body weight gain ( @.@ kg , p = @ ) , but there were no significant group differences on weight gain .\n",
            "Conclusions : Haloperidol or trifluoperazine demonstrated similar efficacy as risperidone or olanzapine for patients with schizophrenia who had failed their first trial with a FGA .\n",
            "Related double-blind , fixed dose studies with a larger sample size are needed to confirm the results of our study .\n",
            "Georg Thieme Verlag KG Stuttgart New York .\n",
            "Objective To evaluate the efficacy and side effects of risperidone and electric convulsive refractory schizophrenia .\n",
            "Methods @ cases of hospital refractory schizophrenia were randomly divided into two groups , application risperidone and electric convulsive therapy , and observed for @ weeks .\n",
            "Panss Scale effects were evaluated using the tess scale assessment of adverse drug reactions .\n",
            "Results risperidone in the treatment group ( @ weeks , the phasing out of the original antipsychotics from the total score of the pan-ss ) from the first six weeks of treatment , panss Scale general psychopathology points and positive symptoms begin to decline , from an overall decline , the tess ratings of each treatment period is not more than @ weeks , the observation ending assess effective rate of @ % , effective rate is @ % .\n",
            "Mect group ( reduction of the original antipsychotics @/@ - @/@ ) total scores from the first four weeks of treatment , panss , panss Scale general psychopathology points and positive symptoms begin to decline , observed the end efficiency of @ % , the effective rate is @ % , high tess score .\n",
            "Conclusion The above two methods of refractory schizophrenia have a better therapeutic effect .\n",
            "Objective To evaluate the efficacy and side effects of risperidone in the treatment of schizophrenia .\n",
            "@ patients with first-episode schizophrenia patients were randomly assigned to risperidone group and chlorpromazine group , treatment and follow-up of eight weeks , with the positive and negative syndrome scale ( PANSS ) to assess the clinical assessment of side effects , side effects scale .\n",
            "Results risperidone group and no statistically significant difference in the efficacy of chlorpromazine group .\n",
            "Risperidone group vice fewer adverse reactions than chlorpromazine group , mainly for insomnia , dry mouth .\n",
            "Objective : Alcohol use disorders and schizophrenia frequently co-occurwith rates higher than in the general population .\n",
            "There is no consensus on the best treatment for patients with these comorbid conditions .\n",
            "Several clinical trials have shown that acamprosate is superior to placebo in reducingdrinking and is particularly effective in sustaining abstinence .\n",
            "No study to date has examined the efficacy of acamprosate in patients with alcohol dependence and comorbid schizophrenia .\n",
            "The aims of this study are to assess the efficacy of acamprosate when compared to placebo in reducing drinking and to examine its effects on schizophrenic symptoms .\n",
            "Methods : This was a doubleblind , randomized , @-week treatment trial of acamprosate versus placebo .\n",
            "Twenty-three recently abstinent patients with diagnosed alcohol dependence and comorbid schizophrenia , schizoaffective disorder , or psychosis not otherwise specified were included in this study .\n",
            "Results : All participants significantly decreased their drinking during medication treatment , although acamprosate was not superior to placebo in increasing consecutive days of abstinence .\n",
            "There was a significant difference favoring the acamprosate group on obsessive thoughts of drinking but no significant group X time interaction .\n",
            "Overall , medication treatment significantly reduced positive symptomsof schizophrenia , but there were no group differences .\n",
            "Conclusions : Acamprosate was not more effective than placebo in reducing drinking or symptoms of schizophrenia .\n",
            "It can be safely used in patients with alcohol dependenceand comorbid schizophrenia spectrum disorders .\n",
            "Taylor & FrancisGroup , LLC .\n",
            "Background ; The promise of improved efficacy and tolerability of the atypical antipsychotics compared with typical or first-generation antipsychotics remains only partially fulfilled .\n",
            "In particular , there are no treatments with proven efficacy ( or primary negative symptoms , which are burdensome for family members and contribute to poor long-term treatment outcomes for patients with schizophrenia .\n",
            "Asenapine is a novel psychopharmacologic agent being developed for the treatment of schizophrenia and bipolar disorder .\n",
            "In the current trial , sublingual asenapine @ mg BID was tested lor efficacy , tolerability , and safety vs placebo and risperidone @ mg BID in patients with acute exacerbation of schizophrenia .\n",
            "Methods : Patients with a diagnosis of schizophrenia and a baseline Positive and Negative Syndrome Scale ( PANSS ) score > @ were randomized to receive asenapine @ mg BID , risperidone @ mg BID , or placebo BID tor B weeks .\n",
            "Weekly efficacy evaluations were made using the PANSS .\n",
            "Data were analyzed by comparison of least squares means ILSM ) based on an ANOVA model of the intent-to-treet < ITT ) population , using a last-observation-carried-forward approach .\n",
            "Results : The ITT population consisted of @ asenapine , @ risperidone , and @ placebo patients .\n",
            "Improvement from baseline to week @ in mean PANSS total score was significantly greater with asenapine ( -@ ; p < @ ) than with placebo ( -@ ) ; improvement with risperidone ( -@ ) was numerically greater than with placebo .\n",
            "CGI scores showed similar improvements with asenapine and risperidone , end both active treatments were superior to placebo .\n",
            "PANSS positive subscale scores improved significantly with asenapine and risperidone vs placebo I both P < @ at end point ) .\n",
            " .\n",
            "All treatments were well tolerated .\n",
            "The incidence ol clinically significant weight gain ( @ % ol baseline body weight ) was comparable with asenapine @/@ .@ % ) and placebo @/@ , @ % ) , but was significantly higher with risperidone ( B/@ ,@ % ; P < @ vs asenapine and placebo ) .\n",
            "Discussion : In this trial , asenapine @ mg BIO showed efficacy superior to placebo for total PANSS scores .\n",
            "PANSS positive subscele .\n",
            "and PANSS negative subscale scores ; efficacy superior to risperidone @ mg BID on the PANSS negative subscale ; and good tolerability without clinically significant weight gain .\n",
            "Additional clinical trials are underway to further evaluate the efficacy of asenapine in the treatment of schizophrenia , including in patients with predominant negative symptoms .\n",
            "Background : ALKS @ ( ALKS @ ) is a linker lipid ester prodrug of aripiprazole ( ARP ) for extended-release intramuscular ( IM ) injection .\n",
            "A water-insoluble lauroyl prodrug approach was selected to chemically \" mask \" ARP following injection , minimizing the potential for injection site reactions and optimizing the ARP release profile for once-monthly dosing .\n",
            "The purpose of this study was to develop a multi-compartmental model capable of describing the pharmacokinetic ( PK ) profile of single dosing ALKS @ utilizing data obtained in a single dose PK , safety and tolerability study of ALKS @ following IM administration at @ dose levels in patients with schizophrenia .\n",
            "The model was subsequently utilized to simulate dose levels and dosing paradigms of oral aripiprazole and ALKS @ .\n",
            "Methods : A randomized , double-blind , placebo-controlled , escalating single-dose study conducted at two sites in the US .\n",
            "Subjects ( @ ; @M/@F ) with chronic , stable schizophrenia participated in the clinical study : mean age was @ years old ( range @-@ ) ; @ % of subjects were Black .\n",
            "Subjects received oral ( PO ) ARP ( Abilify @ mg ) daily for @ days to assess tolerability and PK of ARP , followed by a @-day washout period .\n",
            "Qualified subjects were randomized to ALKS @ or placebo ( PBO ) ( @:@ ) .\n",
            "Thirty-two subjects ( @M/@F ; BMI @-@ mg/kg@ ) were randomized into @ sequential cohorts of ALKS @ : @ mg ( n = @ ) , @ mg ( n = @ ) , and @ mg ( n = @ ) ARP free base equivalents or PBO ( n = @ / cohort ) .\n",
            "PK samples were collected on Day @ and on Day @ ( ALKS @ administration ) pre-dose and at @ , @ , @ , and @ hours postdose .\n",
            "Single PK samples were collected Days @-@ , @ , @ , @-@ , and @ , @ , @ , @ , @ , @ , @ , and @ .\n",
            "PK samples were assayed for levels of ALKS @ , ARP , and dehydroaripiprazole ( dARP ) by LC-MS / MS ( LLOQ = @ ng/mL ) .\n",
            "ARP and dARP Data from @ subjects was used in the model development .\n",
            "Compartmental modeling was conducted using WinNonlin v@ .@ .\n",
            "A stepwise multiple-compartment PK modeling approach was employed to establish PK models for both oral ARP and ALKS @ .\n",
            "A Weibull function best characterized the absorption profile of ARP following ALKS @ administration .\n",
            "In model predictability test , PK parameters from ALKS @ @ mg and @ mg modeling were used to predict drug PK profile of the @ mg dose level in comparison to observed data .\n",
            "The developed model was to simulate anticipated aripiprazole concentrations following monthly dosing ALKS @ administration in planned clinical studies .\n",
            "Results : Tests of model fit and evaluation demonstrated that the model well predicted ARP and dARP concentration and exposure of following oral ARP and IM ALKS @ ( R@ = @ and @ , respectively ) .\n",
            "In accordance with previously reported models , oral ARP PK was best characterized with @-compartment model , with half-life of absorption and elimination of @ hr and @ days , respectively .\n",
            "A @-compartment model was developed to describe ARP and dARP PK following ALKS @ IM administration .\n",
            "ARP exhibited a significantly longer absorption half-life ( @ days ) following ALKS @ administration , consistent with a oncemonthly dose regimen .\n",
            "When PK parameters from the ALKS @ @ mg and @ mg dose levels were used to predict ARP and dARP following @ mg ALSK@ PK , predicted values agreed well with the observed data ( R@ = @ ) , demonstrating the utility of the model for simulation .\n",
            "Using the resulted geometric mean of PK parameters , simulations of once-monthly dosing of ALKS @ @ mg , @ mg and @ mg will result in steady-state concentration levels of ARP comparable to daily oral ARP doses of @ mg , @ mg and @ mg , respectively .\n",
            "Conclusions : ALKS @ was well tolerated with few AEs and minimal reports of discomfort at the injection site .\n",
            "ALKS @ achieved therapeutic levels of ARP following single administration with a concentration-time profile consistent with once monthly administration and predicted minimal peak to trough ratio .\n",
            "Two multi-compartment PK models were successfully developed to describe the PK of ARP and dARP following administration of oral ARP and ALKS @ .\n",
            "Simulated steady-state levels of ARP following ALKS @ administration are consistent with the current PO dose range of @-@ mg/day for the treatment of schizophrenia .\n",
            "Objective : To evaluate the integrated intervention efficacy in patients with schizophrenia receiving free medication .\n",
            "Methods : @ cases of poor patients with schizophrenia were randomly divided into two groups , each group of @ people in each intervention group patients monthly follow-up by professional doctors and medicine and implement comprehensive interventions , patients in the control group is concentrated in the community on a monthly basis medicine .\n",
            "Analysis of two groups of patients with clinical efficacy , social function , the happiness index , guardianship rate , relapse rate observed for @ year , and the readmission number of times and accident Zhaohuo of conditions .\n",
            "Results : The intervention group patients in disease efficacy , social function , the happiness index was significantly better than the control group ( p < @ ) ; accident showed a downward trend Zhaohuo number of average annual relapse frequency , the average annual number of hospitalizations , a statistically significance .\n",
            "Schizophrenia is associated with significant impairment of cognitive function in the domains of memory and learning , including working memory ( WM ) , implicit ( IL ) and probabilistic learning ( PL ) .\n",
            "Previous research suggests that tDCS stimulation can improve cognitive functioning .\n",
            "We investigated if cognitive training with adjunct tDCS would improve learning rates in individuals with schizophrenia .\n",
            "The mechanism of action was investigated during an fMRI visit with concurrent tDCS .\n",
            "@ right-handed patients with schizophrenia were randomized into real or sham tDCS .\n",
            "Participants completed @ sessions of cognitive training , twice a day spread over @ days ( @ , @ , @ and @ ) .\n",
            "Anodal tDCS to the left dorso-lateral prefrontal cortex ( DLPC ) was applied during day @ and day @ .\n",
            "The cognitive training included a WM , IL , and PB task .\n",
            "Those suitable and willing underwent an fMRI scan on day @ , during which they completed an additional executive function ( EF ) task .\n",
            "Multilevel regressions were used to compare the learning rates between the real and sham tDCS groups .\n",
            "General linear models were used to analyse the fMRI data .\n",
            "We found a delayed effect of tDCS upon learning ; real tDCS was associated with improved learning rates in the WM and PL task , but only after consolidation .\n",
            "Real tDCS was associated with reduced activity in the cerebellum during the WM and EF .\n",
            "Increased activity underneath the electrode was noted during the WM task , whereas the EF task was associated with reduced activity in the anterior cingulate cortex .\n",
            "Decreased hippocampal activity was noted during the IP in the real tDCS group .\n",
            "The effect of tDCS on behavioural performance was only observed after consolidation period .\n",
            "tDCS modulated functional activation in local task-related regions , and in more distal nodes in the network .\n",
            "Transcranial direct current stimulation offers a potential novel approach to altering cortical activity and exerting pro-cognitive effects in schizophrenia .\n",
            "Keywords : schizophrenia , tDCS , cognitive training , neuroimaging Copyright   @\n",
            "Introduction : ( - ) - OSU@ belongs to a novel class of functional stabilizers of dopaminergic systems displaying a preclinical pharmacology suggesting possible antipsychotic properties ( @ ) Design : A RANDOMized , double blind , single dose , crossover trial comparing the effect of @ mg/kg body weight ( - ) - OSU@ with placebo .\n",
            "Four patients with schizophrenia where recruited to the study .\n",
            "Baseline PANSS and Simpson-Angus ratings were performed before giving drug/placebo .\n",
            "Ratings were again carried out @ and @ hours post dose .\n",
            "After the @ hours ratings , a new dose of drug/placebo was given .\n",
            "Ratings and sampling of fluids as before .\n",
            "Results : Three patients completed the study .\n",
            "PANSS scores were reduced after administration of ( - ) - OSU@ but not placebo .\n",
            "Baseline PANSS was @ ( @-@ ) , after @ hours on OSU@ it was reduced to @ ( @-@ ) and after @ hours @ ( @-@ ) .\n",
            "No side effects were reported during the trial .\n",
            "Discussion : All three patients responded to ( - ) - OSU@ with a rapid reduction in psychotic symptoms .\n",
            "The duration of the response of the single dose was @-@ hours ( the patient with the highest PANSS score had the shortest duration of response ) .\n",
            "Our observations on these patients are in agreement with observations from patients with Huntingtons chorea where long lasting symptom reductions were seen following single doses of ( - ) - OSU@ ( @ ) .\n",
            "We propose that further exploration of this , or similar , compounds be warranted both as mono treatment and as an add-on to existing antipsychotic therapy in patients with residual symptoms .\n",
            "@ .\n",
            "C. Sonesson et al. ( @ ) Society for Neurosciencem Abs , Vol .\n",
            "@ , Part @ , p. @ @ .\n",
            "J. Tedroff et al .\n",
            "Neurology @ ; @:@-@\n",
            "Introduction : There has been plenty of interest in cognitive rehabilitation for schizophrenia here in Korea since the year @ .\n",
            "But the efficacy studies of cognitive remediation intervention are still deficient .\n",
            "The primary purpose of this study was to develop a computer-assisted cognitive remediation program and conduct a clinical trial in a group of schizophrenic patients .\n",
            "Methods : Sixty patients with schizophrenia were randomly assigned to a computerized cognitive rehabilitation ( Cog-trainer ) group plus usual rehabilitation ( UR ) or to a usual rehabilitation ( UR ) group only .\n",
            "Clinical , neuropsychological and functional outcome variables were assessed at baseline and after intervention .\n",
            "The Cog-trainer group received @ sessions of computerized cognitive remediation training over @ months .\n",
            "This training program consists of @ units , with each unit being divided into three stages : ( i ) practice ; ( ii ) application ; and ( iii ) advanced .\n",
            "Results : Compared to the UR group , the Cog-trainer exhibited a significant improvement in attention , concentration and working memory .\n",
            "The Cog-trainer group also showed improvement in the work quality subscale of the work behavior inventory .\n",
            "However , there were no significant benefits of computerized cognitive remediation where symptoms were concerned .\n",
            "Discussion : These results indicate that computerized cognitive rehabilitation training can contribute to an improvement in the cognitive function of people with schizophrenia .\n",
            "The changes in cognitive outcomes can also contribute to improvement in job functioning .\n",
            "Further study of generalization to other functional outcome measures will be necessary .\n",
            "Long-term follow-up studies are needed to confirm the maintenance of such improvements .\n",
            "@ Wiley Publishing Asia Pty Ltd .\n",
            "Objectives .\n",
            "The current study investigated mental health literacy in an Australian sample to examine sex differences in the identification of and attitudes towards various aspects of mental illness .\n",
            "Method .\n",
            "An online questionnaire was completed by @ participants ( M = @ years ) .\n",
            "Participants were randomly assigned either a male or female version of a vignette depicting an individual exhibiting the symptoms of one of three types of mental illness ( depression , anxiety , or psychosis ) and asked to answer questions relating to aspects of mental health literacy .\n",
            "Results .\n",
            "Males exhibited poorer mental health literacy skills compared to females .\n",
            "Males were less likely to correctly identify the type of mental illness , more likely to rate symptoms as less serious , to perceive the individual as having greater personal control over such symptoms , and less likely to endorse the need for treatment for anxiety or psychosis .\n",
            "Conclusion .\n",
            "Generally , the sample was relatively proficient at correctly identifying mental illness but overall males displayed poorer mental health literacy skills than females .\n",
            "PURPOSE : The purpose of this study was to explore the effects of listening to music in inpatients diagnosed with schizophrenia , on their auditory hallucinations , and positive and negative symptoms .\n",
            "METHODS : A quasi-experimental research design with @x@ cross-over trial and convenience sample was used .\n",
            "Eleven patients ( Group AB ) listened to music followed by a wash out period and then a usual care period , and @ patients ( Group BA ) had a usual care period followed by a wash out period and then listened to music .\n",
            "For one week those who were in the experimental period listened to individualized music using an MP@ player whenever they heard hallucinations .\n",
            "RESULTS : There was a statistically significant decrease in the frequency of auditory hallucinations after listening to the music .\n",
            "There was a decrease in the mean scores for positive symptoms , negative symptoms , and general psychopathology after listening to music , but only negative symptoms showed a statistically significant decrease .\n",
            "The treatment effects on scores for positive symptoms , negative symptoms , and general psychopathology were greater in Group BA than Group AB .\n",
            "CONCLUSION : These findings suggest that listening to music may be useful for managing auditory hallucinations in schizophrenia inpatients .\n",
            "From the viewpoint of both primary and secondary care , what is the effect of a patient held shared record card on the pattern of service use and satisfaction with medical care for the people with long term mental illness , compared to current practice ?\n",
            "Randomised controlled trial .\n",
            "Subjects will be randomised by GP practice using a minimisation method to balance intervention and control groups in terms of practice list size and primary diagnosis .\n",
            "The present state examination , a standardised pyschiatric examination , will be included as part of the assessment .\n",
            "Patients will be followed up for one year .\n",
            "A cost-effectiveness study concentrating on direct NHS costs expected to be affected by the card will also be performed .\n",
            "Objective To compare the efficacy of olanzapine with perphenazine in the treatment of schizophrenia .\n",
            "Methods Sixty schizophrenic patients with marked positive symptoms were randomly divided into two groups received olanzapine or perphenazine for the treatment of six weeks .\n",
            "PANSS and TESS were used before treatment and at the second , and forth and sixth weekend af ter treatment .\n",
            "Results At the second and forth weekend , there had significant differences on efficacy between two group s ( @ = @ .\n",
            "@ , P = @ .\n",
            "@ )  @ = @ .\n",
            "@ , P = @ .\n",
            "@ ) , and at the sixt h weekend , t he difference was not found between t he two group s ( @ = @ .\n",
            "@ , P = @ ) .\n",
            "The scores of PANSS in olanzapine group at the second , forth and sixt h weekend were significantly lower than those before treatment ( P < @ .\n",
            "@ ) , and in perphenazine group the score significantly dicreased at the forth sixth weekend after treatment ( P < @ .\n",
            "@ ) .\n",
            "At the forth sixth weekend , there had significant differences on the scores of TESS between two group ( t = @ .\n",
            "@ , P = @ .\n",
            "@ )  ( t = @ .\n",
            "@ , P = @ .\n",
            "@ ) .\n",
            "Conclusion Olanzapine could be faster and more effective for controlling the positive psychotic symptoms of schizophrenia than perphenazine , and with lower EPSs .\n",
            "Background : Schizophrenia is associated with cognitive deficits and alterations in task-induced brain activity in several cognitive domains ( e.g. attention and working memory ) .\n",
            "Nicotine dependence is more frequent in schizophrenic patients than in the general population .\n",
            "According to the self-medication hypothesis patients with schizophrenia consume nicotine to counteract schizophrenia-associated cognitive deficits .\n",
            "Methods : Randomized , placebo-controlled cross-over nicotine ( @ mg spray ) challenge with simultaneous EEG-fMRI recording from @ smoking schizophrenia patients ( preliminary analysis of @ out of @ patients ) and @ smoking controls during a visual choice reaction time task .\n",
            "Single trial P@ peak amplitude was included in the General Linear Model ( GLM ) analysis of the fMRI data .\n",
            "Results : Applying the EEG P@-informed fMRI BOLD model we found higher cluster-corrected activation of the attention network in the nicotine condition compared to placebo in schizophrenic smokers ( Figure @ ) .\n",
            "No significant nicotine effects were observed in the conventional model ( no EEG ) .\n",
            "In smoking controls neither model ( P@-informed or conventional ) revealed significant nicotine effects .\n",
            "Conclusions : Our data suggest that EEG-informed fMRI may be suited to study subtle drug effects on cognitive processes .\n",
            "The sensitivity may be higher compared to conventional Analyses of the fMRI BOLD signal .\n",
            "Moreover the EEG-informed analysis can emphasize certain aspects of task-induced brain activity such as neuronal sub-processes that are reflected by P@ amplitude .\n",
            "In light of the relationship between P@ amplitude , cognitive performance and schizophrenia our data suggest that positive effects of nicotine on cognition may be pronounced in patients with schizophrenia .\n",
            "This interpretation would be consistent with the self-medication hypothesis .\n",
            "Objectives : This study aimed to compare the efficacy of an integrated treatment ( IT ) versus treatment as usual ( TAU ) in a group of inpatient children and adolescents with first episode psychosis ( FEP ) during a two year follow-up .\n",
            "Method : In a randomized controlled trial , @ children and adolescents with FEP based on DSM-IV criteria were recruited from referrals to Robe Hospital ( Tehran , Iran ) .\n",
            "They were divided into a TAU group ( N = @ ) , and an IT group ( N = @ ) who received a low dose of atypical antipsychotic medications and family psycho-education program , and were followed up by telephone contacts .\n",
            "All participants were evaluated at admission and discharge as well as in @ , @ , @ and @ month intervals using the Kiddie-Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version-Persian Version ( K-SADS-PL-PV ) , Positive and Negative Syndrome Scale ( PANSS ) , Young Mania Rating Scale ( YMRS ) , Children 's Depression Inventory ( CDI ) , Hamilton Depression Rating Scale ( HAM-D ) , Global Assessment of Functioning Scale ( GAF ) , and Children Global Assessment Scale ( CGAS ) .\n",
            "Statistical methods consisted of analysis of independent t and for qualitative variables , and random effect regression model for quantitative variables .\n",
            "Results : The two groups showed significant improvement in all outcome measures at different time-points .\n",
            "The rate and duration of recurrences were lower in the IT group compared to the TAU group .\n",
            "All of the other outcome measures were comparable in the two groups and there was no difference between them in different follow-up periods .\n",
            "Conclusion : Integrated treatment may decrease the rate and duration of recurrences in children and adolescents with FEP .\n",
            "( PsycINFO Database Record ( c ) @ APA , all rights reserved ) ( journal abstract )\n",
            "Background : Individuals with mental illnesses are overrepresented among the homeless .\n",
            "Housing First ( HF ) has been shown to promote positive outcomes in this population .\n",
            "However , key questions remain unresolved , including : how to match support services to client needs , the benefits of housing in scattered sites versus single congregate building , and the effectiveness of HF with individuals actively using substances .\n",
            "The present study aimed to recruit two samples of homeless mentally ill participants who differed in the complexity of their needs .\n",
            "Study details , including recruitment , randomization , and follow-up , are presented.Methods : Eligibility was based on homeless status and current mental disorder .\n",
            "Participants were classified as either moderate needs ( MN ) or high needs ( HN ) .\n",
            "Those with MN were randomized to HF with Intensive Case Management ( HF-ICM ) or usual care .\n",
            "Those with HN were randomized to HF with Assertive Community Treatment ( HF-ACT ) , congregate housing with support , or usual care .\n",
            "Participants were interviewed every @ months for @ years .\n",
            "Separate consent was sought to access administrative data.Results : Participants met eligibility for either MN ( n = @ ) or HN ( n = @ ) and were randomized accordingly .\n",
            "Both samples were primarily male and white .\n",
            "Compared to participants designated MN , HN participants had higher rates of hospitalization for psychiatric reasons prior to randomization , were younger at the time of recruitment , younger when first homeless , more likely to meet criteria for substance dependence , and less likely to have completed high school .\n",
            "Across all study arms , between @ % and @ % of participants were followed over @ months post-randomization .\n",
            "Minimal significant differences were found between study arms following randomization .\n",
            "@ participants ( @ % ) provided consent to access administrative data.Conclusion : The study successfully recruited participants meeting criteria for homelessness and current mental disorder .\n",
            "Both MN and HN groups had high rates of substance dependence , suicidality , and physical illness .\n",
            "Randomization resulted in no meaningful detectable differences between study arms .\n",
            "Trial registration : Current Controlled Trials : ISRCTN@ ( Vancouver at Home study : Housing First plus Assertive Community Treatment versus congregate housing plus supports versus treatment as usual ) and ISRCTN@ ( Vancouver At Home study : Housing First plus Intensive Case Management versus treatment as usual ) .\n",
            "Background : An association between gluten sensitivity and schizophrenia has been reported , but it is unclear which serum biomarkers of gluten sensitivity are elevated .\n",
            "The presence of antibodies against either native gliadin protein ( gliadin antibodies or AGA ) or deaminated gliadin peptides ( DGP antibody ) .\n",
            "The DGP antibody assay is a more specific and sensitive diagnostic test for celiac disease .\n",
            "Here we compare presence of gliadin and DGP antibodies in sera of schizophrenia patients .\n",
            "Methods : Patients were referred by the Johns Hopkins Hospital Community Psychiatry Program or the Maryland Psychiatric Research Center for a double-blind randomized controlled trial of a gluten-free diet for treatment of gliadin-positive schizophrenia .\n",
            "All subjects had a diagnosis of schizophrenia or schizoaffective disorder and were between ages @ and @ , both sexes were included .\n",
            "Sera were analyzed for antibodies against Gliadin IgA and IgG ( INOVA @ , @ ) , DGP IgA and IgG ( @ , @ ) and h-tTG IgA ( @ ) .\n",
            "Results were interpreted according to the manufacturer guidelines ( that is negative = less than @U , weak positive = @-@ U and moderate to strong positive = over @U ) .\n",
            "Results : Out of @ schizophrenia patients only one ( @ % ) was weakly positive for DGP IgA antibodies and none were positive for DGP IgG , which is not statistically different from the @ % and @ % positivity in non-celiac controls reported by the manufacturer .\n",
            "However , @ out of @ of schizophrenia patients ( @ % ) were positive for gliadin IgA ( @ strongly positive ) and @ out of @ patients ( @ % ) were positive for gliadin IgG ( @ strongly positive ) .\n",
            "All @ patients were negative for tTg IgA antibodies , excluding the possibility of undiagnosed Celiac Disease .\n",
            "According to the manufacturer only @ % or @ % of normal healthy controls are positive for gliadin IgA or IgG antibodies , respectively .\n",
            "Conclusion : Forty-five percent of schizophrenia patients are positive for gliadin IgG antibodies and @ % are positive for gliadin IgA antibodies , a much higher proportion than expected based on normal healthy controls data .\n",
            "All patients except one weakly positive were negative for DGP IgG and IgA antibodies .\n",
            "The exclusive presence of anti-gliadin antibodies rather than DGP antibodies in the absence of tTg antibodies , underscores that the pathogenetic mechanism for gluten sensitivity associated with schizophrenia is different from that for Celiac disease .\n",
            "Studied the interchangeability of effective antipsychotic compounds in a clinical setting .\n",
            "@ formerly hospitalized chronic schizophrenics were randomly assigned to chlorpromazine , thiothixene , or continued doctor 's choice medication groups .\n",
            "Dose of antipsychotic medication and schedule of administration were kept constant .\n",
            "During the @-yr study period @ patients ( @ % ) in the combined chlorpromazine and thiothixene groups ( \" switched group \" ) underwent clinical deterioration to an extent that they had to be terminated from the study .\n",
            "Only @ patients ( @ % ) of the control group relapsed during the same period .\n",
            "The significant difference in relapse rates is attributed to the change in antipsychotic medication .\n",
            "Relapses were equal in number during the @st and @nd @ mo of the study .\n",
            "The new antipsychotic ( chlorpromazine or thiothixene ) may have delayed but did not prevent the relapse of these patients .\n",
            "PURPOSE : Evidence for the recommendation to deliver Cognitive Behavioural Therapy ( CBT ) and Family Interventions ( FI ) to under-@s with psychosis derives from adult research , and no previous study has focused exclusively on an adolescent population .\n",
            "We evaluated adaptations of these therapies for adolescent inpatients with psychosis ( CBTpA and FIpA ) , delivered as an adjunct to inpatient standard care ( SC ) .\n",
            "SUBJECTS AND METHODS : Thirty adolescent inpatients with psychotic symptoms on admission were sequentially allocated to receive CBTpA + SC ( n = @ ) ; FIpA + SC ( n = @ ) or SC alone ( n = @ ) .\n",
            "Psychotic symptoms and functioning were measured at admission and discharge .\n",
            "RESULTS : Group comparisons did not reach conventional significance , but effect sizes in this pilot study showed a promising impact of CBTpA compared to SC alone , in reducing symptoms ( ES : d = @ ) , with smaller effect sizes for functioning ( d = @ ) and for FIpA ( symptoms , d = @ and functioning , d = @ ) .\n",
            "There was no advantage of either additional treatment in reducing length of stay , but self-report satisfaction ratings were higher for both psychological therapies .\n",
            "DISCUSSION AND CONCLUSIONS : The study is the first to focus on an exclusively adolescent population , using appropriately adapted therapy protocols .\n",
            "Findings suggest that the interventions are feasible , acceptable and helpful for adolescents with psychosis .\n",
            "Larger randomised controlled trials are now needed .\n",
            "Objective To investigate the efficacy and safety of aripiprazole and risperidone for schizophrenia .\n",
            "Methods @ cases of patients with schizophrenia were randomly divided into a the aripiprazole group of @ cases , @ cases risperidone group ; were given aripiprazole and risperidone in the treatment for @ weeks .\n",
            "@,@,@ weekend before treatment and first , respectively , using the Positive and Negative Syndrome Scale ( panss ) , treatment of adverse symptom scale ( tess ) assessed the two groups .\n",
            "Before treatment , after checking prolactin levels .\n",
            "Results After treatment the panss ratings were significantly lower .\n",
            "Aripiprazole group extrapyramidal side effects , the increase in body mass and menstrual disorders less light than in the risperidone group , and no effect on prolactin levels .\n",
            "Conclusion The results of this study showed that the two drugs for schizophrenia have a better effect , rapid onset of adverse reactions .\n",
            "EDUCATIONAL OBJECTIVES : The reader will learn that paliperidone palmitate ( PP ) , a new investigational long-acting psychotropic , is initiated with a deltoid @ mg eq .\n",
            "dose delivered intramuscularly ( IM ) .\n",
            "When administered with a needle length optimized to assure IM delivery , PP will rapidly achieve plasma levels within its therapeutic range .\n",
            "Subsequent once-monthly IM dosing ( deltoid or gluteal ) maintains a clinically and statistically significant response across the full range of tested doses ( @   @ mg eq ) .\n",
            "SUMMARY : Aim : Establish an optimized dose-initiation strategy for paliperidone palmitate ( PP ) using schizophrenia clinical studies and population ( pop ) PK simulation .\n",
            "Methods : Trial A ( @wk DB ) : pts with acute exacerbation of schizophrenia randomized to ( @ ) flexibly dosed risperidone LAI ( @ , @ or @ mg ) + oral risperidone supplementation ( RLAI+RIS ; placebo [ PB ] injection Day@ , @ mg RLAI [ Day@ , @ ] , followed by flexibly dosed RLAI injection ) ; or ( @ ) PP arm ( initial @ mg eq .\n",
            "gluteal dose on Days@ and @ , plus oral PB , followed by flexibly dosed gluteal PP ( @ , @ , @ or @ mg eq . )\n",
            "every @wks , and PB IM every other @wks to correspond to matched RLAI dosing .\n",
            "Pop PK : a nonlinear mixed-effects model using pooled data was developed and simulations conducted .\n",
            "Trial B ( @wk DB ) : pts with acute exacerbation of schizophrenia randomized to ( @ ) PP@ , @ or @ mg eq .\n",
            "intramuscular ( IM ; Day@ PP@mg eq .\n",
            "IM deltoid muscle , then fixed IM dose of PP in deltoid or gluteal from Day@ and then every @wks ) ; or ( @ ) PB IM on Day@ onwards .\n",
            "Results : Trial A ( n = @ ) : PP@ gluteal injection resulted in lower plasma levels in @-day initiation vs active moiety conc for RLAI+RIS .\n",
            "PP+PB and RLAI+RIS improved mean change PANSS score , but RLAI+RIS vs PP+PB noninferiority was not met ( by @ points ; primary endpoint ) .\n",
            "Rates of AEs were similar for both groups .\n",
            "Pop PK : deltoid injection with higher dose of PP ( @ mg eq . )\n",
            "on Day@ and optimized needle length resulted in faster initial release .\n",
            "Trial B ( ITT = @ ) : differences observed in mean change  SD PANSS score , PP@ =    @  @ ; PP@ =    @  @ ; PP@ =    @  @ vs PB =    @  @ ( p < @ ) , thus validating PK modeling .\n",
            "Safety was similar to earlier studies .\n",
            "Discussion : Initiated as @ mg eq .\n",
            "IM deltoid injection , with optimized needle length , PP rapidly achieved plasma conc associated with effective symptom control .\n",
            "Subsequent monthly dosing ( deltoid or gluteal ) maintained clinically and statistically effective response across @   @ mg eq .\n",
            "Funded by J&J PRD .\n",
            "DESCRIPTION ( Adapted from the Applicant 's Abstract ) : This R@ is a competitive renewal of a MERIT Award .\n",
            "When this project started ( @ ) , the universal view was that the efficacy of ECT was dependent on the generalized seizure , while its cognitive effects were largely determined by electrical dosage .\n",
            "Nonetheless , standard practice involved treating all patients with the same electrical dose , typically at device maximum .\n",
            "Across three studies , we demonstrated marked individual differences in seizure threshold ( ST ) .\n",
            "Many patients were treated orders of magnitude above ST , accounting for much of the adverse cognitive effects of ECT .\n",
            "We also demonstrated that the efficacy of right unilateral ( RUL ) ECT is highly dependent on the degree to which dosage exceeds ST. These findings have been widely replicated .\n",
            "In our most recent study ( started and completed during the MERIT Award period ) , high dosage RUL ECT equaled the efficacy of a robust form of bilateral ( BL ) ECT , and had clinically significant advantages in acute , short-term , and long-term cognitive side effects .\n",
            "These findings have already had impact on practice , and should help resolve the > @ year controversy regarding the relative merits of RUL and BL ECT .\n",
            "The proposed study ( Study @ ) began during the MERIT Award period , and this application requests support for its completion .\n",
            "In addition to replicating the key findings regarding the relative merits of high dosage RUL compared to BL ECT , this study takes a new direction .\n",
            "The traditional ECT stimulus configuration is nonphysiologic .\n",
            "The standard pulse width ( PW ) used in ECT ( @-@ ms ) greatly exceeds the chronaxie for the optimal stimulation necessary for neuronal depoladzation and seizure production ( eg , @-@ ms ) .\n",
            "Excessive PW results in stimulation during refractory periods long following neuronal discharge .\n",
            "By reducing the PW of the ECT stimulus , we should maintain efficacy , but substantially reduce cognitive side effects .\n",
            "Our preliminary data suggest that the magnitude of this effect equals or exceeds the difference in cognitive effects between RUL and BL ECT , and , in fact , the extraordinary difference between sine wave and brief pulse stimulation .\n",
            "This new study uses a randomized , double-masked , parallel group , fully factorial [ RUL vs. BL ECT and ultrabrief PW ( @ ms ) vs. traditional PW ( @ ms ) ] design , with both RUL conditions treated at @ times initial ST and both BL conditions treated at @ times initial ST. We hypothesize that high dose RUL ECT has significant advantages over moderate dose BL ECT [ with both at traditional PW ] .\n",
            "Most critically , use of an ultrabrief PW is equally effective as a long PW , but markedly reduces the short - and long-term cognitive burden of ECT , and is also superior in effects on functional status , subjective cognitive outcome , and neurophysiological alterations .\n",
            "Such findings should have fundamental impact on our understanding of mechanisms and on the practice of ECT .\n",
            "Current meta-analysis revealed small , but significant effects of repetitive transcranial magnetic stimulation ( rTMS ) on negative symptoms in patients with schizophrenia .\n",
            "There is a need for further controlled , multicenter trials to assess the clinical efficacy of rTMS on negative symptoms in schizophrenia in a larger sample of patients .\n",
            "The objective of this multicenter , randomized , sham-controlled , rater - and patient-blind clinical trial is to investigate the efficacy of @-week @-Hz high frequency rTMS add on to antipsychotic therapy , @ sessions per @ weeks , @ stimuli per session , stimulation intensity @ % of the individual motor threshold ) of the left dorsolateral prefrontal cortex for treating negative symptoms in schizophrenia , and to evaluate the effect during a @ weeks of follow-up .\n",
            "The primary efficacy endpoint is a reduction of negative symptoms as assessed by the negative sum score of the positive and negative symptom score ( PANSS ) .\n",
            "A sample size of @ in each group will have @ % power to detect an effect size of @ .\n",
            "Data analysis will be based on the intention to treat population .\n",
            "The study will be conducted at three university hospitals in Germany .\n",
            "This study will provide information about the efficacy of rTMS in the treatment of negative symptoms .\n",
            "In addition to psychopathology , other outcome measures such as neurocognition , social functioning , quality of life and neurobiological parameters will be assessed to investigate basic mechanisms of rTMS in schizophrenia .\n",
            "Main limitations of the trial are the potential influence of antipsychotic dosage changes and the difficulty to ensure adequate blinding .\n",
            "Cognitive remediation therapy ( CRT ) is a novel psychosocial treatment approach designed to improve adaptative functioning by using cognitive compensatory strategies to bypass the cognitive deficits associated with schizophrenia .\n",
            "The effect of CRT was tested on neurocognition , positive and negative symptoms and psychosocial functioning .\n",
            "Cognitive behavioural treatment ( CBT ) is a useful therapy for emotional problems that is not expected to have effects on neurocognition and was used as a control condition .\n",
            "Twenty-four patients with DSM-IV schizophrenia and prominent negative symptoms were randomly assigned for @ months to one of the two treatment conditions : @ ) standard medication follow-up plus CRT , @ ) standard medication follow-up plus CBT .\n",
            "Comprehensive assessments ( Positive and Negative Syndrome Scale , Life Skills Profile , Wechsler Adult Intelligence Scale-III , Wisconsin Card Sorting Test , Stroop Test ) were conducted before and after the treatments .\n",
            "Significant differences were found between the two treatment groups in neurocognition and psychosocial functioning after the treatment .\n",
            "Patients receiving CRT overall had higher levels of improvement in neurocognition and psychosocial functioning ( Lambda de Wilks @ ; p = @ ) but not in symptomatology ( Lambda de Wilks @ ; p = @ ) .\n",
            "Nevertheless , patients receiving CBT showed significant reduction in some aspects of the general psychopathology after treatment .\n",
            "In conclusion , CRT may improve neurocognition and psychosocial functioning for patients with schizophrenia .\n",
            "Although CBT did not improve cognition nor social functioning it might reduce general psychopathology levels .\n",
            "OBJECTIVE : This study examined the effect of adjunctive telmisartan on body metabolism in clozapine - or olanzapine-treated patients with schizophrenia .\n",
            "METHOD : Each subject had been on stable dose of olanzapine or clozapine for at least @ month .\n",
            "In a @-week randomized , double-blind , placebo-controlled study , subjects received either telmisartan ( @ mg once per day ) or placebo .\n",
            "The homeostasis model of assessment of insulin resistance ( HOMA-IR ) was calculated based on fasting blood levels of insulin and glucose .\n",
            "Fasting blood levels of triglycerides and cholesterols , as well as serum levels of high-sensitivity C-reactive protein ( hsCRP ) and interleukin-@ ( IL-@ ) were measured .\n",
            "The whole-body dual-energy X-ray absorptiometry ( DXA ) was used to assess body composition .\n",
            "Lipid particles were assessed using nuclear magnetic resonance ( NMR ) spectroscopy .\n",
            "All assessments were conducted at baseline and repeated at week @ .\n",
            "RESULTS : Fifty-four subjects were randomized and @ completed the study ( @ in the telmisartan group , @ in the placebo group ) .\n",
            "There were no significant differences between the two groups in week @ changes for HOMA-IR or fasting triglycerides ( - @ + / - @ vs @ + / - @ , p = @ ; - @ + / - @ vs - @ + / - @ mg/dL , p = @ , respectively ) ( telmisartan vs placebo ) .\n",
            "Further , there were no significant between group differences in week @ changes for other fasting lipids , body weight , body mass index , waist circumference , as well as various measures of lipid particles ( p 's > @ ) .\n",
            "The DXA assessment showed no significant differences between the two groups in week @ changes for fat mass , lean mass , or total mass ( p 's > @ ) .\n",
            "CONCLUSION : In the present study , adjunctive treatment of telmisartan did not seem to improve body metabolism in schizophrenia patients receiving olanzapine or clozapine .\n",
            "The implications for future studies were discussed .\n",
            "CLINICALTRIALS .\n",
            "GOV IDENTIFIER : NCT@ .\n",
            "@ @-@ yr old chronic schizophrenic inpatients were treated with @ , @ , or @ mg/day EMD-@ @ , an antidepressant , or with placebo in a @-wk double-blind investigation .\n",
            "Changes in behavior ( e.g. , activity , vitality , speech , sociability , and handwriting ) were measured on a @ - point rating scale .\n",
            "Results suggest an increase in activity and initiative in the drug groups , particularly in those receiving @ or @ mg/day , during treatment .\n",
            "Problems concerning some neuroleptic side effects are discussed .\n",
            "( German summary )\n",
            "This study investigated the relationship between erythrocyte membrane fatty acid ( FA ) levels and the severity of symptoms of individuals at ultra-high risk ( UHR ) for psychosis .\n",
            "Subjects of the present study consisted of @ neuroleptic-naive UHR patients .\n",
            "Partial correlation coefficients were calculated between baseline erythrocyte membrane FA levels , measured by gas chromatography , and scores on the Positive and Negative Syndrome Scale ( PANSS ) , Global Assessment of Functioning Scale , and Montgomery-Asberg Depression Rating Scale ( MADRS ) after controlling for age , sex , smoking and cannabis use .\n",
            "Subjects were divided into three groups according to the predominance of positive or negative symptoms based on PANSS subscale scores ; membrane FA levels in the three groups were then compared .\n",
            "More severe negative symptoms measured by PANSS were negatively correlated with two saturated FAs ( myristic and margaric acids ) , one omega-@ monounsaturated FA ( MUFA ; nervonic acid ) , and one omega-@ polyunsaturated FA ( PUFA ; docosapentaenoic acid ) , and were positively correlated with two omega-@ MUFAs ( eicosenoic and erucic acids ) and two omega-@ PUFAs ( gamma-linolenic and docosadienoic acids ) .\n",
            "More severe positive symptoms measured by PANSS were correlated only with nervonic acid .\n",
            "No associations were observed between FAs and MADRS scores .\n",
            "In subjects with predominant negative symptoms , the sum of the omega-@ MUFAs and the omega-@ : omega-@ FA ratio were both significantly higher than in those with predominant positive symptoms , whereas the sum of omega-@ PUFAs was significantly lower .\n",
            "In conclusion , abnormalities in FA metabolism may contribute to the neurobiology of psychopathology in UHR individuals .\n",
            "In particular , membrane FA alterations may play a role in negative symptoms , which are primary psychopathological manifestations of schizophrenia-related disability .\n",
            "Recruitment : Not yet recruiting .\n",
            "Conditions : Schizophrenia .\n",
            "Interventions : Drug : Pregnenolone | Drug : Placebo .\n",
            "Gender : Both .\n",
            "Age Groups : Adult .\n",
            "Enrollment : @ .\n",
            "Study Types : Interventional .\n",
            " Safety/Efficacy Study .\n",
            "Start Date : June @ .\n",
            "Completion Date : June @ .\n",
            "From the viewpoint of both primary and secondary care , what is the effect of a patient held shared record card on the pattern of service use and satisfaction with medical care for people with long term mental illness , compared to current practice ?\n",
            "Randomised controlled trial .\n",
            "Subjects will be randomised by GP practice using a minimisation method to balance intervention and control groups in terms of practice list size and primary diagnosis .\n",
            "The present state examination , a standardised psychiatric examination , will also be included as part of the assessment .\n",
            "Patients will be followed up for one year .\n",
            "A cost-effectiveness study concentrating on direct NHS costs expected to be affected by the card will also be performed .\n",
            "Participants : @ randomly selected patients entered on the North Birmingham Community District Mental Health Team 's \" community team case load census \" database .\n",
            "@ patients will be required for each arm of the study .\n",
            "To avoid contamination bias , patients in the study and control arm will be drawn from different general practices .\n",
            "Eligibility : All patients with more than @ years history of schizophrenia or other psychoses , severe personality disorder , or severe neurosis who require long-term supervision .\n",
            "Patients will be excluded if they have dimentia , or other brain disorder , alcohol or drug misuse , a learning diasability , are @ years or under , or @ year or older .\n",
            "Outcomes : Adherence with treatment ; Loss to follow up ; Satisfaction with medical care ; Number of psychiatric admissions/yearLength of inpatient stay\n",
            "BACKGROUND : Individuals with schizophrenia have functionally significant deficits in automatic and controlled social cognition , but no currently available pharmacologic treatments reduce these deficits .\n",
            "The neuropeptide oxytocin has multiple prosocial effects when administered intranasally in humans and there is growing interest in its therapeutic potential in schizophrenia .\n",
            "METHODS : We administered @ IU of oxytocin and saline placebo intranasally to @ male subjects with schizophrenia and @ age-matched , healthy controls in a randomized , double-blind , placebo-controlled , cross-over study .\n",
            "Social cognition was assessed with The Awareness of Social Inference Test ( TASIT ) and the Reading the Mind in the Eyes Test ( RMET ) .\n",
            "We examined the effects of oxytocin administration on automatic social cognition ( the ability to rapidly interpret and understand emotional cues from the voice , face , and body ) ; controlled social cognition ( the ability to comprehend indirectly expressed emotions , thoughts , and intentions through complex deliberations over longer time periods ) ; and a control task ( the ability to comprehend truthful dialog and perform general task procedures ) in individuals with and without schizophrenia using mixed factorial analysis of variance models .\n",
            "RESULTS : Patients with schizophrenia showed significant impairments in automatic and controlled social cognition compared to healthy controls , and administration of oxytocin significantly improved their controlled , but not automatic , social cognition , F ( @ , @ ) = @ ; p = @ .\n",
            "Conversely , oxytocin administration had limited effects on social cognition in healthy participants .\n",
            "Patients and controls performed equally well and there were no effects of oxytocin administration on the control task .\n",
            "DISCUSSION : Intact social cognitive abilities are associated with better functional outcomes in individuals with schizophrenia .\n",
            "Our data highlight the potentially complex effects of oxytocin on some but not all aspects of social cognition , and support the exploration of intranasal oxytocin as a potential adjunct treatment to improve controlled social cognition in schizophrenia .\n",
            "Objectives : To report the functional improvement results from an openlabel , randomized-controlled , relapse prevention trial ( ConstaTRE ) in stable patients with schizophrenia or schizoaffective disorder treated with risperidone long-acting injectable ( RLAI ) or the oral atypical antipsychotic quetiapine .\n",
            "Methods : Clinically stable adults with schizophrenia or schizoaffective disorder previously treated with oral risperidone , olanzapine , or oral conventional antipsychotics , in whom a switch in treatment was indicated , were randomized to treatment with either RLAI ( @ , @ , or @ mg every two weeks ) or quetiapine ( initiated at @   @ mg/day ) for @ months .\n",
            "Functional improvement was assessed using the Social and Occupational Functioning Assessment Scale ( SOFAS ) and two quality-of-life ( QoL ) measures ( Short-Form @ [ SF-@ ] and Schizophrenia Quality-of-Life Scale Revision @ [ SQLS-R@ ] ) .\n",
            "Results : @ subjects were randomized to treatment with RLAI or quetiapine ( n = @ patients/group ) .\n",
            "@ patients randomized to RLAI and @ patients randomized to quetiapine were included in the efficacy analyses .\n",
            "Baseline demographics were similar between treatment groups .\n",
            "Relapse occurred in @ % RLAI and @ % quetiapine patients .\n",
            "A total of @ RLAI and @ quetiapine patients dropped out of the study for other reasons than relapse , most commonly due to withdrawal of consent .\n",
            "A significant improvement in SOFAS , SF-@ , and SQLS-R@ scores was observed from baseline to month @ with both RLAI and quetiapine .\n",
            "At months @ , @ , and endpoint , SOFAS had significantly increased more for RLAI than quetiapine ( p < @ ) .\n",
            "Conclusions : Improvement in functional status and QoL from baseline was observed with both RLAI and quetiapine .\n",
            "Among stable patients with schizophrenia or schizoaffective disorder , the likelihood of functional improvement appears to be higher in those switching to RLAI .\n",
            "Background : This multicenter , open-label study compared the neurocognitive benefits , safety , and tolerability of aripiprazole , a novel dopamine-serotonin system stabilizer , with olanzapine , in outpatients with stable schizophrenia .\n",
            "Methods : Patients randomized to aripiprazole @ mg qd ( n = @ ) or olanzapine @ mg qd ( n = @ ) were assessed at baseline , and Weeks @ and @ ( or last visit ) .\n",
            "The neurocognitive battery was analyzed by @ factors : general cognitive functioning , executive functioning , and secondary verbal memory .\n",
            "Results : Aripiprazole produced statistically significant improvements from baseline in secondary verbal memory at Weeks @ and @ ( both p < @ ) , which were significantly greater than olanzapine .\n",
            "Both aripiprazole and olanzapine produced a statistically significant improvement at Week @ in general cognitive functioning ( p < @ ) , and a trend toward improvement at Week @ ( p < @ ) .\n",
            "There were no significant changes in executive functioning for either medication .\n",
            "Clinical improvement was not significantly different between the @ groups .\n",
            "The three most prevalent adverse events with aripiprazole were insomnia , nausea , and somnolence , and with olanzapine were weight gain , somnolence and headache .\n",
            "Olanzapine was associated with a greater incidence of weight gain ( @ % ) than aripiprazole ( @ % ) .\n",
            "Olanzapine produced significant increases in cholesterol levels compared to aripiprazole .\n",
            "Conclusions : Aripiprazole appeared to be associated with specific benefits in secondary verbal memory , as well as significantly less weight gain than olanzapine .\n",
            "Background : Relapse rates are high in patients with first-episode psychosis ( FEP ) even in specialized early intervention services .\n",
            "Risk factors associated with relapse have not been properly determined .\n",
            "Objective : Our purpose was to identify factors associated with relapse after a first episode of psychosis .\n",
            "Method : We analyzed sociodemographic and clinical data from a cohort of @ patients treated in a specialized early intervention service during a @-year follow up .\n",
            "These data were collected as part of a prospective , randomized , open-label study conducted from February @ to February @ .\n",
            "We performed univariate analyses followed by logistic regression and survival analyses on a sample of patients at risk of relapse after their FEP .\n",
            "The variables analyzed included gender , age at onset , duration of untreated psychosis ( DUP ) , initial ratings on the Scale for Assessment of Positive and Negative Symptoms ( SAPS and SANS ) , premorbid adjustment , social functioning , cannabis use , family history of psychosis and adherence to medication .\n",
            "Results : Twenty-five of the @ initial patients , dropped out the program and @ entered the prescribed discontinuation treatment program .\n",
            "Eightysix ( @ % ) of the @ remaining patients relapsed over the period of three years .\n",
            "The rate of medication adherence was @ % .\n",
            "We found a statistically significant association between rate of relapse and medication non-adherence ( odds ratio ( OR ) @ , @ % confidence interval ( CI ) @-@ , P = @ ) .\n",
            "Positive family history of psychosis is also associated significatively with a higher rate of relapse ( odds ratio ( OR ) @ , @ % confidence interval ( CI ) @-@ , P = @ ) .\n",
            "Comparison of time to relapse between adherent and non-adherent patients revealed also statistically significant differences ( mean = @ , SD = @ and mean = @ , SD = @ days respectively ) .\n",
            "Despite having been related to relapse previously , we have not found that substance use , premorbid adjustment or duration of untreated psychosis increase the risk of relapse .\n",
            "Conclusions : Non-adherence to medication is the most important factor associated with relapse after a first episode of psychosis , but there are other factors , such as the presence of family history of psychosis , that increase the risk of relapse and could explain the occurrence of relapse in some adherent patients .\n",
            "The use of combinations of antipsychotic drugs is a common clinical practice worldwide , with prevalence @-@ % depending on country of origin .\n",
            "Prescribers report failure to respond to monotherapy as the primary indication for antipsychotic polypharmacy , and that improvement in positive symptoms is the main benefit .\n",
            "However , there are few randomized , placebo-controlled clinical trials of antipsychotic polypharmacy .\n",
            "In a study of patients with incomplete response to clozapine ( n = @ ) , we compared risperidone with placebo augmentation of continued clozapine treatment ( Honer et al. , @ ) .\n",
            "Both groups of subjects improved during the trial , there was no difference in beneficial effects between risperidone and placebo .\n",
            "Continued treatment with open-label risperidone for an additional @ weeks did not show a difference between groups initially randomized to risperidone or placebo .\n",
            "While there were few changes in side effects experienced during the study , the group augmented with risperidone had a statistically significant increase in fasting blood glucose ( p < @ ) , and somewhat poorer verbal working memory ( p < @ ) after @ weeks .\n",
            "This study indicates no benefit of risperidone augmentation of clozapine , and that if a benefit were to be demonstrated in a larger sample , the effect size would likely be small .\n",
            "The results of three smaller studies using a similar placebo-controlled design will be reviewed and integrated with our findings .\n",
            "The possible implications of widespread use of antipsychotic polypharmacy include possible delay in using clozapine for patients who have an incomplete treatment response to other drugs .\n",
            "EDUCATIONAL OBJECTIVE : At the conclusion of this presentation , the participant will be familiar with clinical trial data concerning efficacy of essential fatty acids as a treatment for SCHIZophrenia and major affective disorders .\n",
            "SUMMARY : Background : Most patients with SCHIZophrenia experience disabling residual symptoms and cognitive impairment despite medication .\n",
            "Open and small DOUBLE-blind studies suggest adding omega-@ fatty acids to neuroleptic medications may enhance treatment response and improve residual symptoms .\n",
            "Methods : Patients ( N = @ ) meeting criteria for SCHIZophrenia / SCHIZoaffective disorder who had significant residual symptoms of PSYCHOSIS despite adequate neuroleptic treatment were RANDOMized to eicosapentaenoic acid ( EPA ) @ gms daily ( N = @ ) or placebo ( N = @ ) in a @-week , DOUBLE-blind , supplementation trial .\n",
            "Clinical assessments were performed at baseline and weeks @ , @ , @ , @ , @ , and @ ; cognitive battery at baseline and week @ .\n",
            "Results : Data for the intention-to-treat sample indicated baseline to week @ mean total PANSS change score was -@ + @ ( -@ % ) for EPA and -@ + @ for placebo patients ; mean CGI-I score at week @ ( @ + - @ ) was identical for both groups .\n",
            "MANOVA indicated small statistically significant symptom improvement for both groups , but no time by treatment-group interaction .\n",
            "No difference was found between groups in cognitive tests or in any other clinical measure .\n",
            "Results were similar for the intention-to-treat ( N = @ ) and completer ( N = @ ) samples .\n",
            "Conclusion : Results indicate EPA @ gms daily for @ weeks is no more effective than placebo in improving residual symptoms and cognitive impairments in treated patients with chronic SCHIZophrenia .\n",
            "Further research is needed to evaluate potential treatment effects over longer periods and at earlier phases of illness .\n",
            "CN : No. @ PT : CSG CODE conference USA\n",
            "Background : Weight gain increases risk of cardiovascular disease and diabetes , and has been reported in clinical trials of several antipsychotics .\n",
            "This analysis evaluated long-term weight profile of the investigational partial dopamine agonist bifeprunox in stable schizophrenia .\n",
            "Methods : @ patients with stable schizophrenia were randomized to once-daily bifeprunox @ mg , @ mg , or placebo .\n",
            "Weight and body mass index ( BMI ) were measured at baseline , week @ , month @ and month @ ( or early termination ) .\n",
            "Results : Bifeprunox @ and @ mg resulted in greater raw mean decreases in weight than placebo at endpoint (  @ kg ,  @ kg ,  @ kg , respectively ) .\n",
            "Adjusted mean weight changes ( observed cases ) at month @ showed decreases in all groups ( bifeprunox @ mg ,  @ kg ; @ mg ,  @ kg ; placebo ,  @ kg ) .\n",
            "Patients given bifeprunox @ mg had significantly greater decrease in body weight and BMI versus placebo patients , respectively ( weight :  @ kg versus  @ kg , P = @ ; BMI :  @ kg/m@ versus  @ kg/m@ , P = @ ; last observation carried forward ) .\n",
            "Most common adverse events ( AEs ) with bifeprunox (  @ % and  @X placebo ) were nausea , vomiting , dizziness , anorexia , akathisia , dyskinesia and asthenia .\n",
            "Weight decreases occurred irrespective of nausea and vomiting .\n",
            "A similar proportion of patients withdrew due to AEs in the bifeprunox @ mg and placebo groups , while more withdrew in the bifeprunox @ mg group .\n",
            "Conclusions : In this study , decreases in body weight and BMI were observed over @ months in patients treated with bifeprunox .\n",
            "Supported by H. Lundbeck A/S , Solvay Pharmaceuticals , Inc. , Wyeth Research\n",
            "The Connecticut Department of Mental Health began creating assertive community treatment teams in @ .\n",
            "The authors describe the approach taken by the department in defining the assertive community treatment model , in creating new assertive community treatment teams , and in monitoring the creation and functioning of these teams to ensure that fidelity to the assertive community treatment model is maintained .\n",
            "Assertive community treatment teams can be created even in the absence of funding for new staff by reconfiguring current community-based staff and by moving staff from state hospitals to the community .\n",
            "Preliminary data from a randomized trial in Connecticut comparing assertive community treatment with high-quality case management in areas with an array of community services indicated that the intended models were replicated , with variations in practice style across programs .\n",
            "Clients in assertive community treatment were in the hospital about half as often as clients in standard services and were also less likely to be without a permanent residence .\n",
            "Training and ongoing monitoring of assertive community treatment teams are necessary to detect practices that diverge from the intervention model so that corrective action can be taken .\n",
            "OBJECTIVES : The efficacy of cognitive behaviour therapies for psychosis ( CBTp ) has been sufficiently established for its inclusion in some national treatment guidelines .\n",
            "However , treatment efficacy does not guarantee effectiveness in routine practice , where clinician expertise and patient mix may be different .\n",
            "Thus , we evaluated the applicability , acceptability and effectiveness of CBTp when offered routinely in a public mental health service .\n",
            "DESIGN : A prospectively recruited representative sample ( N = @ ) of patients with psychotic disorders from a geographic catchment area in Melbourne , Australia , was randomized to CBTp or treatment as usual .\n",
            "METHOD : The CBTp intervention included psychoeducation , positive symptom , and co-morbid problem components .\n",
            "Therapists collaboratively negotiated goals with patients and utilized treatment components from a manual .\n",
            "Intention-to-treat analyses used data at baseline , @ months and @ months .\n",
            "RESULTS : Working alliance and client satisfaction measures indicated excellent acceptability .\n",
            "Both groups improved to a similar degree on the Positive And Negative Syndrome Scale , with no advantage for the CBTp group .\n",
            "The most frequent CBTp components implemented were co-morbid disorders/personal issues and personalized psychoeducation ; working with persisting symptoms was the main focus in relatively few sessions .\n",
            "CONCLUSIONS : The lack of advantage for the CBTp group may be due to : the infrequent focus on positive symptoms ( the most replicated outcome domain for CBTp ) ; the unselected nature of the patients ( rather than those with distressing symptoms or referred by clinicians ) ; or , to insufficient therapist expertise .\n",
            "Although the efficacy of the treatment of a variety of antipsychotic drugs on negative symptoms of schizophrenia in varying degrees , but the effects are not very satisfactory , is still not resolved the clinical problem .\n",
            "In recent years , has been reported with selective serotonin reuptake inhibitors combined antipsychotic treatment of negative symptoms of schizophrenia , which combined fluoxetine by more reports .\n",
            "In order to investigate the efficacy of two drugs with the treatment of negative symptoms of schizophrenia , of Paroxetine with antipsychotics , schizophrenic patients with predominantly negative symptoms , efficacy , and for open controlled study , the results reported as follows .\n",
            "@ Data @ subjects :  inclusion criteria : meet the diagnostic criteria of schizophrenia , mental illness classification scheme and diagnostic criteria of the second edition revised ( CCMD @ R ) ; Negative Syndrome Scale ( SAN .\n",
            ".\n",
            ".\n",
            "Objective To investigate the impact of quetiapine and clozapine on efficacy and cognitive function in schizophrenia .\n",
            "The methods conform Ccmd-@ diagnostic criteria for schizophrenia @ patients randomly divided into quetiapine group ( @ patients ) , clozapine group ( n = @ ) for @ weeks .\n",
            "Before treatment and @ weeks , respectively Wechsler Adult Intelligence Scale ( wais-r ) , Wechsler Memory Scale ( wms ) and the WCST ( wcst ) .\n",
            "Results Before treatment , patients had cognitive impairment , @ Zhou Houkui quetiapine and clozapine patients achievements are obvious .\n",
            "The quetiapine group improved significantly better than the clozapine group .\n",
            "This study aimed to test the effectiveness of a nurse-led structured psychosocial intervention program in Chinese patients with first-onset mental illness .\n",
            "A single-blind , parallel group , randomized controlled trial design was used .\n",
            "The study involved @ participants with mild to moderate-severe symptoms of psychotic or mood disorders who were newly referred to two psychiatric outpatient clinics in Hong Kong .\n",
            "Patients were randomly assigned to either an eight-session nurse-led psychosocial intervention program ( plus usual care ) or usual psychiatric outpatient care ( both n = @ ) .\n",
            "The primary outcome was psychiatric symptoms .\n",
            "Outcomes were measured at recruitment , one week and @ months post-intervention .\n",
            "Patients in the psychosocial intervention group reported statistically significant improvements in symptoms compared to treatment as usual .\n",
            "There were also significant improvements in illness insight and perceived quality of life and reduction in length of re-hospitalizations over the @-month follow-up .\n",
            "The findings provide evidence that the nurse-led psychosocial intervention program resulted in improved health outcomes in Chinese patients with first-onset mental illness .\n",
            "Despite public health efforts , individuals with serious mental illness ( SMI ) still have very high rates of tobacco smoking .\n",
            "Innovative approaches to reach this population are needed .\n",
            "These series of case studies aimed to descriptively evaluate the usability , user experience ( UX ) , and user engagement ( UE ) of Learn to Quit ( LTQ ) , an acceptance and commitment therapy smoking cessation app designed for people with SMI , and to compare it with an app designed for the general population , NCI ( National Cancer Institute ) QuitGuide ( QG ) .\n",
            "Both apps were combined with nicotine replacement therapy and technical coaching .\n",
            "Inspired by the ORBIT model , we implemented two case studies with crossover AB interventions , two B-phase training designs , and three bi-phasic AB single-case designs with Start-Point and Order randomization ( A = QG , B = LTQ ) .\n",
            "Study outcomes were measured using the System Usability Scale , UX interviews , and background analytics .\n",
            "LTQ 's usability levels were above the standard cutoff and on average higher than QG .\n",
            "UX outcomes suggested the relative benefits of LTQ 's visual design , gamification and simple design structure .\n",
            "LTQ 's overall UE was high ; the app was opened for an average of @ min per day ( vs. QG : @ min ) .\n",
            "However , users showed low levels of UE with each of the app 's tracking feature .\n",
            "Measures of psychiatric functioning suggested the safety of LTQ in people with SMI .\n",
            "LTQ appears to be a usable and engaging smoking cessation app in people with SMI .\n",
            "An optimized version of LTQ should be tested in a Phase II study .\n",
            "Background : Cognitive effects are among the most important adverse effects of electroconvulsive therapy ( ECT ) .\n",
            "Little is known about the course of cognitive effects in schizophrenia patients who receive ECT .\n",
            "Methods : We examined the persistence of cognitive impairments in a sub-sample of patients ( n = @ ) with schizophrenia who had earlier participated in a clinical trial comparing bi-frontal ( BFECT ; n = @ ) and bi - temporal ( BTECT ; n = @ ) electrode placements .\n",
            "Performance on Hindi Mental State Examination and tests for processing speed , sustained attention , working memory and verbal fluency was assessed at two points : At the end of ECT course and at follow-up after a mean ( SD ) of @ ( @ ) days .\n",
            "The course of cognitive impairments was assessed in BFECT and BTECT patients using Repeated measures ANOVA ( RMANOVA ) .\n",
            "Proportion of patients scoring below respective norms for the cognitive tests at the two assessment points was compared using Mc-Nemar test .\n",
            "Results : Performance on all cognitive tests showed significant improvement at follow-up for all patients ( n = @ ; time effect on RMANOVA : P < @ for all tests ) .\n",
            "Time X Group interaction effect was significant ( RMANOVA : Interaction effect P < @ ) for HMSE and spatial span tests , suggesting that BTECT patients ' cognitive performance improved to catch up with that of BFECT patients .\n",
            "In the entire sample , there was a significant decline in the proportion of patients scoring below the norm in most of the tests ( Mc-Nemar test ; P < @ for all tests except verbal fluency ) .\n",
            "Conclusions : In patients with schizophrenia , cognitive performance improves substantially by the end of three months post-ECT .\n",
            "Improvement occurs irrespective of the electrode placements in bilateral ECT .\n",
            "Objective To investigate the effect of nursing intervention of the menstrual period , the condition of the female patients with schizophrenia .\n",
            "@ female patients with schizophrenia were randomly divided into the study group and the control group , @ patients in both groups received conventional drug therapy , the research group also increased nursing intervention .\n",
            "The two groups of patients enrolled and the menstrual period to receive positive and negative syndrome scale ( PANSS ) , the Clinical Global Impression Scale ( cg i ) the assessment of the hospital for observation scale ( nosie ) .\n",
            "The results intervention before patients within a week of the arrival of the menstrual period , panss , cg i and the nosie scale score is compared with the statistical analysis , all p > @ , the difference was not statistically significant .\n",
            "Patients panss , cg i and nosie scale score after the intervention compared with the statistical analysis , all p < @ , the difference was statistically significant .\n",
            "Objective : The study aimed to compare the efficacy and tolerability of oral risperidone and oral clonazepam with intramuscular haloperidol and oral clonazepam in Filipino patients with acute psychotic agitation .\n",
            "Methods : This study used a prospective randomized design targeting patients who were referred to the emergency department or hospital inpatients exhibiting both psychosis and agitation .\n",
            "Patients were randomized into oral risperidone group or intramuscular haloperidol group .\n",
            "Both groups received oral clonazepam as part of treatment .\n",
            "Patients were observed for @ hours .\n",
            "The main efficacy parameter was the PANSS agitation cluster score .\n",
            "Other parameters were total PANSS , other PANSS subscale scores , time and incidence of additional clonazepam usage .\n",
            "The safety parameter measured as incidence of adverse events .\n",
            "Results : There were @ subjects enrolled in the study : @ in the oral risperidone arm and @ in the intramuscular haloperidol arm .\n",
            "There were significant reductions in the mean PANSS agitation cluster scores for both groups : -@ + / - @ for oral risperidone group ( p < @ ) and -@ + / - @ for intramuscular haloperidol group ( p < @ ) .\n",
            "There was no statistical difference observed in the mean change in PANSS agitation cluster scores among the two groups ( p = @ ) .\n",
            "Similar trends were observed in the total PANSS and other subscale scores .\n",
            "The incidence of additional clonazepam use is numerically higher in the oral risperidone arm than the intramuscular haloperidol arm ( @ % vs. @ % ) , but the difference did not attain statistical significance ( p = @ ) .\n",
            "At the end of the study , @ ( @ % ) and @ ( @ % ) of patients in the risperidone and haloperidol groups experienced varying degrees of sedation .\n",
            "No serious adverse event was reported .\n",
            "Conclusion : Oral risperidone is comparable to intramuscular haloperidol in the treatment of acute psychotic agitation in terms of efficacy and safety .\n",
            "( PsycINFO Database Record ( c ) @ APA , all rights reserved ) ( journal abstract )\n",
            "Ziprasidone 's high affinity for @HT@A receptors and moderate affinity for D@ receptors suggest significant antipsychotic efficacy with low extrapyramidal side-effect liability .\n",
            "This @-week , double-blind , placebo-controlled multicenter study was designed to compare the safety , toleration and efficacy of two fixed-dose regimens of ziprasidone in subjects with an acute exacerbation of schizophrenia or schizo-affective disorder .\n",
            "After a @ to @-day placebo washout , patients were randomized to receive either ziprasidone @ mg bid on days @ to @ ( @ patients ) ; ziprasidone @ mg bid on days @ to @ , followed by @ mg bid on days @ to @ ( @ patients ) ; or placebo ( @ patients ) .\n",
            "On day @ , subjects received a single morning dose .\n",
            "Both the @ mg and @ mg dose groups demonstrated statistically significant changes from baseline in BPRSd total , BPRSd core items , CGI severity and PANSS total scores .\n",
            "All differences were statistically significant .\n",
            "Measurement of negative symptoms by the PANSS negative subscale also showed statistically significant differences between both ziprasidone groups and placebo .\n",
            "Side-effects were limited in both the @ mg and @ mg groups .\n",
            "This indicates that ziprasidone at doses of @ mg and @ mg daily is an effective and well - tolerated antipsychotic .\n",
            "Last visit change in Primary Efficacy Scores ( All Subjects , Last Observation Carried Forward ) Ziprasidone Ziprasidone Placebo @ mg bid @ mg bid BPRSd - total -@ * -@ ** -@ BPRSd - core -@ * -@ ** -@ CGI - severity -@ * -@ ** -@ PANSS - total -@ * -@ ** -@ PANSS - negative -@ * -@ ** -@ subscale * p < @ ** p < @ The author thanks the Ziprasidone Study Group for participation in this study .\n",
            "Design/methodology Randomised controlled trial with blind assessment of outcome Topic/objectives/aim @ .\n",
            "To investigate the determinants of psychotic patients ' adherence to prescribed neuroleptic medication @ .\n",
            "To compare two different approaches to enhancing patients ' adherence to prescribed neuroleptic medication Inclusion/exclusion criteria Patients suffering from DSM-IV schizophrenia or schizoaffective disorder admitted to acute psychiatric wards in the North West of England and North Wales Groups/interventions @ ) Compliance intervention ( patients educated about benefits of neuroleptic medication ) @ .\n",
            "Alliance intervention ( structured intervention in which patients are encouraged to rationally appraise the costs and benefits of their neuroleptic medication @ .\n",
            "Treatment as usual Endpoints/primary outcomes Primary outcomes are :( I ) attitudes towards neuroleptic medication as measured by the Drug Attitudes Inventory ; ( ii ) psychotic symptoms as measured by the Positive and Negative Syndromes Scale Sample size @ + ( we have in fact recruited @ ) Follow up @ months and @ year after the completion of the intervention or equivalent time in treatment as usual group\n",
            "Hyperprolactinemia is frequent in patients with schizophrenic psychoses .\n",
            "It is usually regarded as an adverse effect of antipsychotics but has recently also been shown in patients without antipsychotic medication .\n",
            "Our objective was to test whether hyperprolactinemia occurs in antipsychotic-naive first-episode patients ( FEPs ) .\n",
            "In the framework of the European First Episode Schizophrenia Trial ( EUFEST ) , @ out of @ FEPs were eligible for this study , of whom @ were antipsychotic naive .\n",
            "All patients were investigated regarding their serum prolactin levels with immunoassays standardized against the @rd International Reference Standard @/@ .\n",
            "Twenty-nine ( @ % ) of the @ antipsychotic-naive patients showed hyperprolactinemia not explained by any other reason , @ ( @ % ) of @ women and @ ( @ % ) of @ men .\n",
            "Hyperprolactinemia may be present in patients with schizophrenic psychoses independent of antipsychotic medication .\n",
            "It might be stress induced .\n",
            "As enhanced prolactin can increase dopamine release through a feedback mechanism , this could contribute to explaining how stress can trigger the outbreak of psychosis .\n",
            "Introduction : This was a @-week , double-blind , randomized study ( D@C@ ) comparing efficacy and tolerability of quetiapine sustained release ( SR ) with placebo .\n",
            "Methods : @ patients with acute DSM IV schizophrenia ( PANSS total score  @ ; CGI-S  @ ) were randomized to fixed dose quetiapine SR @ , @ or @ mg/day ( placebo in the morning , active dose in the evening ) , quetiapine immediate release ( IR ) @ mg/day ( @ mg twice-daily ) , or placebo ( twice-daily ) .\n",
            "Quetiapine SR was initiated at @ mg on Day @ ; target doses were reached by Day @ ( SR @ and @ mg ) , Day @ ( SR @ mg ) , and Day @ ( IR @ mg ) .\n",
            "Primary endpoint : change from baseline to Day @ in PANSS total score ( LOCF ) , analyzed using ANCOVA .\n",
            "OC analysis also performed .\n",
            "Secondary endpoints ( to Day @ ) included : PANSS response rates ( percent of patients with  @ % reduction in total score from baseline ) ; percent of patients with CGI-I rating  @ ; change in CGI-S , incidence of AEs .\n",
            "Results : @ patients ( @ % ) completed the study ( @ % placebo ; @-@ % SR ; @ % IR ) .\n",
            "PANSS total score decreased significantly in all groups compared with placebo ( LOCF [ table ] ) .\n",
            "Furthermore , OC analysis also demonstrated efficacy versus placebo .\n",
            "Statistical separation from placebo was shown for PANSS response rates and percent of patients with CGI-I  @ .\n",
            "Improvement in CGI-S was statistically significant for quetiapine SR @ mg ( p = @ ) , @ mg ( p < @ ) , and quetiapine IR ( p = @ ) versus placebo .\n",
            "The tolerability profile of quetiapine SR was consistent with the known profile for quetiapine IR .\n",
            "Most AEs with quetiapine SR were mild to moderate in severity .\n",
            "The most common AEs with SR and IR were somnolence and dizziness .\n",
            "Incidences of somnolence were : @ % to @ % ( quetiapine SR ) , @ % ( IR ) and @ % ( placebo ) ; and dizziness : @ % to @ % , @ % and @ % , respectively .\n",
            "Four patients discontinued due to AEs in the first week ( two with SR [ @ and @ mg ] ; two with IR ) .\n",
            "Incidence of EPS-related AEs was similar to placebo .\n",
            "Conclusions : Once-daily quetiapine SR ( @ to @ mg ) was effective in patients with acute schizophrenia compared with placebo .\n",
            "Rapid dose escalation of quetiapine SR ( @ mg Day @ , @ mg Day @ , @ mg Day @ ) was well tolerated , with a therapeutically effective dose reached by Day @ .\n",
            "Objective To evaluate aripiprazole efficacy and compliance of schizophrenia .\n",
            "@ patients with schizophrenia were randomly divided into two groups , with Chengdu Great Southwest Pharmaceutical Co. , Ltd .\n",
            "Of aripiprazole in the treatment of @ cases with Xi'an Janssen risperidone treatment of @ cases , positive symptom scale and negative Syndrome Scale ( PANSS ) and the side effects of scale ( TESS ) to evaluate the efficacy and adverse reactions .\n",
            "The aripiprazole group efficiency of @ % , with a significant @ % efficiency ; risperidone group was @ % , effective rate of @ % .\n",
            "Both efficacy is similar , the difference was not significant ( P > @ ) Aripiprazole group Bili Pei ketone group better compliance .\n",
            "Conclusions Aripiprazole is an antipsychotic drug safe and effective and have fewer side effects .\n",
            "< > Acute phase of acute schizophrenia performance hallucinations delusions , excitement irritability , hostility uncooperative seriously affect the safety of patients and caregivers as well as the condition of effective intervention , rapid control of symptoms of excitement acute phase treatment focus .\n",
            "The previous high titer the traditional antipsychotic multi become the drug of choice to control the symptoms of excitement [ @ ] .\n",
            "There is a lack of controlled trials examining the effectiveness of electroconvulsive therapy ( ECT ) combined with olanzapine or risperidone in treatment-resistant schizophrenia ( TRS ) .\n",
            "The authors conducted a prospective , open , controlled trial of ECT in TRS in a long-term psychiatric rehabilitation unit in Hong Kong .\n",
            "Thirty patients with TRS from an inpatient psychiatric rehabilitation unit participated in this study .\n",
            "All subjects were resistant to a host of antipsychotic medications given singly or in different combinations .\n",
            "In addition , they were also resistant to or they refused clozapine treatment .\n",
            "Fifteen patients completed a course of ECT consisting of @-@ sessions .\n",
            "Fifteen patients who refused ECT formed the control Subjects were assessed at baseline , @ week , @ month , and @ months after their last ECT .\n",
            "Assessment instruments included the Brief Psychiatric Rating Scale ( BPRS ) , Hamilton Depression Rating Scale ( HDRS ) , Scale for the Assessment of Negative Symptoms ( SANS ) , Global Assessment Scale ( GAS ) , Clinical Global Impression ( CGI ) , CGI Severity of Illness [ CGI ( SOI ) ] , CGI Global Improvement [ CGI ( GI ) ] , Nurses ' Observation Scale for Inpatient Evaluation ( NOSIE-@ ) , and occupational therapists ' rating of the subjects ' functioning with respect to work ( OT-W ) , social ( OT-S ) , and leisure ( OT-L ) activities .\n",
            "In comparison with the control group , the ECT group showed statistically significant improvement only in the GAS and CGI at each posttreatment evaluation .\n",
            "There was a trend for ECT to reduce positive and negative symptoms , although the rate of improvement did not reach statistically significant levels .\n",
            "ECT augmentation of risperidone and olanzapine is of marginal efficacy compared to reports of the greater augmentation of these antipsychotics with other agents .\n",
            "INTRODUCTION : Activation of metabotropic glutamate ( mGluR@/@ ) receptors has been proposed as an alternative mechanism to dopaminergic-based antipsychotics to correct glutamatergic deficits hypothesized to underlie schizophrenia symptoms .\n",
            "This study investigates the efficacy and safety of AZD@ , a selective positive allosteric modulator ( PAM ) at the mGlu@ receptor , in symptomatic patients with schizophrenia .\n",
            "METHODS : Patients were randomized to receive AZD@ @ mg , risperidone @ mg , or placebo as monotherapy .\n",
            "Treatment lasted for @ days , and clinical efficacy was assessed using Positive and Negative Syndrome Scale ( PANSS ) and Clinical Global Impression ( CGI ) scores .\n",
            "RESULTS : There were no significant differences between patients treated with AZD@ versus placebo in change from baseline to endpoint in PANSS total , negative and positive symptom subscale , or CGI-S scores .\n",
            "In contrast , risperidone demonstrated significant efficacy relative to placebo .\n",
            "CONCLUSION : These results do not support a role for the mGluR-@ PAM AZD@ as an antipsychotic and indicate that positive modulation of mGluR type @ receptors alone is not sufficient for antipsychotic effects in acutely ill schizophrenia patients .\n",
            "BACKGROUND : Children born to parents with a severe mental illness , like schizophrenia , bipolar disorder , or major recurrent depression , have an increased risk of developing a mental illness themselves during life .\n",
            "These children are also more likely to have developmental delays , cognitive disabilities , or social problems , and they may have a higher risk than the background population of experiencing adverse life events .\n",
            "This is due to both genetic and environmental factors , but despite the well-documented increased risk for children with a familial high risk , no family-based early intervention has been developed for them .\n",
            "This study aims to investigate the effect of an early intervention that focuses on reducing risk and increasing resilience for children in families where at least one parent has a severe mental illness .\n",
            "METHODS/DESIGN : The study is a randomized clinical trial with @ children aged @-@ with familial high risk .\n",
            "It is performed in the context of the Danish health-care system .\n",
            "Families will be recruited from registers or be referred from the primary sector or hospitals .\n",
            "The children and their parents will be assessed at baseline and thereafter randomized and allocated to either treatment as usual or VIA Family .\n",
            "The intervention group will be assigned to a multidisciplinary team of specialists from adult mental health services , child and adolescent mental health services , and social services .\n",
            "This team will provide the basic treatment elements : case management , psychoeducation for the whole family , parental training , a safety plan , and potentially an early intervention if the child has mental problems .\n",
            "The study period is @ months for both groups , and all participants will be assessed at baseline and after @ months .\n",
            "The primary outcome measure will be daily functioning of the child , and the secondary measures are the psychopathology of the child , days of absence from school , family functioning , child 's home environment , and parental stress .\n",
            "DISCUSSION : This study is to our knowledge the first to explore the effects of a multidisciplinary team intervention that provides an intensive and flexible support to match the families ' needs for children with a familial high risk for severe mental illness .\n",
            "The study will provide important knowledge about the potential for increasing resilience and reducing risk for children by supporting the whole family .\n",
            "However , a longer follow-up period may be needed .\n",
            "TRIAL REGISTRATION : ClinicalTrials.gov , NCT@ .\n",
            "Registered on @ April @ .\n",
            "We undertook this study to determine whether predictors of positive placebo response in chronic schizophrenic outpatients could be identified .\n",
            "Twelve placebo responders and @ placebo nonresponders who participated in a parallel-group , double-blind , @-week clinical drug trial were compared .\n",
            "No significant differences between the groups were found with regard to @ anamnestic and symptom variables .\n",
            "To investigate further which variables at baseline predicted positive placebo response , a stepwise linear regression model was created .\n",
            "Of the seven variables entered into the model , only high scores in the positive domain of the Positive and Negative Syndrome Scale ( delusions , unusual thought content , grandiosity , and suspiciousness/persecution ) at baseline predicted significantly positive placebo response ( p = .@ ) .\n",
            "Because the onset of placebo response was gradual , the authors hypothesize that placebo response in chronic schizophrenia consists mainly of two ingredients : nonspecific psychotherapeutic effect caused by the several assessments carried out during the study , and regression toward the mean .\n",
            "Deficiency of certain vitamins , and especially from the  B  complex , can produce symptoms of psychiatric disorder .\n",
            "Vitamin B@ , or pyridoxine plays an intrinsic role in the synthesis of certain neurotransmitters which take part in development of psychotic states .\n",
            "There are a number reports that vitamin B@ may be a factor in a number of psychiatric disorders , such as autism , Alzheimer s disease , hyperactivity , learning disability , anxiety disorder and depression .\n",
            "Moreover , there are anecdotal reports of a reduction in psychotic symptoms after vitamin B@ supplementation of psychopharmacologic treatment of patients suffering from schizophrenia or organic mental disorder .\n",
            "The aim of this study was to systematically examine whether vitamin B@ therapy influences psychotic symptoms in patients suffering from schizophrenia and schizoaffective disorder .\n",
            "The effect of the supplementation of vitamin B@ to antipsychotic treatment on the positive and negative symptoms in @ schizophrenic and schizoaffective patients were examined in a double-blind , placebo controlled , crossover study spanning @ weeks .\n",
            "All patients had stable psychopathology for at least a month before entry into the study and were maintained on their pre-study psychoactive and antiparkinsonian medications throughout the study .\n",
            "All patients were assessed by Positive and Negative Syndrome Scale for Schizophrenia ( PANSS ) on weekly base .\n",
            "The patients randomly received increasing doses of vitamin B@ or placebo at @ mg/day for the first week , @ mg/day for the second week , @ mg/day for the third week and @ mg/day for the fourth week .\n",
            "PANSS scores revealed no differences between vitamin B@ and placebo-treated patients in amelioration of their mental state .\n",
            "BACKGROUND : Auditory hallucinations are resistant to pharmacotherapy in about @ % of adults with schizophrenia .\n",
            "Treatment with noninvasive brain stimulation would provide a welcomed additional tool for the clinical management of auditory hallucinations .\n",
            "A recent study found a significant reduction in auditory hallucinations in people with schizophrenia after five days of twice-daily transcranial direct current stimulation ( tDCS ) that simultaneously targeted left dorsolateral prefrontal cortex and left temporo-parietal cortex .\n",
            "HYPOTHESIS : We hypothesized that once-daily tDCS with stimulation electrodes over left frontal and temporo-parietal areas reduces auditory hallucinations in patients with schizophrenia .\n",
            "METHODS : We performed a randomized , double-blind , sham-controlled study that evaluated five days of daily tDCS of the same cortical targets in @ outpatients with schizophrenia and schizoaffective disorder with auditory hallucinations .\n",
            "RESULTS : We found a significant reduction in auditory hallucinations measured by the Auditory Hallucination Rating Scale ( F@ ,@ = @ , P < @ ) that was not specific to the treatment group ( F@ ,@ = @ , P = @ ) .\n",
            "No significant change of overall schizophrenia symptom severity measured by the Positive and Negative Syndrome Scale was observed .\n",
            "CONCLUSIONS : The lack of efficacy of tDCS for treatment of auditory hallucinations and the pronounced response in the sham-treated group in this study contrasts with the previous finding and demonstrates the need for further optimization and evaluation of noninvasive brain stimulation strategies .\n",
            "In particular , higher cumulative doses and higher treatment frequencies of tDCS together with strategies to reduce placebo responses should be investigated .\n",
            "Additionally , consideration of more targeted stimulation to engage specific deficits in temporal organization of brain activity in patients with auditory hallucinations may be warranted .\n",
            "For persons with psychiatric disabilities , maintaining a job is often more difficult than acquiring a job .\n",
            "A large proportion of jobs end unsatisfactorily .\n",
            "This study explored job terminations among @ persons with severe mental illness who participated in competitive jobs through supported employment programs .\n",
            "More than half of the job terminations were unsatisfactory , defined as the client quitting without having other job plans or being fired .\n",
            "Baseline ratings of demographic and clinical characteristics , preemployment skills training , and early ratings of job satisfaction and work environment did not predict unsatisfactory terminations .\n",
            "Clients with better work histories were less likely to experience unsatisfactory terminations .\n",
            "In addition , unsatisfactory terminations were associated retrospectively with multiple problems on the job that were related to interpersonal functioning , mental illness , dissatisfaction with jobs , quality of work , medical illnesses , dependability , and substance abuse .\n",
            "These results suggest that supported employment programs need to address job maintenance with interventions that identify and address different types of difficulties as they arise on the job .\n",
            "OBJECTIVE : This study sought to determine differences in the cost-effectiveness of two vocational programs : individual placement and support ( IPS ) , in which employment specialists within a mental health center help patients obtain competitive jobs and provide them with ongoing support , and enhanced vocational rehabilitation ( EVR ) , in which stepwise services that involve prevocational experiences are delivered by rehabilitation agencies .\n",
            "METHODS : A total of @ unemployed inner-city patients with severe mental disorders who expressed an interest in competitive employment were RANDOMly assigned to IPS or EVR programs and were followed for @ months .\n",
            "Wages from all forms of employment and the number of weeks and hours of competitive employment were tracked monthly .\n",
            "Estimates were made of direct mental health costs and vocational costs .\n",
            "Incremental cost-effectiveness ratios ( ICERs ) were calculated for competitive employment outcomes and total wages .\n",
            "RESULTS : No statistically significant differences were found in the overall costs of IPS and EVR .\n",
            "Participation in the IPS program was associated with significantly more hours and weeks of competitive employment .\n",
            "However , the average combined earnings-earnings from competitive and noncompetitive employment-were virtually the same both programs .\n",
            "The ICER estimates indicated that participants in the IPS program worked in competitive employment settings for an additional week over the @-month period at a cost of $ @ ( $ @ an hour ) .\n",
            "CONCLUSIONS : The analyses suggest that IPS participants engaged in competitive employment at a higher cost .\n",
            "When combined earnings were used as the outcome , data from the statistical analyses were insufficient to enable any firm conclusions to be drawn .\n",
            "The findings illustrate the importance of choice of outcomes in evaluations of employment programs\n",
            "Last Refresh Date@ February @ / / Acronym : TAAS / / Primary Sponsor : Qingyun Yin / / Registration Date : @/@/@ / / Export Date : @/@/@ @:@:@ PM / / Recruitment Status : Not recruiting / / Inclusion Age ( min ) : @ Years / / Inclusion Age ( max ) : @ Year / / Inclusion Gender : Both / / Date Enrollement : February @ / / Target Size : @ / / Phase : Phase @ / / Inclusion Criteria : - Diagnostic and Statistical Manual of Mental Disorders-IV Edition ( DSM-IV ) diagnostic criteria for schizophrenia patients .\n",
            "- @-@ years ( including @ and @ ) , male or female .\n",
            "- Treated with a stable dose of an AAPD for at least three months .\n",
            "- Informed consent was obtained ( if the patient is in the acute phase of schizophrenia , does not have the capacity , their guardians need sign informed consent ) .\n",
            "- PANSS negative score = @ .\n",
            "/ / Exclusion Criteria : - Combined Axis?mental illness other than schizophrenia ; - Taking a mood stabilizer , antidepressants , anticholinergic or anxiolytic drugs , and other drugs improve cognitive function ; - Suicidal tendencies ; - Have severe or unstable heart , liver , kidney , endocrine , blood and other medical disease patients - Clinically significant ECG or laboratory abnormalities were - Glaucoma and epilepsy ; - Unsupervised or unable to take prescribed medication ; - History of alcohol and drug abuse ; - Allergic ; - Pregnant or lactating woman ; - Patients participate in other clinical trials during a month ; / / Condition : SchizophreniaSI - Drug : Risperidone/Olanzapine/Quetiapine / Ziprasidone/Aripiprazole ; Drug : Tandospirone / / Primary Outcome : Measurement and treatment Research to Improve Cognition in Schizophrenia ( MATRICS ) Consensus Cognitive Battery ( MCCB ) total score / / Secondary Outcome : MATRICS Consensus Cognitive Battery ( MCCB ) factor score ; Positive and Negative Syndrome Scale ( PANSS ) total score ; Positive and Negative Syndrome Scale ( PANSS ) factor score ; Personal and Social Performance Scale ( PSP ) total score ; Clinical Global Impression ( CGI ) factor score ; Treatment Emergent Symptom Scale ( TESS ) factor score ; Functional magnetic resonance imaging ( FMRI ) / / Secondary ID : DSPC-SED@ / / Source Support : Please refer to primary and secondary sponsors\n",
            "Since blunted prolactin ( PRL ) and partly blunted cortisol responses have been reported for subjects with aggressive impulsive disorders as well as with psychopathy , it seemed worthwhile to try to separate the two types of aggression by their biological response .\n",
            "Since , furthermore , cortisol responses are more readily elicited by @-HT@a challenges and prolactin responses by d-Fenfluramine or uptake inhibitors , these two types of drugs were used to answer the question if these hormone responses are suitable to differentiate between the two types of aggression .\n",
            "Two studies were conducted , one using @ mg of d-Fenfluramine ( d-Fen ) in a double-blind placebo-controlled cross-over design in @ males , the other using @ mg of Ipsapirone ( Ips ) and placebo comparing @ healthy males in each group .\n",
            "In each study subjects were divided according to above and below median aggression and psychoticism scores measured by questionnaire scales and combined into four groups defined by high and low aggression ( Ag + / - ) and psychoticism ( P + / - ) scores respectively .\n",
            "Analyses of covariance based an the two personality factors and the drug revealed for d-Fen cortisol nonresponse in P + as opposed to P - and a blunted PRL response in Ag + as opposed to Ag - .\n",
            "With Ips the cortisol response was positively related to Ag and not to P , while P + showed a blunted PRL response not observed in Ag + .\n",
            "Joyfulness and well-being were also differentially affected by d-Fen in high and low P scorers , but not correlated to respective hormone responses .\n",
            "Different hypothalamic mechanism for eliciting the two hormone responses and differences in pre - and postsynaptic receptor sensitivities in the two personality dimensions are inferred from these findings .\n",
            "OBJECTIVES : The objective of this study was to evaluate the long-term efficacy , safety , and tolerability of paliperidone extended-release ( pali ER ) , in Chinese patients with schizophrenia .\n",
            "METHODS : In this parallel-group , relapse prevention , phase-@ study ( screening [ @-day ] , pali ER open-label run-in [ @-week ] and stabilization [ @-week ] phases , and double-blind ( DB ) treatment [ variable duration ] , and open-label extension phases [ @-week ] ) , @/@ patients with schizophrenia were randomized ( @:@ ) to pali ER ( @-@ mg ) or placebo during the DB phase .\n",
            "RESULTS : Final analysis showed that , out of @ patients in ITT ( DB ) population , @ ( @ % ) had a relapse event , @ ( @ % ) were ongoing at the time the study was stopped , and @ ( @ % ) discontinued from the DB phase .\n",
            "Time to relapse ( primary endpoint ) favored pali ER ( hazard ratio = @ [ @ % CI : @ , @ ] , p < @ ) .\n",
            "Rate of relapses ( @/@ [ @ % ] placebo ; @/@ [ @ % ] pali ER ) and secondary endpoints ( change from baseline in Positive And Negative Syndrome Scale [ PANSS ] and Clinical Global Impression - Severity Scores ) were significantly lower ( p < @ ) in pali ER group vs placebo , in favor of pali ER .\n",
            "More psychiatric-related treatment-emergent adverse events ( TEAEs ) occurred in placebo - ( @ % ) than pali ER group ( @ % ) .\n",
            "Most common ( > @ % ) TEAEs in placebo group were insomnia and schizophrenia ( @ % each ) , while in pali ER group were aggression and akathisia ( @ % each ) , and schizophrenia , tremor , nausea , amenorrhea , and salivary hypersecretion ( @ % each ) .\n",
            "All serious TEAEs were psychiatric-related ( schizophrenia , aggression , completed suicide , auditory hallucination , suicide attempt ) and more frequent in placebo - ( @ % ) versus pali ER group ( @ % ) .\n",
            "Death and tardive dyskinesia-related discontinuation ( n = @ each ) occurred in placebo group .\n",
            "Body weight increase from run-in baseline was greater in pali ER group ( mean increase : @ kg ) versus placebo ( mean increase : @ kg ) .\n",
            "CONCLUSIONS : This study confirms the findings from earlier pali ER global relapse-prevention studies and demonstrates that pali ER treatment ( @-@ mg ) is efficacious over the long-term and significantly delays relapse in Chinese patients with schizophrenia .\n",
            "No new safety signals were detected in this population .\n",
            "Iloperidone is a novel agent with functional affinity across multiple neurotransmitter systems .\n",
            "One of the main features is its high affinity for norepinephrine receptors and , in particular , an a@C/D@ binding ratio similar to the profile of clozapine .\n",
            "This study aimed to identify a simple and safe titration schedule of iloperidone for use in Phase III studies .\n",
            "A high dose ( @ mg/day , bid ) haloperidol group was included for study validation .\n",
            "In total , @ patients with schizophrenia or schizoaffective disorder were randomized in a @:@:@ ratio to iloperidone ( @ to @ mg/day , bid ) , using either slow or rapid titration , or haloperidol ( @ to @ mg/day , bid ) , and were maintained on the target titration doses until day @ .\n",
            "Subsequently , patients in the iloperidone groups were pooled and randomized to qd or bid administration of iloperidone @ mg/day .\n",
            "For @ days , the dose of iloperidone could be increased to @ mg/day , if clinically indicated .\n",
            "Patients who completed day @ had the option to continue their treatment until the end of the study ( week @ ) .\n",
            "Efficacy was assessed using three psychiatric rating scales and cognitive function evaluations .\n",
            "Patients were regularly monitored for vital signs , ECGs , adverse events , extrapyramidal symptoms , and laboratory data .\n",
            "Background : The improvement of quality of life ( QoL ) is a major challenge in the treatment of schizophrenic patients .\n",
            "Maintenance drag treatment is of importance for the management of the disease and the social functioning of the patients .\n",
            "Amisulpride is an atypical antipsychotic agent with a selective activity for dopamine D@/D@ receptors and has a greater affinity for dopamine receptors in limbic area .\n",
            "Clinical experience indicates that amisulpride is effective in the first line treatment of schizophrenia and has a favourable safety profile .\n",
            "Method : In a multicenter , international , open randomised , long-term study , amisulpride was compared to haloperidol .\n",
            "Patients with acute exacerbation of schizophrenia ( DSM III-R ) were treated for @ months .\n",
            "A total of @ patients were exposed to study drag : @ to Amisulpride and @ to haloperidol .\n",
            "Flexible doses of @ to @ mg/d ( up to @ mg/d ) were used for Amisulpride and @ to @ mg/d ( up to @ mg/d ) for haloperidol .\n",
            "At the end of the study , mean daily doses were : @  @ for Amisulpride and @  @ mg for haloperidol .\n",
            "The principal aim of the study was to assess the long-term safety and efficacy of Amisulpride .\n",
            "A secondary objective was to determine social adaptation using the Global Assessment of Functionning ( GAF [ @ ] ) and Quality of Life Scale ( QLS [ @ ] ) Results : Amisulpride was superior to haloperidol in total BPRS score ( mean change from baseline  std @  @ vs @  @ , p < @ ) , PANSS Negative subscore ( mean change from baseline  std @  @ vs @  @ , p < @ ) .\n",
            "Amisulpride provoked significantly less EPS ( Simpson Angus , side effects reporting ) than haloperidol and correspondingly less antiparkinson drugs were prescribed to Amisulpride patients .\n",
            "The improvement in QLS mean item score from baseline to end of study was significantly greater among amisulpride-treated patients ( mean  std ?\n",
            "@  @ ) compared to the haloperidol group ( ?\n",
            "@  @ ) ( p = @ ) .\n",
            "The analysis revealed a significantly greater improvement in the amisulpride group for three of the four subscores in the QLS scale - interpersonal relations ( p = @ ) , instrumental role ( p = @ ) and intrapsychic foundations ( p = @ ) .\n",
            "Statistical significance was also achieved by comparison of the change in mean GAF scores ( D@-Dend mean  std ) , which were ?\n",
            "@  @ for amisulpride and ?\n",
            "@  @ for haloperidol ( p = @ ) .\n",
            "Conclusions : These results support the conclusions that Amisulpride has superior benefit-risk ratio compared to haloperidol and is associated with greater improvement in key componants of patients ' quality of life , during long-term use over a period of @ months .\n",
            "DS : SZ ; Not in mk CN : P. @\n",
            "BACKGROUND : In patients with depression , as well as in patients with schizophrenia , both mood and working memory performance are often impaired .\n",
            "Both issues can only be addressed and improved with medication to some extent .\n",
            "OBJECTIVE : This study investigates the mood and the working memory performance in patients with depression or schizophrenia and whether acupuncture can improve these .\n",
            "DESIGN , SETTING , PARTICIPANTS AND INTERVENTIONS : A pragmatic clinical trial design was used .\n",
            "The study was conducted in a psychiatric clinic .\n",
            "Fifty patients with depression and @ with schizophrenia were randomly divided into an experimental and a waiting-list group .\n",
            "Additionally , @ healthy control participants were included .\n",
            "Twelve weeks of individualized acupuncture treatment was used as the clinical intervention .\n",
            "MAIN OUTCOME MEASURES : All patients were tested before ( T@ ) and after ( T@ ) acupuncture treatment on a mood scale ( Beck Depression Inventory-II , BDI-II ) , a simple working memory task ( digit span ) , and a complex working memory task ( letter-number sequencing ) ; the healthy controls were tested at T@ only .\n",
            "RESULTS : Patients with depression scored worse than the others on the BDI-II , and patients with schizophrenia scored worse than the healthy controls .\n",
            "On the digit span , patients with schizophrenia did not differ from healthy controls whereas they scored worse of all on the letter-number sequencing .\n",
            "With respect to the acupuncture findings , first , the present study showed that the use of acupuncture to treat patients with schizophrenia was both practical and safe .\n",
            "Moreover , acupuncture had a positive effect on the BDI-II for the depression group , but acupuncture had no effect on the digit span and on the letter-number sequencing performance for the two clinical groups .\n",
            "CONCLUSION : The clinical improvement in patients with depression after acupuncture treatment was not accompanied by any significant change in a simple working memory task or in a more complex working memory task ; the same was true for the patients with schizophrenia .\n",
            "TRIAL REGISTRATION : Dutch Trial Register NTR@ .\n",
            "The aim of this paper was to investigate whether changes of psychopathological symptoms are associated with subjective quality of life of schizophrenic patients during therapy with flupenthixol or risperidone .\n",
            "In this multicenter , double-blind trial the efficacy of flupenthixol compared to risperidone in enhancing the quality of life of @ chronic schizophrenic patients was investigated .\n",
            "We evaluated the possible influence of psychopathological symptoms , assessed by means of the five factors of the positive and negative syndrome scale ( PANSS ) - ( @ ) ' negative-symptoms ' , ( @ ) ' uncontrolled hostility/excitement ' , ( @ ) ' disorganized thought ' , ( @ ) ' anxiety/depression ' , ( @ ) ' positive-symptoms ' - on subjective quality of life , measured by the EuroQuol visual scale and the patients ' satisfaction questionnaire , as well as on attitude towards medication , measured by the drug attitude inventory @ ( DAI-@ ) .\n",
            "Additionally all single items of the PANSS were compared in both treatment groups after @ weeks to baseline data .\n",
            "In both treatment groups the decrease of the PANSS factors ' negative-symptoms ' ' anxiety/depression ' , ' disorganized thought ' and ' positive-symptoms ' correlated statistically significant with the increase on the EuroQuol scale ; an improved overall score of the patients ' satisfaction questionnaire correlated with the decrease of ' negative-symptoms ' with both medications as well as with an amelioration of ' disorganized thoughts ' and ' anxiety/depression ' with risperidone .\n",
            "Regarding an improved attitude towards medication a correlation of improved ' negative-symptoms ' was found with flupenthixol as well as with improved ' disorganized thoughts ' and ' anxiety/depression ' with risperidone .\n",
            "Comparing both therapies the PANSS single item ' depression ' improved significantly after @ weeks in advantage of flupenthixol and the single item ' grandiosity ' improved in advantage of risperidone ( ITT-analysis , nominal p < @ ) .\n",
            "From this study we concluded that in our group of patients the improvement of psychopathological symptoms ( negative-symptoms , anxiety/depression , disorganized thought and positive-symptoms ) during a therapy with flupenthixol or risperidone correlates with improved subjective quality of life .\n",
            "In a number of case reports , retrospective studies and open clinical trials , the beneficial effects of benzodiazepines on catatonic symptoms have been described .\n",
            "In order to substantiate these observations and to investigate the efficacy of the benzodiazepine agonist lorazepam in retarded catatonia , a prospective , randomized , double-blind placebo-controlled cross-over study was performed in @ patients suffering from a catatonic syndrome , irrespective of nosological classification , with stupor and mutism as target symptoms .\n",
            "Patients were randomly assigned to be administered either lorazepam @ mg or saline i.v. on @ consecutive days for @ hours , and a structured interview was recorded on video .\n",
            "For assessment of response , time-blind video ratings were performed using the IMPS subscore \" retardation/apathy \" , a @-point clinical global improvement scale , and an abridged version of the Bush-Francis Catatonia Rating Scale as outcome parameters .\n",
            "Analysis of data revealed that lorazepam was significantly superior to placebo in relieving catatonic symptoms like mutism and stupor .\n",
            "While placebo had virtually no effect , lorazepam resulted in a @ % reduction of symptoms .\n",
            "Response was evident after @ hour of the lorazepam infusion .\n",
            "Therefore , short-term administration of lorazepam proved to be an effective and safe treatment of retarded catatonic symptomatology .\n",
            "Paranoia is characterized by a lack of perceived social safeness and associated negative affect .\n",
            "Low self-esteem , negative self-concepts and negative emotions have been shown to contribute to paranoid symptom formation .\n",
            "Thus , interventions focusing on affiliation and positive affect might be particularly helpful for patients with paranoia .\n",
            "The present study experimentally tested the effect of a one-session , brief compassion-focused imagery derived from Compassion-Focused Therapy ( Gilbert , @ ) versus a control imagery condition in a repeated measures randomized design .\n",
            "A negative affective state was induced via in-sensu exposure to a recent distressful social situation in order to provide a minimum level of threat-related arousal to be down-regulated by the interventions thereafter .\n",
            "The sample consisted of psychotic patients with paranoid ideation ( N = @ ) who were randomly assigned to one of the experimental conditions .\n",
            "Effects on postulated causal mechanisms , i.e. , self-relating ( self-reassurance , self-compassion , self-criticism ) , and affect ( self-reported affective states , skin conductance levels ) as well as on state paranoia , were tested .\n",
            "Subjective benefit and appraisals of the intervention were explored .\n",
            "There were no specific intervention effects on negative self-relating , negative affect and skin-conductance or on paranoia .\n",
            "However , compassion-focused imagery had significant effects on self-reassurance and happiness .\n",
            "Explorative analyses revealed that the majority of the participants appraised the intervention in a positive manner , indicating good acceptance .\n",
            "The intervention showed an effect on some of the postulated mechanisms but not on others , which might have been because of its brevity .\n",
            "Further investigation of interventions targeting affiliation for people with paranoid experiences appears worthwhile .\n",
            "Copyright ( c ) @ John Wiley & Sons , Ltd .\n",
            "Key Practitioner Message Affiliative imagery work is feasible and appraised positively in psychotic patients .\n",
            "Brief compassion focused imagery increased feelings of happiness and reassurance but did not improve negative self-relating , negative affect or paranoia .\n",
            "Further investigation is warranted to identify which patients benefit most from affiliative imagery .\n",
            "Objective To probe efficacy and side effect of quetiapine and clozapine in the treatment of first - episode schizophrenia .\n",
            "Methods One hundred and eight first - episode schizophrenics were randomly treated with quetiapine or clozapine .\n",
            "Their therapeutic effects were evaluated with PANSS , CGIGI and ESPS .\n",
            "Results The therapeutic effect of quetiapine was better and side effect milder than those of clozapine .\n",
            "Conclusion Quetiapine is preferred as an ideal agent in the treatment of first - episode\n",
            "Despite treatment , many patients with schizophrenia continue to suffer from psychotic and depressive symptoms .\n",
            "@ to @ % of all schizophrenia patients are physically inactive .\n",
            "Until now , studies with a sample size of @ to @ patients have indicated exercise therapy could be an effective add-on therapy in schizophrenia .\n",
            "In schizophrenia , brain volume reductions have been consistently found .\n",
            "These brain volume reductions appear to be progressive and under the influence of genetic and environmental factors .\n",
            "Exercise training appears to increase hippocampal volume in schizophrenia , but the effect of physical exercise on global brain volumes has not been reported yet .\n",
            "This intervention study examined the effect of exercise versus occupational therapy on psychotic and depressive symptoms .\n",
            "In addition , the effect of exercise therapy on global brain volume change is examined in patients and matched healthy controls .\n",
            "@ patients with schizophrenia and @ matched healthy controls participated in this single blind randomised controlled trial .\n",
            "Positive and Negative Syndrome Scale and Montgomery and Asberg Depression Rating Scale were assessed in patients .\n",
            "Global brain volumes were acquired with a @ Tesla MRI scan in patients and controls .\n",
            "After baseline assessments subjects were assigned to exercise or occupational therapy ( patients ) and exercise versus life as usual ( healthy controls ) one hour twice weekly for six months .\n",
            "Analyses were performed on subject who attended at least @ % of all sessions ( n = @ ) offered .\n",
            "Exercise therapy reduced psychotic symptoms ( p = @ ) and depressive symptoms ( p = @ ) by @ % compared to occupational therapy .\n",
            "Exercise therapy diminished progressive cerebral gray matter volume loss ( time * group * randomization ; p = @ ) compared to occupational therapy in patients .\n",
            "Exercise therapy effectively reduces psychosis and depression in patients with schizophrenia compared to occupational therapy .\n",
            "Furthermore , in patients , exercise therapy diminishes gray matter volume loss compared to occupational therapy .\n",
            "@ .\n",
            "Are new atypical antipsychotics more clinically and cost-effective than conventional anti-psychotics ?\n",
            "@ .\n",
            "Is clozapine more clinically and cost-effective than other new atypical antipsychotics ?\n",
            "Single blind , randomised controlled trial Patients with schizophrenia or related disorder .\n",
            "Quality of life , costs of medical and social services , symptoms , side-effects , compliance with medication .\n",
            "\" OBJECTIVE : The study examined the feasibility and effectiveness of using peer support to reduce recurrent psychiatric hospitalizations .\n",
            "METHODS : A randomized controlled design was used , with follow-up at nine months after an index discharge from an academically affiliated psychiatric hospital .\n",
            "Patients were @ years or older with major mental illness and had been hospitalized three or more times in the prior @ months .\n",
            "Seventy-four patients were recruited , randomly assigned to usual care ( N = @ ) or to a peer mentor plus usual care ( N = @ ) , and assessed at nine months .\n",
            "RESULTS : Participants who were assigned a peer mentor had significantly fewer rehospitalizations ( .@   @ versus @   @ ; p = .@ [ one-tailed ] ) and fewer hospital days ( @   @ versus @   @ days ; p < .@ , [ one tailed ] ) .\n",
            "CONCLUSIONS : Despite the study 's limitations , findings suggest that use of peer mentors is a promising intervention for reducing recurrent psychiatric hospitalizations for patients at risk of readmission .\n",
            "More data after contacting the authors : Lloyd-Evans et al. contacted the authors of Sledge @ and got some unpublished data that has been reported in the following non-Cochrane systematic review which is freely available at http://www.biomedcentral.com/@-@X/@/@ ; the other studies included in the following publication has been checked and added to Cochrane Schizophrenia Group 's Register : Lloyd-Evans B , Mayo-Wilson E , Harrison B , Istead H , Brown E , Pilling S , Johnson S , Kendall T .\n",
            "A systematic review and meta-analysis of randomised controlled trials of peer support for people with severe mental illness .\n",
            "BMC Psychiatry .\n",
            "@ Feb @ ; @ ( @ ) : @ .\n",
            "doi : @ / @-@X-@-@ \"\n",
            "Objective : To investigate short-term outcomes of a computer-assisted cognitive remediation ( CACR ) for adolescents with psychotic disorders or at high risk for psychosis .\n",
            "Method : Cognitive abilities and clinical status were assessed at baseline ( N = @ ) and at @-month follow-up ( N = @ ) after enrolment in either a CACR ( treatment group ) or a computer games ( control group ) program ( @ weeks ) .\n",
            "Results : With regard to the cognitive abilities , no amelioration was found in the control group while , in the CACR group , significant improvements in inhibition ( p = @ ) and reasoning ( p = @ ) were observed .\n",
            "Furthermore , symptom severity decreased significantly in the control group ( p = @ ) and marginally in the CACR group ( p = @ ) .\n",
            "Improvements in cognitive abilities were not associated with symptoms   amelioration .\n",
            "Finally , increase in reasoning abilities was related to the median effective work time in sessions of CACR ( R = @ , p = @ ) .\n",
            "Conclusion : At follow-up , enhanced cognitive abilities ( reasoning and inhibition ) , which are necessary for executing higher-order goals or adapting behaviour to the ever-changing environment , were reported in adolescents participants of the CACR .\n",
            "Thus , further studies are needed to confirm and extend these interesting results .\n",
            "BACKGROUND : Individuals with serious mental illness have high rates of obesity and a need for specialized weight loss intervention programs .\n",
            "This study examines the efficacy of the RENEW weight loss intervention and examines the impact of the intervention setting on outcomes .\n",
            "METHOD : @ individuals with serious mental illness from @ different settings were randomly assigned to receive the RENEW weight loss intervention or a control condition of treatment as usual .\n",
            "The RENEW intervention is a one year program that includes an intensive , maintenance and intermittent supports phase .\n",
            "RESULTS : The intervention group experienced a modest weight loss of @ lbs at @ months , @ lbs at @ months and a slight weight gain of @ lbs at @ months .\n",
            "The control group gained a total of @ lbs at @ months .\n",
            "However when settings were examined separately the responder sites had a weight loss of @ lbs at @ months , @ lbs at @ months and @ lbs at @ months .\n",
            "DISCUSSION : These results suggest that the settings in which individuals receive services may act as a support or hindrance toward response to weight loss interventions .\n",
            "The concept of the obesogenic environment deserves further examination as a factor in the success of weight loss programs .\n",
            "\" CAJ Objective evaluation of the efficacy and safety of quetiapine in the treatment of schizophrenia .\n",
            "Methods A randomized double-blind controlled trial of quetiapine group of @ patients ( male @ cases , female @ cases ) ; clozapine group @ one cases ( male @ cases , @ cases ) , two sets of dose range is @ to @ to @ mg / d ; positive symptoms and negative syndrome scale ( PANSS ) to evaluate the clinical efficacy , side effects scale ( TESS ) assessment of adverse drug reactions .\n",
            "results of quetiapine in the treatment of schizophrenia , the effective rate was @ % ; clozapine 's effective rate was @ % , the efficacy of two drugs is no significant difference between quetiapine adverse reaction less , reduced white blood cell is not found .\n",
            "conclusion of quetiapine is a safe , effective atypical antipsychotics , the schizophrenia positive and negative symptoms are valid / / apologize for any inconvenience Objective To evaluate the efficacy and safety of quetiapine in the treatment of schizophrenia .\n",
            "Methods A randomized double-blind controlled trial of quetiapine in @ cases ( @ males , @ females ) ; clozapine group , @ cases ( @ males and and @ females ) , two sets of dose range is @ to @ mg / d ; positive symptoms and negative syndrome scale ( PANSS ) to evaluate the clinical efficacy , side effects scale ( TESS ) assessment of adverse drug reactions .\n",
            "results seroquel the effective rate of the flat treatment of schizophrenia @ % ; clozapine 's effective rate was @ % , no significant difference in the efficacy of two drugs .\n",
            "quetiapine , fewer adverse reactions and found no reduction in white blood cells .\n",
            "conclusion seroquel level is a safe , effective atypical antipsychotics , schizophrenia positive and negative symptoms .\n",
            "Conducted a @-mo double-blind , placebo controlled study of molindone and chlorpromazine with @ chronic schizophrenics .\n",
            "The chlorpromazine Ss showed the greatest clinical improvement and the greatest EEG changes ( slower , more abundant alpha ; emergence of theta ) .\n",
            "Molindone Ss , while different from placebo Ss in the amount of slow alpha , did not show significant increases in theta .\n",
            "Objective - This was a double-blind , randomized study comparing the safety and efficacy of treatment with ziprasidone ( an antipsychotic with combined antagonism at @HT _ ; zA and D _ receptors ) and placebo in patients with an acute exacerbation of schizophrenia or schizoaffective disorder .\n",
            "Method - After a @ - to @-day placebo washout period , patients were given @ mg or @ mg ziprasidone or placebo twice daily for @ days .\n",
            "Results - A total of @ patients were included in the intention-to-treat efficacy analysis and @ patients completed the trial .\n",
            "There was a statistically significant improvement in psychotic symptoms vs. placebo in the @ mg ziprasidone group , as measured by the total BPRS and CGI scores .\n",
            "Evaluations for parkinsonian symptoms , akathisia , abnormal movements , and sedation did not reveal any notable treatment effects .\n",
            "There were no notable treatment differences in the incidence or severity of adverse events , laboratory test abnormalities , or serious adverse events .\n",
            "Conclusions - This study , therefore , showed that @ mg ziprasidone twice daily was an effective dose in this group of patients .\n",
            "Background : Psychotic syndromes are severe mental disorders characterized by delusions and hallucinations .\n",
            "There is increasing evidence that patients may benefit from cognitive behavioural therapy ( CBT ) .\n",
            "The POSITIVE research network conducts a multi-cen-tre-RCT to evaluate the effectiveness of CBT compared to supportive treatment ( ST ) in psychotic patients with persistent psychotic symptoms ( PPS ) .\n",
            "Aims of the Study : To estimate direct and indirect costs associated with PPS and to analyse the cost-utility and cost-effectiveness of CBT compared to ST for PPS .\n",
            "Methods : @ patients with a diagnosis of psychotic disorder and acute psychotic episode were randomised to CBT ( N = @ ) or ST ( N = @ ) and received @ treatment sessions over @ months .\n",
            "Instruments were assessed at baseline , and after @ , @ and @ months .\n",
            "@-month retrospective health care utilization , sickness absence and presenteism were measured with a modified Client Sociodemo-graphic and Service Receipt Inventory and monetarily valued using @ prices .\n",
            "EQ-@D was used to calculate QALYs and the Positive and Negative Syndrome Scale ( PANSS ) was used to measure clinical effectiveness .\n",
            "Missing data were imputed using multiple imputations by chained equations .\n",
            "To analyse baseline costs , we applied linear regression analyses with bootstrap-corrected standard errors ( @ , @ replications ) using sociodemographic variables , number of preceding hospital stays and PANSS-Score as independent variables .\n",
            "ICERs were calculated using QALYs and PANSS-Score .\n",
            "To control for confounders , we calculated the net-monetary-benefit using a willingness to pay of @ , @ per QALY and conducted linear regression analyses .\n",
            "Results : Mean retrospective @-month baseline costs were @ , @ ( @ , @ ) for direct ( indirect ) costs .\n",
            "Direct costs preliminary resulted from hospital stays ( @ % ) , assisted living ( @ % ) and supportive services ( @ % ) .\n",
            "Regression analyses showed that direct cost were significantly associated with PANSS-score ( @ , @ ; p = .@ ) and the existence of children ( -@ , @ ; p = .@ ) , whereas indirect cost were not significantly associated with independent variables .\n",
            "During treatment ( @ months ) direct costs amounted to @ , @ ( @ , @ ) for CBT ( ST ) , and QALYs were @ ( @ ) respectively .\n",
            "The corresponding between group differences were @ ( p = .@ ) and @ QALYs ( p = .@ ) , resulting in an ICER of @ / QALY .\n",
            "Including indirect costs , a cost difference of -@ resulted ( ICER = -@ , @ Euro/QALY ) .\n",
            "Using PANSS-Score , ICERs were @ , @ / PANSS-score-point for direct and -@ , @ / PANSS-score-point for total costs .\n",
            "Regression on net-benefit showed no significant associations of net-benefit with treatment condition but with baseline PANSS-score ( -@ , @ ; p = .@ ) and the number of former psychiatric hospitalisations ( -@ ; p = .@ ) .\n",
            "Discussion : We found high health care costs for PPS which were strongly associated with disease severity .\n",
            "Mean indirect costs were low due to only @ % employment rate .\n",
            "We found no health economic advantages of either CBT or ST. Implications for Health Care Provision and Use : The neither significant nor relevant differences in costs combined with the significant clinical effectiveness , imply that CBT may present a suitable therapeutic option for the treatment of persistent psychotic disorders .\n",
            "Implications for Further Research : Further research is required to determine the long-term cost-effectiveness of CBT compared to ST and to analyse subgroups of patients with persistent psychotic symptoms .\n",
            "The efficacy and safety of bromperidol were compared with those of haloperidol in a randomized , double-blind study in schizophrenic patients over @ weeks .\n",
            "Thirty-five patients suffering from various forms of schizophrenia completed the study : @ received bromperidol at a daily dose of @ + - @ mg ( mean + - S.D. ) and @ haloperidol at a daily dose of @ + - @ mg .\n",
            "At the end of treatment improvement on the Brief Psychiatric Rating Scale was @ % in the bromperidol group and @ % in the haloperidol group .\n",
            "No significant differences in the final assessment of efficacy were found between the two drugs .\n",
            "A good tolerability was evidenced in both treatment groups .\n",
            "The most frequently reported side effects were extrapyramidal symptoms which were satisfactorily controlled by administration of anticholinergic agents .\n",
            "Neither drug produced significant abnormalities in laboratory tests .\n",
            "The efficacy and safety of timiperone , a new butyrophenone derivative , in schizophrenia as compared with haloperidol were assessed in a multi-clinic double-blind controlled study in a total of @ patients .\n",
            "The patients were given timiperone ( @ mg/tablet ) or haloperidol ( @ mg/tablet ) in a daily dose of @ -- @ tablets for the first day , then up to a maximum of @ tablets depending on symptoms for @ weeks .\n",
            "Timiperone was found to be significantly superior to haloperidol in the final global improvement rating and in the general usefulness rating .\n",
            "In the over-all safety rating there were no statistically significant differences between the two drug treatments .\n",
            "With regard to analysis by stratification timiperone was superior to haloperidol in improving abnormal experiences such as hallucination and delusion as well as deficiency of initiative and blunted affect .\n",
            "From these results it is considered that timiperone could be superior to haloperidol in the treatment of schizophrenia .\n",
            "D-Cycloserine , a partial agonist of the glycine recognition site of the N-methyl-D - aspartate ( NMDA ) receptor , may serve as a probe for human cerebral NMDA receptor function .\n",
            "Since NMDA receptors are involved in neuroendocrine secretion , changes in pituitary secretion in response to D-cycloserine administration could serve as a model for NMDA receptor activity .\n",
            "The effects of an oral dose of @ mg D-cycloserine were assessed in a neuroendocrine challenge paradigm in @ healthy male volunteers , using a double - blind , randomized placebo-controlled crossover design .\n",
            "Luteinizing hormone ( LH ) and cortisol secretion was studied , since preclinical studies indicate that these hormones increase in response to NMDA receptor stimulation .\n",
            "Furthermore , plasma homovanillic acid ( HVA ) secretion was studied , as NMDA receptors are suggested to be involved in the regulation of dopaminergic neurotransmission .\n",
            "D-cycloserine was readily absorbed and did not induce side-effects or changes in vital signs and mood scores .\n",
            "D-Cycloserine stimulated LH secretion and induced a significant rise of the area under the plasma concentration time curve of LH .\n",
            "D-Cycloserine did not stimulate cortisol or plasma HVA secretion .\n",
            "These neuroendocrine effects suggest that D-cycloserine may be used to assess human NMDA receptor function in cerebral disorders , such as schizophrenia .\n",
            "Social cognition was shown as a rate limiting factor for both psychosocial outcome and response to psychosocial intervention in SCHIZOphrenia .\n",
            "In a RANDOMized controlled trial a new cognitive-behavioral group treatment for SCHIZOphrenic inpatients ( the \" Training of Emotional Intelligence \" , TEI ) was tested against the well evaluated \" Integrated Psychological Therapy Program \" ( IPT ) of H. Brenner .\n",
            "Within the framework of P. Salovey 's work the Training of Emotional Intelligence focussed on three domains of deficits in SCHIZOphrenia : emotional perception , emotional understanding and emotional management .\n",
            "In the RANDOMized controlled trial with @ DSM-IV SCHIZOphrenic inpatients no differences were found in problem-solving and negative symptoms , both post treatment and in the @ months-follow up .\n",
            "Additionally there was a better outcome in affect decoding capacity post treatment , and a progress in regulation of negative affects in the follow up .\n",
            "Emotional role taking behavior and social anxiety returned to baseline level , perhaps by reasons of no \" booster sessions \" in the follow up .\n",
            "Unfortunately in contrast to our hypotheses we failed to show treatment-specific effects , which may be due to an underpowered statistical testing .\n",
            "There was only one exception of this : While the Integrated Psychological Therapy Program showed a greater reduction of global psychopathology after treatment , the Training of Emotional Intelligence reduced psychopathology in the follow up more strongly .\n",
            "Possible reasons for these results are discussed\n",
            "Background : Overall results from Cognitive Remediation ( CR ) indicate robust and long-lasting effects with medium effect size on global cognition and functioning , and a small ES on symptoms present at post-treatment but not at follow-up .\n",
            "However , results are not the same in all CR therapies and in some cases no efficacy results are achieved .\n",
            "Aims : To develop an integrative intervention taking into account previous efficacious therapies .\n",
            "To evaluate the efficacy of our cognitive remediation group training : Problem Solving and Cognitive Flexibility training ( REPYFLEC ) , with the aim of improving cognition and functioning in schizophrenia patients .\n",
            "Method : Participants with a diagnosis of schizophrenia or schizoaffective disorder ( n = @ ) were randomized to @ group sessions of REPYFLEC CR , or to @ group sessions of activities without specific objectives and focused on leisure .\n",
            "In both groups the sessions were conducted twice a week .\n",
            "Functioning and psychiatric symptoms were measured at baseline ( week @ ) and thereafter at @ , @ and @ .\n",
            "weeks .\n",
            "Cognition was measured at weeks @ , @ and @ .\n",
            "Mixed Models were used to estimate statistical differences .\n",
            "Results : Patients in the cognitive remediation group demonstrated significant improvements in executive function , negative symptoms and functioning at post-treatment compared with patients in the control group .\n",
            "At @-month follow-up , significant improvements in executive function and functioning remained .\n",
            "Conclusion : These results apparently show that REPYFLEC works as cognitive remediation training , improving executive thinking and functioning outcomes compared with a control group .\n",
            "@ Elsevier B.V.\n",
            "Background : A second antipsychotic is commonly added to clozapine to treat refractory schizophrenia , notwithstanding the limited evidence to support such practice .\n",
            "Methods : The efficacy and adverse effects of this pharmacological strategy were examined in a double-blind , placebo-controlled , @-week randomized trial of clozapine augmentation with amisulpride , involving @ adults with treatment-resistant schizophrenia and persistent symptoms despite a predefined trial of clozapine .\n",
            "Results : There were no statistically significant differences between the amisulpride and placebo groups on the primary outcome measure ( clinical response defined as a @ % reduction in total Positive and Negative Syndrome Scale score ) or other mental state measures .\n",
            "However , the trial under recruited and was therefore underpowered to detect differences in the primary outcome , meaning that acceptance of the null hypothesis carries an increased risk of type II error .\n",
            "The findings suggested that amisulpride-treated participants were more likely to fulfil the clinical response criterion , odds ratio @ ( @ % confidence interval @-@ ) and have a greater reduction in negative symptoms , but these numerical differences were not statistically significant and only evident at @ weeks .\n",
            "A significantly higher proportion of participants in the amisulpride group had at least one adverse event compared with the control group ( p = @ ) , and these were more likely to be cardiac symptoms .\n",
            "Conclusions : Treatment for more than @ weeks may be required for an adequate trial of clozapine augmentation with amisulpride .\n",
            "The greater side-effect burden associated with this treatment strategy highlights the need for safety and tolerability monitoring , including vigilance for indicators of cardiac abnormalities , when it is used in either a clinical or research setting .\n",
            "Twenty-five schizophrenics being treated at an outpatient clinic were assigned to one of two treatment conditions .\n",
            "One treatment group received from @ to @ mg of chlorpromazine daily ; patients in the other condition received injections of fluphenazine decanoate ranging from @ to @ mg at bi-weekly intervals .\n",
            "Subjects remained on the experimental regimes for six weeks during which they completed a series of personality inventories and were rated in psychiatric interviews .\n",
            "After the full period on study drugs , subjects completed tasks designed to assess their ability to learn in both impersonal and social contexts .\n",
            "Both treatment groups demonstrated significant symptom diminution over the course of the experimental trials , these changes being apparent on virtually every measure .\n",
            "Treatments did not affect symptom levels differently .\n",
            "Only on measures of learning could treatment differences be identified .\n",
            "Fluphenazine subjects performed significantly better than those receiving chlorpromazine on all major indices of task learning .\n",
            "Fluphenazine patients also demonstrated significantly greater control or consistency in the interpersonal task .\n",
            "These differences were not entirely unexpected given the greater sedative effects of chlorpromazine .\n",
            "Implications for the chemotherapy of schizophrenia are considered .\n",
            "Background : There is growing evidence that inflammatory processes are involved in the pathogenesis of schizophrenia .\n",
            "Autoimmune disorders are over-represented in patients and relatives and changes in the concentration of circulating cytokines appear consistent in meta-analyses .\n",
            "However , attempts to improve symptoms of schizophrenia with antiinflammatory agents have produced inconsistent results .\n",
            "We reported that minocycline selectively improved negative symptoms when added to treatment as usual ( TAU ) for one year in early psychosis ( PMID : @ ) and this selective benefit survived a meta-analysis of the few studies ( PMID : @ ) .\n",
            "A call by the Stanley Medical Research Institute ( SMRI ) enabled us to determine whether methotrexate with a different mechanism of anti-inflammatory action , might also improve negative or other symptoms .\n",
            "We used low dose methotrexate , an effective anti-inflammatory treatment for psoriasis and rheumatoid arthritis ( RA ) .\n",
            "The mechanism of action is thought to involve inhibition of purine metabolism and T-cell function whereas its high dose anti-cancer effects are mediated by its anti-folate action .\n",
            "Methods : The design and analysis plan were pre-registered ( PMID : @ ; NCT@ ) .\n",
            "This was a double-blind placebo-controlled feasibility study of methotrexate ( @ mg weekly for @ weeks ) added to TAU in patients within @ years of the onset of schizophrenia disorders .\n",
            "After screening , full clinical and safety assessments were carried out at randomization , @ , @ , @ and @ weeks .\n",
            "Cognitive assessments were carried out at randomisation and @ weeks .\n",
            "Efficacy assessments included Positive and Negative Syndrome Scales ( PANSS ) , Clinical Global Impression ( CGI ) , Global Assessment of Functioning Scale ( GAF ) , EQ-@D quality of life scale and an insight scale .\n",
            "Cognitive assessments were : Stroop test , block design , verbal and category fluency , Coughlan visual and verbal list learning .\n",
            "Safety assessments included blood counts and side effects scales in keeping with methotrexate monitoring standards .\n",
            "Statistics .\n",
            "Based on power calculation , we aimed to recruit @ patients assuming a @ % drop-out giving @ per group at @ weeks .\n",
            "The intention to treat analysis determined group effects on @ week clinical and cognitive outcomes covarying for baseline measures with attention to possible biases from drop-outs .\n",
            "Generalised estimating equations ( GEE ) estimated the effect of treatment on longitudinal outcomes .\n",
            "Results : @ participants were randomised , @ to placebo ( PBO ) and @ to methotrexate ( MTX ) with respectively @ and @ completing @ weeks of treatment .\n",
            "The @ dropouts in each group were due to loss of contact or co-operation .\n",
            "@ refused medication in the MTX group .\n",
            "There were no serious adverse events or obvious side-effect differences .\n",
            "There was no statistically significant effect of MTX on PANNS negative syndrome scores but the PANSS positive subscale improved more from baseline to @ weeks on MTX [ Mean ( SD ) @ ( @ ) to @ ( @ ) ] than on placebo [ @ ( @ ) to @ ( @ ) ] giving a MTX/PBO treatment effect beta-@ ; @ % CI ( -@ to-@ ) ; p = .@ .\n",
            "The corresponding treatment effect for the negative syndrome was beta-@ ; @ % CI ( -@ to @ ) ; p = @ .\n",
            "The findings were confirmed by the GEE analysis .\n",
            "There was a significant treatment effect on GAF but not on CGI or quality of life .\n",
            "There were no significant effects of treatment on cognitive performance .\n",
            "WCC reduced slightly in the MTX group over @ weeks producing a significant treatment effect compared to PBO .\n",
            "However , subsequent causal mediation analysis did not indicate a mediating role in improving positive symptoms .\n",
            "Conclusions : Methotrexate appears to exert a selective benefit on positive symptoms of schizophrenia early in the disorder .\n",
            "There were no effects on negative symptoms or cognitive performance .\n",
            "This is in contrast with a possible benefit of minocycline on negative symptoms rather than positive .\n",
            "Minocycline and MTX have a variety of actions on the immune system and they are both effective in some autoimmune disorders although MTX may e more effective in RA and psoriasis .\n",
            "Minocycline , has a number of CNS interactions which may be more relevant to negative symptoms .\n",
            "The efficacy of MTX may point to a role of immune mechanisms in positive symptoms .\n",
            "MTX reduced WCC to a similar extent to that observed in a recent study in patients with RA ( PMID : @ ) .\n",
            "This suggests that patients were compliant with medication .\n",
            "However , this index of immune suppression did not appear to have a mediating role in improvement .\n",
            "This study shows that a definitive RCT of MTX in schizophrenia is worthwhile and feasible , and it provides a clear basis for sample size estimation .\n",
            "This double-blind , six-week , parallel trial compared the efficacy and safety of a dose range of olanzapine , @-@ mg/day , to a dose range of haloperidol , @-@ mg/day , in @ patients with a DSM-III-R diagnosis of schizophrenia ( @ % ) , schizophreniform disorder ( @ % ) , or schizoaffective disorder ( @ % ) .\n",
            "Patients were assigned by random allocation to double-blind therapy .\n",
            "A statistically significantly ( p < .@ ) greater proportion of @ olanzapine patients ( @ % ) than the @ haloperidol patients ( @ % ) completed the acute phase .\n",
            "The proportions of patients discontinuing for lack of efficacy ( LOE ) and adverse events ( ADE ) were also statistically significantly smaller with olanzapine .\n",
            "On the primary analysis of overall efficacy , the difference in baseline to endpoint ( LOCF ) mean change on the BPRS , olanzapine was statistically superior to haloperidol ( -@ , -@ , p = .@ ) .\n",
            "Mean change on CGI-S and response rate ( > @ % improvement on BPRS with three or more weeks treatment ) significantly favored olanzapine as did improvement on BPRS-negative and PANSS-negative .\n",
            "Positive symptom improvement was comparable .\n",
            "There was statistically significantly less treatment emergent dystonia , parkinsonism , and akathisia with olanzapine than with haloperidol .\n",
            "Scores on Simpson Angus , Barnes , and AIMS decreased for olanzapine treated patients and were statistically significantly superior to haloperidol .\n",
            "The efficacy and safety data will be reviewed in greater detail .\n",
            "Introduction : Nicotine has been shown to have beneficial effects on some aspects of cognition .\n",
            "It has been postulated that the prevalence of smoking in schizophrenia is related to these effects .\n",
            "We evaluated the effect of nicotine on attention and eye movements , domains in which schizophrenic patients have robust deficits .\n",
            "Design : Patients ( n = @ ) and controls ( n = @ ) were given a Nicoderm @ mg patch in a double-blind , placebo-controlled , crossover design , and performance on attentional tasks , including the CPT and oculomotor tasks ( pursuit and antisaccade ) were assessed .\n",
            "Results : Nicotine significantly improved attention ( CPT hit rate ) in patients ( p , .@ ) and not controls .\n",
            "Nicotine increased pursuit gain ( p , .@ ) and decreased antisaccade errors ( p , .@ ) in patients and controls equally .\n",
            "Improvement in pursuit seemed to be related to attention , since the effect of nicotine was significant only in the no-monitoring pursuit condition .\n",
            "The magnitude of the improvement on eye movement and attention tasks did not correlate with plasma nicotine concentration ( measured by RIA ) .\n",
            "Conclusion : Nicotinic mechanisms modulate attention and oculomotor functions .\n",
            "The effect of nicotine on pursuit may be mediated by attention .\n",
            "Introduction : This thesis contains three studies which are embedded within the larger CRIMSON trial ; an individual level , randomised control trial comparing joint crisis plans with treatment as usual for people with severe mental illness .\n",
            "This thesis presents sub-analysis from CRIMSON , testing hypotheses about ethnic minorities only within the context of the wider trial .\n",
            "Recruitment and utilisation of the intervention by ethnic minorities is also investigated.Methods : The joint crisis plan intervention documented the service users   treatment preferences for the event of a future crisis .\n",
            "The plan was formulated collaboratively by the service user and their clinical team and was negotiated by an independent facilitator .\n",
            "The settings for the trial were community mental health teams across three sites in England .\n",
            "The hypotheses tested were that compared to receiving treatment as usual , the intervention group would experience fewer compulsory hospital admissions , fewer psychiatric hospital admissions and an improved working alliance with their care coordinator .\n",
            "Following a systematic review , strategies were implemented to overcome barriers to recruiting ethnic minorities into the CRIMSON trial .\n",
            "Diary entries were maintained in the Manchester/Lancashire site detailing attempts to overcome barriers encountered with the recruitment of ethnic minorities .\n",
            "Content analysis was carried out on the completed joint crisis plans to assess culturally relevant statements made regarding service users   mental health and future treatment.Results : In the sub-analysis @ participants were randomised ( @ experimental , @ control group ) .\n",
            "No evidence of treatment effect was seen for compulsory hospital admissions ( OR @ , @ % CI @-@ , p = @ ) any psychiatric admissions ( OR @ , @ % CI @-@ , p = @ ) or service user rated working alliance ( B = @ , @ % CI -@-@ , p = @ ) .\n",
            "Additional sub-analysis found differential effects of the intervention on specific ethnic groups , with a reduction in overall admissions observed for black participants and an increase in admissions for south Asian and white British service user on any admission .\n",
            "Strategies for reducing barriers to participation into the research from ethnic minorities were implemented and @ % of south Asian and black service users who were eligible for CRIMSON were recruited .\n",
            "@ % of south Asian and black participants made culturally relevant statements within their joint crisis plans .\n",
            "This figure was significantly higher for south Asian ( @ % ) compared to black ( @ % ) participants ( p = @ ) .\n",
            "Conclusions : This thesis suggests that joint crisis plans may have a differential effect on people from different ethnic groups , for reasons that at present we do not understand .\n",
            "This is interesting because it emphasises the importance of analyses that look at ethnic minorities and the way that they may help elucidate the effects of complex interventions .\n",
            "It also suggests that different ethnic minorities may react in different ways .\n",
            "This thesis certainly supports the value of efforts to recruit ethnic minorities .\n",
            "It is recommended that future work around joint crisis plans should take a qualitative approach to aid the understanding of what lies behind these apparent differential effects .\n",
            "Background : Recent literature has focused on the weight gain liability associated with atypical antipsychotics .\n",
            "Recommendations are emerging that emphasize the importance of careful monitoring of weight in patients treated with these agents .\n",
            "Furthermore , preliminary data indicate that patients may benefit from interventions that include nutritional counseling and exercise programs to reduce the impact of antipsychotic-related weight gain .\n",
            "Objective : To determine the effect of a modular educational program on weight gain among olanzapine-treated patients .\n",
            "Method : Twelve patients ( @ M , @ F ) with a DSM-IV diagnosis of schizophrenia or schizoaffective disorder entered this four-month study .\n",
            "All patients began olanzapine treatment at study entry .\n",
            "The patients were then RANDOMized into an intervention group ( @ M , @ F ) and a standard care group ( @ M , @ F ) .\n",
            "The intervention group participated in a one-hour , weekly class that used a modular educational program on nutrition and exercise .\n",
            "The patients ' weights and BMIs were measured and recorded monthly .\n",
            "Results : The mean change in weight of the intervention group was +@ lb .\n",
            "( range : -@ to +@ lbs . )\n",
            ", while the mean change in the standard care group was +@ lbs .\n",
            "( range : -@ to +@ lbs . )\n",
            ".\n",
            "The mean change in BMI 's of the intervention group and standard care group was +@ ( range : -@ to +@ ) and +@ ( range : -@ to +@ ) , respectively .\n",
            "Although there was not a statistically significant difference in BMIs ( baseline to endpoint ) in either group , subjective reports of personal comfort and self-image were notably different .\n",
            "Gender differences were noted in both the intervention group and the standard care group .\n",
            "At endpoint , males gained more weight than females in the intervention group ( M = +@ lbs. ; F = -@ lbs . )\n",
            "and the standard care group ( M = +@ lbs. ; F = -@ lbs ) .\n",
            "Conclusions : This small , preliminary study suggests that an educational intervention may positively influence antipsychotic-induced weight gain as well as influence feelings of self-image .\n",
            "Larger , extended , controlled trials are needed to more fully understand the impact that educational interventions may have on preventing or limiting antipsychotic-induced weight gain\n",
            "Objective : Treatment of dyskinetic disorders , in general , and of tardive dyskinesia ( TD ) , in particular , is difficult .\n",
            "The opiate peptide enkephalin coexits with gamma aminobutyric acid in the projection neurons of striatum forming the ' indirect ' pathway .\n",
            "Several lines of preclinical evidence implicate this enkephalin-comediated pathway in the pathophysiology and therapeutics of dyskinesia .\n",
            "However , previous studies , most using relatively low doses of opioid antagonists , showed mixed results .\n",
            "The goal of the current study was to test whether moderately high doses of naltrexone , alone or in combination with a subtherapeutic dose of a gamma aminobutyric acid agonist , improve TD .\n",
            "Methods : In @ double-blind , placebo-controlled , RANDOMized , cross-over trials , effects of naltrexone alone ( n = @ ) and in combination with clonazepam ( n = @ ) were tested on TD .\n",
            "In both trials , patients ' antipsychotic medication and dose remained unchanged through the trial .\n",
            "Naltrexone dose was increased over a period of @ weeks to @ mg/d and maintained at that dose for another week .\n",
            "In the second study , patients were first stabilized on low dose ( @ to @ mg ) of clonazepam for @ weeks or longer .\n",
            "In addition to the TD scores , saccadic peak velocity and latency , as measures of vigilance , and antisaccade error rate were obtained during the fourth week of placebo and naltrexone in a subgroup of patients .\n",
            "Results : There were no significant effects of naltrexone alone on TD ( mean  SD decrease in TD score = @ @ ) , psychosis scores , or eye movement measures .\n",
            "Low dose of clonazepam had no effect on TD .\n",
            "However , addition of naltrexone significantly improved TD ( mean , SD decrease in TD score @  @ ) .\n",
            "There was no clinical or laboratory evidence of increased sedation during treatment with naltrexone compared to placebo .\n",
            "There were no significant effects on the antisaccade error rate or psychosis scores .\n",
            "Conclusion : These findings suggest effectiveness of a strategy of combining a GABA ( gamma aminobutyric acid ) mimetic drug with an enkephalin antagonist to treat dyskinesia\n",
            "The objective of the present study was to compare the pattern of motor activity in unmedicated schizophrenia patients and healthy subjects , and to examine whether the pattern was affected by treatment with typical and atypical antipsychotics .\n",
            "Twenty unmedicated schizophrenic patients wore a wrist actigraph for five days .\n",
            "The actigraph recorded activity levels in one-minute epochs .\n",
            "Patients ' pattern of activity was compared with that of healthy subjects .\n",
            "Patients were randomly assigned to treatment with low-dose haloperidol or risperidone .\n",
            "The impact of treatment on the pattern of activity was examined .\n",
            "Compared to controls , untreated patients showed a diminished mean activity count during morning , early and late night periods .\n",
            "Treatment with haloperidol or risperidone at effective doses showed a significant effect on activity level , being more prominent with haloperidol .\n",
            "The results suggest that unmedicated schizophrenic patients exhibit abnormally low levels of motor activity as measured with an objective activity meter .\n",
            "This persists after antipsychotic treatment even though symptoms improve .\n",
            "Future studies should clarify whether motor disturbances are a primary effect of the illness , or related to the illness-related lifestyle .\n",
            "\" Objective To study the aripiprazole clinical efficacy and safety of the treatment of schizophrenia .\n",
            "Methods will meet the CCMD-@ diagnostic criteria for schizophrenia , @ patients were randomly divided into group A ( @ patients ) and group B ( @ patients condensed schizophrenia scale ( BPRS ) ) .\n",
            "Were given aripiprazole and olanzapine oral after six weeks of treatment , schizophrenia positive and negative scale ( PANSS ) and clinical Global Impression ( CGI ) evaluate the efficacy , adverse reactions scale ( TESS ) and laboratory assessment for the safety of six weeks after treatment , PANSS total scores were significantly lower than before treatment ( P < @ ) , group @ clinical total effective no significant difference in adverse reactions a low incidence of minor degree of patients can tolerate .\n",
            "Similar to the conclusions of the efficacy of aripiprazole and olanzapine , is an effective and safe antipsychotic drugs . \" \"\n",
            "Glucose is the principal energy substrate for the brain , and alterations in glucose availability can alter neuronal function , including cognitive performance .\n",
            "Investigators have previously demonstrated glucose-induced memory and attentional improvements in humans , including a previous report from this group in subjects with schizophrenia .\n",
            "However , the age - and dose-dependence of this effect in schizophrenia has not been addressed .\n",
            "This within-subjects , double-blind experiment evaluated the cognitive effects of placebo-controlled , multiple fixed-dose oral glucose administration ( @ g , @ g , @ g , @ g ) in younger and older patients with schizophrenia ( n = @ ) and healthy age-matched controls ( n = @ ) .\n",
            "Each dose condition was administered on a different morning after a @-h fast , with cognitive testing and plasma sampling following dose administration on each day .\n",
            "Older patients demonstrated dose-dependent improvements in recall performance on a spatial delayed response task and reaction time on a delayed match to sample task , while younger patients had decreases in attentional performance at the @-g dose compared to placebo .\n",
            "As in previous reports , patients demonstrated higher plasma glucose and insulin concentrations than controls in response to fixed glucose dosing .\n",
            "The results provide further evidence that glucose and/or insulin can regulate brain functions relevant to memory and attention , and suggest that systemic changes in glucose regulation in schizophrenia deserve further study .\n",
            "PURPOSE : ALKS @ is composed of a flexible dose of olanzapine and a fixed dose of @-mg samidorphan ( a novel opioid system modulator ) , designed to provide the established antipsychotic efficacy of olanzapine and to mitigate olanzapine-induced weight gain .\n",
            "To support clinical development of ALKS @ , we conducted a multicenter , randomized , open-label , Phase I study to obtain steady-state exposure for olanzapine and samidorphan and short-term safety at the intended therapeutic dose range of ALKS @ @/@ ( @-mg olanzapine/@-mg samidorphan ) to ALKS @ @/@ ( @-mg olanzapine/@-mg samidorphan ) in subjects with schizophrenia .\n",
            "METHODS : After a @-week olanzapine lead-in period , @ subjects ( @ women ) with schizophrenia were randomly assigned ( @:@ ) to receive ALKS @ @/@ or ALKS @ @/@ bilayer oral tablets once daily for @ days .\n",
            "Plasma concentrations of olanzapine and samidorphan were quantified by using an LC-MS/MS method .\n",
            "Pharmacokinetic parameters were calculated according to noncompartmental analysis .\n",
            "Safety was monitored throughout the study .\n",
            "FINDINGS : After a @-week olanzapine lead-in phase with titration of olanzapine dose up to @ mg/d , the steady-state concentration of olanzapine was reached in @-@ days and that of samidorphan was reached in @ days after initiation of once-daily oral administration of ALKS @ @/@ or ALKS @ @/@ .\n",
            "At steady state , exposure to olanzapine increased dose proportionally from @ mg ( ALKS @ @/@ ) to @ mg ( ALKS @ @/@ ) , and exposure to samidorphan was similar between the @ ALKS @ dose groups , indicating that different dose levels of olanzapine in ALKS @ had no impact on the pharmacokinetic profile of samidorphan .\n",
            "ALKS @ was well tolerated , and no safety concerns unique to ALKS @ compared with olanzapine monotherapy were identified .\n",
            "IMPLICATIONS : In the present study , samidorphan exposure was not affected by different dose levels of olanzapine in ALKS @ .\n",
            "In addition , olanzapine exposure as a component of ALKS @ was comparable with previously published data for olanzapine monotherapy .\n",
            "The present data indicate that combining olanzapine with samidorphan does not affect the pharmacokinetic profile of either drug and support continued clinical evaluation of ALKS @ .\n",
            "ClinicalTrials.gov identifier : NCT@ .\n",
            "Objiective To observe the clinical effects and side effects of Fang Feng Tong Sheng San in treating @ patients with schizophrenia.Methods Multicentre open controlled trial was adopted @ cases in the study group were received antipsychotic drugs plus Fang Feng Tong Sheng San , and @ cases in the control group were received antipsy-chotic drugs alone .\n",
            "The clinical effects were assessed by BPRS , SAPS , SANS and CGI .\n",
            "TESS and RSESE were used to evaluate the side effects .\n",
            "Results The\n",
            "@ MALE AND @ FEMALE CHRONIC SCHIZOPHRENIC PATIENTS ATTENDING A COMMUNITY CLINIC WERE RANDOMLY ASSIGNED TO @ OF @ TREATMENT CONDITIONS-CHLORPROMAZINE , PROMAZINE , OR PLACEBO-AND STUDIED FOR CHANGE IN AGGRESSIVE BEHAVIOR AFTER @ MO .\n",
            "OF TREATMENT .\n",
            "IT WAS PREDICTED THAT THE DEGREE OF CONFLICT AND TENSION CHARACTERIZING THE S 'S HOME MILIEU WOULD BE A FACTOR IN MODIFYING THE POTENTIAL EFFECTIVENESS OF DRUG TREATMENT ON AGGRESSIVE BEHAVIOR .\n",
            "THE RESULTS SHOW THAT THE MOST SIGNIFICANT DECREASE IN AGGRESSION OCCURRED AMONG THE CHLORPROMAZINE-TREATED SS FROM LOW CONFLICT AND TENSION HOMES .\n",
            "THE DECREASE FOR CHLORPROMAZINE-TREATED SS FROM HIGH CONFLICT AND TENSION HOMES WAS THE SAME AS THAT FOR PROMAZINE - AND PLACEBO-TREATED SS , REGARDLESS OF DEGREE OF CONFLICT AND TENSION .\n",
            "THE RESULTS WERE INTERPRETED AS INDICATING THAT CHLORPROMAZINE WILL SIGNIFICANTLY REDUCE AN S 'S AGGRESSIVE BEHAVIOR IF THAT BEHAVIOR IS DISSONANT WITH FAMILY INTERACTIONAL PATTERNS ( LOW CONFLICT AND TENSION ) AND WILL BE LESS EFFECTIVE IN THOSE SITUATIONS IN WHICH AGGRESSIVE BEHAVIOR IS CONSISTENT WITH FAMILY INTERACTIONAL PATTERNS ( HIGH CONFLICT AND TENSION ) .\n",
            "EDUCATIONAL OBJECTIVES - At the conclusion of this workshop , participants will be able to describe mechanisms of mental health and primary care service integration and measures of their efficacy .\n",
            "They will also be able to discuss the management of diabetes in patients with serious mental disorders SUMMARY-This workshop will present several studies addressing the value of mental health integration with medical care .\n",
            "Dr. Benjamin Druss of the VA Connecticut ( West Haven ) Health Care System will present the results of a RANDOMized trial of integrated primary care medical services for patients with mental disorders .\n",
            "Improved quality and health outcomes were found in the study patients .\n",
            "Dr. Bradford Felker of the VA Puget Sound Health Care System will address treatment of patients with depression and mixed depression and anxiety in primary care settings .\n",
            "Dr. Lisa Dixon of the VA Maryland ( Baltimore ) Health Care System will discuss a study of persons with schizophrenia , major affective disorders , and those without mental disorders on diabetes-related health behaviors , outcomes , and quality of care .\n",
            "Dr. Frederick Guggenheim , chair of psychiatry at the University of Arkansas School of Medicine , and Dr. Larry Lehmann , VA chief consultant for mental health will serve as co-chairs for the workshop .\n",
            "Each presenter will have @ minutes to present and answer questions from the audience .\n",
            "As discussant , Dr. Lehmann will take @ minutes , allowing a further @ minutes for questions and open discussion at the end of the program .\n",
            "This program is intended for clinicians and health care services delivery researchers interested in integration of mental health and other medical care\n",
            "Despite the prevalence of Internet support groups for individuals with mental illnesses little is known about the potential benefits , or harm , of participating in such groups .\n",
            "Therefore , this randomized controlled trial sought to determine the impact of unmoderated , unstructured Internet peer support , similar to what is naturally occurring on the Internet , on the well-being of individuals with psychiatric disabilities .\n",
            "Three hundred individuals resident in the USA diagnosed with a Schizophrenia Spectrum or an Affective Disorder were randomized into one of three conditions : experimental Internet peer support via a listserv , experimental Internet peer support via a bulletin board , or a control condition .\n",
            "Three measurement time points , baseline , @ - and @ months post-baseline , assessed well-being by examining measures of recovery , quality of life , empowerment , social support , and distress .\n",
            "Time x group interactions in the repeated measures ANOVA showed no differences between conditions on the main outcomes .\n",
            "Post-hoc repeated measures ANOVAs found that those individuals who participated more in Internet peer support reported higher levels of distress than those with less or no participation ( p = @ ) .\n",
            "Those who reported more positive experiences with the Internet peer support group also reported higher levels of psychological distress than those reporting less positive experiences ( p = @ ) .\n",
            "Study results therefore do not support the hypothesis that participation in an unmoderated , unstructured Internet listserv or bulletin board peer support group for individuals with psychiatric disabilities enhances well-being .\n",
            "Counterintuitive findings demonstrating those who report more positive experiences also experienced higher levels of distress are discussed but we also point to the need for additional research .\n",
            "Future research should explore the various structures , formats , and interventions of Internet support , as well as the content and quality of interactions .\n",
            "Knowledge generated from such research can help to inform policies and guidelines for safely navigating online resources and supports to gain maximum benefit .\n",
            "Objective To compare ziprasidone and quetiapine in the treatment of schizophrenia clinical efficacy and safety .\n",
            "@ cases of schizophrenia or schizophreniform psychosis in hospitalized patients were eligible , were randomly divided into a control group the oral ziprasidone treatment group ketone piece and oral quetiapine tablets are @ weeks of treatment .\n",
            "The primary efficacy assessed with schizophrenia positive and negative symptoms rating scale ( panss ) , assessed security adverse reactions Scale ( tess ) .\n",
            "The results at the end of treatment panss less points rate in treatment group ( @  @ ) % in the control group ( @  @ ) % ; clinical total effective rate in the treatment group was @ % and @ % in the control group , the difference of the two groups were no significant ( p > @ ) ; incidence of adverse reactions between the two groups there was no significant difference ( p > @ ) .\n",
            "OBJECTIVE : To compare the tolerability and efficacy of different antipsychotic cross-titration schedules , using data from a brexpiprazole study ( Equator ; NCT@ ) .\n",
            "METHODS : Patients with schizophrenia were cross-titrated from other antipsychotics to brexpiprazole monotherapy in a @-@ week open-label conversion phase , then entered a single-blind brexpiprazole treatment phase .\n",
            "Patients were stratified into four \" conversion groups , \" according to the amount of time spent in the conversion phase .\n",
            "Discontinuation rates , treatment-emergent adverse events ( TEAEs ) , and efficacy ( Positive and Negative Syndrome Scale [ PANSS ] ) were compared between conversion groups .\n",
            "RESULTS : Of the @ patients treated with brexpiprazole , the majority ( @ % ) spent @-@ days in the conversion phase .\n",
            "Discontinuation rates due to lack of efficacy or adverse events were low in all conversion groups .\n",
            "Of the @ patients who successfully switched and completed @ weeks of brexpiprazole treatment , most were converted to brexpiprazole over @-@ days ( @ % ) , and fewer were converted over @-@ days ( @ % ) , @-@ days ( @ % ) , or @-@ days ( @ % ) .\n",
            "The incidence of TEAEs over @ weeks was lower among those converted over @-@ days ( @ % ) than in other conversion groups ( @-@ % ) , although low patient numbers with shorter conversion times limit the generalizability of this finding .\n",
            "Each conversion group showed comparable improvement in PANSS total score from baseline .\n",
            "CONCLUSION : The majority of patients were cross-titrated to brexpiprazole over a period of @-@ days , by investigators ' choice .\n",
            "Additional data on shorter conversions may help clinicians to choose a switching paradigm that best meets their patients ' needs .\n",
            "Objectives : Tardive dyskinesia ( TD ) is a persistent movement disorder that is often induced by chronic exposure to dopamine receptor blocking agents ( e.g. , antipsychotics ) .\n",
            "Valbenazine ( VBZ ; NBI-@ ) is a novel , highly selective vesicular monoamine transporter @ ( VMAT@ ) inhibitor currently in development for TD treatment .\n",
            "VBZ has exhibited a favorable efficacy and safety profile in multiple clinical studies including the KINECT @ ( NCT@ ) trial , a dose-escalating Phase @ trial in which treatment with VBZ vs placebo ( PBO ) resulted in significant and clinically meaningful improvements in TD symptoms .\n",
            "The present analysis evaluated the psychiatric status of subjects in this study .\n",
            "METHODS : KINECT @ was a @-week , randomized , doubleblind , PBO-controlled trial in subjects with schizophrenia , mood disorder , or gastrointestinal disorder and moderateto-severe TD .\n",
            "Subjects were randomized ( @:@ ) to once-daily PBO or VBZ , which was initiated at @ mg and escalated in @ mg increments every @ weeks to a maximum of @ mg .\n",
            "The primary efficacy endpoint was defined as the change from baseline at Week @ in the Abnormal Involuntary Movement Scale ( AIMS ) score for VBZ vs PBO , as scored by two blinded central raters .\n",
            "Safety assessments were analyzed descriptively and included the following psychiatric scales : Positive andNegative Syndrome Scale ( PANSS ) , Calgary Depression Scale for Schizophrenia ( CDSS ) , Young Mania Rating Scale ( YMRS ) , Montgomery-Asberg Depression Rating Scale ( MADRS ) , and Columbia Suicide Severity Rating Scale ( C-SSRS ) .\n",
            "RESULTS : The safety population included @ VBZ and @ PBO subjects ; @ % of the VBZ subjects reached the maximum dose of @ mg .\n",
            "Antipsychotics , antidepressants , and anxiolytics were the most common concomitant medications , taken by .@ % of subjects in each group .\n",
            "The Week @ change from baseline in AIMS score ( primary endpoint ) was significantly greater for VBZ vs PBO ( P = @ ) .\n",
            "Psychiatric status remained stable or improved from baseline in both groups , as shown by the following mean score changes at Week @ : PANSS Positive ( VBZ .@ , PBO-@ ) , PANSS Negative ( VBZ @ , PBO .@ ) , and PANSS General Psychopathology ( VBZ .@ , PBO .@ ) ; CDSS ( VBZ .@ , PBO .@ ) ; YMRS ( VBZ-@ , PBO .@ ) ; and MADRS ( VBZ-@ , PBO .@ ) .\n",
            "The percentage of subjects with suicidal ideation or behavior as measured by the C-SSRS for VBZ vs PBO was @ % vs @ % ( screening ) and @ % vs @ % ( Weeks @-@ ) .\n",
            "CONCLUSIONS : There was no apparent increase in psychopathology , depression , or suicidality with VBZ .\n",
            "Psychiatric status remained stable or improved in subjects with TD who had underlying schizophrenia , schizoaffective disorder , depression or bipolar disorder .\n",
            "\" Cognitive Adaptation Training ( CAT ) improves functional outcomes in schizophrenia outpatients living in the United States .\n",
            "The effectiveness of CAT for patients living outside the US as well as for long-term hospitalized patients remains to be determined .\n",
            "In addition , it has not yet been studied whether CAT can be successful if patients receive the treatment from psychiatric nurses .\n",
            "This pilot study investigated the effectiveness and feasibility of CAT as a nursing intervention in the Netherlands .\n",
            "Thirty schizophrenia patients ( long-term hospitalized patients : @ % ) participated in this study .\n",
            "Sixteen patients received treatment as usual ( TAU ) + CAT , and fourteen patients received TAU .\n",
            "Patients in CAT participated in the treatment for eight months , consisting of weekly home-visits by a psychiatric nurse , supervised by a psychologist .\n",
            "After eight months , CAT interventions were integrated in the usual treatment .\n",
            "Outcome measures were the Multnomah Community Ability Scale ( MCAS ) , the Social and Occupational Functioning Scale ( SOFAS ) , and the Negative Symptom Assessment-Motivation subscale ( NSA-M ) .\n",
            "For inpatients , work-related activities were also tracked for @ months after baseline .\n",
            "Patients receiving TAU+CAT had better scores on the MCAS ( trend ) , compared to TAU patients .\n",
            "Moreover , inpatients ' work-related activities increased in TAU+CAT , relative to TAU inpatients , reaching significance after ten months .\n",
            "Improvements on the SOFAS and NSA-M were not significant .\n",
            "These results indicate that CAT as a nursing intervention may improve outcomes in patients with schizophrenia living in the Netherlands , including long-term hospitalized patients .\n",
            "However , since the current study was designed for exploratory purposes , larger randomized controlled studies are needed to confirm our results and to investigate the long-term effects of CAT as a nursing intervention systematically . \"\n",
            "Early-onset schizophrenia ( EOS ) is a severe form of schizophrenia associated with significant decline or arrest in several cognitive domains .\n",
            "Cognitive Remediation Therapy ( CRT ) is a behavioral intervention that aims to improve cognitive processes with the goal of durability and generalization to patients ' community functioning .\n",
            "Large body of data supports the efficacy of CRT in adults with schizophrenia but few studies have analyzed its effects in young people .\n",
            "Objective : To examine the efficacy of CRT to improve cognition and functional outcome in adolescents with EOS .\n",
            "Methods : Randomized controlled trial of CRT plus treatment as usual ( CRT ) compared to treatment-as-usual as control group ( TAU ) ( NCT@ ) .\n",
            "CRT was implemented on an individual basis following the Frontal/Executive program procedure .\n",
            "Fifty adolescents ( aged @-@ years ) with EOS ( DSM-IV schizophrenia or schizoaffective disorder , onset before @ ) were randomized to the groups ( @ and @ ) .\n",
            "Patients had to be clinically and pharmacologically stabilized during the last @ weeks before the baseline assessment and had to be cognitively impaired .\n",
            "Exclusion criteria were current IQ < @ , active misuse disorder , organic brain syndromes and having received electroconvulsive therapy in the previous @ months .\n",
            "Assessment : Symptoms ( PANSS , Calgary Depression Scale ) , cognitive domains ( tests in Spanish similar to those included in the MATRICS consensus battery ) and functional measures ( Life Skills Profile - LSP - , Vineland Adaptive Behavior Scales - VABS - , C-GAS , Rosenberg Self-Esteem Scale and Caregiver Burden Inventory - CBI ) .\n",
            "Intention-to-treat analyses were used .\n",
            "Repeated measures ANOVA design was employed , between conditions ( CRT vs. TAU ) , and baseline and post-treatment as the time points .\n",
            "ANCOVAs were performed to control for potential confounders .\n",
            "Results : There were no significance baseline differences between groups on demographic measures , IQ , mean chlorpromazine equivalent for antipsychotic medication dosage ( CPZE ) , depressive and positive symptoms , emotional discomfort and hostility .\n",
            "CRT group had more negative symptoms ( t = @ , p = @ ) and total PANSS scores ( t = @ , p = @ ) .\n",
            "The groups were comparable in all cognitive domains and functional measures , excepting for C-GAS ( CRT group scored lower , t = @ , p = @ ) .\n",
            "The groups did not differ in symptoms changes and in CPZE adjustments during the trial .\n",
            "Results showed a beneficial effect of CRT overt TAU on global cognition ( F = @ , p = @ ) , verbal memory ( F = @ , p = @ ) , working memory ( F = @ , p = @ ) and executive functions ( F = @ , p = @ ) .\n",
            "Results did not change when controlling for baseline cognition , excepting in working memory domain ( F = @ , p = @ ) .\n",
            "The addition of symptoms baseline differences between groups as a covariate did not affect the results .\n",
            "CRT group had also greater improvements in LSP ( F = @ , p = @ ) and VABS ( F = @ , p = @ ) , with baseline symptoms differences between groups adjusted for .\n",
            "No significant differences were found in C-GAS or self-esteem .\n",
            "Parents of patients in the CRT group reported greater improvement of their self-perceived burden after treatment ( F = @ , p = @ ) .\n",
            "Conclusions : The findings are consistent with previous studies of CRT and add evidence for its efficacy in ameliorating cognitive impairments and improving functional outcome in adolescents with EOS .\n",
            " @\n",
            "Antipsychotic ( neuroleptic ) drugs remain central to the treatment of the symptoms of schizophrenia .\n",
            "Conventional drugs are effective in @ % of patients but have frequent neurological side effects .\n",
            "The atypical antipsychotics are a new class of drugs with a lower risk of these side effects and , in the case of clozapine , better efficacy .\n",
            "The cost of these new drugs is @-@ times that of conventional drugs .\n",
            "There are currently no reliable data about their comparative effectiveness and cost-effectiveness in NHS settings in which to guide practice .\n",
            "If their use continues to expand , the annual drugs budget for schizophrenia in England will increase from @ million to @ million .\n",
            "A @-centre , prospective , randomised , controlled trial is proposed , to evaluate the relative effectiveness of the new drugs compared to conventional drugs and to clozapine in a sample of @ people with schizophrenia who are resistant to or intolerant of usual treatment .\n",
            "The trial will aim to demonstrate important differences in quality of life and other outcomes at @ year , assess value for money and identify cost-effective management strategies .\n",
            "OBJECTIVE : This study examined whether staff members ' use of interventions for preventing patients ' aggression reduced the number of incidents of aggression on a closed acute admissions ward of a psychiatric hospital in the Netherlands .\n",
            "METHODS : The number and severity of incidents of aggression on three closed wards were measured using the Dutch version of the Staff Observation Aggression Scale ( SOAS ) .\n",
            "Measurements were made for three months before and after staff implemented interventions for preventing aggression on one of the wards .\n",
            "Interventions included a protocol for talking to patients who exhibited aggressive behavior , discussing treatment goals with the patient shortly after admission , explaining why the ward 's door was locked and the exit rules , providing a schedule of staff meetings to explain staff members ' absence from the ward , and clarifying the procedure for making an appointment with the psychiatrists .\n",
            "RESULTS : The frequency of aggressive incidents was reduced on all three wards , with no significant difference between the ward where the interventions were implemented and the two control wards .\n",
            "A marginally significant difference in the severity of aggressive incidents was found between experimental and control wards after the introduction of the preventive measures , with incidents in the experimental ward tending to be less severe .\n",
            "CONCLUSIONS : This study failed to find a robust effect of specific intervention measures on aggressive incidents .\n",
            "However , it did find evidence suggesting that standardized reporting by staff of aggressive incidents on closed psychiatric wards may in itself result in straightforward reduction of violent incidents .\n",
            "Trial Purpose : Evaluate the efficacy of nizatidine in reducing/limiting weight gain in patients with schizophrenia who have been under treatment with olanzapine for at least two months and evaluate the treatment effects on the Eating Inventory , BPRS , number of treatment , emergent adverse events , changes in vital signs , laboratory results and extrapyramidal effects .\n",
            "Primary Outcome Measure : Evaluate the effect of olanzapine associated to nizatidine compared to olanzapine associated to placebo to prevent/control weight gain Secondary Outcome Measure : Compare the effect of olanzapine with nizatidine or placebo evaluated by the average alteration between the groups in cognitive control of appetite , disinhibition and susceptibility to hunger , variation of weight and total punctuation in BPRS Compare the security of the association of olanzapine with nizatidine and olanzapine and placebo in relation to laboratory values , vital signs , and incidence of extrapyramidal symptoms Expected Total Enrollment : @ Participant Eligibility : Ages Eligible for Study : @ Years - @ Years .\n",
            "Genders Eligible for Study : Both Inclusion Criteria : Patients , men or women , with age of @ to @ years .\n",
            "Patients must have schizophrenia that meets disease diagnostic criteria as defined in DSM-IV Sections @ , @ , @ , or @ and not to be in a clinically acute phase , in accordance with the judgment of the investigator .\n",
            "Patients in use of @ mg/day and @ mg/day of olanzapine for a period not less than @ months and not greater than @ months and that have increased at least @ % of their corporal weight since the beginning of the treatment with olanzapine .\n",
            "The individuals must be trustworthy , and have a level of understanding enough to carry out all the tests and examinations demanded for the protocol , to understand the nature of the study and to have signed the informed consent .\n",
            "Women with potential to become pregnant must be using a medically acceptable and reliable means of birth control .\n",
            "Exclusion Criteria : Participation in a clinical study of another drug in investigation within a period of @ month ( @ days ) before the entrance in the study ( Visit @ ) .\n",
            "People who have used clozapine within a period of @ months before the beginning of the study .\n",
            "People with diagnosis of diabetes mellitus types I or II without adjusted clinical control or have initiated the medication use for glycemic control in the last @ months .\n",
            "DSM-IV substance ( except nicotine and caffeine ) dependence within the past @ days .\n",
            "Current participation in programs of weight loss .\n",
            "Background and purpose : Despite the availability of typical and atypical antipsychotic drugs , a large number of patients with schizophrenia do not show a good response to monotherapy with these drugs .\n",
            "This study was done to evaluate the effect of purslane on psychological symptoms of schizophrenic patients .\n",
            "Materials and methods : This randomized clinical trial was carried out in @ chronic schizophrenic patients treated with risperidone in Sina hospital Joneghan , Iran during @-@ .\n",
            "The patients were randomly divided into intervention and control groups .\n",
            "The control group received risperidone @mg/day and Biperiden @mg/day for eight weeks .\n",
            "The Patients in the interventional group received @gr extract of purslane daily with the same regimen for eight weeks .\n",
            "The scales for assessment of positive symptoms ( SAPS ) , assessment of negative symptoms ( SANS ) and CRP level were recorded prior to and @th week after the study .\n",
            "The data was then analyzed using SPSS V. @ .\n",
            "Results : At the end of study , the mean score of positive symptoms were @   @ and @   @ in intervention and control groups , respectively ( P < @ ) , and the mean score of negative symptoms were @   @ and @   @ , respectively ( P < @ ) .\n",
            "The CRP levels of patients in intervention and control groups were @   @ and @   @ , respectively ( P < @ ) .\n",
            "Conclusion : According to findings using purslane as an adjunct to respridone can improve psychological condition of chronic schizophrenic patients and decrease their CRP levels .\n",
            "( Clinical Trials Registry Number : IRCT@N@ )\n",
            "Evaluated the antiparkinsonian activity of lisuride in @ @-@ yr old chronic psychotic patients .\n",
            "During the @st @ wks of the study , all Ss were treated with placebo ; later , lisuride ( @ , @ , @ mg/day ) was administered in gradually increasing doses .\n",
            "After achieving a substantial improvement in objective findings , @ Ss were continued on lisuride and @ were given placebo .\n",
            "Results show a significant dose-dependent decrease of total extrapyramidal symptomatology in the lisuride Ss .\n",
            "Lisuride was well tolerated and in no case was any impairment of psychopathology or biochemistry found .\n",
            "( @ ref )\n",
            "Objectives : the objective was to evaluate the effects of a six-months cbt on symptoms presented by patients with dsm-iv schizophrenia under new neuroleptics .\n",
            "Method : patients consecutively referred , were assigned to two groups using alternative number randomization technique : a group with one hour of cbt every week for six month and the second without .\n",
            "The inclusion criteria were : - age @ to @ ; - schizophrenia ; - persistence of symptoms causing distress and/or dysfunction ; - use of new neuroleptics .\n",
            "Patients were assessed every two-months using : - panss - gafs each group had @ patients .\n",
            "The dropout was of four in the cbt group and of three in the pharmacotherapy group .\n",
            "Results after six-months the reductions on the panss scales was significantly higher for the cbt group .\n",
            "The reductions can not be attributed to the medication .\n",
            "Conclusion cbt seems to be an effective adjunct to pharmacotherapy in the treatment of patients with schizophrenia .\n",
            "There have been few studies of pregnenolone therapy in schizophrenia and those that exist have been subject to several critical limitations , thus yielding inconsistent results .\n",
            "We attempted to assess the therapeutic effect of pregnenolone in a patient sample as homogeneous as possible .\n",
            "In this randomized double-blind clinical trial , @ female inpatients with chronic schizophrenia , who had discontinued their antipsychotic medications for at least one week in case of any oral antipsychotic medication or a month for any depot antipsychotic medication , received risperidone plus either pregnenolone ( @ mg/day ) or placebo for @ weeks .\n",
            "Inclusion criteria were acute illness with a baseline Positive and Negative Syndrome Scale ( PANSS ) negative subscale score of > / = @ .\n",
            "Exclusion criteria were the presence of severe depression or other concomitant psychiatric disorders .\n",
            "Primary outcome was defined as the difference in the PANSS total score change from baseline to week @ in the pregnenolone group compared to the placebo group .\n",
            "No significant difference was found in the PANSS total score changes between the two arms ( mean difference ( CI @ % ) = -@ ( -@ to @ ) ; p = @ ) .\n",
            "Significant differences were initially found for PANSS negative change scores ( mean difference ( CI @ % ) = -@ ( -@ to -@ ) ; p = @ ) and general psychopathology change scores ( mean difference ( CI @ % ) = -@ ( -@ to -@ ) ; p = @ ) .\n",
            "However , these findings did not survive Bonferroni correction for multiple testing .\n",
            "While this trial may suggest a potential effect of pregnenolone on schizophrenia symptoms , further studies are warranted .\n",
            "At the conclusion of this presentation , the participant should be able to understand the use of a disease-specific scale in quality of life research for schizophrenia and the results in one large clinical trial .\n",
            "Objectives - To evaluate the effect of treatment with olanzapine and haloperidol on quality of life ( QOL ) outcomes .\n",
            "Methods - @ patients with DSM-III-R diagnosis of schizophrenia , schizophreniform disorder , or schizoaffective disorder participated in a randomized , double-blind clinical trial .\n",
            "Patients were from @ academic and community centers in @ countries .\n",
            "A total of @ patients had baseline Quality of Life Scale ( QLS ) scores and @ had baseline and six-week QLS scores .\n",
            "Treatment was with either olanzapine @ to @ mg/day or haloperidol @ to @ mg/day for @ weeks .\n",
            "BPRS total scores , PANSS positive and negative scores , CGI Severity scores , and Quality of Life Scale ( QLS ) total and subscale scores were measured .\n",
            "Results - During the acute treatment phase , the olanzapine treatment group had significantly greater improvements in BPRS total ( p = .@ ) , PANSS negative ( p = .@ ) , and CGI Severity ( p = .@ ) , QLS total ( p = .@ ) , intrapsychic foundations ( p = .@ ) , and interpersonal relations ( p = .@ ) compared with the haloperidol treatment group scores during the acute phase .\n",
            "The improvements in QLS total and intrapsychic foundations scores were maintained over the @-week trial .\n",
            "Conclusion - Olanzapine was significantly more effective in reducing severity of psychopathology and in improving quality of life .\n",
            "This superior QOL performance was especially evident in the QLS domains of interpersonal relations and intrapsychic foundations .\n",
            "@ .\n",
            "Schiz Bull @ -@-@ , @ Med Care @ -@-@ , @ .\n",
            "Comorbid substance use disorder in patients with schizophrenia is associated with poor clinical and social outcome and low compliance with integrated outpatient treatment programs .\n",
            "For the first time the present trial compares the efficacy of four sessions of motivational interviewing ( MI ) and four sessions of supportive therapy ( ST ) .\n",
            "The primary outcome was compliance with integrated outpatient treatment post-intervention .\n",
            "Secondary outcomes were substance use , psychopathology , compliance with medication and stage of change in psychotherapy.Sixty inpatients with schizophrenia and substance use disorder were randomised to receive either four sessions of MI or four sessions of ST. Masked assessments took place at baseline , post-treatment and @ - and @-month follow-ups .\n",
            "The integrated outpatient program was attended by @ % of the MI ( n = @ ) and @ % of the ST patients ( n = @ ; p = @ ) .\n",
            "There were no differences regarding secondary outcome between MI and ST groups.The study design allows one for the first time to attribute the findings to the specific effects of MI and thereby emphasizes the effectiveness of this particular treatment approach .\n",
            "In summary , these findings show that the integration of short-term MI for people with both psychosis and substance abuse could significantly improve their chances of attending appropriate outpatient settings and thereby improve their well-being .\n",
            "This study presents data on the use of penfluridol , a once-a-week orally administered , antipsychotic agent , in the treatment of chronic schizophrenic patients .\n",
            "Fifty-nine patients participated in the initial dose titration segment during which doses of penfluridol were adjusted weekly until the patients ' condition became stabilized .\n",
            "The starting dose did not exceed @ mg per week , and the maximum weekly dose did not exceed @ mg .\n",
            "Forty-one of these patients continued on to participate in a double-blind comparison of penfluridol with chlorpromazine .\n",
            "Maximum doses did not exceed @ mg per dose per week for penfluridol and @ mg per week for chlorpromazine in the double-blind segment .\n",
            "Patients were abruptly switched from their previous neuroleptic medication to penfluridol without loss of control .\n",
            "Side effects , mainly extrapyramidal in nature , were readily alleviated with benztropine mesylate .\n",
            "Penfluridol , administered orally once a week , appeared to be well tolerated ; it was comparable to daily chlorpromazine in treating and maintaining schizophrenic patients .\n",
            "Study Design : Double-blind , double-dummy , parallel group , comparative study of ziprasidone versus clozapine .\n",
            "Following Screening and Baseline assessments , subjects were randomized to either ziprasidone or clozapine and underwent treatment for @ weeks plus @ days .\n",
            "All subjects were then evaluated at weekly study visits .\n",
            "At the end of the protocol treatment period , investigators were allowed to break the study blind to enable subjects who had responded to randomized treatment to continue with that medication : responding subjects who had received ziprasidone were allowed to enter a follow-up extension protocol until ziprasidone was commercially available ; responding subjects in the clozapine arm were prescribed the marketed medication .\n",
            "Study hypothesis @ .\n",
            "Does successful treatment of symptoms of schizophrenia produce measurable changes at the brain level ?\n",
            "@ .\n",
            "Are there brain predictors of the clinical response to cognitive behaviour therapy in schizophrenia ?\n",
            "Intervention Functional Magnetic Resonance Imaging ( MRI ) will be applied to investigate brain functions of @ patients with schizophrenia , @ of whom will undergo cognitive behaviour therapy .\n",
            "All patients will be scanned twice , @ to @ months apart , during a series of tasks known or likely to be sensitive to symptoms of schizophrenia .\n",
            "Control data will also be obtained from @ patients with schizophrenia who have shown a good response to their antipsychotic medication and @ healthy subjects .\n",
            "Background : There is considerable evidence that adding SSRI antidepressants to antipsychotic treatment can improve negative symptoms of schizophrenia .\n",
            "This augmentation effect may be due to \" nonspecific \" antidepressant action or be specifically related to action on the serotonergic system Aim : The study examined the serotonergic specificity of SSRI augmentation by comparing an SSRI antidepressant with a comparably effective antidepressant acting via the noradrenergic system .\n",
            "Methods : Consenting chronic schizophrenic patients with prominent negative symptoms were studied .\n",
            "Fluvoxamine or maprotiline was added to their regular antipsychotic treatment in a double blind manner for @ weeks .\n",
            "Subjects were assessed with BPRS , SANS , SAPS , MADRS and SA scales .\n",
            "Results : @ patients completed the study .\n",
            "Negative symptoms improved significantly in the fluvoxamine but not the maprotiline group .\n",
            "Depressive symptoms ( MADRS scores ) were low and did not change significantly in either group .\n",
            "Positive symptoms were not affected by either treatment .\n",
            "Conclusion : The mechanism by which fluvoxamine augmentation improves negative symptoms involves the serotonergic system and is distinct from the antidepressant action .\n",
            "Objective : To understand ECIWO differentiation promoting agent holographic Kang God fluid combination of efficacy and adverse effects of antipsychotic treatment of schizophrenia .\n",
            ": Select standards-compliant patients with schizophrenia and @ cases were randomly divided into holographic group and control group @ cases , a negative positive symptom scale ( PANSS ) , the Clinical Global Impression ( CGI ) , side effects rating scale ( TESS @ ) scale and clinical efficacy assessment of efficacy were assessed .\n",
            "Results : The total effective holographic and control groups were @ % and @ % ( P < @ ) , PANSS total scores of the two groups before and after treatment and between the two groups score difference comparing the differences were significant sex .\n",
            "Two sets of positive scale scores ( P ) , negative scale scores ( N ) changes in group difference was significant ( P < @ ) , the efficacy overall rating ( GI ) after treatment efficacy index ( EI ) and two sets of TESS the difference was significant ( P < @ ) .\n",
            "Using Silverman 's technique of \" subliminal psycho-dynamic activation \" by tachistoscopic presentation of dynamically-relevant visual stimuli , the present study sought : ( @ ) to replicate the finding that the unconscious fantasy MOMMY AND I ARE ONE reduces pathological thinking and behavior , and low self-esteem , in relatively differentiated schizophrenic men ; ( @ ) to test whether this symbiotic fantasy is effective because of its evocation of fantasies of the \" holding environment , \" elaborated by Winnicott ; ( @ ) to compare the efficacy of solely verbal stimuli with verbal + pictorial stimuli ; ( @ ) to explore the relevance of schizophrenics ' high levels of self-touching during discourse to the \" holding environment \" formulation .\n",
            "Ninety-six relatively differentiated male schizophrenic in-patients at Manhattan Psychiatric Center were each assigned to one of eight experimental groups and were seen for two counterbalanced sessions : in one session measures of pathology and self-touching following neutral baseline stimulation and following neutral contol stimulation were obtained ; in the other session the dependent variables were measured following a neutral baseline stimulus and one of the experimental stimuli ( MOMMY AND I ARE ONE , MOMMY AND I ARE ALL , I MAKE MOMMY WHOLE , MOMMY HOLDS ME SAFELY ) .\n",
            "Four groups received the verbal message with a pictorial accompaniment ; four received only the verbal message .\n",
            "Self-esteem was measured after each session .\n",
            "The experiement was conducted double-blind .\n",
            "Only the unaccompanied message MOMMY AND I ARE ONE produced significant reductions in pathology : both cognitive and behavioral measures were affected .\n",
            "Self-esteem increased with MOMMY AND I ARE ALL and across all eight groups .\n",
            "The original finding is replicated , therefore , but its relationship to aspects of the holding environment is not supported here .\n",
            "Exploration of self-touching lent support to two formulations : ( @ ) that it serves a homeostatic function , \" gating \" or restricting incoming stimuli and minimizing perturbations in cognitive performance , and ( @ ) that it activates fantasies of early maternal care and the holding environment .\n",
            "Background : Ziprasidone has been used to treat schizophrenia since @ .\n",
            "It is unknown whether its modest QTc-prolonging effect increases cardiovascular event risk .\n",
            "Purpose : To describe the study design of the Ziprasidone Observational Study of Cardiac Outcomes ( ZODIAC ) .\n",
            "Method : The study was conducted between February @ and February @ .\n",
            "One-year follow-up for the primary endpoint of nonsuicide death ended in April @ .\n",
            "ZODIAC is an open-label , randomized , postmarketing study enrolling patients with schizophrenia in naturalistic practice in @ countries .\n",
            "The primary outcome measure was the rate of nonsuicide mortality in the year after initial recommendation for therapy .\n",
            "Subjects were randomly assigned to either ziprasidone or olanzapine , after which follow-up was conducted by investigators aware of the assigned exposure .\n",
            "A physician-administered questionnaire collected baseline information on patients ' demographics , medical and psychiatric history , and concomitant medication use .\n",
            "Data were self-reported by patients or reported by enrolling physicians .\n",
            "Results : ZODIAC enrolled @ patients with schizophrenia .\n",
            "Most ( @ % ) were from the United States or Brazil .\n",
            "Patients ' baseline mean age was @ years , @ % were male , and @ % were white .\n",
            "At baseline , approximately @ % had hypertension , @ % had hyperlipidemia , @ % currently smoked , @ % had a body mass index [ greater-than or equal to ] @ kg/m <sup> @ </sup> , and @ % had diabetes .\n",
            "Mean time from schizophrenia diagnosis to study enrollment was @ years and mean Clinical Global Impressions scale score was @ ( range : @-@ ) .\n",
            "Nearly one third of patients had ever attempted suicide .\n",
            "Seventy-one percent were using antipsychotics at baseline .\n",
            "Almost @ % were using concomitant medications , with @ % using antidepressants , @ % using anxiolytics , and @ % using mood stabilizers .\n",
            "Less than @ % were using antihypertensives or statins .\n",
            "Conclusions : ZODIAC is a uniquely designed study with an initial randomization to ziprasidone or olanzapine and follow-up largely consistent with usual practice ( i.e. , many characteristics of a nonexperimental study ) .\n",
            "Baseline data suggest this study population has a substantial prevalence of cardiovascular risk factors .\n",
            "Concomitant medications were used frequently , although hyperlipidemia and hypertension may be undertreated .\n",
            "Trial Registration : clinicaltrials.gov Identifier : NCT@ .\n",
            "Background : Several studies have examined the development of clinical remission during treatment of schizophrenia .\n",
            "However , development of remission may not be associated with functional recovery , which must be examined separately .\n",
            "This study examined the development of  functional remission  in a long-term double-blind comparison of haloperidol and ziprasidone .\n",
            "Methods : Community dwelling patients with schizophrenia were randomized to treatment with haloperidol ( n = @ ) or ziprasidone dosed either once or twice daily ( n = @ ) and re-examined at follow-up intervals ranging up to @ weeks .\n",
            "Their community functioning was examined with the HeinrichsCarpenter Quality of Life Scale .\n",
            "Both total scores for employment and social functioning and achievement of improvement milestones across the individual items were analyzed .\n",
            "Results : Mixed random effects models adjusting for length of followup indicated a significant ( pb .@ ) treatment effect favoring ziprasidone for social functioning .\n",
            "While the mixed model was not significant for employment , the @ % confidence interval for changes scores in the haloperidol group overlapped with @ , while mean change was significantly greater than @ for the ziprasidone group .\n",
            "Most importantly , the distributions of change scores across the items showed significantly more items where endpoint scores were @ or @ ( minimal to no impairment ) in ziprasidone treated patients , ( X@ [ @ ] = @ , p = .@ ) .\n",
            "There was an overall shift in the distribution of endpoint scores , with haloperidol patients having fewer items where substantial change was detected than ziprasidone patients .\n",
            "Conclusions : Treatment with ziprasidone was associated with greater functional gains than treatment with haloperidol , even when differential dropout was controlled .\n",
            "Both treatment retention and functional gains favored ziprasidone in this long-term study .\n",
            "Objective - The present study sought to determine cost-effectivness of two neuroleptics recently introduced in Mexico for treatment - resistent schizophrenic patients - clozapine and risperidone .\n",
            "Method - twenty-two treatment-resistant schizophrenic patients admitted were randomly assigned to receive clozapine or risperidone in study open for two years .\n",
            "The clinical response was measured weekly in semistructured interviews with the authors , using PANSS , Dimascio and UKU Side Effect Scale .\n",
            "Detailed information about costs of treatment , lost income and other costs were available for the patients whom remained on the medication for one year .\n",
            "Results - The analysis based on @ patients showed a clear superiority of clozapine - @ % of the clozapine-treated patients met the response criteria as compared to @ % in the risperidone group .\n",
            "In addition to sustained clinical and quality-of-life improvements , the study showed significant decreases in treatment costs , primarily attributed to decrease in the frequency and cost of rehospitalization .\n",
            "Conclusions - The treatment decreses per capita cost of people whom the hospital must support.Reference - Meltzer Hy , Cola P , Way L et al .\n",
            "Cost-Effectiveness of Clozapine in Neuroleptic-Resistant Schizophrenia .\n",
            "Am J Psychiat @ ; @ - @ - .\n",
            "Revicki DA , Luce BR et al Cost-Effectiveness of Clozapine for Treatment-Resistant Schizophrenic Patients .\n",
            "Hosp .\n",
            "Community Psychiat .\n",
            "@ ; @ - @ - .\n",
            "The metabolic syndrome ( MS ) is highly prevalent among patients with schizophrenia ( current estimates @-@ % ) , yet no data exist on the correlation of this diagnosis with illness severity , neurocognitive or quality of life measures in this population .\n",
            "Methods : Using baseline data from the Clinical Antipsychotic Trials of Intervention Effectiveness ( CATIE ) Schizophrenia Trial , assignment of MS status was performed using an updated definition derived from the National Cholesterol Education Program ( NCEP ) criteria .\n",
            "Those with and without MS were compared on the basis of primary and secondary variables of interest from baseline data encompassing psychiatric , neurocognitive and quality of life measures .\n",
            "Results : Of @ subjects enrolled at baseline , MS status could be reliably assigned for @ subjects , with a prevalence of @ % using the NCEP derived criteria .\n",
            "After adjustment for age , gender , race , ethnicity and site variance , those with MS rated themselves significantly lower on physical health by SF-@ ( p < .@ ) , and scored higher on somatic preoccupation ( PANSS item G@ ) ( p = .@ ) .\n",
            "There were no significant differences between the two cohorts on measures of symptom severity , depression , quality of life , neurocognition , or self-rated mental health .\n",
            "Neither years of antipsychotic exposure nor alcohol usage were significant predictors of MS status when adjusted for age , gender , race , and ethnicity .\n",
            "Conclusions : The metabolic syndrome is highly prevalent in this large cohort of schizophrenia patients and is strongly associated with a poor self-rating of physical health and increased somatic preoccupation .\n",
            "These results underscore the need for mental health practitioners to take an active role in the health monitoring of patients with schizophrenia to minimize the impact of medical comorbidity on long-term mortality and on daily functioning .\n",
            "Outcomes data from CATIE will provide important information on the metabolic and clinical impact of antipsychotic treatment for those subjects with MS and other medical comorbidities .\n",
            "In a comparative trial of the conventional neuroleptic flupenthixol ( FLX ) with the atypical risperidone ( RIS ) ( see accompanying abstract by Glaser et al. ) the acceptability of the study medication , the subjective experiences and the overall well-being of the patients have been assessed .\n",
            "@ patients with marked negative symptoms were randomly assigned to one of the two treatments .\n",
            "@ subjects under FLX and @ under RIS fulfilled the valid for efficacy criteria , i.e. in particular a treatment duration of @ weeks .\n",
            "Subjective well-being as documentd by means of the EuroQuol Visual Analogue Scale markedly increased in both groups .\n",
            "At endpoint the increases were statistically significant as compared to baseline with no intergroup difference .\n",
            "The Drug Attitude Inventory-@ ( DAI-@ ) was used to examine the subjective acceptability of the drug treatment .\n",
            "Despite already relatively high baseline scores in the range of @ indicating a rather positive drug attitude a statistically significant increase from baseline to endpoint was found in the FLX - , but not in the RIS-group .\n",
            "For examining subjective experiences the questionaire of Hellewell et al. ( @ ) was used .\n",
            "In general , a higher proportion of FLX - rather than RIS-administered patients reported to have benefited from the treatment .\n",
            "Combining the scores from the three dimensions of the questionaire ( efficacy , quality of life , activities of daily living ) to a total score resulted in a statistically significant effect in favour of FLX .\n",
            "The results clearly show that with respect to the patient 's satisfaction with their treatment FLX and RIS are judged at least equally well or there are even slight advantages for FLX .\n",
            "Thus FLX behaves from a patient 's point of view as a partial atypical neuroleptic .\n",
            "The number of empowerment-oriented consumer-operated service programs ( COSPs ) in mental health has increased dramatically over the past decade ; however , little empirical evidence exists about the effects of such programs on their intended outcomes .\n",
            "This study examined the effects of COSPs on various aspects of empowerment within the context of a multisite , federally funded , randomized clinical trial of COSPs .\n",
            "Results suggest that the individuals who received the consumer-operated services perceived higher levels of personal empowerment than those in the control intervention ; overall , effect sizes were very modest when all sites were examined together in intent-to-treat analyses .\n",
            "However , we noted variations in outcomes by intensity of COSP use and also by study site , which suggest that specific programs had significant effects , while others did not .\n",
            "The implications of these results for the mental health field and for service providers and policy makers are discussed .\n",
            "OBJECTIVES : Data on attaining and maintaining symptom remission associated with specific antipsychotic medications are rare and variant .\n",
            "The aim of this study is to examine remission rates and their variation by antipsychotic medication in chronic schizophrenia in the National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness ( CATIE ) give it has an @-month duration and representative antipsychotic medications .\n",
            "METHODS : Symptom remission was examined using the Remission in Schizophrenia Working Group remission criteria of attaining and maintaining for @ months with mild ratings on @ specific Positive and Negative Syndrome Scale ( PANSS ) items .\n",
            "Remission rates were assessed ( a ) up to @ months across CATIE 's switching phases ( n = @ ) ; and ( b ) in phase @ ( that involved double-blind randomization to one of five antipsychotic medications ) to compare antipsychotic medication differences in attaining and maintaining remission among patients not in remission at baseline ( n = @ ) .\n",
            "RESULTS : A total of @ % of patients were in symptomatic remission at baseline .\n",
            "Across the switching phases of CATIE only @ % attained and then maintained at least @ months of symptomatic remission , and @ % ( n = @ ) experienced no symptom remission at any visit .\n",
            "In phase @ , attaining and maintaining remission for @ months was highest for the olanzapine ( @ % ) medication group followed by quetiapine ( @ % ) , ziprasidone ( @ % ) , perphenazine ( @ % ) , and risperidone ( @ % ) groups .\n",
            "CONCLUSIONS : As currently defined , remission appears to be a very difficult therapeutic target to attain and maintain in chronic schizophrenia and may differ by antipsychotic medication .\n",
            "Pragmatically , remission gradients may be effectively studied by applying modified duration and symptom criteria .\n",
            "A psycho-education programme is provided for patients suffering from psychosis in Scotland 's only high secure hospital .\n",
            "An @-month pilot study was carried out with consecutive case sample ( treatment group ) and ' treatment as usual ' comparison group ( control group ) .\n",
            "Pre , post and @-month follow-up assessments were carried out .\n",
            "A range of outcome measures were used , including two measures of knowledge : a self-report assessment tool - Forensic Assessment of Knowledge Tool and the Understanding Medication Questionnaire .\n",
            "Other measures were used to establish level of insight , Schedule for the Assessment of Insight and assess mental state [ Positive and Negative Syndrome Scale ( PANSS ) ] .\n",
            "Results from ( n = @ ) participants indicate no statistical difference between the treatment and control group scores on any assessment prior to commencement of the intervention , indicating a well-matched sample group .\n",
            "However , all four assessments showed statistically significant changes post group .\n",
            "Treatment group showed an ability to improve knowledge and retain information about psychosis , which may account for their improved mental state and level of insight .\n",
            "Despite methodological limitations and a small sample group , this project has given an early indication of the positive value of this psycho-education programme in a forensic setting .\n",
            "@ Blackwell Publishing .\n",
            "Slow cortical potential shifts such as the late terminal E-wave component of the CNV appear to be determined mainly by the level of motor preparation and as such it was employed to investigate the degree of cortical involvement in schizophrenics exhibiting abnormal motor phenomena induced by prolonged treatment with neuroleptics .\n",
            "The basic experimental task was a constant foreperiod warned reaction time task consisting of a brief warning tone ( S@ ) followed @ sec later by a light , the imperative stimulus ( S@ ) , upon which the subject was instructed to release a response key .\n",
            "The task was presented twice , in a randomized order , under neutral and fast set instructions , to tardive ( TD ) and non - tardive dyskinesia ( NTD ) groups .\n",
            "Computer EEG analysis identified and analysed on early O-wave measured as the average amplitude @-@ msec post S @ , and the latter E-wave measured as the average amplitude @ msec prior to S @ .\n",
            "Two additional epochs of PINV activity were also analysed .\n",
            "The results indicated that the TD group exhibited significantly larger PINV activity , but unlike NTD patients , the TD group failed to exhibit any significant increases in E-wave amplitude concomitant with improved behavioral reaction times .\n",
            "The results are discussed in relation to a disinhibitory theory of tardive dyskinesia .\n",
            "Objective To explore the impact of self-care and quality of life of self-care education on rehabilitation of patients with schizophrenia .\n",
            "The method using the experimental study design , @ patients with schizophrenia were randomly divided into intervention group , @ cases and @ cases of the control group .\n",
            "Control group were treated with general health education , intervention patients individualized self-care education to intervene in the rehabilitation of patients with schizophrenia , a time for three months ; two groups after the intervention knowledge questionnaire with mental illness , ward Nurses Observation Scale ( nosie ) , activities of daily living ( adl ) and schizophrenia quality of life scale ( sqls ) evaluation and investigation .\n",
            "Results through self-care education , the intervention group than in the control group was significantly increased with schizophrenia self-care ability , knowledge of mental illness awareness and quality of life , and the differences were statistically significant ( p < @ or p < @ ) .\n",
            "Reports an error in \" Effects of bilateral repetitive transcranial magnetic stimulation on treatment resistant auditory-verbal hallucinations in schizophrenia : A randomized controlled trial \" by Ans Vercammen , Henderikus Knegtering , Richard Bruggeman , Hanneke .\n",
            "M. Westenbroek , Jack A. Jenner , Cees J. Slooff , Lex Wunderink and Andre Aleman ( Schizophrenia Research , @ [ Oct ] , Vol @ [ @-@ ] , @-@ ) .\n",
            "The authors regret an error in Fig. @ of this manuscript .\n",
            "The figure shows the PANSS scores for the hallucination item ( P@ ) for the rTMS groups , aggregating the left and the bilateral treatment group , compared to the placebo group .\n",
            "The X axis plots the time points at which measurements were available : before the start of the treatment and immediately following the @-day treatment protocol .\n",
            "The Y axis shows the score on the P@ item .\n",
            "Bubble sizes represent the number of subjects with a particular score on the Y axis .\n",
            "It has come to the authors ' attention that the frequency distribution was incorrectly presented in the bubble graph .\n",
            "An amended graph with correct frequency bubble sizes is presented in this corrigendum .\n",
            "The group means as presented in the original graph were correct .\n",
            "( The following abstract of the original article appeared in record @-@-@ ) .\n",
            "Background : Neuroimaging findings implicate bilateral superior temporal regions in the genesis of auditory-verbal hallucinations ( AVH ) .\n",
            "This study aimed to investigate whether @ Hz repetitive transcranial magnetic stimulation ( rTMS ) of the bilateral temporo-parietal region would lead to increased effectiveness in the management of AVH , compared to left rTMS or placebo .\n",
            "Methods : @ patients with schizophrenia ( DSM-IV ) and medication-resistant AVH were randomly assigned to @ Hz rTMS treatment of the left temporo-parietal region , bilateral temporo-parietal regions , or placebo .\n",
            "Stimulation was conducted over @ days , twice daily for @ min , at @ % of the motor threshold .\n",
            "Effect measures included the Auditory Hallucination Rating Scale ( AHRS ) , Positive and Negative Affect Scale ( PANAS ) , and a score for hallucination severity obtained from the Positive and Negative Syndrome Scale ( PANSS ) .\n",
            "Results : All groups showed some improvement on the total AHRS .\n",
            "Hallucination frequency was significantly reduced in the left rTMS group only .\n",
            "The bilateral rTMS group demonstrated the most remarkable reduction in self-reported affective responsiveness to AVH .\n",
            "A modest , but significant decrease on the PANSS hallucination item was observed in the combined rTMS treatment group , whereas no change occurred in the placebo group .\n",
            "The left rTMS group showed a significant reduction on the general psychopathology subscale .\n",
            "Conclusion : Compared to bilateral or sham stimulation , rTMS of the left temporo-parietal region appears most effective in reducing auditory hallucinations , and additionally may have an effect on general psychopathology .\n",
            "Placebo effects should however not be ruled out , since sham stimulation also led to improvement on a number of AVH parameters .\n",
            "( PsycINFO Database Record ( c ) @ APA , all rights reserved ) .\n",
            "BACKGROUND : Increased mortality in schizophrenia is caused largely by coronary heart disease ( CHD ) .\n",
            "Low cardiorespiratory fitness ( CRF ) is a key factor for CHD mortality .\n",
            "We compared CRF in patients with schizophrenia to CRF of matched healthy controls and reference values .\n",
            "Also , we examined the effects of exercise therapy on CRF in patients with schizophrenia and in controls .\n",
            "METHODS : Sixty-three patients with schizophrenia and @ controls , matched for gender , age , and socioeconomic status , were randomized to exercise ( n = @ ) or occupational therapy ( n = @ ) and controls to exercise ( n = @ ) or life as usual ( n = @ ) .\n",
            "CRF was assessed with an incremental cardiopulmonary exercise test and defined as the highest relative oxygen uptake ( V O@peak ) and peak work rate ( Wpeak ) .\n",
            "Minimal compliance was @ % of sessions ( n = @ ) .\n",
            "RESULTS : Male and female patients with schizophrenia had a relative V O@peak of @ + / - @ and @ + / - @ mL.kg.min , respectively .\n",
            "Patients had higher resting HR ( P < @ ) and lower peak HR ( P < @ ) , peak systolic blood pressure ( P = @ ) , relative V O@peak ( P < @ ) , Wpeak ( P < @ ) , RER ( P < @ ) , minute ventilation ( P = @ ) , and HR recovery ( P < @ ) than controls .\n",
            "Relative V O@peak was @ % + / - @ % ( P < @ ) of predicted relative V O@peak in male and @ % + / - @ % ( P = @ ) in female patients .\n",
            "In patients , exercise therapy increased relative V O@peak compared with decreased relative V O@peak after occupational therapy .\n",
            "In controls , relative V O@peak increased after exercise therapy and to a lesser extent after life as usual ( group , P < @ ; randomization , P = @ ) .\n",
            "Exercise therapy increased Wpeak in patients and controls compared with decreased Wpeak in nonexercising patients and controls ( P < @ ) .\n",
            "CONCLUSION : Patients had lower CRF levels compared with controls and reference values .\n",
            "Exercise therapy increased V O@peak and Wpeak in patients and controls .\n",
            "V O@peak and Wpeak decreased in nonexercising patients .\n",
            "We studied the effect of lithium addition to neuroleptic treatment in chronic schizophrenia , for which contradictory results have been produced in previous studies .\n",
            "Twenty-one chronic schizophrenic inpatients received lithium in a study with randomized , double-blind , placebo - controlled , cross-over design consisting of @ weeks each of treatment with lithium capsules and identical placebo capsules .\n",
            "The total Brief Psychiatric Rating Scale ( BPRS ) scores at week @ of the lithium treatment were improved significantly compared with those at week @ of the placebo treatment .\n",
            "Of the BPRS subscales , however , only anxiety-depression improved , whereas none of the subscales for anergia , thought disturbance , activation and hostile-suspiciousness improved .\n",
            "There was no significant difference between the total Scale for the Assessment of Negative Symptoms ( SANS ) scores at any time during lithium and placebo treatment .\n",
            "These results suggest that the addition of lithium to neuroleptic treatment improves anxiety-depression in chronic schizophrenia .\n",
            "Objective : To evaluate the efficacy of comprehensive life skills training for chronic schizophrenia .\n",
            "Methods : @ cases of social disability inpatients were randomly assigned to a treatment group and a control group , and @ months of treatment .\n",
            "Assessment of Negative Symptoms Scale ( SANS ) and evaluate the efficacy of inpatient Social Disability Scale ( SDSI ) .\n",
            "Before and after treatment were total score mean comparison t test .\n",
            "Results : social function and negative symptoms before and after treatment a significant difference between the control group before and after treatment , no significant difference .\n",
            "A double-blind randomized investigation compared withdrawal ( placebo ) with continued use of long-acting neuroleptics ( fluphenazine decanoate or flupenthixol decanoate ) in @ chronic schizophrenic outpatients .\n",
            "After @ weeks there was a tendency toward higher depressive scores in the placebo group , a difference which became statistically significant ( p less than .@ ) at week @ .\n",
            "These results do not support earlier observations that neuroleptic drugs cause depression .\n",
            "Further analyses of the data indicated that depressive symptomatology could be an early sign of relapse .\n",
            "Objective To explore hospital rehabilitation interventions of the efficacy of cognitive impairment in patients with chronic schizophrenia .\n",
            "Long-term hospitalization of @ patients with schizophrenia were randomly divided into two groups , imposed on a set of comprehensive rehabilitation intervention @ months on cognitive function and negative symptoms were assessed with MMSE , SANS .\n",
            "New York , the MMSE : memory , memories and language scores increased in the results of intervention , in particular , a significant difference in the memory ; the SANS : emotional dull , lack of interest factor scores decreased significantly , with a significant difference .\n",
            "While the control group , MMSE , and SANS scores there was no difference .\n",
            "Objective To explore hospital rehabilitation interventions of the efficacy of cognitive impairment in patients with chronic schizophrenia .\n",
            "Long-term hospitalization of @ patients with schizophrenia were randomly divided into two groups , imposed on a set of comprehensive rehabilitation intervention @ months on cognitive function and negative symptoms were assessed with MMSE , SANS .\n",
            "New York , the MMSE : memory , memories and language scores increased in the results of intervention , in particular , a significant difference in the memory ; the SANS : emotional dull , lack of interest factor scores decreased significantly , with a significant difference .\n",
            "While the control group , MMSE , and SANS scores there was no difference .\n",
            "Conclusion hospital rehabilitation interventions to improve the chronic schizophrenia patients with cognitive dysfunction have a certain role .\n",
            "Objective To compare the efficacy and side-effect of risperidone with that of clozapine in patients with treatment-resistant schizophrenia .\n",
            "Methods Patients with diagnosis of treatment-resistant schizophrenia were randomly assigned to two groups that were treated with either risperidone or clozapine for @ weeks .\n",
            "The therapeutic response and side effects were evaluated with the PANSS and TESS .\n",
            "Results The overall therapeutic effect rate of risperidone was @ .\n",
            "@ % .\n",
            "The overall therapeutic\n",
            "Objective To compare the two atypical antipsychotics aripiprazole and risperidone term efficacy and safety of early schizophrenia inpatients .\n",
            "@ patients with schizophrenia were randomly divided into aripiprazole group and the risperidone group , before treatment and the @ weekend assess panss Scale , fasting blood glucose , lipids , serum leptin biochemical indicators , and @ normal subjects as a control group , related indicators compare .\n",
            "Results of aripiprazole and risperidone in the treatment of early schizophrenia term efficacy difference was not significant ( p > @ ) male patients treated with risperidone elevated serum prolactin levels , no difference in serum prolactin levels of female patients before and after treatment aripiprazole on prolactin had no significant effect .\n",
            "Aripiprazole can cause elevated serum leptin levels , and risperidone was no significant effect of leptin .\n",
            "Acute single-dose response of drug-induced parkinsonism ( DIP ) to L - Dopa and apomorphine challenge was evaluated in a DOUBLE-blind crossover study in @ schizophrenic patients .\n",
            "There were two noteworthy negative findings .\n",
            "First , neither L-Dopa nor apomorphine produced significant improvements in DIP and second , no changes ( neither improvement nor worsening ) were found in patients ' psychiatric status .\n",
            "Findings suggest that , for a stimulation dose reaching almost @ % of the responsive dose for idiopathic Parkinson 's disease , no significant changes may reasonably be expected in the parkinsonism of schizophrenic patients treated with neuroleptic drugs .\n",
            "A number of studies have suggested the possibility that delay in introducing antipsychotic drugs to schizophrenic patients may be associated with a poorer long-term prognosis .\n",
            "The work conducted by the late Philip May in the @s has been re-analysed by various authors and they have commented upon the better long-term outcome in the patients who received antipsychotic drugs in the study .\n",
            "The findings of the Northwick Park Study of First Episodes of Schizophrenia ( Johnstone et al , @ ) point essentially to the same conclusion .\n",
            "The study as a whole concerned @ patients who had been admitted to one of nine medical centres in North London with first schizophrenic episodes .\n",
            "All were treated with traditional antipsychotics and @ recovered sufficiently to be discharged from hospital during the period of the study .\n",
            "@ of them were then randomly and blindly allocated to maintenance antipsychotic medication or placebo .\n",
            "They were followed up to the point of relapse or for two years , whichever was sooner .\n",
            "Of those on active medication @ % relapsed , as did @ % of those on placebo , but the most important determinant of relapse was duration of illness prior to starting antipsychotic medication .\n",
            "Patients who , by their own or their relatives ' retrospective account , had had features of illness for more than one year before the introduction of antipsychotics were significantly more likely to relapse ( p < @ ) than those who had had such features for less than one year when antipsychotic medication was commenced .\n",
            "Clearly this suggests the possibility that delay in the introduction of antipsychotics may be associated with long-term detriment , although the alternative possibility that patients to whom antipsychotics were introduced late differed in some relevant way from those to whom they were introduced early can not be discounted , since that aspect of the study did not receive random allocation .\n",
            "The delay in this study , and indeed in earlier work , is of about one year 's duration and most placebo controlled studies of treatment of acute psychotic episodes are very much shorter than this - generally of the order of @ to @ weeks , but if delay in the introduction of antipsychotics for about a year really is detrimental to the long-term prognosis of psychotic illness , then it is important to consider whether the delay in the introduction of active antipsychotic treatment which is necessarily experienced by patients in the placebo groups of placebo controlled randomised clinical trials could be associated with any long term adverse effects .\n",
            "It has been possible to examine this issue in relation to the various elements of the Northwick Park ' Functional ' Psychosis Study ( Johnstone et al , @ ; Johnstone et al , @ ) .\n",
            "This included an investigation of @ patients assessed for a treatment trial of functional psychotic illness .\n",
            "They were randomly and blindly allocated to one of four treatments : ( a ) the traditional antipsychotic , pimozide ; ( b ) lithium ; ( c ) a combination of the two ; ( d ) placebo .\n",
            "These patients were followed up for @ years .\n",
            "The purpose of this analysis is to examine whether a delay in effective treatment may have an adverse effect upon the long-term outcome in terms of the variables considered at @ year follow up .\n",
            "Information from the case notes was available on number of readmissions , months of inpatient and day patient care , treatments received during the follow up period , occupational function during the follow up period , antisocial behaviour as assessed by police contact , drug and alcohol use , and in addition information was available in terms of formal mental state assessments at the @ year follow up appointment .\n",
            "Nonparametric statistics have been used in the data presented here which consist of comparisons between those initially treated with pimozide , lithium , both or placebo .\n",
            "There were no significant differences at all between the groups in terms of subsequent treatment ( i.e. number of admissions , months of inpatient care , day patient care , in rehabilitation services , etc. ) If the initial placebo period produced long term detrimental effect upon the patient it would be expected that the patients who initially received placebo would require more medication or ECT later on .\n",
            "However , there were no differences between the groups in any treatment variables .\n",
            "Next , variables relating to occupation subsequent to discharge were considered .\n",
            "Again there were no differences between the groups and there were none as far as antisocial behaviours were concerned .\n",
            "Lastly , mental state items , in terms of the variables of the Montgomery Asberg , Bech Rafaelsen and Krawiecka scales were considered .\n",
            "Again , differences did not emerge apart from the fact that scores on retardation were higher in patients initially treated with lithium ( p < @ ) ; this is the only significant result in the very many comparisons conducted on this data .\n",
            "Upon examination of the many variables in this study , therefore , there was no evidence at all that a month 's delay in instituting active antipsychotic medication resulted in any lasting harm.Reference : Johnstone E.C. et al ( @ ) .\n",
            "British Journal of Psychiatry @ : @-@ .\n",
            "Reference : Johnstone E.C. et al ( @ ) .\n",
            "Lancet ii : @-@ .\n",
            "Reference : Johnstone E.C. et al ( @ ) .\n",
            "Psychological Medicine @ : @-@ .\n",
            "Background : Systematic cognitive training has led to signifcant gains in cognition in schizophrenia , but methods of enhancing learning during such training could greatly increase its impact .\n",
            "Aerobic exercise stimulates synaptic plasticity and may be an effective way to enhance learning dur-ing cognitive training .\n",
            "We hypothesize that combining aerobic exercise with systematic cognitive training will lead to larger cognitive gains and better work/school functioning than cognitive training alone .\n",
            "Methods : In a randomized clinical trial , @ frst-episode schizophrenia patients were assigned to a @-month intervention of either Cognitive Training & Exercise ( CT&E ) or Cognitive Training ( CT ) .\n",
            "Both groups received neuroplasticity-based computerized cognitive training ( Posit Science BrainHQ and SocialVille ) at the clinic , @ days/week , @ hours/day .\n",
            "The CT&E group also participated in aerobic conditioning for @ min-utes/week , using total body circuit training exercises .\n",
            "Exercise sessions were divided into two at the clinic and two at home .\n",
            "Participants were assessed with repeated measures of cognition ( MATRICS Consensus Cognitive Battery ; MCCB ) and work/school functioning ( Global Functioning Scale : Role ) .\n",
            "Results : By @ months , the MCCB Overall Composite score improved sig-nifcantly more with CT&E than with CT alone ( F = @ , P < .@ ; @ vs. @ T-score gain ) .\n",
            "Reasoning and Problem Solving and Working Memory showed the largest differential gains .\n",
            "Global Functioning Scale : Role ratings showed that work/school functioning increased signifcantly more with CT&E than with CT alone by @ months ( F = @ , P < .@ ; @ vs. @ gain ) .\n",
            "The magnitude of cognitive gain was signifcantly related to the degree of work/school functioning improvement ( r = .@ , P < .@ ) , with Attention/Vigilance and Reasoning and Problem Solving gains being the strongest contributors .\n",
            "Conclusion : The results of this randomized clinical trial indicate that the addition of aerobic exercise training to systematic cognitive training can signifcantly boost the impact of cognitive training cognitive functioning and work/school functioning after a frst episode of schizophrenia .\n",
            "The amount of cognitive gain is signifcantly related to the improvements in work/school functioning , suggesting that the cognitive gains are contributing to functional outcome .\n",
            "Background : Command hallucinations ( CH ) are among the most distressing , high risk and treatment-resistant symptoms for people with psychosis ( Beck-Sander et al. , @ ) .\n",
            "Currently there are no evidence-based treatment options available for this group .\n",
            "The present study investigates the effectiveness of a cognitive behavioural therapy for command hallucinations ( CTCH ) in reducing harmful compliance behaviour and the distress associated with command hallucinations ( CH ) .\n",
            "Derived from the cognitive model of voices ( Chadwick & Birchwood , @ ) , CTCH draws on principles of the social rank theory ( Gilbert , @ ) , and emphasises the importance of cognitive appraisals and the idiosyncratic relationship that the voice hearer develops with their voices in influencing affect and behaviour .\n",
            "Methods : This is a single blind , intention-to-treat , multi-centre randomized controlled trial .\n",
            "Participants are randomly allocated to either CTCH + treatment as usual ( TAU ) or TAU alone .\n",
            "CTCH is offered on an individual basis and is administered over a maximum period of @ months ( @ sessions ) .\n",
            "All participants are followed-up at @ and @ months post randomisation .\n",
            "Individuals meeting the following criteria are invited to take part in the study : a ) over @ years ; b ) ICD-@ diagnosis of schizophrenia or related disorder ( F@-@ ) ; c ) command hallucinations for at least @ months with risk of harm to self/others .\n",
            "Results : Recruitment has concluded ; the trial is currently in the last phase of follow-up .\n",
            "One-hundred-and-ninety-seven participants have been randomised ( @ % consent rate ) .\n",
            "The trial benefits from a high retention rate ; @ % of @-month follow-up assessments have been successfully completed , and @ % of @-month follow-up assessments have so far been completed .\n",
            "Discussion : It is hypothesised that CTCH will lead to a lower conviction in the power of the voices , thereby reducing harmful compliance behaviour and distress associated with CH .\n",
            "If successful , the results will mark a significant breakthrough in the evidence base for the treatment of CH .\n",
            "Objective To compare the impact of clozapine and risperidone on the quality of life in patients with schizophrenia .\n",
            "Method on @ patients with schizophrenia were randomly divided into two groups , @ patients were treated with clozapine , risperidone for @ weeks .\n",
            "Positive and Negative Syndrome Scale ( panss ) , side effects scale ( tess ) , health status questionnaire ( sf-@ ) efficacy , side effects and quality of life assessment .\n",
            "RESULTS panss scores before and after treatment were significant differences compared with each other between the two groups , the difference was no statistical significance .\n",
            "The risperidone dimension of physical health , mental health dimensions and social function dimensions , respectively , higher than the clozapine group were significant difference .\n",
            "Conclusion Risperidone versus clozapine in , quite schizophrenic patients , but the quality of life of the risperidone group than the clozapine group .\n",
            "OBJECTIVE : Smoking prevalence rates are elevated in individuals with schizophrenia spectrum disorders ( SSD ) compared with the general population , with attendant disproportionate smoking-related morbidity and mortality .\n",
            "Pharmacotherapies that improve abstinence rates in this population are underutilized , partly due to concerns about neuropsychiatric safety , particularly for those with comorbid depression or prior suicide attempt .\n",
            "Prospective assessment of the psychiatric safety profile of varenicline in those with SSD is needed .\n",
            "METHODS : Adult smokers with SSD entered a @-week trial of varenicline and behavioral therapy for smoking cessation .\n",
            "Depressive symptoms were assessed with the Calgary Depression Scale for Schizophrenia ( CDSS ) at baseline and weekly thereafter .\n",
            "Participants with baseline and one or more postbaseline CDSS assessments , n = @ , were included in a secondary analysis of change in depressive symptoms with varenicline treatment , adjusting for abstinence status and baseline depressive symptoms .\n",
            "RESULTS : Twenty-seven percent of participants had a CDSS score at baseline consistent with current major depressive disorder , and more than half had a prior suicide attempt .\n",
            "Forty-one percent ( @/@ ) achieved two or more weeks of continuous abstinence at the end of treatment .\n",
            "CDSS scores declined @ % during the @-week treatment period .\n",
            "Controlling for baseline CDSS scores , depressive symptoms declined over time in those who completed the trial , independent of abstinence status , and either declined or remained unchanged in those with major depressive disorder or prior suicide attempt or who were taking antidepressant medication .\n",
            "Those who did not complete the trial had no change in depressive symptoms .\n",
            "DISCUSSION : Depressive symptoms declined in adults with schizophrenia during @ weeks of varenicline treatment and cognitive behavioral therapy , independent of tobacco abstinence .\n",
            "Smokers with SSD who have significant depressive symptoms may be successful in smoking cessation attempts with pharmacotherapeutic aids such as varenicline while maintaining stable psychiatric symptoms .\n",
            "This is a secondary analysis of data collected as part of a clinical trial registered as NCT@ , at www.clinicaltrials.gov .\n",
            "Background : Repetitive transcranial magnetic stimulation ( rTMS ) is a relatively new neuropsychiatric intervention .\n",
            "Approved for use in treatment resistant depression , investigators are now studying RTMS for other psychiatric diseases such Schizophrenia .\n",
            "Cognitive dysfunction is a core facet of Schizophrenia , present early in the course of the illness and contributing to diminished functioning and outcomes .\n",
            "In this study we examined the effect of high frequency RTMS on cognitive function in a group of individuals with early phase psychosis .\n",
            "Methods : Twenty subjects were randomized ( @:@ ) , in double-blind fashion , to RTMS or sham condition .\n",
            "Over two weeks subjects underwent ten sessions of high frequency bilateral RTMS targeting the dorsolateral prefrontal cortex ( DLPFC ) .\n",
            "Stimulation parameters were as follows : @ % of MT , @ Hz , @ trains , @ second per train , @ pulses per train , inter-train interval of @ seconds ( @ pulses/hemisphere , total of @ pulses/session/day ) .\n",
            "Prior to beginning and following completion of study treatment , subjects completed neurocognitive and symptom batteries and magnetic resonance imaging with resting state scan and in-scanner memory tasks .\n",
            "Results : Subjects receiving active treatment demonstrated improved cognitive function as represented by the Brief Assessment of Cognition in Schizophrenia ( BACS ) total score ( F @ @ , p @ ) .\n",
            "Additionally , there was a trend towards improved PANSS total score ( F @ @ , p @ ) .\n",
            "There were no differences in working memory performance or activation .\n",
            "MRI data will be presented .\n",
            "Conclusions : Preliminary results provide support for a potential therapeutic role of RTMS for cognitive impairment in Schizophrenia .\n",
            "Additionally , RTMS was observed to be safe and well tolerated .\n",
            "Background : The treatment of patients with schizophrenia who fail to respond to antispychotics is a major challenge and the proportion of treatment-resistant patients is estimated to be @ to @ % .\n",
            "Recent studies indicate that the traditional Japanese herbal medicine yokukansan ( TJ-@ ) may be safe and useful in treating behavioral and psychological symptoms in dementia and some neuropsychiatric patients .\n",
            "We aimed at evaluating both the efficacy and safety of TJ-@ in patients with treatment-resistant schizophrenia .\n",
            "Methods : This randomized , multi-centre , double-blind , placebo - controlled study was conducted between May @ and August @ .\n",
            "One hundred twenty antipsychotic-treated inpatients from @ psychiatric hospitals in the Japan with a treatment-resistant schizophrenia were included .\n",
            "The study was carried out at the @ psychiatric hospitals in the Japan .\n",
            "Eligible subjects were recruited from the inpatient population in @ psychiatric hospitals .\n",
            "The protocol was approved by the Shimane University School of Medicine Subjects Review Committee and carried out in accordance with the Declaration of Helsinki , with written informed consent obtained from all recruited subjects .\n",
            "Patients were randomized to adjuvant treatment with TJ-@ @ g/day or placebo .\n",
            "During a @-weeks follow-up , psychopathology was assessed with the Positive and Negative Syndrome Scale ( PANSS ) .\n",
            "Other assessments included Drug-induced Extrapyramidal Symptoms Scale ( DIEPSS ) , Global Assessment of Functioning ( GAF ) , and Clinical Global Impression-Severity ( CGI-S ) .\n",
            "The primary efficacy outcome was the change in total , positive , negative , and general PANSS score .\n",
            "Secondary outcomes were changes in individual PANSS items and CGI-S .\n",
            "The analysis was made on a Per Protocol Set ( PPS ) basis with Last Observation Carried Forward ( LOCF ) .\n",
            "Results : TJ-@ group show tendency superiority to placebo group in reducing total , positive , negative , and general PANSS score in treatment-resistant schizophrenia , but there were no significant difference .\n",
            "However , individual PANSS lack of spontaneity and flow of conversation , tension , and poor impulsive control items showed statistically significant improvement in the TJ-@ group compared to the placebo group ( p < @ ) .\n",
            "No substantial side effects were recorded .\n",
            "Conclusion : The present study indicates TJ-@ as a potential adjunctive treatment strategy for the treatment for the treatmentresistant schizophrenia , in particular , lack of spontaneity and flow of conversation , tension , and poor impulsive control .\n",
            "The main limitation of the present trial was its short duration .\n",
            "Long-term desirable or untoward effects of TJ-@ might emerge later on , and thus the optional duration of this treatment still remains to be explored .\n",
            "A relatively small patient size was another limitation , and despite these clear-cut and coherent results and consistently encouraging data from previous studies , larger trials are needed for definitive conclusion .\n",
            "To the best of our knowledge , no double-blind , placebo-controlled trials have been performed to examine the clinical effect of adjunctive TJ-@ to antipsychotics in treatment-resistant schizophrenia .\n",
            " @\n",
            "Introduction : Aberrant cortical connectivity and hypofunction of NMDA receptor signaling may underlie schizophrenia symptoms .\n",
            "Direct activation of mGluR@/@ receptors has been shown to reduce NMDA hypofunction , reverse the psychotomimetic effects of NMDA antagonists , and in some studies , to produce an antipsychotic effect in acute schizophrenia .\n",
            "We have investigated the efficacy and tolerability of AZD@ ( ( C@H@F@N@O@S ) , a selective positive allosteric modulator ( PAM ) at the mGluR@ receptor , in symptomatic patients with schizophrenia .\n",
            "Methods : This was a double blind , double-dummy , placebo controlled , risperidone referenced , parallel groups , proof of concept clinical trial conducted in accordance with the Declaration of Helsinki at @ US sites .\n",
            "Following @ days washout , patients were randomized to receive either AZD@ @ mg ( n = @ ) , risperidone @ mg ( n = @ ) , or placebo ( n = @ ) .\n",
            "Treatment lasted for @ days , and clinical efficacy was assessed using the Positive and Negative Syndrome Scale ( PANSS ) and the Clinical Global Impression Severity Scale and Improvement Scales ( CGI-S/CGI-I ) as primary outcome measures .\n",
            "Change from baseline to endpoint ( LOCF ) was analyzed by ANCOVA .\n",
            "Results : Out of @ patients randomized , @ were screen failed patients who were allocated a randomization number but never received study drug , @ were considered evaluable and included in the efficacy analysis , and @ were used for analysis of safety and tolerability .\n",
            "Overall , @ patients ( @ % ) completed the @-week treatment trial with highest completion rate seen for patients receiving placebo , and the lowest for patients receiving risperidone .\n",
            "The most common reason for withdrawal was lack of efficacy ; the highest rate of withdrawal for this reason was in patients treated with placebo ( @ % ) and the lowest rate was for patients receiving risperidone , where all patients completed the treatment trial .\n",
            "Baseline PANSS did not differ between groups ( AZD@-@ , Placebo - @ , risperidone - @ ) .\n",
            "After @ days of treatment there was no significant difference between the AZD@ and placebo groups in the PANSS total score change from baseline ( D @ and @ respectively p = @ ) Risperidone was significantly different from placebo ( D -@ p < @ ) in PANSS total score change from baseline .\n",
            "Similarly CGI and secondary measures were not different between the AZD@ and placebo groups .\n",
            "Of @ patients who discontinued early due to lack of therapeutic response , @ were on placebo and @ were on AZD@ ; none were randomized to risperidone Conclusion : In symptomatic schizophrenia patients , AZD@ was no more efficacious than placebo treatment as measured by PANSS total scale , the CGI , and PANSS positive and negative symptoms subscales .\n",
            "This single dose study does not support a role for positive modulation of mGluR@ receptors as a mechanism for monotherapy to treat acute schizophrenia .\n",
            "These results are also inconsistent with experimental evidence to date supporting a role for mGluR@ receptor activation in antipsychotic therapy .\n",
            "It remains to be determined whether different treatment regimens or adjunct treatment would provide benefit .\n",
            "Despite the established efficacy of neuroleptics for maintaining schizophrenics in the community , there are data suggesting that those with very good prognostic signs may do as well without drugs .\n",
            "In testing this , we find no evidence that patients with good signs are not in need of drugs ; instead they profit most from drug treatment .\n",
            "Patients who benefit little ( @ ) are men whose families were disrupted earlier in their lives , ( @ ) live alone or with extended families whose attitudes toward the study are not positive , and ( @ ) are irregular in taking their medication .\n",
            "The practical implication is that the drug nonresponder can be helped by some means to ensure regularity of medication taking , such as a visiting nurse or long-acting medication .\n",
            "A second research question is whether major role therapy ( MRT , a combination of social casework and vocational rehabilitation ) can lengthen the time until relapse .\n",
            "Major role therapy affected time to relapse in a disordinal manner ; asymptomatic patients benefited from MRT , while in patients with greater symptom severity MRT - suprisingly -- hastened relapse .\n",
            "It is hypothesized that symptomatic patients are suffering from an inability to manage an expanded and enriched cognitive field ; MRT , a therapy that urges the patient to become more responsible and to expand his horizons , may actually induce a state with which the patient can not cope .\n",
            "It is recommended that a therapy such as MRT be deferred until the patient is essentially asymptomatic .\n",
            "The goal of this study was to evaluate the efficacy and the feasibility of cognitive remediation group therapy in patients with schizophrenia in Greece .\n",
            "For this purpose , the cognitive part of the Integrated Psychological Therapy ( IPT ) , focusing on neuro - and social cognition , was compared in a randomized controlled trial ( RCT ) with treatment as usual ( TAU ) .\n",
            "@ outpatients took part in the study .\n",
            "IPT groups received @ biweekly @-h-therapy sessions .\n",
            "A test-battery was assessed at baseline , after therapy , and at a @-month follow-up .\n",
            "Regarding cognitive functioning , significant effects favouring IPT were found in working memory and social perception during therapy and at follow-up .\n",
            "No effects could be found in verbal memory and vigilance .\n",
            "Significant effects favoring IPT were found in negative symptoms , in insight and in general symptoms during therapy and at follow-up using the Positive and Negative Syndrome Scale ( PANSS ) .\n",
            "No effects were evident in positive symptoms and in psychosocial functioning .\n",
            "Significant effects favoring TAU were found in the quality of life assessment at follow-up .\n",
            "The study supports evidence for the feasibility and efficacy of IPT in psychiatric care in Greece and it hopefully will initiate the broader use of evidenced-based treatments like IPT in Greek Psychiatry .\n",
            "Objective : To investigate the effect of the Boston Psychiatric Rehabilitation ( PR ) Approach on attainment of personal rehabilitation goals , social functioning , empowerment , needs for care , and quality of life in people with severe mental illness ( SMI ) in the Netherlands .\n",
            "Method : A @-month , multicentre , randomized controlled trial was used to compare the results of PR to care as usual ( CAU ) .\n",
            "Patients with SMI were randomly assigned by a central randomization centre to PR ( n = @ ) or CAU ( n = @ ) .\n",
            "The primary outcome of goal attainment was assessed by independent raters blind to treatment allocation .\n",
            "Measures for secondary outcomes were change in work situation and independent living , the Personal Empowerment Scale , the Camberwell Assessment of Needs , and the World Health Organization Quality of Life assessment .\n",
            "Effects were tested at @ and @ months .\n",
            "Data were analyzed according to intention to treat .\n",
            "Covariates were psychiatric centre , psychopathology , number of care contacts , and educational level of the professionals involved .\n",
            "Results : The rate of goal attainment was substantially higher in PR at @ months ( adjusted risk difference : @ % , @ % CI @ % to @ % ; number needed to treat [ NNT ] = @ ) .\n",
            "The approach was also more effective in the area of societal participation ( PR : @ % adjusted increase , CAU : @ % adjusted increase ; NNT = @ ) but not in the other secondary outcome measures .\n",
            "Conclusions : The results suggest that PR is effective in supporting patients with SMI to reach self-formulated rehabilitation goals and in enhancing societal participation , although no effects were found on the measures of functioning , need for care , and quality of life .\n",
            "OBJECTIVE : Illness Management and Recovery ( IMR ) is a psychosocial intervention with a recovery-oriented approach .\n",
            "The program has been evaluated in different settings ; however evidence for the effects of IMR is still deficient .\n",
            "The aim of this trial was to investigate the benefits and harms of the IMR program compared with treatment as usual in Danish patients with schizophrenia or bipolar disorder .\n",
            "METHOD : The trial was designed as a randomized , assessor-blinded , multi-center , clinical trial investigating the IMR program compared with usual treatment .\n",
            "@ people diagnosed with schizophrenia or bipolar disorder participated .\n",
            "The primary outcome was the Global Assessment of Functioning ( GAF-F ) at the end of intervention and the secondary and explorative outcomes included severity of symptoms and service utilization .\n",
            "RESULTS : IMR had no significant effect on functioning , symptoms , substance use or service utilization .\n",
            "CONCLUSION : This randomized trial contributes to the evidence base of IMR by providing a methodological solid base for its conclusions ; however the trial has some important limitations .\n",
            "More research is needed to get a firm answer on the effectiveness of the IMR .\n",
            "Purpose of haloperidol for the control group , the concept Chali Pei ketone merge clonazepam treatment of schizophrenia acute the psychomotor excitement efficacy and adverse reactions .\n",
            "Methods @ patients with acute schizophrenia excited patients were randomly divided into the oral risperidone combined intramuscular clonazepam group of @ cases and @ cases of intramuscular haloperidol group therapy , treatment for @ days .\n",
            "Treatment during the assessment of the Positive and Negative Syndrome Scale ( PANSS ) excitement factor ( PANSS-EC ) , and adverse reactions Scale ( TESS ) .\n",
            "The risperidone group efficiency ( @ % ) efficiency ( @ % ) and haloperidol group , the difference was not significant ( P > @ ) .\n",
            "The acute excitement symptoms were significantly improved in the two groups of patients with schizophrenia and adverse reactions haloperidol group was higher than in the risperidone group ( P < @ ) .\n",
            "OBJECTIVE : The objective of this study was to demonstrate a multivariate health state approach to analyzing complex disease data that allows projection of long-term outcomes using clustering , Markov modeling , and preference weights .\n",
            "SUBJECTS : We studied patients hospitalized @ to @ days with refractory schizophrenia at @ Veterans Affairs medical centers .\n",
            "STUDY DESIGN : We conducted a RANDOMized clinical trial comparing clozapine , an atypical antipsychotic , and haloperidol , a conventional antipsychotic .\n",
            "METHODS : Health status instruments measuring disease-related symptoms and drug side effects were administered in face-to-face interviews at baseline , @ weeks , and quarterly follow-up intervals for @ year .\n",
            "Cost data were derived from Veterans Affairs records supplemented by interviews .\n",
            "K-means clustering was used to identify a small number of health states for each instrument .\n",
            "Markov modeling was used to estimate long-term outcomes .\n",
            "RESULTS : Multivariate models with @ and @ states , respectively , were required to describe patterns of psychiatric symptoms and side effects ( movement disorders ) .\n",
            "Clozapine increased the proportion of clients in states characterized by mild psychiatric symptoms and decreased the proportion with severe positive symptoms but showed no long-term benefit for negative symptoms .\n",
            "Clozapine dramatically increased the proportion of patients with no movement side effects and decreased incidences of mild akathisia .\n",
            "Effects on extrapyramidal symptoms and tardive dyskinesia were far less pronounced and slower to develop .\n",
            "Markov modeling confirms the consistency of these findings .\n",
            "CONCLUSIONS : Analyzing complex disease data using multivariate health state models allows a richer understanding of trial effects and projection of long-term outcomes .\n",
            "Although clozapine generates substantially fewer side effects than haloperidol , its impact on psychiatric aspects of schizophrenia is less robust and primarily involves positive symptoms\n",
            "\" Background : Schizoaffective disorder ( SCA ) is complex and disabling , with high risks of hospitalization , suicidality , and substance abuse .\n",
            "Few large controlled trials have studied its clinical characteristics , optimal treatment , and disease course .\n",
            "The first controlled maintenance SCA study of the long-acting injectable antipsychotic , paliperidone palmitate ( PP ) , is presented .\n",
            "Methods : Randomized , double-blind , placebo-controlled , international study ( NCT@ ) .\n",
            "Subjects met SCID-confirmed SCA diagnosis , experiencing acute psychotic exacerbation with prominent mood symptoms .\n",
            "Subjects could continue adjunctive stable doses of antidepressants ( AD ) / mood stabilizers ( MS ) .\n",
            "After stabilization with PP during an open-label period ( PANSS total < @ , YMRS < @ , HAM-D-@ < @ ) , subjects were randomized to continue PP or receive placebo in the @-month , double-blind , relapse prevention period .\n",
            "Kaplan-Meier estimates summarized time to relapse .\n",
            "Log-rank tests controlling for concomitant medication strata assessed between-group differences .\n",
            "Cox proportional hazards model examined treatment differences .\n",
            "Results : @ subjects enrolled ; @ were stabilized and randomized ( @ % monotherapy ; @ % adjunctive AD/MS ) .\n",
            "PP significantly delayed time to relapse ( P < @ ) .\n",
            "@/@ ( @ % ) relapsed with PP ; @/@ ( @ % ) with placebo .\n",
            "Risk of relapse was @-fold higher with placebo ( @ % CI @-@ ; P < @ ) and was higher with placebo in monotherapy ( HR @ ; @ % CI @-@ ; P = @ ) or in adjunctive AD/MS ( HR @ ; @ % CI @-@ ; P = @ ) subgroups .\n",
            "Most common AEs : weight increased ( PP @ % / placebo @ % ) , insomnia ( @ % / @ % ) , SCA ( @ % / @ % ) , headache ( @ % / @ % ) , and nasopharyngitis ( @ % / @ % ) .\n",
            "Conclusions : PP significantly delayed relapse as monotherapy or adjunctive to AD/MS .\n",
            "Relapse risk was @ times higher when stable SCA subjects stopped treatment versus continuing PP during the @-month double-blind period . \"\n",
            "Schizophrenics have a vulnerability to stress which contributes to relapse and results in multiple hospitalizations .\n",
            "As one component of psychosocial rehabilitation , coping skills training has been demonstrated to be effective in reducing relapse rates ( Anderson , Reiss , & Hogarty , @Bellack , Turner , Hersen , & Luber , @Liberman , Massel , Mosk , & Wong , @ ) .\n",
            "The purpose of this study was to investigate the interaction of coping style with coping skills training .\n",
            "Coping literature suggests that individuals have a preferred style of coping with stress and that matching training to style maximizes response to treatment .\n",
            "For this study the coping orientation -- approach versus avoidance -- was proposed as the variable which distinguishes individuals in their response to stress and to coping skills training .\n",
            "Participants were @ hospitalized individuals with diagnoses of chronic schizophrenia or schizoaffective disorder .\n",
            "There were @ males and @ females ranging in age from @ to @ years .\n",
            "In order to classify subjects on their pretraining coping style , the Ways of Coping Checklist ( WCCL ) and a Coping Vignette inventory developed by the author were administered .\n",
            "Subjects were randomly assigned to coping skills training groups in which they received either approach coping style training or avoidance coping style training in @ sessions .\n",
            "@ subjects received no training .\n",
            "Subsequent to the training , all participants were readministered the WCCL and Vignettes .\n",
            "Pretraining-posttraining score differences were examined for the effects of coping style on response to coping skills training .\n",
            "Results were not significant for an interaction between coping style and coping skills training .\n",
            "There was no significant difference on the basis of training method .\n",
            "Methodological issues , especially concerning the measurement of coping , may have attenuated any effects .\n",
            "In addition , behavioral techniques employed in coping skills training may require more exposure in order to have an impact .\n",
            "UNLABELLED : Studies and meta-analyses investigating the influence of substance use disorder ( SUD ) ( substance abuse or dependence ) on psychopathology and neurocognitive function in schizophrenia patients have revealed controversial results .\n",
            "Most studies did only have small samples and did not focus exclusively on first-episode schizophrenia patients .\n",
            "METHOD : In a post-hoc analysis of the European First Episode Schizophrenia Trial ( EUFEST ) psychopathology and cognitive performances of patients with ( FE-SUD , N = @ , consisting of N = @ patients with persisting SUD at baseline and N = @ patients with previous SUD ) and without SUD ( FE-non-SUD , N = @ ) were compared at baseline and @ months follow-up .\n",
            "Neurocognitive assessment included the Rey Auditory Verbal Learning Test ( RAVLT ) ; Trail Making Tests A and B ( TMT ) , Purdue Pegboard and Digit-Symbol Coding .\n",
            "RESULTS : In total @ % of patients reported SUD , and @ % of patients used cannabis .\n",
            "There were no significant differences between patients with and without SUD concerning PANSS scores , extrapyramidal motor symptoms or neurocognitive measures except better performance in psychomotor speed ( TMT-A , p = @ , Cohen 's d = @ ) in patients with SUD at @ months follow-up .\n",
            "Interestingly , SUD patients with ongoing substance use at follow-up showed elevated positive symptoms ( PANSS positive score , p = @ , Cohen 's d = @ ) compared to those who abstained .\n",
            "PANSS scores at baseline were increased in patients with an onset of SUD before the age of @ years .\n",
            "In addition we found a correlation between longer duration of cannabis use and higher cognitive performance as well as reduced symptom improvement and more extrapyramidal motor symptoms in patients with higher frequency of cannabis consumption .\n",
            "CONCLUSIONS : FE-SUD and FE-non-SUD show similar psychopathology and neuropsychological performances at baseline and during the first @ months of antipsychotic treatment .\n",
            "Copyright @ Elsevier B.V. All rights reserved .\n",
            "Objective To investigate the joint of the efficacy and safety of small doses of antidepressants in the treatment of schizophrenia is associated with anxiety and depression .\n",
            "@ patients with schizophrenia is associated with patients with symptoms of anxiety and depression were randomly divided into two groups , the study group of @ patients , application of antipsychotic drugs in combination with low dose antidepressant treatment , the control group of @ patients , a single treatment with antipsychotics ; than cure before treatment and the end of the @ w Brief Psychiatric Rating Scale , the Hamilton Depression Rating scale , Hamilton Anxiety scale , side effects rating scale clinical efficacy and adverse reactions .\n",
            "Results The two groups Brief Psychiatric Rating Scale , the Hamilton Depression Rating Scale , Hamilton Anxiety total score treatment were significantly decreased ( P < @ ) , Study Group @ at the end of treatment , the total efficiency ( @ % ) was significantly higher than the control group ( @ % ) ( P < @ ) ; @w total effective end quite ( P > @ ) ; two sets of adverse reactions was no significant difference ( P > @ ) .\n",
            "Background : Subgroup analyses of a double-blind [ DB ] , active-control study [ NCT@ ] were conducted to determine effect of paliperidone palmitate @-monthly ( PP@M ) injection on relapse in adult patients with Schizophrenia in Latin America ( Argentina , Brazil , Mexico ) .\n",
            "Methods : After screening ( # @ weeks ) and @-week , open-label phase ( paliperidone @-month formulation [ PP@M ] @ mg eq .\n",
            "on day @ , @ mg eq .\n",
            "on day @ , then @-@ mg eq .\n",
            "every @ weeks ) , @ clinically stable patients ( mean @ SD : age @ @ years ; age at Schizophrenia diagnosis : @ + / - @ years ; @ % male ) were randomized to fixed-dose PP@M ( @ , @ , @ , or @ mg eq . )\n",
            "every @ weeks or PP@M ( @-@ mg eq . )\n",
            "every @ weeks in a @-week DB phase .\n",
            "Results : One ( of @ , @ % ) patient in PP@M group and no patient ( of @ ) in PP@M group relapsed during the DB phase .\n",
            "Based on Kaplan-Meier analysis , @ % CI for difference in relapse-free rates between PP@M and PP@M at Week @ was-@ % , @ % ; i.e. , the lower bound exceeded the pre-specified non-inferiority margin-@ % .\n",
            "The most frequently reported adverse event ( .@ % ) was weight increased ( @ % PP@M , @ % PP@M ) , with mean weight gain from DB baseline to endpoint of @ kg and @ kg in the respective groups .\n",
            "Two patients ( @ % ) in the PP@M group and none in the PP@M group discontinued study drug prematurely due to an adverse event ( anxiety , somnolence ) .\n",
            "Conclusions : Overall , similar efficacy and tolerability were observed between PP@M and PP@M in Latin American patients with stable Schizophrenia , which was consistent with observations globally .\n",
            "Cognitive deficit is common and related to functional outcome in patients with schizophrenia .\n",
            "The possible role of adjunctive pharmacology for cognitive deficit is receiving consideration .\n",
            "There is a bulk of evidence suggesting an important role of cholinergic system in schizophrenia .\n",
            "The aim of this project was to evaluate the effectiveness of augmentation of risperidone by inhibitor of acetylcholinesterase donepezil in the treatment of cognitive impairment in schizophrenia .\n",
            "Thirty patients with schizophrenia and schizoaffective disorder on individual stable dose of risperidone were randomly assigned to double blind treatment with donepezil or placebo .\n",
            "They were administered the neuropsychological battery at baseline and again following @ weeks and @ weeks of experimental treatment .\n",
            "Donepezil did not produce significant improvements in any cognitive parameter compared with placebo .\n",
            "Our results are consistent with the other placebo controlled studies of Friedman et al. @ and Tugul and Yazici @ .\n",
            "Background : Data on treatment effects in patients with deficit syndrome ( ie , primary , enduring negative symptoms ) are limited .\n",
            "This post hoc analysis examined effects of lisdexamfetamine dimesylate ( LDX ) , a d-amphetamine prodrug , in adults with persistent predominant negative symptoms of schizophrenia ( NSS ) and classified post hoc with/without proxy deficit syndrome ( PDS ) or enduring primary negative symptoms .\n",
            "Methods : Outpatients with stable schizophrenia , defined as predominant NSS ( SANS-@ [ items @-@ , @-@ , @-@ , @-@ ] score > = @ , score > = @ on > = @ SANS global items , PAN SS positive score < @ ) and maintained on stable antipsychotic treatment ( > = @ weeks ) were enrolled .\n",
            "Participants received @-week open-label ( OL ) adjunctive LDX ( @-@mg / d ) ; eligible participants ( any SANS-@ improvement at week @ ) entered @-week , double-blind , placebo-controlled randomized withdrawal ( RW ) .\n",
            "Measures included SANS-@ ( primary efficacy outcome ) , PAN SS subscales , and Calgary Depression Scale for Schizophrenia ( CDSS ) .\n",
            "Post hoc analyses included response to OL adjunctive LDX in participants with or without PDS .\n",
            "PDS was defined as baseline scores > = @ for males and > = @ for females on PAN SS composite score of blunted affect item less the depression item .\n",
            "Safety evaluations included treatment-emergent adverse events ( TEAEs ) and PAN SS positive subscale .\n",
            "Results : Of @ males and @ females receiving OL LDX , @ % of males and @ % of females met PDS criteria .\n",
            "Mean ( SD ) baseline SANS-@ scores were @ ( @ ) , @ ( @ ) , and @ ( @ ) for the overall group , and males and females with PDS , respectively .\n",
            "Overall , mean ( @ % CI ) change in SANS-@ score ( week @-@ ) was -@ ( -@ , -@ ) ( P < .@ ) .\n",
            "Mean ( SD ) change in SANS-@ score was -@ ( @ ) for males with PDS and -@ ( @ ) for females with PDS .\n",
            "Small decreases from baseline were shown for PAN SS positive subscores and CDSS scores during adjunctive LDX treatment .\n",
            "In the OL phase , @ % reported TEAEs ; @ % reported serious TEAEs .\n",
            "Conclusion : In conclusion , mean SANS-@ score improved for all participants without worsening of positive symptoms .\n",
            "Improvement occurred in negative symptoms in both males and females with PDS , with greater decreases in females vs males .\n",
            "LDX may improve both primary and secondary negative symptoms , but these results should be confirmed with a larger study .\n",
            "Objective To investigate the efficacy and safety of the Qing Kai Ling combined with low-dose antipsychotic drugs to treat schizophrenia .\n",
            "@ patients with schizophrenia were randomly divided into study group of @ patients , @ cases of the control group .\n",
            "The study group was given intravenous Qingkailing , together with a small dose sulpiride or / and clozapine treatment .\n",
            "The control group was given of sulpiride or / and clozapine treatment .\n",
            "The course of treatment was @w .\n",
            "The positive and negative symptom rating scale clinical efficacy .\n",
            "Results The study group total effective rate of @ % , @ % in the control group , the two groups showed no significant difference ( P > @ ) .\n",
            "Study Group @ case of extrapyramidal adverse reactions , nine cases of the control group extrapyramidal system adverse reactions , akathisia two cases .\n",
            "Conclusion Qingkailing joint antipsychotic drug safe and effective for the treatment of schizophrenia .\n",
            "OBJECTIVE : To investigate the advisability of using aripiprazole in schizophrenic patients with weight gain associated with treatment with atypical neuroleptics .\n",
            "MATERIAL AND METHODS : We studied @ patients with schizophrenia in therapeutic remission .\n",
            "In all patients , weight gain was associated with the administration of atypical neuroleptics of the second generation .\n",
            "The treatment was stopped in @ patients and @ patients continued to receive atypical neuroleptics .\n",
            "RESULTS : Aripiprazole prevented exacerbations of disease and led to the significant reduction of the severity of negative symptoms .\n",
            "Switching patients to aripiprazole resulted in the considerable decrease in body mass up to its normalization .\n",
            "Side-effects included only mild akathisia .\n",
            "CONCLUSION : Comparison of results to literature values revealed that body mass decreased to the same degree as in patients treated with low doses of atypical neuroleptics .\n",
            "However , the use of first generation neuroleptics can not reduce the severity of negative symptoms and tolerability of these drugs is worse .\n",
            "CAJ Objective Aiming at observation of the music therapy effect on schizophrenia , @ mental inpatients were divided into two groups , one group was treated with music therapy against the other untreated group .\n",
            "Results of @ weeks observation were listed in BPRS , SANS table showing evident differences between the two groups and suggesting certain effect of music treatment on schizophrenia .\n",
            "Using symptom factors derived from two models of the Positive and Negative Syndrome Scale ( PANSS ) as covariates , change over time in consumer psychosocial functioning , medication adherence/compliance , and treatment satisfaction outcomes are compared based on a randomized , controlled trial assessing the effectiveness of antipsychotic medications for @ individuals diagnosed with schizophrenia .\n",
            "Random effects regression analysis was used to determine the relative performance of these two @-factor models as covariates in estimating change over time and the goodness of fit of the regression equations for each outcome .\n",
            "Self-reported psychosocial functioning was significantly associated with the relief of positive and negative syndromes , whereas patient satisfaction was more closely and significantly associated with control of excited/activation symptoms .\n",
            "Interviewer-rated psychosocial functioning was significantly associated with relief of positive and negative symptoms , as well as excited/activation and disoriented/autistic preoccupation symptoms .\n",
            "The VDG @-factor model of the PANSS represents the best \" goodness of fit \" model for assessing symptom-related change associated with improved psychosocial outcomes and functional recovery .\n",
            "Five-factor models of the syndromes of schizophrenia , as assessed using the PANSS , are differentially valuable in determining the predictors of psychosocial and satisfaction changes over time , but not of improved medication adherence/compliance .\n",
            "Objective : We examined @ single nucleotide polymorphisms ( SNPs ) previously reported to be associated with response to iloperidone therapy for association with response to risperidone therapy .\n",
            "Method : Patients with schizophrenia ( DSM-IV ) were assessed during @ and @ for response/nonresponse ( defined as > = @ % / < @ % improvement in Positive and Negative Syndrome Scale [ PANSS ] total score ) after @ weeks of risperidone treatment ( @ to @ mg/d ) .\n",
            "Responders continued risperidone treatment ; nonresponders were randomly assigned to either risperidone or olanzapine treatment ( @ to @ mg/d ) for an additional @ weeks .\n",
            "Associations between change in PANSS total ( primary outcome measure ) , positive , and negative scores and the @ SNPs were examined in risperidone-treated patients ( N = @ ) .\n",
            "Genotype frequencies and improvement in PANSS total scores were analyzed for those SNPs significantly associated with change in PANSS total score .\n",
            "Results : The SNPs XKR@ rs@ and GRIA@ rs@ were significantly associated with change in PANSS total response ( adjusted P < .@ for both ) , with the same direction of effect as reported for iloperidone .\n",
            "For patients with nonresponsive genotypes for these SNPs , mean improvement in PANSS total score for African Americans was two-thirds that seen for whites ( XKR@ : -@ versus -@ ; GRIA@ : -@ versus -@ ) .\n",
            "Conclusions : In this retrospective pharmacogenomic analysis , we found that @ SNPs previously linked to iloperidone response were also associated with response to risperidone .\n",
            "Trial Registration : clinicaltrials.gov Identifier : NCT@ .\n",
            "Copyright @ Physicians Postgraduate Press , Inc .\n",
            "Educational Objectives : At the conclusion of this presentation , the participant should have a better understanding of the relationship of patient beliefs about antipsychotic medication use and their likelihood of discontinuing treatment prematurely .\n",
            "Summary : Background : The objective of this study was to examine the relationship between patient beliefs about medication use and their likelihood of discontinuing treatment prematurely .\n",
            "Associations of patient beliefs about medication with clinical psychopathology and their life satisfaction were also assessed .\n",
            "Methods : This post-hoc analysis used data from a randomized , open-label , @-year trial of antipsychotics in the treatment of patients with schizophrenia or schizoaffective disorders ( N = @ ) .\n",
            "Medication management was at doctors ' discretion , reflecting naturalistic treatment in usual clinical care settings .\n",
            "Patient-reported beliefs about medication were assessed by Rating of Medication Influences ( ROMI ) , degree of clinical psychopathology was measured by Positive and Negative Syndrome Scale ( PANSS ) , and patient quality of life was measured by Lehman Quality of Life Interview ( LQLI ) .\n",
            "Results : Patient perception of medication benefit was the only strong predictor of treatment duration among the @ underlying dimensions of medication influences .\n",
            "Low level of perceived beneficial effect of medication was associated with greater likelihood of early treatment discontinuation ( Hazard Ratio = @,@ % Confidence Interval [ @ , @ ] , p = @ ) Patients with greater beliefs in the beneficial effect of treatment also had better clinical psychopathology outcome and were more satisfied with their quality of life and well-being .\n",
            "Conclusion : Understanding the predictors of early treatment discontinuation in the care of schizophrenia patients is important for the development of interventions to improve treatment adherence .\n",
            "Current findings suggest that patient perception of beneficial effect of medication may be a critical factor in patient motivation for treatment adherence and hence a determinant of a satisfactory treatment outcome .\n",
            "The purpose of in-depth understanding of the insight of the impact of education on the negative emotions of patients with schizophrenia , and to further explore its causes , to provide a scientific basis for the improvement of the education of the insight perfection and educational content .\n",
            "Methods @ cases of patients with schizophrenia were randomly divided into the education group and the control group , both groups received antipsychotics system treatment and education group based on eight weeks to insight education , education before and after using the Brief Psychiatric Rating Scale ( BPRS ) , the insight and Treatment Attitudes Questionnaire ( ITAQ ) , anxiety self-assessment scale ( SAS ) , self-Rating Depression scale ( SDS ) were assessed ; according to the assessment results , insight recovery associated with anxiety , depression patients conduct in-depth interviews , will get Giorgi law analysis .\n",
            "Results educated BPRS score between the two groups , the difference was not statistically significant ( P > @ ) ; ITAQ , SAS , SDS score Education Unit were significantly higher ( P < @ ) .\n",
            "Depth interviews with @ patients , drawn psychosocial factors produce negative emotions after the recovery of the patient 's insight : shame and remorse psychology of pathological behavior and its consequences , a sense of belonging are not met , the profound stigma sense , the sense of despair for the future .\n",
            "Conclusions insight education of patients with schizophrenia , educational content and inform strategy should be adjusted at any time according to the patient 's negative emotional condition , and give emotional support for the patient 's social and psychological factors , so that patients recover insight while reducing or eliminate negative emotions .\n",
            "Background : Prospective brain imaging evidence suggests that progressive brain changes occur as schizophrenia develops and evolves .\n",
            "This SMRI treatment trial tested the hypothesis that the antimicroglial and neuroprotective actions of minocycline will prevent cognitive decline and the emergence of negative symptoms in early psychosis .\n",
            "Methods : Design    One year , randomised placebo-controlled double blind pilot add-on study to treatment as usual ( TAU ) .\n",
            "Patients    Less than @ years from first episode in Pakistan and Brazil .\n",
            "Outcome measures    Positive and Negative Symptoms Scale , Clinical Global Impression and neuropsychological tests .\n",
            "Results : A total of @ patients on minocycline and @ on placebo completed @ months of the study .\n",
            "All symptom measures improved significantly over @ months of TAU with trend effect of minocycline on the negative symptoms .\n",
            "Performance on some cognitive tasks declined , this was less on minocycline for verbal fluency and working memory errors ( P < @ one tailed ) .\n",
            "However , improvement in orientation tended to be less on minocycline ( P < @ @-tailed ) .\n",
            "Discussion : Minocycline had no significant effect on the substantial improvement on ratings of symptoms over the course of treatment .\n",
            "Declines in working memory and verbal fluency may reflect neuropathic change in frontal cortex and this was lessened in the minocycline group .\n",
            "Improvements on non-frontal tasks were not affected by minocyline apart from trend effect on orientation .\n",
            "The small effects of minocycline are compatible with a neuroprotective action but may reflect multiple comparisons or pharmacological effects on performance .\n",
            "Larger samples over a longer period are warranted .\n",
            "This study as funded by a Stanley Medical Research Institute grant w ( @T-@ ) .\n",
            "Although olanzapine has been shown to be an effective drug in the treatment of relapsing schizophrenic patients , its effectiveness in the chronic nonresponding schizophrenics is uncertain .\n",
            "Whether olanzapine has additional efficacy in ameliorating neurocognitive deficits characteristic of schizophrenia , which often persist in spite of symptomatic improvement has not been established .\n",
            "In a double-blind study of olanzapine and haloperidol ( with subsequent open label olanzapine follow-up of olanzapine doses up to @ mg/day ) we evaluated the efficacy of olanzapine on clinical symptoms and neurocognitive function in chronically hospitalized schizophrenic patients who had shown a poor clinical response to treatment with traditional neuroleptics and/or other atypical neuroleptics ( risperidone or clozapine ) .\n",
            "Preliminary results on a small initial sample indicate that a greater proportion of patients showed clinical improvement on olanzapine ( O ) than haloperidol ( H ) on a global improvement scale ( CGI [ Improvement score ?\n",
            "@ ] O = @ % , H = @ % ) , and also on positive ( PANSS Pos [ decrease ?\n",
            "@ % ] O = @ % , H = @ % ) and negative ( SANS Total [ decrease ?\n",
            "@ % ] O = @ % H = @ % ) symptoms .\n",
            "Although none of the mean deceases in scores between olanzapine and haloperidol were statistically significant , the direction of mean differences consistently favored olanzapine .\n",
            "At the end of the open-label olanzapine treatment @-@ % of patients showed a > @ % in positive and negative symptom scores compared to baseline .\n",
            "On tests of neurocognitive function , olanzapine significantly decreased total errors on the Wisconsin Card Sorting task whereas haloperidol produced an increase in scores .\n",
            "At the end of double blind treatment period semantic logical memory ( short story ) on the RANDT memory test was significantly better on olanzapine than haloperidol .\n",
            "There were nonsignificant trends for olanzapine subjects to do better than haloperidol subjects on other tests of semantic learning and memory .\n",
            "These results suggest that olanzapine may have some superior efficacy compared to haloperidol in the treatment of clinical and neurocognitive impairments in chronic nonresponding schizophrenic patients .\n",
            "Results on a larger sample we are now completing will be informative about the robustness of these preliminary results .\n",
            "Schizophrenics have among the highest rates of cigarette smoking of any disease category , with some studies showing @-@ % of schizophrenics to be regular cigarette smokers .\n",
            "Neurophysiological studies in schizophrenia have shown that acute cigarette smoking transiently corrects deficits in P@ auditory evoked potential gating response and eye tracing deficits found in many schizophrenic patients .\n",
            "Does acute administration of nicotine or cigarette smoking ameliorate positive or negative schizophrenic symptoms , or components of neurocognitive functioning , such as memory and attention , reported to be abnormal on neuropsychological tests ?\n",
            "We have examined this question in a double-blind placebo controlled paradigm , in which hospitalized chronic schizophrenic patients , smoked high nicotine ( @ mg ) or placebo ( very low nicotine @ mg ) cigarettes , or received active or placebo nicotine nasal spray , on @ different days .\n",
            "Before and after drug administration on each day they were evaluated for positive and negative symptoms with PANSS and SANS subscales , blood pressure and pulse , nicotine and cotinine levels , and a computer battery of neuropsychological tests ( ANAM moderate repeat battery ) .\n",
            "Additional neuropsychological tests ( world fluency , and verbal memory portion of RANDT ) were administered post-drug on each day .\n",
            "Results on the initial sample showed that high dose nicotine cigarettes produced a significant decrease in negative symptoms on the PANSS and SANS scales , but that active vs. placebo nicotine nasal spray showed no significant effect on negative symptoms there was a non-significant trend for high nicotine cigarettes to improve accuracy on performance of a spatial rotation test .\n",
            "There were no significant effects of acute cigarette or nasal pray drug administration on positive symptoms , verbal fluency , or verbal learning and memory .\n",
            "Measured at a time about @-@ minutes after smoking the two several cigarettes , high nicotine cigarettes produced significantly higher plasma nicotine levels after smoking ( @ ng/ml ) than very low nicotine ( placebo ) cigarettes ( @ ng/ml ) .\n",
            "Active nicotine spray produced a small but statistically significant increase in nicotine ( @ ng/ml ) levels whereas placebo spray produced a nonsignificant decrease in nicotine plasma levels .\n",
            "Both high nicotine and very low nicotine cigarettes produced a significant increase in pulse but there was no significant difference between the two cigarettes .\n",
            "The active nicotine spray produced an increase in pulse which was similar in magnitude to the cigarettes whereas the placebo spray produced no change in pulse .\n",
            "Resutls from the full study on a larger sample will be presented at the meeting .\n",
            "Supported by a NARSAD Independent Investigator Award to Dr. Smith Smoking Nicotine Negative symptoms Positive symptoms Cognitive function Schizophrenia : drug therapy\n",
            "Objectives : The STRIDE study assessed whether a lifestyle intervention , tailored for individuals with serious mental illnesses , reduced weight and diabetes risk .\n",
            "The authors hypothesized that the STRIDE intervention would be more effective than usual care in reducing weight and improving glucose metabolism .\n",
            "Method : The study design was a multisite , parallel two-arm randomized controlled trial in community settings and an integrated health plan .\n",
            "Participants who met inclusion criteria were > / = @ years old , were taking antipsychotic agents for > / = @ days , and had a body mass index > / = @ .\n",
            "Exclusions were significant cognitive impairment , pregnancy/breastfeeding , recent psychiatric hospitalization , bariatric surgery , cancer , heart attack , or stroke .\n",
            "The intervention emphasized moderate caloric reduction , the DASH ( Dietary Approaches to Stop Hypertension ) diet , and physical activity .\n",
            "Blinded staff collected data at baseline , @ months , and @ months .\n",
            "Results : Participants ( men , N = @ ; women , N = @ ; mean age = @ years [ SD = @ ] ) were randomly assigned to usual care ( N = @ ) or a @-month weekly group intervention plus six monthly maintenance sessions ( N = @ ) .\n",
            "A total of @ participants ( @ % ) completed @-month assessments , and @ ( @ % ) completed @-month assessments , without differential attrition .\n",
            "Participants attended @ of @ sessions over @ months .\n",
            "Intent-to-treat analyses revealed that intervention participants lost @ kg more than control participants from baseline to @ months ( @ % CI = -@ kg to -@ kg ) and @ kg more than control participants from baseline to @ months ( @ % CI = -@ kg to -@ kg ) .\n",
            "At @ months , fasting glucose levels in the control group had increased from @ mg/dL to @ mg/dL and decreased in the intervention group from @ mg/dL to @ mg/dL .\n",
            "No serious adverse events were study-related ; medical hospitalizations were reduced in the intervention group ( @ % ) compared with the control group ( @ % ) .\n",
            "Conclusions : Individuals taking antipsychotic medications can lose weight and improve fasting glucose levels .\n",
            "Increasing reach of the intervention is an important future step .\n",
            "Since the demonstration of the superior effect of clozapine in treatmentresistant schizophrenia there has been an ongoing search for other drugs with the same effect .\n",
            "Although there have been multiple hypotheses about the mechanism of clozapine s efficacy , none have yet clearly explained clozapine s differential effect .\n",
            "This is largely because there are no other antipsychotics that have shown clozapine s effect in a similarly designed trial .\n",
            "Olanzapine is an excellent candidate drug for study .\n",
            "It has a very similar binding profile to clozapine , but has a higher dose potency .\n",
            "Olanzapine is an effective antipsychotic .\n",
            "We have studied the effect of olanzapine vs. chlorpromazine in a eight-week , double-blind clinical trial .\n",
            "All subjects had a DSM-III-R diagnosis of schizophrenia and were classified as treatment-resistant by failing to have a @ % or greater response to at least two different neuroleptics , exclusive of haloperidol ( at @ mg/day CPZ equivalents for six weeks each ) , been persistently ill with no periods of good functioning for at least five years , and had failed to show a @ % improvement in a six-week prospective trial of haloperidol .\n",
            "All subjects signed informed consent .\n",
            "Subjects had a two-week single-blind neuroleptic washout , followed by eight weeks of treatment either with @ mg/day of olanzapine or @ mg/day of chlorpromazine in a fixed-dose design after a one week titration period .\n",
            "Subjects were rated weekly .\n",
            "One hundred-six subjects have entered the trial .\n",
            "We will report unblinded data at the meeting .\n",
            "Olanzapine is a potential new ' atypical ' anTI : psychotic agent .\n",
            "This double-blind , acute phase study compared two doses of olanzapine [ @ mg/day ( Olz@ .@ ) ; @ mg/day ( Olz@ .@ ) ] with placebo in the treatment of @ patients who met the DSM-III-R criteria for SCHIZophrenia and had a Brief Psychiatric Rating Scale ( BPRS ) - total score ( items scored @-@ ) > = @ .\n",
            "In overall symptomatology improvement [ BPRS-total score and Positive and Negative Syndrome Scale ( PANSS ) - total score ] , Olz@ .@ was statistically significantly superior to placebo .\n",
            "In positive symptom improvement ( PANSS-positive score , BPRS-positive score ) , Olz@ .@ was statistically significantly superior to placebo .\n",
            "In negative symptom improvement ( PANSS-negative score ) , Olz@ .@ was statistically superior to placebo .\n",
            "Olz @ was clinically comparable to placebo in all efficacy comparisons .\n",
            "The only adverse event to show an overall statistically significant incidence difference was anorexia ( reported for @ % of placebo - treated and @ % of Olz@ .@ - treated patients ) .\n",
            "The Olz@-treated patients improved over baseline with respect to parkinsonian and akathisia symptoms , and these changes were comparable with those observed with placebo .\n",
            "There were no dystonias associated with Olz@ .@ treatment .\n",
            "At endpoint , the incidence of patients with elevated prolactin values did not differ statistically significantly between placebo-treated and Olz@ .@ - treated patients .\n",
            "Olanzapine appears to be not only safe and effective , but a promising atypical antipsychotic candidate .\n",
            "BACKGROUND : According to the American Psychiatric Association Clinical Practice Guidelines for schizophrenia , second-generation antipsychotics may be specifically indicated for the treatment of depression in schizophrenia .\n",
            "We examined the impact of these medications on symptoms of depression using the data from the Clinical Antipsychotic Trials of Intervention Effectiveness ( CATIE ) , conducted between January @ and December @ .\n",
            "METHOD : Patients with DSM-IV-defined schizophrenia ( N = @ ) were assigned to treatment with a first-generation antipsychotic ( perphenazine ) or one of @ second-generation drugs ( olanzapine , quetiapine , risperidone , or ziprasidone ) and followed for up to @ months ( phase @ ) .\n",
            "Patients with tardive dyskinesia were excluded from the randomization that included perphenazine .\n",
            "Depression was assessed with the Calgary Depression Scale for Schizophrenia ( CDSS ) .\n",
            "Mixed models were used to evaluate group differences during treatment with the initially assigned drug .\n",
            "An interaction analysis evaluated differences in drug response by whether patients had a baseline score on the CDSS of > / = @ , indicative of a current major depressive episode ( MDE ) .\n",
            "RESULTS : There were no significant differences between treatment groups on phase @ analysis , although there was a significant improvement in depression across all treatments .\n",
            "A significant interaction was found between treatment and experiencing an MDE at baseline ( P = .@ ) , and further paired comparisons suggested that quetiapine was superior to risperidone among patients who were in an MDE at baseline ( P = .@ ) .\n",
            "CONCLUSIONS : We found no differences between any second-generation antipsychotic and the first-generation antipsychotic perphenazine and no support for the clinical practice recommendation , but we did detect a signal indicating a small potential difference favoring quetiapine over risperidone only in patients with an MDE at baseline .\n",
            "AIMS : Pregnenolone ( PREG ) and L-theanine ( LT ) have shown ameliorative effects on various schizophrenia symptoms .\n",
            "This is the first study to evaluate the efficacy and safety of augmentation of antipsychotic treatment among patients with chronic schizophrenia or schizoaffective disorder with PREG-LT .\n",
            "METHODS : Double-blind , placebo-controlled trial of PREG-LT or placebo augmentation was conducted for eight weeks with @ chronic DSM-IV schizophrenia and schizoaffective disorder patients with suboptimal response to antipsychotics .\n",
            "Oral PREG ( @ mg/day ) with LT ( @ mg/day ) or placebo were added to a stable regimen of antipsychotic medication from March @ to October @ .\n",
            "The participants were rated using the Scale for the Assessment of Negative Symptoms ( SANS ) , the Hamilton Scale for Anxiety ( HAM-A ) , and the Positive and Negative Syndrome Scale ( PANSS ) scales bi-weekly .\n",
            "The decrease of SANS and HAM-A scores were the co-primary outcomes .\n",
            "Secondary outcomes included assessments of general functioning and side effects .\n",
            "RESULTS : Negative symptoms such as blunted affect , alogia , and anhedonia ( SANS ) were found to be significantly improved with moderate effect sizes among patients who received PREG-LT , in comparison with the placebo group .\n",
            "Add-on PREG-LT also significantly associated with a reduction of anxiety scores such as anxious mood , tension , and cardiovascular symptoms ( HAM-A ) , and elevation of general functioning ( GAF ) .\n",
            "Positive symptoms , antipsychotic agents , concomitant drugs , and illness duration did not associate significantly with effect of PREG-LT augmentation .\n",
            "PREG-LT was well-tolerated .\n",
            "CONCLUSIONS : Pregnenolone with L-theanine augmentation may offer a new therapeutic strategy for treatment of negative and anxiety symptoms in schizophrenia and schizoaffective disorder .\n",
            "Further studies are warranted .\n",
            "TRIAL REGISTRATION : clinicaltrials.gov Identifier : NCT@ .\n",
            "To substantiate a previously reported disturbance of gamma-aminobutyric acid ( GABA ) in chronic schizophrenia , plasma growth hormone ( GH ) response to a direct GABA agonist ( baclofen , @ mg ) was assessed in @ unmedicated chronic schizophrenic males and @ sex - and age - matched healthy controls .\n",
            "Baclofen and placebo were administered orally , in a double-blind design , and blood samples were collected before and @ , @ , @ , @ , @ , and @ min after drug or placebo administration .\n",
            "Baclofen induced a clear-cut rise in plasma GH levels over baseline values , but the GH increase observed in the patients was significantly smaller than that in controls .\n",
            "These results support the idea that GABA mechanisms may be impaired in chronic schizophrenia .\n",
            "Background : There is growing evidence that structural brain change can be detected in healthy volunteers following short-term changes in physical and/or cognitive activity .\n",
            "A recent study ( Pajonk et al , Archives of General Psychiatry , @ ) found significant increases in hippocampal volume , improved memory performance , and reduced psychopathology ratings in chronic schizophrenia patients who performed twelve weeks of aerobic exercise , compared to a control group who engaged in a non-aerobic activity for a similar period of time .\n",
            "The current study aimed to extend these findings to a sample of young people experiencing a first episode schizophrenia spectrum disorder .\n",
            "Methods : Patients aged between @ and @ years who met DSM-IV criteria for schizophrenia , schizoaffective disorder or schizophreniform disorder were recruited from a community-based early psychosis treatment program .\n",
            "Patients were randomly allocated to either twice-weekly exercise bike training or playing tabletop football ( @-minutes/session ) as a comparison condition that does not involve aerobic conditioning , for a total of twelve weeks .\n",
            "Baseline VO@ max was determined using a three minute ramp protocol on a MONARK cycle ergometer and direct gas analysis ( MedGraphics Ultima gas analysis system ) .\n",
            "ECG , blood pressure and lactate concentrations were monitored .\n",
            "Premorbid IQ was assessed via the Peabody Picture Vocabulary Test .\n",
            "Short term memory was assessed using the Rey Auditory-Verbal Learning Test , and the spatial span subtest of the Wechsler Memory Scale-III .\n",
            "Symptom ratings on the SAPS and SANS were completed and @-D structural MRIs obtained using a @ T Phillips Achieva scanner .\n",
            "A healthy comparison subgroup matched to the patients on pre-test aerobic fitness , age and gender were assigned to the aerobic intervention condition .\n",
            "Hippocampal volumes were extracted using an automated segmentation routine based on the principles of the Active Shape and Appearance Models within a Bayesian framework as implemented by \" FIRST \" in the FSL software package .\n",
            "Prior to segmentation , the skull was stripped from all @-D structural images and the brain tissue extracted .\n",
            "FIRST was then applied to separately estimate left and right volumes of the hippocampus .\n",
            "As part of the segmentation routines , all data were registered to MNI standard space , using a @ DOF affine transformation .\n",
            "Following subcortical registration , a subcortical mask based on shape models and voxel intensities was applied , to isolate the hippocampus .\n",
            "Absolute volumes of the left and right hippocampus were then calculated taking into account the original transformations .\n",
            "A boundary correction ( z-value = @ ) was applied ( corresponding to a @ % certainty ) to determine the boundary voxels and the data was visually inspected for errors .\n",
            "Finally , all data were corrected for intracranial volume .\n",
            "Results : Recruitment is ongoing , with the aim of obtaining complete data on equal group sizes for first episode schizophrenia in both conditions , and for healthy comparison subjects in the aerobic exercise condition ( n = @ ) .\n",
            "Discussion : The potential for significant improvement in memory performance and symptom ratings , accompanied by increased hippocampal volumes in this population via a simple aerobic exercise intervention could have a significant impact on improved functional outcomes and decreased medical morbidity .\n",
            "Statement of the study : Efficacy of the risperidone oral solution , as new , effective therapeutic possibility in the treatment of acute and agitated psychotic patients and is at least as effective as conventional parenteral neuroleptic therapy , has been analyzed at the acute ward of Psychiatric Clinic , Clinical hospital Split .\n",
            "Methods : This was a prospective , naturalistic study , comparing the efficacy , safety and tolerability of risperidone oral solution versus conventional neuroleptic haloperidol in treatment of acute and agitated psychotic patients .\n",
            "The subjects were @ patients admitted at Acute Ward of Psychiatry Clinic of Clinical Hospital Split in Split , Croatia , who required emergency medication for the control of agitation and/or violence .\n",
            "Inclusion criteria included men or women @ years old and older ; ICD X diagnosis of acute exacerbation of schizophrenia or schizoaffective disorder , mania with psychotic features , acute paranoid reaction , or delusional disorders ; a score of s @ on a @-item acute agitation cluster derived from the Positive and negative Syndrome Scale ( PANSS ) ; and a score @ on the Clinical Global Impressions-Severity of Illness scale ( CGI-S ) .\n",
            "Exclusion criteria included delirium , epilepsy , or mental retardation ; intoxication or symptoms of withdrawal from alcohol or other psychoactive substances ; clinical laboratory values indicating serious medical illness ; treatment with any antipsychotic or benzodiazepine within @ hours of screening ; a history of neuroleptic malignant syndrome or known hypersensitivity to an of the trial medications ; treatment with a depot antipsychotic within @ treatment cycle of screening ; and use of disallowed medication .\n",
            "Efficacy was assessed with the Positive and Negative Syndrome Scale ( PANSS ) , @-item acute-agitation cluster , Clinical Global Impressions ( CGI ) Scale and Behavioural Activity Rating Scale ( BARS ) , side effects were also assessed .\n",
            "Summary of the results : Statistically significant difference between the two groups was evident in the group of patients treated with risperidone oral solution during the @ hours ( mean @ , p = @ ) and @ months ( mean @ p = @ ) compared to the patients treated with haloperidol .\n",
            "Statistically significant difference in the CGI scale in the group of patients treated with risperidone oral solution was evident after @ hours of treatment ( mean @ , p = @ ) .\n",
            "Also statistically significant difference between the two groups in the BARS Scale was evident in the group of patients treated with risperidone oral solution after @ hours ( mean @ , p = @ ) and @ days ( mean @ , p = @ ) of the treatment .\n",
            "Conclusion : Fast remission or suppression of positive symptoms , as well as of agitation , hostility , excitement , and aggressiveness , is a primary goal in the treatment of acute schizophrenic exacerbations .\n",
            "Conventional approach to acute psychotic patients was accustomed to parenteral therapy with incisive neuroleptics .\n",
            "The oral solution of atypical antipsychotic risperidone is new , effective therapeutic possibility in acute conditions of the patients , who because of the acute psychotic state , very often refuse to take medication .\n",
            "The oral solution offered as a beverage rarely spares a patient and medical staff of unpleasant parenteral administration of a medicine .\n",
            "@ .\n",
            "Currier GW , Chou JC-Y , Feifel D , Bossie C , Turkoz I , Mahmoud R , Gharabawi G , @ , Acute treatment of psychotic agitation : a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam , Clin psychiatry , @ , @-@ .\n",
            "A double-blind comparative study was carried out on @ psychotic inpatients affected by extrapyramidal syndrome secondary to neuroleptic treatment .\n",
            "The aim of the study was to evaluate the therapeutic efficacy of an anticholinergic antiparkinsonian drug , biperidene ( Akineton , Knoll ) in comparison with placebo under double - blind conditions .\n",
            "Both treatments were administered according to a crossover design ( ten patients in each treatment sequence ) by intramuscular route in the first three days ( @ x @ mg/day ) and by oral route for another ten days ( @ x @ mg/day ) .\n",
            "The evaluation of the antiparkinsonian therapeutic activity was carried out by means of two specific Rating Scales ( Duvoisin 's Rating Scale for Parkinson 's Disease and Hoehn and Yahr 's Scale ) and on the basis of two overall clinical judgement devices ( Patient Termination Record and Clinical Global Impression ) .\n",
            "Possible undesired side effects were registered by means of an appropriate check list ( Dosage Record and Treatment Emergent Symptoms Scale ) .\n",
            "Biperidene was significantly more effective than placebo both on the basis of the two Rating Scales and on the basis of the overall clinical judgements .\n",
            "No side effects attributable to biperidene were detected .\n",
            "Aim : To evaluate whether integrated treatment ( given by OPUS ) , in comparison with standard treatment , significantly reduced the number of patients with substance abuse and improved clinical and social outcome in the group of substance abusers after @ years .\n",
            "Methods : A total of @ patients with first-episode schizophrenia-spectrum disorders were included in the study , @ randomly assigned to OPUS treatment and @ to standard treatment .\n",
            "OPUS treatment consisted of assertive community treatment with family involvement and social skills training .\n",
            "Standard treatment offered contact with a community mental health centre .\n",
            "Main outcome measure was reduction in comorbid substance abuse .\n",
            "Results : At @-year follow up , @ ( @ % ) patients from OPUS and @ ( @ % ) patients from standard treatment met criteria for substance abuse ( odds ratio = @ , @ % confidence interval @-@ ) .\n",
            "OPUS treatment compared with standard treatment significantly reduced negative and disorganized symptoms in the substance abuser group .\n",
            "Patients with substance abuse in the OPUS treatment spent significantly fewer days in hospital during the @-year period than patients given standard treatment ( @ days vs. @ days ) and adhered to treatment significantly more often .\n",
            "Conclusions : Results from this trial indicate that integrated treatment given by OPUS reduced substance abuse and improved clinical outcome in the substance abuser group .\n",
            "Supplementing the OPUS treatment with therapeutic programmes for patients with a comorbid substance abuse would probably further improve outcome .\n",
            "Objective To observe the efficacy and safety of Shaoyao Gancao Decoction ( SGD ) in treating olanzapine induced hyperprolactinemia .\n",
            "Methods Totally @ schizophrenia patients who took Olanzapine Tablet ( OT ) were assigned to the treatment group and the control group by random number table , @ in each group .\n",
            "All patients took OT .\n",
            "Those in the treatment group additionally took SGD .\n",
            "The ther - apeutic course for all was @ weeks .\n",
            "Serum levels of prolactin were measured before treatment and at the end of week @ , @ , and @ after treatment .\n",
            "The spiritual symptoms of patients were assessed by Positive and Negative Syndrome Scale ( PANSS ) before treatment and at the end of week @ after treatment .\n",
            "Adverse reactions were assessed using Treatment Emergent Symptom Scale ( TESS ) before treatment and at the end of week @ after treatment .\n",
            "Results Compared with before treatment in the same group , ser - um levels of prolactin were significantly reduced in the treatment group at the end of week @ and @ after treatment ( P < @ .\n",
            "@ ) .\n",
            "There was no statistical difference in serum levels of prolactin in the control group among each time points ( P > @ .\n",
            "@ ) .\n",
            "Compared with the control group , serum levels of prolactin de - creased significantly in the treatment group at the end of week @ and @ after treatment ( P < @ .\n",
            "@ ) .\n",
            "There was no statistical difference in PANSS between the two groups at the end of week @ after treatment ( P > @ .\n",
            "@ ) .\n",
            "Adverse reactions occurred in @ cases ( @ % ) of the treatment group and @ cases ( @ .\n",
            "@ % ) in the control group .\n",
            "They were manifested as insomnia , headache , constipation , and incapability of sitting quietly .\n",
            "There was no statistical difference in adverse reaction between the two groups ( P ' > @ .\n",
            "@ ) .\n",
            "Con - clusions SGD could effectively improve olanzapine-induced hyperprolactinemia , and had no obvious effect on psychotic symptoms .\n",
            "It showed no obvious adverse reactions .\n",
            "What are the barriers to implementing psychological treatments for schizophrenia and how might these be overcome ?\n",
            "Design/methodology : Cluster randomised trial Participants - inclusion criteria : @ .\n",
            "All professionals in the clinical teams Participants - exclusion criteria : Not provided at time of registration Anticipated start date : @/@/@ Anticipated end date : @/@/@ Status of trial : Ongoing Interventions : Cluster randomised trial of a training and implementation programme of the NICE guideline across community mental health teams in SLaM\n",
            "Objective : Treatment as usual ( TAU ) supplemented by cognitivebehavioral therapy ( CBT ) leads to greater clinical improvement in adult patients with schizophrenia than TAU alone .\n",
            "Until now no cognitive-behavioral therapy for patients with \" early onset psychosis \" ( EOP , a first episode of psychosis between @ and @ years ) has been developed .\n",
            "The present project 's goal is to develop a modified cognitive-behavioral treatment ( mCBT ) for patients with EOP and to evaluate the acceptance , tolerability and efficacy .\n",
            "Methods : @ patients were screened of which @ were included in a randomised controlled trial .\n",
            "Thirteen patients were randomised into the intervention group ( mCBT + TAU ) and @ into the control group ( TAU ) .\n",
            "MCBT was delivered in @ individual sessions ( plus five sessions with relatives ) over a period of @ months .\n",
            "Assessments were performed at baseline and monthly during treatment until treatment stopped using the PANSS Positive-Scale , Global Functioning Scale ( GAF ) and Quality of Life ( MSLQ ) .\n",
            "Results : The average age was @ years .\n",
            "There were no significant differences between groups regarding demographic and clinical features at intake .\n",
            "Eighty percent of planned sessions were conducted .\n",
            "At the descriptive level by the end of treatment more patients in mCBT + TAU were in remission than in TAU ( @ % vs. @ % ) .\n",
            "Differences in GAF between groups ( @ vs. @ , P = @ ) were in favour of mCBT .\n",
            "MSLQ Scores descriptively revealed advantage for the intervention group ( @ vs. @ , P = @ ) .\n",
            "The effect sizes in the mCBT group were moderate for GAF ( d = @ ) and MSLQ ( d = @ ) .\n",
            "Conclusion : The pilot study has shown that mCBT is feasible , acceptable and tolerable in adolescents with schizophrenia .\n",
            "The effect sizes for mCBT were moderate in several secondary outcome parameters but no statistically significant differences between the treatment groups emerged It is likely that due to the small sample size a statistical significant difference could not be detected .\n",
            "In a double-blind , placebo-controlled study , an attempt was made to evaluate butaclamol in @ @-@ yr old chronic institutionalized schizophrenic patients , using chlorpromazine ( CPZ ) as the standard comparative drug .\n",
            "Ss were given doses of butaclamol up to @ mg/day over a @-wk period , and were evaluated at weeks @ , @ , and @ on the Brief Psychiatric Rating Scale , Clinical Global Impressions , and the Nurses ' Observation Scale for Inpatient Evaluation .\n",
            "Results show that butaclamol had significant antipsychotic activity comparable to CPZ but with a much higher incidence of extrapyramidal signs .\n",
            "It is suggested that a more reasonable maintenance dose may be in the range of @-@ mg/day .\n",
            "Rebound insomnia was noted with butaclamol ; this finding warrants further study .\n",
            "Background : Observations that antagonists of the N-methyl-D-aspartate ( NMDA ) receptor of glutamatergic neurons can mimic symptoms of schizophrenia have raised the hope that NMDA agonists can improve symptoms .\n",
            "On the basis of encouraging results of trials in which NMDA agonists were added to antipsychotics , we conducted an adequately powered randomized controlled trial adding D-serine , an NMDA modulator , to antipsychotics .\n",
            "Method : This study was a @-patient , multicenter , double-blind , randomized , placebo-controlled , @-week trial of D-serine @ g/d as an add-on treatment to antipsychotics .\n",
            "Subjects had DSM-IV schizophrenia or schizoaffective disorder and were inpatients or outpatients stabilized on antipsychotics , with persistent negative symptoms .\n",
            "The primary outcome measures were changes in negative symptoms and cognition as measured by the Scale for the Assessment of Negative Symptoms ( SANS ) and the Measurement and Treatment Research to Improve Cognition in Schizophrenia ( MATRICS ) battery , respectively .\n",
            "The study was performed between @ and @ .\n",
            "Results : Mean total Positive and Negative Syndrome Scale scores at baseline were @ .\n",
            "Subjects receiving D-serine and placebo improved in scores on the SANS and MATRICS , but no significant differences were observed between groups : improvement on SANS was @ % for d-serine vs @ % for placebo , F <sub> @ </sub> = @ , P = .@ ; and improvement on MATRICS was @ % for D-serine vs @ % for placebo , F <sub> @ </sub> = @ , P = .@ , respectively .\n",
            "D-Serine was well tolerated .\n",
            "Discussion : This study did not find a significant difference between drug and placebo .\n",
            "However , the results are limited by a relatively large placebo response and somewhat lower-achieved doses than in prior studies .\n",
            "Future studies will administer higher doses and will attempt to affect the NMDA receptor using other mechanisms , such as agonists of the presynaptic metabotropic glutamate @/@ receptor or glycine reuptake inhibitors .\n",
            "Trial Registration : ClinicalTrials.gov identifier : NCT@ .\n",
            "Copyright @ Physicians Postgraduate Press , Inc .\n",
            "There is a need for trials that examine the effect of interventions targeting the cannabis use of young people with psychosis .\n",
            "The CapOpus trial is such a trial .\n",
            "One hundred three young patients with a diagnosis within the schizophrenic spectrum ( F@ , ICD-@ ) and co-occurring cannabis abuse ( F@ , ICD-@ ) have been included in the trial .\n",
            "The study is a randomized , single-blinded clinical trial of the effect of a @-month specialized addiction treatment compared with treatment as usual .\n",
            "The specialized CapOpus treatment consists of an individualized tailor-made combination of Motivational Interviewing ( MI ) and Cognitive Behavioral Therapy ( CBT ) .\n",
            "It functions as an add-on to the usual treatment regimen .\n",
            "Characteristics of CapOpus treatment : Low levels of motivation for change were addressed with MI .\n",
            "When the patients became motivated for change , a more extended use of cognitive behavioural techniques was implemented .\n",
            "Harm reduction was the primary goal .\n",
            "The CapOpus therapists used an assertive outreach approach .\n",
            "Therapists were easily accessible by mobile phones .\n",
            "The patients ' usual case-manager at mental health services was offered ongoing supervision and education through the whole program by the therapists .\n",
            "The therapists aimed to involve the family .\n",
            "This presentation will present the methods used in CapOpus and illustrate how specific CBT techniques and strategies can be beneficial in treating patients within the schizophrenic spectrum that have problems with cannabis and psychosis .\n",
            "It will illustrate how MI and CBT can be mutually supportive in dealing with challenging problems and patients that prefer to smoke cannabis rather than to involve themselves in therapy .\n",
            "Objective : To compare cognitive changes associated with ziprasidone and olanzapine in patients with schizophrenia or schizoaffective disorder .\n",
            "Methods : This was a @-week , randomized study of ziprasidone ( n = @ ) versus olanzapine ( n = @ ) .\n",
            "Cognitive battery , given at baseline and endpoint , included measures of vigilance , executive functioning , verbal learning/memory , verbal fluency , and visuomotor speed .\n",
            "Results : At least @ patients contributed endpoint data for ziprasidone ; at least @ , for olanzapine .\n",
            "Statistically significant improvements from baseline performance were observed with both agents in attention/vigilance , as measured by the Computerized Continuous Performance Test ; visuomotor speed , as measured by the Trailmaking Test , Part A ; and learning/memory , as measured by the Rey Verbal Learning Test and the Spatial Working Memory Test .\n",
            "Executive function improved in both groups by the Trailmaking Test , Part B. Olanzapine patients showed a statistically significant benefit in category fluency ( P less than @ ) , but this finding would not have withstood correction for the overall number of tests performed .\n",
            "Conclusions : Ziprasidone exerted a beneficial effect on several domains of cognition that affect functional outcome in schizophrenia .\n",
            "Improvements in cognitive domains were comparable to those seen with olanzapine .\n",
            "Supported by funding from Pfizer Inc .\n",
            "Background : In the absence of effective treatments for the negative symptom complex of schizophrenia , we explored the effect of @ consecutive weeks of repetitive transcranial magnetic stimulation ( rTMS ) exposure ( @ sessions ) as an add-on treatment to atypical antipsychotics .\n",
            "Methods : Three groups of @ schizophrenic subjects each were exposed to @ treatments of either placebo , @ Hz ( @ pulses per day = @ total ) or @ Hz ( @ pulses per day = @ total ) rTMS at @ % motor threshold over the left dorsolateral prefrontal cortex , while being maintained on their atypical antipsychotic .\n",
            "Subjects were evaluated at baseline , weeks @ and @ , and at @-week follow-up after the last treatment .\n",
            "Results : The primary outcome measure ( change in Scale for Assessment of Negative Symptoms score ) showed a statistically significant drop at weeks @ , @ , and @ for the high frequency ( @ Hz ) group , but not the @ Hz or placebo groups .\n",
            "Secondary outcome measures of the Wisconsin Card Sorting Test and SF-@ did not demonstrate any significant change .\n",
            "Conclusions : rTMS may serve as a relatively noninvasive treatment of the negative and neurocognitive deficits associated with schizophrenia .\n",
            "Objective To investigate the efficacy and safety of aripiprazole and risperidone in the treatment of chronic schizophrenia .\n",
            "@ cases of patients with chronic schizophrenia were randomly divided into @ groups , were given aripiprazole and risperidone @ weeks of treatment , the use of positive and negative syndrome scale ( PANSS ) and side effects scale ( TESS ) before and after treatment @,@ weekend to assess the efficacy and side effects .\n",
            "The results of no significant differences between the aripiprazole group and risperidone group efficacy .\n",
            "The TESS assess the side effects of aripiprazole group is less than the risperidone group ( P < @ ) .\n",
            "Conclusion of aripiprazole and risperidone in chronic schizophrenia have a good effect .\n",
            "BACKGROUND : Few patients have access to cognitive behaviour therapy for psychosis ( CBTp ) even though at least @ sessions of CBTp is recommended in treatment guidelines .\n",
            "Briefer CBTp could improve access as the same number of therapists could see more patients .\n",
            "In addition , focusing on single psychotic symptoms , such as auditory hallucinations ( ' voices ' ) , rather than on psychosis more broadly , may yield greater benefits .\n",
            "METHOD : This pilot RCT recruited @ participants ( with a range of diagnoses ) from NHS mental health services who were distressed by hearing voices .\n",
            "The study compared an @-session guided self-help CBT intervention for distressing voices with a wait-list control .\n",
            "Data were collected at baseline and at @weeks with post-therapy assessments conducted blind to allocation .\n",
            "Voice-impact was the pre-determined primary outcome .\n",
            "Secondary outcomes were depression , anxiety , wellbeing and recovery .\n",
            "Mechanism measures were self-esteem , beliefs about self , beliefs about voices and voice-relating .\n",
            "RESULTS : Recruitment and retention was feasible with low study ( @ % ) and therapy ( @ % ) dropout .\n",
            "There were large , statistically significant between-group effects on the primary outcome of voice-impact ( d = @ ; @ % CIs : @-@ ) , which exceeded the minimum clinically important difference .\n",
            "Large , statistically significant effects were found on a number of secondary and mechanism measures .\n",
            "CONCLUSIONS : Large effects on the pre-determined primary outcome of voice-impact are encouraging , and criteria for progressing to a definitive trial are met .\n",
            "Significant between-group effects on measures of self-esteem , negative beliefs about self and beliefs about voice omnipotence are consistent with these being mechanisms of change and this requires testing in a future trial .\n",
            "OBJECTIVE : This article presents findings from a randomized controlled trial of a peer support mentorship intervention designed for individuals with serious mental illness and frequent , recurrent psychiatric hospitalizations .\n",
            "METHODS : Seventy-six individuals who were diagnosed as having a major psychotic or mood disorder and who had at least two psychiatric hospitalizations or more than three emergency department visits within the @ months prior to the index hospitalization participated in this trial .\n",
            "Participants were randomly assigned to one of two conditions : standard care or a peer mentor plus standard care .\n",
            "Substance use , psychiatric symptoms , psychosocial functioning , and hope were assessed at baseline and at three and nine months after hospital discharge .\n",
            "RESULTS : Participants assigned to the peer mentor condition reported significantly greater reductions in substance use and psychiatric symptoms and greater improvements in functioning compared with participants assigned to standard care .\n",
            "Moreover , participants in the peer mentor program remained out of the hospital for significantly longer periods of time compared with those assigned to standard care .\n",
            "CONCLUSIONS : Peer services for those who are hospitalized recurrently hold promise as an effective component of behavioral health care for persons with serious mental illnesses .\n",
            "[ Objective ] To investigate the impact of skills training on social function and quality of life of communities with chronic schizophrenia patients .\n",
            "[ Method ] to select the four streets duration of @ years , @ cases of schizophrenia patients , randomly divided into skills training group of @ patients and a control group of @ patients in the control group only received drug treatment , skills training group to implement drug treatment and @ months of skills training .\n",
            "[ Results ] @ months , @ months , skills training group training Assessment Scale ( gas ) , Social Disability Screening Schedule ( sdss ) positive psychotic symptoms scale ( saps ) , psychiatric symptoms negative scale ( sans ) , world Health Organization quality of Life scale ( whoqol-bref ) score and the difference was statistically significant for lighting group ; medication compliance higher than that of the control group ; @-year recurrence rate is lower than that of the control group .\n",
            "[ Conclusion ] skills training program will help to improve the quality of life and social function in the community with chronic schizophrenia patients , medication compliance , and reduce the relapse rate .\n",
            "Background : Glucagon-like peptide-@ receptor agonists ( GLP-@RAs ) are registered for treatment of both obesity and type @ diabetes , and we investigated metabolic and cognitive effects of the GLP-@RA , exenatide once weekly , in nondiabetic , antipsychotic-treated , obese patients with schizophrenia .\n",
            "Methods : In this investigator-initiated trial , antipsychotic-treated , obese , nondiabetic , schizophrenia spectrum patients were randomized to double-blinded adjunctive treatment with once weekly subcutaneous exenatide ( n = @ ) or placebo ( n = @ ) injections for @ months .\n",
            "The primary outcome was body weight loss after treatment .\n",
            "Secondary endpoints comprised blood pressure , biochemistry , measurements of body composition , and cognition .\n",
            "Results : Forty patients completed the trial .\n",
            "At baseline , the mean body weight was @ + / - @ kg in the exenatide group and @ + / - @ kg in the placebo group , with no group differences ( P = .@ ) .\n",
            "After @ months of treatment , the exenatide and placebo groups experienced signifcant ( P = .@ ) , but , similar ( P = .@ ) weight losses of @ + / - @ kg and @ + / - @ kg , respectively .\n",
            "The exenatide group had a signifcant decrease in central @-h systolic blood pressure of @ mm/Hg ( P = .@ ) and a decrease in the pulse wave velocity ( a measure of arterial stiffness ) of @ m/s ( P = .@ ) .\n",
            "Changes in biochemistry , body composition , and cognition were similar in the groups ( P < .@ ) .\n",
            "Exenatide once weekly was well tolerated .\n",
            "Conclusion : Treatment with exenatide once weekly did not promote weight loss in obese , antipsychotic-treated patients with schizophrenia compared to placebo .\n",
            "This suggests that the body weight-lowering effect of GLP-@RAs involves dopaminergic signaling and implies that antiobesity regimens effective in the general population may not be readily implemented in antipsychotic-treated patients with schizophrenia .\n",
            "ClinicalTrials.gov identi-fer : NCT@ .\n",
            "OBJECTIVE : Over the past @ years , illness management programs and cognitive-behavioral therapy for psychosis have gained prominence in the treatment of schizophrenia .\n",
            "However , little is known about the long-term benefits of these types of programs when delivered during inpatient treatment following a symptom exacerbation .\n",
            "To evaluate this question , we conducted a randomized controlled trial comparing the long-term effects of a group-based coping-oriented program ( COP ) that combined the elements of illness management with cognitive behavioral-therapy for psychosis , with an equally intensive supportive therapy ( SUP ) program .\n",
            "METHOD : @ inpatients with DSM-IV schizophrenia were randomized to COP or SUP , each lasting @ sessions provided over @-@ weeks .\n",
            "Outcome measures were collected in the hospital at baseline and post-assessment , and following discharge into the community @ and @ years later .\n",
            "We compared the groups on rehospitalizations , symptoms , psychosocial functioning , and knowledge about psychosis .\n",
            "RESULTS : Intent-to-treat analyses indicated that patients in COP learned significantly more information about psychosis , and had greater reductions in overall symptoms and depression/anxiety over the treatment and follow-up period than patients in SUP .\n",
            "Patients in both groups improved significantly in other symptoms and psychosocial functioning .\n",
            "There were no differences between the groups in hospitalization rates , which were low .\n",
            "CONCLUSIONS : People with schizophrenia can benefit from short-term COPs delivered during the inpatient phase , with improvements sustaining for @ years following discharge from the hospital .\n",
            "More research is needed to evaluate the long-term impact of coping-oriented and similar programs provided during inpatient treatment .\n",
            "Objective To investigate the effect of family intervention on the rehabilitation of patients with schizophrenia .\n",
            "@ cases of discharged patients with schizophrenia were randomly divided into observation group and control group @ cases .\n",
            "Both groups were taking antipsychotic medications , the control group with routine care and discharge instructions ; observation group patients discharged from one end of the month to the use of family intervention , and after every @ to @ months .\n",
            "Negative Syndrome Scale ( SANS ) and @ years after discharge Symptom Rating Scale ( SCL-@ ) to assess .\n",
            "Results the two groups before and after the intervention , the factors of the SANS sub , the difference of significance ( P < @ ) after the intervention of the observation group was significantly lower than the control group ( all P < @ ) ; the SCL-@ factor scores and total score and The relapse rates and readmission rates significantly lower than the control group ( P < @ , P < @ ) .\n",
            "HYPOTHESIS : The transition rate into psychosis can be dimished in at risk people with the help of a cognitive behavioural intervention .\n",
            "HEALT CONDITION ( S ) OR PROBLEM ( S ) STUDIED : Psychosis INCLUSION CRITERIA : @ .\n",
            "Age @ to @ ; @ .\n",
            "Fullfilling the At risk criteria of the Comprehensive Assessment of At Risk Mental State ( CAARMS ) ; @ .\n",
            "Help-seeking or referred for psychosis screening .\n",
            "EXCLUSION CRITERIA : @ .\n",
            "Current or prebious recipt of antipsychotic medication ; @ .\n",
            "moderate to severe learning disability ; @ .\n",
            "organic impairment ; @ .\n",
            "non-Dutch speaking .\n",
            "MEC APPROVAL RECEIVED : yes - MULTICENTER TRIAL : yes - RANDOMISED : yes - MASKING/BLINDING : Single - CONTROL : Active - GROUP : Parallel - TYPE : @ or more arms , randomized - STUDYTYPE : intervention - PLANNED STARTDATE : @-dec-@ - PLANNED CLOSINGDATE : @-dec-@ - TARGET NUMBER OF PARTICIPANTS : @ - INTERVENTIONS : Cognitive behavioural therapy.Best practice in control condition for ' comorbid ' disorder .\n",
            "- PRIMARY OUTCOME : Transition into psychosis .\n",
            "- SECONDARY OUTCOME : @ .\n",
            "Depression ; @ .\n",
            "social anxiety ; @ .\n",
            "general health ; @ .\n",
            "personal beliefs about illness ; @ .\n",
            "quality of life ; @ .\n",
            "genetic genotyping .\n",
            "- TIMEPOINTS : @ months : initial assessment ; @ months : end of treatment ; @ months : follow-up ; @ months : follow-up ; Assessment at transition to psychosis .\n",
            "- STATUS : open : patient inclusion BRIEF SUMMARY : This study aims to investigate the effects of a cognitive behavioural therapy in the prevention or delay of a firt psychotic episode .\n",
            "The follow-up period is maximum @ months .\n",
            "Background : The worldwide lifetime morbidity risk of schizophrenia is about @ % across diverse geographic , cultural , and socio-economic regions .@ Regional differences in factors such as healthcare and medication availability , medical practice , disease definition and patient characteristics may lead to different treatment response patterns both with respect to efficacy and safety .@ The safety and efficacy of Aripiprazole lauroxil , a novel long-acting injectable ( LAI ) atypical antipsychotic was demonstrated in a large , multicenter study conducted in three regions ( North America , Eastern Europe and Asia ) .\n",
            "Methods : Post-hoc analyses of efficacy response and adverse events by region were performed using data from a @-week , double-blind , placebo ( PBO ) controlled study in patients experiencing acute exacerbation of schizophrenia ( DSM-IV criteria ) treated with monthly injections of aripiprazole lauroxil @ mg IM , aripiprazole lauroxil @ mg IM or matching PBO IM .\n",
            "The primary efficacy endpoint was the change from baseline to Day @ on the Positive and Negative Syndrome Scale ( PANSS ) total score using analysis of covariance ( ANCOVA ) with last observation carried forward ( LOCF ) approach .\n",
            "Overall treatment response was defined as > @ % decrease in PANSS total score or CGI-I score of @ ( very much improved ) or @ ( much improved ) and analyzed using logistic regression model .\n",
            "Incidence of frequently reported treatment-emergent adverse events ( TEAEs ) was also evaluated by region .\n",
            "Results : A total of @ patients were randomized and received study drug ( Safety Population ) at @ sites in seven countries across three regions .\n",
            "The regional analyses were conducted in @ patients from North America ( aripiprazole lauroxil @ : n = @ ; aripiprazole lauroxil @ : n = @ ; PBO : n = @ ) , @ patients from Europe ( aripiprazole lauroxil @ : n = @ ; aripiprazole lauroxil @ : n = @ ; PBO : n = @ ) , and @ patients from Asia ( aripiprazole lauroxil @ : n = @ ; aripiprazole lauroxil @ : n = @ ; PBO : n = @ ) .\n",
            "Severity of illness at baseline was within the anticipated range across regions with PANSS total scores ( mean + / - SD ) ranging from @ + / -@ to @ + / -@ .\n",
            "Efficacy of aripiprazole lauroxil was demonstrated independently in each of the three regions .\n",
            "Statistically significant and clinically meaningful improvements on the change in PANSS total score at Day @ were observed with both aripiprazole lauroxil @ mg and aripiprazole lauroxil @ mg in each of the regions .\n",
            "The PBO-adjusted differences ( LS mean + / - SE ) for aripiprazole lauroxil @ mg were -@ + / -@ ( p = @ ) in North America , -@ + / -@ ( p < @ ) in Europe and -@ + / -@ ( p < @ ) in Asia .\n",
            "For aripiprazole lauroxil @ mg , the PBO-adjusted differences were -@ + / -@ ( p = @ ) in North America , -@ + / -@ ( p < @ ) in Europe and - @ + / -@ ( p = @ ) in Asia .\n",
            "The OR ( @ % CI ) for meeting response criteria was @ ( @,@ ) and @ ( @,@ ) for aripiprazole lauroxil @ mg and @ mg dose , respectively in North America .\n",
            "In Europe , the OR ( @ % CI ) was @ ( @,@ ) and @ ( @,@ ) while in Asia the OR ( @ % CI ) was @ ( @,@ ) and @ ( @,@ ) for aripiprazole lauroxil @ mg and aripiprazole lauroxil @ mg , respectively .\n",
            "The NNT ranged from @ to @ across the regions .\n",
            "In the study , the most commonly reported TEAE ( @ % of patients in either of the aripiprazole lauroxil dose groups ) were insomnia , akathisia , headache and anxiety .\n",
            "A similar but not identical TEAE profile was observed across the regions .\n",
            "Insomnia and akathisia met the criteria in all three regions .\n",
            "Headache was reported with this frequency in North American and Europe , and anxiety in Europe only .\n",
            "Conclusions : Conclusions : The overall results of the study support the conclusion that aripiprazole lauroxil could represent a new treatment option for patients with schizophrenia .\n",
            "These analyses further establish both doses of aripiprazole lauroxil demonstrated robust efficacy with statistically significant and clinically meaningful improvements across all three regions .\n",
            "Observed regional response patterns are consistent with prev\n",
            "Background & Hypothesis : Peer-led self-management programmes ( PLSMP ) have been used widely , aiming to empower psychiatric patients in achieving recovery to maintain hopeful , self-responsible and functional lives .\n",
            "However , there lacks credible research evidence specific for its effectiveness for schizophrenia .\n",
            "This study hypothesised that participants with schizophrenia who receive PLSMP would report significant improvements in their level of empowerment , perceived recovery , medication adherence , perceived social support and symptom severity after @ months of follow-up .\n",
            "Methods : A randomised controlled trial was conducted at @ community psychiatric rehabilitation centres .\n",
            "A sample of @ for both control and intervention groups was recruited .\n",
            "The PLSMP was developed based on a meta-analysis conducted , and implemented in the intervention group .\n",
            "Self-rated and clinician-rated questionnaires were used to measure the outcomes of empowerment , medication adherence , perceived recovery , social support and symptom severity at pretest , post-test immediate , and post-test at @-month follow-up .\n",
            "Results : Per protocol analysis using Repeated Measures ANOVA was conducted on @ participants from the intervention group and @ from the control group .\n",
            "At @ months follow-up , significant improvements were found in intervention group participants ' level of empowerment ( F ( @ , @ ) = @ , P < @ ) , perceived recovery ( F ( @ , @ ) = @ , P < @ ) , social support ( F ( @ , @ ) = @ , P < @ ) , and symptom severity ( F ( @ , @ ) = @ , P < @ ) .\n",
            "Discussion & Conclusion : The significant results suggested that PLSMP is an effective programme to support patient 's recovery in rebuilding hope and self-responsibility , promoting practical wellness maintenance and social support , and improving active role in their self-management of condition .\n",
            "This programme will further support patient 's community remission through active self-management .\n",
            "Endorphins have been proposed as a possible treatment for schizophrenia .\n",
            "Org @ ( DEE ) has been reported as having efficacy on the basis of its use as adjunct therapy to neuroleptics .\n",
            "A proper evaluation requires a placebo and reference comparison in patients uncontaminated by concomitant medication .\n",
            "In a multicentre study in Europe @ patients suffering from schizophrenia fulfilling DSM III criteria were investigated in a placebo controlled study comparing @ weeks treatment with DEE @ mg i.m. daily and thioridazine @ mg p.o. daily for @ week and @ mg for @ weeks .\n",
            "No other psychotropic drugs were allowed with the exception of low dose lorazepam .\n",
            "The efficacy analysis was carried out on @ evaluable patients completing @ weeks treatment .\n",
            "Thioridazine was associated with a significantly improved response ( p < @ ) measured on the MSS compared with both placebo and DEE at day @ and @ .\n",
            "On the BPRS there was a significant difference between thioridazine and placebo , and thioridazine and DEE at day @ .\n",
            "The intention to treat analysis showed similar results .\n",
            "Depressive symptoms occur commonly in schizophrenia but are not well understood .\n",
            "It is hypothesised that these symptoms are often an integral component of the schizophrenic syndrome and that decreased serotoninergic function is an important aetiological factor in their production .\n",
            "Three studies were carried out to test these hypotheses .\n",
            "In the first study @ stable patients with chronic schizophrenia were assessed for the presence of depressive symptoms .\n",
            "Significant depressive symptoms were present in @ % of the cohort and were associated with positive psychotic symptoms but not with negative symptoms or antipsychotic medication .\n",
            "These findings suggest that depressive symptoms in clinically stable patients are inherent to the illness process , though the possibility that they are , at least sometimes , a psychological reaction to the consequences of schizophrenia , can not be excluded .\n",
            "In the second study , @ patients with chronic schizophrenia , who were significantly depressed but otherwise clinically stable , were entered into a @ week , randomised controlled trial of sertraline , a serotonin selective reuptake inhibitor antidepressant .\n",
            "The patients who received sertraline showed an improvement in their depressive symptoms , as assessed on the Clinical Global Impression Scale and the anxiety-depression subscale of the Brief Psychiatric Rating Scale .\n",
            "In the third study @ patients with stable , chronic schizophrenia were tryptophan-depleted in a double-blind , cross-over design experiment .\n",
            "Tryptophan depletion induced transient depressive symptoms which were detected on a visual analogue scale .\n",
            "Thus it appears that depressive symptoms in stable , chronic schizophrenia can be treated by increasing brain serotonin levels and that a transient lowering of mood can be produced by decreasing brain serotonin levels .\n",
            "These findings suggest that decreased serotoninergic function is an important aetiological factor in the production of depressive symptoms in schizophrenia .\n",
            "Objective : To study the quality of life in patients with schizophrenia , aripiprazole and clozapine .\n",
            "Methods : @ patients with schizophrenia were randomly divided into two groups of @ patients in the study group was treated with aripiprazole treatment and control group was treated with clozapine treatment , treatment of @ weeks .\n",
            "Before treatment and the treatment of the first @ weekends Positive and Negative Syndrome Scale to evaluate the efficacy , quality of life comprehensive assessment questionnaire rating the quality of life , adverse reactions rating scale adverse reactions .\n",
            "Results : The treatment of the @th week , the two groups total efficiency quite , but the study group was significantly higher than the control group ( p < @ ) efficiency .\n",
            "Two sets of positive and negative symptoms self-rating scale total score and factor scores was significantly decreased ( p < @ ) than before treatment ; study group total score and negative symptom factor score than the control group decreased significantly ( p < @ or @ ) .\n",
            "Quality of life for Comprehensive Assessment Questionnaire score study group in addition to material life dimension without significantly with changes , and other various dimension points compared with before treatment , significant resistance to improve ( p - < @ ) , physical health , mental health , social function dimension points are significant with higher than the control group ( p < @ ) .\n",
            "The research group , adverse reaction rates compared with the control group , and to a lesser extent .\n",
            "At the conclusion of this session ( the participant will be able to delineate differences in the effects of olanzapine and haloperidol on brain pathomorphology , measured by quantitative MRI over a @ year period .\n",
            "Longitudinal neuroimaging studies of first-episode schizophrenia have demonstrated morphological changes in cortical gray matter and ventricular volumes .\n",
            "The current study examined the effects of haloperidol and olanzapine on psychopathology , cognition , and brain morphology in patients with schizophrenia or schizoaffective disorder in a multicenter , randomized , double-blind trial .\n",
            "Patients were assessed with sMRI at baseline and after @ , @ , @ , and @ weeks of treatment .\n",
            "A total of @ ( of @ ) patients ( mean age @ years , @ % male ) had baseline and &gt; = @ follow-up sMRI .\n",
            "We assessed group differences at the end of the acute phase ( week @ ) and at @ , @ , and @ weeks .\n",
            "For acute phase data analysis , we used the end-of-acute-phase week @ volume as the response , with baseline volume as a covariate , adjusting for investigator , age , and gender .\n",
            "For total cerebral gray matter , the @-week changes to least squares means  SE for haloperidol was -@  @ , while olanzapine was -@  @ ( P &lt; @ ) .\n",
            "For lateral ventricular volume , the changes to least squares means for haloperidol was @  @ , while olanzapine was -@  @ ( P = @ ) .\n",
            "These results replicate prior studies that found progressive changes in brain morphology consistent with the hypothesized effect of illness progression that can be selectively attenuated by treatment with olanzapine )\n",
            "Background : Auditory verbal hallucinations ( AVHs ) are a key symptom of schizophrenia , @  @ % of hallucinated patients are refractory to antipsychotic drugs .\n",
            "The persistent distress and disability justifies exploring for an adjunct treatment .\n",
            "Functional brain imaging studies have demonstrated blood flow activation in brain areas involved in speech production and perception during AVH experience .\n",
            "Therefore , since @ , several studies have reported low-frequency repetitive transcranial magnetic stimulation ( rTMS ) to reduce cortical activation of these areas .\n",
            "Methods : The study included @ right-handed , treatment-resistant hallucinated schizophrenic patients who met DSM-IV-TR criteria , were included in a double-blind randomized placebo-controlled study .\n",
            "We applied low-frequency rTMS ( @ Hz ) at @ % of motor threshold over left temporo-parietal cortex ( @ sessions of @ min each ) .\n",
            "Hallucinations were assessed using the Auditory Hallucination Rating Scale ( AHRS ) .\n",
            "Results : Only five patients ' AHRS scores improved of at least @ % from baseline , thus meeting Hoffman 's responders ' criteria .\n",
            "However , none of the patients did show significant improvement on AVH symptomatology when end point were compared to baseline scores .\n",
            "Conclusions : Several limitations may account for these results : the small sample size , no functional imaging before stimulation and the used self-rating scale .\n",
            "Deficits in processing speed ( PS ) have been shown to correlate with social aptitude during critical stages of psychological development in CHR , and have been variably identified as risk markers for psychosis .\n",
            "We examined the feasibility of improving PS , the sustainability of training effects , and the association of PS with concurrent social function .\n",
            "This was a doubleblind RCT for @ participants randomized to @ hours of Processing Speed Training ( PST ) or Active Control matched for the same dose and duration of treatment .\n",
            "PST is a tablet-based program designed to improve reaction time and visual scanning efficiency by inhibiting the selection of nonessential targets and discriminating figure-ground details .\n",
            "Pupil dilation is measured as an index of cognitive load , and training exercises are continually titrated based on pupil dilation to provide a tailored and optimal level of cognitive load .\n",
            "Moderate to large effect sizes were found for PST at post ( @-@ ) and @ months ( @-@ ) on motorical and non-motorical PS measures .\n",
            "PST also showed moderate effects at @ months on overall social adjustment ( @ ) and engaging in new social situations ( @ ) .\n",
            "Changes in PS from baseline to @ months were correlated with changes in overall social adjustment and avoidance of new social situations ( r = - @-@ , p < @ ) .\n",
            "This was a pilot that experimentally isolated , controlled and exaggerated speeded response subprocesses .\n",
            "This is the first study to test focal PS training in CHR to address social morbidity .\n",
            "Focused PST appears to be a promising pathway to improving co-morbidity and mitigating a risk factor for psychosis .\n",
            "Does music therapy improve symptoms in people hospitalised with schizophrenia ?\n",
            ", METHOD , Design : Randomised controlled trial. , Allocation : Concealed. , Blinding : Single blind ( assessors blinded ) .\n",
            ", Follow-up period : Three months ( treatment period only ) .\n",
            ", Setting : Four London hospitals , UK ; time period not stated. , Patients : Eighty one adult inpatients ( > / = @ years old ) with a primary diagnosis of schizophrenia or schizophrenia-like psychosis .\n",
            "Exclusions : secondary diagnoses of dementia or organic psychosis. , Intervention : Music therapy ( access to a range of musical instruments and encouragement to express themselves accompanied by a trained music therapist during weekly individual sessions of up to @ min ) plus standard care ( access to occupational , social and other activities and nursing care ) versus standard care alone for up to @ weeks. , Outcomes : Primary outcome measure : symptoms , total score on the Positive and Negative Syndrome Scale ( PANSS ) ; secondary outcome measures : satisfaction with care , Client Satisfaction Questionnaire ( CSQ ) ; global function , Global Assessment of Functioning Scale ( GAF ) .\n",
            ", Patient follow-up : @ % .\n",
            ", MAIN RESULTS , In people hospitalised with schizophrenia , adding music therapy to standard care lead to greater improvement in symptoms compared with standard care alone at @ weeks ( change in PANSS total score from baseline : -@ with music therapy plus standard care vs -@ with standard care alone ; p = @ ) .\n",
            "There was no significant difference in patient satisfaction with care and global function between groups ( change in CSQ score from baseline : +@ with music therapy plus standard care vs +@ with standard care alone ; reported as non-significant ; change in GAF score from baseline : +@ with music therapy plus standard care vs +@ with standard care ; reported as non-significant ) .\n",
            ", CONCLUSIONS , Adding music therapy to standard care improves symptoms compared with standard care alone in people hospitalised with schizophrenia .\n",
            "Adding music therapy to standard care did not have a significant impact on overall patient satisfaction with care and global function. , NOTES , In this issue , Crawford and Patterson review the evidence for arts therapies in schizophrenia ( see page @ ) .\n",
            "Objectives : A RANDOMized DOUBLE-BLIND cross-over study in @ schizophrenic patients compared effects of olanzapine , @ mgrday , and haloperidol , @ mgrday , on DLPFC levels of high-energy @ w x phosphates by P-MRS @ .\n",
            "Additionally , perfusion of DLPFC during cognitive stimulation WCST was measured by fMRI , and clinical efficacy and safety were assessed .\n",
            "Results : Percentages of phosphocreatine PCr % were similar before and after @-@ days of treatment , regardless if haloperidol or olanzapine was given first mean PCr % \" SD , ns@ ; baseline : @ \" @ ; Olz : @ \" @ ; Hal : @ \" @ .\n",
            "Mean treatment group differences in PCr % were tested not significant ps@ .@ ; GLM repeated measures .\n",
            "Functional MRI ns@ revealed increased activation in the medial frontal areas bilaterally followingHal , and in the right frontal area following Olz .\n",
            "Following both treatments , WCST mean response time decreased by @ seconds and the mean number of completed categories improved form @ to @ .\n",
            "PANSS and BPRS total scores decreased clinically significant ns@ ; PANSS baseline : @ , Hal y@ .@ , Olz y@ .@ ; BPRS baseline : @ , Hal : y@ .@ , Olz : y@ .@ .\n",
            "No serious adverse events were reported .\n",
            "EPS reported for @ of @ patients occurred primarily duringthe cross-over phase of treatments .\n",
            "Conclusion : Olanzapine and Haloperidole were equally effective .\n",
            "Small sample size and cross-over design are possible reasons for not detectingdifferences in @PMRS profiles .\n",
            "Objective : To evaluate aripiprazole and risperidone in the treatment of older schizophrenia efficacy and safety .\n",
            "Methods : @ elderly patients with schizophrenia were randomly divided into aripiprazole group and the risperidone group , @ cases in each .\n",
            "@ weeks of treatment and observation of patients in both groups .\n",
            "Before treatment and @,@,@ weekend with the Positive and Negative Syndrome Scale ( panss ) evaluate the efficacy and side effects scale ( tess ) , laboratory and diagnostic instruments assess drug safety checks .\n",
            "Results : Aripiprazole group significant efficiency @ % , and @ % in the risperidone group was , no significant differences in two groups .\n",
            "The two sets of adverse reactions were mild , the azole group A Leekpai lighter in the risperidone group .\n",
            "Conclusion : aripiprazole and risperidone in the treatment of schizophrenic patients are better , but the drug aripiprazole fewer side effects .\n",
            "Objective : The authors compared @-year mortality rates associated with ziprasidone and olanzapine in real-world use .\n",
            "Method : The Ziprasidone Observational Study of Cardiac Outcomes ( ZODIAC ) was an open-label , randomized , postmarketing large simple trial that enrolled patients with schizophrenia ( N = @ ) in naturalistic practice in @ countries .\n",
            "The primary outcome measure was nonsuicide mortality in the year after initiation of assigned treatment .\n",
            "Patients were randomly assigned to receive treatment with either ziprasidone or olanzapine and followed for @ year by unblinded investigators providing usual care .\n",
            "A physician-administered questionnaire was used to collect baseline demographic information , medical and psychiatric history , and concomitant medication use .\n",
            "Follow-up information on hospitalizations and emergency department visits , patients ' vital status , and current antipsychotic drug status was collected and reported by treating psychiatrists .\n",
            "Post hoc analyses of sudden death , a secondary endpoint , were also conducted .\n",
            "Results : The incidence of nonsuicide mortality within @ year of initiating pharmacotherapy was @ for ziprasidone ( N = @ ) and @ for olanzapine ( N = @ ) .\n",
            "The relative risk was @ ( @ % CI = @-@ ) .\n",
            "This finding was confirmed in numerous secondary and sensitivity analyses .\n",
            "Conclusions : Despite the known risk of QTc prolongation with ziprasidone treatment , the findings of this study failed to show that ziprasidone is associated with an elevated risk of nonsuicidal mortality relative to olanzapine in real-world use ; the study excludes a relative risk larger than @ with a high probability .\n",
            "However , the study was neither powered nor designed to examine the risk of rare events like torsade de pointes .\n",
            "Compared a developmental-acquisition model of case management ( CM ) with the usual CM services provided through a mental health center working with @ chronically mentally ill adults .\n",
            "Ss were randomly assigned to receive either the experimental or the standard CM .\n",
            "Assessment instruments included a quality of life questionnaire and measures of environmental adjustment .\n",
            "Significant discriminant functions resulting from the analysis correctly classified @ % of the Ss based on the following : The case manager 's assessment of Ss ' socialization skills , assessment of community living skills by a significant other and the client , Ss ' tolerance of stress , use of leisure time , community behavior , and vocational training .\n",
            "Thirteen out of @ young out-patients with simple schizophrenia under neuroleptic treatment completed a double-blind cross-over trial with Madopar [ L-Dopa + benserazid ( a peripheral decarboxylase inhibitor ) ] and placebo .\n",
            "Nine patients were given @ mg L-Dopa + @ mg benserazid daily , @ patient received @ mg L-Dopa + @ mg benserazid , and @ patients , @ mg L-Dopa + @ mg benserazid .\n",
            "In these doses , L - Dopa was effective against emotional withdrawal , blunted affect , tendency to isolation and apathy , without inducing or aggravating productive , accessory symptoms .\n",
            "The activity score , according to the specific activity-withdrawal scale , was significantly increased ( P less than @ ) , whereas the total BPRS score ( Brief Psychiatric Rating Scale ) was slightly , but significantly reduced ( P less than @ ) .\n",
            "In cases where L - Dopa had to be limited to @ and @ mg daily , a tendency to anxiety , distortion of thinking , and a sense of unreality were observed , depending on the dose of L-Dopa .\n",
            "In no case were gastrointestinal , cardiovascular or neurological side-effects observed .\n",
            "To compare the quality of life ( QOL ) in schizophrenic patient s t reated with aripiprazole or haloperidol .\n",
            "Methods A total of @ schizophrenic patient s in hospital were randomly divided into two group s of receiving aripiprazole or haloperidol respectively for @ months .\n",
            "Positive and Negative Symptom Scale ( PANSS ) , the Treatment Emergent Symptom Scale ( TESS ) and Short Form @ Health Survey Questionnair ( SF - @ ) were used to evaluate the efficacy , the side effect s and the quality of life .\n",
            "Results After t reatment , the scores of PANSS in both group s were significantly decreased ( P < @ .\n",
            "@ ) , and there was no significant difference between two groups .\n",
            "The aripiprazole group were significantly higher than the haloperidol group on the factor - scores of physical functioning , role - physical , vitality , social functioning , role - emotional and the total scores of SF - @ ( P < @ .\n",
            "@ ) .\n",
            "Analysis of multiple stepwise regressions showed the main factors influencing patient  QOL were psychotic symptom , drug , side effect s and the duration of disease .\n",
            "Conclusion The both drugs were similar in efficacy , but the patients with schizophrenia t reated by aripiprazole have better quality of life .\n",
            "From January @ to June @ , @ cases of chronic schizophrenia patients with psychological care [ @ ] , and hospitalized patients with the Nurses Observation Scale ( NOSIE ) [ ] \" the patient carried a @-week observation , scores , statistics , analysis and summary , are as follows .\n",
            "Materials and Methods @ clinical data of @ cases , @ cases of male and @ females were randomly divided into experimental group ( psychological care group ) @ cases , @ cases in the control group ( usual care ) .\n",
            "Their age , duration and NOSIE score , Statistically significant difference ( P > @ ) .\n",
            "@ Methods hospitalized patients Nurses Observation Scale , which includes @ items according to frequency of occurrence in patients with specific manifestations or symptoms , and five scores , symptoms more severe the rating the higher the scale factor of @ .\n",
            "Many antipsychotic medications carry a substantial liability for weight gain , and one mechanism common to all antipsychotics is binding to the dopamine D@ receptor .\n",
            "We therefore examined the relationship between-@C Ins/Del ( rs@ ) , a functional promoter region polymorphism in DRD@ , and antipsychotic-induced weight gain in @ first episode schizophrenia patients enrolled in a randomized trial of risperidone versus olanzapine .\n",
            "Carriers of the deletion allele ( n = @ ) were compared with Ins/Ins homozygotes ( noncarriers , n = @ ) in a mixed model encompassing @ weight measurements over @ weeks .\n",
            "Deletion allele carriers showed significantly more weight gain after @ weeks of treatment regardless of assigned medication .\n",
            "Although deletion carriers were prescribed higher doses of olanzapine ( but not risperidone ) , dose did not seem to account for the genotype effects on weight gain .\n",
            "Given earlier evidence that deletion carriers show reduced symptom response to medication , additional study of appropriate treatment options for these patients seems warranted .\n",
            " Lippincott Williams & Wilkins .\n",
            "A two-site randomised controlled trial of psychosis team-treatment of patients @-@ years old with a diagnose of schizophrenia , delusional disorder and other paranoid states is conducted in Copenhagen and Aarhus , Denmark .\n",
            "The treatment consist of assertive community treatment , psychoeducative treatment in McFarlanes multifamily groups and social skills training .\n",
            "Inclusion of patients started @ February @ .\n",
            "At @ October @ , @ patients were included .\n",
            "Patients were assessed at baseline and at @ , @ , @ and @ month follow-up .\n",
            "At @ month assessment significantly more patients allocated to psychosis team remained in contact as compared with patients in standard treatment .\n",
            "When analysed for men and women separately differences were only significant for women .\n",
            "Global ratings of delusions improved significantly for patients treated in psychosis team , but because of a non-significant improvement among patients in standard treatment , differences in clinical outcome were non-significant .\n",
            "AIM : To assess the feasibility of a randomized pilot trial that evaluated the acceptability and potential clinical utility of the Mindfulness Ambassador Program ( MAP ) , a unique , standardized @-session facilitated group mindfulness-based intervention ( MBI ) for youth experiencing early psychosis .\n",
            "METHODS : Twenty-one patients of an early psychosis intervention program were randomized to receive MAP ( n = @ ) or treatment as usual ( n = @ ) .\n",
            "Acceptability was measured by group attendance rate and client satisfaction ; feasibility of the study design was measured by the recruitment and retention rate .\n",
            "The means , standard deviations , and @ % confidence intervals were described for outcomes of interest .\n",
            "RESULTS : MAP is associated with a high degree of acceptability and has beneficial effects for depression and fatigue .\n",
            "The randomized trial design is feasible .\n",
            "CONCLUSIONS : This study provides important pilot data supporting a larger randomized trial of effectiveness for MAP as a group MBI for early psychosis .\n",
            "Details of MAP and study limitations are discussed .\n",
            "Impaired social cognition , that is , the ability to accurately perceive and interpret social interactions , is a significant causal factor in the characteristic social deficits found in schizophrenia .\n",
            "This study describes SoCog , a novel , group-based , program designed to improve general understanding of others ' thoughts and feelings .\n",
            "Our aim was to investigate the efficacy and implementation of SoCog training , and to evaluate whether any benefits of SoCog training generalized to improvements in self-reported social skills .\n",
            "A secondary aim was to examine relationships between improvements in social cognition and baseline functioning on working memory ( WAIS Digits backwards and Forwards test , Wechsler , @ ) and premorbid IQ ( assessed using the National Adult Reading Test , Nelson & Willison , @ ) .\n",
            "Thirtyfour participants with schizophrenia or schizoaffective volunteered for the study and were randomized according to protocol .\n",
            "Participants underwent baseline testing followed by @-weeks of training or usual treatment and then post-testing to assess potential improvements in social cognitive abilities .\n",
            "Results demonstrate that participants in the SoCog training group showed significant improvements in four areas .\n",
            "Firstly , on a classic test of Theory of Mind ( ToM ) , which was associated with working memory , and premorbid IQ whilst the wait list control group showed little change on this measure - neurocognitive abilities were inversely associated with negative symptoms .\n",
            "Secondly , they improved on a test of cause and effect reasoning ( non-social ) .\n",
            "Thirdly , on a test of the ability to read complex emotions from the eyes , however , the control group also showed a trend toward improved ability on this measure thus practice effects could not be ruled out ; and finally , SoCog also produced improvements on a self-reported measure of social skills .\n",
            "These preliminary findings indicate that SoCog training has the potential to improve ToM abilities and social skills but that individuals with poorer working memory and lower premorbid IQ may be less able to benefit from training .\n",
            "Taken together , these results suggest that some individuals , particularly those with negative symptoms , may need neurocognitive training before they can fully benefit from social cognitive training .\n",
            "In summary , this study supports the efficacy of SoCog and in general is promising in terms of the potential for the benefit psychosocial therapies to improve quality of life for individuals with schizophrenia .\n",
            "The risperidone maintenance treatment in schizophrenia study was designed to identify the duration of maintenance treatment required with an initial therapeutic dose in contrast to reducing the dose over time .\n",
            "This study investigated extrapyramidal symptoms ( EPSs ) in different risperidone maintenance treatment paradigms over @ year .\n",
            "Clinically stabilized patients with schizophrenia ( n = @ ) were randomized to a no-dose-reduction group and @-week and @-week reduction groups , in which the dose was gradually reduced by @ % over @ weeks and maintained .\n",
            "Extrapyramidal symptoms were assessed at baseline and monthly for @ months , followed by every @ months .\n",
            "The Simpson-Angus Scale of Extrapyramidal Symptoms-Chinese version assessed EPS severity .\n",
            "Data were analyzed by a generalized linear mixed model ( GLMM ) .\n",
            "The frequency of EPS at baseline was @ % , @ % , and @ % in the @-week , @-week , and no-dose-reduction groups , respectively .\n",
            "Risperidone dosage , positive symptoms , and disorganized thoughts at baseline predicted development of EPS .\n",
            "The GLMM indicated that a significant decrease in EPS was maintained , and different trajectories occurred over time across groups .\n",
            "In the @ patients who continued treatment after @ year , the incidence of EPS decreased to @ % , @ % , and @ % in the @-week , @-week , and no-dose-reduction groups , respectively , whereas the numbers of dropouts because of intolerable EPS were not significantly different ( @ % , @ % , and @ % , respectively ) .\n",
            "These novel findings indicate EPSs were tolerable and differentially decreased depending on the dose paradigm during the @-year treatment period .\n",
            "Future studies should implement a GLMM to investigate antipsychotic adverse effects during long-term treatment .\n",
            "This study is an analysis of findings of a follow-up study of @ patients with functional psychotic illness who had participated in a random and blind @-week trial of pimozide ( lithium , both and placebo .\n",
            "The intention was to examine the question of whether a @-week delay in initiating antipsychotic treatment has a detrimental effect @ years later .\n",
            "Detailed follow-up measures included need for care over the @ years , treatments required , occupational decline , police contact , substance misuse , psychopathology and cognitive function .\n",
            "There was no evidence at all that those initially randomized to placebo had a poorer outcome in terms of any of these variables .\n",
            "It is concluded that a @-week delay in initiating active treatment in patients with functional psychosis has no long-term adverse effects . )\n",
            "Objective : Assertive Community Treatment ACT is characterized by frequent home visits and monitoring .\n",
            "While effective , ACT is cost prohibitive .\n",
            "Cognitive Adaptation Training CAT is a psychosocial treatment for patients with schizophrenia that significantly improves adaptive functioning and decreases rates of relapse by usingenvironmental supports established on brief weekly home visits to prompt and cue medication adherence and adaptive behavior Velligan et al. , @ ; Velligan et al. , @ .\n",
            "The purpose of the present study was to compare Assertive Community Treatment ACT to Cognitive Adaptation Training CAT in terms of patient outcomes and cost .\n",
            "Methods : Study participants ns@ were current ACT team patients RANDOMly assigned to continue ACT , or receive CAT , for a nine month period .\n",
            "We examined direct cost of treatment delivery per patient and community outcomes .\n",
            "Results and conclusions : The overall cost per patient was substantially lower for patients in CAT with comparable treatment outcomes .\n",
            "By assessing neurocognitive deficits and developing subsequent compensation strategies within a cost-efficient schema , CAT intervention may effectively maintain positive outcomes , while decreasing the cost of treatment for high-service utilization patients .\n",
            "Context : The potential therapeutic utility of estrogens in schizophrenia is increasingly being recognized .\n",
            "Raloxifene , a selective estrogen receptor modulator , appears to act similarly to conjugated estrogens on dopamine and serotonin brain systems and can be a better option since it lacks the possible negative effects of estrogen on breast and uterine tissue .\n",
            "Objective : To assess the utility of raloxifene as an adjunct treatment for negative symptoms and other psychotic symptoms in postmenopausal women with schizophrenia .\n",
            "Methods : In this @-week , double-blind , randomized , placebo-controlled study , patients were recruited from both inpatient and outpatient departments belonging to Sant Joan de Deu-Mental Health Services Network ( Barcelona ) and Corporacio Sanitaria Parc Tauli ( Sabadell ) .\n",
            "Thirty-three postmenopausal women with schizophrenia exhibiting prominent negative symptoms were included in the study .\n",
            "Patients were randomized to receive either adjunctive raloxifene ( @ women ) or adjunctive placebo ( @ women ) for @ months .\n",
            "The main outcome measures were : Psychopathological symptoms were assessed at baseline and weeks @ , @ , and @ by means of the Positive and Negative Symptom Scale .\n",
            "Results : The addition of raloxifene ( @ mg ) to regular antipsychotic treatment significantly reduced negative ( p = @ ) , positive ( p = @ ) , and general psychopathological ( p = @ ) symptoms during the @-week trial as compared with women receiving placebo .\n",
            "Conclusion : The use of raloxifene as an adjuvant treatment in postmenopausal women with schizophrenia who exhibit prominent negative symptoms seems to be useful for improving negative , positive , and general psychopathological symptoms .\n",
            "If more extensive and longer-term studies confirm and expand upon these positive results , the use of raloxifene could be recommended in postmenopausal patients with schizophrenia .\n",
            "\" BACKGROUND : The metabolic syndrome ( MS ) is associated with increased risk for diabetes mellitus and coronary heart disease , and is highly prevalent among schizophrenia patients .\n",
            "Given concerns over antipsychotic metabolic effects , this analysis explored MS status and outcomes in phase @ of the CATIE Schizophrenia Trial .\n",
            "METHODS : The change in proportion of subjects with MS and individual criteria was compared between antipsychotic treatment groups , along with mean changes for individual criteria .\n",
            "Primary analyses examined subjects with fasting laboratory assessments at baseline and @ months .\n",
            "Other analyses examined @-month changes in MS status , waist circumference ( WC ) , HDL cholesterol and blood pressure in all subjects , metabolic changes at the end of phase @ participation ( EOP ) , and repeated measures changes in HDL , blood pressure ( BP ) and WC over phase @ .\n",
            "RESULTS : At @ months , there were no significant between-drug differences for the change in proportion of subjects meeting MS status or individual MS criteria in the smaller fasting cohort ( n = @ ) or for those meeting criteria for parameters not dependent on fasting status ( BP , HDL , WC ) among all subjects ( n = @ ) .\n",
            "Among all subjects whose MS status could be determined at @ months ( n = @ ) , MS prevalence increased for olanzapine ( from @ % to @ % ) , but decreased for ziprasidone ( from @ % to @ % ) ( p = .@ ) .\n",
            "Although effect sizes varied across subgroups , at @ months olanzapine and quetiapine had the largest mean increase in waist circumference ( @ in .\n",
            "for both ) followed by risperidone ( @ in . )\n",
            ", compared to no change for ziprasidone ( @ in . )\n",
            "and a decrease in waist circumference for perphenazine ( -@ in . )\n",
            ".\n",
            "Olanzapine also demonstrated significantly different changes in fasting triglycerides at @ months ( +@ mg/dl ) compared to ziprasidone ( -@ mg/dl ) .\n",
            "EOP exposure data was obtained , on average , nine months from baseline for all metabolic variables .\n",
            "Results from EOP and repeated measures analyses were consistent with those at @ months for mean changes in WC and fasting triglycerides , but between group differences emerged for HDL and SBP .\n",
            "CONCLUSIONS : This large non-industry sponsored study confirms the differential metabolic effects between antipsychotics .\n",
            "Clinicians are advised to monitor all metabolic parameters , including WC , HDL and serum triglycerides , during antipsychotic treatment . \"\n",
            "The families of @ schizophrenic patients who were recently discharged from a Veterans Administration hospital received periodic consultation in their homes from members of a clinical team .\n",
            "The visiting clinicians educated the families and the patients about community resources , consulted with them about interpersonal problems , and were available for crisis intervention following the last scheduled visit .\n",
            "Three months and one year after their discharge , the patients were compared on various measures of outcome with a control group of @ similar patients whose families did not receive periodic consultation .\n",
            "At the three-month follow-up , patients whose families received consultation had spent significantly fewer days in the hospital than had the control patients , but the difference was not significant at one-year follow-up .\n",
            "They also rated themselves significantly higher on the Vets Adjustment Scale at both the three-month and one-year follow-ups .\n",
            "The authors interpret the results in light of other studies of after-care interventions .\n",
            "BACKGROUND : Cognitive remediation ( CR ) is a psychological therapy , which improves cognitive and social functioning in people with schizophrenia .\n",
            "It is now being implemented within routine clinical services and mechanisms of change are being explored .\n",
            "We designed a new generation computerised CR programme , CIRCuiTS ( Computerised Interactive Remediation of Cognition - a Training for Schizophrenia ) , to enhance strategic and metacognitive processing , with an integrated focus on the transfer of cognitive skills to daily living .\n",
            "This large trial tested its feasibility to be delivered in therapist-led and independent sessions , and its efficacy for improved cognitive and social functioning .\n",
            "METHODS : A two arm single blind randomised superiority trial comparing CIRCuiTS plus treatment-as-usual ( TAU ) with TAU alone in @ people with a diagnosis of schizophrenia .\n",
            "Cognitive , social functioning and symptom outcomes were assessed at pre - and post-therapy and @ months later .\n",
            "RESULTS : @ % adhered to CIRCuiTS , completing a median of @ sessions .\n",
            "There were significant improvements in visual memory at post-treatment ( p = @ ) and follow-up ( p = @ ) , and a trend for improvements in executive function at post-treatment ( p = @ ) in favour of the CIRCuiTS group .\n",
            "Community function was also differentially and significantly improved in the CIRCuiTS group at post-treatment ( p = @ ) but not follow-up , and was specifically predicted by improved executive functions .\n",
            "CONCLUSIONS : CIRCuiTS was beneficial for improving memory and social functioning .\n",
            "Improved executive functioning emerges as a consistent predictor of functional gains and should be considered an important CR target to achieve functional change .\n",
            "A larger-scale effectiveness trial of CIRCuiTS is now indicated .\n",
            "The relative efficacy of olanzapine , an atypical antipsychotic drug , was compared with that of the conventional antipsychotic drug haloperidol .\n",
            "A post hoc analysis conducted on a double-blind , @-wk study of @ acute-phase patients with DSM-III-R schizophrenia or schizophreniform or schizoaffective disorders treated with olanzapine ( @-@ mg/day ) or haloperidol ( @-@ mg/day ) assessed the treatment effects on agitation ( Brief Psychiatric Rating Scale [ BPRS ] agitation score ) and positive symptoms ( BPRS positive symptom score ) .\n",
            "It was found that olanzapine-treated Ss experienced significantly greater improvement in behavioral agitation than did haloperidol-treated Ss .\n",
            "Both groups showed similar reductions in agitation scores during the first @ wks of therapy ; olanzapine was associated with significantly greater improvements at wks @ , @ and @ .\n",
            "Also , Ss with predominantly positive psychotic symptoms experienced significantly greater improvement in BPRS positive symptom scores with olanzapine compared with haloperidol .\n",
            "In olanzapine-treated Ss , improvement in BPRS agitation and positive symptom scores was significantly greater at wks @ , @ and @ .\n",
            "It is concluded that olanzapine may be considered a first-line treatment for the patient in an acute episode of schizophrenia .\n",
            "Beta-blockers are emerging as treatments for neuroleptic-induced akathisia ( NIA ) ( @ ) .\n",
            "Propranolol , which blocks both Beta-@ and Beta-@ receptors , has been most extensively studied .\n",
            "The relative contribution of Beta-@ vs. Beta-@ receptors is unclear .\n",
            "In two studies to date the effects of selective Beta-@ blockers were inconsistent ( @ ) .\n",
            "We now describe data from studies of two lipophilic Beta-blockers : @ ) the selective Beta-@ blocker ICI @ and @ ) the selective ( at low doses ) Beta-@ blocker metoprolol .\n",
            "Ten patients were treated in parallel group , double-blind study of ICI @ ( n = @ ) vs placebo ( n = @ ) .\n",
            "Mean measures of akathisia were lower in the ICI cohort than in those who received placebo .\n",
            "This study was halted prior to completion when ICI @ was withdrawn from clinical evaluation .\n",
            "However , four patients to date have shown improvement with low dose metoprolol treatment .\n",
            "This improvement was not enhanced by subsequent treatment with propranolol .\n",
            "This study is still in progress .\n",
            "ICI @ is the only Beta-@ selective blocker studies in akathisia to date .\n",
            "The improvement seen suggests a role for Beta-@ receptors in NIA .\n",
            "On the other hand , improvement after putative selective Beta-@ blockade was also seen .\n",
            "Thus , the role of subsets of Beta receptors is unclear ; it is even possible that there is redundancy of function of rthrese receptors in the CNS .\n",
            "In @ psychotic patients with frequent hallucinations and/or actual delusional experience a possible antipsychotic action of the opiate antagonist naloxone ( N-allyl-noroxymorphone ) was investigated , using a double-blind placebo-controlled cross-over design .\n",
            "@ of these patients were not treated with neuroleptic drugs ; @ suffered from an acute episode of schizophrenia .\n",
            "Psychopathological changes were assessed by the use of the IMPS-scale and of a symptom-specific rating scale ( VBS ) .\n",
            "Intravenous injection of naloxone ( in most cases @ mg ) induced a reduction of psychotic symptomatology ( especially hallucinations ) in the majority of patients .\n",
            "Compared with placebo this effect reached statistical significance within @-@ hours after injection .\n",
            "From this result a possible involvement of endogenous ligands of opiate receptors in the pathogenesis of schizophrenia may be concluded .\n",
            "The primary purpose of this study was to evaluate the effectiveness of a new adrenal steroid ( neurosterone ) in the treatment of acutely ill hospitalized psychiatric patients in whom anxiety or agitation were prominent symptoms .\n",
            "The results provide virtually no support for the view that neurosterone is superior to a placebo , and they clearly indicate that it is inferior to chlorpromazine .\n",
            "There is a very tenuous suggestion that neurosterone may have certain activating properties .\n",
            "This stems from the finding that it was almost significantly more effective than both chlorpromazine and placebo in increasing sociability .\n",
            "Furthermore , the only other target symptom which reflected a trend in favour of neurosterone  although one which did not approach statistical significance  was interest .\n",
            "This might suggest the desirability of exploring the use of neurosterone in patients whose primary symptomatology is apathy and withdrawal , rather than anxiety or agitation .\n",
            "Evaluated the impact of zotepine and clozapine on cognitive dysfunction in schizophrenia in a DOUBLE-blind randomized study .\n",
            "After washout , @ Caucasian patients diagnosed with schizophrenia according to Diagnostic and Statistical Manual of Mental Disorders-III-Revised ( DSM-III-R ) and matched for baseline scores on the Brief Psychiatric Rating Scale ( BPRS ) , the Scale for the Assessment of Negative Symptoms ( SANS ) and age were randomized on zotepine or clozapine .\n",
            "Ss were examined weekly for @ wks .\n",
            "@ matched healthy persons were recruited as controls .\n",
            "Cognitive function was operationalized by a maze test in which patients traversed computer-displayed mazes of increasing complexity .\n",
            "Both clozapine and zotepine achieved a highly significant decrease in overall symptoms ( BPRS ) and negative symptoms ( SANS ) and were equally effective .\n",
            "In the maze tests , motor errors in simple mazes were stable over time and differentiated schizophrenics from controls as a \" trait \" marker .\n",
            "In passage time and maze route , schizophrenics performed worse than controls .\n",
            "An improvement by medication was evident in both medication groups , but was more pronounced in the zotepine-treated group .\n",
            "Studied @ hospitalized schizophrenic patients who in matched groups and under double-blind conditions were treated either with pimozide or with carpipramine .\n",
            "Improvement and side effects were judged on separate rating scales .\n",
            "Results show no significant differences between the @ drugs .\n",
            "( French , Dutch , German , Italian & Spanish summaries )\n",
            "BACKGROUND : In most domains of cognition , individuals with schizophrenia are generally found to be one standard deviation below the mean of the controls .\n",
            "As a result , examining the impact of cognitive remediation in individuals with schizophrenia has been a burgeoning area of research .\n",
            "However , the state of the literature remains unclear as to which domains of cognition should be targeted to produce the most widespread and durable benefits for individuals with schizophrenia .\n",
            "One suggestion is that targeting lower-level cognitive processes that are important for higher-level and more complex aspects of cognition may produce the most widespread benefits in cognition and everyday functioning .\n",
            "Relatively few studies have examined the effects of working memory or processing speed training in schizophrenia , as most studies examine broad-based remediation programs .\n",
            "Thus , a need exists for targeted working memory and processing speed training studies to better understand the mechanisms of cognitive enhancement in patients .\n",
            "This study aims to @ ) investigate near-transfer gains ( that is , the transfer of learning to related contexts ) associated with working memory and processing speed training in schizophrenia patients ; @ ) investigate far-transfer gains ( that is , the transfer of learning to new contexts ) associated with working memory and processing speed training ( that is , gains in other neurocognitive domains and social cognition ) ; and @ ) investigate real-world gains associated with training ( that is , gains in daily functioning ) .\n",
            "METHODS/DESIGN : A double-blind randomized controlled trial with a three parallel group design will be conducted .\n",
            "A random sample of @ patients with schizophrenia or schizoaffective disorder will be recruited through outpatient clinics at Foothills Hospital and community support programs in Calgary , Alberta .\n",
            "Participants will be randomly assigned using a computer-generated program in a @:@:@ ratio to a working memory-training group , a processing speed-training group , or a no-training control group .\n",
            "Training will be completed at home for @ minutes per day , @ days per week , for a total of @ weeks .\n",
            "Neurocognitive , social cognitive , and daily functioning measures will be administered both pre - and post-training to detect training-related gains .\n",
            "The primary outcome measures will include working memory and processing speed ( near-transfer measures ) , as well as fluid intelligence ( far-transfer measure ) .\n",
            "TRIAL REGISTRATION : Current controlled trials NCT@ ( ClinicalTrials.gov , registered on @ June @ ) .\n",
            "Objectives : To compare the effectiveness of a home-based mobile intervention with hospital-based outpatient care for individuals with a first episode of psychosis using a randomized study design .\n",
            "Materials and methods : Clinical services for individuals experiencing a first episode of psychosis at our hospital include both a home intervention for psychosis ( HIP ) team and a specialized first-episode psychosis clinic ( FEPC ) .\n",
            "Individuals referred for care were randomly assigned to either the HIP or FEPC .\n",
            "Subjects provided informed consent for evaluations of effectiveness and costeffectiveness to be carried out at baseline and at @ - and @-month follow-up visits .\n",
            "Symptom severity was assessed using the Brief Psychiatric Rating Scale and functioning was assessed using the Multnomah Community Ability Scale ( MCAS ) .\n",
            "Results : Twenty-five patients have been enrolled to date : mean age of @ ( S.D. = @ ) years , @ % Caucasian/@ .@ % Black/@ .@ % other , @ % homeless and @ % diagnosed with schizophrenia .\n",
            "Conclusion : Further recruitment to this randomized clinical trial will be valuable in understanding whether outcomes from a first episode of psychosis are impacted by the delivery of home-based treatment .\n",
            "AIM : Up to half of patients with borderline personality disorder report auditory verbal hallucinations that are phenomenologically indistinguishable from those in schizophrenia , occur early in the course of the disorder , and are enduring , distressing and disabling .\n",
            "In clinical practice , this symptom is widely assumed to be unresponsive to treatment with antipsychotic medication and early intervention is rarely offered .\n",
            "The Verbal Experiences Response in Borderline personality disorder to Aripiprazole TrIal Medication ( VERBATIM ) study aims to be the first controlled trial to investigate the effectiveness of conventional pharmacotherapy for this symptom in this patient group .\n",
            "METHOD : VERBATIM is a @-week , triple-blind , single-centre , parallel groups randomised controlled trial , with a @-week follow-up period .\n",
            "Participants between the ages of @ and @ years receive either aripiprazole or placebo daily , commencing at @ mg and increasing to @ mg by day @ .\n",
            "Further dose escalations ( up to @ mg ) may occur , as clinically indicated .\n",
            "This trial was prospectively registered with the Australian and New Zealand Clinical Trials Registry ACTRN@ on @/@/@ .\n",
            "RESULTS : The primary outcome is severity of auditory verbal hallucinations assessed using the Psychotic Symptom Rating Scale .\n",
            "Secondary outcomes include the severity of general psychopathology , borderline personality pathology , social and occupational functioning and change in brain resting state connectivity .\n",
            "The primary endpoint is week @ and secondary endpoint is week @ .\n",
            "CONCLUSION : The results will inform treatment decisions for individuals with borderline personality disorder who present with auditory verbal hallucinations .\n",
            "A tentative model for conceptualizing the interplay of vulnerability factors , stressors , and protective factors in the course of schizophrenia is discussed .\n",
            "A study of the initial years after a first schizophrenic episode is testing the predictive role of key factors .\n",
            "During an initial @-year period of depot antipsychotic medication , independent life events and expressed emotion were found to predict the likelihood of psychotic relapse .\n",
            "Initial analyses indicate that independent life events play less of a role in relapse prediction during a medication-free period .\n",
            "These results suggest that maintenance antipsychotic medication raises the threshold for return of psychotic symptoms , such that relapses are less likely unless major environmental stressors occur .\n",
            "A low expressed emotion environment may be a protective factor .\n",
            "OBJECTIVE : This study investigated the efficacy of verapamil in acute mania .\n",
            "METHOD : The study was a @-week double-blind , random - assignment , parallel-group , placebo-controlled inpatient trial of verapamil for patients with acute mania .\n",
            "Of the @ study patients , @ were given placebo and @ were given verapamil .\n",
            "RESULTS : Mean absolute change scores on the Mania Rating Scale at endpoint , with baseline scores as the covariates , did not differ between the verapamil and placebo groups .\n",
            "There were no significant differences between the two groups in age , sex , and presence of psychosis .\n",
            "CONCLUSIONS : The investigators found no benefit of verapamil over placebo in treating acute mania .\n",
            "Objective : BL-@ is a - aminobutyric acid ( GABA ) - enhanced antipsychotic that combines dopamine antagonism with GABA agonist activity .\n",
            "On the basis of animal models , we tested the hypotheses that BL-@ would be effective in ameliorating both psychotic symptoms and cognitive impairments , with a favorable safety profile in acutely ill schizophrenia patients .\n",
            "Method : @ hospital-based psychiatric patients in India , Romania , and United States aged @ to @ years and meeting criteria for DSM-IV-TR diagnosis of chronic schizophrenia were randomized double-blind to receive BL-@ @ mg/d , BL-@ @-@ mg/d , placebo , or risperidone ( @-@ mg/d ) for @ weeks .\n",
            "The main outcome measures were the Positive and Negative Syndrome Scale ( PANSS ) , Brief Assessment of Cognition in Schizophrenia , Readiness for Discharge Questionnaire , Clinical Global Impressions Scale ( CGI ) , and Extrapyramidal Symptom Rating Scale .\n",
            "The study ran from July @ to June @ .\n",
            "Results : BL-@ @-@ mg was significantly better than placebo on PANSS ( P = .@ ) and CGI ( P < .@ ) measurements , with no significant differences noted between BL-@ @-@ mg and risperidone .\n",
            "There were no significant differences in the maximum change on Extrapyramidal Symptom Rating Scale between risperidone and BL-@ @-@ mg , and both were significantly worse ( P < .@ ) than placebo .\n",
            "BL-@ @-@ mg was associated with significantly greater improvements on cognitive functioning as measured by the Brief Assessment of Cognition in Schizophrenia composite score when compared to placebo ( effect size = @ , P = .@ ) , risperidone ( effect size = @ , P = .@ ) , and BL-@ @ mg ( effect size = @ , P = .@ ) after @ weeks .\n",
            "Conclusions : BL-@ appears to be an effective antipsychotic with possible procognitive effects that will need to be further tested for short - and long-term effects .\n",
            "A further randomized controlled trial using the US Food and Drug Administration-recommended Measurement and Treatment Research to Improve Cognition in Schizophrenia cognitive battery is ongoing .\n",
            "Trial Registration : ClinicalTrials.gov identifier : NCT@ .\n",
            "Copyright @ Physicians Postgraduate Press , Inc .\n",
            "Background : The differential effectiveness of atypical antipsychotics versus conventional agents in the long-term treatment of schizophrenia remains controversial .\n",
            "Methods : We conducted a double-blind , randomized , activecontrolled continuation trial in subjects with schizophrenia who completed a core @-week trial of @ dose regimens of ziprasidone , @  @ mg bid ( N = @ ) or @  @ mg qd ( N = @ ) , and haloperidol @  @ mg/d ( N = @ ) .\n",
            "Efficacy evaluation was based on response rate ( z@ % PANSS total improvement from baseline ) and remission rate ( based upon recently proposed remission criteria for schizophrenia : Andreasen NC , et al .\n",
            "Am J Psychiatry .\n",
            "@ ; @:@-@ ) at each visit ( week @ ; months @ , @ , @ , @ , @ , @ , @ , @ , and @ ) .\n",
            "Remission and response rates over time and the significance of treatment-by-time interaction effects were evaluated using the longitudinal Generalized Estimating Equation method .\n",
            "Results : Remission rates at years @ , @ , and @ , respectively , were ziprasidone bid , @ % , @ % , and @ % ; ziprasidone qd , @ % , @ % , and @ % ; and haloperidol , @ % , @ % , and @ % .\n",
            "The increase in these response rates over time was greater for ziprasidone bid and qd than for haloperidol ( P = @ and P = @ , respectively ; treatment - by-time interaction ) .\n",
            "By contrast , responder analysis over time ( up to @ years ) showed response rates as follows : ziprasidone bid , @ % to @ % ; ziprasidone qd , @ % to @ % ; and haloperidol , @ % to @ % ( P = NS ) .\n",
            "Conclusions : Ziprasidone bid and qd dose regimens were both superior to haloperidol over the long term , according to the more stringent criteria for remission .\n",
            "By traditional criteri responder a , rates did not differ significantly between the groups .\n",
            "Studied the therapeutic efficacy and side effects of bromperidol and haloperidol for the treatment of schizophrenia .\n",
            "Ss were @ schizophrenic adults ( aged @-@ yrs ) .\n",
            "Information on sociodemographic variables and clinical symptoms was obtained by semistructured interview .\n",
            "Ss received either bromperidol ( @ mg/day ) or haloperidol ( @ mg/day ) for @ wks .\n",
            "Psychological and clinical symptoms and side effects were evaluated at weekly intervals .\n",
            "The Clinical Global Index , the Brief Psychiatric Rating Scale , the Hamilton Rating Scale for Depression , the Positive Symptom Scale and the Negative Symptom Scale were used .\n",
            "( English abstract )\n",
            "Recruitment : Recruiting .\n",
            "Conditions : Schizophrenia | Schizoaffective Disorder | Psychotic Disorders .\n",
            " Behavioral : Support Group ( control ) .\n",
            "Gender : Both .\n",
            " Senior .\n",
            "Enrollment : @ .\n",
            "Study Types : Interventional .\n",
            "Study Designs : Treatment | Randomized | Open Label | Active Control | Parallel Assignment | Efficacy Study .\n",
            "Start Date : December @ .\n",
            "Completion Date : December @\n",
            "Objective : @ To elucidate if treatment focused on person continuity , reduces the use of coercion .\n",
            "@ To investigate the use of coercion during admittance in the patient population included in the AOPUSB project and in the ADet Nationale SkizofreniprojektB DNS .\n",
            "@ To elucidate if person continuity is negatively correlated to the use of coercion .\n",
            "Material and method : @ Age two-armed : @-@ years , three-armed : @-@ years , permanent address in KbenhavnrFre-deriksbergor Arhus county .\n",
            "@ F@-@ using ICD-@ research criteria .\n",
            "@ Antipsychotic treatment no more than @ weeks .\n",
            "@ No mental retardation , no organic disease causing the symptomatology .\n",
            "@ The symptomatology not caused by the use of psychoactive agents .\n",
            "@ Ability to communicate in the Danish language .\n",
            "Design : The AOPUSB project is a RCT .\n",
            "The DNS is a registration study .\n",
            "The patients were included consecutively @ March @ to @ December @ .\n",
            "They were RANDOMISED into two subgroups .\n",
            "@ The two-armed : To Team - or standard treatment , if the patients a did not need hospital admittance ; b did not accept admission ; c Were aged @-@ .\n",
            "@ The three - armed : To hospital-based rehabilitation in the specialised facility AU@B , team - or standard treatment if the patients a needed hospital admittance ; b were @-@ years old .\n",
            "Operationalisation : The population was investigated at baseline , and again at @ - and @-year follow-ups .\n",
            "Coercion is registered in the Danish Board of Health as legislated .\n",
            "Person continuity will be quantified as actual contacts with the person responsible for the treatment , the primary contact person in the team and in AU@B the doctor in charge of the treatment and actual contacts with a doctor in the standard group .\n",
            "The percentage of contacts with the same person will also be quantified .\n",
            "Severeness of psychopathology : SCAN @ ; SAPS ; SANSS ; PANSS ; GAF ; Strauss-Carpenter ; TAU ogROMI .\n",
            "All data will be extracted from the AOPUSB project , the ADNSB and the Danish Board of Health .\n",
            "Hypotheses : @ The higher the degree of person continuity and percentage contacts with the same treatment responsible person , the lesser the use of coercion .\n",
            "@ The use of coercion in the intervention groups is less frequent .\n",
            "@ There is a higher degree of person continuity in the interventiongroups .\n",
            "@ Only the population RANDOMISED to the three armed subgroup was in need of hospital admission , and therefore had a more severe psychopathology at baseline .\n",
            "The purpose of comparison of quetiapine and risperidone in the treatment of schizophrenia and adverse reactions .\n",
            "@ patients with schizophrenia were randomly divided into two groups , were given quetiapine Lee grains one treatment , treatment for eight weeks .\n",
            "Negative and positive symptoms scale ( pan-ss ) , to evaluate the efficacy and adverse side effects scale ( tess ) and extrapyramidal reactions scale ( esrs ) .\n",
            "Results quetiapine and risperidone treatment , there was no significant difference .\n",
            "Quetiapine adverse the risperidone light .\n",
            "Objective : In a first pilot study we observed that following aerobic exercise training , relative hippocampal volume increased significantly in patients ( @ % ) and healthy subjects ( @ % ) , with no change in the non-exercise group of patients ( -@ % ) ( Pajonk et al. @ ) .\n",
            "The aim of this randomized controlled trial is to replicate the results of our first pilot study and to explore if aerobic exercise combined with cognitive training leads to improvement of cognition in chronic schizophrenia compared to a placebo condition .\n",
            "Furthermore , the investigation is designed to show whether these effects are lasting and whether they could be used to improve cognitive dysfunction in chronic schizophrenia .\n",
            "Methods : The study will be a randomised , controlled trial comparing the combination of physical aerobic exercise and cognitive training with the participation in the sports program ( cycling ) alone or with an alternative activity , spending the same amount of time but without an impact on physical activity ( table football ) in combination with computerized cognitive training ( CogPack ) .\n",
            "All conditions will be provided over a @ months period .\n",
            "Primary outcome measures will be a significant improvement of the sum score in the VLMT as determined when entering the study and after @ months ( primary endpoint ) and after @ months ( secondary endpoint ) .\n",
            "Secondary outcome measures will be an improvement of the PANSS negative subscore , improvement in quality of life domains ( WHO-QoL ) , an increase of hippocampal volume and an elevation of NAA-concentration ( MRS ) .\n",
            "All parameters measured when entering the study , after @ and after @ months .\n",
            "Results : Preliminary results will be shown if already suitable .\n",
            "Conclusion : First conclusions for future studies regarding the impact of aerobic exercise may be drawn .\n",
            "Background : A cognitive model of psychosis suggests that appraisals of psychotic-like experiences ( PLEs ) , and the subsequent responses adopted , are responsible for the maintenance of distress and disability associated with psychosis .\n",
            "Aims : This study aimed to investigate whether it is possible to manipulate appraisals of an anomalous experience in people at risk of psychosis and whether this affects levels of distress .\n",
            "Method : Participants who had experienced an \" at risk mental state \" ( ARMS ) within the past year , were randomized to one of two groups and received either negative or neutral information pertaining to an anomalous experience ( a card trick ) .\n",
            "Participants completed a questionnaire measuring PLEs , then completed pre and post measures of distress and anxiety in relation to the card trick .\n",
            "Participants were also asked to rate a series of psychotic or non-psychotic appraisals regarding how they thought the card trick worked .\n",
            "Results : Data analysis revealed that distress and anxiety were not related to the information group assigned ( our experimental manipulation was unsuccessful ) .\n",
            "However , when analyzed as one group , higher conviction in non-psychotic appraisals was found to be related to lower levels of distress and state anxiety .\n",
            "Conclusions : The findings provide some validation for a relationship between appraisals and distress .\n",
            "Clinical implications , methodological limitations and possible future research directions are discussed .\n",
            "Early intervention with a randomized psychosocial treatment study was carried out in a sample ( n = @ ) of young patients ( mean age : @ years ) with newly onset schizophrenia and a short duration of untreated psychosis in a specialized setting .\n",
            "The @ month intervention showed a beneficial effect on the occurrence of psychotic relapse ( @ % ) .\n",
            "After the @ month intervention study patients were referred to other general mental health agencies .\n",
            "During a five year follow up period the initial beneficial effect was lost : @ % had at least one psychotic relapse , @ % became chronic psychotic .\n",
            "In addition , patients from the family condition were found to spend significantly less days in psychiatric institutions than those whose parents did participate in the family education condition .\n",
            "Premature referrals induce a proliferation of psychotic relapse in early onset schizophrenia .\n",
            "A new intervention trial in the critical period with a @ year duration is in progress .\n",
            "This trial studies the effects of referred and parental groups and shows initial beneficial effects .\n",
            "The clinical efficacy and safety of risperidone ( RIS ) and haloperidol ( HPD ) in the treatment of schizophrenia were evaluated in a multi-centered double-blind study .\n",
            "A total of @ patients ( excluded : @ case ) ( consisting of @ cases for RIS and @ cases for HPD , was analyzed in detail .\n",
            "The results were summarized as follows .\n",
            "@ ) In the FGIR , the \" moderately improved \" or better improvement rates were @ % in the RIS Group and @ % in the HPD Group , while the \" slightly improved \" or better improvement rates were @ % in the RIS Group and @ % in the HPD Group .\n",
            "In addition , the \" slightly aggravated \" or worse rates were @ % in the RIS Group and @ % in the HPD Group , respectively .\n",
            "None of the differences between these pairs of values for the two drug groups were found to be statistically significant in U - test .\n",
            "To explain the finding that the \" moderately improved \" or better improvement rate in the RIS Group was somewhat lower than the rate in the HPD Group , it is surmised that the results with RIS were unfavorably affected by the following biases in the patient background characteristics : ( @ ) the RIS Group included a greater number of patients who had not responded well to the previous medication , ( @ ) the HPD Group included a larger number of cases presenting with a clinical picture of \" excitement \" before the start of this study and ( @ ) the RIS Group included a larger number of patients with longer duration of illness .\n",
            "Concerning the FGIR , by adjusting the biases in the patient background characteristics , the difference in the \" moderately improved \" or better improvement rates between the RIS Group and the HPD Group decreased from ( - ) @ % to ( - ) @ % , and the rates between the two groups were found to be almost the same .\n",
            "Looking at patients who show a decrease of at least @ % in the total BPRS score , improvement rates in patients without a clinical picture of \" excitement \" were the same of @ % in the both RIS and HPD Groups .\n",
            "The rates of reduction in the total BPRS score were @ % in the RIS Group and @ % in the HPD Group : the two rates were at a similar level .\n",
            "@ ) With regard to effects on psychiatric symptoms , RIS showed high rates of improvement for the symptoms of \" somatic concern \" and \" emotional withdrawal \" while HPD showed high rates of improvement for \" grandiosity \" and \" disorientation \" .\n",
            "These findings thus revealed different characteristic actions in the two drug treatment groups .\n",
            "In addition , as a result of consideration of the characteristics of the patients who showed improvement , it was surmised that RIS is more effective than HPD in the treatment of \" emotional withdrawal \" and \" blunted affect \" .\n",
            "Accordingly , it was suggested that RIS has the effect of improving the negative symptoms , as shown in the overseas reports .\n",
            "@ ) With regard to the safety of the drugs in the OSR , the percentage of patients evaluated as having \" shown side effects \" was @ % in the RIS Group and @ % in the HPD Group ; no significant differences were observed .\n",
            "With regard to side effects , the overall incidences were @ % in the RIS Group and @ % in the HPD Group ; it was significantly low in the RIS Group ( p < @ ) .\n",
            "With regard to EPS , the concomitant use of anti-parkinson drugs was rated lower in the RIS Group with a significant tendency than in the HPD Group ( p < @ ) , however , the incidence of akathisia showed a tendency to be significantly higher in the HPD Group ( p < @ ) .\n",
            "The overall incidence of EPS was lower in the RIS Group than in the HPD Group : @ % in the RIS Group and @ % in the HPD Group .\n",
            "However , the difference was not statistically significant .\n",
            "The total number of EPS case was smaller in the RIS Group than in the HPD Group : @ cases in the RIS Group and @ cases in the HPD Group .\n",
            "The drug administration had to be discontinued due to the manifestation of EPS in three HPD Group patients , whereas none of the patients in the RIS Group manifested EPS during this clinical study .\n",
            "The findings regarding EPS in this study were similar to those reported in earlier studies on RIS , and it was surmised that the incidence of EPS in response to RIS administration is low , while the severity of any EPS is mild .\n",
            "RIS seems to require less concomitant use of anti-parkinson drugs than other neuroloeptics may require .\n",
            "There were no cases of serious laboratory test abnormalities in either the RIS Group or the HPD Group .\n",
            "@ ) With regard to the GUR of the drugs , the \" fairly useful \" or better rates were @ % in the RIS Group and @ % in the HPD Group , while the \" slightly useful \" or better rates were @ % in the RIS Group and @ % in the HPD Group .\n",
            "The differences in these rates between the two drug groups were not statistically significant .\n",
            "@ ) In the comparison of the usefulness of the RIS and HPD with the previous medication , the percentage of cases receiving a superior GUR by @ grades in the present study compared with the previous drug were @ % in RIS Group and @ % in HPD Group , and receiving a superior GUR by @ or more grades were @ % in the RIS Group and @ % in the HPD Group .\n",
            "It was confirmed that RIS have the same usefulness as HPD in the comparison with the previous medication .\n",
            "@ ) In the comparison of the FGIR of RIS and HPD with the efficacy of the previous drugs , at the end of the studies , RIS showed higher rates in improving by three grades or more , and improving two grades or more than HPD ( RIS @ % , @ % , HPD @ % , @ % ) .\n",
            "Therefore , RIS is considered to have almost the same effect on improving symptoms as HPD .\n",
            "@ ) On the basis of the above-described findings of the present clinical study , it is concluded that RIS shows clinical efficacy that is almost equivalent to that of HPD in the treatment of schizophrenia .\n",
            "With regard to the safety of RIS , the incidence of side effects , especially EPS , is low , requiring less concomitant use of anti-parkinson drugs .\n",
            "Therefore , RIS seems to be an antipsychotic drug with high utility , as well .\n",
            "It is to be hoped that RIS will be made available for clinical use at the earliest possible date .\n",
            "( author abst . ) )\n",
            "Many schizophrenic patients have documented neuropsychological deficits in attention , memory , and exectuive functions that are relatively refractory to neuroleptic treatment ( Cassen et al. , @ ) .\n",
            "To date , there have been no published studies assessing the effect of clozapine , an atypical antipsychotic drug , on alleviating neuropsychological deficits in schizophrenia .\n",
            "We have shown ( Kenny et al. , in preparation ) that treatment resistant schizophrenic patients shwoed significant improvement in semantic memory retrieval deficits following six weeks of treatment with clozapine ( n = @ ) or standard neuroleptic drugs ( n = @ ) and following six months treatment with clozapine ( @ ) .\n",
            "The changes in controlled word retrieval following clozapine treatment did not correlate significantly with changes in any of athe psychopathology symptoms scores ( BPRS total , BPRS positive , BPRS negative and SADS-C thought disturbance ) .\n",
            "Baseline level of performance on the controlled work retrieval test was also not related to improvements in psychopathology following clozapine treatment .\n",
            "It remains to be determined as to whether neuropsychological dysfunction would be less refractory to treatment with clozapine and typical neuroleptic drugs in early stage schizophrenic patients , wherein the disease process has not had as much time to exact its toll .\n",
            "Schizophrenia is a biopsychosocial disorder .\n",
            "Recent investigations have focussed on biochemical factors .\n",
            "A study by Horrobin et al @ , shows that cell membrane phospholipid composition is abnormal in patients with schizophrenia .\n",
            "Peet et al ( @ ) , Glen et al ( @ ) , found significantly reduced levels of certain n-@ and n-@ essential fatty acids in RBC membranes in the drug treated schizoprhenia patients .\n",
            "A recent study conducted in India and Malaysia with drug niave patients showed abnormal RBC membrane composition when compared to matched controls .\n",
            "Depleted RBC membrane essential fatty acids are seen predominantly in negative schizophrenia and those with tardive dyskinesia ( Glen et al @ , Vaddadi @ ) .\n",
            "The essential fatty acid deficiencey in membrane phospholipids may be due to either decreased synthesis or increased breakdown .\n",
            "Use of special diets to increase fatty acid in membrane phospholipids has not been investigated much .\n",
            "Dietary fatty acid intake may modify fatty acid composition of neuronal membranes ( Bourre et al @ ) .\n",
            "Limited evidence suggests that supplementation with evening primrose oil which is particularly rich in n-@ fatty acids , can reduce manifestations of schizoprhenia as well as tardive dyskinesia ( Vaddadi @ ) .\n",
            "Mellor et al ( @ ) supplemented @ schizophrenic patients for @ weeks with @ gm/day of EPA enriched fish oil .\n",
            "It resulted in significant reduction in both schizophrenic symptomatology as well as tardive dyskinesia .\n",
            "We present study of EPA supplementation in schizophrenic patients who were already stabilised on antipsychotic drugs but without significant improvement .\n",
            "This study was conducted in India .\n",
            "The current study aimed to test the clinical effectiveness of a cognitive-behavioural program ( CBT ) specifically adapted for pathological gamblers with chronic schizophrenia , carried out in a naturalistic setting of community Mental Health Centres .\n",
            "Forty-four pathological gamblers with chronic schizophrenia were assigned either to a standard drug therapy for schizophrenia ( control group ) or to cognitive-behavioural therapy for pathological gambling plus a standard drug therapy for schizophrenia ( experimental group ) .\n",
            "Psychological treatment comprised a @-session program including psychoeducation , stimulus control , gradual exposure and relapse prevention .\n",
            "Therapeutic success was defined as abstinence or the occurrence of only @ or @ episodes of gambling during the follow-up period .\n",
            "While the patients treated in the experimental group showed a rate of success of @ % , only @ % of the participants belonging to the control group gave up gambling at the @-month follow-up .\n",
            "The CBT group also did better than the control group in the number of gambling episodes and in the amount of money spent on gambling .\n",
            "However , the improvement of the experimental group was weaker at the @ - and @-month follow-up .\n",
            "These findings support the beneficial effects of CBT as adjunctive therapy for patients with dual diagnoses ( schizophrenia and pathological gambling ) .\n",
            "( PsycINFO Database Record ( c ) @ APA , all rights reserved ) ( journal abstract )\n",
            "Compared the effects of short - ( @-@ days ) and long-term ( @-@ days ) hospitalization on the clinical outcomes of @ schizophrenics .\n",
            "Short-term treatment goals focused on crisis resolution and symptom relief , while long-term goals emphasized either or both a long-range psychosocial reorganization through psychotherapy and medication or changes in living situation , job , or a workshop placement .\n",
            "Ss in both the short - and long-term groups received phenothiazine treatment .\n",
            "@ outcome measures were administered at admission , at discharge , and @-@ yrs after admission ; these included the Psychiatric Evaluation Form , Soskis 's Brief Follow-up Rating , and Luborsky 's Health-Sickness Rating Scale .\n",
            "Preliminary follow-up results for @ patients indicate that in terms of global outcome , symptomatology , and posthospital treatment , the long - term patients improved more than the short-term patients .\n",
            "Results of a discriminant analysis were not significant .\n",
            "Limitations of the study and differences in cost for the @ groups are discussed .\n",
            "( @ ref )\n",
            "After a family oriented inpatient program the impact of early family intervention and EE status on relapse in @ patients with recent onset schizophrenia spectrum disorders was studied during a twelve months outpatient intervention period .\n",
            "After being stratified in high and low EE , patients were randomly assigned to an individually oriented early intervention programme or to the same programme plus family intervention .\n",
            "Relapses were defined using the Brief Psychiatric Rating Scale and clinical psychiatric criteria .\n",
            "Overall relapse rates during the early intervention to the individually oriented intervention programme did affect the relapse rate - contrary to expectation , patients in low EE families relapsed slightly more in the intervention group with additional family therapy .\n",
            "Family outpatient intervention in low EE families may increase stress , thus influencing relapse .\n",
            "Family oriented early inpatient treatment , followed by an individually oriented outpatient treatment , has a favourable impact on relapse .\n",
            "Histamine has important functions as regulator of several other key neurotransmitters .\n",
            "Patients with schizophrenia have lower histamine H@ receptor levels .\n",
            "Since a case report in @ of an effect of the H@ antagonist famotidine on negative symptoms in schizophrenia , some open-label trials have been performed , but no randomized controlled trial .\n",
            "Recently , it was shown that clozapine is a full inverse agonist at the H@ receptor .\n",
            "We performed a researcher-initiated , academically financed , double-blind , placebo-controlled , parallel-group , randomized trial with the histamine H@ antagonist famotidine in treatment-resistant schizophrenia .\n",
            "Thirty subjects with schizophrenia were randomized to have either famotidine ( @ mg twice daily , n = @ ) or placebo ( n = @ ) orally , added to their normal treatment regimen for @ weeks .\n",
            "They were followed up weekly with the Scale for the Assessment of Negative Symptoms ( SANS ) , the PANSS ( Positive and Negative Syndrome Scale ) , and Clinical Global Impression ( CGI ) Scale .\n",
            "In the famotidine group , the SANS score was reduced by @ ( SD , @ ) points , whereas in the placebo group the SANS score was virtually unchanged ( mean change , +@ [ SD , @ ] ) .\n",
            "The difference did not reach statistical significance ( P = @ ) in Mann-Whitney U analysis .\n",
            "However , the PANSS Total score and the General subscore as well as the CGI showed significantly ( P < @ ) greater change in the famotidine group than in the placebo group .\n",
            "No significant adverse effects were observed .\n",
            "This is the first placebo-controlled , randomized clinical trial showing a beneficial effect of histamine H@ antagonism in schizophrenia .\n",
            "H@ receptor antagonism may provide a new alternative for the treatment of schizophrenia .\n",
            "Olanzapine , structurally a thienobenzodiazepine , has demonstrated in vitro affinity for serotonin ( @-HT ) @a , @-HT@c , dopamine ( D ) @ , D@ , D@ , muscarine ( particularly M@ ) , x@-adrenergic , and H@ receptors .\n",
            "This broad receptor profile includes greater activity at @-HT@a than at D@ receptors .\n",
            "In a randomized DOUBLE blind mulicentre clinical trial desinged to test the efficacy and safety of olanzapine , @ schizophrenic patients were randomly assinged to @ or @ mg/d of olanzapine or placebo ( Pbo ) .\n",
            "When baseline and endpoint scores were compared , the @ mg dose olanzapine ( -@ ) was statistically significantly superior to bo ( -@ ) relative to mean change in BPRS positive , PANSS total , PANSS positive , and PANSS negative scores were compared olanzapine ( @ mg ) was statistically significally superior to Pbo and few treatment emergent extrapyramidal symptoms occurred in patients on olanzapine .\n",
            "Olanzapine ( @ mg does ) was not significantly different than Pbo in terms of efficacy .\n",
            "Olanzapine 's receptor profile , efficacy and its safety profile strongly suggest that olanzapine is a very promising atypical antipsychotic agent .\n",
            "Studies performed during the @ s provide an empirical foundation for developing alternative neuroleptic-based treatment strategies for schizophrenia .\n",
            "Dose reduction strategies arose both from the concern that many patients received more medication than necessary for therapeutic effect and the increased awareness of the long-term adverse effects associated with neuroleptic use .\n",
            "Simultaneously , clinical trials data supporting the efficacy of specific interpersonal treatment strategies have been generated .\n",
            "These results led us to assess the efficacy of combining a dose reduction strategy with interpersonal treatment for treating schizophrenic patients .\n",
            "Data from a comparative trial of continuous , standard dose neuroleptics with intermittent , targeted neuroleptics involving @ patients in a @-year treatment trial will be presented .\n",
            "Substantial dose reduction was achieved with the targeted approach , and the incidence and manifestations of tardive dyskinesia were diminished in patients treated with this approach .\n",
            "In contrast , continuous , standard dose medication proved superior in relapse prevention and , by the end of the study , in improving occupational functioning .\n",
            "Combining interpersonal strategy with dose reduction strategy will be discussed , and data from an analysis identifying good and poor candidates for a targeted drug strategy will be reported .\n",
            "This study reports that there are schizophrenics who do relatively well long term without the routine or continuous use of antipsychotic medication .\n",
            "Specially selected young males undergoing an acute schizophrenic episode were followed , after hospitalization , for up to three years .\n",
            "While hospitalized they were assigned RANDOMly to either placebo or chlorpromazine treatment .\n",
            "Many unmedicated-while-in-hospital patients showed greater long-term improvement , less pathology at follow-up , fewer rehospitalizations and better overall function in the community than patients who were given chlorpromazine while in the hospital .\n",
            "Factors related to post-hospital outcome were good premorbid history and short - lived paranoid characteristics .\n",
            "Considerations which may have an effect on the successful management of acute schizophrenic patients not on medication are mentioned .\n",
            "The findings underline the need for further study of how to utilize antipsychotic medication more selectively in the treatment of schizophrenia .\n",
            "Objectives : There is no doubt that the quality of treatment of schizophrenia has improved as a result of second-generation antipsychotic drugs ( SGAs ) .\n",
            "However , these drugs have side effects , such as weight gain and increases in the levels of glucose and prolactin [ @ ] .\n",
            "No studies have compared the safety of blonanserin ( BNS ) and PAL-ER in patients with schizophrenia .\n",
            "The aim of the present study was to compare the safety of BNS and PAL-ER in patients with acute schizophrenia .\n",
            "Methods : The participants included @ patients with schizophrenia who were admitted to Showa University Karasuyama Hospital in the acute unit .\n",
            "The patients were randomly assigned to receive either BNS ( N = @ , four males ; mean age : @ + / -@ years ) or PAL-ER ( N = @ , four males ; mean age : @ + / -@ years ) .\n",
            "The dose of BNS ranged from @ mg to @ mg per day and that of PAL-ER ranged from @ mg to @ mg per day .\n",
            "Treatment with antipsychotics continued for six weeks .\n",
            "The patients were evaluated at baseline and at two , four and six weeks after the initiation of treatment .\n",
            "Safety was assessed based on measurement of the Drug-Induced Extrapyramidal Symptoms Scale ( DIEPSS ) , the incidence of adverse events ( AEs ) and a clinical examination .\n",
            "The therapeutic effectiveness was rated using the Positive and Negative Syndrome Scale ( PANSS ) and the Clinical Global Impression - Severity ( CGI-S ) scale .\n",
            "Results : Four patients ( all in BNS ) were unable to complete the treatment protocol .\n",
            "Three patients dropped out due to ineffectiveness and one patient withdrew from treatment due to insomnia .\n",
            "Almost all of the patients experienced at least one mild AE .\n",
            "The most common AEs were insomnia , constipation and anxiety .\n",
            "No significant differences in the incidence of AEs were observed between the two groups ( BNS : @ % , PAL-ER : @ % ) .\n",
            "Approximately @ % of the patients in the BNS group and @ % of the patients in the PAL-ER group reported extrapyramidal symptom ( EPS ) - related AEs ; however , no significant differences were observed between the two groups .\n",
            "The incidences of bradykinesia , sialorrhea and gait abnormalities were high , and that of gait abnormalities , in particular , was much higher in the PALER group .\n",
            "Although the total score of the DIEPSS increased by approximately one point in the BNS group ( @ + / -@ vs. @ + / -@ , p = .@ ) , this value decreased by approximately one point in the PAL-ER group ( @ + / -@ vs. @ + / -@ , p = .@ ) .\n",
            "In the clinical examinations , there were no significant differences in the incidence of unusual changes between the two groups .\n",
            "BNS was as effective as PAL-ER in terms of the PANSS and CGI-S scores .\n",
            "Conclusions : To the best of our knowledge , this is the first study to compare the safety of BNS and PAL-ER in patients with acute schizophrenia .\n",
            "Despite the limitation of the small sample size , the present study shows that both BNS and PAR-ER are safe , well tolerated and effective in patients with acute schizophrenia .\n",
            " @\n",
            "The main aim is to determine whether elderly patients treated with amisulpride or risperidone at clinically-titrated dosage over one year have relatively low incidence of tardive , compared to the incidence figures reported with conentional antipsychotics The study is a single blind ( patient and clinical team informed , but the clinical assessor is blind to the treatment allocation ) and pragmatic , in that , although the dose of the antipsychotic drugs is flexible , the recommended ranges will be those commonly used in clinical practice in the elderly .\n",
            "Subjects will be recruited from the inpatient , outpatient and day hospital psychiatric services of Charing Cross Hospital and St. Bernards Wing of Ealing Hospital ( West London Mental Health Trust ) , and St Charles Hospital ( Brent , Kensington and Chelsea and Westminster Mental Health trust ) .\n",
            "The aim will be to recruit @ subjects over @ months ( approx @ subjects a week , taking into account leave sickness ) from a population of around @ older aduls drawn from the ethnicly and socio-economicallydiverse area of North London .\n",
            "The anticipated initiation rate of new antipsychotic prescriptions in antipsychotic-native subjects is approx @ a month in this population .\n",
            "At the heights of the data collection component of the study there would be a maximum of @ subjects ( assuming not attrition ) with @ visits a subject ( for further details and the full inclusion and exclusion criteria please see attached study proposal ) .\n",
            "The effectiveness of selective serotonin reuptake inhibitors for depression in remitted schizophrenia has not been clearly demonstrated .\n",
            "A randomized , double-blind , prospective placebo-controlled study was performed of @ Ss ( aged @-@ yrs ) meeting Mental Disorders-IV ( DSM-IV ) criteria for both schizophrenia in remission and for a major depressive episode .\n",
            "@ patients were randomized to placebo and @ to sertraline .\n",
            "All Ss had a @-wk anticholinergic phase before randomization .\n",
            "The treatment duration was @ wks .\n",
            "Sertraline was started at @ mg/day ; this could be increased to @ mg after @ wks for an inadequate response .\n",
            "There were no statistically significant differences in symptoms between the @ groups at randomization .\n",
            "There were no differences in outcome between treatment groups .\n",
            "In both groups , between @ % and @ % of Ss showed a @ % reduction in depression score .\n",
            "This study does not provide support for the efficacy of sertraline in the treatment of depression in remitted schizophrenia .\n",
            "It is suggested that future studies require a larger sample size and longer duration of treatment .\n",
            "Purpose - Key objectives of this clinical study are to - Determine how well intramuscular ( IM ) olanzapine depot works compared to placebo Evaluate the safety and tolerability of IM olanzapine depot compared to placebo Evaluate different doses of IM olanzapine depot compared to placebo to identify the best dose ( s ) .\n",
            "Primary Outcome Measures - Demonstrate superiority of IM olanzapine depot @ mg/@ weeks , @ mg/@ weeks , and @ mg/@ weeks dosages compared with placebo in the treatment of patients with schizophrenia Secondary Outcome Measures - To assess the efficacy of @ mg/@ weeks , @ mg/@ weeks , and @ mg/@ weeks IM olanzapine depot compared with placebo in CGI-I To determine the earliest time point at which @ mg/@ weeks , @ mg/@ weeks , and @ mg/@ weeks IM olanzapine depot show superior clinical improvement compared with placebo To assess the efficacy of @ mg/@ weeks , @ mg/@ weeks , and @ mg/@ weeks IM olanzapine depot compared with placebo in CGI-S To assess the efficacy of @ mg/@ weeks , @ mg/@ weeks , and @ mg/@ weeks IM olanzapine depot compared with placebo in terms of change in PANSS Positive , PANSS Negative and PANSS General Psychopathology subscales To assess the efficacy of @ mg/@ weeks , @ mg/@ weeks , and @ mg/@ weeks IM olanzapine depot compared with placebo in change from baseline to endpoint in quality of life To evaluate the safety and tolerability of @ mg/@ weeks , @ mg/@ weeks , and @ mg/@ weeks IM olanzapine depot compared with placebo To characterize the pharmacokinetics of olanzapine following multiple dosing with IM olanzapine depot at each of the prescribed dosing regimens Total Enrollment - @ Study start - June @ ; Study completion - April @ Eligibility - Ages Eligible for Study - @ Years - @ Years , Genders Eligible for Study - Both Criteria Inclusion Criteria - Patients must have schizophrenia and be experiencing a psychotic episode Each patient must have a level of understanding sufficient to complete all tests and examinations required by the protocol , and to provide informed consent Patient must not have participated in a clinical trial of another investigational drug , including olanzapine , within @ month ( @ days ) prior to the study entry Female patients must not be pregnant or breast-feeding Female patients must not be experiencing acute , serious or unstable medical conditions other than schizophrenia Exclusion Criteria - Patients who were previously treated with olanzapine and are considered to be treatment-resistant to olanzapine , in the opinion of the investigator One or more seizures without a clear and resolved etiology is exclusionary .\n",
            "However , if the patient has had one or more seizures in the past with an identifiable etiology , and that etiology has been resolved , the patient may be entered .\n",
            "Treatment with clozapine within @ weeks prior to visit @ DSM-IV or DSM-IV-TR substance ( except nicotine and caffeine ) dependence within the past @ days Treatment with remoxipride within @ months ( @ days ) prior to visit @\n",
            "Background : Evidence over the past @ years has shown that that @-@ % of individuals with schizophrenia exhibit profound neurocognitive deficits ( e.g. , Reichenberg & Harvey , @ ) .\n",
            "Particular significance has been attached to these deficits as they have been linked to poorer progress in well-grounded and rigorously tested social skills training ( SST ) programs ( e.g. , Kopelowicz et al. , @ ) , that are a primary treatment modality for individuals with the disorder ( Dixon et al. , @ ) , and that have been shown to reliably improve psychosocial function ( Kurtz & Mueser , @ ) .\n",
            "To evaluate whether cognitive remediation can enhance response to social skills training , investigated the effects of a standardized , comprehensive , drill-and-practice cognitive remediation training program similar to that studied in our previous work ( Kurtz et al. , @ ) when administered as an adjunctive intervention to an extended course of social skills training , on measures of psychosocial function in individuals with schizophrenia .\n",
            "Methods : A prospective , single-blind , randomized design was selected .\n",
            "Thirty-four participants were assigned to either a standardized cognitive remediation program , or a control condition .\n",
            "All participants received a @-month program of SST administered twice weekly and consisting of basic communication and conversation skills , assertiveness and friendship skills , Participants were assessed with proximal measures of cognitive function , intermediate measures of performance-based psychosocial skills , or distal measures of other-rated community function both before and after the interventions .\n",
            "Results : Cognitive remediation produced a trend towards improvement in elementary measures of working memory .\n",
            "More distal measures of other-rated psychosocial functioning showed more improvement in the cognitively-trained group , relative to the group administered SST treatment without remediation ( F ( @ ) = @ , p = @ ; Cohen 's d = @ ) .\n",
            "Discussion : These findings support the idea that amelioration of cognitive deficits in schizophrenia may improve treatment response to evidencebased behavioral interventions such as SST .\n",
            "Durability of effects remains an important area of future study .\n",
            "The implementation of the Psychoedutraining Study in Greece included the random selection of four mental health services , in which eight therapists were trained in the standard or augmented programme .\n",
            "Eight families were treated by the professionals of the standard group and eight families were treated by the professionals of the augmented group .\n",
            "All families received the complete intervention sessions as planned in the study .\n",
            "The implementation of the study in Greece leads to the following preliminary results : a ) mental health services showed interest in applying family interventions ; b ) mental health service managers were willing to facilitate the mental health professionals of their departments to participate in specialized educational programs ; c ) in half of the centers participating in the study , there were more than two professionals initially interested to attend training on behavioral family therapy ; d ) the therapiststrainees participating in the study were highly motivated to participate in the training and to apply family work ; e ) the duration and content of the training as well as the supervision were particularly useful for the trainees , who gained important clinical experience in behavioral family work and in negotiating with the administrators of their services about its integration in everyday work ; f ) regarding the recruitment of the families , it was much more difficult to engage families in the rural regions of Greece than in the cities ; g ) most of the families did not accept to be tape-recorded ; h ) most of the mental health centers neither facilitated nor kept back the trainees from implementing the family work .\n",
            "In most cases the sessions with the families took place in the afternoons and outside the working hours of the trainees , a fact that is expected to be a problem in the integration of family work in the routine of the services ; i ) the treated relatives had a tendency to experience less burden , and to apply more effective coping strategies after the intervention ; j ) the clinical status and the disability index of the patients was the same or had slight improvements at the @ year follow-up .\n",
            "Objective : Assess symptomatic remission rates in patients with schizophrenia receiving aripiprazole or haloperidol in a @-week randomized double-blind multicenter trial .\n",
            "Methods : Patients @-@ years with acute schizophrenia were randomized to aripiprazole n @ ) or haloperidol ( n = @ ) and were treated for @ weeks .\n",
            "Remission status of randomized patients was evaluated based upon recently developed remission criteria ( scores @ ; @ on @ specific PANSS items for @ ; @ months ) .\n",
            "Clinical Global Impression-Improvement ( CGI-I ) scores , AE-related discontinuation rates and EPS medication use were also measured .\n",
            "Results : Significantly more aripiprazole-treated patients satisfied the criteria for symptomatic remission during the trial than those on haloperidol @ % vs. @ % ; P @ ; @ ) .\n",
            "Mean time to achieve PANSS item threshold ( ~ @ months ) and mean time spent in remission ( ~ @ months ) were similar for both groups .\n",
            "Those patients achieving remission showed significant improvement on the CGI-I at endpoint compared with non-remitters ( P @ ; @ in both groups ) .\n",
            "Significantly fewer aripiprazole-treated patients discontinued the study due to AEs compared with haloperidol-treated patients ( @ % vs. @ % , respectively P @ ; @ ) .\n",
            "Significantly fewer aripiprazole-treated patients received concomitant EPS medication compared with haloperidol-treated patients ( @ % vs. @ % , respectively ; P @ , and @ ) .\n",
            "Conclusions : Over the course of @ year , significantly more aripiprazole-treated patients with schizophrenia achieved and maintained symptomatic remission as compared with haloperidol-treated patients .\n",
            "Aripiprazole treatment was also associated with significantly fewer discontinuations due to AE-related events and lower concomitant EPS medication use suggesting that tolerability contributed to the increased remission rate among aripiprazole-treated patients .\n",
            "OBJECTIVE To explore the effects of antipsychotics on the serum prolactin of first-episode schizophrenia patients .\n",
            "METHODS @ first-episode schizophrenic patients were random divided into @ groups , treated with chlorpromazine ; risperidone and quetiapine , respectively .\n",
            "The PANSS , GAF , TESS , RSESE and PRL before treatment and at the end of @ weeks treatment were compared between groups and correlations were determined .\n",
            "RESULTS The scores of PANSS , GAF , TESS , RSESE and PRL had no differemce between groups\n",
            "Several double-blind clinical trials have reported improvement in positive , negative and cognitive symptoms of schizophrenia with raloxifene , a selective receptor estrogen modulator .\n",
            "However , there are some inconsistencies in replicating findings between studies of different countries .\n",
            "The failure to replicate these findings may result from genetic factors that could explain some of the variability in the treatment response .\n",
            "However , pharmacogenetic studies exploring this topic in women with schizophrenia are lacking .\n",
            "We aimed to conduct an exploratory pharmacogenetic analysis of a double-blind , randomized , parallel , placebo-controlled study of @ weeks ' duration of raloxifene aiming to improve negative symptoms in postmenopausal women with schizophrenia .\n",
            "Four single nucleotide polymorphisms ( SNPs ) were studied : rs@ , rs@ and rs@ in the Estrogen Receptor @ ( ESR@ ) gene , and rs@ in the UDP-glucuronosyltransferase @A@ ( UGT@A@ ) gene .\n",
            "Sixty-five postmenopausal women with schizophrenia ( DSM-IV ) were randomized to either @mg/day adjunctive raloxifene ( @ women ) or adjunctive placebo ( @ women ) .\n",
            "Psychopathological symptoms were assessed at baseline and at weeks @ , @ , and @ with the Positive and Negative Syndrome Scale ( PANSS ) .\n",
            "Of the four studied SNPs , the rs@ variant in the UGT@A@ gene was associated with a different treatment response in negative symptoms with raloxifene treatment , whereas the rs@ variant in the ESR@ gene was associated with a distinct response in general psychopathology .\n",
            "In conclusion , our study suggests that genetic variants in UGT@A@ and ESR@ genes modulate the treatment response to adding raloxifene to antipsychotic treatment in postmenopausal women with schizophrenia .\n",
            "OBJECTIVE : Schizophrenia is treated with medications that raise serum anticholinergic activity and are known to adversely affect cognition .\n",
            "The authors examined the relationship between serum anticholinergic activity and baseline cognitive performance and response to computerized cognitive training in outpatients with schizophrenia .\n",
            "METHOD : Fifty-five patients were randomly assigned to either computerized cognitive training or a computer games control condition .\n",
            "A neurocognitive battery based on the Measurement and Treatment Research to Improve Cognition in Schizophrenia ( MATRICS ) initiative was performed at baseline and after the intervention .\n",
            "Serum anticholinergic activity , measured at study entry by radioreceptor assay , was available for @ patients .\n",
            "RESULTS : Serum anticholinergic activity showed a significant negative correlation with baseline performance in verbal working memory and verbal learning and memory , accounting for @ % of the variance in these measures , independent of age , IQ , or symptom severity .\n",
            "Patients in the cognitive training condition ( N = @ ) showed a significant gain in global cognition compared to those in the control condition , but this improvement was negatively correlated with anticholinergic burden .\n",
            "Serum anticholinergic activity uniquely accounted for @ % of the variance in global cognition change , independent of age , IQ , or symptom severity .\n",
            "CONCLUSIONS : Serum anticholinergic activity in schizophrenia patients shows a significant association with impaired performance in MATRICS-based measures of verbal working memory and verbal learning and memory and is significantly associated with a lowered response to an intensive course of computerized cognitive training .\n",
            "These findings underscore the cognitive cost of medications that carry a high anticholinergic burden .\n",
            "The findings also have implications for the design and evaluation of cognitive treatments for schizophrenia .\n",
            "Background : F@ is a new highly potent preferential D@ antagonist , @-HT@A partial agonist with @x lower affinity for the dopamine receptor D@ .\n",
            "F@ has demonstrated antipsychotic-like activity in animal models of positive symptoms of schizophrenia and blocked completely MK-@-induced social interaction deficits showing potential efficacy against negative symptoms .\n",
            "F@ had also promnesic actions in preclinical tests like reversal of scopolamine effect .\n",
            "Phase @ studies performed in healthy volunteers characterised the PK profile and showed a good safety and tolerability profile .\n",
            "A PET-scan study in healthy volunteers after single oral administration determined a high D@ occupancy rate up to @h after a single dose with negligible D@ receptor occupancy in the same experimental conditions .\n",
            "Methods : This double-blind , parallel group , multicenter study included @ patients with acute exacerbation of schizophrenia treated either with F@ fixed dose @ mg ( @ mg bid ) or placebo ( randomization @:@ ) for @ weeks as antipsychotic monotherapy .\n",
            "The primary objective was to evaluate the efficacy of @ mg/day of oral F@ in comparison to placebo .\n",
            "The primary efficacy criterion was the PANSS total score change from baseline to Day @ on the Full Anaysis Set .\n",
            "Inclusion criteria included a well-documented diagnosis of schizophrenia for a minimum of @ year , and a recent acute exacerbation characterised by a PANSS total score at screening = @ ando@ with no significant change of the PANSS positive subscore between the screening and randomisation visits and no prominent negative symptoms ; Clinical Global Impression of Severity ( CGI-S ) score = @ .\n",
            "All patients had discontinued previous treatments within the week prior to administration of study medication .\n",
            "Following screening patients were maintained in hospital till the @rd week of treatment .\n",
            "Patients who had CGI-I score of = @ after @ or @ weeks were then eligible for hospital discharge and could continue study participation as outpatients .\n",
            "Results : A total of @ patients were randomized to one of the two study treatments ( @ in each group ) .\n",
            "Male patients represented @ % of the total population ; mean ( SD ) age was @ ( @ ) years .\n",
            "The majority of patients ( @ % ) experienced schizophrenia of the paranoid type .\n",
            "Mean ( SD ) time since schizophrenia diagnosis was @ ( @ ) years .\n",
            "Baseline PANSS total score ( mean [ SD ] @ [ @ ] ) , and the sub-scores were similar between treatment groups .\n",
            "@ patients ( @ % ) discontinued the study treatment prematurely ( @ % in F@ group and @ % in the placebo group ) .\n",
            "In both groups , the major reasons for premature treatment discontinuation were lack of efficacy or worsening of schizophrenia .\n",
            "The primary analysis , on the change from baseline of PANSS total score to Day @ on the FAS ( LOCF ) , showed a statistically significant difference in favor of F@ over placebo : the adjusted mean ( SE ) change was-@ ( @ ) on F@ and-@ ( @ ) on placebo with a statistically significant treatment effect estimate-@ ( @ ) .\n",
            "Similar results were obtained on the per protocol dataset .\n",
            "Secondary criteria analyses supported the primary analysis results : the effect on the PANSS positive factor , defined by Marder , was statistically significantly greater in the F@ group than in the placebo group .\n",
            "The response rate to treatment defined as the PANSS total score reduction by @ % or @ % from baseline to end of treatment , was statistically higher in the F@ group ( @ % and @ % ) compared to the placebo group ( @ % and @ % ) .\n",
            "A similar proportion of patients in the F@ and placebo groups had at least one intake of any authorised adjunctive benzodiazepine ( lorazepam or oxazepam ) during study treatment ( @ % and @ % , respectively ) .\n",
            "The overall incidence of treatment-emergent adverse events ( TEAEs ) was slightly higher in the F@ group ( @ % ) than in the placebo group ( @ % ) .\n",
            "The most frequently reported TEAEs ( @ % of patients in either group ) with a higher incidence on F@ than on placebo ( @-patient difference ) were worsening of chizophrenia , insomnia , agitation , akathisia , and increase in triglycerides .\n",
            "Most TEAEs were reported with a mild or moderate severity .\n",
            "There were no clinically-relevant hepatic , metabolic including no clinically relevant weight gain , or cardio-vascular disorders .\n",
            "No EPS was reported under F@ ; AEs leading to definitive study drug discontinuation were lower in the F@ group than the placebo group ( @ % vs. @ % , respectively ) .\n",
            "Conclusions : This is the first compound with robust D@ receptor selectivity that demonstrates antipsychotic efficacy and indicates the value of the D@ receptor as a therapeutic target .\n",
            "The results of this phase @ study also show the favorable safety profile of F@ when compared to placebo .\n",
            "Future studies will examine the therapeutic dose range and comparative efficacy to other atypical antipsychotics .\n",
            "Background : Deficient signaling through the N-methyl-D-aspartate ( NMDA ) receptor has been hypothesized to be a key factor underlying many signs and symptoms of schizophrenia .\n",
            "Thus , increasing NMDA receptor function pharmacologically is thought to compensate for the deficient receptor signaling and to provide a way to better manage the symptoms of schizophrenia .\n",
            "Targeting the allosteric glycine site of the NMDA receptor has been proposed as an approach to enhance NMDA receptor functioning .\n",
            "RG@ is a potent and non-competitive inhibitor of glycine transporter type @ ( GlyT@ ) with more than @ - fold selectivity for human GlyT@ versus GlyT@ , and at least @-fold greater selectivity over other targets .\n",
            "Preclinically , RG@ shows efficacy in assays of NMDA receptor functioning and schizophrenia models , and increases cerebrospinal fluid glycine levels in a dosedependent fashion .\n",
            "Methods : The effects of RG@ on negative symptoms of schizophrenia were investigated in a Phase IIb proof-of-concept study .\n",
            "Clinically stable patients with predominant negative symptoms were randomized equally to @ weeks of treatment with three doses of RG@ ( @ mg , @ mg , @ mg ) or placebo once daily as adjunct to ongoing treatment with second-generation antipsychotics .\n",
            "Efficacy parameters were change from baseline in Positive and Negative Syndrome Scale ( PANSS ) negative symptom factor score ( NSFS ) ,@ proportion of responders defined as patients showing Z@ % improvement in NSFS , and Clinical Global Impression ( CGI ) - Improvement in Negative Symptoms .\n",
            "Functional effects were assessed with the Personal and Social Performance ( PSP ) scale .\n",
            "Populations analyzed included S@ ACNP @th Annual Conference intent-to-treat ( ITT ) and per protocol ( PP ; patients who completed @ weeks of treatment without any major protocol violations ) .\n",
            "Results : @ patients were randomized ( male , @ % ; Caucasian , @ % ; mean age , @   @ [ SD ] years ; mean duration of illness , @   @ years ; PANSS total , @   @ ; PANSS NSFS , @   @ ; PANSS positive symptom factor score , @   @ ) .\n",
            "The ITT population included @ patients and the PP population @ patients ( placebo , n  @ ; @ mg , n  @ ; @ mg , n  @ ; @ mg , n  @ ) .\n",
            "Overall , efficacy parameters were consistently improved in the @ mg dose group , to a lesser extent in the @ mg dose group and not so in the @ mg dose group .\n",
            "The NSFS showed a significantly greater decrease from baseline in the @ mg and @ mg dose groups ( D in both dose groups  @ % ) than in the placebo group ( D  @ % ) in the PP population ( @ mg , p  @ ; @ mg , p  @ ) at week @ .\n",
            "In the ITT population , the reduction in NSFS was slightly weaker and approached significance at endpoint in both dose groups ( @ mg : p  @ ; @ mg : p  @ ) .\n",
            "Effect sizes were B@ .@ for both dose groups in both populations .\n",
            "The percentage of responders in the PP population was significantly higher in the @ mg dose group than in the placebo group ( @ % vs @ % ; p  @ ) .\n",
            "The same measure approached significance in the ITT population ( @ % vs @ % ; p  @ ) .\n",
            "Differences in the distribution of the CGI-Improvement in Negative Symptoms were significant between the @ mg dose group and the placebo group in both populations ( ITT , p  @ ; PP , p  @ ) as more patients in the @ mg dose group were rated as   much improved   or   very much improved   than in the placebo group at endpoint .\n",
            "The same comparison approached significance for the @ mg dose group in the PP population ( p  @ ) .\n",
            "Compared with placebo , there was a trend towards functional improvement as evidenced by an increase in PSP score from baseline to week @ in the @ mg dose group in the PP population ( p  @ ) .\n",
            "The @ mg dose group did not differ from placebo in any outcome measure .\n",
            "RG@ was well tolerated .\n",
            "The percentage of patients withdrawn due to adverse events ranged from @ % ( placebo ) to @ % ( @ mg ) .\n",
            "The percentage of withdrawals for any reason was similar in all four treatment groups ( @-@ % ) .\n",
            "Discussion : RG@ demonstrated a consistent and clinically meaningful reduction in negative symptoms that was accompanied by the emergence of a positive effect on functionality .\n",
            "This proof-of-concept study provides clinical support for glycine reuptake inhibition and enhancement of NMDA signaling as a therapeutic approach for negative symptoms in patients with schizophrenia , further strengthening the NMDA hypothesis of schizophrenia .\n",
            "Additionally , to our knowledge RG@ is the first compound in clinical development to demonstrate convincing efficacy against negative symptoms .\n",
            "If these findings are confirmed in Phase III trials , this agent has the potential to expand the therapeutic options for patients with schizophrenia .\n",
            "Does the use of Clozapine or Olanzapine have an affect on the rate of sucidality in patients with schizophrenia/schizoaffective disorder ?\n",
            "Patients will be randomised to one of the two study drugs , given at BNF recommended doses .\n",
            "Blood will be taken at onset , wk @ , wk @ and analysed for standard biochem and haem testing .\n",
            "Patients on clozapine - blood will be taken weekly to week @ and then fortnightly until the end of the study .\n",
            "Patients on olanzapine will have vital signs taken weekly to week @ then fortnightly to week @ .\n",
            "Psychiatric tests , calgary depression scale , extra pyramidal rating scale , positive and negative symptom scale will be carried out blinded and unblinded by study staff at intervals varing from @-@ weeks .\n",
            "Nurses will see patients weekly for the first @ months then fortnightly until completion of the trial .\n",
            "Nurses will also be available to support the patients , carers and families throughout the study .\n",
            "People diagnosed with schizophrenia with a history of self harm or thoughts of self harm .\n",
            "World Wide @ .\n",
            "Hull Study Centre between @-@ .\n",
            "Sample to be derived from referral .\n",
            "Biochemical/haemological tests .\n",
            "STandardised Psychiatric Quesitonnaire scores\n",
            "Cognitive behaviour therapy in addition to neuroleptic drugs ( CBT ) has been found significantly more effective than care as usual in patients with ( therapy refractory ) positive psychotic symptoms .\n",
            "British studies have focussed mainly on delusions , our Dutch study was aimed at hallucinations .\n",
            "Former studies relied heavily on CBT , whilst the latter was more comprehensive and eclectic ( CBT ) .\n",
            "CBT programmes have a major impact on the target symptom , but show little generalisation of effect to hallucinations and daily activities ( Kuipers a.o. @ ; Tarrier a.o. @ ) .\n",
            "The CBT programme ( means Psycho education and Coping Training of patient and relatives ) focussed on auditory hallucinations and resulted in significant reduction ( @ % of the target symptom ( @ % completely free ) and generalisation in terms of improved daily activities , and substantial reduction in anxiety and thought disturbances in addition to ( Jenner a.o. @ ) .\n",
            "The average percentage of patients that suffered from considerable anxiety , loss of control and interference with thinking and daily activities dropped from @ % to @ % .\n",
            "Discussion : CBT can reduce positive psychotic symptoms significantly , even when they seem therapy refractory .\n",
            "Differences in outcome may be due to therapy factors such as differences in target symptom , comprehensiveness and eclecticism of the programme and other factors such as organisation of health care and social security systems .\n",
            "Further research on long term effects and causal factors is in progress .\n",
            "This study is a DOUBLE blind randomized controlled trial comparing zuclopenthixol acetate to haloperidol administered paarenterally initially and followed by oral medication for @ days in the treatment of acute psychosis .\n",
            "The sample included @ patients with schizophrenia , schizophreniform disorder and substance-induced psychotic disorder who required acute neuroleptic treatment .\n",
            "The patients were assessed using the Brief Psychiatric Rating Scale ( BPRS ) , Clinical Global Improvement Scale ( CGI ) and the Simpson Angus Scale ( SAS ) .\n",
            "While patients in both groups improved on all outcome measures , there was no significant differences between the two agents in terms of either efficacy or tolerability .\n",
            "Background : Cognitive enhancement has been demonstrated with novel antipsychotic medications .\n",
            "The duration of these studies has been quite short and there is no information available about the long-term cognitive-enhancing effects of these medications .\n",
            "Methods : Three hundred sixty-seven clinically stable community-dwelling patients with schizophrenia were randomised to @ year 's treatment with risperidone or haloperidol .\n",
            "The patients were examined at @ and @ weeks after baseline with assessment of clinical symptoms and cognitive functioning .\n",
            "Rates of relapse were also examined .\n",
            "Results : @ subjects completed the @-week protocol , while @ % of the risperidone patients and @ % of the haloperidol patients relapsed ( p < .@ ) .\n",
            "Total learning on the California Verbal Learning Test was the one aspect of cognitive functioning that was significantly enhanced by treatment with risperidone at both @ and @ weeks ( p < .@ ) .\n",
            "At @ weeks , @ % of the patients treated with risperidone improved by more than @ SD on this index of learning efficiency , resulting in their having scores in the clinically normal range at the end of the study .\n",
            "Implications : In addition to preventing relapse in the stable patients with more efficiency than haloperidol , risperidone improved memory performance as well .\n",
            "This improvement was clinically as well as statistically significant , indicating that risperidone treatment improves certain aspects of cognitive functioning even in patients who are selected for the absence of notable clinical symptoms .\n",
            "Risperidone Schizophrenia : drug therapy Cognitive function\n",
            "Objective : To investigate the clinical care path of the quality of care of patients with schizophrenia .\n",
            "Methods : @ patients with schizophrenia were randomly divided into experimental group and a control group of @ cases each .\n",
            "The control group were treated with conventional general health education , the experimental group , except for the drugs , the application of clinical path to develop a detailed schedule of health education , a planned , organized the implementation of health education guidance and care of patients .\n",
            "Results : The compliance rate of the experimental group , , @ test differences significantly higher than the control group .\n",
            "OBJECTIVES : A randomized controlled study was conducted to assess the effects of case management and patients ' characteristics on the use of inpatient psychiatric services .\n",
            "METHODS : Inpatients discharged from Harlem Hospital Center in @-@ were randomly assigned to an outreach case management team or standard aftercare .\n",
            "Analysis of variance was used to assess the main effects and two - and three-way interaction effects of treatment status , gender , age , substance abuse , and diagnosis on the number of days of psychiatric rehospitalization in state and city community hospitals .\n",
            "RESULTS : In the follow-up period , @ of the @ patients in the case management group ( @ percent ) and @ of the @ patients in the control group ( @ percent ) were rehospitalized for psychiatric care .\n",
            "On average , patients spent @ days in city hospitals and @ days in state hospitals .\n",
            "Members of the case management team spent a mean total of @ hours a month in direct and indirect care for each patient .\n",
            "They spent most time with substance-abusing older women .\n",
            "Significant three-way interaction effects were found between treatment status and diagnosis and gender , diagnosis and age , and diagnosis and substance abuse on the number of days patients spent rehospitalized for psychiatric care in city and state hospitals .\n",
            "CONCLUSIONS : It is unlikely that case management intervention will reduce rehospitalization rates unless appropriate and effective outpatient and community services are available .\n",
            "Effective surveillance of patient populations by case managers frequently results in rehospitalization as the only treatment alternative if other options for meeting the needs and resolving the crises of patients are not available .\n",
            "Findings from the Psychiatric Genomics Consortium genome-wide association study ( GWAS ) showed that variation at the DRD@ locus is associated with schizophrenia risk .\n",
            "However , the functional significance of rs@ , the top DRD@ single nucleotide polymorphism in the GWAS , is unknown .\n",
            "Dopamine D@ receptor binding is a common mechanism of action for all antipsychotic drugs , and DRD@ variants were related to antipsychotic response in previous studies .\n",
            "The present study examined whether rs@ genotype could predict antipsychotic response , including efficacy and adverse events , in a cohort of patients with first episode of psychosis treated with either risperidone or aripiprazole for @ weeks .\n",
            "Subjects were genotyped using the Illumina Infinium HumanOmniExpressExome array platform .\n",
            "After standard quality control , data from @ subjects ( @ randomly assigned to treatment with aripiprazole and @ assigned to risperidone ) was available for analysis .\n",
            "Subjects were assessed for psychotic symptomatology and medication-related adverse events weekly for @ weeks , then biweekly for @ weeks .\n",
            "Linear mixed model analysis revealed that the homozygotes for the risk ( C ) allele at rs@ had significantly greater reduction in positive symptoms during @ weeks of treatment compared to the T allele carriers .\n",
            "In the aripiprazole group , C/C homozygotes also reported more akathisia than the T allele carriers , while in the risperidone group , male T allele carriers demonstrated greater prolactin elevations compared to male C/C homozygotes .\n",
            "These findings suggest that the schizophrenia risk variant at the DRD@ locus ( or another variant in close proximity ) is associated with observable differences in response to treatments which reduce striatal dopamine signaling .\n",
            "Last Refresh Date@ March @ / / Primary Sponsor : GVK BIOSCIENCES PVT LTD / / Registration Date : @-@-@ / / Export Date : @/@/@ @:@:@ PM / / Recruitment Status : Not Recruiting / / Date Enrollement : @-@-@ / / Target Size : @ / / Inclusion Criteria : @ .\n",
            "Physically healthy male and female Schizophrenic patients of and above @ years of age as certified by physician .\n",
            "@ .\n",
            "Confirmed diagnosed patient of Schizophrenia as defined by DSM-IV criteria .\n",
            "@ .\n",
            "Subjects with a BMI between @ to @ Kg/m@ ( including both ) .\n",
            "@ .\n",
            "Subjects with clinically acceptable physical health as determined by personal medical history , clinical examination , and laboratory examinations including serological tests mentioned in Table below .\n",
            "@ .\n",
            "Subjects having normal @-lead electrocardiogram ( ECG ) as certified by physician .\n",
            "@ .\n",
            "Subjects having normal chest X-Ray ( P/A view ) .\n",
            "@ .\n",
            "Schizophrenic patients ( DSM-IV criteria ) already receiving quetiapine in a stable regimen at least for @ weeks prior to screening .\n",
            "@ .\n",
            "Subjects able to communicate effectively .\n",
            "@ .\n",
            "Subjects willing to give written informed consent along with legally acceptable representative ( where applicable ) willing to give the consent and adhere to all the requirements of this protocol .\n",
            "@ .\n",
            "Female subjects who are - postmenopausal or - surgically sterile or - practicing an acceptable method of birth control for the duration of the study as judged by the investigator ( s ) , such as condoms , foams , jellies , diaphragm , intrauterine device ( IUD ) or abstinence / / Exclusion Criteria : @ .\n",
            "Subjects having contraindications or hypersensitivity to Quetiapine or related group of drugs .\n",
            "@ .\n",
            "History or presence of significant cardiovascular , pulmonary , hepatic , renal , endocrine , immunological , dermatological , neurological disease or disorder .\n",
            "@ .\n",
            "Subjects having clinically significant gastrointestinal pathology .\n",
            "@ .\n",
            "Subjects having Total Blood cell count below @/cmm , Absolute Neutrophil count below @/cmm @ .\n",
            "History or presence of significant alcoholism or drug abuse in the past one year .\n",
            "@ .\n",
            "History or presence of significant smoking ( more than @ cigarettes or bidis/Day or consumption of tobacco products ) .\n",
            "@ .\n",
            "Difficulty with donating blood .\n",
            "@ .\n",
            "Difficulty in swallowing solids like tablets or capsules .\n",
            "@ .\n",
            "Subjects having Systolic Blood Pressure _ ?\n",
            "_ @ mm Hg .\n",
            "@ .\n",
            "Subjects having Diastolic Blood Pressure _ ?\n",
            "_ @ mm Hg .\n",
            "@ .\n",
            "Patient prone to postural hypotension - Drop in Systolic Pressure by @ mm of Hg or Diastolic pressure by @ mm of Hg with change in posture .\n",
            "@ .\n",
            "Subjects with QTc @ ms in screening ECG .\n",
            "@ .\n",
            "A depot neuroleptic drugs within @ months prior to administration of study medication .\n",
            "@ .\n",
            "Use of any of the following cytochrome P@ @A@ inhibitors in the @ Days preceding enrolment including but not limited to : ketoconazole , itraconazole , fluconazole , erythromycin , clarithromycin , troleandomycin , indinavir , nelfinavir , ritonavir , fluvoxamine and saquinavir .\n",
            "@ .\n",
            "Use of any of the following significant cytochrome P@ inducers in the @ Days preceding enrolment , including but not limited to : phenytoin , carbamazepine , barbiturates , rifampin , St. Johns Wort , and glucocorticoids .\n",
            "@ .\n",
            "Patients who are currently receiving : monoamine oxidase inhibitors , tricyclic antidepressants , oral neuroleptics ( other than Quetiapine , Lithium carbonate , Risperidone and Haloperidol ) , or type @C anti-arrhythmics within two weeks of screening ; herbal psychoactive treatments ( St. Johns Wort , Kava Kava , Gingko Biloba ) from at least @ Days preceding enrolment .\n",
            "@ .\n",
            "Major illness during @ months before screening .\n",
            "@ .\n",
            "Participation in a drug research study within past @ months .\n",
            "@ .\n",
            "Donation of blood in the past @ months before screening .\n",
            "@ .\n",
            "Female subjects demonstrating a positive pregnancy screen .\n",
            "@ .\n",
            "Female subjects who are currently breast-feeding .\n",
            "@ .\n",
            "Female subjects with child bearing potential using prohibited contraceptive method ( Oral , Injectable or Implantable hormonal agents ) .\n",
            "@ .\n",
            "Presence of neurological disorders , including organic mental disorder , severe\n",
            "Objective : To investigate the impact of rehabilitation training on the social function of long-term hospitalization of schizophrenic patients .\n",
            "Will meet the standard method : @ patients were randomly divided into the study group and the control group , and @ months of rehabilitation training on the basis of the conventional drug therapy , the patients of the study group at the same time , while the control group using traditional mode of treatment and care , , respectively , prior to the study , research , June @ at the end of the use of nurse inpatient observation Scale ( nosie ) and inpatient rehabilitation effects rating scale ( ipros ) were assessed .\n",
            "Results : training in December after two groups nosie , ipros significant difference ( p < @ , p < @ ) scores .\n",
            "Conclusion : The rehabilitation training to improve the patient 's social function , effective measures to promote the rehabilitation of chronic schizophrenic patients .\n",
            "Purpose - Policy makers and consumers are increasingly concerned about the quality and efficiency of care provided to individuals with severe , chronic illnesses such as schizophrenia .\n",
            "These illnesses are expensive to treat and present significant challenges to organizations that are responsible for providing effective care .\n",
            "Occurring in @ % of the United States population , schizophrenia accounts for @ % of permanently disabled people , and @ % of all healthcare expenditures .\n",
            "Clinical practice guidelines have been promulgated .\n",
            "Schizophrenia is treatable and outcomes can be substantially improved with the appropriate use of antipsychotic medication , caregiver education and counseling , vocational rehabilitation , and assertive treatment .\n",
            "However , in the VA and other mental health systems , many patients with schizophrenia receive substandard care .\n",
            "Methods are needed that improve the quality of usual care for this disorder while being feasible to implement at typical clinics .\n",
            "To date , most efforts to improve care for schizophrenia have focused on educating clinicians or changing the financing of care , and have had limited success .\n",
            "We believe a more fundamental approach should be tried .\n",
            "While there are many potential strategies , experience in chronic medical illness and mental health support the efficacy of specific approaches .\n",
            "Collaborative care models are one such approach .\n",
            "They are a blueprint for reorganizing practice , and involve changes in division of labor and responsibility , adoption of new care protocols , and increased attention to patients ' needs .\n",
            "Although collaborative care models have been successful in other chronic medical conditions , they have not yet been studied in the treatment of schizophrenia .\n",
            "We have developed a collaborative care model for schizophrenia that builds on work in other disorders , and includes service delivery approaches that are known to be effective in schizophrenia .\n",
            "The model focuses on improving treatment through assertive care management , caregiver education and support , and standardized patient assessment with feedback of information to psychiatrists .\n",
            "This project , \" EQUIP \" ( Enhancing Quality Utilization In Psychosis ) is implementing collaborative care and evaluating its effectiveness in schizophrenia .\n",
            "Condition Intervention Schizophrenia Disorders Chronic Illness Schizoaffective Disorder Weight Gain Procedure - Collaborative Chronic Illness Model Primary Outcome Measures - At @ mo. - Provider attitudes on controlling symptoms & side-effects , & on family involvement Patient clinical outcomes Throughout the study - Patient compliance Provider practice patterns & adherence to VA guidelines Patient utilization Secondary Outcome Measures - Process assessment throughout the course of the study of barriers and facilitators to the intervention 's implementation Total Enrollment - @ Study start - January @ ; Study completion - December @ Background - Policy makers and consumers are increasingly concerned about the quality and efficiency of care provided to individuals with severe , chronic illnesses such as schizophrenia .\n",
            "These illnesses are expensive to treat and present significant challenges to organizations that are responsible for providing effective care .\n",
            "Occurring in @ % of the United States population , schizophrenia accounts for @ % of permanently disabled people , and @ % of all healthcare expenditures .\n",
            "Clinical practice guidelines have been promulgated .\n",
            "Schizophrenia is treatable and outcomes can be substantially improved with the appropriate use of antipsychotic medication , caregiver education and counseling , vocational rehabilitation , and assertive treatment .\n",
            "However , in the VA and other mental health systems , many patients with schizophrenia receive substandard care .\n",
            "Methods are needed that improve the quality of usual care for this disorder while being feasible to implement at typical clinics .\n",
            "To date , most efforts to improve care for schizophrenia have focused on educating clinicians or changing the financing of care , and have had limited success .\n",
            "We believe a more fundamental approach should be tried .\n",
            "While there are many potential strategies , experience in chronic medical illness and mental health support the efficacy of specific approaches .\n",
            "Collaborative care models are one such approach .\n",
            "They are a blueprint for reorganizing practice , and involve changes in division of labor and responsibility , adoption of new care protocols , and increased attention to patients ' needs .\n",
            "Although collaborative care models have been successful in other chronic medical conditions , they have not yet been studied in the treatment of schizophrenia .\n",
            "We have developed a collaborative care model for schizophrenia that builds on work in other disorders , and includes service delivery approaches that are known to be effective in schizophrenia .\n",
            "The model focuses on improving treatment through assertive care management , caregiver education and support , and standardized patient assessment with feedback of information to psychiatrists .\n",
            "This project , \" EQUIP \" ( Enhancing Quality Utilization In Psychosis ) is implementing collaborative care and evaluating its effectiveness in schizophrenia .\n",
            "Objectives - The objective of this project is to implement the care model at two large VA mental health centers , and evaluate its effect on clinicians , the organization of care , and treatment appropriateness , utilization and outcomes in veterans with schizophrenia .\n",
            "We hypothesize that this care model will increase provider adherence to treatment guidelines and improve the quality of care .\n",
            "We will describe implementation of the model , and barriers and facilitators to its implementation .\n",
            "We will evaluate the model by comparing treatment under the care model with usual care .\n",
            "Changes in the structure of care are evaluated using qualitative methods .\n",
            "Methods - EQUIP is a controlled trial of the care model .\n",
            "Psychiatrists are randomly assigned to the new care model or to remain with usual care .\n",
            "Data sources include patient interviews , clinician interviews , and data from VistA .\n",
            "The feasibility of more broadly implementing the collaborative care model is assessed utilizing qualitative and quantitative information about the model 's strengths and weaknesses , factors that facilitated/impeded implementation , direct costs of implementation and maintenance , and effects on treatment service utilization .\n",
            "Status - The care model was implemented for more than @ months at two sites - Greater Los Angeles ( GLA ) and Long Beach VA Healthcare Centers .\n",
            "The Long Beach Mental Health Clinic had both intervention and usual care psychiatrists .\n",
            "At GLA , the Sepulveda Mental Health Clinic had both intervention and usual care psychiatrists , and the West Los Angeles Mental Health Clinic had usual care psychiatrists .\n",
            "All eligible psychiatrists except one were enrolled ( n = @ ) .\n",
            "@ patients enrolled , with approximately @ in the intervention group .\n",
            "A computer system was developed to manage the research study and support the collaborative care model .\n",
            "Called the \" Medical Informatics Network Tool \" ( MINT ) , it was implemented for all intervention clinicians , and is also used by research staff to manage enrollment and project data .\n",
            "Research assessments of patients and providers have been conducted at baseline , and the final research assessments and data analyses are underway .\n",
            "Eligibility - Ages Eligible for Study - @ Years and above , Genders Eligible for Study - Both Criteria Inclusion Criteria - Providers ( Psychiatrists , Case Managers , Nurses ) - Working at one of the participating VA Mental Health Clinics Providers - @ Patients - @ Patients - At least @ years old Diagnosis of Schizophrenia , Schizoaffective , or schizophreniform disorder At least @ treatment visits with a psychiatrist at the clinic during the previous @ months .\n",
            "Exclusion Criteria - None\n",
            "There is considerable evidence that adding selective serotonin reuptake inhibitor ( SSRI ) antidepressants to antipsychotic treatment improves negative symptoms of schizophrenia .\n",
            "This augmentation effect may be due to \" nonspecific \" antidepressant action or be specifically related to action on the serotonergic system .\n",
            "This study examined the serotonergic specificity of SSRI augmentation by comparing an SSRI antidepressant with a comparably effective antidepressant acting via the noradrenergic system .\n",
            "Consenting patients having chronic schizophrenia with prominent negative symptoms were studied .\n",
            "Either fluvoxamine or maprotiline was added to their regular antipsychotic treatment in a double-blind manner for @ weeks .\n",
            "Patients were assessed using the Brief Psychiatric Rating Scale ( the Scale for the Assessment of Negative Symptoms , the Scale for the Assessment of Positive Symptoms , the Montgomery-Asberg Depression Rating Scale ( MADRS ) , and the Neurological Rating Scale for Extrapyramidal Side Effects .\n",
            "Twenty-five patients completed the study .\n",
            "Negative symptoms improved significantly in the fluvoxamine group , but not in the maprotiline group .\n",
            "MADRS scores , which were low , did not change significantly in either group .\n",
            "Positive symptoms were not affected by either treatment .\n",
            "It is concluded that the mechanism by which fluvoxamine augmentation improves negative symptoms involves the serotonergic system and is distinct from its antidepressant action . )\n",
            "BACKGROUND : Deficits in social cognition and neurocognition are believed to underlie schizophrenia disability .\n",
            "Attempts at rehabilitation have had circumscribed effects on cognition , without concurrent improvement in broad aspects of behavior and adjustment .\n",
            "OBJECTIVE : To determine the differential effects of cognitive enhancement therapy ( a recovery-phase intervention ) on cognition and behavior compared with state-of-the-art enriched supportive therapy .\n",
            "DESIGN : A @-year , randomized controlled trial with neuropsychological and behavioral assessments completed at baseline and at @ and @ months .\n",
            "SETTING : An outpatient research clinic housed in a medical center 's comprehensive care service for patients with severe mental illness .\n",
            "PATIENTS : A total of @ symptomatically stable , non-substance-abusing but cognitively disabled and chronically ill patients with schizophrenia or schizoaffective disorder .\n",
            "INTERVENTIONS : Cognitive enhancement therapy is a multidimensional , developmental approach that integrates computer-assisted training in neurocognition with social cognitive group exercises .\n",
            "Enriched supportive therapy fosters illness management through applied coping strategies and education .\n",
            "MAIN OUTCOME MEASURES : Six highly reliable summary measures -- Processing Speed , Neurocognition , Cognitive Style , Social Cognition , Social Adjustment and Symptoms -- were tested using analysis of covariance and linear trend analysis .\n",
            "RESULTS : At @ months , robust cognitive enhancement therapy effects were observed on the Neurocognition and Processing Speed composites ( P < .@ ) , with marginal effects observed on the behavioral composites .\n",
            "By @ months , differential cognitive enhancement therapy effects were again observed for the @ neuropsychological composites and for Cognitive Style ( P = .@ ) , Social Cognition ( P = .@ ) , and Social Adjustment ( P = .@ ) .\n",
            "As expected , no differences were observed on the residual Symptoms composite .\n",
            "Effects were unrelated to the type of antipsychotic medication received .\n",
            "Enriched supportive therapy also demonstrated statistically significant within-group effect sizes , suggesting that supportive psychotherapy can also have positive , although more modest , effects on cognitive deficits .\n",
            "CONCLUSION : Many cognitive deficits and related behaviors of patients with stable schizophrenia are improved when sufficient exposure to relevant rehabilitation is provided\n",
            "Objective : Outcomes for negative symptoms over a one-year period were examined in two groups of patients , one receiving psychoeducational multiple - family group treatment and one receiving standard care .\n",
            "Methods : A total of @ outpatients , ages @ to @ years , with DSM-IV diagnoses of schizophrenic disorders were randomly assigned to standard care or multiple-family group psychoeducation treatment at a large mental health center in Spokane , Washington .\n",
            "Treatment assignment was stratified by whether patients were taking typical or atypical antipsychotic medications .\n",
            "Negative symptom status was monitored monthly for one year by raters blind to group assignment and measured as a composite of five symptoms using the Modified Scale for the Assessment of Negative Symptoms .\n",
            "Results : When the analysis controlled for baseline negative symptoms , participants in the multiple-family group experienced significantly reduced negative symptoms compared with those receiving standard care .\n",
            "Taking atypical antipsychotic medication or having a diagnosis of substance abuse was not associated with the severity of negative symptoms .\n",
            "An additional analysis of the five individual negative symptoms indicated small but consistent group differences on all dimensions except inattention .\n",
            "Negative symptoms were significantly correlated with relapse to acute illness but not with outpatient or inpatient service use .\n",
            "Conclusions : The study demonstrated that a psychoeducational multiple-family group intervention was more effective than standard care in managing negative symptoms over a @-month period .\n",
            "The results are particularly relevant because negative symptoms are associated with relapse , poor social and occupational functioning , cognitive impairment , and lower subjective quality of life .\n",
            "Depressive symptoms are common in schizophrenia and are associated with a worse outcome , impaired social and vocational functioning , poor quality of life and an increased risk of relapse and suicide .\n",
            "The introduction of atypical antipsychotics raises the question whether they improve depressive symptoms to a greater extent than classical neuroleptics .\n",
            "Amisulpride is an atypical antipsychotic that has proven efficacy in patients with acute exacerbations of schizophrenia as well as in patients with predominant negative and mixed symptoms .\n",
            "The Brief Psychiatric Rating Scale ( BPRS ) anxiety/depression subscore ( sum of items @ , @ , @ , @ and @ ) has been used to assess depressive symptoms in a pooled analysis of three , short-term ( @ weeks ) , double-blind studies ( n = @ ) comparing amisulpride ( @ mg/day , n = @ ) with haloperidol ( @ mg/day , n = @ ) and risperidone ( @ mg/day , n = @ ) in the treatment of acute exacerbations of schizophrenia ( Mller et al. , @ , Peuskens et al. @ , Puech et al. , @ ) .\n",
            "Treatments were given orally following a placebo wash-out phase of up to @ days .\n",
            "Patients were @  @ years old on average and suffered from paranoid ( @ % ) , disorganised ( @ % ) or undifferentiated ( @ % ) schizophrenia for more than @ years .\n",
            "At endpoint , the mean anxiety/depression subscore improvement showed a significant ( p = @ ) difference in favour of amisulpride ( @  @ ) compared with haloperidol ( @  @ ) and risperidone ( @  @ ) .\n",
            "This advantage in favour of amisulpride was significant from the second week of treatment ( p = @ ) .\n",
            "In a subpopulation ( n = @ ) of severe patients ( subscore > @ at baseline ) , the difference was significant ( p = @ ) and in favour of amisulpride ( @  @ ) compared to haloperidol ( @  @ ) and risperidone ( @  @ ) .\n",
            "Amisulpride improves depressive symptoms to a significantly greater extent than the conventional antipsychotic haloperidol and the atypical antipsychotic risperidone .\n",
            "As amisulpride appears to possess a therapeutic activity against depressive symptoms , treatment with amisulpride holds the possibility for improved patient outcome .\n",
            "Background : Evidence over the past @ years has shown that that @-@ % of individuals with schizophrenia exhibit profound neurocognitive deficits ( e.g. , Reichenberg & Harvey , @ ) .\n",
            "Particular significance has been attached to these deficits as they have been linked to poorer progress in well-grounded and rigorously tested social skills training programs ( e.g. , Kopelowicz et al. , @ ) , that are a primary treatment modality for individuals with the disorder ( Dixon et al. , @ ) , and that have been shown to reliably improve psychosocial function ( Kurtz & Mueser , @ ) .\n",
            "To evaluate whether cognitive remediation can enhance response to social skills training , we investigated the effects of a standardized , comprehensive , drill-andpractice cognitive remediation training program similar to that studied in our previous work ( Kurtz et al. , @ ) when administered as an adjunctive intervention to an extended course of social skills training , on measures of psychosocial function in individuals with schizophrenia .\n",
            "Methods : A prospective , randomized design was selected .\n",
            "Forty-nine participants were assigned to either a standardized cognitive remediation program , or a closely matched , computer-skills control condition .\n",
            "All participants received a @-month program of SST administered twice weekly and consisting of basic communication and conversation skills , assertiveness and friendship skills .\n",
            "Participants were assessed with proximal measures of cognitive function , intermediate measures of performance-based psychosocial skills , and distal measures of third-party rated community function both before and after the interventions .\n",
            "Results : Consistent with our prior work , CR produced improvement in elementary measures of working memory relative to the active control condition .\n",
            "More distal measures of third-party rated psychosocial functioning also showed more improvement in the cognitively-trained group , relative to the group administered SST treatment without remediation .\n",
            "Conclusion : These findings support the idea that amelioration of cognitive deficits in schizophrenia may improve treatment response to evidence-based behavioral interventions such as SST .\n",
            "Durability of effects remains an important area of future study .\n",
            "Phencyclidine ( PCP ) induces a psychotic state closely resembling schizophrenia in normal individuals .\n",
            "PCP and related agents induce their unique behavioral effects by blocking neurotransmission mediated at N-methyl-D-aspartate ( NMDA ) - type glutamate receptors , indicating that dysfunction of NMDA receptor-mediated neurotransmission may play a crucial role in the pathophysiology of schizophrenia .\n",
            "NMDA receptors are activated by the amino acids glutamate and glycine , working at independent binding sites .\n",
            "Glutamate can not be administered exogenously because of excitotoxicity .\n",
            "In contrast , glycine administered exogenously may potentiate NMDA receptor-mediated neurotransmission in vivo following peripheral administration .\n",
            "In rodents , glycine is effective in elevating brain glycine levels and reversing PCP-induced hyperactivity at doses of @ g/kg and above .\n",
            "Three studies have now been completed utilizing moderate to high ( @-@ g/kg/day ) doses of glycine , added to neuroleptics , for the treatment of schizophrenia .\n",
            "Across studies , @ to @ percent improvement in negative symptoms was observed with no corresponding worsening of positive symptoms .\n",
            "Although preliminary , these studies indicate that dietary supplementation with glycine or treatment with other glycinergic agents may be effective in the treatment of schizophrenia .\n",
            "Objective : Atypical antipsychotics are increasingly drugs of first choice in schizophrenia .\n",
            "Amisulpride , a new atypical antipsychotic , is reported to be effective for both positive and negative symptoms of schizophrenia in Western countries but Indian experience is limited .\n",
            "The aim of the present study was therefore to conduct a trial of amisulpride versus olanzapine in Indian schizophrenia patients .\n",
            "Methods : Eighty adult patients of either sex were randomized to receive standard doses of the two drugs orally , in a single blind manner , for @ weeks , with follow up at @ and @ weeks .\n",
            "Effectiveness was assessed by changes in scores on the Brief Psychiatric Rating Scale ( BPRS ) , Scale for Assessment of Positive Symptoms ( SAPS ) , Scale for Assessment of Negative Symptoms ( SANS ) , and physician-administered Clinical Global Impression ( CGI ) scale .\n",
            "Tolerability was assessed by treatment-emergent adverse drug reactions ( ADRs ) .\n",
            "Results : Evaluable were @ patients on amisulpride and @ on olanzapine .\n",
            "The groups were comparable at baseline with respect to demographics , illness duration and rating scores .\n",
            "Final BPRS score was lower for olanzapine ( @ + / - @ ) than for amisulpride ( @ + / - @ ) .\n",
            "SAPS and SANS scores and CGI rating improved individually in both arms but remained comparable between groups throughout the study period , but olanzapine reduced SAPS score to a greater extent .\n",
            "ADRs were encountered in @ % and @ % of patients ( p = @ ) on amisulpride and olanzapine , respectively .\n",
            "Tremor and insomnia were more frequent with amisulpride , while olanzapine caused more weight gain and sedation .\n",
            "No serious ADRs occurred .\n",
            "Conclusions : Amisulpride , although comparable to olanzapine on some measures , did not match the improvement seen with the latter drug in BPRS and SAPS scores .\n",
            "Despite differences in ADR profiles , overall tolerability was satisfactory for both drugs .\n",
            "In Indian patients , amisulpride should therefore be an alternative to olanzapine to a limited extent , such as when weight gain and sedation are undesirable .\n",
            "The effectiveness of a @-week package of cognitive behaviour therapy CBT in early schizophrenia in improving clinical outcomes at @ months , and postponing relapse , was evaluated .\n",
            "A consecutive series of @ patients @ % first episode with DSM@ schizophrenia and related psychoses admitted to inpatient or acute day patient care for the first time from a catchment area of @ million were recruited .\n",
            "Patients were RANDOMISED a median of @ days after admission either to CBT plus routine care , a duration matched supportive counselling intervention SC plus routine care , a routine care alone .\n",
            "Mean baseline PANSS total score was @ .\n",
            "Reassessment at interview blind to treatment group was performed in @ % at @ months , with data on time to readmission in @ % .\n",
            "Intent to treat analysis with covariance for relevant baseline variables was done .\n",
            "Allocation to either CBT or SC groups resulted in lower scores on primary @-month outcomes of PANSS total score ps@ .@ and positive subscale score ps @ .\n",
            "There were trend advantages for CBT over SC in all measures , with CBT better then SC for auditory hallucination score ps@ .@ .\n",
            "There was no effect of experimental treatment on time to relapse or rehospitalisation .\n",
            "Per protocol analyses are being performed .\n",
            "Rates of cigarette smoking are higher in schizophrenia ( @-@ % ) than the general population ( ~ @ % ) .\n",
            "Although pharmacological and behavioral interventions have demonstrated efficacy in schizophrenia , quit rates remain low .\n",
            "rTMS has not yet been evaluated in hard-to-treat populations such as smokers with co-morbid mental illnesses .\n",
            "A @-week , randomized , double-blind , sham-controlled trial of rTMS ( @ sessions ; @ treatments/week in Weeks @-@ ) as an adjunctive to weekly group therapy and transdermal nicotine ( TN ; @ mg ) provided in Weeks was conducted in smokers with schizophrenia .\n",
            "The target quit date was the start of Week @ .\n",
            "This study has two main limitations .\n",
            "First , it was a small study resulting in modest power to detect differences between active and sham rTMS groups .\n",
            "Second , evaluation of rTMS 's effects after Week @ was limited by provision of behavioral and pharmacological interventions to both groups .\n",
            "Future research should evaluate rTMS in the absence of other interventions , after longer periods of abstinence , and in a larger number of subjects balanced for gender .\n",
            "Despite these limitations , this study represents the first evaluation of rTMS in smokers with schizophrenia .\n",
            "( PsycINFO Database Record ( c ) @ APA , all rights reserved )\n",
            "This study introduces a computerized clinical decision-support tool , the Fluid Outpatient Rehabilitation Treatment ( FORT ) , that incorporates individual and ever-evolving patient needs to guide clinicians in developing and updating treatment decisions in real-time .\n",
            "In this proof-of-concept feasibility pilot , FORT was compared against traditional treatment planning using similar behavioral therapies in @ adults with severe mental illness attending community-based day treatment .\n",
            "At posttreatment and follow-up , group differences and moderate-to-large effect sizes favoring FORT were detected in social function , work readiness , self-esteem , working memory , processing speed , and mental flexibility .\n",
            "Of participants who identified obtaining a General Education Diploma as their goal , @ % in FORT passed the examination compared with @ % in traditional treatment planning .\n",
            "FORT was also associated with higher agency cost-effectiveness and a better average benefit-cost ratio , even when considering diagnosis , baseline symptoms , and education .\n",
            "Although the comparison groups were not completely equivalent , the findings suggest computerized decision support systems that collaborate with human decision-makers to personalize psychiatric rehabilitation and address critical decisions may have a role in improving treatment effectiveness and efficiency .\n",
            "Objective : Brain-derived neurotrophic factor ( BDNF ) is stress-responsive and has been implicated in a number of disparate neuropsychiatric disorders .\n",
            "Glucocorticoid antagonists have been shown to have beneficial effects on mood and cognitive function in bipolar disorder but not in schizophrenia .\n",
            "The aim of the present study was to investigate BDNF levels in patients with bipolar disorder and schizophrenia before and after treatment with the glucocorticoid receptor antagonist mifepristone .\n",
            "Methods : Peripheral BDNF levels were measured in patients with bipolar disorder ( n = @ ) , schizophrenia ( n = @ ) and @ matched healthy controls following @ days of adjunctive mifepristone ( @ mg day-@ ) treatment in a double-blind , placebo-controlled crossover design study .\n",
            "Results : Baseline BDNF values were similar in both patient groups and in healthy controls .\n",
            "Following treatment with mifepristone , cortisol levels were significantly increased and BDNF levels decreased in both schizophrenia and bipolar disorder .\n",
            "A significant correlation existed between change in cortisol level and change in BDNF levels following mifepristone treatment in schizophrenia , but not in bipolar disorder .\n",
            "Conclusion : Differing BDNF responses to increasing cortisol levels between patients with schizophrenia and with bipolar disorder may reflect underlying pathophysiological mechanisms .\n",
            "Objective To investigate the aripiprazole 's efficacy and safety of treatment of female schizophrenia .\n",
            "@ female patients with schizophrenia were randomly divided into a treatment group and the control group , @ cases in each group were given aripiprazole and risperidone in the treatment were observed for six weeks , using positive and negative symptoms scale ( panss ) to evaluate the efficacy , side effects scale ( tess ) assessment of adverse reactions .\n",
            "Results after six weeks of treatment of two groups of treatment , the treatment group and the control group , @ % and @ % , respectively , the difference was not significant ( p > @ ) , the treatment group , the incidence of adverse reactions was significantly lower than the control group ( p < @ ) .\n",
            "Objective : To describe the adaptation of the Individual Placement and Support model of supported employment to individuals with a recent first episode of schizophrenia or a related psychotic disorder .\n",
            "Methods and Results : Given that the vocational goals of persons with a recent onset of schizophrenia often involve completion of schooling rather than only com petitive employment , the principles of Individual Placement and Support were ex tended to include supported education .\n",
            "This extension involved initial evaluation of the most appropriate goal for individual participants , having the IPS specialist working on placement either with the participant or directly with educational and employment settings ( depending on permitted disclosure and individual need ) , and follow-along support that included work with teachers and aid in study skills and course planning as well as typical supported employment activities .\n",
            "Work with family members also characterized this application of IPS .\n",
            "A randomized controlled trial is comparing the combination of IPS and skills training with the Workplace Fundamentals Module with the combination of brokered vocational rehabilitation and broad-based social skills training .\n",
            "Participants in the IPS condition have re turned to school , competitive work , and combined school and work with approxi mately equal frequency .\n",
            "Conclusions : IPS principles can be successfully extended to integrate supported education and supported employment within one treatment program .\n",
            "The distribu tion of return to school , work , or their combination in this group of individuals with recent-onset schizophrenia supports the view that an integrated program of sup ported education and supported employment fits this initial period of illness .\n",
            "To decrease the severity of symptoms and functional impairment in youth at high risk of developing psychosis we have established a comprehensive Group and Family-based Cognitive Behavioral Therapy Program ( GF-CBT ) .\n",
            "GF-CBT , which is grounded in theory and research on information processing in delusions , decision making , memory and behavioral change , teaches youth at-risk strategies for reducing biased information processing in order to prevent the formation of delusional beliefs .\n",
            "Families learn CBT techniques to support , encourage and maintain use of these skills at home .\n",
            "Two mixed methods studies were completed : a pilot open trial to evaluate the program 's feasibility and a pilot randomized controlled trial to evaluate its efficacy , as compared to symptom monitoring , over a @-year follow-up .\n",
            "Nineteen youth ages @-@ and @ family members participated .\n",
            "Results support the feasibility and preliminary efficacy of GF-CBT , as evidenced by high levels of program satisfaction and significant remission rates among GF-CBT participants , with the majority no longer meeting ARMS criteria post-CBT , and maintaining recovery at the follow-up .\n",
            "At post-treatment GF-CBT group showed greater decreases in positive and negative symptoms ( CAARMS ) as well as improvements in functioning ( SOFAS ) .\n",
            "The difference between groups increased over time .\n",
            "As part of the SAMHSA funded project to improve outcomes for as many as @ youth and their families affected by , or at risk of , early onset psychosis in the State of Missouri , GF-CBT has been implemented in @ DMH clinics .\n",
            "GF-CBT state-wide implantation , including clinician training and \" Train-the-Trainer \" procedures to allow sustainability of the intervention will be discussed .\n",
            "Objective To compare the effects between queitapine and clozapine on cognitive function in schizophrenics .\n",
            "Methods Sixty cases of schizophrenia patients were randomly divided into two groups and treated with queitapine or clozapine for @ weeks .\n",
            "The cognitive function and clinical efficacy were evaluated separately with brief psychiatric rating scale ( BPRS ) , WMS-RC , WCST and CT before treatment and at the end of the eighth week of treatment .\n",
            "Results The total score of every test was significantly improved after treatment with queitapine or clozapine , but no significant differences were found between two groups .\n",
            "Conclusion Both queitapine and clozapine can improve the congnitive function in schizophrenic patients\n",
            "The beneficial effects of early intervention in first episode schizophrenia show a return to the predominantly unfavorable course at @ year follow-up .\n",
            "Objective : to evaluate the effectiveness of @ year specialized continuity of treatment with or without parent groups in early phase schizophrenia .\n",
            "Methods : randomised controlled trial .\n",
            "Participants were consecutively admitted patients ( n = @ ) aged @  @ years with early schizophrenia-like disorders .\n",
            "Interventions : Continuity of Treatment by professionals Specialized in the treatment of early schizophrenia ( CST ) , Continuity of Specialized Treatment plus Parent groups ( CSTP ) and Continuity of Treatment as Usual ( CTU ) .\n",
            "Outcome measures : rates of first relapse during @ years treatment , time to first relapse after remission , suicide , psychosocial functioning , second and third relapse .\n",
            "Analysis : Cumulative relapse rates were estimated using life-table methods .\n",
            "@ Patients changed from the assigned condition .\n",
            "The effect of the three interventions on time to first relapse after remission was compared using Cox regression analysing both intention to treat ( ITT ) and actually realized treatment ( ART ) grouping .\n",
            "Results : The relapse rate after @ years was relatively low ( @ , @ % confidence interval @  @ ) .\n",
            "No differences between the @ conditions were found in the ITT analysis .\n",
            "However , the ART analyses showed significant lower relapse rates after @ years for CSTP ( @ , @ % CI @  @ ) but not for CST ( @ , @ % CI @-@ ) as compared with CTU ( @ , @ % CI @ _ @ ) .\n",
            "Cox regression showed a significant positive effect in postponing relapse for CSTP condition , corrected for potential confounding factors .\n",
            "Continuity of treatment did nt affect the suicide rate ( n : @ ; @ % ) .\n",
            "@/@ patients started with poor social functioning : @ patients showed improvement ( @ % ) and @ did not change ( @ % ) .\n",
            "Of the @ patients who started with good functioning @ deteriorated ( @ % ) and @ did not change ( @ % ) .\n",
            "No effects of ITT or ART treatment conditions were found on psychosocial functioning .\n",
            "Conclusion : the basic treatment design offered to all patients , including the parental educational approach was associated with a reduced relapse rate .\n",
            "We found no differences in effect between the treatment conditions in the ITT analysis .\n",
            "The favorable CSTP result underlined the importance of active participation of the parents .\n",
            "Psychosocial functioning improved or remained well for a significant proportion of the patients .\n",
            "ID : @\n",
            "Double-blind trial on @ chronic schizophrenic patients divided into @ groups and given either proketazine or placebo .\n",
            "Trial lasted @ weeks .\n",
            "Over-inclusive thinking made slightly worse by withdrawal from maintenance doses of medication , although there was considerable variability .\n",
            "improvement in those who had it .\n",
            "Ward ratings of behaviour not significantly changed by Proketazine .\n",
            "[ Abstract - CSG ]\n",
            "This study will evaluate a new intervention to help young people with early psychosis and severe mood disorder make a social recovery ( engage in constructive leisure and social activity and return to education or work ) .\n",
            "The new therapy is called Social Recovery oriented CBT ( SRCBT ) and will build on the success of previous psychological interventions ( CBT ) and social intervention ( individual placement and support ) .\n",
            "It is an intervention which aims to be delivered by casemanagers ( nurses , occupational therapists , social workers ) who form the bulk of the NHS teams working with people with psychosis rather than highly specialist therapists .\n",
            "We will undertake a randomised controlled trial of SRCBT in which @ people who agree to participate will be randomly allocated to receive either SRCBT or standardised treatment as usual .\n",
            "Our aim is to evaluate the degree to which SRCBT delivered by case managers in early psychosis services can help young people in the early stages of psychosis and severe mental illness to engage in meaningful social and leisure activity and return to employment or education while reducing levels of depression and hopelessness and minimising risk of relapse .\n",
            "The main hypothesis is that the intervention will lead to improved and sustained engagement in social , employment or education activity and associated health economic benefits .\n",
            "The secondary hypotheses are that the intervention will reduce levels of depression and hopelessness and improve psychotic symptoms .\n",
            "The study also aims to estimate the degreee to which variables such as diagnosis , presence of psychotic symptoms , cognitive deficits , and stigmatisation influence the outcome of intervention .\n",
            "A highly detailed analysis of adherence to interventions will also provide a good basis from which to clarify details of training and supervision and ability of staff with different background to apply this intervention .\n",
            "The study will involve a randomised controlled trial which will compare the effect of case managers providing SRCBT with case managers providing standard case management .\n",
            "Participants who consent will be randomised to receive either SRCBT and case management or standard case management alone .\n",
            "The null hypothesis is that there will be no difference between the groups in terms of social and occupational activity after @ months .\n",
            "Inclusion criteria include : Diagnostic criteria for either affective or non-affective functional psychosis ( schizophrenia , bipolar disorder , schizoaffective disorder ) Duration of illness less than five years ( the NHS has recently invested heavily in early intervention in psychosis teams this inclusion criteria relates this research with the evaluation of this strategy ) Unemployed status greater than @ months ( this focusses selection on a homogeneous group of people with relatively severe social disability ) Relative remission of psychotic symptoms ( less than moderate severity on the PANSS ) only people who are in relative remission are suitable for this type of intervention .\n",
            "Exclusion criteria : Organic disorders Presence of acute psychosis Primary diagnosis of drug dependency on opiates or cocaine This excludes cases who are likely to be unsuitable for this type of intervention Primary Outcome Measure will be hours engaged in constructive social , educational or employment activity .\n",
            "Secondary Outcome Measure will ionclude positive and negative psychotc sympptoms , depression , hopelessness and anxiety .\n",
            "The study also aoms to provide a preliminary estimate of the influence of cognitive neuropsychological deficits and appraisals of stigmatisation and demotivation on outcome .\n",
            "Based on recent quantitative EEG findings of increased slow activity in negative schizophrenia indicating organicity , it was hypothesized that neuroleptics decreasing delta/theta activity should be beneficial for schizophrenics with predominantly negative symptoms .\n",
            "Thus , a double - blind , clinical , psychometric and neurophysiological study was carried out in @ hospitalized patients with unproductive schizophrenia ( mean age : @ years ; ICD diagnoses : @ , @ and @ ) who were treated randomly either with the benzamide amisulpride ( AMI ; n = @ ) or low doses of fluphenazine ( FLU ; n = @ ) .\n",
            "In the first @ weeks the daily doses were @ mg AMI or @ mg FLU , respectively , from the third week on up to the sixth week @ mg AMI and @ mg FLU .\n",
            "Clinical evaluations , psychometry and EEG mapping were performed on day @ ( hours @ and @ -- acute effect ) , on day @ ( hour @ -- subacute effect ) and on day @ ( hours @ and @ -- chronic and superimposed effects ) .\n",
            "Three AMI patients discontinued therapy prematurely because of productive symptoms ( days @ , @ and @ ) , while in the FLU group @ patients dropped out due to depressive symptoms ( days @ , @ ) , @ due to productive symptoms ( day @ ) , @ due to ineffectiveness ( day @ ) , and @ because of an akinetic crisis ( day @ ) .\n",
            "Statistical evaluation demonstrated a significant improvement in the AMDP apathy and Andreasen SANS score in both groups with the patients remaining severely ill as rated by the CGI .\n",
            "FLU-treated patients needed significantly more anticholinergic medication than the AMI-treated group .\n",
            "Psychometric evaluation showed in regard to the noopsyche significant improvement after subacute , chronic and superimposed AMI , while FLU - treated patients showed significant improvement only after subacute treatment .\n",
            "AMI was significantly superior to FLU at the hours @ and @ of day @ .\n",
            "The thymopsyche improved after subacute , chronic and superimposed administration of both compounds with a significant superiority of AMI on days @ and @ ( @ h postdrug ) .\n",
            "EEG mapping showed a decrease of delta/theta and increase of beta activity as well as an acceleration of the centroid after acute and superimposed AMI on day @ as compared with baseline ; FLU patients exhibited a decrease of delta/theta activity and an acceleration of the total centroid too , while alpha activity was augmented and beta activity tended to be reduced .\n",
            "Our study demonstrated that , in addition to the new benzamide AMI , FLU in low doses may also be regarded as a neuroleptic with activating properties and may be utilized in the treatment of schizophrenics with predominantly negative symptoms .\n",
            "Study hypothesis : @ .\n",
            "Does information technology ( IT ) affect patients ' insight , quality of life , symptoms , compliance , knowledge of illness and its treatment , support treatment satisfaction , and independence or shore up opportunities for psychosocial functioning more effectively than written patient information or traditional information methods ?\n",
            "@ .\n",
            "Does the use of IT in clinical practice improve the staffs ' knowledge level and IT-related skills , attitudes towards technology use or affect staff co-operation and working methods ?\n",
            "@ .\n",
            "What are the short and long-run costs of IT compared with written material and traditional methods used in clinical practice and does IT benefit the health care organisation and society more than the two other methods from the viewpoint of cost-effectiveness ?\n",
            "Ethics approval Ethics Committee of Pirkanmaa Hospital District approved on the @th December @ ( ref : ETL R@ ) Study design Randomised controlled trial Countries of recruitment Finland Disease/condition/study domain Schizophrenia , schizotypal disorders or delusional disorders Participants - inclusion criteria @ .\n",
            "Aged @ - @ years , either sex @ .\n",
            "Diagnosis of schizophrenia , schizotypal disorders or delusional disorders ( chapters F@ - F@ , International Classification of Disease , version @ [ ICD-@ ] ) Participants - exclusion criteria @ .\n",
            "Unable to use the Finnish language @ .\n",
            "Unable to give written informed consent to participate Anticipated start date @/@/@ Anticipated end date @/@/@ Status of trial Completed Patient information material Not available in web format , please use the contact details below to request a patient information sheet ( Finnish only ) Target number of participants @ Interventions Staff in Group X will receive education ( basic/advanced groups ) on how to use computers , access internet-based services , and use IPSS during their educational sessions with patients .\n",
            "Only nurses in Group X have access to IPSS to avoid inter-group contamination .\n",
            "Staff in Group Y will be educated to manage education sessions with written/oral material only .\n",
            "In patient groups , Intervention Group A will receive need-based computerised information during discussions with a staff member with five technology sessions each lasting about @ - @ minutes roughly twice a week .\n",
            "At the end of the session , patients will receive individualised leaflets .\n",
            "They will also be instructed on how to use IPSS after discharge .\n",
            "Patients in Comparison Group B will have five oral sessions on their education programs ( no use of IT ) .\n",
            "The content , number and length of the sessions is the same as in Group A. Patients in Control Group C will receive standard care , i.e. no educational sessions will be offered and they receive written information ( e.g. leaflets ) according to ward standards .\n",
            "Total duration of intervention was all together five education sessions after baseline measurement during one month and @ - @ sessions/week .\n",
            "Total duration of follow-up for all arms was @ months .\n",
            "Primary outcome measure ( s ) Insight : The Schedule for the Assessment of Insight ( SAI ) , measured at baseline ( BL ) , @ , @ , @ and @ months Secondary outcome measure ( s ) @ .\n",
            "Quality of Life : Quality of life ( the Quality of Well-Being , the Health Utilities Index , EQ-@D ) and the Manchester Quality of Life Instrument ( MANSA ) , measured at BL , @ , @ , @ and @ months @ .\n",
            "Symptoms : Semi-structured interview addressing psychiatric symptoms ( Positive and Negative Syndrome Scale [ PANNS ] ) , measured at BL , @ , @ , @ and @ months @ .\n",
            "Compliance : Patients ' compliance with treatment , patients ' compliance with medication ( Drug Attitude Inventory [ DAI ] ) , measured at BL , @ , @ , @ and @ months @ .\n",
            "Follow-up of medication adherence and treatment appointments ( analysis of medical records ) @ .\n",
            "Knowledge about illness and treatment : Knowledge test , measured at BL , @ , @ , @ and @ months @ .\n",
            "Treatment satisfaction during discharge process ( Client Satisfaction Questionnaire-@ [ CSQ-@ ] ) , measured at BL and before discharge @ .\n",
            "Disability and psychosocial functioning : symptoms disturbing work , social life , and family respo sibilities ( Sheehan Disability Scale ) and the Global Assessment of Functional Scale ( GAF ) , measured at BL , @ , @ , @ and @ months In addition , drop-outs in each arm were analysed to estimate the acceptance of the interventions .\n",
            "OBJECTIVE : The effect of cognitive-behavioral therapy on the delusion in schizophrenic patients was evaluated .\n",
            "METHOD : The patients admitted to a psychiatric ward from September @ to June @ and diagnosed as schizophrenia ( schizophreniform disorder , and schizoaffective disorder by DSM-IV were randomly assigned to cognitive-behavioral therapy ( CBT ) group ( n = @ ) and supportive psychotherapy ( ST ) group ( n = @ ) .\n",
            "During the @ weeks ' treatment period , conviction , preoccupation , and anxiety on delusion , mode of explanation about symptom , and recovery style were regularly measured and compared between groups .\n",
            "RESULTS : @ ) As for conviction and anxiety on delusion , the patients from both groups showed gradual reduction over time , but there was no significant difference between groups .\n",
            "@ ) As for preoccupation of delusion , patients from both groups showed gradual reduction over time , and the patients on CBT group had a significantly more reduction than ST group .\n",
            "@ ) As for mode of explanation and recovery style , CBT group had more marked positive changes than ST group did .\n",
            "CONCLUSION : Cognitive-behavioral therapy is more effective on preoccupation of delusion , explanatory mode about symptom , and recovery style than supportive psychotherapy . )\n",
            "Incidence of tardive dyskinesia ( TD ) has declined with the use of second generation antipsychotic medications , but still as many as @ % of adults and @ % of the elderly taking these medications may develop it annually .\n",
            "Hypoactivity of the central cholinergic system has been implicated in TD since the @s .\n",
            "It is therefore not surprising that availability of cholinesterase inhibitors generated interest in studying these agents as a potential treatment for TD .\n",
            "So far , @ reports have been published in this regard .\n",
            "We performed a randomized controlled crossover trial of donepezil to test the hypothesis that boosting brain cholinergic function would lessen the dyskinetic movements of TD .\n",
            "All subjects provided written informed consent to participate in this institutional review board-approved study .\n",
            "Our initial study was a double-blind , placebo-controlled , crossover trial of @ mg daily of donepezil or placebo each for @ weeks with a @-week washout , in between .\n",
            "In the @-mg daily dose study , we enrolled @ subjects , including @ subjects who had completed the @-mg daily dose study , and @ completed all phases of the trial .\n",
            "We analyzed the @-mg trial data separately and then pooled data from both the @ - and @-mg trials for an additional analysis .\n",
            "Our findings are consistent with results from the only reported randomized , double-blind , placebo-controlled , crossover trial of an anticholinesterase drug for TD .\n",
            "Objectives : Although antipsychotic drugs control acute psychotic manifestations of schizophrenia , improving cognitive symptoms is also important for long-term prognosis .\n",
            "Methods : Three hundred and seventy-seven adult patients with acute psychosis were randomised to either amisulpride ( @-@ mg/d ) or olanzapine ( @-@ mg/d ) for @ months .\n",
            "Neuropsychological performance was assessed at inclusion and after @ months in a subgroup of @ subjects ( @ treated with amisulpride and @ with olanzapine ) using the Auditory Verbal Learning Test ( AVLT ) , the Trail Making Test ( TMT ) and the Controlled Oral Word Association Test ( COWAT ) .\n",
            "Results : The improvement in BPRS score was similar in both treatment groups .\n",
            "No significant differences in test performance between groups were observed at inclusion .\n",
            "After @ months , AVLT scores increased by @ points in the amisulpride group and by @ points in the olanzapine group ( p = @ ) .\n",
            "Completion speed in the TMT increased by @ s ( amisulpride ) and @ s ( olanzapine ) for Part A and by @ and @ s , respectively for Part B. Performance in the COWAT improved little in both groups .\n",
            "Conclusions : Both amisuipride and olanzapine produce sustained improvement in certain measures of neuropsychological performance in patients with schizophrenia ; a significant improvement in score on the AVLT was observed only with amisulpride .\n",
            "It has long been noted that forming therapeutic alliances with persons with schizophrenia can present multiple challenges .\n",
            "One possibility is that these are linked to neurocognitive impairments which are associated with the condition .\n",
            "To explore this possibility we obtained therapist and client ratings of therapeutic alliance using the Working Alliance Inventory short form ( WAI ) in the first and second month of psychotherapy .\n",
            "Participants were @ adults in a post acute phase of a schizophrenia spectrum disorder enrolled in a randomized trial of cognitive behavior therapy and work outcome and were receiving both individual psychotherapy and a work placement .\n",
            "The WAI-S ratings from the first and second month were each correlated with select subtests of the Weschler Adult Intelligence Scale ( WAIS III ) , the Bell Lysaker Emotion Recognition Test ( BLERT ) , the Conners Continuous Performance Test ( CPT @ ) and the Wisconsin Card Sorting Test ( WCST ) .\n",
            "Pearson Correlation revealed neurocognitive test performance was generally unrelated to client or therapist perception of therapeutic alliance in the first month of therapy .\n",
            "In the second month of therapy , therapist perception of alliance was positive correlated with performance on the WCST , BLERT , and the Block Design and Arithmetic Subtests of the WAIS III .\n",
            "Client perception of alliance was positive correlated with performance on the CPT , BLERT , and theVocabulary and Digit Symbol Subtests of the WAIS III .\n",
            "Results suggest that neurocognitive impairments while not an initial barrier to therapeutic alliance may prove an impediment as treatment develops .\n",
            "Implications for treatment are discussed .\n",
            "Purpose - Antipsychotic drugs are effective in treating the positive symptoms of schizophrenia ; however their efficacy in treating negative symptoms is limited .\n",
            "This study wants to evaluate efficacy of selegiline augmentation of antipsychotic medication to treat negative symptoms in inpatients with chronic schizophrenia .\n",
            "With randomized clinical trial two groups of patients will select to receive selegiline or placebo .\n",
            "Primary end point is decreasing in negative symptoms in case group .\n",
            "Inclusion criteria - @ - Patients with moderate to severe negative symptoms @ - Patients with at least one year antipsychotic drug therapy , at the current dose > = @ month .\n",
            "@ - No other psychotropic drugs during past month .\n",
            "Exclusion criteria - @ - Severe major depressive disorder , substance abuse , severe positive symptoms of schizophrenia , Treatment of MDD with antidepressant drugs during past month .\n",
            "Primary Outcome Measures - decreasing in negative symptoms in case group Total Enrollment - @ Study start - April @ ; Study completion - September @ Eligibility - Ages Eligible for Study - @ Years - @ Years , Genders Eligible for Study - Both Criteria Inclusion Criteria - Patients with moderate to severe negative symptoms Patients with at least one year antipsychotic drug therapy , at the current dose > = @ month .\n",
            "No other psychotropic drugs during past month Exclusion Criteria - Severe major depressive disorder Substance abuse Severe positive symptoms of schizophrenia Treatment of MDD with antidepressant drugs during past month .\n",
            "To compare intramuscular injection of clonazepam and IM fluorine yell efficacy and side effects of alcohol on the acute psychotic scheduled on consecutive hospitalized with psychotic vandalism patients randomized , double-sterile intramuscular atmosphere Ryan @mg@ cases ( male @ cases and @ female patients ) , haloperidol @mg@ cases ( male @ cases , @ females ) .\n",
            "Intramuscular injection before and after a glass of bad behavior of the OAS assessment impulse , BPRS assessment of severity .\n",
            "Junction stay to show that all patients with OAS score decreased significantly in @ hours and @ hours after injection , the two groups was no significant difference in reduction rate group of clonazepam adverse reactions are mild .\n",
            "Tip clonazepam can rapidly control acute psychotic vandalism and haloperidol efficacy and mild side effects .\n",
            "Purpose : We evaluated if adjunctive treatment of dopamine partial agonist , aripiprazole , improves hyperprolactinemia induced by haloperidol and is effective for the treatment of schizophrenia symptoms .\n",
            "Method : Fifty-six patients with schizophrenia who had hyperprolactinemia after taking haloperidol were enrolled in this eight-week , double blind , placebo-controlled study .\n",
            "Haloperidol dose was fixed throughout the study and aripiprazole was dosed at @mg/day for the first @ weeks then @ mg for next @ weeks .\n",
            "Serum prolactin levels were measured by using electrochemiluminescent immunoassays , with commercial kits .\n",
            "The psychopathology and adverse event were rated by clinical rating scale such as BPRS , SANS , CGI-S , SARSBARSDAI at baseline and at weeks @ @ , @ , @ and @ .\n",
            "Serum haloperidol and aripiprazole levels were measured at the baseline , week @ , @ , @ and @ .\n",
            "Two-tailed student s t-tes , repeated measures ANOVA , Pearson correlation coefficient was used to analyze the data .\n",
            "Result : Baseline prolactin levels were not significantly different between two groups .\n",
            "During the eight week study , prolactin levels in aripiprazole group , as compared to placebo group , were significantly lowered demonstrating a significant time effect ( p < @ ) and time by group interaction ( p < @ ) on repeated measure ANOVA .\n",
            "No time effect was present in the placebo group over time .\n",
            "The percent decrease in prolactin levels for aripiprazole group was @ @ % ( range ; @ % to @ % , Median ; @ % ) and @ @ % ( range ; @ % to @ % , median ; @ % ) from baseline levels at weeks @ and @ , respectively .\n",
            "Among the @ female patients with menstrual disturbances in the aripiprazole group , @ patients regained menstruation during study , while no patients in placebo group .\n",
            "No significant effect over time and time by group interaction in total and subscale scores were noted for the BPRS or SANS , however , the number of responders , ( defined by SANS total scores ) , was significantly higher in aripiprazole ( @/@ ; @ % ) as compared to the placebo group ( @/@ ; @ % ) .\n",
            "Conclusion : Adjunctive aripiprazole treatment reversed hyperprolactinemia in both sexes , resulting in regaining menstruation in female patients , with overall no significant effect on psychopathology and extrapyramidal symptoms .\n",
            "Although growing evidence supports the efficacy of social cognitive training interventions for schizophrenia , nearly all studies to date have been conducted in Westernized countries .\n",
            "In the current study , we translated and adapted an existing social cognitive skills training ( SCST ) program into Arabic and conducted a preliminary efficacy evaluation in schizophrenia outpatients in Egypt .\n",
            "Twenty-two patients were randomized to @ sessions of group-based SCST and @ were randomized to a format - and time-matched illness management training control condition .\n",
            "Pre - and post-intervention assessments included a primary social cognition outcome measure that assessed four branches of emotional intelligence and a battery of neurocognitive tests .\n",
            "The SCST group demonstrated significant treatment effects on total emotional intelligence scores ( F = @ , p < .@ ) , as well as the sub-areas of Identifying Emotions ( F = @ , p < .@ ) and Managing Emotions ( F = @ , p < .@ ) , compared with those in the control condition .\n",
            "There were no treatment benefits for neurocognition for either condition , and both interventions were well-tolerated by patients .\n",
            "These initial results demonstrate the feasibility of implementing social cognitive interventions in different cultural settings with relatively minor modifications .\n",
            "The findings are encouraging regarding further efforts to maximize the benefits of social cognitive interventions internationally .\n",
            "@ patients ( aged @-@ yrs ) were randomly assigned to alternative psychiatric day treatment programs , and compliance , rehospitalization , self-esteem , social anxiety , locus of control , and self-control were monitored .\n",
            "The @ Ss in the psychoeducational program remained enrolled longer and received more services .\n",
            "These Ss also increased in self-esteem while the psychotherapeutic group decreased on this measure .\n",
            "Nonwhite Ss with schizophrenia stayed in the educational program longer than did nonwhite Ss in the psychotherapeutic alternative .\n",
            "There was a trend for Ss with schizophrenia and affective disorder from the educational program to be hospitalized more frequently , and for Ss with personality disorder from the psychotherapeutic program to be hospitalized more frequently .\n",
            "Objective : The effect of scheduled intermittent hospitalization on the hospital utilization , community adjustment , and self-esteem of persons with serious and persistent mental illness was examined in an experimental study .\n",
            "Methods : Fifty-seven male veterans , aged @ or younger , with a primary axis I psychiatric diagnosis who were frequent utilizers of inpatient care over the previous two years were randomly assigned to two groups .\n",
            "Patients in the experimental group were prescheduled for four hospital admissions , each lasting nine to @ days , per year for two years .\n",
            "Patients in the control group had traditional access to hospital care .\n",
            "Psychiatric bed days , community adjustment , and self-esteem were assessed during and after the intervention .\n",
            "Results : No differences between the groups on demographic or clinical variables were detected at study entry .\n",
            "The experimental group showed improvement in self-esteem , affect , and complaints of physical symptoms at one year .\n",
            "No statistically significant differences between groups were found in hospital utilization , financial management , substance abuse , or psychological well-being at one year .\n",
            "Conclusions : Scheduled intermittent hospitalization may be an appropriate and promising alternative to traditional care for revolving-door patients .\n",
            "This intervention could maintain patients at a higher level of wellness than traditional care and reduce the recurrence of the crises that precipitate hospitalization .\n",
            "This randomized , parallel-group , open study investigated the efficacy and safety of risperidone oral solution ( RIS-OS ) in combination with clonazepam and intramuscular haloperidol for the treatment of acute agitation in patients with schizophrenia , and the study explored the possibility of decreasing the efficacy of an acute @-week treatment by switching intramuscular haloperidol injection to RIS-OS .\n",
            "Two hundred and five agitation-exhibiting schizophrenic inpatients at six hospitals were originally included in the study .\n",
            "The @-day trial consisted of @ days ( session I ) of receiving either oral treatment ( RIS-OS plus clonazepam ) or intramuscular treatment ( intramuscular haloperidol ) and a @-day ( session II ) period of either withdrawing from clonazepam or shifting from intramuscular haloperidol to a RIS-OS period .\n",
            "The primary efficacy outcome was measured as the change in the Positive and Negative Syndrome Scale-Excited Component ( PANSS-EC ) in session I and the change in the PANSS in session II .\n",
            "Safety was assessed by the frequency of the adverse events .\n",
            "Mean PANSS-EC improvement was significant after @ days of treatment in both groups ( P > @ ) and was similar between the two treatment groups ( P < @ ) .\n",
            "Most patients ' PANSS-EC scores improved or remained stable during the drawback/shift treatment period .\n",
            "Efficacy was not significantly different between the two treatment groups after the @-week treatment ( P > @ ) .\n",
            "However , combination treatment exhibited greater efficacy , and adverse events , especially extrapyramidal symptoms , were lower with the oral treatment than with the intramuscular treatment in session I .\n",
            "These results show that RIS-OS in combination with clonazepam is an effective treatment , comparable with intramuscular haloperidol , and is well-tolerated for acute agitation in patients with schizophrenia .\n",
            " Lippincott Williams & Wilkins .\n",
            "Objective : Neurodevelopmental theories of psychosis highlight the potential benefits of early intervention , prevention , and/or preemption .\n",
            "How early intervention should take place has not been established , nor whether interventions based on social learning principles can have preemptive effects .\n",
            "The objective was to test whether a comprehensive psychosocial intervention can significantly alter psychotic symptom trajectories during adolescence   a period of heightened risk for a wide range of psychopathology .\n",
            "Method : This study was a randomized controlled trial ( RCT ) of Multidimensional Treatment Foster Care ( MTFC ) for delinquent adolescent girls .\n",
            "Assessment of psychotic symptoms took place at baseline and then @ , @ , @ , and @ months post-baseline using a standardized self-report instrument ( Brief Symptom Inventory ) .\n",
            "A second source of information about psychotic symptoms was obtained at baseline or @ months , and again at @ months using a structured diagnostic interview ( the Diagnostic Interview Schedule for Children [ DISC ] ) .\n",
            "Results : Significant benefits for MTFC over treatment as usual for psychosis symptoms were observed over a @-month period .\n",
            "Findings were replicated across both measures .\n",
            "Effects were independent of substance use and initial symptom severity and persisted beyond the initial intervention period .\n",
            "Conclusion : Ameliorating nonclinical psychotic symptoms trajectories beginning in mid-adolescence via a multifaceted psychosocial intervention is possible .\n",
            "Developmental research on nonclinical psychotic symptoms and their prognostic value should be complemented by more psychosocial intervention research aimed at modifying these symptom trajectories early in their natural history .\n",
            "Clinical trial registration information   Juvenile Justice Girls Randomized Control Trial : Young Adult Follow-up ; http://clinicaltrials.gov ; NCT@ .\n",
            "The nonselective serotonin ( @-HT ) -@ A antagonists ritanserin , mianserin , and cyproheptadine were found efficacious in neuroleptic-induced akathisia ( NIA ) .\n",
            "Mirtazapine is structurally and pharmacologically similar to mianserin , and the authors sought to determine its anti-NIA activity .\n",
            "Twenty-six neuroleptic-treated schizophrenic patients with DSM-IV diagnosis of NIA received add-on mirtazapine ( @ mg/day ) or placebo for @ days in a double-blind design .\n",
            "Patients were assessed at baseline and days @ and @ with the Barnes Akathisia Scale ( BAS ) , Positive and Negative Symptom Scale , Hamilton Rating Scale for Depression , and Simpson-Angus Scale for parkinsonism .\n",
            "Analysis of covariance with repeated measurements revealed significant group X time effects in favor of the mirtazapine group in both completers ( n = @ in each group ) and intent-to-treat analysis ( n = @ in each group ) for the BAS global subscale ( F [ @ , @ ] = @ , p = @ , and F [ @ , @ ] = @ , p = @ , respectively ) and objective subscale ( F [ @ , @ ] = @ , p = @ , and F [ @ , @ ] = @ , p = @ , respectively ) and borderline significant superiority for the BAS subjective subscale ( F [ @ , @ ] = @ , p = @ , and F [ @ , @ ] = @ , p = @ , respectively ) and distress subscale ( F [ @ , @ ] = @ , p = @ , and F [ @ , @ ] = @ , p = @ , respectively ) .\n",
            "Significantly more mirtazapine - than placebo-treated patients ( @ % [ @/@ ] vs. @ % [ @/@ ] , respectively ; [ chi ] <ovid:sup> @ </ovid:sup> = @ , p = @ ) met operational respons criterion , a reduction of at least two points on the BAS global subscale .\n",
            "Mirtazapine treatment was associated with modest improvement of psychotic and parkinsonian symptoms .\n",
            "Mild sedation was the only side effect .\n",
            "Our study demonstrated that mirtazapine ( @ mg/day ) is an efficacious and well-tolerated therapeutic option in NIA .\n",
            "Marked @HT@A/@C antagonistic activity of mirtazapine apparently accounts for its anti-NIA activity .\n",
            "The role of mirtazapine in the treatment of akathisia induced by atypical antipsychotic agents merits further investigation\n",
            "Objective To investigate the efficacy of comprehensive rehabilitation therapy for chronic schizophrenia .\n",
            "Randomly divided into two groups , the rehabilitation group , antipsychotic drugs and comprehensive rehabilitation therapy , the control group was treated with antipsychotic drugs .\n",
            "Chronic mental patients standardized psychiatric rating scale before and after treatment , respectively .\n",
            "The results of the rehabilitation and control groups of chronic mental patients standardization Psychiatric Rating Scale total score reduction rate of @ % and @ % , respectively , the difference was significant ( P < @ ) .\n",
            "Background : As in other groups of patients with chronic illnesses , patients with psychotic disorders and schizophrenia in particular , report a need for peer support groups to share experiences .\n",
            "This need is even more important since one of the major side effects of experiencing psychosis is the negative influence on ones social life .\n",
            "The validity of this request to make these groups a standard part of care is barely questioned , but till now there is no empiric evidence of its effect and no standard guidelines are available .\n",
            "Methods : With the aim to investigate the effect of a minimally guided peer support group for people with psychosis on quality of life , social network , social support , self-efficacy and self-esteem and to evaluate the methodology and economic consequences , we conducted a multicentre randomized controlled trial comparing the effects of these groups added to the usual care with care as usual alone .\n",
            "Results : The results showed a positive effect on social network and on social support .\n",
            "Patients in the experimental group improved on contact with peers , also outside the sessions and had more positive social contacts supporting their self-esteem .\n",
            "No statistically significant differences between groups in changes on quality of life , self-efficacy and self-esteem were found .\n",
            "There was however an effect on quality of life , social support and self-efficacy when , within the experimental group , completers with non-completers were compared .\n",
            "The economic evaluation showed that the groups can be implemented without negative financial consequences .\n",
            "The methodology was positively evaluated by both participants and nurses guiding the groups .\n",
            "Conclusions : This first RCT showed that peer support groups are a useful intervention for people suffering from psychosis enabling mutual relationships outside the sessions .\n",
            "The study gives also evidence for the importance of intervention adherence as an important predictor of effect .\n",
            "The newly developed methodology fits well within the patients ' perspective and can be implemented without additional healthcare costs .\n",
            "Objective : To evaluate the therapeutic efficacy and adverse effects of risperidone and low dose of clozapine in the treatment of schizophrenia .\n",
            "Methods : @ patients with schizophrenia were recruited and randomly divided into groups A , B and C. All the patients were treated for a total of @ weeks with the protocol as follows .\n",
            "In group A , the patients were treated with risperidone and low dose of clozapine , while risperidone and clozapine were administered to the patients in groups B and C , respectively .\n",
            "Purpose - The purpose of this randomized controlled trial is to develop a cognitive behavioral therapy ( CBT ) for persons with at risk mental states in the early initial prodromal state and to evaluate CBT in comparison to supportive counselling ( SC ) .\n",
            "It is hypothesized that CBT is more effective than SC on transition to subthreshold psychosis , psychosis and schizophrenia as well as on prodromal symptoms and social adjustment .\n",
            "Primary Outcome Measures - transition to subthreshold psychosis ( and psychosis or schizophrenia ) Secondary Outcome Measures - improvement of prodromal symptoms ( basic symptoms , depression , anxiety ) social adjustment Total Enrollment - @ Study start - January @ ; Study completion - June @ Several studies indicated that self-perceived cognitive thought and perception deficits ( basic symptoms ) , negative symptoms , anxiety , depressive symptoms and social stagnation or social decline are usually present years before the first episode of schizophrenia appears .\n",
            "It is also known that delayed treatment of schizophrenia correlates with a poor prognosis , low compliance and high family burden .\n",
            "As consequence of these findings , for the first time we developed a cognitive behavioral therapy ( CBT ) for persons at risk for psychosis in the early initial prodromal state .\n",
            "The early initial prodromal state was defined by the presence of self-perseived neuropsychological deficits , which were found to be predictive for transition to psychosis and by the presence of clinical relevant decline of functioning in combination with that of clinical management ( CM ) .\n",
            "Is CBT more effective than CM with regard to the three aims of intervention @ .\n",
            "transition to psychosis , @ .\n",
            "improvement of prodromal symptoms , @ .\n",
            "prevention of social decline/stagnation , ?\n",
            "A randomized controlled trail is used to compare the efficacy of CBT with that of supportive counselling ( SC ) .\n",
            "Patients are randomized to receive either CBT or SC over a @ months period .\n",
            "CBT comprises of individual and group therapy as well as cognitive remediation and psychoeducation for key persons .\n",
            "SC should provide regular supportive contacts for the patient .\n",
            "No CBT strategies are allowed to be systematically applied in SC .\n",
            "Eligibility - Ages Eligible for Study - @ Years - @ Years , Genders Eligible for Study - Both Criteria Inclusion Criteria - General criteria Age between @ and @ years male or female , in - or outpatients written informed consent , for patients below @ years also signed by their parents Special criteria ( presented within the last three months prior to the study ) Self-experienced neuropsychological deficits ( basic symptoms ) Thought interferences Compulsory like perseverance of thoughts Thought pressure Thought blockages Disturbances of receptive language , either heard or read Decreased ability to discriminate between ideas and perception , fantasy and true memories Unstable ideas of reference ( subject-centrism ) Derealisation Visual perceptual disturbances ( blurred vision , transitory blindness , partial seeing , hypersensitivity of light , etc. . )\n",
            "Acoustic perceptual disturbances ( hypersensitivity to sounds or noise ( hypersensitivity to sounds or noise , acoasms , etc. ) AND/OR Reduction in the Global Assessment of Functioning Score ( DSM IV ) of at least @ points ( within the past year ) and at least one of the following risk factors - First-degree relative with a lifetime-diagnosis of schizophrenia or a schizophrenia spectrum disorder Pre-or perinatal complications Exclusion Criteria - Attenuated or transient positive symptomes Present or past diagnosis of a schizophrenic , schizophreniform , schizoaffective , delusional or bipolar according to DSM IV Present or past diagnosis a brief psychotic disorder according to DSM IV with a duration of more than one week or within the last @ weeks regardless of its duration Diagnosis of delirium , dementia , amnestic or other cognitive disorder , mental retardation psychiatric disorder due to a somatic factor or related to the consumption of psychotropic substances according DSM IV Alcohol - or drug abuse within the last three months prior to inclusion according to DSM IV Deases of the central nervous system ( inflammatory , traumatic , epilepsy etc . )\n",
            "To describe the lifestyle of people with schizophrenia through diet , smoking habits , weight and exercise , and to report risk from cardiovascular disease .\n",
            "Randomised controlled trial .\n",
            "Descriptive study .\n",
            "Dietary habits of @ community-dwelling people with schizophrenia were assessed by the Scottish Health Survey Questionnaire .\n",
            "Also assessed were smoking habits , physical activity , biochemical indices of nutrition and future risk of CHD .\n",
            "@ Patients with DSM-IV diagnosis of schizophrenia were recruited from those living in the community in rural Nithsdale , south-west Scotland , and in urban Partick , west Glasgow , Scotland .\n",
            "The patients approached were all those supported in their homes by mental health care workers .\n",
            "The lifestyle of people with schizophrenia must give cause for concern in relation to coronary heart disease .\n",
            "Care from secondary care service must address physical as well as mental health .\n",
            "Background and Aim : Oxidative stress , coupled with dysregula-tions of inflammation , of NMDA receptor and of dopamine , is involved in schizophrenia ( SZ ) pathophysiology [ @ ] , [ @ ] .\n",
            "Oxidative stress affects the integrity of parvalbumin interneurons [ @ ] , which are critical for cognitive functions .\n",
            "Various SZ animal models present an elevated oxidative stress associated with parvalbumin interneurons impairment in medial prefrontal cortex .\n",
            "In some , the antioxidant N-acetyl-cysteine ( NAC ) prevents all cellular , physiological and behavioural alterations [ @ ] .\n",
            "These preclinical results suggest a convergence of various genetic and environmental risk factors on oxidative stress , which induces the impairment of parvalbumin interneurons .\n",
            "In chronic SZ patients ' a clinical trial , using NAC as add-on treatment showed the improvement of negative symptoms , mismatch negativity and local synchronization [ @ ] .\n",
            "The present study aims at studying the impact of NAC add-on treatment on symptom severity and neurocognition in early stages of SZ .\n",
            "Cohort and Outcome : Early psychosis patients with a diagnosis of SZ and less than @ years of illness ( N = @ ) were supplemented with NAC ( @ g/day for @ months , N = @ ) or placebo ( N = @ ) in a double-blind randomized placebo-controlled trial ( RCT ) .\n",
            "The outcome measures were the following : ( i ) PANSS scores , ( ii ) neurocognition scores ( MATRICS Consensus Cognitive Battery excluding MSCEIT ; N = @ ) ; ( iii ) quantification of glutathione ( GSH ) in medial prefrontal cortex ( mPFC ) by @H magnetic resonance spectroscopy , ( iv ) quantification of redox markers in blood cells , i.e. GSH ( GSH-BC ) and GSH peroxidase activity ( GPx-BC ) .\n",
            "All measures were performed at baseline and at the end of trial .\n",
            "Main Results : While scores of the negative and positive PANSS were not affected by NAC , NAC improved Processing Speed factor ( NAC > placebo ; F [ @ , @ ] = @ , p = @ ) , favouring @ out of @ Processing Speed tasks ( i.e. Trail Making A : F [ @ , @ ] = @ , p = @ and Verbal Fluency : F [ @ , @ ] = @ , p = @ ) .\n",
            "Both GSH in mPFC and GSH in blood cells were increased after NAC ( respectively , +@ % , p = @ and + @ % , p = @ ) .\n",
            "In patients with high baseline blood GPx activity ( > @ U/g of Hb ) , subgroup explorations revealed an improvement of PANSS positive scores compared to placebo ( p = @ ) .\n",
            "The change of PANSS positive correlated negatively with that of blood GPx activity , showing that they improved in parallel to a restoration of redox status .\n",
            "Conclusions : This is the first RCTassessing the impact of NAC treatment in a sample of early psychosis patients and the potential predictive role of peripheral biomarkers of redox dysregulation .\n",
            "The hypothesis that NAC would be beneficial to negative symptoms in early psychosis was not confirmed in this small sample .\n",
            "The NAC-induced increase of GSH in mPFC demon strates its target engagement .\n",
            "NAC improved Processing Speed showing for the first time its cognitive enhancer ability .\n",
            "Peripheral redox status allows identifiying a subgroup of patients with improved positive symptoms .\n",
            "Future biomarker guided antioxi dant interventions in larger early psychosis samples should replicate these findings .\n",
            "With the notable exception of clozapine , there is at present insufficient information on the efficacy of atypical antipsychotic medications in patients with poorly responsive schizophrenia .\n",
            "The present study reports on the efficacy and tolerability of quetiapine and haloperidol in patients with schizophrenia who showed no response to treatment with fluphenazine .\n",
            "This study is a post hoc subanalysis of an @-week , double-blind study of patients receiving quetiapine @ mg/day or haloperidol @ mg/day .\n",
            "The proportion of patients classified as \" Clinical Global Impression responders \" ( defined as Clinical Global Impression Severity of Illness score of < or = @ at study end ) was greater in the quetiapine group compared with the haloperidol group ( @ % vs. @ % ; P = @ ) .\n",
            "Overall , quetiapine was well tolerated with less extrapyramidal side-effects and reduction in prolactin when compared to haloperidol .\n",
            "Weight gain was modest but more apparent in quetiapine-treated patients .\n",
            "Quetiapine is an appropriate treatment choice in patients who do not respond to prior antipsychotic treatment\n",
            "At the conclusion of this presentation , the participant should demonstrate an understanding of the typical pharmacologic profile and the clinical efficacy and side effect profile of ' Seroquel ' ( quetiapine ) , an atypical antipsychotic agent .\n",
            "Quetiapine , ICI @ , @ , a dibenzothiazepine with affinity for multiple brain receptors , is a new atypical antipsychotic agent intended for the treatment of schizophrenia .\n",
            "Phase II clinical trials in patients with acute exacerbation of schizophrenia showed that quetiapine was effective in treating positive and negative symptoms and was well tolerated .\n",
            "The atypical profile of quetiapine was supported by the lack of induction of extrapyramidal symptoms ( EPS ) and the lack of sustained elevations in plasma prolactin levels .\n",
            "In two multicenter , placebo-controlled trials , the incidence of EPS was no greater than with placebo , and no acute dystonic reactions were noted .\n",
            "Similarly , plasma prolactin levels were no greater with quetiapine than with placebo .\n",
            "A six - week , multicenter , randomized , double-blind , placebo-controlled trial evaluated the efficacy , safety , and optimal dose range of quetiapine in patients with acute exacerbation of schizophrenia ( DSMIIIR ) .\n",
            "Overall , @ patients in the US and Canada received one of five fixed doses of quetiapine ( @ , @ , @ , @ , or @ mg daily ) , haloperidol ( @ mg daily ) , or placebo .\n",
            "Patients were assessed weekly using the BPRS , CGI , and SANS for efficacy and the Simpson Scale for EPS .\n",
            "At end point , significant differences ( p < @ , ANCOVA ) in mean changes from baseline were identified in quetiapine , haloperidol , and placebo for BPRS total score , BPRS positive symptom cluster , and the CGI Severity of Illness scores ( quetiapine @-@ mg/day ) , and for SANS summary score ( quetiapine @ mg/day ) .\n",
            "Overall , quetiapine showed a maximal clinical effect at @ mg/day and was well tolerated .\n",
            "There was no difference between quetiapine at any dose across the dose range , and placebo with regard to EPS as assessed by the Simpson Scale , use of concomitant anticholinergic medications , and motor system adverse events .\n",
            "No acute dystonic reactions were noted .\n",
            "Additionally , there was no difference between quetiapine , at any dose across the dose range and placebo with regard to plasma prolactin levels .\n",
            "These results provide further evidence that quetiapine is effective in the treatment of the positive and negative symptoms of schizophrenia at doses of @ to @ mg/day and is well tolerated .\n",
            "The lack of induction of EPS or sustained elevations in plasma prolactin levels further support quetiapine 's atypical profile .\n",
            "@ .\n",
            "Saller CF , Salama AI - ' Seroquel ' - biochemical profile of a potential atypical antipsychotic .\n",
            "Psychopharmacology @ -@-@ , @ .\n",
            "@ .\n",
            "Goldstein JM , Litwin LC , Sutton EB , Malick JB - ' Seroquel ' - electrophysiological profile of a potential atypical antipsychotic .\n",
            "Psychopharmacology @ -@-@ , @ .\n",
            "Trial purpose : To compare the health outcome of patients with schizophrenia , who are at risk for relapse , when treated with a long acting injection form of olanzapine versus treatment with oral olanzapine .\n",
            "Primary outcome measure : To assess the difference between olanzapine pamoate depot and oral olanzapine on time to all-cause discontinuation in outpatients with schizophrenia who are at risk for relapse .\n",
            "Secondary outcome measure : To assess the difference ( s ) between olanzapine pamoate depot and oral olanzapine on health outcome measures patient satisfaction with treatment the incidence of all-cause discontinuation time to relapse incidence of patient 's experiencing relapse change from baseline to endpoint in efficacy scale scores safety and tolerability of treatment .\n",
            "Inclusion criteria : Clinical diagnosis of schizophrenia .\n",
            "Must be an outpatient ( not requiring hospitalization ) now and for at least the past @ weeks .\n",
            "Disease symptoms must meet a certain range as assessed by the clinician .\n",
            "Patient has experienced at least two episodes of clinical worsening of their condition .\n",
            "This could mean admission to a hospital or an emergency room visit .\n",
            "This could mean that a new medication was added , medication dose was increased , or medication was switched in order to better control symptoms of the condition .\n",
            "The patient must have an unsatisfactory response to their current medication or be experiencing negative effects of their current medication or not always take their current medication so that a change in current medication is desired .\n",
            "Exclusion criteria : Patients who are actively suicidal .\n",
            "Patients who are pregnant or nursing .\n",
            "Patients who have stopped past treatment with olanzapine because of adverse events , are treatment resistant or allergic to olanzapine , or have a condition which would prevent use of a long acting form of olanzapine .\n",
            "Patients with uncorrected narrow-angle glaucoma , seizures , uncontrolled diabetes , certain diseases of the liver , uncontrolled thyroid condition or other serious or unstable illness .\n",
            "Patients with Parkinson 's disease , psychosis related to dementia or other related disorders .\n",
            "Expected total enrollment : @ .\n",
            "Participant eligibility : Ages eligible for study : @ years - @ years .\n",
            "Genders eligible for study : both .\n",
            "AIM : Relatively little is known about the effectiveness of return-to-work interventions for employees sick-listed with mental disorders , and the results of the literature are contradictory .\n",
            "This study evaluated the return-to-work effect of a multidisciplinary health assessment for persons sick-listed with mental disorders .\n",
            "METHODS : The study population consisted of @ persons who were allocated to the treatment and control groups based on their birth year .\n",
            "In addition to the usual case management , the treatment group ( n = @ ) was assessed by a team consisting of a case manager , a psychiatrist , and a job coach .\n",
            "The control group ( n = @ ) received the usual case management .\n",
            "We used unique register data to code outcome variables ( sick-leave duration and return-to-work duration ) .\n",
            "RESULTS : The multidisciplinary treatment had no statistically significant effect on the sick-leave duration ( HR = @ ; @ % CI @-@ ) or the return-to-work duration ( HR = @ ; @ % CI @-@ ) .\n",
            "Subgroup analyses showed that the treatment effect did not systematically depend on age , education or severity of the mental disorder .\n",
            "We found no signs of systematic dropout from the study population or of imbalanced data .\n",
            "We found an insignificant tendency indicating that control-group case managers may have learned about the intervention from treatment case managers ( p = @ ) .\n",
            "CONCLUSIONS : This study showed no return-to-work effect of a multidisciplinary assessment of sick-listed individuals with mental disorders .\n",
            "Together with the sparse and inconclusive findings of the literature , this finding suggests that further research is needed for disentangling the elements that constitute an effective intervention .\n",
            "Some patients with tardive dyskinesia fit the cholinergic-dopaminergic imbalance theory , but some do not .\n",
            "In an attempt to study his heterogeneity further , the authors measured the responses of @ patients with tardive dyskinesia to intravenous challenge doses of drugs that facilitate or inhibit acetylcholine transmission ( physostigmine or benztropine , respectively ) .\n",
            "They then measured the response of these patients to an open outpatient deanol trial .\n",
            "They found that the responses of half of the patients followed the classic theory , @ responded paradoxically , and @ responsed inconsistently .\n",
            "They suggest that there is a subgroup of tardive dyskinesia patients who fit the theory but that more research is needed to identify the subgroups who do not .\n",
            "This study is to evaluate the possibility of switching clozapine to zotepine for patients with poor response to clozapine .\n",
            "Schizophrenic patients with bprs greater than @ and taking clozepine for more than @ months were included .\n",
            "Nineteen patients were allocated on a random , rater-blind basis to two groups : group a maintained on clozepine and group b switched to zotepine .\n",
            "We designed a cross-taper schedule for group b that clozapine was discontinued in @ weeks .\n",
            "There is no statistic difference between the two groups for baseline bprs ( @ +@ ) , Cgi ( @ +@ ) , Aims ( @ +@ ) , Sas ( @ +@ ) , Barnes ( @ +@ ) .\n",
            "At @ weeks , mean bprs net change in group b was significantly higher than group a ( @ +@ Vs -@ +@ ) .\n",
            "We found higher bprs score at @ weeks may be due to poorer outcome for female in group b ( cgi net change : @ Vs -@ For female and male respectively , p = @ ) .\n",
            "Last Refresh Date@ March @ / / Primary Sponsor : University of Maryland / / Registration Date : @/@/@ / / Export Date : @/@/@ @:@:@ PM / / Recruitment Status : Not recruiting / / Inclusion Age ( min ) : @ Years / / Inclusion Age ( max ) : @ Year / / Inclusion Gender : Both / / Date Enrollement : July @ / / Target Size : @ / / Phase : N/A / / Inclusion Criteria : - Aged @-@ years .\n",
            "- DSM diagnosis of schizophrenia or schizoaffective disorder .\n",
            "- Ability to give written informed consent .\n",
            "- Either currently smoking and not attempting to quit , or having smoked no more than @ cigarettes , cigarillos or cigars in lifetime and not at all within the last year .\n",
            "- Normal or corrected to normal vision ( at least @/@ ) .\n",
            "- Four weeks of stable pharmacological treatment ( same psychiatric medication at same dose ) and no foreseeable changes at enrollment .\n",
            "/ / Exclusion Criteria : - Alcohol or substance abuse or dependence other than nicotine within the last @ months .\n",
            "- Uncontrolled hypertension ( resting systolic blood pressure above @ or diastolic above @ mm Hg ) .\n",
            "- History of myocardial infarction , heart failure , angina , stroke or severe arrhythmias .\n",
            "- ECG abnormalities .\n",
            "- History of neurological conditions such as stroke , seizures , dementia or organic brain syndrome .\n",
            "- Mental retardation .\n",
            "- Pregnant , verified by urine pregnancy test for females .\n",
            "- Breast-feeding .\n",
            "- Treated with benztropine currently or within the last four weeks .\n",
            "/ / Condition : Schizophrenia ; Schizoaffective DisorderSI - Behavioral : Cognitive remediation training ; Drug : Nicotine polacrilex lozenge / / Primary Outcome : Change in MATRICS Consensus Cognitive Battery ( MCCB ) score ; Progression in training exercise parameters ; Change in Brief Psychiatric Rating Scale ( BPRS ) score ; Change in Scale for the Assessment of Negative Symptoms ( SANS ) score ; Change in Calgary Depression Scale score ; Change in UCSD Performance-Based Skills Assessment ( UPSA ) score ; Change in Abbreviated Schizophrenia Quality of Life Scale score ; Change in Cognitive Assessment Interview ( CAI ) score / / Secondary Outcome : Change in Working memory capacityI@ - Secondary ID : R@MH@ ; HP-@ / / Source Support : Please refer to primary and secondary sponsors / / Secondary Sponsor : National Institute of Mental Health ( NIMH )\n",
            "Objective To evaluate olanzapine and the efficacy and safety of risperidone in the treatment of schizophrenia .\n",
            "Methods @ patients with first-episode schizophrenia patients were randomly divided into the olanzapine and risperidone groups , respectively , @ weeks of treatment .\n",
            "Using the Positive and Negative Syndrome Scale ( panss ) and side effects scale ( tess ) to evaluate the efficacy and side effects .\n",
            "Results of olanzapine and risperidone group , the total efficiency of @ % and @ % , respectively , the difference was not statistically significant ( p > @ ) .\n",
            "The low incidence of adverse reactions , to a lesser degree , the the olanzapine group of body mass increase higher than the risperidone group ; the risperidone group extrapyramidal reaction is higher than the olanzapine group .\n",
            "Conducted a study to identify clinically relevant predictors of short-term ( @-yr ) outcome in schizophrenic patients and to gather these predictors into one simple prognosis model for the course of the disease .\n",
            "@ schizophrenic outpatients classified according to Diagnostic and Statistical Manual of Mental Disorders-III ( DSM-III ) criteria were observed for @ yrs with regard to their relapse ( rehospitalization ) frequency .\n",
            "@ relatives of these Ss were also included in this random assignment controlled intervention study .\n",
            "Predictors of both a high and a low relapse risk permitting a prognostic assessment of the individual case were based on various sources : case history data , especially those relating to the previous course of the disease ; social and therapeutic situation ; psychopathological findings ; emotional family atmosphere ; and prognosis scales .\n",
            "BACKGROUND : Provision of early intervention services has increased the rate of social recovery in patients with first-episode psychosis ; however , many individuals have continuing severe and persistent problems with social functioning .\n",
            "We aimed to assess the efficacy of early intervention services augmented with social recovery therapy in patients with first-episode psychosis .\n",
            "The primary hypothesis was that social recovery therapy plus early intervention services would lead to improvements in social recovery .\n",
            "METHODS : We did this single-blind , phase @ , randomised controlled trial ( SUPEREDEN@ ) at four specialist early intervention services in the UK .\n",
            "We included participants who were aged @-@ years , had non-affective psychosis , had been clients of early intervention services for @-@ months , and had persistent and severe social disability , defined as engagement in less than @ h per week of structured activity .\n",
            "Participants were randomly assigned ( @:@ ) , via computer-generated randomisation with permuted blocks ( sizes of four to six ) , to receive social recovery therapy plus early intervention services or early intervention services alone .\n",
            "Randomisation was stratified by sex and recruitment centre ( Norfolk , Birmingham , Lancashire , and Sussex ) .\n",
            "By necessity , participants were not masked to group allocation , but allocation was concealed from outcome assessors .\n",
            "The primary outcome was time spent in structured activity at @ months , as measured by the Time Use Survey .\n",
            "Analysis was by intention to treat .\n",
            "This trial is registered with ISRCTN , number ISRCTN@ .\n",
            "FINDINGS : Between Oct @ , @ , and June @ , @ , we randomly assigned @ participants to receive social recovery therapy plus early intervention services ( n = @ ) or early intervention services alone ( n = @ ) ; the intention-to-treat population comprised @ patients .\n",
            "At @ months , @ ( @ % ) participants had data for the primary outcome .\n",
            "Social recovery therapy plus early intervention services was associated with an increase in structured activity of @ h ( @ % CI @-@ ; p = @ ) compared with early intervention services alone .\n",
            "No adverse events were deemed attributable to study therapy .\n",
            "INTERPRETATION : Our findings show a clinically important benefit of enhanced social recovery on structured activity in patients with first-episode psychosis who received social recovery therapy plus early intervention services .\n",
            "Social recovery therapy might be useful in improving functional outcomes in people with first-episode psychosis , particularly in individuals not motivated to engage in existing psychosocial interventions targeting functioning , or who have comorbid difficulties preventing them from doing so .\n",
            "FUNDING : National Institute for Health Research .\n",
            "The objective of this study is to examine the main metabolic side effects induced by antipsychotic treatment in a cohort of first-episode drug-naive subjects after the first year of treatment .\n",
            "A randomized , open-label , prospective clinical trial was conducted .\n",
            "Participants were @ consecutive subjects included in a first episode program and never treated with antipsychotic medication .\n",
            "Patients were assigned to haloperidol , olanzapine or risperidone .\n",
            "The main outcome measures were changes at one year in fasting glucose parameters ( glucose , insulin levels and insulin resistance index ) and changes in fasting lipid parameters ( total cholesterol , triglycerides , LDL cholesterol and HDL cholesterol ) .\n",
            "At one year follow-up @ subjects were evaluated .\n",
            "There was a statistically significant increase in the mean values of insulin levels ( @ microU/ml ; P = .@ ) ; HOMA insulin resistance index ( @ ; P = .@ ) ; total cholesterol ( @ mg/dl ; P < .@ ) ; LDL-cholesterol ( _ @ mg/dl ; P < .@ ) and triglycerides ( _ @ mg/dl ; P < .@ ) .\n",
            "No pathological values in fasting glucose plasma levels were found at baseline and there were no changes after one year .\n",
            "Weight gain was positively correlated with changes in insulin increase ( r = .@ , P = .@ ) ; HOMA index ( r = .@ , P < .@ ) and triglyceride levels ( r = .@ , P = .@ ) and negatively correlated with HDL changes ( r = _ @ , P = @ ) .\n",
            "We did not detect statistically significant differences between treatments in any of the parameters evaluated .\n",
            "Fasting glycaemia and insulin concentrations at baseline do not support the hypothesis that schizophrenia is associated with an underlying abnormality in glucose metabolism .\n",
            "To summarize , after the first year of antipsychotic treatment we have observed an increase in insulin-resistance index and a worsening lipid profile   but no clinically relevant illness was detected .\n",
            "The changes in insulin and lipid parameters seem to be related to the magnitude of weight gain .\n",
            "There were no significant differences between haloperidol , olanzapine and risperidone concerning metabolic adverse effects after the first year of treatment .\n",
            "Grants : Instituto de Salud Carlos III , FIS @/@ and SENY Fundatio Research Grant CI @-@ , Fundacion Marques de Valdecilla A/@/@ .\n",
            "No pharmaceutical company supplied financial support .\n",
            "Objective : To evaluate the program , training for the rehabilitation of social function in patients with chronic schizophrenia on community role .\n",
            "Methods : @ cases of day rehabilitation centers for patients with chronic schizophrenia were randomly divided into training group and a control group of @ cases each .\n",
            "Program training training group and the control group using conventional methods .\n",
            "Social Disability Screening Scale ( sdss ) , assessed the effect of daily living scale ( adl ) .\n",
            "Results : training group trained sdss rated lower than the control group ( p < @ ) ; adl score was significantly lower than the control group ( p < @ ) .\n",
            "This article has two objectives : to quantify the access and utilization of services received by chronically mentally ill Medicaid recipients , and to compare service utilization and access under prepayment and fee-for-service ( FFS ) payment .\n",
            "The study setting is Hennepin County ( Minneapolis ) , Minnesota , where @ percent of Medicaid recipients were randomly assigned to receive services from prepaid plans .\n",
            "An algorithm was developed to identify recipients with chronic mental illness , resulting in @ study participants , split approximately evenly between prepayment and FFS Medicaid .\n",
            "Data were collected through in-person surveys at baseline , and after @ year .\n",
            "We found slight improvements in the majority of access measures studied and no significant decreases in the use of inpatient or outpatient services for enrollees in prepaid health plans .\n",
            "The results support efforts to expand the use of prepaid health plans to meet the needs of non-institutionalized chronically mentally ill Medicaid beneficiaries .\n",
            "Objectives : To compare the effects of long-term treatment with aripiprazole and olanzapine on body weight in patients with acute relapse of SCHIZophrenia .\n",
            "Methods : A total of @ patients were RANDOMised to @ weeks of treatment with aripiprazole ( @-@ mg/day ) or olanzapine ( @-@ mg/day ) in this DOUBLE-blind , multicentre study .\n",
            "The primary outcome measure was the proportion of patients experiencing significant weight gain ( ?\n",
            "@ % increase ) from baseline to endpoint .\n",
            "Results : Significantly more olanzapine-treated patients experienced significant weight gain over the course of the study than aripiprazole-treated patients .\n",
            "Mean changes in body weight showed significant differences between the groups at weeks @ and @ ; at week @ there was a mean weight gain with olanzapine treatment of @ kg compared with a mean weight loss with aripiprazole treatment of @ kg ( p < @ ) .\n",
            "Differences favouring aripiprazole were also seen for changes in total cholesterol , HDL cholesterol , and triglycerides .\n",
            "The rate of clinical response did not differ between aripiprazole and olanzapine , either acutely ( week @ ) or in the number of patients remaining in response and on therapy at week @ .\n",
            "Conclusions : Aripiprazole treatment was associated with a significantly lower incidence of weight gain and dyslipidaemias than olanzapine therapy , while clinical response was comparable between the groups .\n",
            "These findings may result in a more advantageous long-term metabolic profile for patients with SCHIZophrenia treated with aripiprazole than for those treated with olanzapine .\n",
            "Last Refresh Date@ March @ / / Primary Sponsor : Beijing Anding hospital / / Registration Date : @-@-@ / / Export Date : @/@/@ @:@:@ PM / / Recruitment Status : Not Recruiting / / Inclusion Age ( min ) : @ / / Inclusion Age ( max ) : @ / / Inclusion Age ( max ) : / / Inclusion Gender : Both / / Date Enrollement : @-@-@ / / Target Size : oxytocin group : @ ; placebo group : @ ; / / Inclusion Criteria : Schizophrenia diagnosis by DSM-@ ; Age : Between @-@ ; The dose of antipsychotics and symptom are stable for @ month .\n",
            "/ / Exclusion Criteria : Comorbidity with other mental illness ; With serious and unstable somatic disease ; History of alcohol or drug abuse in @ months ; History of ECT therapy in @ months ; History of severe allergies or easy to allergies .\n",
            "/ / Condition : schizophreniaSI - oxytocin group : oxytocin @iu bid ; placebo group : placebo @iu bid ; / / Primary Outcome : PANSS ; CGI ; MSCEIT ; oxytocin ; ERP ; PPI ; eye movement ; / / Secondary Outcome : SPSS ; CDSS-C ; RBANS ; / / Source Support : The capital health research and development projects\n",
            "Increasing evidence suggests that inflammation contributes to the etiology and progression of schizophrenia .\n",
            "Molecules that initiate inflammation , such as virus - and toxin-induced cytokines , are implicated in neuronal degeneration and schizophrenia-like behavior .\n",
            "Using therapeutic agents with anti-inflammatory or neurotrophic effects may be beneficial for treating schizophrenia .\n",
            "One hundred healthy controls and @ Han Chinese patients with schizophrenia were tested in this double-blind study .\n",
            "Their PANSS scores , plasma interleukin ( IL ) -@ beta , tumor necrosis factor-alpha ( TNF-alpha ) and brain-derived neurotrophic factor ( BDNF ) levels were measured before and after pharmacological treatment .\n",
            "Pretreatment , plasma levels of IL-@ beta and TNF-alpha were significantly higher in patients with schizophrenia than in controls , but plasma BDNF levels were significantly lower .\n",
            "Patients were treated with the atypical antipsychotic risperidone ( Risp ) only or with Risp + dextromethorphan ( DM ) .\n",
            "PANSS scores and plasma IL-@ beta levels significantly decreased , but plasma TNF-alpha and BDNF levels significantly increased after @ weeks of Risp treatment .\n",
            "Patients in the Risp + DM group showed a greater and earlier reduction of symptoms than did those in the Risp-only group .\n",
            "Moreover , Risp + DM treatment attenuated Risp-induced plasma increases in TNF-alpha .\n",
            "Patients with schizophrenia had a high level of peripheral inflammation and a low level of peripheral BDNF .\n",
            "Long-term Risp treatment attenuated inflammation and potentiated the neurotrophic function but also produced a certain degree of toxicity .\n",
            "Risp + DM was more beneficial and less toxic than Risp-only treatment.Clinical Trial Registration : Protocol Record : HR-@-@ ; Trial Registration number : NCT@ ; URL : http://www.clinicaltrials.gov\n",
            "Objective : To compare clozapine with risperidone schizophrenia patients routine blood .\n",
            "Methods : @ cases of patients not taking antipsychotics before admission were randomly divided into the clozapine group ( @ cases ) and risperidone group ( @ cases ) , and before taking the first four weeks after taking eight weeks to detect routine blood test , the comparison of before and after treatment .\n",
            ": Clozapine patients in the eight weeks after taking the total number of white blood cells showed a downward trend , there is a significant difference ( p < @ ) , the erythrocyte total number of no significant difference ( p > @ ) ; patients in the risperidone group medication before and after comparison , the total number of white blood cells and red blood cells , no significant change ( p > @ ) .\n",
            "Conclusion : clozapine for schizophrenia blood count greater impact , risperidone no significant changes in blood count changes , the application of antipsychotics , should be closely observed .\n",
            "The goal of this project is to evaluate an innovative psychosocial intervention package that will incorporate evidence-based treatment strategies to target the affective-motivational deficits , negative expectancies , and behavioral skills deficits that are central to the maintenance of negative symptoms .\n",
            "The intervention - called Engaging in Community Roles & Experiences ( ENCoRE ) - will include strategies aimed at teaching Veterans with schizophrenia and negative symptoms ways to ( @ ) overcome deficits in anticipatory pleasure , ( @ ) increase intrinsic motivation for goal-directed activities , ( @ ) reduce expectancies for failure , and ( @ ) perform skillfully in new social situations , all of which can impact implementation of new skills and behaviors .\n",
            "Rather than develop a new set of intervention strategies , we will include within EnCoRE evidence-based strategies for these treatment domains .\n",
            "In addition , the investigators will collect qualitative information both from Veterans concerning their perceptions of the strengths , weaknesses , and barriers to participation in EnCoRE , as well as from a sample of mental health providers who work with Veterans with schizophrenia and negative symptoms , in order to inform a larger scale implementation trial should EnCoRE prove effective here .\n",
            "The Ultra-High Risk ( UHR ) clinical phenotype is associated with substantial distress and functional impairment and confers a greatly enhanced risk for transition to full threshold psychosis .\n",
            "A range of interventions aimed at relieving current symptoms and functional impairment and reducing the risk of transition to psychosis have shown promising results , but the optimal type and sequence of intervention remains to be established .\n",
            "Objective : To determine which intervention was most effective at preventing transition to psychosis : cognitive therapy plus low-dose risperidone ( CT+R isp ) ; cognitive therapy plus placebo ( CT+P lac ) , or supportive therapy plus placebo ( Supp + Plac ) .\n",
            "Design : A double-blind randomized placebo controlled trial .\n",
            "Setting : The PACE Clinic , a specialized service for young people at ultra-high risk of psychosis , located in Melbourne , Australia .\n",
            "Participants : a cohort of @ UHR clients recruited from the PACE clinic .\n",
            "Interventions : A @-month trial of risperidone ( @-@ mg/day ) , cognitive therapy , or supportive therapy offered weekly to fortnightly depending on clinical need .\n",
            "Main Outcome Measures : The primary outcome measure was transition to full-threshold psychosis .\n",
            "Secondary outcome measures were psychiatric symptoms , psychosocial functioning and quality of life .\n",
            "Results : The @-monthtransition rates were : CT+R isp , @ % ; CT+P lac , @ % ; Supp + Plac , @ % .\n",
            "While there were no statistically significant differences between the three groups in transition rates , all three groups improved substantially over the course of the trial on dimensional measures , particularly in terms of negative symptoms and overall functioning .\n",
            "Conclusions : Despite some methodological issues , mainly lack of power , the lower than expected and essentially equivalent transition rates in all three groups fail to provide support for the first-line use of antipsychotic medications in UHR patients .\n",
            "An initial psychosocial approach with supportive therapy is likely to be effective and carries fewer risks .\n",
            "Further research is required to guide the treatment of non-responders and more risk-enriched samples .\n",
            "Introduction : Accumulating evidence suggests estrogens may have therapeutic effects in severe mental illnesses , including schizophrenia , via neuromodulatory and neuroprotective activity.Wewill present the results of two research trials comparing the effectiveness of adjunctive transdermal estradiol ( @ or @ ?\n",
            "g/day ) to adjunctive placebo , in the treatment of acute psychotic symptoms .\n",
            "Methods : For the first study , women of childbearing agewith a diagnosis of schizophrenia or schizoaffective disorder were invited to participate in a @-week , double-blind , placebo controlled study .\n",
            "Women were randomized to receive either @ mcg transdermal adjunctive estradiol ( @women ) , or adjunctive transdermal placebo ( @women ) , for a @-day trial period ( and all patients continued to receive their standard antipsychotic treatment ) .\n",
            "Assessments were conducted at baseline , then at days @ , @ , @ and @ , and included psychopathology ( PANSS ) and mood ( MADRS ) ratings , as well as measures of estrogen , progesterone , and gonadotropin levels .\n",
            "A cognitive battery was also completed at each assessment .\n",
            "The subsequent trial is ongoing and involves a similar patient population , participating in an @-week , three-arm ( @ ?\n",
            "g/day adjunctive transdermal estradiol , @ ?\n",
            "g/day adjunctive transdermal estradiol , or adjunctive transdermal placebo ) double-blind , placebo controlled study .\n",
            "The previously described assessment battery is conducted at baseline , then at days @ , @ , @ and @ .\n",
            "Results : Results from the first trial indicated that women receiving @ mcg estradiol improved significantly more than women on the placebo arm , in terms of positive , negative and general symptoms on the PANSS .\n",
            "Conclusions : The findings from both studies indicate that estradiol appears to be a useful adjunctive treatment for women with schizophrenia .\n",
            "This research was supported by The Stanley Medical Research Institute , The National Alliance for Research into Schizophrenia and Depression and The National Health and Medical Research Council of Australia .\n",
            "The RAISE-ETP program was designed to develop and evaluate an integrated treatment for first episode psychosis ( NAVIGATE ) in \" real world , \" non-academic , community treatment sites in the USA We selected @ clinics , located in @ states , and randomized the sites ( clusters ) , rather than individuals , to either implement NAVIGATE or to provide customary Community Care for subjects in the study .\n",
            "Cluster randomization insured that clinicians at Community Care sites were not exposed to NAVIGATE in order to avoid spillover/contamination effects .\n",
            "Diagnostic interviews and major assessments were conducted by trained remote , centralized personnel utilizing live , two-way video .\n",
            "This allowed them to remind blind to study design and treatment assignment .\n",
            "Study enrollment was completed in July @ with @ subjects receiving NAVIGATE and @ Community Care .\n",
            "The final RAISE ETP study sample consisted of @ subjects .\n",
            "Mean age is @ , @ % are male , @ % Caucasian , @ % African American .\n",
            "Eightyeight ( @ % ) were recruited from community outreach activities for the study and the remaining @ ( @ % ) of subjects came from the usual referral sources for the sites ( e.g. a local inpatient unit ) .\n",
            "Approximately half of subjects met DSM-IV criteria for schizophrenia at study entry with the next most common diagnoses being schizophreniform disorder and schizoaffective disorder and @ % had had severe enough symptoms to warrant psychiatric inpatient hospitalization .\n",
            "Data from @ years of treatment and follow up will be available in July of @ and initial results will be presented .\n",
            "Objective : To exp lore the efficacy and safety of quetiap ine in the treatment of schizophrenia .\n",
            "Methods : A total of @ patients with schizophrenia ( CCMD - @ criteria ) were randomly allocated to quetiap ine ( n = @ ) and chlorp romazine ( n = @ ) group .\n",
            "All patients were treated for @ weeks .\n",
            "Efficacy in schizophrenia was determined using the PANSS scale .\n",
            "Safety was evaluated using TESS scale .\n",
            "Results : PANSS scale in endpoint was decreased significantly than baseline in both group s ( P < @ .\n",
            "@ ) .\n",
            "Excellence and remission rate in quetiap ine group was @ .\n",
            "@ % and @ .\n",
            "@ % respectively , chlorp romazine group @ .\n",
            "@ % and @ .\n",
            "@ % respectively .\n",
            "No significant difference exist within treatment group s. Quetiap ine treated patients demonstrated significantly decrease in PANSS negative factor , cognitive factor , PANSS total scale than chlorp romazine - treated patients ( P < @ .\n",
            "@ ) .\n",
            "The adverse effect in chlorp romazine - treated patients was significantly more and greater than quetiap ine - treated patients ( P < @ .\n",
            "@ ) .\n",
            "Conclusion : No significant difference between quetiap ine and chlorp romazine group swas observed for efficacy .\n",
            "Quetiap ine , which has less adverse effect , more ability to imp rove the cognitive function and negative symp tom than chlorp romazine , is an effective and safe antip sychotic drug .\n",
            "BACKGROUND : Substance misuse can trigger or be causally associated with mental health problems .\n",
            "Therapeutic attitude is important in predicting effective engagement with people with alcohol and drug problems but health professionals ' attitudes towards this client group are often negative .\n",
            "Education regarding substance misuse has often been neglected and nurses may lack knowledge to provide appropriate care .\n",
            "OBJECTIVES : To test the impact of training for staff who work with people who have co-existing mental health and substance use problems .\n",
            "DESIGN : A randomised controlled trial .\n",
            "SETTING : An NHS Primary Care Division in the West of Scotland .\n",
            "PARTICIPANTS : Forty-nine mental health nurses .\n",
            "METHODS : Intervention .\n",
            "A four-day training programme .\n",
            "Measurements : ( a ) therapeutic attitudes measured by the co-morbidity problems perceptions questionnaire ; ( b ) knowledge of alcohol , drugs and co-morbidity measured by a structured questionnaire .\n",
            "RESULTS : Significant effects for group ( F = @ , p < @ ) were found in therapeutic attitude scores and also over time ( F = @ , p < @ ) .\n",
            "A significant interaction was also found ( p < @ ) .\n",
            "Post-hoc testing revealed that the mean pre-training attitude score was significantly different from post-training ( p = @ ; @ % CI @ , @ ) and from six-months follow-up ( p < @ ; @ % CI @ , @ ) but that post-training and follow-up mean scores were not significantly different ( p = @ ; @ % CI -@ , @ ) .\n",
            "For knowledge , a significant group effect was found ( F = @ , p = @ ) , and also a significant time effect ( F = @ , p = @ ) but no significant interaction effect was present ( p = @ ) .\n",
            "The post-hoc testing revealed that only a pre-training to six-month follow-up time effect was statistically significant ( p = @ ; @ % CI @ , @ ) .\n",
            "CONCLUSIONS : The training programme was effective in improving the therapeutic attitudes of participants to working with clients who have co-existing mental health and substance use problems , both immediately after the training was delivered , and at six-months follow-up .\n",
            "It was also effective in improving participants ' overall knowledge of alcohol , drugs and co-morbidity .\n",
            "Objective : the atypical antipsychotic olanzapine has extensively been compared with haloperidol , studies vs. Other ( conventional ) neuroleptics are scarce .\n",
            "Method : we compared efficacy and safety of olanzapine ( ola ) and flupentixole ( flu ) , recently considered as \" partially atypical \" , in inpatients with schizophrenia ( dsm-iv ) in a randomized double-blind @-week-trial .\n",
            "Patients ( pts ) received @-@ mg/d of ola ( n = @ ; mean final dose @ Mg/d ) or @-@ mg/d flu ( n = @ ; @ Mg/d ) .\n",
            "Main outcomes : bprs , nsrs , cgi , pgi , sas , aims , aes , labs .\n",
            "Results : median bprs and nsrs totals decreased in ola and flu pts .\n",
            "( All p ?\n",
            "@ ) , No significant group differences .\n",
            "Responder rates ( ?\n",
            "@ % Decrease in bprs ) were similar .\n",
            "More eps events , biperiden use in flu pts ( both p ?\n",
            "@ ) .\n",
            "Weight gain higher in ola pts .\n",
            "( P < @ ) .\n",
            "Fewer pts with aes in ola group ( p = @ ) .\n",
            "Conclusion : overall and negative symptomatology improved in both groups ; ola demonstrated a more favorable adverse event profile , including eps .\n",
            "BACKGROUND : Cognitive training is effective for improving cognitive performance among people with schizophrenia .\n",
            "An individual 's perception of their own cognition is dissociable from performance on objective cognitive tests .\n",
            "Since subjective cognitive benefit may impact engagement , motivation , and satisfaction with time-intensive cognitive interventions , this study aimed to determine whether subjective cognitive difficulties improve in conjunction with cognitive gains following @h of cognitive training .\n",
            "METHODS : Patients with schizophrenia or schizoaffective disorder ( N = @ ) were randomized to treatment as usual ( TAU ) or TAU augmented with auditory-targeted cognitive training ( TCT ) .\n",
            "All participants completed assessment batteries at baseline and follow-up .\n",
            "As previously reported , the TCT group showed significant improvements in verbal learning and memory and reductions in auditory hallucinations relative to the TAU group .\n",
            "RESULTS : Subjective cognitive difficulties did not significantly improve following TCT , even among TCT participants who showed improvements in cognitive performance ( all ps > @ ) .\n",
            "Subjective cognitive difficulties were significantly associated with severity of depressive symptoms and hallucinations ( r = @ and r = @ , p < @ ) , but not global or specific domains of cognition ( all rs < @ ) at baseline .\n",
            "There were no significant relationships between change in subjective cognitive difficulties and change in cognitive or clinical variables ( all ps > @ ) .\n",
            "DISCUSSION : Patients with schizophrenia do not detect change in their cognition following cognitive training , even among those who showed robust gains in cognitive performance .\n",
            "Failure to detect improvement may undermine treatment engagement , motivation , and satisfaction .\n",
            "Translating score improvements on the cognitive exercises into tangible metrics , and providing ongoing , clinician-delivered feedback on performance may facilitate patient ability to detect improvements and improve motivation to engage with cognitive training interventions .\n",
            "Background : Naturalistic effectiveness trials of atypical antipsychotics are needed to provide broader information on efficacy , safety , and tolerability in patients with schizophrenia treated in a community practice setting .\n",
            "Method : In this @-week , open-label , multicentre study , patients with schizophrenia requiring a switch in antipsychotic medication because current medication was not well tolerated and/or clinical symptoms were not well controlled were randomized to receive aripiprazole or an atypical antipsychotic standard of care ( SOC ) treatment ( i.e. , olanzapine , quetiapine , or risperidone based on the investigator 's judgment of the optimal treatment for the individual patient and the patient 's prior response to antipsychotic medication ) .\n",
            "The primary objective was to compare the effectiveness of a @-week treatment of aripiprazole versus SOC , as measured by the Investigator Assessment Questionnaire ( IAQ ) total score at Week @ last observation carried forward ( LOCF ) ( primary endpoint ) , a validated measure that monitors relief or worsening of @ key symptoms associated with the psychopathology of schizophrenia and side effects of antipsychotic treatment .\n",
            "Secondary objectives were to further assess effectiveness using the Clinical Global Impression-Global Improvement ( CGI-I ) and Clinical Global Impression-Severity of Illness scale , to assess time to treatment discontinuation , patient preference of medication , quality of life , and the tolerability of aripiprazole compared with SOC .\n",
            "Results Aripiprazole treatment ( n = @ ) resulted in significantly better effectiveness than SOC treatment ( n = @ ; P < @ ; Week @ LOCF ) as evidenced by the IAQ total score beginning at Week @ ( the first assessment point ) and sustained through Week @ .\n",
            "A similar relationship was demonstrated among patients who completed the study ( observed cases analysis ) ; aripiprazole was associated with significantly better effectiveness at all time points with a greater differential effect from SOC over time .\n",
            "Patients treated with aripiprazole also demonstrated significantly greater improvements on the CGI-I scale ( responder rate , P = @ at Week @ LOCF ) , as well as on quality of life ( Quality of Life scale total score ; P < @ at Week @ ) .\n",
            "Furthermore , a significantly higher proportion of patients receiving aripiprazole rated their study medication as \" much better \" on the Preference of Medication Questionnaire ( POM ) scale than their pre-study medication compared with SOC patients ( P < @ ; Week @ ) .\n",
            "Time to treatment discontinuation and rates of discontinuation due to adverse events were similar in both treatment groups .\n",
            "The incidence of patients with one or more extrapyramidal symptom ( e.g. , akathisia , dystonia , parkinsonian events , and residual events ) was higher in patients receiving aripiprazole compared with patients treated with SOC ( @ % vs. @ % ) ; however , a higher proportion of patients in the SOC-treated group had clinically significant weight gain ( @ % vs. @ % for aripiprazole ) and potentially clinically relevant elevated fasting levels of total cholesterol , low-density lipoprotein cholesterol , triglycerides , and serum prolactin compared with patients receiving aripiprazole .\n",
            "Conclusions : Aripiprazole is an effective atypical antipsychotic for the treatment of schizophrenia , demonstrating better effectiveness than SOC agents used in this study in patients for whom a switch in antipsychotic medication was warranted .\n",
            "This trial is to evaluate the impact of a new Early Detection & Crisis Assessment team ( LEOCAT ) on Duration of Untreated Psychosis , pathways to care and engagement in community treatment of young people with first episode psychosis .\n",
            "LEOCAT is part of a larger Early Intervention service , the Lambeth Early Onset ( LEO ) service , for young people ( aged @ @ ) living in an inner city London borough .\n",
            "LEO CAT clinicians provided a brief GP education program as well as rapid access to initial assessments for new referrals .\n",
            "The trial involved a cluster randomisation of the @ GP practices in Lambeth ( only intervention group GPs received the education and rapid assessment from LEOCAT ) .\n",
            "@ patients with suspected first episode psychosis were referred to mental health services in Lambeth during the @ month study period .\n",
            "@ met the criteria for first presentation first episode psychosis and were followed up by LEO .\n",
            "@ consented to being interviewed for the study .\n",
            "@ % were registered with a GP ( @ % with the randomised Lambeth GPs ) .\n",
            "The intervention group practices did not refer more patients .\n",
            "The mean DUP of the Intervention Group patients was not found to be shorter though differences were observed in the final steps in their pathways to care and hospitalisation rates .\n",
            "Conclusion : GP education alone has limited impact on reducing overall DUP suggesting that broad public health education program is required to reduce DUP .\n",
            "However , early detection teams may be effective in reducing initial hospitalisation rates .\n",
            "Key-words : First Episode Psychosis , Early Detection & Intervention\n",
            "Meta-analytic data from over a decade of research in cognitive remediation , when combined with recent findings from basic and clinical neuroscience , have resulted in a new understanding of the critical elements that can contribute to successful cognitive training approaches for schizophrenia .\n",
            "Some of these elements include : the use of computerized repetitive practice methods , high dosing schedules , a focus on sensory processing , and carefully constrained and individually adapted learning trials .\n",
            "In a preliminary randomized controlled trial of cognitive training exercises based on these principles , we demonstrated significant improvements in working memory , verbal learning and memory , and global cognition in patients with schizophrenia .\n",
            "These cognitive improvements were accompanied by neurobiological findings suggestive of learning-induced cortical plasticity .\n",
            "Future directions for research and essential remaining questions are discussed .\n",
            "Pyritinol ( former chemical name pyrithioxine ) is a scavenger of free radicals and central cholinomimetic agent ( Benesov , Krejc , and Pavlk , @ ) .\n",
            "Its therapeutic efficacy in tardive dyskinesia ( TD ) was tested in a @-week double-blind cross-over placebo-controlled trial .\n",
            "To our knowledge , pyritinol was used in the treatment of TD for the first time .\n",
            "Pyritinol ( @ mg/day perorally ) or placebo were administered for the @ weeks after a one-week single-blind placebo period .\n",
            "The next @ weeks the medication was reversed .\n",
            "The neuroleptic dosage was kept constant for the whole trial .\n",
            "Twelve of seventeen psychiatric inpatients ( @ men and @ women , @ diagnosed as schizophrenia and @ as schizoaffective psychosis according to DSM-III-R ) completed the trial .\n",
            "The withdrawal of @ patients was unrelated to the experimental therapy .\n",
            "Mean age (  SD ) of the patients group was @  @ years .\n",
            "TD was assessed from videotape by two independent raters , using the Abnormal Involuntary Movement Scale ( AIMS ) .\n",
            "Pyritinol was significantly better than placebo in improving TD as measured by the total score of the AIMS ( ANOVA , df = @ ; F = @ ; P = @ ) .\n",
            "Simpson and Angus Rating Scale for Extrapyramidal Side Effects , Brief Psychiatric Rating Scale ( BPRS ) and Structured Adverse Effects Rating Scale ( SARS ) did not detect any treatment emergent symptoms on @ % level of significance .\n",
            "Our results support both hypotheses on the importance of free radicals ( Cadet et al. , @ ) and central cholinergic hypofunction ( Klawans , @ ) in TD development .\n",
            "Reference : Benesov , O. , Krejc , I. , Pavlk , A. ( @ ) Nootropic drugs .\n",
            "Avicenum , Prague , @ .\n",
            "Cadet , J.-L , Lohr , J. B. , Jeste , D. V. ( @ ) Free radicals and tardive dyskinesia .\n",
            "Trends Neurosci. , @ , @ , @ .\n",
            "Klawans , H. L. ( @ ) The pharmacology of tardive dyskinesias .\n",
            "Amer .\n",
            "J. Psychiatry @ , @ .\n",
            "@ actively hallucinating chronic female patients were administered to the Hospital Adjustment Scale ( HAS ) .\n",
            "They were then divided into @ groups with nearly equal group means .\n",
            "A psychologist and a pharmacist were the only ones aware of which patients received Frenquel and which received placebo pills .\n",
            "@ patients received @ mg of Frenquel tid for @ month , while @ patients received @ placebo pill for @ month .\n",
            "In @ of the @ patients in the Frenquel group , hallucinations were demonstrated and @ showed an increase in their expression of hallucinations .\n",
            "Of the @ placebo patients , one showed slight decrease in hallucinations and @ showed an increase in their expression of them .\n",
            "Both groups showed slight improvement on the HAS .\n",
            "There was no significant difference between the Frenquel and placebo groups either before or after treatment .\n",
            "[ Abstract - CSG ]\n",
            "To date , no study has evaluated the joint role of symptoms and adverse events as mediators of the effect of second-generation antipsychotics on patients ' social functioning .\n",
            "We used recently developed methods for mediation analysis with multiple mediators to clarify the interplay of adverse events and symptoms in explaining the effects of paliperidone ( R code for implementing the mediation analysis for multiple mediators is provided ) .\n",
            "We used data from @ participants in a @-week randomized dose-response trial that assigned three fixed dosages of ER OROS paliperidone ( @ , @ , and @ mg/day ) .\n",
            "The primary outcome was an individual 's score on the social performance scale assessed after @ weeks .\n",
            "The sum of Positive and Negative Syndrome Scale ( PANSS ) , weight gain , and extrapyramidal symptoms measured via the Simpson-Angus Scale after @ weeks were investigated as potential mediators and effect modifiers of treatment effects .\n",
            "Results from mediation analyses showed that the improvements in social functioning are partly explained by reduction in PANSS symptoms .\n",
            "Suggestive evidence that adverse events could play a role as mediators was found .\n",
            "In particular , weight gain displayed a non-linear relationship with social functioning , whereby beneficial effects observed at small levels of weight gain were reduced in the presence of excessive weight gain .\n",
            "In conclusion , we found that the short-term effects of paliperidone on social functioning were dependent on the successful reduction in PANSS symptoms and possibly the occurrence of excessive weight gain , thus suggesting future directions for treatment and interventions .\n",
            "Individuals with serious mental illnesses have high rates of comorbid physical health issues and have numerous barriers to addressing their health and health care needs .\n",
            "The present pilot study tested the feasibility of a modified form of the \" Bridge \" peer-health navigator intervention delivered in a usual care setting by agency personnel .\n",
            "The modifications concerned the use of an electronic personal health record with individuals experiencing with housing instability .\n",
            "Twenty participants were randomized to receive the intervention immediately or after @ months .\n",
            "Health navigator contacts and use of personal health records were associated with improvements in health care and self-management .\n",
            "This pilot study demonstrated promising evidence for the feasibility of adding personal health record use to a peer-led intervention .\n",
            "In this study , the efficacy and side effects of risperidone in treatment of positive symptoms of schizophrenia , and compared with conventional antipsychotics , the results reported below .\n",
            "An object and method , the object according to the CCMD schizophrenia diagnostic criteria [ @ ] and the Brief Psychiatric Rating Scale ( BPRS ) [ @ ] > @ points , sub-scale of the positive symptoms ( SAPS ) [ @ ]  @ points , negative Syndrome Scale ( SANS ) in [ @ ]  @ points .\n",
            "Meet the inclusion criteria in-patients in May @ to October @ , a total of @ cases .\n",
            "Were randomly divided into experimental and control groups , two groups of patients are traditional antipsychotics and have not been effective by .\n",
            "Course of @ to @ years , the average ( @ @  @ @ ) year .\n",
            "Second , the method of experimental group were treated with risperidone monotherapy .\n",
            "@  @ .\n",
            "sIntroduction : Neuroleptic-induced acute akathisia ( NIA ) is a common and distressing extrapyramidal symptom usually resulting from the use of antipsychotic medication.Despite its high incidence ( @ % -@ % ) , the underlying mechanism of NIA has not yet been adequately explained .\n",
            "Although treatment strategies for NIA have traditionally included anticholinergic agents , gamma-aminobutyric acid agents , dopamine enhancers , and the beta-adrenergic antagonists , many patients fail to respond .\n",
            "Trazodone ( Trz ) is an antidepressant agent demonstrating prominent serotonergic antagonistic properties .\n",
            "In a recent pilot open-label trial , Trz demonstrated to be strongly effective in the treatment of NIA in @ female schizophrenic patients.Objective : On the basis of the results of this pilot study , we investigate further the efficacy of Trz in the treatment of NIA in a double-blind , placebo ( Pla ) - controlled , crossover design.Methods : Thirteen inpatients with Diagnostic and Statistical Manual of Mental Disorders , Fourth Edition schizophrenia or schizo-affective disorder and with Diagnostic and Statistical Manual of Mental Disorders , Fourth Edition NIA with a severity of at least mild akathisia according to the Barnes Akathisia Rating Scale participated in the study .\n",
            "Patients were randomly assigned to either the order Trz-Pla or the order Pla-Trz in the treatment periods .\n",
            "Each period lasted for @ consecutive days ( days @-@ and @-@ ) .\n",
            "Eight patients were treated with the Trz-Pla order ( @ mg/d before bedtime ) ; and @ , with the opposite order ( Pla-Trz ) .\n",
            "Results : Statistically significant improvement in most symptoms of NIA , as measured by the Barnes Akathisia Rating Scale , was detected with Trz compared with Pla treatment.Conclusions : The findings of this double-blind , placebo-controlled , crossover study indicate the efficacy of Trz in the management of NIA , corroborating the results of a preliminary pilot study .\n",
            "We suggest that Trz 's property of serotonin @A postsynaptic receptor antagonism may be its principal mechanism for the improvement of NIA .\n",
            "Objective To explore the role of cognitive behavioral therapy for anxiety in rehabilitation of patients with schizophrenia .\n",
            "Hospitalized rehabilitation of schizophrenia patients met inclusion criteria , @ cases according to the order of hospitalization were randomly divided into experimental and control groups , experimental group cognitive behavioral therapy , the control group of conventional care , respectively , to participate in the case before and after Zung 's self-rating anxiety scale ( SAS ) assessed .\n",
            "SAS points of SAS score in the experimental group of patients participated in cognitive behavioral therapy was significantly lower than control group scores between groups was statistically significant ( P < @ ) , the experimental group participated in cognitive behavioral therapy significantly lower than before the event , by comparison statistically significant ( P < @ ) .\n",
            "Administered haloperidol ( @ mg/day ) and lorazepam ( @ mg/day ) or placebo to @ acutely psychotic patients in strict random order and on a double-blind between-Ss design .\n",
            "Ss were evaluated weekly for @ wks on a target-symptoms scale and on the M. Hamilton anxiety rating scale .\n",
            "A global clinical assessment was also made weekly to evaluate the state of the disease in relation to the immediately preceding week , and a final global clinical assessment was made after all @ wks of therapy .\n",
            "Results show a trend in favor of the lorazepam-treated group which , however , did not reach statistical significance ( p < .@ ) for the values of the rating scales .\n",
            "Lorazepam did have a beneficial effect on some individual symptoms ( e.g. , anxious mood , insomnia , delusions-hallucinations , fears , behavior in the ward and at interview , and agitation ) .\n",
            "These benefits showed either as more Ss improving earlier or as a total of more Ss improving at the end of the trial .\n",
            "When Ss were assessed from a clinical point of view , with the state of the disease evaluated in terms of the immediately preceding week , significantly more Ss on lorazepam than on placebo improved in the @st and last weeks of treatment .\n",
            "The incidence and type of side effects were similar in both groups .\n",
            "Background : Brain glutathione levels are decreased in schizophrenia , a disorder that often is chronic and refractory to treatment .\n",
            "N-acetyl cysteine ( NAC ) increases brain glutathione in rodents .\n",
            "This study was conducted to evaluate the safety and effectiveness of oral NAC ( @ g orally twice daily [ b.i.d. ] ) as an add-on to maintenance medication for the treatment of chronic schizophrenia over a @-week period .\n",
            "Methods : A randomized , multicenter , double-blind , placebo-controlled study .\n",
            "The primary readout was change from baseline on the Positive and Negative Symptoms Scale ( PANSS ) and its components .\n",
            "Secondary readouts included the Clinical Global Impression ( CGI ) Severity and Improvement scales , as well as general functioning and extrapyramidal rating scales .\n",
            "Changes following a @-week treatment discontinuation were evaluated .\n",
            "One hundred forty people with chronic schizophrenia on maintenance antipsychotic medication were randomized ; @ completed treatment .\n",
            "Results : Intent-to-treat analysis revealed that subjects treated with NAC improved more than placebo-treated subjects over the study period in PANSS total [ -@ ( -@ , -@ ) , p = .@ ] , PANSS negative [ mean difference -@ ( @ % confidence interval : -@ , -.@ ) , p = .@ ] , and PANSS general [ -@ ( -@ , -.@ ) , p = .@ ] , CGI-Severity ( CGI-S ) [ -.@ ( -.@ , -.@ ) , p = .@ ] , and CGI-Improvement ( CGI-I ) [ -.@ ( -.@ , -.@ ) , p = .@ ] scores .\n",
            "No significant change on the PANSS positive subscale was seen .\n",
            "N-acetyl cysteine treatment also was associated with an improvement in akathisia ( p = .@ ) .\n",
            "Effect sizes at end point were consistent with moderate benefits .\n",
            "Conclusions : These data suggest that adjunctive NAC has potential as a safe and moderately effective augmentation strategy for chronic schizophrenia .\n",
            "Service level agreements ( SLAs ) are a means of improving communication and collaboration between primary and secondary care .\n",
            "They reflect local needs and resources and specify the services to be provided , including guidelines for communication , referral and shared care .\n",
            "This study will use a randomised controlled trial to examine the effect of locally negotiated SLAs on the health and quality of care of the long term mentally ill .\n",
            "Funding for a @ month pilot study has been agreed in the first instance .\n",
            "Randomized-controlled-trial Practices : General practices with a majority of their patients within the Mental Health Trust boundaries , with a computerised repeat prescribing system .\n",
            "Global Assessment of Functioning ( GAF ) , Health of the Nation Outcome Scale ( HoNOS ) , Verona Satisfaction Scales ( VECS and VSSS ) , GHQ for patient carers , Client Service Receipt Interview ( CSRI ) to assess cost , questionnaires to evaluate staff views on the clarity of roles and attitudes to the primary / secondary care interface .\n",
            "Purpose : To compare the efficacy and tolerability of ziprasidone @-@ mg BID and risperidone @-@ mg BID in acute exacerbation of schizophrenia or schizoaffective disorder .\n",
            "Methods : In an @-week ( randomized , double-blind trial , primary efficacy evaluations were PANSS Total and CGI # S scores ; secondary variables included PANSS Negative Subscale score , BPRSd Total and Core scores , and Global Assessment of Functioning ( GAF ) .\n",
            "Primary efficacy analyses were based on evaluable patients ( = @ days of treatment ) .\n",
            "Completers could enter a @-week , double-blind continuation study .\n",
            "Results : On the basis of a predetermined equivalency criterion , evaluable ziprasidone ( n = @ ) and risperidone ( n = @ ) patients demonstrated equivalent efficacy improvements in primary and secondary measurements .\n",
            "Ziprasidone had a significantly lower mean Movement Disorder Burden Score ( MDBS ) and lower incidences of prolactin elevation and weight gain = @ % .\n",
            "In the @-week continuation , ziprasidone ( n = @ ) and risperidone ( n = @ ) groups exhibited comparable , sustained improvement in efficacy variables from baseline of the @-week study .\n",
            "MDBS and incidences of prolactin elevation and weight gain = @ % remained lower with ziprasidone .\n",
            "Conclusion : Patients receiving @ weeks of double-blind ziprasidone or risperidone demonstrated comparable symptom improvement ; patients on ziprasidone had a lower movement disorder burden and lower incidences of prolactin elevation and clinically significant weight gain . )\n",
            "@ schizophrenic outpatients randomly assigned to chlorpromazine , promazine , or placebo treatments were studied .\n",
            "A method of coding the frequency of treatment emergent somatic complaints ( TEF ) from psychiatric chart notes was devised .\n",
            "The study sought to determine : ( a ) the association between such complaints and the @ treatments , and ( b ) the association between frequency of TEF and reduction in paranoid symptoms in a high paranoid subsample receiving drug treatment only ( N = @ ) .\n",
            "Both active drugs could be differentiated from placebo in terms of frequency of TEF ( p < .@ ) , and the communication of such complaints was positively associated with reduction in paranoid thought ( p < .@ ) .\n",
            "Drugs appear to facilitate a form of communication which in turn is a response leading to symptom change .\n",
            "The communication of somatic complaints is viewed as a cognitive process interfering with paranoid ideation .\n",
            "( @ ref . )\n",
            "INTRODUCTION : Efficacy of repetitive Transcranial Magnetic Stimulation ( rTMS ) targeting the temporo-parietal junction ( TPJ ) for the treatment of auditory verbal hallucinations ( AVH ) remains under debate .\n",
            "We assessed the influence of a @Hz rTMS treatment on neural networks involved in a cognitive mechanism proposed to subserve AVH .\n",
            "METHODS : Patients with schizophrenia ( N = @ ) experiencing medication-resistant AVH completed a @-day @Hz rTMS treatment .\n",
            "Participants were randomized to active stimulation of the left or bilateral TPJ , or sham stimulation .\n",
            "The effects of rTMS on neural networks were investigated with an inner speech task during fMRI .\n",
            "Changes within and between neural networks were analyzed using Independent Component Analysis .\n",
            "RESULTS : rTMS of the left and bilateral TPJ areas resulted in a weaker network contribution of the left supramarginal gyrus to the bilateral fronto-temporal network .\n",
            "Left-sided rTMS resulted in stronger network contributions of the right superior temporal gyrus to the auditory-sensorimotor network , right inferior gyrus to the left fronto-parietal network , and left middle frontal gyrus to the default mode network .\n",
            "Bilateral rTMS was associated with a predominant inhibitory effect on network contribution .\n",
            "Sham stimulation showed different patterns of change compared to active rTMS .\n",
            "CONCLUSION : rTMS of the left temporo-parietal region decreased the contribution of the left supramarginal gyrus to the bilateral fronto-temporal network , which may reduce the likelihood of speech intrusions .\n",
            "On the other hand , left rTMS appeared to increase the contribution of functionally connected regions involved in perception , cognitive control and self-referential processing .\n",
            "These findings hint to potential neural mechanisms underlying rTMS for hallucinations but need corroboration in larger samples .\n",
            "This study investigated the effect of \" dose \" and the components of Cognitive Behavioral Therapy ( CBT ) on treatment effects .\n",
            "It is a secondary analysis of the ACTION ( Assessment of Cognitive Therapy Instead of Neuroleptics ) trial which investigated CBT for people with schizophrenia spectrum disorders that chose not to take antipsychotic medication .\n",
            "Using instrumental variable methods , we found a \" dose-response \" such that each CBT session attended , reduced the primary outcome measure ( the PANSS total score ) by approximately @ points ( @ % CI -@ to -@ , p = @ ) .\n",
            "This suggests that length of therapy is important for those that receive CBT in the absence of antipsychotic medication .\n",
            "Secondly , using principal stratification we examined the process variables that modified treatment effects .\n",
            "Findings revealed that those who received a longitudinal formulation in the first @ sessions of CBT had poorer treatment effects than those who did not , however this finding was not statistically significant ( @ % CI -@ , @ , p = @ ) .\n",
            "However , it is important to note that these findings were evident in an exploratory analysis with a small sample .\n",
            "Future larger scale studies are needed to help understand components of effective treatment .\n",
            "Objective To compare risperidone insight of the ketone and haloperidol in the treatment of patients with schizophrenia to improve the situation .\n",
            "Patients with schizophrenia randomized to use these two drugs , application Markova insight in the table , changes in total insight score and factor scores before and after treatment .\n",
            "The two groups of patients knew the force of the total score no significant difference between the results before and after treatment , factor @ there are significant differences .\n",
            "Conclusion Risperidone for schizophrenia patients knew that the recovery of force .\n",
            "Background : Paliperidone extended-release tablet ( paliperidone ER ) is an oral psychotropic agent developed for schizophrenia treatment .\n",
            "Paliperidone ( @-OH-risperidone , metabolite of risperidone ) , when used with OROS technology has a unique pharmacokinetic profile undergoing limited hepatic metabolism .\n",
            "Methods : The efficacy and safety of once-daily paliperidone ER ( @ mg , @ mg and @ mg ) were compared with placebo in @ patients with acute schizophrenia in a @-week , multicenter , double-blind , randomized , parallel-group study .\n",
            "An assay sensitivity group with known efficacy was included to confirm trial validity ( olanzapine @ mg ) .\n",
            "Results : All doses of paliperidone ER demonstrated significant improvements in PANSS total and PANSS factors scores ( p < @ ) and in personal and social functioning ( p < @ ) compared with placebo .\n",
            "Symptom improvement has been observed at the first observation assessment ( Day @ ) ( p < @ ) compared with placebo , suggesting a rapid onset of action for paliperidone ER .\n",
            "Paliperidone ER was associated with a low incidence of treatment-emergent adverse events .\n",
            "The incidence of movement disorder-related adverse events and rating scale scores were similar in the paliperidone ER @ mg and placebo groups and increased with dose .\n",
            "Increases in prolactin plasma levels and dose-related increases in body weight ( < @ kg ) were observed ; there were no significant changes in serum lipid or glucose levels .\n",
            "Conclusion : In this study , all doses of paliperidone ER were effective in significantly improving the symptoms of schizophrenia and personal and social functioning and were generally well tolerated .\n",
            "As such , paliperidone ER may provide a valuable new treatment option for patients with schizophrenia .\n",
            "We aimed to evaluate the feasibility of Cognitive Therapy ( CT ) as an intervention for internalised stigma in people with psychosis .\n",
            "We conducted a single-blind randomised controlled pilot trial comparing CT plus treatment as usual ( TAU ) with TAU only .\n",
            "Participants were assessed at end of treatment ( @ months ) and follow-up ( @ months ) .\n",
            "Twenty-nine participants with schizophrenia spectrum disorders were randomised ( sixteen of whom were from early intervention services ) .\n",
            "CT incorporated up to @ sessions over @ months ( mean sessions = @ ) .\n",
            "Primary outcome was the Internalised Stigma of Mental Illness Scale - Revised ( ISMI-R ) total score , which provides a continuous measure of internalised stigma associated with mental health problems .\n",
            "Secondary outcomes included self-rated recovery , internalised shame , emotional problems , hopelessness and self-esteem .\n",
            "Recruitment rates and retention for this trial were good .\n",
            "Changes in outcomes were analysed following the intention-to-treat principle , using ANCOVAs adjusted for baseline symptoms .\n",
            "There was no effect on our primary outcome , with a sizeable reduction observed in both groups , but several secondary outcomes were significantly improved in the group assigned to CT , in comparison with TAU , including internalised shame , hopelessness and self-rated recovery .\n",
            "Exploratory analyses focusing on those within early intervention services will also be presented .\n",
            "Stigma-focused CT appears feasible and acceptable in people with psychosis who have high levels of internalised stigma .\n",
            "A larger , definitive trial is required .\n",
            "To investigate the effect of group therapy by nurses on chronic psychiatric patients , @ chronic psychiatric patients between the ages of @ and @ , hospitalized on two regressed , continued care wards and one community care preparation ward at the Veterans Administration Hospital , Augusta , Georgia , were paired , using the variables of age , diagnosis , and number and duration of hospitalizations , and assigned to five control and five experimental groups ( ten patients per group ) .\n",
            "Experimental subjects attended group therapy sessions , led by two nurses , twice a week ; control subjects did not .\n",
            "All subjects were evaluated by two nursing assistants on the NOSIE-@ scale prior to group therapy , after ten sessions , and at the end of @ sessions .\n",
            "Paired t-tests were computed on pre - and postdata for six factors .\n",
            "Data from an evaluation scale of the most regressed ward indicated leader-patient interaction .\n",
            "Sociogram evaluation revealed @ percent positive interactions .\n",
            "Topics most frequently mentioned were nature in regard to delusional systems and interpersonal relations in the hospital and home .\n",
            "Findings supported the use of group therapy with chronic regressed psychiatric patients .\n",
            "\" Objective To compare the quetiapine and risperidone in the treatment of women with schizophrenia the efficacy and safety of @ female patients with schizophrenia were randomly divided into @ groups of @ cases , quetiapine quetiapine @ @ mg  d ^ -@ , po , bid ; risperidone group risperidone @ @ mg  d ^ -@ , po , bid .\n",
            "Adverse reactions with the Brief Psychiatric Rating Scale ( BPRS ) , Scale ( TESS ) assessing observed for six weeks .\n",
            "Results quetiapine group @ % , markedly effective rate @ % cure rate @ % , similar to the risperidone group .\n",
            "Quetiapine control excitement impulse aggression than risperidone ( P < @ ) , extrapyramidal symptoms , weight gain , a lighter menstrual disorders and other adverse reactions ( P < @ or P < @ ) .\n",
            "Other adverse reactions between the two groups is similar , and to a lesser extent .\n",
            "Conclusion of quetiapine in the treatment of female schizophrenia is safe and effective , especially for the young , not fertility patients . \" \"\n",
            "\" OBJECTIVE : To assess sublingual asenapine for acute agitation .\n",
            "METHOD : Agitated adults @-@ years ( any diagnosis ) presenting for treatment in an emergency department and found to have a score of > / = @ on the Positive and Negative Syndrome Scale-Excited Component ( PANSS-EC ) were randomized to receive either a single dose of a sublingual @ mg tablet of asenapine or placebo .\n",
            "Primary outcome measure was change in the PANSS-EC score from baseline to @ h after medication or placebo administration .\n",
            "Secondary outcomes included the percentage of responders with a > / = @ % reduction from baseline on the PANSS-EC score at @ h. RESULTS : A total of @ subjects were randomized , @ each to sublingual asenapine or placebo .\n",
            "Mean ( SE ) baseline PANSS-EC scores for the asenapine-treated and placebo-treated subjects were @ + / - @ and @ + / - @ , respectively .\n",
            "Mean PANSS-EC scores at endpoint ( LOCF ) was @ + / - @ for the asenapine-treated subjects and @ + / - @ for the placebo-treated subjects .\n",
            "Change in PANSS-EC score at @ h was statistically significantly greater for the asenapine-treated subjects compared with the placebo-treated subjects .\n",
            "NNT for response vs. placebo was @ ( @ % CI @-@ ) .\n",
            "CONCLUSION : Sublingual asenapine was efficacious in the treatment of agitation with an effect size comparable to that observed in prior studies of intramuscular antipsychotics . \"\n",
            "Objective - Tardive dyskinesia ( TD ) is a severe side effect of classical antipsychotics .\n",
            "We designed a DOUBLE-blind , PLACEBO-controlled study to evaluate the effect of risperidone on reducing the severit of TD .\n",
            "Method : Fifty patients with schizophrenia with severe TD were included .\n",
            "Their original antipsychotic dosage was less than @ mg/day of chlorpromazine equivalents .\n",
            "All the antipsychotics were withdrawn for @ weeks , then the patients were RANDOMly assigned to receive risperidone or PLACEBO .\n",
            "Risperidone , @ mg/day and an identical-looking PLACEBO were prescribed to each group for @ weeks .\n",
            "The TD condition was evaluated blindly by a psychiatrist with the Abnormal Involuntary Movement Scale ( AIMS ) every @ weeks .\n",
            "Result : Eight patients dropped out due to unstable psychiatric or medical conditions .\n",
            "The final sample consisted of @ cases in the risperidone group and @ cases in the control group .\n",
            "The baseline AIMS score of all patients was @  @ .\n",
            "Sixteen patients ( @ % ) in the risperidone group and five patients ( @ % ) in the control group had significant reductions in TD ( Fisher 's exact p = @ ) .\n",
            "The final average AIMS score was @ ( SD = @ ) for the risperidone group and @ ( SD = @ ) for the control group ( t = -@ , df = @ , p = @ ) .\n",
            "Conclusion : For patients with severe TD , changing to risperidone can decrease TD more significantly than neuroleptic withdrawal\n",
            "A double-blind , RANDOMized study of parallel group design comparing remoxipride and thioridazine ( dose range @-@ mg/day of either drug ) was undertaken at @ Australian centres .\n",
            "A total of @ patients ( remoxipride = @ , thioridazine = @ ) with DSM-III-R schizophrenia or schizophreniform disorder commenced the study , and @ patients ( remoxipride = @ , thioridazine = @ ) completed the @ weeks of the trial .\n",
            "The mean daily doses at last rating were @ mg ( remoxipride ) and @ mg ( thioridazine ) .\n",
            "Initial Brief Psychiatric Rating Scale scores decreased by a mean @ points in both remoxipride and thioridazine groups .\n",
            "Equivalent treatment responses were also confirmed by Clinical Global Impression .\n",
            "During the study , sedatives or hypnotics were needed by @ % of the remoxipride patients and @ % of the thioridazine patients .\n",
            "Thioridazine was associated with more postural hypotension , drowsiness , increased sleep , headache , dizziness on rising , dry mouth , sexual dysfunction and weight gain , while remoxipride patients reported more insomnia .\n",
            "There were no differences between remoxipride and thioridazine on dystonia , hypokinesia , dyskinesia , rigidity and akathisia .\n",
            "The results indicate that remoxipride has similar antipsychotic efficacy to thioridazine but causes fewer side effects .\n",
            "Objective To compare risperidone and clozapine on the quality of life of patients with schizophrenia .\n",
            "@ patients with schizophrenia were randomly divided into the risperidone group and the clozapine group , respectively , risperidone , clozapine treatment in August .\n",
            "Positive and negative symptoms scale ( PANSS ) , the comprehensive assessment of the quality of life questionnaire ( GQOLI ) , side effects scale ( TESS ) to evaluate the efficacy , quality of life and side effects .\n",
            "PANSS score after treatment , the risperidone group decreased significantly ( P < @ ) , quite with the clozapine group ( P > @ ) ; GQOLI score in the risperidone group after treatment was significantly higher ( P < @ ) was significantly higher than the chlorine mirtazapine group ( P < @ ) ; risperidone group TESS total score after treatment was significantly lower than in clozapine group ( P < @ ) ; GQOLI total score and PANSS total scores and TESS score was negatively correlated .\n",
            "Zotepine is a unique dibenzothiepine antipsychotic , effective in the treatment of schizophrenia .\n",
            "This drug produces a balanced inhibition of human dopamine receptors ( Needham et al , this meeting ) which may be the basis of its atypical antipsychotic activity .\n",
            "In this study we have compared the efficacy and tolerance of zotepine with that of haloperidol .\n",
            "Using the DSM-III-R definition of schizophrenia , @ patients were recruited suffering from an acute exacerbation of subchronic or chronic disease , with a score of @ or more on the Clinical Global Impressions ( CGI ) severity scale .\n",
            "They were randomized to receive zotepine @ mg daily or haloperidol @ mg daily with the facility to reduce the dose to half , if required , during this eight-week , double-blind , multicentre , parallel-group study .\n",
            "Change in mean scores from baseline to endpoint was used for both efficacy measurement : Brief Psychiatric Rating Scale ( BPRS ) , Scale for Assessment of Negative Symptoms ( SANS ) , CGI severity and improvement scales , and tolerance : Simpson and Angus Extrapyramidal Scale ( EPMS ) and Abnormal Involuntary Movement Scale ( AIMS ) .\n",
            "Analysis of the scores is presented in the table for the \" intention to treat \" data .\n",
            "Changes in mean scores from baseline to endpoint Scale Zotepine Haloperidol @ % Cl for Significance n = @ n = @ difference BPRS -@ -@ - @ to @ N.S. SANS -@ -@ -@ to @ p = @ CGI Improvement +@ +@ - @ to @ N.S. CGI Severity -@ -@ -@ to @ N.S. AIMS -@ +@ N.A. * N.S. EPMS -@ +@ -@ to -@ p = @ * Analysis based on ranked data There was no significant difference in the number of patients reporting adverse events ( zotepine @ % , haloperidol @ % ) .\n",
            "The frequency and type of side effect differed between the drugs , e.g. akathisia was only reported in the haloperidol group ( p = @ ) and EPMS side effects were less in the zotepine group ( N.S. ) .\n",
            "Reports of increased liver enzyme measurements ( AST , ALT ) were more frequent for zotepine but not significantly different for haloperidol .\n",
            "The study demonstrated that both drugs are effective antipsychotic agents reducing mean BPRS scores in excess of @ % ( zotepine @ , haloperidol @ ) .\n",
            "Both drugs were well tolerated with differing side-effect profiles , zotepine producing fewer EPMS side effects .\n",
            "The significant reduction in the SANS score ( p = @ ) with zotepine suggests that a further study in negative symptoms should be performed .\n",
            "Reference : P L Needham , J Atkinson and D J Heal , Binding of zotepine and other antipsychotics to cloned human dopamine receptors ( this meeting ) .\n",
            "The clinical effects of chlorpromazine ( CPZ ) administered in accordance with a double-blind design in one of three doses ( @ , @ or @ mg ) were examined in @ psychotic patients .\n",
            "The relationships between the effects and the CPZ concentrations in plasma and cerebrospinal fluid ( CSF ) were analyzed .\n",
            "The antipsychotic and side effects were rated according to the CPRS and the Simpson and Angus scale .\n",
            "CPZ concentrations were measured by a mass fragmentographic method .\n",
            "Treatment with CPZ resulted in a significant reduction of morbidity scores , without any clear dose relation .\n",
            "The final outcome was more favourable in women than in men .\n",
            "Extrapyramidal side effects but not somnolence were positively dose related .\n",
            "The antipsychotic effects tended to be positively related to the dose of CPZ in mg/kg as well as the CPZ concentrations in plasma and CSF .\n",
            "The greatest number of significant correlations between the CPZ concentration in CSF and the morbidity scores were seen after @ weeks of treatment .\n",
            "The results indicated marked clinical improvement with CPZ concentrations above @ ng/ml in CSF and @ ng/ml in plasma .\n",
            "After @ weeks of treatment the correlations between the CPZ concentrations and the clinical improvement were still positive but the coefficients were lower than at @ weeks and only occosionally significant .\n",
            "Extrapyramidal symptoms were significantly related to the CPZ concentrations in plasma and CSF .\n",
            "Somnolence was significantly related to the CPZ concentrations in CSF .\n",
            "Objective : To evaluate the safety and tolerability of asenapine a novel psychopharmacologic agent in patients with acute schizophrenia .\n",
            "Methods : In a double-blind multicenter trial adult patients with acute exacerbation of schizophrenia were randomly assigned to @ weeks of treatment with sublingual asenapine @ mg BID plus oral placebo oral risperidone @ mg BID plus sublingual placebo or double placebo BID .\n",
            "Adverse events and extrapyramidal symptoms EPS were assessed weekly and @ days after study exit .\n",
            "Results : Among @ patients who received study medication asenapine n@ ; risperidone , n@ ; placebo , n@ ) , @ ( @ % ) had @ ; @ adverse event .\n",
            "The most frequently reported events were headache and agitation ( placebo and risperidone ) , followed by transient sleep disturbances active medications Although there were no significant between-group differences on formal ratings of EPS hypertonia and hyperkinesia were more frequent with risperidone @ % and @ % respectively than with placebo @ % @ % or asenapine @ % @ % and concomitant use of antiparkinsonian drugs was more frequent with risperidone @ % than with asenapine @ % Clinically significant weight gain @ ; @ % increase in body weight ) occurred more often with risperidone ( @ % ) than with asenapine or placebo ( @ % and @ % ; both P @ ; @ ) ; mean weight gain was similar in all @ treatment groups among normal-weight patients , but greater with risperidone among overweight patients .\n",
            "The incidence of hyperprolactinemia was higher with risperidone @ % than with asenapine or placebo @ % and @ % ; both P @ , and @ ) .\n",
            "Changes in blood pressure and heart rate were comparably small in all @ treatment groups , and there were no cases of QTc prolongation beyond @ ms in any group .\n",
            "Conclusions : Asenapine appears to be well tolerated by patients with acute schizophrenia and is associated with low incidence rates of EPS hyperprolactinemia and clinically significant weight gain .\n",
            "Funding Source .\n",
            "This study was supported by Organon USA Inc and Pfizer Inc .\n",
            "Oculomotor dysfunctions have been well documented within schizophrenia spectrum populations and are thought to represent sensitive biomarkers of antipsychotic as well as cognitive enhancing compounds .\n",
            "The study examines the effects of antipsychotic and procholinergic compounds on oculomotor performance and investigates if schizotypal individuals show a differential profile of drug response than controls .\n",
            "@ participants performed prosaccade , antisaccade and smooth pursuit eye movement tasks after being randomly assigned to one of @ drug groups ( nicotine , risperidone , amisulpride , placebo ) .\n",
            "Participants were classified into medium and high schizotypy groups measured by the Schizotypal Personality Questionnaire ( SPQ ) .\n",
            "A main effect of Drug was found for saccadic peak velocity ( p < @ ) , indicating reduced velocity with risperidone .\n",
            "AS error rate showed a main effect of Drug ( p < @ ) with nicotine improving performance ( p = @ ) , as well as a Drug by Schizotypy interaction ( p = @ ) indicating higher error rates in medium schizotypes under risperidone compared to placebo ( p = @ ) .\n",
            "High schizotypes showed a non significant trend ( p = @ ) for improvement under the influence of antipsychotics .\n",
            "For the key biomarker of antisaccade error rate there was a trend towards the expected modulation of drug effects by schizotypy status .\n",
            "The findings represent promising trends for future research investigating pharmacological influences on high risk and schizophrenia spectrum populations .\n",
            "BACKGROUND : Almost a quarter of patients with schizophrenia present with resistant auditory verbal hallucinations ( AVH ) , a phenomenon that may relate to activation of brain areas underlying speech perception .\n",
            "Repetitive transcranial magnetic stimulation ( rTMS ) at @ Hz reduces cortical activation , and recent results have shown that @-Hz left temporoparietal rTMS may reduce AVH .\n",
            "The aim of this study was to replicate recent data and investigate whether low-frequency rTMS with a high total stimulation number delivered in a shorter @-day block produces similar benefit .\n",
            "METHODS : Ten right-handed schizophrenia patients with resistant AVH received @ days of active rTMS and @ days of sham rTMS ( @ stimulations per day at @ % of motor threshold ) over the left temporoparietal cortex in a double-blind crossover design .\n",
            "The two weeks of stimulation were separated by a @-week washout period .\n",
            "RESULTS : AVH were robustly improved ( @ % ) by @ days active rTMS , whereas no variation was observed after sham .\n",
            "Seven patients were responders to active treatment , five of whom maintained improvement for at least @ months .\n",
            "CONCLUSIONS : These data confirm the efficiency of low-frequency rTMS applied to the left temporoparietal cortex , compared with sham stimulation , in reducing resistant AVH .\n",
            "This improvement can be obtained in only @ days without serious initial adverse events .\n",
            "Allocated @ chronic schizophrenic patients to @ matched groups , @ group acting as an own-ward no-treatment control group .\n",
            "The @ other groups moved to a token economy ward , where the token group received contingent tokens , social reinforcement , and informational feedback as a consequence of appropriate behavior , and where the control group received contingent social reinforcement and feedback with a matched amount of noncontingent tokens .\n",
            "After a @-mo baseline phase , this procedure was followed for a total of @ mo .\n",
            "A continuous assessment system was used with some weekly and monthly assessments , incorporating nursing checklists and ratings , psychiatric ratings , psychological tests , and time - sampling procedures , as well as continuous monitoring of the ward program .\n",
            "The introduction of contingent tokens had an immediate positive effect in @ areas of behavior , but this advantage disappeared over the @ mo owing to the slower but sustained improvement in the control group .\n",
            "Significant improvement was limited to the areas of social withdrawal , appearance , and routine .\n",
            "The patients who improved the most on any measure were those who were initially the most deteriorated .\n",
            "There were paradoxical changes in nontarget behavior , and in symptomatic behavior .\n",
            "It is noted that suggestions and instructions to nurses may play a major part in influencing patient behavior within and between experimental phases .\n",
            "( @ ref )\n",
            "Objective To compare the Invensys between Sulpiride for schizophrenia , the clinical efficacy and the role of the characteristics of each symptom group , to observe the side effects .\n",
            "Method will meet the inclusion criteria of patients with schizophrenia were randomly divided into two groups of risperidone and sulpiride , to assess its efficacy and side effects using the PANSS , CGI and TESS .\n",
            "Risperidone group the results of @ cases , @ cases of sulpiride group , the overall efficacy of risperidone group than the sulpiride group , and its negative symptoms , general psychopathology symptom factor scores and PANSS total scores and SI , the GI score better than the sulpiride group .\n",
            "more significant effect on negative symptoms .\n",
            "No significant difference in the TESS between the two groups .\n",
            "A large amount of studies suggests that the noradrenergic and serotoninergic systems are involved in the pathogenesis of schizophrenia ( @ ) .\n",
            "In a preliminary prospective study , @ patients hospitalized for schizophrenic relapse were administered haloperidol at a fixed dose ( @ mg/kg/day ) for six weeks , plus clonidine ( @.@ mg/day ) in the first week of hospitalization .\n",
            "In the following @ days clonidine was tapered and stopped while maintaining the same haloperidol dosage .\n",
            "Six patients had a quick decrease of positive symptoms , while two of them showed no benefit from the haloperidol-clonidine association .\n",
            "Two weeks later , desipramine ( @ mg/day ) or paroxetine ( @ mg/day ) were randomly associated to haloperidol .\n",
            "Four patients received desipramine and @ received paroxetine .\n",
            "Six patients benefited from the haloperidol-clonidine combined treatment : four of them received desipramine and @ received paroxetine .\n",
            "All the patients who received desipramine showed a rapid remission of their symptoms and could be discharged from the hospital in the next @ days .\n",
            "One of the patients who received paroxetine showed no improvement , while the other showed a significant worsening of his symptomatology .\n",
            "The @ patients who had not benefited from the haloperidol-clonidine association received paroxetine .\n",
            "Both of them improved their clinical conditions as much as to be discharged in the following @ days .\n",
            "Strikingly , patients who had benefited from the haloperidol-desipramine or haloperidol-paroxetine association were discharged in such good clinical conditions as never experienced in previous relapse episodes .\n",
            "Our results are undoubtedly preliminary because of the small number of patients studied , but some suggestions may be put forward for future research .\n",
            "Firstly , the haloperidol-clonidine association may be helpful in reducing positive symptoms in the first period of schizophrenic relapse .\n",
            "Secondly , noradrenergic or serotoninergic antidepressants associated to haloperidol might give a better outcome than haloperidol alone in the treatment of schizophrenic relapse .\n",
            "Thirdly , the response to haloperidol-clonidine association may help when choosing a noradrenergic or serotoninergic compound to associate in the treatment of schizophrenic patients .\n",
            "Reference : @ ) Van Kammen D.P. , Gelernter J. ( @ ) .\n",
            "Biochemical instability in schizophrenia : the norepinephrine system .\n",
            "In : \" Psychopharmacology .\n",
            "The third generation of progress \" .\n",
            "H.Y. Meltzer ( ed . )\n",
            ".\n",
            "Raven Press , New York , pp. @ .\n",
            "@ ) Roth B.L. , Meltzer H.Y. ( @ ) .\n",
            "The role of serotonin in schizophrenia .\n",
            "In : \" Psychopharmacology .\n",
            "The fourth generation of progress \" .\n",
            "F.E. Bloom , D.J. Kupfer ( eds . )\n",
            ".\n",
            "Raven Press , New York , pp. @ .\n",
            "Comparative cost-effectiveness was assessed in a supplemental analysis of a @-month multicenter , open-label , RANDOMized trial ( QUEST ) that compared the efficacy and safety of quetiapine with risperidone in a broad outpatient population with schizophrenia and other psychotic disorders .\n",
            "Method : Mild , moderate , and severe health state profiles were constructed using cluster analysis on Positive and Negative Syndrome Scale ( PANSS ) scores .\n",
            "Descriptive narratives were developed , and @ psychiatric nurses were interviewed using the standard gamble ( SG ) method to obtain utility values for each health state .\n",
            "Patients in QUEST were then categorized into @ of the @ states based on the overall PANSS scores at baseline and at @ months and @ months or last observation carried forward ( LOCF ) .\n",
            "The difference in expected utilities from baseline were calculated for each treatment group .\n",
            "Results : The @ health states were mild ( PANSS total score @ ) , moderate ( PANSS score > @ and @ ) , and severe ( PANSS score @ ) .\n",
            "The SG interviews resulted in utilities of @  @ , @  @ , and @  @ for the mild , moderate , and severe health states , respectively .\n",
            "At baseline , for the quetiapine group , @ ( @ % ) , @ ( @ % ) , and @ ( @ % ) had mild , moderate , or severe symptoms , respectively , compared with @ ( @ % ) , @ ( @ % ) , and @ ( @ % ) for the risperidone group .\n",
            "For patients in the mild or moderate health state at baseline , both treatment groups improved but there were no statistically significant differences in performance between groups .\n",
            "For patients with severe symptoms at baseline , more quetiapine patients than risperidone patients improved to less severe health states at @ months , @ months , and LOCF .\n",
            "At @ months , @ % vs. @ % of the patients in the severe state at baseline were in the mild state , with @ % vs. @ % in the moderate state ( p = @ ) .\n",
            "At @ months , the comparative proportions still favored quetiapine , with @ % compared with @ % in the mild state , and @ % vs. @ % in the moderate state ( p = @ ) .\n",
            "Using LOCF , @ % vs. @ % of the severe patients were in the mild state , and @ % vs. @ % in the moderate , with @ % vs. @ % remaining in the severe state for quetiapine and risperidone patients ( p = @ ) , respectively .\n",
            "When utility weights were applied , the incremental gains in utilities were @ vs. @ , @ vs. @ , and @ vs. @ for quetiapine compared with risperidone at @ months , @ months , and LOCF , respectively .\n",
            "Based on LOCF , the difference equates to an average incremental gain in quality-adjusted life years for quetiapine-treated patients of @ years per patient ( p < @ ) .\n",
            "Average daily doses were @ mg for quetiapine and @ mg for risperidone , yielding average daily costs to US consumers of $ @ and $ @ .\n",
            "At average retail costs to consumers in the US , quetiapine reduces costs by $ @ per day , or $ @ annually .\n",
            "Conclusion : In patients with severe symptoms , treatment with quetiapine results in significant clinical benefits , effectiveness , and cost savings compared with risperidone .\n",
            "In mild and moderate patients , quetiapine is cost saving while achieving similar clinical benefits .\n",
            "The goal of this study was to determine whether an educational intervention designed to reduce stigmatization of individuals with schizophrenia improves implicit attitudes , in addition to the improvements in explicit attitudes that have been demonstrated in past research .\n",
            "Participants were @ undergraduate students randomly assigned to one of two conditions : the experimental group received education about low rates of violence in individuals with schizophrenia ; the control group read facts unrelated to mental health .\n",
            "Participants completed an Implicit Attitudes Test measuring unconscious attitudes about schizophrenia and violence before and after reading their assigned information ; participants then reported the social distance they desired from individuals with schizophrenia .\n",
            "The intervention improved explicit but not implicit attitudes about schizophrenia , suggesting that educational interventions may not be sufficient to improve the lives of people with schizophrenia by reducing stigmatization against them .\n",
            "Objective : To evaluate the impact of the overall care of chronic schizophrenic patients with activities of daily living .\n",
            "Methods : @ patients with chronic schizophrenia were randomly divided into experimental and control groups , the experimental group to implement the overall care .\n",
            "Brief Psychiatric Rating Scale ( bprs ) and activities of daily living ( adl ) ratings , respectively , into the group , and six months after the two groups of patients .\n",
            "Results : The two groups of patients after six months bprs score differences , adl score experimental group than the control group , the difference was significant ( p < @ ) .\n",
            "Conclusion : carry out the overall care of patients with chronic schizophrenia can improve their daily living skills , to improve the quality of life and alleviate the burden of the family and society , and worthy of promotion .\n",
            "Background : Schizophrenia is a chronic disabling mental disorder that involves impairments in several cognitive domains , especially in executive functions ( EF ) , as well as impairments in functional performance .\n",
            "This is particularly true in patients with Treatment-Resistant Schizophrenia ( TRS ) .\n",
            "The aim of this study was to test the effcacy of the Occupational Goal Intervention ( OGI ) method for the improvement of EF in patients with TRS .\n",
            "Methods : In this randomized , controlled , single-blind pilot study , @ TRS patients were randomly assigned to attend @ sessions of either OGI or craft activities ( control ) over a @-week period and evaluated by the Behavioural Assessment of the Dysexecutive Syndrome ( BADS ) as the primary outcome and the Direct Assessment of Functional Status ( DAFS-BR ) as well as the Independent Living Skills Survey ( ILSS-BR ) as secondary outcomes , all adapted for the Brazilian population .\n",
            "The Positive and Negative Syndrome Scale ( PANSS ) was used for monitoring symptom severity .\n",
            "Results : The results showed signifcant statistical differences , favoring the OGI group in terms of improvement on the BADS , in the subtests Action Program ( d = @ , P = .@ ) , Key Search ( d = @ , P = .@ ) and Zoo Map ( d = @ , P = .@ ) and the BADS total score ( d = @ , P = .@ ) .\n",
            "Improvements in EFs were observed by families in various dimensions as measured by different subtests of the ILSS-BR inventory : Personal Hygiene ( d = @ , P = .@ ) , Household ( d = @ , @ ) , Food prepare/storage ( d = @ , P = .@ ) , Leisure ( d = @ , P = .@ ) and ILSS-BR total score ( d = @ , P = .@ ) .\n",
            "The OGI group showed no signifcant results in secondary outcomes ( DAFS-BR ) except in terms of improvement of communication skills ( d = @ , P = .@ ) .\n",
            "Conclusion : Although preliminary , the OGI method has been shown to be reliable and effective for patients with TRS , improving social and functional aspects .\n",
            "Objective To compare risperidone , aripiprazole female schizophrenia thyroxine levels .\n",
            "CCMD- and ICD-@ diagnostic criteria in @ cases of schizophrenia patients were randomly divided into Lee grains ketone group and aripiprazole group .\n",
            "Medication : Lee grains ketone starting dose of @ mg / d ~ @ mg / d , aripiprazole starting dose of @ mg / d to @ mg / d .\n",
            "The treatment lasted for @ weeks , before and after treatment serum FT@ , FT@ , TSH levels , respectively , compared with the healthy control group , using the PANSS , CGI , TESS assessment of psychiatric symptoms , clinical efficacy , and other relevant factors .\n",
            "The the results Lee grains ketone group FT@ decreased after treatment , the difference was statistically significant ( p < @ ) .\n",
            "Aripiprazole group FT@ , FT@ significantly decreased , and the difference was statistically significant ( p < @ ) .\n",
            "Background : Young people with mental illness , especially those with firstepisode psychosis ( FEP ) , nominate employment as a number one goal .\n",
            "Despite this in most places , young people with psychosis have high rates of unemployment at entry to service and these rates increase rapidly .\n",
            "Individual placement and support ( IPS ) is an employment intervention with a growing evidence base in FEP .\n",
            "Method : IPS was compared to high-quality early psychosis treatment as usual ( TAU ) for @ young people attending an FEP clinic in Melbourne , Australia .\n",
            "Assessments were conducted a four time points baseline , @ months ( end of intervention ) and @ months .\n",
            "Results : The IPS group achieved higher employment and education rates , although this was only significant for employment at @ months end of intervention ( @ % vs @ % , p = @ ) .\n",
            "Interestingly , the control group achieved outcomes that mimic IPS intervention groups in other RCTs .\n",
            "Results were maintained across the follow-up period with @ % and @ % in the TAU and IPS groups , respectively .\n",
            "When education was factored in @ % , and @ % of the TAU and IPS groups , respectively , were either in education , training or employment at @ months .\n",
            "Conclusion : IPS produced a significant early benefit in terms of employment .\n",
            "This advantage was lost over time , however .\n",
            "Overall , participants in both groups had outcomes significantly better than those in routine early psychosis settings and those in non-specialised mental health settings .\n",
            "Induced weight gain is a disturbing side effect of Olanzapine that affects the quality of life in psychotic patients .\n",
            "The aim of this study was to assess the efficacy of Ranitidine in attenuating or preventing Olanzapine-induced weight gain .\n",
            "A parallel @-arm clinical trial was done on @ patients with schizophrenia , schizoaffective and schizophreniform disorders who received Olanzapine for the first time .\n",
            "All these were first-episode admitted patients .\n",
            "They were randomly allocated to receive either Ranitidine or placebo .\n",
            "The trend of body mass index ( BMI ) was compared between groups over @-week course of treatment .\n",
            "Mean weight was @ ( SD : @ ) kg at baseline .\n",
            "Thirty-three subjects ( @ % ) had positive family history of obesity .\n",
            "The average BMI increment was @ for Ranitidine group and @ for the placebo group .\n",
            "The multivariate analysis showed this effect to be independent of sex , family history of obesity , and baseline BMI value .\n",
            "The longitudinal modeling after controlling for baseline values failed to show the whole trend slope to be different .\n",
            "Although the slight change in trend 's slope puts forward a hypothesis that combined use of Ranitidine and Olanzapine may attenuate the weight gain long run , this needs to be retested in future larger scale long-term studies .\n",
            "This trial is registered with IRCT.ir @N@ .\n",
            "Objective : To evaluate the efficacy and tolerability of domestic blonanserin tablets for the treatment of Chinese patients with acute schizophrenia .\n",
            "Methods : A randomized , double-blind , multi-center , non-inferiority , risperidone-controlled design was adopted .\n",
            "@ patients aged @ to @ years with schizophrenia were randomly assigned to domestic blonanserin or risperidone treatment for @ weeks .\n",
            "The efficacy was assessed using the mean change in Positive and Negative Syndrome Scale ( PANSS ) total scores from baseline to week @ .\n",
            "The dosage was @ ~ @ mg.d <sup> -@ </sup> and @ ~ @ mg.d <sup> -@ </sup> , respectively .\n",
            "Safety assessments included monitoring of vital signs , physical examination , laboratory tests , and adverse events .\n",
            "Results : Among @ enrolled patients , @ received blonanserin and @ received risperidone .\n",
            "The mean change in the PANSS total score at the final evaluation time point was @ + / -@ for the blonanserin group and @ + / -@ for the risperidone group .\n",
            "The clinical response rates were @ % for blonanserin and @ % for risperidone , respectively ( chi <sup> @ </sup> = @ , P = @ @ ) .\n",
            "The incidences of adverse events in the two groups were similar .\n",
            "Blonanserin showed smaller weight gain and smaller effect on prolactin level compared with risperidone ( F = @ , P = @ @ ) ( F = @ , P = @ ) .\n",
            "Conclusion : Blonanserin is non-inferior to risperidone in the treatment of Chinese schizophrenic patients and is more tolerable with a better safety profile , particularly with respect to prolactin elevation and weight gain .\n",
            "These findings suggest that domestic blonanserin is useful in the treatment of acute schizophrenia .\n",
            "\" OBJECTIVE : In this study , we assessed the efficacy of @ pharmacodynamically different antidepressants , citalopram ( a selective serotonin reuptake inhibitor ) and reboxetine ( a norepinephrine reuptake inhibitor ) , as adjunctive therapy to risperidone and olanzapine for the treatment of negative symptoms in schizophrenia .\n",
            "METHOD : We performed a @-month , multicenter , double-blind , randomized , placebo-controlled clinical trial .\n",
            "The recruitment period was from November @ to December @ .\n",
            "The sample comprised @ patients with a diagnosis of schizophrenia ( DSM-IV criteria ) who exhibited negative symptoms .\n",
            "The patients were recruited from @ centers in different cities of the Spanish State .\n",
            "The primary efficacy measure was change in score on the negative subscale of the Positive and Negative Syndrome Scale ( PANSS ) between baseline and @-month assessment .\n",
            "Other efficacy measures were changes in the PANSS subscales and total score , as well as the Scale for the Assessment of Negative Symptoms ( SANS ) subscales and total score .\n",
            "RESULTS : For statistical analysis , we employed mixed-effects models .\n",
            "We did not find statistically significant differences between the placebo group and the @ treatment groups at @-month assessments for the PANSS total ( P = .@ ) , any PANSS subscale ( negative [ P = .@ ] , positive [ P = .@ ] , or general psychopathology [ P = .@ ] ) , or the SANS ( P = .@ ) .\n",
            "Cohen d measure showed a small effect size below the @ threshold for all comparisons .\n",
            "CONCLUSIONS : In conclusion , our results do not support adjunctive use of citalopram or reboxetine with risperidone or olanzapine for the treatment of negative symptoms in schizophrenia .\n",
            "TRIAL REGISTRATION : ClinicalTrials.gov identifier : NCT@ . \"\n",
            "Objective To investigate of Chinese proprietary lotus pure heart sugar merge clozapine with clozapine in the treatment of immune function in patients with schizophrenia .\n",
            "Methods @ patients with schizophrenia were randomly divided into two groups , the treatment group to the lotus pure heart sugar combination clozapine clozapine treatment control group to a total of six weeks .\n",
            "T-cell count treatment group differences in the results before and after treatment is very significant with ( p - < @ ) , significant sex ( p - < @ ) differences in the control group ; between the two groups after treatment t cell count differences have significantly with sex ( p - < @ ) ; clinical the efficacy evaluation treatment group , the cure rate was higher than that of the control group ( p < @ ) ; treatment group , adverse reaction in scores after @ weeks of treatment was significantly lower than the control group ( p < @ ) .\n",
            "Conclusion lotus seeds and the Qingxin sugar merge clozapine treatment of schizophrenia can improve efficacy , reduce side effects , can significantly improve the immunity levels of patients with schizophrenia .\n",
            "The drug-food and drug-drug interaction between grapefruit juice ( GFJ ) and ketoconazole ( KETO ) was evaluated in schizophrenic patients given a single dose of clozapine ( CLZ ) .\n",
            "CLZ is metabolized primarily by CYP isozymes @A@ and @A@ to two principal metabolites , desmethylclozapine ( DCLZ ) and clozapine N-oxide ( CNO ) .\n",
            "GFJ and KETO are well known potent CYP @A@ inhibitors in the gastrointestinal tract and hepatic isozymes , respectively .\n",
            "Twenty-one schizophrenic patients participated in the co-administration of CLZ @ mg and GFJ .\n",
            "After a one-week washout , five patients were given double the GFJ ( HGFJ ) dose for @ consecutive days .\n",
            "In another group of five patients , ketoconazole ( KETO ) @ mg was given for @ consecutive days .\n",
            "At the end of the @-day period for both groups , CLZ was co-administered with the HGFJ and KETO groups .\n",
            "CLZ , DCLZ and CNO were assayed by HPLC .\n",
            "GFJ , HGJF and ketoconazole failed to significantly change CLZ disposition .\n",
            "Metabolites DCLZ and CNO concentrations remained unchanged during the study .\n",
            "The only exception was decreased C <inf> max </inf> in DCLZ and CNO concentrations .\n",
            "These results indicate that CYP @A@ inhibition may not be clinically significant compared to CYP @A@ , as previous studies show a dramatic increase in CLZ plasma concentrations with fluvoxamine ( CYP @A@ inhibitor ) .\n",
            "The reasons for the lack of drug-food and drug-drug interactions with CLZ and CYP @A@ inhibitors can be explained by the higher K <inf> i </inf> values for gastrointestinal and hepatic CYP @A@ isozymes .\n",
            "\" Objective : This study aimed to identify the predictors of psychiatric hospitalization in the maintenance treatment of schizophrenia patients with olanzapine long acting injection ( olanzapine-LAI ) and assess four hospitalization parameters : the prevalence of hospitalization , its incidence rate , duration , and the time to first hospitalization .\n",
            "This analysis also compared olanzapine-LAI with pseudo-placebo ( a very low dose of olanzapine-LAI ) and with oral olanzapine on the hospitalization parameters .\n",
            "Methods : This was a post hoc exploratory analysis of a randomized double-blind study comparing the safety and efficacy of olanzapine - LAI ( pooled active depot groups : @ mg/@ weeks , @ mg/@weeks , @ mgs/@ weeks ) with oral olanzapine and olanzapine-LAI @ mg / @ weeks ( pseudo-placebo ) during @ months maintenance treatment of clinically stable outpatients with schizophrenia ( n = @ ) .\n",
            "Within the olanzapine-LAI group , patients with and without a hospitalization were compared on baseline characteristics .\n",
            "A logistic regression model was used to identify the best predictors of hospitalization .\n",
            "Comparisons between olanzapine-LAI , pseudo-placebo , and oral olanzapine on hospitalization parameters employed Chi-square , Wilcoxon-Mann and Whitney tests , and the Kaplan Meier estimator .\n",
            "Results : Hospitalization was best predicted by suicide threats at baseline and by prior hospitalization .\n",
            "Compared with pseudoplacebo , olanzapine-LAI was associated with a significantly lower hospitalization rate ( @ % vs. @ % , p = @ ) , lower mean number of hospitalizations ( @ vs. @ , p = @ ) , shorter mean hospitalized duration ( @ days vs. @ days , p = @ ) and similar median time to first hospitalization among hospitalized patients ( @ vs. @ days , p = @ ) .\n",
            "Olanzapine-LAI did not significantly differ from oral olanzapine on studied hospitalization parameters .\n",
            "Conclusion : During the @-month maintenance treatment of schizophrenia patients with olanzapine-LAI , psychiatric hospitalization was best predicted by patients ' suicide threats at baseline and prior psychiatric hospitalization .\n",
            "Olanzapine-LAI was associated with a significantly lower prevalence and incidence of psychiatric hospitalization and shorter hospitalized duration compared to pseudo-placebo therapy .\n",
            "Olanzapine-LAI did not significantly differ on these hospitalization parameters from oral olanzapine . \"\n",
            "The relative efficacy and safety of risperidone versus haloperidol in the treatment of SCHIZOaffective disorder was studied .\n",
            "Sixty-two patients ( @ depressed type ; @ bipolar type ) entered a three-site , RANDOMized , double-BLIND , @-week trial of risperidone ( up to @ mg/day ) or haloperidol ( up to @ mg/day ) .\n",
            "Trained raters assessed baseline , weekly , and end-of-study levels of psychopathology with the Positive and Negative Syndrome Scale ( PANSS ) , the @-item Hamilton Rating Scale for Depression ( HAM-D-@ ) and the Clinician-Administered Rating Scale for Mania ( CARS-M ) .\n",
            "The authors were unable to statistically distinguish between risperidone and haloperidol in the amelioration of psychotic and manic symptoms .\n",
            "In addition , there was no difference in worsening of mania between the two agents in either subgroup ( i.e. , depressed or bipolar subgroups ) .\n",
            "For the total PANSS , risperidone produced a mean decrease of @ points from baseline compared with a @-point decrease with haloperidol .\n",
            "For the total CARS-M scale , risperidone and haloperidol produced mean change scores of @ and @ points , respectively , and for the CARS-M Mania subscale , @ and @ points , respectively .\n",
            "Additionally , risperidone produced a mean decrease of @ points from the baseline @-item HAM-D , compared with an @-point decrease with haloperidol .\n",
            "In those patients who had more severe depressive symptoms ( i.e. , HAM-D baseline score > @ ) , risperidone produced at least a @ % mean improvement in @ ( @ % ) of @ patients in comparison to @ ( @ % ) of @ patients receiving haloperidol .\n",
            "Haloperidol produced significantly more extrapyramidal side effects and resulted in more dropouts caused by any side effect .\n",
            "There was no difference between risperidone and haloperidol in reducing both psychotic and manic symptoms in this group of patients with SCHIZOaffective disorder .\n",
            "Risperidone did not demonstrate a propensity to precipitate mania and was better tolerated than haloperidol .\n",
            "In those subjects with higher baseline HAM-D scores ( i.e. , > @ ) , risperidone produced a greater improvement in depressive symptoms than haloperidol\n",
            "Maintenance drug treatment in schizophrenia is of utmost importance for the management of the disease and the social functioning of the patients .\n",
            "New antipsychotics with good efficacy on positive and negative symptoms and good tolerability will be well accepted by patients , increase compliance and decrease relapse rates .\n",
            "The long-term efficacy and safety of amisulpride ( AMI ) , a specific D@/D@ dopamine receptor blocker with limbic selectivity , was assessed in a @-month open randomised study versus haloperidol ( HAL ) in schizophrenic patients with acute exacerbations ( DSM III-R ) .\n",
            "A total of @ patients was included in the study ( AMI @ , HAL @ ) , @ % were male , mean age was @ ( AMI ) and @ years ( HAL ) , mean duration of illness was @ years .\n",
            "A total of @ patients ( AMI @ , HAL @ ) having reached at least a @ % improvement of their BPRS baseline total score after one month , were analysed with a survival method to test maintenance of efficacy .\n",
            "Patients having a response < @ % BPRS baseline score on one of the following visits , dropouts and patients with missing data were considered as failures .\n",
            "Using this conservative approach , @ % of AMI patients and @ % of HAL patients maintained efficacy up to @ months ( Kaplan-Meier estimates , log rank @ ) .\n",
            "When time course of mean BPRS total scores of all patients ( LOCF ) was compared , AMI was superior to HAL from the third month of treatment .\n",
            "On an intent to treat basis , AMI was superior to HAL in total BPRS score ( mean change from baseline @  @ vs @  @ , p < @ ) , PANSS Negative subscore ( mean change from baseline @  @ vs @  @ , p < @ ) and quality of life ( all dimensions of the QLS ) .\n",
            "AMI provoked significantly less EPS than HAL and correspondingly less antiparkinson drugs were prescribed to AMI patients .\n",
            "Overall , AMI was safe and efficacious in the long-term treatment of schizophrenia .\n",
            "Negative symptoms often inhibit the social integration of people suffering from schizophrenia .\n",
            "Reducing severe negative symptoms ( SNS ) in a clinically relevant way is a major unmet need .\n",
            "The aim of this study was to investigate whether Integrated Neurocognitive Therapy ( INT ) , a group cognitive remediation therapy ( CRT ) , reduces SNS in schizophrenia outpatients .\n",
            "INT was compared with Treatment As Usual ( TAU ) in a randomized-controlled trial ( RCT ) .\n",
            "A total of @ SNS outpatients participated in the study , @ were allocated to the INT group and @ to the TAU group .\n",
            "A test-battery was used at baseline , post-treatment at @weeks , and @-year-follow-up .\n",
            "Remission rates of SNS after therapy were significantly higher for INT compared to TAU .\n",
            "A trend favoring INT was obtained at follow-up .\n",
            "Furthermore , INT showed significantly higher functional outcome during follow-up compared to TAU .\n",
            "Regarding cognition , the strongest significant effect was found in attention post-treatment .\n",
            "No effects between groups on more complex neurocognition and social cognition were evident .\n",
            "SNS outpatients seem to accept INT group intervention as suggested by the high attendance rate .\n",
            "OBJECTIVE : Placebo effects remain largely unexplored in clinical trials of long-acting injectable ( LAI ) antipsychotics for schizophrenia .\n",
            "This study aims to characterize patients showing improvements after placebo injections and to search for criteria for the prediction of subsequent response based on the magnitude of score changes after the first week of treatment .\n",
            "METHODS : Data from @ patients with schizophrenia ( DSM-IV ) who received placebo injections in @ double-blind randomized controlled trials evaluating efficacy of LAI paliperidone palmitate obtained through the Yale University Open Data Access ( YODA ) project were analyzed .\n",
            "These @ studies were conducted from October @ to March @ .\n",
            "Multiple logistic regression analyses were conducted to examine associations between placebo response and demographic and clinical characteristics .\n",
            "The predictive power of improvement at week @ for response at week @ was investigated ; sensitivity and specificity of incremental @ % cutoff points between a @ % and @ % reduction in Positive and Negative Syndrome Scale ( PANSS ) total score at week @ were calculated .\n",
            "RESULTS : Percent reduction in the PANSS total score at week @ and a lower PANSS G@ item score ( ie , better in judgment and insight ) at baseline were significantly associated with placebo response at week @ ( odds ratio [ OR ] = @ ; @ % CI , @-@ , P < .@ ; and OR = @ ; @ % CI , @-@ , P = .@ , respectively , in the per-protocol analysis ) .\n",
            "Cutoffs of a @ % ( accuracy = @ in the per-protocol analysis ) and @ % ( accuracy = @ in the last-observation-carried-forward analysis ) reduction in the PANSS total score at week @ showed the highest predictive power .\n",
            "CONCLUSIONS : The appreciation that longer-term response following placebo injections can be predicted by a @ % -@ % PANSS total score reduction at week @ could guide the design of future clinical trials of LAI antipsychotics in schizophrenia to identify and exclude potential placebo responders early during the course of the study .\n",
            "@ hospitalized psychiatric patients with neuroleptic-induced tardive dyskinesia were treated with alpha-methyl-para-tyrosine ( AMPT ) , @ g daily for @ days , and biperiden , @ mg daily for @ weeks .\n",
            "The results were evaluated blindly by means of videotape technique .\n",
            "The frequency of tardive dyskinesia was significantly reduced by AMPT and significantly increased by biperiden .\n",
            "The amplitude was reduced by AMPT in ten cases , unchanged in @ cases and increased in two cases .\n",
            "Biperiden significantly increased the amplitude .\n",
            "The duration of each separate tongue protrusion and/or mouth opening was significantly increased by AMPT and reduced or unchanged by biperiden .\n",
            "It is concluded that a reduced dopaminergic activity ( pharmacological or organic ) may constitute the primary pathogenetic background for tardive dyskinesia , but that dopaminergic hypersensitivity and/or cholinergic hypofunction is necessary before the hyperkinetic element of the movement disturbances can minifest itself .\n",
            "FAU - Gerlach , J\n",
            "Background : The objective of the DREaM study is to demonstrate the superiority of paliperidone palmitate ( PP ) once-monthly and once-every-@-months injectable formulations over oral antipsychotics ( OAs ) for disease progression and modification in patients with recent-onset schizophrenia .\n",
            "Disease modification is based on a totality-of-evidence approach that evaluates the course and pathophysiology of the illness with measures of symptoms , functioning , and biological change .\n",
            "Herein , we describe DREaM 's unique study design .\n",
            "Methods : Patients with a DSM-@ diagnosis of schizophrenia or schizophreniform disorder and first psychotic episode within @ years of enrollment are eligible .\n",
            "DREaM includes @ treatment phases : @-month open-label run-in ( Part @ ) , @-month disease progression ( Part @ ) , and @-month disease progression/modification ( Part @ ) .\n",
            "After completing run-in with paliperidone extended-release ( or other OA ) treatment , patients will be randomized in a @:@ ratio to flexible-dose PP or OAs , respectively .\n",
            "After @ months , the OA group will be further randomized @:@ to PP or continued on flexible-dose OAs .\n",
            "Primary endpoint : time to first treatment failure .\n",
            "Changes in cognition , patient functioning , and volume of brain intracortical myelin ( ICM ) will all be assessed as measures of disease progression ( Parts @ and @ ) and modification ( Part @ ) .\n",
            "Results : Sample size of @ subjects is planned ( ~ @ % with ICM assessment ) .\n",
            "Conclusions : Key innovations of the DREaM study include randomized matched-control of patients for a randomized delayed - start design .\n",
            "The results may provide important insights into disease progression and potential disease modification in recent - onset schizophrenia , as well as the comparative effectiveness of PP long-acting injectables and OAs for treating this disorder .\n",
            "Objective : Vitamin E ( alpha - tocopherol ) , a free-radical scavenger , has been reported to improve symptoms of tardive dyskinesia .\n",
            "The authors attempted to replicate this finding under more controlled conditions in a larger study group .\n",
            "Method : Fifteen inpatients and six outpatients with tardive dyskinesia received up to @ IU/day of vitamin E for @ weeks in a double-blind , placebo-controlled crossover study .\n",
            "Abnormal Involuntary Movement Scale ( AIMS ) examinations of these patients were videotaped and rated independently by two trained raters .\n",
            "Levels of neuroleptic medication and vitamin E were measured during both treatment periods .\n",
            "Eighteen patients who demonstrated high blood levels of vitamin E were included in the data analysis .\n",
            "In order to investigate the links between primary negative symptoms and dopamine D@ receptors , young , drug-free negative schizophrenics were selected .\n",
            "The therapeutic effects of low doses of a benzamide specific for D@/D@ receptors , were assessed in these patients with respect to placebo - it improved some negative symptoms in a double blind therapeutic trial.The relationships between the in vivo D@ receptor occupancy by neuroleptics and their dosages were investigated in an extended sample of patients .\n",
            "The levels of D@ occupancy associated with the dosages recommended for therapeutic effects on positive , or on negative symptoms differed , but there was no evidence of a difference in D@ occupancy in responders or non-responder patients .\n",
            "In order to look for the optimal therapeutic dose range for amisulpride in responder patients , the in vivo D@ occupancy intervals were studied in a group of schizophrenics before , then while receiving this compound .\n",
            "A range of @ - % occupancy of the striatal D@ receptors , suggested as an optimal interval for therapeutic action on positive psychotic symptoms , was obtained with an amisulpride dosage ranging between @ and @ mg a day , while an occupancy of @ % , suggested to be associated with pronounced extrapyramidal side - effects , was reached with @ mg a day .\n",
            "These studies illustrate the capacity of in vivo receptor imaging to provide patient-specific data on psychotropic drugs dose range finding.Reference - Am J Psychiatry @ @ - @ - .\n",
            "Psychopharmacology @ @ - @ - .\n",
            "Seventeen patients with acute schizophrenia and @ with chronic schizophrenia were included in a randomized , double-blind parallel - group trial comparing sulpiride and perphenazine .\n",
            "Patients were evaluated using the @-item Brief Psychiatric Rating Scale ( BPRS ) prior to the onset of treatment and @ and @ weeks , and @ , @ , @ , and @ months thereafter .\n",
            "In patients with acute schizophrenia , total BPRS scores declined significantly at the end of the trial compared with pretreatment values in sulpiride-treated patients but not in schizophrenics treated with perphenazine .\n",
            "Differences in response between the groups did not reach statistical significance , however .\n",
            "For patients suffering from chronic schizophrenia , a statistically significant decline was observed in total BPRS scores at @ months compared with pretreatment scores in both sulpiride and perphenazine groups .\n",
            "There was no significant difference in the treatment response between the groups .\n",
            "Sulpiride appeared to be somewhat more effective than perphenazine for treatment of acute schizophrenia .\n",
            "Efficacy of both compounds was less marked in chronic forms of schizophrenia .\n",
            "Thirty schizophrenic patients received intravenous dextro-amphetamine while on and off pimozide .\n",
            "The results provide evidence that negative symptoms and depressed mood in schizophrenia respond in part to intravenous challenges of dextro-amphetamine .\n",
            "Improvement in negative symptoms while on d-amphetamine correlated significantly with subsequent improvement in the same negative symptoms while on pimozide .\n",
            "These results do not support the Type II model of irreversible negative symptoms in schizophrenia in our patient sample .\n",
            "Changes in negative symptoms may be related to state dependent changes in the dopamine system , but noradrenergic mechanisms can not be excluded either .\n",
            "Akathisia is a common adverse effect of antipsychotic drugs and is characterized by subjective feelings of restlessness .\n",
            "First-line treatment usually consists of propranolol , a beta adrenergic antagonist .\n",
            "However , propranolol does not seem to be efficacious in up to @ % of patients .\n",
            "This study was aimed to evaluate the effect of vitamin B@ versus propranolol on antipsychotic-induced akathisia ( AIA ) .\n",
            "This study was a comparative , double-blind , randomized trial .\n",
            "In the present study , @ adult patients with antipsychotic-induced akathisia were enrolled and randomized into three groups , and received vitamin B@ @ mg/@ h or @ mg/@ h or propranolol @ mg/@ h .\n",
            "The diagnosis of AIA was made by clinical examination and its severity was assessed by the Barnes Akathisia Rating Scale .\n",
            "Fifty one patients completed @ days of the trial .\n",
            "The results showed that there was no significant difference in BARS score among the different groups which means that vitamin B@ attenuated the AIA similar to propranolol .\n",
            "However , there was n't any significant difference between high or low dose of vitamin B@ .\n",
            "In conclusion , the results of this trial suggest that vitamin B@ may be beneficial for ameliorating of antipsychotic-induced akathisia .\n",
            "Copyright   @ by School of Pharmacy Shaheed Beheshti University of Medical Sciences and Health Services .\n",
            "Objectives - To compare economic consequences associated with amisulpride ( AMI ) or risperidone ( RISP ) alongside a @-month clinical trial in schizophrenic patients .\n",
            "Methods - International RANDOMized double-blind trial compared @ to @ mg/day amisulpride ( N = @ ) and @ to @ mg/day risperidone ( n = @ ) .\n",
            "Resources utilization analysis is performed on the @ completers ( AMI : @ , RISP : @ ) with bootstrap bias-corrected accelerated percentile confidence interval .\n",
            "Results - Patient demographics are similar and efficacy results comparable in @ groups ( Mean PANSS improvement : AMI -@ ; RISP -@ ) .\n",
            "AMI patients have less full time hospitalization .\n",
            "Mean number of days hospitalized : AMI : @ ; RISP : @ , difference confidence interval is [ -@ ; @ ] .\n",
            "This trend is observed in most countries and the difference is significant in Belgium ( AMI : @ ; RISP : @ ; p = @ ) and in Germany ( AMI : @ ; RISP : @ ; p = @ ) .\n",
            "Conclusion : Amisulpride showed a comparable efficacy profile to risperidone with trends to less hospitalization .\n",
            "EDUCATIONAL OBJECTIVES : At the conclusion of this session , the participant should have a better understanding of the comparative safety and tolerability of lurasidone and ziprasidone across key metabolic , cardiac , extrapyramidal , and tolerability parameters .\n",
            "SUMMARY : Objective : Lurasidone is a novel psychotropic agent with high affinity for D@ and @-HT@A receptors , and for receptors implicated in enhancement of cognition , mood and negative symptoms ( @ - HT@ , @-HT@A and a@c ) .\n",
            "The current study is the first to evaluate the comparative safety and efficacy of lurasidone vs. ziprasidone in stable outpatients with schizophrenia or schizoaffective disorder .\n",
            "Method : Outpatients were recruited who met DSM-IV criteria for chronic , stable schizophrenia or schizoaffective disorder .\n",
            "After a @-@ day single-blind , placebo run-in period , patients were randomized to @ days of treatment with a fixed daily dose of lurasidone @ mg ( N = @ ; PANSS total = @ ; starting dose , @ mg for @ days ) or ziprasidone @ mg ( N = @ ; PANSS total = @ ; starting dose , @ mg/day for @ days ) .\n",
            "Results : The proportion of patients reporting at least one adverse event was lower for lurasidone compared to ziprasidone ( @ % vs. @ % ; P = @ ) .\n",
            "Median endpoint change in weight was similar for both lurasidone and ziprasidone ( -@ vs. -@ lbs ) .\n",
            "Treatment with lurasidone versus ziprasidone was associated with greater median reduction in triglycerides ( -@ vs. +@ mg/dL ) , similar endpoint reduction in total cholesterol ( -@ vs. -@ mg/dL ) , and similar change in glucose ( +@ vs. +@ mg/dL ) .\n",
            "Treatment with lurasidone was associated with lower endpoint change in the QTcF : +@ vs. +@ msec ) .\n",
            "Treatment with lurasidone versus ziprasidone , respectively , resulted in significantly greater early improvement on the PANSS total score at Week @ ( -@ vs. -@ ; P < @ ) , but not Week @ , ( -@ vs. -@ ) or Week @ ( -@ vs. -@ ; MMRM analysis ) .\n",
            "Conclusion : Treatment with lurasidone was safe and well-tolerated , and was not associated with clinically significant changes in weight , lipids or QTc .\n",
            "The efficacy of lurasidone was comparable to ziprasidone , but with earlier improvement in the PANSS total score .\n",
            "Individuals with schizophrenia have high smoking-related morbidity and mortality rates and need powerful and innovative smoking cessation interventions.This proof-of-concept study investigated the feasibility and initial efficacy of combining a contingency management intervention with bupropion to reduce smoking in people with schizophrenia.Using a double-blind , placebo-controlled , between-groups design , @ non-treatment-seeking participants were randomized to receive @ mg/day bupropion or placebo .\n",
            "One week later , participants were randomized to a contingency management ( CM ) intervention in which reductions in urinary cotinine levels were reinforced , or a non-contingent reinforcement ( NR ) condition in which session attendance was reinforced , regardless of cotinine level .\n",
            "Over the @-day study period , participants visited the laboratory approximately three times per week to provide urine samples for analysis of cotinine levels , to give breath samples for analysis of carbon monoxide ( CO ) levels , and to report number of cigarettes smoked per day , nicotine withdrawal symptoms , cigarette craving , and psychiatric symptoms.Cotinine and CO levels significantly decreased during the study period in participants randomized to the CM condition , but not the NR condition .\n",
            "Bupropion did not reduce cotinine levels or increase the efficacy of CM .\n",
            "Cigarette craving and psychiatric symptom levels significantly decreased during the study in all groups.The results of this study indicate the efficacy and feasibility of this CM intervention for reducing smoking in individuals with schizophrenia .\n",
            "ABSTRACT : Objective : We aimed to compare the clinical efficacy of olanzapine and risperidone in patients with schizophrenia .\n",
            "Method : A total of @ patients with the diagnosis of schizophrenia according to DSM-IV criteria and with a Brief Psychiatric Rating Scale ( BPRS ) score of at least @ were included in the study .\n",
            "Patients were randomized into olanzapine ( n = @ ) and risperidone ( n = @ ) groups .\n",
            "Olanzapine was administered in a fixed dose of @ mgs/day , and risperidone in flexible doses @-@ mgs/day ( mean : @  @ mgs/day ) .\n",
            "Outcome measures were BPRS , Scale for the Assessment of Positive Symptoms ( SAPS ) , Scale for the Assessment of Negative Symptoms ( SANS ) and Hamilton Depression Rating Scale ( HDRS ) .\n",
            "Adverse effects were evaluated by clinical interview and/or spontaneous reporting of the patients .\n",
            "Results : Both olanzapine and risperidone groups showed a significant decrease in BPRS , SAPS , SANS and HDRS scores at end-point compared to baseline .\n",
            "There were no statistically significant differences between the two groups with respect to decrease in BPRS , SAPS , SANS and HDRS scores .\n",
            "However , the rates of patients having a HDRS score below @ at end-point were significantly higher in the olanzapine group .\n",
            "Conclusion : This @-week follow-up study showed that both olanzapine and risperidone were effective in the treatment of schizophrenia and they were equally effective on positive and negative symptoms of schizophrenia .\n",
            "Our results suggested that olanzapine may be more advantageous for schizophrenia with depressive symptoms .\n",
            "Introduction : Clozapine is still regarded as the last antipsychotics for refractory schizophrenia .\n",
            "However ( some patients show partial response to clozapine and some patients may experience intolerable adverse effects .\n",
            "Zotepine is an atypical antipsychotics with pharmacological profile of activity similar to that of clozapine , but without significant risk of agranulocytosis .\n",
            "The purpose of this study is to evaluate the clinical effect and safety of switching clozapine to zotepine .\n",
            "Methods : Schizophrenic patients who took clozepine for more than @ months and aged @-@ years were included .\n",
            "Fifty-nine patients were allocated on a random , rater-blind basis to two groups : one maintained on clozepine ( N = @ ) and another switched to zotepine ( N = @ ) .\n",
            "We designed a cross-titration schedule for zotepine group that clozapine dose was decreased @-@ mg weekly and discontinued in @ weeks , while zotepine was gradually titrated up by @-@ mg weekly until weeks @ .\n",
            "The total study period was @ weeks .\n",
            "Symptoms and adverse effects were assessed at weeks @ , @ , @ , @ , and @ by @-item Brief Psychiatric Rating Scale ( BPRS ) , Clinical Global Impression ( CGI ) , Simpson and Angus Scale ( SAS ) , Abnormal Involuntary Movement Scale ( AIMS ) , Barnes Akathisia Scale ( BAS ) , and UKU Side Effect Rating Scale ( UKU ) .\n",
            "Laboratory tests ( hematology , biochemistry and urinalysis ) were performed at weeks @ , @ , and @ .\n",
            "The criteria for responders were successfully completing the @-weeks study and no increase in CGI severity score .\n",
            "Results : At endpoint , the response rates were @ % and @ % for clozapine and zotepine groups respectively ( p = @ , Fisher 's exact test , @-sided ) .\n",
            "At the end of the study , the mean zotepine and clozepine dose for clozapine and zotepine groups were @  @ mg/day @  @ mg/day respectively .\n",
            "There was no statistically significant difference for CGI , AIMS , SAS , UKU , and BAS net change between zotepine and clozapine groups .\n",
            "Zotepine group had a significant increased BPRS score ( @  @ vs  V@ .@  @ ; t-test , @-sided , df = @ , p = @ ) , increased blood prolactin level ( @ and  V@ .@ ng/ml ; t-test , @-sided , df = @ , p = @ ) , and decreased blood uric acid level (  V@ .@ and @ mg/dl ; t-test , @-sided , df = @ , p = @ ) than clozapine group .\n",
            "Concurrent use of anticholinergics and beta-blocker were significantly higher in zotepine than clozepine ( @ % vs @ % , p = @ ; @ % vs @ % ; Fisher 's exact test , @-sided , p = @ ) .\n",
            "Conclusion : In this @-week study , the crossover from clozapine to zotepine had a response rate of @ % .\n",
            "However , more concurrent use of anticholinergics and beta-blocker were higher in zotepine patients .\n",
            "Longer tapering period of clozapine and precautious evaluation of EPS for higher dose zotepine patients are suggested . )\n",
            "Objective : The limited studies have shown quetiapine to have beneficial effects on affective symptoms and especially depression .\n",
            "In the present study , it was planned to evaluate the efficacy of quetiapine comparing haloperidol , the most frequent used antipsychotic in the treatment of schizophrenia , on depressive symptoms .\n",
            "Method : The study was consisted of @ patients who were at least two weeks drug-free and were diagnosed with schizophrenia and comorbid major depressive disorder according to DSM-IV criteria .\n",
            "The patients were randomly divided into two subgroups ; quetiapine ( n = @ ) and haloperidol ( n = @ ) .\n",
            "All patients were assessed by The Positive and Negative Syndrome Scale ( PANSS ) , Extrapyramidal Symptom Rating Scale ( ESRS ) and Hamilton Depression Rating Scale ( HDRS ) and Clinical Global Impression-Improvement Scale ( CGI-I ) .\n",
            "Results : Both quetiapine and haloperidol provided similar score decrease on PANSS .\n",
            "However , decreasing scores on HDRS was statistically significant in quetiapine group than haloperidol group .\n",
            "Conclusion : In this eight weeks follow-up study evaluated the efficacy of quetiapine and haloperidol on depresive symptoms , it was demonstrated that quetiapine had more favorable effects on comorbid depressive disorder in the patients with schizophrenia compared to haloperidol .\n",
            "Primary Drug / Intervention : Reboxetine Dosage : @ mg b.i.d. Secondary Drug / Intervention : Other Drug / Intervention : Olanzapine Dosage : @ mg Illness : Schizophrenia Sample Size : @ Trial Design : Double-blind , placebo-controlled , adjunctive , randomized Duration of Study Period for Each Subject : @ weeks Outcome Measurements : Body weight , body mass index , SAPS , SANS , HDRS Results : Patients receiving olanzapine were randomized to receive adjunctive reboxetine ( a selective norepinephrine re-uptake inhibitor ) or placebo in an effort to prevent excessive weight gain .\n",
            "Patients receiving reboxetine gained less weight than the placebo group ( mean = @ kg ) but the results did not achieve statistical significance .\n",
            "The addition of reboxetine also did not appear to improve ratings of psychiatric symptoms .\n",
            "Serum interleukin ( IL ) -@ levels in schizophrenia correlate with the severity of negative symptoms .\n",
            "This study aimed to explore the potential immune mechanism of SSRI augmentation in the management of patients with treatment-resistant schizophrenia , assessing changes in IL-@ and CRP amounts .\n",
            "This was a randomized double-blind , placebo-controlled , @-week study of escitalopram augmentation in @ schizophrenic patients treated in @-@ at the Shandong Mental Health Center .\n",
            "Twenty-nine healthy controls were also included .\n",
            "Patients received add-on escitalopram or placebo for @ weeks .\n",
            "Serum IL-@ and CRP were measured at baseline and @ weeks .\n",
            "The primary outcome was the Positive and Negative Syndrome Scale ( PANSS ) .\n",
            "After @ weeks of treatment , reductions in total PANSS , negative subscore , and affective subscore were more important in escitalopram treated patients than in the placebo group ( all P < @ ) .\n",
            "Escitalopram significantly decreased CRP and IL-@ levels ( both P < @ ) .\n",
            "At baseline , IL-@ 's effects on negative and cognitive symptoms represented @ % and @ % , respectively ; at week @ , these effects were @ % and @ % on negative and cognitive symptoms , respectively .\n",
            "CRP had no impact on any PANSS score .\n",
            "Overall , escitalopram augmentation may be a useful addition for schizophrenic patients with persistent negative symptoms .\n",
            "Changes in IL-@ may be associated with negative and cognitive symptoms .\n",
            "Objective : to find outif there was any difference of serum prolactin and growth hormone level between schizophrenics and normal control , to observe the change of these two hormone after treatment of antipsychotics , and compare the hormone change after risperidone and chlorprom azine treatment .\n",
            "Method : RIA was used to examine serum levels of prolactin and growth hormone in @ @schizophrenics before treatment , after@ weeks ' , @ weeks ' and@weeks ' treatments .\n",
            "The@ @patients were randomly assigned to risperidone gro\n",
            "Aims : We present results from an integrative treatment program and research project in Hamburg PERSIST to investigate and differentiate atypical antipsychotics in the treatment of schizophrenic first and multiple episode patients .\n",
            "Methods : Patients ns@ with a schizophrenia were treated with atypical antipsychotics amisulpride , olanzapine , quetiapine , risperidone or zotepine in a RANDOMISED open label study .\n",
            "Psychopathology PANSS , SCL-@R , BDI , side effects UKU , neurocognitive dysfunctions , subjective well-being SWN and quality of life SF-@ ; MLDL were measured before start of antipsychotic treatment , at discharge , after @ months and after @ year .\n",
            "Results : The psychopathology of patients treated by zotepine was significantly lower at discharge compared to the other atypical antipsychotics p-@ .\n",
            "Patients rated their quality of life significantly higher at the time of discharge from inpatient treatment compared to the beginning of treatment p-@ .\n",
            "Psychopathology , side effects and subjective rating of quality of life were only slightly correlated .\n",
            "Conclusions : The treatment with atypical antipsychotics increases the quality of life .\n",
            "Psychotic symptoms seem to have little influence on the subjective ratingof quality of life .\n",
            "So both , quality of life and psychopathology , should be measured independently .\n",
            "The assessment of quality of life may be a valuable addition in the measurement of outcome in the treatment of schizophrenia .\n",
            "Further results of the study , especially differences between the atypicals will be presented .\n",
            "BACKGROUND : The British Society for Disability and Oral Health guidelines made recommendations for oral health care for people with mental health problems , including providing oral health advice , support , promotion and education .\n",
            "The effectiveness of interventions based on these guidelines on oral health-related outcomes in mental health service users is untested .\n",
            "OBJECTIVE : To acquire basic data on the oral health of people with or at risk of serious mental illness .\n",
            "To determine the effects of an oral health checklist in routine clinical practice .\n",
            "DESIGN : Clinician and service user-designed cluster randomised trial .\n",
            "SETTINGS AND PARTICIPANTS : The trial compared a simple form for monitoring oral health care with standard care ( no form ) for outcomes relevant to service use and dental health behaviour for people with suspected psychosis in Mid and North England .\n",
            "Thirty-five teams were divided into two groups and recruited across @-@ with one year follow up .\n",
            "RESULTS : @ intervention teams returned @ baseline intervention forms and @ outcome sheets one year later ( @ % ) .\n",
            "Control teams ( n = @ ) returned @ baseline forms .\n",
            "For the proportion for which data were available at one year we found no significant differences for any outcomes between those allocated to the initial monitoring checklist and people in the control group ( Registered with dentist ( p = @ ) , routine check-up within last year ( p = @ ) , owning a toothbrush ( p = @ ) , cleaning teeth twice a day ( p = @ ) , requiring urgent dental treatment ( p = @ ) .\n",
            "CONCLUSION : This trial provides no clear evidence that Care Co-ordinators ( largely nursing staff ) using an oral health checklist improves oral health behaviour or oral health state in those thought to be at risk of psychosis or with early psychosis .\n",
            "Objectives : All antiPSYCHOTIC drugs are associated with weight gain .\n",
            "Currently there are relatively few treatment options to mitigate this side effect .\n",
            "Nizatidine is a histamine ( H ) -@ receptor blocker and has been reported to have appetite-suppressant properties .\n",
            "This DOUBLE-blind study evaluated the role of nizatidine in ameliorating olanzapine-associated weight gain for @ weeks in patients with SCHIZophrenia and related disorders.Methods : After an initial screening period of @ _ @ days , patients were RANDOMly assigned to receive olanzapine ( @ _ @ mg ) + placebo , olanzapine ( @ _ @ mg ) + nizatidine ( @ mg ) , or olanzapine ( @ _ @ mg ) + nizatidine ( @ mg ) .\n",
            "Seventy-four patients were included in this analysis .\n",
            "Patients were followed for change in weight ( primary objective ) as well as effects on appetite and primary psychopathology.Results : Patients treated with olanzapine + nizatidine ( @ mg ) had gained substantially less weight at week @ than did those treated with olanzapine and placebo ( p < @ ) .\n",
            "This amelioration was seen as early as @ weeks .\n",
            "Nizatidine was well-tolerated without significant adverse events , and overall clinical outcomes were not adversely affected .\n",
            "Conclusions : Nizatidine may ameliorate the weight gain associated with olanzapine treatment.Funding provided by Eli Lilly and Company CN : NR@ Thursday , May @ , @:@ p.m.-@ : @ p.m. PT : CSG CODE conference USA\n",
            "BACKGROUND : Persecutory delusions may be unfounded threat beliefs maintained by safety-seeking behaviours that prevent disconfirmatory evidence being successfully processed .\n",
            "Use of virtual reality could facilitate new learning .\n",
            "AIMS : To test the hypothesis that enabling patients to test the threat predictions of persecutory delusions in virtual reality social environments with the dropping of safety-seeking behaviours ( virtual reality cognitive therapy ) would lead to greater delusion reduction than exposure alone ( virtual reality exposure ) .\n",
            "METHOD : Conviction in delusions and distress in a real-world situation were assessed in @ patients with persecutory delusions .\n",
            "Patients were then randomised to virtual reality cognitive therapy or virtual reality exposure , both with @ min in graded virtual reality social environments .\n",
            "Delusion conviction and real-world distress were then reassessed .\n",
            "RESULTS : In comparison with exposure , virtual reality cognitive therapy led to large reductions in delusional conviction ( reduction @ % , P = @ , Cohen 's d = @ ) and real-world distress ( reduction @ % , P = @ , Cohen 's d = @ ) .\n",
            "CONCLUSION : Cognitive therapy using virtual reality could prove highly effective in treating delusions .\n",
            "Summary : Clinical experience with clozapin in @ psychotic patients showed favourable antipsychotic effect of the drug in patients from the schizofrenia sphere , particularly in patients with productive symptomatology in which cases certain specificity of therapeutic action was apparent .\n",
            "The drug was effectve aslo with long term administration in @ per cent of patients who showed some degree of pharmacoresistance to other neuroleptic drugs .\n",
            "By means of clozapin results comparable to tricyclic thymoleptic drugs were obtained also in the treatment of endogenous depression .\n",
            "Particularly indicated appeared clozapin in atypic , agitated and anxiety forms of depression .\n",
            "From the side effects , in comparison with other neuroleptic drugs , in the foreground was vegetative symptomatology with extremely low affinity to extrapyramidal system .\n",
            "Electroencephalographic changes in the course of therapy were characterized by significant increase in slow activity , slowing of the dominant rhythm and its spread also over the middle part of the scull , appearance of paroxysmal activities represented frequently by episodes of delta and increase on beta activity .\n",
            "Sy s .\n",
            "Psychit. , @ , @ , No. @ , p.@-@ .\n",
            "In addition to disabling symptoms , chronic schizophrenia is characterized by neurocognitive and neurological deficits that may be more closely related to underlying pathology and social functioning .\n",
            "To assess the efficacy of olanzapine on clinical improvement and neurocognitive functioning in chronic nonresponding schizophrenic patients , we conducted a DOUBLE-blind study of olanzapine and haloperidol , with open-label olanzapine follow-up of up to @ mg/day .\n",
            "Assessments included a variety of neurocognitive tests and quantitative clinical scales at baseline and several time points during the drug trial .\n",
            "Results with a sample of @ patients showed that compared to haloperidol , olanzapine significantly improved performance on the Wisconsin Card Sorting Task ( WCST ) at the end of the DOUBLE-blind phase compared to baseline testing .\n",
            "There were nonsignificant trends for more improvement with olanzapine than haloperidol on some other measures of verbal learning and memory at the end of the DOUBLE-blind phase .\n",
            "At the end of the open-label olanzapine treatment phase , performance on several verbal memory tests from the RANDT and Sternberg memory task is were improved over baseline .\n",
            "Olanzapine improved visual-spatial memory at the end of the open olanzapine phase , but there were no differences between olanzapine and haloperidol after only @ weeks of the DOUBLE-blind treatment .\n",
            "Olanzapine tended to improve verbal fluency .\n",
            "Olanzapine 's - effects on improving neurocognitive performance were not strongly correlated with its effects on changes in rating scale clinical symptom scores .\n",
            "The effects of olanzapine on performance on the WCST , RANDT , and Sternberg memory and visual-spatial memory tasks suggest that olanzapine may have ameliorative effects on neurocognitive functions involving verbal memory , visual-spatial memory , and executive functions .\n",
            "The lack of significant correlations between the effects of olanzapine on neurocognitive and clinical improvements suggest that these may be separate domains of clinical effects .\n",
            "( Supported by a grant from Lilly Pharmaceuticals )\n",
            "It has been proposed that new atypical antipsychotics cause minimal prolactin ( PRL ) elevation compared to traditional antipsychotic agents because they spare dopamine blockade within the brain 's tuberoinfundibular tract .\n",
            "The aim of this study was to compare the effects of olanzapine and haloperidol on PRL secretion in male schizophrenic patients .\n",
            "Twenty-nine male schizophrenic inpatients were included in the study .\n",
            "Fifteen of them were given olanzapine in a fixed dose of @ mg/day PO and @ of them were given haloperidol in a fixed dose of @ mg/day PO for @ weeks after a @-week drug washout period .\n",
            "Fifteen age-matched healthy control subjects were used as control group .\n",
            "PRL levels were measured both before and after the @-week treatment period in the patients .\n",
            "At the end of the @th week , the PRL values observed with olanzapine treatment were significantly less than those observed with haloperidol , but not different from those of the controls .\n",
            "There was a significant positive correlation between the PRL values and the severity of extrapyramidal side effects in only the haloperidol group after the six week 's treatment period .\n",
            "Our data indicate that short-term olanzapine treatment at doses of @ mg/day PO causes minimal elevations in PRL secretion in male schizophrenic patients in contrast to haloperidol .\n",
            "This finding is consistent with the previous reports and may be attributed to olanzapine 's differential effects on dopamine neurotransmission\n",
            "Background : The overrepresentation of people with serious mental illness ( SMI ) in US jails and prisons is an important public mental health problem [ @-@ ] .\n",
            "According to a recent analysis of US Department of Justice data there are three times as many people with SMI in correctional settings than in psychiatric inpatient facilities [ @ ] .\n",
            "After release from incarceration , community reentry is challenged by barriers to obtaining essential healthcare , social services , and financial resources , perpetuating a revolving door of incarceration , followed by failed community reentry and recidivism to jail or prison [ @ ] .\n",
            "Although untreated psychotic illness may be a significant variable , no studies comparing the effectiveness of psychopharmacologic treatments in individuals with schizophrenia following release from jail have been conducted [ @ ] .\n",
            "A recently initiated clinical study compares a monthly , long-acting injectable antipsychotic with daily oral antipsychotics in delaying time to reentry failure in patients with schizophrenia who have been recently released from jail .\n",
            "The study is being conducted at approximately @ US sites .\n",
            "There is extensive site variation due to regional differences in the mental health systems and available services for this population among the states and counties where the sites are located .\n",
            "This both reflects the real world nature of the study and poses methodological challenges for the study design and analysis .\n",
            "We report on the nature of the problem , the study rationale , and methodological questions encountered in designing a psychopharmacology intervention trial that addresses public health and clinical dimensions of a problem frequently encountered by people with schizophrenia .\n",
            "Methods : This is a prospective , randomized , open-label , multicenter , effectiveness study comparing paliperidone palmitate with oral antipsychotics in subjects with schizophrenia who were recently released from jail and who were incarcerated at least twice within the preceding @ months .\n",
            "The study consists of a @-day screening phase and @-month treatment phase .\n",
            "Before randomization , the investigator / clinicians and the subjects identify individually suitable oral antipsychotics from a list of seven commonly prescribed oral antipsychotics ( aripiprazole , haloperidol , olanzapine , paliperidone , perphenazine , quetiapine , or risperidone ) .\n",
            "At randomization ( @:@ ) , subjects are assigned treatment to paliperidone palmitate or to one of the oral antipsychotic agents that were prespecified as appropriate therapy for that individual .\n",
            "The primary endpoint is time to occurrence of a treatment failure event , defined as arrest ; hospitalization ; suicide ; discontinuation of antipsychotic treatment due to inadequate efficacy , safety , or tolerability ; treatment supplementation with another antipsychotic due to inadequate efficacy ; or an increase in the level of psychiatric services in order to prevent imminent psychiatric hospitalization .\n",
            "Other measures include the Clinical Global Impressions - Severity scale , Medication Satisfaction Questionnaire , Activities of Daily Living , Sheehan Disability scale , alcohol and drug abuse section of the Addiction Severity Index , Personal and Social Performance scale , and resource utilization measurements .\n",
            "Discussion : This is a comparative effectiveness study to determine whether time to treatment failure for people with schizophrenia recently released from jail differs between treatment with paliperidone palmitate , a long-acting atypical injectable antipsychotic , and commonly prescribed oral antipsychotics .\n",
            "Endpoints were chosen to address meaningful clinical and public health outcomes .\n",
            "Aim : To observe the clinical therapeutic and side effect of jiawei lingguizhugan tang on obesity induced by psychoactive drugs .\n",
            "Methods : Ninety psychotic inpatients and outpatients with obesity induced by psychoactive drugs from Guangzhou Psychiatric Hospital between August @ and February @ were selected and randomly divided into @ groups with @ cases in each group : jiawei lingguizhugan tang group including @ males and @ females aged ( @ + / -@ ) years with an illness course of ( @ + / -@ ) years : The patients in this group orally took the jiawei lingguizhugan tang ( composed of fuling , guizhi , baizhu , cangzhu , zexie , heye , yuanzhi , fanxieye , fabanxia , dafupi , zhishi and so on ) ; lingguizhugan tang group including @ males and @ females aged ( @ + / -@ ) years with an illness course of ( @ + / -@ ) years : The patients orally took lingguizhugan tang ( composed of fuling , guizhi , baizhu , cangzhu , zexie , heye , yuanzhi , chang pu , fanxieye , fabanxia and so on ) ; and control group including @ males and @ females aged ( @ + / -@ ) years with an illness course of ( @ + / -@ ) years : The patients in this group orally took the placebo ( composed of sangye , juhua and so on ) .\n",
            "The drug mixture of each group contained @ g/L crude drugs , which was orally taken twice a day , @ mL each time for a @-week treatment .\n",
            "The changes were determined by means of the Brief Psychiatric Rating Scale and Treatment Emergent Symptom Scale , and the body mass was recorded before and the @nd , @th , @th weekend after treatment .\n",
            "Results : All @ patients entered the result analysis .\n",
            "@ Comparison of the therapeutic effects : The total effective rates of jiawei lingguizhugan tang group , lingguizhugan tang group and control group were @ % ( @/@ ) , @ % ( @/@ ) and @ % ( @/@ ) respectively ; The efficacy of the jiawei lingguizhugan tang group and the lingguizhugan tang group were similar and better than that of the control group after treatment , but no significant difference between two treatment groups was found ( P < @ ) .\n",
            "@ Comparison of the changes in body mass : The difference in body mass among the three groups was not significant before treatment [ ( @ + / -@ ) , ( @ + / -@ ) , ( @ + / -@ ) kg , P > @ ] ; but the body mass of the jiawei lingguizhugan tang group and lingguizhugan tang group were obviously lower than the control group after the @-week treatment [ ( @ + / -@ ) , ( @ + / -@ ) , ( @ + / -@ ) kg , P < @ .\n",
            "@ Comparison of the changes in Brief Psychiatric Rating Scale scores : The scores of all groups after @ weeks treatment were obviously reduced compared with those before treatment ( P < @ or P < @ ) ; but no obvious difference was found among the three groups at each time point ( P > @ ) .\n",
            "@ Adverse events and side effect : All the patients in the lingguizhugan tang group presented an increase frequency in defecation after treatment : @-@ times daily , and @ cases with @-@ times a day .\n",
            "The patients in the jiawei lingguizhugan tang group had no obviously increased frequency of defecation , and no diarrhea was found in the control group .\n",
            "Conclusion .\n",
            "Jiawei lingguizhugan tang is an effective and safe herb to treat the obesity induced by psychoactive drugs with fewer side effects .\n",
            "Objective To compare the efficacy and safety of risperidone ketone oral liquid merge clonazepam tablets and haloperidol intramuscular to control schizophrenia excited agitation symptoms , replace haloperidol and risperidone oral solution in after the excitement agitation control the intramuscularly 's efficacy and safety .\n",
            "Approach into @ cases of excited agitation in patients with schizophrenia : @ cases were randomly divided the Ruli Pei ketone group risperidone oral solution ( @ ~ @ ml / d ) combined clonazepam ( @ to @ mg / d ) , @ days since clonazepam tapering total observation @d ; @ Legislation Sub into the haloperidol group , haloperidol intramuscular injection ( @ to @ mg / d ) @ days before and six days gradually replaced with risperidone oral solution ( @ ~ @ ml / d ) , were observed @d .\n",
            "Positive and Negative Syndrome Scale ( PANSS ) , the Barnes Akathisia Scale ( BAS ) , class of Parkinson 's Syndrome Scale ( SAS ) to evaluate the efficacy and adverse reactions .\n",
            "An average of five days risperidone group and haloperidol group at the end of the PANSS excitement agitation factor scores ( standard deviation ) decreased score were @ ( @ ) points , @ ( @ ) points , t = @ , P = @ The average PANSS total score decreased score were @ ( @ ) min , @ ( @ ) min , t = @ , P = @ .\n",
            "The end of the five days risperidone group SAS score lower than haloperidol intramuscularly group [ @ ( @ ) points , @ ( @ ) points , Z = @ , P = @ ] .\n",
            "Conclusion Risperidone Oral Solution merger clonazepam tablets can be effective and safe in the treatment of schizophrenia acute excitement and agitation .\n",
            "Direct change in the control excitement agitation after haloperidol intramuscular risperidone oral solution , but also to maintain the efficacy .\n",
            "Background : Cognitive remediation therapy ( CRT ) has demonstrated eff-cacy for improving cognition in schizophrenia patients .\n",
            "Trials of agents designed to enhance cognition , on the other hand , have been largely negative in schizophrenia , although we have demonstrated substantial positive effects on cognition in the schizophrenia spectrum with guanfacine , an agent that enhances alpha-@ adrenergic activity .\n",
            "However , there have been no controlled trials of the effects of medications that specifcally enhance cognition in the schizophrenia spectrum , in conjunction with CRT , to facilitate and consolidate the effectiveness of the remediation nor have there been examinations of the effcacy of CRT in the broader spectrum in participants with schizo-typal personality disorder ( SPD ) , a group with a similar pattern of cognitive and functional defcits , albeit less severe , to what is seen in schizophrenia but which is free of many potential confounds of schizophrenia samples .\n",
            "Methods : We enrolled participants with SPD in an @-week , randomized , double-blind , placebo-controlled trial of guanfacine paired with CRT consisting of @ computerized training sessions and @ social skills groups per week .\n",
            "All participants were administered the Matrics Clinical Consensus Battery ( MCCB ) , assessing cognitive performance , and the UCSD Performance Based Skills Assessment ( UPSA ) , assessing functional skills , both pre-and posttreatment .\n",
            "Results : We conducted a series of repeated measures analyses of variance for each of our DVs with time ( pre and post ) and medication status ( guan-facine and placebo ) as our IVs .\n",
            "Overall , we found signifcant main effects for time on MCCB speed of processing , verbal learning , visual learning , and working memory as well as UPSA total score ( all Ps > .@ ) , suggesting that participants benefted from the intervention .\n",
            "In addition , there was a signifcant Time x Medication interaction for MCCB planning and organization and UPSA total score ( Ps > .@ ) , with individuals in our guanfacine group demonstrating greater improvement following treatment than those in our placebo group .\n",
            "There were no signifcant improvements on MCCM working memory or attention ( Ps > .@ ) .\n",
            "Conclusion : Participants with SPD who were treated with CRT plus guan-facine demonstrated statistically signifcant improvements in reasoning and problem-solving and in their functional skills , suggesting that guanfacine may be an appropriate agent to augment CRT in the schizophrenia spectrum .\n",
            "The serum levels of the two geometric isomers of clopenthixol and N-dealkylated clopenthixol were estimated in @ patients , who received cis ( Z ) - clopenthixol ( Cisordinol , Clopixol tabl . )\n",
            "in one period and the double dose of cis ( Z ) / trans ( E ) - clopenthixol ( Sordinol , Ciatyl ) in another period .\n",
            "Nearly equal concentrations of the neuroleptically active isomer , cis ( Z ) - clopenthixol , were found in the two periods .\n",
            "This finding is in agreement with the clinical experience , but in disagreement with the administered amounts of cis ( Z ) - clopenthixol , which were larger when the cis ( Z ) - isomer was given alone .\n",
            "Highly significant correlations were found between dose and mean serum level of cis ( Z ) - clopenthixol and between dose and area under the serum concentration curves for @ of the patients , the ninth patient , who had received additional medication showed deviating results .\n",
            "No indication of transformation of cis ( Z ) - clopenthixol into trans ( E ) - clopenthixol or vice versa was found .\n",
            "Trans ( E ) - clopenthixol was found in the serum samples even after administration for one week with the cis ( Z ) - clopenthixol tablets indicating a relatively long half - life of the trans ( E ) - isomer .\n",
            "The cis ( Z ) - isomer of N-dealkyl clopenthixol was found in about the same concentration as cis ( Z ) - clopenthixol in both periods , while trans ( E ) - N-dealkyl clopenthixol occurred in about @ times higher concentrations in patients who had either been given cis ( Z ) / trans ( E ) - clopenthixol before they went into the study or had received it in the first period of this study .\n",
            "Metacognitive training ( MCT ) was developed to promote awareness of reasoning biases among patients with schizophrenia .\n",
            "While MCT has been translated into @ languages , most MCT studies were conducted in Europe , including newer evidence recommending an individualized approach of delivery .\n",
            "As reasoning biases covered in MCT are separable processes and are associated with different symptoms , testing the effect of selected MCT modules would help to develop a targeted and cost-effective intervention for specific symptoms and associated mechanisms .\n",
            "This study tested the efficacy of a four-session metacognitive training for delusions , MCTd ( in Traditional Chinese with cultural adaptations , provided individually ) , as an adjunct to antipsychotics in reducing severity and conviction of delusions , jumping to conclusions ( JTC ) bias and belief inflexibility .\n",
            "Forty-four patients with delusions were randomized into the MCTd or the wait-list control condition .\n",
            "Patients on wait-list received the same MCTd after @ weeks of treatment as usual ( TAU ) .\n",
            "Assessment interviews took place before and after the treatment , and at @-week follow-up .\n",
            "There was an additional baseline assessment for the controls .\n",
            "JTC and belief flexibility were measured by the beads tasks and the Maudsley Assessment of Delusions Scale .\n",
            "Attendance rate of the MCTd was satisfactory ( @ % ) .\n",
            "Compared to TAU , there was a greater reduction in psychotic symptoms , delusional severity and conviction following MCTd .\n",
            "There was a large treatment effect size in improvement in belief flexibility .\n",
            "Improvement in reaction to hypothetical contradiction predicted treatment effect in positive symptoms and delusions .\n",
            "JTC bias was reduced following MCTd , although the treatment effect was not significantly larger than TAU .\n",
            "Our results support the use of process-based interventions that target psychological mechanisms underlying specific psychotic symptoms as adjuncts to more conventional approaches .\n",
            "BACKGROUND : Cognitive behavior therapy for psychosis has been a prominent intervention in the psychological treatment of psychosis .\n",
            "It is , however , a challenging therapy to deliver and , in the context of increasingly rigorous trials , recent reviews have tempered initial enthusiasm about its effectiveness in improving clinical outcomes .\n",
            "Acceptance and commitment therapy shows promise as a briefer , more easily implemented therapy but has not yet been rigorously evaluated in the context of psychosis .\n",
            "The purpose of this trial is to evaluate whether Acceptance and Commitment Therapy could reduce the distress and disability associated with psychotic symptoms in a sample of community-residing patients with chronic medication-resistant symptoms.Methods / design : This is a single ( rater ) - blind multi-centre randomised controlled trial comparing Acceptance and Commitment Therapy with an active comparison condition , Befriending .\n",
            "Eligible participants have current residual hallucinations or delusions with associated distress or disability which have been present continuously over the past six months despite therapeutic doses of antipsychotic medication .\n",
            "Following baseline assessment , participants are randomly allocated to treatment condition with blinded , post-treatment assessments conducted at the end of treatment and at @ months follow-up .\n",
            "The primary outcome is overall mental state as measured using the Positive and Negative Syndrome Scale .\n",
            "Secondary outcomes include preoccupation , conviction , distress and disruption to life associated with symptoms as measured by the Psychotic Symptom Rating Scales , as well as social functioning and service utilisation .\n",
            "The main analyses will be by intention-to-treat using mixed-model repeated measures with non-parametric methods employed if required .\n",
            "The model of change underpinning ACT will be tested using mediation analyses .\n",
            "DISCUSSION : This protocol describes the first randomised controlled trial of Acceptance and commitment therapy in chronic medication-resistant psychosis with an active comparison condition .\n",
            "The rigor of the design will provide an important test of its action and efficacy in this population.Trial registration : Australian New Zealand Clinical Trials Registry : ACTRN@ .\n",
            "Date registered : @ April @ .\n",
            "OBJECTIVE : Individuals with serious mental illness also have high rates of comorbid physical health issues .\n",
            "To address those issues , this population needs interventions that improve self-management of health and healthcare .\n",
            "METHODS : In order to improve the health and healthcare of individuals with serious mental illnesses , @ consumers with serious mental illness were randomized to receive either usual mental healthcare plus the Bridge intervention ( n = @ ) or usual mental healthcare while on a @ month waitlist ( n = @ ) .\n",
            "The waitlist group received the intervention after the waitlist period .\n",
            "RESULTS : Change score comparisons ( difference of differences ) of the treatment vs the waitlist groups revealed that the treated group showed significantly greater improvement in access and use of primary care health services , higher quality of the consumer-physician relationship , decreased preference for emergency , urgent care , or avoiding health services and increased preference for primary care clinics , improved detection of chronic health conditions , reductions in pain , and increased confidence in consumer self-management of healthcare .\n",
            "CONCLUSIONS : Peer providers using a manualized intervention can be an important part of the efforts to address the general medical care of individuals with serious mental illnesses .\n",
            "Purpose : The benefits of early intervention with optimal treatment of first-episode psychosis are well established .\n",
            "While atypical antipsychotics are an effective therapy for the treatment of first-episode psychosis , there is little information available regarding the relative efficacy and safety of the different atypicals in this population .\n",
            "Here we compare the efficacy and tolerability of quetiapine and risperidone in patients with first-episode psychosis ( Study number BU-@-@ ) .\n",
            "Methods : We present @-week interim data from an ongoing @-week , RANDOMised , rater-blinded , parallel-group study of quetiapine and risperidone in patients experiencing a first episode of SCHIZophreniform psychosis ( ICD-@ criteria ) .\n",
            "Efficacy measures included the Positive and Negative Syndrome Scale ( PANSS ) , Clinical Global Impression - Severity of Illness ( CGI-S ) , Global Assessment of Functioning ( GAF ) , Calgary Depression Scale for SCHIZophrenia ( CDSS ) and the Calgary Anxiety Scale for SCHIZophrenia ( CASS ) .\n",
            "Tolerability was measured using the Antipsychotic Non-Neurological Side Effect Rating Scale ( ANNSERS ) .\n",
            "Patients were assessed at baseline and at @ and @ weeks and analysed on a last observation carried forward basis .\n",
            "Patient recruitment is ongoing .\n",
            "Results : A total of @ patients were RANDOMised to treatment .\n",
            "Of these , @ patients ( @ % male , mean age @ years ) received quetiapine , @ ( @ % male , mean age @ years ) received risperidone , and @ refused treatment .\n",
            "The mean rate of patient discontinuation was similar in each group ( approximately @ weeks ) .\n",
            "The mean ( SD ) doses at @ weeks were @ ( @ ) mg and @ ( @ ) mg for quetiapine and risperidone , respectively .\n",
            "There was no difference between treatments for any of the efficacy assessments .\n",
            "In the overall study population , mean ( SD ) baseline scores on PANSS positive subscale , CGI and GAF were @ ( @ ) , @ ( @ ) and @ ( @ ) , respectively .\n",
            "After @ weeks of treatment , symptoms improved by ?\n",
            "@ , ?\n",
            "@ and +@ on PANSS , CGI-S and GAF , respectively ( all p < @ ) .\n",
            "Furthermore , the overall population showed a non-significant trend towards improvement in depressive symptoms with a change in mean ( SD ) CDSS score from @ ( @ ) at baseline , to @ ( @ ) after @ weeks of treatment ( p = @ ) .\n",
            "There was no significant improvement in PANSS negative subscale scores or CASS scores .\n",
            "Change from baseline in sexual dysfunction was not significant in the quetiapine cohort .\n",
            "The intensity of sexual dysfunction was greater in the risperidone treated patients compared with those receiving quetiapine ( p = @ ) .\n",
            "In the overall population , ANNSERS scores showed that the intensity of problems with sexual arousal were mild ; however , the longitudinal increase was significant after @ weeks of treatment ( p = @ ) .\n",
            "The most common side effects were hyposexuality and difficulty waking in the morning ( risperidone and quetiapine groups , respectively ) .\n",
            "Very low incidences of Parkinsonian extrapyramidal symptoms , akathisia and abnormal movements were reported .\n",
            "All side effects were of mild-to-moderate intensity .\n",
            "Conclusions : Quetiapine and risperidone show comparable efficacy in a broad range of symptoms of first-episode SCHIZophreniform psychosis .\n",
            "Risperidone was associated with higher levels of sexual dysfunction compared with quetiapine .\n",
            "These effects were evident at relatively low doses , consistent with evidence that first-episode patients are more sensitive to the therapeutic and adverse effects of these drugs .\n",
            "Gafoor R , Matthiasson P , Craig T , Power P , Kerwin R , McGuire P , Efficacy , side effects and endocrine disturbance in patients with a first episode of psychosis treated with atypical antipsychotics .\n",
            "Abstracts of the XII th Biennial Winter Workshop on SCHIZophrenia .\n",
            "SCHIZophrenia Research .\n",
            "@ : Vol @ No@ Supplement .\n",
            "Objective To investigate the efficacy of risperidone and clozapine in refractory schizophrenia patients .\n",
            "After diagnosis of @ cases of patients with refractory schizophrenia CCMD  R standard , randomly divided into two groups , risperidone and clozapine treatment for @ months before treatment and after @ , evaluate the efficacy of @ months using the BPRS , SANS , SDSS , CGI scale .\n",
            "Risperidone in the treatment of refractory schizophrenia , the efficiency of @-@ % , clozapine @-@ % , the scale show the two drugs is similar to the treatment of refractory schizophrenia , risperidone unscrupulous reactions were mild akathisia , tremor , acute dystonia , clozapine , drowsiness , dizziness , nausea , vomiting , salivation .\n",
            "BACKGROUND : One of the major causes of death in schizophrenia is a metabolic syndrome .\n",
            "The clozapine has the highest rate of weight gain among antipsychotics .\n",
            "It has been shown that metformin can promote weight loss .\n",
            "We aimed to investigate the effect of metformin as an adjunctive therapy with clozapine to prevent metabolic syndrome in patients with schizophrenia .\n",
            "MATERIALS AND METHODS : A total of @ patients consisting metformin group ( @ cases ) and a group of placebo consisting of @ cases were evaluated .\n",
            "A brief psychiatric rating scale score ( BPRS ) and metabolic profiles was determined for all patients .\n",
            "All of the variables were also determined at @ , @ , @ , and @ weeks after the onset of the study .\n",
            "RESULTS : The mean age of the group of metformin was @ + / - @ compared with @ + / - @ for the group of placebo .\n",
            "The difference in mean waist circumference and serum level of triglyceride at baseline compared with the end of study showed a statistically significant difference between two groups ( P = @ .\n",
            "@ ) .\n",
            "A statistically significant difference was also observed in a comparison of mean difference of weight and body mass index at baseline compared with end of study ( P = @ .\n",
            "@ ) .\n",
            "There was a statistically significant difference of fasting blood sugar ( P = @ ) and serum high-density lipoprotein ( P = @ ) between two groups but this difference was not significant for mean BPRS scores , mean systolic and diastolic blood pressure , serum level of triiodothyronine , thyroxin and thyroid stimulating hormone , serum low-density lipoprotein and serum cholesterol .\n",
            "CONCLUSION : Metformin could be considered an adjunctive therapy with clozapine to prevent metabolic syndrome in schizophrenic patients .\n",
            "OBJECTIVE : The purpose of this study was to evaluate the safety and efficacy of asenapine in adolescents with schizophrenia .\n",
            "METHODS : In an @ week , randomized , double-blind placebo-controlled trial , subjects ( @-@ years of age ) meeting Diagnostic and Statistical Manual of Mental Disorders , @th ed. , Text Revision ( DSM-IV-TR ) criteria for schizophrenia were randomized @:@:@ to placebo , asenapine @ mg b.i.d. , or asenapine @ mg b.i.d. Subjects who completed the @ week acute study could participate in a @ week flexible-dose asenapine-only open-label extension ( OLE ) .\n",
            "RESULTS : A similar percentage of subjects completed treatment on day @ ( @ mg b.i.d. ( n = @ ) : @ % ; @ mg b.i.d. [ n = @ ] : @ % ; placebo [ n = @ ] : @ % ) .\n",
            "In the mixed model for repeated measures analysis of the primary end-point ( with Hochberg correction for multiplicity ) , least squares ( LS ) mean differences between asenapine and placebo on the Positive and Negative Syndrome Scale ( PANSS ) total score at day @ were not significant ( -@ for @ mg b.i.d. , p = @ ; -@ for @ mg b.i.d. , p = @ ) .\n",
            "Significant improvement in the Clinical Global Impressions-Severity score was observed in the @ mg b.i.d. group versus placebo on day @ ( LS mean -@ , p = @ ) .\n",
            "In the acute phase , > / = @ % weight gain and the composite event of somnolence , sedation , and hypersomnia were more common in both asenapine groups than in the placebo group .\n",
            "Akathisia , fasting glucose elevation , and extrapyramidal syndrome were more common in the @ mg b.i.d. group than in the placebo group .\n",
            "There were no unexpected adverse events in the OLE , and PANSS total scores decreased by -@ points in the group previously treated with placebo ( n = @ ) and by -@ points in the continuous asenapine group ( n = @ ) from OLE baseline to week @ .\n",
            "CONCLUSIONS : Although improvements in PANSS total score at day @ of the acute phase were numerically greater for both asenapine @ and @ mg b.i.d. than for placebo and were maintained in the OLE , the primary end-point did not achieve statistical significance in the acute phase .\n",
            "No new or unexpected safety concerns were detected during the acute phase or after an additional @ weeks of asenapine treatment in the adolescent population with schizophrenia .\n",
            "CLINICAL TRIALS REGISTRY : NCT@ and NCT@ at ClinicalTrials.gov .\n",
            "Background : Schizophrenia and other severe mentally ill ( SMI ) patients have an increased cardiometabolic risk , which is associated with life style factors ( lack of exercise , diet , smoking ) , their illness ( negative , disorganized and depressive symptoms ) and their treatment ( antipsychotic medication , inadequate somatic treatment ) .\n",
            "The aim of this study was to assess the effectiveness of a combined diet-and-exercise lifestyle intervention targeting the obesogenic environment of SMI residential patients .\n",
            "Methods : A cluster randomized controlled trial with @ residential and supported living teams yielding a total of @ eligible patients .\n",
            "Measurements were at the start and after @ and @ months intervention .\n",
            "The @-month intervention involved the training of health care staff to create a healthier environment for their patients and was based on general recommendations .\n",
            "The intervention started with a lifestyle plan supported by patients and staff , followed by @ months implementation and @ months monitoring based on a benchmark approach evaluating effectuated intervention .\n",
            "Main outcome measure was a reduction in cardiometabolic risk , measured as waist circumference .\n",
            "Other measures included systolic and diastolic blood pressure , plasma triglycerides , cholesterol ( LDL , HDL , and total cholesterol ) , glucose metabolism and BMI .\n",
            "Results : Preliminary analyses ( n = @ intervention ; n = @ control ) using mixed models show that the intervention group improved after @ months in waist circumference ( -@ cm ; control group + @ cm , p-value group * time @ ) , HbA@c ( -@ % , control group +@ % , p-value group * time @ ) , When we take into account the level of effectuated intervention , patients in the best locations improved more in waist circumference after @ months compared to patients in other intervention locations ( mean waist circumference - @ cm vs. + @ respectively ; difference between groups @ cm ( CI = @ ; @ , t [ @ ] = @ , p = @ ) .\n",
            "Men profited more from the intervention than women in terms of BMI , blood pressure and fasting glucose .\n",
            "Conclusion : Targeting the obesogenic environment of SMI residential patients leads to a decrease in cardiovascular risk .\n",
            "\" \" The purpose concept Chakui quetiapine efficacy and safety of treatment of refractory schizophrenia .\n",
            "Methods @ patients with refractory schizophrenia patients were randomly divided into experimental and control groups were given quetiapine , clozapine @ weeks of treatment , with positive symptoms and negative syndrome scale ( PANSS ) evaluate the clinical efficacy and adverse reaction symptom scale ( TESS ) evaluation of adverse drug reactions and results between the two groups the difference was not statistically significant ( P > @ ) ; Kui The sulfur level in drowsiness , dry mouth , constipation , salivation , weight gain , tachycardia , ECG abnormalities , nausea , vomiting , leukopenia significantly less than clozapine ( P < @ ) .\n",
            "Conclusion of quetiapine in the treatment of refractory schizophrenia safe and effective drugs . \"\n",
            "Objective : The relative effectiveness of newly started antipsychotic drugs for individuals with schizophrenia may depend on multiple factors , including each patient 's previous treatment response and the reason for a new medication trial .\n",
            "This randomized , double-blind study compared olanzapine , quetiapine , and risperidone in patients who had just discontinued the older antipsychotic perphenazine .\n",
            "Method : Subjects with schizophrenia ( N = @ ) who had been randomly assigned to and then discontinued perphenazine in phase @ of the Clinical Antipsychotic Trials of Intervention Effectiveness ( CATIE ) schizophrenia study were reassigned randomly to double-blinded treatment with olanzapine , @-@ mg/day ( N = @ ) ; quetiapine , @-@ mg/day ( N = @ ) ; or risperidone , @-@ mg/day ( N = @ ) .\n",
            "The primary aim was to determine whether there were differences among these three treatments in effectiveness , as measured by time to treatment discontinuation for any reason .\n",
            "Secondary outcomes included reasons for treatment discontinuation and measures of drug tolerability .\n",
            "Results : The time to treatment discontinuation was longer for patients treated with quetiapine ( median , @ months ) and olanzapine ( @ months ) than with risperidone ( @ months ) .\n",
            "There were no significant differences between treatments on discontinuation due to inefficacy , intolerability , or patient decision .\n",
            "Conclusions : Among this group of patients with chronic schizophrenia who had just discontinued the older antipsychotic perphenazine , quetiapine and olanzapine were more effective than risperidone , as reflected by longer time to discontinuation for any reason .\n",
            "In the context of other results from the CATIE study , the effectiveness and acceptability of antipsychotic drugs appears to vary considerably according to clinical circumstances .\n",
            "Objectives : To compare therapeutic effects and costs between risperidone and clozapine in the treatment of schizophrenia during hospitalization .\n",
            "Method : Thirty patients with schizophrenia received risperidone treatment , and twenty-six patients received clozapine treatment .\n",
            "The therapeutic effects and total costs were evaluated and compared .\n",
            "Results : The response rates of this two drugs were similar , the major durg costs in risperidone group were higher than those of clozapine and the total\n",
            "The purpose of this study is to assess the efficacy of d-cycloserine ( DCS ) as an augmentation strategy in two psychotic patients with a triplication ( @ copies ) of the glycine decarboxylase ( GLDC ) gene .\n",
            "Subjects will first undergo an eight-week open-label arm of treatment with DCS ( @ mg/d ) followed by six @-week double-blind placebo-controlled exposures to DCS or placebo .\n",
            "The length of each double-blind arm is limited to six weeks to minimize the length of symptom exacerbation experienced by the subjects when they are receiving placebo .\n",
            "The randomization scheme will allow two consecutive exposures to DCS , but will not allow two consecutive exposures to placebo , again to minimize the length of any symptom exacerbation .\n",
            "At the end of the open-label DCS trial , the following procedures will be carried out : structural MRI ( @T ) , proton @H MRS ( @T ) , fMRI ( @T ) , steady-state auditory evoked potentials , and electroretinogram recordings .\n",
            "In addition , @H MRS ( @T ) for @ hours after a single oral dose of a DCS will be assessed .\n",
            "Baseline data on all of these measures were previously obtained as part of a different study registered in clinical trials.gov - NCT@ ) .\n",
            "Positive , negative , and affective symptoms and neurocognitive function as well as plasma levels of large neutral and large and small neutral and excitatory amino acids and psychotropic drug levels will be assessed periodically .\n",
            "Pharmaceutical grade DCS ) or placebo will be compounded and dispensed by the McLean Hospital Pharmacy .\n",
            "The investigators hypothesize that mutation carriers will have reduced endogenous brain glycine and GABA levels and increased brain glutamate and glutamine levels .\n",
            "DCS administration will increase brain glycine in the two carriers compared to baseline and treatment with glycine ( @ g/kg ) .\n",
            "The investigators hypothesize reduced activation of magnocellular pathways and abnormal ERPs modulated by NMDA in mutation carriers compared with non-carrier family members and controls .\n",
            "The investigators hypothesize that DCS , but not placebo , will improve positive , negative and affective symptoms as well as neurocognitive function .\n",
            "The investigators also hypothesize that DCS will improve clinical and cognitive functioning , will partially normalize decreased baseline glycine and GABA and increased glutamate and glutamine , and will partially normalize magnocellular pathway activation and abnormal evoked potentials .\n",
            "Objective : To investigate the clinical efficacy and side effects of risperidone and clozapine in the treatment of chronic schizophrenia .\n",
            "Methods : @ patients with CCMD @ R diagnostic criteria of schizophrenia , the course of five years , the PANSS scale score  @ @ points of the hospitalized patients were randomly divided into two groups , the risperidone group of @ patients , clozapine group of @ cases .\n",
            "The study period of nine weeks .\n",
            "Risperidone group , the average daily doses @ mg .\n",
            "Clozapine group , the average daily amount of @ mg .\n",
            "Twice PANSS scale were assessed before and after the study .\n",
            "Study before and after the points deduction @ is divided into threshold values ; the side effects frequency for the two sets of side effects .\n",
            "RESULTS : Both groups can significantly improve mental symptoms .\n",
            "Risperidone group was @ % .\n",
            "Clozapine group , the effective rate of @ % .\n",
            "Two sets of side effects were mild , able to face-to-face .\n",
            "Auditory verbal hallucinations ( AVH ) in patients with schizophrenia are associated with abnormal hyperactivity in the left temporo-parietal junction ( TPJ ) and abnormal connectivity between frontal and temporal areas .\n",
            "Recent findings suggest that fronto-temporal transcranial Direct Current stimulation ( tDCS ) with the cathode placed over the left TPJ and the anode over the left prefrontal cortex can alleviate treatment-resistant AVH in patients with schizophrenia .\n",
            "However , brain correlates of the AVH reduction are unclear .\n",
            "Here , we investigated the effect of tDCS on the resting-state functional connectivity ( rs-FC ) of the left TPJ .\n",
            "Twenty-three patients with schizophrenia and treatment-resistant AVH were randomly allocated to receive @ sessions of active ( @ mA , @ min ) or sham tDCS ( @ sessions/d for @ d ) .\n",
            "We compared the rs-FC of the left TPJ between patients before and after they received active or sham tDCS .\n",
            "Relative to sham tDCS , active tDCS significantly reduced AVH as well as the negative symptoms .\n",
            "Active tDCS also reduced rs-FC of the left TPJ with the left anterior insula and the right inferior frontal gyrus and increased rs-FC of the left TPJ with the left angular gyrus , the left dorsolateral prefrontal cortex and the precuneus .\n",
            "The reduction of AVH severity was correlated with the reduction of the rs-FC between the left TPJ and the left anterior insula .\n",
            "These findings suggest that the reduction of AVH induced by tDCS is associated with a modulation of the rs-FC within an AVH-related brain network , including brain areas involved in inner speech production and monitoring .\n",
            "BACKGROUND : D-Cycloserine , a partial agonist at the glycine recognition site of the NMDA receptor , has previously been shown to improve negative symptoms when added to conventional antipsychotics and , in one preliminary dose-finding study , worsened negative symptoms when added to clozapine .\n",
            "METHODS : Seventeen schizophrenia outpatients treated with clozapine were assigned in random order to @-week trials of D-cycloserine @ mg/day and placebo in a crossover design separated by a @ week placebo washout .\n",
            "RESULTS : Eleven patients competed the @-week study .\n",
            "D-Cycloserine significantly worsened ratings of negative symptoms compared to placebo but did not significantly affect ratings of psychotic symptoms .\n",
            "CONCLUSIONS : The differing effects of D - cycloserine on negative symptoms when added to clozapine compared to conventional antipsychotics suggests that activation of the glycine recognition site may play a role in clozapine 's efficacy for negative symptoms .\n",
            "Loxapine is a drug which is used in the treatment of psychotic disorders .\n",
            "The drug is extensively biotransformed in humans to produce a variety of metabolites , some of which have pharmacological activity .\n",
            "Seven-hydroxyloxapine is @-@ times more active than the parent drug , although its concentrations in plasma are relatively low .\n",
            "Eight-hydroxyloxapine , on the other hand , is inactive , but is present in higher concentrations in plasma than the parent drug .\n",
            "In the present randomized crossover study to evaluate the bioequivalence of two dosage forms containing loxapine , the parent drug and its @ - hydroxy and @-hydroxy metabolites were monitored for up to @ hours after the administration of the test or reference formulations .\n",
            "Estimates of average bioavailability ( AUC ( infinity ) @ , AUC ( t ) @ and C ( max ) ) were obtained by the difference of the least squares means of log test and log reference .\n",
            "A @ % confidence interval for the log difference was derived from the within-subject error .\n",
            "The test of bioequivalence requires the @ % confidence band so calculated to fall entirely within an imposed regulatory interval of @ - @ % .\n",
            "The results showed the two formulations to be bioequivalent in terms of the log mean differences and @ % confidence bands calculated for all three analytes .\n",
            "In fact , the within-subject variabilities of the metabolites were relatively low , so that the @ % confidence intervals for ln AUC ( infinity ) @ , ln AUC ( t ) @ and ln C ( max ) calculated for the metabolites , were narrower that those for the parent drug .\n",
            "Moreover , the within - subject variability of ln C ( max ) for the parent drug was @ % , which means that if the study were repeated , there would be a good chance that the @ % confidence interval for ln C ( max ) might fail to fall entirely within the imposed regulatory interval .\n",
            "In such an eventuality , it would be appropriate to base the bioequivalence decision on data from either metabolite .\n",
            "Forty-four schizophrenic patients were followed up for five years after their first admission to hospital for a first episode of illness .\n",
            "Thirteen ( @ % ) of @ patients had not relapsed ; @ of the @ patients who did relapse did so within the first @ months .\n",
            "The relapses occurred despite antipsychotic drug therapy .\n",
            "Also , @ % of patients had at least one course of ECT .\n",
            "Only @ % of the patients at five years were in open employment ; unemployment was strongly associated with relapse .\n",
            "Eighteen per cent had neither relapses nor schizophrenic symptoms at follow - up .\n",
            "Poor outcome at five years was associated with greater psychological distress among relatives at first admission .\n",
            "At five years @ % of relatives continued to show case level psychological stress .\n",
            "Background : Family intervention reduces relapse rates in psychosis .\n",
            "Cognitive-behavioural therapy ( CBT ) improves positive symptoms but effects on relapse rates are not established .\n",
            "Aims : To test the effectiveness of CBT and family intervention in reducing relapse , and in improving symptoms and functioning in patients who had recently relapsed with non-affective psychosis .\n",
            "Method : A multicentre randomised controlled trial ( ISRCTN@ ) with two pathways : those without carers were allocated to treatment as usual or CBT plus treatment as usual , those with carers to treatment as usual , CBT plus treatment as usual or family intervention plus treatment as usual .\n",
            "The CBT and family intervention were focused on relapse prevention for @ sessions over @ months .\n",
            "Results : A total of @ patients and @ carers participated .\n",
            "Primary outcome data were available on @ % of the total sample .\n",
            "The CBT and family intervention had no effects on rates of remission and relapse or on days in hospital at @ or @ months .\n",
            "For secondary outcomes , CBT showed a beneficial effect on depression at @ months and there were no effects for family intervention , in people with carers , CBT significantly improved delusional distress and social functioning .\n",
            "Therapy did not change key psychological processes .\n",
            "Conclusions : Generic CBT for psychosis is not indicated for routine relapse prevention in people recovering from a recent relapse of psychosis and should currently be reserved for those with distressing medication-unresponsive positive symptoms .\n",
            "Any CBT targeted at this acute population requires development .\n",
            "The lack of effect of family intervention on relapse may be attributable to the low overall relapse rate in those with carers .\n",
            "OBJECTIVE : To test the hypothesis that reported in vitro muscarinic receptor affinity differences between olanzapine and risperidone would be reflected in peripheral solicited anticholinergic adverse event frequencies .\n",
            "METHOD : Data from a double-blind , randomized trial of olanzapine versus risperidone in @ patients ( age range , @-@ years ) with DSM-IV schizophrenia spectrum acute psychosis were retrospectively analyzed .\n",
            "Subgroups based on the median of the mean daily drug dose were constructed ( olanzapine < / = @ mg ; olanzapine > @ mg ; risperidone < / = @ mg ; risperidone > @ mg ) .\n",
            "Mean daily dose of adjunctive anticholinergic medication was compared using ANOVA , and frequencies of treatment-emergent solicited adverse events defined by the Association de Methodologie et de Documentation en Psychiatrie ( AMDP-@ ) were analyzed using categorical methods .\n",
            "RESULTS : Mean daily anticholinergic dose was significantly higher overall for the risperidone group ( @ + / - @ mg ) than for the olanzapine group ( @ + / - @ mg ) ( p = .@ ) .\n",
            "When only patients who did not receive anticholinergic adjunct therapy were considered , no significant differences in the frequency of specific anticholinergic adverse events occurred in olanzapine-treated patients as compared with risperidone-treated patients ( p > / = .@ ) .\n",
            "There was also no significant difference between olanzapine and risperidone in the frequency of any anticholinergic adverse event ( p = .@ ) .\n",
            "CONCLUSION : At clinically effective doses , olanzapine and risperidone did not differ significantly in frequency of peripheral anticholinergic events .\n",
            "These results support the view that , for olanzapine and risperidone , in vitro anticholinergic receptor binding ( K ( i ) values ) may not predict in vivo peripheral events .\n",
            "Objective To explore the music therapy combined with electric convulsive treatment of refractory schizophrenia and clinical application .\n",
            "Methods @ patients with refractory schizophrenia were randomly divided into a treatment group ( @ cases ) and control group ( @ cases ) .\n",
            "Joint non-electric convulsive therapy , the control group with no electric convulsive therapy , music therapy , the treatment group and the two groups of patients using the Positive and Negative Syndrome Scale ( pan-ss ) the side reactions Scale ( tess ) , Wechsler Memory amount table @ ( wms ) project ( recognition , picture , Lenovo and back number ) before treatment , after the patient assessment .\n",
            "Results  After treatment panss rated , were significantly decreased , and with the duration of treatment , the lower apparent , after chi-square analysis , a statistically significant difference , p < @ ;  treatment group the wms rated recovery time was significantly faster than the control group , after the card square analysis of a statistically significant difference ( p < @ ) .\n",
            "OBJECTIVE : Taurine is an inhibitory neuromodulatory amino acid in the central nervous system that activates the GABA - and glycine-insensitive chloride channel and inhibits the N-methyl-D-aspartate receptor .\n",
            "It also functions as a neuroprotective agent and has a role in neural development and neurogenesis .\n",
            "The aim of this study was to determine the efficacy of adjunctive taurine in improving symptomatology and cognition among patients with a DSM-IV first-episode psychotic disorder .\n",
            "METHODS : @ patients with first-episode psychosis , aged @-@ years , attending early intervention services consented to participate in this randomized , double-blind , placebo-controlled trial conducted from January @ to May @ .\n",
            "Patients taking low-dose antipsychotic medication were randomly assigned to receive once-daily taurine @ g or placebo for @ weeks .\n",
            "The coprimary outcomes were change in symptomatology ( measured by the Brief Psychiatric Rating Scale [ BPRS ] total score ) and change in cognition ( measured by the Measurement and Treatment Research to Improve Cognition in Schizophrenia [ MATRICS ] Consensus Cognitive Battery composite score ) at @ weeks .\n",
            "Secondary outcomes included tolerability and safety and additional clinical and functioning measures .\n",
            "RESULTS : @ participants ( n = @ taurine ; n = @ placebo ) were included in the final analysis .\n",
            "Taurine significantly improved symptomatology measured by the BPRS total score ( @ % CI , @-@ ; P = .@ ) and psychotic subscale ( @ % CI , @-@ ; P = .@ ) compared to placebo .\n",
            "Additionally , improvements were observed in the Calgary Depression Scale for Schizophrenia ( @ % CI , @-@ ; P = .@ ) and Global Assessment of Functioning ( @ % CI , @-@ ; P = .@ ) scores .\n",
            "There was no group difference in composite cognitive score ( @ % CI , -@ to @ ; P = .@ ) .\n",
            "A significant group difference was found on one safety and tolerability item ( psychic item @ , asthenia/lassitude/increased fatigability ) of the Udvalg for Kliniske Undersogelser , with the taurine group showing a more favorable outcome ( P = .@ ) .\n",
            "CONCLUSIONS : Adjunctive taurine did not improve cognition , but it appears to improve psychopathology in patients with first-episode psychosis .\n",
            "The use of taurine warrants further investigation in larger randomized studies , particularly early in the course of psychosis .\n",
            "TRIAL REGISTRATION : ClinicalTrials.gov identifier : NCT@ .\n",
            "Objective : To compare the efficacy and adverse effects of quetiapine ( tradename Kai-dimensional ) and perphenazine in the treatment of schizophrenia .\n",
            "Methods : @ patients with schizophrenia were randomly divided into quetiapine , and perphenazine group , using the Positive and Negative Syndrome Scale ( panss ) and adverse drug reactions Scale ( tess ) assessment of drug efficacy and adverse reactions .\n",
            "Results : @ cases of patients with schizophrenia completed @ weeks of treatment , the two groups panss factor scores score than before treatment were significantly lower ( p < @ ) , quetiapine group was @ % , perphenazine group @ % , the two groups no significant difference between the two sets of negative symptom scores after treatment a significant difference ( p < @ ) , quetiapine group than in the perphenazine group , fewer quetiapine combination trihexyphenidyl the two groups , there are significant differences .\n",
            "Conclusion : Quetiapine treatment of schizophrenic patients with perphenazine similar efficacy for negative symptoms better than perphenazine , fewer adverse reactions , good compliance .\n",
            "Background : Schizophrenia is associated with significant neurocognitive deficits which predict poor functioning .\n",
            "Electrophysiological ( EEG ) biomarkers related to cognitive dysfunction in schizophrenia have been linked to abnormal NMDA glutamatergic neurotransmission .\n",
            "N-acetylcysteine ( NAC ) is an amino acid that modulates NMDA receptor function and has been previously shown to improve clinical symptoms of schizophrenia .\n",
            "The current pilot study evaluated whether NAC could improve cognitive function and related EEG biomarkers .\n",
            "Methods : @ adult outpatients with schizophrenia were randomized ( double-blind ) to receive @ mg NAC or placebo twice daily for @ weeks as an adjunct to antipsychotic treatment .\n",
            "Patients were assessed at baseline , @ weeks , and @ weeks on measures of clinical psychopathology ( Positive and Negative Syndrome Scale ( PANSS ) ; Clinical Assessment Interview for Negative Symptoms ( CAINS ) ; Clinical Global Impression ( CGI ) ) , cognition ( MATRICS Consensus Cognitive Battery ( MCCB ) ) , and side effects .\n",
            "Participants also underwent an EEG assessment battery examining mismatch negativity , gamma oscillation power and synchrony , and visual cortical neuroplasticity .\n",
            "Generalized linear mixed models for repeated measures were used to compare effects of NAC vs. placebo across the @ weeks .\n",
            "Results : @ participants completed all study visits ( @ who received NAC and @ who received placebo ) .\n",
            "There were no significant effects of NAC vs. placebo on the PANSS total score ( p = .@ ) or subscales ; the CAINS ( p = .@ on motivation/pleasure and p = .@ on expression scales ) ; the CGI ( p = .@ ) ; or the MCCB composite score ( p = .@ ) or subdomain scores .\n",
            "EEG data on mismatch negativity , gamma oscillations , and the visual cortical plasticity paradigm are undergoing analysis and will be presented .\n",
            "The treatment was generally well-tolerated , with gastrointestinal complaints representing the most commonly reported side effect .\n",
            "Conclusions : This study demonstrates the feasibility of assessing clinical symptoms and EEG biomarkers in a longitudinal clinical trial evaluating a potential treatment for schizophrenia .\n",
            "In our limited sample size , we found no evidence supporting NAC for improving clinical symptoms or cognitive deficits of schizophrenia .\n",
            "Analysis of EEG data will determine whether NAC had measurable effects on electrophysiological biomarkers related to cognition and NMDA glutamatergic function .\n",
            "Objective : To examine the effects on metabolic parameters ( glucose ( lipids and glycosylated hemoglobin levels ) of long-term treatment with aripiprazole , a new antipsychotic associated with minimal weight gain .\n",
            "Methods : Metabolic parameters were assessed in a @-week , randomized , placebo-controlled trial of aripiprazole treatment for the prevention of relapse in patients with chronic stable schizophrenia .\n",
            "Levels of glucose , plasma lipids , and glycosylated hemoglobin ( A@C ) were determined from fasted blood samples collected during the study .\n",
            "Results : Mean fasting plasma glucose levels showed minimal changes from baseline to endpoint in both the aripiprazole ( @ mg/dL ) and placebo ( @ mg/dL ) groups .\n",
            "Decreases in A@C levels of @ % were observed in the placebo group and @ % in the aripiprazole group .\n",
            "Fasting total cholesterol and fasting LDL cholesterol levels showed small decreases with the two treatments , while there were slight increases in fasting HDL cholesterol levels in both aripiprazole and placebo groups .\n",
            "Median fasting plasma triglyceride levels decreased by @ mg/dL in the aripiprazole group and @ mg/dL in the placebo group from baseline to endpoint .\n",
            "Conclusion : Aripiprazole treatment was not associated with adverse metabolic changes during long-term therapy in patients with schizophrenia .\n",
            "Effects on glycemic control and plasma lipid profile were similar to those observed with placebo . )\n",
            "Objectives : The goal of this Symposium is to review the implementation , outcomes , and clinical correlates of coordinated specialty care programs for treating the first episode of psychosis .\n",
            "Methods : Maria Monroe-DeVita , PhD , characterized the implementation of Washington State 's New Journeys program , a coordinated specialty care program for first-episode psychosis .\n",
            "Oladunni Oluwoye , PhD , and Michael McDonell , PhD , conducted secondary analyses of the NAVIGATE study , a large multisite , randomized controlled trial examining the effectiveness of a model-coordinated specialty care program , compared with community treatment .\n",
            "Krystal Ozanick , MD , reviewed the basic treatment components of the NAVIGATE model , including individual resiliency training , psychopharmacology protocols , and family education .\n",
            "Results : The participants who enrolled in Washington State 's New Journeys programs ( n = @ ) reported significantly lower levels of anxiety ( beta = @ ; p < @ ) , depression ( beta = @ ; p < @ ) , and psychosis symptoms ( beta = @ ; p < @ ) and significant improvements in the quality of life ( beta = @ ; p < @ ) and employment ( Z = -@ ; p < @ ) during the @ months of treatment .\n",
            "There were no significant changes in substance use .\n",
            "In the NAVIGATE study , African Americans randomized to community care had subscale scores that showed significantly higher positive symptoms ( beta = @ ; p = @ ) and disorganized thoughts ( beta = @ ; p = @ ) throughout treatment compared with Caucasians .\n",
            "African Americans were less likely to receive medication management ( OR = @ ; p = @ ) and individual therapy ( OR = @ ; p = @ ) compared with Caucasians .\n",
            "Race was not associated with differences in symptoms of mental illness in the NAVIGATE treatment arm .\n",
            "Tobacco smokers ( n = @ ) had higher levels of illness severity ( beta = @ ; p < @ ) , a higher number of missed pills ( beta = @ ; p < @ ) , a higher number of mental illness symptoms , and a lower quality of life during treatment compared with nonsmokers .\n",
            "Alcohol users ( n = @ ) had a higher number of missed pills ( beta = @ ; p < @ ) during treatment , and cannabis users ( n = @ ) had higher levels of illness severity ( beta = @ ; p < @ ) and positive symptoms ( beta = @ ; p < @ ) compared with nonusers .\n",
            "Conclusions : Coordinated specialty care improves symptom severity , treatment adherence , and functional outcomes compared with community treatment for first-episode psychosis .\n",
            "In a double-blind design , length of hospital stay , changes in psychiatric symptoms , ward behavior , and posthospitalization treatment recommendations were examined as a function of good or poor premorbid status and medication or placebo treatment in a sample of men with acute schizophrenia .\n",
            "There were few initial differences in psychiatric symptoms or in ward functioning between the premorbid groups .\n",
            "Nevertheless , the good premorbid patients showed more rapid remission of symptoms and , hence , earlier discharge .\n",
            "Of the patients who were discharged early , more of the good premorbid patients fell in the placebo group in sharp contrast to the discharged poor premorbid patients , who were predominantly in the medication group .\n",
            "This trend toward more rapid improvement among patients with a good premorbid history in the absence of phenothiazines was supported by data indicating they required less posthospitalization medication .\n",
            "Introduction : Depressive symptoms are associated with poor outcomes , increased risk of relapse and high suicide rates in patients with schizophrenia and schizoaffective disorder ( @ , @ ) .\n",
            "Objective : Assess the efficacy of quetiapine XR ( QTP-XR ) versus risperidone on depressive symptoms in schizophrenia and schizoaffective disorder .\n",
            "Methods : A randomised , open-label , parallel-group , flexible-dose study ( NCT@ ) .\n",
            "Primary endpoint : LSM change from baseline to Week @ in Calgary Depression Scale for Schizophrenia ( CDSS ) ( @ ) score .\n",
            "Secondary endpoints : change in HAM-D and PANSS scores , and adverse events ( AEs ) .\n",
            "No correction for multiplicity was done for the secondary endpoints .\n",
            "Results : @ patients received QTP-XR ( n = @ ; @-@mg / day ) or risperidone ( n = @ ; @ - @mg/day ) .\n",
            "From baseline , QTP-XR significantly reduced CDSS , HAM-D and PANSS negative total scores compared with risperidone ( QTP-XR vs risperidone : -@ versus -@ , p = @ ; -@ versus -@ , p = @ ; -@ versus -@ , p = @ , respectively ) .\n",
            "No major differences in AEs were observed between QTP-XR and risperidone .\n",
            "Four serious AEs were experienced with QTP-XR and @ with risperidone .\n",
            "Two patients receiving QTP-XR died ( unrelated to study drug ) .\n",
            "Prolactin levels were significantly reduced from baseline with QTP-XR versus risperidone ( -@ ng/mL and +@ ng/mL respectively ; p < @ ) .\n",
            "No important differences were seen in other laboratory parameters .\n",
            "Conclusions : In this study , QTP-XR was superior to risperidone at reducing depressive symptoms in schizophrenia or schizoaffective disorder according to CDSS , HAM-D and PANSS negative scores .\n",
            "Two groups of schizophrenic outpatients were treated with perphenazine decanoate ( N = @ ) and cis ( z ) - flupentixol decanoate ( N = @ ) respectively .\n",
            "Every @ months the dose was gradually reduced until symptoms appeared that were suggestive of a prodromal phase of a psychotic episode .\n",
            "A slightly higher dose was then promptly reinstituted ( the minimum effective dose ) .\n",
            "At each dose level , two blood samples were drawn for determination of serum concentration .\n",
            "The mean minimum effective dose of perphenazine decanoate was @ mg/@ weeks ( range @ - @ ) , while the mean minimum effective dose of cis ( z ) - flupentixol decanoate was @ mg/@ weeks ( range @-@ ) .\n",
            "The corresponding mean serum level of perphenazine decanoate was @ nmol/l ( range @-@ ) and of cis ( z ) - flupentixol decanoate @ nmol/l ( range @-@ ) .\n",
            "There was a significant correlation between the administered doses and the corresponding serum levels for both drugs ( r = @ , P less than @ ) .\n",
            "A weak positive correlation was found between serum levels at the minimum effective dose and symptom intensity ( BPRS total score ) ( r = @ , P less than @ ) for perphenazine , but not cis ( z ) - flupentixol .\n",
            "No correlation was found between serum levels and side effects or length of neuroleptic treatment .\n",
            "It is concluded that the serum drug concentrations corresponding to the lowest effective dose are so variable that routine serum level monitoring may be of limited value in the long-term maintenance treatment of schizophrenia .\n",
            "Objective : To study chlorpromazine , risperidone , quetiapine and olanzapine pituitary gonadal axis in male patients with schizophrenia .\n",
            "Methods : @ cases of first male schizophrenic patients were randomly divided into chlorpromazine , risperidone group , quetiapine and olanzapine level group detected before treatment , treatment for @ weeks and @ weeks serum follicle stimulating hormone ( FSH ) , luteal erythropoietin ( lh ) , prolactin ( prl ) , testosterone ( t ) the level of change .\n",
            "Results : chlorpromazine group after @ weeks of treatment , the level of serum prl significantly higher than before treatment .\n",
            "The risperidone group prl after @ and @ weeks of treatment were significantly higher than before treatment , after @ weeks of treatment , t and lh level significantly lower than before treatment .\n",
            "The quetiapine group in the @ and @ weeks after treatment serum prl lh , t levels before treatment comparison showed no significant difference .\n",
            "Prl level olanzapine group after @ weeks of treatment was significantly higher than before treatment , immediately after @ weeks of treatment before treatment differences no statistically significant .\n",
            "According to the dopamine ( DA ) hypothesis of schizophrenia , there is a functional excess of dopaminergic activity within unspecified areas of the brain in schizophrenic patients .\n",
            "As a clinical test of this hypothesis , we administered metyrosine for three weeks to symptomatic chronic male schizophrenic patients who were maintained on suboptimal doses of neuroleptic agents .\n",
            "Metyrosine inhibits tyrosine hydroxylase , the rate - limiting enzymatic step in the synthesis of DA .\n",
            "No clinical improvement was observed , using the National Institute of Mental Health Inpatient Behavioral Rating Scale or the Brief Psychiatric Rating Scale .\n",
            "Central inhibition of DA synthesis by metyrosine was suggested , however , by ( @ ) the development of extrapyramidal side effects and ( @ ) a significant increase in plasma prolactin concentrations .\n",
            "Plasma chlorpromazine concentrations remained unchanged during metyrosine treatment .\n",
            "There was , nevertheless , a significant improvement on the scores of the Wechsler Adult Intelligence Scale Comprehension subtest , which measures judgment and common sense .\n",
            "This finding suggests that DA may be involved in the regulation of subtle psychological processes .\n",
            "The results are discussed in light of the DA hypothesis of schizophrenia and previous reports suggesting that metyrosine potentiates the antipsychotic effect of neuroleptics in schizophrenia .\n",
            "Impairments in social functioning are serious , subjectively very stressful characteristics of schizophrenic disorders .\n",
            "They contribute to a reduced quality of life and counteract a comprehensive recovery .\n",
            "Current drug and psychosocial treatment have insufficient effects in this regard , as well as specific treatment approaches that focus either on basic cognition , or social cognition or social behavioral competencies as key determinants of functioning .\n",
            "Therefore , in an ongoing multicenter randomized controlled clinical trial of the ESPRIT research network , attempts are being made to improve psychosocial functioning more effectively by integrating social cognitive and social behavioral treatment strategies .\n",
            "In addition to the rate of treatment adherence as the common endpoint of all clinical trials in the ESPRIT network , social functioning and subjective quality of life are assessed as outcome measures before ( V@ ) and at the end of the six-month treatment period ( V@ ) as well as after six months of follow-up ( V@ ) .\n",
            "OBJECTIVE : Four studies using identical protocols evaluated the safety and efficacy of four novel , evidence-based targets for antipsychotic agents : a neurokinin ( NK ( @ ) ) antagonist ( SR@ ) , a serotonin @A/@C ( @-HT ( @A/@C ) ) antagonist ( SR@B ) , a central cannabinoid ( CB ( @ ) ) antagonist ( SR@ ) , and a neurotensin ( NTS ( @ ) ) antagonist ( SR@ ) .\n",
            "METHOD : Adults with schizophrenia or schizoaffective disorder ( N = @ ) were RANDOMly assigned in a @:@:@ ratio to receive fixed doses of investigational drug , placebo , or haloperidol for @ weeks .\n",
            "Primary efficacy variables included changes from baseline in total score on the Positive and Negative Syndrome Scale , severity of illness score on the Clinical Global Impression ( CGI ) , and total score and psychosis cluster score on the Brief Psychiatric Rating Scale ( BPRS ) .\n",
            "RESULTS : Significantly greater improvement in all primary efficacy variables was seen in the group receiving haloperidol than in the group receiving placebo at @ weeks ( endpoint analyses ) , indicating the validity of the study .\n",
            "The group receiving the NK ( @ ) antagonist showed significantly greater improvement over baseline than the group receiving placebo as measured by Positive and Negative Syndrome Scale total score , CGI severity of illness score , and BPRS psychosis cluster score .\n",
            "Reductions in the Positive and Negative Syndrome Scale total and negative scores in the group receiving the @-HT ( @A/@C ) antagonist were significantly larger than those in the group receiving placebo .\n",
            "The improvements in psychopathology produced by the NK ( @ ) and @-HT ( @A/@C ) antagonists were smaller than those produced by haloperidol , although the response to the NK ( @ ) antagonist was positively correlated with plasma levels .\n",
            "The groups receiving the CB ( @ ) and NTS ( @ ) antagonists did not differ from the group receiving placebo on any outcome measure .\n",
            "All investigational drugs were well tolerated .\n",
            "CONCLUSIONS : The novel design used in this study permitted the use of a smaller number of patients receiving placebo to test the efficacy of the four novel compounds .\n",
            "The NK ( @ ) and @-HT ( @A/@C ) antagonists showed evidence of efficacy in the treatment of schizophrenia and schizoaffective disorder .\n",
            "Study limitations preclude a definitive conclusion on the efficacy of CB ( @ ) and NTS ( @ ) antagonists in the treatment of schizophrenia .\n",
            "Further study of these two promising nondopaminergic mechanisms to treat schizophrenia and schizoaffective disorder appears indicated\n",
            "A double blind comparative study was conducted to evaluate the efficacy and safety of penfluridol and trifluoperazine in patients of chronic schizophrenia .\n",
            "Penfluridol was administered once weekly while trifluoperazine was administered twice daily by preparing identical capsules .\n",
            "The data revealed that both the compounds were similarly effective in maintaining control of symptoms of chronic schizophrenia .\n",
            "However , penfluridol has a definite advantage over trifluoperazine since it is administered once a week instead of twice a day .\n",
            "Mount Sinai School of Medicine , Psychiatry , New York , USA ; Pfizer Inc , Neuroscience , New York , USA ; Pfizer Italy , Clinical , Rome , Italy ; University of Brescia , Psychiatry , Brescia , Italy Background : Recent data from the CATIE schizophrenia trial has suggested that there may be few differences in cognitive effects of antipsychotic medications .\n",
            "However , assessment of such effects can be complex , due a number of confounds , including subject characteristics and dosage of the treatments .\n",
            "A problem with CATIE study was that the treatment-resistant patients treated with clozapine constituted such a small sample that they could not be compared for cognitive benftis to other treatments .\n",
            "Previous research has indicated that treatment resistant patients may show a substantial dissociation between clinical and cognitive benefits , with clozapine showing fewer cognitive benefits .\n",
            "Previous studies have shown that clozapine treatment may be inferior to other atypical antipsychotics for cognitive enhancement , while demonstrating as good or better clinical bebefits .\n",
            "This study compared the cognitive benefits of clozapine and ziprasidone in patients with a history of failure to respond to or intolerance of previous antipsychotic treatments .\n",
            "Methods : Patients with a documented history of either failure to respond to multiple previous adequate antipsychotic treatments or intolerance of treatment were randomized in doubleblind fashion to either clozapine or ziprasidone in a single country ( Italy ) , multi-site trial .\n",
            "Efficacy assessments included the Positive and Negative Syndrome Scale ( PANSS ) and a cognitive assessment battery examining episodic memory ( RAVLT ) , executive functioning ( Stroop test ) , and processing speed ( Trail-making test Parts A and B ) .\n",
            "Assessments were performed at baseline week @ , and week @ of treatment .\n",
            "Results : Analyses of the cognitive variables found statistically significant ( p < @ ) within group improvements at the @-week endpoint for ziprasidone in learning and delayed recall on the RAVLT and Trail Making Parts A and B. Clozapine treated patients improved on the RAVLT , but not on the trail making test .\n",
            "A composite cognitive score improved in both groups , but the improvements were significantly larger in the ziprasidone group ( p = @ ) .\n",
            "Exploratory analyses of week @ performance found continued benefits for ziprasidone treatment on trail making test part A ( p < @ ) , but no incremental benefits over time for clozapine treated patients p = @ .\n",
            "Discussion : This study indicated that cognitive functioning improved following treatment with ziprasidone in patients with a history of either treatment resistance or intolerance .\n",
            "In line with previous research , there was no correlation between clinical changes and cognitive benefits of these antipsychotic treatment .\n",
            "While cognitive improvements were only found for a subset of items in the battery , processing speed and episodic memory may be related to functional disability and the overall improvement was larger in the ziprasidone group .\n",
            "These findings are consistent with several prior studies on the cognitive effects of atypical antipsychotics and suggest that clozapine treatment may not be associated with substantial benefits in cognition for many patients receiving the treatment .\n",
            "More research will be required to fully substantiate the benefits of ziprasidone treatment for patients with a history of previous failures to respond to treatment .\n",
            "In the iterim , these data suggest some potential for cognitive benefits and potential functional changes .\n",
            "OBJECTIVE : To investigate the effects of the atypical antipsychotic drugs risperidone , olanzapine , quetiapine , and perospirone on the subjective quality of sleep in patients with schizophrenia .\n",
            "METHOD : Subjects were @ inpatients ( mean age = @ years ) who had been receiving treatment with conventional antipsychotic drugs and who met the DSM-IV criteria for schizophrenia .\n",
            "Subjects were randomly assigned to receive @ of @ atypical antipsychotic drugs ( olanzapine , perospirone , quetiapine , and risperidone ) .\n",
            "Subjective sleep quality and psychopathology were assessed twice : at baseline and @ weeks after switching .\n",
            "Data were collected from June @ to December @ .\n",
            "Subjective sleep quality was assessed by the Pittsburgh Sleep Quality Index ( PSQI ) , and psychopathology was measured by the Positive and Negative Syndrome Scale ( PANSS ) .\n",
            "RESULTS : Subjective sleep quality as assessed by the PSQI was significantly improved with administration of olanzapine , risperidone , or quetiapine , but not with perospirone , in comparison with conventional antipsychotic drugs .\n",
            "Multiple regression analysis revealed that the improvement of sleep quality with administration of atypical antipsychotic drugs was predicted by poor sleep quality at baseline .\n",
            "In addition , improvement of sleep quality was significantly correlated with improvement of negative symptoms as assessed by the PANSS .\n",
            "CONCLUSION : These results demonstrated that atypical antipsychotic drugs improved subjective quality of sleep in patients with schizophrenia compared with conventional antipsychotic drugs , suggesting that the marked potency of serotonin-@ receptor blockade in atypical antipsychotic drugs may be involved in the mechanism of this improvement .\n",
            "These improvements were correlated with improvement of negative symptoms\n",
            "The objective of this study was to explore the perceived benefits of engaging in health behavior change from the viewpoint of overweight and obese Latinos with severe mental illness ( SMI ) enrolled in the U.S. Qualitative , semistructured interviews were conducted with @ obese Latinos with SMI who were enrolled in a randomized trial evaluating the effectiveness of a motivational health promotion intervention adapted for persons with SMI .\n",
            "Overweight and obese Latino participants believed that engaging in health behavior change would have both physical and mental health benefits , including chronic disease management , changes in weight and body composition , and increased self-esteem .\n",
            "Interventions that explicitly link physical activity and healthy eating to improvements in mental health and well-being may motivate Latinos with SMI to adopt health behavior change .\n",
            "Long-acting risperidone microspheres intramuscular formulation , the first long-acting atypical antipsychotic , was investigated in @ patients with schizophrenia in a @-week , RANDOMized , DOUBLE-BLIND trial .\n",
            "Duringweek @ , previous antipsychotics were withdrawn and patients received up to @ mgrday of oral risperidone .\n",
            "Then for @ weeks of DOUBLE-BLIND treatment , patients received injections of placebo or @ , @ , or @ mgof long-acting risperidone every @ weeks .\n",
            "Oral risperidone was continued during the first @ weeks to ensure adequate risperidone plasma exposure .\n",
            "Improvements in PANSS total scores were larger in all long-acting risperidone groups than in placebo patients p-@ for all doses .\n",
            "Improvements from baseline on the PANSS positive and negative symptom scores were significantly in all risperidone groups p-@ .\n",
            "Improvements of ) @ % in PANSS scores at endpoint were seen in @ % , @ % , and @ % of the three risperidone groups and in @ % of the placebo group pF@ .@ for all doses .\n",
            "No added benefit of a long-acting risperidone dose above @ mg was apparent .\n",
            "The incidence of extrapyramidal symptoms was similar in the placebo and @-mgrisperidone groups .\n",
            "Cardiovascular and metabolic adverse-event profiles were similar in the placebo and risperidone groups .\n",
            "No injection site pain with this new formulation was reported for more than @ % of patients on average .\n",
            "It is concluded that long-acting risperidone was well tolerated and provided continued relief or improvement of symptoms over a @-month period .\n",
            "Reports an error in \" Effectiveness of occupational goal intervention for clients with schizophrenia \" by Noomi Katz and Navah Keren ( American Journal of Occupational Therapy , @ [ May-Jun ] , Vol @ [ @ ] , @-@ ) .\n",
            "In the original article , the e-mail address for the corresponding author was incorrect .\n",
            "The correct e-mail address for the corresponding author is noomi.katz @ ono.ac.il .\n",
            "The correct e-mail address is given in the erratum .\n",
            "( The following abstract of the original article appeared in record @-@-@ ) .\n",
            "Objective : The effectiveness of Occupational Goal Intervention ( OGl ) in clients with schizophrenia ms compared with that of the Frontal Executive Program and a control group .\n",
            "Method : We used a quasi-experimental design with @ adult participants ages @-@ who were randomly assigned to three groups .\n",
            "Testing was performed before treatment , after treatment , and at @-mo follow-up ( Time @ ) .\n",
            "Instruments assessed executive functions ( EFs ) and activity and participation .\n",
            "Participants received @ treatment sessions over a period of @-@ wk .\n",
            "Results : We found no significant differences among the groups on pretest-posttest change : however , we did find significant differences within groups before and after intervention and moderate to high effect sizes .\n",
            "The OGl group showed relative improvement on all measures of EF and activity and participation .\n",
            "Most participants ' achievements were maintained at Time @ .\n",
            "Conclusions : Results provide initial support for the QGI 's effectiveness for clients with schizophrenia .\n",
            "Further studies are needed to verify these initial findings .\n",
            "( PsycINFO Database Record ( c ) @ APA , all rights reserved )\n",
            "Objective quetiapine and clozapine in the efficacy and safety of treatment of chronic schizophrenia .\n",
            "@ patients with chronic schizophrenia were randomly divided into two groups , respectively , quetiapine and clozapine treatment for @ weeks .\n",
            "The positive and negative syndrome scale ( banss ) and side effects scale ( tess ) assessed the efficacy and adverse reactions .\n",
            "Results after @ weeks of treatment , the two groups panss score significantly lower than before treatment , the difference was not significant ( p > @ ) , quetiapine group of fewer adverse reactions .\n",
            "Conclusion quetiapine and clozapine efficacy of treatment of patients with chronic schizophrenia , quetiapine adverse light , security , and worthy of promotion .\n",
            "OBJECTIVES : Electroconvulsive therapy ( ECT ) results in significant cardiovascular changes .\n",
            "The acute cardiac autonomic changes during ECT remain unexplored .\n",
            "The primary objective of this study was to compare autonomic dysfunction with and without atropine premedication during ECT and secondarily to evaluate dysautonomia across psychiatric diagnoses before and after ECT .\n",
            "METHODS : In this crossover study , @ psychiatric patients were monitored during @ ECT sessions .\n",
            "Patients were randomized either to receive atropine or not to receive atropine during their second ECT session and were crossed over during their third session .\n",
            "Heart rate , blood pressure , and oxygen saturation were continuously monitored from stimulus application until @ seconds after ECT .\n",
            "Demographic characteristics and ANSiscope indices derived pre - and post-ECT were collected .\n",
            "RESULTS : Autonomic dysfunction ( % ) before ECT was similar between atropine and no-atropine sessions ( @ + / - @ vs @ + / - @ ; @ % confidence interval , -@ to @ ; P = @ ) but increased significantly after ECT to @ + / - @ and to @ + / - @ , respectively , and this difference was significant ( @ % confidence interval , @-@ ; P < @ ) .\n",
            "There was no difference in the autonomic function across psychiatric diagnoses both before ( P = @ ) and after ECT ( P = @ ) .\n",
            "CONCLUSIONS : Cardiac autonomic dysfunction worsens after ECT in patients with psychiatric illnesses and to a significantly greater extent with atropine premedication .\n",
            "The degree of dysautonomia is similar across various psychiatric diagnoses both before and after ECT .\n",
            "Atropine premedication during ECT should be restricted to select patients susceptible to bradyarrhythmia and could be avoided in others .\n",
            "Reports an error in the original article by P. A. Garety et al ( British Journal of Psychiatry , @ , Vol @ , @-@ ) .\n",
            "The seventh author 's name is Jason Read .\n",
            "( The following abstract of this article originally appeared in record @-@-@ . )\n",
            "Background : The provision of early intervention services for people with psychosis is UK government policy , although evidence for benefit of such services is sparse .\n",
            "Aims : To evaluate the effects of a service providing specialised care for early psychosis ( the Lambeth Early Onset team ) on clinical and social outcomes , and on service user satisfaction .\n",
            "Method : One hundred and forty-four people with psychosis , presenting to mental health services for the first or second time ( if previously failed to engage in treatment ) , were randomly allocated to care by the early onset team or to standard care .\n",
            "Information was obtained on symptoms , treatment adherence , social and vocational functioning , satisfaction and quality of life .\n",
            "Relapse and rehospitalisation data have been reported separately .\n",
            "Results Outcomes for the participants treated by the early onset team were significantly better at @ months for aspects of social and vocational functioning , satisfaction , quality of life and medication adherence .\n",
            "Symptom improvement did not significantly differ between the groups .\n",
            "Conclusions : The provision of specialised care for early psychosis can achieve better outcomes .\n",
            "The study therefore provides support for current policy .\n",
            "The authors performed a double-blind study in which @ inpatients diagnosed as schizophrenic with depressive symptoms were treated with either bupropion and thiothixene or placebo and thiothixene .\n",
            "Of the @ patients who completed @ weeks of study treatment , the placebo - thiothixene treated patients did significantly better than the bupropion-thiothixene treated patients on BPRS total scores as well as anxiety and depression items .\n",
            "The bupropion-thiothixene treated patients reported significantly more dry mouth and constipation than the placebo - thiothixene treated group , whereas the placebo - thiothixene treated group reported more frequent occurrences of increased appetite , menstrual disturbance , and decreased sex drive .\n",
            "Neither group differed on ratings of pseudoparkinson or dyskinetic signs .\n",
            "The antidepressant bupropion as an adjunct to thiothixene was less effective in the treatment of depressed schizophrenic patients than the antipsychotic alone and appeared to inhibit the therapeutic effects of thiothixene primarily in the depressive symptoms of the syndrome .\n",
            "Background : Studies with first episode populations offer the unique opportunity to examine the effectiveness and side effects of medications without the confounding effects of prior medication use .\n",
            "The Preventing Morbidity in First Episode Schizophrenia study compares outcomes with treatment with olanzapine and risperidone over three years in a variety of domains .\n",
            "This report presents response rates , negative symptom outcomes and side effects over the first four months of treatment .\n",
            "Methods : One hundred twelve subjects ( @ % male ; mean age @ ( SD = @ ) years ) with a first episode of schizophrenia , schizophreniform or schizoaffective disorder were randomly assigned to treatment with olanzapine ( @ to @ mg daily ) or risperidone ( @ to @ mg daily ) .\n",
            "Response criteria are : a rating of @ ( mild ) or less on the following SADS-C + PD items : severity of delusions ; severity of hallucinations ; impaired understandability ; derailment ; illogical thinking ; bizarre behavior , and a rating of very much improved or much improved on the CGI improvement item .\n",
            "This level of improvement had to be maintained on two consecutive ratings .\n",
            "Results : Response rates were @ % ( @ % CI : @ % , @ % ) with olanzapine and @ % ( @ % CI : @ % , @ % ) with risperidone ( p = @ ) .\n",
            "The percent of responding subjects having a subsequent rating not meeting response criteria was higher among subjects assigned to olanzapine ( @ % ; @ % CI : @ % , @ % ) than those taking risperidone ( @ % ; @ % CI : @ % , @ % ) but the difference was not statistically significant ( p = @ ) .\n",
            "There were no differences between the medications in negative symptom outcomes .\n",
            "Motor side effects : EPS scores were slightly higher with risperidone [ @ ( @ % CI : @ , @ ) ] than with olanzapine [ @ ( @ % CI : @ , @ ) ] but the difference was not statistically significant ( p = @ ) .\n",
            "The frequency of akathisia was low and did not differ between the medications .\n",
            "Weight gain : Weight gain was more with olanzapine than with risperidone ( p = @ ) .\n",
            "Percent gain from baseline weight at @ weeks with olanzapine was @ % ( @ % CI : @ % , @ % ) and @ % ( @ % CI : @ % , @ % ) with risperidone .\n",
            "Discussion : Both olanzapine and risperidone are effective at promoting response .\n",
            "There may be differences between the medications in stability of response and side effects .\n",
            "Objective To investigate the schizophrenia patients recovering from mental health conditions and psychological care intervention effect .\n",
            "Method @ cases convalescent patients with schizophrenia were randomly divided into two groups of @ cases of psychological care intervention ( intervention group ) , and compared with the control group ( not intervention group ) .\n",
            "Symptom Checklist ( scl-@ ) @ weekend were assessed before and after intervention to intervene .\n",
            "Results schizophrenic patients recovering from major psychological problems such as depression , anxiety , interpersonal relationships , obsessive-compulsive , hostility , paranoia , and @ weeks after the intervention group in the intervention scl-@ anxiety , depression , interpersonal relationships , obsessive-compulsive , hostility , paranoia @ a factor score before intervention compared the difference was statistically significant ( p < @ ) ; compared the difference was not statistically significant ( p > @ ) in the control group scores before and after the intervention .\n",
            "Conclusion Psychological nursing intervention can significantly improve schizophrenic patients recovering from mental health conditions and promote the rehabilitation of patients .\n",
            "Objective To compare clinical efficacy and side effects of quetiapine and chlorpromazine in the treatment of schizophrenia .\n",
            "Methods Eighty - nine schizophrenics meeting entrance criterion were randomly divided into quetiapine group ( n = @ ) and chlorpromazine group ( n = @ ) , and the efficacy and side effects were rated with the PANSS , CGI and TESS .\n",
            "Results After treatment , there was no significant difference in scores of PANSS and CGI between the @ groups , with TESS the side effects of\n",
            "This item is an abstract of \" The New Hampshire study of supported employment for people with severe mental illness \" ( [ @ ] , Journal of Consulting and Clinical Psychology , @ , @-@ ) .\n",
            "This study compared supported employment services in @ contrasting programs : ( a ) Group Skills Training , a professional rehabilitation agency outside of the mental health center that provided preemployment skills training and support in obtaining and maintaining jobs , or ( b ) the Individual Placement and Support ( IPS ) model , which integrated clinical and vocational services within the mental health center .\n",
            "People with severe mental disorders who expressed interest in competitive employment ( N = @ ) were randomly assigned to @ of these @ programs .\n",
            "Results showed that clients in the IPS program were more likely to be competitively employed throughout most of the @-month follow-up .\n",
            "Among those who obtained jobs , there were few group differences , although workers in the IPS program did work more total hours and earn more total wages during the @-month followup .\n",
            "There were no group differences on nonvocational outcomes .\n",
            "Background : Social dysfunction is the most common symptom as well as the primary cause of disability in schizophrenia and remains unresponsive to currently available antipsychotic medications .\n",
            "Social impairment has been strongly linked to deficits in social cognition , mental capabilities that facilitate social decisions and behavior .\n",
            "Decades of animal research have established that oxytocin ( OT ) has many pro-social effects .\n",
            "Preclinical investigations have demonstrated that OT has antipsychotic-like efficacy .\n",
            "In recent human studies , acute intranasal OT administration increased interpersonal trust , eye contact , performance on tests of face emotion recognition and theory of mind ( inferring the thoughts and feelings of others ) as well as social reciprocity in normal and autistic subjects .\n",
            "Feifel et al recently reported that OT treatment of subjects with schizophrenia for @ wks decreased PANSS scores .\n",
            "We hypothesized that intranasal OT treatment of patients with schizophrenia may improve social cognition as well as reduce psychotic symptoms .\n",
            "Methods : We conducted a randomized , double blind , placebocontrolled pilot study in subjects with paranoid or undifferentiated schizophrenia for @ yr or more and baseline PANSS total scores of @ or more comparing the effects of @ days of twice daily intranasal OT ( @ IU/dose , N = @ ) vs. placebo ( N = @ ) administration on the following outcomes : a ) PANSS total and subscale scores ; b ) a priori selected items on the PANSS , c ) subject self-ratings on the Paranoia Scale and d ) a battery of social cognition tests .\n",
            "Subjects ' symptoms and psychotropic medication regimens were stable for @ month prior to the treatment trial and medication doses remained unchanged during the study period .\n",
            "Results : The sample was comprised of @ men and @ women ; @ white and @ African-American .\n",
            "There were no significant demographic or psychiatric history differences between the treatment groups and no significant changes in laboratory tests or vital signs during the treatment period ( assessed at multiple time points ) .\n",
            "Weight increased significantly in the placebo group but not the OT group .\n",
            "No adverse events occurred and no side effects were reported or observed .\n",
            "Baseline measures did not differ between treatment groups except the OT group had lower face trustworthiness ratings .\n",
            "The OT group had significant reductions from baseline to treatment day @ in PANSS total scores ( t = @ , p = .@ ) , positive symptom subscale scores ( t = @ , p = .@ ) , general symptom subscale scores ( t = @ , p = .@ ) , suspiciousness item scores ( t = @ , p = .@ ) , anxiety item scores ( t = @ , p < .@ ) and Paranoia Scale scores ( t = @ , p = .@ ) , as well as significant improvements in accurate identification of @nd order false belief in the Brune Theory of Mind task ( t = -@ , p = .@ ) .\n",
            "In addition , OT recipients showed a weak trend toward rating untrustworthy faces ( faces rated by a normative sample as untrustworthy ) as less untrustworthy ( t = @ , p = .@ ) .\n",
            "The mean scores on an a priori subset of PANSS items relevant to social functioning ( P@ [ suspiciousness / persecutory ] , P@ [ hostility ] , N@ [ passive/apathetic social withdrawal ] , G@ [ uncooperativeness ] and G@ [ active social avoidance ] ) decreased more than any other variable ( t = @ , p = .@ ) .\n",
            "The placebo group had no significant or trend level changes from baseline to treatment day @ on any of these measures .\n",
            "ANCOVAs controlling for baseline revealed that the OT compared to the placebo group had significantly greater declines in PANSS anxiety item scores ( F = @ , p < .@ ) and mean social function relevant item scores ( F = @ , p < .@ ) and trends for greater improvement in all other variables described above except for trustworthy ratings of faces ( p values from @-@ ) .\n",
            "Discussion : This is the first study to demonstrate that OT treatment improves social cognition in schizophrenia and replicates the findings of Feifel et al that OT decreases psychotic symptoms .\n",
            "Our results raise several pressing questions .\n",
            "@ ) Will a longer period of OT treatment improve social functioning and further reduce psychotic symptoms ?\n",
            "@ ) Is OT an effective monotherapy or is it only efficacious as an augmentor of antipsychotic medications ?\n",
            "@ ) Would concomitant OT treatment improve outcomes of psychosocial interventions ?\n",
            "@ ) Can OT treatment stave off the social and functional deterioration observed early in the course of schizophrenia ( first episode ) or even prior to the development of the illness ( prodrome ) ?\n",
            "Validation of our findings would justify new lines of investigation into the pathophysiology of schizophrenia focusing on the role of central OT systems .\n",
            "Objective : To report the long-term remission results from the relapse prevention trial ( ConstaTRE ) in stable patients treated either with risperidone long-acting injectable ( RLAI ) or the oral atypical antipsychotic quetiapine .\n",
            "Methods : Clinically stable adults with schizophrenia or schizoaffective disorder treated with oral risperidone , olanzapine , or oral conventional antipsychotics were randomized to treatment with RLAI or oral quetiapine .\n",
            "Dosing was according to package-insert recommendation .\n",
            "Efficacy and tolerability were recorded for up to @ months of treatment .\n",
            "Remission was defined as achieving and maintaining mild or less symptoms of schizophrenia over a @-month period as defined by Andreasen et al , ( @ ) .\n",
            "Results : @ patients were randomized ( n = @ per group ) to either RLAI or quetiapine .\n",
            "Demographics were similar between treatment groups .\n",
            "Relapse occurred in @ RLAI ( @ % ) and @ quetiapine ( @ % ) patients ( p < @ ) .\n",
            "Full remission was achieved by @ % RLAI and @ % of quetiapine-treated patients ( p = @ ) and was maintained until the end of the trial by @ % of RLAI and @ % of quetiapine patients .\n",
            "Mean duration of full remission was @ + / -@ and @ + / -@ days for RLAI and quetiapine groups , respectively ( p = @ ) .\n",
            "Tolerability was similar between treatment groups .\n",
            "Most adverse events ( AEs ) were transient .\n",
            "Six RLAI and @ quetiapine patients discontinued study treatment due to AEs .\n",
            "Conclusions : Among stable patients with schizophrenia or schizoaffective disorder , remission was more likely to occur in patients switching to RLAI when compared with quetiapine .\n",
            "Both RLAI and quetiapine treatments were well tolerated .\n",
            "Background/Objective : Individuals with schizophrenia and co-caine-dependence have intense craving early in recovery that may play a role in the high substance abuse relapses common in this population ( Carol et al. , @ ; Smelson et al. , @ ) .\n",
            "These studies highlight the need to develop pharmacological anticraving interventions to augment the traditional psychosocial treatments .\n",
            "While open label studies suggest that atypical neuroleptics may be useful for treating schizophrenia and cocaine dependence ( Smelson et al. , @ ) , more double-blind studies are needed .\n",
            "Methods : We conducted a @-week double-blind trial comparing olanzapine and haloperidolfor reducing substance abuse relapses and craving in individuals diagnosed with schizophrenia and cocaine dependence , believing that those in the olanzapine group will have better outcomes .\n",
            "Subjects were administered random urine toxicology screens along with a weekly cue-exposure procedure to prime patients with cocaine cues and study the acute anticraving effects .\n",
            "Results : Individuals treated with olanzapine ( n = @ ) showed fewer positive urine toxicology screening for an illicit substance ( @ % ) compared to those in the haloperidol group ( @ % ) ( n = @ ) , and less cue-elicited craving on the energy ( @ ) and sick ( @ ) dimensions of craving .\n",
            "This difference in craving reduction was greater for the study completers .\n",
            "Olanzapine was also well tolerated in this subgroup of individuals with schizophrenia and cocaine dependence in doses as high as @ mg daily .\n",
            "Conclusion : Olanzapine appears to be an effective adjunctive treatment for decreasing cocaine craving and preventing relapses among individuals with schizophrenia and cocaine dependence .\n",
            "Cognitive behavioural intervention provided by graduate mental health workers.Follow up length : @ months Social Anxiety Interaction Scale @ .\n",
            "Paranoia Scale @ .\n",
            "Brief Core Schema Scale National Institute for Health Research ( NIHR ) ( UK ) - Research for Innovation , Speculation and Creativity ( RISC ) programme\n",
            "Background : Cognitive remediation ( CR ) is increasingly recognized as an effective means for producing small to moderate-sized improvements in cognitive skills in schizophrenia .\n",
            "However , existing treatments are complex and usually consist of practice on multiple exercises and application of many different strategies and thus the active ingredients of these interventions remain unknown .\n",
            "The current study was designed to investigate two brief , specific and alternative compensatory strategies for improving verbal episodic memory in schizophrenia ( adapted from the head injury literature ) .\n",
            "The goal was to provide a rationale for inclusion in broader CR training batteries .\n",
            "Methods : Forty participants with schizophrenia or schizoaffective disorder were randomly assigned to one of three groups : group one \" the story method \" consisted of presenting participants with to-be-learned words in the context of a detailed narrative .\n",
            "In condition two , participants were presented with pairs of words and asked to imagine these pairs of words interacting with one another , with no further narrative structure .\n",
            "In group three participants were exposed to the to-be-learned words an equivalent number of times , but without provision of a strategy .\n",
            "Outcomes were assessed with learning measures from the trained word-lists , as well as measures of generalization to both a word list task consisting of different words from those selected as part of the training , and a prose recall task .\n",
            "Assessments were conducted by blinded administrators both before and immediately after the intervention and at a one-week follow-up .\n",
            "Results : Results revealed that the story method produced learning on the trained words that generalized to a prose recall task ( but not a list learning task ) .\n",
            "This evidence of generalization , however , was only evident at the oneweek follow-up .\n",
            "The imagery training , as well as repeated passive exposure to a word list in the non-trained condition , did not produce improvement on the list learning or prose recall outcome tasks .\n",
            "Conclusion : These results support the potential role of narrative strategies for improving verbal episodic memory in programs of CR for schizophrenia .\n",
            "These findings also suggest that the effects of these strategies may require consolidation over time .\n",
            "Seroquel ( tm ) ( ICI @ ) is an atypical dibenzothiazepine antipsychotic agent .\n",
            "The pharmacological profile of SEROQUEL is clozapine - like in terms of predicting a low propensity to produce extrapyramidal side effects ( EPS ) .\n",
            "Like clozapine , SEROQUEL is active at multiple brain receptors with greater affinity for serotonin @HT@ receptors than for dopamine D@ receptors .\n",
            "SEROQUEL demonstrates greater activity at limbic than at striatal dopamine receptors .\n",
            "In haloperidol-sensitised and drug-naive monkeys , SEROQUEL and clozapine are distinct from other antipsychotic agents , in that they produce minimal dystonic liability , which may translate into a low propensity to induce EPS in man .\n",
            "In contrast to standard antipsychotics , SEROQUEL does not produce sustained elevations in plasma prolactin .\n",
            "Two hundred and one hospitalised patients with acute exacerbation of chronic or subchronic schizophrenia ( DSM-IIIR criteria ) entered this @ - week , multicentre , randomised , chlorpromazine-controlled , double-blind study .\n",
            "Both SEROQUEL and chlorpromazine were titrated flexibly from an initial dose of @ mg/day , according to tolerability and clinical response up to a maximum of @ mg/day .\n",
            "Efficacy was assessed using the BPRS and CGI .\n",
            "Safety was evaluated through neurological assessment ( AIMS , Simpson Scale and Barnes Akathisia Scale ) , adverse events monitoring , clinical laboratory tests , ECGs , vital signs , and physical examination .\n",
            "These data demonstrate that : SEROQUEL is an effective antipsychotic SEROQUEL is well tolerated SEROQUEL treated patients demonstrate a low incidence of emergent EPS SEROQUEL does not produce sustained elevations of prolactin in man .\n",
            "These clinical data support the atypical profile of SEROQUEL .\n",
            "SEROQUEL ( tm ) is a trademark , the property of ZENECA Limited .\n",
            "Amisulpride is an atypical antipsychotic , which has demonstrated efficacy across the range of symptoms of schizophrenia .\n",
            "This study compares the treatment costs of amisulpride ( including drug costs , hospital costs , and costs of clinician and nurse visits ) with those of risperidone over a six-month treatment period , from the perspective of the UK National Health Service .\n",
            "Resource utilisation data were collected alongside an international , multicentre clinical trial comparing amisulpride ( @-@ mg/day ) with risperidone ( @-@ mg/day ) in @ patients with schizophrenia .\n",
            "As this trial demonstrated that amisulpride had at least equivalent efficacy to risperidone , the present study was a cost-minimisation analysis .\n",
            "Unit cost data for the UK were obtained from published sources and applied to the clinical data to calculate direct treatment costs .\n",
            "Amisulpride was associated with lower drug acquisition costs and lower resource utilisation costs than risperidone , although the differences did not reach statistical significance .\n",
            "Overall , the average total cost per patient for six months treatment with amisulpride ( [ pounds ] @ ; @ % CI : @ , @ ) was [ pounds ] @ less than for risperidone ( [ pounds ] @ ; @ % CI : @ , @ ) .\n",
            "These findings are similar to those of a previous study that compared the treatment costs of amisulpride with those of haloperidol , and found that amisulpride was associated with significantly lower direct treatment costs than haloperidol .\n",
            "Amisulpride is a valuable treatment option in patients with schizophrenia\n",
            "Examined whether the addition of fenfluramine ( FF ) for @ wks to neuroleptic therapy in a double-blind multiple baseline design could produce clinical improvement in @ chronic schizophrenics ( aged @-@ yrs ) who were limited responders to adequate doses of neuroleptics .\n",
            "Interrelations among FF dosage , whole blood serotonin levels , and plasma neuroleptic levels were also investigated .\n",
            "Measures included an expanded Brief Psychological Rating Scale and the MACC Behavioral Adjustment Scale .\n",
            "Results show that FF made Ss worse , and that clinical deterioration was correlated with FF-induced reductions in blood serotonin levels and persisted beyond the point of discontinuation of FF .\n",
            "Objective : to examine the effects of a program for promoting partnership between self-help groups and professionals based on the partnership model proposed by stewart et al. ( @ ) , among local self-help groups of families with the mentally ill and professionals in Japan .\n",
            "Methods : family group subjects were randomly assigned either the experimental ( n = @ ) or control group ( n = @ ) .\n",
            "Over the intervention period of @ months , professionals participated in the meetings regularly once a month , members and professionals clarified shared goals and roles of each other , and professionals attended at a seminar using guidelines .\n",
            "Results : the program had a significant increase in members ( p = @ ) .\n",
            "Members were satisfied with the program ( p < @ ) , And empowered about using services for their relatives ( p = @ ) .\n",
            "Also , the program had an effect on empowering professionals who lack the knowledge and experience of supporting family groups ( p = @ ) .\n",
            "Conclusions : a program for promoting partnership can be effective for both family groups and professionals .\n",
            "BACKGROUND : Previous studies report that @ % to @ % of those initially diagnosed with schizotypal disorder go on to develop a psychotic disorder ( predominantly schizophrenia ) .\n",
            "Schizotypal disorder share some traits of those used to identify patients at ultra-high risk for psychosis .\n",
            "METHOD : As part of a randomized clinical trial testing the effect of prolonged specialized early intervention , we recruited @ participants diagnosed with a schizotypal disorder .\n",
            "Participants were recruited @ months into their two-year treatment program , and follow-up interviews were conducted three and a half year later .\n",
            "They were randomized to either discontinuation after the standard two year treatment or continuation of the specialized treatment for totally five year .\n",
            "The study investigated whether prolonged treatment could affect the rate of transition to psychosis and other clinical outcomes , and what would predict transition to psychosis .\n",
            "RESULTS : Of those @ who attended the follow-up interview @ ( @ % ) developed a psychotic disorder at follow-up .\n",
            "There were no differences between the two treatment groups on transition rates or clinical outcomes .\n",
            "We found that lower level of functioning at baseline predicted transition to psychosis .\n",
            "DISCUSSION : Comparable to previous ultra-high risk studies , we found that level of functioning was the strongest predictor of transition to psychosis .\n",
            "Prior studies have found effect of specialized early intervention on transition rates , but we were not able to reproduce this finding .\n",
            "This may be attributable to the intervention in our study occurring at a later stage in the illness than prior studies .\n",
            "Background : Studies of antipsychotic efficacy often report clinical response in terms of reduction in acute psychopathology .\n",
            "As a result , little information is available on how symptomatic change is associated with improvement in other comorbid symptom domains such as quality of life QoL as well as depressive symptoms .\n",
            "The Objective of this analysis was to explore the association of improvement in QoL and depressive symptoms with robust acute treatment response of olanzapine OLZ versus haloperidol HAL .\n",
            "Methods : Data was analyzed post-hoc from the acute phase of a large , prospective , RANDOMized OLZ versus HAL , DOUBLE-BLIND trial , conducted in @ countries with @ patients who met the DSM-III-R criteria for schizophrenia , schizophreniform disorder , or schizoaffective disorder .\n",
            "The acute treatment response was classified into four groups based upon the categorical improvement on the Brief Psychiatric RatingScale BPRS total scores at @ weeks : less than @ % improvement , @-@ % improvement , @-@ % improvement and @ % or greater improvement .\n",
            "Mean percent changes of Quality of Life Scale QLS scores and Montgomery-Asberg Depression Rating Scale MADRS scores from baseline to the end of week @ were tested using t-tests .\n",
            "Results : There was a significant positive association between the more robust level of response i.e. , G@ % and improvements in depressive symptoms and QLS across treatment groups .\n",
            "Patients treated with OLZ started to access moderate improvement ) @ % improvement in QLS once they attained a @ % or greater improvement in BPRS while for the HAL-treated patients , only those who had a @ % or greater response in BPRS could exceed moderate QLS improvement .\n",
            "The mean percent change in QLS in the @-@ % BPRS response group was @ % for OLZ versus @ % for HAL ps@ .@ and in the @ % or greater BPRS response group was @ % for OLZ versus @ % for HAL ps@ .@ .\n",
            "Similar observations were demonstrated in improvement on the MADRS .\n",
            "For patients with a @-@ % BPRS response , the improvement in MADRS was @ % for OLZ versus @ % for HAL ps@ .@ .\n",
            "Conclusion : A more robust categorical acute treatment response resulted in greater improvement in QoL and depressive symptoms across treatment groups .\n",
            "Even for patients attaining the same level of acute treatment response though , there may be significantly greater improvements in QoL and depressive symptoms enjoyed by OLZ-treated patients compared to those treated with HAL .\n",
            "Further studies are needed to evaluate whether a high level of acute response achieved during OLZ treatment of schizophrenia is associated with a broad spectrum of symptomatic and functional improvement .\n",
            "Objective To compare the efficacy and safety of risperidone and perphenazine elderly schizophrenia .\n",
            "Methods @ cases of elderly patients with schizophrenia were randomly divided into two groups , respectively , @ weeks of treatment with risperidone or perphenazine ; Both groups before treatment and after @ , @ , @ weekend Positive and Negative Syndrome Scale ( panss ) and adverse reactions Syndrome Scale ( tess ) [ @ ] assessed the efficacy and adverse reactions .\n",
            "Results risperidone group effective rate of @ % , perphenazine group was @ % , the clinical efficacy was no significant difference ( p > @ ) ; risperidone group @ weekends negative symptoms after treatment significantly lower than the perphenazine group , adverse reactions than perphenazine group were few and mild .\n",
            "The Graduated Recovery Intervention Program ( GRIP ) is a new individual cognitive-behavioral therapy program designed to facilitate functional recovery in people who have experienced an initial episode of psychosis .\n",
            "The purposes of this study were to evaluate the feasibility and tolerability of the GRIP intervention , and to compare the effectiveness of GRIP versus treatment as usual ( TAU ) for improving specific clinical and psychosocial outcomes .\n",
            "Forty-six individuals with first episode psychosis were randomized to GRIP .\n",
            "+ .\n",
            "TAU or TAU alone .\n",
            "Primary outcomes focused on social and role functioning , and quality of life .\n",
            "Secondary outcomes included psychotic symptoms , depression , substance use , social support , attitudes toward medications , well-being , and hospitalizations .\n",
            "The results indicate that GRIP was well-tolerated , as evidenced by good attendance and low drop-out rates , and well-received ( based on positive feedback from participants ) .\n",
            "Although the majority of mixed model analyses were not statistically significant , examination of within-group changes and effect sizes suggests an advantage for GRIP over TAU in improving functional outcomes .\n",
            "These advantages and the fact that the GRIP intervention demonstrated feasibility and tolerability suggest that this intervention is worthy of further investigation .\n",
            "@ Elsevier B.V.\n",
            "In symptomatic patients with borderline disorder , we conducted a double-blind , placebo-controlled trial of haloperidol and amitriptyline hydrochloride to test the differential efficacy of medication against the affective and schizotypal symptoms that characterize the disorder .\n",
            "Sixty - one patients , diagnosed by the Diagnostic Interview for Borderline of Gunderson et al , completed randomized trials of haloperidol ( n = @ ) , amitriptyline ( n = @ ) , and placebo ( n = @ ) .\n",
            "Medications were given in dose ranges of @ to @ mg for haloperidol ( mean , @ mg ) and @ to @ mg for amitriptyline hydrochloride ( mean , @ mg ) for five-week periods , with weekly self-rated and observer-rated measures of mood , schizotypal symptoms , and global functioning .\n",
            "Haloperidol was superior to both amitriptyline and placebo on a composite measure of overall symptom severity , with no difference between amitriptyline and placebo .\n",
            "Haloperidol produced significant improvement on a broad spectrum of symptom patterns , including depression , anxiety , hostility , paranoid ideation , and psychoticism .\n",
            "In contrast , amitriptyline was minimally effective , with small gains limited to some areas of depressive content .\n",
            "The magnitude of change tended to be modest and was more apparent in self-rated than observer-rated measures .\n",
            "Knowledge of the function of vitamins in the human body has expanded rapidly in the last decades .\n",
            "Deficiency of certain vitamins , and especially from the ' B ' complex , can produce symptoms of psychiatric disorder .\n",
            "Vitamin B@ , or pyridoxine plays an intrinsic role in the synthesis of certain neurotransmitters , which take part in development of psychotic states .\n",
            "There are a number reports that vitamin B@ may be a factor in a number of psychiatric disorders , such as autism , Alzheimer 's disease , hyperactivity , learning disability , anxiety disorder and depression .\n",
            "Moreover , there are anecdotal reports of a reduction in psychotic symptoms after vitamin B@ supplementation of psychopharmacologic treatment of patients suffering from schizophrenia or organic mental disorder .\n",
            "The aim of this study was to examine whether vitamin B@ therapy influences psychotic symptoms in patients suffering from schizophrenia and schizoaffective disorder .\n",
            "The effect of the supplementation of vitamin B@ to antipsychotic treatment on the positive and negative symptoms in @ schizophrenic and schizoaffective patients were examined in a double-blind , placebo controlled , crossover study spanning @ weeks .\n",
            "All patients had stable psychopathology for at least a month before entry into the study and were maintained on their pre-study psychoactive and antiparkinsonian medications throughout the study .\n",
            "All patients were assessed by Positive and Negative Syndrome Scale for Schizophrenia ( PANSS ) on weekly base .\n",
            "The patients RANDOMly received increasing doses of vitamin B@ or placebo at @ mg/day for the first week , @ mg/day for the second week , @ mg/day for the third week and @ mg/day for the fourth week .\n",
            "Vitamin B@ was well tolerated by all patients , and all patients were able to receive the maximal dose of @ mg/day without any adverse effects .\n",
            "Repeated-measures of ANOVA for the two-period crossover design also revealed no significant differences ( p < .@ ) between vitamin B@ and placebo treatment , with respect to the end-point mean scores on PANSS .\n",
            "There were no significant correlations between PP level and PANSS scores ( R = @ for the negative symptom subscale and R = @ for positive symptom subscale ) .\n",
            "Further studies with larger populations , shorter duration of illness and more uniform inclusion criteria are needed in order to clarify the question of the possible efficacy of vitamin B@ in treatment of psychotic symptoms in schizophrenia .\n",
            "P. @ Desloratadine does not impair actual driving performance : A @-way crossover comparison with diphenhydramine and placebo E.F.P.M. Vuurman , J.G. Ramaekers , G. Rikken , F. De Halleux , The Netherlands , U.S.A.\n",
            "Background : There are few evaluated psychological interventions or theoretical approaches which are specifically aimed at reducing problems related to adjustment and adaptation following a first episode of psychosis .\n",
            "In view of this , a form of cognitive therapy ( CRI ) was developed to help first episode patients with trauma , depression , low self esteem , social rank and appraisals of psychotic illness .\n",
            "Aims : To test the efficacy of CRI in reducing trauma , depression and low self esteem following a first episode of psychosis , in a single-blind randomised controlled trial .\n",
            "Method : A total of @ patients who had recently experienced a first episode of psychosis were randomly assigned to CRI or treatment as usual ( TAU ) and followed up at @ months and @ months .\n",
            "Results A significantly greater number of people in the cognitive therapy group benefited from reduced trauma symptoms ( effect size @ ; OR @ ; CI : @-@ ) at @ months follow up .\n",
            "Improvements were also observed in the CRI group but not the control group regarding positive psychotic symptoms at @ months ( p < @ ) .\n",
            "Although there were general improvements in depression , appraisals of illness , social rank and self esteem over a year , these were the same across both conditions .\n",
            "Conclusions : CRI may be a useful intervention to help some young patients adapt to certain aspects of first episode psychosis .\n",
            "Rationale : Schizophrenia is a disorder with cognitive deficits that could stem from cholinergic dysfunction .\n",
            "Objectives : Our aim was to examine if donepezil administered to stable , medicated outpatients with schizophrenia improves cognition and psychopathology .\n",
            "Methods : We conducted a double-blind placebo-controlled trial of donepezil up to @ mg/day added for @ weeks to ongoing antipsychotic treatment in @ typical community-treated schizophrenia patients not selected for cognitive impairment .\n",
            "Results : Donepezil did not improve measures of cognition or psychopathology .\n",
            "It was well tolerated .\n",
            "Conclusion : Consistent with other studies , addition of donepezil to stable patients with schizophrenia did not improve cognition or measures of psychopathology .\n",
            "This result does not support the hypothesis that residual symptoms and cognitive problems result from a cholinergic deficit that can be remedied by an acetylcholinesterase inhibitor .\n",
            "A donepezil add-on strategy might make sense in selected schizophrenia cases where a pathological process is known to affect cholinergic neurons ( e.g. , history of head injury or comorbid dementia ) .\n",
            "copyright Springer-Verlag @\n",
            "Objective : To compare risperidone and the efficacy and safety of quetiapine in the treatment of schizophrenia .\n",
            "Method : the version of the diagnostic criteria for the classification and diagnostic criteria of the @ patients with mental disorders @ episode schizophrenia patients , random level risperidone group and quetiapine group @ cases , the course of six weeks .\n",
            "Positive and Negative Syndrome Scale ( panss ) , to evaluate the efficacy and adverse side effects scale ( tess ) .\n",
            "Results : risperidone group positive symptom score decreased significantly larger than the quetiapine group ; two sets of negative symptoms , general psychopathology symptoms and panss of the total score decreased difference was not statistically significant ( p > @ ) .\n",
            "The risperidone group adverse reactions for the increase in body weight ( bw ) , liver dysfunction and extrapyramidal symptoms ; the quetiapine group of major adverse reaction to drowsiness and dizziness .\n",
            "Conclusion : positive symptoms of schizophrenia , Risperdal more effective than quetiapine , adverse reactions of the two drugs are relatively light .\n",
            "There has been a continuing debate on the prevalence , association , specifity and development of negative and depressive symptoms in acute schizophrenia with productive symptoms and treatment outcome under antipsychotic drugs .\n",
            "In prospective investigations on the the concomittant occurrence and @ years ' course of negative and depressive symptomatology in schizophrenic and affective disorders we found that _ apart from a substantial overlap of the symptomatologies _ primary enduring negative symptoms are non-specific and were present in both diagnostic groups .\n",
            "Even in the longitudinal course of schizophrenia , this symptomatology was not more frequent than in affective disorders , and was observed in about @ % of both diagnostic groups .\n",
            "In order to evaluate the efficacy of the mixed @-HT@ - / D@-like receptor antagonist risperidone vs. haloperidol and amitriptyline in a functionally defined combined psychotic and depressive syndrome , @ patients suffering from either major depression with synthymic or mood-incongruent psychotic features , a depressive type of schizoaffective disorder or a non-residual schizophrenia with prominent depressive symptoms have been investigated .\n",
            "The combination of amitriptyline and haloperidol was superior to risperidone in major depression with psychotic features but not in the depressive type of schizoaffective disorder , where both treatment groups showed comparable reductions of BPRS and BRMS scores .\n",
            "Thus , the nosological distinction by categorical diagnoses could be corroborated by pharmacological means .\n",
            "In another clinical trial , the efficacy of the selective D@-like antagonist amisulpride was investigated versus the D@ - / D@ - like/@-HT @ receptor antagonist flupentixol in schizophrenia with predominant positive symptomatology , and improvement of co-occuring negative and depressive symptoms was evaluated in @ patients .\n",
            "Both drugs improved negative symptoms as measured by the SANS but this effect was more marked in the amisulpride group .\n",
            "With regard to depressive symptoms , amisulpride produced a greater BRMS decrease than flupentixol , but this difference did not reach statistical significance .\n",
            "However , it has to be taken into account that amisulpride caused less extrapyramidal side effects than flupentixol .\n",
            "The distinction between negative and depressive symptomatology provokes methodological problems with regard to syndromal overlap , appropriate assessment scales and their sensitivity to change .\n",
            "A pharmacological dissection between negative and depressive symptomatology by the response to selective psychotropic agents may contribute to a more powerful and workable functional definition .\n",
            "Certainly , not only positive symptoms improve under neuroleptic treatment .\n",
            "Specific neuroleptics with different receptor affinity profiles and antidepressive/antipsychotic combinations may be effective treatments for psychotic syndromes with both depressive and negative symptoms , and their differential effect sizes have to be clarified by further clinical trials .\n",
            "Patients with severe mental disorders die on average @ years prior to the general population .\n",
            "This mortality gap is mainly due to the higher prevalence of physical diseases and the adoption of unhealthy lifestyle behaviors.The LIFESTYLE trial aims to evaluate the efficacy of a new psychosocial group intervention ( including psychoeducational , motivational , and problem-solving techniques ) focused on healthy lifestyle behavior compared to a brief educational group intervention in a community sample of patients with severe mental disorders .\n",
            "The trial is a national-funded , multicentric , randomized controlled trial with blinded outcome assessments , which is carried out in six outpatient units of the Universities of Campania \" Luigi Vanvitelli \" in Naples , Bari , Genova , L'Aquila , Pisa , and Rome-Tor Vergata .\n",
            "All patients are assessed at the following time points : baseline ( T@ ) ; @ months post-randomization ( T@ ) ; @ months post-randomization ( T@ ) ; @ months post-randomization ( T@ ) ; @ months post-randomization ( T@ ) ; and @ months post-randomization ( T@ ) .\n",
            "T@ and T@ assessments include only anthropometric tests .\n",
            "The BMI , a reliable and feasible anthropometric parameter , has been selected as primary outcome .\n",
            "In particular , the mean value of BMI at @ months from baseline ( T@ ) will be evaluated through a Generalized Estimated Equation model .\n",
            "The work hypothesis is that the LIFESTYLE psychosocial group intervention will be more effective than the brief educational group intervention in reducing the BMI .\n",
            "We expect a mean difference between the two groups of at least one point ( and standard deviation of two points ) at BMI .\n",
            "Secondary outcomes are : the improvement in dietary patterns , in smoking habits , in sleeping habits , physical activity , personal and social functioning , severity of physical comorbidities , and adherence to medications .\n",
            "The expected sample size consists of @ patients ( @ patients for each of the six participating centers ) , and they are allocated with a @:@ ratio randomization , stratified according to center , age , gender , and educational level .\n",
            "Heavy smoking , sedentary behavior , and unhealthy diet pattern are very frequent and are associated with a reduced life expectancy and higher levels of physical comorbidities in people with severe mental disorders .\n",
            "New interventions are needed and we hope that the LIFESTYLE protocol will help to fill this gap .\n",
            "TRIAL REGISTRATION NUMBER : @C@S .\n",
            "Background : Currently available antipsychotic medications offer only modest , if any , effects on cognitive performance in people with schizophrenia .\n",
            "Treatments that would improve these impairments could lead to better functional outcomes .\n",
            "Atomoxetine is a nonstimulant , selective norepinephrine reuptake inhibitor approved for the treatment of attention-deficit/hyperactivity disorder .\n",
            "In animals , it has been shown to increase extracellular levels of acetylcholine and dopamine in cortical and hippocampal regions .\n",
            "Method : Following a @-week stabilization period , @ subjects with DSM-IV-diagnosed schizophrenia or schizoaffective disorder were randomly assigned to atomoxetine ( @ mg daily ) or placebo for @ weeks .\n",
            "All subjects were treated with antipsychotic monotherapy ( excluding clozapine , aripiprazole , and first-generation antipsychotics ) .\n",
            "Neuropsychological test performance was the primary outcome variable , and the neuropsychological test battery included measures of attention , motor speed , executive function , processing speed , verbal and visual memory , and working memory ( rated at baseline and end point ) .\n",
            "Symptom and side-effect ratings were performed every @ weeks .\n",
            "The study was conducted from April @ through December @ .\n",
            "Results : There were no treatment group differences on the primary study outcome measure ( overall mean z-score : Wilcoxon chi@ = @ , df = @ , p = .@ ) ; nor was there significant evidence of variation in treatment effects on z-score changes across the individual neuropsychological tests ( chi@ = @ , df = @ , p = .@ ) .\n",
            "No between-group differences were noted in symptom changes .\n",
            "Atomoxetine was well tolerated and was associated with a trend for improvement in extrapyramidal side effects relative to placebo ( p = .@ ) .\n",
            "Conclusion : Our results provide further evidence that atomoxetine has limited benefit for improving cognition in people with schizophrenia .\n",
            "Trial Registration : clinicaltrials.gov Identifier : NCT@ .\n",
            "OBJECTIVE : This @-week pilot study assessed the efficacy , tolerability , and safety of adjunctive metformin versus placebo for the prevention of olanzapine-associated weight gain in community-dwelling adult patients with schizophrenia , schizoaffective disorder , bipolar disorder , or major depression with psychotic features .\n",
            "METHODS : In a double-blind study , @ patients were randomly assigned to receive @ weeks of either olanzapine plus metformin or olanzapine plus placebo .\n",
            "Metformin extended release was titrated to @ mg daily as tolerated .\n",
            "No other antipsychotics were allowed , whereas psychotropic medications including antidepressants and mood stabilizers were permitted .\n",
            "The primary outcome measures were change in body weight and homeostatic model assessment for insulin resistance from baseline to week @ .\n",
            "RESULTS : The intent-to-treat population comprised patients who had @ or more post-baseline visit .\n",
            "Mean change in body weight for the olanzapine plus metformin ( O/M ) group was @ lb , which was less than the @ lb gain for the olanzapine plus placebo ( O/P ) group ( P < @ ) .\n",
            "Compared with O/P group who gained @ % of their body weight , patients in the O/M group gained @ % ( P < @ ) .\n",
            "Body mass index change in the O/M group was @ versus @ in the O/P group ( P < @ ) .\n",
            "There was a trend for a greater increase in baseline to end point homeostatic model assessment for insulin resistance and waist circumference in the O/P group versus the O/M group .\n",
            "CONCLUSIONS : In this naturalistic sample of typical US community-dwelling patients , metformin was effective and well tolerated for the prevention of olanzapine-associated weight gain .\n",
            "Adjunctive metformin should be studied in a similar but larger population to determine its role in the prevention of olanzapine-associated weight gain .\n",
            "Introduction : Sleep disturbances ( e.g. increased sleep latencies , frequent awakenings , deficiency in slow-wave sleep [ SWS ] ) are commonly reported in schizophrenia , contributing to patient distress .\n",
            "SWS deficits may also be associated with poor clinical outcome .@ , @ The effects of antipsychotic drugs on sleep regulation are important , but data from controlled trials are scarce .\n",
            "Risperidone , an atypical antipsychotic , has been shown to improve sleep efficiency in schizophrenic patients .@ Objective : The current RANDOMised double-blind , parallel group study compared the effects of risperidone and haloperidol on the sleep of schizophrenic patients with a baseline sleep efficiency below @ % .\n",
            "Methods : The trial consisted of @ consecutive phases : A wash-out phase for psychotropic medication ( @ weeks ) , a screening phase ( @ week ) , a titration phase ( @ week ) and an evaluation phase ( @ weeks ) .\n",
            "Twenty-three patients , aged @ to @ years , were RANDOMised to risperidone ( n = @ ) or haloperidol ( n = @ ) .\n",
            "Polysomnography was performed at the end of the wash-out period and at trial endpoint .\n",
            "In addition , subjective sleep evaluation was obtained .\n",
            "Results : The average daily dose of trial medication was @ mg for risperidone and @ mg for haloperidol at endpoint .\n",
            "Of the @ patients , @ had insufficient data , @ patients had to be excluded due to disallowed concomitant medication ( benzodiazepines ) .\n",
            "Adequate sleep data were obtained in @ patients ( risperidone @ , haloperidol @ ) .\n",
            "The duration of stage @ SWS increased significantly in the risperidone group ( +@ min ) versus haloperidol ( -@ min , p = @ ) .\n",
            "Compared to baseline values , sleep maintenance ( defined as sleep duration as a fraction of total sleep time ) increased more in the risperidone group compared to haloperidol ( p = @ ) and tended to be higher at endpoint ( @ % vs. @ % ) .\n",
            "The number of short awakenings ( @ s ) decreased from @ to @ in the risperidone group , but was unchanged in patients receiving haloperidol ( p = @ ) .\n",
            "Subjective sleep quality did not differ between the groups .\n",
            "Both treatments were well tolerated ; known side effects of risperidone and haloperidol were observed , but no serious adverse events occurred .\n",
            "Conclusion : This study demonstrated that sleep maintenance and continuity were improved .\n",
            "Furthermore there was a significant prolongation of slow-wave sleep with risperidone compared to haloperidol .\n",
            "Deficits in slow-wave sleep are associated with poor psychosocial performance .\n",
            "Therefore , the positive effects of risperidone on SWS may contribute to a better clinical outcome in schizophrenic patients .\n",
            "Further studies including larger patient samples are warranted .\n",
            "HYPOTHESIS : ECT is effective as treatment of psychosis in patients suffering from clozapine resistant schizophrenia .\n",
            "HEALT CONDITION ( S ) OR PROBLEM ( S ) STUDIED : Schizophrenia , Psychosis , Clozapine , Electroconvulsive therapy INCLUSION CRITERIA : @ .\n",
            "Age : @ yrs or older .\n",
            "@ .\n",
            "Suffering from schizophrenia .\n",
            "@ .\n",
            "Able to give informed consent .\n",
            "@ .\n",
            "Treatment with clozapine for at least eight weeks with blood levels of at least @ ng/ml has been shown to be inadequate .\n",
            "@ .\n",
            "Inadequate treatment is defined as a score of at least @ on @ of the @ psychotic items ( paranoia , delusions , hallucinations , formal thought disorder ) of the Brief Psychiatris Rating Scale ( BPRS ) EXCLUSION CRITERIA : @ .\n",
            "Contra-indication for ECT : myocardial infarction less than @ months old .\n",
            "@ .\n",
            "Drugs or alcohol abuse less than a month ago .\n",
            "@ .\n",
            "Clozapine blood levels higher than @ ng/ml MEC APPROVAL RECEIVED ; yes ; MULTICENTER TRIAL : no ; RANDOMISED : yes ; MASKING/BLINDING : Single ; CONTROL : Active ; GROUP : Parallel ; TYPE : @ or more arms , randomized ; STUDYTYPE : intervention ; PLANNED STARTDATE : @-feb-@ ; PLANNED CLOSINGDATE : @-dec-@ ; TARGET NUMBER OF PARTICIPANTS : @ : INTERVENTIONS : Clozapine vs. clozapine + ECT ; PRIMARY OUTCOME : Positive symptoms score on the Positive and Negative syndrome scale ( PANSS ) ; SECONDARY OUTCOME : BPRS score ; TIMEPOINTS : Baseline , two weeks , four weeks , six weeks ( end point ) ; STATUS : open : patient inclusion BRIEF SUMMARY : In the Netherlands electroconvulsive therapy ( ECT ) is mainly used for treatment of depression .\n",
            "The ECT guidelines from the Nederlandse Vereniging van Psychiatrie ( NVVP @ ) broaden the use of ECT .\n",
            "These guidelines recommend the use of ECT for treatment of schizophrenia when an adequate treatment with clozapine has not been efficacious .\n",
            "There is however little evidence for the efficacy of ECT in clozapine resistant schizophrenia .\n",
            "In this study the efficacy of ECT in the treatment of schizophrenia is explored in patients who are still suffering from psychosis despite adequate treatment with clozapine .\n",
            "Patients are randomized in two groups .\n",
            "In the control group patients continue treatment with clozapine .\n",
            "In the treatment group patients receive ECT treatment and clozapine is also continued .\n",
            "The primary outcome criterion is the reduction in positive symptoms of schizophrenia , which is assessed using the Positive and Negative Syndrome Scale ( PANSS ) .\n",
            "In the follow up phase the time to relapse after a successful ECT course is explored .\n",
            "A single blind , prospective , randomized , controlled study design is used .\n",
            "Background : PF @ is being developed for the treatment of cognitive impairment associated with schizophrenia ( CIAS ) .\n",
            "PF @ is a potent and highly selective positive allosteric modulator of a amino @ hydroxy @ methyl @ isoxazolepropionic acid ( AMPA ) receptors ( an AMPA potentiator ) that represents a mechanistically novel approach to the treatment of CIAS .\n",
            "In response to glutamate , postsynaptic AMPA receptors produce a rapid membrane depolarization that removes the magnesium block from co localized N methyl D aspartate ( NMDA ) receptor-gated ion channels and allows calcium influx into the cell .\n",
            "The resulting intracellular cascade activates kinases and transcription factors , which induce long-term potentiation and gene expression .\n",
            "This process , which produces changes in synaptic morphology and strength , is believed to underlie learning and memory .\n",
            "Pharmacologic antagonism of NMDA receptors in healthy humans and genetic manipulation of NMDA receptors in rodents produce cognitive impairment and behavioral effects suggestive of schizophrenia ; postmortem studies of subjects with schizophrenia have found decreased AMPA receptor density in the hippocampus to be among the strongest evidence for dysregulation of glutamatergic transmission in schizophrenia .\n",
            "PF-@ has been evaluated in @ preclinical models in two species ( rat and non-human primate [ NHP ] ) , including @ models with NMDA receptor antagonist-mediated deficits and a rat functional model examining fluorodeoxyglucosepositron emission tomography ( FDG-PET ) .\n",
            "Overall , these preclinical studies , in aggregate , predicted a minimal efficacious plasma exposure of @ ng/mL in clinical studies .\n",
            "These preclinical models have translated to prior clinical studies , where PF-@ has demonstrated pharmacological activity both via functional Magnetic Resonance Imaging ( fMRI ) detected reduction in activity in the left inferior parietal cortex of healthy subjects undergoing a @D spatial working memory ( WM ) task , p = @ and behaviorally via an attenuation of ketamine-induced cognitive impairment on the Hopkins Verbal Learning Test-Revised-Immediate Recall ( HVLT-R-IR ) , p = @ at exposures predicted to be efficacious .\n",
            "Methods : @ studies were conducted to evaluate the safety , tolerability and PK of multiple escalating doses of oral PF-@ administered to subjects with stable schizophrenia receiving antipsychotic medication .\n",
            "The studies were randomized , double-blind , sponsor-open , placebo-controlled , parallel-group , multiple ascending dose studies of PF-@ ( N = @ ) or placebo ( N = @ ) administered daily for @ consecutive days .\n",
            "Exploratory objectives included an evaluation of PF-@ on cognitive behavioral endpoints .\n",
            "Results : @ subjects with schizophrenia were enrolled in these studies .\n",
            "PF-@ was safe and well-tolerated .\n",
            "Exploratory efficacy analyses demonstrated a statistically significant dose-related improvement on the Measurement and Treatment Research to Improve Cognition in Schizophrenia ( MATRICS ) Consensus Cognitive Battery ( MCCB ) WM Domain at the highest dose evaluated after @ weeks of dosing .\n",
            "These results are supported by a significant relationship between average plasma PF-@ concentration at steady-state ( Css , avg , ng/mL ) and the MCCB WM Domain ( change from baseline to @ days ) .\n",
            "Conclusions : PF-@ was safe and well-tolerated after multiple doses .\n",
            "The exploratory efficacy data from the MCCB WM domain provides clinical translation from preclinical models and support further evaluation in longer term efficacy studies in subjects with cognitive impairment associated with stable schizophrenia .\n",
            "Intervention during the prodromal phase of psychotic disorder has become the frontline focus in early intervention research and is aimed at delaying or preventing the onset of psychosis in already symptomatic high risk patients , as well as alleviating current symptoms , distress and disability .\n",
            "The PACE Clinic at ORYGEN Youth Health has conducted a second randomized controlled trial ( RCT ) under double blind conditions comparing the effectiveness of lowdose risperidone ( @-@ mg/day ) and intensive CBT-based psychological treatment versus placebo and intensive CBT-based psychological treatment versus placebo and a control psychological treatment ( supportive therapy ) .\n",
            "The trial consists of a @-month treatment phase , followed by a @-month follow up phase , due to be completed in March @ .\n",
            "The primary outcome of interest is the proportion of patients meeting onset of psychosis criteria during the treatment and follow up phases .\n",
            "The validity of potential predictors of transition from the subthreshold or ultra-high risk ( UHR ) mental state to psychotic disorder will also be assessed .\n",
            "Secondary outcomes involve improvement on dimensional measures of symptoms , distress , functioning and quality of life .\n",
            "This presentation will report baseline characteristics of the sample .\n",
            "@ participants ( mean age = @ years , male = @ % ) meeting UHR criteria for psychotic disorder were randomized to the three treatment groups .\n",
            "A range of psychopathological , neuropsychological , and physical assessments were conducted at baseline and at regular follow up points .\n",
            "Baseline characteristics will be compared between : i ) the three treatment groups and ii ) the treatment groups and a monitoring group ( N = @ , mean age = @ years , male = @ % ) , who received  treatment as usual  .\n",
            "Background : Cannabis use in schizophrenia is associated with poor clinical outcomes and high levels of family burden .\n",
            "An intervention for carers is needed to reduce their burden and to help them motivate the patient with schizophrenia to change cannabis use .\n",
            "We hypothesize that training carers in motivational interviewing and interaction skills facilitates positive behaviour changes in their family member with schizophrenia and cannabis use .\n",
            "Aims : To test the effectiveness of a family training in motivational and interaction skills ( FMI ) compared to a control condition of psycho-education ( PE ) only for carers of young adults with recent-onset schizophrenia .\n",
            "Method : In a single-blind , randomized clinical trial of @ patients with recent-onset schizophrenia and cannabis use , carers were assigned to FMI ( n = @ ) or PE ( n = @ ) .\n",
            "Assessments were conducted at baseline and at @-month follow-up on cannabis use , medication compliance and well-being in patients and on burden in carers .\n",
            "Results : FMI was significant more effective than PE in reducing the use of cannabis and the craving for cannabis in patients .\n",
            "FMI was not superior to PE in reducing the burden in carers and in increasing the well-being in patients .\n",
            "Medication compliance remained stable in both conditions .\n",
            "Conclusion : Data will be presented showing that teaching carers in motivational interviewing and interaction skills are more effective than psycho-education only in reducing cannabis use and craving for cannabis in patients with recent-onset schizophrenia .\n",
            "Background : The hypothesis of early-onset action of antipsychotics proposes no notable delay in onset of action and a gradual improvement towards a plateau .\n",
            "The hypothesis has not been tested in children and adolescents There is no consensus on the definition and the predictive value of early response of antipsychotic drugs .\n",
            "Also no consensus has been reached on when a non-responding patient should be switched to a potentially more effective treatment .\n",
            "Early onset effects of antipsychotics have shown to be a stable predictor of clinical response in adults with schizophrenia .\n",
            "A metaanalysis of double-masked studies including @ patients have shown greater improvement in the first @ treatment weeks than in the next @ weeks measured as reductions in total scores on the BPRS and PANSS .\n",
            "A multicenter study including @ schizophrenic patients showed that both @ - and @-week-measures significantly improved the prediction of remission after @ months compared with baseline and @-week-assessments .\n",
            "This study aims to @ ) identify and define early predictors of clinical response of an antipsychotic drug in children and adolescents aged @-@ years with psychosis @ ) compare the early effects of quetiapine and aripiprazole and @ ) describe the predictive value of early effects on response and remission after @ weeks .\n",
            "Methods : The study is a randomized , double-blinded trial with aripiprazole vs. quetiapine for patients aged @-@ years with first-episode psychosis .\n",
            "Early effects are measured as improvement after @ and @ weeks on the PANSS positive and total score .\n",
            "Response and remission after @ weeks is defined according to recommendations for schizophrenia .\n",
            "The discriminative and predictive value of early effect is evaluated with a ROC curve , where the AUC expresses the balance between the true positive and the true negative cases .\n",
            "The best discriminative definition of early effect is identified by calculating AUC , sensitivity , specificity and positive and negative predictive values for all possible early improvement cut-offs of a percentage PANSS total score improvement .\n",
            "Results : Inclusion of patients in the trial started in May @ .\n",
            "@ patients will be included by @ Child - and Adolescent Psychiatric Centers in Denmark .\n",
            "Conclusion : Evidence on early indicators of later sustained clinical effects of antipsychotics is of great clinical relevance .\n",
            "ClinicalTrials.gov Identifier : NCT@ .\n",
            "Background : Although many antipsychotic medications are available to patients with schizophrenia , their efficacy rates are limited to B @-@ % , highlighting the need for objective biomarkers that predict treatment response .\n",
            "We have found lower cortical and thalamic binding potential with the high-affinity D@/D@ dopamine PET ligand @F-fallypride in never-medicated patients with schizophrenia .\n",
            "This suggests the hypothesis that individuals with low binding potential at baseline examination might show a greater subsequent response to antipsychotic therapy with risperidone or aripiprazole .\n",
            "This is an early report of our efforts to characterize potential biomarkers predictive of antipsychotic treatment response .\n",
            "Methods : We acquired @F-fallypride PET images from @ unmedicated patients ( @ medication na    ve ) with schizophrenia .\n",
            "Dopamine D@/D@ receptor levels were measured as binding potential ( BP ) using Logan analysis and a cerebellar reference .\n",
            "MRI images in standard Talairach position and segmented into gray and white matter were coregistered to fallypride images .\n",
            "A stereotaxic atlas of @ Brodmann areas ( BA ) was applied , allowing calculation of BP in each BA .\n",
            "Subjects were then randomized into a @-week double-blind aripiprazole ( n  @ ) or risperidone ( n  @ ) trial .\n",
            "Baseline vs. end-of-trial PANSS change scores were compared to BP values in an intent-to-treat analysis .\n",
            "Results : Data were analyzed for the combined sample ( aripiprazole + risperidone ) .\n",
            "@F-fallypride BP in the parahippocampal gyrus ( BA@ and @ ) , orbitofrontal cortex ( BA@ and @ ) , BA@ , and the putamen and caudate had correlations above r  @ ( po@ .@ , @-tailed ) with PANSS change scores ( general score and , in some instances , total score plus positive or negative symptom scores ) .\n",
            "The left thalamus ( @ ) also showed a significant correlation with improvement on the negative scores .\n",
            "For the medial dorsal nucleus on the right ( which had significantly lower BP in our larger cohort of @ medication-na    ve patients ) , the correlations were @ , @,@ , and @ for PANSS total , positive , negative , and general symptoms , respectively , and @ , @ , @ , @ for the left medial dorsal nucleus .\n",
            "Caudate values were @ , @ , @ , @ for the left and @ , @ , @ , @ for the right .\n",
            "The results were not dissimilar when analyzed only for the risperidone treatment group ( n  @ ) .\n",
            "Discussion : Dopamine receptor affinity and density estimated by BP appear to be an effective means to identify a testable biomarker associated with antipsychotic treatment response , particularly in temporal and subcortical regions of corticolimbic and corticostriatothalamic circuits previously implicated in the pathophysiology of schizophrenia .\n",
            "Results are consistent with the interpretation that lower binding of fallypride at baseline predicts greater clinical response to antipsychotic medication .\n",
            "Clearly , a larger sample is needed to extend these results , and importantly , to determine whether @F-fallypride BP , as measured by PET , might provide a biomarker predictive of treatment response to antipsychotic drugs .\n",
            "ALLOCATION : Double-blind study PARTICIPANTS : DSMIIR schizophrenia inpatients with predominant negative symptoms .\n",
            "INTERVENTION : Amisulpride vs haloperidol OUTCOMES : Fourteen patients experienced psychotic exacerbations that were controlled with increase in dosage .\n",
            "Overall , positive symptoms were stable over the year , and social behaviour and tardive dyskinesia showed no significant changes in sample and no significant differences between the treatment groups .\n",
            "Aim : To investigate the influence of community managed prevention and treatment on the effect and economic factors of patients with schizophrenia .\n",
            "Methods : From May @ to June @ , totally @ patients with schizophrenia in the community of Enshi city were RANDOMly divided into observational group ( n = @ ) and control group ( n = @ ) .\n",
            "They were followed up for @ year by prospective control observation .\n",
            "Community observational group : the patients were registered to create cards , and involved in the rehabilitative network of prevention and treatment , rehabilitative program was worked out , the community treatment group was also founded .\n",
            "Concrete measures : @ Drug rehabilitation : The patients were treated with intramuscular injection of ultralente agent or oral antipsychotic drug , and the dosage equal to ( @ + / -@ ) mg per day ( chloropromazine ) .\n",
            "@ family interventions : Instructions were given to the subjects and their family members on the spot , including grouped and individual family treatments .\n",
            "@ Occupational rehabilitation : It was emphasized that the final purpose of treatment was the recovery of skills and return to society .\n",
            "@ The monthly clinical symptoms , medication , medical cost and family income of the patients were traced and recorded .\n",
            "Control group : The patients went to the hospital at exacerbation , and they were treated with routine drug treatment , the dosage equal to ( @ + / -@ ) mg per day ( chloropromazine ) .\n",
            "The curative effect was evaluated with brief psychiatric rating scale ( BPRS ) and social disability screening schedule ( SDSS ) before , during ( @ months ) and after treatment ( @ months ) respectively .\n",
            "The test of normality , analysis of variance and chi-square test were used to compare the changes of clinical symptoms , medical care and other economic loss before and after @-year treatment .\n",
            "Results : @ At the end of @-year treatment , the scores of BPRS and SDSS in the community observational group were obviously lower than those before treatment and those in the control group at the same period ( @ + / -@ , @ + / -@ , @ + / -@ ; @ + / -@ , @ + / -@ , @ + / -@ , t = @-@ , P < @-@ ) , and the total score of SDSS at the end of the @th month was obviously lower in the community observational group than in the control group ( @ + / -@ , @ + / -@ , t = @ , P < @ ) .\n",
            "@ The regular rate of drug treatment in the community observational group was increased from @ cases ( @ % ) to @ cases ( @ % ) , and that in the control group was only maintained at @ cases ( @ % ) .\n",
            "It reoccurred in @ cases ( @ % ) in the community observational group , which was significantly different from that in the control group ( @ cases , @ % ) ( t = @ , P < @ ) .\n",
            "@ Compared with the control group , the absent days of patients in the community observational group was averagely decreased by @ days per month , and equal to @ yuan per month ; and those of relatives was averagely decreased by @ days per month , and equal to @ yuan per month ; the indirect cost for each person was averagely reduced by @ yuan per month .\n",
            "In the control group , @ cases were hospitalized within one years , the total cost of hospitalization was @ @ yuan , no one hospitalized in the community observational group , the cost of treatment was significantly lower than that in the control group ( t = @ , P < @ ) .\n",
            "Conclusion : The community management and regular prevention and treatment can ameliorate the clinical symptom , reduce reoccurrence rate and medical cost of patients with schizophrenia , it is also good for the social rehabilitation of the patients .\n",
            "Objective : To compare olanzapine and haloperidol in the treatment of schizophrenia and side effects .\n",
            "Methods : @ patients with schizophrenia were randomly divided into two groups , were given olanzapine and haloperidol in the treatment of eight weeks .\n",
            "Schizophrenia positive and negative symptoms rating scale ( panss ) to evaluate the efficacy , side effects scale ( tess ) rating side effects .\n",
            "Results : Olanzapine effective rate of @ % and @ % for haloperidol compared the two groups was no significant difference ( p > @ ) .\n",
            "Conclusion : olanzapine on negative symptoms of schizophrenia , positive symptoms have improved efficiency are better than haloperidol , well tolerated , and side effects of olanzapine , safe , worthy of clinical use .\n",
            "Objective : To evaluate the efficacy of cognitive behavior therapy ( CBT ) on the patients with slowly - episode schizophrenia .\n",
            "Methods : @ patients with slowly - episode schizophrenia were randomly assigned to drug treatment group without CBT ( control group , n = @ ) and drug treatment plus CBT group ( study group , n = @ ) .\n",
            "All the patients were assessed with Positive and Negative Syndrome scale ( PANSS ) before and after treatments for @ , @ , @ weeks .\n",
            "Results : According to the scores of PANSS , the efficacy was better in study group than in control group ( P < @ .\n",
            "@ ) .\n",
            "Conclusions : It is suggested that CBT improve the symptoms in the slowly - episode schizophrenia patients\n",
            "Effects of thioridazine or clozapine on positiveand negative symptoms in @ schizophrenics and itsrelations to drug plasma levels were reported withSAPS , SANS , BPRS , CGL and TESS assesseddouble-blindly .\n",
            "The results showed that thioridazinehad signifficantly effects on positive and negativesymptoms as clozapine .\n",
            "Besides , side effects increased when blood concentration of thioridazine wasabove @ .\n",
            "@-@ .\n",
            "@mol/L .\n",
            "The monitoring of bloodconcentration was suggested .\n",
            "The objective of the study is to evaluate whether a form of cognitive therapy ( recovery intervention ) is an effective intervention to promote personal adjustment to psychosis and reduce depression , trauma and other characteristic negative consequences of psychosis .\n",
            "Design/methodology : Randomised controlled trial Participants - inclusion criteria : Patients conforming to International Statistical Classification of Diseases and Related Health Problems , Tenth revision ( ICD-@ ) schizophrenia or related disorder Participants - exclusion criteria : Not available Anticipated start date : @/@/@ Anticipated end date : @/@/@ Status of trial : Completed Interventions : i .\n",
            "The intervention group will receive cognitive therapy over a @ month period\n",
            "Objective To explore the efficacy and side effects of aripiprazole on negative symptoms of schizophrenia .\n",
            "@ cases of patients with schizophrenia ( negative symptoms ) by a random number table random , odd experimental group , even into the control group and were followed for six months , the use of aripiprazole and haloperidol-controlled study ; using BPRS , SANS and TESS and clinical efficacy were assessed .\n",
            "The result the aripiprazole is better than haloperidol , and side reactions are also low .\n",
            "Objective : The objective of this study was to assess the dose-response relationship of standard and higher doses of olanzapine in acutely ill , non-treatmentresistant patients with schizophrenia or schizoaffective disorder with suboptimal response to their current treatment .\n",
            "Methods : This randomized , double-blind , @-week , fixed-dose study compared olanzapine @ mg/d ( n = @ ) , @ mg/d ( n = @ ) and @ mg/d ( n = @ ) for patients with schizophrenia or schizoaffective disorder , with baseline BPRS score _ @ , scores on at least @ of the @ BPRS positive symptom items _ @ ( moderate ) , CGI-Severity score _ @ , and less than optimal response to current treatment .\n",
            "Patients with history of antipsychotic treatment resistance , in particular to atypical antipsychotics , were excluded .\n",
            "The primary outcome measure was a change in Positive and Negative Syndrome Scale ( PANSS ) total score .\n",
            "Dose  response relationship was assessed by linear regression analysis with the logtransformed dose as the independent variable and PANSS total score as the dependent variable .\n",
            "Results : The proportion of patients completing the study ( @ % ; between group p = .@ ) and time to treatment discontinuation ( p = .@ ) did not significantly differ between dose groups .\n",
            "All @ dose groups showed statistically significant improvement in PANSS total scores from baseline to endpoint , without significant dose-response relationship .\n",
            "( p = .@ ) .\n",
            "However , a post-hoc analysis of treatment response ( assessed by PANSS total score ) showed a significant interaction between baseline PANSS and dose .\n",
            "( p = @ ) : patients with higher baseline PANSS scores responded better to higher doses .\n",
            "There was a significant difference between the @ and @ mg dose groups ( p = .@ ) , but not between the @ and @ mg ( p = .@ ) or @ and @ mg ( p = .@ ) dose groups for mean change in weight ( @ kg [ @ mg/d ] , @ [ @ mg/d ] , @ [ @ mg/d ] ) .\n",
            "There was also a significant difference between the @ and @ mg ( p < @ ) , @ and @ mg ( p = .@ ) , and @ and @ mg ( p = .@ ) dose groups for mean change in prolactin levels ( -@ ng/ml [ @ mg/d ] , -@ [ @ mg/d ] , @ [ @ mg/d ] ) .\n",
            "Conclusions : Over @ weeks , acutely-ill , non-treatment-resistant patients with schizophrenia responded to all @ doses of olanzapine , without significant doseresponse relationship .\n",
            "These results suggest that most individuals in the general population of patients with schizophrenia or schizoaffective disorder will respond to the approved olanzapine dosing range ( @  @ mg/d ) .\n",
            "However , the use of higher doses ( up to @ mg/d ) for a more severely ill patient population may be warranted .\n",
            "Clinicians should consider the relative risks and benefits when optimizing medication dose .\n",
            "We conducted a secondary analysis of a completed study of the differential efficacy and side effects of aripiprazole versus haloperidol in early-stage schizophrenia ( ESS ) , a subpopulation of patients which does not include first episode or chronic patients .\n",
            "A subpopulation of @ individuals with ESS were identified from a randomized , multi-center , double-blind study of @ individuals with schizophrenia at different stages of illness who were randomized to treatment with aripiprazole ( ESS = @ ) or haloperidol ( ESS = @ ) for one year .\n",
            "The primary outcome measure was response rate based on a @ % reduction of Positive and Negative Syndrome Scale ( PANSS ) total scores .\n",
            "Secondary outcomes included several efficacy and safety measures , as well as treatment discontinuation .\n",
            "More individuals in the aripiprazole group ( @ % ) than in the haloperidol group ( @ % ; p < @ ) completed the study .\n",
            "Response rates were greater in the aripiprazole group ( @ % [ .\n",
            "N = @ ] ) than in the haloperidol group ( @ % [ .\n",
            "N = @ ] ; p < @ ) .\n",
            "Aripiprazole was associated with fewer extrapyramidal side effects .\n",
            "ESS subjects in the haloperidol group were more likely than those in the aripiprazole group to discontinue the study drug due to an adverse event other than worsening illness ( @ % and @ % , respectively ; p < @ ) , and efficacy differences were reduced by interventions to mitigate side effects ( decreasing antipsychotic dose with or without adding antiparkinsonian medication ) .\n",
            "Aripiprazole has a favorable efficacy/safety profile in ESS and appeared to be superior to haloperidol on a number of efficacy and safety outcomes .\n",
            "However , excessive dosing of the antipsychotic medications , in particular haloperidol , may have played an important role in accounting for the differences between aripiprazole and haloperidol in this study .\n",
            "@ Elsevier Ltd .\n",
            "Electrocardiographic ( ECG ) abnormalities are commonly found during treatment with thiothixene and thioridazine , the two drugs were given in schizophrenia with phenothiazine derivatives .\n",
            "Thioridazine ( Mellaril , Sandoz ) has been studied extensively for its electrocardiographic effects , and has been shown to cause evidence of altered repolarization , with prolonged QT intervals and T wave changes .\n",
            "Reports of sudden death apparently related to cardiac arrest have appeared .\n",
            "In a recent double-blind study performed by the authors , definite ECG changes were recognized in @ out of @ patients receiving thioridazine up to @ mg .\n",
            "daily , and two other patients have equivocal ECG changes .\n",
            "Thiothixene ( Navane , Roerig ) is a thioxanthene derivative with chemical and pharmacological similarities to the phenothiazine drugs .\n",
            "While certain nonspecific ECG changes have been reported during thiothixene administration , the incidence has apparently been lower than with the phenothiazines .\n",
            "In order to determine the relative incidence of these changes during treatment with thiothixene and thioridazine , the two drugs were given in double-blind fashion to @ hospalized schizophrenic patients and @ healthy volunteers , using progressively larger doses over a six - week period .\n",
            "ECGs were obtained prior to therapy , and during the second , third , fourth , and sixth week of the drug study .\n",
            "An additional tracing was recorded @ weeks after cessation of medication .\n",
            "A group of @ employeess , workng on the research unit , had their EKGs recorded at the same time intervals .\n",
            "These subjects were used as a control comparison grouP - ECGs were interpreted by the authors without knowledge of which drug the subject was receiving , and the results submitted for biostatistical analysis .\n",
            "Observations indicated a significant difference between the two drugs in regard to their effects upon the ECG .\n",
            "These results will be presented along with illustrative ECGs and clinical findings .\n",
            "OBJECTIVES : In schizophrenia , the ability to adaptively infer the thoughts and feelings of others ( i.e. , social cognition ) is strongly associated with community functioning .\n",
            "Researchers have designed psychosocial interventions to improve social cognition with the aim of improving downstream social functioning .\n",
            "Social Cognition and Interaction Training ( SCIT ) is one such intervention .\n",
            "Previous research on SCIT has been promising , but has consisted largely of smaller trials with insufficient experimental control .\n",
            "DESIGN : Randomized , controlled trial .\n",
            "METHODS : The current article reports on a controlled trial of @ adults with schizophrenia randomized to receive either SCIT ( n = @ ) , delivered in weekly group sessions , or treatment as usual ( n = @ ) for @ months .\n",
            "Participants completed assessments of social cognition , social functioning , neurocognition and symptoms at baseline , post-treatment , and @-month follow-up .\n",
            "RESULTS : Primary analyses suggest that SCIT may improve social functioning , negative symptoms , and possibly hostile attributional bias .\n",
            "Post-hoc analyses suggest a dose-response effect .\n",
            "CONCLUSIONS : Findings are discussed in the context of continuing to refine and improve social cognitive interventions for schizophrenia .\n",
            "PRACTITIONER POINTS : Social cognitive intervention is a feasible and promising approach to improving social functioning among individuals with schizophrenia-spectrum disorders .\n",
            "Dose-response findings suggest that delivering social cognitive interventions with greater frequency may maximize their benefit to patients .\n",
            "Research on social cognitive interventions is still young and effects from well-controlled trials have been inconsistent .\n",
            "It is not yet clear which components of social cognitive training may be the key active ingredients .\n",
            "A double-blind controlled study was conducted to determine the value of maintenance phenothiazine therapy in an outpatient clinic , schizophrenic population .\n",
            "Urine tests were found to be a useful way of checking drug ingestion .\n",
            "It was found that @ of @ patients on placebo relapsed , whereas only one of @ on active medication relapsed .\n",
            "The importance of maintenance medication is stressed ; involvement of the family physician is suggested .\n",
            "It is well known that atypical neuroleptics , such clozapine , show few similarities with traditional neuroleptics , such haloperidol : different receptors affinity , low extrapyramidal side effects and good efficacy in the treatment of both positive and negative symptoms of schizophrenia are points in agreement with their specifical pharmacodynamical mechanism [ @ ] .\n",
            "The aim of this study was to evaluate the acute electroencephalografic modifications induced by oral administration of clozapine and haloperidol in subjects affected by schizophrenia , according DSM-IV criteria .\n",
            "Eighteen schizophrenic patients , hospitalised during an acute exacerbation ( @ males , mean age : @ years , range : @ years ; @ females , mean age : @ years , range : @ years ) , were randomly divided into two groups of @ subjects each .\n",
            "The first group received @ mg/d of clozapine , and the second group @ mg/d of haloperidol .\n",
            "The acute pharmacodynamical effects of clozapine and haloperidol were investigated using a computerised quantitative electrophysiological approach ( computerised electroencephalography , CEEG ) : each subject underwent a CEEG recording during psychosensorial rest in a drug free condition and @/@ hr , @ hr , @ hrs , @ hrs and @ hrs after drug administration .\n",
            "Data concerning the relative power of delta ( @ Hz ) , theta ( @Hz ) , alpha ( @Hz ) and beta ( @Hz ) were statistically evaluated ( Friedman test , Wilcoxon test , Linear Regression and Correlation test ) .\n",
            "Both clozapine and haloperidol induced a small increase of beta activity ; on the other hand , data concerning slow activity were not univocal .\n",
            "With respect to alpha acitivity , a significant reduction was observed in the clozapine group ( p = @ ) and it was more evident between @ min and @ hr after the drug administration ( p = @ ) ; between @ and @ hrs after the drug administration , alpha activity increased again ( p = @ ) .\n",
            "At the same time delta activity showed an initial increase that was reduced after @ hrs .\n",
            "A significant correlation between alpha and delta modifications was observed ( p < @ ) .\n",
            "Such a pattern was not observed in the haloperidol group .\n",
            "In conclusion , CEEG was useful in monitoring the different acute pharmacodynamical effects of the two drugs .\n",
            "Reference - Stille G. , Hippius H. : Kritische Stellungnahme zum Begriff der Neuroleptika ( und von pharmakologischen und klinischen Befunden mit Clozapin ) .\n",
            "Pharmacopsychiatrie , @ : @ , @ .\n",
            "Compared the efficacy of the neuroleptic hydroxyprotepine decanoate ( HD ) with that of fluphenazine decanoate ( FD ) in @ patients , aged @-@ yrs .\n",
            "The apparent superiority of HD over FD , as assessed by the Brief Psychiatric Rating Scale , disappeared after correcting for the order of their administration ( the drug administered first produced a more marked therapeutic effect ) .\n",
            "Side effects due to both drugs were minor , although HD caused them in fewer Ss than FD .\n",
            "( English abstract ) ( @ ref )\n",
            "Background : Inasmuch as the cognitive and functional decline associated with onset of schizophrenia can be reduced or prevented , it seems timely to consider cognitive remediation in the early stages of the illness .\n",
            "The study was an investigation of the effects of cognitive remediation ( CR ) combined with a comprehensive psychosocial program ( OPUS ) for patients with first episode schizophrenia compared with the comprehensive psychosocial program alone .\n",
            "Methods : A total of @ outpatients ( aged @-@ ) with a first episode schizophrenia spectrum disorder were randomly assigned to CR combined with OPUS treatment or OPUS treatment alone .\n",
            "The CR program used a hybrid approach that incorporated both restorative and compensatory learning for @-@ hours a week for @ weeks .\n",
            "Statistical analysis of effect was based on the intentionto - treat principle .\n",
            "Results : At post-training @ patients were available for assessments : The CR group had improved significantly on self-esteem , general psychopathology symptoms , and verbal learning .\n",
            "At follow-up assessment , @ patients were available for assessments : The CR group retained the significant improvements on verbal learning .\n",
            "Significant improvements were also observed on working memory and positive symptoms , while improvement on the composite cognitive score was marginally significant .\n",
            "Overall , functional capacity did not improve , however , a subgroup analysis to circumvent ceiling effects on the functional capacity measure showed a trend in favor of the CR group .\n",
            "An additional analysis of the impact of CR attendance showed that ' high-attenders ' gained significant improvements on self-esteem , psychopathology , and cognition compared to ' low-attenders ' .\n",
            "Conclusion : The results correspond to meta-analytic evidence of durable improvements of cognitive remediation with small to medium effect sizes .\n",
            "Background : A large DOUBLE-blind trial compared risperidone ( RIS ) and olanzapine ( OLA ) at doses most frequently used in clinical practice .\n",
            "Methods : A total of @ adults at @ sites received flexible doses of RIS ( @-@ mg/day ) or OLA ( @-@ mg/day ) for eight weeks .\n",
            "Assessments included PANSS , ESRS .\n",
            "Statistical testing was two-tailed .\n",
            "Two sites were excluded due to data quality concerns , leaving @ patients for analysis .\n",
            "Data quality was verified by audit of every patient file .\n",
            "Results : Mean modal doses were @ mg/day RIS and @ mg/day OLA .\n",
            "Both drugs were associated with significant and similar symptom improvement ( total PANSS ) .\n",
            "Among patients completing eight weeks , there was significantly greater symptom improvement with RIS than OLA on PANSS scores for anxiety/depression ( p < @ ) and positive symptoms ( p < @ ) .\n",
            "A greater number of RIS patients had positive symptom improvement ( significant improvement level , p < @ ) .\n",
            "There were no significant differences in the improvement of extrapyramidal symptoms ( total ESRS scores ) .\n",
            "OLA patients had significantly greater increases in mean body weight and BMI .\n",
            "Conclusions : Patients treated with RIS or OLA had significant clinical improvement .\n",
            "Both drugs were generally well tolerated .\n",
            "This study suggests efficacy advantages for RIS for anxiety/depression and positive symptoms .\n",
            "With the exception of substantial weight gain among OLA patients , tolerability profiles were similar\n",
            "Background The physical health of people with serious mental illness [ SMI ] represents a significant public health challenge .\n",
            "It is estimated that they have a mortality rate two to three times greater than in the general population and the mortality gap is widening .\n",
            "Although suicide makes a significant contribution , cardiovascular disease [ CVD ] is the primary cause of death .\n",
            "A higher than expected prevalence of physical comorbidities in people with SMI has been identified in almost every system organ class [ SOC ] of the body with considerable overlap between them .\n",
            "This indicates multiple genetic , environmental , psychological , social , behavioural and system ( of care ) risk factors .\n",
            "A lower than expected incidence of comorbidities in the health records of people with SMI in primary and secondary care in the United Kingdom [ UK ] points to considerable under-diagnosis and treatment and presents an opportunity for intervention .\n",
            "There remains a paucity of evidence to support interventions that can be successfully implemented to make a difference to physical health outcomes in this vulnerable population .\n",
            "The SMI Health Improvement Profile [ HIP ] was developed by the author and two colleagues as a complex but pragmatic intervention to target physical wellbeing in SMI through the existing role of the mental health nurse in secondary care .\n",
            "The HIP Programme ( the HIP and HIP training ) is intended to support the mental health nurse working with people with SMI to undertake a structured health check and negotiate and implement an individualised physical health care plan as a result .\n",
            "Aim The aim of this research is to enable mental health nurses in secondary care to address the physical health needs of people with SMI by implementing a nurse-led structured physical health check and care planning process .\n",
            "Methods This project used a programme of research to evaluate the impact of the HIP Programme on care processes and patient outcomes that included : @ .\n",
            "A systematic review of the efficacy of educational interventions for healthcare professionals .\n",
            "@ .\n",
            "Description of the development of the HIP Programme and a pilot study to test the clinical utility and effectiveness of the HIP Programme in @ patients in a nurse-led outpatient clinic .\n",
            "@ .\n",
            "A clinical audit of the use of the HIP in @ patients .\n",
            "@ .\n",
            "A cluster RCT of the HIP Programme across four National Health Service [ NHS ] sites .\n",
            "@ .\n",
            "A process observation in a subsample of patient and nurse participants from the cluster randomised controlled trial .\n",
            "@ .\n",
            "Evaluation of evidence of impact from national and international dissemination of the HIP and the HIP Programme .\n",
            "Results @ .\n",
            "The systematic review identified that there was no evidence examining how to train healthcare professionals to deliver a structured health check for people with serious mental illness [ SMI ] .\n",
            "@ .\n",
            "The pilot study identified that the HIP was acceptable to people with SMI and healthcare professionals and that two mental health nurses could successfully implement the HIP following brief training .\n",
            "@ .\n",
            "The audit showed that it was possible to identify comorbidities in people with SMI using the structured health check in secondary care and that change in health behaviours and outcomes was possible .\n",
            "@ .\n",
            "The cluster RCT in community mental health teams across four NHS sites demonstrated no difference in health outcomes between HIP Programme and Treatment As Usual [ TAU ] patients at @ months .\n",
            "Despite acceptable levels of patient attrition in the trial , rates of implementation of the HIP by nurse participants was very low .\n",
            "@ .\n",
            "The process evaluation highlighted the complexity of the processes we were trying to change .\n",
            "Barriers included service redesign and resource issues coupled with the time taken to complete the HIP and care plan .\n",
            "Nurse participants reported that they did not work with the same patients with SMI for long enough to follow through a ( @ month ) plan of physical health checks and intervention .\n",
            "There was a perception of structured physical health checks and care as a ( new ) extension to an already pressured role where ment l health risk assessment and management takes priority over physical health risk .\n",
            "@ .\n",
            "The HIP is being used widely in practice but this is largely in inpatient services .\n",
            "Where it has been repeated at @ months , improvements in some metabolic parameters have been seen .\n",
            "Discussion The need for better care for the physical health of people with SMIs is evident .\n",
            "This program of research developed a package of training and tool to support a structured health check and care planning process for people with SMI in secondary care .\n",
            "The cluster RCT did not demonstrate benefit on patient ( quality of life ) outcomes .\n",
            "Substantial structural barriers prevented the patients from receiving the intervention from the mental health nurses involved in the trial , despite the positive attitude of the nurse participants towards the importance of a physical health care role .\n",
            "Despite this disappointing finding the intervention is being used in practice across the United Kingdom [ UK ] and internationally with demonstrated benefits , including the achievement of commissioning targets for health screening and signs of improvement in some outcomes where it has been used in the same person over time .\n",
            "This programme of research demonstrates the challenge of conducting useful RCTs in rapidly changing service environments in the NHS .\n",
            "Future research should develop the intervention beyond the nurse and patient dyad to target the system barriers and levers to implementation .\n",
            "Major problems with existing RCTs evaluating psychosocial interventions for psychosis and substance misuse have been identified , in particular small sample sizes , high attrition rates , and short follow up periods .\n",
            "With a sample size of @ and a follow up of @ years , the MIDAS trial in the UK is to date the largest RCT for people with psychosis and substance use and is evaluating an integrated MI and CBT ( \" MiCBT \" ) client therapy .\n",
            "Whilst the outcomes of the study are not yet available , data on recruitment and retention indicate that attrition rates in MIDAS are low and the majority of those allocated to treatment received a substantial number of therapy sessions .\n",
            "Sample characteristics are in line with those reported in epidemiological studies and are indicative of the challenges facing mental health services attempting to manage the client group : substance use is often longstanding , with frequent use at moderate or severe level and low motivation for change , and seen in the context of low levels of functioning and significant psychopathology .\n",
            "We conclude that this is a methodologically robust study that will have results generalisable to mental health services .\n",
            "/ d \n",
            "Objective : To compare the efficacy and safety of clonazepam , haloperidol and haloperidol combined with clonazepam in the treatment of the acute phase schizophrenia .\n",
            "Methods : @ cases were treated with clonazepam with the dose of ( @  @ ) c / d , @ cases were treated with haloperidol at the dose of ( @  @ ) c / d , @ cases were treated with clonazepam ( @  @ ) c / d and haloperidol ( @  @ ) c / d. Brief Psychiatric Rating Scale ( BPRS ) and Clinical Global Imp ression ( CGI ) were used to measure the efficacy and safety for @ hours .\n",
            "Results : The efficacy of three group s in treating the acute phase schizophrenia was similar .\n",
            "Acute agitation in schizophrenia was significantly alleviated in each group ( P @ .\n",
            "@ ) .\n",
            "Conclusion s : Clonazepam was as efficacious as haloperidol and clonazepam combined with haloperidol in controlling excitement and agitation in schizophrenia patients .\n",
            "Background : Novel antipsychotic medications have been reported to enhance cognition in patients with schizophrenia , in contrast to the negligible effects of conventional medications .\n",
            "In this study , the relative cognitive enhancing effects of risperidone and olanzapine , the two most commonly used of the newer medications , were compared .\n",
            "Methods : Three hundred seventy-seven outpatients with schizophrenia or schizoaffective disorder were RANDOMized to eight weeks of DOUBLE-blind treatment with @-@ mg/day of risperidone or @-@ mg/day of olanzapine .\n",
            "The patients were rated with assessments of clinical symptoms and side effects ( reported separately ) and with a cognitive functioning battery examining secondary and working memory , vigilance , visuomotor speed , executive functioning , and verbal fluency .\n",
            "Results : Statistically significant improvements from baseline functioning for patients treated with risperidone ( n > @ , n 's vary by the test ) were detected at eight weeks for total learning over five trials on the California Verbal Learning Test ( CVLT ) , Wisconsin Card Sorting Test ( WCST ) categories completed , and WCST total errors .\n",
            "Olanzapine ( n > @ , n 's vary by the test ) improved performance on Trail Making Test part B , CVLT total learning , and the CPT .\n",
            "There were no statistically significant differences between the two medications in the extent of cognitive enhancement on any of the measures .\n",
            "Implications : Risperidone treatment enhances cognitive functions that are known to be correlated with functional outcome in schizophrenia .\n",
            "In contrast to a small number of reports based on small sample sizes with different dosing schedules , there was no evidence of superiority of olanzapine to risperidone in enhancing any aspect of cognitive functioning .\n",
            "These findings replicate several previously published studies of cognitive change with risperidone treatment , using a larger sample size , more representative samples of patients with schizophrenia , and DOUBLE-blind methodology .\n",
            "Given these findings , differential cognitive benefits may play a lesser role than other efficacy and safety factors when choosing among atypical antipsychotics\n",
            "OBJECTIVE : The objective of the study was to compare metabolic effects of ziprasidone versus olanzapine treatment in patients with first-episode schizophrenia .\n",
            "METHODS : In this @-week , multicenter , open-label trial , @ patients were randomly assigned to receive ziprasidone or olanzapine treatment ( @ per group ) .\n",
            "Primary metabolic measures were changes in weight and body mass index ( BMI ) .\n",
            "Secondary metabolic measures were changes in glucose , insulin , lipids , and blood pressure .\n",
            "Efficacy and safety were also measured additionally .\n",
            "RESULTS : A total number of @ patients completed the study .\n",
            "The mean daily dosages were @ ( @ ) mg for ziprasidone and @ ( @ ) mg for olanzapine .\n",
            "After @-week treatment , there were significant between-group differences in change scores on weight [ @ ( @ ) kg versus -@ ( @ ) kg , p < @ ] and BMI [ @ ( @ ) versus -@ ( @ ) , p < @ ] .\n",
            "In addition , there were significant between-group differences in change scores on fasting plasma glucose , insulin , homeostasis model assessment @-insulin resistance , low-density lipoprotein , total cholesterol , and triglycerides ( p < @ ) ; all the changes were clinically in favor of ziprasidone treatment .\n",
            "Both medications were effective in improving schizophrenia symptoms , but the decreases in Positive and Negative Syndrome Scale total scores of the olanzapine group were significantly greater than that of the ziprasidone group ( p < @ ) .\n",
            "Compared with olanzapine , ziprasidone also induced more prolonging of corrected QT interval and extrapyramidal side effects ( p < @ ) .\n",
            "Both medications were well tolerated , and no serious adverse events were observed in either group .\n",
            "CONCLUSIONS : Compared with olanzapine , ziprasidone treatment was associated with less adverse effects on glucose and lipid metabolism in patients with first-episode schizophrenia .\n",
            "AMPA-receptor-positive modulators ( Ampakines ) facilitate learning and memory in animal models and in preliminary trials in human subjects .\n",
            "CX@ is the first Ampakine to be studied for cognitive enhancement in schizophrenia .\n",
            "Stable schizophrenia patients treated with clozapine ( n = @ ) , olanzapine ( n = @ ) , or risperidone ( n = @ ) were randomly assigned to add-on treatment with CX@ @ mg three times daily or placebo for @ weeks .\n",
            "Subjects were assessed with a cognitive battery at baseline , week @ , and at @-week follow-up .\n",
            "Clinical scales and safety monitoring were also performed .\n",
            "The primary endpoint was the change from baseline in a composite cognitive score at week @ for the intent-to-treat sample .\n",
            "Additional analyses examined change in symptom rating scores and examined drug effects on patients treated with clozapine separately from patients treated with either olanzapine or risperidone .\n",
            "A total of @ patients were randomized and @ ( @ % ) completed the @-week trial .\n",
            "Patients treated with CX@ did not differ from placebo in change from baseline on the composite cognitive score , or on any cognitive test at weeks @ or @ .\n",
            "The between groups effect size at week @ for the cognitive composite score was -@ for clozapine-treated patients and @ for patients treated with olanzapine or risperidone .\n",
            "The placebo group improved more on the PANSS total score than the CX@ group ; no other clinical rating differed between treatment groups .\n",
            "CX@ was associated with fatigue , insomnia and epigastric discomfort compared to placebo , but was generally well tolerated .\n",
            "CX@ was not effective for cognition or for symptoms of schizophrenia when added to clozapine , olanzapine , or risperidone .\n",
            "RN @ ( @ - ( quinoxalin-@-ylcarbonyl ) piperidine ) .\n",
            "@ ( Antipsychotic Agents ) .\n",
            "@ ( Benzodiazepines ) .\n",
            "@ ( Dioxoles ) .\n",
            "@ ( Piperidines ) .\n",
            "@-@-@ ( Risperidone ) .\n",
            "@-@-@ ( olanzapine ) .\n",
            "@-@-@ ( Clozapine ) .\n",
            "OBJECTIVE : This study explored the effectiveness of a psychoeducational family intervention for schizophrenia on patients ' personal and social functioning as well as on relatives ' burden and perceived support .\n",
            "METHODS : Thirty-four mental health professionals from @ public mental health centers in Italy selected @ families of consumers with schizophrenia .\n",
            "Forty-two families were randomly assigned to a group that received the intervention for six months , and @ families were assigned to a waiting list for six months .\n",
            "At baseline and six months later , validated tools were used to assess patients ' clinical status , personal and social functioning , and social network as well as relatives ' burden , social resources , and perception of professional support .\n",
            "RESULTS : In the intervention group the number of patients with poor or very poor global personal and social functioning decreased significantly , from @ ( @ percent ) at baseline to nine ( @ percent ) at follow-up .\n",
            "A significant improvement was found for the intervention group in patients ' social relationships , interests in obtaining a job , maintenance of social interests , and management of social conflicts .\n",
            "Twenty-seven patients ( @ percent ) reported that their social relationships had improved during the six-month period .\n",
            "For both the intervention and control groups , family burden significantly improved .\n",
            "Relatives ' social contacts and perception of professional support significantly increased only in the intervention group .\n",
            "CONCLUSIONS : The results suggest that a psychoeducational family intervention may have a significant impact on functional outcomes of schizophrenia when provided to patients and caregivers in real-world settings .\n",
            "OBJECTIVE : Psychosocial treatment seems to be effective in the management of schizophrenia , although less in the area of quality of life and social functioning .\n",
            "To study the effectiveness of a hallucination focused integrated treatment with cognitive-behaviour therapy and coping training among schizophrenia patients suffering from ' hearing voices ' .\n",
            "METHOD : In a randomized controlled trial ( RCT ) with @ patients in the integrated treatment condition and @ patients in the routine care condition , quality of life was assessed with the self-report questionnaire of the WHO ( Bref ) , and social role functioning with an interviewer based schedule , at entry and @ ( post-treatment ) and @ months later .\n",
            "RESULTS : Follow-up data suggest a significant improvement of quality of life and in particular in social role functioning ( effect size @ ) in favour of the integrated treatment .\n",
            "CONCLUSION : The integrated treatment seems to be effective in reducing overall disability levels and number of patients with serious disabilities\n",
            "Poor cognitive outcomes among people with schizophrenia are associated with poor function in daily life .\n",
            "Cognitive interventions aimed at improving function lead to better cognitive outcomes , but the question of generalization to real-world functioning remains relevant .\n",
            "The ability to generalize or to apply learned skills in the clinic to everyday functioning must include metacognitive components which are the underlying mechanisms of function .\n",
            "To address such generalization , we developed a metacognitive group intervention based on Toglia 's ( @ ) dynamic interactional model , which aims to promote daily activities and participation by focusing on metacognitive components .\n",
            "We assessed @ participants with schizophrenia ( @ in the control group and @ in the intervention group ) before and after completing the intervention and at a @-week follow-up .\n",
            "Assessments addressed executive function , performance , and participation .\n",
            "The intervention group 's performance , participation , and everyday functions significantly increased post-intervention and at follow-up , compared with the control group .\n",
            "Results provide important information about the potential for change in real-world functioning and a basis for the rationale of employing metacognitive interventions in this population .\n",
            "Objective : To investigate the Kai-dimensional ( fumarate quetiapine ) in the treatment of the negative symptoms of schizophrenia clinical efficacy and safety .\n",
            "METHODS : A case-control study was conducted to select @ cases of patients with predominantly negative symptoms of schizophrenia were randomly divided into experimental group ( @ cases ) and control group ( n = @ ) , respectively , with Kai-dimensional treatment with clozapine treatment period @ weeks , SANS , TESS , efficacy assessment scale to assess the clinical .\n",
            "The results : two groups of @ weekend efficacy similar ( P > @ ) , the experimental group was efficiency ( @ % ) , @ % efficiency ; control group was @ % , @ % efficiency .\n",
            "Conclusion : Kai-dimensional treatment of the negative symptoms of schizophrenia efficacy of some degree of certainty , similar to clozapine efficacy , there is a significant difference .\n",
            "What is the effectiveness of low doses of haloperidol and regular doses of amisulpride , olanzapine , quetiapine , and ziprasidone on ( loss of ) one year retention in patients with recent onset of schizophrenia , schizoaffective , and schizophreniform disorder ?\n",
            "Design/methodology : Randomised controlled trial Participants - inclusion criteria : @ .\n",
            "Diagnosis of schizophrenia , schizophreniform or schizoaffective disorder Participants - exclusion criteria : @ .\n",
            "A time interval between the onset of positive symptoms ( hallucinations and/or delusions ) and study entry exceeding two years Anticipated start date : @/@/@ Anticipated end date : @/@/@ Status of trial : Completed Interventions : Drug : Amisulpride @-@ mg/day\n",
            "Affective symptoms are common in patients with schizophrenia and are associated with significant morbidity , mortality , and impaired functioning .\n",
            "Therapies effective in reducing affective symptoms without worsening negative or cognitive symptoms or inducing extrapyramidal symptoms ( EPS ) would represent an important advance .\n",
            "' Seroquel ' ( quetiapine fumarate ) , a recently approved antipsychotic , is effective in treating positive and negative symptoms of psychotic disorders , including schizophrenia .\n",
            "Quetiapine is well tolerated and does not produce treatment-emergent or dose-related EPS and does not elevate plasma prolactin levels .\n",
            "We present results from two , six-week , placebo-controlled , double-blind , randomized , parallel-group , efficacy and safety trials in hospitalized patients with acute exacerbation of schizophrenia .\n",
            "Trial @ ( n = @ ) evaluated five fixed doses of quetiapine ( @ , @ , @ , @ , @ mg/day ) and a single haloperidol dose ( @ mg/day ) ; Trial @ ( n = @ ) was dose-titrated .\n",
            "Efficacy was assessed using the @-item Brief Psychiatric Rating Scale ( BPRS ) and the Clinical Global Impression ( CGI ) .\n",
            "Affective symptoms were assessed using the BPRS factor I score ( mean of depressive mood , guilt feelings , somatic concern , anxiety ) and a BPRS mood cluster score ( mean of depressive mood , guilt feelings , anxiety , tension ) .\n",
            "In both trials , quetiapine was superior to placebo in improving affective symptoms , as assessed by the BPRS factor I and mood cluster scores , while haloperidol ( Trial @ ) was not ( p < @ ) .\n",
            "Affective symptoms were improved on both measures in a statistically significantly greater proportion of patients treated with quetiapine than with placebo ( Trials @ and @ ) or haloperidol ( Trial @ ) .\n",
            "These results provide evidence that quetiapine is effective in the treatment of affective symptoms associated with schizophrenia and may have a better therapeutic effect in this important area of psychopathology than standard agents .\n",
            "A favorable safety and tolerability profile across the dose range , combined with data supporting efficacy in the treatment of positive , negative , and affective symptoms of schizophrenia , suggest that quetiapine may represent an important advance in the treatment of psychotic disorders .\n",
            "Seroquel is a trademark , the property of Zeneca Limited .\n",
            "NEW RESEARCH ER :\n",
            "A decision-tree simulation model is used to examine the costs associated with olanzapine versus haloperidol in the treatment of patients with schizophrenia in the UK .\n",
            "Parameter values and outcome scores were derived mainly from an international clinical trial .\n",
            "Resource consequences were examined on the basis of assumed service delivery and actual unit costs specific to the UK .\n",
            "While olanzapine is more expensive to prescribe than haloperidol , it generates savings by reducing utilisation of medical services .\n",
            "As a result , a comparison of the @ drugs is approximately cost neutral .\n",
            "Model uncertainties are examined using extensive sensitivity analysis ; in most scenarios , cost-neutral results are maintained .\n",
            "Olanzapine is more effective than haloperidol as measured by Brief Psychiatric Rating Scale scores and non-relapse rates .\n",
            "With such gains in effectiveness and near equivalence in terms of costs , olanzapine , in comparison with haloperidol , may represent a cost-effective treatment option .\n",
            "RN @ ( Benzodiazepines ) .\n",
            "@-@-@ ( olanzapine ) .\n",
            "@-@-@ ( Haloperidol ) .\n",
            "Investigated the effectiveness of an @-yr-old intensive community-based residential treatment ( IRT ) program as a viable alternative to state hospitalization for the chronic mentally ill .\n",
            "@ patients treated in the IRT were compared with @ patients treated in the state hospital , using @ measures - length of stay during the index admission , number of days spent in a state hospital during the @ mo after the index discharge , and cost per treatment episode .\n",
            "Compared with the inpatient state hospital treatment , the IRT program was able to achieve comparable results in a shorter period of time , with greater cost efficiency and less rehospitalization of Ss after discharge from the index treatment .\n",
            "Objectives : To evaluate the efficacy and safety of aripiprazole in patients hospitalized due to an acute relapse of SCHIZophrenia or SCHIZoaffective disorder.Methods : This multicenter , DOUBLE-blind , placebo-controlled study involved @ inpatients with acute exacerbation of SCHIZophrenia or SCHIZoaffective disorder ( DSM-IV ) .\n",
            "All patients had a history of response to antiPSYCHOTIC therapy .\n",
            "Following a @ _ @ day washout period , patients were RANDOMly assigned to receive placebo ( N = @ ) , aripiprazole @ mg/day ( N = @ ) , aripiprazole @ mg/day ( N = @ ) , or risperidone @ mg bid ( N = @ ) for @ weeks .\n",
            "Baseline PANSS scores ranged from @ to @ in the four treatment arms.Results : Positive and negative symptoms were significantly reduced in all active treatment groups compared with placebo ( p < @ ) ; earlier improvement in negative symptoms was seen with aripiprazole ( week @ ) .\n",
            "Aripiprazole and risperidone were also well tolerated .\n",
            "Neither drug produced significant extrapyramidal symptoms .\n",
            "Mean plasma prolactin levels showed no change with aripiprazole but increased @-fold over placebo in the risperidone group .\n",
            "The incidence of QTc prolongation ( > @ % over baseline ) was similar to placebo in the aripiprazole group , and approximately @-fold greater than placebo in the risperidone group .\n",
            "Conclusions : Aripiprazole provides effective treatment for acute relapse of SCHIZophrenia and may have tolerability advantages over available antiPSYCHOTICs .\n",
            "CN : NR@ Tuesday , May @ , @:@ p.m.-@ : @ p.m. PT : CSG CODE conference USA\n",
            "The negative symptoms of schizophrenia still cause of the major problems in therapeutic work with schizophrenics .\n",
            "Although there has been great progress in the filed of pharmacology for identifying effective drugs to alleviate the negative symptoms , we are still far away from having satisfactory and successful results .\n",
            "The purpose of the present project was to study the effects of dopamine agonists such as Bromocriptine on the negative symptoms of schizophrenia .\n",
            "A double-blind , cross-over controlled design was applied for this purpose .\n",
            "The participants were chosen on the basis of their diagnosis to prevent the effects of confounding factors .\n",
            "Caution was made to choose those patients who showed severe negative symptoms , but who did not have any of the following : depression , active psychosis , substance abuse , physical diseases drug side-effects , and did not use drugs or have disorders which contraindicated the use of Bromocriptine .\n",
            "Out of @ patients under treatment for schizophrenia , @ met the above mentioned criteria , two of which refused to participate , ( n = @ ) .\n",
            "The @ participants were randomly assigned to the experimental and the control groups , and were observed for @ weeks .\n",
            "For @ weeks the patients in the experimental group received @ mg of Bromocriptine and those in the control group received placebo .\n",
            "For one week , both groups received placebo ( washing period ) , and for the final @ weeks the two groups were crossed over , the former experimental group receiving placebo , and the former control group receiving @ mg of Bromocriptine .\n",
            "For measuring the effects of the drug on the positive and negative symptoms , the PANSS wgicg is a standardized instrument for this purpose was applied .\n",
            "The data was analyzed by Wilcoxon , using the SPSS computer program , in two different ways .\n",
            "The results of the analysis showed that adding a dopamine agonist such as Bromocriptine to the drug regimen , can have significant effects on the negative symptoms of the patients with schizophrenia .\n",
            "Bromocriptine can not only reduce the negative symptoms of schizophrenia , but also prevent the risk of psychosis .\n",
            "BACKGROUND : There is interest in the possibility of indicated prevention of psychosis .\n",
            "There is a strong case for using psychological approaches to prevent transition to psychosis in high-risk patients .\n",
            "AIMS : To identify individuals at high risk of transition to psychosis , and psychological characteristics relevant to the development of psychosis in this group .\n",
            "METHOD : The design of a randomised controlled trial of cognitive therapy for the prevention of psychosis in people at high risk ( meeting operational criteria of brief or attenuated psychotic symptoms , or first-degree family history with functional decline ) is outlined .\n",
            "The first patients recruited are compared with non-patient samples on cognitive and personality factors ; an interim analysis of transition rate is reported .\n",
            "RESULTS : Cases ( n = @ ) were recruited mainly from primary care .\n",
            "Of the @ high-risk patients monitored for @-@ months , @ ( @ % ) made the transition to psychosis .\n",
            "The high-risk group scored significantly higher than non-patients on measures of schizotypy , metacognitive beliefs and dysfunctional self-schemas ( sociotropy ) .\n",
            "CONCLUSIONS : The findings validate the methods of identifying individuals at high risk of experiencing a psychotic episode .\n",
            "Compared with non-patient controls , the cases showed dysfunctional metacognitive beliefs and self-schemas\n",
            "Objective - The primary intent of this study was to compare the efficacy and safety of olanzapine versus clozapine in schizophrenic patients having failed to adequately respond to standard acceptable antipsychotic medication , or because of intolerable side effects caused by the medication .\n",
            "Method : This was a RANDOMized , DOUBLE-blind , parallel study of @ patients meeting diagnosis criteria for schizophrenia according to the DSM-IV , and who were non-responsive or intolerant of standard acceptable antipsychotic therapy .\n",
            "The DOUBLE-blind study period was @ weeks in duration .\n",
            "Results : At the @ week endpoint ( LOCF ) , no statistically significant differences between olanzapine and clozapine were found with any efficacy measure used : BPRS total , positive , negative , or PANSS total , positive , negative , and general psychopathology .\n",
            "Regarding EPS , no statistically significant differences in parkinsonism , akathisia , and dyskinesia were noted .\n",
            "Conclusion : Olanzapine demonstrated similar efficacy and safety to clozapine among treatment resistant schizophrenic patients\n",
            "OBJECTIVE : Only a few studies in patients with first-episode psychosis have included gender in the study hypothesis or considered this a primary study variable .\n",
            "The aim of this study was to explore the influence of gender in the pattern of substance use in patients with first-episode psychosis .\n",
            "METHODS : This is a sub-analysis of a randomized open clinical trial that compared @-year treatment retention rates of patients with first-episode psychosis randomized to haloperidol , olanzapine , quetiapine , risperidone , or ziprasidone .\n",
            "Our sub-analysis included @ men and @ women .\n",
            "RESULTS : Substance use was relatively high among these patients and differed significantly by gender .\n",
            "Men were more likely to use substances overall than women ( @ % for men vs. @ % for women ) , chi ( @ ) = @ , df = @ , p < .@ , and were also more likely to use alcohol ( chi ( @ ) = @ , df = @ , p < .@ ) , cannabis ( chi ( @ ) = @ ; df = @ , p < .@ ) , and cocaine ( chi ( @ ) = @ ; df = @ , p < .@ ) , compared to women .\n",
            "While there were no gender differences in age at first consumption of alcohol or cocaine , men were significantly younger at first consumption of cannabis ( M = @ years , SD = @ ) than women ( M = @ years , SD = @ ) , F ( @ , @ ) = @ , p < .@ .\n",
            "When analyzed separately by gender , women showed no significant differences in the influence of number of substances used on age at onset of psychosis , F ( @ , @ ) = @ , p = .@ .\n",
            "However , there was a significant difference among men , with earlier onset of psychosis noted in men consuming multiple substances ; F ( @ , @ ) = @ , p < .@ .\n",
            "Regarding prediction of age at onset of psychosis , both male gender and the use of a higher number of substances significantly predicted an earlier age at onset of psychosis .\n",
            "CONCLUSIONS : Our study provides some evidence of gender differences in the pattern of substance use in patients with first-episode psychosis , suggesting the possible need for gender-specific approaches in the interventions performed in these patients .\n",
            "This study is registered as # @ with the Australian New Zealand Clinical Trials Registry ( www.anzctr.org.au ) .\n",
            "The negative symptoms of schizophrenia remain a major clinical challenge .\n",
            "Reboxetine is an antidepressant whose major mechanism of action is as a noradrenergic reuptake inhibitor .\n",
            "This study was a @-week randomized placebo-controlled trial of reboxetine or placebo add on to haloperidol @ mg in the treatment of @ patients with DSM-IV schizophrenia .\n",
            "The trial failed to demonstrate any significant difference between the placebo and reboxetine groups on any of the outcome measures .\n",
            "This trial does not suggest that increased noradrenergic drive mediated by reuptake inhibition in patients taking dopamine antagonists is of therapeutic value in schizophrenia .\n",
            "Objective : Long-term efficacy and tolerability have not been well studied for second-generation ( atypical ) antipsychotics in comparison to conventional agents in schizophrenia .\n",
            "We compare the effectiveness of @ dose regimens of ziprasidone ( BID @-@ mg/d ; N = @ or QD @-@ mg/d ; N = @ ) with haloperidol ( @-@ mg/d ; N = @ ) in the long-term treatment of schizophrenia .\n",
            "Methods : A sample of @ patients who had completed a @-week , double-blind core phase , and had a GAF score > @ ( entry criteria for both core and extension studies ) was enrolled in this double-blind , @-year ( @ weeks ) continuation study .\n",
            "We performed post-hoc analyses to compare the two dose regimens of ziprasidone ( BID and QD ) with haloperidol using the recently proposed consensus-based operational criteria for symptomatic remission in schizophrenia@ .\n",
            "The main outcome measure is the remission rate in the @ months preceding the last visit ( Week @ or early termination ) .\n",
            "The cross-sectional remission rate ( excluding the time component ) and measures of Heinrichs-Carpenter Quality-of-Life Scale ( QLS ) over time ( at core baseline , weeks @ , @ , @ , @ - end of core phase , @ , @ , @ , @ , @ , @ ) were analyzed using Generalized Estimating Equations ( GEEs ) .\n",
            "A mediator analysis was performed to test whether differential effects of ziprasidone vs. haloperidol on remission rates accounted for differential trends in QLS scores between treatment groups over time .\n",
            "Results : Demographic and clinical characteristics of the patients were comparable among the @ treatment groups at core baseline ( week @ ) .\n",
            "Ziprasidone treatment was associated with a greater proportion of patients meeting full remission criteria ( p < @ ) in the @ months preceding the last endpoint visit ( Week @ or early termination ) .\n",
            "Longitudinal assessment of cross-sectional remission and quality of life in the continuation phase demonstrated superior improvement ( slope of trends ) in the ziprasidone BID ( all p < @ ) and QD ( all p < @ ) groups when compared with the haloperidol group .\n",
            "The significantly greater increase in remission rates with ziprasidone BID ( Week @ through Week @ ) and QD ( Week @ and Week @ ) treatment compared to haloperidol was accompanied by corresponding improvement in quality of life total and subscale scores .\n",
            "These temporal trends were concurrent and showed significant correlation in the mediator analysis ( p < @ ) .\n",
            "Conclusions : This study is the first long-term ( @-week core and @-year extension ) , double-blind trial to evaluate the comparative effectiveness of an atypical antipsychotics versus a conventional drug in treatment of schizophrenia .\n",
            "Ziprasidone was superior to haloperidol in achieving symptomatic remission and favorable QLS outcomes during continuation therapy .\n",
            "The temporal trends in prevalence of remission were correlated with improvement in QLS outcomes .\n",
            "Our findings enhance the existing knowledge on new schizophrenia remission criteria and its association with patients ' quality of life outcomes .\n",
            "@ .\n",
            "Andreasen NC , Carpenter WT , Kane JM , Lasser RA , Marder SR , Weinberger DR , @ , Remission in Schizophrenia : Proposed criteria and rationale for consensus , Am J Psychiatry , @ , @-@ .\n",
            "Background : Antipsychotic-induced weight gain is one of the most distressing adverse effects being observed in recent times .\n",
            "Most studies have been limited by several confounders .\n",
            "Aim : To evaluate the predictors of antipsychotic-induced weight gain in drug-naive patients with first-episode psychosis treated with olanzapine , risperidone , or haloperidol and compare them with a healthy matched control group .\n",
            "Methods : Newly diagnosed patients with first-episode schizophrenia treated with antipsychotic medication -- olanzapine , risperidone , or haloperidol -- and matched healthy controls were followed for @ weeks .\n",
            "Body mass index ( BMI ) , waist circumference , and weight changes and proportions of subjects with more than @ % weight gain were calculated .\n",
            "The predictors of weight gain were explored .\n",
            "Results : Ninety-nine patients with first-episode schizophrenia and @ healthy controls were examined .\n",
            "Waist circumference ( r = -@ ; P < @ ) and weight ( r = -@ ; P < @ ) at baseline in addition to the disease process ( P < @ ) as well as antipsychotic use ( P < @ ) were associated with greater increases in weight and BMI .\n",
            "Olanzapine ( @ % ) had greater clinically significant weight gain as compared with risperidone ( @ % ) and haloperidol ( @ % ) .\n",
            "Lower BMI at baseline and a diagnosis of undifferentiated schizophrenia were associated with antipsychotic-induced weight gain .\n",
            "Conclusions : The results confirm clinically significant and substantial weight gain induced by antipsychotic treatment in drug-naive patients with first-episode schizophrenia and identify several risk factors for weight gain such as lower BMI scores , use of olanzapine , and a diagnosis of undifferentiated schizophrenia .\n",
            "\" Register : ChiCTR Last refreshed on : @ January @ Main ID : ChiCTR-TRC-@ Date of registration : @-@-@ Primary sponsor : Beijing anding hospital Public title : A study of the cognitive behavior therapy for first-episode schizophrenia Scientific title : A study of the cognitive behavior therapy for first-episode schizophrenia Date of first enrolment : @-@-@ Target sample size : Cognitive and behavioral therapy group : @ ; routine group : @ ; Recruitment status : Recruiting URL : http://www.chictr.org/en/proj/show.aspx?proj=@ Study type : Interventional Study design : Randomized parallel control Countries of recruitment China Contacts Name : Zhaoyan Fu Address : Beijing anding hospital , No. @ Ankang Hutong , Deshengmen Wai , Xicheng District , Beijing Telephone : +@ @ @ Email : fuzhaoyan@@.com Affiliation : Name : Zhanjiang Li Address : NO. @ , Ankang hutong , Dewai main street , Xicheng District , Beijing Telephone : +@ @ @ Email : lizhanjiang@@sina.com Affiliation : Key inclusion & exclusion criteria Inclusion criteria : Inclusion criteria : Patients with a diagnosis of schizophrenia based on DSM-IV ; Age between @ and @ years ; The first time attack , or the length of illness less than @ years and continuous treatment less than @ month or intermittent treatment less than @ months ; Using a single atypical antipsychotic drug treatment at present ; The total score of delusion ( p@ ) or illusion ( p@ ) = four points according to Positive And Negative Syndrome Scale ( PANSS ) ; The informed consent of patients and their families .\n",
            "Exclusion criteria : Exclusion criteria : With other mental diseases ; Patients have attack or impulsive behavior , and need be constrained ; Modified electroconvulsive therapy ; Accepting other system psychological therapy or physical therapy ; Combine with serious or unstable physical diseases .\n",
            "Age minimum : @ Age maximum : @ Gender : Both Health Condition ( s ) or Problem ( s ) studied schizophrenia Intervention ( s ) Cognitive and behavioral therapy group : antipsychotics combined with CBT ; routine group : routine antipsychotics ; Primary Outcome ( s ) The positive and negative symptoms of schizophrenia Scale ; The Psychotic Symptom Rating Scales ( PSYRATS ; The Clinical Global Impressions ( CGI ) scale ; Schedule of Assessing Insight ; Rosenberg Self-Esteem Scale ; Secondary Outcome ( s ) Secondary ID ( s ) Source ( s ) of Monetary Support Beijing Municipal Science & Technology Commission \"\n",
            "To enhance the ability to control the impulsive action in female patients with psychosis ( @ patients who had hospitalized in Feb. to Oct. @ and accorded with the CCMD-@-R diagnostic standard were divided randomly into both tested and control groups .\n",
            "The traditional managing method was used to the control group , and training with activities for control of patient 's impulsive action was used to the tested group and the specially assigned nurse was put in charge of the work .\n",
            "Both groups were assessed with nurses observation scale for inpatients evaluation ( NOSIE ) and compared after @ weeks .\n",
            "The results showed that in tested group the score of social interest factor in all @ factors increased markedly ( P < @ ) and the score of arousing factor decreased markedly ( P < @ ) .\n",
            "It suggests that taking part in planned activities has an effect upon stabilizing the emotion , decreasing the arousing expression , and increasing the ability to control the impulsive action in these patients . )\n",
            "[ Objective ] To observe the efficacy and safety of homemade the Compound GEGEN oral solution .\n",
            "[ Object ] will meet the diagnostic criteria for schizophrenia Icd-@ [ @ ] of @ patients were randomly divided into two groups .\n",
            "[ Method ] , respectively , taking homemade Compound Pueraria oral solution @ weeks of treatment with haloperidol .\n",
            "[ Results ] of Compound Pueraria oral solution group and haloperidol group significant efficiency were @ % , @ % , between the two groups was not statistically significant ( p > @ ) .\n",
            "After extrapyramidal side effects detected between the two groups ( p < @ ) There are very significant differences .\n",
            "[ Conclusion ] made compound Pueraria oral treatment of schizophrenia has better efficacy and toxic side effects , suitable for clinical application .\n",
            "Objectives : Schizophrenia is a chronic debilitating disorder whose pharmacological treatment consists of typical or atypical neuroleptics .\n",
            "Surprisingly , there are many more comparative pharmacological studies in adults than in aged patients although the elderly are more at risk for the development of side-effects .\n",
            "In the present study the authors retrospectively analysed clinical efficacy and side-effects of risperidone treatment compared with typical antipsychotic agents in elderly chronic schizophrenia patients .\n",
            "The duration of treatment was @ months and all patients were inpatients in a psychogeriatric ward .\n",
            "Methods : Fifty-one ( @ male , @ female ) patients aged @-@ years were included in the study .\n",
            "Mean disease duration was longer than @ years .\n",
            "Patients were randomly assigned to either risperidone ( n = @ ) or typical neuroleptic treatment ( n = @ ) , for @ months .\n",
            "Schizophrenia was diagnosed according to DSM-IV criteria .\n",
            "At baseline , @ and @ months patients were scored on the PANSS , CGI and structured side-effects and adverse-events forms .\n",
            "In addition , weight was recorded at the same time points .\n",
            "Results : Baseline PANSS scores did not differ between groups .\n",
            "Positive therapeutic effect reflected by decrease in PANSS scores was observed in both treatment groups .\n",
            "Analysis of inter-group differences revealed a more significant effect on positive symptoms in the risperidone group after @ months ( p < @ ) and after @ months ( p < @ ) .\n",
            "No inter-group differences were observed for the negative symptoms .\n",
            "Significant difference in the PANSS total scores between groups were observed only comparing baseline to @ months of treatment ( p < @ ) .\n",
            "CGI ratings differed significantly between groups , favouring risperidone treatment , after @ months ( but not after @ months ) .\n",
            "Side-effects were recorded in @/@ risperidone treated patients ( sedation , tremor and agitation ) and in @/@ of patients treated with typical neuroleptics ( EPS , sedation and hypotension ) .\n",
            "Body mass index ( BMI ) was calculated and found to be unchanged in both groups .\n",
            "Conclusions : This retrospective study demonstrates in this cohort of elderly , chronic schizophrenic patients that long-term ( @ months ) risperidone treatment had a better effect on positive psychotic symptoms as well as on total PANSS score .\n",
            "Subjects treated with risperidone had less side-effects and a better outcome as evaluated by the CGI .\n",
            "The stable BMI in both groups may be attributed to length of previous neuroleptic treatment in all patients studied .\n",
            "We suggest that risperidone is efficient and better tolerated in chronic elderly schizophrenic patients .\n",
            "Risperidone Elderly Schizophrenia : drug therapy\n",
            "Although social skills training ( SST ) is an effective approach for improving social skills for schizophrenia , the motivational deficit attenuates its efficacy .\n",
            "Virtual reality ( VR ) applications have allowed individuals with mental disabilities to enhance their motivation for rehabilitations .\n",
            "We compared SST using VR role-playing ( SST-VR ) to SST using traditional role-playing ( SST-TR ) .\n",
            "This randomized , controlled trial included @ inpatients with schizophrenia who were assigned to either SST-VR ( n = @ ) or SST-TR ( n = @ ) .\n",
            "Both groups were administered over @ semiweekly group sessions .\n",
            "An experienced , blinded rater assessed vocal , nonverbal and conversational skills .\n",
            "We also obtained data on motivation for SST and various social abilities .\n",
            "Throughout the @ sessions , the SST-VR group ( n = @ ) showed greater interest in SST and generalization of the skills than the SST-TR group ( n = @ ) .\n",
            "After SST , the SST-VR group improved more in conversational skills and assertiveness than the SST-TR group , but less in nonverbal skills .\n",
            "The VR application in role-plays of SST for schizophrenia may be particularly beneficial in terms of improving the conversational skills and assertiveness , possibly through its advantages in enhancing motivation for SST and generalization of the skills , and thus it may be a useful supplement to traditional SST .\n",
            "@ Elsevier Ltd .\n",
            "Objective To investigate family nursing intervention and first onset schizophrenics rehabilitation .\n",
            "Methods One hundred patients with first onset schizophrenics were randomly divided into study group and control group equally .\n",
            "The patients were subjected to one year family nursing intervention .\n",
            "The brief psychiatric rating scale ( BPRS ) and social disability screening schedule ( SDSS ) were used to assess the compliance and relapse rate .\n",
            "Results In the study group , the scores of BPRS\n",
            "BACKGROUND : First-episode psychosis intervention may improve the course and outcome of schizophrenic disorders .\n",
            "AIMS : To describe the Danish National Schizophrenia Project and to measure the outcome of two different forms of intervention after @ year , compared with standard treatment .\n",
            "METHOD : A prospective , prospective , longitudinal , multicentre investigation included @ patients , consecutively referred over a @-year period , with a first episode of psychosis .\n",
            "Patients were allocated to supportive psychodynamic psychotherapy as a supplement to treatment as usual , an integrated , assertive , psychosocial and educational treatment programme or treatment as usual .\n",
            "RESULTS : There was a non-significant tendency towards greater improvement in social functioning in the integrated treatment group and the supportive psychodynamic psychotherapy group compared with the treatment as usual group .\n",
            "Significance was reached for some measures when the confounding effect of drug and alcohol misuse was included .\n",
            "CONCLUSIONS : Integrated treatment and supportive psychodynamic psychotherapy in addition to treatment as usual may improve outcome after @ year of treatment for people with first-episode psychosis , compared with treatment as usual alone .\n",
            "Psychoeducation was originally conceived as a composite of numerous therapeutic elements within a complex family therapy intervention .\n",
            "Patients and their relatives were , by means of preliminary briefing concerning the illness , supposed to develop a fundamental understanding of the therapy and further be convinced to commit to more long-term involvement .\n",
            "Since the mid @s , psychoeducation in German-speaking countries has evolved into an independent therapeutic program with a focus on the didactically skillful communication of key information within the framework of a cognitive-behavioral approach .\n",
            "Through this , patients and their relatives should be empowered to understand and accept the illness and cope with it in a successful manner .\n",
            "Achievement of this basic-level competency is considered to constitute an \" obligatory-exercise \" program upon which additional \" voluntary-exercise \" programs such as individual behavioral therapy , self-assertiveness training , problem-solving training , communication training , and further family therapy interventions can be built .\n",
            "Psychoeducation looks to combine the factor of empowerment of the affected with scientifically founded treatment expertise in as efficient a manner as possible .\n",
            "A randomized multicenter study based in Munich showed that within a @-year period such a program was related to a significant reduction in rehospitalization rates from @ % to @ % and also a shortening of intermittent days spent in hospital from @ to @ days .\n",
            "Psychoeducation , in the form of an obligatory - exercise program , should be made available to all patients suffering from a schizophrenic disorder and their families .\n",
            "Introduction : Young people with first episode psychosis ( FEP ) are prone to high risk outcomes at the time of discharge .\n",
            "Aim : This poster will describe the development of a randomised control trial ( RCT ) testing the feasibility and effects of a peer support intervention in individuals being discharged from a mental health service following a FEP .\n",
            "Method : An @-month RCT with @ month intervention will be piloted with @ participants aged between @ and @ who are facing discharge from a specialised clinic for FEP at Orygen Youth Health .\n",
            "@ participants will receive the intervention plus treatment as usual ( TAU ) while the remaining @ will receive TAU ( control group ) .\n",
            "Intervention : Each participant will be allocated a peer support worker ( PSW ) for @ months .\n",
            "PSWs will offer @ hours of contact per fortnight and will engage the participant and support them in their transition to their new treating service via in-reach and out-of-service contact .\n",
            "PSWs may accompany participants to the new service , assist them with session attendance , understanding local and broader health services , and motivating the participant to develop supports and contacts for the future .\n",
            "Discussion/implications : It is anticipated that this pilot study will provide some indication as to what supports young people require at the time of discharge and whether or not it is realistic to expect other young people to provide this .\n",
            "Objective : After acute treatment of the first illness episode in schizophrenia , antipsychotic maintenance treatment is recommended for at least @ year .\n",
            "Evidence for the optimal subsequent treatment is still scarce .\n",
            "Targeted intermittent treatment was found to be less effective than continuous treatment at preventing relapse in multiple episode patients ; however , a post hoc analysis of our own data from a previous study suggested comparable efficacy of the @ treatment approaches in first-episode patients .\n",
            "The current study was therefore designed to compare prospectively the relapse preventive efficacy of further maintenance treatment and targeted intermittent treatment in patients with ICD-@-diagnosed first-episode schizophrenia .\n",
            "Method : A randomized controlled trial was conducted within the German Research Network on Schizophrenia .\n",
            "Entry screening took place between November @ and May @ .\n",
            "After @ year of antipsychotic maintenance treatment , stable first-episode patients were randomly assigned to @ months of further maintenance treatment or stepwise drug discontinuation and targeted intermittent treatment .\n",
            "In case of prodromal symptoms of an impending relapse , patients in both groups received early drug intervention , guided by a decision algorithm .\n",
            "The primary outcome measure was relapse ( increase in the Positive and Negative Syndrome Scale positive score > @ , Clinical Global Impressions-Change score > = @ , and decrease in Global Assessment of Functioning score > @ between @ visits ) .\n",
            "Results : Of @ first-episode patients , only @ were eligible for the assigned treatment ( maintenance treatment , n = @ ; intermittent treatment , n = @ ) .\n",
            "The rates of relapse ( @ % vs @ % ; P = .@ ) and deterioration ( up to @ % vs @ % ; P < .@ ) were significantly higher in the intermittent treatment group than in the maintenance treatment group , but quality-of-life scores were comparable .\n",
            "Intermittent treatment patients received a significantly lower amount of antipsychotics ( in haloperidol equivalents ; P < .@ ) and tended to show fewer side effects , particularly extrapyramidal side effects .\n",
            "Conclusions : Maintenance treatment is more effective than targeted intermittent treatment in preventing relapse , even in stable first-episode patients after @ year of maintenance treatment , and should be the preferred treatment option .\n",
            "However , about @ % of patients remain stable at a significantly lower drug dose and show fewer side effects , and a substantial proportion refuse maintenance treatment .\n",
            "Alternative long-term treatment strategies , including targeted intermittent treatment , should therefore be provided in individual cases .\n",
            "Trial Registration : clinicaltrials.gov Identifier : NCT@ Copyright @ Physicians Postgraduate Press , Inc .\n",
            "Introduction : Impaired neurocognition , especially social cognition , predicts disability in schizophrenia .\n",
            "Early intervention to target impairment is theoretically attractive as a means to minimise chronic disability .\n",
            "Many trials confirm that Cognitive Remediation ( CR ) produces meaningful , durable improvements in cognition and functioning but few interventions remediate social cognition or focus on the early stages of schizophrenia .\n",
            "Methods : A systematic review and meta-analysis of @ randomised controlled trials ( RCTs ) of CR in first episode psychosis ( FEP ) was completed .\n",
            "A randomised controlled pilot trial was then conducted to investigate a combined CR and social cognition training ( CR+SCT ) intervention in FEP compared to CR alone , assessing cognition , functioning and symptoms at baseline and follow-up .\n",
            "Qualitative feedback was also obtained in a nested feasibility and acceptability study to assess engagement , intervention suitability and attrition .\n",
            "Results : In the systematic review and meta-analysis , random effects models revealed a non-significant effect of CR on global cognition in FEP .\n",
            "However , there was a significant effect on functioning and symptoms , which was larger in trials with adjunctive psychiatric rehabilitation and small group interventions .\n",
            "In the pilot trial , the CR+SCT group had significantly better social functioning scores post-treatment , especially on the interpersonal relationships scale , however there was no significant effect on social cognition .\n",
            "CR+SCT also improved visual learning and set-shifting .\n",
            "There was no specific effect on symptoms .\n",
            "The nested feasibility and acceptability study found CR and CR+SCT to be acceptable and feasible for early intervention in psychosis service users , with high engagement rates and high user-reported satisfaction .\n",
            "Users perceived improvements in neurocognition and reported using strategies learnt during CR in daily life .\n",
            "Conclusions : Meta-analysis suggests that CR is beneficial in FEP .\n",
            "Evidence from the pilot trial shows that a CR intervention enhanced with SCT can improve functioning more than CR alone and that such an intervention is feasible and acceptable .\n",
            "A larger RCT is required to explore the full benefits of a CR+SCT intervention compared to CR and treatment as usual .\n",
            "INTRODUCTION : Evidence about the anti-inflammatory properties of antipsychotics has grown .\n",
            "However , no previous studies have compared the immunomodulatory effect of risperidone and aripiprazole .\n",
            "OBJECTIVES : The main aim of the present work is to compare the anti-inflammatory effect of risperidone and aripiprazole on a large array of serum cytokines at @ months following the onset of treatment .\n",
            "METHODS : This is a prospective , randomized , open-label study .\n",
            "Patients were randomly assigned to risperidone or aripiprazole .\n",
            "From this randomization , @ patients and @ healthy volunteers that matched with the selected patients were picked for entry in this study .\n",
            "Serum concentrations of @ cytokines/chemokines were measured at baseline and @ months following the initiation of antipsychotic medication .\n",
            "RESULTS : Those patients who were randomly assigned to risperidone had higher levels of IL-@ ( p = @ ) and MIP-@beta ( p = @ ) than healthy volunteers at baseline , whereas no differences were found between patients initially assigned to aripiprazole and healthy volunteers .\n",
            "Three months following the onset of medication several cytokines decreased significantly : IL-@ , MIP-@beta , Fractalkine , TNF-alpha , IL-@ , IL-@ , IL-@alpha , IL-@ , IL-@ ( all ps < @ ) .\n",
            "No differences were found in the percentages of change between both treatments .\n",
            "The effect size of the two antipsychotics was similar , except for TNF-alpha , IL-@ , IL-@alpha and Fractalkine , in which aripiprazole seems to have a greater effect size than risperidone , whereas risperidone seems to have a greater effect size than aripiprazole on MIP-@beta .\n",
            "CONCLUSIONS : This is the first study that has compared the immunomodulatory effect of risperidone and aripiprazole , finding that the anti-inflammatory effect of both treatments was similar .\n",
            "Background : We assessed efficacy and tolerability of an investigational , injectable antipsychotic , paliperidone palmitate ( PP ) , in preventing symptom recurrence in adults with schizophrenia .\n",
            "Methods : Eligible patients ( PANSS total scores < @ ) were transitioned to gluteal injections of PP during a @-week ( wk ) open-label flexible-dose phase .\n",
            "The first @ injections of @ mg eq .\n",
            "were given @ wk apart .\n",
            "Subsequent injections , which could be adjusted ( @ , @ , or @ mg eq . )\n",
            ", occurred every @ weeks .\n",
            "Patients with total PANSS < @ at wk @ continued into the @-wk maintenance phase .\n",
            "Patients clinically stable on a fixed dose for the last @ wks were randomized @:@ to continue on their PP dose or start placebo in the double-blind phase of variable duration .\n",
            "Results : The preplanned interim analysis at @ recurrence events included @ patients : mean age = @ yrs , @ % men , @ % white , baseline PANSS ( SD ) : placebo , @ ( @ ) ; PP , @ ( @ ) .\n",
            "Time-to-first-recurrence ( primary measure ) favored PP ( p < @ , log-rank test ) : median time-to-first-recurrence was @ days for placebo and not estimable for PP .\n",
            "Based on the significant efficacy results , the study was stopped early .\n",
            "Treatment-emergent AE rates during double-blind phase ( final analysis : N = @ ) were : @ % PP , @ % placebo .\n",
            "Weight increase and gastroenteritis ( viral ) occurred more frequently with PP ( difference  @ % vs. placebo ) .\n",
            "Local injection-site tolerability was good .\n",
            "For PP treated patients ( n = @ ) , the investigators reported injection-site pain as usually absent ( @ % ) or mild ( @ % ) at double-blind endpoint , similar to placebo-treatment .\n",
            "Conclusions : Paliperidone palmitate treatment significantly delayed time-tofirst recurrence and was generally well-tolerated , locally and systemically , in patients with schizophrenia .\n",
            "Supported by Johnson & Johnson Pharmaceutical Research & Development\n",
            "' Seroquel ' ( quetiapine , ICI @ ) a dibenzothiazepine with affinity for multiple brain receptors , is a new antipsychotic agent intended for the treatment of schizophrenia .\n",
            "Phase II clinical trials in patients with acute exacerbation of schizophrenia showed that quetiapine was effective in treating positive and negative symptoms and was well tolerated .\n",
            "Quetiapine showed a lack of induction of extrapyramidal symptoms ( EPS ) and the lack of sustained elevations in plasma prolactin levels .\n",
            "In two multi centre , placebo-controlled trials , the incidence of EPS was no greater than the placebo , and no acute dystonic reactions were noted .\n",
            "Similarly , plasma prolactin levels were no greater with quetiapine than with placebo .\n",
            "A six-week , multi centre , randomised , double-blind placebo-controlled trial evaluated the efficacy , safety , and optimal dose range of quetiapine in patients with acute exacerbation of schizophrenia ( DSM-III-R ) .\n",
            "Overall , @ patients in the US and Canada received one of five fixed doses of quetiapine ( @ , @ , @ , @ , or @ mg daily ) , haloperidol ( @ mg daily ) or placebo .\n",
            "Patients were assessed weekly using the BPRS , CGI and SANS for efficacy and the Simpson Scale for EPS .\n",
            "At one point , significant differences ( p < @ , ANCOVA ) in mean changes from baseline were identified between quetiapine or haloperidol and placebo for BPRS total score , BPRS positive symptom cluster , and the CGI Severity of Illness scores ( quetiapine @-@ mg/day ) , and the SANS summary score ( quetiapine @ mg/day ) .\n",
            "Overall , quetiapine showed a maximal clinical effect at @ mg/day and was well tolerated .\n",
            "There was no difference between quetiapine , at any dose across the dose range , and placebo with regard to EPS as assessed by the Simpson Scale , use of concomitant anticholinergic medications , and motor system adverse events .\n",
            "No acute dystonic reactions were noted .\n",
            "Additionally , there were no differences between quetiapine , at any dose across the dose range , and placebo with regard to plasma prolactin levels .\n",
            "These results provide further evidence that quetiapine is effective in the treatment of the positive and negative symptoms of schizophrenia at doses of @-@ mg/day and is well tolerated .\n",
            "The authors compared penfluridol , a long-acting neuroleptic that can be administered orally once a week , with chlorpromazine in the treatment of @ newly admitted schizophrenic patients in a brief therapy unit .\n",
            "Patients receiving either drug improved enough to be discharged in @ weeks .\n",
            "Penfluridol-treated patients experienced less drowsiness than those treated with chlorpromazine , but the severity of extrapyramidal symptoms appeared to be greater with penfluridol .\n",
            "Social cognition has received increased attention in schizophrenia research because it is associated with functional outcomes .\n",
            "Psychosocial interventions are being developed to enhance social cognition , however less attention has been paid to the association between antipsychotic medication use and social cognition .\n",
            "This study evaluated whether individuals treated with olanzapine ( n = @ ) or quetiapine ( n = @ ) achieved improvements in social cognition .\n",
            "Participants were drawn from a larger @-month , multi-site , randomized , double-blind clinical trial .\n",
            "Social cognition was assessed using signal detection analysis of performance on the Social Cue Recognition Test .\n",
            "Social functioning was measured with an interpersonal functioning index and a broader quality of life measure .\n",
            "Results revealed that participants in both medication groups improved significantly but modestly on three out of four social cognition subscales .\n",
            "The small observed effect in this trial is generally consistent with previous studies , and supports the need for ongoing research into the biological mechanisms of social cognitive dysfunction in schizophrenia .\n",
            "Objective To explore the effects on serum prolactin ( PRL ) of seroquel and rrisperidong in the treatmemt of female schizophrenic patients and the relationship between the level of serum PRL and drug s effect .\n",
            "Methods @ female schizophrenic patientswere treated with seroquel or risperidone randomly .\n",
            "The levels of serum PRL were measured and the scores of PANSS were evaluated before treatment and at the @ th week respectively .\n",
            "Results There were no significant differences in PANSS basal scores and the decreased score value after the treatment in two groups .\n",
            "The level of serum PRL in risperidone group increased markedly than seroquel group .\n",
            "Both drug s effect are not related with serum PRL .\n",
            "Conclusion Seroquel has less effect on the level of serum PRL in female schizophrenic patients .\n",
            "So seroquel ismore suitable for the treatment of female schizophrenic patients\n",
            "Recruitment : Recruiting .\n",
            "Study Results : No Results Available .\n",
            "Conditions : Schizophrenia .\n",
            "Interventions : Drug : CYR-@ | Drug : Placebo .\n",
            "Age Groups : Adult .\n",
            "Enrollment : @ .\n",
            "Study Types : Interventional .\n",
            " Safety/Efficacy Study .\n",
            "Start Date : March @ .\n",
            "Completion Date :\n",
            "\" Objective : Neurocognitive impairments in schizophrenia are common and clinically relevant .\n",
            "The majority of people diagnosed with schizophrenia will experience a significant decline in global , social and occupational function levels in the course of their illness .\n",
            "This disability is largely driven by cognitive impairment .\n",
            "Amongst the different cognitive domains , memory impairments in particular are regarded as possible intermediate phenotypes of schizophrenia .\n",
            "Whether haloperidol and risperidone two neuroleptic drugs with differential receptor binding profiles show distinct impacts on functional networks mediating working memory is subject of the current study .\n",
            "Methods : @ first episode schizophrenia patients ( DSM IV ) were recruited as part of the German Research Network of schizophrenia .\n",
            "Patients received either risperidone ( N = @ , mean daily dose : @ +@ ) or haloperidol ( N = @ , mean daily dose : @ +@ ) in a double blind treatment regime .\n",
            "The task during fMRI data acquisition ( @ Tesla scanner ) consisted of an n-back paradigm with a randomized sequence of @-back and @-back conditions arranged in a block design .\n",
            "The data was analysed using a flexible factorial design ( SPM@ ) including medication dose ( in mg ) and gender as a covariate .\n",
            "Results : Functional analysis revealed greater activations in the risperidone group in a network comprising of superior parietal , orbitofrontal , middle frontal , thalamic , temporal and occipital areas ; p < @ at voxel level , Monte-Carlo-corrected p < @ , > @ continuous voxels .\n",
            "Conclusion : Risperidone treated patients showed stronger activations in a cortical network that has previously been associated with this kind of working memory task than patients treated with a comparably moderate dose of haloperidol .\n",
            "As the results were controlled for dose , and neither side effects nor co-treatment differed between the groups the results are not likely to be affected by these confounding factors , but rather reflect the drugs different receptor binding profile .\n",
            "Risperidone binds much stronger to @-HT@A and less strong to D@-and D@-receptors , which might be responsible for the differences in BOLD between the two medication groups . \"\n",
            "AIM : To compare the therapeutic effects of cyproheptadine ( Cyp ) and propranolol ( Pro ) in treating neuroleptic _ induced akathisia .\n",
            "METHODS : Cyproheptadine group of @ patients received Cyp @ mg , po , tid , for @ d , propranolol group of @ patients received Pro @ mg , po , tid , for @ d. RESULTS : Total response rate of Cyp group was @ % , that of Pro group was @ % ( P > @ .\n",
            "@ ) .\n",
            "CONCLUSION : The therapeutic effects of Cyp and Pro in treating neuroleptic _ induced akathisia were similar .\n",
            "?\n",
            "Background : The child psychiatric hospital at Mexico City developed a clinical guideline for schizophrenia , it was evaluated according to WHO recommendations , but its efficacy must be determined .\n",
            "The objectives were to compare the treatment compliance , severity of illness and social functioning of adolescents treated according to guideline ( GT ) vs patients on usual treatment ( UT ) on a @ month follow up .\n",
            "Methods : Adolescents with a DSM-IV diagnoses of schizophrenia or schizophreniform disorder were randomized to UT or GT group .\n",
            "GT drug treatment followed an algorithm where an atypical antipsychotic should be maintained during @ weeks before the evaluation of medication change .\n",
            "GT psychosocial treatment included a ) psychoeducation ( three @ min sessions with the family and two @ min sessions with the patients ) , b ) Social skills training ( seven @ min sessions focused on verbal and non-verbal communication , as well as in conversation skills , c ) Training on healthy life style ( nine @ min sessions followed by @ min of exercise ) .\n",
            "Assessments were made each @ weeks until the third month .\n",
            "The last was done by a clinician who was blind to the patients group .\n",
            "Efficacy was evaluated with PAN SS and CGI-SCH and psychosocial functioning with PSP .\n",
            "Results : @ patients with a mean age of @ + / - @ y.o. , @ % male , have been included .\n",
            "Seven ( @ % ) were randomized to the GT group ; there were no differences on baseline severity or diagnostic distribution .\n",
            "Patients on both groups received an atypical antipsychotic on similar doses ; only @ patient ( @ % ) on the UT group received psychosocial treatment .\n",
            "Follow up visits were completed by @ % of patients on the GT and by @ % of patients on the UT .\n",
            "The third month assessment is shown in table @ .\n",
            "Conclusion : These results suggest that GT group had a better compliance and less negative symptoms on a three month follow-up .\n",
            "( Table presented ) .\n",
            "Background : Schizophrenia is a complex and chronic disorder , and many patients do not achieve complete recovery .\n",
            "Remission , or the alleviation of symptoms to levels that do not signifcantly interfere with behavior , is therefore an important goal of schizophrenia treatment .\n",
            "The dopamine D@/D@ receptor partial agonist antipsychotic cariprazine is FDA approved in the United States for the treatment of adults with acute schizophrenia and mixed and manic episodes of bipolar disorder .\n",
            "These post hoc analyses investigated the effcacy of cariprazine in maintaining remission in stable patients with schizophrenia .\n",
            "Methods : Analyses were based on data from a long-term , randomized , double-blind , fxed-dose , placebo-controlled relapse prevention study of cariprazine in patients with schizophrenia ( NCT@ ) .\n",
            "Patients were frst stabilized with cariprazine during a @-week , open-label phase , and then randomized @:@ to fxed-dose cariprazine ( @ , @ , or @ mg/d ) or placebo for up to @ weeks of double-blind treatment .\n",
            "In these post hoc analyses , the defnition of symptomatic remission was based on the Remission in Schizophrenia Working Group criteria : scores < = @ on the Positive and Negative Syndrome Scale items mannerisms and posturing ( G@ ) , unusual thought content ( G@ ) , blunted affect ( N@ ) , social withdrawal ( N@ ) , lack of spontaneity ( N@ ) , delusions ( P@ ) , conceptual disorganization ( P@ ) , and hallucinatory behavior ( P@ ) .\n",
            "Sustained remission was defned as meeting remission criteria at the visit in question and all previous double-blind visits .\n",
            "Time to loss of sustained remission was estimated using Kaplan-Meier analysis ; P value was based on the log-rank test .\n",
            "The hazard ratio estimate was based on the Cox proportional hazards regression model .\n",
            "Results : Of the @ patients randomized to double-blind treatment , approximately @ % met symptomatic remission criteria at randomization .\n",
            "During double-blind treatment , @ % of cariprazine-treated patients and @ % of placebo-treated patients had sustained remission through their fnal visit ( number needed to treat = @ ) .\n",
            "Time to loss of sustained remission was signifcantly longer with cariprazine than with placebo ( P = .@ ; hazard ratio [ @ % confdence interval ] : @ [ @-@ ] ) .\n",
            "For cariprazine-and placebo-treated patients , the mean duration of sustained remission during double-blind treatment was @ + / - @ and @ + / - @ days , respectively ; the median duration of sustained remission was @ days and @ days , respectively .\n",
            "Conclusion : Cariprazine treatment was associated with signifcantly higher rates of sustained remission and longer duration of sustained remission compared to placebo , suggesting that cariprazine was effective in maintaining stable , long-term remission in patients with schizophrenia .\n",
            "Background : Employment is an important aspect of psychiatric rehabilitation .\n",
            "The objective of this analysis was to explore how quality of life ( QoL ) may affect the outcome of supported employment and vice versa .\n",
            "Methods : A total of @ participants with severe mental disorders were randomly assigned to either @ , @ , or @ h placement budgets , which comprises job coaches ' time resources to support a client in finding a job .\n",
            "The intervention followed the individual placement and support model and lasted up to @ months .\n",
            "Primary outcome was employment in the first labor market for at least @ months .\n",
            "QoL was assessed @ times over the entire @-months observation period using the WHO QoL Bref , which comprises the dimensions physical health , psychological , social relationships , and environment .\n",
            "Results : The three placement budgets did not differentially relate to QoL , but QoL environment showed a significant increase over time across all three groups .\n",
            "Baseline QoL environment weakly predicted subsequent obtainment of employment ( F = @ , df = @ , p = @ , Cohen 's d = @ ) .\n",
            "Controlling for baseline QoL , those participants who obtained a job , as compared to those who did not , showed persistent increases in QoL physical health ( b = @ , p = @ , Cohen 's d = @ ) and QoL psychological ( b = @ , p < @ , Cohen 's d = @ ) .\n",
            "Conclusion : Obtaining employment in the first labor market improves patients ' QoL .\n",
            "Supported employment is a valuable intervention that may benefit patients with severe mental disorder .\n",
            "Beginning Predictions!\n",
            "Prediction took time  0:00:00.055826\n",
            "in model fn\n",
            "<class 'NoneType'>\n",
            "/content/drive/My Drive/scibert_scivocab_uncased/bert_model.ckpt\n",
            "mode: infer probabilities: Tensor(\"loss/Sigmoid:0\", shape=(?, 7), dtype=float32)\n"
          ],
          "name": "stdout"
        },
        {
          "output_type": "stream",
          "text": [
            "/usr/local/lib/python3.6/dist-packages/ipykernel_launcher.py:66: FutureWarning: The signature of `Series.to_csv` was aligned to that of `DataFrame.to_csv`, and argument 'header' will change its default value from False to True: please pass an explicit value to suppress this warning.\n"
          ],
          "name": "stderr"
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/html": [
              "<div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>id</th>\n",
              "      <th>comment_text</th>\n",
              "      <th>P</th>\n",
              "      <th>I</th>\n",
              "      <th>O</th>\n",
              "      <th>A</th>\n",
              "      <th>M</th>\n",
              "      <th>R</th>\n",
              "      <th>C</th>\n",
              "      <th>P</th>\n",
              "      <th>I</th>\n",
              "      <th>O</th>\n",
              "      <th>A</th>\n",
              "      <th>M</th>\n",
              "      <th>R</th>\n",
              "      <th>C</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>###1179:0</td>\n",
              "      <td>Subjects were @ schizophrenic patients .</td>\n",
              "      <td>1</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0.955339</td>\n",
              "      <td>0.007371</td>\n",
              "      <td>0.003245</td>\n",
              "      <td>0.002584</td>\n",
              "      <td>0.008536</td>\n",
              "      <td>0.021955</td>\n",
              "      <td>0.003171</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>###1179:1</td>\n",
              "      <td>Matched in pairs , one of each pair was random...</td>\n",
              "      <td>0</td>\n",
              "      <td>1</td>\n",
              "      <td>1</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0.204080</td>\n",
              "      <td>0.352545</td>\n",
              "      <td>0.014428</td>\n",
              "      <td>0.001098</td>\n",
              "      <td>0.304461</td>\n",
              "      <td>0.017020</td>\n",
              "      <td>0.001171</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>###1179:2</td>\n",
              "      <td>@ experimental months .</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0.010303</td>\n",
              "      <td>0.189702</td>\n",
              "      <td>0.056595</td>\n",
              "      <td>0.001379</td>\n",
              "      <td>0.759739</td>\n",
              "      <td>0.007478</td>\n",
              "      <td>0.001673</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>###1179:3</td>\n",
              "      <td>Rehabilitation patients kept occupied usefully...</td>\n",
              "      <td>0</td>\n",
              "      <td>1</td>\n",
              "      <td>1</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0.012613</td>\n",
              "      <td>0.872743</td>\n",
              "      <td>0.007549</td>\n",
              "      <td>0.001915</td>\n",
              "      <td>0.011983</td>\n",
              "      <td>0.068000</td>\n",
              "      <td>0.010686</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>###1179:4</td>\n",
              "      <td>Although a strong trend for the rehabilitation...</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>1</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0.002297</td>\n",
              "      <td>0.001196</td>\n",
              "      <td>0.002950</td>\n",
              "      <td>0.005342</td>\n",
              "      <td>0.002027</td>\n",
              "      <td>0.114465</td>\n",
              "      <td>0.864080</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>"
            ],
            "text/plain": [
              "          id  ...         C\n",
              "0  ###1179:0  ...  0.003171\n",
              "1  ###1179:1  ...  0.001171\n",
              "2  ###1179:2  ...  0.001673\n",
              "3  ###1179:3  ...  0.010686\n",
              "4  ###1179:4  ...  0.864080\n",
              "\n",
              "[5 rows x 16 columns]"
            ]
          },
          "metadata": {
            "tags": []
          },
          "execution_count": 106
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "BUMEKQLAFbPr",
        "colab_type": "code",
        "outputId": "c34d1c14-34f3-4615-f0d3-05c22abc2151",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 35
        }
      },
      "source": [
        "from google.colab import drive\n",
        "drive.mount('/content/drive')"
      ],
      "execution_count": 107,
      "outputs": [
        {
          "output_type": "stream",
          "text": [
            "Drive already mounted at /content/drive; to attempt to forcibly remount, call drive.mount(\"/content/drive\", force_remount=True).\n"
          ],
          "name": "stdout"
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "mH5KNRt3LYXi",
        "colab_type": "code",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 126
        },
        "outputId": "92f30cce-706a-4a56-aabc-a25155da8cad"
      },
      "source": [
        "output_df.to_csv(os.path.join(OUTPUT_DIR, 'predCSZG.csv'))\n",
        "#output_df.to_pickle(os.path.join(OUTPUT_DIR, 'predictions.df'))#save predictions\n",
        "print(output_df.head())"
      ],
      "execution_count": 108,
      "outputs": [
        {
          "output_type": "stream",
          "text": [
            "          P         I         O         A         M         R         C\n",
            "0  0.955339  0.007371  0.003245  0.002584  0.008536  0.021955  0.003171\n",
            "1  0.204080  0.352545  0.014428  0.001098  0.304461  0.017020  0.001171\n",
            "2  0.010303  0.189702  0.056595  0.001379  0.759739  0.007478  0.001673\n",
            "3  0.012613  0.872743  0.007549  0.001915  0.011983  0.068000  0.010686\n",
            "4  0.002297  0.001196  0.002950  0.005342  0.002027  0.114465  0.864080\n"
          ],
          "name": "stdout"
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "H-u3nrVmwqzz",
        "colab_type": "code",
        "colab": {}
      },
      "source": [
        ""
      ],
      "execution_count": 0,
      "outputs": []
    }
  ]
}